data_1mfn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1mfn _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.6 mt . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.482 ' HB2' ' CB ' ' A' ' 25' ' ' PRO . 1.0 OUTLIER -99.84 162.34 13.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.886 . . . . 0.0 109.084 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.452 ' HA ' ' HG2' ' A' ' 82' ' ' PRO . 79.6 p -95.15 136.62 22.54 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.109 -0.995 . . . . 0.0 109.762 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.478 ' O ' ' HB2' ' A' ' 84' ' ' LEU . 35.9 Cg_endo -79.27 119.07 4.1 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.602 2.201 . . . . 0.0 110.067 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.473 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -141.43 -163.21 1.52 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.021 -1.049 . . . . 0.0 109.746 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 60.29 22.46 58.54 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.573 ' C ' ' CD1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -82.28 168.05 17.99 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.863 -0.786 . . . . 0.0 109.538 -179.17 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.517 ' O ' ' CG1' ' A' ' 20' ' ' VAL . 3.6 t70 -165.28 -163.93 0.72 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.9 t -142.91 149.16 38.09 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.151 -0.968 . . . . 0.0 109.643 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.475 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 40.4 p -176.24 -163.52 0.1 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 109.286 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.525 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.6 OUTLIER 45.8 37.11 3.2 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -178.622 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.634 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.8 mt -85.5 165.03 2.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.65 -177.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.534 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 0.7 OUTLIER -154.41 -165.21 2.02 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.512 ' CB ' ' HB3' ' A' ' 64' ' ' PRO . . . -86.62 -44.96 11.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.022 -1.049 . . . . 0.0 109.875 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -110.32 11.15 23.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.91 -1.119 . . . . 0.0 109.486 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.488 ' O ' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -160.9 150.11 16.85 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.767 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.634 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 2.1 p90 -165.51 143.35 5.91 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.009 -1.057 . . . . 0.0 108.855 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 61.6 m -107.95 163.85 12.78 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.823 -1.173 . . . . 0.0 111.099 -178.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.569 HG13 ' CE2' ' A' ' 8' ' ' PHE . 0.9 OUTLIER -132.09 170.88 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.475 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 18.1 m-70 -142.07 158.44 43.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.994 -1.066 . . . . 0.0 110.195 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.542 ' CB ' ' HB2' ' A' ' 8' ' ' PHE . 23.9 p90 -170.84 135.19 1.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.43 -0.794 . . . . 0.0 109.24 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.37 166.53 2.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.135 -0.978 . . . . 0.0 109.363 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.48 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -98.03 174.07 3.46 Favored Pre-proline 0 C--N 1.298 -1.639 0 O-C-N 121.666 -0.646 . . . . 0.0 109.772 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.482 ' CB ' ' HB2' ' A' ' 3' ' ' ASP . 35.6 Cg_endo -78.64 177.35 8.84 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.682 2.255 . . . . 0.0 110.457 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -86.73 9.13 19.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -0.932 . . . . 0.0 109.388 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.41 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . . . -126.07 168.06 15.18 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.496 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 27' ' ' ALA . 35.4 Cg_endo -78.12 133.04 11.94 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.695 2.264 . . . . 0.0 110.444 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.557 HD12 ' CE1' ' A' ' 32' ' ' TYR . 27.2 pt -118.18 -172.79 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.435 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.4 p -123.12 -10.24 8.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 109.555 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.501 ' O ' ' CG2' ' A' ' 75' ' ' VAL . . . 157.38 151.21 5.94 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 74' ' ' ALA . 2.4 m-30 -114.07 139.09 49.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -1.133 . . . . 0.0 109.612 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.522 ' CG2' ' HD2' ' A' ' 49' ' ' ARG . 1.7 mp -93.01 128.97 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.233 -0.917 . . . . 0.0 109.087 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.522 ' CD1' HG21 ' A' ' 50' ' ' VAL . 1.8 mm -115.86 109.25 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.214 -0.929 . . . . 0.0 109.76 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.475 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -109.86 137.11 48.11 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.13 -0.981 . . . . 0.0 109.012 179.36 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.566 ' CD2' HD21 ' A' ' 59' ' ' LEU . 5.4 p-80 -129.84 146.74 51.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.109 -0.994 . . . . 0.0 110.076 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.547 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 28.6 p-80 -168.24 133.34 1.76 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.339 -0.851 . . . . 0.0 109.87 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.542 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . . . -66.08 137.54 57.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 109.243 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.423 ' HB3' HG22 ' A' ' 69' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.195 -0.941 . . . . 0.0 109.759 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.465 ' HB2' ' NE2' ' A' ' 36' ' ' HIS . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -123.14 117.16 24.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 109.958 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.479 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 1.3 m-20 -120.04 107.68 13.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.413 -0.804 . . . . 0.0 108.893 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.522 ' HD2' ' CG2' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -91.28 142.28 27.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.07 -1.019 . . . . 0.0 109.8 -179.504 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.538 HG23 ' CH2' ' A' ' 22' ' ' TRP . 5.8 m -119.3 161.97 34.35 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.44 -0.787 . . . . 0.0 109.107 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.516 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.5 Cg_endo -76.88 173.93 13.67 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.501 2.134 . . . . 0.0 110.293 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 35.4 Cg_endo -77.35 -15.32 15.93 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.648 2.232 . . . . 0.0 110.545 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.3 29.27 4.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.576 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.516 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 12.0 mmt85 -138.96 119.85 14.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 109.562 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.541 ' O ' ' CE3' ' A' ' 22' ' ' TRP . 10.2 p-10 -99.24 -3.66 33.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 109.468 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 74.8 p -135.14 158.59 43.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.175 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.467 HD12 ' HB3' ' A' ' 48' ' ' ASP . 3.5 tt -142.29 124.4 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.155 -0.966 . . . . 0.0 109.607 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.484 ' CG2' ' OG1' ' A' ' 19' ' ' THR . 0.3 OUTLIER -82.53 117.1 22.28 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.31 -0.868 . . . . 0.0 109.414 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.566 HD21 ' CD2' ' A' ' 36' ' ' HIS . 1.2 mt -95.93 143.37 27.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.893 . . . . 0.0 109.562 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.461 ' CG2' ' HB3' ' A' ' 17' ' ' SER . 39.2 p -134.61 -177.4 4.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 109.35 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.439 ' O ' HD22 ' A' ' 62' ' ' LEU . 4.4 m-80 53.03 56.37 7.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.385 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.46 HD12 ' HB3' ' A' ' 59' ' ' LEU . 6.0 mt -134.13 134.65 42.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.495 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.469 ' CB ' ' OH ' ' A' ' 68' ' ' TYR . 3.2 t30 -51.17 130.05 31.41 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 109.081 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.512 ' HB3' ' CB ' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -78.52 134.0 12.13 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.355 2.037 . . . . 0.0 110.712 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 82.83 60.95 1.99 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.4 m -163.73 154.26 15.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.323 -1.104 . . . . 0.0 109.924 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -88.92 127.1 35.64 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.542 ' CE1' ' HB3' ' A' ' 38' ' ' ALA . 23.5 m-85 -118.27 124.02 46.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.011 -1.055 . . . . 0.0 109.879 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.547 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 22.7 t -83.65 122.28 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 108.976 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 24.6 t -110.88 122.56 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -0.985 . . . . 0.0 109.55 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.514 ' HB2' ' CD1' ' A' ' 85' ' ' ILE . 82.3 p -103.54 117.13 33.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.192 -0.943 . . . . 0.0 109.903 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.517 ' O ' ' N ' ' A' ' 84' ' ' LEU . 11.2 mm -94.08 120.16 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.324 -0.86 . . . . 0.0 109.648 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.568 ' N ' ' CD1' ' A' ' 73' ' ' ILE . 1.4 mp -112.11 132.74 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.165 -0.959 . . . . 0.0 109.124 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . . . -95.94 154.48 17.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.557 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.501 ' CG2' ' O ' ' A' ' 31' ' ' GLY . 11.7 m -154.97 130.28 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 109.449 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -103.03 45.56 0.95 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.36 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.68 -85.21 0.99 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -111.64 -1.14 15.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -1.141 . . . . 0.0 109.404 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -97.09 -166.26 1.37 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 0.0 109.311 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -146.36 -167.07 2.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.14 -0.975 . . . . 0.0 109.854 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.569 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -172.44 -178.87 0.46 Allowed Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.569 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.1 Cg_endo -76.6 134.2 14.99 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.021 1.814 . . . . 0.0 109.69 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 35.2 Cg_endo -77.1 108.83 2.71 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.437 2.091 . . . . 0.0 111.129 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.521 ' CD2' ' HB3' ' A' ' 8' ' ' PHE . 9.7 tp -77.4 80.94 3.89 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.296 -0.878 . . . . 0.0 108.638 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.514 ' CD1' ' HB2' ' A' ' 71' ' ' SER . 4.2 mt -86.06 151.47 3.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.184 -0.947 . . . . 0.0 110.216 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.484 ' N ' HG21 ' A' ' 85' ' ' ILE . . . -145.42 -169.13 13.47 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.424 ' HG3' ' C ' ' A' ' 86' ' ' GLY . 30.8 mt-30 -150.73 126.89 10.55 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.168 -1.195 . . . . 0.0 109.676 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.521 ' OE1' ' N ' ' A' ' 88' ' ' GLN . 9.6 pm0 -129.3 -155.31 0.69 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.317 -0.864 . . . . 0.0 108.752 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -159.73 136.13 8.99 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.037 -1.04 . . . . 0.0 110.002 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.93 137.16 41.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.401 -0.812 . . . . 0.0 108.997 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.526 ' O ' ' N ' ' A' ' 65' ' ' GLY . 3.1 t . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.407 0.622 . . . . 0.0 110.092 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.459 ' HB2' ' HB2' ' A' ' 112' ' ' TRP . 36.3 Cg_endo . . . . . 0 C--O 1.215 -0.636 0 N-CA-C 109.656 -0.94 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.504 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -169.9 158.54 7.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.091 -1.006 . . . . 0.0 109.604 179.591 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 4.5 t0 78.13 26.83 0.57 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.435 -0.791 . . . . 0.0 109.715 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.501 ' CD1' HD22 ' A' ' 162' ' ' LEU . 1.7 tt -60.3 99.4 0.08 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.13 -0.981 . . . . 0.0 109.057 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -138.05 165.38 26.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.616 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 13.3 p -96.31 147.24 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.762 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.51 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 14.1 pt -127.99 -4.32 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 0.0 109.704 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.531 ' CB ' ' HB2' ' A' ' 109' ' ' LEU . . . -153.03 105.28 2.9 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.517 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 10.0 m -100.79 91.08 4.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -0.933 . . . . 0.0 110.588 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.483 ' OG1' ' OG ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -83.35 163.28 50.81 Favored Pre-proline 0 C--N 1.306 -1.306 0 O-C-N 121.126 -0.983 . . . . 0.0 108.671 178.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -69.2 -2.12 9.21 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.296 1.997 . . . . 0.0 110.795 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.52 ' HA ' HG21 ' A' ' 152' ' ' ILE . 23.2 p -147.56 12.58 1.03 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 109.497 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.529 ' CB ' ' HA ' ' A' ' 150' ' ' ASN . 3.2 p -169.84 164.69 9.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.809 -1.182 . . . . 0.0 110.198 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.584 HD23 ' CE2' ' A' ' 182' ' ' TYR . 0.6 OUTLIER -139.13 155.4 47.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.306 -0.871 . . . . 0.0 109.131 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.531 ' HB2' ' CB ' ' A' ' 102' ' ' ALA . 1.3 mt -105.41 116.23 31.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.295 -0.878 . . . . 0.0 109.329 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 146' ' ' THR . 1.6 pt -99.01 143.55 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 109.494 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.512 ' CB ' HG23 ' A' ' 146' ' ' THR . 41.3 p -140.24 131.2 26.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.352 -0.843 . . . . 0.0 109.58 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.564 ' CD2' ' O ' ' A' ' 145' ' ' SER . 47.0 p90 -135.85 151.69 50.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.358 -0.839 . . . . 0.0 109.35 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.465 ' HG3' ' HG3' ' A' ' 96' ' ' ARG . 14.2 mt-10 . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.485 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.507 ' HB2' ' O ' ' A' ' 140' ' ' VAL . 1.5 p90 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 121.214 0.53 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 1.4 m-85 -125.96 140.4 52.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.251 -0.906 . . . . 0.0 109.013 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.576 ' CG ' ' HB2' ' A' ' 163' ' ' TYR . 0.1 OUTLIER -113.12 98.95 7.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.655 -1.278 . . . . 0.0 108.214 178.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.599 ' HB ' ' CZ ' ' A' ' 138' ' ' PHE . 20.8 mt -92.25 156.73 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.354 -0.841 . . . . 0.0 110.629 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 82.1 p -116.01 135.84 53.59 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.76 -0.588 . . . . 0.0 109.594 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.642 ' CE2' ' CG2' ' A' ' 149' ' ' ILE . 14.1 m-85 -74.17 143.62 45.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 109.368 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.581 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.86 94.02 0.94 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.224 -1.163 . . . . 0.0 109.427 179.634 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.483 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 1.9 tt0 . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 8.2 pt-20 -84.38 126.9 33.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 110.372 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.599 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 11.7 p90 -131.27 136.73 48.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.345 -0.847 . . . . 0.0 108.834 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.7 p -74.78 157.55 35.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.235 -0.916 . . . . 0.0 110.755 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 39.7 t -121.5 127.14 26.22 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 143' ' ' SER . 36.3 Cg_endo -79.01 42.11 1.22 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.282 1.988 . . . . 0.0 111.352 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 141' ' ' PRO . . . 35.49 31.86 0.03 OUTLIER Glycine 0 N--CA 1.498 2.804 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.9 OUTLIER -50.43 -41.22 52.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -1.102 . . . . 0.0 109.835 -179.354 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.455 ' HD2' ' OG1' ' A' ' 146' ' ' THR . 0.4 OUTLIER 179.43 -168.69 0.1 Allowed 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.609 -0.682 . . . . 0.0 109.628 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.564 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -71.98 -4.54 29.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.499 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.512 HG23 ' CB ' ' A' ' 111' ' ' SER . 75.7 p -124.37 133.09 53.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.178 -0.951 . . . . 0.0 109.396 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 110' ' ' ILE . . . -117.54 169.87 9.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.608 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.42 ' C ' HG12 ' A' ' 149' ' ' ILE . 12.2 t -99.24 164.47 12.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.382 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.642 ' CG2' ' CE2' ' A' ' 126' ' ' TYR . 17.7 mm -143.59 65.86 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.448 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.579 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 0.8 OUTLIER -78.7 -152.23 0.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.479 -0.763 . . . . 0.0 109.792 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.4 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 24.0 t-20 47.1 26.43 0.64 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 109.418 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.52 HG21 ' HA ' ' A' ' 106' ' ' THR . 3.3 tt -92.19 160.74 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.304 -0.873 . . . . 0.0 109.637 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.58 127.65 25.72 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.189 -0.945 . . . . 0.0 109.268 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.435 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 36.1 Cg_endo -78.59 155.87 27.96 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.467 2.111 . . . . 0.0 110.593 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.504 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . 81.76 64.89 1.7 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 162.3 132.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.287 -1.125 . . . . 0.0 109.657 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.59 164.83 0.2 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.634 ' CD1' ' CG2' ' A' ' 184' ' ' THR . 0.2 OUTLIER -145.21 -175.87 4.87 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.705 -1.247 . . . . 0.0 110.519 -179.149 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.549 ' CG2' ' N ' ' A' ' 160' ' ' ILE . 2.9 m -162.97 168.16 21.51 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.549 ' N ' ' CG2' ' A' ' 159' ' ' THR . 67.0 mt -152.55 136.25 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.856 -1.152 . . . . 0.0 109.908 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.525 ' O ' ' CG2' ' A' ' 124' ' ' ILE . 0.2 OUTLIER -138.74 131.25 28.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.316 -0.865 . . . . 0.0 109.081 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.548 ' CB ' HG12 ' A' ' 124' ' ' ILE . 3.7 pp -114.68 141.27 48.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.076 -1.015 . . . . 0.0 111.23 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.652 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 1.4 m-85 -122.56 72.49 1.07 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.554 ' HB3' ' CD2' ' A' ' 122' ' ' TYR . . . -45.5 120.12 2.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.864 -1.147 . . . . 0.0 109.284 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.443 ' CG2' ' HD3' ' A' ' 123' ' ' ARG . 74.0 t . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.285 -0.884 . . . . 0.0 109.722 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 175' ' ' SER . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 174' ' ' SER . 3.4 p -52.8 -171.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -0.852 . . . . 0.0 109.619 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.11 144.86 95.83 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.652 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.1 Cg_endo -77.86 128.88 9.53 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.446 2.097 . . . . 0.0 111.641 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 98' ' ' LEU . 2.7 t -95.52 124.2 48.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.525 ' CB ' HG21 ' A' ' 161' ' ' THR . 0.0 OUTLIER -115.2 146.7 41.15 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 110.811 -178.372 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 98' ' ' LEU . 5.2 pt -130.81 -164.92 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -126.16 164.86 20.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.961 -1.087 . . . . 0.0 109.491 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.584 ' CE2' HD23 ' A' ' 108' ' ' LEU . 63.4 t80 -165.08 132.87 3.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.205 -0.935 . . . . 0.0 109.461 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -103.21 129.84 50.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.208 -0.932 . . . . 0.0 109.613 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.634 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 30.8 p . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.494 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.525 HD12 ' CG ' ' A' ' 79' ' ' GLU . 4.9 mt . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 121.415 0.626 . . . . 0.0 109.616 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.543 ' HB3' ' CG ' ' A' ' 25' ' ' PRO . 1.1 m-20 -73.94 77.35 1.66 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.395 -0.816 . . . . 0.0 109.133 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.532 ' OG ' ' CG ' ' A' ' 82' ' ' PRO . 14.8 m -95.58 109.59 46.53 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.431 -0.793 . . . . 0.0 109.772 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.577 ' HG3' ' CE2' ' A' ' 32' ' ' TYR . 36.7 Cg_endo -79.66 145.52 18.3 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.375 2.05 . . . . 0.0 110.077 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.466 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -161.43 -171.87 3.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.099 -1.0 . . . . 0.0 109.762 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 45.44 27.33 1.88 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.62 ' C ' ' CD1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -71.65 -161.63 0.07 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.598 -0.943 . . . . 0.0 109.867 -179.242 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.517 ' N ' ' CG ' ' A' ' 8' ' ' PHE . 1.5 t70 -165.58 -170.97 1.96 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.361 -0.837 . . . . 0.0 108.993 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.506 ' OG ' ' NE2' ' A' ' 88' ' ' GLN . 5.1 p -154.37 133.08 12.18 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.69 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.515 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 51.3 p -161.15 -159.64 0.67 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.253 -0.904 . . . . 0.0 109.42 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.496 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.8 OUTLIER 45.37 33.68 1.32 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -178.247 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.626 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.3 mt -75.71 163.43 3.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.485 -177.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.538 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 0.1 OUTLIER -149.71 -167.92 2.96 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.027 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.53 ' CB ' ' HB3' ' A' ' 64' ' ' PRO . . . -88.12 -47.55 8.4 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.901 -1.125 . . . . 0.0 109.361 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -105.59 19.72 20.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.915 -1.116 . . . . 0.0 109.001 179.623 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.528 ' HB3' ' CG2' ' A' ' 60' ' ' THR . 0.0 OUTLIER -172.64 153.33 2.76 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.626 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 4.7 p90 -166.19 140.73 4.43 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.955 -1.09 . . . . 0.0 108.985 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.496 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 2.3 m -89.07 160.34 17.1 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.922 -1.111 . . . . 0.0 111.252 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.2 OUTLIER -137.46 122.39 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.515 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 29.2 m-70 -99.31 153.09 19.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.097 -1.002 . . . . 0.0 110.104 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.53 ' CH2' HG22 ' A' ' 50' ' ' VAL . 22.3 p90 -161.5 133.48 5.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.382 -0.824 . . . . 0.0 109.523 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.548 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.41 170.54 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.234 -0.917 . . . . 0.0 109.295 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.548 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -100.76 159.58 29.18 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.623 -0.673 . . . . 0.0 109.378 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.543 ' CG ' ' HB3' ' A' ' 3' ' ' ASP . 36.2 Cg_endo -78.28 -159.11 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.7 2.266 . . . . 0.0 110.403 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -107.07 1.19 24.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.541 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.411 ' HB2' ' OD1' ' A' ' 3' ' ' ASP . . . -104.24 164.13 15.9 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.45 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.5 141.4 19.93 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.669 2.246 . . . . 0.0 110.307 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.566 HD13 ' CD1' ' A' ' 32' ' ' TYR . 18.7 pt -133.69 163.33 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.763 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.2 p -117.73 1.78 12.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.406 -0.809 . . . . 0.0 109.234 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.524 ' O ' ' CG2' ' A' ' 75' ' ' VAL . . . 164.24 161.18 12.86 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -125.82 124.18 40.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.633 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.527 ' CD1' ' HG3' ' A' ' 49' ' ' ARG . 14.6 mm -87.64 118.61 33.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.198 -0.939 . . . . 0.0 109.318 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.531 ' CG1' HD11 ' A' ' 57' ' ' ILE . 1.5 mm -107.2 110.22 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.185 -0.947 . . . . 0.0 109.86 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.464 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 35.6 ttp180 -109.05 142.82 39.19 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.146 -0.971 . . . . 0.0 108.657 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.621 ' CE1' ' CD2' ' A' ' 59' ' ' LEU . 21.9 p-80 -132.06 151.75 51.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.986 -1.071 . . . . 0.0 110.187 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.456 ' O ' ' O ' ' A' ' 38' ' ' ALA . 54.6 p-80 -168.55 126.66 1.09 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.512 -0.743 . . . . 0.0 109.023 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -47.55 174.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.15 -0.969 . . . . 0.0 109.6 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.44 ' HG2' HG22 ' A' ' 69' ' ' VAL . 1.3 mt-10 . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.101 -0.999 . . . . 0.0 109.582 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.578 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -123.27 103.91 8.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.943 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.531 ' HB3' ' CD1' ' A' ' 57' ' ' ILE . 4.8 m-20 -98.41 112.88 24.75 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.258 -0.901 . . . . 0.0 108.856 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.528 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -96.69 152.91 18.2 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.133 -0.979 . . . . 0.0 109.858 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.53 HG22 ' CH2' ' A' ' 22' ' ' TRP . 5.1 m -134.46 162.12 59.6 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.462 -0.774 . . . . 0.0 109.034 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.532 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.7 Cg_endo -77.02 174.16 13.29 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.481 2.12 . . . . 0.0 110.365 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.454 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 35.3 Cg_endo -77.63 -15.26 15.5 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.549 2.166 . . . . 0.0 110.419 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.39 29.73 3.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.477 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.532 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 4.5 mmt180 -139.17 132.89 30.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.569 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.412 ' O ' ' CE3' ' A' ' 22' ' ' TRP . 21.7 p-10 -112.61 -3.0 14.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 0.0 109.38 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 88.5 p -132.2 148.38 52.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.922 . . . . 0.0 109.35 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.531 HD11 ' CG1' ' A' ' 34' ' ' ILE . 5.9 tt -139.35 127.24 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 0.0 109.821 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.74 115.51 24.22 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.206 -0.934 . . . . 0.0 109.298 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.621 ' CD2' ' CE1' ' A' ' 36' ' ' HIS . 6.5 mt -88.31 160.47 17.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.738 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.528 ' CG2' ' HB3' ' A' ' 17' ' ' SER . 19.7 p -147.2 173.3 12.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.827 . . . . 0.0 109.609 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.437 ' O ' HD22 ' A' ' 62' ' ' LEU . 4.2 m-80 62.07 53.2 3.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.352 -0.843 . . . . 0.0 109.915 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 16' ' ' ASN . 3.0 mt -132.69 135.61 45.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 109.315 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.469 ' CB ' ' OH ' ' A' ' 68' ' ' TYR . 3.2 t30 -47.24 131.54 9.68 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.094 -1.004 . . . . 0.0 108.889 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.53 ' HB3' ' CB ' ' A' ' 15' ' ' ALA . 36.6 Cg_endo -78.68 134.2 12.04 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.475 2.117 . . . . 0.0 111.258 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 78.95 62.03 2.29 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.553 HG21 ' CE1' ' A' ' 68' ' ' TYR . 1.2 m -161.99 144.04 11.28 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.275 -1.133 . . . . 0.0 110.2 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -79.19 133.37 36.7 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 50.7 m-85 -124.88 171.55 10.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.903 -1.123 . . . . 0.0 110.832 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 86' ' ' GLY . 3.2 t -124.37 137.54 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 2.2 t -126.8 129.38 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.847 -1.158 . . . . 0.0 110.356 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.547 ' CB ' HG12 ' A' ' 85' ' ' ILE . 5.0 p -100.42 101.45 12.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.323 -0.86 . . . . 0.0 109.996 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.48 HD13 ' CE3' ' A' ' 22' ' ' TRP . 26.0 mm -80.91 84.2 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.094 -1.004 . . . . 0.0 109.317 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.483 HG22 HD11 ' A' ' 73' ' ' ILE . 9.1 mt -81.87 159.2 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -0.943 . . . . 0.0 109.587 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . . . -121.05 169.87 10.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.9 . . . . 0.0 109.434 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -154.94 140.51 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 109.547 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.429 ' O ' ' CG ' ' A' ' 76' ' ' ASN . 27.1 t-20 -137.24 49.44 2.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 109.585 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.71 -96.15 1.44 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.37 1.7 16.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -1.096 . . . . 0.0 109.519 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.525 ' CG ' HD12 ' A' ' 2' ' ' LEU . 1.2 tt0 -98.29 170.08 9.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.266 -0.897 . . . . 0.0 109.387 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 2.3 mp0 -148.89 108.35 3.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.112 -0.993 . . . . 0.0 110.009 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.56 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -59.92 -178.34 0.14 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 108.649 179.245 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.56 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.0 Cg_endo -76.87 154.33 33.78 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.177 1.918 . . . . 0.0 110.127 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.418 ' HA ' HG12 ' A' ' 73' ' ' ILE . 35.4 Cg_endo -77.2 103.8 1.8 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.66 2.24 . . . . 0.0 111.356 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 6' ' ' THR . 5.6 tp -81.48 93.64 6.69 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.547 HG12 ' CB ' ' A' ' 71' ' ' SER . 3.0 mt -100.09 126.69 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.177 -0.952 . . . . 0.0 110.157 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.542 ' HA3' ' CZ ' ' A' ' 8' ' ' PHE . . . -121.45 -164.71 12.39 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -143.99 123.85 13.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.947 -1.325 . . . . 0.0 110.198 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.506 ' NE2' ' OG ' ' A' ' 10' ' ' SER . 3.9 mm100 -121.5 -152.79 0.52 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.516 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.4 143.36 6.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.089 -1.007 . . . . 0.0 109.904 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.81 138.13 31.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.411 -0.805 . . . . 0.0 109.196 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 65' ' ' GLY . 2.9 t . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 121.592 0.711 . . . . 0.0 110.99 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.658 ' CB ' ' CD1' ' A' ' 112' ' ' TRP . 35.8 Cg_endo . . . . . 0 C--O 1.215 -0.67 0 N-CA-C 109.924 -0.837 . . . . 0.0 109.924 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.504 ' CG ' ' N ' ' A' ' 97' ' ' ASP . 32.5 ttt85 -77.5 164.56 25.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.321 -0.862 . . . . 0.0 109.752 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.51 ' HB2' ' CG ' ' A' ' 113' ' ' GLU . 2.8 t0 77.63 33.58 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.417 -0.802 . . . . 0.0 109.781 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.509 HD23 ' CD2' ' A' ' 162' ' ' LEU . 33.0 tp -77.15 102.53 6.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.959 . . . . 0.0 109.486 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -140.25 169.89 16.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -0.904 . . . . 0.0 109.392 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 7.9 p -94.17 138.86 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.922 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.451 HG13 ' HB3' ' A' ' 109' ' ' LEU . 1.3 pp -123.93 -7.97 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.395 -0.816 . . . . 0.0 109.312 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.457 ' HB1' ' CD1' ' A' ' 109' ' ' LEU . . . -158.54 99.08 1.57 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.528 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 0.1 OUTLIER -103.58 109.86 21.7 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.442 -0.786 . . . . 0.0 110.648 -178.52 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.491 ' OG1' ' OG ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -91.3 166.39 18.56 Favored Pre-proline 0 C--N 1.306 -1.317 0 O-C-N 121.293 -0.88 . . . . 0.0 108.749 178.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 30.3 Cg_endo -69.55 -2.05 9.35 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.258 1.972 . . . . 0.0 110.617 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.52 ' HA ' HG21 ' A' ' 152' ' ' ILE . 62.0 p -145.41 10.47 1.26 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.277 -0.889 . . . . 0.0 109.59 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 149' ' ' ILE . 3.1 p -167.3 153.69 8.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.826 -1.171 . . . . 0.0 109.992 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.6 HD23 ' CE1' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -120.9 151.38 39.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.256 -0.902 . . . . 0.0 109.422 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.457 ' CD1' ' HB1' ' A' ' 102' ' ' ALA . 0.7 OUTLIER -106.03 120.9 42.98 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.528 ' CD1' HD11 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -105.46 133.22 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.981 -1.074 . . . . 0.0 110.105 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.43 ' HB3' HG22 ' A' ' 101' ' ' ILE . 4.9 t -130.82 121.51 25.46 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.658 ' CD1' ' CB ' ' A' ' 95' ' ' PRO . 41.8 p90 -138.28 163.93 30.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.834 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.51 ' CG ' ' HB2' ' A' ' 97' ' ' ASP . 1.8 mt-10 . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.901 . . . . 0.0 108.655 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 1.2 p90 . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.518 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 11.5 m-85 -103.18 135.86 44.05 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.521 ' CB ' ' HB2' ' A' ' 163' ' ' TYR . 3.2 ttp-105 -90.98 82.85 5.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.997 -1.064 . . . . 0.0 109.889 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.642 ' CG2' ' CE2' ' A' ' 138' ' ' PHE . 78.9 mt -83.6 143.64 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 3.2 p -136.76 152.69 50.61 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.931 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.643 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 2.4 m-85 -86.21 134.84 33.75 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.607 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -106.19 119.49 6.04 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 C--N 1.299 -1.591 0 O-C-N 121.19 -1.182 . . . . 0.0 109.133 179.631 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.546 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 1.6 tm-20 -89.05 117.44 28.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.833 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.642 ' CE2' ' CG2' ' A' ' 124' ' ' ILE . 25.5 p90 -118.28 136.74 53.51 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.505 HG23 ' CE1' ' A' ' 121' ' ' TYR . 4.6 p -74.01 172.15 12.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.13 -0.981 . . . . 0.0 110.331 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.589 ' CG2' ' CD1' ' A' ' 124' ' ' ILE . 25.3 t -142.85 139.16 16.68 Favored Pre-proline 0 C--N 1.302 -1.464 0 O-C-N 121.494 -0.754 . . . . 0.0 109.884 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.449 ' HD2' HG12 ' A' ' 140' ' ' VAL . 35.4 Cg_endo -78.35 144.32 20.38 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.411 2.074 . . . . 0.0 109.943 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.27 40.87 3.06 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.9 m -105.45 -1.21 25.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -1.168 . . . . 0.0 109.847 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.3 158.6 39.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.976 . . . . 0.0 109.835 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.575 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -95.42 8.19 43.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.388 -0.82 . . . . 0.0 109.714 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.562 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 54.7 p -133.39 147.55 51.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.193 -0.942 . . . . 0.0 109.442 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.495 ' N ' ' CH2' ' A' ' 112' ' ' TRP . . . -132.63 173.16 11.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.142 -0.974 . . . . 0.0 109.459 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.4 ' C ' ' CD1' ' A' ' 149' ' ' ILE . 1.9 t -125.77 138.88 53.87 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.188 -0.945 . . . . 0.0 109.698 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.643 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 1.0 OUTLIER -113.09 83.68 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.52 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 3.6 m-20 -92.96 175.23 6.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.313 -0.867 . . . . 0.0 110.153 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 151' ' ' ASN . 1.1 m120 70.21 30.46 3.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 108.912 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.571 HG13 ' CE2' ' A' ' 158' ' ' TYR . 9.4 tt -89.33 163.92 2.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.489 -0.757 . . . . 0.0 109.731 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -107.36 121.53 44.17 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.331 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.13 146.68 22.91 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.382 2.055 . . . . 0.0 110.507 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.485 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . 87.37 65.57 1.36 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.485 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 164.23 130.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -1.149 . . . . 0.0 109.631 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -48.64 163.58 0.07 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.097 -1.002 . . . . 0.0 108.495 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.607 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -147.08 -176.11 5.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.823 -1.173 . . . . 0.0 110.147 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.51 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 4.8 m -163.69 115.55 1.42 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.458 HD13 HD13 ' A' ' 108' ' ' LEU . 39.5 mm -100.06 129.34 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.737 -1.227 . . . . 0.0 109.83 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.586 ' CG2' ' CB ' ' A' ' 179' ' ' SER . 2.0 m -136.78 168.32 19.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.206 -0.933 . . . . 0.0 109.766 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 124' ' ' ILE . 0.5 OUTLIER -158.64 147.3 18.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.044 -1.035 . . . . 0.0 111.304 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.649 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 23.0 m-85 -121.15 105.86 10.99 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -70.64 93.7 0.95 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.911 -1.118 . . . . 0.0 109.158 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.527 ' HA ' ' CB ' ' A' ' 174' ' ' SER . 2.4 t . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 109.896 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.527 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . 44.3 p . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.36 0.6 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 174' ' ' SER . 33.7 p 42.0 -164.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.463 ' O ' ' HG3' ' A' ' 176' ' ' LYS . 0.0 OUTLIER -86.58 148.51 46.61 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 120.993 -1.067 . . . . 0.0 108.559 179.276 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.649 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 31.3 Cg_endo -73.54 119.3 5.87 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.143 1.895 . . . . 0.0 111.058 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.438 HG13 HD21 ' A' ' 98' ' ' LEU . 2.1 t -107.85 124.33 63.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.586 ' CB ' ' CG2' ' A' ' 161' ' ' THR . 1.1 p -127.89 176.87 7.25 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.346 -0.846 . . . . 0.0 111.032 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.467 HG12 HD22 ' A' ' 98' ' ' LEU . 11.4 pt -157.31 152.02 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -85.78 158.58 19.97 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.926 -1.109 . . . . 0.0 109.674 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.6 ' CE1' HD23 ' A' ' 108' ' ' LEU . 47.0 t80 -158.25 127.69 5.79 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.358 -0.839 . . . . 0.0 109.328 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -101.86 128.52 48.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 109.527 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.564 HG23 ' CD1' ' A' ' 158' ' ' TYR . 7.5 p . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.505 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.471 ' HB2' ' OG ' ' A' ' 81' ' ' SER . 1.8 mt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -106.33 153.22 22.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.473 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.525 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 0.3 OUTLIER -95.33 132.32 28.02 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.763 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.479 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 36.1 Cg_endo -79.54 102.13 1.46 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.515 2.143 . . . . 0.0 109.968 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.485 ' CG2' HD12 ' A' ' 84' ' ' LEU . 1.4 p -95.58 -110.58 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 109.792 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.458 ' HA3' ' HB ' ' A' ' 23' ' ' VAL . . . 44.3 27.39 1.17 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.583 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 28.2 t80 -51.54 124.5 12.28 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.55 -0.971 . . . . 0.0 110.011 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 0.7 OUTLIER -153.21 87.78 1.28 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 92.7 p -84.29 124.59 31.4 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 109.648 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 12' ' ' ASP . 13.2 p -153.55 -159.34 0.97 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.397 -0.814 . . . . 0.0 109.05 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.476 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 1.1 m-20 45.88 40.12 6.26 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.617 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 2.7 mt -85.14 131.76 33.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.721 0.772 . . . . 0.0 111.284 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.527 ' CA ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -115.62 -167.13 1.21 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.161 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.491 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -78.48 -70.57 0.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.935 -1.103 . . . . 0.0 109.794 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 52.4 m-20 -83.06 14.21 3.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.127 -0.983 . . . . 0.0 110.156 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 14' ' ' THR . 1.6 t -165.35 156.46 14.21 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.104 -0.998 . . . . 0.0 109.085 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.619 ' CE2' ' NE2' ' A' ' 88' ' ' GLN . 4.7 p90 -164.32 145.33 8.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.162 -0.962 . . . . 0.0 109.112 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.476 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 3.8 m -89.24 149.69 22.97 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.815 -1.178 . . . . 0.0 111.441 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.554 HG21 ' CE1' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -130.37 114.17 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 9' ' ' ASP . 4.4 m-70 -96.42 170.91 8.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.995 -1.066 . . . . 0.0 110.748 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.49 ' CD1' ' O ' ' A' ' 22' ' ' TRP . 21.0 p90 178.23 136.43 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.48 164.85 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.011 -1.056 . . . . 0.0 109.789 -179.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.467 ' HB3' ' OH ' ' A' ' 32' ' ' TYR . . . -97.53 167.3 12.05 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.71 -0.619 . . . . 0.0 109.595 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 5' ' ' PRO . 36.3 Cg_endo -79.32 -159.28 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.607 2.205 . . . . 0.0 110.294 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -126.24 16.68 7.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.298 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.525 ' CB ' ' HD2' ' A' ' 28' ' ' PRO . . . -117.75 176.08 1.77 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.324 -0.86 . . . . 0.0 109.424 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 35.5 Cg_endo -78.16 136.57 14.61 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.635 2.224 . . . . 0.0 110.457 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.643 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 27.5 pt -150.06 -179.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.331 -0.856 . . . . 0.0 109.406 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.2 p -120.81 4.53 10.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.583 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.96 173.37 17.15 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.643 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 16.6 m-85 -118.71 123.65 45.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -1.174 . . . . 0.0 109.634 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.523 ' CD1' HG23 ' A' ' 75' ' ' VAL . 1.7 mp -79.69 135.18 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.215 -0.928 . . . . 0.0 108.768 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 48' ' ' ASP . 2.9 mm -115.47 107.02 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.069 -1.019 . . . . 0.0 110.064 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.464 ' O ' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -109.18 117.02 33.03 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.62 ' CE1' ' CD2' ' A' ' 59' ' ' LEU . 51.2 p-80 -126.83 176.19 7.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.009 -1.057 . . . . 0.0 110.682 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 38' ' ' ALA . 42.4 p-80 175.18 145.48 0.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.578 ' HA ' ' CD2' ' A' ' 68' ' ' TYR . . . -41.57 163.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.22 -0.925 . . . . 0.0 109.617 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.529 ' HG2' ' CA ' ' A' ' 68' ' ' TYR . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.08 -1.012 . . . . 0.0 109.567 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.572 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 121.364 0.602 . . . . 0.0 109.53 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.46 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -120.95 122.63 40.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.464 -0.772 . . . . 0.0 110.076 -179.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 34' ' ' ILE . 63.2 m-20 -144.54 120.04 10.36 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.452 ' HD2' HG21 ' A' ' 33' ' ' ILE . 5.1 mmt-85 -104.09 152.23 22.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.971 -1.081 . . . . 0.0 110.23 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.498 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 10.7 m -128.02 161.29 56.82 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.533 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 33.7 Cg_endo -76.36 174.13 13.34 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.358 2.039 . . . . 0.0 110.34 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.544 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 35.2 Cg_endo -77.07 -15.46 16.33 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.582 2.188 . . . . 0.0 110.604 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.2 t -101.97 17.84 22.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 0.0 109.652 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.533 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.5 OUTLIER -122.77 100.78 7.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.19 -0.944 . . . . 0.0 109.914 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -84.85 -3.0 58.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.14 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 56.5 p -137.52 149.02 46.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.432 -0.793 . . . . 0.0 109.031 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.2 tt -136.44 125.95 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.075 -1.016 . . . . 0.0 109.746 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.29 107.4 19.04 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.408 -0.807 . . . . 0.0 109.269 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.62 ' CD2' ' CE1' ' A' ' 36' ' ' HIS . 1.0 OUTLIER -84.91 152.02 23.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.533 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.45 ' HA ' ' HB2' ' A' ' 17' ' ' SER . 29.2 p -137.98 -177.49 4.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.467 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.3 m120 55.7 29.67 14.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.356 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.49 ' CD1' ' HB3' ' A' ' 59' ' ' LEU . 5.1 mt -107.53 136.26 47.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 0.0 109.403 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.516 ' CB ' ' OH ' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -44.76 126.61 5.13 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.147 -0.97 . . . . 0.0 108.868 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 35.9 Cg_endo -77.42 131.41 11.59 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.29 1.994 . . . . 0.0 110.852 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 78.25 61.35 2.51 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.585 HG23 ' CE1' ' A' ' 68' ' ' TYR . 13.2 m -157.16 165.79 35.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.258 -1.142 . . . . 0.0 109.93 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.535 ' N ' ' CG2' ' A' ' 66' ' ' THR . 1.8 mp0 -115.33 132.64 56.55 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.445 -0.784 . . . . 0.0 109.174 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.608 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 1.2 m-85 -130.57 173.83 10.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.93 . . . . 0.0 109.377 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.447 ' CG2' ' HA ' ' A' ' 39' ' ' GLU . 8.4 t -112.82 114.9 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.465 HG22 ' HG2' ' A' ' 88' ' ' GLN . 4.5 t -96.99 138.49 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.09 -1.006 . . . . 0.0 110.067 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.528 ' CB ' HG12 ' A' ' 85' ' ' ILE . 14.5 p -119.56 138.74 53.0 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.296 -0.878 . . . . 0.0 110.233 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.2 mm -111.78 95.11 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.397 -0.815 . . . . 0.0 109.397 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.582 ' N ' ' CD1' ' A' ' 73' ' ' ILE . 1.3 mp -85.24 122.84 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.339 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.459 ' HB2' ' HB2' ' A' ' 81' ' ' SER . . . -97.34 137.62 36.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.924 . . . . 0.0 109.368 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.523 HG23 ' CD1' ' A' ' 33' ' ' ILE . 4.6 m -140.78 171.82 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.905 . . . . 0.0 109.471 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.441 ' OD1' ' HA ' ' A' ' 29' ' ' ILE . 49.2 t30 -146.39 43.23 1.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.915 . . . . 0.0 109.439 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 112.31 -87.03 0.44 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.04 -8.25 10.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -1.141 . . . . 0.0 109.625 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -84.81 -167.21 1.72 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.382 -0.824 . . . . 0.0 109.276 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.46 ' HG2' HG11 ' A' ' 75' ' ' VAL . 16.2 mt-10 -159.4 131.14 6.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.188 -0.945 . . . . 0.0 109.929 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.565 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -98.62 -178.33 0.69 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.393 -0.817 . . . . 0.0 108.882 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.565 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.4 Cg_endo -77.34 131.21 11.52 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.118 1.879 . . . . 0.0 109.908 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.46 ' HB3' HG13 ' A' ' 73' ' ' ILE . 35.7 Cg_endo -77.75 115.48 3.84 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.491 2.127 . . . . 0.0 111.117 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.485 HD12 ' CG2' ' A' ' 6' ' ' THR . 0.7 OUTLIER -88.53 106.5 18.33 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.187 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.528 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.8 mt -95.48 146.4 7.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.116 -0.99 . . . . 0.0 110.105 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.583 ' HA3' ' CZ ' ' A' ' 8' ' ' PHE . . . -142.75 161.37 27.46 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 108.134 -1.987 . . . . 0.0 108.134 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.463 ' HG2' ' N ' ' A' ' 88' ' ' GLN . 5.8 tt0 -102.05 148.38 25.45 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.18 -1.188 . . . . 0.0 110.028 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.619 ' NE2' ' CE2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -149.82 -176.35 5.39 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.517 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -160.2 134.61 7.49 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 109.969 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.5 143.36 36.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.358 -0.839 . . . . 0.0 109.019 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.527 HG22 ' CA ' ' A' ' 14' ' ' THR . 2.0 t . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.512 -0.743 . . . . 0.0 109.888 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.519 ' HB2' ' CD1' ' A' ' 112' ' ' TRP . 36.0 Cg_endo . . . . . 0 C--O 1.215 -0.645 0 N-CA-C 110.162 -0.745 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.56 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 4.2 ttt180 -66.62 170.71 5.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.319 -0.863 . . . . 0.0 109.813 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 1.1 t0 81.87 34.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.736 . . . . 0.0 110.113 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.506 ' CD2' HD22 ' A' ' 162' ' ' LEU . 21.8 tp -76.46 101.56 5.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.134 -0.979 . . . . 0.0 109.288 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -151.85 -175.24 5.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 109.077 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 47.8 t -119.23 149.37 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.0 -1.063 . . . . 0.0 110.164 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.536 HG12 ' CD2' ' A' ' 109' ' ' LEU . 6.9 pt -119.6 -17.14 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.737 0.779 . . . . 0.0 109.356 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' A' ' 109' ' ' LEU . . . -150.84 142.12 23.27 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.532 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 51.5 p -150.49 132.09 14.85 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.695 -1.253 . . . . 0.0 111.299 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.552 ' HB ' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -98.02 171.38 5.94 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.552 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 29.9 Cg_endo -69.66 -1.05 7.73 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.918 1.746 . . . . 0.0 110.63 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.503 ' HA ' HG21 ' A' ' 152' ' ' ILE . 19.2 p -143.02 8.23 1.65 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.194 -0.941 . . . . 0.0 109.655 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' A' ' 149' ' ' ILE . 2.9 p -164.33 149.68 10.32 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.819 -1.152 . . . . 0.0 109.96 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.575 HD21 ' CZ ' ' A' ' 182' ' ' TYR . 0.9 OUTLIER -123.69 156.33 36.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.909 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.536 ' CD2' HG12 ' A' ' 101' ' ' ILE . 11.1 tp -105.27 108.81 20.52 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.518 ' CD1' ' HB1' ' A' ' 147' ' ' ALA . 3.1 pt -92.26 150.04 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.237 -0.914 . . . . 0.0 109.998 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 146' ' ' THR . 31.8 m -148.36 135.82 20.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.421 -0.799 . . . . 0.0 109.325 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.571 ' CD2' ' O ' ' A' ' 145' ' ' SER . 14.4 p90 -135.68 159.06 42.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 109.42 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.068 -1.02 . . . . 0.0 109.315 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.573 ' CE2' ' HB ' ' A' ' 165' ' ' VAL . 1.9 p90 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 121.267 0.556 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.621 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 2.2 m-85 -136.63 131.59 33.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -0.871 . . . . 0.0 109.097 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 4.6 ttt180 -84.69 154.4 22.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.019 -1.05 . . . . 0.0 108.541 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.612 ' HB ' ' CE2' ' A' ' 138' ' ' PHE . 17.6 mt -151.03 138.82 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.006 -1.059 . . . . 0.0 110.394 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 136' ' ' GLN . 2.2 p -106.28 141.77 37.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.607 -0.683 . . . . 0.0 109.721 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.571 ' CZ ' HG21 ' A' ' 149' ' ' ILE . 1.6 m-85 -88.26 118.83 28.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.369 -0.832 . . . . 0.0 108.758 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.624 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.8 113.73 4.3 Favored Glycine 0 N--CA 1.487 2.073 0 C-N-CA 119.607 -1.282 . . . . 0.0 111.217 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 . . . . . 0 C--N 1.3 -1.566 0 O-C-N 121.173 -1.192 . . . . 0.0 108.384 178.494 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.562 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.49 ' HG3' ' CG2' ' A' ' 125' ' ' THR . 0.1 OUTLIER -156.71 152.16 26.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.144 -1.598 . . . . 0.0 111.702 -179.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.612 ' CE2' ' HB ' ' A' ' 124' ' ' ILE . 11.7 p90 -165.11 134.73 3.6 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.7 p -74.57 171.85 13.09 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.175 -0.953 . . . . 0.0 110.944 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.53 HG23 ' CD1' ' A' ' 124' ' ' ILE . 28.5 t -131.83 140.53 38.52 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.52 -0.738 . . . . 0.0 109.542 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.454 ' HD2' HG12 ' A' ' 140' ' ' VAL . 35.5 Cg_endo -77.99 125.47 7.31 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.428 2.086 . . . . 0.0 109.919 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.32 51.65 3.31 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.418 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 16.0 p -105.5 -4.71 20.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.194 -1.18 . . . . 0.0 109.551 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.418 ' CG ' ' O ' ' A' ' 143' ' ' SER . 0.6 OUTLIER -173.55 178.21 2.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.513 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.571 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 0.3 OUTLIER -95.12 15.33 19.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.584 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.531 ' C ' ' CH2' ' A' ' 112' ' ' TRP . 2.1 p -123.52 146.15 48.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.465 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.518 ' HB1' ' CD1' ' A' ' 110' ' ' ILE . . . -133.12 167.19 20.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.246 -0.909 . . . . 0.0 109.461 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.518 HG23 ' N ' ' A' ' 149' ' ' ILE . 14.0 m -108.49 164.07 12.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 109.465 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.571 HG21 ' CZ ' ' A' ' 126' ' ' TYR . 11.7 mm -143.24 66.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.0 109.335 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.544 ' HA ' ' CB ' ' A' ' 107' ' ' SER . 4.3 m120 -78.28 -167.51 1.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.692 -0.63 . . . . 0.0 109.814 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 50.92 42.0 27.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.081 -1.012 . . . . 0.0 109.053 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.608 HG13 ' CE2' ' A' ' 158' ' ' TYR . 4.4 tt -106.18 160.03 5.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.422 -0.799 . . . . 0.0 109.915 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -93.58 125.22 54.63 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 109.17 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.467 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 35.8 Cg_endo -78.73 140.25 16.36 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.436 2.091 . . . . 0.0 110.859 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 75.09 63.23 2.58 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.452 ' N ' ' OG1' ' A' ' 184' ' ' THR . . . 178.13 127.2 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.174 -1.192 . . . . 0.0 110.147 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.465 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 9.7 t70 -48.58 167.94 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.624 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.4 OUTLIER -146.6 -167.88 2.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.973 -1.079 . . . . 0.0 109.991 -179.544 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 127' ' ' GLY . 4.4 m -168.41 96.39 0.4 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.1 mt -91.86 133.01 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.049 -1.032 . . . . 0.0 110.05 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.565 ' CG2' ' CB ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -131.27 159.91 36.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.329 -0.857 . . . . 0.0 108.764 179.311 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 124' ' ' ILE . 1.7 pp -150.82 150.08 30.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.734 -1.229 . . . . 0.0 111.714 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.627 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.3 m-85 -125.99 79.59 1.85 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -43.92 125.69 4.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.976 -1.077 . . . . 0.0 109.322 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.573 ' HB ' ' CE2' ' A' ' 121' ' ' TYR . 55.2 t . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 110.079 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 84.5 p . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.281 0.562 . . . . 0.0 109.706 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 176' ' ' LYS . 3.0 p -54.12 174.86 0.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.301 -0.874 . . . . 0.0 109.217 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 175' ' ' SER . 1.4 mmtp -45.81 136.87 6.06 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.16 -0.963 . . . . 0.0 108.618 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.627 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.2 Cg_endo -77.39 144.94 23.38 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.267 1.978 . . . . 0.0 110.885 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.458 HG13 HD21 ' A' ' 98' ' ' LEU . 3.1 t -120.62 130.79 74.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.565 ' CB ' ' CG2' ' A' ' 161' ' ' THR . 0.9 OUTLIER -122.84 158.32 30.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 110.704 -178.617 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 98' ' ' LEU . 29.3 pt -146.7 153.12 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 159' ' ' THR . 73.7 m-80 -93.15 153.98 18.33 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.035 -1.041 . . . . 0.0 109.41 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.575 ' CZ ' HD21 ' A' ' 108' ' ' LEU . 92.1 t80 -141.81 123.9 15.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.282 -0.886 . . . . 0.0 109.721 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -87.69 111.45 21.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.066 -1.021 . . . . 0.0 109.477 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.47 HG23 ' CD2' ' A' ' 182' ' ' TYR . 21.9 p . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.485 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.514 ' CD1' ' HB3' ' A' ' 81' ' ' SER . 2.6 mp . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.321 0.581 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.49 ' HB2' ' CB ' ' A' ' 25' ' ' PRO . 1.3 m-20 -108.37 164.41 12.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.0 109.526 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.5 m -95.41 120.3 64.01 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.486 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.522 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 35.6 Cg_endo -78.41 95.56 1.07 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.394 2.063 . . . . 0.0 110.296 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 7' ' ' GLY . 1.2 p -85.02 -107.72 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.959 . . . . 0.0 109.614 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 43.7 29.24 1.26 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.579 ' CE2' ' HA3' ' A' ' 86' ' ' GLY . 20.5 t80 -53.08 129.92 32.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.399 -1.059 . . . . 0.0 110.166 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 21' ' ' HIS . 1.9 t70 -165.29 134.2 3.36 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.514 ' CB ' ' HG2' ' A' ' 88' ' ' GLN . 4.7 m -118.19 139.38 51.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.923 -1.11 . . . . 0.0 110.276 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.481 ' O ' ' C ' ' A' ' 12' ' ' ASP . 8.9 p -153.43 -169.38 3.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.435 -0.791 . . . . 0.0 109.2 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.524 ' CB ' ' OG1' ' A' ' 19' ' ' THR . 0.8 OUTLIER 41.39 46.93 3.01 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.047 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.557 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 41.5 mm -77.67 130.73 35.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.622 0.725 . . . . 0.0 111.349 -178.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.572 ' CB ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -119.67 176.81 5.2 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.183 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.528 ' CB ' ' HB3' ' A' ' 64' ' ' PRO . . . -71.01 -70.03 0.33 Allowed 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.528 -1.358 . . . . 0.0 109.559 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 50.2 m-80 -81.2 -6.84 59.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.056 -1.027 . . . . 0.0 109.362 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.572 ' O ' ' CB ' ' A' ' 14' ' ' THR . 3.4 t -137.42 158.01 45.33 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.591 ' CE1' ' HG3' ' A' ' 88' ' ' GLN . 2.2 p90 -167.76 139.88 3.11 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.991 -1.068 . . . . 0.0 108.494 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.524 ' OG1' ' CB ' ' A' ' 12' ' ' ASP . 23.0 m -84.48 154.88 22.46 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.785 -1.197 . . . . 0.0 110.898 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.576 HG21 ' CE1' ' A' ' 18' ' ' PHE . 1.5 t -128.6 177.76 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' A' ' 20' ' ' VAL . 55.6 m-70 -156.2 163.64 39.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.017 -1.052 . . . . 0.0 110.158 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 46.0 p90 179.87 142.94 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.447 -0.783 . . . . 0.0 109.239 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.537 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.43 169.79 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.113 -0.992 . . . . 0.0 109.145 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.537 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -102.38 165.89 13.0 Favored Pre-proline 0 C--N 1.299 -1.606 0 O-C-N 121.504 -0.747 . . . . 0.0 109.794 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.49 ' CB ' ' HB2' ' A' ' 3' ' ' ASP . 35.7 Cg_endo -78.26 -164.7 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.672 2.248 . . . . 0.0 110.38 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 -115.31 26.5 10.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.37 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.41 169.75 13.06 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.29 -0.881 . . . . 0.0 109.383 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.78 136.62 15.3 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.612 2.208 . . . . 0.0 110.356 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.625 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 16.3 pt -145.52 -171.52 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.493 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 77' ' ' GLY . 60.5 p -126.56 6.38 6.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.87 . . . . 0.0 109.527 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.416 ' HA2' ' C ' ' A' ' 51' ' ' PRO . . . 139.8 172.92 12.96 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.625 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -123.76 125.26 44.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -1.165 . . . . 0.0 109.543 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.528 HG12 ' CG2' ' A' ' 75' ' ' VAL . 16.1 mm -74.8 120.51 24.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.231 -0.918 . . . . 0.0 109.289 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.513 ' N ' HD11 ' A' ' 34' ' ' ILE . 2.3 mm -99.26 129.74 49.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.169 -0.957 . . . . 0.0 109.393 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.469 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 58.2 ttt180 -118.9 119.57 34.74 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.264 -0.898 . . . . 0.0 109.115 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.645 ' NE2' ' CG ' ' A' ' 68' ' ' TYR . 0.3 OUTLIER -93.46 149.14 21.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.32 -0.863 . . . . 0.0 109.472 -179.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.51 ' ND1' ' O ' ' A' ' 69' ' ' VAL . 44.3 p-80 178.27 133.64 0.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.54 -0.725 . . . . 0.0 109.408 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -56.65 -165.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.262 -0.899 . . . . 0.0 109.802 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 109.655 -179.874 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.456 ' HD2' HD21 ' A' ' 62' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.36 0.6 . . . . 0.0 109.75 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -132.47 111.12 11.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.632 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.488 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 0.8 OUTLIER -116.31 125.05 51.61 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.307 -0.87 . . . . 0.0 108.794 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.545 ' CD ' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -104.31 160.64 14.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.119 -0.988 . . . . 0.0 109.847 -179.087 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.52 ' CG1' HD13 ' A' ' 57' ' ' ILE . 3.7 m -142.51 159.93 55.94 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.42 -0.8 . . . . 0.0 109.298 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.527 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 33.7 Cg_endo -76.37 174.27 13.11 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.484 2.123 . . . . 0.0 110.224 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.575 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.9 Cg_endo -76.81 -25.8 8.77 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.62 2.213 . . . . 0.0 111.07 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.8 p -89.35 -3.0 58.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.098 -1.002 . . . . 0.0 109.666 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.527 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -101.02 111.69 23.95 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.281 -0.887 . . . . 0.0 110.137 -179.54 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.487 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 40.6 p-10 -92.92 -8.82 42.18 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.446 -0.784 . . . . 0.0 109.084 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 18.2 p -124.3 150.51 45.33 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.52 HD13 ' CG1' ' A' ' 50' ' ' VAL . 4.6 tt -134.92 133.16 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.926 -1.109 . . . . 0.0 110.295 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.95 102.7 14.53 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.519 ' HB3' ' CD1' ' A' ' 62' ' ' LEU . 1.0 OUTLIER -84.47 156.89 21.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.16 -0.963 . . . . 0.0 109.763 -179.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.471 ' HA ' ' HB2' ' A' ' 17' ' ' SER . 33.0 p -143.12 -179.65 6.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.403 -0.811 . . . . 0.0 109.35 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.451 ' O ' ' CZ ' ' A' ' 46' ' ' ARG . 17.5 m-80 55.28 19.26 2.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 109.395 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.519 ' CD1' ' HB3' ' A' ' 59' ' ' LEU . 4.9 mt -91.62 168.03 11.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 0.0 109.332 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.53 ' CB ' ' OH ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER -77.38 130.98 72.87 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.154 -0.966 . . . . 0.0 108.576 179.404 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.528 ' HB3' ' CB ' ' A' ' 15' ' ' ALA . 36.6 Cg_endo -78.84 133.87 11.6 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.371 2.048 . . . . 0.0 111.566 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 73.57 62.76 2.94 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.641 ' CG2' ' CZ ' ' A' ' 68' ' ' TYR . 3.3 m -159.22 145.73 16.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.179 -1.189 . . . . 0.0 110.698 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 1.4 mt-10 -87.66 99.24 11.92 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.645 ' CG ' ' NE2' ' A' ' 36' ' ' HIS . 29.1 m-85 -103.46 119.68 39.36 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.191 -0.943 . . . . 0.0 110.284 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.51 ' O ' ' ND1' ' A' ' 37' ' ' HIS . 20.7 t -68.99 117.82 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.423 -0.798 . . . . 0.0 109.25 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.3 t -96.25 109.99 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.088 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -84.49 110.11 18.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.947 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.489 ' O ' ' CA ' ' A' ' 83' ' ' PRO . 15.5 mm -79.98 120.58 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.398 -0.814 . . . . 0.0 109.653 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.56 ' N ' ' CD1' ' A' ' 73' ' ' ILE . 1.3 mp -112.59 144.12 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.04 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.463 ' HB2' ' OG ' ' A' ' 81' ' ' SER . . . -104.43 128.69 52.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.415 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.528 ' CG2' HG12 ' A' ' 33' ' ' ILE . 16.9 m -133.55 130.56 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.47 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.417 ' ND2' ' HA ' ' A' ' 29' ' ' ILE . 3.1 t-20 -99.82 44.6 1.01 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.284 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.515 ' N ' ' OG1' ' A' ' 30' ' ' THR . . . 95.42 -63.32 1.39 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.02 3.22 3.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -1.141 . . . . 0.0 109.59 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -103.05 -164.39 1.07 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.437 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.413 ' C ' ' OG ' ' A' ' 81' ' ' SER . 32.8 mt-10 -144.13 -169.21 3.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.8 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.574 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -176.58 -178.8 0.31 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 109.066 -179.563 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.574 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.8 Cg_endo -77.08 116.13 4.13 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.212 1.941 . . . . 0.0 109.929 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.489 ' CA ' ' O ' ' A' ' 72' ' ' ILE . 36.2 Cg_endo -78.27 146.9 22.7 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.585 2.19 . . . . 0.0 111.272 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.455 HD21 ' O ' ' A' ' 5' ' ' PRO . 0.7 OUTLIER -108.97 107.74 18.22 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 2.1 mt -87.94 148.05 4.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.071 -1.018 . . . . 0.0 110.228 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.579 ' HA3' ' CE2' ' A' ' 8' ' ' PHE . . . -155.4 161.21 30.37 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -98.63 143.53 28.92 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.231 -1.158 . . . . 0.0 110.065 -179.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.591 ' HG3' ' CE1' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -142.41 137.5 30.45 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.278 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -107.6 124.25 49.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.027 -1.046 . . . . 0.0 110.982 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.76 138.11 42.46 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.139 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.553 ' O ' ' N ' ' A' ' 65' ' ' GLY . 1.2 t . . . . . 0 N--CA 1.491 1.609 0 C-N-CA 118.833 -1.147 . . . . 0.0 108.714 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.511 ' CB ' ' CD1' ' A' ' 112' ' ' TRP . 35.9 Cg_endo . . . . . 0 C--O 1.214 -0.678 0 N-CA-C 110.183 -0.737 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 113' ' ' GLU . 13.2 ptp180 -174.67 160.13 2.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.257 -0.902 . . . . 0.0 109.373 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.2 OUTLIER 74.97 17.86 2.66 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.218 -0.926 . . . . 0.0 109.516 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.586 ' CD1' ' CD2' ' A' ' 162' ' ' LEU . 0.6 OUTLIER -51.58 103.7 0.07 Allowed 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.118 -0.989 . . . . 0.0 109.427 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -130.25 161.85 30.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.333 -0.854 . . . . 0.0 109.458 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 12.6 p -97.6 144.76 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.739 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.483 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 23.9 pt -127.72 -3.87 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.305 -0.872 . . . . 0.0 109.612 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.531 ' CB ' ' HB2' ' A' ' 109' ' ' LEU . . . -157.84 106.17 2.03 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.467 ' OG ' ' OH ' ' A' ' 182' ' ' TYR . 1.0 OUTLIER -103.94 106.65 17.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 0.0 110.592 -178.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -94.31 166.48 15.34 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.466 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 29.8 Cg_endo -68.97 -2.59 9.88 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.332 2.021 . . . . 0.0 110.665 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.52 ' HA ' HG21 ' A' ' 152' ' ' ILE . 3.2 p -148.8 13.9 0.92 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.24 -0.912 . . . . 0.0 109.346 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.535 ' O ' ' CD2' ' A' ' 108' ' ' LEU . 3.3 p -172.31 168.43 5.58 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 118.764 -1.174 . . . . 0.0 109.989 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.585 HD23 ' CE2' ' A' ' 182' ' ' TYR . 0.5 OUTLIER -144.35 155.17 43.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.329 -0.857 . . . . 0.0 109.375 -179.468 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.531 ' HB2' ' CB ' ' A' ' 102' ' ' ALA . 5.8 mt -97.11 140.12 32.09 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.523 ' CD1' HD13 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -122.58 132.62 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.946 -1.096 . . . . 0.0 110.663 -179.126 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.3 t -131.03 111.3 11.9 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.511 ' CD1' ' CB ' ' A' ' 95' ' ' PRO . 45.1 p90 -123.63 144.68 49.46 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.182 -0.949 . . . . 0.0 110.75 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 96' ' ' ARG . 4.4 mm-40 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.643 ' CE1' ' CG1' ' A' ' 165' ' ' VAL . 5.4 p90 . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.626 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 1.1 m-85 -136.65 161.56 35.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.19 -0.944 . . . . 0.0 109.494 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -120.67 98.9 6.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.929 . . . . 0.0 108.672 179.434 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.585 ' HB ' ' CE1' ' A' ' 138' ' ' PHE . 20.3 mt -84.3 146.47 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.139 -0.975 . . . . 0.0 110.012 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 21.6 p -120.9 153.04 37.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 0.0 110.415 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.64 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 2.6 m-85 -101.9 121.88 42.97 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.596 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.1 117.4 5.56 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.272 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 . . . . . 0 C--N 1.3 -1.573 0 O-C-N 121.226 -1.161 . . . . 0.0 108.988 179.164 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.486 ' O ' ' N ' ' A' ' 126' ' ' TYR . 87.3 mm-40 . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -119.57 158.07 27.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.939 -1.101 . . . . 0.0 111.557 -178.332 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.585 ' CE1' ' HB ' ' A' ' 124' ' ' ILE . 33.8 p90 -140.7 162.86 34.4 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.58 ' O ' ' CD2' ' A' ' 138' ' ' PHE . 0.7 OUTLIER -74.51 -171.14 1.15 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.752 -1.217 . . . . 0.0 110.164 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.572 ' CG2' ' CD1' ' A' ' 124' ' ' ILE . 40.0 t -149.88 133.98 9.02 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.213 -0.93 . . . . 0.0 109.86 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.33 117.34 4.05 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.357 2.038 . . . . 0.0 110.097 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -71.77 55.81 1.33 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.48 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 39.3 m -105.46 -1.62 24.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.164 -1.198 . . . . 0.0 109.492 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.48 ' CG ' ' O ' ' A' ' 143' ' ' SER . 3.0 mtmt -176.16 -179.75 1.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.919 . . . . 0.0 109.43 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.99 13.75 24.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.57 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 110' ' ' ILE . 18.0 p -125.36 152.84 44.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.912 . . . . 0.0 109.527 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.487 ' HB1' ' CH2' ' A' ' 112' ' ' TRP . . . -142.4 171.73 13.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.0 109.548 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.464 HG22 ' OD1' ' A' ' 150' ' ' ASN . 11.3 t -110.7 155.85 21.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.328 -0.858 . . . . 0.0 109.379 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.64 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 16.1 mm -133.26 81.9 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 109.506 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.543 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -92.69 167.64 11.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.389 -0.819 . . . . 0.0 109.979 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 0.3 OUTLIER 75.15 47.4 0.1 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 0.0 109.298 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.52 HG21 ' HA ' ' A' ' 106' ' ' THR . 4.2 tt -110.67 158.85 10.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.35 -0.844 . . . . 0.0 109.922 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.409 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 1.7 tttp -97.77 112.45 61.59 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.351 -0.843 . . . . 0.0 108.944 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.466 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 34.7 Cg_endo -77.2 138.17 17.72 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.387 2.058 . . . . 0.0 110.692 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . 87.99 67.7 1.3 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 163.26 130.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -1.117 . . . . 0.0 109.633 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 156' ' ' ALA . 1.2 t0 -46.36 158.92 0.1 Allowed 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.596 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -143.08 -179.47 6.39 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.0 -1.063 . . . . 0.0 109.884 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 127' ' ' GLY . 4.8 m -150.94 101.41 2.89 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 179' ' ' SER . 16.2 mm -84.84 136.55 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.117 -0.989 . . . . 0.0 110.118 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.536 ' CG2' ' HB3' ' A' ' 179' ' ' SER . 2.0 m -147.45 168.87 20.78 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.586 ' CD2' ' CD1' ' A' ' 98' ' ' LEU . 0.8 OUTLIER -163.54 147.64 10.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.871 -1.143 . . . . 0.0 110.859 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 177' ' ' PRO . 2.0 m-85 -116.08 103.42 10.55 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.475 ' O ' HG21 ' A' ' 165' ' ' VAL . . . -61.32 167.25 3.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.007 -1.058 . . . . 0.0 109.459 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.643 ' CG1' ' CE1' ' A' ' 121' ' ' TYR . 84.4 t . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.146 -0.971 . . . . 0.0 110.543 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 165' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 176' ' ' LYS . 96.6 p -146.14 163.76 34.34 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.173 -0.954 . . . . 0.0 109.817 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 175' ' ' SER . 0.0 OUTLIER -47.0 139.99 6.58 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.278 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 163' ' ' TYR . 34.8 Cg_endo -77.39 117.49 4.36 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.204 1.936 . . . . 0.0 111.757 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.466 ' O ' HG21 ' A' ' 161' ' ' THR . 2.3 t -84.59 131.57 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.536 ' HB3' ' CG2' ' A' ' 161' ' ' THR . 54.4 p -128.14 149.37 50.45 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.05 -1.031 . . . . 0.0 111.218 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.521 ' CG1' HD21 ' A' ' 98' ' ' LEU . 18.8 pt -134.94 152.65 33.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -84.18 147.03 27.52 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.928 -1.108 . . . . 0.0 109.698 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.585 ' CE2' HD23 ' A' ' 108' ' ' LEU . 74.4 t80 -147.43 121.63 9.55 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.452 -0.78 . . . . 0.0 109.335 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 183' ' ' LYS . 8.0 pttm -96.04 121.86 38.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.994 . . . . 0.0 109.505 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.573 HG22 ' CD1' ' A' ' 158' ' ' TYR . 44.7 p . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.483 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.521 HD21 ' N ' ' A' ' 2' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 121.384 0.612 . . . . 0.0 109.51 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.531 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 7.5 m-20 -74.62 90.13 2.25 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.422 -0.799 . . . . 0.0 110.134 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.6 m -96.71 106.72 32.09 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 3' ' ' ASP . 36.7 Cg_endo -79.61 159.66 25.2 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.322 2.015 . . . . 0.0 110.642 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.526 ' HA ' ' CD2' ' A' ' 84' ' ' LEU . 3.8 p -151.94 -121.1 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 109.074 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 43.33 28.14 0.85 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.573 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 7.6 t80 -48.68 133.57 16.94 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.705 -0.88 . . . . 0.0 110.327 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 9.2 t0 -165.05 94.1 0.64 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -84.4 118.32 24.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -0.885 . . . . 0.0 109.764 -179.345 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.464 ' O ' ' C ' ' A' ' 12' ' ' ASP . 96.3 p -151.86 -159.1 0.97 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.396 -0.815 . . . . 0.0 108.981 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.49 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.7 OUTLIER 46.46 33.58 2.0 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -178.305 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.609 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.2 mt -76.69 162.67 4.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.679 -177.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.546 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 0.1 OUTLIER -151.2 -175.27 5.1 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.081 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.568 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -78.37 -52.11 9.08 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.123 -0.986 . . . . 0.0 109.752 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 60' ' ' THR . 1.8 p-10 -97.83 -1.9 42.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.78 -1.2 . . . . 0.0 109.936 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 59' ' ' LEU . 3.4 p -150.98 157.33 42.75 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.32 -0.863 . . . . 0.0 108.825 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.609 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 2.1 p90 -165.71 141.45 5.07 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.17 -0.956 . . . . 0.0 108.559 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 1.7 m -94.82 155.68 16.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.855 -1.153 . . . . 0.0 111.7 -177.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.4 OUTLIER -130.16 120.07 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.52 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 4.0 m-70 -101.26 148.91 24.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.118 -0.989 . . . . 0.0 110.81 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.576 ' CD1' ' O ' ' A' ' 22' ' ' TRP . 11.9 p90 -171.47 129.94 0.7 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.536 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.53 169.07 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.985 -1.072 . . . . 0.0 109.566 -179.782 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.536 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -107.66 160.42 26.77 Favored Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.685 -0.634 . . . . 0.0 109.366 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.54 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 36.9 Cg_endo -78.38 -99.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.676 2.251 . . . . 0.0 110.371 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.54 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -174.57 -34.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.076 -1.015 . . . . 0.0 109.984 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.529 ' N ' ' OD1' ' A' ' 3' ' ' ASP . . . -54.38 168.13 0.5 Allowed Pre-proline 0 C--N 1.296 -1.729 0 O-C-N 121.5 -0.75 . . . . 0.0 109.368 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 27' ' ' ALA . 35.1 Cg_endo -77.52 142.18 20.57 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.529 2.153 . . . . 0.0 110.354 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.638 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 14.2 pt -148.11 176.98 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.921 . . . . 0.0 109.751 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.0 p -120.77 1.05 10.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.412 -0.805 . . . . 0.0 109.256 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.462 ' O ' ' CG2' ' A' ' 75' ' ' VAL . . . 139.3 150.97 5.61 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.638 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -100.63 135.56 41.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.254 -1.144 . . . . 0.0 109.322 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.582 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 1.2 mp -86.53 133.14 30.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.149 -0.969 . . . . 0.0 109.094 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.482 ' N ' ' O ' ' A' ' 48' ' ' ASP . 2.9 mm -112.12 102.15 13.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.354 -0.841 . . . . 0.0 109.346 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.517 ' HG2' ' N ' ' A' ' 36' ' ' HIS . 5.4 ttt180 -100.62 158.1 16.18 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.145 -0.972 . . . . 0.0 109.218 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.65 ' CE1' ' CG2' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -140.07 144.59 36.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.165 -0.96 . . . . 0.0 109.635 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.579 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 35.6 p-80 -163.5 128.85 3.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.834 . . . . 0.0 109.533 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.557 ' HA ' ' HB3' ' A' ' 68' ' ' TYR . . . -40.32 163.6 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.415 -0.803 . . . . 0.0 110.03 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.524 ' HG2' ' CG2' ' A' ' 69' ' ' VAL . 2.1 mt-10 . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.168 -0.958 . . . . 0.0 109.481 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 36' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.366 0.603 . . . . 0.0 109.631 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -143.39 126.97 16.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.339 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 34' ' ' ILE . 21.2 m-20 -138.21 159.22 42.61 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.497 ' NH1' HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -139.18 159.03 43.11 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.286 -0.884 . . . . 0.0 109.85 -179.474 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.576 ' CG1' ' CD1' ' A' ' 57' ' ' ILE . 32.7 m -142.72 159.22 57.88 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.865 . . . . 0.0 109.189 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.528 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.4 Cg_endo -77.21 174.42 12.8 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.503 2.135 . . . . 0.0 110.324 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.552 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 35.3 Cg_endo -77.21 -15.5 16.08 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.596 2.198 . . . . 0.0 110.52 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 p -102.8 24.11 11.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.65 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.528 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 5.7 mmt180 -126.83 109.04 11.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.186 -0.946 . . . . 0.0 109.966 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 22' ' ' TRP . 16.5 p30 -94.09 -11.23 31.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.031 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 20.0 p -131.21 137.13 48.79 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.576 ' CD1' ' CG1' ' A' ' 50' ' ' VAL . 6.4 tt -131.35 129.65 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.982 -1.074 . . . . 0.0 110.264 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.63 111.09 23.1 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.528 ' O ' ' CB ' ' A' ' 17' ' ' SER . 2.0 mt -84.48 158.37 21.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.165 -0.959 . . . . 0.0 109.541 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.464 ' O ' HD22 ' A' ' 62' ' ' LEU . 19.4 p -145.65 177.6 8.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 109.394 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 50.93 46.6 26.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.517 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.469 ' CD1' ' HB3' ' A' ' 59' ' ' LEU . 3.7 mt -118.19 147.34 43.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 109.355 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.478 ' O ' ' OH ' ' A' ' 68' ' ' TYR . 28.3 m-80 -44.89 117.2 3.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.197 -0.939 . . . . 0.0 108.686 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.4 Cg_endo -77.47 125.72 7.84 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.144 1.896 . . . . 0.0 111.41 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.99 59.99 2.11 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.564 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 2.6 m -151.8 166.51 31.16 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.154 -1.204 . . . . 0.0 109.506 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.564 ' N ' ' CG2' ' A' ' 66' ' ' THR . 5.1 mt-10 -125.56 127.25 46.09 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.305 -0.872 . . . . 0.0 109.21 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -134.23 -159.53 0.97 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.139 -0.975 . . . . 0.0 109.773 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.586 ' CG1' ' CG2' ' A' ' 85' ' ' ILE . 41.7 t -137.36 116.68 15.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.65 ' CG2' ' CE1' ' A' ' 36' ' ' HIS . 3.7 t -88.58 127.73 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.031 -1.043 . . . . 0.0 109.621 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.531 ' HB3' ' CD1' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -101.0 104.72 15.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 110.065 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.46 ' HB ' ' O ' ' A' ' 84' ' ' LEU . 15.0 mm -79.4 154.56 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.341 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.52 ' CG2' ' N ' ' A' ' 74' ' ' ALA . 48.3 mt -153.1 165.03 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 0.0 109.593 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.52 ' N ' ' CG2' ' A' ' 73' ' ' ILE . . . -132.57 120.62 22.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.298 -0.877 . . . . 0.0 109.389 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.503 HG23 ' CD1' ' A' ' 33' ' ' ILE . 2.4 m -112.63 144.52 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.524 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -135.94 45.23 2.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.892 . . . . 0.0 109.361 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.13 -96.46 1.15 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -109.72 -1.4 18.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.244 -1.15 . . . . 0.0 109.554 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.528 ' O ' ' CG ' ' A' ' 80' ' ' GLU . 19.8 mt-10 -106.52 172.89 6.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 0.0 109.121 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 79' ' ' GLU . 46.0 mt-10 -158.33 115.75 2.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.125 -0.984 . . . . 0.0 110.022 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.595 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -60.29 -175.17 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.283 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.595 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.1 Cg_endo -76.5 146.15 27.19 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.925 1.75 . . . . 0.0 110.107 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.471 ' HB3' HG12 ' A' ' 73' ' ' ILE . 35.6 Cg_endo -77.22 109.56 2.84 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.674 2.249 . . . . 0.0 111.357 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.526 ' CD2' ' HA ' ' A' ' 6' ' ' THR . 17.9 tp -84.21 94.54 8.42 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.586 ' CG2' ' CG1' ' A' ' 69' ' ' VAL . 2.2 mt -85.72 151.34 3.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.128 -0.983 . . . . 0.0 110.678 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.573 ' HA3' ' CZ ' ' A' ' 8' ' ' PHE . . . -142.62 179.25 20.47 Favored Glycine 0 N--CA 1.483 1.824 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.423 ' HG3' ' C ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -131.73 146.4 52.14 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.992 -1.299 . . . . 0.0 110.058 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.538 ' NE2' ' NE2' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -163.13 -167.69 1.54 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.521 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.41 136.64 3.94 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.973 -1.079 . . . . 0.0 109.953 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.485 ' OG1' ' OH ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -74.59 162.18 29.01 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.193 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.515 ' O ' ' CB ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.612 0 O-C-N 121.142 -0.973 . . . . 0.0 110.201 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.624 ' CB ' ' CD1' ' A' ' 112' ' ' TRP . 36.4 Cg_endo . . . . . 0 C--O 1.216 -0.599 0 N-CA-C 109.886 -0.852 . . . . 0.0 109.886 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.462 ' CG ' ' HG3' ' A' ' 113' ' ' GLU . 5.9 ptm85 -60.05 179.15 0.15 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.403 -0.811 . . . . 0.0 109.569 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.1 t0 67.35 8.11 6.02 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.243 -0.911 . . . . 0.0 109.272 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.583 ' CD2' ' CD1' ' A' ' 180' ' ' ILE . 8.7 tt -53.59 99.98 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.216 -0.927 . . . . 0.0 109.13 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -124.98 157.29 36.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.306 -0.871 . . . . 0.0 109.532 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 8.1 p -91.1 139.67 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.381 -0.824 . . . . 0.0 109.606 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.477 HG12 ' HB3' ' A' ' 109' ' ' LEU . 20.0 pt -125.23 -5.86 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.503 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.533 ' CB ' ' HB2' ' A' ' 109' ' ' LEU . . . -149.4 97.77 2.7 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.465 ' HB2' ' OH ' ' A' ' 182' ' ' TYR . 17.4 p -90.0 90.56 8.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.368 -0.832 . . . . 0.0 110.293 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -80.37 157.49 72.79 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 121.237 -0.914 . . . . 0.0 108.776 179.059 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.472 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.2 Cg_endo -69.9 -2.73 10.77 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.397 2.065 . . . . 0.0 110.502 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.476 ' HA ' HG21 ' A' ' 152' ' ' ILE . 1.4 p -150.53 18.38 0.82 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 149' ' ' ILE . 0.7 OUTLIER -167.22 171.63 10.63 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.034 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.586 HD23 ' CE2' ' A' ' 182' ' ' TYR . 0.5 OUTLIER -144.43 152.63 40.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.309 -0.869 . . . . 0.0 109.173 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.533 ' HB2' ' CB ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -105.75 120.72 42.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 108.86 179.293 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 147' ' ' ALA . 1.0 OUTLIER -106.29 138.06 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.115 -0.991 . . . . 0.0 110.024 -179.68 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.472 ' HB2' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -142.87 115.17 8.44 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.455 -0.778 . . . . 0.0 109.259 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.624 ' CD1' ' CB ' ' A' ' 95' ' ' PRO . 43.4 p90 -125.97 -177.43 3.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 109.561 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.462 ' HG3' ' CG ' ' A' ' 96' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.912 . . . . 0.0 109.424 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 140' ' ' VAL . 9.0 p90 . . . . . 0 N--CA 1.486 1.367 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.488 ' HB2' ' HB ' ' A' ' 140' ' ' VAL . 14.4 m-85 -103.74 129.59 51.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.03 -1.044 . . . . 0.0 108.589 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.533 ' HG3' ' CG ' ' A' ' 137' ' ' GLU . 1.5 ttm180 -95.34 85.94 4.39 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.286 -0.884 . . . . 0.0 109.518 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.608 ' HB ' ' CZ ' ' A' ' 138' ' ' PHE . 21.6 mt -84.37 153.16 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.364 -0.835 . . . . 0.0 109.193 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 27.7 p -138.73 142.45 38.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.136 -0.978 . . . . 0.0 110.189 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.621 ' CE2' ' CG2' ' A' ' 149' ' ' ILE . 4.1 m-85 -79.59 126.68 31.21 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.577 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.35 120.42 6.49 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 C--N 1.3 -1.569 0 O-C-N 121.447 -1.031 . . . . 0.0 109.064 179.571 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.572 ' HB3' ' CD1' ' A' ' 126' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.533 ' CG ' ' HG3' ' A' ' 123' ' ' ARG . 6.4 tm-20 -76.54 117.48 18.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 110.665 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.608 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 26.7 p90 -121.94 138.59 54.35 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 7.4 p -74.21 168.39 19.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.083 -1.01 . . . . 0.0 110.534 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.584 ' CG2' ' CD1' ' A' ' 124' ' ' ILE . 50.9 t -138.31 141.5 31.92 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.523 -0.736 . . . . 0.0 109.647 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.455 ' HD2' HG12 ' A' ' 140' ' ' VAL . 35.0 Cg_endo -77.17 141.43 20.69 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.528 2.152 . . . . 0.0 110.657 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.82 53.55 3.33 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.505 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 28.4 t -103.7 -11.85 17.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.178 -1.189 . . . . 0.0 109.888 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 143' ' ' SER . 1.5 mmmt 179.54 175.81 0.7 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 109.777 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.581 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -95.26 -1.23 51.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.585 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.472 ' CG2' ' HB2' ' A' ' 111' ' ' SER . 41.4 p -102.0 129.79 48.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.09 -1.006 . . . . 0.0 108.913 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.47 ' O ' HG13 ' A' ' 110' ' ' ILE . . . -126.81 156.5 41.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.118 -0.988 . . . . 0.0 109.78 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.441 HG23 ' OD1' ' A' ' 150' ' ' ASN . 8.9 m -100.82 152.26 20.72 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.352 -0.843 . . . . 0.0 109.097 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.621 ' CG2' ' CE2' ' A' ' 126' ' ' TYR . 49.9 mm -127.93 107.95 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.252 -0.905 . . . . 0.0 109.199 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.586 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 2.9 m120 -116.0 166.1 12.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.418 -0.801 . . . . 0.0 109.929 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 150' ' ' ASN . 4.0 m-80 76.07 37.73 0.36 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 109.268 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.581 HG13 ' CE2' ' A' ' 158' ' ' TYR . 4.7 tt -96.93 156.17 3.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.392 -0.817 . . . . 0.0 109.795 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 184' ' ' THR . 9.0 mttp -84.64 117.57 69.06 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 109.349 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.472 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 36.4 Cg_endo -78.73 75.88 4.78 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.479 2.12 . . . . 0.0 110.684 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . 143.08 73.05 0.03 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.52 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 162.25 134.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -1.107 . . . . 0.0 109.67 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.08 164.43 0.05 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.11 -0.994 . . . . 0.0 108.338 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.581 ' CE2' HG13 ' A' ' 152' ' ' ILE . 0.4 OUTLIER -144.97 -167.44 2.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.865 -1.147 . . . . 0.0 110.352 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.512 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 31.6 m -169.6 102.75 0.33 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.463 ' CD1' HD13 ' A' ' 108' ' ' LEU . 33.0 mm -88.11 118.6 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.025 -1.047 . . . . 0.0 109.785 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.571 ' CG2' ' CB ' ' A' ' 179' ' ' SER . 1.1 m -126.37 165.41 19.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.904 . . . . 0.0 109.19 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.549 ' CD2' ' CD1' ' A' ' 98' ' ' LEU . 1.9 pp -165.86 154.4 11.26 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.997 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.61 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 1.8 m-85 -122.69 160.38 25.97 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -127.26 101.68 6.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.865 -1.147 . . . . 0.0 109.342 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 174' ' ' SER . 15.1 t . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.333 -0.854 . . . . 0.0 109.677 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 165' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.382 0.61 . . . . 0.0 109.697 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.49 ' O ' ' O ' ' A' ' 174' ' ' SER . 0.7 OUTLIER 42.1 -166.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.19 139.71 23.1 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 120.999 -1.063 . . . . 0.0 108.229 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.61 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 33.8 Cg_endo -76.14 140.91 22.91 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.206 1.937 . . . . 0.0 111.158 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.2 t -122.11 138.22 53.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.571 ' CB ' ' CG2' ' A' ' 161' ' ' THR . 0.3 OUTLIER -131.36 155.45 47.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.088 -1.007 . . . . 0.0 110.821 -178.663 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.583 ' CD1' ' CD2' ' A' ' 98' ' ' LEU . 14.0 pt -136.96 153.3 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -91.67 156.67 17.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.0 -1.063 . . . . 0.0 110.051 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.586 ' CE2' HD23 ' A' ' 108' ' ' LEU . 51.9 t80 -143.98 169.78 17.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.405 -0.809 . . . . 0.0 109.296 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.477 ' N ' ' CD2' ' A' ' 182' ' ' TYR . 8.6 tttp -139.86 121.69 15.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.231 -0.918 . . . . 0.0 109.537 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.455 ' CB ' ' O ' ' A' ' 153' ' ' LYS . 14.7 p . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.46 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 2' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 26' ' ' ARG . 1.6 m-20 -96.62 167.61 11.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 0.0 109.344 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.524 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 4.8 p -94.52 133.62 26.64 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.491 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.533 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 36.3 Cg_endo -79.14 86.72 1.64 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.54 2.16 . . . . 0.0 110.394 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.466 ' O ' ' C ' ' A' ' 7' ' ' GLY . 16.5 p -89.32 -126.87 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.04 -1.038 . . . . 0.0 109.304 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 44.48 28.42 1.51 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.039 -2.025 . . . . 0.0 108.039 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.577 ' CE2' HG13 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -92.34 152.32 19.83 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.851 -0.794 . . . . 0.0 109.879 -178.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.431 ' O ' HG13 ' A' ' 20' ' ' VAL . 2.5 t70 -165.0 -163.15 0.68 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.471 ' OG ' ' OE1' ' A' ' 88' ' ' GLN . 83.0 p -137.45 121.26 17.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.048 -1.032 . . . . 0.0 109.908 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.496 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 3.7 p -140.6 -171.01 3.13 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.356 -0.84 . . . . 0.0 108.847 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.509 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.9 OUTLIER 43.84 36.01 1.24 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -178.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.566 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.2 mt -79.52 132.69 31.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.729 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -122.83 -179.94 4.42 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.198 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -74.08 -63.39 1.23 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.751 -1.218 . . . . 0.0 109.75 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 3.4 m-20 -88.46 23.77 2.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.148 -0.97 . . . . 0.0 109.446 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 14' ' ' THR . 42.0 p -176.04 153.68 1.34 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.57 ' CE1' HG21 ' A' ' 20' ' ' VAL . 2.5 p90 -165.66 140.53 4.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 0.0 109.089 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.509 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 4.6 m -89.79 161.44 16.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.922 -1.111 . . . . 0.0 110.964 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.577 HG13 ' CE2' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -133.54 173.23 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.543 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 28.3 m-70 -147.68 170.6 17.17 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.89 -1.131 . . . . 0.0 110.541 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.578 ' CD1' ' O ' ' A' ' 22' ' ' TRP . 16.3 p90 179.81 135.28 0.11 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.533 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.51 167.6 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.087 -1.008 . . . . 0.0 109.267 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.511 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -92.21 168.77 12.15 Favored Pre-proline 0 C--N 1.299 -1.606 0 O-C-N 121.647 -0.658 . . . . 0.0 109.796 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.18 172.75 14.94 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.675 2.25 . . . . 0.0 110.387 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.456 ' HB2' ' OD1' ' A' ' 3' ' ' ASP . 45.5 mmt-85 -90.68 28.73 1.45 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.229 -0.92 . . . . 0.0 109.48 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.503 ' CB ' ' HD2' ' A' ' 28' ' ' PRO . . . -146.26 175.35 2.77 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 109.428 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 35.3 Cg_endo -77.83 142.38 20.01 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.647 2.231 . . . . 0.0 110.35 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.638 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 46.3 pt -145.68 -170.6 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.602 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.8 p -121.26 -8.64 9.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.278 -0.889 . . . . 0.0 109.416 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.04 -168.34 32.41 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.638 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -138.64 131.54 29.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -1.178 . . . . 0.0 109.526 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.59 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 1.1 mp -83.48 133.05 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.21 -0.931 . . . . 0.0 108.835 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.496 ' CD1' HG23 ' A' ' 50' ' ' VAL . 2.4 mm -111.97 101.03 11.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.185 -0.947 . . . . 0.0 109.829 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 71' ' ' SER . 0.2 OUTLIER -109.39 111.14 22.52 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 108.602 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.572 ' CE1' HD22 ' A' ' 59' ' ' LEU . 2.1 p-80 -119.13 160.6 21.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.135 -0.978 . . . . 0.0 110.385 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.51 ' NE2' ' HB ' ' A' ' 69' ' ' VAL . 30.3 p-80 -167.25 136.02 2.67 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -47.51 177.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.922 . . . . 0.0 110.033 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.889 . . . . 0.0 109.767 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.565 ' HB2' ' CD2' ' A' ' 36' ' ' HIS . 4.1 mmt85 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.451 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 3.8 mt-30 -87.77 133.3 33.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.885 . . . . 0.0 109.95 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.52 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 1.0 OUTLIER -155.21 117.08 4.1 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.582 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.521 ' HD2' ' CG2' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -105.64 165.02 11.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.982 -1.074 . . . . 0.0 110.205 -179.124 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.559 HG22 ' CH2' ' A' ' 22' ' ' TRP . 7.2 m -140.0 161.84 53.63 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.533 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.3 Cg_endo -76.37 174.1 13.39 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.324 2.016 . . . . 0.0 110.354 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.506 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.5 Cg_endo -76.86 -14.43 17.24 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.558 2.172 . . . . 0.0 110.273 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.12 23.39 13.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.349 -0.845 . . . . 0.0 109.513 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.533 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 10.5 mmt180 -124.77 97.99 5.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -0.953 . . . . 0.0 109.719 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 3.7 p30 -85.06 -0.97 56.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.181 -0.95 . . . . 0.0 109.305 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 63.5 p -136.52 149.1 47.97 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.406 -0.808 . . . . 0.0 109.028 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.512 HD11 ' CG1' ' A' ' 50' ' ' VAL . 3.4 tt -134.14 123.22 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.116 -0.99 . . . . 0.0 109.741 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 66.4 m -91.74 116.37 28.83 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.358 -0.838 . . . . 0.0 109.456 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.572 HD22 ' CE1' ' A' ' 36' ' ' HIS . 7.2 mt -92.51 151.4 20.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.203 -0.936 . . . . 0.0 109.618 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.471 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 1.2 p -133.12 169.66 16.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.382 -0.824 . . . . 0.0 109.561 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.6 m120 59.4 39.85 21.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -0.879 . . . . 0.0 109.455 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.538 ' CD1' ' HB3' ' A' ' 59' ' ' LEU . 4.3 mt -108.89 157.64 18.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 0.0 109.293 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.475 ' O ' ' OH ' ' A' ' 68' ' ' TYR . 13.0 m-20 -60.87 134.74 92.59 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.142 -0.974 . . . . 0.0 108.819 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 37.0 Cg_endo -78.49 117.9 4.13 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.289 1.993 . . . . 0.0 110.502 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 77.46 60.51 2.81 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.552 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 2.1 m -146.58 166.67 25.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.535 -0.979 . . . . 0.0 109.895 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.552 ' N ' ' CG2' ' A' ' 66' ' ' THR . 7.5 pt-20 -121.18 136.46 54.97 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.418 -0.801 . . . . 0.0 109.303 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.576 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 0.2 OUTLIER -132.49 176.97 7.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.19 -0.944 . . . . 0.0 109.577 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.51 ' HB ' ' NE2' ' A' ' 37' ' ' HIS . 74.9 t -108.69 97.02 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.516 ' CG1' ' HB3' ' A' ' 36' ' ' HIS . 1.9 t -84.76 124.51 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.863 . . . . 0.0 110.13 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.569 ' CB ' ' CG1' ' A' ' 85' ' ' ILE . 15.5 p -105.72 137.72 43.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.877 . . . . 0.0 110.295 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.457 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 30.9 mm -124.06 120.95 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.465 -0.772 . . . . 0.0 109.149 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.541 ' CG2' ' N ' ' A' ' 74' ' ' ALA . 49.2 mt -117.6 167.16 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 109.428 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.541 ' N ' ' CG2' ' A' ' 73' ' ' ILE . . . -132.13 124.75 29.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.911 . . . . 0.0 109.393 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.459 HG23 HD11 ' A' ' 33' ' ' ILE . 0.7 OUTLIER -116.03 136.21 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 109.588 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.405 ' CB ' ' HA ' ' A' ' 29' ' ' ILE . 48.3 t30 -121.31 50.14 1.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -0.94 . . . . 0.0 109.448 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.41 -82.12 0.95 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.449 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 20.0 tpt180 -117.35 2.01 12.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -1.166 . . . . 0.0 109.62 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 1.1 mt-10 -92.96 176.45 6.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.133 -0.979 . . . . 0.0 109.415 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 36.0 mt-10 -154.57 96.31 1.88 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.522 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.551 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -59.9 178.99 0.22 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.134 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.551 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.3 Cg_endo -77.3 152.22 30.43 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.352 2.035 . . . . 0.0 110.139 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.467 ' HA ' HG12 ' A' ' 73' ' ' ILE . 35.5 Cg_endo -77.8 105.49 2.03 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.532 2.155 . . . . 0.0 110.759 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.514 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 23.1 tp -84.57 100.8 11.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -0.888 . . . . 0.0 108.941 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.569 ' CG1' ' CB ' ' A' ' 71' ' ' SER . 2.3 mt -110.1 149.92 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.126 -0.984 . . . . 0.0 110.09 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -153.47 160.5 29.26 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.434 ' HG3' HG21 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -104.19 105.09 15.12 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.127 -1.219 . . . . 0.0 109.792 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.471 ' OE1' ' OG ' ' A' ' 10' ' ' SER . 36.0 mm-40 -104.79 -165.92 1.18 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.74 145.39 6.43 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.902 -1.119 . . . . 0.0 110.929 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -78.26 140.09 38.87 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.144 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.534 ' O ' ' N ' ' A' ' 65' ' ' GLY . 2.1 t . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.549 ' HB3' ' CD1' ' A' ' 112' ' ' TRP . 34.7 Cg_endo . . . . . 0 C--O 1.215 -0.648 0 N-CA-C 109.097 -1.155 . . . . 0.0 109.097 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 9.2 ptm85 -158.81 147.6 18.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.871 -1.143 . . . . 0.0 109.682 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 4.4 t70 75.71 24.26 1.3 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.352 -0.843 . . . . 0.0 109.301 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.544 ' CD1' ' CD2' ' A' ' 162' ' ' LEU . 3.4 tp -54.96 99.81 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.186 -0.946 . . . . 0.0 109.207 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -142.8 161.78 37.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.906 . . . . 0.0 109.599 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 109' ' ' LEU . 38.4 t -103.72 150.54 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.273 -0.892 . . . . 0.0 109.592 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.527 HG12 ' CD2' ' A' ' 109' ' ' LEU . 1.2 pt -120.01 -16.06 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.378 -0.826 . . . . 0.0 109.44 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.515 ' CB ' HD22 ' A' ' 109' ' ' LEU . . . -135.99 143.1 44.63 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.532 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.8 p -135.31 93.22 2.95 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.94 -1.1 . . . . 0.0 110.531 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -75.77 165.95 49.21 Favored Pre-proline 0 C--N 1.306 -1.296 0 O-C-N 121.102 -0.999 . . . . 0.0 108.512 178.715 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 30.0 Cg_endo -69.34 -1.89 8.92 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.296 1.997 . . . . 0.0 110.58 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.478 ' HA ' HG21 ' A' ' 152' ' ' ILE . 3.3 p -151.41 17.24 0.72 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.353 -0.842 . . . . 0.0 108.953 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 149' ' ' ILE . 0.7 OUTLIER -169.93 161.54 8.91 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.768 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.578 HD23 ' CZ ' ' A' ' 182' ' ' TYR . 0.4 OUTLIER -148.05 147.76 29.93 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.412 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.527 ' CD2' HG12 ' A' ' 101' ' ' ILE . 1.5 pp -106.99 135.93 47.72 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.149 -0.969 . . . . 0.0 109.222 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.514 ' N ' HD11 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -112.47 167.05 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.109 -0.994 . . . . 0.0 110.1 -179.659 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 146' ' ' THR . 32.4 t -152.03 136.3 16.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.483 -0.761 . . . . 0.0 109.146 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.578 ' CE3' ' O ' ' A' ' 145' ' ' SER . 15.5 p90 -141.08 172.18 13.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.198 -0.939 . . . . 0.0 109.711 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.49 ' HB2' ' CG ' ' A' ' 96' ' ' ARG . 5.4 mt-10 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.299 -0.875 . . . . 0.0 109.52 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.639 ' CZ ' ' CG2' ' A' ' 165' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -125.74 171.98 10.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.034 -1.041 . . . . 0.0 109.908 -179.48 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.513 ' NE ' ' OH ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -131.8 90.36 2.82 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.076 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.603 ' HB ' ' CE1' ' A' ' 138' ' ' PHE . 12.9 mt -83.48 164.37 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.339 -0.851 . . . . 0.0 110.021 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 136' ' ' GLN . 1.9 p -141.14 151.4 43.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.372 -0.83 . . . . 0.0 109.697 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.626 ' CE2' ' CG2' ' A' ' 149' ' ' ILE . 2.9 m-85 -87.01 141.64 28.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 108.685 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.593 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -105.31 111.54 3.75 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.114 -1.227 . . . . 0.0 109.356 179.453 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.52 ' O ' ' HA ' ' A' ' 125' ' ' THR . 1.3 mp0 . . . . . 0 N--CA 1.496 1.839 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 32.5 tt0 -74.01 114.97 12.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.869 . . . . 0.0 111.349 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.603 ' CE1' ' HB ' ' A' ' 124' ' ' ILE . 44.0 p90 -117.48 156.74 27.48 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.578 ' O ' ' CD2' ' A' ' 138' ' ' PHE . 0.7 OUTLIER -74.19 -171.76 1.24 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.824 -1.172 . . . . 0.0 110.744 -178.31 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.559 ' CG2' ' CD1' ' A' ' 124' ' ' ILE . 71.2 t -154.53 143.12 14.59 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.32 -0.862 . . . . 0.0 109.41 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.522 ' HD2' ' CG1' ' A' ' 140' ' ' VAL . 35.5 Cg_endo -78.48 140.55 17.11 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.451 2.101 . . . . 0.0 110.2 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.94 38.29 3.2 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.7 t -105.15 -0.74 26.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -1.166 . . . . 0.0 109.694 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.57 162.65 32.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.117 -0.989 . . . . 0.0 109.527 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.578 ' O ' ' CE3' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -90.9 9.17 31.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.559 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.558 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 71.7 p -119.72 158.78 25.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.887 . . . . 0.0 109.281 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.596 ' CB ' ' CD1' ' A' ' 124' ' ' ILE . . . -135.51 153.32 51.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.193 -0.942 . . . . 0.0 109.633 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.3 t -98.94 151.26 21.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.193 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.626 ' CG2' ' CE2' ' A' ' 126' ' ' TYR . 12.4 mm -133.05 111.36 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.198 -0.939 . . . . 0.0 109.399 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.581 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 9.8 m120 -122.32 169.18 11.19 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.311 -0.868 . . . . 0.0 109.955 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 2.0 m120 76.12 20.23 1.68 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.959 . . . . 0.0 109.041 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.522 ' CD1' HD12 ' A' ' 108' ' ' LEU . 7.4 tt -76.7 149.45 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.441 -0.787 . . . . 0.0 109.643 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.47 ' HB2' ' OH ' ' A' ' 158' ' ' TYR . 4.2 mtpm? -103.7 117.44 59.83 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.959 . . . . 0.0 109.487 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.515 ' HA ' ' CB ' ' A' ' 184' ' ' THR . 35.3 Cg_endo -77.83 166.67 24.93 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.407 2.072 . . . . 0.0 110.481 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . 74.07 59.43 3.96 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 162.92 130.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -1.147 . . . . 0.0 109.599 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 156' ' ' ALA . 0.3 OUTLIER -47.22 161.72 0.07 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -141.78 176.58 8.8 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.773 -1.204 . . . . 0.0 110.44 -179.186 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.522 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 0.6 OUTLIER -146.89 168.72 20.76 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 179.235 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.501 ' CD1' ' O ' ' A' ' 159' ' ' THR . 31.1 mm -147.47 120.5 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.668 -1.27 . . . . 0.0 109.707 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 179' ' ' SER . 0.9 OUTLIER -126.89 163.7 23.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.244 -0.91 . . . . 0.0 109.119 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.544 ' CD2' ' CD1' ' A' ' 98' ' ' LEU . 2.5 pp -160.86 146.32 14.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.867 -1.146 . . . . 0.0 110.988 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.593 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 1.9 m-85 -115.71 90.7 3.4 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.43 ' HB1' ' HD3' ' A' ' 95' ' ' PRO . . . -57.18 135.37 56.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.933 -1.104 . . . . 0.0 109.437 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.639 ' CG2' ' CZ ' ' A' ' 121' ' ' TYR . 48.2 t . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 109.576 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 175' ' ' SER . 5.0 p . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.256 0.55 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 174' ' ' SER . 85.8 p -54.35 -168.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 109.439 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.47 151.91 89.67 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.942 . . . . 0.0 108.89 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.593 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 35.9 Cg_endo -79.24 118.92 4.08 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.427 2.085 . . . . 0.0 111.433 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 161' ' ' THR . 2.7 t -84.79 127.71 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 161' ' ' THR . 0.0 OUTLIER -124.52 129.31 50.38 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.21 -0.932 . . . . 0.0 110.586 -178.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.514 ' O ' ' CG2' ' A' ' 159' ' ' THR . 40.3 pt -114.78 -162.79 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.474 ' OD1' ' N ' ' A' ' 181' ' ' ASN . 1.1 m120 -124.5 156.81 36.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.047 -1.033 . . . . 0.0 109.758 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.578 ' CZ ' HD23 ' A' ' 108' ' ' LEU . 64.9 t80 -153.19 170.55 20.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.312 -0.868 . . . . 0.0 109.164 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.412 ' N ' ' CG ' ' A' ' 182' ' ' TYR . 19.2 mtpt -139.18 134.21 32.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 109.448 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.593 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 2.9 p . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.467 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.522 ' CD1' ' O ' ' A' ' 80' ' ' GLU . 1.3 mp . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.272 0.558 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.45 ' OD2' ' HB2' ' A' ' 26' ' ' ARG . 1.1 m-20 -100.75 152.79 20.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 0.0 109.511 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -95.08 125.89 48.77 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.496 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.533 ' O ' ' CD2' ' A' ' 84' ' ' LEU . 36.2 Cg_endo -78.67 81.95 2.62 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.464 2.11 . . . . 0.0 110.322 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.536 ' HA ' ' CD2' ' A' ' 84' ' ' LEU . 2.7 p -74.68 -109.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.163 -0.96 . . . . 0.0 109.666 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.425 ' HA3' ' HB ' ' A' ' 23' ' ' VAL . . . 45.71 26.72 1.92 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.566 ' CE2' ' HA3' ' A' ' 86' ' ' GLY . 14.1 t80 -56.14 128.03 33.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.544 -0.974 . . . . 0.0 110.094 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 0.8 OUTLIER -147.75 -179.28 6.77 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.457 ' HB2' HD12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -155.42 117.86 4.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.104 -0.997 . . . . 0.0 110.062 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.51 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 0.8 OUTLIER -145.73 -167.65 2.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.059 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.511 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 4.6 m-20 42.23 38.49 1.16 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 18' ' ' PHE . 2.5 mt -80.45 149.84 5.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.775 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -140.48 169.15 18.2 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -65.43 -62.61 1.43 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.71 -1.244 . . . . 0.0 110.159 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.9 OUTLIER -91.37 27.86 1.83 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.116 -0.99 . . . . 0.0 109.511 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 14' ' ' THR . 56.7 p 179.48 154.72 0.5 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 13' ' ' ILE . 3.5 p90 -166.83 144.18 4.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.13 -0.981 . . . . 0.0 109.279 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 28.9 m -85.95 148.18 25.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.637 -1.289 . . . . 0.0 110.369 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.582 HG21 ' CE1' ' A' ' 18' ' ' PHE . 1.3 t -118.16 171.62 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.536 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 49.8 m-70 -151.76 165.02 35.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.004 -1.06 . . . . 0.0 110.006 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.585 ' CZ2' HG23 ' A' ' 50' ' ' VAL . 42.6 p90 -171.98 145.42 1.84 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.442 -0.786 . . . . 0.0 109.152 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.521 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.51 169.21 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.054 -1.029 . . . . 0.0 109.189 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.52 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -98.65 161.05 26.41 Favored Pre-proline 0 C--N 1.298 -1.643 0 O-C-N 121.54 -0.725 . . . . 0.0 109.819 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' A' ' 5' ' ' PRO . 35.8 Cg_endo -78.79 159.78 27.85 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.687 2.258 . . . . 0.0 110.397 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.45 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 5.1 mmm180 -90.28 17.07 7.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.222 -0.924 . . . . 0.0 109.408 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.54 ' CB ' ' HD2' ' A' ' 28' ' ' PRO . . . -121.04 177.13 1.57 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 109.374 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 35.4 Cg_endo -77.83 140.03 18.09 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.52 2.147 . . . . 0.0 110.333 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.636 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 28.7 pt -153.86 -173.47 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.526 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 17.1 p -133.95 3.31 3.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 109.579 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.57 -172.19 30.34 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.636 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -144.25 127.95 17.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.237 -1.155 . . . . 0.0 109.668 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.532 ' CG2' ' HD2' ' A' ' 49' ' ' ARG . 1.6 mp -80.74 130.84 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.274 -0.891 . . . . 0.0 108.772 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 48' ' ' ASP . 2.5 mm -107.54 112.34 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.166 -0.959 . . . . 0.0 109.966 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.529 ' CG ' ' HG2' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -104.55 116.77 32.65 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.137 -0.977 . . . . 0.0 108.582 179.098 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.553 ' CD2' ' C ' ' A' ' 36' ' ' HIS . 0.1 OUTLIER -105.95 144.36 32.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.085 -1.01 . . . . 0.0 109.797 -179.11 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.579 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 41.6 p-80 -169.5 114.47 0.54 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.586 -0.696 . . . . 0.0 109.91 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.511 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . . . -61.37 175.21 0.6 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.42 -0.8 . . . . 0.0 109.609 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.909 . . . . 0.0 109.323 179.779 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.51 ' CZ ' ' CB ' ' A' ' 46' ' ' ARG . 2.8 ptm85 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.297 0.57 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.529 ' HG2' ' CG ' ' A' ' 35' ' ' ARG . 30.1 mt-30 -139.18 119.58 13.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.276 -0.89 . . . . 0.0 109.701 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.522 ' HB3' ' CD1' ' A' ' 57' ' ' ILE . 0.6 OUTLIER -111.58 118.22 35.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.358 -0.839 . . . . 0.0 108.822 179.503 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.532 ' HD2' ' CG2' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -92.99 140.31 29.6 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.013 -1.054 . . . . 0.0 109.546 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.585 HG23 ' CZ2' ' A' ' 22' ' ' TRP . 1.8 m -117.58 163.16 25.15 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.277 -0.89 . . . . 0.0 109.555 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.467 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 34.5 Cg_endo -76.98 174.84 12.2 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.634 2.222 . . . . 0.0 110.486 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.562 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.9 Cg_endo -76.73 -15.8 16.84 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.562 2.175 . . . . 0.0 110.316 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.6 m -103.26 25.71 9.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.277 -0.889 . . . . 0.0 109.16 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.463 ' HG3' ' HG2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -127.14 126.22 42.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.37 -0.831 . . . . 0.0 109.509 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.466 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 25.2 p-10 -111.82 5.43 19.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.884 . . . . 0.0 109.528 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.498 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 89.3 p -146.12 150.05 35.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 0.0 109.313 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 48' ' ' ASP . 4.2 tt -138.21 125.16 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -0.94 . . . . 0.0 109.586 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 0.3 OUTLIER -84.83 107.64 17.1 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.351 -0.843 . . . . 0.0 109.496 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 17' ' ' SER . 0.4 OUTLIER -84.82 149.61 25.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.94 . . . . 0.0 109.259 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.465 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 6.3 p -134.61 166.15 23.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.139 -0.976 . . . . 0.0 109.703 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 60' ' ' THR . 3.7 m120 61.04 61.06 1.68 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.283 -0.886 . . . . 0.0 109.655 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 16' ' ' ASN . 1.7 mt -132.92 138.18 46.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.352 -0.842 . . . . 0.0 109.166 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.542 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 3.0 m-20 -44.56 133.3 4.78 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.12 -0.988 . . . . 0.0 108.797 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.456 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 35.9 Cg_endo -77.74 135.22 14.17 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.333 2.022 . . . . 0.0 111.373 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 71.36 64.91 2.59 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.43 HG21 ' N ' ' A' ' 67' ' ' GLU . 2.6 m -158.44 151.57 22.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.251 -1.146 . . . . 0.0 110.889 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 1.7 tt0 -84.43 133.95 34.48 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.542 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 28.0 m-85 -119.81 130.98 55.18 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.882 -1.136 . . . . 0.0 110.856 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.579 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 3.4 t -85.56 97.49 5.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.429 HG21 ' NE2' ' A' ' 88' ' ' GLN . 3.1 t -94.06 125.48 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.291 -0.88 . . . . 0.0 109.759 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.507 ' CB ' HG12 ' A' ' 85' ' ' ILE . 1.3 p -96.74 138.62 34.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 109.72 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.442 ' O ' HG23 ' A' ' 72' ' ' ILE . 17.8 mm -114.45 77.35 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.332 -0.855 . . . . 0.0 109.27 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.491 ' CG2' ' N ' ' A' ' 74' ' ' ALA . 24.5 mt -75.04 163.71 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 109.46 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.491 ' N ' ' CG2' ' A' ' 73' ' ' ILE . . . -121.89 160.2 25.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 0.0 109.583 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.446 ' O ' ' OG1' ' A' ' 30' ' ' THR . 0.4 OUTLIER -145.11 131.9 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -0.923 . . . . 0.0 109.318 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -116.63 50.47 1.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.278 -0.889 . . . . 0.0 109.395 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.05 -90.24 1.34 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.414 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 17.4 tpp180 -114.53 0.77 14.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -1.129 . . . . 0.0 109.638 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 0.8 OUTLIER -96.44 -164.54 1.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.136 -0.978 . . . . 0.0 109.262 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.522 ' O ' ' CD1' ' A' ' 2' ' ' LEU . 23.2 mt-10 -147.58 -169.56 3.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.171 -0.956 . . . . 0.0 109.571 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.577 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.6 OUTLIER -155.33 -177.41 0.73 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.371 -0.831 . . . . 0.0 109.062 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.577 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.1 Cg_endo -77.85 131.03 10.88 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.162 1.908 . . . . 0.0 109.963 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.464 ' HA ' HG12 ' A' ' 73' ' ' ILE . 36.0 Cg_endo -77.8 86.87 1.58 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.524 2.149 . . . . 0.0 111.179 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.536 ' CD2' ' HA ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -75.26 131.28 40.25 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.096 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.545 ' CG2' ' CG1' ' A' ' 69' ' ' VAL . 3.8 mt -117.54 150.65 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.011 -1.055 . . . . 0.0 110.346 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.566 ' HA3' ' CE2' ' A' ' 8' ' ' PHE . . . -132.58 176.97 19.15 Favored Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.074 -2.011 . . . . 0.0 108.074 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -142.66 111.9 6.59 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.101 -1.234 . . . . 0.0 110.344 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.576 ' HG3' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -113.24 -158.82 0.66 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.014 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -148.07 130.06 15.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.716 -1.24 . . . . 0.0 110.525 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.508 ' OG1' ' CE2' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -74.45 134.83 42.32 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 65' ' ' GLY . 7.5 t . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.54 ' CB ' ' O ' ' A' ' 113' ' ' GLU . 36.7 Cg_endo . . . . . 0 C--O 1.215 -0.637 0 N-CA-C 110.267 -0.705 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.476 ' O ' ' N ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -86.53 -168.27 2.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.155 -0.966 . . . . 0.0 109.511 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 111' ' ' SER . 11.5 t0 71.78 33.09 1.8 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 109.702 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.527 HD22 ' CG2' ' A' ' 180' ' ' ILE . 31.5 tp -71.95 92.77 1.3 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.912 . . . . 0.0 109.396 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -133.28 157.88 44.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -0.926 . . . . 0.0 109.668 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 9.5 p -96.96 141.77 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.81 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.544 ' CD1' ' CD2' ' A' ' 109' ' ' LEU . 12.1 pt -123.59 -8.55 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.532 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 108' ' ' LEU . . . -147.12 112.83 5.69 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.488 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 12.9 m -112.72 96.44 5.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.136 -0.977 . . . . 0.0 110.599 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -83.11 165.92 38.3 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.243 -0.91 . . . . 0.0 108.653 178.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.457 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 30.0 Cg_endo -69.44 -3.83 12.58 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.275 1.984 . . . . 0.0 110.478 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.48 ' HA ' HG21 ' A' ' 152' ' ' ILE . 4.9 p -149.08 16.67 0.95 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.396 -0.815 . . . . 0.0 108.94 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.542 ' O ' ' CD2' ' A' ' 108' ' ' LEU . 0.7 OUTLIER -169.92 165.46 9.59 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.071 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.592 HD23 ' CE2' ' A' ' 182' ' ' TYR . 0.6 OUTLIER -145.65 155.69 43.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.358 -0.839 . . . . 0.0 109.259 -179.706 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.544 ' CD2' ' CD1' ' A' ' 101' ' ' ILE . 21.1 tp -105.42 136.52 44.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.284 -0.885 . . . . 0.0 108.94 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.523 ' CD1' ' HB1' ' A' ' 147' ' ' ALA . 1.2 pt -124.82 140.72 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.055 -1.028 . . . . 0.0 110.369 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 97' ' ' ASP . 7.5 t -134.46 145.19 48.61 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.602 ' CH2' ' N ' ' A' ' 147' ' ' ALA . 11.9 p90 -134.56 -171.31 2.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.076 -1.015 . . . . 0.0 110.707 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 95' ' ' PRO . 4.4 mm-40 . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.591 -0.693 . . . . 0.0 109.668 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.483 ' HB2' ' O ' ' A' ' 140' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.484 ' HB2' ' HB ' ' A' ' 140' ' ' VAL . 2.7 m-85 -111.76 147.89 34.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.965 -1.084 . . . . 0.0 109.83 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.582 ' O ' ' CD1' ' A' ' 163' ' ' TYR . 21.4 ttm180 -120.42 84.22 2.19 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.601 ' HB ' ' CE1' ' A' ' 138' ' ' PHE . 7.6 mt -84.42 168.72 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 110.274 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 136' ' ' GLN . 1.5 p -144.37 156.08 44.07 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.61 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.6 ' CE2' HG23 ' A' ' 149' ' ' ILE . 3.5 m-85 -91.24 137.43 32.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.519 -0.738 . . . . 0.0 109.034 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.615 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -102.69 111.52 4.02 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 . . . . . 0 C--N 1.298 -1.652 0 O-C-N 121.134 -1.215 . . . . 0.0 109.311 179.293 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.478 ' O ' ' HA ' ' A' ' 125' ' ' THR . 1.2 tt0 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 0.5 OUTLIER -74.72 133.18 42.07 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.346 -0.846 . . . . 0.0 110.89 -178.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.601 ' CE1' ' HB ' ' A' ' 124' ' ' ILE . 43.6 p90 -134.69 145.19 48.28 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.458 ' O ' HG21 ' A' ' 140' ' ' VAL . 1.2 p -74.05 -175.71 2.29 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.943 -1.098 . . . . 0.0 110.791 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.544 ' CG1' ' HD2' ' A' ' 141' ' ' PRO . 72.0 t -157.21 144.03 13.38 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.446 -0.784 . . . . 0.0 109.297 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.544 ' HD2' ' CG1' ' A' ' 140' ' ' VAL . 34.0 Cg_endo -76.17 140.89 22.81 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.379 2.052 . . . . 0.0 110.361 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -88.58 35.62 3.58 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.401 ' C ' ' HD3' ' A' ' 144' ' ' LYS . 0.3 OUTLIER -105.27 -22.01 13.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.096 -1.237 . . . . 0.0 109.463 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.401 ' HD3' ' C ' ' A' ' 143' ' ' SER . 2.3 mptt -116.44 150.77 37.29 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.522 -0.736 . . . . 0.0 110.03 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.56 4.01 50.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.351 -0.843 . . . . 0.0 109.108 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.543 ' C ' ' CH2' ' A' ' 112' ' ' TRP . 1.6 p -130.2 151.94 50.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.389 -0.819 . . . . 0.0 108.827 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.602 ' N ' ' CH2' ' A' ' 112' ' ' TRP . . . -116.76 153.41 32.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.029 -1.045 . . . . 0.0 109.969 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.8 t -104.66 154.19 20.28 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.365 -0.834 . . . . 0.0 109.1 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.6 HG23 ' CE2' ' A' ' 126' ' ' TYR . 9.4 mm -134.75 114.25 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.482 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.58 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 3.2 m120 -122.28 170.95 9.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.287 -0.883 . . . . 0.0 109.984 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 4.3 m120 70.57 28.19 3.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 0.0 109.115 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.525 ' CD1' HD13 ' A' ' 108' ' ' LEU . 5.1 tt -84.56 147.13 5.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.393 -0.817 . . . . 0.0 109.713 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.459 ' HB2' ' OH ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -93.22 111.3 51.28 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.345 -0.847 . . . . 0.0 109.19 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.454 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 35.8 Cg_endo -77.29 141.51 20.5 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.319 2.013 . . . . 0.0 110.451 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . 90.41 64.59 1.22 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 163.49 134.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -1.154 . . . . 0.0 109.491 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 6.9 t0 -49.31 151.62 1.43 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.615 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -135.29 178.66 6.86 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.847 -1.158 . . . . 0.0 110.246 -179.285 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.555 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 3.4 m -150.06 107.7 3.67 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.531 ' CD1' HD11 ' A' ' 108' ' ' LEU . 9.0 mt -94.39 130.08 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.617 -1.302 . . . . 0.0 109.966 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.52 HG22 ' CB ' ' A' ' 179' ' ' SER . 1.8 m -132.15 113.67 13.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.356 -0.84 . . . . 0.0 109.265 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.583 ' HB2' HG12 ' A' ' 124' ' ' ILE . 2.1 pp -99.18 127.16 45.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.29 -0.881 . . . . 0.0 110.164 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.619 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 4.2 m-85 -100.39 171.94 7.45 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.468 ' HB2' ' OG ' ' A' ' 175' ' ' SER . . . -148.92 135.24 19.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.138 -0.976 . . . . 0.0 109.628 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.464 HG21 ' HA ' ' A' ' 174' ' ' SER . 97.0 t . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 109.399 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.464 ' HA ' HG21 ' A' ' 165' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.575 0.702 . . . . 0.0 110.062 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.468 ' OG ' ' HB2' ' A' ' 164' ' ' ALA . 0.6 OUTLIER -115.66 159.89 20.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.667 -0.646 . . . . 0.0 109.561 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 175' ' ' SER . 1.7 ptmt -42.36 118.69 2.2 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.171 -0.955 . . . . 0.0 110.45 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.619 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 29.7 Cg_endo -70.96 122.1 8.48 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.368 2.045 . . . . 0.0 111.199 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 161' ' ' THR . 57.4 t -84.77 118.79 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.52 ' CB ' HG22 ' A' ' 161' ' ' THR . 0.0 OUTLIER -109.9 126.52 53.95 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.132 -0.98 . . . . 0.0 110.551 -178.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.527 ' CG2' HD22 ' A' ' 98' ' ' LEU . 32.1 pt -117.55 151.16 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -79.5 163.33 24.8 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.006 -1.059 . . . . 0.0 109.8 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.592 ' CE2' HD23 ' A' ' 108' ' ' LEU . 46.2 t80 -159.19 114.98 2.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.437 -0.789 . . . . 0.0 109.122 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -87.14 116.87 25.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.113 -0.992 . . . . 0.0 109.447 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.558 HG23 ' CD1' ' A' ' 158' ' ' TYR . 9.2 p . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.481 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.512 HD11 ' CB ' ' A' ' 25' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.437 ' CG ' ' HB2' ' A' ' 26' ' ' ARG . 1.5 m-20 -81.04 161.53 24.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.235 -0.916 . . . . 0.0 109.459 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.1 t -95.2 112.01 57.0 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.513 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.49 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 35.1 Cg_endo -77.25 78.78 3.35 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.34 2.027 . . . . 0.0 110.134 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.468 ' HA ' ' CD2' ' A' ' 84' ' ' LEU . 0.9 OUTLIER -87.48 -104.6 0.07 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.238 -0.913 . . . . 0.0 109.565 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 9' ' ' ASP . . . 44.2 27.03 1.03 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.402 ' N ' ' C ' ' A' ' 6' ' ' THR . 12.7 t80 -49.06 93.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.44 -1.035 . . . . 0.0 109.688 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 7' ' ' GLY . 9.8 t0 -121.3 84.07 2.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.366 -0.833 . . . . 0.0 108.994 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 83.1 p -84.43 131.79 34.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.495 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.47 ' O ' ' HB ' ' A' ' 19' ' ' THR . 76.7 p -156.01 -156.36 0.63 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.336 -0.853 . . . . 0.0 109.537 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.542 ' CB ' ' OG1' ' A' ' 19' ' ' THR . 0.6 OUTLIER 45.0 34.59 1.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -178.537 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.566 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 13.6 mm -62.13 134.25 27.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.749 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.571 ' CB ' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -123.0 178.24 5.15 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 177.149 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 91' ' ' VAL . . . -74.07 -74.73 0.18 Allowed 'General case' 0 C--N 1.292 -1.902 0 O-C-N 120.605 -1.309 . . . . 0.0 109.155 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.6 OUTLIER -75.68 -1.35 24.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.159 -0.963 . . . . 0.0 109.338 179.731 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.571 ' O ' ' CB ' ' A' ' 14' ' ' THR . 14.4 p -146.54 162.08 39.11 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.281 -0.887 . . . . 0.0 109.096 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.624 ' CD2' ' NE2' ' A' ' 88' ' ' GLN . 4.9 p90 -167.38 137.72 2.92 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.907 -1.121 . . . . 0.0 108.419 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.542 ' OG1' ' CB ' ' A' ' 12' ' ' ASP . 11.9 m -80.99 150.01 29.08 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.77 -1.206 . . . . 0.0 111.172 -178.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.623 ' CG2' ' CE1' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -135.34 109.85 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.518 ' CE1' HG23 ' A' ' 19' ' ' THR . 3.0 m-70 -102.01 166.31 10.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.032 -1.043 . . . . 0.0 110.509 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.502 ' CH2' HG23 ' A' ' 57' ' ' ILE . 38.9 p90 -175.71 147.72 0.83 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.49 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -74.51 159.27 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.966 -1.084 . . . . 0.0 110.083 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.79 168.97 8.46 Favored Pre-proline 0 C--N 1.299 -1.63 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.512 ' CB ' HD11 ' A' ' 2' ' ' LEU . 35.9 Cg_endo -78.61 -159.53 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.63 2.22 . . . . 0.0 110.196 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.437 ' HB2' ' CG ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -127.66 12.69 6.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.297 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.503 ' CB ' ' HD2' ' A' ' 28' ' ' PRO . . . -123.17 175.14 2.9 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 109.38 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 35.6 Cg_endo -78.24 112.05 3.15 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.586 2.19 . . . . 0.0 110.418 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.504 HD11 ' CG ' ' A' ' 25' ' ' PRO . 7.6 pt -116.0 -174.23 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.9 . . . . 0.0 109.388 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.5 p -114.88 2.87 14.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.567 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.507 ' HA2' ' N ' ' A' ' 52' ' ' PRO . . . 131.41 -173.04 20.59 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -134.26 145.3 48.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -1.111 . . . . 0.0 109.35 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.524 ' CG2' ' HD2' ' A' ' 49' ' ' ARG . 1.8 mp -92.9 129.17 43.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.269 -0.895 . . . . 0.0 109.065 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.522 ' CD1' HG21 ' A' ' 50' ' ' VAL . 1.7 mm -109.76 104.38 16.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.243 -0.91 . . . . 0.0 109.673 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 10.2 ttp85 -106.87 131.0 54.46 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.11 -0.994 . . . . 0.0 109.209 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.621 ' CD2' ' CD2' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -117.41 131.82 56.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.171 -0.956 . . . . 0.0 109.622 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.561 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 41.9 p-80 -151.04 132.74 14.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.316 -0.865 . . . . 0.0 109.796 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -53.22 -168.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.356 -0.84 . . . . 0.0 109.87 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.047 -1.033 . . . . 0.0 110.4 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.585 ' HG3' ' CE1' ' A' ' 36' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -127.77 126.78 42.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 109.993 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.478 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 0.8 OUTLIER -117.5 118.11 31.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.357 -0.84 . . . . 0.0 108.831 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.524 ' HD2' ' CG2' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -92.73 153.63 18.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.033 -1.042 . . . . 0.0 110.034 -179.407 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.522 HG21 ' CD1' ' A' ' 34' ' ' ILE . 1.1 m -129.03 163.75 43.66 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.824 . . . . 0.0 109.297 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.522 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.8 Cg_endo -77.43 174.8 12.15 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.593 2.195 . . . . 0.0 110.419 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.576 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 35.1 Cg_endo -77.06 -15.64 16.26 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.622 2.215 . . . . 0.0 110.582 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.19 28.71 6.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.244 -0.91 . . . . 0.0 109.555 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.522 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -128.87 103.33 6.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.93 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.68 -12.23 37.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.185 -0.947 . . . . 0.0 109.104 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 56.1 p -135.7 130.35 34.09 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.522 HD13 ' CG1' ' A' ' 50' ' ' VAL . 3.4 tt -126.65 133.78 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.075 -1.015 . . . . 0.0 110.083 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.49 106.12 18.1 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.621 ' CD2' ' CD2' ' A' ' 36' ' ' HIS . 1.5 mt -84.62 148.56 26.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.155 -0.965 . . . . 0.0 109.566 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.503 ' CG2' ' HB3' ' A' ' 17' ' ' SER . 27.6 p -142.24 -179.61 6.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.341 -0.849 . . . . 0.0 109.435 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 60' ' ' THR . 17.5 m-80 60.93 16.3 6.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.255 -0.903 . . . . 0.0 109.365 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.528 ' CD1' ' HB3' ' A' ' 59' ' ' LEU . 0.9 OUTLIER -94.86 143.57 26.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 109.261 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.46 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 2.5 t-20 -45.71 116.01 3.06 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 34.6 Cg_endo -75.86 136.63 18.93 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.214 1.943 . . . . 0.0 111.043 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 74.93 63.69 2.49 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.526 ' CG2' ' CE2' ' A' ' 68' ' ' TYR . 2.0 m -162.88 146.25 10.99 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.071 -1.253 . . . . 0.0 110.138 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.544 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 2.2 tp10 -74.79 128.23 35.07 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 20.4 m-85 -136.45 110.59 8.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.967 -1.083 . . . . 0.0 110.041 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.561 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 93.4 t -71.02 141.63 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 35' ' ' ARG . 1.3 t -117.57 126.5 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.993 -1.067 . . . . 0.0 110.022 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.483 ' HA ' HG12 ' A' ' 85' ' ' ILE . 3.1 p -102.76 112.14 24.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -0.861 . . . . 0.0 109.735 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.466 HD11 HD11 ' A' ' 34' ' ' ILE . 24.8 mm -94.41 111.29 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 0.0 109.528 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.578 ' N ' ' CD1' ' A' ' 73' ' ' ILE . 1.4 mp -112.3 122.44 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.961 . . . . 0.0 109.34 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.527 ' CB ' ' OG ' ' A' ' 81' ' ' SER . . . -98.03 122.05 40.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.238 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.411 HG13 ' HG2' ' A' ' 80' ' ' GLU . 13.0 m -132.79 141.04 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 109.7 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.456 ' HB2' ' HA ' ' A' ' 29' ' ' ILE . 30.8 t30 -110.91 44.71 1.24 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 109.363 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.11 -95.94 0.86 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -0.35 19.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -1.123 . . . . 0.0 109.624 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 1.2 tt0 -116.88 171.88 7.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.58 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 30.3 mt-10 -149.84 96.46 2.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.437 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.553 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -59.77 179.62 0.2 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.265 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.4 Cg_endo -77.48 154.87 31.76 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.355 2.037 . . . . 0.0 110.348 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.52 143.73 21.95 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.636 2.224 . . . . 0.0 110.761 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.468 ' CD2' ' HA ' ' A' ' 6' ' ' THR . 23.7 tp -138.74 92.96 2.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.44 -0.788 . . . . 0.0 108.923 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.483 HG12 ' HA ' ' A' ' 71' ' ' SER . 1.9 mt -99.33 153.16 4.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.134 -0.979 . . . . 0.0 110.075 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.526 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . -148.37 -166.84 13.13 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -125.8 138.17 53.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.163 -1.198 . . . . 0.0 109.603 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.624 ' NE2' ' CD2' ' A' ' 18' ' ' PHE . 11.7 tm0? -154.5 115.09 3.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.293 -0.88 . . . . 0.0 109.197 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.544 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -98.55 134.3 41.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.315 -0.866 . . . . 0.0 109.714 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.435 ' CG2' ' O ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -74.24 162.67 28.69 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.131 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.547 ' CG2' HG21 ' A' ' 13' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.132 -0.98 . . . . 0.0 110.982 -178.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.649 ' CB ' ' CD1' ' A' ' 112' ' ' TRP . 34.6 Cg_endo . . . . . 0 C--O 1.215 -0.656 0 N-CA-C 109.487 -1.005 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 112' ' ' TRP . 0.9 OUTLIER -49.96 -178.53 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.695 -0.628 . . . . 0.0 109.634 -179.502 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER 67.46 8.25 6.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.332 -0.855 . . . . 0.0 109.333 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.532 ' CD1' HD13 ' A' ' 162' ' ' LEU . 7.9 tp -57.27 90.21 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.221 -0.924 . . . . 0.0 108.923 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 97' ' ' ASP . 11.1 pt-20 -130.36 161.31 31.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.934 . . . . 0.0 109.523 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 10.7 p -95.76 144.27 10.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.29 -0.881 . . . . 0.0 109.638 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.532 ' CG1' HD21 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -132.6 3.79 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.279 -0.888 . . . . 0.0 109.449 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.52 ' CB ' ' HB2' ' A' ' 109' ' ' LEU . . . -162.97 94.26 0.83 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.469 ' HB2' ' OH ' ' A' ' 182' ' ' TYR . 21.0 p -91.68 105.85 18.04 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.409 -0.807 . . . . 0.0 110.585 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -93.25 159.39 35.43 Favored Pre-proline 0 C--N 1.304 -1.373 0 O-C-N 121.371 -0.83 . . . . 0.0 108.889 178.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.426 ' O ' ' HG3' ' A' ' 154' ' ' PRO . 30.6 Cg_endo -70.22 -2.65 10.84 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.472 2.114 . . . . 0.0 110.455 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.515 ' HA ' HG21 ' A' ' 152' ' ' ILE . 61.9 p -150.5 19.49 0.83 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 149' ' ' ILE . 0.5 OUTLIER -168.98 167.7 10.59 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.982 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.585 HD23 ' CE2' ' A' ' 182' ' ' TYR . 0.5 OUTLIER -140.37 151.77 45.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.335 -0.853 . . . . 0.0 109.224 -179.782 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.532 HD21 ' CG1' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -106.26 118.84 37.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.109 179.389 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.532 HD12 ' CA ' ' A' ' 148' ' ' THR . 0.0 OUTLIER -101.85 145.1 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.258 -0.901 . . . . 0.0 109.764 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.458 ' OG ' HG23 ' A' ' 146' ' ' THR . 0.4 OUTLIER -140.82 115.75 9.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.403 -0.811 . . . . 0.0 109.135 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.649 ' CD1' ' CB ' ' A' ' 95' ' ' PRO . 25.8 p90 -145.01 170.61 15.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.408 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.421 ' HG3' ' HG3' ' A' ' 96' ' ' ARG . 4.8 mt-10 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.15 -0.969 . . . . 0.0 109.495 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.593 ' CD2' ' N ' ' A' ' 122' ' ' TYR . 4.7 p90 . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.593 ' N ' ' CD2' ' A' ' 121' ' ' TYR . 4.2 m-85 -130.42 139.43 50.6 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.591 ' HG2' ' CE2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -96.73 102.88 14.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.785 -1.197 . . . . 0.0 110.035 -179.017 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.566 HD13 ' CZ ' ' A' ' 138' ' ' PHE . 6.4 mt -84.57 106.07 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.531 ' HA ' ' CB ' ' A' ' 137' ' ' GLU . 32.3 p -93.05 141.96 27.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 110.549 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.656 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 4.8 m-30 -94.66 136.77 34.58 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.603 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -105.09 108.94 3.16 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.244 -1.151 . . . . 0.0 109.734 179.923 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.59 ' O ' ' CG ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.531 ' CB ' ' HA ' ' A' ' 125' ' ' THR . 7.3 pt-20 -112.38 145.62 39.77 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.918 -1.114 . . . . 0.0 110.774 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.566 ' CZ ' HD13 ' A' ' 124' ' ' ILE . 6.3 p90 -135.23 150.52 50.09 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.504 ' CG2' ' CE2' ' A' ' 121' ' ' TYR . 2.0 p -74.61 142.69 44.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.988 -1.07 . . . . 0.0 111.106 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.529 ' CG2' HG13 ' A' ' 124' ' ' ILE . 2.0 t -110.61 146.24 33.94 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.481 ' N ' HG11 ' A' ' 140' ' ' VAL . 34.5 Cg_endo -77.38 140.12 19.1 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.342 2.028 . . . . 0.0 109.761 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.08 13.63 43.44 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.458 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 7.6 t -105.25 23.59 13.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.034 -1.274 . . . . 0.0 109.855 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 143' ' ' SER . 1.6 mmtt -155.11 142.0 19.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.115 -0.991 . . . . 0.0 109.85 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.562 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -95.11 -8.74 35.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.349 -0.844 . . . . 0.0 109.404 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.563 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 32.2 p -130.37 150.61 51.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.234 -0.916 . . . . 0.0 109.216 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.458 ' O ' HG12 ' A' ' 110' ' ' ILE . . . -145.89 -172.6 3.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.128 -0.982 . . . . 0.0 109.538 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.532 ' CA ' HD12 ' A' ' 110' ' ' ILE . 51.8 m -144.95 134.94 23.81 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.217 -0.927 . . . . 0.0 109.577 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.656 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 1.0 OUTLIER -81.05 145.0 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.322 -0.861 . . . . 0.0 108.953 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.498 ' N ' HG21 ' A' ' 149' ' ' ILE . 10.6 m-20 -130.49 169.56 15.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.332 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 150' ' ' ASN . 3.0 p30 40.68 62.36 1.41 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.37 -0.831 . . . . 0.0 109.81 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.515 HG21 ' HA ' ' A' ' 106' ' ' THR . 10.6 tt -106.95 165.77 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.301 -0.875 . . . . 0.0 109.334 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.492 ' N ' HG12 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -101.37 105.86 42.29 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.119 -0.988 . . . . 0.0 109.369 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 152' ' ' ILE . 35.6 Cg_endo -77.98 169.24 20.82 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.404 2.069 . . . . 0.0 110.456 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . 70.17 60.69 4.66 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 164.48 131.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.318 -1.107 . . . . 0.0 109.628 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -47.56 162.25 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.096 -1.003 . . . . 0.0 108.387 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.647 ' CD1' ' CG2' ' A' ' 184' ' ' THR . 0.3 OUTLIER -140.53 -174.57 4.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.888 -1.133 . . . . 0.0 110.211 -179.524 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.538 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 2.6 m -158.1 110.36 2.32 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.523 HD13 ' CD1' ' A' ' 108' ' ' LEU . 40.6 mm -94.27 141.73 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.839 -1.163 . . . . 0.0 110.567 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.532 ' CG2' ' HB2' ' A' ' 179' ' ' SER . 0.2 OUTLIER -141.57 133.61 27.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.459 -0.776 . . . . 0.0 109.137 179.455 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.536 ' CD2' HG12 ' A' ' 124' ' ' ILE . 1.8 mt -112.55 135.19 53.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 0.0 110.564 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.601 ' CD1' ' HB3' ' A' ' 177' ' ' PRO . 22.0 m-85 -117.94 164.87 14.42 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.549 ' HB3' ' CD2' ' A' ' 122' ' ' TYR . . . -142.88 88.59 2.06 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.015 -1.053 . . . . 0.0 109.406 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.446 ' HA ' ' HB3' ' A' ' 174' ' ' SER . 47.9 t . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.378 -0.826 . . . . 0.0 109.72 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 95.4 p . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.526 ' OG ' ' CB ' ' A' ' 164' ' ' ALA . 0.6 OUTLIER -54.65 -168.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.188 -0.945 . . . . 0.0 109.476 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.447 ' HD2' ' HD2' ' A' ' 177' ' ' PRO . 0.0 OUTLIER -78.52 129.59 73.95 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.325 -0.859 . . . . 0.0 109.312 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.601 ' HB3' ' CD1' ' A' ' 163' ' ' TYR . 35.3 Cg_endo -77.53 127.14 8.72 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.07 1.847 . . . . 0.0 110.244 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.29 136.29 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.532 ' HB2' ' CG2' ' A' ' 161' ' ' THR . 4.7 t -119.62 165.47 14.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 110.476 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.471 HG13 ' HB ' ' A' ' 160' ' ' ILE . 11.8 pt -154.3 152.09 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -81.85 162.99 22.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.096 -1.003 . . . . 0.0 109.943 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.585 ' CE2' HD23 ' A' ' 108' ' ' LEU . 64.5 t80 -154.9 159.31 40.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.419 -0.801 . . . . 0.0 109.45 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.97 116.95 17.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.285 -0.884 . . . . 0.0 109.33 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.647 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.521 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.493 ' CD1' ' HB3' ' A' ' 79' ' ' GLU . 72.5 mt . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.312 0.577 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 45.2 m-20 -156.11 125.49 6.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.572 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.542 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -95.26 178.3 1.51 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.0 109.309 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.595 ' HD3' ' CE1' ' A' ' 32' ' ' TYR . 35.9 Cg_endo -78.9 164.03 25.5 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.593 2.195 . . . . 0.0 109.989 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.499 ' CG2' ' O ' ' A' ' 5' ' ' PRO . 4.0 p -162.08 174.63 12.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.068 -1.02 . . . . 0.0 109.711 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 44.54 27.16 1.2 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.585 ' C ' ' CD1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -72.29 -162.43 0.09 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.392 -1.064 . . . . 0.0 109.587 -179.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.76 -163.35 0.63 Allowed 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.112 -0.993 . . . . 0.0 109.592 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.529 ' CB ' ' HG2' ' A' ' 88' ' ' GLN . 0.3 OUTLIER -154.86 141.93 19.31 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.362 -0.836 . . . . 0.0 109.351 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.515 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 3.5 p -146.72 -163.29 1.72 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.304 -0.873 . . . . 0.0 109.498 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.525 ' CB ' ' OG1' ' A' ' 19' ' ' THR . 4.5 m-20 44.45 38.07 2.39 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.533 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 40.6 mm -70.1 125.7 28.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.587 0.708 . . . . 0.0 110.305 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.562 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -119.5 177.75 4.81 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.31 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -72.9 -69.59 0.4 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.722 -1.236 . . . . 0.0 109.457 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -83.06 8.6 12.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.973 -1.079 . . . . 0.0 109.414 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 14' ' ' THR . 2.8 t -154.51 156.56 36.89 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.59 ' CE1' ' CG2' ' A' ' 20' ' ' VAL . 2.2 p90 -166.66 137.19 3.25 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.525 ' OG1' ' CB ' ' A' ' 12' ' ' ASP . 10.1 m -87.76 153.98 20.92 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.949 -1.095 . . . . 0.0 111.174 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.59 ' CG2' ' CE1' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -134.41 119.52 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.148 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.515 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 20.1 m-70 -103.36 164.28 11.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.02 -1.05 . . . . 0.0 110.368 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.527 ' CB ' ' HB2' ' A' ' 8' ' ' PHE . 22.8 p90 -177.3 135.59 0.19 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.555 -0.715 . . . . 0.0 109.084 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.29 167.43 2.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.183 -0.948 . . . . 0.0 109.517 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.517 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -102.18 165.38 13.98 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.474 ' HB3' ' O ' ' A' ' 3' ' ' ASP . 36.0 Cg_endo -78.23 -163.14 0.2 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.499 2.133 . . . . 0.0 110.299 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -120.59 28.33 8.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.925 . . . . 0.0 109.404 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.472 ' CB ' ' HD2' ' A' ' 28' ' ' PRO . . . -129.36 173.54 5.59 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 0.0 109.551 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.472 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 36.1 Cg_endo -78.4 130.44 10.0 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.615 2.21 . . . . 0.0 110.453 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.566 HD11 ' CE2' ' A' ' 32' ' ' TYR . 17.6 pt -135.98 169.93 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.918 . . . . 0.0 109.474 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.465 HG22 ' N ' ' A' ' 77' ' ' GLY . 17.4 p -107.12 -19.95 13.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.476 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.08 -152.83 15.5 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.641 ' CE1' ' CB ' ' A' ' 74' ' ' ALA . 1.2 m-85 -162.08 123.23 2.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -1.123 . . . . 0.0 109.447 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.537 HD11 ' CD ' ' A' ' 49' ' ' ARG . 14.9 mm -85.41 122.65 38.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.189 -0.945 . . . . 0.0 109.624 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.588 ' CG2' ' CD1' ' A' ' 72' ' ' ILE . 2.6 mm -102.89 114.31 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.056 -1.028 . . . . 0.0 109.321 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.485 ' CB ' ' OG ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -105.58 144.86 31.75 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.103 -0.998 . . . . 0.0 108.912 179.361 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.624 ' CD2' ' CD2' ' A' ' 59' ' ' LEU . 0.9 OUTLIER -143.53 140.14 30.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.056 -1.027 . . . . 0.0 110.032 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -176.17 144.39 0.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.32 -0.863 . . . . 0.0 109.665 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.557 ' HA ' ' CB ' ' A' ' 68' ' ' TYR . . . -64.99 170.48 4.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 109.605 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.33 -0.856 . . . . 0.0 109.453 -179.92 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.555 ' HD3' ' CE1' ' A' ' 36' ' ' HIS . 1.2 ptp85 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.489 0.661 . . . . 0.0 109.748 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.472 ' CG ' ' HG3' ' A' ' 35' ' ' ARG . 14.2 mp0 -126.91 118.1 23.89 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.312 -0.867 . . . . 0.0 109.568 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 34' ' ' ILE . 65.8 m-20 -100.96 122.8 44.13 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.537 ' CD ' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.18 140.53 32.35 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.031 -1.043 . . . . 0.0 109.493 -179.264 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.527 ' CG2' HD12 ' A' ' 34' ' ' ILE . 11.9 m -124.08 159.56 56.13 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.341 -0.849 . . . . 0.0 109.355 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 34.5 Cg_endo -77.14 174.37 12.92 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.581 2.187 . . . . 0.0 110.279 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 34.6 Cg_endo -76.96 -16.09 16.2 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.498 2.132 . . . . 0.0 110.486 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.401 ' O ' ' OG ' ' A' ' 53' ' ' SER . 11.7 t -100.85 27.86 5.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.351 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.432 ' HG3' ' HG2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -130.65 116.71 18.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.938 . . . . 0.0 109.677 -179.819 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -102.87 -6.01 22.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.394 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 62.7 p -139.2 130.84 27.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.357 -0.84 . . . . 0.0 109.018 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.509 HD11 ' CG1' ' A' ' 50' ' ' VAL . 5.4 tt -123.24 124.92 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.164 -0.96 . . . . 0.0 109.816 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.75 109.91 20.56 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.441 -0.787 . . . . 0.0 109.184 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.624 ' CD2' ' CD2' ' A' ' 36' ' ' HIS . 1.2 mp -84.83 158.65 20.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.164 -0.96 . . . . 0.0 109.778 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.527 ' CG2' ' HB2' ' A' ' 17' ' ' SER . 0.8 OUTLIER -150.86 175.29 12.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.654 -0.654 . . . . 0.0 109.332 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.499 ' O ' ' NH2' ' A' ' 46' ' ' ARG . 6.1 m120 52.57 37.8 24.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 0.0 109.496 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.527 ' CD1' ' HB3' ' A' ' 59' ' ' LEU . 5.2 mt -109.59 161.17 15.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 109.387 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -55.07 113.33 5.26 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.526 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 34.5 Cg_endo -74.19 123.64 8.43 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.984 1.79 . . . . 0.0 111.009 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 82.67 64.56 1.68 Allowed Glycine 0 N--CA 1.485 1.916 0 N-CA-C 108.186 -1.966 . . . . 0.0 108.186 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.0 m -152.27 118.9 5.69 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.126 -1.22 . . . . 0.0 110.821 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.531 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 11.6 tt0 -74.82 135.74 41.62 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.584 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -153.44 176.54 11.9 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.79 -1.193 . . . . 0.0 111.076 -178.436 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' ' 86' ' ' GLY . 1.9 t -107.27 151.55 9.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.438 HG11 ' O ' ' A' ' 35' ' ' ARG . 1.1 t -132.98 130.92 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.983 -1.073 . . . . 0.0 109.492 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.565 ' CB ' ' CG1' ' A' ' 85' ' ' ILE . 10.5 p -108.44 156.43 19.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.254 -0.904 . . . . 0.0 110.484 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.588 ' CD1' ' CG2' ' A' ' 34' ' ' ILE . 28.4 mm -135.71 92.51 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.516 ' CD1' ' HB3' ' A' ' 83' ' ' PRO . 1.2 mm -83.71 140.85 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.106 -0.996 . . . . 0.0 109.928 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.641 ' CB ' ' CE1' ' A' ' 32' ' ' TYR . . . -96.38 157.86 15.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 109.181 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.446 HG11 ' O ' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -148.69 136.55 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 109.47 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 76' ' ' ASN . 12.6 t-20 -135.14 46.37 2.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 109.424 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.465 ' N ' HG22 ' A' ' 30' ' ' THR . . . 103.52 -91.57 0.84 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.51 1.36 13.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -1.167 . . . . 0.0 109.647 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.516 ' O ' ' CG ' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -92.72 -171.66 2.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.97 . . . . 0.0 109.47 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 79' ' ' GLU . 4.9 mt-10 -171.16 91.49 0.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.487 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.569 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.6 OUTLIER -59.55 -179.18 0.15 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 108.987 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.569 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 31.4 Cg_endo -74.49 150.35 40.68 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.08 1.853 . . . . 0.0 110.348 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.516 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 36.1 Cg_endo -77.57 144.11 22.17 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.811 2.341 . . . . 0.0 111.62 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.502 HD21 ' CB ' ' A' ' 5' ' ' PRO . 3.4 tp -109.7 93.65 4.61 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.565 ' CG1' ' CB ' ' A' ' 71' ' ' SER . 3.3 mt -100.23 141.19 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.939 . . . . 0.0 110.15 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.528 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . -136.66 -165.06 10.38 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -129.94 140.0 51.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.985 -1.303 . . . . 0.0 109.77 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.529 ' HG2' ' CB ' ' A' ' 10' ' ' SER . 2.4 tp60 -154.29 -165.36 2.07 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.372 -0.83 . . . . 0.0 109.318 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.531 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.43 130.28 2.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.256 -0.903 . . . . 0.0 109.57 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.583 ' OG1' ' CE2' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -73.16 138.35 45.66 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.281 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.598 ' O ' ' N ' ' A' ' 65' ' ' GLY . 2.3 t . . . . . 0 C--N 1.302 -1.48 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.587 ' CG ' ' CD1' ' A' ' 162' ' ' LEU . 35.7 Cg_endo . . . . . 0 C--O 1.215 -0.664 0 N-CA-C 109.891 -0.849 . . . . 0.0 109.891 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.576 ' CB ' ' CZ ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -65.9 -165.34 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.444 -0.785 . . . . 0.0 109.734 -179.648 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.41 11.62 6.66 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.235 -0.915 . . . . 0.0 109.227 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.495 ' CD2' HG12 ' A' ' 180' ' ' ILE . 19.7 tp -59.25 92.77 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.281 -0.887 . . . . 0.0 109.213 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -126.5 160.53 30.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.264 -0.898 . . . . 0.0 109.335 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 8.5 p -104.64 138.47 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.402 -0.811 . . . . 0.0 109.818 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.522 ' CG1' HD21 ' A' ' 109' ' ' LEU . 8.7 pt -122.96 -11.23 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.389 -0.82 . . . . 0.0 109.407 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.426 ' HB2' ' HB2' ' A' ' 109' ' ' LEU . . . -134.73 82.12 1.94 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.526 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 6.4 m -85.81 95.4 9.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.816 . . . . 0.0 110.45 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.495 ' OG1' ' OG ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -96.24 159.66 31.55 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 121.244 -0.91 . . . . 0.0 109.036 179.052 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.476 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.4 Cg_endo -70.47 -1.74 9.55 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.509 2.139 . . . . 0.0 110.738 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.499 ' HA ' HG21 ' A' ' 152' ' ' ILE . 7.1 p -144.68 10.93 1.41 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 109.342 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 149' ' ' ILE . 3.2 p -169.01 166.6 11.02 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 118.907 -1.117 . . . . 0.0 109.767 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.608 HD23 ' CE1' ' A' ' 182' ' ' TYR . 0.4 OUTLIER -141.75 150.77 42.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.137 -0.977 . . . . 0.0 109.091 -179.557 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.522 HD21 ' CG1' ' A' ' 101' ' ' ILE . 13.9 tp -106.26 116.33 31.74 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 108.824 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.588 ' CD1' ' CD1' ' A' ' 124' ' ' ILE . 3.2 pt -102.35 149.4 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.079 -1.013 . . . . 0.0 110.192 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 146' ' ' THR . 5.1 t -153.1 125.18 7.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.516 -0.74 . . . . 0.0 109.382 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.578 ' CE2' ' O ' ' A' ' 145' ' ' SER . 3.1 p90 -124.21 -170.13 2.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.233 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.14 -0.975 . . . . 0.0 109.914 -179.541 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.485 ' HB2' ' O ' ' A' ' 140' ' ' VAL . 1.6 p90 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.546 ' CD2' ' HB3' ' A' ' 164' ' ' ALA . 3.0 m-85 -106.11 115.35 30.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.98 -1.075 . . . . 0.0 109.56 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 5.5 ttm180 -84.62 98.81 10.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.11 -0.994 . . . . 0.0 109.017 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.588 ' CD1' ' CD1' ' A' ' 110' ' ' ILE . 55.2 mt -84.25 151.42 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 0.0 110.045 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 46.2 p -123.92 133.27 53.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.46 -0.775 . . . . 0.0 109.901 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.652 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 4.9 m-85 -80.19 118.36 21.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.49 -0.756 . . . . 0.0 109.359 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' A' ' 158' ' ' TYR . . . -91.94 105.74 3.32 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.285 -1.126 . . . . 0.0 108.876 179.08 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.527 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 2.6 mm100 . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 13.2 pt-20 -101.96 149.87 23.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -0.948 . . . . 0.0 110.743 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.586 ' CZ ' HD13 ' A' ' 124' ' ' ILE . 34.1 p90 -143.07 145.75 33.17 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.0 p -75.01 149.69 39.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.99 -1.069 . . . . 0.0 110.589 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.537 ' CG2' HD13 ' A' ' 124' ' ' ILE . 53.7 t -112.31 141.6 25.4 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 121.762 -0.586 . . . . 0.0 109.443 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.467 ' HD2' HG12 ' A' ' 140' ' ' VAL . 35.6 Cg_endo -77.66 141.81 19.92 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.433 2.088 . . . . 0.0 110.307 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -88.03 23.0 15.68 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.414 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 1.9 m -104.42 -0.94 27.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -1.149 . . . . 0.0 109.576 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 143' ' ' SER . 15.2 mmtt -143.02 153.85 43.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 109.48 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.578 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 0.4 OUTLIER -93.35 -18.27 22.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 109.395 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 111' ' ' SER . 66.1 p -107.77 152.79 23.89 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.199 -0.938 . . . . 0.0 108.941 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.517 ' HB1' ' CD1' ' A' ' 110' ' ' ILE . . . -130.96 148.17 52.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.064 -1.023 . . . . 0.0 109.635 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 8.2 t -91.08 147.42 23.09 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.184 -0.948 . . . . 0.0 109.347 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.652 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 13.9 mm -128.46 95.62 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.358 -0.839 . . . . 0.0 109.119 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.522 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 2.6 m-20 -104.54 -164.17 1.03 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.517 -0.74 . . . . 0.0 109.733 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.511 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 6.6 p-10 42.03 60.58 2.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.429 -0.794 . . . . 0.0 109.902 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.569 HG13 ' CE2' ' A' ' 158' ' ' TYR . 6.4 tt -116.52 155.28 18.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.269 -0.894 . . . . 0.0 109.568 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.07 117.19 67.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.753 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.476 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 35.9 Cg_endo -78.91 163.85 25.63 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.518 2.146 . . . . 0.0 110.562 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 61.8 51.47 57.07 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -177.37 130.45 0.16 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.223 -1.163 . . . . 0.0 109.699 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -51.62 165.93 0.15 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.569 ' CE2' HG13 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -144.98 172.68 12.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.881 -1.137 . . . . 0.0 110.255 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.527 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 1.8 m -145.7 96.74 2.86 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 179' ' ' SER . 51.5 mm -84.69 132.44 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.889 -1.132 . . . . 0.0 109.705 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.52 HG21 ' CB ' ' A' ' 179' ' ' SER . 1.1 m -142.26 165.33 27.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.309 -0.869 . . . . 0.0 109.24 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.587 ' CD1' ' CG ' ' A' ' 95' ' ' PRO . 1.3 pp -159.64 151.13 20.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.013 -1.054 . . . . 0.0 110.72 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.599 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 2.1 m-85 -122.03 90.45 3.31 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.546 ' HB3' ' CD2' ' A' ' 122' ' ' TYR . . . -54.0 117.47 3.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.864 -1.147 . . . . 0.0 109.039 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 22.2 t . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.892 -179.612 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 175' ' ' SER . 1.2 p . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 174' ' ' SER . 84.6 p -55.47 -166.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.168 -0.957 . . . . 0.0 109.21 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.436 ' N ' ' CD ' ' A' ' 176' ' ' LYS . 0.0 OUTLIER -74.59 145.78 82.58 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 108.829 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.599 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 34.9 Cg_endo -77.71 133.77 13.04 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.429 2.086 . . . . 0.0 111.019 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.471 ' O ' HG21 ' A' ' 161' ' ' THR . 2.2 t -105.82 134.47 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.52 ' CB ' HG21 ' A' ' 161' ' ' THR . 1.3 p -131.45 143.24 50.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 110.558 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.495 HG12 ' CD2' ' A' ' 98' ' ' LEU . 13.4 pt -129.89 152.44 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -82.57 168.71 17.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.082 -1.012 . . . . 0.0 109.7 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.608 ' CE1' HD23 ' A' ' 108' ' ' LEU . 44.2 t80 -165.21 124.32 1.75 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.323 -0.86 . . . . 0.0 109.415 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -95.19 112.13 23.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.009 -1.057 . . . . 0.0 109.443 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.427 ' HB ' ' HA ' ' A' ' 154' ' ' PRO . 28.9 p . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.524 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.459 HD12 ' HB3' ' A' ' 81' ' ' SER . 1.5 pp . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 21.7 m-20 -74.91 148.12 40.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.391 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.491 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 18.0 p -84.5 159.97 57.49 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.591 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.526 ' O ' ' CD2' ' A' ' 84' ' ' LEU . 35.5 Cg_endo -78.27 96.77 1.1 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.715 2.277 . . . . 0.0 109.943 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.438 ' HA ' HD21 ' A' ' 84' ' ' LEU . 2.1 p -83.89 -111.65 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.166 -0.959 . . . . 0.0 109.79 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 22' ' ' TRP . . . 45.53 26.12 1.58 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.447 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 13.5 t80 -55.59 107.76 0.37 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.485 -1.009 . . . . 0.0 110.003 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -133.52 100.21 4.74 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.405 -0.809 . . . . 0.0 108.841 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.455 ' HA ' HG11 ' A' ' 20' ' ' VAL . 4.7 m -84.63 128.27 34.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.216 -0.928 . . . . 0.0 109.578 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 19' ' ' THR . 5.5 p -164.0 -157.06 0.37 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.316 -0.865 . . . . 0.0 109.402 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.494 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 2.5 m-20 47.33 38.01 6.71 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.648 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.5 mt -87.07 163.84 2.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.761 0.791 . . . . 0.0 111.427 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.516 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 0.7 OUTLIER -155.27 -172.83 4.31 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -81.02 -44.14 18.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.931 -1.106 . . . . 0.0 109.484 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 17' ' ' SER . 1.5 m120 -114.6 39.75 2.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.991 -1.068 . . . . 0.0 109.037 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.473 ' O ' HG21 ' A' ' 14' ' ' THR . 5.8 p 168.55 145.5 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.648 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 2.0 p90 -164.97 145.38 7.3 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.108 -0.995 . . . . 0.0 108.827 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.504 ' CG2' ' N ' ' A' ' 20' ' ' VAL . 52.3 m -112.34 164.23 13.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.737 -1.227 . . . . 0.0 111.132 -178.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.516 ' C ' ' CD2' ' A' ' 21' ' ' HIS . 1.6 t -130.43 168.42 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.516 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 19.9 m-70 -144.35 161.88 37.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.936 -1.102 . . . . 0.0 110.104 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.576 ' CD1' ' O ' ' A' ' 22' ' ' TRP . 10.0 p90 -168.18 142.19 3.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.434 -0.791 . . . . 0.0 109.171 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.85 166.02 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.04 -1.037 . . . . 0.0 109.435 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.486 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -94.01 165.57 17.5 Favored Pre-proline 0 C--N 1.3 -1.585 0 O-C-N 121.634 -0.666 . . . . 0.0 109.632 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 24' ' ' ALA . 35.7 Cg_endo -78.27 178.12 7.95 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.606 2.204 . . . . 0.0 110.384 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.08 12.82 26.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 109.442 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.526 ' CB ' ' HD2' ' A' ' 28' ' ' PRO . . . -118.13 176.71 1.52 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.409 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.526 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 34.9 Cg_endo -77.7 118.05 4.42 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.538 2.159 . . . . 0.0 110.285 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.633 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 47.3 pt -131.47 179.99 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 109.614 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.7 p -120.71 -22.11 6.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.864 . . . . 0.0 109.458 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 167.97 174.68 37.08 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.633 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -124.42 133.73 53.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.248 -1.148 . . . . 0.0 109.391 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.514 HG21 ' N ' ' A' ' 34' ' ' ILE . 44.8 mm -74.95 144.42 12.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.187 -0.945 . . . . 0.0 109.251 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.517 ' CG1' HG21 ' A' ' 50' ' ' VAL . 7.9 mm -124.57 93.15 2.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.21 -0.931 . . . . 0.0 110.058 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.464 ' HB2' ' OG ' ' A' ' 71' ' ' SER . 1.0 OUTLIER -104.17 128.53 51.86 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.581 ' NE2' ' CD2' ' A' ' 59' ' ' LEU . 54.5 p-80 -148.33 176.85 9.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.727 -1.233 . . . . 0.0 110.845 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.582 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 9.1 p-80 176.9 -173.37 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.48 ' CB ' ' CE1' ' A' ' 68' ' ' TYR . . . -112.55 132.17 55.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.165 -0.959 . . . . 0.0 109.175 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.463 ' HG2' ' HB2' ' A' ' 67' ' ' GLU . 1.3 pt-20 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 0.0 109.556 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.52 ' NE ' ' OD1' ' A' ' 48' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.454 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 47.0 mt-30 -100.43 134.63 43.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 110.589 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.52 ' OD1' ' NE ' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -149.24 147.82 28.84 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.508 ' HG3' ' CD1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -134.53 158.79 43.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.864 -1.147 . . . . 0.0 110.104 -179.055 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.517 HG21 ' CG1' ' A' ' 34' ' ' ILE . 12.3 m -136.87 161.08 63.64 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.468 -0.77 . . . . 0.0 109.076 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.508 ' HG2' ' CD ' ' A' ' 54' ' ' ARG . 33.5 Cg_endo -76.21 174.12 13.35 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.478 2.119 . . . . 0.0 110.333 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.567 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.2 Cg_endo -76.49 -29.51 5.91 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.587 2.192 . . . . 0.0 110.518 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -82.91 -7.78 59.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.398 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.518 ' HD3' ' N ' ' A' ' 54' ' ' ARG . 3.4 mpt_? -93.96 109.34 21.08 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.412 -0.805 . . . . 0.0 109.838 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -97.27 -1.51 44.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.423 -0.798 . . . . 0.0 109.377 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 77.2 p -140.99 147.83 39.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.297 -0.877 . . . . 0.0 109.168 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.43 ' C ' HG21 ' A' ' 19' ' ' THR . 1.4 tt -131.95 119.49 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.119 -0.988 . . . . 0.0 109.388 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.46 ' OG1' ' OG1' ' A' ' 19' ' ' THR . 45.7 m -87.85 138.06 31.79 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.349 -0.845 . . . . 0.0 109.62 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.581 ' CD2' ' NE2' ' A' ' 36' ' ' HIS . 4.6 mt -111.23 159.46 17.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.512 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.437 HG21 ' O ' ' A' ' 59' ' ' LEU . 7.5 p -144.37 173.37 11.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -0.882 . . . . 0.0 109.475 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m120 52.9 52.36 14.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -0.891 . . . . 0.0 109.546 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.528 ' CD1' ' HB3' ' A' ' 59' ' ' LEU . 7.7 mt -122.17 133.51 54.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.472 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.498 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 42.5 m-20 -48.66 128.15 13.77 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.056 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.1 Cg_endo -78.01 133.6 12.5 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.36 2.04 . . . . 0.0 110.665 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 82.89 61.24 1.96 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.462 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 4.5 m -162.37 159.86 25.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.392 -1.064 . . . . 0.0 109.734 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 2.0 mm-40 -90.77 134.5 34.38 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.369 -0.832 . . . . 0.0 108.839 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.516 ' CZ ' ' HB3' ' A' ' 62' ' ' LEU . 15.0 m-85 -119.17 115.52 24.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.086 -1.009 . . . . 0.0 109.709 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.582 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 1.4 t -82.48 120.06 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.899 . . . . 0.0 108.99 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.541 ' HA ' ' CB ' ' A' ' 36' ' ' HIS . 27.1 t -117.92 138.61 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 109.443 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.545 ' CB ' HG12 ' A' ' 85' ' ' ILE . 80.2 p -116.84 139.1 51.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 110.13 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.7 mm -120.49 92.37 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.415 -0.803 . . . . 0.0 109.207 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.452 ' HB ' ' HB ' ' A' ' 33' ' ' ILE . 25.1 mm -90.78 137.52 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 109.634 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' A' ' 81' ' ' SER . . . -99.54 137.79 37.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.423 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.23 150.21 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 0.0 109.444 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 28' ' ' PRO . 1.8 t-20 -137.53 49.82 1.98 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.43 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.91 -94.48 2.0 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.0 tpt85 -106.65 -0.76 23.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -1.153 . . . . 0.0 109.501 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 1.6 mt-10 -100.38 148.99 24.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.191 -0.943 . . . . 0.0 109.316 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.72 103.85 8.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.676 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.579 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -59.7 -178.41 0.13 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 108.931 179.687 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.579 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 32.7 Cg_endo -75.82 151.08 35.54 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.171 1.914 . . . . 0.0 110.204 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.406 ' HA ' HD11 ' A' ' 73' ' ' ILE . 35.0 Cg_endo -77.23 115.21 3.91 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.675 2.25 . . . . 0.0 111.379 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.526 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 12.5 tp -106.08 104.25 13.91 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.545 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.8 mt -111.56 162.25 9.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.039 -1.038 . . . . 0.0 110.4 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.501 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -155.77 162.91 31.49 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.467 ' HG2' ' CG1' ' A' ' 69' ' ' VAL . 4.0 mt-30 -136.66 118.56 15.22 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.119 -1.224 . . . . 0.0 110.042 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -110.59 -146.94 0.41 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.54 136.72 3.88 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.879 -1.138 . . . . 0.0 110.341 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.93 137.88 41.97 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.19 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.539 ' O ' ' N ' ' A' ' 65' ' ' GLY . 1.8 t . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.517 -0.739 . . . . 0.0 109.308 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.528 ' HB2' ' CD1' ' A' ' 112' ' ' TRP . 36.4 Cg_endo . . . . . 0 C--O 1.215 -0.671 0 N-CA-C 110.186 -0.736 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.6 OUTLIER -70.61 -176.62 1.32 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.63 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER 77.01 27.82 0.68 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 109.67 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.402 HD22 HG12 ' A' ' 180' ' ' ILE . 33.6 tp -76.97 101.88 6.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.148 -0.97 . . . . 0.0 109.394 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -137.15 170.2 16.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.561 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 11.8 p -93.75 147.97 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.197 -0.939 . . . . 0.0 109.665 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.524 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 11.7 pt -129.7 -2.41 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.369 -0.832 . . . . 0.0 109.552 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.523 ' HB1' ' CD1' ' A' ' 109' ' ' LEU . . . -165.33 116.26 1.11 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.318 -0.864 . . . . 0.0 108.68 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.504 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.8 t -104.48 93.23 4.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.114 -0.991 . . . . 0.0 110.221 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.56 ' OG1' ' N ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -78.41 163.48 61.5 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.314 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.459 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 29.6 Cg_endo -68.4 -2.44 9.12 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.4 2.067 . . . . 0.0 110.856 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.523 ' HA ' HG21 ' A' ' 152' ' ' ILE . 11.6 p -155.26 20.75 0.42 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.294 -0.879 . . . . 0.0 108.723 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.56 ' N ' ' OG1' ' A' ' 104' ' ' THR . 52.4 p -173.43 161.47 4.11 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.935 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.6 ' CD1' ' CE1' ' A' ' 182' ' ' TYR . 0.6 OUTLIER -139.67 155.76 47.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.371 -0.83 . . . . 0.0 109.274 -179.665 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.524 ' HB3' ' CG1' ' A' ' 101' ' ' ILE . 19.8 mt -100.29 132.78 45.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.291 -0.881 . . . . 0.0 108.892 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.553 ' CD1' ' CD1' ' A' ' 149' ' ' ILE . 0.5 OUTLIER -119.63 141.27 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.168 -0.958 . . . . 0.0 109.809 -179.617 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 97' ' ' ASP . 37.8 t -133.75 135.17 43.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.411 -0.806 . . . . 0.0 109.385 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.568 ' CE2' ' O ' ' A' ' 145' ' ' SER . 43.4 p90 -140.28 143.21 35.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.399 -0.813 . . . . 0.0 109.288 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 8.9 mm-40 . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.944 . . . . 0.0 109.282 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.584 ' CE2' ' HG2' ' A' ' 123' ' ' ARG . 2.8 p90 . . . . . 0 N--CA 1.487 1.389 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.486 ' HB2' ' HB ' ' A' ' 140' ' ' VAL . 5.5 m-85 -120.54 154.52 35.22 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.791 -1.193 . . . . 0.0 110.085 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.584 ' HG2' ' CE2' ' A' ' 121' ' ' TYR . 4.5 mmm-85 -112.07 88.08 2.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.389 -0.819 . . . . 0.0 109.032 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.629 ' CG2' ' CE2' ' A' ' 138' ' ' PHE . 88.9 mt -84.08 160.24 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 109.491 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 18.5 p -145.32 150.78 37.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.127 -0.983 . . . . 0.0 110.474 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.65 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 2.5 m-85 -87.31 139.72 30.27 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.598 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -105.74 107.48 2.8 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.11 -1.229 . . . . 0.0 109.475 179.609 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.476 ' O ' ' HA ' ' A' ' 125' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 0.8 OUTLIER -79.38 128.19 33.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 111.057 -178.6 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.629 ' CE2' ' CG2' ' A' ' 124' ' ' ILE . 17.8 p90 -128.11 140.04 52.16 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.482 ' CG2' ' CE2' ' A' ' 121' ' ' TYR . 1.2 p -74.44 153.52 39.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.046 -1.034 . . . . 0.0 111.103 -178.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.537 ' CG2' HD13 ' A' ' 124' ' ' ILE . 94.5 t -118.07 143.18 32.29 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.536 ' HD2' ' CG1' ' A' ' 140' ' ' VAL . 34.2 Cg_endo -76.81 119.65 5.21 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.332 2.021 . . . . 0.0 110.298 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -55.47 -17.13 11.94 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.3 t -83.84 12.32 6.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.157 -1.202 . . . . 0.0 109.696 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.447 ' HB2' ' HG2' ' A' ' 141' ' ' PRO . 43.1 mmtt -139.08 122.53 17.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.954 . . . . 0.0 109.552 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.568 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 11.9 p -82.28 -5.37 58.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.919 . . . . 0.0 109.506 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.54 ' C ' ' CH2' ' A' ' 112' ' ' TRP . 6.9 p -124.87 154.08 41.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.25 -0.906 . . . . 0.0 109.357 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.584 ' CB ' ' CD1' ' A' ' 124' ' ' ILE . . . -123.98 168.52 12.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.882 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.528 ' CG2' ' OD1' ' A' ' 150' ' ' ASN . 22.4 m -130.8 104.12 6.98 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.303 -0.873 . . . . 0.0 109.306 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.65 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -82.57 93.3 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.033 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.542 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 1.7 m-20 -100.28 174.1 6.29 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.282 -0.886 . . . . 0.0 109.632 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 67.09 37.0 3.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 109.193 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.523 HG21 ' HA ' ' A' ' 106' ' ' THR . 4.5 tt -95.45 161.8 2.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.445 -0.784 . . . . 0.0 109.733 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -98.27 108.85 49.6 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.222 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.461 ' HG3' HG21 ' A' ' 106' ' ' THR . 36.2 Cg_endo -77.22 75.74 4.5 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.483 2.122 . . . . 0.0 110.568 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . 168.48 59.36 0.03 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 163.59 136.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -1.109 . . . . 0.0 109.533 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 156' ' ' ALA . 22.8 t70 -46.34 158.01 0.12 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.63 ' CD1' ' CG2' ' A' ' 184' ' ' THR . 0.3 OUTLIER -140.6 -177.21 4.94 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.873 -1.142 . . . . 0.0 110.496 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.57 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 3.1 m -157.83 114.45 2.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.484 -0.76 . . . . 0.0 109.093 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.465 HG21 HD11 ' A' ' 160' ' ' ILE . 25.4 mm -97.03 126.71 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.567 -1.333 . . . . 0.0 109.73 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.576 ' CG2' ' CB ' ' A' ' 179' ' ' SER . 1.3 m -138.96 167.2 22.58 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.221 -0.924 . . . . 0.0 109.357 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 0.9 OUTLIER -162.95 150.35 13.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.912 -1.117 . . . . 0.0 111.109 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.612 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.3 m-85 -121.39 100.11 6.85 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -55.13 129.26 37.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.871 -1.143 . . . . 0.0 109.084 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.568 HG22 ' CZ ' ' A' ' 121' ' ' TYR . 65.1 t . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.931 . . . . 0.0 109.863 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 2.0 p . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.401 0.62 . . . . 0.0 110.011 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 174' ' ' SER . 16.8 p -54.85 -168.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.327 -0.858 . . . . 0.0 109.035 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt -68.16 144.27 96.69 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.0 -1.062 . . . . 0.0 108.706 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.612 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.1 Cg_endo -76.68 132.78 13.53 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.317 2.011 . . . . 0.0 111.437 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 3.7 t -106.01 130.64 57.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.576 ' CB ' ' CG2' ' A' ' 161' ' ' THR . 1.1 p -130.17 147.88 51.95 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.123 -0.986 . . . . 0.0 110.808 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.402 HG12 HD22 ' A' ' 98' ' ' LEU . 19.0 pt -131.55 151.84 36.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -86.04 156.58 20.36 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.046 -1.034 . . . . 0.0 109.672 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.6 ' CE1' ' CD1' ' A' ' 108' ' ' LEU . 54.1 t80 -161.22 123.8 3.11 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.335 -0.853 . . . . 0.0 109.432 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.87 130.78 38.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.23 -0.919 . . . . 0.0 109.542 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.63 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 6.4 p . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.495 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' ' 79' ' ' GLU . 1.4 mp . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.527 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 3.2 m-20 -74.89 153.52 38.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.866 . . . . 0.0 108.954 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.452 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 89.9 p -96.53 107.81 38.49 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.344 -0.847 . . . . 0.0 110.115 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.601 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 36.4 Cg_endo -80.15 77.72 3.96 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.56 2.173 . . . . 0.0 109.893 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.594 ' CG2' ' CD2' ' A' ' 84' ' ' LEU . 73.6 p -93.16 -104.74 0.12 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.154 -0.966 . . . . 0.0 110.112 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 55.81 20.73 26.96 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -44.68 127.67 6.28 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.749 -0.853 . . . . 0.0 109.929 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.452 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 4.7 t0 -162.81 105.81 1.07 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.362 -0.836 . . . . 0.0 109.047 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 16.1 m -84.89 127.29 34.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.908 . . . . 0.0 109.736 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.512 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 3.5 p -154.49 -163.17 1.54 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.518 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 2.4 m-20 44.9 38.59 3.03 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.609 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.6 mm -74.57 130.01 36.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.581 0.705 . . . . 0.0 110.851 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.549 ' CB ' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -119.35 175.63 5.73 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -67.01 -75.56 0.09 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.865 -1.147 . . . . 0.0 109.463 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 15.3 p-10 -78.66 -2.5 39.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.302 -0.874 . . . . 0.0 109.82 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.549 ' O ' ' CB ' ' A' ' 14' ' ' THR . 6.4 t -143.27 160.83 39.76 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.245 -0.909 . . . . 0.0 109.058 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.629 ' CE2' ' NE2' ' A' ' 88' ' ' GLN . 3.5 p90 -167.33 145.66 4.85 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.518 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 2.8 m -109.98 157.18 19.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.353 -1.467 . . . . 0.0 111.395 -178.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 56' ' ' SER . 1.0 OUTLIER -123.11 166.63 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.017 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.512 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 26.1 m-70 -137.67 160.23 39.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.94 -1.1 . . . . 0.0 110.404 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.579 ' CZ2' HG23 ' A' ' 50' ' ' VAL . 21.7 p90 177.56 139.61 0.08 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.487 HG11 ' N ' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -74.34 159.19 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 120.946 -1.096 . . . . 0.0 110.116 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.487 ' N ' HG11 ' A' ' 23' ' ' VAL . . . -96.82 165.58 15.66 Favored Pre-proline 0 C--N 1.3 -1.545 0 O-C-N 121.819 -0.551 . . . . 0.0 109.774 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.562 ' CG ' ' CD1' ' A' ' 29' ' ' ILE . 36.2 Cg_endo -79.56 145.38 18.41 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.604 2.203 . . . . 0.0 110.181 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.451 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 0.7 OUTLIER -80.21 5.52 14.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 0.0 109.493 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.476 ' CB ' ' HD2' ' A' ' 28' ' ' PRO . . . -108.23 173.68 2.89 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.935 . . . . 0.0 109.448 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 35.7 Cg_endo -78.03 88.57 1.42 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.657 2.238 . . . . 0.0 110.55 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.562 ' CD1' ' CG ' ' A' ' 25' ' ' PRO . 36.0 pt -98.13 -179.79 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.397 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.507 HG23 ' N ' ' A' ' 77' ' ' GLY . 2.3 p -102.13 -21.49 14.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.345 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.49 165.36 10.27 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.633 ' CD1' ' CG2' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -90.5 148.6 22.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -1.091 . . . . 0.0 110.314 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.604 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -102.3 103.38 14.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.839 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.538 ' N ' ' CD1' ' A' ' 34' ' ' ILE . 1.3 mm -88.28 117.59 32.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 O-C-N 121.314 -0.866 . . . . 0.0 109.885 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -122.72 111.77 17.13 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.374 -0.829 . . . . 0.0 108.879 179.407 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.634 ' CE1' ' CD2' ' A' ' 59' ' ' LEU . 1.4 p-80 -105.98 122.0 45.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.935 . . . . 0.0 110.11 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.574 ' CE1' ' O ' ' A' ' 69' ' ' VAL . 37.3 p-80 -140.71 127.68 20.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.423 -0.798 . . . . 0.0 109.008 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -39.4 151.5 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.803 . . . . 0.0 110.008 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.49 ' OE1' ' CG2' ' A' ' 69' ' ' VAL . 5.7 mm-40 . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.527 ' HB2' ' NE2' ' A' ' 36' ' ' HIS . 3.1 mmm180 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 47' ' ' GLN . 16.9 pt20 -113.2 102.44 10.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.248 -0.907 . . . . 0.0 109.482 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.486 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 1.7 m-20 -106.34 115.8 30.83 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -0.907 . . . . 0.0 109.254 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.51 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.2 OUTLIER -92.6 140.54 29.44 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.194 -0.941 . . . . 0.0 109.476 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.579 HG23 ' CZ2' ' A' ' 22' ' ' TRP . 26.8 m -115.54 151.65 46.3 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.301 -0.874 . . . . 0.0 109.309 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.468 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 35.3 Cg_endo -77.7 174.27 12.87 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.599 2.2 . . . . 0.0 110.373 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.468 ' HB3' HG13 ' A' ' 29' ' ' ILE . 34.0 Cg_endo -77.07 -15.59 16.27 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.573 2.182 . . . . 0.0 110.269 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -90.43 14.78 12.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.314 -0.867 . . . . 0.0 109.22 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.468 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 5.9 mmm-85 -133.48 126.33 30.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 109.575 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 2.8 p-10 -109.83 -4.96 15.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.93 . . . . 0.0 109.431 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 16.0 p -130.53 145.43 51.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 109.068 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.519 HD13 ' CG1' ' A' ' 50' ' ' VAL . 3.0 tt -129.12 118.89 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.953 . . . . 0.0 109.642 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.74 103.04 15.65 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.364 -0.835 . . . . 0.0 109.241 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.634 ' CD2' ' CE1' ' A' ' 36' ' ' HIS . 2.5 mt -84.92 144.82 28.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -0.922 . . . . 0.0 109.672 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.465 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 63.7 p -137.69 -174.77 3.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 0.0 109.414 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 56.39 20.1 4.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.416 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.533 ' CD1' ' HB3' ' A' ' 59' ' ' LEU . 2.4 mt -96.49 156.85 16.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.929 . . . . 0.0 109.242 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.468 ' O ' ' OH ' ' A' ' 68' ' ' TYR . 2.3 t30 -61.44 132.71 92.93 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.097 -1.002 . . . . 0.0 108.485 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.3 Cg_endo -77.51 124.64 7.14 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.159 1.906 . . . . 0.0 110.767 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 77.8 60.98 2.64 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.565 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 3.0 m -145.88 167.0 24.32 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.242 -1.152 . . . . 0.0 110.084 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.565 ' N ' ' CG2' ' A' ' 66' ' ' THR . 0.8 OUTLIER -125.2 121.51 34.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.434 -0.791 . . . . 0.0 109.674 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.601 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -124.89 -172.57 2.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 0.0 109.302 179.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.574 ' O ' ' CE1' ' A' ' 37' ' ' HIS . 41.7 t -122.28 110.62 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 35' ' ' ARG . 3.5 t -96.57 127.19 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.778 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 95.1 p -108.01 133.98 51.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.32 -0.862 . . . . 0.0 109.951 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.633 ' CG2' ' CD1' ' A' ' 32' ' ' TYR . 5.2 mm -115.57 104.16 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.892 . . . . 0.0 109.242 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 83' ' ' PRO . 21.1 mm -109.81 109.49 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.13 -0.981 . . . . 0.0 109.57 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.624 ' N ' ' CE1' ' A' ' 32' ' ' TYR . . . -75.88 140.81 42.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -0.959 . . . . 0.0 109.299 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.512 ' CG2' HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -131.43 176.35 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.289 -0.882 . . . . 0.0 109.561 -179.734 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.509 ' ND2' ' OE1' ' A' ' 79' ' ' GLU . 34.2 t30 -156.44 43.68 0.4 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.476 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.507 ' N ' HG23 ' A' ' 30' ' ' THR . . . 91.13 -77.12 1.45 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.439 ' HD2' ' C ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -125.18 3.22 7.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -1.164 . . . . 0.0 109.679 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.509 ' OE1' ' ND2' ' A' ' 76' ' ' ASN . 4.0 mt-10 -100.34 -174.9 2.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.182 -0.949 . . . . 0.0 109.486 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 0.8 OUTLIER -149.9 143.93 25.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.889 . . . . 0.0 109.596 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.567 ' CB ' ' CD ' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -110.34 -178.78 0.58 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.408 -0.807 . . . . 0.0 109.065 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.567 ' CD ' ' CB ' ' A' ' 81' ' ' SER . 34.0 Cg_endo -77.66 131.11 11.12 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.21 1.94 . . . . 0.0 110.168 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.529 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 36.1 Cg_endo -78.25 152.43 27.24 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.483 2.122 . . . . 0.0 110.775 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.594 ' CD2' ' CG2' ' A' ' 6' ' ' THR . 0.0 OUTLIER -146.61 54.13 1.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 108.875 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 86' ' ' GLY . 6.4 mt -57.87 162.6 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.306 -0.871 . . . . 0.0 109.871 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.489 ' N ' HG23 ' A' ' 85' ' ' ILE . . . -164.98 160.85 34.2 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.418 ' HG2' ' OE2' ' A' ' 39' ' ' GLU . 0.7 OUTLIER -95.75 127.86 42.13 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.268 -1.136 . . . . 0.0 109.493 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.629 ' NE2' ' CE2' ' A' ' 18' ' ' PHE . 1.3 tm0? -125.31 128.26 47.95 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -107.44 130.39 54.83 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.198 -0.939 . . . . 0.0 110.235 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.465 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -74.41 135.9 42.39 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.145 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 65' ' ' GLY . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.212 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.592 ' HB2' ' CD1' ' A' ' 112' ' ' TRP . 35.3 Cg_endo . . . . . 0 C--O 1.215 -0.649 0 N-CA-C 109.997 -0.809 . . . . 0.0 109.997 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -64.38 -179.37 0.46 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.258 -0.901 . . . . 0.0 109.678 -179.655 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER 77.06 21.14 1.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.312 -0.868 . . . . 0.0 109.622 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.497 ' CD2' HD21 ' A' ' 162' ' ' LEU . 15.1 tp -69.87 102.6 2.0 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.162 -0.961 . . . . 0.0 109.291 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 97' ' ' ASP . 8.6 pt-20 -149.1 -174.04 4.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.134 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 41.7 t -127.57 151.18 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.084 -1.01 . . . . 0.0 109.971 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.402 HG23 HD11 ' A' ' 101' ' ' ILE . 4.1 pt -119.13 -14.2 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.524 -0.735 . . . . 0.0 109.332 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -142.32 149.3 39.3 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.518 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 0.7 OUTLIER -134.88 106.07 6.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.993 -1.067 . . . . 0.0 110.234 -179.452 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.479 ' OG1' ' OG ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -91.73 158.18 40.57 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.4 -0.812 . . . . 0.0 108.97 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.3 Cg_endo -70.32 -2.51 10.69 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.383 2.055 . . . . 0.0 110.385 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.539 ' HA ' HG21 ' A' ' 152' ' ' ILE . 64.7 p -150.34 19.08 0.85 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 149' ' ' ILE . 0.6 OUTLIER -168.0 168.56 11.9 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.801 179.742 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.593 HD23 ' CE2' ' A' ' 182' ' ' TYR . 0.5 OUTLIER -141.33 154.2 45.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.67 -179.383 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 0.8 OUTLIER -105.31 106.66 17.26 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.513 ' CD1' HD13 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -100.76 140.81 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.226 -0.921 . . . . 0.0 110.206 -179.117 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.461 ' HA ' ' HB ' ' A' ' 146' ' ' THR . 47.4 p -144.49 120.51 10.71 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.592 ' CD1' ' HB2' ' A' ' 95' ' ' PRO . 47.5 p90 -124.69 168.87 12.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.944 . . . . 0.0 109.662 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.457 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . 4.3 mt-10 . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.287 -0.883 . . . . 0.0 109.245 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.46 ' HB2' ' O ' ' A' ' 140' ' ' VAL . 1.5 p90 . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.464 ' HB2' ' HB ' ' A' ' 140' ' ' VAL . 5.5 m-85 -128.72 122.21 30.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.114 -0.991 . . . . 0.0 109.426 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.48 ' CD ' ' OE1' ' A' ' 137' ' ' GLU . 9.9 ttm180 -89.96 105.76 18.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.194 -0.942 . . . . 0.0 109.248 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.637 ' CD1' ' CZ ' ' A' ' 138' ' ' PHE . 43.3 mt -84.7 166.46 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.677 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.545 ' CB ' ' HG2' ' A' ' 137' ' ' GLU . 1.3 p -141.8 137.22 31.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.866 . . . . 0.0 109.704 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.661 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 3.2 m-30 -92.04 132.4 36.59 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.597 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -103.42 112.31 4.18 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.287 -1.125 . . . . 0.0 109.136 179.348 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.598 ' HG2' ' CG ' ' A' ' 126' ' ' TYR . 4.7 pt20 . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.545 ' HG2' ' CB ' ' A' ' 125' ' ' THR . 84.0 mt-10 -96.76 152.23 18.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.105 -0.997 . . . . 0.0 111.434 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.637 ' CZ ' ' CD1' ' A' ' 124' ' ' ILE . 1.7 p90 -143.88 139.89 29.47 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.6 p -74.2 144.37 44.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.029 -1.044 . . . . 0.0 111.317 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.528 ' CG2' HG13 ' A' ' 124' ' ' ILE . 48.5 t -108.78 145.77 32.36 Favored Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.527 ' HD2' ' CG1' ' A' ' 140' ' ' VAL . 34.3 Cg_endo -77.11 146.3 25.35 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.327 2.018 . . . . 0.0 110.011 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.17 19.62 25.77 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.437 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 0.5 OUTLIER -105.16 10.63 33.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.115 -1.226 . . . . 0.0 109.518 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 143' ' ' SER . 19.2 mmtp -152.42 135.93 16.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 109.616 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.572 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 7.2 p -83.53 1.72 40.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.921 . . . . 0.0 109.467 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.461 ' HB ' ' HA ' ' A' ' 111' ' ' SER . 11.7 p -137.38 146.51 44.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.914 . . . . 0.0 108.911 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.481 ' N ' ' CZ3' ' A' ' 112' ' ' TRP . . . -126.07 -171.42 2.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.07 -1.019 . . . . 0.0 109.593 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.417 HG23 ' N ' ' A' ' 149' ' ' ILE . 82.8 m -137.6 167.55 21.44 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.304 -0.872 . . . . 0.0 109.168 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.661 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 1.6 mt -126.36 141.41 45.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.251 -0.906 . . . . 0.0 109.134 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.468 ' N ' HG21 ' A' ' 149' ' ' ILE . 43.5 m-80 -134.5 176.09 8.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.325 -0.859 . . . . 0.0 109.539 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 150' ' ' ASN . 1.3 p30 41.02 52.9 3.37 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.32 -0.862 . . . . 0.0 109.78 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.539 HG21 ' HA ' ' A' ' 106' ' ' THR . 8.4 tt -101.66 164.07 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.322 -0.861 . . . . 0.0 109.216 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.461 ' HB2' ' OH ' ' A' ' 158' ' ' TYR . 19.5 mmmt -99.89 108.01 49.46 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.113 -0.992 . . . . 0.0 109.806 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.469 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 36.5 Cg_endo -79.38 174.69 11.62 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.571 2.181 . . . . 0.0 110.573 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.94 56.06 18.5 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 184' ' ' THR . . . 170.47 138.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -1.114 . . . . 0.0 109.654 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -54.79 161.05 1.68 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.597 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.3 OUTLIER -140.33 176.54 8.69 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.908 -1.12 . . . . 0.0 110.135 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.509 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 3.2 m -146.2 109.63 4.76 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.508 HG21 ' N ' ' A' ' 161' ' ' THR . 29.6 mm -89.86 143.19 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.953 -1.092 . . . . 0.0 110.349 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.508 ' N ' HG21 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -153.12 160.0 42.83 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.414 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.497 HD21 ' CD2' ' A' ' 98' ' ' LEU . 2.1 pp -161.48 148.45 14.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.914 -1.116 . . . . 0.0 110.632 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.596 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 2.4 m-85 -113.07 164.45 13.46 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -134.33 102.87 5.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.027 -1.045 . . . . 0.0 109.582 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.48 HG21 ' CB ' ' A' ' 174' ' ' SER . 51.5 t . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 109.725 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 175' ' ' SER . 14.2 p . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.453 0.644 . . . . 0.0 109.798 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 174' ' ' SER . 5.9 p 42.08 -165.54 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.06 140.58 29.03 Favored Pre-proline 0 C--N 1.305 -1.35 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.596 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 34.9 Cg_endo -77.51 130.23 10.69 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.354 2.036 . . . . 0.0 110.76 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.459 ' O ' HG21 ' A' ' 161' ' ' THR . 5.3 t -101.47 134.36 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 161' ' ' THR . 1.3 p -126.61 155.63 42.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.172 -0.955 . . . . 0.0 110.191 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.504 ' CG1' ' HB ' ' A' ' 160' ' ' ILE . 24.6 pt -141.58 178.82 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -103.41 151.66 22.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.098 -1.001 . . . . 0.0 109.519 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.593 ' CE2' HD23 ' A' ' 108' ' ' LEU . 83.8 t80 -155.23 122.63 5.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.361 -0.837 . . . . 0.0 109.495 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.418 ' O ' ' CD ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -99.24 127.9 45.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.148 -0.97 . . . . 0.0 109.446 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.574 HG22 ' CD1' ' A' ' 158' ' ' TYR . 51.3 p . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.539 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.513 ' CD1' ' HB2' ' A' ' 81' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 25' ' ' PRO . 10.8 m-20 -84.93 123.08 30.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.425 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.54 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -95.73 177.5 1.75 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 109.528 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 4' ' ' SER . 36.2 Cg_endo -78.86 147.07 21.22 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.648 2.232 . . . . 0.0 110.096 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 5' ' ' PRO . 0.8 OUTLIER -161.25 -170.48 2.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.065 -1.022 . . . . 0.0 109.8 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 44.08 32.59 2.48 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.628 ' C ' ' CD1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -75.1 -167.68 0.65 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.51 -0.994 . . . . 0.0 109.99 -179.242 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -165.32 129.1 2.31 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.233 -0.917 . . . . 0.0 109.216 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.531 ' CB ' ' HG3' ' A' ' 88' ' ' GLN . 0.3 OUTLIER -88.49 140.05 29.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.153 -0.967 . . . . 0.0 109.64 -179.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.507 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 60.2 p -148.16 -162.54 1.57 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.256 -0.903 . . . . 0.0 109.545 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.519 ' CB ' ' OG1' ' A' ' 19' ' ' THR . 4.4 m-20 45.34 39.77 4.7 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.53 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 24.5 mm -73.35 92.33 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.494 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.572 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -93.04 166.38 12.39 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 176.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.497 ' HA ' ' O ' ' A' ' 91' ' ' VAL . . . -56.06 -77.81 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.961 -1.087 . . . . 0.0 111.106 -177.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.447 ' OD1' ' HG3' ' A' ' 64' ' ' PRO . 0.7 OUTLIER -77.04 -0.08 23.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.109 -0.994 . . . . 0.0 110.177 -178.735 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.572 ' O ' ' N ' ' A' ' 14' ' ' THR . 20.8 p -144.67 123.58 12.73 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.164 -0.96 . . . . 0.0 109.237 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.575 ' CE1' HG21 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -135.09 136.05 41.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.119 -0.988 . . . . 0.0 108.335 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.519 ' OG1' ' CB ' ' A' ' 12' ' ' ASP . 16.2 m -87.18 156.99 19.46 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.094 -1.004 . . . . 0.0 112.013 -177.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.575 HG21 ' CE1' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -135.58 97.94 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.507 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 15.5 m-70 -87.72 163.17 16.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.153 -0.967 . . . . 0.0 110.882 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.532 ' CB ' ' HB2' ' A' ' 8' ' ' PHE . 25.9 p90 -174.79 139.99 0.55 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.0 161.1 5.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.152 -0.967 . . . . 0.0 109.827 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.15 151.0 38.0 Favored Pre-proline 0 C--N 1.297 -1.691 0 O-C-N 121.779 -0.576 . . . . 0.0 109.511 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.528 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 36.2 Cg_endo -78.53 152.8 26.53 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.538 2.159 . . . . 0.0 110.247 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' A' ' 26' ' ' ARG . 20.7 mmm180 -92.69 27.06 2.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 109.627 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.515 ' CB ' ' HD2' ' A' ' 28' ' ' PRO . . . -105.34 175.32 2.18 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 109.271 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 35.2 Cg_endo -77.77 98.87 1.24 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.586 2.191 . . . . 0.0 110.363 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.635 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 39.4 pt -126.93 173.81 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 109.518 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.6 p -114.2 -18.83 11.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.262 -0.898 . . . . 0.0 109.346 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.28 170.68 26.27 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.635 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 1.2 m-85 -112.49 134.23 54.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -1.193 . . . . 0.0 109.492 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.501 HG12 ' HG3' ' A' ' 49' ' ' ARG . 2.0 mt -88.54 126.8 41.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.303 -0.873 . . . . 0.0 109.069 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.562 ' N ' ' CD1' ' A' ' 34' ' ' ILE . 1.1 mm -104.28 111.25 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.084 -1.01 . . . . 0.0 109.882 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.433 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 42.2 ttt-85 -121.7 108.16 13.21 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.301 -0.874 . . . . 0.0 108.898 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.626 ' CE1' ' CD2' ' A' ' 59' ' ' LEU . 18.3 p-80 -117.41 170.77 8.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 110.069 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.44 ' O ' ' O ' ' A' ' 38' ' ' ALA . 54.7 p-80 -179.61 130.38 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.43 -0.794 . . . . 0.0 109.723 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -55.31 -168.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.262 -0.899 . . . . 0.0 109.318 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.124 -0.985 . . . . 0.0 109.329 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.558 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 3.7 mmt85 . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -110.23 85.26 2.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 0.0 109.63 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.498 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 29.7 m-20 -100.74 99.86 10.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.241 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.532 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -84.81 134.49 34.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.037 -1.039 . . . . 0.0 109.617 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.477 HG12 HD11 ' A' ' 57' ' ' ILE . 13.6 m -118.97 159.67 43.83 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.38 -0.825 . . . . 0.0 109.256 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 34.7 Cg_endo -77.0 174.16 13.3 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.528 2.152 . . . . 0.0 110.263 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.537 ' HA ' ' CE2' ' A' ' 32' ' ' TYR . 34.9 Cg_endo -76.89 -15.63 16.6 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.605 2.203 . . . . 0.0 110.43 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.87 23.53 2.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.473 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.435 ' O ' ' CZ2' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -137.52 109.47 7.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.923 . . . . 0.0 109.647 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 22' ' ' TRP . 5.2 p30 -95.13 -6.96 40.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 21' ' ' HIS . 64.9 p -139.1 129.49 25.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.318 -0.864 . . . . 0.0 109.057 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.477 HD11 HG12 ' A' ' 50' ' ' VAL . 3.4 tt -118.33 119.36 61.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.258 -0.902 . . . . 0.0 109.594 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.459 HG22 ' OG1' ' A' ' 19' ' ' THR . 0.3 OUTLIER -85.13 108.75 17.84 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.411 -0.806 . . . . 0.0 108.829 179.628 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.626 ' CD2' ' CE1' ' A' ' 36' ' ' HIS . 0.9 OUTLIER -84.72 152.46 23.71 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.204 -0.935 . . . . 0.0 109.24 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.463 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 21.5 p -142.93 -179.69 6.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.568 -0.708 . . . . 0.0 109.449 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.44 18.29 3.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 109.392 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.53 ' CD1' ' HB3' ' A' ' 59' ' ' LEU . 3.5 mt -92.68 142.8 26.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.246 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 62' ' ' LEU . 7.5 t-20 -45.86 123.99 6.4 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.204 -0.935 . . . . 0.0 108.651 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.447 ' HG3' ' OD1' ' A' ' 16' ' ' ASN . 35.2 Cg_endo -76.96 131.78 12.35 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.23 1.954 . . . . 0.0 110.32 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 71.89 61.6 3.71 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 90' ' ' THR . 3.3 m -154.91 149.3 26.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -1.136 . . . . 0.0 109.654 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.522 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 16.5 mt-10 -74.41 130.33 39.44 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.096 -1.002 . . . . 0.0 108.417 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 3.0 m-85 -126.0 115.97 20.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.093 -1.004 . . . . 0.0 110.377 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 36' ' ' HIS . 2.1 t -83.52 123.37 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.524 ' CG1' ' HB3' ' A' ' 36' ' ' HIS . 2.2 t -112.34 123.8 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.003 -1.061 . . . . 0.0 110.18 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.485 ' CB ' HG12 ' A' ' 85' ' ' ILE . 61.2 p -112.97 122.28 47.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.371 -0.831 . . . . 0.0 109.689 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.519 ' CD1' ' CG2' ' A' ' 34' ' ' ILE . 10.7 mm -107.19 136.49 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.273 -0.892 . . . . 0.0 109.54 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.513 HD11 ' N ' ' A' ' 73' ' ' ILE . 1.7 mp -122.6 156.38 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 0.0 109.2 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.537 ' CB ' ' OG ' ' A' ' 81' ' ' SER . . . -119.35 115.57 24.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.379 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.35 164.02 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.167 -0.958 . . . . 0.0 109.441 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -140.21 49.93 1.73 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.398 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.58 -82.24 1.65 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.426 ' HD3' ' C ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -120.19 -2.37 10.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -1.154 . . . . 0.0 109.564 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -92.96 -166.59 1.56 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.427 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 37.5 mt-10 -154.01 155.03 34.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.2 -0.938 . . . . 0.0 109.745 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.555 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.7 OUTLIER -129.49 179.89 1.19 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.385 -0.822 . . . . 0.0 108.978 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.555 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.3 Cg_endo -76.04 142.74 25.15 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.194 1.929 . . . . 0.0 109.855 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.81 132.33 11.82 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.685 2.257 . . . . 0.0 111.529 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 84' ' ' LEU . 9.0 tp -108.16 100.75 10.03 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.485 HG12 ' CB ' ' A' ' 71' ' ' SER . 2.0 mt -105.63 157.35 6.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.065 -1.022 . . . . 0.0 110.486 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.435 ' N ' HG23 ' A' ' 85' ' ' ILE . . . -151.42 178.97 28.45 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -131.59 137.2 48.32 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.113 -1.228 . . . . 0.0 109.766 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.531 ' HG3' ' CB ' ' A' ' 10' ' ' SER . 1.8 mm100 -163.76 126.94 2.61 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.313 -0.867 . . . . 0.0 109.174 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.522 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -94.5 145.91 24.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.354 -0.841 . . . . 0.0 110.098 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.71 145.93 42.69 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.458 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.557 HG21 ' C ' ' A' ' 14' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.462 -0.774 . . . . 0.0 109.096 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.466 ' HB2' ' HB2' ' A' ' 112' ' ' TRP . 36.2 Cg_endo . . . . . 0 C--O 1.214 -0.681 0 N-CA-C 109.499 -1.001 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 5.1 ptp180 -45.94 173.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.44 -0.788 . . . . 0.0 109.974 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 1.7 t70 82.38 15.34 0.43 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.68 -0.637 . . . . 0.0 110.004 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.564 ' CD1' ' CD2' ' A' ' 162' ' ' LEU . 20.7 tp -70.27 100.45 1.71 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.042 -1.037 . . . . 0.0 109.137 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 110' ' ' ILE . 0.7 OUTLIER -153.3 176.85 11.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.233 -0.917 . . . . 0.0 109.649 -179.797 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.469 HG21 ' O ' ' A' ' 109' ' ' LEU . 9.2 p -105.25 171.23 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.342 -0.849 . . . . 0.0 109.537 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.535 ' CG1' ' HB2' ' A' ' 109' ' ' LEU . 3.6 pt -136.51 -42.69 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.277 -0.89 . . . . 0.0 109.166 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.582 ' CB ' ' CD1' ' A' ' 109' ' ' LEU . . . -121.99 114.29 20.75 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.537 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.2 t -99.94 99.16 9.88 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.24 -0.913 . . . . 0.0 110.5 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.516 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -89.38 160.74 41.67 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.639 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -69.64 -0.81 7.35 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.423 2.082 . . . . 0.0 110.937 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.523 ' HA ' HG21 ' A' ' 152' ' ' ILE . 56.0 p -146.45 11.5 1.14 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.269 -0.894 . . . . 0.0 109.485 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.538 ' O ' ' CD2' ' A' ' 108' ' ' LEU . 85.3 p -172.48 165.52 5.67 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.682 -1.207 . . . . 0.0 110.41 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.603 HD23 ' CE1' ' A' ' 182' ' ' TYR . 0.4 OUTLIER -145.92 149.57 34.47 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.582 ' CD1' ' CB ' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -106.63 116.52 32.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.199 -0.938 . . . . 0.0 108.952 179.214 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.53 ' CG1' ' HB1' ' A' ' 147' ' ' ALA . 2.4 pt -100.03 -179.14 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.984 -1.072 . . . . 0.0 109.719 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 146' ' ' THR . 1.0 OUTLIER -168.42 150.96 5.26 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.551 -0.718 . . . . 0.0 109.778 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.569 ' CE3' ' O ' ' A' ' 145' ' ' SER . 24.2 p90 -154.03 -176.8 6.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.43 -0.794 . . . . 0.0 109.307 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 95' ' ' PRO . 19.1 mm-40 . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.095 -1.003 . . . . 0.0 109.742 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.491 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 1.2 p90 . . . . . 0 N--CA 1.486 1.373 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.541 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 7.0 m-85 -107.58 123.43 48.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.013 -1.054 . . . . 0.0 109.331 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 4.2 ttp180 -86.11 106.11 17.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.206 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.596 ' HB ' ' CZ ' ' A' ' 138' ' ' PHE . 26.1 mt -99.09 150.09 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.296 -0.878 . . . . 0.0 109.902 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 25.3 p -133.48 132.73 41.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.865 . . . . 0.0 109.932 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.641 ' CE2' ' CG2' ' A' ' 149' ' ' ILE . 30.5 m-85 -74.8 134.22 41.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.86 . . . . 0.0 109.225 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.586 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.32 106.73 2.71 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.198 -1.178 . . . . 0.0 109.529 179.882 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.557 ' HB3' ' CD1' ' A' ' 126' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 4.8 tt0 -85.82 111.75 20.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 110.372 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.596 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 13.3 p90 -122.39 132.18 54.25 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.482 ' CG2' ' CE1' ' A' ' 121' ' ' TYR . 1.7 p -74.29 174.48 8.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.225 -0.922 . . . . 0.0 110.741 -178.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.545 HG23 ' CD1' ' A' ' 124' ' ' ILE . 24.9 t -137.03 138.08 24.72 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.667 -0.646 . . . . 0.0 109.294 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.492 ' HD2' HG11 ' A' ' 140' ' ' VAL . 35.2 Cg_endo -76.95 132.72 13.12 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.346 2.031 . . . . 0.0 110.35 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.45 0.44 55.04 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -4.64 25.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.114 -1.227 . . . . 0.0 109.751 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.531 ' CD ' ' O ' ' A' ' 146' ' ' THR . 0.0 OUTLIER -154.71 157.67 38.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.935 . . . . 0.0 109.376 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.569 ' O ' ' CE3' ' A' ' 112' ' ' TRP . 0.1 OUTLIER -95.84 2.06 53.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.265 -0.897 . . . . 0.0 110.313 -179.348 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.531 ' O ' ' CD ' ' A' ' 144' ' ' LYS . 43.4 p -108.32 162.34 14.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.981 -1.075 . . . . 0.0 109.624 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.53 ' HB1' ' CG1' ' A' ' 110' ' ' ILE . . . -145.9 134.45 22.09 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.991 . . . . 0.0 109.749 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.2 t -83.91 153.47 23.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.328 -0.858 . . . . 0.0 109.031 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.641 ' CG2' ' CE2' ' A' ' 126' ' ' TYR . 14.3 mm -133.98 66.26 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.135 -0.978 . . . . 0.0 109.674 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.566 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 2.4 m-20 -84.2 -176.26 6.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.403 -0.811 . . . . 0.0 109.636 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 13.3 m120 68.47 21.4 8.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.22 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.523 HG21 ' HA ' ' A' ' 106' ' ' THR . 2.8 tt -85.91 155.11 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.341 -0.849 . . . . 0.0 109.615 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.465 ' O ' ' OG1' ' A' ' 184' ' ' THR . 0.0 OUTLIER -103.88 123.81 39.79 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.231 -0.918 . . . . 0.0 109.298 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.466 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 35.9 Cg_endo -78.43 149.63 24.52 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.415 2.076 . . . . 0.0 110.402 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . 78.43 66.16 1.77 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 163.97 131.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -1.162 . . . . 0.0 109.653 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.17 164.87 0.26 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.617 ' CD1' ' CG2' ' A' ' 184' ' ' THR . 0.2 OUTLIER -142.69 -179.36 6.27 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.846 -1.159 . . . . 0.0 110.363 -179.419 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.545 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 1.7 m -153.12 106.75 3.03 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.487 ' CD1' HD11 ' A' ' 108' ' ' LEU . 27.5 mt -97.72 116.79 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.805 -1.184 . . . . 0.0 109.754 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.554 ' CG2' ' CB ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -125.04 153.52 42.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 109.165 179.68 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.564 ' CD2' ' CD1' ' A' ' 98' ' ' LEU . 2.3 pp -149.95 145.62 26.58 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.055 -1.028 . . . . 0.0 110.682 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.607 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 4.1 m-85 -114.11 177.39 4.66 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -140.53 110.09 6.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.231 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 95.7 t . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.276 -0.89 . . . . 0.0 109.639 -179.71 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.276 0.56 . . . . 0.0 109.589 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 73.5 p -64.07 -164.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.847 . . . . 0.0 109.365 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.24 144.84 51.06 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 108.91 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.607 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 35.7 Cg_endo -78.55 127.96 8.41 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.547 2.164 . . . . 0.0 110.931 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.559 ' CG1' ' CD2' ' A' ' 98' ' ' LEU . 69.1 t -96.5 123.51 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -0.91 . . . . 0.0 108.56 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.554 ' CB ' ' CG2' ' A' ' 161' ' ' THR . 0.4 OUTLIER -118.53 143.71 46.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.167 -0.958 . . . . 0.0 109.914 -179.537 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.5 pt -136.14 151.75 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -84.66 162.67 19.63 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.111 -0.993 . . . . 0.0 109.347 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.603 ' CE1' HD23 ' A' ' 108' ' ' LEU . 49.6 t80 -155.1 157.88 38.17 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.314 -0.867 . . . . 0.0 109.368 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.439 ' N ' ' CD1' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -126.57 119.06 26.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.18 -0.95 . . . . 0.0 109.474 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.617 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 10.8 p . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.54 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.521 HD21 ' CG2' ' A' ' 29' ' ' ILE . 1.9 mp . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.425 ' HB2' ' CB ' ' A' ' 25' ' ' PRO . 29.2 m-20 -115.34 169.84 8.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.43 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.458 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 37.1 p -94.8 119.22 66.37 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.541 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.49 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 35.2 Cg_endo -77.85 88.13 1.45 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.367 2.045 . . . . 0.0 110.109 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.439 ' HA ' HD23 ' A' ' 84' ' ' LEU . 1.8 p -80.87 -109.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.92 . . . . 0.0 109.682 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 22' ' ' TRP . . . 45.7 26.44 1.82 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.781 -1.727 . . . . 0.0 108.781 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.551 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 30.9 t80 -53.74 132.23 40.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.526 -0.985 . . . . 0.0 110.112 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 21' ' ' HIS . 5.2 t0 -165.22 153.83 11.97 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.533 ' CB ' ' HG2' ' A' ' 88' ' ' GLN . 2.1 p -136.44 139.03 42.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.047 -1.033 . . . . 0.0 109.696 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' HB ' ' A' ' 19' ' ' THR . 17.8 p -160.12 -165.6 1.51 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.249 -0.907 . . . . 0.0 109.579 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.537 ' CB ' ' OG1' ' A' ' 19' ' ' THR . 10.0 m-20 42.31 36.21 0.71 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.583 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 26.2 mm -66.32 134.2 30.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-O 121.418 0.628 . . . . 0.0 110.367 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.556 ' CB ' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -124.73 -179.8 4.66 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.328 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -72.4 -76.01 0.12 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.932 -1.105 . . . . 0.0 109.336 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 2.1 p-10 -76.69 0.78 19.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.87 . . . . 0.0 109.648 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.556 ' O ' ' CB ' ' A' ' 14' ' ' THR . 3.6 t -150.47 162.47 40.52 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.246 -0.909 . . . . 0.0 109.139 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.583 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 7.7 p90 -166.69 139.87 3.81 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.537 ' OG1' ' CB ' ' A' ' 12' ' ' ASP . 23.6 m -83.02 158.74 22.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.738 -1.226 . . . . 0.0 111.447 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.571 HG21 ' CE1' ' A' ' 18' ' ' PHE . 1.5 t -136.89 166.58 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.503 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 14.2 m-70 -148.53 165.43 31.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.898 -1.126 . . . . 0.0 110.416 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.549 ' CZ2' HG23 ' A' ' 50' ' ' VAL . 39.4 p90 -177.13 140.93 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.31 167.54 2.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 120.932 -1.105 . . . . 0.0 109.376 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.508 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -103.32 168.7 8.36 Favored Pre-proline 0 C--N 1.3 -1.581 0 O-C-N 121.671 -0.643 . . . . 0.0 109.936 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.425 ' CB ' ' HB2' ' A' ' 3' ' ' ASP . 35.5 Cg_endo -78.48 -158.73 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.703 2.269 . . . . 0.0 110.347 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.48 28.38 8.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.551 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.73 166.84 16.62 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.547 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.25 89.88 1.31 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.633 2.222 . . . . 0.0 110.42 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.614 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 11.7 pt -87.83 -172.09 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -0.938 . . . . 0.0 109.457 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 2.8 p -112.33 -5.8 14.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.94 . . . . 0.0 109.563 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.06 172.35 12.49 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.622 ' CD1' ' N ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -120.83 144.27 48.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -1.148 . . . . 0.0 109.375 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.516 ' CD1' ' HG3' ' A' ' 49' ' ' ARG . 22.6 mm -82.1 101.81 7.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.212 -0.93 . . . . 0.0 109.594 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.53 ' N ' ' CD1' ' A' ' 34' ' ' ILE . 1.5 mm -83.42 105.35 13.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.345 -0.847 . . . . 0.0 109.715 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.526 ' CB ' ' OG ' ' A' ' 71' ' ' SER . 0.6 OUTLIER -102.94 155.37 18.4 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.117 -0.989 . . . . 0.0 108.757 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.613 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 23.7 p80 -144.93 136.6 25.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.983 -1.073 . . . . 0.0 110.04 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.565 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 27.9 p-80 -167.73 129.79 1.54 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.882 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -58.66 -172.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.401 -0.812 . . . . 0.0 109.436 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 179.968 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.512 ' HG2' ' NE2' ' A' ' 36' ' ' HIS . 6.2 ptm180 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 121.452 0.644 . . . . 0.0 109.798 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.488 ' HA ' ' CG ' ' A' ' 35' ' ' ARG . 3.8 pt20 -113.16 130.23 56.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.409 -0.807 . . . . 0.0 109.436 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.504 ' C ' ' CD ' ' A' ' 49' ' ' ARG . 9.0 m-20 -112.91 158.27 20.41 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.516 ' HG3' ' CD1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -133.12 157.5 45.15 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.398 -0.814 . . . . 0.0 109.872 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.562 ' CG1' ' CD1' ' A' ' 57' ' ' ILE . 27.0 m -143.02 159.71 55.27 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.434 -0.791 . . . . 0.0 109.247 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.521 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 35.3 Cg_endo -77.6 173.93 13.43 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.567 2.178 . . . . 0.0 110.517 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 30' ' ' THR . 35.6 Cg_endo -77.86 -15.49 14.98 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.674 2.25 . . . . 0.0 110.518 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.3 t -97.8 18.41 15.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.493 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.521 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 15.4 mmm180 -127.31 109.35 11.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.802 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.466 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 13.3 p-10 -94.81 -7.12 41.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.219 -0.925 . . . . 0.0 109.199 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 42.0 p -134.56 130.62 36.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.42 -0.8 . . . . 0.0 108.987 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.562 ' CD1' ' CG1' ' A' ' 50' ' ' VAL . 1.5 tt -132.06 143.42 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.143 -0.973 . . . . 0.0 109.795 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 16.8 m -102.63 125.7 49.46 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.295 -0.878 . . . . 0.0 109.328 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.561 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -91.13 153.73 19.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.888 . . . . 0.0 109.329 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.465 ' O ' ' CD2' ' A' ' 62' ' ' LEU . 13.8 p -139.51 -178.79 5.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 109.462 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 54.69 27.38 8.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 109.364 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.613 ' CD2' ' CE1' ' A' ' 36' ' ' HIS . 2.1 mt -105.46 148.16 27.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.121 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.409 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 6.0 m120 -49.33 130.21 17.51 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.106 -0.996 . . . . 0.0 108.525 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.1 Cg_endo -76.85 129.18 10.54 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.33 2.02 . . . . 0.0 110.756 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 69.8 63.87 3.16 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.4 m -156.86 152.01 26.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.339 -1.095 . . . . 0.0 110.486 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.6 OUTLIER -78.6 124.44 28.16 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.463 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.498 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 2.2 m-85 -119.19 119.42 34.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.983 -1.073 . . . . 0.0 110.319 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.565 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 16.3 t -78.67 122.37 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.512 ' CG1' ' O ' ' A' ' 35' ' ' ARG . 2.8 t -107.08 136.35 42.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.11 -0.994 . . . . 0.0 110.188 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.526 ' OG ' ' CB ' ' A' ' 35' ' ' ARG . 10.5 p -110.91 108.43 18.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.363 -0.836 . . . . 0.0 109.67 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.479 HD13 HG22 ' A' ' 72' ' ' ILE . 17.1 mm -91.87 110.1 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 109.959 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.568 ' N ' ' CD1' ' A' ' 73' ' ' ILE . 1.5 mp -113.96 153.33 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.16 -0.962 . . . . 0.0 109.092 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.5 ' HB2' ' CB ' ' A' ' 81' ' ' SER . . . -112.71 145.46 40.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.527 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.464 ' O ' ' OG1' ' A' ' 30' ' ' THR . 0.9 OUTLIER -147.13 142.19 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.294 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.466 ' HB3' ' HB2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -112.96 50.13 0.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.214 -0.929 . . . . 0.0 109.472 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.41 -59.19 3.69 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.515 ' N ' ' HD2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -130.36 0.16 4.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -1.123 . . . . 0.0 109.63 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 7.3 mt-10 -100.9 -164.7 1.13 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 0.0 109.365 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 20.2 mt-10 -151.03 -170.44 3.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 109.592 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.57 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -167.74 -178.08 0.6 Allowed Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.57 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.7 Cg_endo -76.67 142.56 23.09 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.126 1.884 . . . . 0.0 110.151 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.56 129.97 10.47 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.678 2.252 . . . . 0.0 110.967 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.466 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 22.3 tp -120.13 84.04 2.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -0.825 . . . . 0.0 109.01 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.494 ' CD1' ' HB2' ' A' ' 71' ' ' SER . 3.0 mt -94.67 152.8 3.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.208 -0.933 . . . . 0.0 109.954 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.551 ' HA3' ' CZ ' ' A' ' 8' ' ' PHE . . . -143.95 -172.45 14.7 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.469 ' O ' ' HG3' ' A' ' 88' ' ' GLN . 9.8 mt-30 -138.26 131.01 29.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -1.183 . . . . 0.0 109.766 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.533 ' HG2' ' CB ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -141.32 -152.0 0.39 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 108.962 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.28 145.54 7.01 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.878 -1.139 . . . . 0.0 110.59 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.47 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -84.85 142.43 29.74 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.544 ' O ' ' N ' ' A' ' 65' ' ' GLY . 1.9 t . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.416 -0.802 . . . . 0.0 109.307 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.602 ' CB ' ' CD1' ' A' ' 112' ' ' TRP . 33.9 Cg_endo . . . . . 0 C--O 1.215 -0.674 0 N-CA-C 109.886 -0.851 . . . . 0.0 109.886 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 13.9 tpp85 -61.76 158.86 14.74 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.538 -0.726 . . . . 0.0 109.516 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.9 OUTLIER 80.1 17.17 0.71 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.559 -0.713 . . . . 0.0 109.507 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.524 ' CG ' HG22 ' A' ' 180' ' ' ILE . 26.7 tp -60.51 100.07 0.09 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.228 -0.92 . . . . 0.0 108.918 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -140.56 -171.75 3.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.206 -0.934 . . . . 0.0 109.173 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 35.3 t -126.41 150.53 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.16 -0.963 . . . . 0.0 110.014 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.536 HG12 ' CD1' ' A' ' 109' ' ' LEU . 3.0 pt -121.21 -14.43 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.475 -0.766 . . . . 0.0 109.505 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.509 ' CB ' ' HB2' ' A' ' 109' ' ' LEU . . . -134.08 133.42 41.11 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.517 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.8 p -122.73 81.91 1.92 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.033 -1.042 . . . . 0.0 110.374 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.54 ' OG1' ' N ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -73.76 163.52 67.82 Favored Pre-proline 0 C--N 1.305 -1.365 0 O-C-N 121.147 -0.971 . . . . 0.0 108.51 179.177 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.475 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 29.7 Cg_endo -68.56 -2.32 9.05 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.4 2.066 . . . . 0.0 110.777 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.596 ' HA ' HG21 ' A' ' 152' ' ' ILE . 17.1 p -155.38 21.55 0.41 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.326 -0.859 . . . . 0.0 108.684 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.54 ' N ' ' OG1' ' A' ' 104' ' ' THR . 49.6 p -173.24 158.88 3.71 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.467 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.64 ' CD1' ' CE2' ' A' ' 182' ' ' TYR . 0.5 OUTLIER -143.91 151.82 40.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.149 -0.969 . . . . 0.0 109.514 -179.569 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.536 ' CD1' HG12 ' A' ' 101' ' ' ILE . 2.8 tm? -86.9 144.76 26.83 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.433 -0.792 . . . . 0.0 109.091 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.536 ' N ' ' CD1' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -127.09 150.71 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.083 -1.011 . . . . 0.0 109.953 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.6 t -156.1 139.99 16.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.45 -0.782 . . . . 0.0 109.32 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.602 ' CD1' ' CB ' ' A' ' 95' ' ' PRO . 28.5 p90 -150.63 160.69 43.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.512 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.446 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 59.4 mt-10 . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.0 109.498 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.594 ' CD2' ' N ' ' A' ' 122' ' ' TYR . 3.2 p90 . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.442 0.639 . . . . 0.0 109.887 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 1.6 m-85 -141.01 142.7 34.21 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.532 ' CD ' ' HB2' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -113.63 106.56 14.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.012 -1.055 . . . . 0.0 109.413 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.592 ' HB ' ' CE1' ' A' ' 138' ' ' PHE . 20.2 mt -84.62 164.99 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.355 -0.84 . . . . 0.0 109.141 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.571 ' CG2' ' CG ' ' A' ' 137' ' ' GLU . 3.0 p -135.39 140.83 45.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.914 . . . . 0.0 110.105 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.644 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 3.6 m-30 -85.9 124.01 31.89 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.606 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -95.05 112.11 4.32 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 . . . . . 0 C--N 1.297 -1.688 0 O-C-N 121.228 -1.16 . . . . 0.0 109.295 179.258 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 126' ' ' TYR . 1.5 tt0 . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.571 ' CG ' ' CG2' ' A' ' 125' ' ' THR . 0.5 OUTLIER -105.18 119.23 38.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.128 -0.983 . . . . 0.0 110.808 -179.045 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.592 ' CE1' ' HB ' ' A' ' 124' ' ' ILE . 26.5 p90 -118.89 149.49 41.48 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.571 ' O ' ' CD2' ' A' ' 138' ' ' PHE . 1.3 p -73.97 -174.03 1.74 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.008 -1.057 . . . . 0.0 110.879 -177.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.539 ' CG2' HD13 ' A' ' 124' ' ' ILE . 55.7 t -153.0 141.16 13.78 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.239 -0.913 . . . . 0.0 109.715 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.456 ' HD2' HG12 ' A' ' 140' ' ' VAL . 36.0 Cg_endo -78.5 128.88 9.02 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.396 2.064 . . . . 0.0 110.052 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -81.96 47.28 3.66 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.3 p -105.42 -2.48 23.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -1.175 . . . . 0.0 109.747 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -166.2 170.03 13.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.142 -0.974 . . . . 0.0 109.683 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.05 21.2 8.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.321 -0.862 . . . . 0.0 109.642 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.559 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 70.0 p -139.01 152.32 47.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.175 -0.953 . . . . 0.0 109.504 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.483 ' C ' ' CG1' ' A' ' 110' ' ' ILE . . . -144.13 -164.29 1.86 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.213 -0.93 . . . . 0.0 109.239 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.539 ' CG2' ' N ' ' A' ' 149' ' ' ILE . 20.9 m -146.21 165.77 28.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 109.736 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.644 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -138.89 111.87 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.367 -0.833 . . . . 0.0 109.109 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.455 ' HA ' ' CB ' ' A' ' 107' ' ' SER . 13.6 m-80 -109.62 177.5 4.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.858 . . . . 0.0 109.369 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 30.0 m120 54.97 69.41 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 108.998 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.596 HG21 ' HA ' ' A' ' 106' ' ' THR . 9.2 tt -129.34 163.86 33.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.385 -0.822 . . . . 0.0 109.897 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.466 ' N ' HG12 ' A' ' 152' ' ' ILE . 0.3 OUTLIER -94.37 110.77 50.6 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 109.177 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.475 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 35.7 Cg_endo -78.35 153.37 27.53 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.4 2.067 . . . . 0.0 110.638 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 74.99 64.07 2.4 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . 171.37 131.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -1.145 . . . . 0.0 109.659 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.78 133.9 42.3 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.606 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -116.22 177.28 4.74 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.904 -1.123 . . . . 0.0 110.23 -179.069 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.579 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 1.8 m -143.53 98.55 3.27 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 179' ' ' SER . 32.9 mm -84.94 125.45 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.933 -1.104 . . . . 0.0 110.213 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 179' ' ' SER . 1.4 m -133.29 170.5 15.36 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.509 ' CD1' ' HG3' ' A' ' 95' ' ' PRO . 0.9 OUTLIER -167.79 150.68 5.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.792 -1.192 . . . . 0.0 111.048 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.592 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 1.2 m-85 -124.45 119.92 30.55 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.457 ' HB3' ' CD2' ' A' ' 122' ' ' TYR . . . -85.12 116.13 23.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.877 -1.139 . . . . 0.0 109.226 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.564 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 53.2 t . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 109.99 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 175' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 174' ' ' SER . 0.7 OUTLIER -54.39 -169.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.011 179.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.453 ' HG3' ' HD2' ' A' ' 177' ' ' PRO . 0.5 OUTLIER -80.98 145.89 58.0 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.543 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.592 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.7 Cg_endo -77.21 139.12 18.59 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.474 2.116 . . . . 0.0 111.042 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.483 ' O ' ' HA ' ' A' ' 161' ' ' THR . 2.2 t -113.48 139.14 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 161' ' ' THR . 0.4 OUTLIER -130.48 136.0 48.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 110.17 -179.282 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.524 HG22 ' CG ' ' A' ' 98' ' ' LEU . 9.8 pt -125.16 152.08 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 29.5 m-20 -85.32 160.6 19.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.126 -0.984 . . . . 0.0 109.634 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.64 ' CE2' ' CD1' ' A' ' 108' ' ' LEU . 66.8 t80 -159.25 116.47 2.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 109.437 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -84.81 113.16 21.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.92 . . . . 0.0 109.549 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.503 HG22 ' CD1' ' A' ' 158' ' ' TYR . 21.6 p . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.489 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.452 HD11 ' O ' ' A' ' 80' ' ' GLU . 94.7 mt . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 28.5 m-20 -75.05 167.04 22.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.868 . . . . 0.0 109.447 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.513 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 22.7 t -94.82 124.15 55.52 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.952 . . . . 0.0 109.639 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.521 ' O ' ' CD2' ' A' ' 84' ' ' LEU . 35.6 Cg_endo -78.78 83.76 2.18 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.437 2.091 . . . . 0.0 110.161 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.514 HG21 ' CD1' ' A' ' 84' ' ' LEU . 1.9 p -75.92 -109.85 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 22' ' ' TRP . . . 45.46 26.16 1.53 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.411 ' N ' ' C ' ' A' ' 6' ' ' THR . 22.5 t80 -55.25 121.09 8.1 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.519 -0.989 . . . . 0.0 109.958 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 1.0 OUTLIER -149.26 103.42 3.31 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.425 -0.797 . . . . 0.0 108.853 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.482 ' HB3' ' NE2' ' A' ' 88' ' ' GLN . 3.8 p -84.54 124.78 31.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 109.586 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 19' ' ' THR . 3.6 p -155.34 -162.17 1.3 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.202 -0.936 . . . . 0.0 109.32 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.522 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.9 OUTLIER 44.9 38.15 2.77 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -178.796 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.631 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 2.3 mt -88.12 141.31 14.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.81 0.814 . . . . 0.0 111.417 -177.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.61 ' N ' ' O ' ' A' ' 17' ' ' SER . 1.5 p -127.43 156.87 41.4 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 64' ' ' PRO . . . -58.95 -36.9 75.57 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.009 -1.057 . . . . 0.0 110.26 -178.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 17' ' ' SER . 0.5 OUTLIER -112.36 38.17 2.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.562 -1.336 . . . . 0.0 109.3 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.61 ' O ' ' N ' ' A' ' 14' ' ' THR . 1.4 t 160.65 155.65 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.631 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 5.1 p90 -165.88 152.09 9.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.624 -1.298 . . . . 0.0 109.886 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.522 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 25.4 m -109.09 153.6 23.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.766 -1.209 . . . . 0.0 110.86 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.536 ' C ' ' CD2' ' A' ' 21' ' ' HIS . 0.7 OUTLIER -118.43 169.43 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.431 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.536 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 17.7 m-70 -143.71 157.57 44.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.177 -0.952 . . . . 0.0 109.79 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.531 ' CZ2' HG22 ' A' ' 50' ' ' VAL . 32.4 p90 -164.64 146.63 8.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.304 -0.873 . . . . 0.0 109.392 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.7 167.48 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.127 -0.983 . . . . 0.0 109.273 179.717 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.502 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -95.9 160.8 29.32 Favored Pre-proline 0 C--N 1.299 -1.63 0 O-C-N 121.584 -0.698 . . . . 0.0 109.541 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 5' ' ' PRO . 36.0 Cg_endo -79.16 160.28 26.53 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.6 2.2 . . . . 0.0 110.377 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.434 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 1.2 mtm-85 -84.02 46.34 1.18 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.923 . . . . 0.0 109.487 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.458 ' CB ' ' HD2' ' A' ' 28' ' ' PRO . . . -158.31 173.32 5.1 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.374 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.458 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 35.8 Cg_endo -78.35 136.14 13.94 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.586 2.191 . . . . 0.0 110.445 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.639 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 21.0 pt -140.93 -170.39 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 46.2 p -132.44 2.44 3.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.584 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 52' ' ' PRO . . . 147.5 -168.58 28.5 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.639 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -146.29 133.38 20.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -1.137 . . . . 0.0 109.516 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.584 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -87.29 123.57 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.179 -0.951 . . . . 0.0 108.766 179.581 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.585 ' CG2' ' CD1' ' A' ' 72' ' ' ILE . 1.1 mm -109.37 158.25 9.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.244 -0.91 . . . . 0.0 109.167 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.481 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 50.7 ttp180 -155.49 146.62 22.58 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.53 ' NE2' ' HD2' ' A' ' 46' ' ' ARG . 1.1 p80 -128.9 151.99 49.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.926 -1.109 . . . . 0.0 109.964 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.628 ' CE1' ' CG1' ' A' ' 69' ' ' VAL . 55.9 p-80 -170.4 108.81 0.35 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.743 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -45.92 160.26 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.244 -0.91 . . . . 0.0 109.447 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.424 ' HG3' ' HB2' ' A' ' 67' ' ' GLU . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 109.56 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.53 ' HD2' ' NE2' ' A' ' 36' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -106.98 120.28 41.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.368 -0.832 . . . . 0.0 110.124 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.529 ' CB ' HD12 ' A' ' 57' ' ' ILE . 6.6 m-20 -102.48 117.98 35.88 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.512 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -98.1 155.25 17.23 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.095 -1.003 . . . . 0.0 110.054 -179.223 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.533 ' CG1' ' HB ' ' A' ' 57' ' ' ILE . 15.1 m -136.09 158.99 72.68 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.478 -0.764 . . . . 0.0 109.199 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.507 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.3 Cg_endo -76.49 174.08 13.43 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.552 2.168 . . . . 0.0 110.302 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.513 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 35.5 Cg_endo -77.17 -15.97 15.89 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.606 2.204 . . . . 0.0 110.448 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.3 p -97.86 8.47 44.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.442 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.507 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -115.74 106.21 13.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.206 -0.934 . . . . 0.0 109.759 -179.742 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 17.9 p-10 -85.46 -2.58 58.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.168 -0.958 . . . . 0.0 109.245 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 61.4 p -137.96 144.62 41.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.868 . . . . 0.0 109.119 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.537 HD11 ' CG1' ' A' ' 34' ' ' ILE . 8.0 tt -118.58 127.73 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.112 -0.993 . . . . 0.0 109.792 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.429 ' CG2' ' OG1' ' A' ' 19' ' ' THR . 0.3 OUTLIER -90.31 113.95 25.91 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.411 -0.806 . . . . 0.0 109.458 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.566 HD11 ' CZ ' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -84.86 147.75 26.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.43 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.464 ' O ' HD22 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -126.41 154.19 43.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 109.63 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.514 ' O ' ' CD2' ' A' ' 62' ' ' LEU . 1.1 m-80 61.85 79.57 0.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.362 -0.836 . . . . 0.0 109.595 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.526 ' CD1' ' HA ' ' A' ' 17' ' ' SER . 6.0 mt -143.33 134.68 26.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -0.879 . . . . 0.0 109.449 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -55.05 130.63 67.78 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.254 -0.904 . . . . 0.0 109.043 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.527 ' HB3' ' CB ' ' A' ' 15' ' ' ALA . 36.4 Cg_endo -78.1 128.36 9.02 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.389 2.059 . . . . 0.0 110.692 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.14 58.65 2.42 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 90' ' ' THR . 2.5 m -157.28 143.37 17.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.31 -1.112 . . . . 0.0 109.22 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.524 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 3.2 mt-10 -74.41 130.28 39.36 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.027 -1.046 . . . . 0.0 108.793 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 4.1 m-85 -121.5 101.17 7.45 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.16 -0.962 . . . . 0.0 110.046 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.628 ' CG1' ' CE1' ' A' ' 37' ' ' HIS . 58.9 t -67.98 130.08 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.53 ' CG2' ' OE1' ' A' ' 88' ' ' GLN . 47.0 t -126.0 136.97 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.993 -1.067 . . . . 0.0 109.962 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.523 ' CB ' HG12 ' A' ' 85' ' ' ILE . 92.3 p -111.53 123.86 51.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 110.146 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.585 ' CD1' ' CG2' ' A' ' 34' ' ' ILE . 11.6 mm -100.65 131.86 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.373 -0.829 . . . . 0.0 109.621 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.518 HD11 ' N ' ' A' ' 73' ' ' ILE . 1.7 mp -126.14 164.12 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -0.858 . . . . 0.0 108.919 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.515 ' N ' ' CG2' ' A' ' 73' ' ' ILE . . . -128.36 141.88 51.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.284 -0.885 . . . . 0.0 109.595 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.464 HG23 HD12 ' A' ' 33' ' ' ILE . 3.6 m -135.41 134.13 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.343 -0.848 . . . . 0.0 109.347 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.457 ' HB3' ' HB2' ' A' ' 79' ' ' GLU . 2.9 t-20 -108.93 46.46 0.97 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.522 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 87.03 -80.39 1.74 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.52 -1.97 13.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.179 -1.189 . . . . 0.0 109.6 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 1.3 mp0 -100.62 -165.75 1.24 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 109.27 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.452 ' O ' HD11 ' A' ' 2' ' ' LEU . 23.7 mt-10 -146.58 -168.66 3.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 109.665 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.566 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -159.37 -179.17 1.03 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.396 -0.815 . . . . 0.0 108.983 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.566 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.4 Cg_endo -77.36 141.93 20.72 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.23 1.954 . . . . 0.0 109.943 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.71 88.83 1.38 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.524 2.15 . . . . 0.0 111.038 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 4.6 tp -75.08 104.11 5.53 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.523 HG12 ' CB ' ' A' ' 71' ' ' SER . 2.5 mt -105.0 163.27 4.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.095 -1.003 . . . . 0.0 110.375 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.515 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -159.36 159.24 30.3 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.481 -1.847 . . . . 0.0 108.481 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.427 ' HG2' HG12 ' A' ' 69' ' ' VAL . 29.5 mt-30 -117.76 131.29 56.61 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.185 -1.185 . . . . 0.0 109.815 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.56 ' NE2' ' CE1' ' A' ' 18' ' ' PHE . 3.6 pt20 -136.37 -165.59 1.75 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.524 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -154.74 146.57 23.42 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.025 -1.047 . . . . 0.0 109.75 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.91 132.94 41.82 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.543 -0.863 . . . . 0.0 108.91 179.563 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.565 ' CG2' ' C ' ' A' ' 14' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.826 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 113' ' ' GLU . 30.6 Cg_endo . . . . . 0 C--O 1.215 -0.632 0 N-CA-C 109.375 -1.048 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 17.9 ttt180 -60.27 177.09 0.29 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.389 0.614 . . . . 0.0 110.387 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 112' ' ' TRP . 0.7 OUTLIER 66.4 24.79 10.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.513 -0.742 . . . . 0.0 109.256 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.586 ' CD2' ' CD1' ' A' ' 162' ' ' LEU . 0.2 OUTLIER -61.61 102.45 0.25 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.349 -0.844 . . . . 0.0 109.531 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 97' ' ' ASP . 3.8 pt-20 -153.78 171.57 18.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.209 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.504 HG11 ' N ' ' A' ' 101' ' ' ILE . 40.2 t -115.1 155.87 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.157 -0.964 . . . . 0.0 109.747 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.575 ' CG1' ' CD2' ' A' ' 109' ' ' LEU . 0.8 OUTLIER -127.91 -7.39 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.46 -0.775 . . . . 0.0 109.821 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 109' ' ' LEU . . . -136.47 122.13 19.73 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.527 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.4 p -112.62 75.66 0.93 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.092 -1.005 . . . . 0.0 110.415 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 107' ' ' SER . 0.7 OUTLIER -74.0 159.59 83.73 Favored Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.15 -0.969 . . . . 0.0 108.622 179.225 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.464 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.1 Cg_endo -69.04 -1.85 8.62 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.493 2.129 . . . . 0.0 111.003 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.522 ' HA ' HG21 ' A' ' 152' ' ' ILE . 70.7 p -152.33 19.13 0.65 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 108.893 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.566 ' N ' ' OG1' ' A' ' 104' ' ' THR . 6.8 p -173.71 147.54 1.39 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.024 -1.071 . . . . 0.0 110.144 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.621 ' CD1' ' CD2' ' A' ' 182' ' ' TYR . 0.3 OUTLIER -124.29 154.72 39.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.404 -0.81 . . . . 0.0 109.294 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.575 ' CD2' ' CG1' ' A' ' 101' ' ' ILE . 13.0 tp -105.22 107.16 17.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.269 -0.894 . . . . 0.0 108.731 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.484 ' CG1' ' O ' ' A' ' 147' ' ' ALA . 1.4 pt -85.8 129.48 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.221 -0.924 . . . . 0.0 110.262 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.516 ' HB3' ' CG2' ' A' ' 101' ' ' ILE . 1.3 p -126.32 123.28 37.68 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.582 ' CE3' ' O ' ' A' ' 145' ' ' SER . 19.3 p90 -152.64 -175.73 5.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.947 -1.095 . . . . 0.0 110.464 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 45.2 mm-40 . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.624 ' CD2' ' N ' ' A' ' 122' ' ' TYR . 13.6 p90 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 121.408 0.623 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.624 ' N ' ' CD2' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -140.19 137.53 34.42 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.134 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.47 ' CB ' ' HB2' ' A' ' 163' ' ' TYR . 5.8 ttt180 -95.64 101.92 13.67 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.271 -0.893 . . . . 0.0 109.089 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.654 ' CG2' ' CE2' ' A' ' 138' ' ' PHE . 19.7 mt -85.35 117.64 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.209 -0.932 . . . . 0.0 109.013 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 43.3 p -93.55 130.11 39.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.413 -0.804 . . . . 0.0 110.488 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.651 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 3.0 m-85 -81.35 122.78 27.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.564 -0.71 . . . . 0.0 109.15 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.588 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -102.32 99.18 1.82 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.497 ' HG2' ' CZ ' ' A' ' 158' ' ' TYR . 7.4 mt-10 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.16 -1.2 . . . . 0.0 109.474 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.539 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 1.9 tt0 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 4.8 pt-20 -92.25 137.13 32.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 110.762 -178.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.654 ' CE2' ' CG2' ' A' ' 124' ' ' ILE . 43.4 p90 -134.79 147.48 49.98 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.7 p -74.17 171.07 14.24 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.111 -0.993 . . . . 0.0 111.013 -177.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.537 ' CG2' HG13 ' A' ' 124' ' ' ILE . 25.1 t -143.19 140.45 17.82 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.423 -0.798 . . . . 0.0 110.102 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.452 ' HD2' HG12 ' A' ' 140' ' ' VAL . 36.4 Cg_endo -79.94 142.34 15.57 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.475 2.117 . . . . 0.0 110.201 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.428 ' HA2' ' OH ' ' A' ' 122' ' ' TYR . . . -84.06 45.76 3.54 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.59 -81.46 0.54 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -1.152 . . . . 0.0 110.096 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -78.98 157.67 28.09 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.545 0.688 . . . . 0.0 110.271 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.582 ' O ' ' CE3' ' A' ' 112' ' ' TRP . 0.1 OUTLIER -95.38 -3.17 47.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.473 -0.767 . . . . 0.0 109.577 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 110' ' ' ILE . 7.1 p -116.63 142.04 47.41 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.484 ' O ' ' CG1' ' A' ' 110' ' ' ILE . . . -134.51 150.88 50.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.876 -1.14 . . . . 0.0 110.06 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 6.9 t -96.17 146.4 24.71 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.367 -0.833 . . . . 0.0 109.028 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.651 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 19.2 mm -126.07 73.18 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.233 -0.917 . . . . 0.0 109.513 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.529 ' HA ' ' CB ' ' A' ' 107' ' ' SER . 4.9 m-80 -79.22 -165.03 0.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.711 -0.618 . . . . 0.0 109.597 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 25.2 m120 57.93 20.65 6.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.057 -1.027 . . . . 0.0 109.017 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.585 HG13 ' CE2' ' A' ' 158' ' ' TYR . 3.5 tt -89.69 161.04 2.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.478 -0.764 . . . . 0.0 109.67 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.58 122.89 40.44 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.166 -0.959 . . . . 0.0 109.221 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.464 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 36.3 Cg_endo -77.73 145.3 22.82 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.439 2.093 . . . . 0.0 110.563 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 184' ' ' THR . . . 81.12 65.69 1.67 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 167.14 130.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -1.208 . . . . 0.0 109.748 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.412 ' CG ' ' N ' ' A' ' 158' ' ' TYR . 2.0 t70 -50.34 165.78 0.09 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.588 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -144.53 173.07 12.12 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.804 -1.185 . . . . 0.0 110.248 -179.66 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.556 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 1.8 m -147.59 99.34 3.1 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 88.1 mt -97.39 129.62 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.701 -1.249 . . . . 0.0 109.403 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 179' ' ' SER . 1.7 m -133.8 139.2 46.15 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.099 -1.001 . . . . 0.0 110.428 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.586 ' CD1' ' CD2' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -110.79 145.6 37.86 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.529 -0.732 . . . . 0.0 110.478 -179.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.607 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 37.8 m-85 -131.33 83.73 2.12 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.528 ' O ' ' CB ' ' A' ' 174' ' ' SER . . . -63.73 123.25 18.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.128 -0.983 . . . . 0.0 109.726 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.542 HG23 ' CZ ' ' A' ' 121' ' ' TYR . 5.3 t . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 109.452 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 164' ' ' ALA . 1.7 p . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 174' ' ' SER . 0.9 OUTLIER -44.6 167.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 108.995 179.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 175' ' ' SER . 0.2 OUTLIER -47.98 133.4 11.8 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.987 -1.071 . . . . 0.0 108.491 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.607 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.8 Cg_endo -76.57 157.23 36.24 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.121 1.881 . . . . 0.0 110.324 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -140.35 137.04 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.317 -0.864 . . . . 0.0 108.829 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 161' ' ' THR . 0.1 OUTLIER -126.73 -178.6 4.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 110.512 -178.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.53 ' CG2' ' HB3' ' A' ' 98' ' ' LEU . 27.8 pt -158.14 152.3 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -95.72 151.6 19.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.056 -1.028 . . . . 0.0 109.475 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.621 ' CD2' ' CD1' ' A' ' 108' ' ' LEU . 70.7 t80 -147.11 131.26 17.35 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.271 -0.893 . . . . 0.0 109.4 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.82 119.65 39.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.084 -1.01 . . . . 0.0 109.524 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 155' ' ' GLY . 18.4 p . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.46 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.508 ' N ' HD11 ' A' ' 2' ' ' LEU . 1.1 mp . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.54 ' HB2' ' CB ' ' A' ' 25' ' ' PRO . 1.1 m-20 -94.17 144.06 25.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.338 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.527 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 10.3 m -78.15 145.33 68.88 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.509 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.467 ' O ' ' CD1' ' A' ' 84' ' ' LEU . 35.7 Cg_endo -78.52 125.77 7.1 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.68 2.253 . . . . 0.0 110.336 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.454 ' HA ' HD12 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -143.35 -164.96 1.97 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.905 . . . . 0.0 109.988 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 8' ' ' PHE . . . 83.13 16.89 68.37 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 107.691 -2.163 . . . . 0.0 107.691 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.415 ' C ' ' O ' ' A' ' 7' ' ' GLY . 2.4 t80 -40.49 140.32 0.67 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.794 -0.827 . . . . 0.0 110.28 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 21' ' ' HIS . 15.1 t0 -165.26 97.68 0.71 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.5 ' CB ' ' HB3' ' A' ' 88' ' ' GLN . 5.4 m -84.59 128.44 34.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.159 -0.963 . . . . 0.0 109.651 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.494 ' O ' ' C ' ' A' ' 12' ' ' ASP . 3.5 p -146.87 -164.74 2.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.327 -0.858 . . . . 0.0 109.026 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.51 ' CB ' ' OG1' ' A' ' 19' ' ' THR . 0.8 OUTLIER 41.61 35.92 0.52 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -178.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.599 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 2.3 mt -78.73 144.53 10.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.202 -177.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.548 ' N ' HG21 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -123.5 -157.69 0.77 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.379 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 64' ' ' PRO . . . -93.2 -48.65 6.36 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.887 -1.133 . . . . 0.0 109.167 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 15.2 p30 -99.63 -9.12 23.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.043 -1.036 . . . . 0.0 109.155 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 14' ' ' THR . 27.4 p -142.62 159.53 42.06 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.599 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 9.9 p90 -166.13 142.16 4.92 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.911 -1.118 . . . . 0.0 109.435 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.51 ' OG1' ' CB ' ' A' ' 12' ' ' ASP . 17.1 m -81.33 153.76 26.86 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.897 -1.127 . . . . 0.0 110.773 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.568 ' CG2' ' CD1' ' A' ' 59' ' ' LEU . 0.3 OUTLIER -132.18 116.98 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.52 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.547 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 3.1 m-70 -103.07 161.95 13.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.053 -1.03 . . . . 0.0 110.34 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.445 ' CH2' HG23 ' A' ' 50' ' ' VAL . 23.4 p90 -171.42 137.47 1.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.484 -0.76 . . . . 0.0 109.083 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.35 163.14 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.073 -1.017 . . . . 0.0 109.652 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.45 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . . . -98.62 173.45 3.86 Favored Pre-proline 0 C--N 1.299 -1.63 0 O-C-N 121.713 -0.617 . . . . 0.0 109.733 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.54 ' CB ' ' HB2' ' A' ' 3' ' ' ASP . 35.8 Cg_endo -78.42 -162.18 0.17 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.644 2.229 . . . . 0.0 110.307 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.494 ' HB2' ' NH2' ' A' ' 26' ' ' ARG . 0.5 OUTLIER -119.55 18.53 12.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.957 . . . . 0.0 109.426 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.45 ' CB ' ' HD2' ' A' ' 28' ' ' PRO . . . -121.83 172.7 4.76 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.886 . . . . 0.0 109.489 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.462 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 35.7 Cg_endo -78.0 88.25 1.45 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.653 2.236 . . . . 0.0 110.421 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.511 HD13 ' CB ' ' A' ' 52' ' ' PRO . 9.1 pt -80.12 -176.89 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 109.498 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.453 ' OG1' ' N ' ' A' ' 77' ' ' GLY . 59.6 p -131.72 -2.14 3.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 109.929 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.499 ' O ' ' CD1' ' A' ' 32' ' ' TYR . . . 162.51 -178.56 38.24 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.578 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 1.7 m-85 -149.53 131.66 15.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -1.168 . . . . 0.0 109.732 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.593 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -99.38 130.4 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -0.892 . . . . 0.0 108.897 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 48' ' ' ASP . 1.4 mm -117.57 119.34 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.013 -1.054 . . . . 0.0 109.985 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.456 ' HB2' ' OG ' ' A' ' 71' ' ' SER . 34.8 mtp180 -119.35 138.91 52.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.19 -0.944 . . . . 0.0 108.508 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.636 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 8.4 p80 -129.88 160.26 34.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.905 -1.122 . . . . 0.0 110.688 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.519 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 28.6 p-80 -171.86 121.9 0.49 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.617 -0.677 . . . . 0.0 109.332 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.642 ' CB ' ' CE1' ' A' ' 68' ' ' TYR . . . -50.58 -178.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.177 -0.952 . . . . 0.0 109.554 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 . . . . . 0 N--CA 1.488 1.428 0 O-C-N 121.227 -0.92 . . . . 0.0 109.403 179.902 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.586 ' CG ' ' NE2' ' A' ' 36' ' ' HIS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.42 ' HG2' ' HG2' ' A' ' 35' ' ' ARG . 70.0 mt-30 -109.94 103.52 12.3 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.341 -0.849 . . . . 0.0 109.881 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.519 ' HB3' ' CD1' ' A' ' 57' ' ' ILE . 70.8 m-20 -93.93 115.93 28.34 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.522 ' HD2' ' CG2' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -97.27 156.72 16.31 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.109 -0.995 . . . . 0.0 109.87 -179.47 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.47 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 15.8 m -141.9 160.54 55.38 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 109.113 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.533 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.4 Cg_endo -77.11 174.18 13.23 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.466 2.111 . . . . 0.0 110.03 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.511 ' CB ' HD13 ' A' ' 29' ' ' ILE . 35.3 Cg_endo -77.54 -15.42 15.56 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.443 2.096 . . . . 0.0 110.516 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.9 t -99.23 18.45 17.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.576 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.533 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -125.86 119.08 26.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 109.799 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 22' ' ' TRP . 0.8 OUTLIER -103.48 -0.39 29.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.321 -0.862 . . . . 0.0 109.283 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 30.8 p -131.08 129.94 42.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 109.462 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.519 ' CD1' ' HB3' ' A' ' 48' ' ' ASP . 4.4 tt -125.05 140.12 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.254 -0.904 . . . . 0.0 109.361 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 8.8 m -102.75 136.68 42.13 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.264 -0.897 . . . . 0.0 109.302 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.627 ' CD2' ' CD2' ' A' ' 36' ' ' HIS . 1.1 mp -115.16 161.0 19.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.637 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.441 HG21 ' HB3' ' A' ' 17' ' ' SER . 23.5 p -139.12 -170.32 2.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.402 -0.811 . . . . 0.0 109.344 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 51.93 54.62 10.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.195 -0.941 . . . . 0.0 109.51 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.636 ' CD2' ' CE1' ' A' ' 36' ' ' HIS . 6.8 mt -129.27 169.93 14.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.473 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -84.64 142.83 40.13 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.263 -0.898 . . . . 0.0 109.3 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.52 ' HB3' ' CB ' ' A' ' 15' ' ' ALA . 36.9 Cg_endo -78.78 122.29 5.37 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.556 2.171 . . . . 0.0 110.395 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 75.12 62.49 2.75 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.113 -1.995 . . . . 0.0 108.113 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.605 ' CG2' ' CE2' ' A' ' 68' ' ' TYR . 1.3 m -149.17 144.76 26.8 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.309 -1.112 . . . . 0.0 110.899 -178.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -81.38 105.63 12.71 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.468 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.642 ' CE1' ' CB ' ' A' ' 38' ' ' ALA . 13.5 m-85 -103.91 150.52 24.11 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.27 -0.894 . . . . 0.0 109.979 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.462 HG12 ' HB3' ' A' ' 87' ' ' GLN . 4.1 t -109.75 154.98 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.321 -0.862 . . . . 0.0 109.193 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 40.9 t -139.51 129.02 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.126 -0.984 . . . . 0.0 109.709 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 79.2 p -103.18 101.18 11.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.862 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 84' ' ' LEU . 10.9 mm -74.98 153.12 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.094 -1.004 . . . . 0.0 109.702 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.572 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 15.5 mt -143.3 158.68 17.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.383 -0.823 . . . . 0.0 108.892 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.578 ' HB1' ' CZ ' ' A' ' 32' ' ' TYR . . . -131.21 153.02 49.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.437 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.9 m -141.12 135.61 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 109.389 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 79' ' ' GLU . 1.1 t30 -110.72 43.66 1.39 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 109.513 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.453 ' N ' ' OG1' ' A' ' 30' ' ' THR . . . 77.25 -57.1 3.67 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -126.19 -2.96 6.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -1.147 . . . . 0.0 109.737 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 0.5 OUTLIER -110.07 177.02 4.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.571 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -147.78 95.43 2.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.32 -0.863 . . . . 0.0 109.434 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.566 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.7 OUTLIER -59.64 -179.05 0.15 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.891 . . . . 0.0 109.084 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.566 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.5 Cg_endo -77.71 146.28 23.72 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.277 1.985 . . . . 0.0 110.365 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.93 100.99 1.43 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.675 2.25 . . . . 0.0 110.896 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.469 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 4.1 tp -75.0 103.83 5.34 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 1.9 mt -93.98 143.52 11.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 120.887 -1.133 . . . . 0.0 110.636 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.427 ' O ' HG11 ' A' ' 69' ' ' VAL . . . -148.11 -163.22 10.61 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.462 ' HB3' HG12 ' A' ' 69' ' ' VAL . 8.2 pt20 -166.78 164.96 16.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.997 -1.296 . . . . 0.0 110.038 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.557 ' HG3' ' CE1' ' A' ' 18' ' ' PHE . 1.9 pm0 -159.73 151.43 20.2 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -90.94 136.67 32.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.153 -0.967 . . . . 0.0 110.431 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.481 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -74.45 134.27 42.35 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.144 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 65' ' ' GLY . 9.4 t . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.574 0.702 . . . . 0.0 110.599 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.573 ' CB ' ' CD1' ' A' ' 112' ' ' TRP . 36.5 Cg_endo . . . . . 0 C--O 1.216 -0.614 0 N-CA-C 109.496 -1.002 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -76.07 177.19 7.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.318 -0.864 . . . . 0.0 109.677 -179.366 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER 76.28 19.57 1.7 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -0.846 . . . . 0.0 109.64 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.58 ' CD1' ' CD2' ' A' ' 162' ' ' LEU . 0.5 OUTLIER -62.21 99.95 0.15 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.121 -0.987 . . . . 0.0 109.029 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 97' ' ' ASP . 0.1 OUTLIER -144.64 163.74 33.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 109.715 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.429 HG22 ' HB3' ' A' ' 108' ' ' LEU . 9.6 p -104.05 148.75 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.548 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.463 HG12 ' HB3' ' A' ' 109' ' ' LEU . 25.1 pt -125.44 -5.46 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -0.891 . . . . 0.0 109.589 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.513 ' CB ' ' HB2' ' A' ' 109' ' ' LEU . . . -150.49 108.46 3.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.371 -0.831 . . . . 0.0 108.783 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.521 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.7 t -101.7 93.95 5.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 110.229 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -80.01 164.28 53.58 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.339 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 30.1 Cg_endo -69.18 -2.95 10.66 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.425 2.083 . . . . 0.0 110.748 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.491 ' C ' ' CG2' ' A' ' 152' ' ' ILE . 7.5 p -152.48 19.24 0.63 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.542 ' N ' ' OG1' ' A' ' 104' ' ' THR . 54.5 p -172.89 160.4 4.32 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.96 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.581 HD23 ' CE2' ' A' ' 182' ' ' TYR . 0.5 OUTLIER -135.52 155.33 50.67 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.354 -0.841 . . . . 0.0 108.947 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.513 ' HB2' ' CB ' ' A' ' 102' ' ' ALA . 0.4 OUTLIER -105.04 95.41 5.83 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.239 -0.913 . . . . 0.0 109.346 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 147' ' ' ALA . 15.7 pt -74.88 167.82 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.927 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.47 ' OG ' HG23 ' A' ' 146' ' ' THR . 3.7 m -165.34 100.41 0.72 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.634 -0.666 . . . . 0.0 109.365 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.575 ' CD2' ' O ' ' A' ' 145' ' ' SER . 41.3 p90 -111.4 141.77 44.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.207 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 96' ' ' ARG . 11.3 mm-40 . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.168 -0.957 . . . . 0.0 109.352 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.615 ' CZ ' ' CG2' ' A' ' 165' ' ' VAL . 2.7 p90 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.643 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 1.6 m-85 -134.8 132.91 39.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.924 . . . . 0.0 109.282 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 8.7 ttm180 -85.28 159.33 20.08 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.909 -1.12 . . . . 0.0 108.459 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.596 ' HB ' ' CZ ' ' A' ' 138' ' ' PHE . 13.9 mt -148.85 119.75 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.033 -1.042 . . . . 0.0 109.779 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 64.9 p -91.39 128.99 37.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.595 -0.691 . . . . 0.0 109.94 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.641 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 2.4 m-85 -74.53 138.59 43.22 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.59 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.91 89.23 0.6 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.579 ' HG2' ' CE2' ' A' ' 158' ' ' TYR . 6.8 mt-10 . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.218 -1.166 . . . . 0.0 109.735 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.557 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 1.1 mt-30 . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 0.9 OUTLIER -74.7 155.36 37.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.242 -0.911 . . . . 0.0 110.751 -178.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.596 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 3.2 p90 -161.4 139.19 9.16 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 p -74.81 149.74 39.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.068 -1.02 . . . . 0.0 111.145 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.54 ' CG1' ' HD2' ' A' ' 141' ' ' PRO . 55.7 t -111.71 145.46 32.7 Favored Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.54 ' HD2' ' CG1' ' A' ' 140' ' ' VAL . 34.8 Cg_endo -77.54 132.23 12.05 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.395 2.063 . . . . 0.0 109.882 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -85.87 37.63 3.07 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.407 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 2.7 m -105.27 -1.46 25.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.096 -1.238 . . . . 0.0 109.595 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.407 ' CG ' ' O ' ' A' ' 143' ' ' SER . 12.3 mttp -163.01 172.29 15.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.917 . . . . 0.0 109.57 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.575 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 5.0 p -95.3 -23.82 17.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.221 -0.925 . . . . 0.0 109.899 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.47 HG23 ' OG ' ' A' ' 111' ' ' SER . 3.3 p -102.23 163.77 12.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.079 -1.013 . . . . 0.0 109.483 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.448 ' O ' HG12 ' A' ' 110' ' ' ILE . . . -153.7 173.34 15.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.95 . . . . 0.0 109.682 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.1 t -104.45 152.39 22.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 109.097 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.641 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 34.0 mm -131.29 73.52 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.137 -0.977 . . . . 0.0 109.49 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.531 ' HA ' ' CB ' ' A' ' 107' ' ' SER . 3.7 m120 -80.7 -146.62 0.05 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.551 -0.718 . . . . 0.0 109.731 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 150' ' ' ASN . 4.9 m120 43.38 26.88 0.11 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 109.523 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.508 HG23 ' N ' ' A' ' 107' ' ' SER . 4.5 tt -93.37 158.28 2.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.281 -0.887 . . . . 0.0 109.549 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 153' ' ' LYS . 26.2 mmtt -114.17 120.51 38.37 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.92 . . . . 0.0 109.234 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.466 ' HA ' ' CB ' ' A' ' 184' ' ' THR . 35.4 Cg_endo -78.04 146.31 22.85 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.413 2.075 . . . . 0.0 110.566 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . 93.7 60.0 1.17 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 162.3 131.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.411 -1.052 . . . . 0.0 109.41 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 156' ' ' ALA . 24.6 t0 -46.83 166.52 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.594 ' CD1' ' CG2' ' A' ' 184' ' ' THR . 0.2 OUTLIER -145.04 -178.2 5.93 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.51 -1.369 . . . . 0.0 110.048 -179.464 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.55 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 2.5 m -157.98 165.23 35.66 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.491 ' N ' ' CG2' ' A' ' 159' ' ' THR . 22.5 mt -155.27 132.57 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.749 -1.22 . . . . 0.0 110.11 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.575 ' CG2' ' CB ' ' A' ' 179' ' ' SER . 1.6 m -136.91 172.09 13.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.855 . . . . 0.0 108.844 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.58 ' CD2' ' CD1' ' A' ' 98' ' ' LEU . 0.6 OUTLIER -163.42 151.55 13.48 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.679 -1.208 . . . . 0.0 111.597 -179.481 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.624 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 4.2 m-85 -125.11 120.79 32.41 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.592 ' HB3' ' CD2' ' A' ' 122' ' ' TYR . . . -81.57 99.75 9.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.847 -1.158 . . . . 0.0 109.532 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.615 ' CG2' ' CZ ' ' A' ' 121' ' ' TYR . 18.7 t . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.263 -0.898 . . . . 0.0 109.369 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' A' ' 163' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.281 0.562 . . . . 0.0 109.507 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.46 ' OG ' ' HB2' ' A' ' 164' ' ' ALA . 0.6 OUTLIER -46.96 166.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.611 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 175' ' ' SER . 0.0 OUTLIER -41.05 127.88 2.03 Favored Pre-proline 0 C--N 1.304 -1.383 0 O-C-N 121.595 -0.691 . . . . 0.0 109.878 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.624 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.2 Cg_endo -77.43 131.4 11.56 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.022 1.815 . . . . 0.0 110.492 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.34 137.48 47.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.575 ' CB ' ' CG2' ' A' ' 161' ' ' THR . 1.0 OUTLIER -129.53 165.67 21.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 110.811 -178.406 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.469 HG22 ' HB3' ' A' ' 98' ' ' LEU . 5.5 pt -144.2 -170.53 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -119.12 169.64 9.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.042 -1.036 . . . . 0.0 109.402 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.581 ' CE2' HD23 ' A' ' 108' ' ' LEU . 56.3 t80 -164.63 166.45 20.13 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.163 -0.961 . . . . 0.0 109.428 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -147.56 129.14 15.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.902 . . . . 0.0 109.455 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.594 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.48 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.431 HD13 ' HB2' ' A' ' 81' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 1.1 m-20 -113.66 146.2 40.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.423 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.478 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 10.8 p -95.4 155.91 38.22 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 0.0 109.595 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.579 ' HG3' ' CD1' ' A' ' 32' ' ' TYR . 36.3 Cg_endo -79.05 110.48 2.76 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.725 2.283 . . . . 0.0 110.128 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.449 ' HA ' HD23 ' A' ' 84' ' ' LEU . 1.8 p -97.94 -113.21 0.15 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.131 -0.981 . . . . 0.0 109.472 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.465 ' HA3' ' HB ' ' A' ' 23' ' ' VAL . . . 44.14 27.08 1.02 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.426 ' N ' ' O ' ' A' ' 6' ' ' THR . 8.7 t80 -58.17 95.07 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.582 -0.952 . . . . 0.0 109.861 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.525 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 38.0 t70 -126.82 95.77 4.43 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.344 -0.848 . . . . 0.0 109.055 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.536 ' CB ' ' HG3' ' A' ' 88' ' ' GLN . 32.8 m -84.66 135.3 34.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.297 -0.877 . . . . 0.0 109.38 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.456 ' O ' ' C ' ' A' ' 12' ' ' ASP . 5.5 p -156.42 -159.78 0.92 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.407 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.497 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 1.2 m-20 45.96 40.7 7.18 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.605 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.5 mt -83.45 129.32 37.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.604 -177.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.594 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -115.91 174.1 6.21 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 178.194 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -67.63 -65.1 0.73 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.764 -1.21 . . . . 0.0 109.924 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.467 ' O ' ' OG ' ' A' ' 17' ' ' SER . 6.5 m-80 -86.66 17.15 4.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.012 -1.055 . . . . 0.0 110.017 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.594 ' O ' ' N ' ' A' ' 14' ' ' THR . 21.8 m -168.46 156.37 8.18 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.605 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 4.3 p90 -165.89 143.05 5.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.143 -0.973 . . . . 0.0 109.281 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.497 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 8.5 m -89.55 156.17 18.79 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.849 -1.157 . . . . 0.0 111.293 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.554 HG21 ' CE1' ' A' ' 18' ' ' PHE . 1.3 t -132.58 134.34 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.536 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 2.1 m-70 -121.25 166.36 14.12 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.924 -1.11 . . . . 0.0 110.328 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.579 ' CD1' ' O ' ' A' ' 22' ' ' TRP . 6.2 p90 -174.12 137.78 0.56 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.477 -0.765 . . . . 0.0 109.189 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -78.75 162.43 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.053 -1.029 . . . . 0.0 109.773 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.463 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . . . -86.86 168.71 17.1 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.73 -0.606 . . . . 0.0 109.587 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 5' ' ' PRO . 36.3 Cg_endo -79.45 -172.54 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.647 2.232 . . . . 0.0 110.459 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -113.87 16.09 18.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -0.871 . . . . 0.0 109.3 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.531 ' CB ' ' HD2' ' A' ' 28' ' ' PRO . . . -124.55 177.9 1.63 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.341 -0.849 . . . . 0.0 109.26 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 34.6 Cg_endo -77.84 135.84 14.54 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.476 2.117 . . . . 0.0 110.256 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.501 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 45.9 pt -152.04 -179.13 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.915 . . . . 0.0 109.546 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.8 p -114.32 -20.89 10.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 109.476 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.16 172.1 28.04 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.579 ' CD1' ' HG3' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -112.17 150.25 31.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -1.154 . . . . 0.0 109.47 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.578 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 1.4 mp -95.08 137.23 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.158 -0.964 . . . . 0.0 108.858 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.512 ' CG1' HG11 ' A' ' 50' ' ' VAL . 3.4 mm -116.94 95.05 3.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.4 -0.812 . . . . 0.0 109.937 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.486 ' HG3' ' HA ' ' A' ' 47' ' ' GLN . 54.7 ttp180 -106.28 117.01 32.93 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 108.522 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.518 ' NE2' ' CG ' ' A' ' 46' ' ' ARG . 3.1 p-80 -106.69 147.35 29.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.966 -1.084 . . . . 0.0 110.273 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.531 ' CE1' HG13 ' A' ' 69' ' ' VAL . 41.3 p-80 -162.05 124.43 2.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.45 -0.781 . . . . 0.0 109.577 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -56.58 -161.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.263 -0.898 . . . . 0.0 109.624 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.769 -179.823 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.518 ' CG ' ' NE2' ' A' ' 36' ' ' HIS . 12.9 ptm180 . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.362 0.601 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.486 ' HA ' ' HG3' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -105.89 114.17 28.16 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.341 -0.849 . . . . 0.0 109.48 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.472 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 19.5 m-20 -107.42 168.81 8.98 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.491 ' HD2' ' CG2' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -136.4 164.07 28.99 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.509 -0.744 . . . . 0.0 109.587 -179.524 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.551 HG23 ' CH2' ' A' ' 22' ' ' TRP . 33.5 m -149.56 158.86 37.39 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.421 -0.799 . . . . 0.0 109.295 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 33.9 Cg_endo -75.72 174.25 13.13 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.529 2.153 . . . . 0.0 110.373 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.577 ' HA ' ' CE2' ' A' ' 32' ' ' TYR . 34.3 Cg_endo -76.63 -22.63 11.9 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.574 2.182 . . . . 0.0 110.68 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.95 -8.77 53.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.135 -0.978 . . . . 0.0 109.505 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.522 ' HD3' ' N ' ' A' ' 54' ' ' ARG . 1.6 mpt_? -94.78 112.13 23.88 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.291 -0.881 . . . . 0.0 109.593 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 7.9 p-10 -107.41 -2.29 20.68 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.448 -0.782 . . . . 0.0 109.725 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 27.0 p -136.17 129.83 32.3 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.111 -0.993 . . . . 0.0 109.815 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.9 tt -129.44 120.28 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -0.871 . . . . 0.0 109.045 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 0.3 OUTLIER -88.09 131.43 34.69 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.298 -0.876 . . . . 0.0 109.615 -179.601 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.461 ' O ' ' HB3' ' A' ' 17' ' ' SER . 1.3 mt -104.56 142.63 34.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 109.38 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.461 ' HA ' ' OG ' ' A' ' 17' ' ' SER . 6.7 p -130.02 178.12 6.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.949 . . . . 0.0 109.537 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.9 m120 54.78 40.95 32.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 109.497 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.529 ' HB3' ' CE2' ' A' ' 68' ' ' TYR . 4.6 mt -111.94 145.12 40.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.301 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.463 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 2.6 m120 -54.63 130.6 64.17 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.113 -0.992 . . . . 0.0 108.681 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.1 Cg_endo -77.4 125.36 7.66 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.217 1.944 . . . . 0.0 110.642 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 80.46 61.73 2.16 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.406 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 3.5 m -152.89 155.85 37.84 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.349 -1.089 . . . . 0.0 110.385 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 2.0 mp0 -85.43 116.95 24.05 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.529 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 9.8 m-85 -112.72 106.88 15.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.121 -0.987 . . . . 0.0 109.898 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.531 HG13 ' CE1' ' A' ' 37' ' ' HIS . 3.4 t -73.93 133.03 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.923 . . . . 0.0 108.839 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 19.4 t -122.36 117.72 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.096 -1.002 . . . . 0.0 109.837 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.531 ' CB ' HG12 ' A' ' 85' ' ' ILE . 1.8 p -92.84 133.37 36.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.0 110.282 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.543 HG22 HD11 ' A' ' 72' ' ' ILE . 21.4 mm -120.74 79.39 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.523 ' CD1' ' HA ' ' A' ' 83' ' ' PRO . 23.4 mm -76.75 163.87 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.943 . . . . 0.0 109.604 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.492 ' CB ' ' OG ' ' A' ' 81' ' ' SER . . . -131.71 117.22 18.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.54 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.408 HG23 ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -107.65 173.98 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.289 -0.882 . . . . 0.0 109.283 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.497 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 18.6 t30 -153.33 49.35 0.7 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 109.446 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.69 -80.72 1.73 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.425 ' NH2' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -119.74 -1.95 10.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -1.15 . . . . 0.0 109.59 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 1.2 mp0 -90.9 -173.44 3.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.371 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 16.8 mt-10 -156.65 93.56 1.39 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.19 -0.943 . . . . 0.0 109.584 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.533 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -59.48 178.85 0.22 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.014 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.4 Cg_endo -76.8 158.16 35.15 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.289 1.992 . . . . 0.0 110.167 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.523 ' HA ' ' CD1' ' A' ' 73' ' ' ILE . 34.7 Cg_endo -77.15 145.25 24.29 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.621 2.214 . . . . 0.0 111.103 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.518 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 25.5 tp -136.21 85.97 2.19 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.531 HG12 ' CB ' ' A' ' 71' ' ' SER . 2.3 mt -99.93 139.85 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.185 -0.947 . . . . 0.0 109.789 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.405 ' O ' HG11 ' A' ' 69' ' ' VAL . . . -128.08 -171.13 12.95 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -148.59 125.04 10.97 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.14 -1.211 . . . . 0.0 109.691 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.536 ' HG3' ' CB ' ' A' ' 10' ' ' SER . 1.1 tm0? -135.81 114.61 12.02 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.321 -0.862 . . . . 0.0 109.006 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -74.9 133.53 41.78 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.295 -0.878 . . . . 0.0 110.02 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.44 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -74.15 138.12 43.63 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.336 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 65' ' ' GLY . 1.4 t . . . . . 0 C--N 1.3 -1.571 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.432 ' CB ' ' O ' ' A' ' 113' ' ' GLU . 34.3 Cg_endo . . . . . 0 C--O 1.215 -0.645 0 N-CA-C 109.346 -1.059 . . . . 0.0 109.346 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 1.5 ptm85 -168.44 171.91 8.7 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.072 -1.018 . . . . 0.0 109.575 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 2.0 t70 79.47 17.86 0.8 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 0.0 109.661 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.521 HD22 ' CD2' ' A' ' 162' ' ' LEU . 0.8 OUTLIER -54.33 87.22 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.225 -0.922 . . . . 0.0 109.486 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 97' ' ' ASP . 0.6 OUTLIER -138.89 169.49 17.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.107 -0.996 . . . . 0.0 109.796 -179.748 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 7.0 p -102.84 144.01 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -0.878 . . . . 0.0 109.81 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.528 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 6.8 pt -126.1 -4.49 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.367 -0.833 . . . . 0.0 109.266 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.523 ' CB ' ' HB2' ' A' ' 109' ' ' LEU . . . -151.74 88.87 1.43 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.541 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 6.0 p -84.09 93.52 8.14 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.595 -0.69 . . . . 0.0 110.27 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.46 ' OG1' ' OG ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -84.42 161.38 54.41 Favored Pre-proline 0 C--N 1.306 -1.297 0 O-C-N 121.127 -0.983 . . . . 0.0 108.949 179.156 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.476 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.6 Cg_endo -69.65 -3.04 11.14 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.44 2.093 . . . . 0.0 110.56 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.492 ' C ' ' CG2' ' A' ' 152' ' ' ILE . 37.8 p -151.33 19.1 0.74 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 149' ' ' ILE . 1.1 p -170.85 176.22 4.21 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.719 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.621 ' N ' ' CD1' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -154.11 155.91 36.27 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.406 -0.809 . . . . 0.0 109.143 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.528 ' HB3' ' CG1' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -102.33 123.73 46.65 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.248 -0.908 . . . . 0.0 108.572 179.122 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.597 ' CD1' ' CD1' ' A' ' 149' ' ' ILE . 0.0 OUTLIER -103.21 135.41 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.122 -0.987 . . . . 0.0 109.92 -179.33 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 97' ' ' ASP . 0.4 OUTLIER -131.0 128.57 40.64 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.505 -0.747 . . . . 0.0 108.997 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.578 ' CD2' ' O ' ' A' ' 145' ' ' SER . 28.2 p90 -151.55 145.36 25.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.403 -0.81 . . . . 0.0 109.325 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.454 ' HB2' ' HG2' ' A' ' 96' ' ' ARG . 29.2 mm-40 . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 0.0 109.408 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.629 ' CE2' ' CG2' ' A' ' 165' ' ' VAL . 3.0 p90 . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 4.0 m-85 -115.18 145.98 41.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.035 -1.041 . . . . 0.0 109.737 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.582 ' HG2' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -108.39 95.8 5.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.459 -0.776 . . . . 0.0 109.197 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.592 ' HB ' ' CE2' ' A' ' 138' ' ' PHE . 45.1 mt -84.36 145.12 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.315 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 77.0 p -131.54 144.53 51.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.945 . . . . 0.0 110.451 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.667 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 2.8 m-30 -88.06 132.19 34.38 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.589 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.68 111.35 3.64 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.422 ' HG2' ' CZ ' ' A' ' 158' ' ' TYR . 14.1 mt-10 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.263 -1.139 . . . . 0.0 109.45 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.575 ' HB3' ' CG ' ' A' ' 126' ' ' TYR . 2.8 tt0 . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 18.7 tt0 -102.34 118.48 36.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.858 . . . . 0.0 111.076 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.592 ' CE2' ' HB ' ' A' ' 124' ' ' ILE . 35.9 p90 -121.92 142.49 50.23 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.481 HG21 ' CE1' ' A' ' 121' ' ' TYR . 1.5 p -74.15 175.06 7.86 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.966 -1.084 . . . . 0.0 110.834 -178.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.526 HG23 ' CD1' ' A' ' 124' ' ' ILE . 53.7 t -144.35 142.73 20.07 Favored Pre-proline 0 C--N 1.304 -1.392 0 O-C-N 121.553 -0.717 . . . . 0.0 109.321 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.472 ' HD2' HG12 ' A' ' 140' ' ' VAL . 35.2 Cg_endo -77.34 148.73 27.06 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.454 2.103 . . . . 0.0 110.331 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.06 17.88 39.31 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.4 p -105.25 27.81 7.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -1.151 . . . . 0.0 109.613 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.99 139.01 4.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 0.0 109.585 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.578 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 1.3 p -92.48 -15.56 26.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 109.404 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.5 p -123.12 132.39 54.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.292 -0.88 . . . . 0.0 109.185 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.445 ' HB1' ' CH2' ' A' ' 112' ' ' TRP . . . -120.91 -165.43 1.21 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.23 -0.918 . . . . 0.0 109.239 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.538 ' CG2' ' N ' ' A' ' 149' ' ' ILE . 23.8 m -145.13 166.08 26.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.151 -0.968 . . . . 0.0 109.646 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.667 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 1.2 mt -137.12 121.76 24.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.3 -0.875 . . . . 0.0 109.334 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.462 ' HA ' ' HB3' ' A' ' 107' ' ' SER . 6.8 m-80 -123.2 177.27 5.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.4 -0.812 . . . . 0.0 109.514 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 2.7 m-20 65.54 31.43 10.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 109.161 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.536 ' CG1' ' CE2' ' A' ' 158' ' ' TYR . 16.2 tt -89.86 166.9 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.397 -0.814 . . . . 0.0 109.714 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -107.14 112.17 63.14 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 109.445 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.476 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 34.7 Cg_endo -77.26 167.12 25.24 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.454 2.103 . . . . 0.0 110.6 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . 76.73 57.23 3.88 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 163.55 134.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -1.128 . . . . 0.0 109.516 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.452 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 0.6 OUTLIER -51.49 164.57 0.2 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.093 -1.004 . . . . 0.0 108.443 179.436 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.589 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.4 OUTLIER -142.0 177.06 8.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.8 -1.187 . . . . 0.0 110.381 -179.528 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.535 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 2.2 m -147.73 109.66 4.48 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.403 ' HA ' HD11 ' A' ' 160' ' ' ILE . 21.8 mm -97.59 134.87 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.789 -1.194 . . . . 0.0 109.994 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.539 ' CG2' ' HB3' ' A' ' 179' ' ' SER . 68.8 m -145.11 147.65 32.76 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.283 -0.886 . . . . 0.0 109.717 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 124' ' ' ILE . 2.6 pt? -140.26 150.61 44.29 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.177 -0.952 . . . . 0.0 110.112 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.603 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 4.1 m-85 -115.47 -176.15 2.86 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -147.02 104.32 3.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.862 . . . . 0.0 109.153 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.629 ' CG2' ' CE2' ' A' ' 121' ' ' TYR . 63.8 t . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 109.909 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 16.7 p . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.326 0.584 . . . . 0.0 109.698 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 51.9 p -53.91 -176.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.322 -0.861 . . . . 0.0 109.303 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.36 140.92 96.93 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.139 -0.975 . . . . 0.0 108.809 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.603 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 35.0 Cg_endo -78.18 136.47 14.48 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.335 2.023 . . . . 0.0 111.145 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.469 ' O ' HD22 ' A' ' 162' ' ' LEU . 2.1 t -108.12 138.14 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.539 ' HB3' ' CG2' ' A' ' 161' ' ' THR . 80.7 p -133.91 173.65 11.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.065 -1.022 . . . . 0.0 110.75 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.514 HG22 ' CD1' ' A' ' 98' ' ' LEU . 38.2 pt -154.53 169.08 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -98.49 178.29 5.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.042 -1.036 . . . . 0.0 109.686 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.606 ' CE1' HD21 ' A' ' 108' ' ' LEU . 25.0 t80 -163.33 172.21 14.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -0.859 . . . . 0.0 109.605 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 157' ' ' ASP . 6.6 tttt -148.85 109.75 4.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 109.264 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.575 HG22 ' CD1' ' A' ' 158' ' ' TYR . 1.4 p . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.482 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.424 HD12 ' HB2' ' A' ' 76' ' ' ASN . 3.2 mt . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 1.6 m-20 -80.11 135.9 36.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.908 . . . . 0.0 109.363 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.87 111.42 55.94 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 109.964 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.534 ' CD ' ' OH ' ' A' ' 32' ' ' TYR . 35.0 Cg_endo -77.05 112.26 3.38 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.471 2.114 . . . . 0.0 109.629 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.495 ' HA ' HD23 ' A' ' 84' ' ' LEU . 1.7 p -110.31 -110.22 0.33 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.187 -0.945 . . . . 0.0 109.856 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 9' ' ' ASP . . . 46.5 25.23 1.99 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -46.24 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.426 -1.043 . . . . 0.0 109.855 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 7' ' ' GLY . 7.3 t0 -126.92 101.45 6.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.358 -0.839 . . . . 0.0 108.795 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.535 ' OG ' ' CG1' ' A' ' 20' ' ' VAL . 38.2 m -87.25 143.58 27.21 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.166 -0.959 . . . . 0.0 110.217 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.478 ' O ' ' HB ' ' A' ' 19' ' ' THR . 49.1 p -144.35 -161.34 1.26 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.486 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 1.4 m-20 42.73 35.95 0.77 Allowed 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -178.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.582 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.3 mt -77.21 156.48 5.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 122.582 1.182 . . . . 0.0 112.638 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.545 ' CA ' HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -150.57 161.74 41.97 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 177.226 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.516 ' HB2' ' CB ' ' A' ' 64' ' ' PRO . . . -73.98 -36.21 64.54 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.324 -1.485 . . . . 0.0 109.704 -178.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.495 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.6 OUTLIER -98.59 22.11 10.35 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.048 -1.032 . . . . 0.0 108.809 179.453 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.532 ' O ' ' N ' ' A' ' 14' ' ' THR . 13.0 p 167.01 154.96 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.582 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 8.9 p90 -166.95 139.49 3.51 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.653 -1.279 . . . . 0.0 109.681 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 28.8 m -79.47 152.72 30.09 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.94 -1.1 . . . . 0.0 110.743 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.58 HG21 ' CE1' ' A' ' 18' ' ' PHE . 2.5 t -126.04 135.07 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.569 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 2.6 m-70 -126.98 170.89 11.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.91 -1.119 . . . . 0.0 110.339 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.45 ' HB2' ' O ' ' A' ' 6' ' ' THR . 27.8 p90 -179.85 149.18 0.34 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -76.89 147.78 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 120.966 -1.084 . . . . 0.0 109.929 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.47 161.63 73.87 Favored Pre-proline 0 C--N 1.298 -1.66 0 O-C-N 121.835 -0.541 . . . . 0.0 109.57 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.53 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 35.9 Cg_endo -78.09 153.41 28.49 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.582 2.188 . . . . 0.0 110.478 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.447 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 17.0 mtt180 -75.35 -0.92 21.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 109.569 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.17 164.75 15.15 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 109.579 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.463 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 35.9 Cg_endo -78.38 105.66 2.01 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.729 2.286 . . . . 0.0 110.357 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.53 ' CG2' ' HG2' ' A' ' 25' ' ' PRO . 31.4 pt -100.37 168.61 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.425 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 59.8 p -113.23 -16.67 12.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.0 109.338 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.82 -165.23 35.25 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.652 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -165.42 120.72 1.31 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -1.151 . . . . 0.0 110.049 -179.818 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.453 ' HA ' ' HG3' ' A' ' 49' ' ' ARG . 22.2 mm -75.33 147.89 7.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 121.104 -0.998 . . . . 0.0 108.658 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.576 ' CG1' ' CG2' ' A' ' 50' ' ' VAL . 14.7 mm -133.24 92.89 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.078 -1.014 . . . . 0.0 109.857 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.542 ' CG ' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -100.57 157.01 16.98 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.171 -0.955 . . . . 0.0 108.69 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.606 ' CG ' ' CD2' ' A' ' 59' ' ' LEU . 1.3 p-80 -143.15 143.27 31.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.004 -1.06 . . . . 0.0 110.055 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.573 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 37.2 p-80 -163.16 130.57 3.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.377 -0.827 . . . . 0.0 109.716 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.645 ' CB ' ' CE1' ' A' ' 68' ' ' TYR . . . -75.28 130.84 39.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.258 -0.901 . . . . 0.0 109.256 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.166 -0.959 . . . . 0.0 109.359 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.517 ' HB2' ' NE2' ' A' ' 36' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.341 0.591 . . . . 0.0 109.747 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -141.06 111.49 6.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -0.866 . . . . 0.0 109.979 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.534 ' O ' ' CD ' ' A' ' 49' ' ' ARG . 20.9 m-20 -110.78 178.59 4.31 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.534 ' CD ' ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -153.98 155.74 36.13 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.217 -0.927 . . . . 0.0 109.951 -179.736 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.576 ' CG2' ' CG1' ' A' ' 34' ' ' ILE . 15.9 m -142.46 160.9 52.56 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.477 -0.764 . . . . 0.0 108.989 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.523 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 33.7 Cg_endo -75.82 173.94 13.66 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.369 2.046 . . . . 0.0 110.211 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 35.0 Cg_endo -77.16 -17.44 15.04 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.491 2.127 . . . . 0.0 110.568 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.419 ' O ' ' OG ' ' A' ' 53' ' ' SER . 5.1 t -102.23 17.29 23.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 109.342 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.523 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -115.56 104.63 11.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -0.865 . . . . 0.0 109.454 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 2.7 p-10 -89.38 -6.17 56.83 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.923 . . . . 0.0 109.561 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 6.3 p -126.23 142.76 51.4 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.39 -0.819 . . . . 0.0 109.567 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.52 ' CG2' ' HB ' ' A' ' 20' ' ' VAL . 5.1 tt -137.11 134.72 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 109.391 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 87.8 m -96.63 125.49 41.14 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.194 -0.941 . . . . 0.0 109.6 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.606 ' CD2' ' CG ' ' A' ' 36' ' ' HIS . 0.9 OUTLIER -102.99 142.24 34.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 109.354 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.465 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 0.9 OUTLIER -122.4 156.67 33.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 109.799 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.518 ' O ' ' CD2' ' A' ' 62' ' ' LEU . 9.0 m-80 62.27 79.83 0.24 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.364 -0.835 . . . . 0.0 109.905 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.57 ' HB3' ' CE2' ' A' ' 68' ' ' TYR . 6.5 mt -143.24 138.88 29.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -0.881 . . . . 0.0 109.414 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.458 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 3.4 m120 -42.59 136.01 2.57 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 109.429 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.516 ' CB ' ' HB2' ' A' ' 15' ' ' ALA . 36.6 Cg_endo -79.2 131.42 9.76 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.476 2.118 . . . . 0.0 110.732 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 63.47 64.15 3.95 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.249 -1.941 . . . . 0.0 108.249 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 m -156.72 151.72 26.14 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.391 -1.064 . . . . 0.0 110.667 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -85.38 123.92 31.39 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.633 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.645 ' CE1' ' CB ' ' A' ' 38' ' ' ALA . 3.1 m-85 -111.25 133.8 53.32 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.073 -1.017 . . . . 0.0 110.605 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.573 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 1.6 t -89.16 107.79 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 35' ' ' ARG . 1.6 t -103.53 129.47 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.205 -0.935 . . . . 0.0 109.533 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.55 ' CB ' HG12 ' A' ' 85' ' ' ILE . 1.3 p -100.07 147.05 26.06 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.142 -0.974 . . . . 0.0 110.35 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.52 HG23 ' CD1' ' A' ' 32' ' ' TYR . 5.1 mm -131.62 94.22 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.584 ' N ' ' CD1' ' A' ' 73' ' ' ILE . 1.4 mp -90.62 135.86 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 109.716 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.652 ' CB ' ' CZ ' ' A' ' 32' ' ' TYR . . . -96.85 144.22 27.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -0.83 . . . . 0.0 109.522 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.457 ' O ' ' OG1' ' A' ' 30' ' ' THR . 1.7 m -130.99 133.18 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.275 -0.891 . . . . 0.0 109.058 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.463 ' OD1' ' O ' ' A' ' 28' ' ' PRO . 24.9 t30 -116.35 45.1 1.85 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.792 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . 0.432 ' N ' HG22 ' A' ' 30' ' ' THR . . . 82.67 -81.55 1.71 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.42 -5.83 16.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -1.186 . . . . 0.0 109.816 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.504 ' HG3' ' N ' ' A' ' 80' ' ' GLU . 16.2 tp10 -107.34 155.92 19.47 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.242 -0.911 . . . . 0.0 109.247 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.504 ' N ' ' HG3' ' A' ' 79' ' ' GLU . 8.1 mt-10 -129.94 105.61 8.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.214 -0.928 . . . . 0.0 109.473 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.551 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -63.96 -179.87 0.31 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.218 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.551 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.4 Cg_endo -77.52 155.76 31.98 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.358 2.039 . . . . 0.0 110.513 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.83 136.14 14.82 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.706 2.27 . . . . 0.0 111.099 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.502 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 15.5 tp -117.71 93.27 4.09 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.55 HG12 ' CB ' ' A' ' 71' ' ' SER . 2.5 mt -96.09 141.36 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.118 -0.989 . . . . 0.0 109.572 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.421 ' O ' HG11 ' A' ' 69' ' ' VAL . . . -130.43 -177.67 15.01 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -146.18 101.26 3.49 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.187 -1.184 . . . . 0.0 109.961 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 41.8 mm-40 -98.26 -161.17 0.85 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -144.65 130.93 19.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.916 -1.115 . . . . 0.0 110.37 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.498 ' O ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.37 139.01 43.79 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.224 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.547 ' O ' ' N ' ' A' ' 65' ' ' GLY . 12.1 t . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 121.557 0.694 . . . . 0.0 110.29 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.528 ' HG3' ' CD1' ' A' ' 162' ' ' LEU . 36.8 Cg_endo . . . . . 0 C--O 1.216 -0.612 0 N-CA-C 109.744 -0.906 . . . . 0.0 109.744 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 2.2 ptt180 -106.27 153.41 22.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.055 -1.028 . . . . 0.0 109.851 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.9 OUTLIER 76.98 25.82 0.79 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 109.853 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.517 HD22 ' CG2' ' A' ' 180' ' ' ILE . 31.1 tp -64.01 100.46 0.32 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.064 -1.022 . . . . 0.0 109.239 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 110' ' ' ILE . 18.4 pt-20 -128.22 170.15 13.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.95 . . . . 0.0 109.572 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 9.1 p -109.24 172.66 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 109.766 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -150.3 -81.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.361 -0.837 . . . . 0.0 109.226 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.519 ' CB ' HD12 ' A' ' 109' ' ' LEU . . . -74.89 101.84 4.55 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.528 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 5.2 p -98.98 90.14 4.53 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.868 . . . . 0.0 110.479 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -76.5 165.71 50.57 Favored Pre-proline 0 C--N 1.306 -1.325 0 O-C-N 121.154 -0.966 . . . . 0.0 108.759 178.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.466 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 29.9 Cg_endo -69.42 -2.81 10.57 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.421 2.081 . . . . 0.0 110.602 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.492 ' HA ' HG21 ' A' ' 152' ' ' ILE . 1.0 OUTLIER -150.64 17.49 0.8 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.394 -0.817 . . . . 0.0 108.805 179.002 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 149' ' ' ILE . 0.5 OUTLIER -169.05 159.33 9.13 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.127 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.599 HD23 ' CE2' ' A' ' 182' ' ' TYR . 0.6 OUTLIER -143.87 154.69 43.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.324 -0.86 . . . . 0.0 109.263 -179.818 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.529 ' HB3' ' CD1' ' A' ' 101' ' ' ILE . 0.4 OUTLIER -105.58 132.97 51.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.318 -0.863 . . . . 0.0 108.833 179.32 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.531 ' CD1' HD12 ' A' ' 124' ' ' ILE . 1.1 pt -115.67 144.69 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.084 -1.01 . . . . 0.0 109.96 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.6 t -143.31 126.55 16.57 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.579 ' CZ3' ' HA ' ' A' ' 146' ' ' THR . 3.3 p90 -123.33 171.33 9.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.947 . . . . 0.0 109.835 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.456 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . 6.0 mm-40 . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.388 -0.82 . . . . 0.0 109.338 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.528 ' CE1' ' HB ' ' A' ' 165' ' ' VAL . 1.8 p90 . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.627 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.2 OUTLIER -135.01 150.37 50.31 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.692 -1.255 . . . . 0.0 110.69 -179.014 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 15.6 mtp180 -109.42 92.63 4.13 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.604 ' HB ' ' CE1' ' A' ' 138' ' ' PHE . 52.8 mt -84.2 163.83 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.926 . . . . 0.0 110.421 -178.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 23.3 p -145.35 140.85 28.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.505 -0.747 . . . . 0.0 109.586 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.651 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 2.6 m-85 -82.06 134.24 35.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.876 . . . . 0.0 109.227 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.62 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -106.0 124.87 7.98 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 . . . . . 0 C--N 1.295 -1.786 0 O-C-N 121.213 -1.169 . . . . 0.0 109.201 179.472 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.517 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 2.1 pt-20 -92.8 154.0 18.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.379 -0.826 . . . . 0.0 110.918 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.604 ' CE1' ' HB ' ' A' ' 124' ' ' ILE . 31.7 p90 -164.74 147.39 8.53 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.509 ' O ' ' CD2' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -73.85 -176.6 2.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.011 -1.056 . . . . 0.0 110.553 -178.19 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.588 ' CG2' ' CD1' ' A' ' 124' ' ' ILE . 71.6 t -146.69 139.07 13.91 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.465 -0.772 . . . . 0.0 109.199 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.463 ' HD2' HG12 ' A' ' 140' ' ' VAL . 34.8 Cg_endo -76.97 127.88 9.63 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.419 2.079 . . . . 0.0 110.396 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -79.4 51.16 3.9 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.504 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 1.0 OUTLIER -104.65 -3.4 23.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.18 -1.188 . . . . 0.0 109.457 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.504 ' CG ' ' O ' ' A' ' 143' ' ' SER . 18.2 mttt -165.3 174.66 9.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 0.0 109.275 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.443 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 4.7 p -93.15 4.35 54.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.512 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.579 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 3.1 p -119.11 155.76 30.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.317 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.459 ' CB ' HD13 ' A' ' 124' ' ' ILE . . . -129.61 161.22 31.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.411 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.6 m -107.69 153.63 22.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.269 -0.894 . . . . 0.0 109.521 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.651 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 7.5 mm -134.65 119.03 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.352 -0.842 . . . . 0.0 109.304 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.531 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 41.8 m-20 -124.72 173.79 8.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.323 -0.86 . . . . 0.0 109.825 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 15.2 m120 62.94 33.92 14.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.134 -0.979 . . . . 0.0 109.074 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.537 HG13 ' CE2' ' A' ' 158' ' ' TYR . 7.2 tt -89.32 147.68 5.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.519 -0.738 . . . . 0.0 109.739 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.417 ' HB2' ' OH ' ' A' ' 158' ' ' TYR . 25.3 mttt -82.67 113.87 47.98 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.175 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.466 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 35.8 Cg_endo -78.11 146.61 22.9 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.413 2.075 . . . . 0.0 110.606 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . 78.2 65.28 1.89 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.509 ' N ' ' OG1' ' A' ' 184' ' ' THR . . . 166.7 128.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -1.163 . . . . 0.0 109.772 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -46.34 160.56 0.07 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.62 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -141.66 177.75 7.94 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.886 -1.134 . . . . 0.0 110.356 -179.346 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.537 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -146.42 108.15 4.32 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.295 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.521 ' HB ' ' CG1' ' A' ' 180' ' ' ILE . 43.3 mm -93.73 112.68 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.735 -1.228 . . . . 0.0 109.867 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.53 ' CG2' ' HB2' ' A' ' 179' ' ' SER . 7.5 m -123.37 148.79 45.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -0.87 . . . . 0.0 108.954 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.528 ' CD1' ' HG3' ' A' ' 95' ' ' PRO . 0.5 OUTLIER -145.15 156.15 43.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.91 -1.118 . . . . 0.0 110.706 -179.779 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.589 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 1.8 m-85 -119.76 77.8 1.26 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.453 ' O ' HG21 ' A' ' 165' ' ' VAL . . . -47.41 150.01 0.99 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.959 -1.088 . . . . 0.0 109.456 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.528 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 51.6 t . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.208 -0.932 . . . . 0.0 109.739 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.517 ' HB3' ' CG2' ' A' ' 165' ' ' VAL . 1.2 p . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 174' ' ' SER . 83.9 p -44.2 168.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.342 -0.849 . . . . 0.0 109.443 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.26 143.61 9.29 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.043 -1.035 . . . . 0.0 108.508 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.589 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 35.7 Cg_endo -78.44 136.49 14.07 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.407 2.071 . . . . 0.0 111.337 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.2 t -109.56 136.95 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.53 ' HB2' ' CG2' ' A' ' 161' ' ' THR . 33.0 t -124.67 160.33 28.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.058 -1.026 . . . . 0.0 110.951 -178.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.521 ' CG1' ' HB ' ' A' ' 160' ' ' ILE . 39.3 pt -140.95 171.86 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.473 ' OD1' ' N ' ' A' ' 181' ' ' ASN . 1.2 m120 -103.72 166.0 10.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.936 -1.102 . . . . 0.0 110.036 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.599 ' CE2' HD23 ' A' ' 108' ' ' LEU . 48.3 t80 -154.15 172.47 17.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.512 -0.743 . . . . 0.0 109.2 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -145.1 118.38 8.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.149 -0.969 . . . . 0.0 109.562 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.509 ' OG1' ' N ' ' A' ' 156' ' ' ALA . 8.0 p . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.42 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.486 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 2.5 m-20 -76.04 97.44 4.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.351 -0.843 . . . . 0.0 109.152 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -40.59 101.34 0.24 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.597 -0.689 . . . . 0.0 109.888 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.518 ' HG2' ' CB ' ' A' ' 74' ' ' ALA . 34.9 Cg_endo -77.44 71.97 6.19 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.51 2.14 . . . . 0.0 109.733 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.542 ' HA ' ' CD2' ' A' ' 84' ' ' LEU . 16.7 p -91.16 -98.67 0.11 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.269 -0.894 . . . . 0.0 109.937 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 9' ' ' ASP . . . 48.64 24.72 4.22 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.402 ' N ' ' C ' ' A' ' 6' ' ' THR . 29.7 t80 -55.55 91.79 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.567 -0.961 . . . . 0.0 109.325 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 7' ' ' GLY . 7.8 t70 -137.36 111.99 8.76 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.529 ' CB ' ' HG3' ' A' ' 88' ' ' GLN . 0.3 OUTLIER -84.3 134.23 34.52 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.253 -0.904 . . . . 0.0 109.452 -179.573 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.471 ' O ' ' C ' ' A' ' 12' ' ' ASP . 86.8 p -150.33 -160.84 1.23 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.304 -0.873 . . . . 0.0 109.064 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.492 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 19.2 m-20 46.17 33.12 1.64 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.662 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.9 mt -86.97 111.02 21.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.317 -177.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -94.23 -177.04 4.15 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 177.568 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -88.58 -11.07 46.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.668 -1.27 . . . . 0.0 109.684 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.444 ' O ' ' HB3' ' A' ' 17' ' ' SER . 0.6 OUTLIER -131.95 22.14 4.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.887 -1.133 . . . . 0.0 108.115 178.605 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.52 ' CB ' ' HA ' ' A' ' 60' ' ' THR . 76.0 p 174.19 127.15 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.662 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 2.2 p90 -137.97 147.0 43.84 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.699 -1.251 . . . . 0.0 109.883 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.544 ' OG1' ' CG2' ' A' ' 58' ' ' THR . 60.1 m -111.97 164.62 12.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.914 -1.116 . . . . 0.0 110.5 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.519 ' N ' HG23 ' A' ' 19' ' ' THR . 1.8 t -127.27 162.88 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.514 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 3.5 m-70 -151.77 137.45 17.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.926 -1.108 . . . . 0.0 110.155 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.569 ' CH2' HG23 ' A' ' 50' ' ' VAL . 48.4 p90 -133.81 156.48 47.96 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.462 HG11 ' N ' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -74.38 156.63 6.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 120.864 -1.147 . . . . 0.0 109.957 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.462 ' N ' HG11 ' A' ' 23' ' ' VAL . . . -101.64 153.31 37.99 Favored Pre-proline 0 C--N 1.298 -1.668 0 O-C-N 121.841 -0.537 . . . . 0.0 109.731 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.567 ' CG ' ' CD1' ' A' ' 29' ' ' ILE . 36.7 Cg_endo -79.65 133.78 10.61 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.623 2.216 . . . . 0.0 110.171 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -69.51 -5.74 26.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 109.574 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.473 ' CB ' ' HD2' ' A' ' 28' ' ' PRO . . . -97.25 173.8 3.75 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 0.0 109.384 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.473 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 35.3 Cg_endo -78.17 107.19 2.28 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.605 2.203 . . . . 0.0 110.484 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.57 HD13 ' CZ ' ' A' ' 32' ' ' TYR . 18.6 pt -108.66 -171.72 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.411 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 7.9 p -115.63 -7.1 12.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.902 . . . . 0.0 109.568 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.24 -178.98 17.4 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.57 ' CZ ' HD13 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -126.82 158.02 37.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -1.145 . . . . 0.0 109.488 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.523 ' CG2' ' HD2' ' A' ' 49' ' ' ARG . 5.9 mt -111.56 136.32 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.241 -0.912 . . . . 0.0 108.898 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.529 ' CG2' HD11 ' A' ' 57' ' ' ILE . 1.4 mm -119.08 125.4 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.109 -0.994 . . . . 0.0 110.283 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.528 ' CB ' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -122.6 129.71 52.2 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.555 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.582 ' CE1' ' HD2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -125.09 140.12 53.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.833 -1.167 . . . . 0.0 110.542 -178.819 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.584 ' CE1' ' CG1' ' A' ' 69' ' ' VAL . 38.5 p-80 -166.32 122.29 1.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.424 -0.797 . . . . 0.0 109.753 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -55.22 -164.25 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.252 -0.905 . . . . 0.0 109.66 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 38' ' ' ALA . 1.4 mp0 . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.189 -0.944 . . . . 0.0 109.615 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.582 ' HD2' ' CE1' ' A' ' 36' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.597 0.713 . . . . 0.0 109.817 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.521 ' CB ' ' HG3' ' A' ' 35' ' ' ARG . 1.6 mt-30 -119.78 99.42 6.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.517 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -84.66 106.53 16.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.269 -0.894 . . . . 0.0 109.072 179.55 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.533 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -84.65 137.7 33.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.241 -0.912 . . . . 0.0 109.142 -179.803 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.569 HG23 ' CH2' ' A' ' 22' ' ' TRP . 21.9 m -114.07 154.75 46.08 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 109.706 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.489 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 35.2 Cg_endo -77.99 175.3 11.34 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.76 2.307 . . . . 0.0 110.29 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.5 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.1 Cg_endo -76.26 -15.87 17.82 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.528 2.152 . . . . 0.0 110.121 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.72 11.13 18.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 0.0 109.25 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -137.98 134.89 35.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.306 -0.871 . . . . 0.0 109.21 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.492 ' HA ' ' CE2' ' A' ' 22' ' ' TRP . 2.1 p-10 -124.75 18.69 8.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 0.0 109.638 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 84.4 p -145.78 138.59 25.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 109.776 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.529 HD11 ' CG2' ' A' ' 34' ' ' ILE . 1.5 tt -119.1 120.03 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.359 -0.838 . . . . 0.0 108.988 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.544 ' CG2' ' OG1' ' A' ' 19' ' ' THR . 0.4 OUTLIER -91.03 133.05 35.62 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.269 -0.894 . . . . 0.0 110.405 -179.115 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.5 mt -117.29 140.45 49.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.0 109.112 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.52 ' HA ' ' CB ' ' A' ' 17' ' ' SER . 25.1 p -129.05 174.65 9.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.354 -0.841 . . . . 0.0 109.909 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . 0.454 ' O ' HD21 ' A' ' 62' ' ' LEU . 8.9 m-20 51.63 66.43 1.2 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.377 -0.827 . . . . 0.0 109.515 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.577 ' HB3' ' CE2' ' A' ' 68' ' ' TYR . 9.0 mt -134.41 133.94 41.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.467 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -48.12 134.88 11.95 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 108.819 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.4 Cg_endo -77.97 128.21 9.03 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.362 2.041 . . . . 0.0 110.681 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 79.37 60.87 2.43 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 90' ' ' THR . 1.5 m -149.59 142.23 24.51 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.366 -1.079 . . . . 0.0 109.7 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.534 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 3.0 mt-10 -74.59 134.72 42.09 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.973 -1.079 . . . . 0.0 108.768 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.577 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 3.6 m-85 -123.23 98.1 5.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.125 -0.984 . . . . 0.0 109.761 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.584 ' CG1' ' CE1' ' A' ' 37' ' ' HIS . 6.6 t -59.6 133.67 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.157 -0.965 . . . . 0.0 108.874 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 35' ' ' ARG . 11.0 t -137.86 137.36 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.106 -0.996 . . . . 0.0 109.375 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.536 ' CB ' ' CD1' ' A' ' 85' ' ' ILE . 88.9 p -116.53 134.68 54.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.188 -0.945 . . . . 0.0 110.133 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.536 ' CG2' HD13 ' A' ' 84' ' ' LEU . 21.5 mm -120.21 143.0 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 109.334 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.518 ' CD1' ' HB3' ' A' ' 83' ' ' PRO . 36.9 mm -138.5 162.11 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.148 -0.97 . . . . 0.0 109.704 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.518 ' CB ' ' HG2' ' A' ' 5' ' ' PRO . . . -134.61 98.23 4.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.357 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.468 ' O ' ' OG1' ' A' ' 30' ' ' THR . 2.5 m -96.65 154.69 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 109.399 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 28' ' ' PRO . 30.2 t30 -133.63 45.94 2.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 109.55 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.87 -97.2 1.84 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -94.14 2.61 55.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -1.164 . . . . 0.0 109.534 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 2.2 mt-10 -109.49 -173.39 2.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.162 -0.961 . . . . 0.0 109.552 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 0.6 OUTLIER -163.31 100.16 0.94 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.357 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.553 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -59.64 -179.7 0.17 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.899 . . . . 0.0 108.878 179.716 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.1 Cg_endo -77.16 138.35 17.98 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.2 1.933 . . . . 0.0 110.187 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.518 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 36.0 Cg_endo -77.9 139.94 17.86 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.572 2.182 . . . . 0.0 110.571 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.542 ' CD2' ' HA ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -136.1 91.87 2.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.318 -0.864 . . . . 0.0 109.565 179.755 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.536 ' CD1' ' CB ' ' A' ' 71' ' ' SER . 4.1 mt -97.09 159.1 3.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.373 -0.829 . . . . 0.0 109.341 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.433 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -162.84 159.08 31.46 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -112.81 118.36 34.73 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.367 -1.078 . . . . 0.0 109.435 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.529 ' HG3' ' CB ' ' A' ' 10' ' ' SER . 1.7 mm-40 -109.64 -157.64 0.62 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.534 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -162.31 148.4 13.04 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.978 -1.076 . . . . 0.0 110.081 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.47 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.47 136.97 42.28 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 13' ' ' ILE . 5.2 t . . . . . 0 C--N 1.298 -1.647 0 CA-C-O 121.741 0.782 . . . . 0.0 110.902 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.525 ' CB ' ' O ' ' A' ' 113' ' ' GLU . 34.2 Cg_endo . . . . . 0 C--O 1.214 -0.681 0 N-CA-C 109.293 -1.079 . . . . 0.0 109.293 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 1.7 ptp180 -163.37 164.77 24.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.912 -1.117 . . . . 0.0 110.064 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 21.0 t0 79.26 21.2 0.65 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.552 -0.718 . . . . 0.0 110.146 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.531 ' CD1' HG11 ' A' ' 178' ' ' VAL . 0.3 OUTLIER -63.77 99.28 0.23 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.9 -1.125 . . . . 0.0 108.928 179.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.69 -174.95 4.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.49 ' CG2' ' O ' ' A' ' 109' ' ' LEU . 5.0 p -114.93 152.43 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.195 -0.941 . . . . 0.0 110.013 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.458 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 5.2 pt -119.08 -16.11 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.394 -0.816 . . . . 0.0 109.314 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -140.95 168.79 18.94 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.454 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.9 t -156.16 102.22 2.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.891 -1.131 . . . . 0.0 110.506 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -90.74 166.92 17.6 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.798 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 29.9 Cg_endo -69.41 -1.97 9.1 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.257 1.971 . . . . 0.0 110.579 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.501 ' HA ' HG21 ' A' ' 152' ' ' ILE . 3.9 p -151.26 17.43 0.74 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.331 -0.856 . . . . 0.0 108.985 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.544 ' O ' ' CD2' ' A' ' 108' ' ' LEU . 0.6 OUTLIER -170.72 162.42 7.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.991 -1.068 . . . . 0.0 110.343 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.601 HD23 ' CE2' ' A' ' 182' ' ' TYR . 0.7 OUTLIER -141.84 156.85 45.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.464 -0.772 . . . . 0.0 109.099 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.49 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 0.3 OUTLIER -104.24 121.83 44.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 109.207 179.704 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.525 ' CD1' HD12 ' A' ' 124' ' ' ILE . 2.0 pt -103.35 148.23 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -0.903 . . . . 0.0 109.934 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 84.9 p -146.16 137.46 24.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.4 -0.813 . . . . 0.0 109.052 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.57 ' CE3' ' O ' ' A' ' 145' ' ' SER . 37.1 p90 -158.87 -167.33 2.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.728 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 95' ' ' PRO . 2.1 mt-10 . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 108.959 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 5.2 p90 . . . . . 0 N--CA 1.485 1.279 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 2.6 m-85 -129.11 137.67 51.36 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -94.91 86.6 4.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 109.548 -179.479 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.593 ' CD1' ' CG2' ' A' ' 140' ' ' VAL . 77.1 mt -84.19 148.47 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.882 . . . . 0.0 109.192 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 2.5 p -131.44 150.59 52.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.92 . . . . 0.0 110.348 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.606 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 2.9 m-85 -85.33 133.51 34.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.436 -0.79 . . . . 0.0 108.942 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.592 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.83 116.57 5.21 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.227 -1.161 . . . . 0.0 109.316 179.695 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.582 ' HB2' ' CD1' ' A' ' 126' ' ' TYR . 39.3 mt-30 . . . . . 0 N--CA 1.496 1.84 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 7.2 pt-20 -76.54 130.24 37.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.448 -0.783 . . . . 0.0 111.103 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.59 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 38.1 p90 -137.27 143.66 42.31 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 12.7 p -74.28 165.62 24.86 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.996 -1.065 . . . . 0.0 110.69 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.593 ' CG2' ' CD1' ' A' ' 124' ' ' ILE . 8.2 t -137.33 139.63 28.34 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.603 -0.686 . . . . 0.0 109.773 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.48 ' HD2' HG11 ' A' ' 140' ' ' VAL . 33.7 Cg_endo -75.64 125.81 9.15 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.303 2.002 . . . . 0.0 110.364 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.61 -1.85 54.21 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.429 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 4.9 p -75.4 1.02 14.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.175 -1.191 . . . . 0.0 109.656 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 143' ' ' SER . 1.8 mmtp -152.39 149.68 28.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.152 -0.968 . . . . 0.0 109.67 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.57 ' O ' ' CE3' ' A' ' 112' ' ' TRP . 1.7 m -93.96 -13.17 27.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 109.296 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 64.4 p -107.26 130.64 54.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.285 -0.884 . . . . 0.0 108.974 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.483 ' HB1' ' CD1' ' A' ' 110' ' ' ILE . . . -118.49 161.34 20.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.975 . . . . 0.0 109.905 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 11.2 t -103.07 155.96 18.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.33 -0.856 . . . . 0.0 109.074 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.606 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 20.2 mm -133.07 113.68 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 109.725 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.547 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 3.3 m120 -120.79 173.34 7.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.384 -0.822 . . . . 0.0 109.705 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 0.5 OUTLIER 69.12 34.19 3.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.914 . . . . 0.0 109.291 -179.912 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.517 ' CD1' HD12 ' A' ' 108' ' ' LEU . 4.5 tt -93.89 158.7 2.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.37 -0.831 . . . . 0.0 109.788 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.442 ' N ' ' OH ' ' A' ' 158' ' ' TYR . 0.5 OUTLIER -98.42 115.65 65.71 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.262 -0.899 . . . . 0.0 109.121 179.7 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.448 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 35.4 Cg_endo -77.42 138.17 17.32 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.391 2.061 . . . . 0.0 110.743 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . 86.41 68.06 1.35 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 163.73 130.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -1.155 . . . . 0.0 109.637 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -47.53 162.63 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.17 -0.956 . . . . 0.0 108.559 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.592 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.3 OUTLIER -142.94 -170.8 3.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.918 -1.114 . . . . 0.0 110.234 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.51 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 3.2 m -165.41 110.83 0.9 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.513 ' HB ' ' CG1' ' A' ' 180' ' ' ILE . 30.1 mm -95.82 120.23 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.995 -1.066 . . . . 0.0 109.843 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 179' ' ' SER . 2.2 m -124.9 164.31 20.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.241 -0.912 . . . . 0.0 109.145 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.525 HD21 ' CD1' ' A' ' 98' ' ' LEU . 1.6 pp -159.53 142.88 14.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.933 -1.104 . . . . 0.0 111.135 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.616 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.2 m-85 -113.78 80.25 1.35 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 163' ' ' TYR . . . -43.79 96.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.14 -0.975 . . . . 0.0 109.328 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' A' ' 163' ' ' TYR . 58.0 t . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 109.494 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.406 ' HB3' ' HA ' ' A' ' 165' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.8 p -57.14 -167.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.171 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -66.71 146.45 99.07 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.149 -0.969 . . . . 0.0 108.808 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.616 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.6 Cg_endo -77.32 122.72 6.22 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.455 2.103 . . . . 0.0 111.158 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.531 HG11 ' CD1' ' A' ' 98' ' ' LEU . 2.2 t -91.41 133.63 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 161' ' ' THR . 1.4 p -124.71 151.37 45.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.11 -0.994 . . . . 0.0 110.72 -178.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.513 ' CG1' ' HB ' ' A' ' 160' ' ' ILE . 3.1 pt -138.84 152.19 24.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.45 162.79 16.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.002 -1.061 . . . . 0.0 109.824 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.601 ' CE2' HD23 ' A' ' 108' ' ' LEU . 74.9 t80 -152.8 167.33 29.41 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.414 -0.804 . . . . 0.0 109.268 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.412 ' N ' ' CG ' ' A' ' 182' ' ' TYR . 5.7 tttp -138.3 118.35 13.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.55 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 17.0 p . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.46 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . 0.454 ' O ' ' OG ' ' A' ' 81' ' ' SER . 96.4 mt . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 2.9 m-20 -74.87 140.11 43.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 109.545 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.533 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 2.4 t -95.08 149.52 36.36 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.555 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.586 ' HG3' ' CD1' ' A' ' 32' ' ' TYR . 36.4 Cg_endo -78.89 117.72 3.97 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.711 2.274 . . . . 0.0 110.347 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.466 HG21 HD11 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -101.92 -107.78 0.24 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.947 . . . . 0.0 109.382 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 22' ' ' TRP . . . 42.5 27.83 0.54 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.442 ' N ' ' O ' ' A' ' 6' ' ' THR . 25.8 t80 -48.36 124.75 8.43 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.431 -1.041 . . . . 0.0 109.849 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 21' ' ' HIS . 4.2 t70 -164.96 84.06 0.39 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.405 -0.809 . . . . 0.0 109.019 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.515 ' OG ' ' CG1' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -84.6 137.84 33.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.195 -0.941 . . . . 0.0 109.684 -179.63 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.465 ' O ' ' HB ' ' A' ' 19' ' ' THR . 82.6 p -159.19 -158.67 0.7 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.36 -0.837 . . . . 0.0 109.143 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.497 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.5 OUTLIER 44.62 34.75 1.2 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -178.417 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.619 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.3 mt -72.37 140.48 17.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.495 -177.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.568 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -122.93 -175.09 3.08 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.611 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 91' ' ' VAL . . . -75.18 -70.97 0.39 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.908 -1.12 . . . . 0.0 109.499 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 5.8 p-10 -83.74 9.16 12.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.168 -0.957 . . . . 0.0 109.459 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.568 ' O ' ' N ' ' A' ' 14' ' ' THR . 0.1 OUTLIER -157.82 159.33 36.6 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.619 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 5.8 p90 -166.01 140.72 4.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.207 -0.933 . . . . 0.0 108.839 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.497 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 9.3 m -79.37 153.8 29.49 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.814 -1.179 . . . . 0.0 111.209 -178.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.583 ' CG2' ' CD1' ' A' ' 59' ' ' LEU . 1.3 t -134.69 115.82 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.464 ' HB2' ' O ' ' A' ' 9' ' ' ASP . 17.2 m-70 -105.46 159.11 16.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.044 -1.035 . . . . 0.0 110.132 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.49 ' CH2' HG23 ' A' ' 57' ' ' ILE . 20.9 p90 -175.09 140.25 0.51 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.366 -0.834 . . . . 0.0 109.209 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.481 HG11 ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.61 162.32 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.134 -0.979 . . . . 0.0 109.965 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.481 ' N ' HG11 ' A' ' 23' ' ' VAL . . . -93.96 169.59 9.72 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.766 -0.584 . . . . 0.0 109.696 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 24' ' ' ALA . 35.2 Cg_endo -78.12 -159.88 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.611 2.207 . . . . 0.0 110.346 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.82 8.05 4.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 109.592 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.535 ' CB ' ' HD2' ' A' ' 28' ' ' PRO . . . -110.47 176.98 1.32 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.335 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 34.8 Cg_endo -77.54 110.67 3.01 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.478 2.119 . . . . 0.0 110.294 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.619 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 50.2 pt -126.29 -173.01 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 0.0 109.557 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.419 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 32.0 p -125.32 -5.43 7.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.483 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.476 ' HA2' ' N ' ' A' ' 52' ' ' PRO . . . 149.62 -178.78 26.91 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.619 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 1.8 m-85 -124.28 145.93 49.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -1.189 . . . . 0.0 109.631 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.59 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -99.76 130.43 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.329 -0.857 . . . . 0.0 108.727 179.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' A' ' 48' ' ' ASP . 1.4 mm -109.08 108.76 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.935 -1.103 . . . . 0.0 110.08 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.523 ' CB ' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -112.61 108.65 17.79 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.752 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.651 ' CE1' ' CD2' ' A' ' 59' ' ' LEU . 1.7 p-80 -114.62 166.79 11.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.022 . . . . 0.0 110.355 -178.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.455 ' O ' ' O ' ' A' ' 38' ' ' ALA . 40.0 p-80 177.73 136.19 0.07 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.594 -0.691 . . . . 0.0 109.282 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -56.31 -163.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.926 . . . . 0.0 109.372 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.18 -0.95 . . . . 0.0 109.606 -179.999 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.578 ' HB2' ' CD2' ' A' ' 36' ' ' HIS . 12.7 mmm180 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.305 0.574 . . . . 0.0 109.637 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.411 ' HG3' ' C ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -130.01 90.07 2.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.684 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.528 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 9.5 m-20 -99.1 114.3 26.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.267 -0.896 . . . . 0.0 108.862 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.528 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -92.11 150.21 21.07 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.978 -1.076 . . . . 0.0 109.822 -179.469 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.518 HG13 ' CD1' ' A' ' 57' ' ' ILE . 10.3 m -133.4 160.1 69.96 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.431 -0.793 . . . . 0.0 109.3 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.482 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 33.6 Cg_endo -76.27 174.35 12.98 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.561 2.174 . . . . 0.0 110.381 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.579 ' HA ' ' CE2' ' A' ' 32' ' ' TYR . 35.1 Cg_endo -77.17 -21.74 11.76 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.672 2.248 . . . . 0.0 110.999 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.8 t -92.51 -4.51 53.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.074 -1.016 . . . . 0.0 109.716 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.524 ' HD3' ' N ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -97.8 111.42 23.72 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.286 -0.884 . . . . 0.0 109.895 -179.744 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -101.04 -6.43 24.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.447 -0.783 . . . . 0.0 109.46 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 53.1 p -135.69 129.84 33.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.384 -0.822 . . . . 0.0 109.189 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.518 ' CD1' HG13 ' A' ' 50' ' ' VAL . 6.1 tt -133.33 129.14 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.231 -0.918 . . . . 0.0 109.672 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.1 115.39 24.46 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.337 -0.852 . . . . 0.0 109.074 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.651 ' CD2' ' CE1' ' A' ' 36' ' ' HIS . 1.3 mt -84.74 156.22 21.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.14 -0.975 . . . . 0.0 109.642 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.491 ' CG2' ' HB3' ' A' ' 17' ' ' SER . 15.5 p -145.65 -178.2 5.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.404 -0.81 . . . . 0.0 109.33 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.9 m120 55.48 20.04 3.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.364 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.528 ' CD1' ' HB3' ' A' ' 59' ' ' LEU . 3.5 mt -96.15 138.69 33.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.872 . . . . 0.0 109.302 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.496 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 6.2 t-20 -45.72 126.41 6.56 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.191 -0.943 . . . . 0.0 108.804 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 35.8 Cg_endo -77.81 134.67 13.62 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.307 2.004 . . . . 0.0 110.699 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 68.16 62.6 4.09 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.0 m -160.67 153.01 20.46 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.264 -1.139 . . . . 0.0 110.134 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 1.2 tt0 -77.09 121.27 23.33 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.524 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 1.0 OUTLIER -116.71 114.54 24.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.085 -1.01 . . . . 0.0 110.019 -179.158 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.8 t -79.5 118.44 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 108.678 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.468 ' HA ' ' HB3' ' A' ' 36' ' ' HIS . 1.4 t -100.4 135.77 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.129 -0.982 . . . . 0.0 109.611 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.523 ' OG ' ' CB ' ' A' ' 35' ' ' ARG . 10.8 p -114.72 108.3 16.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.345 -0.847 . . . . 0.0 110.084 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.439 ' O ' ' N ' ' A' ' 84' ' ' LEU . 17.0 mm -87.96 119.17 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 0.0 109.428 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.524 ' N ' ' CD1' ' A' ' 73' ' ' ILE . 1.6 mp -116.74 158.63 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 109.256 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.43 ' N ' ' CG2' ' A' ' 73' ' ' ILE . . . -119.32 157.43 28.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.492 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.465 HG23 HD11 ' A' ' 33' ' ' ILE . 3.9 m -151.95 148.4 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 0.0 109.487 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -131.33 44.22 2.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.289 -0.882 . . . . 0.0 109.376 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.95 -88.13 0.67 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.95 -1.68 11.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.247 -1.149 . . . . 0.0 109.463 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.77 -162.59 0.92 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 109.394 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -159.15 173.74 15.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.198 -0.939 . . . . 0.0 109.797 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.574 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -145.05 -176.74 0.58 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.574 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.1 Cg_endo -77.3 136.54 16.04 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.068 1.845 . . . . 0.0 110.118 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.413 ' HB3' HG13 ' A' ' 73' ' ' ILE . 36.2 Cg_endo -78.43 104.0 1.76 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.65 2.234 . . . . 0.0 111.221 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.466 HD11 HG21 ' A' ' 6' ' ' THR . 0.9 OUTLIER -80.99 90.52 5.97 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.069 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.517 ' CD1' ' HB2' ' A' ' 71' ' ' SER . 2.7 mt -92.93 159.8 2.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.146 -0.971 . . . . 0.0 110.703 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.509 ' N ' HG21 ' A' ' 85' ' ' ILE . . . -154.22 168.34 32.5 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -117.27 139.94 50.18 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.129 -1.218 . . . . 0.0 109.915 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.491 ' OE1' ' CB ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -139.68 -162.75 1.38 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.371 -0.831 . . . . 0.0 109.029 179.758 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -156.76 129.23 7.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.114 -0.991 . . . . 0.0 109.886 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.452 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -78.8 146.26 33.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.385 -0.822 . . . . 0.0 108.999 179.693 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 65' ' ' GLY . 1.4 t . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.506 -0.746 . . . . 0.0 110.114 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . 0.484 ' CB ' ' CD1' ' A' ' 112' ' ' TRP . 36.2 Cg_endo . . . . . 0 C--O 1.214 -0.686 0 N-CA-C 108.63 -1.334 . . . . 0.0 108.63 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 112' ' ' TRP . 24.9 mtt180 -72.51 -163.65 0.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.665 0.745 . . . . 0.0 110.392 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 96' ' ' ARG . 8.4 m-20 64.64 9.48 5.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.614 -0.679 . . . . 0.0 109.588 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.488 ' CD2' HD22 ' A' ' 162' ' ' LEU . 25.1 tp -61.71 99.13 0.11 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.138 -0.976 . . . . 0.0 109.439 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -137.76 159.96 40.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.902 . . . . 0.0 109.673 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.7 p -81.35 139.78 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.362 -0.836 . . . . 0.0 109.716 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.512 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 41.6 pt -134.62 4.46 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.404 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.528 ' CB ' ' HB2' ' A' ' 109' ' ' LEU . . . -165.12 88.27 0.45 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.516 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 0.7 OUTLIER -82.72 96.44 8.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.417 -0.802 . . . . 0.0 110.609 -178.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -84.01 162.72 51.22 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.244 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 29.4 Cg_endo -67.82 -3.21 9.99 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.532 2.155 . . . . 0.0 111.138 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.501 ' C ' ' CG2' ' A' ' 152' ' ' ILE . 2.3 p -156.6 22.39 0.34 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.567 ' N ' ' OG1' ' A' ' 104' ' ' THR . 18.2 p -172.54 175.91 3.39 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.118 -1.033 . . . . 0.0 109.924 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.603 ' N ' ' CD1' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -153.69 154.48 34.2 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.484 -0.76 . . . . 0.0 109.203 -179.627 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.528 ' HB2' ' CB ' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -103.02 114.55 28.94 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.095 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.562 ' CD1' ' CD1' ' A' ' 149' ' ' ILE . 0.4 OUTLIER -103.61 131.62 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.113 -0.992 . . . . 0.0 109.954 -179.512 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 97' ' ' ASP . 3.3 m -123.52 132.53 53.94 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.572 ' CD2' ' O ' ' A' ' 145' ' ' SER . 49.0 p90 -135.99 169.52 17.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.935 . . . . 0.0 109.695 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.181 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.584 ' CE1' ' CG2' ' A' ' 139' ' ' THR . 1.4 p90 . . . . . 0 N--CA 1.485 1.317 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 163' ' ' TYR . 32.2 m-85 -93.51 134.42 35.8 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.998 -1.064 . . . . 0.0 108.85 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 4.3 ttp-105 -101.19 94.83 6.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.246 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.587 HD13 ' CZ ' ' A' ' 138' ' ' PHE . 19.6 mt -85.79 141.52 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.299 -0.876 . . . . 0.0 109.96 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.589 ' CG2' ' CG ' ' A' ' 137' ' ' GLU . 5.1 p -113.79 127.44 56.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.372 -0.83 . . . . 0.0 109.507 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.664 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 3.4 m-30 -74.95 113.93 12.82 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.613 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -101.77 119.83 6.63 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 120.214 -0.994 . . . . 0.0 110.852 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 . . . . . 0 C--N 1.297 -1.697 0 O-C-N 121.269 -1.136 . . . . 0.0 108.529 178.725 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.544 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.589 ' CG ' ' CG2' ' A' ' 125' ' ' THR . 14.4 mp0 -142.79 157.76 44.3 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.902 -1.124 . . . . 0.0 110.985 -178.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.587 ' CZ ' HD13 ' A' ' 124' ' ' ILE . 6.0 p90 -155.51 135.14 12.59 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.584 ' CG2' ' CE1' ' A' ' 121' ' ' TYR . 12.2 p -74.37 165.29 25.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.083 -1.011 . . . . 0.0 110.905 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.535 ' CG2' HD13 ' A' ' 124' ' ' ILE . 2.8 t -136.07 140.96 34.63 Favored Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.481 ' HD2' HG11 ' A' ' 140' ' ' VAL . 34.3 Cg_endo -76.29 146.75 28.53 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.334 2.023 . . . . 0.0 110.142 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.33 37.33 3.14 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.4 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 89.4 p -105.12 -1.1 25.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.111 -1.229 . . . . 0.0 109.624 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 143' ' ' SER . 5.7 mttt -151.45 154.5 36.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.186 -0.946 . . . . 0.0 109.52 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.572 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 0.4 OUTLIER -91.8 2.24 56.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 109.552 179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 110' ' ' ILE . 2.0 p -124.56 151.41 44.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.054 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.546 ' HB1' ' CH2' ' A' ' 112' ' ' TRP . . . -118.12 178.14 4.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.141 -0.975 . . . . 0.0 109.409 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.454 HG23 ' OD1' ' A' ' 150' ' ' ASN . 57.4 m -133.2 97.31 3.95 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.252 -0.905 . . . . 0.0 109.568 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.664 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 1.0 OUTLIER -79.17 93.11 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.333 -0.855 . . . . 0.0 109.051 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.527 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 82.9 m-20 -101.29 178.23 4.71 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.935 . . . . 0.0 109.356 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 28.7 m120 57.67 55.92 5.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.892 . . . . 0.0 109.355 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.557 HG13 ' CE2' ' A' ' 158' ' ' TYR . 13.8 tt -111.63 164.4 7.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.268 -0.895 . . . . 0.0 109.699 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -95.03 110.26 49.0 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.134 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 152' ' ' ILE . 34.9 Cg_endo -76.77 139.66 20.06 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.355 2.036 . . . . 0.0 110.522 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . 0.474 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . 95.55 62.49 0.99 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.474 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 164.6 132.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -1.136 . . . . 0.0 109.524 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.462 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 1.8 t70 -48.19 168.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.613 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -146.69 -164.7 2.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.837 -1.164 . . . . 0.0 110.275 -179.638 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 127' ' ' GLY . 9.2 m -174.79 105.21 0.1 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.439 HD13 HD23 ' A' ' 108' ' ' LEU . 54.8 mt -97.75 117.2 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.909 -1.119 . . . . 0.0 110.286 -178.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.533 ' CG2' ' HB2' ' A' ' 179' ' ' SER . 36.9 m -120.46 161.86 20.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.28 -0.888 . . . . 0.0 108.723 178.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 124' ' ' ILE . 0.5 OUTLIER -156.72 148.6 22.8 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 118.742 -1.183 . . . . 0.0 111.441 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.634 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.9 m-85 -120.54 161.87 20.57 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.524 ' CB ' ' OG ' ' A' ' 175' ' ' SER . . . -113.68 102.15 9.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.938 -1.102 . . . . 0.0 109.016 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 51.7 t . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.383 -0.823 . . . . 0.0 110.218 -179.192 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 2.4 p . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.224 0.535 . . . . 0.0 109.669 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.524 ' OG ' ' CB ' ' A' ' 164' ' ' ALA . 0.7 OUTLIER -50.81 169.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.29 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 175' ' ' SER . 0.3 OUTLIER -44.36 123.68 4.47 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.286 -0.884 . . . . 0.0 109.274 179.705 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.634 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 33.7 Cg_endo -77.61 140.45 18.88 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.018 1.812 . . . . 0.0 110.902 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.37 135.48 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.533 ' HB2' ' CG2' ' A' ' 161' ' ' THR . 30.6 t -122.83 170.76 9.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.164 -0.96 . . . . 0.0 111.332 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.469 HG21 HD22 ' A' ' 98' ' ' LEU . 7.1 pt -152.21 152.65 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 159' ' ' THR . 67.0 m-80 -96.22 157.72 15.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.946 -1.096 . . . . 0.0 110.028 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.59 ' CE1' HD21 ' A' ' 108' ' ' LEU . 39.8 t80 -141.1 171.86 13.48 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.384 -0.823 . . . . 0.0 109.448 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 157' ' ' ASP . 3.4 tmtt? -145.05 108.09 4.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.532 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.452 ' OG1' ' N ' ' A' ' 155' ' ' GLY . 5.2 p . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.443 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 4.8 m-20 -91.25 132.46 36.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 109.439 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.524 ' OG ' ' CG ' ' A' ' 82' ' ' PRO . 15.2 m -95.79 150.05 36.86 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.305 -0.872 . . . . 0.0 109.808 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PRO . . . . . 0.563 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 36.2 Cg_endo -79.74 131.05 9.0 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.746 2.297 . . . . 0.0 109.873 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.447 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -157.75 -167.62 2.31 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.053 -1.029 . . . . 0.0 109.591 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 46.25 27.06 2.54 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.056 -2.017 . . . . 0.0 108.056 -179.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PHE . . . . . 0.624 ' C ' ' CD1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -70.21 -170.33 0.36 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.74 -0.859 . . . . 0.0 109.57 -179.235 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.437 ' N ' ' CG ' ' A' ' 8' ' ' PHE . 21.3 t70 -165.55 110.19 0.86 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.229 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . 0.514 ' OG ' ' CG ' ' A' ' 88' ' ' GLN . 4.6 p -84.75 139.6 31.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.196 -0.94 . . . . 0.0 109.355 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.466 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 5.1 p -164.74 -157.96 0.38 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.185 -0.947 . . . . 0.0 109.623 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.505 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.6 OUTLIER 44.3 36.34 1.55 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -178.56 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ILE . . . . . 0.627 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.6 mt -74.63 145.29 11.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.862 -178.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.59 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -124.78 172.57 9.21 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.012 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.504 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -67.92 -65.11 0.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.704 -1.248 . . . . 0.0 109.419 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.471 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -90.5 27.44 1.71 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.06 -1.025 . . . . 0.0 109.323 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.59 ' O ' ' N ' ' A' ' 14' ' ' THR . 3.5 p -178.02 161.28 1.51 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.648 ' CE1' ' CD1' ' A' ' 59' ' ' LEU . 17.5 p90 -167.74 147.86 5.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.891 -1.131 . . . . 0.0 109.644 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 4.0 m -90.7 158.41 16.91 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.843 -1.16 . . . . 0.0 111.164 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.554 ' CG2' ' CD1' ' A' ' 59' ' ' LEU . 0.8 OUTLIER -139.23 104.26 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.38 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.466 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 7.9 m-70 -86.23 162.7 18.17 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.153 -0.967 . . . . 0.0 110.261 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' TRP . . . . . 0.526 ' CB ' ' HB2' ' A' ' 8' ' ' PHE . 16.3 p90 -175.08 136.4 0.38 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.469 -0.77 . . . . 0.0 109.305 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.425 HG11 ' N ' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -74.74 161.57 4.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 O-C-N 121.091 -1.006 . . . . 0.0 109.693 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.425 ' N ' HG11 ' A' ' 23' ' ' VAL . . . -96.74 160.96 28.13 Favored Pre-proline 0 C--N 1.298 -1.664 0 O-C-N 121.745 -0.597 . . . . 0.0 109.703 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.466 ' HB3' ' O ' ' A' ' 3' ' ' ASP . 36.1 Cg_endo -78.44 163.57 27.04 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.647 2.231 . . . . 0.0 110.326 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.49 28.76 1.89 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.427 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.443 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . . . -118.92 161.32 36.88 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.456 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.455 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 35.5 Cg_endo -78.18 89.9 1.31 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.612 2.208 . . . . 0.0 110.39 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.571 HD11 ' CD2' ' A' ' 32' ' ' TYR . 20.3 pt -97.45 171.59 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.506 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.1 p -100.57 -26.65 13.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.894 . . . . 0.0 109.433 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.08 -152.11 9.94 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.634 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -165.12 126.26 2.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -1.17 . . . . 0.0 109.647 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.529 ' CG2' ' HD2' ' A' ' 49' ' ' ARG . 6.1 mt -94.78 138.92 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.203 -0.936 . . . . 0.0 109.288 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.604 ' CG2' ' CE1' ' A' ' 36' ' ' HIS . 1.5 mm -119.85 117.91 55.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.298 -0.876 . . . . 0.0 109.077 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ARG . . . . . 0.534 ' CG ' ' OG ' ' A' ' 71' ' ' SER . 3.1 ptp180 -121.94 140.5 52.37 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.881 -1.137 . . . . 0.0 108.698 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.64 ' CD2' ' CD2' ' A' ' 59' ' ' LEU . 28.5 m-70 -137.43 167.21 22.07 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.055 -1.028 . . . . 0.0 110.496 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' HIS . . . . . 0.471 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 45.9 p-80 -173.37 149.46 1.73 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.594 ' HA ' ' CD2' ' A' ' 68' ' ' TYR . . . -56.15 -163.65 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.564 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.459 ' OE2' ' OE2' ' A' ' 67' ' ' GLU . 5.3 mm-40 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.955 . . . . 0.0 109.718 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.524 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.247 0.546 . . . . 0.0 109.557 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLN . . . . . 0.5 ' HB3' ' NE ' ' A' ' 49' ' ' ARG . 1.0 OUTLIER -126.66 109.52 12.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 110.174 -179.574 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 34' ' ' ILE . 64.9 m-20 -92.68 111.54 23.18 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.42 -0.8 . . . . 0.0 108.928 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ARG . . . . . 0.537 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 9.6 mmt85 -90.58 137.82 32.05 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.16 -0.963 . . . . 0.0 109.339 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.473 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 5.5 m -126.66 160.19 59.82 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.296 -0.878 . . . . 0.0 109.432 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.476 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 34.9 Cg_endo -77.25 174.72 12.33 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.555 2.17 . . . . 0.0 110.343 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 34.8 Cg_endo -76.88 -15.4 16.75 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.513 2.142 . . . . 0.0 110.356 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 m -93.87 13.13 23.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.263 -0.898 . . . . 0.0 109.451 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.436 ' O ' ' CZ2' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -123.93 121.36 35.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.921 . . . . 0.0 109.499 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.498 ' O ' ' CE3' ' A' ' 22' ' ' TRP . 3.6 p30 -107.25 -0.86 22.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 109.523 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.7 p -132.55 129.76 39.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.648 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.522 HD11 ' CB ' ' A' ' 34' ' ' ILE . 2.3 tt -125.63 141.27 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.309 -0.869 . . . . 0.0 109.126 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 19.4 m -104.5 127.34 52.19 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.158 -0.964 . . . . 0.0 109.966 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.648 ' CD1' ' CE1' ' A' ' 18' ' ' PHE . 5.0 mp -84.39 160.73 20.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.341 -0.85 . . . . 0.0 109.674 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.492 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 0.8 OUTLIER -152.9 169.22 23.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.619 -0.676 . . . . 0.0 109.553 179.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.6 m120 60.07 48.28 8.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.886 . . . . 0.0 109.39 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . 0.525 ' CD1' ' HB3' ' A' ' 59' ' ' LEU . 2.0 mt -127.7 157.19 40.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.292 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASN . . . . . 0.499 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 1.4 m-20 -63.1 132.59 95.13 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.119 -0.988 . . . . 0.0 108.693 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.3 Cg_endo -77.49 125.4 7.62 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.288 1.992 . . . . 0.0 110.638 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 90' ' ' THR . . . 77.94 61.67 2.49 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.575 HG21 ' CE1' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -154.66 145.12 22.15 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.255 -1.144 . . . . 0.0 110.155 -179.164 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 23.4 tt0 -74.87 129.57 37.91 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.594 ' CD2' ' HA ' ' A' ' 38' ' ' ALA . 27.9 m-85 -125.42 164.56 20.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.997 -1.065 . . . . 0.0 110.251 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' VAL . . . . . 0.471 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 53.9 t -110.28 164.49 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 4.6 t -149.67 144.07 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.832 -1.167 . . . . 0.0 110.168 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.556 ' CB ' HG12 ' A' ' 85' ' ' ILE . 1.3 p -142.09 118.76 11.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.2 -0.938 . . . . 0.0 109.897 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . 0.528 ' CD1' HG22 ' A' ' 34' ' ' ILE . 4.5 mm -91.38 131.85 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.493 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.583 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 5.4 mt -116.91 150.75 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 109.201 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.634 ' CB ' ' CZ ' ' A' ' 32' ' ' TYR . . . -123.21 147.09 47.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.361 -0.837 . . . . 0.0 109.642 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.432 HG11 ' HG2' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -133.21 132.71 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 109.384 179.86 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -121.08 53.37 1.14 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 109.422 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.95 -69.85 3.17 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.407 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 17.8 tpp85 -126.08 -0.58 7.15 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -1.166 . . . . 0.0 109.647 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.525 ' O ' ' CG ' ' A' ' 80' ' ' GLU . 6.7 mm-40 -106.71 178.11 4.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.917 . . . . 0.0 109.399 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.525 ' CG ' ' O ' ' A' ' 79' ' ' GLU . 56.1 mt-10 -160.81 105.52 1.39 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.659 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.545 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -60.15 179.57 0.21 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 109.103 179.71 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.3 Cg_endo -77.43 149.25 27.3 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.35 2.033 . . . . 0.0 110.238 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 35.8 Cg_endo -77.96 106.24 2.14 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.65 2.233 . . . . 0.0 111.175 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . 0.458 HD21 ' O ' ' A' ' 5' ' ' PRO . 12.3 tp -78.91 119.91 22.76 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ILE . . . . . 0.556 HG12 ' CB ' ' A' ' 71' ' ' SER . 0.5 OUTLIER -106.88 163.95 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.008 -1.058 . . . . 0.0 110.292 -179.365 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.554 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -156.42 164.31 32.44 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -117.93 141.66 48.19 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.124 -1.221 . . . . 0.0 110.034 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.534 ' CG ' HD12 ' A' ' 13' ' ' ILE . 2.1 mm-40 -165.27 137.6 4.29 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.558 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -103.26 148.87 25.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 110.102 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.477 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.7 OUTLIER -74.75 139.83 43.66 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.55 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.427 ' O ' ' N ' ' A' ' 65' ' ' GLY . 2.3 t . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.486 0.66 . . . . 0.0 110.571 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 C--O 1.215 -0.665 0 N-CA-C 109.947 -0.828 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -174.28 156.12 2.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.194 -0.941 . . . . 0.0 109.635 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 1.4 t0 78.38 25.5 0.58 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.396 -0.815 . . . . 0.0 109.928 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.506 ' CD2' ' CD2' ' A' ' 162' ' ' LEU . 27.9 tp -67.46 101.39 0.97 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.062 -1.023 . . . . 0.0 109.114 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -138.26 -171.92 3.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 109.642 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.5 p -107.14 144.24 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.227 -0.921 . . . . 0.0 109.837 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.519 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 22.8 pt -126.75 -4.32 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.373 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.522 ' CB ' ' HB2' ' A' ' 109' ' ' LEU . . . -152.38 91.38 1.58 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . 0.485 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 4.9 p -85.31 85.97 7.41 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.526 -0.733 . . . . 0.0 110.298 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' THR . . . . . 0.547 ' OG1' ' N ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -74.42 163.29 69.33 Favored Pre-proline 0 C--N 1.306 -1.307 0 O-C-N 121.045 -1.034 . . . . 0.0 108.462 179.215 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 29.7 Cg_endo -68.47 -3.1 10.36 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.437 2.091 . . . . 0.0 110.775 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.493 ' C ' ' CG2' ' A' ' 152' ' ' ILE . 21.7 p -153.68 20.1 0.53 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' SER . . . . . 0.547 ' N ' ' OG1' ' A' ' 104' ' ' THR . 6.3 p -170.84 165.58 7.83 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.999 -1.08 . . . . 0.0 110.281 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.64 ' CD2' ' CZ ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -139.42 153.36 47.58 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.884 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.522 ' HB2' ' CB ' ' A' ' 102' ' ' ALA . 0.3 OUTLIER -105.53 98.43 8.13 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.319 -0.863 . . . . 0.0 108.904 179.296 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 147' ' ' ALA . 1.3 pt -74.62 134.56 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.168 -0.958 . . . . 0.0 109.612 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' SER . . . . . 0.448 ' HB2' HG22 ' A' ' 101' ' ' ILE . 12.8 t -134.05 111.15 10.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.554 -0.716 . . . . 0.0 109.237 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' TRP . . . . . 0.576 ' CD2' ' O ' ' A' ' 145' ' ' SER . 37.4 p90 -130.03 137.96 50.52 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.331 -0.855 . . . . 0.0 109.158 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 112' ' ' TRP . 2.4 mt-10 . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.187 -0.946 . . . . 0.0 108.944 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . 0.505 ' HB2' ' O ' ' A' ' 140' ' ' VAL . 3.6 p90 . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' TYR . . . . . 0.553 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 3.6 m-85 -111.46 126.83 55.37 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 15.1 ttp180 -84.9 91.6 8.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.139 -0.976 . . . . 0.0 109.398 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ILE . . . . . 0.595 ' HB ' ' CZ ' ' A' ' 138' ' ' PHE . 19.2 mt -84.45 138.77 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.889 . . . . 0.0 109.59 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 25.9 p -112.7 129.63 56.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.411 -0.805 . . . . 0.0 109.889 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' TYR . . . . . 0.647 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 2.2 m-85 -75.36 131.75 40.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.449 -0.782 . . . . 0.0 109.091 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLY . . . . . 0.601 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -101.47 107.03 3.15 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 . . . . . 0 C--N 1.298 -1.647 0 O-C-N 121.115 -1.227 . . . . 0.0 108.932 179.111 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' GLN . . . . . 0.545 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 1.9 tm-20 -88.57 123.22 32.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 110.39 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.595 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 38.7 p90 -125.42 140.62 52.63 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.5 p -74.44 162.8 28.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.106 -0.996 . . . . 0.0 110.342 -178.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.524 HG13 ' CD1' ' A' ' 122' ' ' TYR . 2.4 t -131.44 142.37 45.13 Favored Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 121.602 -0.686 . . . . 0.0 109.625 -178.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' PRO . . . . . 0.457 ' HD2' HG11 ' A' ' 140' ' ' VAL . 34.9 Cg_endo -77.48 140.54 19.23 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.408 2.072 . . . . 0.0 109.935 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.3 24.88 8.68 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.51 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 2.1 p -105.42 32.22 4.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.147 -1.207 . . . . 0.0 109.664 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.51 ' CG ' ' O ' ' A' ' 143' ' ' SER . 1.7 mttt -177.83 156.63 1.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.095 -1.003 . . . . 0.0 109.773 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.576 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 1.1 p -95.17 -14.52 24.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.884 . . . . 0.0 109.357 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 110' ' ' ILE . 6.5 p -118.92 137.88 53.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.118 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.462 ' O ' HG13 ' A' ' 110' ' ' ILE . . . -118.99 164.22 15.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.143 -0.973 . . . . 0.0 109.696 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.8 t -95.15 156.48 16.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.246 -0.909 . . . . 0.0 109.144 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.647 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 9.7 mm -134.96 68.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.202 -0.936 . . . . 0.0 109.577 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.534 ' O ' ' CB ' ' A' ' 151' ' ' ASN . 1.4 m-80 -83.44 166.39 18.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.46 -0.775 . . . . 0.0 109.496 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 2.0 t30 79.02 31.6 0.3 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.352 -0.843 . . . . 0.0 109.794 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.525 HG13 ' CE2' ' A' ' 158' ' ' TYR . 2.7 tt -94.04 159.96 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.169 -0.957 . . . . 0.0 109.47 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt -103.94 120.77 50.14 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.301 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.14 147.45 23.53 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.424 2.083 . . . . 0.0 110.507 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 72.52 61.59 3.55 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.488 ' N ' ' OG1' ' A' ' 184' ' ' THR . . . 177.56 129.17 0.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -1.124 . . . . 0.0 109.582 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -46.05 160.69 0.06 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.129 -0.982 . . . . 0.0 108.455 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TYR . . . . . 0.601 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -148.39 178.46 8.57 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.736 -1.228 . . . . 0.0 110.242 -179.574 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' THR . . . . . 0.547 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 6.1 m -161.73 108.92 1.39 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.38 -0.825 . . . . 0.0 109.209 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.499 ' CD1' HD11 ' A' ' 108' ' ' LEU . 15.4 mt -98.85 133.21 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.608 -1.307 . . . . 0.0 109.824 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.573 ' CG2' ' CB ' ' A' ' 179' ' ' SER . 1.6 m -141.39 174.18 10.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.312 -0.867 . . . . 0.0 109.339 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 124' ' ' ILE . 0.7 OUTLIER -163.99 148.63 10.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.063 -1.023 . . . . 0.0 110.997 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' TYR . . . . . 0.6 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.6 m-85 -125.32 81.73 2.0 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.544 ' HB3' ' CE2' ' A' ' 122' ' ' TYR . . . -45.18 99.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.952 -1.093 . . . . 0.0 109.15 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . 0.471 ' N ' ' O ' ' A' ' 163' ' ' TYR . 70.7 t . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.898 . . . . 0.0 109.917 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' SER . . . . . 0.461 ' HB3' HG21 ' A' ' 165' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.371 -0.604 . . . . 0.0 109.371 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 96.9 p -53.82 161.33 1.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.929 . . . . 0.0 109.351 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -46.25 142.95 3.94 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.174 -0.954 . . . . 0.0 108.588 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.6 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 35.0 Cg_endo -77.88 141.52 19.2 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.345 2.03 . . . . 0.0 111.397 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.466 ' O ' HG21 ' A' ' 161' ' ' THR . 2.2 t -114.99 134.68 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' SER . . . . . 0.573 ' CB ' ' CG2' ' A' ' 161' ' ' THR . 1.1 p -133.29 162.25 32.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 111.02 -178.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . 0.465 HG21 ' O ' ' A' ' 179' ' ' SER . 13.5 pt -142.26 152.13 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -93.33 152.1 19.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.987 -1.071 . . . . 0.0 109.853 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.64 ' CZ ' ' CD2' ' A' ' 108' ' ' LEU . 53.6 t80 -146.53 130.03 16.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.399 -0.813 . . . . 0.0 109.468 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -106.34 119.34 39.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.444 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' THR . . . . . 0.488 ' OG1' ' N ' ' A' ' 156' ' ' ALA . 1.5 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.484 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.6 mt -127.86 -164.44 1.37 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.297 -1.119 . . . . 0.0 109.245 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.482 ' HB2' ' CB ' ' A' ' 25' ' ' PRO . 1.0 OUTLIER -99.84 162.34 13.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.886 . . . . 0.0 109.084 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.452 ' HA ' ' HG2' ' A' ' 82' ' ' PRO . 79.6 p -95.15 136.62 22.54 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.109 -0.995 . . . . 0.0 109.762 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.478 ' O ' ' HB2' ' A' ' 84' ' ' LEU . 35.9 Cg_endo -79.27 119.07 4.1 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.602 2.201 . . . . 0.0 110.067 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.473 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -141.43 -163.21 1.52 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.021 -1.049 . . . . 0.0 109.746 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 60.29 22.46 58.54 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -178.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.573 ' C ' ' CD1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -82.28 168.05 17.99 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.863 -0.786 . . . . 0.0 109.538 -179.17 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.517 ' O ' ' CG1' ' A' ' 20' ' ' VAL . 3.6 t70 -165.28 -163.93 0.72 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.9 t -142.91 149.16 38.09 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.151 -0.968 . . . . 0.0 109.643 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.475 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 40.4 p -176.24 -163.52 0.1 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 109.286 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.525 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.6 OUTLIER 45.8 37.11 3.2 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -178.622 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.634 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.8 mt -85.5 165.03 2.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.65 -177.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.534 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 0.7 OUTLIER -154.41 -165.21 2.02 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.525 ' CB ' ' OD1' ' A' ' 93' ' ' ASP . . . -86.62 -44.96 11.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.022 -1.049 . . . . 0.0 109.875 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.508 ' OD1' ' NH1' ' A' ' 168' ' ' ARG . 1.6 p-10 -110.32 11.15 23.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.91 -1.119 . . . . 0.0 109.486 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.488 ' O ' HG21 ' A' ' 14' ' ' THR . 0.0 OUTLIER -160.9 150.11 16.85 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.767 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.634 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 2.1 p90 -165.51 143.35 5.91 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.009 -1.057 . . . . 0.0 108.855 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 61.6 m -107.95 163.85 12.78 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.823 -1.173 . . . . 0.0 111.099 -178.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.569 HG13 ' CE2' ' A' ' 8' ' ' PHE . 0.9 OUTLIER -132.09 170.88 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.475 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 18.1 m-70 -142.07 158.44 43.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.994 -1.066 . . . . 0.0 110.195 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.542 ' CB ' ' HB2' ' A' ' 8' ' ' PHE . 23.9 p90 -170.84 135.19 1.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.43 -0.794 . . . . 0.0 109.24 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.37 166.53 2.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.135 -0.978 . . . . 0.0 109.363 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.48 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -98.03 174.07 3.46 Favored Pre-proline 0 C--N 1.298 -1.639 0 O-C-N 121.666 -0.646 . . . . 0.0 109.772 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.482 ' CB ' ' HB2' ' A' ' 3' ' ' ASP . 35.6 Cg_endo -78.64 177.35 8.84 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.682 2.255 . . . . 0.0 110.457 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -86.73 9.13 19.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -0.932 . . . . 0.0 109.388 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.41 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . . . -126.07 168.06 15.18 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.496 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.41 ' HD2' ' HB2' ' A' ' 27' ' ' ALA . 35.4 Cg_endo -78.12 133.04 11.94 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.695 2.264 . . . . 0.0 110.444 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.557 HD12 ' CE1' ' A' ' 32' ' ' TYR . 27.2 pt -118.18 -172.79 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.435 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.4 p -123.12 -10.24 8.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 109.555 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.501 ' O ' ' CG2' ' A' ' 75' ' ' VAL . . . 157.38 151.21 5.94 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 74' ' ' ALA . 2.4 m-30 -114.07 139.09 49.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -1.133 . . . . 0.0 109.612 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.522 ' CG2' ' HD2' ' A' ' 49' ' ' ARG . 1.7 mp -93.01 128.97 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.233 -0.917 . . . . 0.0 109.087 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.522 ' CD1' HG21 ' A' ' 50' ' ' VAL . 1.8 mm -115.86 109.25 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.214 -0.929 . . . . 0.0 109.76 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.475 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -109.86 137.11 48.11 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.13 -0.981 . . . . 0.0 109.012 179.36 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.566 ' CD2' HD21 ' A' ' 59' ' ' LEU . 5.4 p-80 -129.84 146.74 51.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.109 -0.994 . . . . 0.0 110.076 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.547 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 28.6 p-80 -168.24 133.34 1.76 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.339 -0.851 . . . . 0.0 109.87 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.542 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . . . -66.08 137.54 57.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 109.243 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.423 ' HB3' HG22 ' A' ' 69' ' ' VAL . 0.2 OUTLIER -73.03 -2.35 20.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.195 -0.941 . . . . 0.0 109.759 -179.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -99.84 29.48 4.15 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.143 -0.973 . . . . 0.0 109.676 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.5 p -150.48 153.76 36.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.529 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.9 p -117.35 -0.75 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.221 -0.925 . . . . 0.0 109.583 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.25 -168.06 0.71 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -80.51 134.54 54.39 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.278 -1.13 . . . . 0.0 109.368 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.453 ' HB3' ' HB3' ' A' ' 37' ' ' HIS . 36.3 Cg_endo -78.93 145.39 19.72 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.535 2.157 . . . . 0.0 110.468 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.465 ' HB2' ' NE2' ' A' ' 36' ' ' HIS . 0.6 OUTLIER -74.59 151.86 39.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.217 -0.927 . . . . 0.0 109.239 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -123.14 117.16 24.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 109.958 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.479 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 1.3 m-20 -120.04 107.68 13.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.413 -0.804 . . . . 0.0 108.893 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.522 ' HD2' ' CG2' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -91.28 142.28 27.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.07 -1.019 . . . . 0.0 109.8 -179.504 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.538 HG23 ' CH2' ' A' ' 22' ' ' TRP . 5.8 m -119.3 161.97 34.35 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.44 -0.787 . . . . 0.0 109.107 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.516 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.5 Cg_endo -76.88 173.93 13.67 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.501 2.134 . . . . 0.0 110.293 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 35.4 Cg_endo -77.35 -15.32 15.93 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.648 2.232 . . . . 0.0 110.545 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.3 29.27 4.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.576 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.516 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 12.0 mmt85 -138.96 119.85 14.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 109.562 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.541 ' O ' ' CE3' ' A' ' 22' ' ' TRP . 10.2 p-10 -99.24 -3.66 33.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 109.468 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.463 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 74.8 p -135.14 158.59 43.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.175 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.467 HD12 ' HB3' ' A' ' 48' ' ' ASP . 3.5 tt -142.29 124.4 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.155 -0.966 . . . . 0.0 109.607 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.484 ' CG2' ' OG1' ' A' ' 19' ' ' THR . 0.3 OUTLIER -82.53 117.1 22.28 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.31 -0.868 . . . . 0.0 109.414 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.566 HD21 ' CD2' ' A' ' 36' ' ' HIS . 1.2 mt -95.93 143.37 27.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.893 . . . . 0.0 109.562 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.461 ' CG2' ' HB3' ' A' ' 17' ' ' SER . 39.2 p -134.61 -177.4 4.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 109.35 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.439 ' O ' HD22 ' A' ' 62' ' ' LEU . 4.4 m-80 53.03 56.37 7.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.385 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.46 HD12 ' HB3' ' A' ' 59' ' ' LEU . 6.0 mt -134.13 134.65 42.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.495 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.469 ' CB ' ' OH ' ' A' ' 68' ' ' TYR . 3.2 t30 -51.17 130.05 31.41 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 109.081 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.512 ' HB3' ' CB ' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -78.52 134.0 12.13 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.355 2.037 . . . . 0.0 110.712 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 82.83 60.95 1.99 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.4 m -163.73 154.26 15.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.323 -1.104 . . . . 0.0 109.924 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -88.92 127.1 35.64 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.929 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.542 ' CE1' ' HB3' ' A' ' 38' ' ' ALA . 23.5 m-85 -118.27 124.02 46.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.011 -1.055 . . . . 0.0 109.879 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.547 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 22.7 t -83.65 122.28 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 108.976 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 24.6 t -110.88 122.56 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -0.985 . . . . 0.0 109.55 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.514 ' HB2' ' CD1' ' A' ' 85' ' ' ILE . 82.3 p -103.54 117.13 33.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.192 -0.943 . . . . 0.0 109.903 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.517 ' O ' ' N ' ' A' ' 84' ' ' LEU . 11.2 mm -94.08 120.16 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.324 -0.86 . . . . 0.0 109.648 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.568 ' N ' ' CD1' ' A' ' 73' ' ' ILE . 1.4 mp -112.11 132.74 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.165 -0.959 . . . . 0.0 109.124 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . . . -95.94 154.48 17.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.557 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.501 ' CG2' ' O ' ' A' ' 31' ' ' GLY . 11.7 m -154.97 130.28 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 109.449 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -103.03 45.56 0.95 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.36 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.68 -85.21 0.99 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -111.64 -1.14 15.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -1.141 . . . . 0.0 109.404 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -97.09 -166.26 1.37 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 0.0 109.311 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -146.36 -167.07 2.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.14 -0.975 . . . . 0.0 109.854 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.569 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -172.44 -178.87 0.46 Allowed Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.569 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.1 Cg_endo -76.6 134.2 14.99 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.021 1.814 . . . . 0.0 109.69 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 35.2 Cg_endo -77.1 108.83 2.71 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.437 2.091 . . . . 0.0 111.129 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.521 ' CD2' ' HB3' ' A' ' 8' ' ' PHE . 9.7 tp -77.4 80.94 3.89 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.296 -0.878 . . . . 0.0 108.638 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.514 ' CD1' ' HB2' ' A' ' 71' ' ' SER . 4.2 mt -86.06 151.47 3.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.184 -0.947 . . . . 0.0 110.216 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.484 ' N ' HG21 ' A' ' 85' ' ' ILE . . . -145.42 -169.13 13.47 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.424 ' HG3' ' C ' ' A' ' 86' ' ' GLY . 30.8 mt-30 -150.73 126.89 10.55 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.168 -1.195 . . . . 0.0 109.676 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.521 ' OE1' ' N ' ' A' ' 88' ' ' GLN . 9.6 pm0 -129.3 -155.31 0.69 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.317 -0.864 . . . . 0.0 108.752 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -159.73 136.13 8.99 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.037 -1.04 . . . . 0.0 110.002 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.93 137.16 41.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.401 -0.812 . . . . 0.0 108.997 179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.54 HG12 ' CB ' ' A' ' 116' ' ' ALA . 3.1 t -53.92 164.87 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 121.407 0.622 . . . . 0.0 110.092 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.9 t -90.95 154.29 19.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.471 -0.768 . . . . 0.0 108.984 179.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.525 ' OD1' ' CB ' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -97.25 -37.79 9.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.107 -0.996 . . . . 0.0 110.068 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.567 ' CG1' ' HB2' ' A' ' 175' ' ' SER . 1.4 mt -76.27 140.84 69.59 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 121.002 -1.061 . . . . 0.0 109.557 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.497 ' HD2' HG22 ' A' ' 94' ' ' ILE . 36.3 Cg_endo -80.77 -159.28 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.597 2.198 . . . . 0.0 109.656 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.504 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -169.9 158.54 7.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.091 -1.006 . . . . 0.0 109.604 179.591 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 4.5 t0 78.13 26.83 0.57 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.435 -0.791 . . . . 0.0 109.715 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.501 ' CD1' HD22 ' A' ' 162' ' ' LEU . 1.7 tt -60.3 99.4 0.08 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.13 -0.981 . . . . 0.0 109.057 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -138.05 165.38 26.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.616 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 13.3 p -96.31 147.24 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.762 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.51 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 14.1 pt -127.99 -4.32 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 0.0 109.704 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.531 ' CB ' ' HB2' ' A' ' 109' ' ' LEU . . . -153.03 105.28 2.9 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.517 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 10.0 m -100.79 91.08 4.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -0.933 . . . . 0.0 110.588 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.483 ' OG1' ' OG ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -83.35 163.28 50.81 Favored Pre-proline 0 C--N 1.306 -1.306 0 O-C-N 121.126 -0.983 . . . . 0.0 108.671 178.726 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -69.2 -2.12 9.21 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.296 1.997 . . . . 0.0 110.795 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.52 ' HA ' HG21 ' A' ' 152' ' ' ILE . 23.2 p -147.56 12.58 1.03 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 109.497 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.529 ' CB ' ' HA ' ' A' ' 150' ' ' ASN . 3.2 p -169.84 164.69 9.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.809 -1.182 . . . . 0.0 110.198 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.584 HD23 ' CE2' ' A' ' 182' ' ' TYR . 0.6 OUTLIER -139.13 155.4 47.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.306 -0.871 . . . . 0.0 109.131 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.531 ' HB2' ' CB ' ' A' ' 102' ' ' ALA . 1.3 mt -105.41 116.23 31.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.295 -0.878 . . . . 0.0 109.329 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.466 ' O ' ' HA ' ' A' ' 146' ' ' THR . 1.6 pt -99.01 143.55 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 109.494 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.512 ' CB ' HG23 ' A' ' 146' ' ' THR . 41.3 p -140.24 131.2 26.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.352 -0.843 . . . . 0.0 109.58 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.564 ' CD2' ' O ' ' A' ' 145' ' ' SER . 47.0 p90 -135.85 151.69 50.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.358 -0.839 . . . . 0.0 109.35 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.465 ' HG3' ' HG3' ' A' ' 96' ' ' ARG . 14.2 mt-10 -56.46 141.61 71.16 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.485 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.31 118.07 3.9 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.645 2.23 . . . . 0.0 110.459 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 117' ' ' VAL . 34.9 Cg_endo -78.04 138.05 16.03 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.379 2.053 . . . . 0.0 110.276 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.54 ' CB ' HG12 ' A' ' 91' ' ' VAL . . . -69.84 59.65 0.16 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.142 -0.974 . . . . 0.0 109.431 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.454 ' N ' ' O ' ' A' ' 115' ' ' PRO . 14.8 m -146.21 154.18 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.44 -0.787 . . . . 0.0 109.257 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.6 m -83.7 86.2 7.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -0.911 . . . . 0.0 109.515 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.576 HG13 ' CZ ' ' A' ' 122' ' ' TYR . 1.7 t -74.92 125.76 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.909 . . . . 0.0 109.439 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 165' ' ' VAL . 0.2 OUTLIER -75.05 -45.98 37.92 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.121 -0.987 . . . . 0.0 108.746 179.39 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.507 ' HB2' ' O ' ' A' ' 140' ' ' VAL . 1.5 p90 -167.22 165.53 15.3 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.151 -0.968 . . . . 0.0 109.575 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 1.4 m-85 -125.96 140.4 52.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.251 -0.906 . . . . 0.0 109.013 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.576 ' CG ' ' HB2' ' A' ' 163' ' ' TYR . 0.1 OUTLIER -113.12 98.95 7.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.655 -1.278 . . . . 0.0 108.214 178.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.599 ' HB ' ' CZ ' ' A' ' 138' ' ' PHE . 20.8 mt -92.25 156.73 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.354 -0.841 . . . . 0.0 110.629 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 82.1 p -116.01 135.84 53.59 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.76 -0.588 . . . . 0.0 109.594 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.642 ' CE2' ' CG2' ' A' ' 149' ' ' ILE . 14.1 m-85 -74.17 143.62 45.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 109.368 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.581 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.86 94.02 0.94 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -106.63 139.12 41.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -1.163 . . . . 0.0 109.427 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.534 ' CG2' ' HB3' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -81.34 -89.91 0.07 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.197 -0.939 . . . . 0.0 109.653 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -108.6 56.79 0.46 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -84.26 -83.02 0.98 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.471 ' O ' ' CB ' ' A' ' 133' ' ' SER . 19.5 p-10 -173.24 33.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -1.167 . . . . 0.0 109.436 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.526 ' CB ' ' HD2' ' A' ' 134' ' ' PRO . 0.3 OUTLIER 166.42 176.33 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.473 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.526 ' HD2' ' CB ' ' A' ' 133' ' ' SER . 35.5 Cg_endo -77.72 -173.93 2.01 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.578 2.185 . . . . 0.0 110.384 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.457 ' HA ' ' O ' ' A' ' 126' ' ' TYR . 3.0 m -52.8 149.8 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.239 -0.913 . . . . 0.0 109.827 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.483 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 1.9 tt0 -105.32 113.96 27.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.91 . . . . 0.0 109.402 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.471 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 8.2 pt-20 -84.38 126.9 33.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 110.372 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.599 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 11.7 p90 -131.27 136.73 48.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.345 -0.847 . . . . 0.0 108.834 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.7 p -74.78 157.55 35.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.235 -0.916 . . . . 0.0 110.755 -178.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.507 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 39.7 t -121.5 127.14 26.22 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 143' ' ' SER . 36.3 Cg_endo -79.01 42.11 1.22 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.282 1.988 . . . . 0.0 111.352 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 141' ' ' PRO . . . 35.49 31.86 0.03 OUTLIER Glycine 0 N--CA 1.498 2.804 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.9 OUTLIER -50.43 -41.22 52.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -1.102 . . . . 0.0 109.835 -179.354 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.455 ' HD2' ' OG1' ' A' ' 146' ' ' THR . 0.4 OUTLIER 179.43 -168.69 0.1 Allowed 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.609 -0.682 . . . . 0.0 109.628 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.564 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -71.98 -4.54 29.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.499 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.512 HG23 ' CB ' ' A' ' 111' ' ' SER . 75.7 p -124.37 133.09 53.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.178 -0.951 . . . . 0.0 109.396 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.463 ' O ' HG13 ' A' ' 110' ' ' ILE . . . -117.54 169.87 9.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.608 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.42 ' C ' HG12 ' A' ' 149' ' ' ILE . 12.2 t -99.24 164.47 12.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.382 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.642 ' CG2' ' CE2' ' A' ' 126' ' ' TYR . 17.7 mm -143.59 65.86 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.448 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.579 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 0.8 OUTLIER -78.7 -152.23 0.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.479 -0.763 . . . . 0.0 109.792 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.4 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 24.0 t-20 47.1 26.43 0.64 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 109.418 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.52 HG21 ' HA ' ' A' ' 106' ' ' THR . 3.3 tt -92.19 160.74 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.304 -0.873 . . . . 0.0 109.637 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.58 127.65 25.72 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.189 -0.945 . . . . 0.0 109.268 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.435 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 36.1 Cg_endo -78.59 155.87 27.96 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.467 2.111 . . . . 0.0 110.593 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.504 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . 81.76 64.89 1.7 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.504 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 162.3 132.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.287 -1.125 . . . . 0.0 109.657 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.534 ' HB3' ' CG2' ' A' ' 129' ' ' THR . 0.9 OUTLIER -51.59 164.83 0.2 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.634 ' CD1' ' CG2' ' A' ' 184' ' ' THR . 0.2 OUTLIER -145.21 -175.87 4.87 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.705 -1.247 . . . . 0.0 110.519 -179.149 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.549 ' CG2' ' N ' ' A' ' 160' ' ' ILE . 2.9 m -162.97 168.16 21.51 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.549 ' N ' ' CG2' ' A' ' 159' ' ' THR . 67.0 mt -152.55 136.25 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.856 -1.152 . . . . 0.0 109.908 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.525 ' O ' ' CG2' ' A' ' 124' ' ' ILE . 0.2 OUTLIER -138.74 131.25 28.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.316 -0.865 . . . . 0.0 109.081 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.548 ' CB ' HG12 ' A' ' 124' ' ' ILE . 3.7 pp -114.68 141.27 48.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.076 -1.015 . . . . 0.0 111.23 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.652 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 1.4 m-85 -122.56 72.49 1.07 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.554 ' HB3' ' CD2' ' A' ' 122' ' ' TYR . . . -45.5 120.12 2.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.864 -1.147 . . . . 0.0 109.284 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.474 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 74.0 t -98.93 124.37 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.285 -0.884 . . . . 0.0 109.722 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 173' ' ' ALA . 69.8 p -114.52 130.81 56.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.45 -0.781 . . . . 0.0 108.929 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.527 ' O ' ' CD ' ' A' ' 168' ' ' ARG . . . -69.43 157.32 53.5 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.527 ' CD ' ' O ' ' A' ' 167' ' ' GLY . 0.7 OUTLIER -140.97 13.0 2.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -1.104 . . . . 0.0 109.543 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 117.24 -116.67 3.58 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.8 -1.01 20.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -1.158 . . . . 0.0 109.468 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 168' ' ' ARG . 22.9 m -160.6 125.0 2.07 Favored Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.481 ' HA ' ' HA2' ' A' ' 167' ' ' GLY . 34.5 Cg_endo -76.15 -168.94 0.61 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.262 1.975 . . . . 0.0 110.636 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 166' ' ' THR . . . -155.29 164.25 39.03 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.248 -0.907 . . . . 0.0 110.062 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 175' ' ' SER . 0.7 OUTLIER -146.68 108.81 4.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.404 -0.81 . . . . 0.0 109.186 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.567 ' HB2' ' CG1' ' A' ' 94' ' ' ILE . 3.4 p -52.8 -171.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -0.852 . . . . 0.0 109.619 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.547 ' CB ' HD12 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -69.11 144.86 95.83 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.55 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.652 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.1 Cg_endo -77.86 128.88 9.53 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.446 2.097 . . . . 0.0 111.641 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 98' ' ' LEU . 2.7 t -95.52 124.2 48.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.525 ' CB ' HG21 ' A' ' 161' ' ' THR . 0.0 OUTLIER -115.2 146.7 41.15 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 110.811 -178.372 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.449 HG22 ' O ' ' A' ' 98' ' ' LEU . 5.2 pt -130.81 -164.92 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -126.16 164.86 20.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.961 -1.087 . . . . 0.0 109.491 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.584 ' CE2' HD23 ' A' ' 108' ' ' LEU . 63.4 t80 -165.08 132.87 3.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.205 -0.935 . . . . 0.0 109.461 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -103.21 129.84 50.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.208 -0.932 . . . . 0.0 109.613 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.634 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 30.8 p . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.494 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.525 HD12 ' CG ' ' A' ' 79' ' ' GLU . 4.9 mt -78.52 -160.87 0.24 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.286 -1.126 . . . . 0.0 109.616 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.543 ' HB3' ' CG ' ' A' ' 25' ' ' PRO . 1.1 m-20 -73.94 77.35 1.66 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.395 -0.816 . . . . 0.0 109.133 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.532 ' OG ' ' CG ' ' A' ' 82' ' ' PRO . 14.8 m -95.58 109.59 46.53 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.431 -0.793 . . . . 0.0 109.772 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.577 ' HG3' ' CE2' ' A' ' 32' ' ' TYR . 36.7 Cg_endo -79.66 145.52 18.3 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.375 2.05 . . . . 0.0 110.077 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.466 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -161.43 -171.87 3.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.099 -1.0 . . . . 0.0 109.762 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 45.44 27.33 1.88 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.62 ' C ' ' CD1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -71.65 -161.63 0.07 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.598 -0.943 . . . . 0.0 109.867 -179.242 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.517 ' N ' ' CG ' ' A' ' 8' ' ' PHE . 1.5 t70 -165.58 -170.97 1.96 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.361 -0.837 . . . . 0.0 108.993 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.506 ' OG ' ' NE2' ' A' ' 88' ' ' GLN . 5.1 p -154.37 133.08 12.18 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.69 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.515 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 51.3 p -161.15 -159.64 0.67 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.253 -0.904 . . . . 0.0 109.42 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.496 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.8 OUTLIER 45.37 33.68 1.32 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -178.247 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.626 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.3 mt -75.71 163.43 3.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.485 -177.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.556 ' HA ' ' CB ' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -149.71 -167.92 2.96 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.027 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.587 ' CB ' ' CG1' ' A' ' 117' ' ' VAL . . . -88.12 -47.55 8.4 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.901 -1.125 . . . . 0.0 109.361 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -105.59 19.72 20.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.915 -1.116 . . . . 0.0 109.001 179.623 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.528 ' HB3' ' CG2' ' A' ' 60' ' ' THR . 0.0 OUTLIER -172.64 153.33 2.76 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.626 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 4.7 p90 -166.19 140.73 4.43 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.955 -1.09 . . . . 0.0 108.985 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.496 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 2.3 m -89.07 160.34 17.1 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.922 -1.111 . . . . 0.0 111.252 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.471 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.2 OUTLIER -137.46 122.39 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.515 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 29.2 m-70 -99.31 153.09 19.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.097 -1.002 . . . . 0.0 110.104 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.53 ' CH2' HG22 ' A' ' 50' ' ' VAL . 22.3 p90 -161.5 133.48 5.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.382 -0.824 . . . . 0.0 109.523 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.548 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.41 170.54 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.234 -0.917 . . . . 0.0 109.295 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.548 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -100.76 159.58 29.18 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.623 -0.673 . . . . 0.0 109.378 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.543 ' CG ' ' HB3' ' A' ' 3' ' ' ASP . 36.2 Cg_endo -78.28 -159.11 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.7 2.266 . . . . 0.0 110.403 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -107.07 1.19 24.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.541 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.411 ' HB2' ' OD1' ' A' ' 3' ' ' ASP . . . -104.24 164.13 15.9 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.45 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.5 141.4 19.93 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.669 2.246 . . . . 0.0 110.307 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.566 HD13 ' CD1' ' A' ' 32' ' ' TYR . 18.7 pt -133.69 163.33 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.763 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.2 p -117.73 1.78 12.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.406 -0.809 . . . . 0.0 109.234 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.524 ' O ' ' CG2' ' A' ' 75' ' ' VAL . . . 164.24 161.18 12.86 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 74' ' ' ALA . 0.5 OUTLIER -125.82 124.18 40.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.633 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.527 ' CD1' ' HG3' ' A' ' 49' ' ' ARG . 14.6 mm -87.64 118.61 33.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.198 -0.939 . . . . 0.0 109.318 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.531 ' CG1' HD11 ' A' ' 57' ' ' ILE . 1.5 mm -107.2 110.22 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.185 -0.947 . . . . 0.0 109.86 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.464 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 35.6 ttp180 -109.05 142.82 39.19 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.146 -0.971 . . . . 0.0 108.657 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.621 ' CE1' ' CD2' ' A' ' 59' ' ' LEU . 21.9 p-80 -132.06 151.75 51.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.986 -1.071 . . . . 0.0 110.187 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.519 ' CB ' ' HB3' ' A' ' 45' ' ' PRO . 54.6 p-80 -168.55 126.66 1.09 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.512 -0.743 . . . . 0.0 109.023 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -47.55 174.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.15 -0.969 . . . . 0.0 109.6 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.509 ' HB2' ' CD2' ' A' ' 40' ' ' HIS . 1.3 mt-10 -89.12 -24.42 22.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.101 -0.999 . . . . 0.0 109.582 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.509 ' CD2' ' HB2' ' A' ' 39' ' ' GLU . 6.8 p80 -165.32 23.67 0.05 Allowed 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.509 -0.744 . . . . 0.0 109.867 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.429 ' OG ' ' HB1' ' A' ' 38' ' ' ALA . 4.6 p -83.23 165.09 19.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.328 -0.858 . . . . 0.0 109.554 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.0 t -87.29 -0.54 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.617 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.44 -175.26 1.71 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.59 140.63 26.95 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.259 -1.141 . . . . 0.0 109.435 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.519 ' HB3' ' CB ' ' A' ' 37' ' ' HIS . 36.3 Cg_endo -78.79 120.09 4.59 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.508 2.138 . . . . 0.0 110.421 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.578 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 0.1 OUTLIER -106.59 174.64 5.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.946 . . . . 0.0 109.363 179.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -123.27 103.91 8.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.943 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.531 ' HB3' ' CD1' ' A' ' 57' ' ' ILE . 4.8 m-20 -98.41 112.88 24.75 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.258 -0.901 . . . . 0.0 108.856 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.528 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -96.69 152.91 18.2 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.133 -0.979 . . . . 0.0 109.858 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.53 HG22 ' CH2' ' A' ' 22' ' ' TRP . 5.1 m -134.46 162.12 59.6 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.462 -0.774 . . . . 0.0 109.034 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.532 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.7 Cg_endo -77.02 174.16 13.29 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.481 2.12 . . . . 0.0 110.365 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.454 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 35.3 Cg_endo -77.63 -15.26 15.5 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.549 2.166 . . . . 0.0 110.419 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.39 29.73 3.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.477 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.532 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 4.5 mmt180 -139.17 132.89 30.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.569 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.412 ' O ' ' CE3' ' A' ' 22' ' ' TRP . 21.7 p-10 -112.61 -3.0 14.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 0.0 109.38 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 88.5 p -132.2 148.38 52.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.922 . . . . 0.0 109.35 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.531 HD11 ' CG1' ' A' ' 34' ' ' ILE . 5.9 tt -139.35 127.24 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 0.0 109.821 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.74 115.51 24.22 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.206 -0.934 . . . . 0.0 109.298 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.621 ' CD2' ' CE1' ' A' ' 36' ' ' HIS . 6.5 mt -88.31 160.47 17.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.738 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.528 ' CG2' ' HB3' ' A' ' 17' ' ' SER . 19.7 p -147.2 173.3 12.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.827 . . . . 0.0 109.609 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.437 ' O ' HD22 ' A' ' 62' ' ' LEU . 4.2 m-80 62.07 53.2 3.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.352 -0.843 . . . . 0.0 109.915 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.446 ' O ' ' HA ' ' A' ' 16' ' ' ASN . 3.0 mt -132.69 135.61 45.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 109.315 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.469 ' CB ' ' OH ' ' A' ' 68' ' ' TYR . 3.2 t30 -47.24 131.54 9.68 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.094 -1.004 . . . . 0.0 108.889 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.53 ' HB3' ' CB ' ' A' ' 15' ' ' ALA . 36.6 Cg_endo -78.68 134.2 12.04 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.475 2.117 . . . . 0.0 111.258 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 78.95 62.03 2.29 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.553 HG21 ' CE1' ' A' ' 68' ' ' TYR . 1.2 m -161.99 144.04 11.28 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.275 -1.133 . . . . 0.0 110.2 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -79.19 133.37 36.7 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.652 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.57 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 50.7 m-85 -124.88 171.55 10.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.903 -1.123 . . . . 0.0 110.832 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 86' ' ' GLY . 3.2 t -124.37 137.54 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 2.2 t -126.8 129.38 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.847 -1.158 . . . . 0.0 110.356 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.547 ' CB ' HG12 ' A' ' 85' ' ' ILE . 5.0 p -100.42 101.45 12.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.323 -0.86 . . . . 0.0 109.996 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.48 HD13 ' CE3' ' A' ' 22' ' ' TRP . 26.0 mm -80.91 84.2 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.094 -1.004 . . . . 0.0 109.317 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.483 HG22 HD11 ' A' ' 73' ' ' ILE . 9.1 mt -81.87 159.2 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -0.943 . . . . 0.0 109.587 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 32' ' ' TYR . . . -121.05 169.87 10.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.9 . . . . 0.0 109.434 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -154.94 140.51 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 109.547 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.429 ' O ' ' CG ' ' A' ' 76' ' ' ASN . 27.1 t-20 -137.24 49.44 2.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 109.585 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.71 -96.15 1.44 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.37 1.7 16.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -1.096 . . . . 0.0 109.519 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.525 ' CG ' HD12 ' A' ' 2' ' ' LEU . 1.2 tt0 -98.29 170.08 9.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.266 -0.897 . . . . 0.0 109.387 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.454 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 2.3 mp0 -148.89 108.35 3.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.112 -0.993 . . . . 0.0 110.009 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.56 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -59.92 -178.34 0.14 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 108.649 179.245 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.56 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.0 Cg_endo -76.87 154.33 33.78 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.177 1.918 . . . . 0.0 110.127 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.418 ' HA ' HG12 ' A' ' 73' ' ' ILE . 35.4 Cg_endo -77.2 103.8 1.8 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.66 2.24 . . . . 0.0 111.356 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 6' ' ' THR . 5.6 tp -81.48 93.64 6.69 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.547 HG12 ' CB ' ' A' ' 71' ' ' SER . 3.0 mt -100.09 126.69 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.177 -0.952 . . . . 0.0 110.157 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.542 ' HA3' ' CZ ' ' A' ' 8' ' ' PHE . . . -121.45 -164.71 12.39 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -143.99 123.85 13.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.947 -1.325 . . . . 0.0 110.198 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.506 ' NE2' ' OG ' ' A' ' 10' ' ' SER . 3.9 mm100 -121.5 -152.79 0.52 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.516 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.4 143.36 6.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.089 -1.007 . . . . 0.0 109.904 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -87.81 138.13 31.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.411 -0.805 . . . . 0.0 109.196 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.524 ' O ' ' N ' ' A' ' 65' ' ' GLY . 2.9 t -55.12 173.16 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.592 0.711 . . . . 0.0 110.99 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.29 158.41 19.08 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.564 -0.71 . . . . 0.0 109.858 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.529 ' OD2' ' CG ' ' A' ' 64' ' ' PRO . 2.5 m-20 -86.07 -43.99 12.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.496 -0.753 . . . . 0.0 109.802 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.587 ' CD1' ' CG ' ' A' ' 176' ' ' LYS . 0.8 OUTLIER -90.34 144.2 30.58 Favored Pre-proline 0 N--CA 1.486 1.368 0 O-C-N 121.125 -0.984 . . . . 0.0 110.302 -179.058 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.658 ' CB ' ' CD1' ' A' ' 112' ' ' TRP . 35.8 Cg_endo -79.55 80.34 3.1 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.691 2.261 . . . . 0.0 109.924 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.504 ' CG ' ' N ' ' A' ' 97' ' ' ASP . 32.5 ttt85 -77.5 164.56 25.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.321 -0.862 . . . . 0.0 109.752 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.51 ' HB2' ' CG ' ' A' ' 113' ' ' GLU . 2.8 t0 77.63 33.58 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.417 -0.802 . . . . 0.0 109.781 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.509 HD23 ' CD2' ' A' ' 162' ' ' LEU . 33.0 tp -77.15 102.53 6.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.959 . . . . 0.0 109.486 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -140.25 169.89 16.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -0.904 . . . . 0.0 109.392 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 7.9 p -94.17 138.86 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.922 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.451 HG13 ' HB3' ' A' ' 109' ' ' LEU . 1.3 pp -123.93 -7.97 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.395 -0.816 . . . . 0.0 109.312 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.457 ' HB1' ' CD1' ' A' ' 109' ' ' LEU . . . -158.54 99.08 1.57 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.528 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 0.1 OUTLIER -103.58 109.86 21.7 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.442 -0.786 . . . . 0.0 110.648 -178.52 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.491 ' OG1' ' OG ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -91.3 166.39 18.56 Favored Pre-proline 0 C--N 1.306 -1.317 0 O-C-N 121.293 -0.88 . . . . 0.0 108.749 178.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.449 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 30.3 Cg_endo -69.55 -2.05 9.35 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.258 1.972 . . . . 0.0 110.617 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.52 ' HA ' HG21 ' A' ' 152' ' ' ILE . 62.0 p -145.41 10.47 1.26 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.277 -0.889 . . . . 0.0 109.59 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 149' ' ' ILE . 3.1 p -167.3 153.69 8.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.826 -1.171 . . . . 0.0 109.992 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.6 HD23 ' CE1' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -120.9 151.38 39.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.256 -0.902 . . . . 0.0 109.422 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.457 ' CD1' ' HB1' ' A' ' 102' ' ' ALA . 0.7 OUTLIER -106.03 120.9 42.98 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.528 ' CD1' HD11 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -105.46 133.22 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.981 -1.074 . . . . 0.0 110.105 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.43 ' HB3' HG22 ' A' ' 101' ' ' ILE . 4.9 t -130.82 121.51 25.46 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.658 ' CD1' ' CB ' ' A' ' 95' ' ' PRO . 41.8 p90 -138.28 163.93 30.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.834 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.51 ' CG ' ' HB2' ' A' ' 97' ' ' ASP . 1.8 mt-10 -55.55 135.76 70.73 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.901 . . . . 0.0 108.655 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.482 ' HB3' ' CB ' ' A' ' 145' ' ' SER . 36.2 Cg_endo -78.73 111.39 2.97 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.393 2.062 . . . . 0.0 111.238 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 113' ' ' GLU . 35.8 Cg_endo -78.4 -166.7 0.42 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.37 2.047 . . . . 0.0 108.912 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.556 ' CB ' ' HA ' ' A' ' 14' ' ' THR . . . -170.35 22.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.659 -1.276 . . . . 0.0 111.162 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.587 ' CG1' ' CB ' ' A' ' 15' ' ' ALA . 6.8 m -80.49 -170.83 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.797 -1.189 . . . . 0.0 108.647 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.474 ' O ' ' HB ' ' A' ' 166' ' ' THR . 43.9 m -69.73 58.88 0.14 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.973 -1.08 . . . . 0.0 108.873 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.586 ' CG2' ' CG2' ' A' ' 117' ' ' VAL . 2.7 t -87.56 111.2 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 0.0 109.963 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.456 ' NE ' ' HG2' ' A' ' 168' ' ' ARG . 0.3 OUTLIER -74.48 -41.38 60.84 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.045 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.543 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 1.2 p90 -166.81 158.34 12.72 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.393 -0.817 . . . . 0.0 109.364 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.518 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 11.5 m-85 -103.18 135.86 44.05 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.521 ' CB ' ' HB2' ' A' ' 163' ' ' TYR . 3.2 ttp-105 -90.98 82.85 5.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.997 -1.064 . . . . 0.0 109.889 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.642 ' CG2' ' CE2' ' A' ' 138' ' ' PHE . 78.9 mt -83.6 143.64 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 3.2 p -136.76 152.69 50.61 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.931 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.643 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 2.4 m-85 -86.21 134.84 33.75 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.607 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -106.19 119.49 6.04 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.505 ' O ' ' C ' ' A' ' 129' ' ' THR . 2.8 mt-10 -101.08 154.05 19.04 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.19 -1.182 . . . . 0.0 109.133 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.574 ' CG2' ' CB ' ' A' ' 156' ' ' ALA . 1.1 p -33.64 -47.9 0.25 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.302 0.573 . . . . 0.0 109.95 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 131' ' ' GLY . . . -94.8 -96.43 1.66 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 130' ' ' GLY . . . 45.44 76.55 0.12 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.489 ' O ' ' CB ' ' A' ' 133' ' ' SER . 8.4 t-20 -84.32 15.51 3.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.326 -1.102 . . . . 0.0 109.631 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.542 ' CB ' ' HD3' ' A' ' 134' ' ' PRO . 0.1 OUTLIER 166.3 -53.42 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.152 -0.967 . . . . 0.0 109.617 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.542 ' HD3' ' CB ' ' A' ' 133' ' ' SER . 36.1 Cg_endo -78.69 85.46 1.84 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.458 2.105 . . . . 0.0 110.597 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 126' ' ' TYR . 0.1 OUTLIER -108.09 -164.18 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 109.036 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.546 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 0.4 OUTLIER -104.28 91.84 4.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.05 -1.031 . . . . 0.0 109.042 179.704 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 1.6 tm-20 -89.05 117.44 28.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.833 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.642 ' CE2' ' CG2' ' A' ' 124' ' ' ILE . 25.5 p90 -118.28 136.74 53.51 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.505 HG23 ' CE1' ' A' ' 121' ' ' TYR . 4.6 p -74.01 172.15 12.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.13 -0.981 . . . . 0.0 110.331 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.589 ' CG2' ' CD1' ' A' ' 124' ' ' ILE . 25.3 t -142.85 139.16 16.68 Favored Pre-proline 0 C--N 1.302 -1.464 0 O-C-N 121.494 -0.754 . . . . 0.0 109.884 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.449 ' HD2' HG12 ' A' ' 140' ' ' VAL . 35.4 Cg_endo -78.35 144.32 20.38 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.411 2.074 . . . . 0.0 109.943 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.27 40.87 3.06 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.9 m -105.45 -1.21 25.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -1.168 . . . . 0.0 109.847 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.3 158.6 39.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.976 . . . . 0.0 109.835 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.575 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -95.42 8.19 43.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.388 -0.82 . . . . 0.0 109.714 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.562 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 54.7 p -133.39 147.55 51.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.193 -0.942 . . . . 0.0 109.442 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.495 ' N ' ' CH2' ' A' ' 112' ' ' TRP . . . -132.63 173.16 11.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.142 -0.974 . . . . 0.0 109.459 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.4 ' C ' ' CD1' ' A' ' 149' ' ' ILE . 1.9 t -125.77 138.88 53.87 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.188 -0.945 . . . . 0.0 109.698 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.643 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 1.0 OUTLIER -113.09 83.68 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.52 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 3.6 m-20 -92.96 175.23 6.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.313 -0.867 . . . . 0.0 110.153 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 151' ' ' ASN . 1.1 m120 70.21 30.46 3.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 108.912 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.571 HG13 ' CE2' ' A' ' 158' ' ' TYR . 9.4 tt -89.33 163.92 2.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.489 -0.757 . . . . 0.0 109.731 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -107.36 121.53 44.17 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.331 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.13 146.68 22.91 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.382 2.055 . . . . 0.0 110.507 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.485 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . 87.37 65.57 1.36 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.574 ' CB ' ' CG2' ' A' ' 129' ' ' THR . . . 164.23 130.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -1.149 . . . . 0.0 109.631 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.508 ' N ' HG21 ' A' ' 129' ' ' THR . 32.9 t70 -48.64 163.58 0.07 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.097 -1.002 . . . . 0.0 108.495 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.607 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -147.08 -176.11 5.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.823 -1.173 . . . . 0.0 110.147 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.51 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 4.8 m -163.69 115.55 1.42 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.458 HD13 HD13 ' A' ' 108' ' ' LEU . 39.5 mm -100.06 129.34 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.737 -1.227 . . . . 0.0 109.83 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.586 ' CG2' ' CB ' ' A' ' 179' ' ' SER . 2.0 m -136.78 168.32 19.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.206 -0.933 . . . . 0.0 109.766 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 124' ' ' ILE . 0.5 OUTLIER -158.64 147.3 18.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.044 -1.035 . . . . 0.0 111.304 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.649 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 23.0 m-85 -121.15 105.86 10.99 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -70.64 93.7 0.95 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.911 -1.118 . . . . 0.0 109.158 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.527 ' HA ' ' CB ' ' A' ' 174' ' ' SER . 2.4 t -78.56 130.73 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 109.896 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.533 ' CG2' ' HA ' ' A' ' 119' ' ' VAL . 33.2 p -122.87 -59.6 1.58 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.502 -0.749 . . . . 0.0 109.575 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.519 ' O ' ' CG ' ' A' ' 168' ' ' ARG . . . -53.82 178.33 0.19 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.519 ' CG ' ' O ' ' A' ' 167' ' ' GLY . 14.8 mtm180 -159.43 111.91 2.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.326 -1.102 . . . . 0.0 109.415 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 160.99 -149.61 18.79 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -78.49 1.44 22.31 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.347 -1.09 . . . . 0.0 109.534 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.45 ' N ' ' HD3' ' A' ' 172' ' ' PRO . 0.7 OUTLIER -150.27 65.22 7.17 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.909 . . . . 0.0 109.392 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 171' ' ' SER . 35.5 Cg_endo -77.9 103.87 1.77 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.63 2.22 . . . . 0.0 110.394 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -87.72 132.18 34.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.343 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.527 ' CB ' ' HA ' ' A' ' 165' ' ' VAL . 44.3 p -112.53 62.39 0.63 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.56 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 174' ' ' SER . 33.7 p 42.0 -164.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.587 ' CG ' ' CD1' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -86.58 148.51 46.61 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 120.993 -1.067 . . . . 0.0 108.559 179.276 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.649 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 31.3 Cg_endo -73.54 119.3 5.87 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.143 1.895 . . . . 0.0 111.058 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.438 HG13 HD21 ' A' ' 98' ' ' LEU . 2.1 t -107.85 124.33 63.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.586 ' CB ' ' CG2' ' A' ' 161' ' ' THR . 1.1 p -127.89 176.87 7.25 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.346 -0.846 . . . . 0.0 111.032 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.467 HG12 HD22 ' A' ' 98' ' ' LEU . 11.4 pt -157.31 152.02 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -85.78 158.58 19.97 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.926 -1.109 . . . . 0.0 109.674 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.6 ' CE1' HD23 ' A' ' 108' ' ' LEU . 47.0 t80 -158.25 127.69 5.79 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.358 -0.839 . . . . 0.0 109.328 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -101.86 128.52 48.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 109.527 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.564 HG23 ' CD1' ' A' ' 158' ' ' TYR . 7.5 p . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.505 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.471 ' HB2' ' OG ' ' A' ' 81' ' ' SER . 1.8 mt -129.31 -162.81 1.23 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -1.136 . . . . 0.0 109.325 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -106.33 153.22 22.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.473 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.525 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 0.3 OUTLIER -95.33 132.32 28.02 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.763 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.479 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 36.1 Cg_endo -79.54 102.13 1.46 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.515 2.143 . . . . 0.0 109.968 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.485 ' CG2' HD12 ' A' ' 84' ' ' LEU . 1.4 p -95.58 -110.58 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 109.792 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.458 ' HA3' ' HB ' ' A' ' 23' ' ' VAL . . . 44.3 27.39 1.17 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.583 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 28.2 t80 -51.54 124.5 12.28 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.55 -0.971 . . . . 0.0 110.011 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 0.7 OUTLIER -153.21 87.78 1.28 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 92.7 p -84.29 124.59 31.4 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 109.648 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 12' ' ' ASP . 13.2 p -153.55 -159.34 0.97 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.397 -0.814 . . . . 0.0 109.05 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.476 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 1.1 m-20 45.88 40.12 6.26 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.617 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 2.7 mt -85.14 131.76 33.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.721 0.772 . . . . 0.0 111.284 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.527 ' CA ' HG22 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -115.62 -167.13 1.21 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.161 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.52 ' HB1' ' CG1' ' A' ' 117' ' ' VAL . . . -78.48 -70.57 0.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.935 -1.103 . . . . 0.0 109.794 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 52.4 m-20 -83.06 14.21 3.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.127 -0.983 . . . . 0.0 110.156 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 14' ' ' THR . 1.6 t -165.35 156.46 14.21 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.104 -0.998 . . . . 0.0 109.085 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.619 ' CE2' ' NE2' ' A' ' 88' ' ' GLN . 4.7 p90 -164.32 145.33 8.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.162 -0.962 . . . . 0.0 109.112 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.476 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 3.8 m -89.24 149.69 22.97 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.815 -1.178 . . . . 0.0 111.441 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.554 HG21 ' CE1' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -130.37 114.17 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.938 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 9' ' ' ASP . 4.4 m-70 -96.42 170.91 8.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.995 -1.066 . . . . 0.0 110.748 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.49 ' CD1' ' O ' ' A' ' 22' ' ' TRP . 21.0 p90 178.23 136.43 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.48 164.85 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.011 -1.056 . . . . 0.0 109.789 -179.693 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.467 ' HB3' ' OH ' ' A' ' 32' ' ' TYR . . . -97.53 167.3 12.05 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.71 -0.619 . . . . 0.0 109.595 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.469 ' HD3' ' HB3' ' A' ' 5' ' ' PRO . 36.3 Cg_endo -79.32 -159.28 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.607 2.205 . . . . 0.0 110.294 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -126.24 16.68 7.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.298 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.525 ' CB ' ' HD2' ' A' ' 28' ' ' PRO . . . -117.75 176.08 1.77 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.324 -0.86 . . . . 0.0 109.424 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 35.5 Cg_endo -78.16 136.57 14.61 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.635 2.224 . . . . 0.0 110.457 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.643 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 27.5 pt -150.06 -179.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.331 -0.856 . . . . 0.0 109.406 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.2 p -120.81 4.53 10.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.583 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.96 173.37 17.15 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.643 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 16.6 m-85 -118.71 123.65 45.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -1.174 . . . . 0.0 109.634 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.523 ' CD1' HG23 ' A' ' 75' ' ' VAL . 1.7 mp -79.69 135.18 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.215 -0.928 . . . . 0.0 108.768 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.495 ' N ' ' O ' ' A' ' 48' ' ' ASP . 2.9 mm -115.47 107.02 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.069 -1.019 . . . . 0.0 110.064 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.464 ' O ' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -109.18 117.02 33.03 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.62 ' CE1' ' CD2' ' A' ' 59' ' ' LEU . 51.2 p-80 -126.83 176.19 7.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.009 -1.057 . . . . 0.0 110.682 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 38' ' ' ALA . 42.4 p-80 175.18 145.48 0.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.578 ' HA ' ' CD2' ' A' ' 68' ' ' TYR . . . -41.57 163.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.22 -0.925 . . . . 0.0 109.617 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.529 ' HG2' ' CA ' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -82.55 -8.23 59.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.08 -1.012 . . . . 0.0 109.567 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.42 36.17 3.88 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.329 -0.857 . . . . 0.0 109.56 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.4 p -154.97 92.28 1.44 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.51 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.473 ' CG1' ' O ' ' A' ' 42' ' ' VAL . 79.6 t -87.81 6.48 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 109.486 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.456 ' O ' ' HD3' ' A' ' 45' ' ' PRO . . . -76.32 -160.56 10.23 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 43' ' ' GLY . 17.2 mtt85 -42.32 102.38 0.27 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.379 -1.071 . . . . 0.0 109.588 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 35.6 Cg_endo -78.1 161.42 29.51 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.451 2.101 . . . . 0.0 110.308 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.572 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -73.96 149.51 41.32 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.134 -0.979 . . . . 0.0 109.53 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.46 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -120.95 122.63 40.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.464 -0.772 . . . . 0.0 110.076 -179.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 34' ' ' ILE . 63.2 m-20 -144.54 120.04 10.36 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.452 ' HD2' HG21 ' A' ' 33' ' ' ILE . 5.1 mmt-85 -104.09 152.23 22.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.971 -1.081 . . . . 0.0 110.23 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.498 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 10.7 m -128.02 161.29 56.82 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.533 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 33.7 Cg_endo -76.36 174.13 13.34 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.358 2.039 . . . . 0.0 110.34 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.544 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 35.2 Cg_endo -77.07 -15.46 16.33 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.582 2.188 . . . . 0.0 110.604 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.2 t -101.97 17.84 22.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 0.0 109.652 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.533 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.5 OUTLIER -122.77 100.78 7.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.19 -0.944 . . . . 0.0 109.914 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -84.85 -3.0 58.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.14 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 56.5 p -137.52 149.02 46.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.432 -0.793 . . . . 0.0 109.031 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 5.2 tt -136.44 125.95 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.075 -1.016 . . . . 0.0 109.746 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.29 107.4 19.04 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.408 -0.807 . . . . 0.0 109.269 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.62 ' CD2' ' CE1' ' A' ' 36' ' ' HIS . 1.0 OUTLIER -84.91 152.02 23.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.533 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.45 ' HA ' ' HB2' ' A' ' 17' ' ' SER . 29.2 p -137.98 -177.49 4.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.467 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.3 m120 55.7 29.67 14.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.356 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.49 ' CD1' ' HB3' ' A' ' 59' ' ' LEU . 5.1 mt -107.53 136.26 47.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 0.0 109.403 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.516 ' CB ' ' OH ' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -44.76 126.61 5.13 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.147 -0.97 . . . . 0.0 108.868 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.491 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 35.9 Cg_endo -77.42 131.41 11.59 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.29 1.994 . . . . 0.0 110.852 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 78.25 61.35 2.51 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.585 HG23 ' CE1' ' A' ' 68' ' ' TYR . 13.2 m -157.16 165.79 35.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.258 -1.142 . . . . 0.0 109.93 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.535 ' N ' ' CG2' ' A' ' 66' ' ' THR . 1.8 mp0 -115.33 132.64 56.55 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.445 -0.784 . . . . 0.0 109.174 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.608 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 1.2 m-85 -130.57 173.83 10.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.93 . . . . 0.0 109.377 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.447 ' CG2' ' HA ' ' A' ' 39' ' ' GLU . 8.4 t -112.82 114.9 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.465 HG22 ' HG2' ' A' ' 88' ' ' GLN . 4.5 t -96.99 138.49 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.09 -1.006 . . . . 0.0 110.067 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.528 ' CB ' HG12 ' A' ' 85' ' ' ILE . 14.5 p -119.56 138.74 53.0 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.296 -0.878 . . . . 0.0 110.233 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 13.2 mm -111.78 95.11 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.397 -0.815 . . . . 0.0 109.397 179.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.582 ' N ' ' CD1' ' A' ' 73' ' ' ILE . 1.3 mp -85.24 122.84 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.339 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.459 ' HB2' ' HB2' ' A' ' 81' ' ' SER . . . -97.34 137.62 36.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.924 . . . . 0.0 109.368 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.523 HG23 ' CD1' ' A' ' 33' ' ' ILE . 4.6 m -140.78 171.82 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.905 . . . . 0.0 109.471 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.441 ' OD1' ' HA ' ' A' ' 29' ' ' ILE . 49.2 t30 -146.39 43.23 1.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.915 . . . . 0.0 109.439 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 112.31 -87.03 0.44 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.04 -8.25 10.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -1.141 . . . . 0.0 109.625 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -84.81 -167.21 1.72 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.382 -0.824 . . . . 0.0 109.276 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.46 ' HG2' HG11 ' A' ' 75' ' ' VAL . 16.2 mt-10 -159.4 131.14 6.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.188 -0.945 . . . . 0.0 109.929 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.565 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -98.62 -178.33 0.69 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.393 -0.817 . . . . 0.0 108.882 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.565 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.4 Cg_endo -77.34 131.21 11.52 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.118 1.879 . . . . 0.0 109.908 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.46 ' HB3' HG13 ' A' ' 73' ' ' ILE . 35.7 Cg_endo -77.75 115.48 3.84 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.491 2.127 . . . . 0.0 111.117 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.485 HD12 ' CG2' ' A' ' 6' ' ' THR . 0.7 OUTLIER -88.53 106.5 18.33 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.187 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.528 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.8 mt -95.48 146.4 7.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.116 -0.99 . . . . 0.0 110.105 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.583 ' HA3' ' CZ ' ' A' ' 8' ' ' PHE . . . -142.75 161.37 27.46 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 108.134 -1.987 . . . . 0.0 108.134 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.463 ' HG2' ' N ' ' A' ' 88' ' ' GLN . 5.8 tt0 -102.05 148.38 25.45 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.18 -1.188 . . . . 0.0 110.028 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.619 ' NE2' ' CE2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -149.82 -176.35 5.39 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.517 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -160.2 134.61 7.49 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 109.969 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.5 143.36 36.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.358 -0.839 . . . . 0.0 109.019 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.527 HG22 ' CA ' ' A' ' 14' ' ' THR . 2.0 t -64.13 163.17 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.512 -0.743 . . . . 0.0 109.888 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.0 t -69.33 169.06 13.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.383 -0.823 . . . . 0.0 109.699 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' A' ' 64' ' ' PRO . 1.4 p30 -115.07 -34.96 4.87 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.728 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.509 HG22 ' HD2' ' A' ' 95' ' ' PRO . 1.6 mt -83.96 143.08 42.44 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.136 -0.978 . . . . 0.0 109.486 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.519 ' HB2' ' CD1' ' A' ' 112' ' ' TRP . 36.0 Cg_endo -79.54 81.98 2.63 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.652 2.235 . . . . 0.0 110.162 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.56 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 4.2 ttt180 -66.62 170.71 5.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.319 -0.863 . . . . 0.0 109.813 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 1.1 t0 81.87 34.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.736 . . . . 0.0 110.113 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.506 ' CD2' HD22 ' A' ' 162' ' ' LEU . 21.8 tp -76.46 101.56 5.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.134 -0.979 . . . . 0.0 109.288 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -151.85 -175.24 5.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 109.077 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 47.8 t -119.23 149.37 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.0 -1.063 . . . . 0.0 110.164 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.536 HG12 ' CD2' ' A' ' 109' ' ' LEU . 6.9 pt -119.6 -17.14 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.737 0.779 . . . . 0.0 109.356 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' A' ' 109' ' ' LEU . . . -150.84 142.12 23.27 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.532 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 51.5 p -150.49 132.09 14.85 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.695 -1.253 . . . . 0.0 111.299 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.552 ' HB ' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -98.02 171.38 5.94 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.527 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.552 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 29.9 Cg_endo -69.66 -1.05 7.73 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.918 1.746 . . . . 0.0 110.63 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.503 ' HA ' HG21 ' A' ' 152' ' ' ILE . 19.2 p -143.02 8.23 1.65 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.194 -0.941 . . . . 0.0 109.655 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' A' ' 149' ' ' ILE . 2.9 p -164.33 149.68 10.32 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.819 -1.152 . . . . 0.0 109.96 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.575 HD21 ' CZ ' ' A' ' 182' ' ' TYR . 0.9 OUTLIER -123.69 156.33 36.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.909 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.536 ' CD2' HG12 ' A' ' 101' ' ' ILE . 11.1 tp -105.27 108.81 20.52 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.518 ' CD1' ' HB1' ' A' ' 147' ' ' ALA . 3.1 pt -92.26 150.04 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.237 -0.914 . . . . 0.0 109.998 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.456 ' HA ' ' HA ' ' A' ' 146' ' ' THR . 31.8 m -148.36 135.82 20.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.421 -0.799 . . . . 0.0 109.325 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.571 ' CD2' ' O ' ' A' ' 145' ' ' SER . 14.4 p90 -135.68 159.06 42.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 109.42 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -65.32 142.19 98.37 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.068 -1.02 . . . . 0.0 109.315 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.65 119.15 4.35 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.575 2.183 . . . . 0.0 110.484 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.419 ' HB2' HG21 ' A' ' 117' ' ' VAL . 35.8 Cg_endo -78.1 148.93 24.97 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.422 2.081 . . . . 0.0 110.328 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.522 ' O ' ' CG2' ' A' ' 14' ' ' THR . . . -80.49 57.16 2.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 109.579 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.52 ' CG1' ' HB1' ' A' ' 15' ' ' ALA . 25.9 m -142.67 164.5 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.851 . . . . 0.0 109.459 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.4 m -92.18 93.86 8.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.445 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.475 HG13 ' CE2' ' A' ' 122' ' ' TYR . 1.9 t -93.69 144.71 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 109.598 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.531 ' CG ' ' O ' ' A' ' 166' ' ' THR . 2.4 mmt85 -95.44 -37.89 10.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 108.76 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.573 ' CE2' ' HB ' ' A' ' 165' ' ' VAL . 1.9 p90 -163.98 175.32 10.44 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.291 -0.88 . . . . 0.0 109.509 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.621 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 2.2 m-85 -136.63 131.59 33.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -0.871 . . . . 0.0 109.097 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.497 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 4.6 ttt180 -84.69 154.4 22.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.019 -1.05 . . . . 0.0 108.541 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.612 ' HB ' ' CE2' ' A' ' 138' ' ' PHE . 17.6 mt -151.03 138.82 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.006 -1.059 . . . . 0.0 110.394 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 136' ' ' GLN . 2.2 p -106.28 141.77 37.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.607 -0.683 . . . . 0.0 109.721 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.571 ' CZ ' HG21 ' A' ' 149' ' ' ILE . 1.6 m-85 -88.26 118.83 28.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.369 -0.832 . . . . 0.0 108.758 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.624 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.8 113.73 4.3 Favored Glycine 0 N--CA 1.487 2.073 0 C-N-CA 119.607 -1.282 . . . . 0.0 111.217 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.479 ' O ' ' C ' ' A' ' 129' ' ' THR . 25.4 mt-10 -90.21 175.35 7.17 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.173 -1.192 . . . . 0.0 108.384 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.552 ' CG2' ' N ' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -36.11 -93.04 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.603 -0.685 . . . . 0.0 110.517 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 153.06 97.18 0.14 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.411 ' C ' ' OD1' ' A' ' 132' ' ' ASN . . . -148.07 -39.15 0.04 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.417 ' N ' ' OD1' ' A' ' 132' ' ' ASN . 0.8 OUTLIER -171.01 57.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -1.162 . . . . 0.0 109.584 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -173.64 142.92 0.96 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 109.449 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.73 -161.64 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.597 2.198 . . . . 0.0 110.415 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.554 ' CG1' ' N ' ' A' ' 136' ' ' GLN . 0.3 OUTLIER -90.4 -166.28 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 122.098 0.952 . . . . 0.0 109.36 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.562 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 0.7 OUTLIER -135.79 -166.95 1.94 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.373 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.49 ' HG3' ' CG2' ' A' ' 125' ' ' THR . 0.1 OUTLIER -156.71 152.16 26.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.144 -1.598 . . . . 0.0 111.702 -179.506 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.612 ' CE2' ' HB ' ' A' ' 124' ' ' ILE . 11.7 p90 -165.11 134.73 3.6 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.7 p -74.57 171.85 13.09 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.175 -0.953 . . . . 0.0 110.944 -178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.53 HG23 ' CD1' ' A' ' 124' ' ' ILE . 28.5 t -131.83 140.53 38.52 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.52 -0.738 . . . . 0.0 109.542 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.454 ' HD2' HG12 ' A' ' 140' ' ' VAL . 35.5 Cg_endo -77.99 125.47 7.31 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.428 2.086 . . . . 0.0 109.919 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.32 51.65 3.31 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.418 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 16.0 p -105.5 -4.71 20.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.194 -1.18 . . . . 0.0 109.551 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.418 ' CG ' ' O ' ' A' ' 143' ' ' SER . 0.6 OUTLIER -173.55 178.21 2.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.513 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.571 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 0.3 OUTLIER -95.12 15.33 19.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.584 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.531 ' C ' ' CH2' ' A' ' 112' ' ' TRP . 2.1 p -123.52 146.15 48.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.465 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.518 ' HB1' ' CD1' ' A' ' 110' ' ' ILE . . . -133.12 167.19 20.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.246 -0.909 . . . . 0.0 109.461 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.518 HG23 ' N ' ' A' ' 149' ' ' ILE . 14.0 m -108.49 164.07 12.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 109.465 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.571 HG21 ' CZ ' ' A' ' 126' ' ' TYR . 11.7 mm -143.24 66.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.0 109.335 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.544 ' HA ' ' CB ' ' A' ' 107' ' ' SER . 4.3 m120 -78.28 -167.51 1.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.692 -0.63 . . . . 0.0 109.814 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 50.92 42.0 27.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.081 -1.012 . . . . 0.0 109.053 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.608 HG13 ' CE2' ' A' ' 158' ' ' TYR . 4.4 tt -106.18 160.03 5.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.422 -0.799 . . . . 0.0 109.915 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -93.58 125.22 54.63 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 109.17 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.467 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 35.8 Cg_endo -78.73 140.25 16.36 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.436 2.091 . . . . 0.0 110.859 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 75.09 63.23 2.58 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.452 ' N ' ' OG1' ' A' ' 184' ' ' THR . . . 178.13 127.2 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.174 -1.192 . . . . 0.0 110.147 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.552 ' N ' ' CG2' ' A' ' 129' ' ' THR . 9.7 t70 -48.58 167.94 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.624 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.4 OUTLIER -146.6 -167.88 2.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.973 -1.079 . . . . 0.0 109.991 -179.544 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.515 ' N ' ' O ' ' A' ' 127' ' ' GLY . 4.4 m -168.41 96.39 0.4 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 7.1 mt -91.86 133.01 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.049 -1.032 . . . . 0.0 110.05 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.565 ' CG2' ' CB ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -131.27 159.91 36.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.329 -0.857 . . . . 0.0 108.764 179.311 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 124' ' ' ILE . 1.7 pp -150.82 150.08 30.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.734 -1.229 . . . . 0.0 111.714 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.627 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.3 m-85 -125.99 79.59 1.85 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -43.92 125.69 4.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.976 -1.077 . . . . 0.0 109.322 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.573 ' HB ' ' CE2' ' A' ' 121' ' ' TYR . 55.2 t -113.16 135.66 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 110.079 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.531 ' O ' ' CG ' ' A' ' 120' ' ' ARG . 0.7 OUTLIER -105.96 -38.65 6.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.532 -0.73 . . . . 0.0 109.383 179.673 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -82.29 150.49 28.78 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -150.88 140.71 21.86 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.192 -1.181 . . . . 0.0 109.523 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 134.66 -72.87 0.46 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' A' ' 171' ' ' SER . 0.2 OUTLIER -146.94 42.13 1.12 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -1.138 . . . . 0.0 109.382 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 0.9 OUTLIER 163.73 69.88 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.316 -0.865 . . . . 0.0 109.291 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.448 ' CB ' HG12 ' A' ' 165' ' ' VAL . 35.8 Cg_endo -77.87 102.5 1.59 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.639 2.226 . . . . 0.0 110.515 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 165' ' ' VAL . . . -84.82 175.83 8.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.187 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 84.5 p -164.61 127.82 2.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.145 -0.972 . . . . 0.0 109.706 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.471 ' HB2' HG12 ' A' ' 94' ' ' ILE . 3.0 p -54.12 174.86 0.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.301 -0.874 . . . . 0.0 109.217 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.486 ' CB ' HD12 ' A' ' 94' ' ' ILE . 1.4 mmtp -45.81 136.87 6.06 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.16 -0.963 . . . . 0.0 108.618 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.627 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.2 Cg_endo -77.39 144.94 23.38 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.267 1.978 . . . . 0.0 110.885 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.458 HG13 HD21 ' A' ' 98' ' ' LEU . 3.1 t -120.62 130.79 74.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.565 ' CB ' ' CG2' ' A' ' 161' ' ' THR . 0.9 OUTLIER -122.84 158.32 30.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 110.704 -178.617 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.473 HG22 ' O ' ' A' ' 98' ' ' LEU . 29.3 pt -146.7 153.12 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.476 ' HA ' ' HA ' ' A' ' 159' ' ' THR . 73.7 m-80 -93.15 153.98 18.33 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.035 -1.041 . . . . 0.0 109.41 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.575 ' CZ ' HD21 ' A' ' 108' ' ' LEU . 92.1 t80 -141.81 123.9 15.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.282 -0.886 . . . . 0.0 109.721 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.465 ' HA ' ' HA ' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -87.69 111.45 21.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.066 -1.021 . . . . 0.0 109.477 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.47 HG23 ' CD2' ' A' ' 182' ' ' TYR . 21.9 p . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.485 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.514 ' CD1' ' HB3' ' A' ' 81' ' ' SER . 2.6 mp -127.67 -162.59 1.18 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.243 -1.151 . . . . 0.0 109.511 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.49 ' HB2' ' CB ' ' A' ' 25' ' ' PRO . 1.3 m-20 -108.37 164.41 12.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.0 109.526 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.5 m -95.41 120.3 64.01 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.486 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.522 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 35.6 Cg_endo -78.41 95.56 1.07 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.394 2.063 . . . . 0.0 110.296 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.429 ' O ' ' C ' ' A' ' 7' ' ' GLY . 1.2 p -85.02 -107.72 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.959 . . . . 0.0 109.614 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 43.7 29.24 1.26 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.579 ' CE2' ' HA3' ' A' ' 86' ' ' GLY . 20.5 t80 -53.08 129.92 32.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.399 -1.059 . . . . 0.0 110.166 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 21' ' ' HIS . 1.9 t70 -165.29 134.2 3.36 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.514 ' CB ' ' HG2' ' A' ' 88' ' ' GLN . 4.7 m -118.19 139.38 51.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.923 -1.11 . . . . 0.0 110.276 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.481 ' O ' ' C ' ' A' ' 12' ' ' ASP . 8.9 p -153.43 -169.38 3.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.435 -0.791 . . . . 0.0 109.2 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.524 ' CB ' ' OG1' ' A' ' 19' ' ' THR . 0.8 OUTLIER 41.39 46.93 3.01 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.047 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.557 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 41.5 mm -77.67 130.73 35.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.622 0.725 . . . . 0.0 111.349 -178.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.572 ' CB ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -119.67 176.81 5.2 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.183 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.575 ' CB ' HG12 ' A' ' 117' ' ' VAL . . . -71.01 -70.03 0.33 Allowed 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.528 -1.358 . . . . 0.0 109.559 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 50.2 m-80 -81.2 -6.84 59.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.056 -1.027 . . . . 0.0 109.362 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.572 ' O ' ' CB ' ' A' ' 14' ' ' THR . 3.4 t -137.42 158.01 45.33 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.591 ' CE1' ' HG3' ' A' ' 88' ' ' GLN . 2.2 p90 -167.76 139.88 3.11 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.991 -1.068 . . . . 0.0 108.494 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.524 ' OG1' ' CB ' ' A' ' 12' ' ' ASP . 23.0 m -84.48 154.88 22.46 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.785 -1.197 . . . . 0.0 110.898 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.576 HG21 ' CE1' ' A' ' 18' ' ' PHE . 1.5 t -128.6 177.76 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' A' ' 20' ' ' VAL . 55.6 m-70 -156.2 163.64 39.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.017 -1.052 . . . . 0.0 110.158 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . . . . . . . . . 46.0 p90 179.87 142.94 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.447 -0.783 . . . . 0.0 109.239 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.537 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.43 169.79 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.113 -0.992 . . . . 0.0 109.145 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.537 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -102.38 165.89 13.0 Favored Pre-proline 0 C--N 1.299 -1.606 0 O-C-N 121.504 -0.747 . . . . 0.0 109.794 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.49 ' CB ' ' HB2' ' A' ' 3' ' ' ASP . 35.7 Cg_endo -78.26 -164.7 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.672 2.248 . . . . 0.0 110.38 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 -115.31 26.5 10.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.37 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -134.41 169.75 13.06 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.29 -0.881 . . . . 0.0 109.383 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.78 136.62 15.3 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.612 2.208 . . . . 0.0 110.356 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.625 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 16.3 pt -145.52 -171.52 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.493 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 77' ' ' GLY . 60.5 p -126.56 6.38 6.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.87 . . . . 0.0 109.527 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.416 ' HA2' ' C ' ' A' ' 51' ' ' PRO . . . 139.8 172.92 12.96 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.625 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -123.76 125.26 44.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -1.165 . . . . 0.0 109.543 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.528 HG12 ' CG2' ' A' ' 75' ' ' VAL . 16.1 mm -74.8 120.51 24.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.231 -0.918 . . . . 0.0 109.289 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.513 ' N ' HD11 ' A' ' 34' ' ' ILE . 2.3 mm -99.26 129.74 49.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.169 -0.957 . . . . 0.0 109.393 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.469 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 58.2 ttt180 -118.9 119.57 34.74 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.264 -0.898 . . . . 0.0 109.115 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.645 ' NE2' ' CG ' ' A' ' 68' ' ' TYR . 0.3 OUTLIER -93.46 149.14 21.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.32 -0.863 . . . . 0.0 109.472 -179.552 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.519 ' CB ' ' HB3' ' A' ' 45' ' ' PRO . 44.3 p-80 178.27 133.64 0.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.54 -0.725 . . . . 0.0 109.408 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -56.65 -165.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.262 -0.899 . . . . 0.0 109.802 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -95.37 -99.45 0.16 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 109.655 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -74.53 -1.05 19.67 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.232 -0.917 . . . . 0.0 109.72 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.491 ' OG ' ' CB ' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -97.85 91.54 5.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.197 -0.94 . . . . 0.0 109.342 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 t -75.09 55.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.511 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.91 -114.94 0.03 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.0 mtm-85 -120.07 98.64 49.07 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.239 -1.154 . . . . 0.0 109.536 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.519 ' HB3' ' CB ' ' A' ' 37' ' ' HIS . 35.6 Cg_endo -77.65 125.33 7.45 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.581 2.187 . . . . 0.0 110.339 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.456 ' HD2' HD21 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -90.05 177.42 6.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 0.0 109.75 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -132.47 111.12 11.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.632 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.488 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 0.8 OUTLIER -116.31 125.05 51.61 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.307 -0.87 . . . . 0.0 108.794 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.545 ' CD ' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -104.31 160.64 14.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.119 -0.988 . . . . 0.0 109.847 -179.087 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.52 ' CG1' HD13 ' A' ' 57' ' ' ILE . 3.7 m -142.51 159.93 55.94 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.42 -0.8 . . . . 0.0 109.298 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.527 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 33.7 Cg_endo -76.37 174.27 13.11 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.484 2.123 . . . . 0.0 110.224 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.575 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.9 Cg_endo -76.81 -25.8 8.77 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.62 2.213 . . . . 0.0 111.07 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.8 p -89.35 -3.0 58.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.098 -1.002 . . . . 0.0 109.666 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.527 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -101.02 111.69 23.95 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.281 -0.887 . . . . 0.0 110.137 -179.54 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.487 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 40.6 p-10 -92.92 -8.82 42.18 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.446 -0.784 . . . . 0.0 109.084 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 18.2 p -124.3 150.51 45.33 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.52 HD13 ' CG1' ' A' ' 50' ' ' VAL . 4.6 tt -134.92 133.16 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.926 -1.109 . . . . 0.0 110.295 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.95 102.7 14.53 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.519 ' HB3' ' CD1' ' A' ' 62' ' ' LEU . 1.0 OUTLIER -84.47 156.89 21.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.16 -0.963 . . . . 0.0 109.763 -179.532 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.471 ' HA ' ' HB2' ' A' ' 17' ' ' SER . 33.0 p -143.12 -179.65 6.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.403 -0.811 . . . . 0.0 109.35 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.451 ' O ' ' CZ ' ' A' ' 46' ' ' ARG . 17.5 m-80 55.28 19.26 2.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 109.395 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.519 ' CD1' ' HB3' ' A' ' 59' ' ' LEU . 4.9 mt -91.62 168.03 11.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 0.0 109.332 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.53 ' CB ' ' OH ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER -77.38 130.98 72.87 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.154 -0.966 . . . . 0.0 108.576 179.404 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.528 ' HB3' ' CB ' ' A' ' 15' ' ' ALA . 36.6 Cg_endo -78.84 133.87 11.6 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.371 2.048 . . . . 0.0 111.566 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 73.57 62.76 2.94 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.641 ' CG2' ' CZ ' ' A' ' 68' ' ' TYR . 3.3 m -159.22 145.73 16.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.179 -1.189 . . . . 0.0 110.698 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 1.4 mt-10 -87.66 99.24 11.92 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.645 ' CG ' ' NE2' ' A' ' 36' ' ' HIS . 29.1 m-85 -103.46 119.68 39.36 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.191 -0.943 . . . . 0.0 110.284 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.51 ' O ' ' ND1' ' A' ' 37' ' ' HIS . 20.7 t -68.99 117.82 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.423 -0.798 . . . . 0.0 109.25 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.3 t -96.25 109.99 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.088 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -84.49 110.11 18.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.947 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.489 ' O ' ' CA ' ' A' ' 83' ' ' PRO . 15.5 mm -79.98 120.58 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.398 -0.814 . . . . 0.0 109.653 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.56 ' N ' ' CD1' ' A' ' 73' ' ' ILE . 1.3 mp -112.59 144.12 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.04 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.463 ' HB2' ' OG ' ' A' ' 81' ' ' SER . . . -104.43 128.69 52.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.415 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.528 ' CG2' HG12 ' A' ' 33' ' ' ILE . 16.9 m -133.55 130.56 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.47 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.417 ' ND2' ' HA ' ' A' ' 29' ' ' ILE . 3.1 t-20 -99.82 44.6 1.01 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.284 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.515 ' N ' ' OG1' ' A' ' 30' ' ' THR . . . 95.42 -63.32 1.39 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.02 3.22 3.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -1.141 . . . . 0.0 109.59 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -103.05 -164.39 1.07 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.437 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.413 ' C ' ' OG ' ' A' ' 81' ' ' SER . 32.8 mt-10 -144.13 -169.21 3.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.8 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.574 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -176.58 -178.8 0.31 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 109.066 -179.563 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.574 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.8 Cg_endo -77.08 116.13 4.13 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.212 1.941 . . . . 0.0 109.929 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.489 ' CA ' ' O ' ' A' ' 72' ' ' ILE . 36.2 Cg_endo -78.27 146.9 22.7 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.585 2.19 . . . . 0.0 111.272 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.455 HD21 ' O ' ' A' ' 5' ' ' PRO . 0.7 OUTLIER -108.97 107.74 18.22 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.493 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 2.1 mt -87.94 148.05 4.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.071 -1.018 . . . . 0.0 110.228 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.579 ' HA3' ' CE2' ' A' ' 8' ' ' PHE . . . -155.4 161.21 30.37 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.465 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -98.63 143.53 28.92 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.231 -1.158 . . . . 0.0 110.065 -179.486 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.591 ' HG3' ' CE1' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -142.41 137.5 30.45 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.278 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -107.6 124.25 49.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.027 -1.046 . . . . 0.0 110.982 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.76 138.11 42.46 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.139 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.553 ' O ' ' N ' ' A' ' 65' ' ' GLY . 1.2 t -47.43 147.55 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 118.833 -1.147 . . . . 0.0 108.714 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.541 ' O ' ' HB3' ' A' ' 175' ' ' SER . 5.4 t -107.85 64.47 0.63 Allowed 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.562 ' HB3' ' CG2' ' A' ' 117' ' ' VAL . 0.0 OUTLIER 54.04 25.71 5.78 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.113 -0.992 . . . . 0.0 108.586 -179.168 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.536 HD12 ' CB ' ' A' ' 176' ' ' LYS . 1.4 mt -72.08 141.71 84.24 Favored Pre-proline 0 N--CA 1.487 1.407 0 O-C-N 121.32 -0.863 . . . . 0.0 109.02 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.511 ' CB ' ' CD1' ' A' ' 112' ' ' TRP . 35.9 Cg_endo -79.13 -163.08 0.2 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.513 2.142 . . . . 0.0 110.183 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.512 ' O ' ' N ' ' A' ' 113' ' ' GLU . 13.2 ptp180 -174.67 160.13 2.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.257 -0.902 . . . . 0.0 109.373 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.2 OUTLIER 74.97 17.86 2.66 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.218 -0.926 . . . . 0.0 109.516 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.586 ' CD1' ' CD2' ' A' ' 162' ' ' LEU . 0.6 OUTLIER -51.58 103.7 0.07 Allowed 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.118 -0.989 . . . . 0.0 109.427 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -130.25 161.85 30.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.333 -0.854 . . . . 0.0 109.458 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 12.6 p -97.6 144.76 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.739 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.483 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 23.9 pt -127.72 -3.87 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.305 -0.872 . . . . 0.0 109.612 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.531 ' CB ' ' HB2' ' A' ' 109' ' ' LEU . . . -157.84 106.17 2.03 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.467 ' OG ' ' OH ' ' A' ' 182' ' ' TYR . 1.0 OUTLIER -103.94 106.65 17.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 0.0 110.592 -178.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -94.31 166.48 15.34 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.466 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 29.8 Cg_endo -68.97 -2.59 9.88 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.332 2.021 . . . . 0.0 110.665 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.52 ' HA ' HG21 ' A' ' 152' ' ' ILE . 3.2 p -148.8 13.9 0.92 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.24 -0.912 . . . . 0.0 109.346 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.535 ' O ' ' CD2' ' A' ' 108' ' ' LEU . 3.3 p -172.31 168.43 5.58 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 118.764 -1.174 . . . . 0.0 109.989 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.585 HD23 ' CE2' ' A' ' 182' ' ' TYR . 0.5 OUTLIER -144.35 155.17 43.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.329 -0.857 . . . . 0.0 109.375 -179.468 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.531 ' HB2' ' CB ' ' A' ' 102' ' ' ALA . 5.8 mt -97.11 140.12 32.09 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.523 ' CD1' HD13 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -122.58 132.62 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.946 -1.096 . . . . 0.0 110.663 -179.126 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.3 t -131.03 111.3 11.9 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.511 ' CD1' ' CB ' ' A' ' 95' ' ' PRO . 45.1 p90 -123.63 144.68 49.46 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.182 -0.949 . . . . 0.0 110.75 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.535 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 4.4 mm-40 -55.21 168.35 0.57 Allowed Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' A' ' 113' ' ' GLU . 30.2 Cg_endo -72.94 146.37 41.82 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 122.297 1.998 . . . . 0.0 109.926 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.532 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 31.9 Cg_endo -75.24 -172.58 1.32 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.543 2.162 . . . . 0.0 111.99 -178.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.527 ' HB2' ' CB ' ' A' ' 15' ' ' ALA . . . -69.94 -12.04 61.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.647 -0.658 . . . . 0.0 110.38 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.575 HG12 ' CB ' ' A' ' 15' ' ' ALA . 6.1 m -159.59 -166.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.138 -0.976 . . . . 0.0 109.593 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.487 ' C ' ' CG2' ' A' ' 119' ' ' VAL . 0.1 OUTLIER -75.27 179.82 4.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.868 . . . . 0.0 109.047 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.575 ' HB ' ' CZ ' ' A' ' 122' ' ' TYR . 1.4 t -156.25 135.05 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.062 -1.024 . . . . 0.0 109.878 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -74.68 -42.98 57.44 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.643 ' CE1' ' CG1' ' A' ' 165' ' ' VAL . 5.4 p90 -165.76 176.42 7.99 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.63 -0.669 . . . . 0.0 109.289 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.626 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 1.1 m-85 -136.65 161.56 35.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.19 -0.944 . . . . 0.0 109.494 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.499 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -120.67 98.9 6.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.929 . . . . 0.0 108.672 179.434 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.585 ' HB ' ' CE1' ' A' ' 138' ' ' PHE . 20.3 mt -84.3 146.47 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.139 -0.975 . . . . 0.0 110.012 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 21.6 p -120.9 153.04 37.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 0.0 110.415 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.64 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 2.6 m-85 -101.9 121.88 42.97 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.596 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.1 117.4 5.56 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.272 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 129' ' ' THR . 15.9 mt-10 -87.93 169.54 11.92 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.226 -1.161 . . . . 0.0 108.988 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.581 ' CG2' ' N ' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -36.74 -79.48 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.65 -0.656 . . . . 0.0 110.475 179.744 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 129' ' ' THR . . . -42.44 -71.53 0.37 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 96.51 -21.72 44.09 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -70.56 -5.34 28.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -1.174 . . . . 0.0 109.586 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.553 ' CB ' ' HD2' ' A' ' 134' ' ' PRO . 0.9 OUTLIER -90.14 -179.99 1.35 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.25 -0.906 . . . . 0.0 109.174 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 133' ' ' SER . 34.6 Cg_endo -77.61 92.78 1.11 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.384 2.056 . . . . 0.0 110.137 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 126' ' ' TYR . 3.4 m -46.67 161.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.443 -0.786 . . . . 0.0 110.132 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 134' ' ' PRO . 87.3 mm-40 -107.27 115.83 30.86 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 0.0 OUTLIER -119.57 158.07 27.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.939 -1.101 . . . . 0.0 111.557 -178.332 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.585 ' CE1' ' HB ' ' A' ' 124' ' ' ILE . 33.8 p90 -140.7 162.86 34.4 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.58 ' O ' ' CD2' ' A' ' 138' ' ' PHE . 0.7 OUTLIER -74.51 -171.14 1.15 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.752 -1.217 . . . . 0.0 110.164 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.572 ' CG2' ' CD1' ' A' ' 124' ' ' ILE . 40.0 t -149.88 133.98 9.02 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.213 -0.93 . . . . 0.0 109.86 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.33 117.34 4.05 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.357 2.038 . . . . 0.0 110.097 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -71.77 55.81 1.33 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.48 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 39.3 m -105.46 -1.62 24.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.164 -1.198 . . . . 0.0 109.492 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.48 ' CG ' ' O ' ' A' ' 143' ' ' SER . 3.0 mtmt -176.16 -179.75 1.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.919 . . . . 0.0 109.43 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.99 13.75 24.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.57 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.437 ' HA ' ' O ' ' A' ' 110' ' ' ILE . 18.0 p -125.36 152.84 44.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.912 . . . . 0.0 109.527 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.487 ' HB1' ' CH2' ' A' ' 112' ' ' TRP . . . -142.4 171.73 13.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.0 109.548 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.464 HG22 ' OD1' ' A' ' 150' ' ' ASN . 11.3 t -110.7 155.85 21.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.328 -0.858 . . . . 0.0 109.379 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.64 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 16.1 mm -133.26 81.9 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 109.506 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.543 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -92.69 167.64 11.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.389 -0.819 . . . . 0.0 109.979 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 0.3 OUTLIER 75.15 47.4 0.1 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 0.0 109.298 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.52 HG21 ' HA ' ' A' ' 106' ' ' THR . 4.2 tt -110.67 158.85 10.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.35 -0.844 . . . . 0.0 109.922 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.409 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 1.7 tttp -97.77 112.45 61.59 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.351 -0.843 . . . . 0.0 108.944 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.466 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 34.7 Cg_endo -77.2 138.17 17.72 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.387 2.058 . . . . 0.0 110.692 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . 87.99 67.7 1.3 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 163.26 130.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -1.117 . . . . 0.0 109.633 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.581 ' N ' ' CG2' ' A' ' 129' ' ' THR . 1.2 t0 -46.36 158.92 0.1 Allowed 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.596 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -143.08 -179.47 6.39 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.0 -1.063 . . . . 0.0 109.884 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 127' ' ' GLY . 4.8 m -150.94 101.41 2.89 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 179' ' ' SER . 16.2 mm -84.84 136.55 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.117 -0.989 . . . . 0.0 110.118 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.536 ' CG2' ' HB3' ' A' ' 179' ' ' SER . 2.0 m -147.45 168.87 20.78 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.586 ' CD2' ' CD1' ' A' ' 98' ' ' LEU . 0.8 OUTLIER -163.54 147.64 10.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.871 -1.143 . . . . 0.0 110.859 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 177' ' ' PRO . 2.0 m-85 -116.08 103.42 10.55 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.475 ' O ' HG21 ' A' ' 165' ' ' VAL . . . -61.32 167.25 3.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.007 -1.058 . . . . 0.0 109.459 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.643 ' CG1' ' CE1' ' A' ' 121' ' ' TYR . 84.4 t -143.79 114.72 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.146 -0.971 . . . . 0.0 110.543 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.481 HG21 ' HA ' ' A' ' 119' ' ' VAL . 0.7 OUTLIER -109.93 131.88 54.66 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.634 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.479 ' HA2' ' HA ' ' A' ' 172' ' ' PRO . . . -58.54 167.11 6.68 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.498 ' NE ' ' HB1' ' A' ' 173' ' ' ALA . 1.1 mtm180 -149.48 15.36 0.88 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -1.118 . . . . 0.0 109.795 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 113.25 -116.86 4.07 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -75.28 0.5 16.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -1.138 . . . . 0.0 109.536 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 168' ' ' ARG . 9.5 m -163.18 128.8 2.19 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.479 ' HA ' ' HA2' ' A' ' 167' ' ' GLY . 33.8 Cg_endo -75.27 -170.59 0.82 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.346 2.031 . . . . 0.0 110.557 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.498 ' HB1' ' NE ' ' A' ' 168' ' ' ARG . . . -155.3 150.99 27.46 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.235 -0.915 . . . . 0.0 109.821 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 165' ' ' VAL . 0.6 OUTLIER -103.29 -165.97 1.22 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.368 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.541 ' HB3' ' O ' ' A' ' 92' ' ' SER . 96.6 p -146.14 163.76 34.34 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.173 -0.954 . . . . 0.0 109.817 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.536 ' CB ' HD12 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -47.0 139.99 6.58 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.278 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 163' ' ' TYR . 34.8 Cg_endo -77.39 117.49 4.36 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.204 1.936 . . . . 0.0 111.757 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.466 ' O ' HG21 ' A' ' 161' ' ' THR . 2.3 t -84.59 131.57 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.536 ' HB3' ' CG2' ' A' ' 161' ' ' THR . 54.4 p -128.14 149.37 50.45 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.05 -1.031 . . . . 0.0 111.218 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.521 ' CG1' HD21 ' A' ' 98' ' ' LEU . 18.8 pt -134.94 152.65 33.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -84.18 147.03 27.52 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.928 -1.108 . . . . 0.0 109.698 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.585 ' CE2' HD23 ' A' ' 108' ' ' LEU . 74.4 t80 -147.43 121.63 9.55 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.452 -0.78 . . . . 0.0 109.335 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 183' ' ' LYS . 8.0 pttm -96.04 121.86 38.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.994 . . . . 0.0 109.505 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.573 HG22 ' CD1' ' A' ' 158' ' ' TYR . 44.7 p . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.483 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.521 HD21 ' N ' ' A' ' 2' ' ' LEU . 0.1 OUTLIER -74.55 -163.17 0.19 Allowed 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.265 -1.138 . . . . 0.0 109.51 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.531 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 7.5 m-20 -74.62 90.13 2.25 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.422 -0.799 . . . . 0.0 110.134 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.6 m -96.71 106.72 32.09 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 3' ' ' ASP . 36.7 Cg_endo -79.61 159.66 25.2 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.322 2.015 . . . . 0.0 110.642 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.526 ' HA ' ' CD2' ' A' ' 84' ' ' LEU . 3.8 p -151.94 -121.1 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 109.074 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 43.33 28.14 0.85 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.573 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 7.6 t80 -48.68 133.57 16.94 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.705 -0.88 . . . . 0.0 110.327 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.429 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 9.2 t0 -165.05 94.1 0.64 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -84.4 118.32 24.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -0.885 . . . . 0.0 109.764 -179.345 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.464 ' O ' ' C ' ' A' ' 12' ' ' ASP . 96.3 p -151.86 -159.1 0.97 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.396 -0.815 . . . . 0.0 108.981 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.49 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.7 OUTLIER 46.46 33.58 2.0 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -178.305 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.609 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.2 mt -76.69 162.67 4.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.679 -177.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.546 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 0.1 OUTLIER -151.2 -175.27 5.1 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.081 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.568 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -78.37 -52.11 9.08 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.123 -0.986 . . . . 0.0 109.752 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.461 ' O ' ' HA ' ' A' ' 60' ' ' THR . 1.8 p-10 -97.83 -1.9 42.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.78 -1.2 . . . . 0.0 109.936 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 59' ' ' LEU . 3.4 p -150.98 157.33 42.75 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.32 -0.863 . . . . 0.0 108.825 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.609 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 2.1 p90 -165.71 141.45 5.07 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.17 -0.956 . . . . 0.0 108.559 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.49 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 1.7 m -94.82 155.68 16.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.855 -1.153 . . . . 0.0 111.7 -177.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 56' ' ' SER . 0.4 OUTLIER -130.16 120.07 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.52 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 4.0 m-70 -101.26 148.91 24.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.118 -0.989 . . . . 0.0 110.81 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.576 ' CD1' ' O ' ' A' ' 22' ' ' TRP . 11.9 p90 -171.47 129.94 0.7 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.536 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.53 169.07 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.985 -1.072 . . . . 0.0 109.566 -179.782 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.536 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -107.66 160.42 26.77 Favored Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.685 -0.634 . . . . 0.0 109.366 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.54 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 36.9 Cg_endo -78.38 -99.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.676 2.251 . . . . 0.0 110.371 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.54 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -174.57 -34.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.076 -1.015 . . . . 0.0 109.984 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.529 ' N ' ' OD1' ' A' ' 3' ' ' ASP . . . -54.38 168.13 0.5 Allowed Pre-proline 0 C--N 1.296 -1.729 0 O-C-N 121.5 -0.75 . . . . 0.0 109.368 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 27' ' ' ALA . 35.1 Cg_endo -77.52 142.18 20.57 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.529 2.153 . . . . 0.0 110.354 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.638 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 14.2 pt -148.11 176.98 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.921 . . . . 0.0 109.751 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.0 p -120.77 1.05 10.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.412 -0.805 . . . . 0.0 109.256 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.462 ' O ' ' CG2' ' A' ' 75' ' ' VAL . . . 139.3 150.97 5.61 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.638 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -100.63 135.56 41.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.254 -1.144 . . . . 0.0 109.322 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.582 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 1.2 mp -86.53 133.14 30.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.149 -0.969 . . . . 0.0 109.094 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.482 ' N ' ' O ' ' A' ' 48' ' ' ASP . 2.9 mm -112.12 102.15 13.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.354 -0.841 . . . . 0.0 109.346 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.517 ' HG2' ' N ' ' A' ' 36' ' ' HIS . 5.4 ttt180 -100.62 158.1 16.18 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.145 -0.972 . . . . 0.0 109.218 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.65 ' CE1' ' CG2' ' A' ' 70' ' ' VAL . 0.3 OUTLIER -140.07 144.59 36.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.165 -0.96 . . . . 0.0 109.635 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.579 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 35.6 p-80 -163.5 128.85 3.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.834 . . . . 0.0 109.533 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.557 ' HA ' ' HB3' ' A' ' 68' ' ' TYR . . . -40.32 163.6 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.415 -0.803 . . . . 0.0 110.03 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.524 ' HG2' ' CG2' ' A' ' 69' ' ' VAL . 2.1 mt-10 -84.42 -98.04 0.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.168 -0.958 . . . . 0.0 109.481 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -87.77 -3.22 58.96 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.349 -0.844 . . . . 0.0 109.714 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.45 ' OG ' ' HB2' ' A' ' 38' ' ' ALA . 22.9 p -84.98 -177.12 6.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 109.477 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.9 t -101.46 29.6 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.245 -0.909 . . . . 0.0 109.492 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.467 ' CA ' ' HB1' ' A' ' 38' ' ' ALA . . . -64.2 125.85 32.65 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -55.92 143.99 59.44 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.254 -1.145 . . . . 0.0 109.417 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.446 ' HA ' ' HA ' ' A' ' 37' ' ' HIS . 35.8 Cg_endo -78.57 106.14 2.07 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.547 2.165 . . . . 0.0 110.352 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -74.82 179.68 4.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.631 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -143.39 126.97 16.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.339 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.482 ' O ' ' N ' ' A' ' 34' ' ' ILE . 21.2 m-20 -138.21 159.22 42.61 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.497 ' NH1' HG22 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -139.18 159.03 43.11 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.286 -0.884 . . . . 0.0 109.85 -179.474 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.576 ' CG1' ' CD1' ' A' ' 57' ' ' ILE . 32.7 m -142.72 159.22 57.88 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.865 . . . . 0.0 109.189 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.528 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.4 Cg_endo -77.21 174.42 12.8 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.503 2.135 . . . . 0.0 110.324 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.552 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 35.3 Cg_endo -77.21 -15.5 16.08 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.596 2.198 . . . . 0.0 110.52 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 p -102.8 24.11 11.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.65 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.528 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 5.7 mmt180 -126.83 109.04 11.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.186 -0.946 . . . . 0.0 109.966 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 22' ' ' TRP . 16.5 p30 -94.09 -11.23 31.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.031 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 20.0 p -131.21 137.13 48.79 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.576 ' CD1' ' CG1' ' A' ' 50' ' ' VAL . 6.4 tt -131.35 129.65 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.982 -1.074 . . . . 0.0 110.264 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.63 111.09 23.1 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.528 ' O ' ' CB ' ' A' ' 17' ' ' SER . 2.0 mt -84.48 158.37 21.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.165 -0.959 . . . . 0.0 109.541 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.464 ' O ' HD22 ' A' ' 62' ' ' LEU . 19.4 p -145.65 177.6 8.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 109.394 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 50.93 46.6 26.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.517 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.469 ' CD1' ' HB3' ' A' ' 59' ' ' LEU . 3.7 mt -118.19 147.34 43.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 109.355 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.478 ' O ' ' OH ' ' A' ' 68' ' ' TYR . 28.3 m-80 -44.89 117.2 3.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.197 -0.939 . . . . 0.0 108.686 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.568 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.4 Cg_endo -77.47 125.72 7.84 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.144 1.896 . . . . 0.0 111.41 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.99 59.99 2.11 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.564 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 2.6 m -151.8 166.51 31.16 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.154 -1.204 . . . . 0.0 109.506 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.564 ' N ' ' CG2' ' A' ' 66' ' ' THR . 5.1 mt-10 -125.56 127.25 46.09 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.305 -0.872 . . . . 0.0 109.21 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -134.23 -159.53 0.97 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.139 -0.975 . . . . 0.0 109.773 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.586 ' CG1' ' CG2' ' A' ' 85' ' ' ILE . 41.7 t -137.36 116.68 15.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.65 ' CG2' ' CE1' ' A' ' 36' ' ' HIS . 3.7 t -88.58 127.73 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.031 -1.043 . . . . 0.0 109.621 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.531 ' HB3' ' CD1' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -101.0 104.72 15.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 110.065 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.46 ' HB ' ' O ' ' A' ' 84' ' ' LEU . 15.0 mm -79.4 154.56 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.341 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.52 ' CG2' ' N ' ' A' ' 74' ' ' ALA . 48.3 mt -153.1 165.03 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 0.0 109.593 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.52 ' N ' ' CG2' ' A' ' 73' ' ' ILE . . . -132.57 120.62 22.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.298 -0.877 . . . . 0.0 109.389 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.503 HG23 ' CD1' ' A' ' 33' ' ' ILE . 2.4 m -112.63 144.52 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.524 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -135.94 45.23 2.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.892 . . . . 0.0 109.361 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.13 -96.46 1.15 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -109.72 -1.4 18.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.244 -1.15 . . . . 0.0 109.554 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.528 ' O ' ' CG ' ' A' ' 80' ' ' GLU . 19.8 mt-10 -106.52 172.89 6.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 0.0 109.121 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.528 ' CG ' ' O ' ' A' ' 79' ' ' GLU . 46.0 mt-10 -158.33 115.75 2.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.125 -0.984 . . . . 0.0 110.022 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.595 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -60.29 -175.17 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.283 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.595 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.1 Cg_endo -76.5 146.15 27.19 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.925 1.75 . . . . 0.0 110.107 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.471 ' HB3' HG12 ' A' ' 73' ' ' ILE . 35.6 Cg_endo -77.22 109.56 2.84 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.674 2.249 . . . . 0.0 111.357 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.526 ' CD2' ' HA ' ' A' ' 6' ' ' THR . 17.9 tp -84.21 94.54 8.42 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.586 ' CG2' ' CG1' ' A' ' 69' ' ' VAL . 2.2 mt -85.72 151.34 3.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.128 -0.983 . . . . 0.0 110.678 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.573 ' HA3' ' CZ ' ' A' ' 8' ' ' PHE . . . -142.62 179.25 20.47 Favored Glycine 0 N--CA 1.483 1.824 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.423 ' HG3' ' C ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -131.73 146.4 52.14 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.992 -1.299 . . . . 0.0 110.058 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.538 ' NE2' ' NE2' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -163.13 -167.69 1.54 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.521 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.41 136.64 3.94 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.973 -1.079 . . . . 0.0 109.953 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.485 ' OG1' ' OH ' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -74.59 162.18 29.01 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.193 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.576 HG12 ' CB ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -99.05 154.79 4.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.142 -0.973 . . . . 0.0 110.201 -179.691 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 11.4 p -70.53 105.31 3.05 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.536 ' HB2' ' CB ' ' A' ' 15' ' ' ALA . 1.3 t0 -67.52 -56.86 7.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.623 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.54 ' CD1' ' HB2' ' A' ' 176' ' ' LYS . 1.2 mt -76.81 142.99 70.47 Favored Pre-proline 0 C--N 1.302 -1.464 0 O-C-N 121.216 -0.927 . . . . 0.0 109.605 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.624 ' CB ' ' CD1' ' A' ' 112' ' ' TRP . 36.4 Cg_endo -80.63 46.0 2.14 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.451 2.101 . . . . 0.0 109.886 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.462 ' CG ' ' HG3' ' A' ' 113' ' ' GLU . 5.9 ptm85 -60.05 179.15 0.15 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.403 -0.811 . . . . 0.0 109.569 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.1 t0 67.35 8.11 6.02 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.243 -0.911 . . . . 0.0 109.272 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.583 ' CD2' ' CD1' ' A' ' 180' ' ' ILE . 8.7 tt -53.59 99.98 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.216 -0.927 . . . . 0.0 109.13 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -124.98 157.29 36.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.306 -0.871 . . . . 0.0 109.532 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 8.1 p -91.1 139.67 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.381 -0.824 . . . . 0.0 109.606 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.477 HG12 ' HB3' ' A' ' 109' ' ' LEU . 20.0 pt -125.23 -5.86 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.503 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.533 ' CB ' ' HB2' ' A' ' 109' ' ' LEU . . . -149.4 97.77 2.7 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.465 ' HB2' ' OH ' ' A' ' 182' ' ' TYR . 17.4 p -90.0 90.56 8.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.368 -0.832 . . . . 0.0 110.293 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -80.37 157.49 72.79 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 121.237 -0.914 . . . . 0.0 108.776 179.059 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.472 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.2 Cg_endo -69.9 -2.73 10.77 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.397 2.065 . . . . 0.0 110.502 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.476 ' HA ' HG21 ' A' ' 152' ' ' ILE . 1.4 p -150.53 18.38 0.82 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.543 ' CB ' ' O ' ' A' ' 149' ' ' ILE . 0.7 OUTLIER -167.22 171.63 10.63 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.034 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.586 HD23 ' CE2' ' A' ' 182' ' ' TYR . 0.5 OUTLIER -144.43 152.63 40.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.309 -0.869 . . . . 0.0 109.173 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.533 ' HB2' ' CB ' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -105.75 120.72 42.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 108.86 179.293 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 147' ' ' ALA . 1.0 OUTLIER -106.29 138.06 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.115 -0.991 . . . . 0.0 110.024 -179.68 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.472 ' HB2' ' CG2' ' A' ' 146' ' ' THR . 0.0 OUTLIER -142.87 115.17 8.44 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.455 -0.778 . . . . 0.0 109.259 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.624 ' CD1' ' CB ' ' A' ' 95' ' ' PRO . 43.4 p90 -125.97 -177.43 3.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 109.561 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.508 ' O ' ' HD3' ' A' ' 115' ' ' PRO . 1.0 OUTLIER -56.73 133.82 78.48 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.912 . . . . 0.0 109.424 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.471 ' HA ' ' OG ' ' A' ' 145' ' ' SER . 36.6 Cg_endo -79.98 109.92 2.47 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.788 2.325 . . . . 0.0 110.806 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 113' ' ' GLU . 36.3 Cg_endo -81.34 164.37 19.23 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.322 2.014 . . . . 0.0 110.243 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.576 ' CB ' HG12 ' A' ' 91' ' ' VAL . . . -142.59 14.22 1.96 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.519 HG23 ' CG2' ' A' ' 119' ' ' VAL . 3.0 m -79.38 179.83 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.466 ' O ' ' HB ' ' A' ' 166' ' ' THR . 11.1 m -69.52 59.35 0.13 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.054 -1.029 . . . . 0.0 108.786 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.529 ' HA ' ' CG2' ' A' ' 166' ' ' THR . 21.3 t -74.65 125.88 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.362 -0.836 . . . . 0.0 109.993 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER -74.93 -58.62 3.17 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 140' ' ' VAL . 9.0 p90 -166.93 163.4 16.1 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.488 ' HB2' ' HB ' ' A' ' 140' ' ' VAL . 14.4 m-85 -103.74 129.59 51.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.03 -1.044 . . . . 0.0 108.589 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.533 ' HG3' ' CG ' ' A' ' 137' ' ' GLU . 1.5 ttm180 -95.34 85.94 4.39 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.286 -0.884 . . . . 0.0 109.518 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.608 ' HB ' ' CZ ' ' A' ' 138' ' ' PHE . 21.6 mt -84.37 153.16 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.364 -0.835 . . . . 0.0 109.193 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.483 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 27.7 p -138.73 142.45 38.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.136 -0.978 . . . . 0.0 110.189 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.621 ' CE2' ' CG2' ' A' ' 149' ' ' ILE . 4.1 m-85 -79.59 126.68 31.21 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.577 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.35 120.42 6.49 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 130' ' ' GLY . 2.3 mt-10 -90.52 170.12 10.46 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.447 -1.031 . . . . 0.0 109.064 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.526 ' CG2' ' HB2' ' A' ' 156' ' ' ALA . 1.2 p -39.81 -28.46 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.465 -0.772 . . . . 0.0 109.887 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 128' ' ' GLU . . . -59.41 -84.67 0.04 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 96.8 100.0 1.96 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -145.12 -71.71 0.26 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.327 -1.102 . . . . 0.0 109.348 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.553 ' CB ' ' HD3' ' A' ' 134' ' ' PRO . 0.5 OUTLIER 171.48 -55.48 0.0 OUTLIER Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.553 ' HD3' ' CB ' ' A' ' 133' ' ' SER . 35.7 Cg_endo -78.16 71.63 6.61 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.336 2.024 . . . . 0.0 109.995 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.554 ' CG1' ' O ' ' A' ' 126' ' ' TYR . 0.2 OUTLIER -109.64 -143.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.437 -0.789 . . . . 0.0 109.326 -179.655 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.572 ' HB3' ' CD1' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -80.96 76.1 7.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.846 -1.159 . . . . 0.0 109.14 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.533 ' CG ' ' HG3' ' A' ' 123' ' ' ARG . 6.4 tm-20 -76.54 117.48 18.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 110.665 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.608 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 26.7 p90 -121.94 138.59 54.35 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 7.4 p -74.21 168.39 19.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.083 -1.01 . . . . 0.0 110.534 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.584 ' CG2' ' CD1' ' A' ' 124' ' ' ILE . 50.9 t -138.31 141.5 31.92 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.523 -0.736 . . . . 0.0 109.647 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.455 ' HD2' HG12 ' A' ' 140' ' ' VAL . 35.0 Cg_endo -77.17 141.43 20.69 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.528 2.152 . . . . 0.0 110.657 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.82 53.55 3.33 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.505 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 28.4 t -103.7 -11.85 17.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.178 -1.189 . . . . 0.0 109.888 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 143' ' ' SER . 1.5 mmmt 179.54 175.81 0.7 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 109.777 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.581 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -95.26 -1.23 51.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.585 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.472 ' CG2' ' HB2' ' A' ' 111' ' ' SER . 41.4 p -102.0 129.79 48.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.09 -1.006 . . . . 0.0 108.913 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.47 ' O ' HG13 ' A' ' 110' ' ' ILE . . . -126.81 156.5 41.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.118 -0.988 . . . . 0.0 109.78 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.441 HG23 ' OD1' ' A' ' 150' ' ' ASN . 8.9 m -100.82 152.26 20.72 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.352 -0.843 . . . . 0.0 109.097 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.621 ' CG2' ' CE2' ' A' ' 126' ' ' TYR . 49.9 mm -127.93 107.95 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.252 -0.905 . . . . 0.0 109.199 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.586 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 2.9 m120 -116.0 166.1 12.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.418 -0.801 . . . . 0.0 109.929 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 150' ' ' ASN . 4.0 m-80 76.07 37.73 0.36 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 109.268 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.581 HG13 ' CE2' ' A' ' 158' ' ' TYR . 4.7 tt -96.93 156.17 3.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.392 -0.817 . . . . 0.0 109.795 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 184' ' ' THR . 9.0 mttp -84.64 117.57 69.06 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 109.349 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.472 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 36.4 Cg_endo -78.73 75.88 4.78 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.479 2.12 . . . . 0.0 110.684 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . 143.08 73.05 0.03 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.526 ' HB2' ' CG2' ' A' ' 129' ' ' THR . . . 162.25 134.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -1.107 . . . . 0.0 109.67 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.518 ' N ' HG21 ' A' ' 129' ' ' THR . 1.0 OUTLIER -48.08 164.43 0.05 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.11 -0.994 . . . . 0.0 108.338 179.292 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.581 ' CE2' HG13 ' A' ' 152' ' ' ILE . 0.4 OUTLIER -144.97 -167.44 2.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.865 -1.147 . . . . 0.0 110.352 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.512 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 31.6 m -169.6 102.75 0.33 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.463 ' CD1' HD13 ' A' ' 108' ' ' LEU . 33.0 mm -88.11 118.6 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.025 -1.047 . . . . 0.0 109.785 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.571 ' CG2' ' CB ' ' A' ' 179' ' ' SER . 1.1 m -126.37 165.41 19.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.904 . . . . 0.0 109.19 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.549 ' CD2' ' CD1' ' A' ' 98' ' ' LEU . 1.9 pp -165.86 154.4 11.26 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.997 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.61 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 1.8 m-85 -122.69 160.38 25.97 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.469 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -127.26 101.68 6.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.865 -1.147 . . . . 0.0 109.342 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.531 ' HA ' ' HA ' ' A' ' 174' ' ' SER . 15.1 t -87.74 131.42 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.333 -0.854 . . . . 0.0 109.677 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.529 ' CG2' ' HA ' ' A' ' 119' ' ' VAL . 17.0 p -130.89 -66.97 0.73 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.768 -0.582 . . . . 0.0 109.512 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.51 ' N ' ' OG1' ' A' ' 166' ' ' THR . . . -43.18 139.28 3.09 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -141.22 104.53 4.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -1.149 . . . . 0.0 109.453 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 166.68 -122.49 1.06 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 170' ' ' ASP . 7.3 p-10 -93.29 12.07 25.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -1.155 . . . . 0.0 109.47 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.468 ' N ' ' HD3' ' A' ' 172' ' ' PRO . 64.8 m -158.58 64.8 2.85 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.355 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.468 ' HD3' ' N ' ' A' ' 171' ' ' SER . 35.7 Cg_endo -78.18 98.84 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.658 2.239 . . . . 0.0 110.574 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -103.59 -179.29 3.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 109.307 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.531 ' HA ' ' HA ' ' A' ' 165' ' ' VAL . 0.7 OUTLIER -144.68 48.26 1.33 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.103 -0.998 . . . . 0.0 109.697 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.49 ' O ' ' O ' ' A' ' 174' ' ' SER . 0.7 OUTLIER 42.1 -166.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.54 ' HB2' ' CD1' ' A' ' 94' ' ' ILE . 0.1 OUTLIER -93.19 139.71 23.1 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 120.999 -1.063 . . . . 0.0 108.229 179.165 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.61 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 33.8 Cg_endo -76.14 140.91 22.91 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.206 1.937 . . . . 0.0 111.158 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.2 t -122.11 138.22 53.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.571 ' CB ' ' CG2' ' A' ' 161' ' ' THR . 0.3 OUTLIER -131.36 155.45 47.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.088 -1.007 . . . . 0.0 110.821 -178.663 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.583 ' CD1' ' CD2' ' A' ' 98' ' ' LEU . 14.0 pt -136.96 153.3 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -91.67 156.67 17.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.0 -1.063 . . . . 0.0 110.051 -179.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.586 ' CE2' HD23 ' A' ' 108' ' ' LEU . 51.9 t80 -143.98 169.78 17.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.405 -0.809 . . . . 0.0 109.296 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.477 ' N ' ' CD2' ' A' ' 182' ' ' TYR . 8.6 tttp -139.86 121.69 15.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.231 -0.918 . . . . 0.0 109.537 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.455 ' CB ' ' O ' ' A' ' 153' ' ' LYS . 14.7 p . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.46 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 2' ' ' LEU . 0.2 OUTLIER -119.58 -162.87 0.94 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.268 -1.137 . . . . 0.0 109.342 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 26' ' ' ARG . 1.6 m-20 -96.62 167.61 11.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 0.0 109.344 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.524 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 4.8 p -94.52 133.62 26.64 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.491 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.533 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 36.3 Cg_endo -79.14 86.72 1.64 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.54 2.16 . . . . 0.0 110.394 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.466 ' O ' ' C ' ' A' ' 7' ' ' GLY . 16.5 p -89.32 -126.87 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.04 -1.038 . . . . 0.0 109.304 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 44.48 28.42 1.51 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.039 -2.025 . . . . 0.0 108.039 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.577 ' CE2' HG13 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -92.34 152.32 19.83 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.851 -0.794 . . . . 0.0 109.879 -178.603 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.431 ' O ' HG13 ' A' ' 20' ' ' VAL . 2.5 t70 -165.0 -163.15 0.68 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.471 ' OG ' ' OE1' ' A' ' 88' ' ' GLN . 83.0 p -137.45 121.26 17.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.048 -1.032 . . . . 0.0 109.908 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.496 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 3.7 p -140.6 -171.01 3.13 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.356 -0.84 . . . . 0.0 108.847 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.509 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.9 OUTLIER 43.84 36.01 1.24 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -178.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.566 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.2 mt -79.52 132.69 31.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.729 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.548 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -122.83 -179.94 4.42 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.198 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.535 ' CB ' HG13 ' A' ' 117' ' ' VAL . . . -74.08 -63.39 1.23 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.751 -1.218 . . . . 0.0 109.75 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 3.4 m-20 -88.46 23.77 2.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.148 -0.97 . . . . 0.0 109.446 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.548 ' O ' ' N ' ' A' ' 14' ' ' THR . 42.0 p -176.04 153.68 1.34 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.57 ' CE1' HG21 ' A' ' 20' ' ' VAL . 2.5 p90 -165.66 140.53 4.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 0.0 109.089 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.509 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 4.6 m -89.79 161.44 16.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.922 -1.111 . . . . 0.0 110.964 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.577 HG13 ' CE2' ' A' ' 8' ' ' PHE . 0.2 OUTLIER -133.54 173.23 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.543 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 28.3 m-70 -147.68 170.6 17.17 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.89 -1.131 . . . . 0.0 110.541 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.578 ' CD1' ' O ' ' A' ' 22' ' ' TRP . 16.3 p90 179.81 135.28 0.11 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.533 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.51 167.6 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.087 -1.008 . . . . 0.0 109.267 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.511 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -92.21 168.77 12.15 Favored Pre-proline 0 C--N 1.299 -1.606 0 O-C-N 121.647 -0.658 . . . . 0.0 109.796 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.18 172.75 14.94 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.675 2.25 . . . . 0.0 110.387 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.456 ' HB2' ' OD1' ' A' ' 3' ' ' ASP . 45.5 mmt-85 -90.68 28.73 1.45 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.229 -0.92 . . . . 0.0 109.48 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.503 ' CB ' ' HD2' ' A' ' 28' ' ' PRO . . . -146.26 175.35 2.77 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 109.428 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 35.3 Cg_endo -77.83 142.38 20.01 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.647 2.231 . . . . 0.0 110.35 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.638 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 46.3 pt -145.68 -170.6 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.602 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.8 p -121.26 -8.64 9.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.278 -0.889 . . . . 0.0 109.416 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.04 -168.34 32.41 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.638 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -138.64 131.54 29.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -1.178 . . . . 0.0 109.526 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.59 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 1.1 mp -83.48 133.05 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.21 -0.931 . . . . 0.0 108.835 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.496 ' CD1' HG23 ' A' ' 50' ' ' VAL . 2.4 mm -111.97 101.03 11.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.185 -0.947 . . . . 0.0 109.829 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 71' ' ' SER . 0.2 OUTLIER -109.39 111.14 22.52 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 108.602 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.572 ' CE1' HD22 ' A' ' 59' ' ' LEU . 2.1 p-80 -119.13 160.6 21.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.135 -0.978 . . . . 0.0 110.385 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.53 ' HB3' ' CB ' ' A' ' 45' ' ' PRO . 30.3 p-80 -167.25 136.02 2.67 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -47.51 177.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.922 . . . . 0.0 110.033 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -42.96 -75.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.889 . . . . 0.0 109.767 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -149.06 47.68 0.99 Allowed 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.689 -0.632 . . . . 0.0 109.512 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.9 p -74.88 -94.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.579 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.2 t -74.78 -179.35 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.36 -0.838 . . . . 0.0 109.536 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -84.81 -90.97 0.8 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.435 ' HD3' ' HD2' ' A' ' 45' ' ' PRO . 0.8 OUTLIER -51.95 139.32 33.04 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.28 -1.13 . . . . 0.0 109.396 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.53 ' CB ' ' HB3' ' A' ' 37' ' ' HIS . 36.4 Cg_endo -79.08 164.48 24.75 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.573 2.182 . . . . 0.0 110.6 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.565 ' HB2' ' CD2' ' A' ' 36' ' ' HIS . 4.1 mmt85 -75.64 128.61 35.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.868 . . . . 0.0 109.209 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.451 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 3.8 mt-30 -87.77 133.3 33.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.885 . . . . 0.0 109.95 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.52 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 1.0 OUTLIER -155.21 117.08 4.1 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.582 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.521 ' HD2' ' CG2' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -105.64 165.02 11.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.982 -1.074 . . . . 0.0 110.205 -179.124 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.559 HG22 ' CH2' ' A' ' 22' ' ' TRP . 7.2 m -140.0 161.84 53.63 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.533 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.3 Cg_endo -76.37 174.1 13.39 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.324 2.016 . . . . 0.0 110.354 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.506 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.5 Cg_endo -76.86 -14.43 17.24 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.558 2.172 . . . . 0.0 110.273 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.12 23.39 13.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.349 -0.845 . . . . 0.0 109.513 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.533 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 10.5 mmt180 -124.77 97.99 5.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -0.953 . . . . 0.0 109.719 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 3.7 p30 -85.06 -0.97 56.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.181 -0.95 . . . . 0.0 109.305 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 63.5 p -136.52 149.1 47.97 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.406 -0.808 . . . . 0.0 109.028 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.512 HD11 ' CG1' ' A' ' 50' ' ' VAL . 3.4 tt -134.14 123.22 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.116 -0.99 . . . . 0.0 109.741 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 66.4 m -91.74 116.37 28.83 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.358 -0.838 . . . . 0.0 109.456 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.572 HD22 ' CE1' ' A' ' 36' ' ' HIS . 7.2 mt -92.51 151.4 20.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.203 -0.936 . . . . 0.0 109.618 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.471 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 1.2 p -133.12 169.66 16.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.382 -0.824 . . . . 0.0 109.561 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.6 m120 59.4 39.85 21.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -0.879 . . . . 0.0 109.455 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.538 ' CD1' ' HB3' ' A' ' 59' ' ' LEU . 4.3 mt -108.89 157.64 18.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 0.0 109.293 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.475 ' O ' ' OH ' ' A' ' 68' ' ' TYR . 13.0 m-20 -60.87 134.74 92.59 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.142 -0.974 . . . . 0.0 108.819 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.474 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 37.0 Cg_endo -78.49 117.9 4.13 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.289 1.993 . . . . 0.0 110.502 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 77.46 60.51 2.81 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.552 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 2.1 m -146.58 166.67 25.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.535 -0.979 . . . . 0.0 109.895 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.552 ' N ' ' CG2' ' A' ' 66' ' ' THR . 7.5 pt-20 -121.18 136.46 54.97 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.418 -0.801 . . . . 0.0 109.303 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.576 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 0.2 OUTLIER -132.49 176.97 7.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.19 -0.944 . . . . 0.0 109.577 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.51 ' HB ' ' NE2' ' A' ' 37' ' ' HIS . 74.9 t -108.69 97.02 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.516 ' CG1' ' HB3' ' A' ' 36' ' ' HIS . 1.9 t -84.76 124.51 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.863 . . . . 0.0 110.13 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.569 ' CB ' ' CG1' ' A' ' 85' ' ' ILE . 15.5 p -105.72 137.72 43.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.877 . . . . 0.0 110.295 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.457 ' HB ' ' HB3' ' A' ' 84' ' ' LEU . 30.9 mm -124.06 120.95 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.465 -0.772 . . . . 0.0 109.149 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.541 ' CG2' ' N ' ' A' ' 74' ' ' ALA . 49.2 mt -117.6 167.16 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 109.428 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.541 ' N ' ' CG2' ' A' ' 73' ' ' ILE . . . -132.13 124.75 29.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.911 . . . . 0.0 109.393 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.459 HG23 HD11 ' A' ' 33' ' ' ILE . 0.7 OUTLIER -116.03 136.21 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 109.588 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.405 ' CB ' ' HA ' ' A' ' 29' ' ' ILE . 48.3 t30 -121.31 50.14 1.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -0.94 . . . . 0.0 109.448 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.41 -82.12 0.95 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.449 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 20.0 tpt180 -117.35 2.01 12.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -1.166 . . . . 0.0 109.62 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.457 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 1.1 mt-10 -92.96 176.45 6.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.133 -0.979 . . . . 0.0 109.415 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 36.0 mt-10 -154.57 96.31 1.88 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.522 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.551 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -59.9 178.99 0.22 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.134 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.551 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.3 Cg_endo -77.3 152.22 30.43 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.352 2.035 . . . . 0.0 110.139 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.467 ' HA ' HG12 ' A' ' 73' ' ' ILE . 35.5 Cg_endo -77.8 105.49 2.03 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.532 2.155 . . . . 0.0 110.759 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.514 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 23.1 tp -84.57 100.8 11.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -0.888 . . . . 0.0 108.941 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.569 ' CG1' ' CB ' ' A' ' 71' ' ' SER . 2.3 mt -110.1 149.92 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.126 -0.984 . . . . 0.0 110.09 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -153.47 160.5 29.26 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.434 ' HG3' HG21 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -104.19 105.09 15.12 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.127 -1.219 . . . . 0.0 109.792 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.471 ' OE1' ' OG ' ' A' ' 10' ' ' SER . 36.0 mm-40 -104.79 -165.92 1.18 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.74 145.39 6.43 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.902 -1.119 . . . . 0.0 110.929 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.467 HG23 ' O ' ' A' ' 15' ' ' ALA . 0.0 OUTLIER -78.26 140.09 38.87 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.144 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.538 ' CG1' ' CB ' ' A' ' 116' ' ' ALA . 2.1 t -42.35 158.67 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.525 ' HA ' ' CA ' ' A' ' 65' ' ' GLY . 0.3 OUTLIER -106.01 135.29 47.72 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.441 -0.787 . . . . 0.0 109.841 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.511 ' CB ' ' OG1' ' A' ' 166' ' ' THR . 0.7 OUTLIER -70.8 -4.51 24.37 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.441 -0.787 . . . . 0.0 108.878 179.302 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 95' ' ' PRO . 5.3 mt -50.31 144.24 11.98 Favored Pre-proline 0 N--CA 1.484 1.231 0 O-C-N 121.307 -0.871 . . . . 0.0 109.673 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.549 ' HB3' ' CD1' ' A' ' 112' ' ' TRP . 34.7 Cg_endo -77.49 -163.83 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.163 1.909 . . . . 0.0 109.097 178.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 9.2 ptm85 -158.81 147.6 18.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.871 -1.143 . . . . 0.0 109.682 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 4.4 t70 75.71 24.26 1.3 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.352 -0.843 . . . . 0.0 109.301 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.544 ' CD1' ' CD2' ' A' ' 162' ' ' LEU . 3.4 tp -54.96 99.81 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.186 -0.946 . . . . 0.0 109.207 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -142.8 161.78 37.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.906 . . . . 0.0 109.599 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.469 HG12 ' O ' ' A' ' 109' ' ' LEU . 38.4 t -103.72 150.54 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.273 -0.892 . . . . 0.0 109.592 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.527 HG12 ' CD2' ' A' ' 109' ' ' LEU . 1.2 pt -120.01 -16.06 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.378 -0.826 . . . . 0.0 109.44 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.515 ' CB ' HD22 ' A' ' 109' ' ' LEU . . . -135.99 143.1 44.63 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.532 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.8 p -135.31 93.22 2.95 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.94 -1.1 . . . . 0.0 110.531 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -75.77 165.95 49.21 Favored Pre-proline 0 C--N 1.306 -1.296 0 O-C-N 121.102 -0.999 . . . . 0.0 108.512 178.715 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.453 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 30.0 Cg_endo -69.34 -1.89 8.92 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.296 1.997 . . . . 0.0 110.58 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.478 ' HA ' HG21 ' A' ' 152' ' ' ILE . 3.3 p -151.41 17.24 0.72 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.353 -0.842 . . . . 0.0 108.953 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 149' ' ' ILE . 0.7 OUTLIER -169.93 161.54 8.91 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.768 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.578 HD23 ' CZ ' ' A' ' 182' ' ' TYR . 0.4 OUTLIER -148.05 147.76 29.93 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.412 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.527 ' CD2' HG12 ' A' ' 101' ' ' ILE . 1.5 pp -106.99 135.93 47.72 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.149 -0.969 . . . . 0.0 109.222 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.514 ' N ' HD11 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -112.47 167.05 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.109 -0.994 . . . . 0.0 110.1 -179.659 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.474 ' HA ' ' HA ' ' A' ' 146' ' ' THR . 32.4 t -152.03 136.3 16.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.483 -0.761 . . . . 0.0 109.146 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.578 ' CE3' ' O ' ' A' ' 145' ' ' SER . 15.5 p90 -141.08 172.18 13.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.198 -0.939 . . . . 0.0 109.711 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.49 ' HB2' ' CG ' ' A' ' 96' ' ' ARG . 5.4 mt-10 -108.03 164.16 15.38 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.299 -0.875 . . . . 0.0 109.52 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.459 ' HD2' ' HB3' ' A' ' 113' ' ' GLU . 34.7 Cg_endo -78.15 132.54 11.58 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.803 2.335 . . . . 0.0 110.771 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.476 ' HG3' ' O ' ' A' ' 93' ' ' ASP . 35.1 Cg_endo -79.23 -157.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.752 2.301 . . . . 0.0 110.813 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.538 ' CB ' ' CG1' ' A' ' 91' ' ' VAL . . . -69.29 -4.28 17.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.362 -0.836 . . . . 0.0 109.942 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.535 HG13 ' CB ' ' A' ' 15' ' ' ALA . 3.5 m -134.64 158.68 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.142 -0.974 . . . . 0.0 109.723 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.467 ' O ' HG23 ' A' ' 166' ' ' THR . 74.9 p -69.85 -161.68 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.925 . . . . 0.0 108.897 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.643 ' CG1' ' CE2' ' A' ' 122' ' ' TYR . 2.9 t -152.99 139.79 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.082 -1.011 . . . . 0.0 110.411 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.51 ' NH2' ' HG2' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -98.97 -43.39 6.72 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.689 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.639 ' CZ ' ' CG2' ' A' ' 165' ' ' VAL . 0.9 OUTLIER -165.4 161.13 18.7 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.046 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.643 ' CE2' ' CG1' ' A' ' 119' ' ' VAL . 0.3 OUTLIER -125.74 171.98 10.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.034 -1.041 . . . . 0.0 109.908 -179.48 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.513 ' NE ' ' OH ' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -131.8 90.36 2.82 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.076 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.603 ' HB ' ' CE1' ' A' ' 138' ' ' PHE . 12.9 mt -83.48 164.37 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.339 -0.851 . . . . 0.0 110.021 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.52 ' HA ' ' O ' ' A' ' 136' ' ' GLN . 1.9 p -141.14 151.4 43.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.372 -0.83 . . . . 0.0 109.697 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.626 ' CE2' ' CG2' ' A' ' 149' ' ' ILE . 2.9 m-85 -87.01 141.64 28.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 108.685 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.593 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -105.31 111.54 3.75 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -105.56 144.06 32.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.114 -1.227 . . . . 0.0 109.356 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.596 ' CG2' ' CB ' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -56.14 159.68 3.29 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.245 -0.909 . . . . 0.0 109.75 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 54.29 57.55 16.57 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.423 ' C ' ' HD2' ' A' ' 134' ' ' PRO . . . -154.39 -78.56 0.02 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.44 ' O ' ' CB ' ' A' ' 133' ' ' SER . 67.9 m-20 58.86 41.48 21.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.271 -1.135 . . . . 0.0 109.485 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.545 ' CB ' ' HD3' ' A' ' 134' ' ' PRO . 0.1 OUTLIER 169.17 -54.81 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.554 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.545 ' HD3' ' CB ' ' A' ' 133' ' ' SER . 35.7 Cg_endo -77.95 78.33 3.61 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.404 2.07 . . . . 0.0 110.004 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.543 ' CG1' ' O ' ' A' ' 126' ' ' TYR . 0.7 OUTLIER -109.47 170.35 3.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.378 -0.826 . . . . 0.0 109.618 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.52 ' O ' ' HA ' ' A' ' 125' ' ' THR . 1.3 mp0 -94.84 83.4 4.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.145 -0.972 . . . . 0.0 108.811 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.472 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 32.5 tt0 -74.01 114.97 12.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.869 . . . . 0.0 111.349 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.603 ' CE1' ' HB ' ' A' ' 124' ' ' ILE . 44.0 p90 -117.48 156.74 27.48 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.578 ' O ' ' CD2' ' A' ' 138' ' ' PHE . 0.7 OUTLIER -74.19 -171.76 1.24 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.824 -1.172 . . . . 0.0 110.744 -178.31 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.559 ' CG2' ' CD1' ' A' ' 124' ' ' ILE . 71.2 t -154.53 143.12 14.59 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.32 -0.862 . . . . 0.0 109.41 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.522 ' HD2' ' CG1' ' A' ' 140' ' ' VAL . 35.5 Cg_endo -78.48 140.55 17.11 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.451 2.101 . . . . 0.0 110.2 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.94 38.29 3.2 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.7 t -105.15 -0.74 26.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -1.166 . . . . 0.0 109.694 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.57 162.65 32.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.117 -0.989 . . . . 0.0 109.527 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.578 ' O ' ' CE3' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -90.9 9.17 31.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.559 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.558 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 71.7 p -119.72 158.78 25.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.887 . . . . 0.0 109.281 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.596 ' CB ' ' CD1' ' A' ' 124' ' ' ILE . . . -135.51 153.32 51.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.193 -0.942 . . . . 0.0 109.633 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.3 t -98.94 151.26 21.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.193 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.626 ' CG2' ' CE2' ' A' ' 126' ' ' TYR . 12.4 mm -133.05 111.36 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.198 -0.939 . . . . 0.0 109.399 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.581 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 9.8 m120 -122.32 169.18 11.19 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.311 -0.868 . . . . 0.0 109.955 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 2.0 m120 76.12 20.23 1.68 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.959 . . . . 0.0 109.041 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.522 ' CD1' HD12 ' A' ' 108' ' ' LEU . 7.4 tt -76.7 149.45 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.441 -0.787 . . . . 0.0 109.643 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.47 ' HB2' ' OH ' ' A' ' 158' ' ' TYR . 4.2 mtpm? -103.7 117.44 59.83 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.959 . . . . 0.0 109.487 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.515 ' HA ' ' CB ' ' A' ' 184' ' ' THR . 35.3 Cg_endo -77.83 166.67 24.93 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.407 2.072 . . . . 0.0 110.481 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.513 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . 74.07 59.43 3.96 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 162.92 130.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -1.147 . . . . 0.0 109.599 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.596 ' CB ' ' CG2' ' A' ' 129' ' ' THR . 0.3 OUTLIER -47.22 161.72 0.07 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -141.78 176.58 8.8 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.773 -1.204 . . . . 0.0 110.44 -179.186 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.522 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 0.6 OUTLIER -146.89 168.72 20.76 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 179.235 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.501 ' CD1' ' O ' ' A' ' 159' ' ' THR . 31.1 mm -147.47 120.5 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.668 -1.27 . . . . 0.0 109.707 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.481 ' HA ' ' HA ' ' A' ' 179' ' ' SER . 0.9 OUTLIER -126.89 163.7 23.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.244 -0.91 . . . . 0.0 109.119 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.544 ' CD2' ' CD1' ' A' ' 98' ' ' LEU . 2.5 pp -160.86 146.32 14.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.867 -1.146 . . . . 0.0 110.988 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.593 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 1.9 m-85 -115.71 90.7 3.4 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.43 ' HB1' ' HD3' ' A' ' 95' ' ' PRO . . . -57.18 135.37 56.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.933 -1.104 . . . . 0.0 109.437 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.639 ' CG2' ' CZ ' ' A' ' 121' ' ' TYR . 48.2 t -107.56 124.65 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 109.576 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.533 ' CG2' ' HA ' ' A' ' 119' ' ' VAL . 0.7 OUTLIER -135.1 -38.22 0.78 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.665 -0.647 . . . . 0.0 109.744 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 166' ' ' THR . . . -37.91 139.12 0.58 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.51 ' HG2' ' NH2' ' A' ' 120' ' ' ARG . 1.4 mtp180 -150.17 16.38 0.84 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.335 -1.097 . . . . 0.0 109.572 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -82.15 -110.44 0.42 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.496 ' O ' ' CB ' ' A' ' 171' ' ' SER . 9.2 p-10 -89.34 21.06 3.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -1.137 . . . . 0.0 109.312 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 0.8 OUTLIER 162.97 139.15 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.349 -0.844 . . . . 0.0 109.175 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.66 96.6 1.1 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.502 2.135 . . . . 0.0 110.471 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -85.63 -166.53 1.55 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 109.432 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 175' ' ' SER . 5.0 p -155.14 126.97 7.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.227 -0.921 . . . . 0.0 109.536 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.481 ' HB2' HG13 ' A' ' 94' ' ' ILE . 85.8 p -54.35 -168.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 109.439 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.536 ' HB2' ' CD1' ' A' ' 94' ' ' ILE . 0.8 OUTLIER -73.47 151.91 89.67 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.942 . . . . 0.0 108.89 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.593 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 35.9 Cg_endo -79.24 118.92 4.08 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.427 2.085 . . . . 0.0 111.433 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.535 ' CG2' ' CG2' ' A' ' 94' ' ' ILE . 2.7 t -84.79 127.71 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 161' ' ' THR . 0.0 OUTLIER -124.52 129.31 50.38 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.21 -0.932 . . . . 0.0 110.586 -178.779 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.514 ' O ' ' CG2' ' A' ' 159' ' ' THR . 40.3 pt -114.78 -162.79 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.474 ' OD1' ' N ' ' A' ' 181' ' ' ASN . 1.1 m120 -124.5 156.81 36.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.047 -1.033 . . . . 0.0 109.758 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.578 ' CZ ' HD23 ' A' ' 108' ' ' LEU . 64.9 t80 -153.19 170.55 20.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.312 -0.868 . . . . 0.0 109.164 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.412 ' N ' ' CG ' ' A' ' 182' ' ' TYR . 19.2 mtpt -139.18 134.21 32.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 109.448 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.593 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 2.9 p . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.467 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.522 ' CD1' ' O ' ' A' ' 80' ' ' GLU . 1.3 mp -134.17 -162.87 1.29 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.234 -1.157 . . . . 0.0 109.534 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.45 ' OD2' ' HB2' ' A' ' 26' ' ' ARG . 1.1 m-20 -100.75 152.79 20.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 0.0 109.511 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -95.08 125.89 48.77 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.496 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.533 ' O ' ' CD2' ' A' ' 84' ' ' LEU . 36.2 Cg_endo -78.67 81.95 2.62 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.464 2.11 . . . . 0.0 110.322 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.536 ' HA ' ' CD2' ' A' ' 84' ' ' LEU . 2.7 p -74.68 -109.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.163 -0.96 . . . . 0.0 109.666 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.425 ' HA3' ' HB ' ' A' ' 23' ' ' VAL . . . 45.71 26.72 1.92 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.566 ' CE2' ' HA3' ' A' ' 86' ' ' GLY . 14.1 t80 -56.14 128.03 33.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.544 -0.974 . . . . 0.0 110.094 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.468 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 0.8 OUTLIER -147.75 -179.28 6.77 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.457 ' HB2' HD12 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -155.42 117.86 4.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.104 -0.997 . . . . 0.0 110.062 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.51 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 0.8 OUTLIER -145.73 -167.65 2.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.059 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.511 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 4.6 m-20 42.23 38.49 1.16 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 18' ' ' PHE . 2.5 mt -80.45 149.84 5.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.775 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -140.48 169.15 18.2 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.538 ' CB ' HG13 ' A' ' 117' ' ' VAL . . . -65.43 -62.61 1.43 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.71 -1.244 . . . . 0.0 110.159 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.503 ' ND2' ' OG1' ' A' ' 166' ' ' THR . 0.9 OUTLIER -91.37 27.86 1.83 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.116 -0.99 . . . . 0.0 109.511 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 14' ' ' THR . 56.7 p 179.48 154.72 0.5 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 13' ' ' ILE . 3.5 p90 -166.83 144.18 4.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.13 -0.981 . . . . 0.0 109.279 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.511 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 28.9 m -85.95 148.18 25.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.637 -1.289 . . . . 0.0 110.369 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.582 HG21 ' CE1' ' A' ' 18' ' ' PHE . 1.3 t -118.16 171.62 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.536 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 49.8 m-70 -151.76 165.02 35.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.004 -1.06 . . . . 0.0 110.006 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.585 ' CZ2' HG23 ' A' ' 50' ' ' VAL . 42.6 p90 -171.98 145.42 1.84 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.442 -0.786 . . . . 0.0 109.152 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.521 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.51 169.21 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.054 -1.029 . . . . 0.0 109.189 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.52 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -98.65 161.05 26.41 Favored Pre-proline 0 C--N 1.298 -1.643 0 O-C-N 121.54 -0.725 . . . . 0.0 109.819 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.463 ' HD3' ' HB3' ' A' ' 5' ' ' PRO . 35.8 Cg_endo -78.79 159.78 27.85 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.687 2.258 . . . . 0.0 110.397 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.45 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 5.1 mmm180 -90.28 17.07 7.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.222 -0.924 . . . . 0.0 109.408 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.54 ' CB ' ' HD2' ' A' ' 28' ' ' PRO . . . -121.04 177.13 1.57 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 109.374 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 35.4 Cg_endo -77.83 140.03 18.09 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.52 2.147 . . . . 0.0 110.333 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.636 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 28.7 pt -153.86 -173.47 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.526 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 17.1 p -133.95 3.31 3.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 109.579 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.57 -172.19 30.34 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.636 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -144.25 127.95 17.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.237 -1.155 . . . . 0.0 109.668 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.532 ' CG2' ' HD2' ' A' ' 49' ' ' ARG . 1.6 mp -80.74 130.84 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.274 -0.891 . . . . 0.0 108.772 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 48' ' ' ASP . 2.5 mm -107.54 112.34 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.166 -0.959 . . . . 0.0 109.966 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.529 ' CG ' ' HG2' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -104.55 116.77 32.65 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.137 -0.977 . . . . 0.0 108.582 179.098 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.553 ' CD2' ' C ' ' A' ' 36' ' ' HIS . 0.1 OUTLIER -105.95 144.36 32.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.085 -1.01 . . . . 0.0 109.797 -179.11 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.579 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 41.6 p-80 -169.5 114.47 0.54 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.586 -0.696 . . . . 0.0 109.91 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.513 ' HB1' ' CG2' ' A' ' 42' ' ' VAL . . . -61.37 175.21 0.6 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.42 -0.8 . . . . 0.0 109.609 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -54.86 -68.74 0.16 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.909 . . . . 0.0 109.323 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -165.25 50.06 0.1 Allowed 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.745 -0.597 . . . . 0.0 109.514 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.421 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 2.6 p -127.46 8.56 6.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.577 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.513 ' CG2' ' HB1' ' A' ' 38' ' ' ALA . 2.1 t -123.03 149.68 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.172 -0.955 . . . . 0.0 109.518 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -53.46 -88.63 0.01 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -117.22 146.26 37.79 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.292 -1.123 . . . . 0.0 109.421 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.528 ' HB3' ' CB ' ' A' ' 37' ' ' HIS . 36.2 Cg_endo -78.39 144.16 20.12 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.61 2.207 . . . . 0.0 110.534 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.51 ' CZ ' ' CB ' ' A' ' 46' ' ' ARG . 2.8 ptm85 -107.6 176.97 4.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 109.52 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.529 ' HG2' ' CG ' ' A' ' 35' ' ' ARG . 30.1 mt-30 -139.18 119.58 13.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.276 -0.89 . . . . 0.0 109.701 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.522 ' HB3' ' CD1' ' A' ' 57' ' ' ILE . 0.6 OUTLIER -111.58 118.22 35.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.358 -0.839 . . . . 0.0 108.822 179.503 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.532 ' HD2' ' CG2' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -92.99 140.31 29.6 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.013 -1.054 . . . . 0.0 109.546 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.585 HG23 ' CZ2' ' A' ' 22' ' ' TRP . 1.8 m -117.58 163.16 25.15 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.277 -0.89 . . . . 0.0 109.555 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.467 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 34.5 Cg_endo -76.98 174.84 12.2 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.634 2.222 . . . . 0.0 110.486 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.562 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.9 Cg_endo -76.73 -15.8 16.84 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.562 2.175 . . . . 0.0 110.316 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.6 m -103.26 25.71 9.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.277 -0.889 . . . . 0.0 109.16 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.463 ' HG3' ' HG2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -127.14 126.22 42.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.37 -0.831 . . . . 0.0 109.509 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.466 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 25.2 p-10 -111.82 5.43 19.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.884 . . . . 0.0 109.528 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.498 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 89.3 p -146.12 150.05 35.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 0.0 109.313 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 48' ' ' ASP . 4.2 tt -138.21 125.16 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -0.94 . . . . 0.0 109.586 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.468 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 0.3 OUTLIER -84.83 107.64 17.1 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.351 -0.843 . . . . 0.0 109.496 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.464 ' O ' ' HB2' ' A' ' 17' ' ' SER . 0.4 OUTLIER -84.82 149.61 25.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.94 . . . . 0.0 109.259 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.465 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 6.3 p -134.61 166.15 23.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.139 -0.976 . . . . 0.0 109.703 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 60' ' ' THR . 3.7 m120 61.04 61.06 1.68 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.283 -0.886 . . . . 0.0 109.655 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' A' ' 16' ' ' ASN . 1.7 mt -132.92 138.18 46.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.352 -0.842 . . . . 0.0 109.166 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.542 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 3.0 m-20 -44.56 133.3 4.78 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.12 -0.988 . . . . 0.0 108.797 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.498 ' HG2' ' OD2' ' A' ' 93' ' ' ASP . 35.9 Cg_endo -77.74 135.22 14.17 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.333 2.022 . . . . 0.0 111.373 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 71.36 64.91 2.59 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.43 HG21 ' N ' ' A' ' 67' ' ' GLU . 2.6 m -158.44 151.57 22.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.251 -1.146 . . . . 0.0 110.889 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.542 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 1.7 tt0 -84.43 133.95 34.48 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.542 ' OH ' ' N ' ' A' ' 63' ' ' ASN . 28.0 m-85 -119.81 130.98 55.18 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.882 -1.136 . . . . 0.0 110.856 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.579 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 3.4 t -85.56 97.49 5.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.429 HG21 ' NE2' ' A' ' 88' ' ' GLN . 3.1 t -94.06 125.48 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.291 -0.88 . . . . 0.0 109.759 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.507 ' CB ' HG12 ' A' ' 85' ' ' ILE . 1.3 p -96.74 138.62 34.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 109.72 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.442 ' O ' HG23 ' A' ' 72' ' ' ILE . 17.8 mm -114.45 77.35 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.332 -0.855 . . . . 0.0 109.27 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.491 ' CG2' ' N ' ' A' ' 74' ' ' ALA . 24.5 mt -75.04 163.71 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 109.46 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.491 ' N ' ' CG2' ' A' ' 73' ' ' ILE . . . -121.89 160.2 25.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 0.0 109.583 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.446 ' O ' ' OG1' ' A' ' 30' ' ' THR . 0.4 OUTLIER -145.11 131.9 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -0.923 . . . . 0.0 109.318 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -116.63 50.47 1.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.278 -0.889 . . . . 0.0 109.395 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.05 -90.24 1.34 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.414 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 17.4 tpp180 -114.53 0.77 14.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -1.129 . . . . 0.0 109.638 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.437 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 0.8 OUTLIER -96.44 -164.54 1.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.136 -0.978 . . . . 0.0 109.262 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.522 ' O ' ' CD1' ' A' ' 2' ' ' LEU . 23.2 mt-10 -147.58 -169.56 3.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.171 -0.956 . . . . 0.0 109.571 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.577 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.6 OUTLIER -155.33 -177.41 0.73 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.371 -0.831 . . . . 0.0 109.062 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.577 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.1 Cg_endo -77.85 131.03 10.88 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.162 1.908 . . . . 0.0 109.963 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.464 ' HA ' HG12 ' A' ' 73' ' ' ILE . 36.0 Cg_endo -77.8 86.87 1.58 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.524 2.149 . . . . 0.0 111.179 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.536 ' CD2' ' HA ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -75.26 131.28 40.25 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.096 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.545 ' CG2' ' CG1' ' A' ' 69' ' ' VAL . 3.8 mt -117.54 150.65 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.011 -1.055 . . . . 0.0 110.346 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.566 ' HA3' ' CE2' ' A' ' 8' ' ' PHE . . . -132.58 176.97 19.15 Favored Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.074 -2.011 . . . . 0.0 108.074 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -142.66 111.9 6.59 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.101 -1.234 . . . . 0.0 110.344 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.576 ' HG3' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -113.24 -158.82 0.66 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.014 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.542 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -148.07 130.06 15.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.716 -1.24 . . . . 0.0 110.525 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.508 ' OG1' ' CE2' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -74.45 134.83 42.32 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 65' ' ' GLY . 7.5 t -44.32 167.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.554 ' CB ' ' HD3' ' A' ' 176' ' ' LYS . 16.1 p -97.53 107.39 19.88 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 109.093 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.498 ' OD2' ' HG2' ' A' ' 64' ' ' PRO . 1.0 OUTLIER -59.62 -12.25 6.41 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.162 -0.961 . . . . 0.0 109.19 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.653 ' CD1' ' O ' ' A' ' 176' ' ' LYS . 0.4 OUTLIER -60.88 138.44 93.76 Favored Pre-proline 0 N--CA 1.483 1.201 0 O-C-N 120.936 -1.103 . . . . 0.0 108.525 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.54 ' CB ' ' O ' ' A' ' 113' ' ' GLU . 36.7 Cg_endo -82.58 137.82 9.26 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.502 2.135 . . . . 0.0 110.267 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.476 ' O ' ' N ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -86.53 -168.27 2.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.155 -0.966 . . . . 0.0 109.511 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 111' ' ' SER . 11.5 t0 71.78 33.09 1.8 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 109.702 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.527 HD22 ' CG2' ' A' ' 180' ' ' ILE . 31.5 tp -71.95 92.77 1.3 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.912 . . . . 0.0 109.396 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -133.28 157.88 44.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -0.926 . . . . 0.0 109.668 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.463 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 9.5 p -96.96 141.77 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.81 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.544 ' CD1' ' CD2' ' A' ' 109' ' ' LEU . 12.1 pt -123.59 -8.55 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.532 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 108' ' ' LEU . . . -147.12 112.83 5.69 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.488 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 12.9 m -112.72 96.44 5.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.136 -0.977 . . . . 0.0 110.599 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -83.11 165.92 38.3 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.243 -0.91 . . . . 0.0 108.653 178.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.457 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 30.0 Cg_endo -69.44 -3.83 12.58 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.275 1.984 . . . . 0.0 110.478 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.48 ' HA ' HG21 ' A' ' 152' ' ' ILE . 4.9 p -149.08 16.67 0.95 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.396 -0.815 . . . . 0.0 108.94 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.542 ' O ' ' CD2' ' A' ' 108' ' ' LEU . 0.7 OUTLIER -169.92 165.46 9.59 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.071 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.592 HD23 ' CE2' ' A' ' 182' ' ' TYR . 0.6 OUTLIER -145.65 155.69 43.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.358 -0.839 . . . . 0.0 109.259 -179.706 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.544 ' CD2' ' CD1' ' A' ' 101' ' ' ILE . 21.1 tp -105.42 136.52 44.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.284 -0.885 . . . . 0.0 108.94 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.523 ' CD1' ' HB1' ' A' ' 147' ' ' ALA . 1.2 pt -124.82 140.72 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.055 -1.028 . . . . 0.0 110.369 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 97' ' ' ASP . 7.5 t -134.46 145.19 48.61 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.602 ' CH2' ' N ' ' A' ' 147' ' ' ALA . 11.9 p90 -134.56 -171.31 2.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.076 -1.015 . . . . 0.0 110.707 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 95' ' ' PRO . 4.4 mm-40 -119.58 169.52 8.18 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.591 -0.693 . . . . 0.0 109.668 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 113' ' ' GLU . 32.4 Cg_endo -76.04 119.95 5.55 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.817 2.345 . . . . 0.0 110.743 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.502 ' HB3' ' O ' ' A' ' 94' ' ' ILE . 35.7 Cg_endo -80.36 -158.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.97 2.446 . . . . 0.0 111.732 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.481 ' O ' HG11 ' A' ' 117' ' ' VAL . . . -69.12 -5.4 22.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.5 -0.75 . . . . 0.0 109.927 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.538 HG13 ' CB ' ' A' ' 15' ' ' ALA . 2.4 m -155.84 -167.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.099 -1.001 . . . . 0.0 110.289 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.474 ' O ' HG22 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -89.44 -158.85 0.53 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.508 -0.745 . . . . 0.0 109.099 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.5 ' HA ' ' CG2' ' A' ' 166' ' ' THR . 2.1 t -154.94 131.37 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -0.941 . . . . 0.0 109.909 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.437 ' HB2' ' HA ' ' A' ' 166' ' ' THR . 12.6 ttt180 -78.08 -44.27 26.77 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.483 ' HB2' ' O ' ' A' ' 140' ' ' VAL . 0.8 OUTLIER -165.3 157.59 15.44 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.5 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.484 ' HB2' ' HB ' ' A' ' 140' ' ' VAL . 2.7 m-85 -111.76 147.89 34.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.965 -1.084 . . . . 0.0 109.83 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.582 ' O ' ' CD1' ' A' ' 163' ' ' TYR . 21.4 ttm180 -120.42 84.22 2.19 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.601 ' HB ' ' CE1' ' A' ' 138' ' ' PHE . 7.6 mt -84.42 168.72 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 110.274 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 136' ' ' GLN . 1.5 p -144.37 156.08 44.07 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.61 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.6 ' CE2' HG23 ' A' ' 149' ' ' ILE . 3.5 m-85 -91.24 137.43 32.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.519 -0.738 . . . . 0.0 109.034 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.615 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -102.69 111.52 4.02 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.46 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 5.8 mt-10 -107.92 75.11 0.98 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.134 -1.215 . . . . 0.0 109.311 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.95 141.62 57.91 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.052 -1.03 . . . . 0.0 109.644 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 152.28 -32.82 0.86 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -120.98 -103.69 1.9 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -102.33 -72.76 0.68 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -1.107 . . . . 0.0 109.414 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.533 ' N ' ' HD3' ' A' ' 134' ' ' PRO . 1.8 t -175.44 59.89 0.2 Allowed Pre-proline 0 C--N 1.294 -1.823 0 O-C-N 121.726 -0.609 . . . . 0.0 109.724 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 133' ' ' SER . 35.9 Cg_endo -77.61 112.72 3.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.582 2.188 . . . . 0.0 110.228 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.529 ' CG1' ' O ' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -122.3 147.0 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.133 -0.979 . . . . 0.0 109.698 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.478 ' O ' ' HA ' ' A' ' 125' ' ' THR . 1.2 tt0 -111.95 90.81 3.44 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 124' ' ' ILE . 0.5 OUTLIER -74.72 133.18 42.07 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.346 -0.846 . . . . 0.0 110.89 -178.679 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.601 ' CE1' ' HB ' ' A' ' 124' ' ' ILE . 43.6 p90 -134.69 145.19 48.28 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.458 ' O ' HG21 ' A' ' 140' ' ' VAL . 1.2 p -74.05 -175.71 2.29 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.943 -1.098 . . . . 0.0 110.791 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.544 ' CG1' ' HD2' ' A' ' 141' ' ' PRO . 72.0 t -157.21 144.03 13.38 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.446 -0.784 . . . . 0.0 109.297 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.544 ' HD2' ' CG1' ' A' ' 140' ' ' VAL . 34.0 Cg_endo -76.17 140.89 22.81 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.379 2.052 . . . . 0.0 110.361 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -88.58 35.62 3.58 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.401 ' C ' ' HD3' ' A' ' 144' ' ' LYS . 0.3 OUTLIER -105.27 -22.01 13.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.096 -1.237 . . . . 0.0 109.463 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.401 ' HD3' ' C ' ' A' ' 143' ' ' SER . 2.3 mptt -116.44 150.77 37.29 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.522 -0.736 . . . . 0.0 110.03 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.56 4.01 50.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.351 -0.843 . . . . 0.0 109.108 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.543 ' C ' ' CH2' ' A' ' 112' ' ' TRP . 1.6 p -130.2 151.94 50.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.389 -0.819 . . . . 0.0 108.827 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.602 ' N ' ' CH2' ' A' ' 112' ' ' TRP . . . -116.76 153.41 32.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.029 -1.045 . . . . 0.0 109.969 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.8 t -104.66 154.19 20.28 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.365 -0.834 . . . . 0.0 109.1 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.6 HG23 ' CE2' ' A' ' 126' ' ' TYR . 9.4 mm -134.75 114.25 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.482 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.58 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 3.2 m120 -122.28 170.95 9.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.287 -0.883 . . . . 0.0 109.984 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.439 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 4.3 m120 70.57 28.19 3.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 0.0 109.115 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.525 ' CD1' HD13 ' A' ' 108' ' ' LEU . 5.1 tt -84.56 147.13 5.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.393 -0.817 . . . . 0.0 109.713 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.459 ' HB2' ' OH ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -93.22 111.3 51.28 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.345 -0.847 . . . . 0.0 109.19 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.454 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 35.8 Cg_endo -77.29 141.51 20.5 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.319 2.013 . . . . 0.0 110.451 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.498 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . 90.41 64.59 1.22 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.498 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 163.49 134.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -1.154 . . . . 0.0 109.491 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 6.9 t0 -49.31 151.62 1.43 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.615 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -135.29 178.66 6.86 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.847 -1.158 . . . . 0.0 110.246 -179.285 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.555 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 3.4 m -150.06 107.7 3.67 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.531 ' CD1' HD11 ' A' ' 108' ' ' LEU . 9.0 mt -94.39 130.08 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.617 -1.302 . . . . 0.0 109.966 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.52 HG22 ' CB ' ' A' ' 179' ' ' SER . 1.8 m -132.15 113.67 13.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.356 -0.84 . . . . 0.0 109.265 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.583 ' HB2' HG12 ' A' ' 124' ' ' ILE . 2.1 pp -99.18 127.16 45.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.29 -0.881 . . . . 0.0 110.164 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.619 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 4.2 m-85 -100.39 171.94 7.45 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.534 ' CB ' HG12 ' A' ' 94' ' ' ILE . . . -148.92 135.24 19.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.138 -0.976 . . . . 0.0 109.628 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.517 ' CG1' ' O ' ' A' ' 173' ' ' ALA . 97.0 t -131.02 162.18 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 109.399 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.503 ' OG1' ' ND2' ' A' ' 16' ' ' ASN . 0.8 OUTLIER -139.43 -40.06 0.47 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.325 -0.859 . . . . 0.0 109.409 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 166' ' ' THR . . . -53.2 -170.17 0.03 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.4 -147.98 0.39 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -1.148 . . . . 0.0 109.597 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -74.46 -27.07 66.31 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.449 ' O ' ' OG ' ' A' ' 171' ' ' SER . 16.0 p-10 -74.87 -0.82 19.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.257 -1.143 . . . . 0.0 109.619 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.473 ' N ' ' HD3' ' A' ' 172' ' ' PRO . 3.0 m 177.33 63.97 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 108.989 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.473 ' HD3' ' N ' ' A' ' 171' ' ' SER . 34.8 Cg_endo -77.54 79.14 3.28 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.656 2.237 . . . . 0.0 110.885 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.517 ' O ' ' CG1' ' A' ' 165' ' ' VAL . . . -95.91 -165.96 1.36 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.313 -0.867 . . . . 0.0 108.806 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.464 ' HA ' HG21 ' A' ' 165' ' ' VAL . 0.7 OUTLIER -151.73 177.53 10.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.928 -1.107 . . . . 0.0 110.062 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.619 ' CB ' HG13 ' A' ' 94' ' ' ILE . 0.6 OUTLIER -115.66 159.89 20.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.667 -0.646 . . . . 0.0 109.561 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.653 ' O ' ' CD1' ' A' ' 94' ' ' ILE . 1.7 ptmt -42.36 118.69 2.2 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.171 -0.955 . . . . 0.0 110.45 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.619 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 29.7 Cg_endo -70.96 122.1 8.48 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.368 2.045 . . . . 0.0 111.199 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 161' ' ' THR . 57.4 t -84.77 118.79 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.52 ' CB ' HG22 ' A' ' 161' ' ' THR . 0.0 OUTLIER -109.9 126.52 53.95 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.132 -0.98 . . . . 0.0 110.551 -178.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.527 ' CG2' HD22 ' A' ' 98' ' ' LEU . 32.1 pt -117.55 151.16 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -79.5 163.33 24.8 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.006 -1.059 . . . . 0.0 109.8 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.592 ' CE2' HD23 ' A' ' 108' ' ' LEU . 46.2 t80 -159.19 114.98 2.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.437 -0.789 . . . . 0.0 109.122 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -87.14 116.87 25.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.113 -0.992 . . . . 0.0 109.447 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.558 HG23 ' CD1' ' A' ' 158' ' ' TYR . 9.2 p . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.481 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.512 HD11 ' CB ' ' A' ' 25' ' ' PRO . 0.5 OUTLIER -140.54 -163.7 1.58 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -1.164 . . . . 0.0 109.449 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.437 ' CG ' ' HB2' ' A' ' 26' ' ' ARG . 1.5 m-20 -81.04 161.53 24.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.235 -0.916 . . . . 0.0 109.459 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.1 t -95.2 112.01 57.0 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.513 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.49 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 35.1 Cg_endo -77.25 78.78 3.35 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.34 2.027 . . . . 0.0 110.134 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.468 ' HA ' ' CD2' ' A' ' 84' ' ' LEU . 0.9 OUTLIER -87.48 -104.6 0.07 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.238 -0.913 . . . . 0.0 109.565 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 9' ' ' ASP . . . 44.2 27.03 1.03 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.402 ' N ' ' C ' ' A' ' 6' ' ' THR . 12.7 t80 -49.06 93.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.44 -1.035 . . . . 0.0 109.688 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 7' ' ' GLY . 9.8 t0 -121.3 84.07 2.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.366 -0.833 . . . . 0.0 108.994 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 83.1 p -84.43 131.79 34.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.495 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.47 ' O ' ' HB ' ' A' ' 19' ' ' THR . 76.7 p -156.01 -156.36 0.63 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.336 -0.853 . . . . 0.0 109.537 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.542 ' CB ' ' OG1' ' A' ' 19' ' ' THR . 0.6 OUTLIER 45.0 34.59 1.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -178.537 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.566 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 13.6 mm -62.13 134.25 27.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.749 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.571 ' CB ' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -123.0 178.24 5.15 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 177.149 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.541 ' CB ' ' HB2' ' A' ' 93' ' ' ASP . . . -74.07 -74.73 0.18 Allowed 'General case' 0 C--N 1.292 -1.902 0 O-C-N 120.605 -1.309 . . . . 0.0 109.155 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.6 OUTLIER -75.68 -1.35 24.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.159 -0.963 . . . . 0.0 109.338 179.731 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.571 ' O ' ' CB ' ' A' ' 14' ' ' THR . 14.4 p -146.54 162.08 39.11 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.281 -0.887 . . . . 0.0 109.096 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.624 ' CD2' ' NE2' ' A' ' 88' ' ' GLN . 4.9 p90 -167.38 137.72 2.92 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.907 -1.121 . . . . 0.0 108.419 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.542 ' OG1' ' CB ' ' A' ' 12' ' ' ASP . 11.9 m -80.99 150.01 29.08 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.77 -1.206 . . . . 0.0 111.172 -178.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.623 ' CG2' ' CE1' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -135.34 109.85 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.518 ' CE1' HG23 ' A' ' 19' ' ' THR . 3.0 m-70 -102.01 166.31 10.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.032 -1.043 . . . . 0.0 110.509 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.502 ' CH2' HG23 ' A' ' 57' ' ' ILE . 38.9 p90 -175.71 147.72 0.83 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.49 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -74.51 159.27 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.966 -1.084 . . . . 0.0 110.083 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.79 168.97 8.46 Favored Pre-proline 0 C--N 1.299 -1.63 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.512 ' CB ' HD11 ' A' ' 2' ' ' LEU . 35.9 Cg_endo -78.61 -159.53 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.63 2.22 . . . . 0.0 110.196 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.437 ' HB2' ' CG ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -127.66 12.69 6.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.297 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.503 ' CB ' ' HD2' ' A' ' 28' ' ' PRO . . . -123.17 175.14 2.9 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 109.38 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 35.6 Cg_endo -78.24 112.05 3.15 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.586 2.19 . . . . 0.0 110.418 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.504 HD11 ' CG ' ' A' ' 25' ' ' PRO . 7.6 pt -116.0 -174.23 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.9 . . . . 0.0 109.388 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.5 p -114.88 2.87 14.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.567 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.507 ' HA2' ' N ' ' A' ' 52' ' ' PRO . . . 131.41 -173.04 20.59 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -134.26 145.3 48.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -1.111 . . . . 0.0 109.35 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.524 ' CG2' ' HD2' ' A' ' 49' ' ' ARG . 1.8 mp -92.9 129.17 43.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.269 -0.895 . . . . 0.0 109.065 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.522 ' CD1' HG21 ' A' ' 50' ' ' VAL . 1.7 mm -109.76 104.38 16.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.243 -0.91 . . . . 0.0 109.673 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.469 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 10.2 ttp85 -106.87 131.0 54.46 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.11 -0.994 . . . . 0.0 109.209 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.621 ' CD2' ' CD2' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -117.41 131.82 56.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.171 -0.956 . . . . 0.0 109.622 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.561 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 41.9 p-80 -151.04 132.74 14.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.316 -0.865 . . . . 0.0 109.796 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -53.22 -168.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.356 -0.84 . . . . 0.0 109.87 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.14 -99.06 0.16 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.047 -1.033 . . . . 0.0 110.4 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -74.31 -0.42 17.04 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.245 -0.909 . . . . 0.0 110.015 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.518 ' OG ' ' CB ' ' A' ' 38' ' ' ALA . 4.0 p -74.73 103.84 5.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.075 -1.016 . . . . 0.0 109.047 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 t -74.89 54.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.187 -0.946 . . . . 0.0 109.515 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.444 ' O ' ' HD3' ' A' ' 45' ' ' PRO . . . -105.22 134.05 11.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -48.59 106.67 0.64 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.344 -1.091 . . . . 0.0 109.387 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.444 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 35.5 Cg_endo -77.53 160.23 31.9 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.417 2.078 . . . . 0.0 110.386 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.585 ' HG3' ' CE1' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -106.92 163.95 12.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.206 -0.934 . . . . 0.0 109.4 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -127.77 126.78 42.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 109.993 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.478 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 0.8 OUTLIER -117.5 118.11 31.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.357 -0.84 . . . . 0.0 108.831 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.524 ' HD2' ' CG2' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -92.73 153.63 18.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.033 -1.042 . . . . 0.0 110.034 -179.407 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.522 HG21 ' CD1' ' A' ' 34' ' ' ILE . 1.1 m -129.03 163.75 43.66 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.824 . . . . 0.0 109.297 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.522 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.8 Cg_endo -77.43 174.8 12.15 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.593 2.195 . . . . 0.0 110.419 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.576 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 35.1 Cg_endo -77.06 -15.64 16.26 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.622 2.215 . . . . 0.0 110.582 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.19 28.71 6.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.244 -0.91 . . . . 0.0 109.555 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.522 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -128.87 103.33 6.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.93 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.68 -12.23 37.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.185 -0.947 . . . . 0.0 109.104 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 56.1 p -135.7 130.35 34.09 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.522 HD13 ' CG1' ' A' ' 50' ' ' VAL . 3.4 tt -126.65 133.78 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.075 -1.015 . . . . 0.0 110.083 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.49 106.12 18.1 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.621 ' CD2' ' CD2' ' A' ' 36' ' ' HIS . 1.5 mt -84.62 148.56 26.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.155 -0.965 . . . . 0.0 109.566 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.503 ' CG2' ' HB3' ' A' ' 17' ' ' SER . 27.6 p -142.24 -179.61 6.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.341 -0.849 . . . . 0.0 109.435 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.417 ' HB2' ' O ' ' A' ' 60' ' ' THR . 17.5 m-80 60.93 16.3 6.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.255 -0.903 . . . . 0.0 109.365 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.528 ' CD1' ' HB3' ' A' ' 59' ' ' LEU . 0.9 OUTLIER -94.86 143.57 26.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 109.261 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.46 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 2.5 t-20 -45.71 116.01 3.06 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 34.6 Cg_endo -75.86 136.63 18.93 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.214 1.943 . . . . 0.0 111.043 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 74.93 63.69 2.49 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.526 ' CG2' ' CE2' ' A' ' 68' ' ' TYR . 2.0 m -162.88 146.25 10.99 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.071 -1.253 . . . . 0.0 110.138 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.544 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 2.2 tp10 -74.79 128.23 35.07 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.536 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 20.4 m-85 -136.45 110.59 8.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.967 -1.083 . . . . 0.0 110.041 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.561 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 93.4 t -71.02 141.63 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.469 ' HA ' ' O ' ' A' ' 35' ' ' ARG . 1.3 t -117.57 126.5 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.993 -1.067 . . . . 0.0 110.022 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.483 ' HA ' HG12 ' A' ' 85' ' ' ILE . 3.1 p -102.76 112.14 24.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -0.861 . . . . 0.0 109.735 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.466 HD11 HD11 ' A' ' 34' ' ' ILE . 24.8 mm -94.41 111.29 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 0.0 109.528 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.578 ' N ' ' CD1' ' A' ' 73' ' ' ILE . 1.4 mp -112.3 122.44 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.961 . . . . 0.0 109.34 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.527 ' CB ' ' OG ' ' A' ' 81' ' ' SER . . . -98.03 122.05 40.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.238 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.411 HG13 ' HG2' ' A' ' 80' ' ' GLU . 13.0 m -132.79 141.04 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 109.7 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.456 ' HB2' ' HA ' ' A' ' 29' ' ' ILE . 30.8 t30 -110.91 44.71 1.24 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 109.363 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.11 -95.94 0.86 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.42 -0.35 19.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -1.123 . . . . 0.0 109.624 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.423 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 1.2 tt0 -116.88 171.88 7.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.58 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.423 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 30.3 mt-10 -149.84 96.46 2.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.437 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.553 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -59.77 179.62 0.2 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.265 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.4 Cg_endo -77.48 154.87 31.76 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.355 2.037 . . . . 0.0 110.348 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.52 143.73 21.95 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.636 2.224 . . . . 0.0 110.761 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.468 ' CD2' ' HA ' ' A' ' 6' ' ' THR . 23.7 tp -138.74 92.96 2.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.44 -0.788 . . . . 0.0 108.923 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.483 HG12 ' HA ' ' A' ' 71' ' ' SER . 1.9 mt -99.33 153.16 4.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.134 -0.979 . . . . 0.0 110.075 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.526 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . -148.37 -166.84 13.13 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -125.8 138.17 53.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.163 -1.198 . . . . 0.0 109.603 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.624 ' NE2' ' CD2' ' A' ' 18' ' ' PHE . 11.7 tm0? -154.5 115.09 3.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.293 -0.88 . . . . 0.0 109.197 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.544 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -98.55 134.3 41.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.315 -0.866 . . . . 0.0 109.714 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.435 ' CG2' ' O ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -74.24 162.67 28.69 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.131 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.57 HG12 ' CA ' ' A' ' 116' ' ' ALA . 0.2 OUTLIER -98.61 168.54 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.132 -0.98 . . . . 0.0 110.982 -178.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.507 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 17.0 p -79.62 110.26 14.78 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.541 ' HB2' ' CB ' ' A' ' 15' ' ' ALA . 2.0 t0 -68.48 -58.47 4.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.169 -0.957 . . . . 0.0 110.65 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.603 ' CD1' ' CB ' ' A' ' 176' ' ' LYS . 4.3 mt -80.12 140.56 53.46 Favored Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.15 -0.969 . . . . 0.0 110.305 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.649 ' CB ' ' CD1' ' A' ' 112' ' ' TRP . 34.6 Cg_endo -78.48 53.12 4.42 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.463 2.109 . . . . 0.0 109.487 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.463 ' O ' ' HB2' ' A' ' 112' ' ' TRP . 0.9 OUTLIER -49.96 -178.53 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.695 -0.628 . . . . 0.0 109.634 -179.502 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER 67.46 8.25 6.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.332 -0.855 . . . . 0.0 109.333 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.532 ' CD1' HD13 ' A' ' 162' ' ' LEU . 7.9 tp -57.27 90.21 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.221 -0.924 . . . . 0.0 108.923 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 97' ' ' ASP . 11.1 pt-20 -130.36 161.31 31.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.934 . . . . 0.0 109.523 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 10.7 p -95.76 144.27 10.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.29 -0.881 . . . . 0.0 109.638 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.532 ' CG1' HD21 ' A' ' 109' ' ' LEU . 0.2 OUTLIER -132.6 3.79 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.279 -0.888 . . . . 0.0 109.449 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.52 ' CB ' ' HB2' ' A' ' 109' ' ' LEU . . . -162.97 94.26 0.83 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.469 ' HB2' ' OH ' ' A' ' 182' ' ' TYR . 21.0 p -91.68 105.85 18.04 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.409 -0.807 . . . . 0.0 110.585 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.478 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -93.25 159.39 35.43 Favored Pre-proline 0 C--N 1.304 -1.373 0 O-C-N 121.371 -0.83 . . . . 0.0 108.889 178.886 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.426 ' O ' ' HG3' ' A' ' 154' ' ' PRO . 30.6 Cg_endo -70.22 -2.65 10.84 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.472 2.114 . . . . 0.0 110.455 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.515 ' HA ' HG21 ' A' ' 152' ' ' ILE . 61.9 p -150.5 19.49 0.83 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.55 ' CB ' ' O ' ' A' ' 149' ' ' ILE . 0.5 OUTLIER -168.98 167.7 10.59 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.982 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.585 HD23 ' CE2' ' A' ' 182' ' ' TYR . 0.5 OUTLIER -140.37 151.77 45.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.335 -0.853 . . . . 0.0 109.224 -179.782 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.532 HD21 ' CG1' ' A' ' 101' ' ' ILE . 0.1 OUTLIER -106.26 118.84 37.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.109 179.389 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.532 HD12 ' CA ' ' A' ' 148' ' ' THR . 0.0 OUTLIER -101.85 145.1 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.258 -0.901 . . . . 0.0 109.764 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.458 ' OG ' HG23 ' A' ' 146' ' ' THR . 0.4 OUTLIER -140.82 115.75 9.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.403 -0.811 . . . . 0.0 109.135 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.649 ' CD1' ' CB ' ' A' ' 95' ' ' PRO . 25.8 p90 -145.01 170.61 15.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.408 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.462 ' O ' ' HD3' ' A' ' 115' ' ' PRO . 4.8 mt-10 -71.06 139.98 85.47 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.15 -0.969 . . . . 0.0 109.495 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.534 ' HB3' ' CB ' ' A' ' 145' ' ' SER . 35.3 Cg_endo -78.41 111.24 2.99 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.507 2.138 . . . . 0.0 110.471 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.507 ' HB3' ' O ' ' A' ' 92' ' ' SER . 35.8 Cg_endo -78.84 99.16 1.24 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.334 2.023 . . . . 0.0 110.318 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.57 ' CA ' HG12 ' A' ' 91' ' ' VAL . . . -76.49 53.8 0.88 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.315 -0.865 . . . . 0.0 109.12 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.598 ' CG2' ' CG2' ' A' ' 119' ' ' VAL . 16.3 m -109.0 172.42 2.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.275 -0.891 . . . . 0.0 109.517 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.472 ' O ' ' HB ' ' A' ' 166' ' ' THR . 29.2 m -69.57 64.82 0.19 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.162 -0.961 . . . . 0.0 109.622 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.598 ' CG2' ' CG2' ' A' ' 117' ' ' VAL . 43.7 t -102.75 131.73 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.547 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.538 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -74.33 -42.71 58.97 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.593 ' CD2' ' N ' ' A' ' 122' ' ' TYR . 4.7 p90 -166.3 -174.91 3.06 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.562 -0.711 . . . . 0.0 109.385 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.593 ' N ' ' CD2' ' A' ' 121' ' ' TYR . 4.2 m-85 -130.42 139.43 50.6 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.591 ' HG2' ' CE2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -96.73 102.88 14.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.785 -1.197 . . . . 0.0 110.035 -179.017 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.566 HD13 ' CZ ' ' A' ' 138' ' ' PHE . 6.4 mt -84.57 106.07 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.531 ' HA ' ' CB ' ' A' ' 137' ' ' GLU . 32.3 p -93.05 141.96 27.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 110.549 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.656 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 4.8 m-30 -94.66 136.77 34.58 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.603 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -105.09 108.94 3.16 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -107.26 136.78 46.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -1.151 . . . . 0.0 109.734 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.541 ' CG2' ' HB3' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -88.91 152.69 21.58 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.191 -0.943 . . . . 0.0 109.288 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 124.78 -38.23 2.39 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.33 7.6 60.7 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.454 ' O ' ' ND2' ' A' ' 132' ' ' ASN . 0.2 OUTLIER -96.84 23.97 6.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -1.153 . . . . 0.0 109.397 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.85 157.07 2.16 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.284 -0.885 . . . . 0.0 109.473 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.01 147.78 24.2 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.609 2.206 . . . . 0.0 110.334 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -54.85 170.89 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.288 -0.882 . . . . 0.0 109.585 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.59 ' O ' ' CG ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -123.41 100.85 7.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.34 -0.85 . . . . 0.0 108.958 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.531 ' CB ' ' HA ' ' A' ' 125' ' ' THR . 7.3 pt-20 -112.38 145.62 39.77 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.918 -1.114 . . . . 0.0 110.774 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.566 ' CZ ' HD13 ' A' ' 124' ' ' ILE . 6.3 p90 -135.23 150.52 50.09 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.504 ' CG2' ' CE2' ' A' ' 121' ' ' TYR . 2.0 p -74.61 142.69 44.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.988 -1.07 . . . . 0.0 111.106 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.529 ' CG2' HG13 ' A' ' 124' ' ' ILE . 2.0 t -110.61 146.24 33.94 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.481 ' N ' HG11 ' A' ' 140' ' ' VAL . 34.5 Cg_endo -77.38 140.12 19.1 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.342 2.028 . . . . 0.0 109.761 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -83.08 13.63 43.44 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.458 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 7.6 t -105.25 23.59 13.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.034 -1.274 . . . . 0.0 109.855 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.458 ' HG2' ' O ' ' A' ' 143' ' ' SER . 1.6 mmtt -155.11 142.0 19.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.115 -0.991 . . . . 0.0 109.85 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.562 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -95.11 -8.74 35.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.349 -0.844 . . . . 0.0 109.404 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.563 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 32.2 p -130.37 150.61 51.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.234 -0.916 . . . . 0.0 109.216 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.458 ' O ' HG12 ' A' ' 110' ' ' ILE . . . -145.89 -172.6 3.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.128 -0.982 . . . . 0.0 109.538 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.532 ' CA ' HD12 ' A' ' 110' ' ' ILE . 51.8 m -144.95 134.94 23.81 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.217 -0.927 . . . . 0.0 109.577 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.656 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 1.0 OUTLIER -81.05 145.0 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.322 -0.861 . . . . 0.0 108.953 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.498 ' N ' HG21 ' A' ' 149' ' ' ILE . 10.6 m-20 -130.49 169.56 15.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.332 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 150' ' ' ASN . 3.0 p30 40.68 62.36 1.41 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.37 -0.831 . . . . 0.0 109.81 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.515 HG21 ' HA ' ' A' ' 106' ' ' THR . 10.6 tt -106.95 165.77 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.301 -0.875 . . . . 0.0 109.334 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.492 ' N ' HG12 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -101.37 105.86 42.29 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.119 -0.988 . . . . 0.0 109.369 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 152' ' ' ILE . 35.6 Cg_endo -77.98 169.24 20.82 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.404 2.069 . . . . 0.0 110.456 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . 70.17 60.69 4.66 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 164.48 131.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.318 -1.107 . . . . 0.0 109.628 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.541 ' HB3' ' CG2' ' A' ' 129' ' ' THR . 2.2 t0 -47.56 162.25 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.096 -1.003 . . . . 0.0 108.387 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.647 ' CD1' ' CG2' ' A' ' 184' ' ' THR . 0.3 OUTLIER -140.53 -174.57 4.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.888 -1.133 . . . . 0.0 110.211 -179.524 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.538 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 2.6 m -158.1 110.36 2.32 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.523 HD13 ' CD1' ' A' ' 108' ' ' LEU . 40.6 mm -94.27 141.73 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.839 -1.163 . . . . 0.0 110.567 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.532 ' CG2' ' HB2' ' A' ' 179' ' ' SER . 0.2 OUTLIER -141.57 133.61 27.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.459 -0.776 . . . . 0.0 109.137 179.455 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.536 ' CD2' HG12 ' A' ' 124' ' ' ILE . 1.8 mt -112.55 135.19 53.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 0.0 110.564 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.601 ' CD1' ' HB3' ' A' ' 177' ' ' PRO . 22.0 m-85 -117.94 164.87 14.42 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.549 ' HB3' ' CD2' ' A' ' 122' ' ' TYR . . . -142.88 88.59 2.06 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.015 -1.053 . . . . 0.0 109.406 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.446 ' HA ' ' HB3' ' A' ' 174' ' ' SER . 47.9 t -72.94 130.31 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.378 -0.826 . . . . 0.0 109.72 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.518 ' O ' ' CD ' ' A' ' 120' ' ' ARG . 42.1 p -121.77 -67.79 0.94 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.427 -0.796 . . . . 0.0 109.387 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 172' ' ' PRO . . . -59.22 128.38 47.25 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.45 ' HG3' ' HG3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -147.67 15.24 1.1 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.273 -1.134 . . . . 0.0 109.532 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -126.35 -55.07 0.15 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.518 ' O ' ' CB ' ' A' ' 171' ' ' SER . 0.3 OUTLIER -99.29 1.05 44.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -1.133 . . . . 0.0 109.583 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 0.9 OUTLIER 163.49 138.08 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.252 -0.905 . . . . 0.0 109.296 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.45 ' HA ' ' O ' ' A' ' 167' ' ' GLY . 35.9 Cg_endo -78.21 102.02 1.53 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.499 2.133 . . . . 0.0 110.274 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -121.09 169.42 10.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.215 -0.928 . . . . 0.0 109.585 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 95.4 p -161.95 144.11 11.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.323 -0.861 . . . . 0.0 109.433 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.526 ' OG ' ' CB ' ' A' ' 164' ' ' ALA . 0.6 OUTLIER -54.65 -168.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.188 -0.945 . . . . 0.0 109.476 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.603 ' CB ' ' CD1' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -78.52 129.59 73.95 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.325 -0.859 . . . . 0.0 109.312 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.601 ' HB3' ' CD1' ' A' ' 163' ' ' TYR . 35.3 Cg_endo -77.53 127.14 8.72 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.07 1.847 . . . . 0.0 110.244 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.519 ' CG2' HG23 ' A' ' 94' ' ' ILE . 2.1 t -110.29 136.29 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.532 ' HB2' ' CG2' ' A' ' 161' ' ' THR . 4.7 t -119.62 165.47 14.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 110.476 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.471 HG13 ' HB ' ' A' ' 160' ' ' ILE . 11.8 pt -154.3 152.09 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -81.85 162.99 22.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.096 -1.003 . . . . 0.0 109.943 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.585 ' CE2' HD23 ' A' ' 108' ' ' LEU . 64.5 t80 -154.9 159.31 40.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.419 -0.801 . . . . 0.0 109.45 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.97 116.95 17.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.285 -0.884 . . . . 0.0 109.33 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.647 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.521 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.493 ' CD1' ' HB3' ' A' ' 79' ' ' GLU . 72.5 mt -128.95 -162.85 1.23 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -1.157 . . . . 0.0 109.5 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 45.2 m-20 -156.11 125.49 6.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.572 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.542 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -95.26 178.3 1.51 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.0 109.309 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.595 ' HD3' ' CE1' ' A' ' 32' ' ' TYR . 35.9 Cg_endo -78.9 164.03 25.5 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.593 2.195 . . . . 0.0 109.989 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.499 ' CG2' ' O ' ' A' ' 5' ' ' PRO . 4.0 p -162.08 174.63 12.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.068 -1.02 . . . . 0.0 109.711 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 44.54 27.16 1.2 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.585 ' C ' ' CD1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -72.29 -162.43 0.09 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.392 -1.064 . . . . 0.0 109.587 -179.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.76 -163.35 0.63 Allowed 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.112 -0.993 . . . . 0.0 109.592 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.529 ' CB ' ' HG2' ' A' ' 88' ' ' GLN . 0.3 OUTLIER -154.86 141.93 19.31 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.362 -0.836 . . . . 0.0 109.351 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.515 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 3.5 p -146.72 -163.29 1.72 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.304 -0.873 . . . . 0.0 109.498 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.525 ' CB ' ' OG1' ' A' ' 19' ' ' THR . 4.5 m-20 44.45 38.07 2.39 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.533 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 40.6 mm -70.1 125.7 28.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.587 0.708 . . . . 0.0 110.305 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.562 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -119.5 177.75 4.81 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.31 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.526 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -72.9 -69.59 0.4 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.722 -1.236 . . . . 0.0 109.457 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -83.06 8.6 12.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.973 -1.079 . . . . 0.0 109.414 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.562 ' O ' ' N ' ' A' ' 14' ' ' THR . 2.8 t -154.51 156.56 36.89 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.59 ' CE1' ' CG2' ' A' ' 20' ' ' VAL . 2.2 p90 -166.66 137.19 3.25 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.525 ' OG1' ' CB ' ' A' ' 12' ' ' ASP . 10.1 m -87.76 153.98 20.92 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.949 -1.095 . . . . 0.0 111.174 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.59 ' CG2' ' CE1' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -134.41 119.52 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.148 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.515 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 20.1 m-70 -103.36 164.28 11.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.02 -1.05 . . . . 0.0 110.368 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.527 ' CB ' ' HB2' ' A' ' 8' ' ' PHE . 22.8 p90 -177.3 135.59 0.19 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.555 -0.715 . . . . 0.0 109.084 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.29 167.43 2.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.183 -0.948 . . . . 0.0 109.517 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.517 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -102.18 165.38 13.98 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.474 ' HB3' ' O ' ' A' ' 3' ' ' ASP . 36.0 Cg_endo -78.23 -163.14 0.2 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.499 2.133 . . . . 0.0 110.299 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -120.59 28.33 8.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.925 . . . . 0.0 109.404 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.472 ' CB ' ' HD2' ' A' ' 28' ' ' PRO . . . -129.36 173.54 5.59 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 0.0 109.551 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.472 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 36.1 Cg_endo -78.4 130.44 10.0 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.615 2.21 . . . . 0.0 110.453 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.566 HD11 ' CE2' ' A' ' 32' ' ' TYR . 17.6 pt -135.98 169.93 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.918 . . . . 0.0 109.474 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.465 HG22 ' N ' ' A' ' 77' ' ' GLY . 17.4 p -107.12 -19.95 13.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.476 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.08 -152.83 15.5 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.641 ' CE1' ' CB ' ' A' ' 74' ' ' ALA . 1.2 m-85 -162.08 123.23 2.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -1.123 . . . . 0.0 109.447 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.537 HD11 ' CD ' ' A' ' 49' ' ' ARG . 14.9 mm -85.41 122.65 38.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.189 -0.945 . . . . 0.0 109.624 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.588 ' CG2' ' CD1' ' A' ' 72' ' ' ILE . 2.6 mm -102.89 114.31 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.056 -1.028 . . . . 0.0 109.321 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.485 ' CB ' ' OG ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -105.58 144.86 31.75 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.103 -0.998 . . . . 0.0 108.912 179.361 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.624 ' CD2' ' CD2' ' A' ' 59' ' ' LEU . 0.9 OUTLIER -143.53 140.14 30.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.056 -1.027 . . . . 0.0 110.032 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -176.17 144.39 0.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.32 -0.863 . . . . 0.0 109.665 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.557 ' HA ' ' CB ' ' A' ' 68' ' ' TYR . . . -64.99 170.48 4.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 109.605 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -76.84 -27.45 55.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.33 -0.856 . . . . 0.0 109.453 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -120.01 10.9 11.6 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.53 ' OG ' ' CB ' ' A' ' 38' ' ' ALA . 20.6 p -106.41 93.46 4.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 109.668 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.449 ' CG1' ' O ' ' A' ' 42' ' ' VAL . 59.1 t -114.66 31.15 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.933 . . . . 0.0 109.114 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.494 ' C ' ' HD3' ' A' ' 45' ' ' PRO . . . -104.44 -42.16 1.92 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.538 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 45.9 mtm-85 -121.94 51.67 3.1 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.14 -1.212 . . . . 0.0 111.037 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.538 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 34.9 Cg_endo -75.3 121.98 6.79 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.052 1.835 . . . . 0.0 110.171 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.555 ' HD3' ' CE1' ' A' ' 36' ' ' HIS . 1.2 ptp85 -119.89 162.26 19.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.748 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.472 ' CG ' ' HG3' ' A' ' 35' ' ' ARG . 14.2 mp0 -126.91 118.1 23.89 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.312 -0.867 . . . . 0.0 109.568 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 34' ' ' ILE . 65.8 m-20 -100.96 122.8 44.13 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.537 ' CD ' HD11 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.18 140.53 32.35 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.031 -1.043 . . . . 0.0 109.493 -179.264 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.527 ' CG2' HD12 ' A' ' 34' ' ' ILE . 11.9 m -124.08 159.56 56.13 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.341 -0.849 . . . . 0.0 109.355 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 34.5 Cg_endo -77.14 174.37 12.92 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.581 2.187 . . . . 0.0 110.279 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.457 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 34.6 Cg_endo -76.96 -16.09 16.2 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.498 2.132 . . . . 0.0 110.486 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.401 ' O ' ' OG ' ' A' ' 53' ' ' SER . 11.7 t -100.85 27.86 5.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.351 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.432 ' HG3' ' HG2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -130.65 116.71 18.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.938 . . . . 0.0 109.677 -179.819 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -102.87 -6.01 22.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.394 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 62.7 p -139.2 130.84 27.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.357 -0.84 . . . . 0.0 109.018 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.509 HD11 ' CG1' ' A' ' 50' ' ' VAL . 5.4 tt -123.24 124.92 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.164 -0.96 . . . . 0.0 109.816 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.75 109.91 20.56 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.441 -0.787 . . . . 0.0 109.184 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.624 ' CD2' ' CD2' ' A' ' 36' ' ' HIS . 1.2 mp -84.83 158.65 20.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.164 -0.96 . . . . 0.0 109.778 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.527 ' CG2' ' HB2' ' A' ' 17' ' ' SER . 0.8 OUTLIER -150.86 175.29 12.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.654 -0.654 . . . . 0.0 109.332 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.499 ' O ' ' NH2' ' A' ' 46' ' ' ARG . 6.1 m120 52.57 37.8 24.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 0.0 109.496 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.527 ' CD1' ' HB3' ' A' ' 59' ' ' LEU . 5.2 mt -109.59 161.17 15.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 109.387 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -55.07 113.33 5.26 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.526 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 34.5 Cg_endo -74.19 123.64 8.43 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.984 1.79 . . . . 0.0 111.009 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 82.67 64.56 1.68 Allowed Glycine 0 N--CA 1.485 1.916 0 N-CA-C 108.186 -1.966 . . . . 0.0 108.186 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.0 m -152.27 118.9 5.69 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.126 -1.22 . . . . 0.0 110.821 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.531 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 11.6 tt0 -74.82 135.74 41.62 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.584 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -153.44 176.54 11.9 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.79 -1.193 . . . . 0.0 111.076 -178.436 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.528 ' CG1' ' O ' ' A' ' 86' ' ' GLY . 1.9 t -107.27 151.55 9.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.438 HG11 ' O ' ' A' ' 35' ' ' ARG . 1.1 t -132.98 130.92 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.983 -1.073 . . . . 0.0 109.492 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.565 ' CB ' ' CG1' ' A' ' 85' ' ' ILE . 10.5 p -108.44 156.43 19.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.254 -0.904 . . . . 0.0 110.484 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.588 ' CD1' ' CG2' ' A' ' 34' ' ' ILE . 28.4 mm -135.71 92.51 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.516 ' CD1' ' HB3' ' A' ' 83' ' ' PRO . 1.2 mm -83.71 140.85 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.106 -0.996 . . . . 0.0 109.928 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.641 ' CB ' ' CE1' ' A' ' 32' ' ' TYR . . . -96.38 157.86 15.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 109.181 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.446 HG11 ' O ' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -148.69 136.55 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 109.47 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 76' ' ' ASN . 12.6 t-20 -135.14 46.37 2.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 109.424 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.465 ' N ' HG22 ' A' ' 30' ' ' THR . . . 103.52 -91.57 0.84 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.51 1.36 13.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -1.167 . . . . 0.0 109.647 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.516 ' O ' ' CG ' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -92.72 -171.66 2.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.97 . . . . 0.0 109.47 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 79' ' ' GLU . 4.9 mt-10 -171.16 91.49 0.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.487 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.569 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.6 OUTLIER -59.55 -179.18 0.15 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 108.987 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.569 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 31.4 Cg_endo -74.49 150.35 40.68 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.08 1.853 . . . . 0.0 110.348 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.516 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 36.1 Cg_endo -77.57 144.11 22.17 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.811 2.341 . . . . 0.0 111.62 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.502 HD21 ' CB ' ' A' ' 5' ' ' PRO . 3.4 tp -109.7 93.65 4.61 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.565 ' CG1' ' CB ' ' A' ' 71' ' ' SER . 3.3 mt -100.23 141.19 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.939 . . . . 0.0 110.15 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.528 ' O ' ' CG1' ' A' ' 69' ' ' VAL . . . -136.66 -165.06 10.38 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -129.94 140.0 51.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.985 -1.303 . . . . 0.0 109.77 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.529 ' HG2' ' CB ' ' A' ' 10' ' ' SER . 2.4 tp60 -154.29 -165.36 2.07 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.372 -0.83 . . . . 0.0 109.318 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.531 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.43 130.28 2.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.256 -0.903 . . . . 0.0 109.57 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.583 ' OG1' ' CE2' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -73.16 138.35 45.66 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.281 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.598 ' O ' ' N ' ' A' ' 65' ' ' GLY . 2.3 t -56.94 -169.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 178.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.528 ' CB ' ' HA ' ' A' ' 115' ' ' PRO . 20.9 t -133.35 176.69 8.3 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.196 -1.565 . . . . 0.0 110.925 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.524 ' HA ' HG22 ' A' ' 117' ' ' VAL . 0.5 OUTLIER -165.57 -46.05 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.542 ' CD1' ' HB2' ' A' ' 176' ' ' LYS . 8.1 mt -104.82 141.68 23.06 Favored Pre-proline 0 C--N 1.304 -1.38 0 O-C-N 121.485 -0.759 . . . . 0.0 109.102 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.587 ' CG ' ' CD1' ' A' ' 162' ' ' LEU . 35.7 Cg_endo -78.83 70.51 7.39 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.38 2.053 . . . . 0.0 109.891 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.576 ' CB ' ' CZ ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -65.9 -165.34 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.444 -0.785 . . . . 0.0 109.734 -179.648 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 64.41 11.62 6.66 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.235 -0.915 . . . . 0.0 109.227 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.495 ' CD2' HG12 ' A' ' 180' ' ' ILE . 19.7 tp -59.25 92.77 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.281 -0.887 . . . . 0.0 109.213 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -126.5 160.53 30.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.264 -0.898 . . . . 0.0 109.335 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 8.5 p -104.64 138.47 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.402 -0.811 . . . . 0.0 109.818 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.522 ' CG1' HD21 ' A' ' 109' ' ' LEU . 8.7 pt -122.96 -11.23 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.389 -0.82 . . . . 0.0 109.407 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.426 ' HB2' ' HB2' ' A' ' 109' ' ' LEU . . . -134.73 82.12 1.94 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.526 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 6.4 m -85.81 95.4 9.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.816 . . . . 0.0 110.45 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.495 ' OG1' ' OG ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -96.24 159.66 31.55 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 121.244 -0.91 . . . . 0.0 109.036 179.052 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.476 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.4 Cg_endo -70.47 -1.74 9.55 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.509 2.139 . . . . 0.0 110.738 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.499 ' HA ' HG21 ' A' ' 152' ' ' ILE . 7.1 p -144.68 10.93 1.41 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 109.342 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.534 ' HA ' ' O ' ' A' ' 149' ' ' ILE . 3.2 p -169.01 166.6 11.02 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 118.907 -1.117 . . . . 0.0 109.767 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.608 HD23 ' CE1' ' A' ' 182' ' ' TYR . 0.4 OUTLIER -141.75 150.77 42.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.137 -0.977 . . . . 0.0 109.091 -179.557 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.522 HD21 ' CG1' ' A' ' 101' ' ' ILE . 13.9 tp -106.26 116.33 31.74 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 108.824 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.588 ' CD1' ' CD1' ' A' ' 124' ' ' ILE . 3.2 pt -102.35 149.4 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.079 -1.013 . . . . 0.0 110.192 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.467 ' HA ' ' HA ' ' A' ' 146' ' ' THR . 5.1 t -153.1 125.18 7.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.516 -0.74 . . . . 0.0 109.382 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.578 ' CE2' ' O ' ' A' ' 145' ' ' SER . 3.1 p90 -124.21 -170.13 2.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.233 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -102.08 157.52 33.54 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.14 -0.975 . . . . 0.0 109.914 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.38 121.46 5.23 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.783 2.322 . . . . 0.0 110.164 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.53 ' HG2' ' CG2' ' A' ' 119' ' ' VAL . 35.8 Cg_endo -77.81 140.0 18.11 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.458 2.105 . . . . 0.0 110.881 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.95 -6.28 31.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.273 -0.892 . . . . 0.0 109.255 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.524 HG22 ' HA ' ' A' ' 93' ' ' ASP . 3.0 m -94.3 177.02 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.388 -0.82 . . . . 0.0 109.277 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.523 ' O ' ' CG2' ' A' ' 166' ' ' THR . 58.6 m -78.23 155.58 30.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 109.771 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.579 HG13 ' CZ ' ' A' ' 122' ' ' TYR . 19.5 t -144.69 129.68 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.362 -0.836 . . . . 0.0 109.566 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 166' ' ' THR . 2.8 tpm_? -95.01 -53.84 3.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.255 -0.903 . . . . 0.0 109.065 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.485 ' HB2' ' O ' ' A' ' 140' ' ' VAL . 1.6 p90 -165.36 151.15 9.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.371 -0.831 . . . . 0.0 108.995 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.579 ' CZ ' HG13 ' A' ' 119' ' ' VAL . 3.0 m-85 -106.11 115.35 30.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.98 -1.075 . . . . 0.0 109.56 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 5.5 ttm180 -84.62 98.81 10.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.11 -0.994 . . . . 0.0 109.017 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.588 ' CD1' ' CD1' ' A' ' 110' ' ' ILE . 55.2 mt -84.25 151.42 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 0.0 110.045 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 46.2 p -123.92 133.27 53.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.46 -0.775 . . . . 0.0 109.901 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.652 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 4.9 m-85 -80.19 118.36 21.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.49 -0.756 . . . . 0.0 109.359 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.56 ' O ' ' HA ' ' A' ' 158' ' ' TYR . . . -91.94 105.74 3.32 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -107.47 96.61 6.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -1.126 . . . . 0.0 108.876 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -55.2 -80.59 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 O-C-N 120.948 -1.095 . . . . 0.0 109.544 -179.893 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -83.5 46.09 3.58 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -89.86 -77.36 1.32 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.521 ' O ' ' CB ' ' A' ' 133' ' ' SER . 5.3 t-20 -159.48 -44.31 0.05 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.211 -1.17 . . . . 0.0 109.769 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.543 ' N ' ' HD2' ' A' ' 134' ' ' PRO . 0.1 OUTLIER 162.01 -53.09 0.0 OUTLIER Pre-proline 0 C--N 1.297 -1.695 0 O-C-N 121.724 -0.61 . . . . 0.0 109.813 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 133' ' ' SER . 35.5 Cg_endo -77.44 160.34 32.14 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.517 2.145 . . . . 0.0 110.688 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.535 ' CG1' ' O ' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -108.98 170.92 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.362 -0.837 . . . . 0.0 109.25 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.527 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 2.6 mm100 -119.36 99.39 6.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.199 -0.938 . . . . 0.0 108.874 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 13.2 pt-20 -101.96 149.87 23.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -0.948 . . . . 0.0 110.743 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.586 ' CZ ' HD13 ' A' ' 124' ' ' ILE . 34.1 p90 -143.07 145.75 33.17 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.0 p -75.01 149.69 39.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.99 -1.069 . . . . 0.0 110.589 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.537 ' CG2' HD13 ' A' ' 124' ' ' ILE . 53.7 t -112.31 141.6 25.4 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 121.762 -0.586 . . . . 0.0 109.443 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.467 ' HD2' HG12 ' A' ' 140' ' ' VAL . 35.6 Cg_endo -77.66 141.81 19.92 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.433 2.088 . . . . 0.0 110.307 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -88.03 23.0 15.68 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.414 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 1.9 m -104.42 -0.94 27.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -1.149 . . . . 0.0 109.576 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 143' ' ' SER . 15.2 mmtt -143.02 153.85 43.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 109.48 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.578 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 0.4 OUTLIER -93.35 -18.27 22.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 109.395 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.467 ' HA ' ' HA ' ' A' ' 111' ' ' SER . 66.1 p -107.77 152.79 23.89 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.199 -0.938 . . . . 0.0 108.941 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.517 ' HB1' ' CD1' ' A' ' 110' ' ' ILE . . . -130.96 148.17 52.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.064 -1.023 . . . . 0.0 109.635 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 8.2 t -91.08 147.42 23.09 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.184 -0.948 . . . . 0.0 109.347 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.652 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 13.9 mm -128.46 95.62 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.358 -0.839 . . . . 0.0 109.119 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.522 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 2.6 m-20 -104.54 -164.17 1.03 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.517 -0.74 . . . . 0.0 109.733 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.511 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 6.6 p-10 42.03 60.58 2.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.429 -0.794 . . . . 0.0 109.902 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.569 HG13 ' CE2' ' A' ' 158' ' ' TYR . 6.4 tt -116.52 155.28 18.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.269 -0.894 . . . . 0.0 109.568 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.07 117.19 67.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.753 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.476 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 35.9 Cg_endo -78.91 163.85 25.63 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.518 2.146 . . . . 0.0 110.562 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 61.8 51.47 57.07 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -177.37 130.45 0.16 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.223 -1.163 . . . . 0.0 109.699 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.486 ' O ' ' OG1' ' A' ' 129' ' ' THR . 1.1 t0 -51.62 165.93 0.15 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.569 ' CE2' HG13 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -144.98 172.68 12.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.881 -1.137 . . . . 0.0 110.255 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.527 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 1.8 m -145.7 96.74 2.86 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 179' ' ' SER . 51.5 mm -84.69 132.44 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.889 -1.132 . . . . 0.0 109.705 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.52 HG21 ' CB ' ' A' ' 179' ' ' SER . 1.1 m -142.26 165.33 27.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.309 -0.869 . . . . 0.0 109.24 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.587 ' CD1' ' CG ' ' A' ' 95' ' ' PRO . 1.3 pp -159.64 151.13 20.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.013 -1.054 . . . . 0.0 110.72 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.599 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 2.1 m-85 -122.03 90.45 3.31 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.546 ' HB3' ' CD2' ' A' ' 122' ' ' TYR . . . -54.0 117.47 3.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.864 -1.147 . . . . 0.0 109.039 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 22.2 t -102.76 168.57 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.892 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.531 ' CG2' ' HA ' ' A' ' 119' ' ' VAL . 0.8 OUTLIER -145.08 -40.41 0.24 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.332 -0.855 . . . . 0.0 109.548 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -99.97 138.93 14.15 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -146.72 88.57 1.77 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -1.121 . . . . 0.0 109.484 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -174.59 -81.9 0.05 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 2.4 m-20 -119.02 10.03 12.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.324 -1.104 . . . . 0.0 109.349 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 170' ' ' ASP . 75.5 m -168.63 81.27 0.75 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.275 -0.891 . . . . 0.0 109.552 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.86 98.83 1.23 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.643 2.228 . . . . 0.0 110.412 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -100.52 166.42 10.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.36 -0.838 . . . . 0.0 109.558 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 175' ' ' SER . 1.2 p -165.09 132.65 3.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.335 -0.853 . . . . 0.0 109.422 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 174' ' ' SER . 84.6 p -55.47 -166.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.168 -0.957 . . . . 0.0 109.21 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.542 ' HB2' ' CD1' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -74.59 145.78 82.58 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 108.829 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.599 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 34.9 Cg_endo -77.71 133.77 13.04 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.429 2.086 . . . . 0.0 111.019 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.54 ' CG2' HG23 ' A' ' 94' ' ' ILE . 2.2 t -105.82 134.47 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.52 ' CB ' HG21 ' A' ' 161' ' ' THR . 1.3 p -131.45 143.24 50.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 110.558 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.495 HG12 ' CD2' ' A' ' 98' ' ' LEU . 13.4 pt -129.89 152.44 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -82.57 168.71 17.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.082 -1.012 . . . . 0.0 109.7 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.608 ' CE1' HD23 ' A' ' 108' ' ' LEU . 44.2 t80 -165.21 124.32 1.75 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.323 -0.86 . . . . 0.0 109.415 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -95.19 112.13 23.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.009 -1.057 . . . . 0.0 109.443 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.427 ' HB ' ' HA ' ' A' ' 154' ' ' PRO . 28.9 p . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.524 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.459 HD12 ' HB3' ' A' ' 81' ' ' SER . 1.5 pp -161.71 143.74 11.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -1.144 . . . . 0.0 109.472 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.44 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 21.7 m-20 -74.91 148.12 40.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.391 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.491 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 18.0 p -84.5 159.97 57.49 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.591 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.526 ' O ' ' CD2' ' A' ' 84' ' ' LEU . 35.5 Cg_endo -78.27 96.77 1.1 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.715 2.277 . . . . 0.0 109.943 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.438 ' HA ' HD21 ' A' ' 84' ' ' LEU . 2.1 p -83.89 -111.65 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.166 -0.959 . . . . 0.0 109.79 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 22' ' ' TRP . . . 45.53 26.12 1.58 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.447 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 13.5 t80 -55.59 107.76 0.37 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.485 -1.009 . . . . 0.0 110.003 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -133.52 100.21 4.74 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.405 -0.809 . . . . 0.0 108.841 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.455 ' HA ' HG11 ' A' ' 20' ' ' VAL . 4.7 m -84.63 128.27 34.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.216 -0.928 . . . . 0.0 109.578 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 19' ' ' THR . 5.5 p -164.0 -157.06 0.37 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.316 -0.865 . . . . 0.0 109.402 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.494 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 2.5 m-20 47.33 38.01 6.71 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.648 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.5 mt -87.07 163.84 2.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.761 0.791 . . . . 0.0 111.427 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.516 ' N ' ' CG2' ' A' ' 13' ' ' ILE . 0.7 OUTLIER -155.27 -172.83 4.31 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.492 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -81.02 -44.14 18.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.931 -1.106 . . . . 0.0 109.484 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 17' ' ' SER . 1.5 m120 -114.6 39.75 2.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.991 -1.068 . . . . 0.0 109.037 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.473 ' O ' HG21 ' A' ' 14' ' ' THR . 5.8 p 168.55 145.5 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.648 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 2.0 p90 -164.97 145.38 7.3 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.108 -0.995 . . . . 0.0 108.827 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.504 ' CG2' ' N ' ' A' ' 20' ' ' VAL . 52.3 m -112.34 164.23 13.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.737 -1.227 . . . . 0.0 111.132 -178.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.516 ' C ' ' CD2' ' A' ' 21' ' ' HIS . 1.6 t -130.43 168.42 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.516 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 19.9 m-70 -144.35 161.88 37.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.936 -1.102 . . . . 0.0 110.104 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.576 ' CD1' ' O ' ' A' ' 22' ' ' TRP . 10.0 p90 -168.18 142.19 3.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.434 -0.791 . . . . 0.0 109.171 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.85 166.02 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.04 -1.037 . . . . 0.0 109.435 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.486 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -94.01 165.57 17.5 Favored Pre-proline 0 C--N 1.3 -1.585 0 O-C-N 121.634 -0.666 . . . . 0.0 109.632 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.449 ' HD2' ' HB2' ' A' ' 24' ' ' ALA . 35.7 Cg_endo -78.27 178.12 7.95 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.606 2.204 . . . . 0.0 110.384 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.08 12.82 26.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 109.442 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.526 ' CB ' ' HD2' ' A' ' 28' ' ' PRO . . . -118.13 176.71 1.52 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.409 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.526 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 34.9 Cg_endo -77.7 118.05 4.42 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.538 2.159 . . . . 0.0 110.285 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.633 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 47.3 pt -131.47 179.99 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 109.614 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.7 p -120.71 -22.11 6.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.864 . . . . 0.0 109.458 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 167.97 174.68 37.08 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.633 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -124.42 133.73 53.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.248 -1.148 . . . . 0.0 109.391 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.514 HG21 ' N ' ' A' ' 34' ' ' ILE . 44.8 mm -74.95 144.42 12.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.187 -0.945 . . . . 0.0 109.251 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.517 ' CG1' HG21 ' A' ' 50' ' ' VAL . 7.9 mm -124.57 93.15 2.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.21 -0.931 . . . . 0.0 110.058 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.464 ' HB2' ' OG ' ' A' ' 71' ' ' SER . 1.0 OUTLIER -104.17 128.53 51.86 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.581 ' NE2' ' CD2' ' A' ' 59' ' ' LEU . 54.5 p-80 -148.33 176.85 9.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.727 -1.233 . . . . 0.0 110.845 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.582 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 9.1 p-80 176.9 -173.37 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.48 ' CB ' ' CE1' ' A' ' 68' ' ' TYR . . . -112.55 132.17 55.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.165 -0.959 . . . . 0.0 109.175 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.463 ' HG2' ' HB2' ' A' ' 67' ' ' GLU . 1.3 pt-20 -54.78 -18.55 4.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 0.0 109.556 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -104.74 14.17 30.15 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 109.469 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 60.3 p -99.91 -147.74 0.35 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.517 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.472 HG23 ' N ' ' A' ' 43' ' ' GLY . 11.2 p -74.92 167.56 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.187 -0.946 . . . . 0.0 109.563 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.472 ' N ' HG23 ' A' ' 42' ' ' VAL . . . -54.58 -99.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.7 mmm180 -46.54 143.05 4.22 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.195 -1.179 . . . . 0.0 109.397 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.58 ' HB3' ' CG ' ' A' ' 37' ' ' HIS . 36.4 Cg_endo -79.39 171.55 15.82 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.571 2.181 . . . . 0.0 110.447 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.52 ' NE ' ' OD1' ' A' ' 48' ' ' ASP . 0.8 OUTLIER -84.38 159.59 20.82 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.197 -0.939 . . . . 0.0 108.986 179.49 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.454 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 47.0 mt-30 -100.43 134.63 43.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 110.589 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.52 ' OD1' ' NE ' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -149.24 147.82 28.84 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.967 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.508 ' HG3' ' CD1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -134.53 158.79 43.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.864 -1.147 . . . . 0.0 110.104 -179.055 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.517 HG21 ' CG1' ' A' ' 34' ' ' ILE . 12.3 m -136.87 161.08 63.64 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.468 -0.77 . . . . 0.0 109.076 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.508 ' HG2' ' CD ' ' A' ' 54' ' ' ARG . 33.5 Cg_endo -76.21 174.12 13.35 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.478 2.119 . . . . 0.0 110.333 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.567 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.2 Cg_endo -76.49 -29.51 5.91 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.587 2.192 . . . . 0.0 110.518 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -82.91 -7.78 59.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.398 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.518 ' HD3' ' N ' ' A' ' 54' ' ' ARG . 3.4 mpt_? -93.96 109.34 21.08 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.412 -0.805 . . . . 0.0 109.838 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -97.27 -1.51 44.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.423 -0.798 . . . . 0.0 109.377 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 77.2 p -140.99 147.83 39.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.297 -0.877 . . . . 0.0 109.168 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.43 ' C ' HG21 ' A' ' 19' ' ' THR . 1.4 tt -131.95 119.49 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.119 -0.988 . . . . 0.0 109.388 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.46 ' OG1' ' OG1' ' A' ' 19' ' ' THR . 45.7 m -87.85 138.06 31.79 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.349 -0.845 . . . . 0.0 109.62 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.581 ' CD2' ' NE2' ' A' ' 36' ' ' HIS . 4.6 mt -111.23 159.46 17.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.512 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.437 HG21 ' O ' ' A' ' 59' ' ' LEU . 7.5 p -144.37 173.37 11.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -0.882 . . . . 0.0 109.475 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m120 52.9 52.36 14.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -0.891 . . . . 0.0 109.546 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.528 ' CD1' ' HB3' ' A' ' 59' ' ' LEU . 7.7 mt -122.17 133.51 54.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.472 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.498 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 42.5 m-20 -48.66 128.15 13.77 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.056 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.1 Cg_endo -78.01 133.6 12.5 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.36 2.04 . . . . 0.0 110.665 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 82.89 61.24 1.96 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.462 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 4.5 m -162.37 159.86 25.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.392 -1.064 . . . . 0.0 109.734 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.527 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 2.0 mm-40 -90.77 134.5 34.38 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.369 -0.832 . . . . 0.0 108.839 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.516 ' CZ ' ' HB3' ' A' ' 62' ' ' LEU . 15.0 m-85 -119.17 115.52 24.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.086 -1.009 . . . . 0.0 109.709 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.582 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 1.4 t -82.48 120.06 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.899 . . . . 0.0 108.99 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.541 ' HA ' ' CB ' ' A' ' 36' ' ' HIS . 27.1 t -117.92 138.61 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 109.443 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.545 ' CB ' HG12 ' A' ' 85' ' ' ILE . 80.2 p -116.84 139.1 51.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 110.13 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.7 mm -120.49 92.37 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.415 -0.803 . . . . 0.0 109.207 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.452 ' HB ' ' HB ' ' A' ' 33' ' ' ILE . 25.1 mm -90.78 137.52 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 109.634 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.442 ' HB2' ' HB3' ' A' ' 81' ' ' SER . . . -99.54 137.79 37.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.423 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.23 150.21 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 0.0 109.444 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.436 ' ND2' ' O ' ' A' ' 28' ' ' PRO . 1.8 t-20 -137.53 49.82 1.98 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.43 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.91 -94.48 2.0 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.0 tpt85 -106.65 -0.76 23.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -1.153 . . . . 0.0 109.501 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 1.6 mt-10 -100.38 148.99 24.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.191 -0.943 . . . . 0.0 109.316 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.72 103.85 8.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.676 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.579 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -59.7 -178.41 0.13 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 108.931 179.687 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.579 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 32.7 Cg_endo -75.82 151.08 35.54 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.171 1.914 . . . . 0.0 110.204 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.406 ' HA ' HD11 ' A' ' 73' ' ' ILE . 35.0 Cg_endo -77.23 115.21 3.91 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.675 2.25 . . . . 0.0 111.379 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.526 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 12.5 tp -106.08 104.25 13.91 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.545 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.8 mt -111.56 162.25 9.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.039 -1.038 . . . . 0.0 110.4 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.501 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -155.77 162.91 31.49 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.467 ' HG2' ' CG1' ' A' ' 69' ' ' VAL . 4.0 mt-30 -136.66 118.56 15.22 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.119 -1.224 . . . . 0.0 110.042 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -110.59 -146.94 0.41 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.54 136.72 3.88 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.879 -1.138 . . . . 0.0 110.341 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.93 137.88 41.97 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.19 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.581 ' CG1' ' CB ' ' A' ' 116' ' ' ALA . 1.8 t -54.87 161.01 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.517 -0.739 . . . . 0.0 109.308 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.5 m -102.67 154.26 19.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 109.795 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -91.48 -40.65 11.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.355 -0.84 . . . . 0.0 109.416 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.535 HD12 ' CB ' ' A' ' 176' ' ' LYS . 2.7 mt -77.23 141.56 66.85 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.171 -0.956 . . . . 0.0 109.208 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.528 ' HB2' ' CD1' ' A' ' 112' ' ' TRP . 36.4 Cg_endo -80.61 82.95 2.33 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.592 2.195 . . . . 0.0 110.186 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.6 OUTLIER -70.61 -176.62 1.32 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.63 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER 77.01 27.82 0.68 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 109.67 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.402 HD22 HG12 ' A' ' 180' ' ' ILE . 33.6 tp -76.97 101.88 6.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.148 -0.97 . . . . 0.0 109.394 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -137.15 170.2 16.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.561 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 11.8 p -93.75 147.97 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.197 -0.939 . . . . 0.0 109.665 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.524 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 11.7 pt -129.7 -2.41 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.369 -0.832 . . . . 0.0 109.552 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.523 ' HB1' ' CD1' ' A' ' 109' ' ' LEU . . . -165.33 116.26 1.11 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.318 -0.864 . . . . 0.0 108.68 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.504 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.8 t -104.48 93.23 4.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.114 -0.991 . . . . 0.0 110.221 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.56 ' OG1' ' N ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -78.41 163.48 61.5 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.314 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.459 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 29.6 Cg_endo -68.4 -2.44 9.12 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.4 2.067 . . . . 0.0 110.856 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.523 ' HA ' HG21 ' A' ' 152' ' ' ILE . 11.6 p -155.26 20.75 0.42 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.294 -0.879 . . . . 0.0 108.723 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.56 ' N ' ' OG1' ' A' ' 104' ' ' THR . 52.4 p -173.43 161.47 4.11 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.935 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.6 ' CD1' ' CE1' ' A' ' 182' ' ' TYR . 0.6 OUTLIER -139.67 155.76 47.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.371 -0.83 . . . . 0.0 109.274 -179.665 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.524 ' HB3' ' CG1' ' A' ' 101' ' ' ILE . 19.8 mt -100.29 132.78 45.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.291 -0.881 . . . . 0.0 108.892 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.553 ' CD1' ' CD1' ' A' ' 149' ' ' ILE . 0.5 OUTLIER -119.63 141.27 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.168 -0.958 . . . . 0.0 109.809 -179.617 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 97' ' ' ASP . 37.8 t -133.75 135.17 43.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.411 -0.806 . . . . 0.0 109.385 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.568 ' CE2' ' O ' ' A' ' 145' ' ' SER . 43.4 p90 -140.28 143.21 35.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.399 -0.813 . . . . 0.0 109.288 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.463 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 8.9 mm-40 -69.88 136.67 87.54 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.944 . . . . 0.0 109.282 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.74 142.84 18.23 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.425 2.083 . . . . 0.0 110.385 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.531 ' HG2' ' CG2' ' A' ' 119' ' ' VAL . 35.8 Cg_endo -78.48 175.87 10.57 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.525 2.15 . . . . 0.0 110.265 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.581 ' CB ' ' CG1' ' A' ' 91' ' ' VAL . . . -95.05 3.73 54.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 109.57 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 4.9 m -95.36 171.01 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.175 -0.953 . . . . 0.0 109.404 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.468 ' O ' HG23 ' A' ' 166' ' ' THR . 0.4 OUTLIER -82.9 98.16 9.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.396 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.573 HG12 ' CE2' ' A' ' 122' ' ' TYR . 22.4 t -86.37 127.54 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 109.752 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -55.46 5.88 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.584 ' CE2' ' HG2' ' A' ' 123' ' ' ARG . 2.8 p90 -165.61 174.76 9.5 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.573 ' CE2' HG12 ' A' ' 119' ' ' VAL . 5.5 m-85 -120.54 154.52 35.22 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.791 -1.193 . . . . 0.0 110.085 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.584 ' HG2' ' CE2' ' A' ' 121' ' ' TYR . 4.5 mmm-85 -112.07 88.08 2.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.389 -0.819 . . . . 0.0 109.032 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.629 ' CG2' ' CE2' ' A' ' 138' ' ' PHE . 88.9 mt -84.08 160.24 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 109.491 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.534 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 18.5 p -145.32 150.78 37.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.127 -0.983 . . . . 0.0 110.474 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.65 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 2.5 m-85 -87.31 139.72 30.27 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.598 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -105.74 107.48 2.8 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.463 ' O ' ' HD2' ' A' ' 134' ' ' PRO . 6.2 mt-10 -107.61 85.98 2.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.11 -1.229 . . . . 0.0 109.475 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.451 HG22 ' OD2' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -63.19 140.77 58.91 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.008 -1.057 . . . . 0.0 109.826 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 176.18 -89.62 0.08 OUTLIER Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 132' ' ' ASN . . . -154.39 64.83 0.33 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 131' ' ' GLY . 0.3 OUTLIER 160.31 -22.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.467 -1.02 . . . . 0.0 109.3 179.795 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.562 ' N ' ' HD3' ' A' ' 134' ' ' PRO . 1.4 m 64.4 56.4 1.54 Allowed Pre-proline 0 C--N 1.298 -1.651 0 O-C-N 121.632 -0.668 . . . . 0.0 110.359 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 133' ' ' SER . 36.1 Cg_endo -77.74 118.53 4.53 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.423 2.082 . . . . 0.0 109.594 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.527 ' CG1' ' O ' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -113.01 141.7 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.116 -0.99 . . . . 0.0 110.13 -179.177 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.476 ' O ' ' HA ' ' A' ' 125' ' ' THR . 0.1 OUTLIER -108.59 98.51 8.02 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.206 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 0.8 OUTLIER -79.38 128.19 33.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 111.057 -178.6 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.629 ' CE2' ' CG2' ' A' ' 124' ' ' ILE . 17.8 p90 -128.11 140.04 52.16 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.482 ' CG2' ' CE2' ' A' ' 121' ' ' TYR . 1.2 p -74.44 153.52 39.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.046 -1.034 . . . . 0.0 111.103 -178.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.537 ' CG2' HD13 ' A' ' 124' ' ' ILE . 94.5 t -118.07 143.18 32.29 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.536 ' HD2' ' CG1' ' A' ' 140' ' ' VAL . 34.2 Cg_endo -76.81 119.65 5.21 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.332 2.021 . . . . 0.0 110.298 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -55.47 -17.13 11.94 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.3 t -83.84 12.32 6.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.157 -1.202 . . . . 0.0 109.696 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.447 ' HB2' ' HG2' ' A' ' 141' ' ' PRO . 43.1 mmtt -139.08 122.53 17.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.954 . . . . 0.0 109.552 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.568 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 11.9 p -82.28 -5.37 58.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.919 . . . . 0.0 109.506 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.54 ' C ' ' CH2' ' A' ' 112' ' ' TRP . 6.9 p -124.87 154.08 41.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.25 -0.906 . . . . 0.0 109.357 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.584 ' CB ' ' CD1' ' A' ' 124' ' ' ILE . . . -123.98 168.52 12.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.882 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.528 ' CG2' ' OD1' ' A' ' 150' ' ' ASN . 22.4 m -130.8 104.12 6.98 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.303 -0.873 . . . . 0.0 109.306 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.65 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -82.57 93.3 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.033 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.542 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 1.7 m-20 -100.28 174.1 6.29 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.282 -0.886 . . . . 0.0 109.632 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 67.09 37.0 3.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 109.193 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.523 HG21 ' HA ' ' A' ' 106' ' ' THR . 4.5 tt -95.45 161.8 2.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.445 -0.784 . . . . 0.0 109.733 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -98.27 108.85 49.6 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.222 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.461 ' HG3' HG21 ' A' ' 106' ' ' THR . 36.2 Cg_endo -77.22 75.74 4.5 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.483 2.122 . . . . 0.0 110.568 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . 168.48 59.36 0.03 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 163.59 136.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -1.109 . . . . 0.0 109.533 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.451 ' OD2' HG22 ' A' ' 129' ' ' THR . 22.8 t70 -46.34 158.01 0.12 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.63 ' CD1' ' CG2' ' A' ' 184' ' ' THR . 0.3 OUTLIER -140.6 -177.21 4.94 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.873 -1.142 . . . . 0.0 110.496 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.57 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 3.1 m -157.83 114.45 2.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.484 -0.76 . . . . 0.0 109.093 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.465 HG21 HD11 ' A' ' 160' ' ' ILE . 25.4 mm -97.03 126.71 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.567 -1.333 . . . . 0.0 109.73 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.576 ' CG2' ' CB ' ' A' ' 179' ' ' SER . 1.3 m -138.96 167.2 22.58 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.221 -0.924 . . . . 0.0 109.357 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.511 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 0.9 OUTLIER -162.95 150.35 13.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.912 -1.117 . . . . 0.0 111.109 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.612 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.3 m-85 -121.39 100.11 6.85 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -55.13 129.26 37.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.871 -1.143 . . . . 0.0 109.084 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.568 HG22 ' CZ ' ' A' ' 121' ' ' TYR . 65.1 t -106.29 153.59 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.931 . . . . 0.0 109.863 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.526 ' CG2' ' HA ' ' A' ' 119' ' ' VAL . 0.7 OUTLIER -148.26 -38.88 0.18 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.443 -0.786 . . . . 0.0 109.608 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 166' ' ' THR . . . -59.11 -138.99 0.01 OUTLIER Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.501 ' N ' ' HB3' ' A' ' 172' ' ' PRO . 4.6 mmm180 -74.31 -131.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -1.115 . . . . 0.0 110.253 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -137.82 -44.78 0.08 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -74.69 -11.49 60.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -1.171 . . . . 0.0 109.258 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.548 ' N ' ' HD3' ' A' ' 172' ' ' PRO . 0.9 OUTLIER -176.6 59.84 0.18 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.492 -0.755 . . . . 0.0 109.279 179.582 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 171' ' ' SER . 36.2 Cg_endo -79.25 -171.44 1.25 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.507 2.138 . . . . 0.0 110.533 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -111.44 129.32 56.06 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 2.0 p -121.57 130.83 53.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.148 -0.97 . . . . 0.0 110.011 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.469 ' OG ' HG12 ' A' ' 94' ' ' ILE . 16.8 p -54.85 -168.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.327 -0.858 . . . . 0.0 109.035 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.535 ' CB ' HD12 ' A' ' 94' ' ' ILE . 1.8 mtmt -68.16 144.27 96.69 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.0 -1.062 . . . . 0.0 108.706 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.612 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.1 Cg_endo -76.68 132.78 13.53 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.317 2.011 . . . . 0.0 111.437 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.439 HG22 ' CG2' ' A' ' 94' ' ' ILE . 3.7 t -106.01 130.64 57.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.576 ' CB ' ' CG2' ' A' ' 161' ' ' THR . 1.1 p -130.17 147.88 51.95 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.123 -0.986 . . . . 0.0 110.808 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.402 HG12 HD22 ' A' ' 98' ' ' LEU . 19.0 pt -131.55 151.84 36.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -86.04 156.58 20.36 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.046 -1.034 . . . . 0.0 109.672 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.6 ' CE1' ' CD1' ' A' ' 108' ' ' LEU . 54.1 t80 -161.22 123.8 3.11 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.335 -0.853 . . . . 0.0 109.432 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.87 130.78 38.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.23 -0.919 . . . . 0.0 109.542 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.63 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 6.4 p . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.495 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.434 ' C ' ' HG ' ' A' ' 2' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.458 HD12 ' HB3' ' A' ' 79' ' ' GLU . 1.4 mp -138.6 -167.96 2.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.185 -1.185 . . . . 0.0 109.298 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.527 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 3.2 m-20 -74.89 153.52 38.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.866 . . . . 0.0 108.954 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.452 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 89.9 p -96.53 107.81 38.49 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.344 -0.847 . . . . 0.0 110.115 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.601 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 36.4 Cg_endo -80.15 77.72 3.96 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.56 2.173 . . . . 0.0 109.893 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.594 ' CG2' ' CD2' ' A' ' 84' ' ' LEU . 73.6 p -93.16 -104.74 0.12 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.154 -0.966 . . . . 0.0 110.112 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 55.81 20.73 26.96 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -44.68 127.67 6.28 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.749 -0.853 . . . . 0.0 109.929 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.452 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 4.7 t0 -162.81 105.81 1.07 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.362 -0.836 . . . . 0.0 109.047 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.466 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 16.1 m -84.89 127.29 34.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.908 . . . . 0.0 109.736 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.512 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 3.5 p -154.49 -163.17 1.54 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.518 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 2.4 m-20 44.9 38.59 3.03 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.609 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.6 mm -74.57 130.01 36.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.581 0.705 . . . . 0.0 110.851 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.549 ' CB ' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -119.35 175.63 5.73 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.923 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' CB ' ' OD1' ' A' ' 93' ' ' ASP . . . -67.01 -75.56 0.09 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.865 -1.147 . . . . 0.0 109.463 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 15.3 p-10 -78.66 -2.5 39.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.302 -0.874 . . . . 0.0 109.82 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.549 ' O ' ' CB ' ' A' ' 14' ' ' THR . 6.4 t -143.27 160.83 39.76 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.245 -0.909 . . . . 0.0 109.058 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.629 ' CE2' ' NE2' ' A' ' 88' ' ' GLN . 3.5 p90 -167.33 145.66 4.85 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.518 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 2.8 m -109.98 157.18 19.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.353 -1.467 . . . . 0.0 111.395 -178.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 56' ' ' SER . 1.0 OUTLIER -123.11 166.63 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.017 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.512 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 26.1 m-70 -137.67 160.23 39.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.94 -1.1 . . . . 0.0 110.404 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.579 ' CZ2' HG23 ' A' ' 50' ' ' VAL . 21.7 p90 177.56 139.61 0.08 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.487 HG11 ' N ' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -74.34 159.19 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 120.946 -1.096 . . . . 0.0 110.116 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.487 ' N ' HG11 ' A' ' 23' ' ' VAL . . . -96.82 165.58 15.66 Favored Pre-proline 0 C--N 1.3 -1.545 0 O-C-N 121.819 -0.551 . . . . 0.0 109.774 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.562 ' CG ' ' CD1' ' A' ' 29' ' ' ILE . 36.2 Cg_endo -79.56 145.38 18.41 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.604 2.203 . . . . 0.0 110.181 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.451 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 0.7 OUTLIER -80.21 5.52 14.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 0.0 109.493 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.476 ' CB ' ' HD2' ' A' ' 28' ' ' PRO . . . -108.23 173.68 2.89 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.935 . . . . 0.0 109.448 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.476 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 35.7 Cg_endo -78.03 88.57 1.42 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.657 2.238 . . . . 0.0 110.55 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.562 ' CD1' ' CG ' ' A' ' 25' ' ' PRO . 36.0 pt -98.13 -179.79 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.397 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.507 HG23 ' N ' ' A' ' 77' ' ' GLY . 2.3 p -102.13 -21.49 14.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.345 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.49 165.36 10.27 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.633 ' CD1' ' CG2' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -90.5 148.6 22.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -1.091 . . . . 0.0 110.314 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.604 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -102.3 103.38 14.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.839 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.538 ' N ' ' CD1' ' A' ' 34' ' ' ILE . 1.3 mm -88.28 117.59 32.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 O-C-N 121.314 -0.866 . . . . 0.0 109.885 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -122.72 111.77 17.13 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.374 -0.829 . . . . 0.0 108.879 179.407 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.634 ' CE1' ' CD2' ' A' ' 59' ' ' LEU . 1.4 p-80 -105.98 122.0 45.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.935 . . . . 0.0 110.11 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.574 ' CE1' ' O ' ' A' ' 69' ' ' VAL . 37.3 p-80 -140.71 127.68 20.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.423 -0.798 . . . . 0.0 109.008 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.553 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -39.4 151.5 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.803 . . . . 0.0 110.008 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.49 ' OE1' ' CG2' ' A' ' 69' ' ' VAL . 5.7 mm-40 -55.76 -74.42 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -86.16 -68.18 0.76 Allowed 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.525 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -165.92 117.84 1.07 Allowed 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.205 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 41' ' ' SER . 84.9 t -157.93 -100.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.509 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.466 ' O ' ' O ' ' A' ' 42' ' ' VAL . . . -60.29 -146.31 0.01 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.463 ' HB2' ' HD3' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -119.64 137.64 25.78 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.209 -1.171 . . . . 0.0 109.418 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 36.3 Cg_endo -78.68 85.2 1.88 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.536 2.157 . . . . 0.0 110.329 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.527 ' HB2' ' NE2' ' A' ' 36' ' ' HIS . 3.1 mmm180 -96.73 156.4 16.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.226 -0.922 . . . . 0.0 109.348 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 47' ' ' GLN . 16.9 pt20 -113.2 102.44 10.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.248 -0.907 . . . . 0.0 109.482 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.486 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 1.7 m-20 -106.34 115.8 30.83 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -0.907 . . . . 0.0 109.254 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.51 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.2 OUTLIER -92.6 140.54 29.44 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.194 -0.941 . . . . 0.0 109.476 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.579 HG23 ' CZ2' ' A' ' 22' ' ' TRP . 26.8 m -115.54 151.65 46.3 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.301 -0.874 . . . . 0.0 109.309 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.468 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 35.3 Cg_endo -77.7 174.27 12.87 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.599 2.2 . . . . 0.0 110.373 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.468 ' HB3' HG13 ' A' ' 29' ' ' ILE . 34.0 Cg_endo -77.07 -15.59 16.27 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.573 2.182 . . . . 0.0 110.269 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -90.43 14.78 12.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.314 -0.867 . . . . 0.0 109.22 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.468 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 5.9 mmm-85 -133.48 126.33 30.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 109.575 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 2.8 p-10 -109.83 -4.96 15.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.93 . . . . 0.0 109.431 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 16.0 p -130.53 145.43 51.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 109.068 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.519 HD13 ' CG1' ' A' ' 50' ' ' VAL . 3.0 tt -129.12 118.89 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.953 . . . . 0.0 109.642 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -91.74 103.04 15.65 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.364 -0.835 . . . . 0.0 109.241 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.634 ' CD2' ' CE1' ' A' ' 36' ' ' HIS . 2.5 mt -84.92 144.82 28.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -0.922 . . . . 0.0 109.672 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.465 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 63.7 p -137.69 -174.77 3.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 0.0 109.414 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 56.39 20.1 4.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.416 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.533 ' CD1' ' HB3' ' A' ' 59' ' ' LEU . 2.4 mt -96.49 156.85 16.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.929 . . . . 0.0 109.242 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.468 ' O ' ' OH ' ' A' ' 68' ' ' TYR . 2.3 t30 -61.44 132.71 92.93 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.097 -1.002 . . . . 0.0 108.485 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.3 Cg_endo -77.51 124.64 7.14 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.159 1.906 . . . . 0.0 110.767 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.546 ' CA ' ' HA ' ' A' ' 92' ' ' SER . . . 77.8 60.98 2.64 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.565 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 3.0 m -145.88 167.0 24.32 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.242 -1.152 . . . . 0.0 110.084 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.565 ' N ' ' CG2' ' A' ' 66' ' ' THR . 0.8 OUTLIER -125.2 121.51 34.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.434 -0.791 . . . . 0.0 109.674 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.601 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -124.89 -172.57 2.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 0.0 109.302 179.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.574 ' O ' ' CE1' ' A' ' 37' ' ' HIS . 41.7 t -122.28 110.62 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 35' ' ' ARG . 3.5 t -96.57 127.19 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.778 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.485 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 95.1 p -108.01 133.98 51.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.32 -0.862 . . . . 0.0 109.951 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.633 ' CG2' ' CD1' ' A' ' 32' ' ' TYR . 5.2 mm -115.57 104.16 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.892 . . . . 0.0 109.242 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 83' ' ' PRO . 21.1 mm -109.81 109.49 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.13 -0.981 . . . . 0.0 109.57 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.624 ' N ' ' CE1' ' A' ' 32' ' ' TYR . . . -75.88 140.81 42.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -0.959 . . . . 0.0 109.299 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.512 ' CG2' HD13 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -131.43 176.35 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.289 -0.882 . . . . 0.0 109.561 -179.734 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.509 ' ND2' ' OE1' ' A' ' 79' ' ' GLU . 34.2 t30 -156.44 43.68 0.4 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.476 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.507 ' N ' HG23 ' A' ' 30' ' ' THR . . . 91.13 -77.12 1.45 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.439 ' HD2' ' C ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -125.18 3.22 7.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -1.164 . . . . 0.0 109.679 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.509 ' OE1' ' ND2' ' A' ' 76' ' ' ASN . 4.0 mt-10 -100.34 -174.9 2.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.182 -0.949 . . . . 0.0 109.486 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 0.8 OUTLIER -149.9 143.93 25.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.889 . . . . 0.0 109.596 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.567 ' CB ' ' CD ' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -110.34 -178.78 0.58 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.408 -0.807 . . . . 0.0 109.065 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.567 ' CD ' ' CB ' ' A' ' 81' ' ' SER . 34.0 Cg_endo -77.66 131.11 11.12 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.21 1.94 . . . . 0.0 110.168 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.529 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 36.1 Cg_endo -78.25 152.43 27.24 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.483 2.122 . . . . 0.0 110.775 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.594 ' CD2' ' CG2' ' A' ' 6' ' ' THR . 0.0 OUTLIER -146.61 54.13 1.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 108.875 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.489 HG23 ' N ' ' A' ' 86' ' ' GLY . 6.4 mt -57.87 162.6 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.306 -0.871 . . . . 0.0 109.871 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.489 ' N ' HG23 ' A' ' 85' ' ' ILE . . . -164.98 160.85 34.2 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.418 ' HG2' ' OE2' ' A' ' 39' ' ' GLU . 0.7 OUTLIER -95.75 127.86 42.13 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.268 -1.136 . . . . 0.0 109.493 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.629 ' NE2' ' CE2' ' A' ' 18' ' ' PHE . 1.3 tm0? -125.31 128.26 47.95 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -107.44 130.39 54.83 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.198 -0.939 . . . . 0.0 110.235 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.465 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -74.41 135.9 42.39 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.145 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 65' ' ' GLY . 1.0 OUTLIER -44.41 156.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.212 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.546 ' HA ' ' CA ' ' A' ' 65' ' ' GLY . 0.4 OUTLIER -105.52 31.72 4.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.235 -0.916 . . . . 0.0 109.248 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.511 ' OD1' ' CB ' ' A' ' 15' ' ' ALA . 0.6 OUTLIER 52.83 16.88 0.75 Allowed 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.718 -0.614 . . . . 0.0 110.121 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.54 HD12 ' CB ' ' A' ' 176' ' ' LYS . 6.7 mt -108.5 143.78 28.18 Favored Pre-proline 0 N--CA 1.484 1.259 0 O-C-N 120.99 -1.069 . . . . 0.0 109.623 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.592 ' HB2' ' CD1' ' A' ' 112' ' ' TRP . 35.3 Cg_endo -78.96 81.94 2.65 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.494 2.129 . . . . 0.0 109.997 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -64.38 -179.37 0.46 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.258 -0.901 . . . . 0.0 109.678 -179.655 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER 77.06 21.14 1.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.312 -0.868 . . . . 0.0 109.622 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.497 ' CD2' HD21 ' A' ' 162' ' ' LEU . 15.1 tp -69.87 102.6 2.0 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.162 -0.961 . . . . 0.0 109.291 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 97' ' ' ASP . 8.6 pt-20 -149.1 -174.04 4.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.134 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 41.7 t -127.57 151.18 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.084 -1.01 . . . . 0.0 109.971 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.402 HG23 HD11 ' A' ' 101' ' ' ILE . 4.1 pt -119.13 -14.2 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.524 -0.735 . . . . 0.0 109.332 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -142.32 149.3 39.3 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.518 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 0.7 OUTLIER -134.88 106.07 6.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.993 -1.067 . . . . 0.0 110.234 -179.452 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.479 ' OG1' ' OG ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -91.73 158.18 40.57 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.4 -0.812 . . . . 0.0 108.97 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.3 Cg_endo -70.32 -2.51 10.69 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.383 2.055 . . . . 0.0 110.385 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.539 ' HA ' HG21 ' A' ' 152' ' ' ILE . 64.7 p -150.34 19.08 0.85 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.556 ' CB ' ' O ' ' A' ' 149' ' ' ILE . 0.6 OUTLIER -168.0 168.56 11.9 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.801 179.742 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.593 HD23 ' CE2' ' A' ' 182' ' ' TYR . 0.5 OUTLIER -141.33 154.2 45.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.67 -179.383 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 100' ' ' VAL . 0.8 OUTLIER -105.31 106.66 17.26 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.921 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.513 ' CD1' HD13 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -100.76 140.81 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.226 -0.921 . . . . 0.0 110.206 -179.117 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.461 ' HA ' ' HB ' ' A' ' 146' ' ' THR . 47.4 p -144.49 120.51 10.71 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.592 ' CD1' ' HB2' ' A' ' 95' ' ' PRO . 47.5 p90 -124.69 168.87 12.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.944 . . . . 0.0 109.662 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.457 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . 4.3 mt-10 -90.67 159.99 39.68 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.287 -0.883 . . . . 0.0 109.245 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.36 142.49 21.23 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.628 2.219 . . . . 0.0 110.242 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.496 ' CG ' ' CG2' ' A' ' 119' ' ' VAL . 35.0 Cg_endo -77.72 -171.21 1.12 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.588 2.192 . . . . 0.0 110.481 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.53 ' CB ' ' HA ' ' A' ' 14' ' ' THR . . . -103.52 32.98 3.55 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.543 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.527 ' CG1' ' O ' ' A' ' 116' ' ' ALA . 27.7 m -159.49 163.42 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.908 . . . . 0.0 109.511 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.45 ' O ' HG23 ' A' ' 166' ' ' THR . 0.3 OUTLIER -69.9 121.42 17.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.235 -0.916 . . . . 0.0 109.245 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.561 ' CG1' ' CE2' ' A' ' 122' ' ' TYR . 3.1 t -99.81 139.7 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.231 -0.918 . . . . 0.0 109.738 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.443 ' HG2' ' HD2' ' A' ' 168' ' ' ARG . 3.8 tpt180 -82.29 -48.92 10.64 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.46 ' HB2' ' O ' ' A' ' 140' ' ' VAL . 1.5 p90 -165.3 171.31 13.7 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.372 -0.83 . . . . 0.0 109.038 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.561 ' CE2' ' CG1' ' A' ' 119' ' ' VAL . 5.5 m-85 -128.72 122.21 30.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.114 -0.991 . . . . 0.0 109.426 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.48 ' CD ' ' OE1' ' A' ' 137' ' ' GLU . 9.9 ttm180 -89.96 105.76 18.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.194 -0.942 . . . . 0.0 109.248 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.637 ' CD1' ' CZ ' ' A' ' 138' ' ' PHE . 43.3 mt -84.7 166.46 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.677 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.545 ' CB ' ' HG2' ' A' ' 137' ' ' GLU . 1.3 p -141.8 137.22 31.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.866 . . . . 0.0 109.704 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.661 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 3.2 m-30 -92.04 132.4 36.59 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.597 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -103.42 112.31 4.18 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -107.1 136.49 46.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -1.125 . . . . 0.0 109.136 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.529 ' CG2' ' HB3' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -86.65 149.48 24.88 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.114 -0.991 . . . . 0.0 109.765 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 160.8 -83.38 0.13 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -151.24 -87.24 0.06 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.95 -7.35 34.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -1.139 . . . . 0.0 109.37 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 21.7 t 45.1 79.22 0.35 Allowed Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.379 -0.826 . . . . 0.0 109.871 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.04 73.63 5.65 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.581 2.188 . . . . 0.0 109.949 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 126' ' ' TYR . 2.4 m -58.63 154.48 2.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.479 -0.763 . . . . 0.0 110.127 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.598 ' HG2' ' CG ' ' A' ' 126' ' ' TYR . 4.7 pt20 -125.05 117.6 24.32 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.545 ' HG2' ' CB ' ' A' ' 125' ' ' THR . 84.0 mt-10 -96.76 152.23 18.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.105 -0.997 . . . . 0.0 111.434 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.637 ' CZ ' ' CD1' ' A' ' 124' ' ' ILE . 1.7 p90 -143.88 139.89 29.47 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.6 p -74.2 144.37 44.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.029 -1.044 . . . . 0.0 111.317 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.528 ' CG2' HG13 ' A' ' 124' ' ' ILE . 48.5 t -108.78 145.77 32.36 Favored Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.527 ' HD2' ' CG1' ' A' ' 140' ' ' VAL . 34.3 Cg_endo -77.11 146.3 25.35 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.327 2.018 . . . . 0.0 110.011 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.17 19.62 25.77 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.437 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 0.5 OUTLIER -105.16 10.63 33.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.115 -1.226 . . . . 0.0 109.518 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.437 ' HG2' ' O ' ' A' ' 143' ' ' SER . 19.2 mmtp -152.42 135.93 16.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 109.616 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.572 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 7.2 p -83.53 1.72 40.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.921 . . . . 0.0 109.467 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.461 ' HB ' ' HA ' ' A' ' 111' ' ' SER . 11.7 p -137.38 146.51 44.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.914 . . . . 0.0 108.911 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.481 ' N ' ' CZ3' ' A' ' 112' ' ' TRP . . . -126.07 -171.42 2.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.07 -1.019 . . . . 0.0 109.593 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.417 HG23 ' N ' ' A' ' 149' ' ' ILE . 82.8 m -137.6 167.55 21.44 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.304 -0.872 . . . . 0.0 109.168 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.661 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 1.6 mt -126.36 141.41 45.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.251 -0.906 . . . . 0.0 109.134 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.468 ' N ' HG21 ' A' ' 149' ' ' ILE . 43.5 m-80 -134.5 176.09 8.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.325 -0.859 . . . . 0.0 109.539 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 150' ' ' ASN . 1.3 p30 41.02 52.9 3.37 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.32 -0.862 . . . . 0.0 109.78 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.539 HG21 ' HA ' ' A' ' 106' ' ' THR . 8.4 tt -101.66 164.07 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.322 -0.861 . . . . 0.0 109.216 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.461 ' HB2' ' OH ' ' A' ' 158' ' ' TYR . 19.5 mmmt -99.89 108.01 49.46 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.113 -0.992 . . . . 0.0 109.806 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.469 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 36.5 Cg_endo -79.38 174.69 11.62 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.571 2.181 . . . . 0.0 110.573 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 64.94 56.06 18.5 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.426 ' O ' ' OG1' ' A' ' 184' ' ' THR . . . 170.47 138.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -1.114 . . . . 0.0 109.654 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.529 ' HB3' ' CG2' ' A' ' 129' ' ' THR . 4.0 t0 -54.79 161.05 1.68 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.597 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.3 OUTLIER -140.33 176.54 8.69 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.908 -1.12 . . . . 0.0 110.135 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.509 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 3.2 m -146.2 109.63 4.76 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.508 HG21 ' N ' ' A' ' 161' ' ' THR . 29.6 mm -89.86 143.19 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.953 -1.092 . . . . 0.0 110.349 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.508 ' N ' HG21 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -153.12 160.0 42.83 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.414 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.497 HD21 ' CD2' ' A' ' 98' ' ' LEU . 2.1 pp -161.48 148.45 14.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.914 -1.116 . . . . 0.0 110.632 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.596 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 2.4 m-85 -113.07 164.45 13.46 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -134.33 102.87 5.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.027 -1.045 . . . . 0.0 109.582 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.48 HG21 ' CB ' ' A' ' 174' ' ' SER . 51.5 t -97.38 156.11 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 109.725 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.519 ' CG2' ' HA ' ' A' ' 119' ' ' VAL . 62.9 p -135.88 -56.61 0.77 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.362 -0.836 . . . . 0.0 109.259 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -70.97 135.19 24.15 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.443 ' HD2' ' HG2' ' A' ' 120' ' ' ARG . 18.8 mtp180 -143.8 61.64 1.37 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -1.139 . . . . 0.0 109.515 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -178.85 -43.66 0.07 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.428 ' O ' ' OG ' ' A' ' 171' ' ' SER . 18.3 t70 -138.82 10.13 2.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -1.135 . . . . 0.0 109.494 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 170' ' ' ASP . 64.8 m -168.74 76.58 0.78 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.929 . . . . 0.0 109.413 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.1 84.45 2.0 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.675 2.25 . . . . 0.0 110.54 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 165' ' ' VAL . . . -108.49 166.02 11.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 109.186 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 175' ' ' SER . 14.2 p -146.46 29.27 1.05 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.975 . . . . 0.0 109.798 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 174' ' ' SER . 5.9 p 42.08 -165.54 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.54 ' CB ' HD12 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -89.06 140.58 29.03 Favored Pre-proline 0 C--N 1.305 -1.35 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.327 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.596 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 34.9 Cg_endo -77.51 130.23 10.69 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.354 2.036 . . . . 0.0 110.76 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.459 ' O ' HG21 ' A' ' 161' ' ' THR . 5.3 t -101.47 134.36 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 161' ' ' THR . 1.3 p -126.61 155.63 42.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.172 -0.955 . . . . 0.0 110.191 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.504 ' CG1' ' HB ' ' A' ' 160' ' ' ILE . 24.6 pt -141.58 178.82 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -103.41 151.66 22.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.098 -1.001 . . . . 0.0 109.519 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.593 ' CE2' HD23 ' A' ' 108' ' ' LEU . 83.8 t80 -155.23 122.63 5.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.361 -0.837 . . . . 0.0 109.495 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.418 ' O ' ' CD ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -99.24 127.9 45.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.148 -0.97 . . . . 0.0 109.446 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.574 HG22 ' CD1' ' A' ' 158' ' ' TYR . 51.3 p . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.539 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.513 ' CD1' ' HB2' ' A' ' 81' ' ' SER . 0.6 OUTLIER -164.79 149.07 9.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -1.136 . . . . 0.0 109.354 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 25' ' ' PRO . 10.8 m-20 -84.93 123.08 30.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.425 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.54 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -95.73 177.5 1.75 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 109.528 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.54 ' HD2' ' CB ' ' A' ' 4' ' ' SER . 36.2 Cg_endo -78.86 147.07 21.22 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.648 2.232 . . . . 0.0 110.096 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 5' ' ' PRO . 0.8 OUTLIER -161.25 -170.48 2.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.065 -1.022 . . . . 0.0 109.8 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 44.08 32.59 2.48 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.628 ' C ' ' CD1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -75.1 -167.68 0.65 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.51 -0.994 . . . . 0.0 109.99 -179.242 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -165.32 129.1 2.31 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.233 -0.917 . . . . 0.0 109.216 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.531 ' CB ' ' HG3' ' A' ' 88' ' ' GLN . 0.3 OUTLIER -88.49 140.05 29.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.153 -0.967 . . . . 0.0 109.64 -179.728 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.507 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 60.2 p -148.16 -162.54 1.57 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.256 -0.903 . . . . 0.0 109.545 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.519 ' CB ' ' OG1' ' A' ' 19' ' ' THR . 4.4 m-20 45.34 39.77 4.7 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.53 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 24.5 mm -73.35 92.33 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.494 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.572 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -93.04 166.38 12.39 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 176.702 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.547 ' CB ' ' CB ' ' A' ' 93' ' ' ASP . . . -56.06 -77.81 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.961 -1.087 . . . . 0.0 111.106 -177.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.447 ' OD1' ' HG3' ' A' ' 64' ' ' PRO . 0.7 OUTLIER -77.04 -0.08 23.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.109 -0.994 . . . . 0.0 110.177 -178.735 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.572 ' O ' ' N ' ' A' ' 14' ' ' THR . 20.8 p -144.67 123.58 12.73 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.164 -0.96 . . . . 0.0 109.237 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.575 ' CE1' HG21 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -135.09 136.05 41.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.119 -0.988 . . . . 0.0 108.335 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.519 ' OG1' ' CB ' ' A' ' 12' ' ' ASP . 16.2 m -87.18 156.99 19.46 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.094 -1.004 . . . . 0.0 112.013 -177.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.575 HG21 ' CE1' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -135.58 97.94 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.673 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.507 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 15.5 m-70 -87.72 163.17 16.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.153 -0.967 . . . . 0.0 110.882 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.532 ' CB ' ' HB2' ' A' ' 8' ' ' PHE . 25.9 p90 -174.79 139.99 0.55 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.0 161.1 5.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.152 -0.967 . . . . 0.0 109.827 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.15 151.0 38.0 Favored Pre-proline 0 C--N 1.297 -1.691 0 O-C-N 121.779 -0.576 . . . . 0.0 109.511 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.528 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 36.2 Cg_endo -78.53 152.8 26.53 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.538 2.159 . . . . 0.0 110.247 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' A' ' 26' ' ' ARG . 20.7 mmm180 -92.69 27.06 2.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 109.627 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.515 ' CB ' ' HD2' ' A' ' 28' ' ' PRO . . . -105.34 175.32 2.18 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 109.271 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.515 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 35.2 Cg_endo -77.77 98.87 1.24 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.586 2.191 . . . . 0.0 110.363 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.635 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 39.4 pt -126.93 173.81 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 109.518 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.6 p -114.2 -18.83 11.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.262 -0.898 . . . . 0.0 109.346 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.28 170.68 26.27 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.635 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 1.2 m-85 -112.49 134.23 54.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -1.193 . . . . 0.0 109.492 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.501 HG12 ' HG3' ' A' ' 49' ' ' ARG . 2.0 mt -88.54 126.8 41.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.303 -0.873 . . . . 0.0 109.069 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.562 ' N ' ' CD1' ' A' ' 34' ' ' ILE . 1.1 mm -104.28 111.25 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.084 -1.01 . . . . 0.0 109.882 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.433 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 42.2 ttt-85 -121.7 108.16 13.21 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.301 -0.874 . . . . 0.0 108.898 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.626 ' CE1' ' CD2' ' A' ' 59' ' ' LEU . 18.3 p-80 -117.41 170.77 8.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 110.069 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.44 ' O ' ' O ' ' A' ' 38' ' ' ALA . 54.7 p-80 -179.61 130.38 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.43 -0.794 . . . . 0.0 109.723 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -55.31 -168.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.262 -0.899 . . . . 0.0 109.318 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.515 ' HB2' ' CD2' ' A' ' 40' ' ' HIS . 0.7 OUTLIER -47.17 -79.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.124 -0.985 . . . . 0.0 109.329 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.526 ' CD2' ' N ' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -164.8 55.33 0.13 Allowed 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.551 0.691 . . . . 0.0 109.313 179.741 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.1 p -101.4 10.57 40.38 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.506 -0.746 . . . . 0.0 109.575 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.428 ' CG2' ' N ' ' A' ' 43' ' ' GLY . 7.1 p -143.46 165.0 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.194 -0.941 . . . . 0.0 109.593 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.428 ' N ' ' CG2' ' A' ' 42' ' ' VAL . . . -77.66 -72.1 1.16 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -93.55 145.69 30.42 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.256 -1.143 . . . . 0.0 109.33 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.84 163.19 28.97 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.557 2.171 . . . . 0.0 110.312 179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.558 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 3.7 mmt85 -74.89 127.8 34.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.198 -0.938 . . . . 0.0 109.27 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -110.23 85.26 2.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 0.0 109.63 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.498 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 29.7 m-20 -100.74 99.86 10.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.241 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.532 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -84.81 134.49 34.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.037 -1.039 . . . . 0.0 109.617 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.477 HG12 HD11 ' A' ' 57' ' ' ILE . 13.6 m -118.97 159.67 43.83 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.38 -0.825 . . . . 0.0 109.256 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.476 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 34.7 Cg_endo -77.0 174.16 13.3 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.528 2.152 . . . . 0.0 110.263 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.537 ' HA ' ' CE2' ' A' ' 32' ' ' TYR . 34.9 Cg_endo -76.89 -15.63 16.6 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.605 2.203 . . . . 0.0 110.43 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.87 23.53 2.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.473 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.435 ' O ' ' CZ2' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -137.52 109.47 7.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.923 . . . . 0.0 109.647 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 22' ' ' TRP . 5.2 p30 -95.13 -6.96 40.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 21' ' ' HIS . 64.9 p -139.1 129.49 25.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.318 -0.864 . . . . 0.0 109.057 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.477 HD11 HG12 ' A' ' 50' ' ' VAL . 3.4 tt -118.33 119.36 61.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.258 -0.902 . . . . 0.0 109.594 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.459 HG22 ' OG1' ' A' ' 19' ' ' THR . 0.3 OUTLIER -85.13 108.75 17.84 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.411 -0.806 . . . . 0.0 108.829 179.628 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.626 ' CD2' ' CE1' ' A' ' 36' ' ' HIS . 0.9 OUTLIER -84.72 152.46 23.71 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.204 -0.935 . . . . 0.0 109.24 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.463 ' O ' ' HG ' ' A' ' 62' ' ' LEU . 21.5 p -142.93 -179.69 6.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.568 -0.708 . . . . 0.0 109.449 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.44 18.29 3.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 109.392 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.53 ' CD1' ' HB3' ' A' ' 59' ' ' LEU . 3.5 mt -92.68 142.8 26.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.246 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 62' ' ' LEU . 7.5 t-20 -45.86 123.99 6.4 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.204 -0.935 . . . . 0.0 108.651 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.531 ' CB ' ' HB2' ' A' ' 93' ' ' ASP . 35.2 Cg_endo -76.96 131.78 12.35 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.23 1.954 . . . . 0.0 110.32 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 71.89 61.6 3.71 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 90' ' ' THR . 3.3 m -154.91 149.3 26.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -1.136 . . . . 0.0 109.654 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.522 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 16.5 mt-10 -74.41 130.33 39.44 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.096 -1.002 . . . . 0.0 108.417 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.496 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 3.0 m-85 -126.0 115.97 20.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.093 -1.004 . . . . 0.0 110.377 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 36' ' ' HIS . 2.1 t -83.52 123.37 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.524 ' CG1' ' HB3' ' A' ' 36' ' ' HIS . 2.2 t -112.34 123.8 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.003 -1.061 . . . . 0.0 110.18 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.485 ' CB ' HG12 ' A' ' 85' ' ' ILE . 61.2 p -112.97 122.28 47.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.371 -0.831 . . . . 0.0 109.689 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.519 ' CD1' ' CG2' ' A' ' 34' ' ' ILE . 10.7 mm -107.19 136.49 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.273 -0.892 . . . . 0.0 109.54 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.513 HD11 ' N ' ' A' ' 73' ' ' ILE . 1.7 mp -122.6 156.38 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 0.0 109.2 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.537 ' CB ' ' OG ' ' A' ' 81' ' ' SER . . . -119.35 115.57 24.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.379 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.35 164.02 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.167 -0.958 . . . . 0.0 109.441 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -140.21 49.93 1.73 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.398 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.58 -82.24 1.65 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.426 ' HD3' ' C ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -120.19 -2.37 10.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -1.154 . . . . 0.0 109.564 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.465 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -92.96 -166.59 1.56 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.427 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 37.5 mt-10 -154.01 155.03 34.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.2 -0.938 . . . . 0.0 109.745 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.555 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.7 OUTLIER -129.49 179.89 1.19 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.385 -0.822 . . . . 0.0 108.978 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.555 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.3 Cg_endo -76.04 142.74 25.15 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.194 1.929 . . . . 0.0 109.855 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.81 132.33 11.82 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.685 2.257 . . . . 0.0 111.529 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 84' ' ' LEU . 9.0 tp -108.16 100.75 10.03 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.485 HG12 ' CB ' ' A' ' 71' ' ' SER . 2.0 mt -105.63 157.35 6.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.065 -1.022 . . . . 0.0 110.486 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.435 ' N ' HG23 ' A' ' 85' ' ' ILE . . . -151.42 178.97 28.45 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -131.59 137.2 48.32 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.113 -1.228 . . . . 0.0 109.766 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.531 ' HG3' ' CB ' ' A' ' 10' ' ' SER . 1.8 mm100 -163.76 126.94 2.61 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.313 -0.867 . . . . 0.0 109.174 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.522 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -94.5 145.91 24.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.354 -0.841 . . . . 0.0 110.098 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.71 145.93 42.69 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.458 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.557 HG21 ' C ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -70.21 159.31 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.462 -0.774 . . . . 0.0 109.096 179.426 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.521 ' HB2' ' CB ' ' A' ' 115' ' ' PRO . 12.3 m -76.18 139.13 41.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.001 -1.062 . . . . 0.0 108.803 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.547 ' CB ' ' CB ' ' A' ' 15' ' ' ALA . 3.3 t0 -103.14 -50.14 3.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.211 -0.93 . . . . 0.0 110.168 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.59 ' CG2' ' CG2' ' A' ' 178' ' ' VAL . 5.6 mt -98.39 140.46 21.86 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.238 -0.914 . . . . 0.0 110.176 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.498 ' HD2' HG22 ' A' ' 94' ' ' ILE . 36.2 Cg_endo -81.05 77.51 4.01 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.615 2.21 . . . . 0.0 109.499 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 5.1 ptp180 -45.94 173.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.44 -0.788 . . . . 0.0 109.974 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 1.7 t70 82.38 15.34 0.43 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.68 -0.637 . . . . 0.0 110.004 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.564 ' CD1' ' CD2' ' A' ' 162' ' ' LEU . 20.7 tp -70.27 100.45 1.71 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.042 -1.037 . . . . 0.0 109.137 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 110' ' ' ILE . 0.7 OUTLIER -153.3 176.85 11.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.233 -0.917 . . . . 0.0 109.649 -179.797 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.469 HG21 ' O ' ' A' ' 109' ' ' LEU . 9.2 p -105.25 171.23 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.342 -0.849 . . . . 0.0 109.537 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.535 ' CG1' ' HB2' ' A' ' 109' ' ' LEU . 3.6 pt -136.51 -42.69 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.277 -0.89 . . . . 0.0 109.166 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.582 ' CB ' ' CD1' ' A' ' 109' ' ' LEU . . . -121.99 114.29 20.75 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.537 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.2 t -99.94 99.16 9.88 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.24 -0.913 . . . . 0.0 110.5 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.516 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -89.38 160.74 41.67 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.639 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -69.64 -0.81 7.35 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.423 2.082 . . . . 0.0 110.937 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.523 ' HA ' HG21 ' A' ' 152' ' ' ILE . 56.0 p -146.45 11.5 1.14 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.269 -0.894 . . . . 0.0 109.485 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.538 ' O ' ' CD2' ' A' ' 108' ' ' LEU . 85.3 p -172.48 165.52 5.67 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.682 -1.207 . . . . 0.0 110.41 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.603 HD23 ' CE1' ' A' ' 182' ' ' TYR . 0.4 OUTLIER -145.92 149.57 34.47 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.582 ' CD1' ' CB ' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -106.63 116.52 32.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.199 -0.938 . . . . 0.0 108.952 179.214 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.53 ' CG1' ' HB1' ' A' ' 147' ' ' ALA . 2.4 pt -100.03 -179.14 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.984 -1.072 . . . . 0.0 109.719 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.483 ' HA ' ' HA ' ' A' ' 146' ' ' THR . 1.0 OUTLIER -168.42 150.96 5.26 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.551 -0.718 . . . . 0.0 109.778 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.569 ' CE3' ' O ' ' A' ' 145' ' ' SER . 24.2 p90 -154.03 -176.8 6.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.43 -0.794 . . . . 0.0 109.307 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 95' ' ' PRO . 19.1 mm-40 -120.21 150.39 51.37 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.095 -1.003 . . . . 0.0 109.742 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.79 132.63 10.89 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.725 2.283 . . . . 0.0 110.705 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.521 ' CB ' ' HB2' ' A' ' 92' ' ' SER . 36.4 Cg_endo -79.87 -167.68 0.54 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.705 2.27 . . . . 0.0 110.557 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.531 ' HB1' ' CG1' ' A' ' 91' ' ' VAL . . . -87.82 -12.15 45.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 109.273 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.428 HG21 ' HG2' ' A' ' 115' ' ' PRO . 30.0 m -88.54 161.84 2.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.397 -0.814 . . . . 0.0 109.332 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.519 ' O ' ' CG2' ' A' ' 166' ' ' THR . 9.0 m -76.41 122.92 25.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 109.561 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.568 HG12 ' CE2' ' A' ' 122' ' ' TYR . 2.8 t -100.85 114.91 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.189 -0.944 . . . . 0.0 109.715 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.499 ' HA ' ' NE ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -74.85 -51.48 13.85 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.206 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.491 ' C ' ' CD1' ' A' ' 121' ' ' TYR . 1.2 p90 -165.49 158.09 15.5 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.568 ' CE2' HG12 ' A' ' 119' ' ' VAL . 7.0 m-85 -107.58 123.43 48.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.013 -1.054 . . . . 0.0 109.331 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 4.2 ttp180 -86.11 106.11 17.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.206 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.596 ' HB ' ' CZ ' ' A' ' 138' ' ' PHE . 26.1 mt -99.09 150.09 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.296 -0.878 . . . . 0.0 109.902 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 25.3 p -133.48 132.73 41.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.865 . . . . 0.0 109.932 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.641 ' CE2' ' CG2' ' A' ' 149' ' ' ILE . 30.5 m-85 -74.8 134.22 41.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.86 . . . . 0.0 109.225 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.586 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.32 106.73 2.71 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -106.01 140.7 38.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.198 -1.178 . . . . 0.0 109.529 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.535 ' CG2' ' HB3' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -67.87 -82.53 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.24 -0.912 . . . . 0.0 109.674 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -134.04 69.61 0.53 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -100.98 25.45 28.31 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.403 ' O ' ' CG ' ' A' ' 132' ' ' ASN . 37.6 t30 55.91 34.38 23.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.334 -1.098 . . . . 0.0 109.453 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.61 153.79 26.94 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.24 -0.912 . . . . 0.0 109.425 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.22 173.61 13.64 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.609 2.206 . . . . 0.0 110.457 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.5 m -62.45 157.69 3.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.267 -0.896 . . . . 0.0 109.661 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.557 ' HB3' ' CD1' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -107.74 104.29 13.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 0.0 109.028 179.626 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 4.8 tt0 -85.82 111.75 20.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 110.372 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.596 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 13.3 p90 -122.39 132.18 54.25 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.482 ' CG2' ' CE1' ' A' ' 121' ' ' TYR . 1.7 p -74.29 174.48 8.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.225 -0.922 . . . . 0.0 110.741 -178.352 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.545 HG23 ' CD1' ' A' ' 124' ' ' ILE . 24.9 t -137.03 138.08 24.72 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.667 -0.646 . . . . 0.0 109.294 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.492 ' HD2' HG11 ' A' ' 140' ' ' VAL . 35.2 Cg_endo -76.95 132.72 13.12 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.346 2.031 . . . . 0.0 110.35 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.45 0.44 55.04 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -4.64 25.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.114 -1.227 . . . . 0.0 109.751 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.531 ' CD ' ' O ' ' A' ' 146' ' ' THR . 0.0 OUTLIER -154.71 157.67 38.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.935 . . . . 0.0 109.376 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.569 ' O ' ' CE3' ' A' ' 112' ' ' TRP . 0.1 OUTLIER -95.84 2.06 53.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.265 -0.897 . . . . 0.0 110.313 -179.348 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.531 ' O ' ' CD ' ' A' ' 144' ' ' LYS . 43.4 p -108.32 162.34 14.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.981 -1.075 . . . . 0.0 109.624 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.53 ' HB1' ' CG1' ' A' ' 110' ' ' ILE . . . -145.9 134.45 22.09 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.991 . . . . 0.0 109.749 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.2 t -83.91 153.47 23.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.328 -0.858 . . . . 0.0 109.031 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.641 ' CG2' ' CE2' ' A' ' 126' ' ' TYR . 14.3 mm -133.98 66.26 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.135 -0.978 . . . . 0.0 109.674 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.566 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 2.4 m-20 -84.2 -176.26 6.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.403 -0.811 . . . . 0.0 109.636 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 13.3 m120 68.47 21.4 8.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.22 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.523 HG21 ' HA ' ' A' ' 106' ' ' THR . 2.8 tt -85.91 155.11 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.341 -0.849 . . . . 0.0 109.615 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.465 ' O ' ' OG1' ' A' ' 184' ' ' THR . 0.0 OUTLIER -103.88 123.81 39.79 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.231 -0.918 . . . . 0.0 109.298 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.466 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 35.9 Cg_endo -78.43 149.63 24.52 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.415 2.076 . . . . 0.0 110.402 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . 78.43 66.16 1.77 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.511 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 163.97 131.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -1.162 . . . . 0.0 109.653 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.535 ' HB3' ' CG2' ' A' ' 129' ' ' THR . 0.9 OUTLIER -52.17 164.87 0.26 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.346 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.617 ' CD1' ' CG2' ' A' ' 184' ' ' THR . 0.2 OUTLIER -142.69 -179.36 6.27 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.846 -1.159 . . . . 0.0 110.363 -179.419 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.545 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 1.7 m -153.12 106.75 3.03 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.487 ' CD1' HD11 ' A' ' 108' ' ' LEU . 27.5 mt -97.72 116.79 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.805 -1.184 . . . . 0.0 109.754 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.554 ' CG2' ' CB ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -125.04 153.52 42.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 109.165 179.68 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.564 ' CD2' ' CD1' ' A' ' 98' ' ' LEU . 2.3 pp -149.95 145.62 26.58 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.055 -1.028 . . . . 0.0 110.682 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.607 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 4.1 m-85 -114.11 177.39 4.66 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -140.53 110.09 6.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.231 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 95.7 t -101.48 152.3 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -0.89 . . . . 0.0 109.639 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.519 ' CG2' ' O ' ' A' ' 118' ' ' SER . 21.8 p -122.73 -69.97 0.8 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 109.722 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.495 ' N ' ' OG1' ' A' ' 166' ' ' THR . . . -64.58 172.28 19.1 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.22 44.16 0.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.294 -1.121 . . . . 0.0 109.679 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 161.94 -39.77 0.39 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.524 ' O ' ' CB ' ' A' ' 171' ' ' SER . 10.3 p-10 -108.83 -2.26 18.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.147 -1.208 . . . . 0.0 109.697 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 1.0 OUTLIER 163.43 83.05 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 109.435 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.89 86.54 1.64 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.627 2.218 . . . . 0.0 110.431 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -96.99 174.8 6.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.327 -0.858 . . . . 0.0 109.34 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 0.6 OUTLIER -164.38 131.88 3.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.162 -0.961 . . . . 0.0 109.589 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 73.5 p -64.07 -164.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.847 . . . . 0.0 109.365 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.537 ' HB2' ' CD1' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -82.24 144.84 51.06 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 108.91 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.607 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 35.7 Cg_endo -78.55 127.96 8.41 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.547 2.164 . . . . 0.0 110.931 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.59 ' CG2' ' CG2' ' A' ' 94' ' ' ILE . 69.1 t -96.5 123.51 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -0.91 . . . . 0.0 108.56 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.554 ' CB ' ' CG2' ' A' ' 161' ' ' THR . 0.4 OUTLIER -118.53 143.71 46.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.167 -0.958 . . . . 0.0 109.914 -179.537 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.5 pt -136.14 151.75 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -84.66 162.67 19.63 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.111 -0.993 . . . . 0.0 109.347 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.603 ' CE1' HD23 ' A' ' 108' ' ' LEU . 49.6 t80 -155.1 157.88 38.17 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.314 -0.867 . . . . 0.0 109.368 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.439 ' N ' ' CD1' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -126.57 119.06 26.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.18 -0.95 . . . . 0.0 109.474 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.617 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 10.8 p . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.54 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.446 ' O ' ' HG ' ' A' ' 2' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.521 HD21 ' CG2' ' A' ' 29' ' ' ILE . 1.9 mp -141.2 -163.32 1.53 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.257 -1.143 . . . . 0.0 109.367 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.425 ' HB2' ' CB ' ' A' ' 25' ' ' PRO . 29.2 m-20 -115.34 169.84 8.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.43 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.458 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 37.1 p -94.8 119.22 66.37 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.541 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.49 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 35.2 Cg_endo -77.85 88.13 1.45 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.367 2.045 . . . . 0.0 110.109 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.439 ' HA ' HD23 ' A' ' 84' ' ' LEU . 1.8 p -80.87 -109.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.92 . . . . 0.0 109.682 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.466 ' O ' ' HA ' ' A' ' 22' ' ' TRP . . . 45.7 26.44 1.82 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.781 -1.727 . . . . 0.0 108.781 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.551 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 30.9 t80 -53.74 132.23 40.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.526 -0.985 . . . . 0.0 110.112 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.474 ' O ' ' N ' ' A' ' 21' ' ' HIS . 5.2 t0 -165.22 153.83 11.97 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.533 ' CB ' ' HG2' ' A' ' 88' ' ' GLN . 2.1 p -136.44 139.03 42.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.047 -1.033 . . . . 0.0 109.696 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.463 ' O ' ' HB ' ' A' ' 19' ' ' THR . 17.8 p -160.12 -165.6 1.51 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.249 -0.907 . . . . 0.0 109.579 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.537 ' CB ' ' OG1' ' A' ' 19' ' ' THR . 10.0 m-20 42.31 36.21 0.71 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.583 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 26.2 mm -66.32 134.2 30.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-O 121.418 0.628 . . . . 0.0 110.367 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.556 ' CB ' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -124.73 -179.8 4.66 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.328 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.525 ' CB ' ' HB3' ' A' ' 93' ' ' ASP . . . -72.4 -76.01 0.12 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.932 -1.105 . . . . 0.0 109.336 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 2.1 p-10 -76.69 0.78 19.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.87 . . . . 0.0 109.648 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.556 ' O ' ' CB ' ' A' ' 14' ' ' THR . 3.6 t -150.47 162.47 40.52 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.246 -0.909 . . . . 0.0 109.139 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.583 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 7.7 p90 -166.69 139.87 3.81 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.537 ' OG1' ' CB ' ' A' ' 12' ' ' ASP . 23.6 m -83.02 158.74 22.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.738 -1.226 . . . . 0.0 111.447 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.571 HG21 ' CE1' ' A' ' 18' ' ' PHE . 1.5 t -136.89 166.58 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.503 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 14.2 m-70 -148.53 165.43 31.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.898 -1.126 . . . . 0.0 110.416 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.549 ' CZ2' HG23 ' A' ' 50' ' ' VAL . 39.4 p90 -177.13 140.93 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.31 167.54 2.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 120.932 -1.105 . . . . 0.0 109.376 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.508 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -103.32 168.7 8.36 Favored Pre-proline 0 C--N 1.3 -1.581 0 O-C-N 121.671 -0.643 . . . . 0.0 109.936 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.425 ' CB ' ' HB2' ' A' ' 3' ' ' ASP . 35.5 Cg_endo -78.48 -158.73 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.703 2.269 . . . . 0.0 110.347 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.48 28.38 8.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.551 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.73 166.84 16.62 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.547 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.25 89.88 1.31 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.633 2.222 . . . . 0.0 110.42 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.614 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 11.7 pt -87.83 -172.09 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -0.938 . . . . 0.0 109.457 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 2.8 p -112.33 -5.8 14.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.94 . . . . 0.0 109.563 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.06 172.35 12.49 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.622 ' CD1' ' N ' ' A' ' 32' ' ' TYR . 0.1 OUTLIER -120.83 144.27 48.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -1.148 . . . . 0.0 109.375 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.516 ' CD1' ' HG3' ' A' ' 49' ' ' ARG . 22.6 mm -82.1 101.81 7.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.212 -0.93 . . . . 0.0 109.594 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.53 ' N ' ' CD1' ' A' ' 34' ' ' ILE . 1.5 mm -83.42 105.35 13.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.345 -0.847 . . . . 0.0 109.715 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.526 ' CB ' ' OG ' ' A' ' 71' ' ' SER . 0.6 OUTLIER -102.94 155.37 18.4 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.117 -0.989 . . . . 0.0 108.757 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.613 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 23.7 p80 -144.93 136.6 25.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.983 -1.073 . . . . 0.0 110.04 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.565 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 27.9 p-80 -167.73 129.79 1.54 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.882 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -58.66 -172.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.401 -0.812 . . . . 0.0 109.436 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -94.64 -10.93 30.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -128.87 11.12 6.06 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.376 -0.828 . . . . 0.0 109.278 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.477 ' CB ' ' HG3' ' A' ' 45' ' ' PRO . 9.9 p -82.09 176.84 9.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.342 -0.849 . . . . 0.0 109.562 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.575 ' CG2' ' N ' ' A' ' 43' ' ' GLY . 0.6 OUTLIER -142.54 -91.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.729 -179.831 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.575 ' N ' ' CG2' ' A' ' 42' ' ' VAL . . . -89.12 -21.39 42.11 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.604 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 2.1 mmp_? -51.07 -46.92 88.46 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.292 -1.123 . . . . 0.0 110.481 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 44' ' ' ARG . 36.2 Cg_endo -77.51 154.98 31.7 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.06 1.84 . . . . 0.0 110.434 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.512 ' HG2' ' NE2' ' A' ' 36' ' ' HIS . 6.2 ptm180 -139.77 -165.49 1.89 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.272 -0.892 . . . . 0.0 109.798 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.488 ' HA ' ' CG ' ' A' ' 35' ' ' ARG . 3.8 pt20 -113.16 130.23 56.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.409 -0.807 . . . . 0.0 109.436 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.504 ' C ' ' CD ' ' A' ' 49' ' ' ARG . 9.0 m-20 -112.91 158.27 20.41 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.516 ' HG3' ' CD1' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -133.12 157.5 45.15 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.398 -0.814 . . . . 0.0 109.872 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.562 ' CG1' ' CD1' ' A' ' 57' ' ' ILE . 27.0 m -143.02 159.71 55.27 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.434 -0.791 . . . . 0.0 109.247 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.521 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 35.3 Cg_endo -77.6 173.93 13.43 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.567 2.178 . . . . 0.0 110.517 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 30' ' ' THR . 35.6 Cg_endo -77.86 -15.49 14.98 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.674 2.25 . . . . 0.0 110.518 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.3 t -97.8 18.41 15.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.493 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.521 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 15.4 mmm180 -127.31 109.35 11.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.802 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.466 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 13.3 p-10 -94.81 -7.12 41.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.219 -0.925 . . . . 0.0 109.199 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 42.0 p -134.56 130.62 36.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.42 -0.8 . . . . 0.0 108.987 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.562 ' CD1' ' CG1' ' A' ' 50' ' ' VAL . 1.5 tt -132.06 143.42 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.143 -0.973 . . . . 0.0 109.795 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 16.8 m -102.63 125.7 49.46 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.295 -0.878 . . . . 0.0 109.328 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.561 HD12 ' CZ ' ' A' ' 18' ' ' PHE . 0.9 OUTLIER -91.13 153.73 19.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.888 . . . . 0.0 109.329 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.465 ' O ' ' CD2' ' A' ' 62' ' ' LEU . 13.8 p -139.51 -178.79 5.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 109.462 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 54.69 27.38 8.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 109.364 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.613 ' CD2' ' CE1' ' A' ' 36' ' ' HIS . 2.1 mt -105.46 148.16 27.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.121 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.409 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 6.0 m120 -49.33 130.21 17.51 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.106 -0.996 . . . . 0.0 108.525 179.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.492 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.1 Cg_endo -76.85 129.18 10.54 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.33 2.02 . . . . 0.0 110.756 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 69.8 63.87 3.16 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.4 m -156.86 152.01 26.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.339 -1.095 . . . . 0.0 110.486 -178.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.548 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.6 OUTLIER -78.6 124.44 28.16 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.463 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.498 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 2.2 m-85 -119.19 119.42 34.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.983 -1.073 . . . . 0.0 110.319 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.565 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 16.3 t -78.67 122.37 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.512 ' CG1' ' O ' ' A' ' 35' ' ' ARG . 2.8 t -107.08 136.35 42.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.11 -0.994 . . . . 0.0 110.188 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.526 ' OG ' ' CB ' ' A' ' 35' ' ' ARG . 10.5 p -110.91 108.43 18.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.363 -0.836 . . . . 0.0 109.67 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.479 HD13 HG22 ' A' ' 72' ' ' ILE . 17.1 mm -91.87 110.1 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 109.959 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.568 ' N ' ' CD1' ' A' ' 73' ' ' ILE . 1.5 mp -113.96 153.33 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.16 -0.962 . . . . 0.0 109.092 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.5 ' HB2' ' CB ' ' A' ' 81' ' ' SER . . . -112.71 145.46 40.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.527 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.464 ' O ' ' OG1' ' A' ' 30' ' ' THR . 0.9 OUTLIER -147.13 142.19 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.294 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.466 ' HB3' ' HB2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -112.96 50.13 0.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.214 -0.929 . . . . 0.0 109.472 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.41 -59.19 3.69 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.515 ' N ' ' HD2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -130.36 0.16 4.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -1.123 . . . . 0.0 109.63 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 7.3 mt-10 -100.9 -164.7 1.13 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 0.0 109.365 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 20.2 mt-10 -151.03 -170.44 3.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 109.592 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.57 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -167.74 -178.08 0.6 Allowed Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.57 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.7 Cg_endo -76.67 142.56 23.09 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.126 1.884 . . . . 0.0 110.151 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.56 129.97 10.47 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.678 2.252 . . . . 0.0 110.967 -179.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.466 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 22.3 tp -120.13 84.04 2.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -0.825 . . . . 0.0 109.01 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.494 ' CD1' ' HB2' ' A' ' 71' ' ' SER . 3.0 mt -94.67 152.8 3.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.208 -0.933 . . . . 0.0 109.954 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.551 ' HA3' ' CZ ' ' A' ' 8' ' ' PHE . . . -143.95 -172.45 14.7 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.469 ' O ' ' HG3' ' A' ' 88' ' ' GLN . 9.8 mt-30 -138.26 131.01 29.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -1.183 . . . . 0.0 109.766 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.533 ' HG2' ' CB ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -141.32 -152.0 0.39 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 108.962 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.548 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.28 145.54 7.01 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.878 -1.139 . . . . 0.0 110.59 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.47 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.1 OUTLIER -84.85 142.43 29.74 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.576 ' CG1' ' CB ' ' A' ' 116' ' ' ALA . 1.9 t -61.87 176.84 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.416 -0.802 . . . . 0.0 109.307 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.68 106.79 17.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.164 -0.96 . . . . 0.0 109.645 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.525 ' HB3' ' CB ' ' A' ' 15' ' ' ALA . 7.5 p30 -78.82 -35.15 44.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.141 -0.974 . . . . 0.0 109.08 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.567 ' CG2' ' CG2' ' A' ' 178' ' ' VAL . 8.8 mt -58.53 144.36 79.22 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.371 -0.831 . . . . 0.0 109.205 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.602 ' CB ' ' CD1' ' A' ' 112' ' ' TRP . 33.9 Cg_endo -76.08 74.6 4.48 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.271 1.98 . . . . 0.0 109.886 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 13.9 tpp85 -61.76 158.86 14.74 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.538 -0.726 . . . . 0.0 109.516 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.9 OUTLIER 80.1 17.17 0.71 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.559 -0.713 . . . . 0.0 109.507 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.524 ' CG ' HG22 ' A' ' 180' ' ' ILE . 26.7 tp -60.51 100.07 0.09 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.228 -0.92 . . . . 0.0 108.918 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -140.56 -171.75 3.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.206 -0.934 . . . . 0.0 109.173 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 35.3 t -126.41 150.53 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.16 -0.963 . . . . 0.0 110.014 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.536 HG12 ' CD1' ' A' ' 109' ' ' LEU . 3.0 pt -121.21 -14.43 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.475 -0.766 . . . . 0.0 109.505 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.509 ' CB ' ' HB2' ' A' ' 109' ' ' LEU . . . -134.08 133.42 41.11 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.517 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.8 p -122.73 81.91 1.92 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.033 -1.042 . . . . 0.0 110.374 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.54 ' OG1' ' N ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -73.76 163.52 67.82 Favored Pre-proline 0 C--N 1.305 -1.365 0 O-C-N 121.147 -0.971 . . . . 0.0 108.51 179.177 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.475 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 29.7 Cg_endo -68.56 -2.32 9.05 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.4 2.066 . . . . 0.0 110.777 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.596 ' HA ' HG21 ' A' ' 152' ' ' ILE . 17.1 p -155.38 21.55 0.41 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.326 -0.859 . . . . 0.0 108.684 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.54 ' N ' ' OG1' ' A' ' 104' ' ' THR . 49.6 p -173.24 158.88 3.71 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.467 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.64 ' CD1' ' CE2' ' A' ' 182' ' ' TYR . 0.5 OUTLIER -143.91 151.82 40.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.149 -0.969 . . . . 0.0 109.514 -179.569 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.536 ' CD1' HG12 ' A' ' 101' ' ' ILE . 2.8 tm? -86.9 144.76 26.83 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.433 -0.792 . . . . 0.0 109.091 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.536 ' N ' ' CD1' ' A' ' 109' ' ' LEU . 0.6 OUTLIER -127.09 150.71 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.083 -1.011 . . . . 0.0 109.953 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.6 t -156.1 139.99 16.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.45 -0.782 . . . . 0.0 109.32 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.602 ' CD1' ' CB ' ' A' ' 95' ' ' PRO . 28.5 p90 -150.63 160.69 43.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.512 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.446 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 59.4 mt-10 -74.2 146.63 84.72 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.0 109.498 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.72 141.12 17.03 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.586 2.19 . . . . 0.0 110.416 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.466 ' CB ' ' HA ' ' A' ' 93' ' ' ASP . 35.1 Cg_endo -78.45 173.0 14.38 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.582 2.188 . . . . 0.0 110.571 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.576 ' CB ' ' CG1' ' A' ' 91' ' ' VAL . . . -96.19 25.42 4.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.371 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.439 HG11 ' CG2' ' A' ' 14' ' ' THR . 3.7 m -134.93 158.09 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.256 -0.903 . . . . 0.0 109.492 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.487 ' C ' ' CG2' ' A' ' 119' ' ' VAL . 4.2 m -70.47 164.75 24.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.91 . . . . 0.0 109.391 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.557 HG13 ' CE2' ' A' ' 122' ' ' TYR . 1.5 t -156.16 134.17 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 0.0 109.506 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.535 ' CG ' ' O ' ' A' ' 166' ' ' THR . 0.1 OUTLIER -78.3 -45.48 22.62 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.162 -0.961 . . . . 0.0 108.871 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.594 ' CD2' ' N ' ' A' ' 122' ' ' TYR . 3.2 p90 -165.21 -177.21 4.44 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.269 -0.894 . . . . 0.0 109.887 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 1.6 m-85 -141.01 142.7 34.21 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.532 ' CD ' ' HB2' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -113.63 106.56 14.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.012 -1.055 . . . . 0.0 109.413 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.592 ' HB ' ' CE1' ' A' ' 138' ' ' PHE . 20.2 mt -84.62 164.99 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.355 -0.84 . . . . 0.0 109.141 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.571 ' CG2' ' CG ' ' A' ' 137' ' ' GLU . 3.0 p -135.39 140.83 45.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.914 . . . . 0.0 110.105 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.644 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 3.6 m-30 -85.9 124.01 31.89 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.606 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -95.05 112.11 4.32 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -107.35 134.14 50.85 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.228 -1.16 . . . . 0.0 109.295 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.504 ' CG2' ' HB3' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -82.47 -85.69 0.11 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.052 -1.03 . . . . 0.0 109.648 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -84.5 45.49 3.51 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.445 ' O ' ' OG ' ' A' ' 133' ' ' SER . . . -93.43 -14.24 53.98 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 48.85 23.87 0.75 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -1.15 . . . . 0.0 109.343 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 131' ' ' GLY . 0.0 OUTLIER -131.81 171.74 8.59 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.322 -0.861 . . . . 0.0 109.41 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 133' ' ' SER . 35.3 Cg_endo -78.27 132.88 11.65 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.62 2.213 . . . . 0.0 110.432 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 126' ' ' TYR . 3.3 m -45.97 165.26 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.229 -0.919 . . . . 0.0 109.596 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 126' ' ' TYR . 1.5 tt0 -112.48 117.12 31.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.143 -0.973 . . . . 0.0 109.117 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.571 ' CG ' ' CG2' ' A' ' 125' ' ' THR . 0.5 OUTLIER -105.18 119.23 38.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.128 -0.983 . . . . 0.0 110.808 -179.045 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.592 ' CE1' ' HB ' ' A' ' 124' ' ' ILE . 26.5 p90 -118.89 149.49 41.48 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.571 ' O ' ' CD2' ' A' ' 138' ' ' PHE . 1.3 p -73.97 -174.03 1.74 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.008 -1.057 . . . . 0.0 110.879 -177.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.539 ' CG2' HD13 ' A' ' 124' ' ' ILE . 55.7 t -153.0 141.16 13.78 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.239 -0.913 . . . . 0.0 109.715 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.456 ' HD2' HG12 ' A' ' 140' ' ' VAL . 36.0 Cg_endo -78.5 128.88 9.02 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.396 2.064 . . . . 0.0 110.052 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -81.96 47.28 3.66 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.3 p -105.42 -2.48 23.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -1.175 . . . . 0.0 109.747 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -166.2 170.03 13.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.142 -0.974 . . . . 0.0 109.683 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.05 21.2 8.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.321 -0.862 . . . . 0.0 109.642 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.559 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 70.0 p -139.01 152.32 47.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.175 -0.953 . . . . 0.0 109.504 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.483 ' C ' ' CG1' ' A' ' 110' ' ' ILE . . . -144.13 -164.29 1.86 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.213 -0.93 . . . . 0.0 109.239 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.539 ' CG2' ' N ' ' A' ' 149' ' ' ILE . 20.9 m -146.21 165.77 28.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 109.736 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.644 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -138.89 111.87 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.367 -0.833 . . . . 0.0 109.109 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.455 ' HA ' ' CB ' ' A' ' 107' ' ' SER . 13.6 m-80 -109.62 177.5 4.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.858 . . . . 0.0 109.369 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 30.0 m120 54.97 69.41 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 108.998 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.596 HG21 ' HA ' ' A' ' 106' ' ' THR . 9.2 tt -129.34 163.86 33.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.385 -0.822 . . . . 0.0 109.897 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.466 ' N ' HG12 ' A' ' 152' ' ' ILE . 0.3 OUTLIER -94.37 110.77 50.6 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 109.177 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.475 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 35.7 Cg_endo -78.35 153.37 27.53 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.4 2.067 . . . . 0.0 110.638 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 74.99 64.07 2.4 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . 171.37 131.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -1.145 . . . . 0.0 109.659 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.504 ' HB3' ' CG2' ' A' ' 129' ' ' THR . 0.9 OUTLIER -53.78 133.9 42.3 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.266 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.606 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -116.22 177.28 4.74 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.904 -1.123 . . . . 0.0 110.23 -179.069 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.579 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 1.8 m -143.53 98.55 3.27 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 179' ' ' SER . 32.9 mm -84.94 125.45 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.933 -1.104 . . . . 0.0 110.213 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 179' ' ' SER . 1.4 m -133.29 170.5 15.36 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.509 ' CD1' ' HG3' ' A' ' 95' ' ' PRO . 0.9 OUTLIER -167.79 150.68 5.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.792 -1.192 . . . . 0.0 111.048 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.592 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 1.2 m-85 -124.45 119.92 30.55 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.457 ' HB3' ' CD2' ' A' ' 122' ' ' TYR . . . -85.12 116.13 23.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.877 -1.139 . . . . 0.0 109.226 179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.564 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 53.2 t -93.96 134.19 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 109.99 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.535 ' O ' ' CG ' ' A' ' 120' ' ' ARG . 0.7 OUTLIER -112.88 -39.26 4.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.467 -0.771 . . . . 0.0 109.37 179.757 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 172' ' ' PRO . . . -101.01 139.37 14.36 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.35 58.33 1.46 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.224 -1.162 . . . . 0.0 109.529 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -160.09 -118.23 0.49 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -86.32 12.7 9.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -1.166 . . . . 0.0 109.47 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 73.7 m -164.49 69.52 1.51 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.391 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.426 ' HA ' ' O ' ' A' ' 167' ' ' GLY . 35.6 Cg_endo -78.0 107.27 2.31 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.713 2.275 . . . . 0.0 110.464 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -105.39 166.69 10.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.899 . . . . 0.0 109.538 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 175' ' ' SER . 0.6 OUTLIER -160.27 122.48 3.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.441 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 174' ' ' SER . 0.7 OUTLIER -54.39 -169.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.011 179.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.535 ' HG2' ' CD1' ' A' ' 94' ' ' ILE . 0.5 OUTLIER -80.98 145.89 58.0 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.543 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.592 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.7 Cg_endo -77.21 139.12 18.59 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.474 2.116 . . . . 0.0 111.042 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.567 ' CG2' ' CG2' ' A' ' 94' ' ' ILE . 2.2 t -113.48 139.14 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.494 ' HA ' ' HA ' ' A' ' 161' ' ' THR . 0.4 OUTLIER -130.48 136.0 48.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 110.17 -179.282 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.524 HG22 ' CG ' ' A' ' 98' ' ' LEU . 9.8 pt -125.16 152.08 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 29.5 m-20 -85.32 160.6 19.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.126 -0.984 . . . . 0.0 109.634 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.64 ' CE2' ' CD1' ' A' ' 108' ' ' LEU . 66.8 t80 -159.25 116.47 2.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 109.437 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -84.81 113.16 21.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.92 . . . . 0.0 109.549 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.503 HG22 ' CD1' ' A' ' 158' ' ' TYR . 21.6 p . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.489 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.415 ' O ' HD22 ' A' ' 2' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.452 HD11 ' O ' ' A' ' 80' ' ' GLU . 94.7 mt -152.53 143.93 23.33 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.225 -1.161 . . . . 0.0 109.435 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 28.5 m-20 -75.05 167.04 22.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.868 . . . . 0.0 109.447 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.513 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 22.7 t -94.82 124.15 55.52 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.952 . . . . 0.0 109.639 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.521 ' O ' ' CD2' ' A' ' 84' ' ' LEU . 35.6 Cg_endo -78.78 83.76 2.18 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.437 2.091 . . . . 0.0 110.161 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.514 HG21 ' CD1' ' A' ' 84' ' ' LEU . 1.9 p -75.92 -109.85 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 22' ' ' TRP . . . 45.46 26.16 1.53 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.411 ' N ' ' C ' ' A' ' 6' ' ' THR . 22.5 t80 -55.25 121.09 8.1 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.519 -0.989 . . . . 0.0 109.958 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 1.0 OUTLIER -149.26 103.42 3.31 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.425 -0.797 . . . . 0.0 108.853 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.482 ' HB3' ' NE2' ' A' ' 88' ' ' GLN . 3.8 p -84.54 124.78 31.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 109.586 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 19' ' ' THR . 3.6 p -155.34 -162.17 1.3 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.202 -0.936 . . . . 0.0 109.32 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.522 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.9 OUTLIER 44.9 38.15 2.77 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -178.796 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.631 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 2.3 mt -88.12 141.31 14.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.81 0.814 . . . . 0.0 111.417 -177.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.61 ' N ' ' O ' ' A' ' 17' ' ' SER . 1.5 p -127.43 156.87 41.4 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.527 ' CB ' ' HB3' ' A' ' 64' ' ' PRO . . . -58.95 -36.9 75.57 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.009 -1.057 . . . . 0.0 110.26 -178.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 17' ' ' SER . 0.5 OUTLIER -112.36 38.17 2.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.562 -1.336 . . . . 0.0 109.3 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.61 ' O ' ' N ' ' A' ' 14' ' ' THR . 1.4 t 160.65 155.65 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.631 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 5.1 p90 -165.88 152.09 9.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.624 -1.298 . . . . 0.0 109.886 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.522 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 25.4 m -109.09 153.6 23.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.766 -1.209 . . . . 0.0 110.86 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.536 ' C ' ' CD2' ' A' ' 21' ' ' HIS . 0.7 OUTLIER -118.43 169.43 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.431 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.536 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 17.7 m-70 -143.71 157.57 44.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.177 -0.952 . . . . 0.0 109.79 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.531 ' CZ2' HG22 ' A' ' 50' ' ' VAL . 32.4 p90 -164.64 146.63 8.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.304 -0.873 . . . . 0.0 109.392 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.7 167.48 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.127 -0.983 . . . . 0.0 109.273 179.717 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.502 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -95.9 160.8 29.32 Favored Pre-proline 0 C--N 1.299 -1.63 0 O-C-N 121.584 -0.698 . . . . 0.0 109.541 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.474 ' HD3' ' HB3' ' A' ' 5' ' ' PRO . 36.0 Cg_endo -79.16 160.28 26.53 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.6 2.2 . . . . 0.0 110.377 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.434 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 1.2 mtm-85 -84.02 46.34 1.18 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.923 . . . . 0.0 109.487 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.458 ' CB ' ' HD2' ' A' ' 28' ' ' PRO . . . -158.31 173.32 5.1 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.374 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.458 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 35.8 Cg_endo -78.35 136.14 13.94 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.586 2.191 . . . . 0.0 110.445 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.639 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 21.0 pt -140.93 -170.39 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 46.2 p -132.44 2.44 3.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.584 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.443 ' HA2' ' HA ' ' A' ' 52' ' ' PRO . . . 147.5 -168.58 28.5 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.639 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -146.29 133.38 20.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -1.137 . . . . 0.0 109.516 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.584 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 0.7 OUTLIER -87.29 123.57 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.179 -0.951 . . . . 0.0 108.766 179.581 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.585 ' CG2' ' CD1' ' A' ' 72' ' ' ILE . 1.1 mm -109.37 158.25 9.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.244 -0.91 . . . . 0.0 109.167 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.481 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 50.7 ttp180 -155.49 146.62 22.58 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.53 ' NE2' ' HD2' ' A' ' 46' ' ' ARG . 1.1 p80 -128.9 151.99 49.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.926 -1.109 . . . . 0.0 109.964 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.628 ' CE1' ' CG1' ' A' ' 69' ' ' VAL . 55.9 p-80 -170.4 108.81 0.35 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.743 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -45.92 160.26 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.244 -0.91 . . . . 0.0 109.447 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.424 ' HG3' ' HB2' ' A' ' 67' ' ' GLU . 1.0 OUTLIER -69.28 -8.4 45.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 109.56 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -108.23 18.05 21.53 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.306 -0.871 . . . . 0.0 109.516 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 37' ' ' HIS . 62.7 p -159.98 100.93 1.42 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 109.773 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.8 p -130.97 5.06 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.397 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.505 ' C ' ' HD3' ' A' ' 45' ' ' PRO . . . -78.4 -53.49 4.72 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.585 ' CD ' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -122.29 62.66 16.35 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.079 -1.247 . . . . 0.0 110.712 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.505 ' HD3' ' C ' ' A' ' 43' ' ' GLY . 36.9 Cg_endo -77.85 155.57 30.64 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.393 2.062 . . . . 0.0 110.062 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.53 ' HD2' ' NE2' ' A' ' 36' ' ' HIS . 1.0 OUTLIER -97.29 149.86 21.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.015 -1.053 . . . . 0.0 109.417 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -106.98 120.28 41.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.368 -0.832 . . . . 0.0 110.124 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.529 ' CB ' HD12 ' A' ' 57' ' ' ILE . 6.6 m-20 -102.48 117.98 35.88 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.512 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -98.1 155.25 17.23 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.095 -1.003 . . . . 0.0 110.054 -179.223 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.533 ' CG1' ' HB ' ' A' ' 57' ' ' ILE . 15.1 m -136.09 158.99 72.68 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.478 -0.764 . . . . 0.0 109.199 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.507 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.3 Cg_endo -76.49 174.08 13.43 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.552 2.168 . . . . 0.0 110.302 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.513 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 35.5 Cg_endo -77.17 -15.97 15.89 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.606 2.204 . . . . 0.0 110.448 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.3 p -97.86 8.47 44.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.442 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.507 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -115.74 106.21 13.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.206 -0.934 . . . . 0.0 109.759 -179.742 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.409 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 17.9 p-10 -85.46 -2.58 58.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.168 -0.958 . . . . 0.0 109.245 179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 61.4 p -137.96 144.62 41.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.868 . . . . 0.0 109.119 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.537 HD11 ' CG1' ' A' ' 34' ' ' ILE . 8.0 tt -118.58 127.73 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.112 -0.993 . . . . 0.0 109.792 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.429 ' CG2' ' OG1' ' A' ' 19' ' ' THR . 0.3 OUTLIER -90.31 113.95 25.91 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.411 -0.806 . . . . 0.0 109.458 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.566 HD11 ' CZ ' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -84.86 147.75 26.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.43 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.464 ' O ' HD22 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -126.41 154.19 43.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 109.63 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.514 ' O ' ' CD2' ' A' ' 62' ' ' LEU . 1.1 m-80 61.85 79.57 0.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.362 -0.836 . . . . 0.0 109.595 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.526 ' CD1' ' HA ' ' A' ' 17' ' ' SER . 6.0 mt -143.33 134.68 26.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -0.879 . . . . 0.0 109.449 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -55.05 130.63 67.78 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.254 -0.904 . . . . 0.0 109.043 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.527 ' HB3' ' CB ' ' A' ' 15' ' ' ALA . 36.4 Cg_endo -78.1 128.36 9.02 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.389 2.059 . . . . 0.0 110.692 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.463 ' HA3' ' OG ' ' A' ' 92' ' ' SER . . . 82.14 58.65 2.42 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 90' ' ' THR . 2.5 m -157.28 143.37 17.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.31 -1.112 . . . . 0.0 109.22 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.524 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 3.2 mt-10 -74.41 130.28 39.36 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.027 -1.046 . . . . 0.0 108.793 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 4.1 m-85 -121.5 101.17 7.45 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.16 -0.962 . . . . 0.0 110.046 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.628 ' CG1' ' CE1' ' A' ' 37' ' ' HIS . 58.9 t -67.98 130.08 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.067 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.53 ' CG2' ' OE1' ' A' ' 88' ' ' GLN . 47.0 t -126.0 136.97 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.993 -1.067 . . . . 0.0 109.962 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.523 ' CB ' HG12 ' A' ' 85' ' ' ILE . 92.3 p -111.53 123.86 51.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 110.146 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.585 ' CD1' ' CG2' ' A' ' 34' ' ' ILE . 11.6 mm -100.65 131.86 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.373 -0.829 . . . . 0.0 109.621 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.518 HD11 ' N ' ' A' ' 73' ' ' ILE . 1.7 mp -126.14 164.12 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -0.858 . . . . 0.0 108.919 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.515 ' N ' ' CG2' ' A' ' 73' ' ' ILE . . . -128.36 141.88 51.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.284 -0.885 . . . . 0.0 109.595 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.464 HG23 HD12 ' A' ' 33' ' ' ILE . 3.6 m -135.41 134.13 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.343 -0.848 . . . . 0.0 109.347 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.457 ' HB3' ' HB2' ' A' ' 79' ' ' GLU . 2.9 t-20 -108.93 46.46 0.97 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.522 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 87.03 -80.39 1.74 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.52 -1.97 13.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.179 -1.189 . . . . 0.0 109.6 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.457 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 1.3 mp0 -100.62 -165.75 1.24 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 109.27 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.452 ' O ' HD11 ' A' ' 2' ' ' LEU . 23.7 mt-10 -146.58 -168.66 3.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 109.665 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.566 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -159.37 -179.17 1.03 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.396 -0.815 . . . . 0.0 108.983 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.566 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.4 Cg_endo -77.36 141.93 20.72 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.23 1.954 . . . . 0.0 109.943 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.71 88.83 1.38 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.524 2.15 . . . . 0.0 111.038 -179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.521 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 4.6 tp -75.08 104.11 5.53 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.523 HG12 ' CB ' ' A' ' 71' ' ' SER . 2.5 mt -105.0 163.27 4.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.095 -1.003 . . . . 0.0 110.375 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.515 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -159.36 159.24 30.3 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.481 -1.847 . . . . 0.0 108.481 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.427 ' HG2' HG12 ' A' ' 69' ' ' VAL . 29.5 mt-30 -117.76 131.29 56.61 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.185 -1.185 . . . . 0.0 109.815 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.56 ' NE2' ' CE1' ' A' ' 18' ' ' PHE . 3.6 pt20 -136.37 -165.59 1.75 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.524 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -154.74 146.57 23.42 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.025 -1.047 . . . . 0.0 109.75 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.91 132.94 41.82 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.543 -0.863 . . . . 0.0 108.91 179.563 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.57 ' CG1' ' O ' ' A' ' 114' ' ' PRO . 0.0 OUTLIER -47.09 136.4 2.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.57 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.463 ' OG ' ' HA3' ' A' ' 65' ' ' GLY . 1.5 t -107.27 151.88 24.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 109.621 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.528 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 6.6 p-10 -48.19 -25.34 1.46 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.208 -0.932 . . . . 0.0 108.846 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.582 ' CG2' ' HD2' ' A' ' 95' ' ' PRO . 2.6 mt -107.15 147.9 36.03 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.582 ' HD2' ' CG2' ' A' ' 94' ' ' ILE . 30.6 Cg_endo -72.03 59.16 2.91 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.783 1.655 . . . . 0.0 109.375 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.472 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 17.9 ttt180 -60.27 177.09 0.29 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.389 0.614 . . . . 0.0 110.387 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.478 ' O ' ' HA ' ' A' ' 112' ' ' TRP . 0.7 OUTLIER 66.4 24.79 10.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.513 -0.742 . . . . 0.0 109.256 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.586 ' CD2' ' CD1' ' A' ' 162' ' ' LEU . 0.2 OUTLIER -61.61 102.45 0.25 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.349 -0.844 . . . . 0.0 109.531 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.457 ' HG2' ' O ' ' A' ' 97' ' ' ASP . 3.8 pt-20 -153.78 171.57 18.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.209 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.504 HG11 ' N ' ' A' ' 101' ' ' ILE . 40.2 t -115.1 155.87 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.157 -0.964 . . . . 0.0 109.747 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.575 ' CG1' ' CD2' ' A' ' 109' ' ' LEU . 0.8 OUTLIER -127.91 -7.39 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.46 -0.775 . . . . 0.0 109.821 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.52 ' CB ' ' HB3' ' A' ' 109' ' ' LEU . . . -136.47 122.13 19.73 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.527 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.4 p -112.62 75.66 0.93 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.092 -1.005 . . . . 0.0 110.415 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 107' ' ' SER . 0.7 OUTLIER -74.0 159.59 83.73 Favored Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.15 -0.969 . . . . 0.0 108.622 179.225 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.464 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.1 Cg_endo -69.04 -1.85 8.62 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.493 2.129 . . . . 0.0 111.003 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.522 ' HA ' HG21 ' A' ' 152' ' ' ILE . 70.7 p -152.33 19.13 0.65 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 108.893 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.566 ' N ' ' OG1' ' A' ' 104' ' ' THR . 6.8 p -173.71 147.54 1.39 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.024 -1.071 . . . . 0.0 110.144 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.621 ' CD1' ' CD2' ' A' ' 182' ' ' TYR . 0.3 OUTLIER -124.29 154.72 39.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.404 -0.81 . . . . 0.0 109.294 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.575 ' CD2' ' CG1' ' A' ' 101' ' ' ILE . 13.0 tp -105.22 107.16 17.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.269 -0.894 . . . . 0.0 108.731 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.484 ' CG1' ' O ' ' A' ' 147' ' ' ALA . 1.4 pt -85.8 129.48 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.221 -0.924 . . . . 0.0 110.262 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.516 ' HB3' ' CG2' ' A' ' 101' ' ' ILE . 1.3 p -126.32 123.28 37.68 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.582 ' CE3' ' O ' ' A' ' 145' ' ' SER . 19.3 p90 -152.64 -175.73 5.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.947 -1.095 . . . . 0.0 110.464 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 45.2 mm-40 -105.56 100.49 26.84 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.57 ' O ' ' CG1' ' A' ' 91' ' ' VAL . 34.0 Cg_endo -73.24 165.47 32.54 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.5 2.133 . . . . 0.0 111.364 -178.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.528 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 37.3 Cg_endo -81.98 85.61 1.67 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.76 2.307 . . . . 0.0 110.416 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.564 ' HB1' ' CG1' ' A' ' 91' ' ' VAL . . . -69.54 61.04 0.15 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.069 -1.019 . . . . 0.0 108.563 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.488 ' N ' ' O ' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -133.72 -162.39 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.585 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.8 m -68.91 70.99 0.21 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.883 -1.136 . . . . 0.0 109.207 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.512 ' HA ' ' CG2' ' A' ' 166' ' ' THR . 2.6 t -107.5 142.89 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.306 -0.871 . . . . 0.0 109.839 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.524 ' HD2' ' NE ' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -89.98 -51.67 5.35 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.225 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.624 ' CD2' ' N ' ' A' ' 122' ' ' TYR . 13.6 p90 -165.74 -168.71 1.36 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.508 -0.745 . . . . 0.0 109.53 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.624 ' N ' ' CD2' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -140.19 137.53 34.42 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.134 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.47 ' CB ' ' HB2' ' A' ' 163' ' ' TYR . 5.8 ttt180 -95.64 101.92 13.67 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.271 -0.893 . . . . 0.0 109.089 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.654 ' CG2' ' CE2' ' A' ' 138' ' ' PHE . 19.7 mt -85.35 117.64 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.209 -0.932 . . . . 0.0 109.013 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 43.3 p -93.55 130.11 39.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.413 -0.804 . . . . 0.0 110.488 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.651 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 3.0 m-85 -81.35 122.78 27.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.564 -0.71 . . . . 0.0 109.15 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.588 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -102.32 99.18 1.82 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.497 ' HG2' ' CZ ' ' A' ' 158' ' ' TYR . 7.4 mt-10 -107.36 89.86 3.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.16 -1.2 . . . . 0.0 109.474 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -72.51 145.07 47.75 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.029 -1.045 . . . . 0.0 109.605 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 161.17 -77.79 0.17 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -114.94 45.26 1.33 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 50.53 23.34 1.27 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -1.164 . . . . 0.0 109.502 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.426 ' CB ' ' CD ' ' A' ' 134' ' ' PRO . 0.1 OUTLIER -55.52 171.93 0.32 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.491 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.426 ' CD ' ' CB ' ' A' ' 133' ' ' SER . 35.8 Cg_endo -78.58 177.22 8.99 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.674 2.249 . . . . 0.0 110.434 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' A' ' 126' ' ' TYR . 0.1 OUTLIER -105.53 144.89 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.303 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.539 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 1.9 tt0 -102.61 98.49 8.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.924 . . . . 0.0 108.939 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.537 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 4.8 pt-20 -92.25 137.13 32.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 110.762 -178.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.654 ' CE2' ' CG2' ' A' ' 124' ' ' ILE . 43.4 p90 -134.79 147.48 49.98 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.7 p -74.17 171.07 14.24 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.111 -0.993 . . . . 0.0 111.013 -177.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.537 ' CG2' HG13 ' A' ' 124' ' ' ILE . 25.1 t -143.19 140.45 17.82 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.423 -0.798 . . . . 0.0 110.102 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.452 ' HD2' HG12 ' A' ' 140' ' ' VAL . 36.4 Cg_endo -79.94 142.34 15.57 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.475 2.117 . . . . 0.0 110.201 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.428 ' HA2' ' OH ' ' A' ' 122' ' ' TYR . . . -84.06 45.76 3.54 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.59 -81.46 0.54 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -1.152 . . . . 0.0 110.096 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -78.98 157.67 28.09 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.545 0.688 . . . . 0.0 110.271 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.582 ' O ' ' CE3' ' A' ' 112' ' ' TRP . 0.1 OUTLIER -95.38 -3.17 47.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.473 -0.767 . . . . 0.0 109.577 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 110' ' ' ILE . 7.1 p -116.63 142.04 47.41 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.484 ' O ' ' CG1' ' A' ' 110' ' ' ILE . . . -134.51 150.88 50.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.876 -1.14 . . . . 0.0 110.06 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 6.9 t -96.17 146.4 24.71 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.367 -0.833 . . . . 0.0 109.028 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.651 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 19.2 mm -126.07 73.18 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.233 -0.917 . . . . 0.0 109.513 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.529 ' HA ' ' CB ' ' A' ' 107' ' ' SER . 4.9 m-80 -79.22 -165.03 0.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.711 -0.618 . . . . 0.0 109.597 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 25.2 m120 57.93 20.65 6.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.057 -1.027 . . . . 0.0 109.017 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.585 HG13 ' CE2' ' A' ' 158' ' ' TYR . 3.5 tt -89.69 161.04 2.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.478 -0.764 . . . . 0.0 109.67 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.58 122.89 40.44 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.166 -0.959 . . . . 0.0 109.221 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.464 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 36.3 Cg_endo -77.73 145.3 22.82 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.439 2.093 . . . . 0.0 110.563 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 184' ' ' THR . . . 81.12 65.69 1.67 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.467 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 167.14 130.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -1.208 . . . . 0.0 109.748 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.436 ' O ' ' OG1' ' A' ' 129' ' ' THR . 2.0 t70 -50.34 165.78 0.09 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.588 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -144.53 173.07 12.12 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.804 -1.185 . . . . 0.0 110.248 -179.66 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.556 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 1.8 m -147.59 99.34 3.1 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . . . . . . . . . 88.1 mt -97.39 129.62 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.701 -1.249 . . . . 0.0 109.403 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.574 ' HA ' ' HA ' ' A' ' 179' ' ' SER . 1.7 m -133.8 139.2 46.15 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.099 -1.001 . . . . 0.0 110.428 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.586 ' CD1' ' CD2' ' A' ' 98' ' ' LEU . 0.5 OUTLIER -110.79 145.6 37.86 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.529 -0.732 . . . . 0.0 110.478 -179.72 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.607 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 37.8 m-85 -131.33 83.73 2.12 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.528 ' O ' ' CB ' ' A' ' 174' ' ' SER . . . -63.73 123.25 18.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.128 -0.983 . . . . 0.0 109.726 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.542 HG23 ' CZ ' ' A' ' 121' ' ' TYR . 5.3 t -104.32 129.18 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 109.452 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.512 ' CG2' ' HA ' ' A' ' 119' ' ' VAL . 21.0 p -120.0 -52.25 2.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.405 -0.81 . . . . 0.0 109.617 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.463 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -42.66 157.32 0.09 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.524 ' NE ' ' HD2' ' A' ' 120' ' ' ARG . 3.3 mpt_? -141.5 106.06 4.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.309 -1.112 . . . . 0.0 109.489 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 162.13 -155.47 26.76 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -75.05 -2.05 25.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -1.15 . . . . 0.0 109.426 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 22.4 m -147.64 82.68 7.92 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.209 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.55 104.62 1.91 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.533 2.155 . . . . 0.0 110.397 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -85.78 129.86 34.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.376 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 164' ' ' ALA . 1.7 p -108.5 133.92 51.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -0.891 . . . . 0.0 109.405 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 174' ' ' SER . 0.9 OUTLIER -44.6 167.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 108.995 179.773 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.532 ' HB2' ' CD1' ' A' ' 94' ' ' ILE . 0.2 OUTLIER -47.98 133.4 11.8 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.987 -1.071 . . . . 0.0 108.491 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.607 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.8 Cg_endo -76.57 157.23 36.24 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.121 1.881 . . . . 0.0 110.324 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -140.35 137.04 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.317 -0.864 . . . . 0.0 108.829 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.574 ' HA ' ' HA ' ' A' ' 161' ' ' THR . 0.1 OUTLIER -126.73 -178.6 4.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 110.512 -178.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.53 ' CG2' ' HB3' ' A' ' 98' ' ' LEU . 27.8 pt -158.14 152.3 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -95.72 151.6 19.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.056 -1.028 . . . . 0.0 109.475 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.621 ' CD2' ' CD1' ' A' ' 108' ' ' LEU . 70.7 t80 -147.11 131.26 17.35 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.271 -0.893 . . . . 0.0 109.4 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.82 119.65 39.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.084 -1.01 . . . . 0.0 109.524 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 155' ' ' GLY . 18.4 p . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.46 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.508 ' N ' HD11 ' A' ' 2' ' ' LEU . 1.1 mp -139.15 -164.03 1.59 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -1.147 . . . . 0.0 109.425 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.54 ' HB2' ' CB ' ' A' ' 25' ' ' PRO . 1.1 m-20 -94.17 144.06 25.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.338 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.527 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 10.3 m -78.15 145.33 68.88 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.509 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.467 ' O ' ' CD1' ' A' ' 84' ' ' LEU . 35.7 Cg_endo -78.52 125.77 7.1 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.68 2.253 . . . . 0.0 110.336 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.454 ' HA ' HD12 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -143.35 -164.96 1.97 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.905 . . . . 0.0 109.988 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 8' ' ' PHE . . . 83.13 16.89 68.37 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 107.691 -2.163 . . . . 0.0 107.691 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.415 ' C ' ' O ' ' A' ' 7' ' ' GLY . 2.4 t80 -40.49 140.32 0.67 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.794 -0.827 . . . . 0.0 110.28 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 21' ' ' HIS . 15.1 t0 -165.26 97.68 0.71 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.5 ' CB ' ' HB3' ' A' ' 88' ' ' GLN . 5.4 m -84.59 128.44 34.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.159 -0.963 . . . . 0.0 109.651 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.494 ' O ' ' C ' ' A' ' 12' ' ' ASP . 3.5 p -146.87 -164.74 2.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.327 -0.858 . . . . 0.0 109.026 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.51 ' CB ' ' OG1' ' A' ' 19' ' ' THR . 0.8 OUTLIER 41.61 35.92 0.52 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -178.935 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.599 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 2.3 mt -78.73 144.53 10.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.202 -177.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.548 ' N ' HG21 ' A' ' 13' ' ' ILE . 0.2 OUTLIER -123.5 -157.69 0.77 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.379 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.529 ' CB ' HG12 ' A' ' 117' ' ' VAL . . . -93.2 -48.65 6.36 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.887 -1.133 . . . . 0.0 109.167 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.464 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 15.2 p30 -99.63 -9.12 23.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.043 -1.036 . . . . 0.0 109.155 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 14' ' ' THR . 27.4 p -142.62 159.53 42.06 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.599 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 9.9 p90 -166.13 142.16 4.92 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.911 -1.118 . . . . 0.0 109.435 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.51 ' OG1' ' CB ' ' A' ' 12' ' ' ASP . 17.1 m -81.33 153.76 26.86 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.897 -1.127 . . . . 0.0 110.773 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.568 ' CG2' ' CD1' ' A' ' 59' ' ' LEU . 0.3 OUTLIER -132.18 116.98 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.52 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.547 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 3.1 m-70 -103.07 161.95 13.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.053 -1.03 . . . . 0.0 110.34 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.445 ' CH2' HG23 ' A' ' 50' ' ' VAL . 23.4 p90 -171.42 137.47 1.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.484 -0.76 . . . . 0.0 109.083 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.35 163.14 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.073 -1.017 . . . . 0.0 109.652 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.45 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . . . -98.62 173.45 3.86 Favored Pre-proline 0 C--N 1.299 -1.63 0 O-C-N 121.713 -0.617 . . . . 0.0 109.733 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.54 ' CB ' ' HB2' ' A' ' 3' ' ' ASP . 35.8 Cg_endo -78.42 -162.18 0.17 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.644 2.229 . . . . 0.0 110.307 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.494 ' HB2' ' NH2' ' A' ' 26' ' ' ARG . 0.5 OUTLIER -119.55 18.53 12.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.957 . . . . 0.0 109.426 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.45 ' CB ' ' HD2' ' A' ' 28' ' ' PRO . . . -121.83 172.7 4.76 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.886 . . . . 0.0 109.489 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.462 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 35.7 Cg_endo -78.0 88.25 1.45 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.653 2.236 . . . . 0.0 110.421 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.511 HD13 ' CB ' ' A' ' 52' ' ' PRO . 9.1 pt -80.12 -176.89 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 109.498 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.453 ' OG1' ' N ' ' A' ' 77' ' ' GLY . 59.6 p -131.72 -2.14 3.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 109.929 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.499 ' O ' ' CD1' ' A' ' 32' ' ' TYR . . . 162.51 -178.56 38.24 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.578 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 1.7 m-85 -149.53 131.66 15.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -1.168 . . . . 0.0 109.732 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.593 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -99.38 130.4 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -0.892 . . . . 0.0 108.897 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 48' ' ' ASP . 1.4 mm -117.57 119.34 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.013 -1.054 . . . . 0.0 109.985 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.456 ' HB2' ' OG ' ' A' ' 71' ' ' SER . 34.8 mtp180 -119.35 138.91 52.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.19 -0.944 . . . . 0.0 108.508 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.636 ' CE1' ' CD2' ' A' ' 62' ' ' LEU . 8.4 p80 -129.88 160.26 34.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.905 -1.122 . . . . 0.0 110.688 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.519 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 28.6 p-80 -171.86 121.9 0.49 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.617 -0.677 . . . . 0.0 109.332 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.642 ' CB ' ' CE1' ' A' ' 68' ' ' TYR . . . -50.58 -178.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.177 -0.952 . . . . 0.0 109.554 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -79.14 -95.12 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.227 -0.92 . . . . 0.0 109.403 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -100.32 28.96 4.6 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.308 -0.87 . . . . 0.0 109.586 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.468 ' HB3' ' HB2' ' A' ' 38' ' ' ALA . 6.0 p -75.87 -161.9 0.19 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.462 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.436 ' O ' HG21 ' A' ' 42' ' ' VAL . 8.0 p -127.32 -1.22 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.602 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.4 141.62 41.16 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 17.8 mtm180 -72.61 140.92 82.02 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.227 -1.161 . . . . 0.0 109.417 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.461 ' HB3' ' HB3' ' A' ' 37' ' ' HIS . 36.3 Cg_endo -78.94 112.34 3.08 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.546 2.164 . . . . 0.0 110.423 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.586 ' CG ' ' NE2' ' A' ' 36' ' ' HIS . 0.7 OUTLIER -95.09 160.9 14.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.937 . . . . 0.0 109.356 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.42 ' HG2' ' HG2' ' A' ' 35' ' ' ARG . 70.0 mt-30 -109.94 103.52 12.3 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.341 -0.849 . . . . 0.0 109.881 -179.656 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.519 ' HB3' ' CD1' ' A' ' 57' ' ' ILE . 70.8 m-20 -93.93 115.93 28.34 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.522 ' HD2' ' CG2' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -97.27 156.72 16.31 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.109 -0.995 . . . . 0.0 109.87 -179.47 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.47 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 15.8 m -141.9 160.54 55.38 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 109.113 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.533 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.4 Cg_endo -77.11 174.18 13.23 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.466 2.111 . . . . 0.0 110.03 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.511 ' CB ' HD13 ' A' ' 29' ' ' ILE . 35.3 Cg_endo -77.54 -15.42 15.56 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.443 2.096 . . . . 0.0 110.516 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.9 t -99.23 18.45 17.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.576 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.533 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -125.86 119.08 26.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 109.799 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 22' ' ' TRP . 0.8 OUTLIER -103.48 -0.39 29.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.321 -0.862 . . . . 0.0 109.283 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 30.8 p -131.08 129.94 42.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 109.462 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.519 ' CD1' ' HB3' ' A' ' 48' ' ' ASP . 4.4 tt -125.05 140.12 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.254 -0.904 . . . . 0.0 109.361 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 8.8 m -102.75 136.68 42.13 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.264 -0.897 . . . . 0.0 109.302 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.627 ' CD2' ' CD2' ' A' ' 36' ' ' HIS . 1.1 mp -115.16 161.0 19.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.637 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.441 HG21 ' HB3' ' A' ' 17' ' ' SER . 23.5 p -139.12 -170.32 2.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.402 -0.811 . . . . 0.0 109.344 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 50.8 m-20 51.93 54.62 10.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.195 -0.941 . . . . 0.0 109.51 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.636 ' CD2' ' CE1' ' A' ' 36' ' ' HIS . 6.8 mt -129.27 169.93 14.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.473 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -84.64 142.83 40.13 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.263 -0.898 . . . . 0.0 109.3 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.52 ' HB3' ' CB ' ' A' ' 15' ' ' ALA . 36.9 Cg_endo -78.78 122.29 5.37 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.556 2.171 . . . . 0.0 110.395 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 75.12 62.49 2.75 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.113 -1.995 . . . . 0.0 108.113 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.605 ' CG2' ' CE2' ' A' ' 68' ' ' TYR . 1.3 m -149.17 144.76 26.8 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.309 -1.112 . . . . 0.0 110.899 -178.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.54 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -81.38 105.63 12.71 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.468 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.642 ' CE1' ' CB ' ' A' ' 38' ' ' ALA . 13.5 m-85 -103.91 150.52 24.11 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.27 -0.894 . . . . 0.0 109.979 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.462 HG12 ' HB3' ' A' ' 87' ' ' GLN . 4.1 t -109.75 154.98 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.321 -0.862 . . . . 0.0 109.193 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.493 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 40.9 t -139.51 129.02 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.126 -0.984 . . . . 0.0 109.709 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.507 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 79.2 p -103.18 101.18 11.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.862 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.469 ' HB ' ' O ' ' A' ' 84' ' ' LEU . 10.9 mm -74.98 153.12 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.094 -1.004 . . . . 0.0 109.702 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.572 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 15.5 mt -143.3 158.68 17.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.383 -0.823 . . . . 0.0 108.892 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.578 ' HB1' ' CZ ' ' A' ' 32' ' ' TYR . . . -131.21 153.02 49.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.437 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.9 m -141.12 135.61 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 109.389 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 79' ' ' GLU . 1.1 t30 -110.72 43.66 1.39 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 109.513 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.453 ' N ' ' OG1' ' A' ' 30' ' ' THR . . . 77.25 -57.1 3.67 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -126.19 -2.96 6.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -1.147 . . . . 0.0 109.737 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.468 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 0.5 OUTLIER -110.07 177.02 4.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.571 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -147.78 95.43 2.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.32 -0.863 . . . . 0.0 109.434 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.566 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.7 OUTLIER -59.64 -179.05 0.15 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.891 . . . . 0.0 109.084 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.566 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.5 Cg_endo -77.71 146.28 23.72 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.277 1.985 . . . . 0.0 110.365 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -77.93 100.99 1.43 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.675 2.25 . . . . 0.0 110.896 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.469 ' O ' ' HB ' ' A' ' 72' ' ' ILE . 4.1 tp -75.0 103.83 5.34 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.507 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 1.9 mt -93.98 143.52 11.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 120.887 -1.133 . . . . 0.0 110.636 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.427 ' O ' HG11 ' A' ' 69' ' ' VAL . . . -148.11 -163.22 10.61 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 179.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.462 ' HB3' HG12 ' A' ' 69' ' ' VAL . 8.2 pt20 -166.78 164.96 16.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.997 -1.296 . . . . 0.0 110.038 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.557 ' HG3' ' CE1' ' A' ' 18' ' ' PHE . 1.9 pm0 -159.73 151.43 20.2 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -90.94 136.67 32.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.153 -0.967 . . . . 0.0 110.431 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.481 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -74.45 134.27 42.35 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.144 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.542 ' O ' ' N ' ' A' ' 65' ' ' GLY . 9.4 t -41.98 169.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.574 0.702 . . . . 0.0 110.599 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.1 t -102.97 158.13 16.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.344 -0.848 . . . . 0.0 109.839 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -86.63 -33.4 20.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.443 -0.786 . . . . 0.0 110.527 -179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.588 ' CD1' ' CB ' ' A' ' 176' ' ' LYS . 2.5 mt -55.64 139.77 67.88 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 120.804 -1.185 . . . . 0.0 109.716 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.573 ' CB ' ' CD1' ' A' ' 112' ' ' TRP . 36.5 Cg_endo -80.89 78.05 3.81 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.571 2.181 . . . . 0.0 109.496 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -76.07 177.19 7.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.318 -0.864 . . . . 0.0 109.677 -179.366 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER 76.28 19.57 1.7 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -0.846 . . . . 0.0 109.64 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.58 ' CD1' ' CD2' ' A' ' 162' ' ' LEU . 0.5 OUTLIER -62.21 99.95 0.15 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.121 -0.987 . . . . 0.0 109.029 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 97' ' ' ASP . 0.1 OUTLIER -144.64 163.74 33.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 109.715 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.429 HG22 ' HB3' ' A' ' 108' ' ' LEU . 9.6 p -104.05 148.75 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.548 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.463 HG12 ' HB3' ' A' ' 109' ' ' LEU . 25.1 pt -125.44 -5.46 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -0.891 . . . . 0.0 109.589 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.513 ' CB ' ' HB2' ' A' ' 109' ' ' LEU . . . -150.49 108.46 3.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.371 -0.831 . . . . 0.0 108.783 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.521 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.7 t -101.7 93.95 5.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 110.229 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -80.01 164.28 53.58 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.339 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.462 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 30.1 Cg_endo -69.18 -2.95 10.66 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.425 2.083 . . . . 0.0 110.748 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.491 ' C ' ' CG2' ' A' ' 152' ' ' ILE . 7.5 p -152.48 19.24 0.63 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.542 ' N ' ' OG1' ' A' ' 104' ' ' THR . 54.5 p -172.89 160.4 4.32 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.96 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.581 HD23 ' CE2' ' A' ' 182' ' ' TYR . 0.5 OUTLIER -135.52 155.33 50.67 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.354 -0.841 . . . . 0.0 108.947 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.513 ' HB2' ' CB ' ' A' ' 102' ' ' ALA . 0.4 OUTLIER -105.04 95.41 5.83 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.239 -0.913 . . . . 0.0 109.346 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.448 HG12 ' O ' ' A' ' 147' ' ' ALA . 15.7 pt -74.88 167.82 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.927 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.47 ' OG ' HG23 ' A' ' 146' ' ' THR . 3.7 m -165.34 100.41 0.72 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.634 -0.666 . . . . 0.0 109.365 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.575 ' CD2' ' O ' ' A' ' 145' ' ' SER . 41.3 p90 -111.4 141.77 44.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.207 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 96' ' ' ARG . 11.3 mm-40 -48.84 145.52 6.21 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.168 -0.957 . . . . 0.0 109.352 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.458 ' HD2' ' OE1' ' A' ' 113' ' ' GLU . 35.2 Cg_endo -77.63 138.79 17.46 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.411 2.074 . . . . 0.0 109.987 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.433 ' HB2' HG21 ' A' ' 117' ' ' VAL . 35.8 Cg_endo -77.79 141.58 19.44 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.35 2.033 . . . . 0.0 110.115 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.539 ' HB3' ' CA ' ' A' ' 14' ' ' THR . . . -87.01 42.52 1.03 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.328 -0.858 . . . . 0.0 109.452 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.529 HG12 ' CB ' ' A' ' 15' ' ' ALA . 5.0 m -141.58 178.19 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 109.491 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.8 m -90.27 96.6 10.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.267 -0.896 . . . . 0.0 109.126 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.521 ' HA ' ' CG2' ' A' ' 166' ' ' THR . 1.5 t -100.08 133.51 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 109.811 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.516 ' HG3' ' N ' ' A' ' 121' ' ' TYR . 8.8 ptm85 -75.21 -46.1 36.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.256 -0.903 . . . . 0.0 108.873 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.615 ' CZ ' ' CG2' ' A' ' 165' ' ' VAL . 2.7 p90 -165.8 177.16 7.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.896 . . . . 0.0 109.503 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.643 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 1.6 m-85 -134.8 132.91 39.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.924 . . . . 0.0 109.282 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 8.7 ttm180 -85.28 159.33 20.08 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.909 -1.12 . . . . 0.0 108.459 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.596 ' HB ' ' CZ ' ' A' ' 138' ' ' PHE . 13.9 mt -148.85 119.75 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.033 -1.042 . . . . 0.0 109.779 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 64.9 p -91.39 128.99 37.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.595 -0.691 . . . . 0.0 109.94 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.641 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 2.4 m-85 -74.53 138.59 43.22 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.59 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.91 89.23 0.6 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.579 ' HG2' ' CE2' ' A' ' 158' ' ' TYR . 6.8 mt-10 -107.27 138.47 43.4 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.218 -1.166 . . . . 0.0 109.735 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -94.39 147.46 23.2 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.182 -0.949 . . . . 0.0 109.299 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.406 ' O ' ' HG3' ' A' ' 134' ' ' PRO . . . 127.02 103.19 1.25 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 132' ' ' ASN . . . 117.94 -62.24 0.43 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 133' ' ' SER . 14.5 p30 169.95 -30.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.388 -1.066 . . . . 0.0 109.098 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.497 ' N ' ' OD1' ' A' ' 132' ' ' ASN . 0.6 OUTLIER 167.42 65.33 0.01 OUTLIER Pre-proline 0 C--N 1.297 -1.676 0 O-C-N 121.693 -0.629 . . . . 0.0 109.716 179.778 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.461 ' HG2' ' O ' ' A' ' 128' ' ' GLU . 36.3 Cg_endo -79.58 107.27 2.12 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.574 2.183 . . . . 0.0 109.871 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -112.69 146.26 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.104 -0.998 . . . . 0.0 109.897 -179.496 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.557 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 1.1 mt-30 -124.61 99.92 6.4 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.419 -0.801 . . . . 0.0 108.866 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 0.9 OUTLIER -74.7 155.36 37.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.242 -0.911 . . . . 0.0 110.751 -178.94 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.596 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 3.2 p90 -161.4 139.19 9.16 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.6 p -74.81 149.74 39.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.068 -1.02 . . . . 0.0 111.145 -178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.54 ' CG1' ' HD2' ' A' ' 141' ' ' PRO . 55.7 t -111.71 145.46 32.7 Favored Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.54 ' HD2' ' CG1' ' A' ' 140' ' ' VAL . 34.8 Cg_endo -77.54 132.23 12.05 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.395 2.063 . . . . 0.0 109.882 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -85.87 37.63 3.07 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.407 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 2.7 m -105.27 -1.46 25.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.096 -1.238 . . . . 0.0 109.595 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.407 ' CG ' ' O ' ' A' ' 143' ' ' SER . 12.3 mttp -163.01 172.29 15.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.917 . . . . 0.0 109.57 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.575 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 5.0 p -95.3 -23.82 17.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.221 -0.925 . . . . 0.0 109.899 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.47 HG23 ' OG ' ' A' ' 111' ' ' SER . 3.3 p -102.23 163.77 12.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.079 -1.013 . . . . 0.0 109.483 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.448 ' O ' HG12 ' A' ' 110' ' ' ILE . . . -153.7 173.34 15.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.95 . . . . 0.0 109.682 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.1 t -104.45 152.39 22.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 109.097 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.641 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 34.0 mm -131.29 73.52 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.137 -0.977 . . . . 0.0 109.49 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.531 ' HA ' ' CB ' ' A' ' 107' ' ' SER . 3.7 m120 -80.7 -146.62 0.05 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.551 -0.718 . . . . 0.0 109.731 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 150' ' ' ASN . 4.9 m120 43.38 26.88 0.11 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 109.523 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.508 HG23 ' N ' ' A' ' 107' ' ' SER . 4.5 tt -93.37 158.28 2.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.281 -0.887 . . . . 0.0 109.549 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 153' ' ' LYS . 26.2 mmtt -114.17 120.51 38.37 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.92 . . . . 0.0 109.234 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.466 ' HA ' ' CB ' ' A' ' 184' ' ' THR . 35.4 Cg_endo -78.04 146.31 22.85 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.413 2.075 . . . . 0.0 110.566 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . 93.7 60.0 1.17 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 162.3 131.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.411 -1.052 . . . . 0.0 109.41 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 156' ' ' ALA . 24.6 t0 -46.83 166.52 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.594 ' CD1' ' CG2' ' A' ' 184' ' ' THR . 0.2 OUTLIER -145.04 -178.2 5.93 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.51 -1.369 . . . . 0.0 110.048 -179.464 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.55 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 2.5 m -157.98 165.23 35.66 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.491 ' N ' ' CG2' ' A' ' 159' ' ' THR . 22.5 mt -155.27 132.57 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.749 -1.22 . . . . 0.0 110.11 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.575 ' CG2' ' CB ' ' A' ' 179' ' ' SER . 1.6 m -136.91 172.09 13.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.855 . . . . 0.0 108.844 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.58 ' CD2' ' CD1' ' A' ' 98' ' ' LEU . 0.6 OUTLIER -163.42 151.55 13.48 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.679 -1.208 . . . . 0.0 111.597 -179.481 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.624 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 4.2 m-85 -125.11 120.79 32.41 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.592 ' HB3' ' CD2' ' A' ' 122' ' ' TYR . . . -81.57 99.75 9.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.847 -1.158 . . . . 0.0 109.532 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.615 ' CG2' ' CZ ' ' A' ' 121' ' ' TYR . 18.7 t -78.46 142.98 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -0.898 . . . . 0.0 109.369 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.521 ' CG2' ' HA ' ' A' ' 119' ' ' VAL . 1.1 p -136.88 -42.68 0.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.394 -0.816 . . . . 0.0 109.732 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.469 ' O ' ' O ' ' A' ' 166' ' ' THR . . . -53.33 -170.38 0.03 OUTLIER Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.432 ' O ' ' HB3' ' A' ' 172' ' ' PRO . 22.1 mtt180 -109.57 -158.22 0.64 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -1.17 . . . . 0.0 109.818 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -81.48 -35.49 22.8 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 2.4 m-20 -74.71 -1.13 20.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -1.173 . . . . 0.0 109.437 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 0.8 OUTLIER 168.93 75.16 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.282 -0.886 . . . . 0.0 108.963 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.468 ' HA ' ' HA3' ' A' ' 167' ' ' GLY . 35.3 Cg_endo -77.87 175.83 10.73 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.603 2.202 . . . . 0.0 110.339 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 165' ' ' VAL . . . -155.67 130.85 9.44 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.485 -0.759 . . . . 0.0 109.4 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.469 ' HB2' ' HB3' ' A' ' 163' ' ' TYR . 0.7 OUTLIER -112.33 104.71 12.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.46 ' OG ' ' HB2' ' A' ' 164' ' ' ALA . 0.6 OUTLIER -46.96 166.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.611 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.588 ' CB ' ' CD1' ' A' ' 94' ' ' ILE . 0.0 OUTLIER -41.05 127.88 2.03 Favored Pre-proline 0 C--N 1.304 -1.383 0 O-C-N 121.595 -0.691 . . . . 0.0 109.878 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.624 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.2 Cg_endo -77.43 131.4 11.56 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.022 1.815 . . . . 0.0 110.492 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.415 HG22 ' CG2' ' A' ' 94' ' ' ILE . 2.1 t -114.34 137.48 47.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.575 ' CB ' ' CG2' ' A' ' 161' ' ' THR . 1.0 OUTLIER -129.53 165.67 21.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 110.811 -178.406 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.469 HG22 ' HB3' ' A' ' 98' ' ' LEU . 5.5 pt -144.2 -170.53 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -119.12 169.64 9.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.042 -1.036 . . . . 0.0 109.402 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.581 ' CE2' HD23 ' A' ' 108' ' ' LEU . 56.3 t80 -164.63 166.45 20.13 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.163 -0.961 . . . . 0.0 109.428 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -147.56 129.14 15.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.902 . . . . 0.0 109.455 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.594 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.48 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.431 HD13 ' HB2' ' A' ' 81' ' ' SER . 0.6 OUTLIER -157.21 -163.72 1.45 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.289 -1.124 . . . . 0.0 109.384 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 1.1 m-20 -113.66 146.2 40.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.423 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.478 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 10.8 p -95.4 155.91 38.22 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 0.0 109.595 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.579 ' HG3' ' CD1' ' A' ' 32' ' ' TYR . 36.3 Cg_endo -79.05 110.48 2.76 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.725 2.283 . . . . 0.0 110.128 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.449 ' HA ' HD23 ' A' ' 84' ' ' LEU . 1.8 p -97.94 -113.21 0.15 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.131 -0.981 . . . . 0.0 109.472 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.465 ' HA3' ' HB ' ' A' ' 23' ' ' VAL . . . 44.14 27.08 1.02 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.426 ' N ' ' O ' ' A' ' 6' ' ' THR . 8.7 t80 -58.17 95.07 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.582 -0.952 . . . . 0.0 109.861 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.525 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 38.0 t70 -126.82 95.77 4.43 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.344 -0.848 . . . . 0.0 109.055 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.536 ' CB ' ' HG3' ' A' ' 88' ' ' GLN . 32.8 m -84.66 135.3 34.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.297 -0.877 . . . . 0.0 109.38 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.456 ' O ' ' C ' ' A' ' 12' ' ' ASP . 5.5 p -156.42 -159.78 0.92 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.407 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.497 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 1.2 m-20 45.96 40.7 7.18 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.605 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.5 mt -83.45 129.32 37.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.604 -177.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.594 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -115.91 174.1 6.21 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 178.194 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -67.63 -65.1 0.73 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.764 -1.21 . . . . 0.0 109.924 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.467 ' O ' ' OG ' ' A' ' 17' ' ' SER . 6.5 m-80 -86.66 17.15 4.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.012 -1.055 . . . . 0.0 110.017 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.594 ' O ' ' N ' ' A' ' 14' ' ' THR . 21.8 m -168.46 156.37 8.18 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.605 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 4.3 p90 -165.89 143.05 5.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.143 -0.973 . . . . 0.0 109.281 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.497 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 8.5 m -89.55 156.17 18.79 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.849 -1.157 . . . . 0.0 111.293 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.554 HG21 ' CE1' ' A' ' 18' ' ' PHE . 1.3 t -132.58 134.34 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.536 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 2.1 m-70 -121.25 166.36 14.12 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.924 -1.11 . . . . 0.0 110.328 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.579 ' CD1' ' O ' ' A' ' 22' ' ' TRP . 6.2 p90 -174.12 137.78 0.56 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.477 -0.765 . . . . 0.0 109.189 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -78.75 162.43 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.053 -1.029 . . . . 0.0 109.773 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.463 ' HA ' ' HB3' ' A' ' 5' ' ' PRO . . . -86.86 168.71 17.1 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.73 -0.606 . . . . 0.0 109.587 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.467 ' HD3' ' HB3' ' A' ' 5' ' ' PRO . 36.3 Cg_endo -79.45 -172.54 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.647 2.232 . . . . 0.0 110.459 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -113.87 16.09 18.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -0.871 . . . . 0.0 109.3 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.531 ' CB ' ' HD2' ' A' ' 28' ' ' PRO . . . -124.55 177.9 1.63 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.341 -0.849 . . . . 0.0 109.26 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 34.6 Cg_endo -77.84 135.84 14.54 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.476 2.117 . . . . 0.0 110.256 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.501 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 45.9 pt -152.04 -179.13 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.915 . . . . 0.0 109.546 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.8 p -114.32 -20.89 10.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 109.476 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.16 172.1 28.04 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.579 ' CD1' ' HG3' ' A' ' 5' ' ' PRO . 0.5 OUTLIER -112.17 150.25 31.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -1.154 . . . . 0.0 109.47 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.578 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 1.4 mp -95.08 137.23 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.158 -0.964 . . . . 0.0 108.858 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.512 ' CG1' HG11 ' A' ' 50' ' ' VAL . 3.4 mm -116.94 95.05 3.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.4 -0.812 . . . . 0.0 109.937 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.486 ' HG3' ' HA ' ' A' ' 47' ' ' GLN . 54.7 ttp180 -106.28 117.01 32.93 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 108.522 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.518 ' NE2' ' CG ' ' A' ' 46' ' ' ARG . 3.1 p-80 -106.69 147.35 29.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.966 -1.084 . . . . 0.0 110.273 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.531 ' CE1' HG13 ' A' ' 69' ' ' VAL . 41.3 p-80 -162.05 124.43 2.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.45 -0.781 . . . . 0.0 109.577 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.496 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -56.58 -161.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.263 -0.898 . . . . 0.0 109.624 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -83.68 -97.17 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.769 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -105.32 -6.71 19.41 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.774 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.6 p -81.43 116.08 21.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.134 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -74.91 92.81 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.171 -0.956 . . . . 0.0 109.448 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.505 ' C ' ' HD3' ' A' ' 45' ' ' PRO . . . -105.63 -105.18 3.0 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.491 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 12.9 mtt180 -122.3 55.93 7.08 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.256 -1.144 . . . . 0.0 110.41 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.505 ' HD3' ' C ' ' A' ' 43' ' ' GLY . 35.2 Cg_endo -75.04 81.78 2.15 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.204 1.936 . . . . 0.0 110.434 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.518 ' CG ' ' NE2' ' A' ' 36' ' ' HIS . 12.9 ptm180 -105.73 169.72 8.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.246 -0.909 . . . . 0.0 109.531 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.486 ' HA ' ' HG3' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -105.89 114.17 28.16 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.341 -0.849 . . . . 0.0 109.48 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.472 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 19.5 m-20 -107.42 168.81 8.98 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.491 ' HD2' ' CG2' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -136.4 164.07 28.99 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.509 -0.744 . . . . 0.0 109.587 -179.524 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.551 HG23 ' CH2' ' A' ' 22' ' ' TRP . 33.5 m -149.56 158.86 37.39 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.421 -0.799 . . . . 0.0 109.295 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.472 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 33.9 Cg_endo -75.72 174.25 13.13 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.529 2.153 . . . . 0.0 110.373 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.577 ' HA ' ' CE2' ' A' ' 32' ' ' TYR . 34.3 Cg_endo -76.63 -22.63 11.9 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.574 2.182 . . . . 0.0 110.68 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.95 -8.77 53.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.135 -0.978 . . . . 0.0 109.505 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.522 ' HD3' ' N ' ' A' ' 54' ' ' ARG . 1.6 mpt_? -94.78 112.13 23.88 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.291 -0.881 . . . . 0.0 109.593 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.505 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 7.9 p-10 -107.41 -2.29 20.68 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.448 -0.782 . . . . 0.0 109.725 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 27.0 p -136.17 129.83 32.3 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.111 -0.993 . . . . 0.0 109.815 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . . . . . . . . . 1.9 tt -129.44 120.28 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -0.871 . . . . 0.0 109.045 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.432 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 0.3 OUTLIER -88.09 131.43 34.69 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.298 -0.876 . . . . 0.0 109.615 -179.601 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.461 ' O ' ' HB3' ' A' ' 17' ' ' SER . 1.3 mt -104.56 142.63 34.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 109.38 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.461 ' HA ' ' OG ' ' A' ' 17' ' ' SER . 6.7 p -130.02 178.12 6.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.949 . . . . 0.0 109.537 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.9 m120 54.78 40.95 32.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 109.497 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.529 ' HB3' ' CE2' ' A' ' 68' ' ' TYR . 4.6 mt -111.94 145.12 40.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.301 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.463 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 2.6 m120 -54.63 130.6 64.17 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.113 -0.992 . . . . 0.0 108.681 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.1 Cg_endo -77.4 125.36 7.66 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.217 1.944 . . . . 0.0 110.642 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 80.46 61.73 2.16 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.406 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 3.5 m -152.89 155.85 37.84 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.349 -1.089 . . . . 0.0 110.385 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 2.0 mp0 -85.43 116.95 24.05 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.529 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 9.8 m-85 -112.72 106.88 15.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.121 -0.987 . . . . 0.0 109.898 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.531 HG13 ' CE1' ' A' ' 37' ' ' HIS . 3.4 t -73.93 133.03 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.923 . . . . 0.0 108.839 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.467 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 19.4 t -122.36 117.72 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.096 -1.002 . . . . 0.0 109.837 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.531 ' CB ' HG12 ' A' ' 85' ' ' ILE . 1.8 p -92.84 133.37 36.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.0 110.282 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.543 HG22 HD11 ' A' ' 72' ' ' ILE . 21.4 mm -120.74 79.39 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.523 ' CD1' ' HA ' ' A' ' 83' ' ' PRO . 23.4 mm -76.75 163.87 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.943 . . . . 0.0 109.604 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.492 ' CB ' ' OG ' ' A' ' 81' ' ' SER . . . -131.71 117.22 18.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.54 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.408 HG23 ' CD1' ' A' ' 33' ' ' ILE . 0.3 OUTLIER -107.65 173.98 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.289 -0.882 . . . . 0.0 109.283 179.831 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.497 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 18.6 t30 -153.33 49.35 0.7 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 109.446 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.69 -80.72 1.73 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.425 ' NH2' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -119.74 -1.95 10.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -1.15 . . . . 0.0 109.59 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.46 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 1.2 mp0 -90.9 -173.44 3.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.371 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.46 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 16.8 mt-10 -156.65 93.56 1.39 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.19 -0.943 . . . . 0.0 109.584 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.533 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -59.48 178.85 0.22 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.014 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.533 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.4 Cg_endo -76.8 158.16 35.15 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.289 1.992 . . . . 0.0 110.167 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.523 ' HA ' ' CD1' ' A' ' 73' ' ' ILE . 34.7 Cg_endo -77.15 145.25 24.29 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.621 2.214 . . . . 0.0 111.103 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.518 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 25.5 tp -136.21 85.97 2.19 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.531 HG12 ' CB ' ' A' ' 71' ' ' SER . 2.3 mt -99.93 139.85 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.185 -0.947 . . . . 0.0 109.789 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.405 ' O ' HG11 ' A' ' 69' ' ' VAL . . . -128.08 -171.13 12.95 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -148.59 125.04 10.97 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.14 -1.211 . . . . 0.0 109.691 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.536 ' HG3' ' CB ' ' A' ' 10' ' ' SER . 1.1 tm0? -135.81 114.61 12.02 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.321 -0.862 . . . . 0.0 109.006 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -74.9 133.53 41.78 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.295 -0.878 . . . . 0.0 110.02 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.44 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -74.15 138.12 43.63 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.336 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.556 ' O ' ' N ' ' A' ' 65' ' ' GLY . 1.4 t -50.37 155.09 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.527 ' O ' ' CG2' ' A' ' 117' ' ' VAL . 1.2 m -114.78 162.38 16.94 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.389 -0.82 . . . . 0.0 109.747 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.468 ' HA ' HG23 ' A' ' 117' ' ' VAL . 0.2 OUTLIER -111.93 -45.35 3.33 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.744 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.537 HD12 ' CB ' ' A' ' 176' ' ' LYS . 3.1 mt -99.85 145.56 30.37 Favored Pre-proline 0 C--N 1.304 -1.373 0 O-C-N 121.382 -0.824 . . . . 0.0 109.518 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.535 ' HD2' ' CG2' ' A' ' 94' ' ' ILE . 34.3 Cg_endo -77.28 -161.53 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.319 2.013 . . . . 0.0 109.346 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 1.5 ptm85 -168.44 171.91 8.7 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.072 -1.018 . . . . 0.0 109.575 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 2.0 t70 79.47 17.86 0.8 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 0.0 109.661 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.521 HD22 ' CD2' ' A' ' 162' ' ' LEU . 0.8 OUTLIER -54.33 87.22 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.225 -0.922 . . . . 0.0 109.486 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 97' ' ' ASP . 0.6 OUTLIER -138.89 169.49 17.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.107 -0.996 . . . . 0.0 109.796 -179.748 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 7.0 p -102.84 144.01 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -0.878 . . . . 0.0 109.81 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.528 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 6.8 pt -126.1 -4.49 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.367 -0.833 . . . . 0.0 109.266 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.523 ' CB ' ' HB2' ' A' ' 109' ' ' LEU . . . -151.74 88.87 1.43 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.541 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 6.0 p -84.09 93.52 8.14 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.595 -0.69 . . . . 0.0 110.27 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.46 ' OG1' ' OG ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -84.42 161.38 54.41 Favored Pre-proline 0 C--N 1.306 -1.297 0 O-C-N 121.127 -0.983 . . . . 0.0 108.949 179.156 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.476 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.6 Cg_endo -69.65 -3.04 11.14 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.44 2.093 . . . . 0.0 110.56 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.492 ' C ' ' CG2' ' A' ' 152' ' ' ILE . 37.8 p -151.33 19.1 0.74 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.476 ' CB ' ' O ' ' A' ' 149' ' ' ILE . 1.1 p -170.85 176.22 4.21 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.719 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.621 ' N ' ' CD1' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -154.11 155.91 36.27 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.406 -0.809 . . . . 0.0 109.143 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.528 ' HB3' ' CG1' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -102.33 123.73 46.65 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.248 -0.908 . . . . 0.0 108.572 179.122 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.597 ' CD1' ' CD1' ' A' ' 149' ' ' ILE . 0.0 OUTLIER -103.21 135.41 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.122 -0.987 . . . . 0.0 109.92 -179.33 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 97' ' ' ASP . 0.4 OUTLIER -131.0 128.57 40.64 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.505 -0.747 . . . . 0.0 108.997 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.578 ' CD2' ' O ' ' A' ' 145' ' ' SER . 28.2 p90 -151.55 145.36 25.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.403 -0.81 . . . . 0.0 109.325 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.454 ' HB2' ' HG2' ' A' ' 96' ' ' ARG . 29.2 mm-40 -81.4 130.48 61.98 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 0.0 109.408 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.46 ' HG3' ' HB3' ' A' ' 145' ' ' SER . 36.4 Cg_endo -78.92 151.22 24.09 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.458 2.105 . . . . 0.0 110.598 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.524 ' HG2' ' CG2' ' A' ' 119' ' ' VAL . 35.4 Cg_endo -78.37 -169.09 0.7 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.744 2.296 . . . . 0.0 110.148 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.531 ' CB ' HG12 ' A' ' 91' ' ' VAL . . . -113.68 -14.49 12.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.121 -0.987 . . . . 0.0 109.704 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.543 ' CG1' HG13 ' A' ' 91' ' ' VAL . 18.6 m -74.73 165.49 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.212 -0.93 . . . . 0.0 109.083 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.469 ' O ' HG23 ' A' ' 166' ' ' THR . 0.3 OUTLIER -69.5 106.08 2.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 109.684 -179.35 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.524 ' CG2' ' HG2' ' A' ' 115' ' ' PRO . 58.2 t -95.26 132.41 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.334 -0.854 . . . . 0.0 109.535 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER -74.55 -64.5 1.02 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.236 -0.915 . . . . 0.0 108.684 179.494 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.629 ' CE2' ' CG2' ' A' ' 165' ' ' VAL . 3.0 p90 -165.42 171.4 13.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.456 -0.778 . . . . 0.0 109.01 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 4.0 m-85 -115.18 145.98 41.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.035 -1.041 . . . . 0.0 109.737 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.582 ' HG2' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -108.39 95.8 5.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.459 -0.776 . . . . 0.0 109.197 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.592 ' HB ' ' CE2' ' A' ' 138' ' ' PHE . 45.1 mt -84.36 145.12 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.315 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.507 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 77.0 p -131.54 144.53 51.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.945 . . . . 0.0 110.451 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.667 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 2.8 m-30 -88.06 132.19 34.38 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.589 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.68 111.35 3.64 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 132' ' ' ASN . 14.1 mt-10 -106.16 141.97 36.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -1.139 . . . . 0.0 109.45 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.522 ' CG2' ' HB3' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -90.16 140.03 30.06 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.999 -1.063 . . . . 0.0 109.776 179.833 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.98 93.46 1.01 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 51.85 80.11 0.07 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 128' ' ' GLU . 3.0 p-10 -134.03 29.06 3.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -1.128 . . . . 0.0 109.735 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.556 ' CB ' ' HD3' ' A' ' 134' ' ' PRO . 0.1 OUTLIER -44.61 -54.05 13.54 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.114 -0.991 . . . . 0.0 109.32 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.556 ' HD3' ' CB ' ' A' ' 133' ' ' SER . 36.4 Cg_endo -79.39 77.18 4.19 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.426 2.084 . . . . 0.0 110.254 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.46 ' HB ' ' O ' ' A' ' 126' ' ' TYR . 3.2 m -66.1 176.93 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.266 -0.896 . . . . 0.0 109.376 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.575 ' HB3' ' CG ' ' A' ' 126' ' ' TYR . 2.8 tt0 -101.95 103.38 14.02 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.148 -0.97 . . . . 0.0 109.131 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 18.7 tt0 -102.34 118.48 36.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.858 . . . . 0.0 111.076 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.592 ' CE2' ' HB ' ' A' ' 124' ' ' ILE . 35.9 p90 -121.92 142.49 50.23 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.481 HG21 ' CE1' ' A' ' 121' ' ' TYR . 1.5 p -74.15 175.06 7.86 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.966 -1.084 . . . . 0.0 110.834 -178.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.526 HG23 ' CD1' ' A' ' 124' ' ' ILE . 53.7 t -144.35 142.73 20.07 Favored Pre-proline 0 C--N 1.304 -1.392 0 O-C-N 121.553 -0.717 . . . . 0.0 109.321 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.472 ' HD2' HG12 ' A' ' 140' ' ' VAL . 35.2 Cg_endo -77.34 148.73 27.06 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.454 2.103 . . . . 0.0 110.331 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.06 17.88 39.31 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.4 p -105.25 27.81 7.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -1.151 . . . . 0.0 109.613 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.99 139.01 4.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 0.0 109.585 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.578 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 1.3 p -92.48 -15.56 26.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 109.404 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.5 p -123.12 132.39 54.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.292 -0.88 . . . . 0.0 109.185 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.445 ' HB1' ' CH2' ' A' ' 112' ' ' TRP . . . -120.91 -165.43 1.21 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.23 -0.918 . . . . 0.0 109.239 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.538 ' CG2' ' N ' ' A' ' 149' ' ' ILE . 23.8 m -145.13 166.08 26.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.151 -0.968 . . . . 0.0 109.646 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.667 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 1.2 mt -137.12 121.76 24.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.3 -0.875 . . . . 0.0 109.334 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.462 ' HA ' ' HB3' ' A' ' 107' ' ' SER . 6.8 m-80 -123.2 177.27 5.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.4 -0.812 . . . . 0.0 109.514 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.452 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 2.7 m-20 65.54 31.43 10.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 109.161 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.536 ' CG1' ' CE2' ' A' ' 158' ' ' TYR . 16.2 tt -89.86 166.9 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.397 -0.814 . . . . 0.0 109.714 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -107.14 112.17 63.14 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 109.445 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.476 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 34.7 Cg_endo -77.26 167.12 25.24 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.454 2.103 . . . . 0.0 110.6 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.51 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . 76.73 57.23 3.88 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 163.55 134.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -1.128 . . . . 0.0 109.516 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.522 ' HB3' ' CG2' ' A' ' 129' ' ' THR . 0.6 OUTLIER -51.49 164.57 0.2 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.093 -1.004 . . . . 0.0 108.443 179.436 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.589 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.4 OUTLIER -142.0 177.06 8.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.8 -1.187 . . . . 0.0 110.381 -179.528 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.535 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 2.2 m -147.73 109.66 4.48 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.403 ' HA ' HD11 ' A' ' 160' ' ' ILE . 21.8 mm -97.59 134.87 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.789 -1.194 . . . . 0.0 109.994 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.539 ' CG2' ' HB3' ' A' ' 179' ' ' SER . 68.8 m -145.11 147.65 32.76 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.283 -0.886 . . . . 0.0 109.717 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 124' ' ' ILE . 2.6 pt? -140.26 150.61 44.29 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.177 -0.952 . . . . 0.0 110.112 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.603 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 4.1 m-85 -115.47 -176.15 2.86 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.473 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -147.02 104.32 3.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.862 . . . . 0.0 109.153 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.629 ' CG2' ' CE2' ' A' ' 121' ' ' TYR . 63.8 t -79.82 133.16 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 109.909 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.53 ' O ' ' CG ' ' A' ' 168' ' ' ARG . 0.7 OUTLIER -130.52 -49.83 1.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.558 -0.714 . . . . 0.0 109.526 179.812 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.489 ' C ' ' CG ' ' A' ' 168' ' ' ARG . . . -42.84 151.83 0.31 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.53 ' CG ' ' O ' ' A' ' 166' ' ' THR . 2.0 mtp180 -156.67 58.3 0.55 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.354 -1.086 . . . . 0.0 109.389 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -152.17 -100.89 0.2 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.515 ' O ' ' CB ' ' A' ' 171' ' ' SER . 12.5 t70 -77.13 2.79 14.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -1.126 . . . . 0.0 109.688 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 1.0 OUTLIER 163.94 138.07 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.216 -0.928 . . . . 0.0 109.164 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.63 102.58 1.61 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.5 2.133 . . . . 0.0 110.44 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.454 ' O ' ' HA ' ' A' ' 165' ' ' VAL . . . -84.66 -171.88 3.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.261 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 16.7 p -164.38 135.41 4.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 109.698 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.526 ' HB2' ' CG1' ' A' ' 94' ' ' ILE . 51.9 p -53.91 -176.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.322 -0.861 . . . . 0.0 109.303 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.537 ' CB ' HD12 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -66.36 140.92 96.93 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.139 -0.975 . . . . 0.0 108.809 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.603 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 35.0 Cg_endo -78.18 136.47 14.48 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.335 2.023 . . . . 0.0 111.145 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.469 ' O ' HD22 ' A' ' 162' ' ' LEU . 2.1 t -108.12 138.14 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.539 ' HB3' ' CG2' ' A' ' 161' ' ' THR . 80.7 p -133.91 173.65 11.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.065 -1.022 . . . . 0.0 110.75 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.514 HG22 ' CD1' ' A' ' 98' ' ' LEU . 38.2 pt -154.53 169.08 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -98.49 178.29 5.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.042 -1.036 . . . . 0.0 109.686 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.606 ' CE1' HD21 ' A' ' 108' ' ' LEU . 25.0 t80 -163.33 172.21 14.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -0.859 . . . . 0.0 109.605 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.452 ' HA ' ' HA ' ' A' ' 157' ' ' ASP . 6.6 tttt -148.85 109.75 4.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 109.264 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.575 HG22 ' CD1' ' A' ' 158' ' ' TYR . 1.4 p . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.482 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.514 ' O ' ' CD2' ' A' ' 2' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.514 ' CD2' ' O ' ' A' ' 1' ' ' GLY . 3.2 mt -142.45 -166.3 2.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -1.165 . . . . 0.0 109.246 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 1.6 m-20 -80.11 135.9 36.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.908 . . . . 0.0 109.363 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.87 111.42 55.94 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 109.964 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.534 ' CD ' ' OH ' ' A' ' 32' ' ' TYR . 35.0 Cg_endo -77.05 112.26 3.38 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.471 2.114 . . . . 0.0 109.629 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.495 ' HA ' HD23 ' A' ' 84' ' ' LEU . 1.7 p -110.31 -110.22 0.33 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.187 -0.945 . . . . 0.0 109.856 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 9' ' ' ASP . . . 46.5 25.23 1.99 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -46.24 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.426 -1.043 . . . . 0.0 109.855 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 7' ' ' GLY . 7.3 t0 -126.92 101.45 6.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.358 -0.839 . . . . 0.0 108.795 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.535 ' OG ' ' CG1' ' A' ' 20' ' ' VAL . 38.2 m -87.25 143.58 27.21 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.166 -0.959 . . . . 0.0 110.217 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.478 ' O ' ' HB ' ' A' ' 19' ' ' THR . 49.1 p -144.35 -161.34 1.26 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.486 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 1.4 m-20 42.73 35.95 0.77 Allowed 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -178.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.582 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.3 mt -77.21 156.48 5.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 122.582 1.182 . . . . 0.0 112.638 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.545 ' CA ' HG22 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -150.57 161.74 41.97 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 177.226 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.626 ' CB ' ' CG1' ' A' ' 117' ' ' VAL . . . -73.98 -36.21 64.54 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.324 -1.485 . . . . 0.0 109.704 -178.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.495 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.6 OUTLIER -98.59 22.11 10.35 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.048 -1.032 . . . . 0.0 108.809 179.453 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.532 ' O ' ' N ' ' A' ' 14' ' ' THR . 13.0 p 167.01 154.96 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.582 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 8.9 p90 -166.95 139.49 3.51 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.653 -1.279 . . . . 0.0 109.681 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 28.8 m -79.47 152.72 30.09 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.94 -1.1 . . . . 0.0 110.743 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.58 HG21 ' CE1' ' A' ' 18' ' ' PHE . 2.5 t -126.04 135.07 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.569 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 2.6 m-70 -126.98 170.89 11.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.91 -1.119 . . . . 0.0 110.339 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.45 ' HB2' ' O ' ' A' ' 6' ' ' THR . 27.8 p90 -179.85 149.18 0.34 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -76.89 147.78 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 120.966 -1.084 . . . . 0.0 109.929 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -76.47 161.63 73.87 Favored Pre-proline 0 C--N 1.298 -1.66 0 O-C-N 121.835 -0.541 . . . . 0.0 109.57 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.53 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 35.9 Cg_endo -78.09 153.41 28.49 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.582 2.188 . . . . 0.0 110.478 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.447 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 17.0 mtt180 -75.35 -0.92 21.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 109.569 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.17 164.75 15.15 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 109.579 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.463 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 35.9 Cg_endo -78.38 105.66 2.01 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.729 2.286 . . . . 0.0 110.357 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.53 ' CG2' ' HG2' ' A' ' 25' ' ' PRO . 31.4 pt -100.37 168.61 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.425 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.457 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 59.8 p -113.23 -16.67 12.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.0 109.338 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.82 -165.23 35.25 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.652 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -165.42 120.72 1.31 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -1.151 . . . . 0.0 110.049 -179.818 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.453 ' HA ' ' HG3' ' A' ' 49' ' ' ARG . 22.2 mm -75.33 147.89 7.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 121.104 -0.998 . . . . 0.0 108.658 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.576 ' CG1' ' CG2' ' A' ' 50' ' ' VAL . 14.7 mm -133.24 92.89 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.078 -1.014 . . . . 0.0 109.857 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.542 ' CG ' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -100.57 157.01 16.98 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.171 -0.955 . . . . 0.0 108.69 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.606 ' CG ' ' CD2' ' A' ' 59' ' ' LEU . 1.3 p-80 -143.15 143.27 31.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.004 -1.06 . . . . 0.0 110.055 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.573 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 37.2 p-80 -163.16 130.57 3.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.377 -0.827 . . . . 0.0 109.716 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.645 ' CB ' ' CE1' ' A' ' 68' ' ' TYR . . . -75.28 130.84 39.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.258 -0.901 . . . . 0.0 109.256 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.15 -13.61 28.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.166 -0.959 . . . . 0.0 109.359 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -108.24 15.72 23.85 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.478 -0.764 . . . . 0.0 109.28 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 52.5 p -92.84 152.83 19.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.619 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.0 t -115.77 -0.27 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.253 -0.904 . . . . 0.0 109.586 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.88 156.01 19.26 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.465 ' HA ' ' NE ' ' A' ' 44' ' ' ARG . 5.8 mmp_? -45.54 147.16 1.54 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.207 -1.172 . . . . 0.0 109.463 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.487 ' HB3' ' CB ' ' A' ' 37' ' ' HIS . 36.0 Cg_endo -78.28 137.59 15.22 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.623 2.215 . . . . 0.0 110.293 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.517 ' HB2' ' NE2' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -74.86 169.25 18.3 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.166 -0.959 . . . . 0.0 109.747 -179.846 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -141.06 111.49 6.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -0.866 . . . . 0.0 109.979 -179.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.534 ' O ' ' CD ' ' A' ' 49' ' ' ARG . 20.9 m-20 -110.78 178.59 4.31 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.534 ' CD ' ' O ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -153.98 155.74 36.13 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.217 -0.927 . . . . 0.0 109.951 -179.736 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.576 ' CG2' ' CG1' ' A' ' 34' ' ' ILE . 15.9 m -142.46 160.9 52.56 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.477 -0.764 . . . . 0.0 108.989 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.523 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 33.7 Cg_endo -75.82 173.94 13.66 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.369 2.046 . . . . 0.0 110.211 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 35.0 Cg_endo -77.16 -17.44 15.04 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.491 2.127 . . . . 0.0 110.568 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.419 ' O ' ' OG ' ' A' ' 53' ' ' SER . 5.1 t -102.23 17.29 23.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 109.342 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.523 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -115.56 104.63 11.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -0.865 . . . . 0.0 109.454 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.499 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 2.7 p-10 -89.38 -6.17 56.83 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.923 . . . . 0.0 109.561 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 6.3 p -126.23 142.76 51.4 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.39 -0.819 . . . . 0.0 109.567 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.52 ' CG2' ' HB ' ' A' ' 20' ' ' VAL . 5.1 tt -137.11 134.72 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 109.391 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.477 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 87.8 m -96.63 125.49 41.14 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.194 -0.941 . . . . 0.0 109.6 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.606 ' CD2' ' CG ' ' A' ' 36' ' ' HIS . 0.9 OUTLIER -102.99 142.24 34.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 109.354 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.465 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 0.9 OUTLIER -122.4 156.67 33.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 109.799 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.518 ' O ' ' CD2' ' A' ' 62' ' ' LEU . 9.0 m-80 62.27 79.83 0.24 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.364 -0.835 . . . . 0.0 109.905 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.57 ' HB3' ' CE2' ' A' ' 68' ' ' TYR . 6.5 mt -143.24 138.88 29.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -0.881 . . . . 0.0 109.414 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.458 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 3.4 m120 -42.59 136.01 2.57 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 109.429 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.547 ' CB ' HG12 ' A' ' 117' ' ' VAL . 36.6 Cg_endo -79.2 131.42 9.76 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.476 2.118 . . . . 0.0 110.732 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 63.47 64.15 3.95 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.249 -1.941 . . . . 0.0 108.249 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 m -156.72 151.72 26.14 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.391 -1.064 . . . . 0.0 110.667 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.532 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -85.38 123.92 31.39 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.633 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.645 ' CE1' ' CB ' ' A' ' 38' ' ' ALA . 3.1 m-85 -111.25 133.8 53.32 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.073 -1.017 . . . . 0.0 110.605 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.573 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 1.6 t -89.16 107.79 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 35' ' ' ARG . 1.6 t -103.53 129.47 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.205 -0.935 . . . . 0.0 109.533 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.55 ' CB ' HG12 ' A' ' 85' ' ' ILE . 1.3 p -100.07 147.05 26.06 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.142 -0.974 . . . . 0.0 110.35 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.52 HG23 ' CD1' ' A' ' 32' ' ' TYR . 5.1 mm -131.62 94.22 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.584 ' N ' ' CD1' ' A' ' 73' ' ' ILE . 1.4 mp -90.62 135.86 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 109.716 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.652 ' CB ' ' CZ ' ' A' ' 32' ' ' TYR . . . -96.85 144.22 27.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -0.83 . . . . 0.0 109.522 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.457 ' O ' ' OG1' ' A' ' 30' ' ' THR . 1.7 m -130.99 133.18 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.275 -0.891 . . . . 0.0 109.058 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.463 ' OD1' ' O ' ' A' ' 28' ' ' PRO . 24.9 t30 -116.35 45.1 1.85 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.792 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . 0.432 ' N ' HG22 ' A' ' 30' ' ' THR . . . 82.67 -81.55 1.71 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.42 -5.83 16.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -1.186 . . . . 0.0 109.816 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.504 ' HG3' ' N ' ' A' ' 80' ' ' GLU . 16.2 tp10 -107.34 155.92 19.47 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.242 -0.911 . . . . 0.0 109.247 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.504 ' N ' ' HG3' ' A' ' 79' ' ' GLU . 8.1 mt-10 -129.94 105.61 8.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.214 -0.928 . . . . 0.0 109.473 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.551 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -63.96 -179.87 0.31 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.218 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.551 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.4 Cg_endo -77.52 155.76 31.98 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.358 2.039 . . . . 0.0 110.513 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.83 136.14 14.82 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.706 2.27 . . . . 0.0 111.099 -179.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.502 ' CD2' ' O ' ' A' ' 5' ' ' PRO . 15.5 tp -117.71 93.27 4.09 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.55 HG12 ' CB ' ' A' ' 71' ' ' SER . 2.5 mt -96.09 141.36 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.118 -0.989 . . . . 0.0 109.572 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.421 ' O ' HG11 ' A' ' 69' ' ' VAL . . . -130.43 -177.67 15.01 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 60.7 mt-30 -146.18 101.26 3.49 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.187 -1.184 . . . . 0.0 109.961 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 41.8 mm-40 -98.26 -161.17 0.85 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -144.65 130.93 19.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.916 -1.115 . . . . 0.0 110.37 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.498 ' O ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.37 139.01 43.79 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.224 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.547 ' O ' ' N ' ' A' ' 65' ' ' GLY . 12.1 t -41.68 169.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-O 121.557 0.694 . . . . 0.0 110.29 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.539 ' HB2' ' CB ' ' A' ' 175' ' ' SER . 64.7 p -110.22 168.26 9.58 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.251 -0.906 . . . . 0.0 109.685 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.488 ' OD1' ' O ' ' A' ' 118' ' ' SER . 16.2 t70 -84.97 22.37 1.41 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.494 -0.754 . . . . 0.0 110.236 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.537 ' CD1' ' HB2' ' A' ' 176' ' ' LYS . 1.1 mt -42.86 142.39 1.43 Allowed Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.75 -1.219 . . . . 0.0 109.501 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.536 ' HD2' HG22 ' A' ' 94' ' ' ILE . 36.8 Cg_endo -83.1 113.57 2.13 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.666 2.244 . . . . 0.0 109.744 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 2.2 ptt180 -106.27 153.41 22.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.055 -1.028 . . . . 0.0 109.851 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.9 OUTLIER 76.98 25.82 0.79 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 109.853 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.517 HD22 ' CG2' ' A' ' 180' ' ' ILE . 31.1 tp -64.01 100.46 0.32 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.064 -1.022 . . . . 0.0 109.239 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.421 ' O ' ' HA ' ' A' ' 110' ' ' ILE . 18.4 pt-20 -128.22 170.15 13.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.95 . . . . 0.0 109.572 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 9.1 p -109.24 172.66 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 109.766 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -150.3 -81.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.361 -0.837 . . . . 0.0 109.226 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.519 ' CB ' HD12 ' A' ' 109' ' ' LEU . . . -74.89 101.84 4.55 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.528 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 5.2 p -98.98 90.14 4.53 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.868 . . . . 0.0 110.479 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -76.5 165.71 50.57 Favored Pre-proline 0 C--N 1.306 -1.325 0 O-C-N 121.154 -0.966 . . . . 0.0 108.759 178.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.466 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 29.9 Cg_endo -69.42 -2.81 10.57 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.421 2.081 . . . . 0.0 110.602 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.492 ' HA ' HG21 ' A' ' 152' ' ' ILE . 1.0 OUTLIER -150.64 17.49 0.8 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.394 -0.817 . . . . 0.0 108.805 179.002 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.548 ' CB ' ' O ' ' A' ' 149' ' ' ILE . 0.5 OUTLIER -169.05 159.33 9.13 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.127 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.599 HD23 ' CE2' ' A' ' 182' ' ' TYR . 0.6 OUTLIER -143.87 154.69 43.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.324 -0.86 . . . . 0.0 109.263 -179.818 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.529 ' HB3' ' CD1' ' A' ' 101' ' ' ILE . 0.4 OUTLIER -105.58 132.97 51.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.318 -0.863 . . . . 0.0 108.833 179.32 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.531 ' CD1' HD12 ' A' ' 124' ' ' ILE . 1.1 pt -115.67 144.69 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.084 -1.01 . . . . 0.0 109.96 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 32.6 t -143.31 126.55 16.57 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.579 ' CZ3' ' HA ' ' A' ' 146' ' ' THR . 3.3 p90 -123.33 171.33 9.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.947 . . . . 0.0 109.835 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.461 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 6.0 mm-40 -94.81 165.33 17.36 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.388 -0.82 . . . . 0.0 109.338 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.461 ' HD2' ' HB3' ' A' ' 113' ' ' GLU . 34.6 Cg_endo -78.2 127.36 8.32 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.621 2.214 . . . . 0.0 110.564 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.487 ' HG2' ' OD1' ' A' ' 93' ' ' ASP . 34.6 Cg_endo -76.91 -152.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.608 2.205 . . . . 0.0 110.206 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.496 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . . . -69.05 -1.36 7.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -0.956 . . . . 0.0 109.817 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.626 ' CG1' ' CB ' ' A' ' 15' ' ' ALA . 1.8 m -150.24 -163.09 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.937 -1.102 . . . . 0.0 110.263 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.488 ' O ' ' OD1' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -97.69 -164.5 1.15 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.065 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.644 ' CG1' ' CE2' ' A' ' 122' ' ' TYR . 1.4 t -141.48 129.3 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.635 -1.29 . . . . 0.0 110.87 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.545 ' O ' ' NE ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -74.86 -49.42 20.53 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.467 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.528 ' CE1' ' HB ' ' A' ' 165' ' ' VAL . 1.8 p90 -163.99 173.08 13.01 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.644 ' CE2' ' CG1' ' A' ' 119' ' ' VAL . 0.2 OUTLIER -135.01 150.37 50.31 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.692 -1.255 . . . . 0.0 110.69 -179.014 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 15.6 mtp180 -109.42 92.63 4.13 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.604 ' HB ' ' CE1' ' A' ' 138' ' ' PHE . 52.8 mt -84.2 163.83 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.926 . . . . 0.0 110.421 -178.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 23.3 p -145.35 140.85 28.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.505 -0.747 . . . . 0.0 109.586 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.651 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 2.6 m-85 -82.06 134.24 35.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.876 . . . . 0.0 109.227 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.62 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -106.0 124.87 7.98 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 129' ' ' THR . 15.5 mt-10 -105.1 148.7 26.54 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.213 -1.169 . . . . 0.0 109.201 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.538 ' CG2' ' N ' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -40.89 -92.98 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.394 -0.816 . . . . 0.0 110.08 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -139.33 -102.04 0.53 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 46.84 24.68 1.99 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 51.77 20.97 1.26 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -1.17 . . . . 0.0 109.394 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.3 148.87 95.84 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.238 -0.914 . . . . 0.0 109.353 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.65 -162.15 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.542 2.162 . . . . 0.0 110.321 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 126' ' ' TYR . 0.7 OUTLIER -120.28 157.64 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.204 -0.935 . . . . 0.0 109.369 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.517 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -112.6 100.53 8.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 108.948 179.525 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.529 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 2.1 pt-20 -92.8 154.0 18.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.379 -0.826 . . . . 0.0 110.918 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.604 ' CE1' ' HB ' ' A' ' 124' ' ' ILE . 31.7 p90 -164.74 147.39 8.53 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.509 ' O ' ' CD2' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -73.85 -176.6 2.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.011 -1.056 . . . . 0.0 110.553 -178.19 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.588 ' CG2' ' CD1' ' A' ' 124' ' ' ILE . 71.6 t -146.69 139.07 13.91 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.465 -0.772 . . . . 0.0 109.199 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.463 ' HD2' HG12 ' A' ' 140' ' ' VAL . 34.8 Cg_endo -76.97 127.88 9.63 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.419 2.079 . . . . 0.0 110.396 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -79.4 51.16 3.9 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.504 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 1.0 OUTLIER -104.65 -3.4 23.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.18 -1.188 . . . . 0.0 109.457 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.504 ' CG ' ' O ' ' A' ' 143' ' ' SER . 18.2 mttt -165.3 174.66 9.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 0.0 109.275 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.443 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 4.7 p -93.15 4.35 54.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.512 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.579 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 3.1 p -119.11 155.76 30.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.317 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.459 ' CB ' HD13 ' A' ' 124' ' ' ILE . . . -129.61 161.22 31.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.411 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.6 m -107.69 153.63 22.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.269 -0.894 . . . . 0.0 109.521 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.651 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 7.5 mm -134.65 119.03 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.352 -0.842 . . . . 0.0 109.304 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.531 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 41.8 m-20 -124.72 173.79 8.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.323 -0.86 . . . . 0.0 109.825 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 15.2 m120 62.94 33.92 14.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.134 -0.979 . . . . 0.0 109.074 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.537 HG13 ' CE2' ' A' ' 158' ' ' TYR . 7.2 tt -89.32 147.68 5.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.519 -0.738 . . . . 0.0 109.739 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.417 ' HB2' ' OH ' ' A' ' 158' ' ' TYR . 25.3 mttt -82.67 113.87 47.98 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.175 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.466 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 35.8 Cg_endo -78.11 146.61 22.9 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.413 2.075 . . . . 0.0 110.606 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.464 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . 78.2 65.28 1.89 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.509 ' N ' ' OG1' ' A' ' 184' ' ' THR . . . 166.7 128.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -1.163 . . . . 0.0 109.772 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.538 ' N ' ' CG2' ' A' ' 129' ' ' THR . 0.6 OUTLIER -46.34 160.56 0.07 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.62 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -141.66 177.75 7.94 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.886 -1.134 . . . . 0.0 110.356 -179.346 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.537 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -146.42 108.15 4.32 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.295 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.521 ' HB ' ' CG1' ' A' ' 180' ' ' ILE . 43.3 mm -93.73 112.68 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.735 -1.228 . . . . 0.0 109.867 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.53 ' CG2' ' HB2' ' A' ' 179' ' ' SER . 7.5 m -123.37 148.79 45.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -0.87 . . . . 0.0 108.954 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.528 ' CD1' ' HG3' ' A' ' 95' ' ' PRO . 0.5 OUTLIER -145.15 156.15 43.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.91 -1.118 . . . . 0.0 110.706 -179.779 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.589 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 1.8 m-85 -119.76 77.8 1.26 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.453 ' O ' HG21 ' A' ' 165' ' ' VAL . . . -47.41 150.01 0.99 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.959 -1.088 . . . . 0.0 109.456 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.528 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 51.6 t -140.54 131.08 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.208 -0.932 . . . . 0.0 109.739 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.499 ' CG2' ' HA ' ' A' ' 119' ' ' VAL . 0.8 OUTLIER -119.24 -41.02 2.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.326 -0.859 . . . . 0.0 109.114 179.692 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.466 ' O ' ' HG2' ' A' ' 168' ' ' ARG . . . -54.26 156.62 6.72 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.466 ' HG2' ' O ' ' A' ' 167' ' ' GLY . 0.0 OUTLIER -164.59 90.36 0.54 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -1.121 . . . . 0.0 109.375 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -165.65 -125.69 0.78 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -89.54 23.21 2.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -1.157 . . . . 0.0 109.515 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 176.77 91.2 0.11 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 109.571 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.89 95.95 1.08 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.623 2.215 . . . . 0.0 110.27 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -92.1 131.09 37.63 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.915 . . . . 0.0 109.652 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.517 ' HB3' ' CG2' ' A' ' 165' ' ' VAL . 1.2 p -99.35 119.07 37.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.217 -0.927 . . . . 0.0 109.252 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.539 ' CB ' ' HB2' ' A' ' 92' ' ' SER . 83.9 p -44.2 168.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.342 -0.849 . . . . 0.0 109.443 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.537 ' HB2' ' CD1' ' A' ' 94' ' ' ILE . 0.4 OUTLIER -49.26 143.61 9.29 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.043 -1.035 . . . . 0.0 108.508 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.589 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 35.7 Cg_endo -78.44 136.49 14.07 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.407 2.071 . . . . 0.0 111.337 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.2 t -109.56 136.95 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.53 ' HB2' ' CG2' ' A' ' 161' ' ' THR . 33.0 t -124.67 160.33 28.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.058 -1.026 . . . . 0.0 110.951 -178.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.521 ' CG1' ' HB ' ' A' ' 160' ' ' ILE . 39.3 pt -140.95 171.86 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.473 ' OD1' ' N ' ' A' ' 181' ' ' ASN . 1.2 m120 -103.72 166.0 10.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.936 -1.102 . . . . 0.0 110.036 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.599 ' CE2' HD23 ' A' ' 108' ' ' LEU . 48.3 t80 -154.15 172.47 17.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.512 -0.743 . . . . 0.0 109.2 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -145.1 118.38 8.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.149 -0.969 . . . . 0.0 109.562 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.509 ' OG1' ' N ' ' A' ' 156' ' ' ALA . 8.0 p . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.42 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -104.36 -162.13 0.87 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.265 -1.138 . . . . 0.0 109.228 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.486 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 2.5 m-20 -76.04 97.44 4.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.351 -0.843 . . . . 0.0 109.152 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -40.59 101.34 0.24 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.597 -0.689 . . . . 0.0 109.888 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.518 ' HG2' ' CB ' ' A' ' 74' ' ' ALA . 34.9 Cg_endo -77.44 71.97 6.19 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.51 2.14 . . . . 0.0 109.733 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.542 ' HA ' ' CD2' ' A' ' 84' ' ' LEU . 16.7 p -91.16 -98.67 0.11 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.269 -0.894 . . . . 0.0 109.937 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 9' ' ' ASP . . . 48.64 24.72 4.22 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.402 ' N ' ' C ' ' A' ' 6' ' ' THR . 29.7 t80 -55.55 91.79 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.567 -0.961 . . . . 0.0 109.325 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 7' ' ' GLY . 7.8 t70 -137.36 111.99 8.76 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.529 ' CB ' ' HG3' ' A' ' 88' ' ' GLN . 0.3 OUTLIER -84.3 134.23 34.52 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.253 -0.904 . . . . 0.0 109.452 -179.573 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.471 ' O ' ' C ' ' A' ' 12' ' ' ASP . 86.8 p -150.33 -160.84 1.23 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.304 -0.873 . . . . 0.0 109.064 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.492 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 19.2 m-20 46.17 33.12 1.64 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.662 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.9 mt -86.97 111.02 21.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.317 -177.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -94.23 -177.04 4.15 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 177.568 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.532 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -88.58 -11.07 46.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.668 -1.27 . . . . 0.0 109.684 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.444 ' O ' ' HB3' ' A' ' 17' ' ' SER . 0.6 OUTLIER -131.95 22.14 4.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.887 -1.133 . . . . 0.0 108.115 178.605 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.52 ' CB ' ' HA ' ' A' ' 60' ' ' THR . 76.0 p 174.19 127.15 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.662 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 2.2 p90 -137.97 147.0 43.84 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.699 -1.251 . . . . 0.0 109.883 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.544 ' OG1' ' CG2' ' A' ' 58' ' ' THR . 60.1 m -111.97 164.62 12.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.914 -1.116 . . . . 0.0 110.5 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.519 ' N ' HG23 ' A' ' 19' ' ' THR . 1.8 t -127.27 162.88 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.514 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 3.5 m-70 -151.77 137.45 17.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.926 -1.108 . . . . 0.0 110.155 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.569 ' CH2' HG23 ' A' ' 50' ' ' VAL . 48.4 p90 -133.81 156.48 47.96 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.462 HG11 ' N ' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -74.38 156.63 6.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 120.864 -1.147 . . . . 0.0 109.957 -179.788 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.462 ' N ' HG11 ' A' ' 23' ' ' VAL . . . -101.64 153.31 37.99 Favored Pre-proline 0 C--N 1.298 -1.668 0 O-C-N 121.841 -0.537 . . . . 0.0 109.731 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.567 ' CG ' ' CD1' ' A' ' 29' ' ' ILE . 36.7 Cg_endo -79.65 133.78 10.61 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.623 2.216 . . . . 0.0 110.171 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -69.51 -5.74 26.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 109.574 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.473 ' CB ' ' HD2' ' A' ' 28' ' ' PRO . . . -97.25 173.8 3.75 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 0.0 109.384 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.473 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 35.3 Cg_endo -78.17 107.19 2.28 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.605 2.203 . . . . 0.0 110.484 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.57 HD13 ' CZ ' ' A' ' 32' ' ' TYR . 18.6 pt -108.66 -171.72 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.411 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 7.9 p -115.63 -7.1 12.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.902 . . . . 0.0 109.568 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.24 -178.98 17.4 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.57 ' CZ ' HD13 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -126.82 158.02 37.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -1.145 . . . . 0.0 109.488 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.523 ' CG2' ' HD2' ' A' ' 49' ' ' ARG . 5.9 mt -111.56 136.32 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.241 -0.912 . . . . 0.0 108.898 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.529 ' CG2' HD11 ' A' ' 57' ' ' ILE . 1.4 mm -119.08 125.4 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.109 -0.994 . . . . 0.0 110.283 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.528 ' CB ' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -122.6 129.71 52.2 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.555 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.582 ' CE1' ' HD2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -125.09 140.12 53.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.833 -1.167 . . . . 0.0 110.542 -178.819 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.584 ' CE1' ' CG1' ' A' ' 69' ' ' VAL . 38.5 p-80 -166.32 122.29 1.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.424 -0.797 . . . . 0.0 109.753 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -55.22 -164.25 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.252 -0.905 . . . . 0.0 109.66 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 38' ' ' ALA . 1.4 mp0 -44.44 -74.97 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.189 -0.944 . . . . 0.0 109.615 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -165.98 66.44 0.11 Allowed 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.589 -0.694 . . . . 0.0 109.414 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 85.7 p -74.55 161.6 29.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.41 -0.806 . . . . 0.0 109.568 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.8 p -74.91 -0.71 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.691 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 44' ' ' ARG . . . -90.57 109.94 3.73 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 43' ' ' GLY . 13.8 mmm180 -44.04 133.8 4.16 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.238 -1.154 . . . . 0.0 109.403 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.53 ' HB3' ' CB ' ' A' ' 37' ' ' HIS . 36.6 Cg_endo -79.11 154.65 25.5 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.502 2.135 . . . . 0.0 110.307 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.582 ' HD2' ' CE1' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -109.57 162.03 14.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.0 109.817 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.521 ' CB ' ' HG3' ' A' ' 35' ' ' ARG . 1.6 mt-30 -119.78 99.42 6.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.517 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -84.66 106.53 16.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.269 -0.894 . . . . 0.0 109.072 179.55 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.533 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -84.65 137.7 33.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.241 -0.912 . . . . 0.0 109.142 -179.803 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.569 HG23 ' CH2' ' A' ' 22' ' ' TRP . 21.9 m -114.07 154.75 46.08 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 109.706 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.489 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 35.2 Cg_endo -77.99 175.3 11.34 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.76 2.307 . . . . 0.0 110.29 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.5 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.1 Cg_endo -76.26 -15.87 17.82 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.528 2.152 . . . . 0.0 110.121 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.72 11.13 18.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 0.0 109.25 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.2 mmt180 -137.98 134.89 35.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.306 -0.871 . . . . 0.0 109.21 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.492 ' HA ' ' CE2' ' A' ' 22' ' ' TRP . 2.1 p-10 -124.75 18.69 8.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 0.0 109.638 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 84.4 p -145.78 138.59 25.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 109.776 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.529 HD11 ' CG2' ' A' ' 34' ' ' ILE . 1.5 tt -119.1 120.03 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.359 -0.838 . . . . 0.0 108.988 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.544 ' CG2' ' OG1' ' A' ' 19' ' ' THR . 0.4 OUTLIER -91.03 133.05 35.62 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.269 -0.894 . . . . 0.0 110.405 -179.115 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.5 mt -117.29 140.45 49.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.0 109.112 179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.52 ' HA ' ' CB ' ' A' ' 17' ' ' SER . 25.1 p -129.05 174.65 9.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.354 -0.841 . . . . 0.0 109.909 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . 0.454 ' O ' HD21 ' A' ' 62' ' ' LEU . 8.9 m-20 51.63 66.43 1.2 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.377 -0.827 . . . . 0.0 109.515 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.577 ' HB3' ' CE2' ' A' ' 68' ' ' TYR . 9.0 mt -134.41 133.94 41.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.467 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -48.12 134.88 11.95 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 108.819 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.4 Cg_endo -77.97 128.21 9.03 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.362 2.041 . . . . 0.0 110.681 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 79.37 60.87 2.43 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 90' ' ' THR . 1.5 m -149.59 142.23 24.51 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.366 -1.079 . . . . 0.0 109.7 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.534 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 3.0 mt-10 -74.59 134.72 42.09 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.973 -1.079 . . . . 0.0 108.768 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.577 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 3.6 m-85 -123.23 98.1 5.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.125 -0.984 . . . . 0.0 109.761 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.584 ' CG1' ' CE1' ' A' ' 37' ' ' HIS . 6.6 t -59.6 133.67 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.157 -0.965 . . . . 0.0 108.874 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.486 ' HA ' ' O ' ' A' ' 35' ' ' ARG . 11.0 t -137.86 137.36 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.106 -0.996 . . . . 0.0 109.375 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.536 ' CB ' ' CD1' ' A' ' 85' ' ' ILE . 88.9 p -116.53 134.68 54.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.188 -0.945 . . . . 0.0 110.133 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.536 ' CG2' HD13 ' A' ' 84' ' ' LEU . 21.5 mm -120.21 143.0 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 109.334 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.518 ' CD1' ' HB3' ' A' ' 83' ' ' PRO . 36.9 mm -138.5 162.11 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.148 -0.97 . . . . 0.0 109.704 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.518 ' CB ' ' HG2' ' A' ' 5' ' ' PRO . . . -134.61 98.23 4.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.357 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.468 ' O ' ' OG1' ' A' ' 30' ' ' THR . 2.5 m -96.65 154.69 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 109.399 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 28' ' ' PRO . 30.2 t30 -133.63 45.94 2.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 109.55 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.87 -97.2 1.84 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -94.14 2.61 55.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -1.164 . . . . 0.0 109.534 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 2.2 mt-10 -109.49 -173.39 2.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.162 -0.961 . . . . 0.0 109.552 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 0.6 OUTLIER -163.31 100.16 0.94 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.357 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.553 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -59.64 -179.7 0.17 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.899 . . . . 0.0 108.878 179.716 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.553 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.1 Cg_endo -77.16 138.35 17.98 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.2 1.933 . . . . 0.0 110.187 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.518 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 36.0 Cg_endo -77.9 139.94 17.86 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.572 2.182 . . . . 0.0 110.571 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.542 ' CD2' ' HA ' ' A' ' 6' ' ' THR . 0.1 OUTLIER -136.1 91.87 2.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.318 -0.864 . . . . 0.0 109.565 179.755 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.536 ' CD1' ' CB ' ' A' ' 71' ' ' SER . 4.1 mt -97.09 159.1 3.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.373 -0.829 . . . . 0.0 109.341 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.433 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -162.84 159.08 31.46 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . 0.493 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -112.81 118.36 34.73 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.367 -1.078 . . . . 0.0 109.435 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.529 ' HG3' ' CB ' ' A' ' 10' ' ' SER . 1.7 mm-40 -109.64 -157.64 0.62 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.534 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -162.31 148.4 13.04 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.978 -1.076 . . . . 0.0 110.081 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.47 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.47 136.97 42.28 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.606 ' CG1' ' N ' ' A' ' 117' ' ' VAL . 5.2 t -44.95 168.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-O 121.741 0.782 . . . . 0.0 110.902 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.461 ' O ' ' HB2' ' A' ' 115' ' ' PRO . 3.0 t -105.53 127.45 53.03 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.99 -52.95 12.51 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.031 -1.043 . . . . 0.0 109.912 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.557 ' CG2' ' HD2' ' A' ' 95' ' ' PRO . 3.1 mt -111.28 144.2 29.98 Favored Pre-proline 0 C--N 1.304 -1.372 0 O-C-N 121.169 -0.957 . . . . 0.0 110.34 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.557 ' HD2' ' CG2' ' A' ' 94' ' ' ILE . 34.2 Cg_endo -76.72 -161.46 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.406 2.071 . . . . 0.0 109.293 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 1.7 ptp180 -163.37 164.77 24.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.912 -1.117 . . . . 0.0 110.064 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 21.0 t0 79.26 21.2 0.65 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.552 -0.718 . . . . 0.0 110.146 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.531 ' CD1' HG11 ' A' ' 178' ' ' VAL . 0.3 OUTLIER -63.77 99.28 0.23 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.9 -1.125 . . . . 0.0 108.928 179.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.69 -174.95 4.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.49 ' CG2' ' O ' ' A' ' 109' ' ' LEU . 5.0 p -114.93 152.43 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.195 -0.941 . . . . 0.0 110.013 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.458 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 5.2 pt -119.08 -16.11 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.394 -0.816 . . . . 0.0 109.314 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -140.95 168.79 18.94 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.454 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.9 t -156.16 102.22 2.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.891 -1.131 . . . . 0.0 110.506 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -90.74 166.92 17.6 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.798 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 29.9 Cg_endo -69.41 -1.97 9.1 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.257 1.971 . . . . 0.0 110.579 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.501 ' HA ' HG21 ' A' ' 152' ' ' ILE . 3.9 p -151.26 17.43 0.74 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.331 -0.856 . . . . 0.0 108.985 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.544 ' O ' ' CD2' ' A' ' 108' ' ' LEU . 0.6 OUTLIER -170.72 162.42 7.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.991 -1.068 . . . . 0.0 110.343 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.601 HD23 ' CE2' ' A' ' 182' ' ' TYR . 0.7 OUTLIER -141.84 156.85 45.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.464 -0.772 . . . . 0.0 109.099 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.49 ' O ' ' CG2' ' A' ' 100' ' ' VAL . 0.3 OUTLIER -104.24 121.83 44.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 109.207 179.704 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.525 ' CD1' HD12 ' A' ' 124' ' ' ILE . 2.0 pt -103.35 148.23 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -0.903 . . . . 0.0 109.934 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 84.9 p -146.16 137.46 24.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.4 -0.813 . . . . 0.0 109.052 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.57 ' CE3' ' O ' ' A' ' 145' ' ' SER . 37.1 p90 -158.87 -167.33 2.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.728 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 95' ' ' PRO . 2.1 mt-10 -124.63 119.07 25.92 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 108.959 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.456 ' HD3' ' HB3' ' A' ' 145' ' ' SER . 34.6 Cg_endo -76.8 152.3 32.48 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.309 2.006 . . . . 0.0 110.69 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.461 ' HB2' ' O ' ' A' ' 92' ' ' SER . 35.2 Cg_endo -77.53 -159.86 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.64 2.226 . . . . 0.0 110.413 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.496 ' C ' ' CG1' ' A' ' 91' ' ' VAL . . . -120.39 11.27 11.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.306 -0.871 . . . . 0.0 109.791 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.606 ' N ' ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -82.16 -179.47 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.006 -1.058 . . . . 0.0 109.381 -179.681 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' SER . . . . . 0.522 ' O ' ' CA ' ' A' ' 166' ' ' THR . 24.3 m -70.63 61.0 0.23 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.362 -0.836 . . . . 0.0 110.07 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.527 ' HA ' ' CG2' ' A' ' 166' ' ' THR . 1.5 t -76.96 97.22 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 109.438 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.522 ' CG ' ' O ' ' A' ' 166' ' ' THR . 0.1 OUTLIER -74.9 -32.26 61.77 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.208 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.552 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 5.2 p90 -165.85 178.58 6.43 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.612 -0.68 . . . . 0.0 109.364 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 2.6 m-85 -129.11 137.67 51.36 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.489 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -94.91 86.6 4.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 109.548 -179.479 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.593 ' CD1' ' CG2' ' A' ' 140' ' ' VAL . 77.1 mt -84.19 148.47 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.882 . . . . 0.0 109.192 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.504 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 2.5 p -131.44 150.59 52.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.92 . . . . 0.0 110.348 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.606 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 2.9 m-85 -85.33 133.51 34.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.436 -0.79 . . . . 0.0 108.942 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.592 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.83 116.57 5.21 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -105.46 146.83 29.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.227 -1.161 . . . . 0.0 109.316 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.591 ' CG2' ' CB ' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -47.18 142.97 3.45 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.178 -0.951 . . . . 0.0 109.777 179.723 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 50.96 77.25 0.14 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -138.42 -91.63 0.25 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.439 ' C ' ' OG ' ' A' ' 133' ' ' SER . 0.1 OUTLIER 66.5 32.35 7.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -1.142 . . . . 0.0 109.339 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.555 ' CB ' ' HD3' ' A' ' 134' ' ' PRO . 0.0 OUTLIER 177.57 -57.38 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.327 -0.858 . . . . 0.0 109.633 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.555 ' HD3' ' CB ' ' A' ' 133' ' ' SER . 35.1 Cg_endo -76.42 82.29 2.29 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.243 1.962 . . . . 0.0 110.3 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -115.01 148.11 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.396 -0.815 . . . . 0.0 109.123 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.582 ' HB2' ' CD1' ' A' ' 126' ' ' TYR . 39.3 mt-30 -93.4 87.16 5.49 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.12 -0.987 . . . . 0.0 109.134 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 7.2 pt-20 -76.54 130.24 37.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.448 -0.783 . . . . 0.0 111.103 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.59 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 38.1 p90 -137.27 143.66 42.31 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 12.7 p -74.28 165.62 24.86 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.996 -1.065 . . . . 0.0 110.69 -178.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.593 ' CG2' ' CD1' ' A' ' 124' ' ' ILE . 8.2 t -137.33 139.63 28.34 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.603 -0.686 . . . . 0.0 109.773 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.48 ' HD2' HG11 ' A' ' 140' ' ' VAL . 33.7 Cg_endo -75.64 125.81 9.15 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.303 2.002 . . . . 0.0 110.364 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.61 -1.85 54.21 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.429 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 4.9 p -75.4 1.02 14.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.175 -1.191 . . . . 0.0 109.656 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 143' ' ' SER . 1.8 mmtp -152.39 149.68 28.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.152 -0.968 . . . . 0.0 109.67 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.57 ' O ' ' CE3' ' A' ' 112' ' ' TRP . 1.7 m -93.96 -13.17 27.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 109.296 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 64.4 p -107.26 130.64 54.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.285 -0.884 . . . . 0.0 108.974 179.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.483 ' HB1' ' CD1' ' A' ' 110' ' ' ILE . . . -118.49 161.34 20.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.975 . . . . 0.0 109.905 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 11.2 t -103.07 155.96 18.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.33 -0.856 . . . . 0.0 109.074 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.606 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 20.2 mm -133.07 113.68 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 109.725 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.547 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 3.3 m120 -120.79 173.34 7.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.384 -0.822 . . . . 0.0 109.705 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 0.5 OUTLIER 69.12 34.19 3.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.914 . . . . 0.0 109.291 -179.912 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.517 ' CD1' HD12 ' A' ' 108' ' ' LEU . 4.5 tt -93.89 158.7 2.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.37 -0.831 . . . . 0.0 109.788 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.442 ' N ' ' OH ' ' A' ' 158' ' ' TYR . 0.5 OUTLIER -98.42 115.65 65.71 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.262 -0.899 . . . . 0.0 109.121 179.7 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.448 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 35.4 Cg_endo -77.42 138.17 17.32 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.391 2.061 . . . . 0.0 110.743 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.518 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . 86.41 68.06 1.35 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 155' ' ' GLY . . . 163.73 130.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -1.155 . . . . 0.0 109.637 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.591 ' CB ' ' CG2' ' A' ' 129' ' ' THR . 1.2 t0 -47.53 162.63 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.17 -0.956 . . . . 0.0 108.559 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.592 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.3 OUTLIER -142.94 -170.8 3.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.918 -1.114 . . . . 0.0 110.234 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.51 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 3.2 m -165.41 110.83 0.9 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.513 ' HB ' ' CG1' ' A' ' 180' ' ' ILE . 30.1 mm -95.82 120.23 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.995 -1.066 . . . . 0.0 109.843 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 179' ' ' SER . 2.2 m -124.9 164.31 20.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.241 -0.912 . . . . 0.0 109.145 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.525 HD21 ' CD1' ' A' ' 98' ' ' LEU . 1.6 pp -159.53 142.88 14.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.933 -1.104 . . . . 0.0 111.135 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.616 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.2 m-85 -113.78 80.25 1.35 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.434 ' C ' ' O ' ' A' ' 163' ' ' TYR . . . -43.79 96.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.14 -0.975 . . . . 0.0 109.328 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.515 ' N ' ' O ' ' A' ' 163' ' ' TYR . 58.0 t -83.64 135.15 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 109.494 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.527 ' CG2' ' HA ' ' A' ' 119' ' ' VAL . 19.3 p -116.05 -51.49 2.64 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.286 -0.884 . . . . 0.0 109.604 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 171' ' ' SER . . . -69.36 149.08 48.23 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.437 ' HB2' ' CD ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -159.29 -166.09 1.73 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -1.187 . . . . 0.0 109.411 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 65.8 -79.94 0.09 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.14 13.51 4.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -1.162 . . . . 0.0 109.508 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' SER . . . . . 0.468 ' O ' ' HA3' ' A' ' 167' ' ' GLY . 66.6 m -155.2 86.52 3.35 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.368 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.458 ' HA ' ' O ' ' A' ' 167' ' ' GLY . 36.2 Cg_endo -78.74 108.41 2.42 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.726 2.284 . . . . 0.0 110.544 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -114.84 156.42 24.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.387 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.406 ' HB3' ' HA ' ' A' ' 165' ' ' VAL . 0.7 OUTLIER -164.8 119.63 1.37 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.541 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.8 p -57.14 -167.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.171 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.526 ' HB2' ' CD1' ' A' ' 94' ' ' ILE . 1.3 mttp -66.71 146.45 99.07 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.149 -0.969 . . . . 0.0 108.808 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.616 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.6 Cg_endo -77.32 122.72 6.22 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.455 2.103 . . . . 0.0 111.158 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.531 HG11 ' CD1' ' A' ' 98' ' ' LEU . 2.2 t -91.41 133.63 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.491 ' HA ' ' HA ' ' A' ' 161' ' ' THR . 1.4 p -124.71 151.37 45.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.11 -0.994 . . . . 0.0 110.72 -178.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.513 ' CG1' ' HB ' ' A' ' 160' ' ' ILE . 3.1 pt -138.84 152.19 24.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.45 162.79 16.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.002 -1.061 . . . . 0.0 109.824 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.601 ' CE2' HD23 ' A' ' 108' ' ' LEU . 74.9 t80 -152.8 167.33 29.41 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.414 -0.804 . . . . 0.0 109.268 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.412 ' N ' ' CG ' ' A' ' 182' ' ' TYR . 5.7 tttp -138.3 118.35 13.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.55 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 17.0 p . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.46 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . 0.454 ' O ' ' OG ' ' A' ' 81' ' ' SER . 96.4 mt -145.43 138.81 26.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.174 -1.192 . . . . 0.0 109.41 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.416 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 2.9 m-20 -74.87 140.11 43.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 109.545 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.533 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 2.4 t -95.08 149.52 36.36 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.555 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.586 ' HG3' ' CD1' ' A' ' 32' ' ' TYR . 36.4 Cg_endo -78.89 117.72 3.97 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.711 2.274 . . . . 0.0 110.347 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.466 HG21 HD11 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -101.92 -107.78 0.24 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.947 . . . . 0.0 109.382 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 22' ' ' TRP . . . 42.5 27.83 0.54 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.442 ' N ' ' O ' ' A' ' 6' ' ' THR . 25.8 t80 -48.36 124.75 8.43 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.431 -1.041 . . . . 0.0 109.849 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' A' ' 21' ' ' HIS . 4.2 t70 -164.96 84.06 0.39 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.405 -0.809 . . . . 0.0 109.019 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.515 ' OG ' ' CG1' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -84.6 137.84 33.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.195 -0.941 . . . . 0.0 109.684 -179.63 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.465 ' O ' ' HB ' ' A' ' 19' ' ' THR . 82.6 p -159.19 -158.67 0.7 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.36 -0.837 . . . . 0.0 109.143 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.497 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.5 OUTLIER 44.62 34.75 1.2 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -178.417 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.619 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.3 mt -72.37 140.48 17.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.495 -177.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.568 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -122.93 -175.09 3.08 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.611 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.517 ' HB2' ' CG1' ' A' ' 117' ' ' VAL . . . -75.18 -70.97 0.39 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.908 -1.12 . . . . 0.0 109.499 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 5.8 p-10 -83.74 9.16 12.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.168 -0.957 . . . . 0.0 109.459 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.568 ' O ' ' N ' ' A' ' 14' ' ' THR . 0.1 OUTLIER -157.82 159.33 36.6 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.619 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 5.8 p90 -166.01 140.72 4.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.207 -0.933 . . . . 0.0 108.839 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.497 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 9.3 m -79.37 153.8 29.49 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.814 -1.179 . . . . 0.0 111.209 -178.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.583 ' CG2' ' CD1' ' A' ' 59' ' ' LEU . 1.3 t -134.69 115.82 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.464 ' HB2' ' O ' ' A' ' 9' ' ' ASP . 17.2 m-70 -105.46 159.11 16.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.044 -1.035 . . . . 0.0 110.132 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.49 ' CH2' HG23 ' A' ' 57' ' ' ILE . 20.9 p90 -175.09 140.25 0.51 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.366 -0.834 . . . . 0.0 109.209 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.481 HG11 ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.61 162.32 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.134 -0.979 . . . . 0.0 109.965 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.481 ' N ' HG11 ' A' ' 23' ' ' VAL . . . -93.96 169.59 9.72 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.766 -0.584 . . . . 0.0 109.696 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 24' ' ' ALA . 35.2 Cg_endo -78.12 -159.88 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.611 2.207 . . . . 0.0 110.346 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.82 8.05 4.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 109.592 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.535 ' CB ' ' HD2' ' A' ' 28' ' ' PRO . . . -110.47 176.98 1.32 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.335 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' A' ' 27' ' ' ALA . 34.8 Cg_endo -77.54 110.67 3.01 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.478 2.119 . . . . 0.0 110.294 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.619 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 50.2 pt -126.29 -173.01 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 0.0 109.557 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.419 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 32.0 p -125.32 -5.43 7.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.483 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.476 ' HA2' ' N ' ' A' ' 52' ' ' PRO . . . 149.62 -178.78 26.91 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.619 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 1.8 m-85 -124.28 145.93 49.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -1.189 . . . . 0.0 109.631 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.59 ' CD1' ' N ' ' A' ' 33' ' ' ILE . 0.9 OUTLIER -99.76 130.43 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.329 -0.857 . . . . 0.0 108.727 179.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.528 ' HB ' ' O ' ' A' ' 48' ' ' ASP . 1.4 mm -109.08 108.76 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.935 -1.103 . . . . 0.0 110.08 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.523 ' CB ' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -112.61 108.65 17.79 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.752 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.651 ' CE1' ' CD2' ' A' ' 59' ' ' LEU . 1.7 p-80 -114.62 166.79 11.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.022 . . . . 0.0 110.355 -178.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.455 ' O ' ' O ' ' A' ' 38' ' ' ALA . 40.0 p-80 177.73 136.19 0.07 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.594 -0.691 . . . . 0.0 109.282 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.477 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -56.31 -163.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.926 . . . . 0.0 109.372 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -70.5 -92.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.18 -0.95 . . . . 0.0 109.606 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -126.17 29.91 5.73 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.502 -0.749 . . . . 0.0 109.526 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.1 p -75.24 -96.99 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 109.599 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.3 t -74.89 153.25 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.902 . . . . 0.0 109.474 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.468 ' O ' ' HD3' ' A' ' 45' ' ' PRO . . . -87.86 -63.88 1.38 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 43' ' ' GLY . 30.4 mtm180 -43.09 103.27 0.31 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.371 -1.076 . . . . 0.0 109.508 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 35.1 Cg_endo -77.17 137.2 16.89 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.394 2.063 . . . . 0.0 110.264 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.578 ' HB2' ' CD2' ' A' ' 36' ' ' HIS . 12.7 mmm180 -74.72 141.17 44.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.289 -0.882 . . . . 0.0 109.637 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.411 ' HG3' ' C ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -130.01 90.07 2.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.684 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.528 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 9.5 m-20 -99.1 114.3 26.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.267 -0.896 . . . . 0.0 108.862 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.528 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.0 OUTLIER -92.11 150.21 21.07 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.978 -1.076 . . . . 0.0 109.822 -179.469 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.518 HG13 ' CD1' ' A' ' 57' ' ' ILE . 10.3 m -133.4 160.1 69.96 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.431 -0.793 . . . . 0.0 109.3 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.482 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 33.6 Cg_endo -76.27 174.35 12.98 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.561 2.174 . . . . 0.0 110.381 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.579 ' HA ' ' CE2' ' A' ' 32' ' ' TYR . 35.1 Cg_endo -77.17 -21.74 11.76 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.672 2.248 . . . . 0.0 110.999 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.8 t -92.51 -4.51 53.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.074 -1.016 . . . . 0.0 109.716 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.524 ' HD3' ' N ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -97.8 111.42 23.72 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.286 -0.884 . . . . 0.0 109.895 -179.744 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -101.04 -6.43 24.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.447 -0.783 . . . . 0.0 109.46 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 53.1 p -135.69 129.84 33.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.384 -0.822 . . . . 0.0 109.189 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.518 ' CD1' HG13 ' A' ' 50' ' ' VAL . 6.1 tt -133.33 129.14 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.231 -0.918 . . . . 0.0 109.672 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.1 115.39 24.46 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.337 -0.852 . . . . 0.0 109.074 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.651 ' CD2' ' CE1' ' A' ' 36' ' ' HIS . 1.3 mt -84.74 156.22 21.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.14 -0.975 . . . . 0.0 109.642 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.491 ' CG2' ' HB3' ' A' ' 17' ' ' SER . 15.5 p -145.65 -178.2 5.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.404 -0.81 . . . . 0.0 109.33 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.9 m120 55.48 20.04 3.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.364 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.528 ' CD1' ' HB3' ' A' ' 59' ' ' LEU . 3.5 mt -96.15 138.69 33.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.872 . . . . 0.0 109.302 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.496 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 6.2 t-20 -45.72 126.41 6.56 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.191 -0.943 . . . . 0.0 108.804 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.528 ' CB ' ' HB2' ' A' ' 93' ' ' ASP . 35.8 Cg_endo -77.81 134.67 13.62 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.307 2.004 . . . . 0.0 110.699 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 68.16 62.6 4.09 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.0 m -160.67 153.01 20.46 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.264 -1.139 . . . . 0.0 110.134 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 1.2 tt0 -77.09 121.27 23.33 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.524 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 1.0 OUTLIER -116.71 114.54 24.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.085 -1.01 . . . . 0.0 110.019 -179.158 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.8 t -79.5 118.44 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 108.678 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.468 ' HA ' ' HB3' ' A' ' 36' ' ' HIS . 1.4 t -100.4 135.77 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.129 -0.982 . . . . 0.0 109.611 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.523 ' OG ' ' CB ' ' A' ' 35' ' ' ARG . 10.8 p -114.72 108.3 16.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.345 -0.847 . . . . 0.0 110.084 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.439 ' O ' ' N ' ' A' ' 84' ' ' LEU . 17.0 mm -87.96 119.17 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 0.0 109.428 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.524 ' N ' ' CD1' ' A' ' 73' ' ' ILE . 1.6 mp -116.74 158.63 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 109.256 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.43 ' N ' ' CG2' ' A' ' 73' ' ' ILE . . . -119.32 157.43 28.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.492 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.465 HG23 HD11 ' A' ' 33' ' ' ILE . 3.9 m -151.95 148.4 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 0.0 109.487 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -131.33 44.22 2.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.289 -0.882 . . . . 0.0 109.376 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.95 -88.13 0.67 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.95 -1.68 11.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.247 -1.149 . . . . 0.0 109.463 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.77 -162.59 0.92 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 109.394 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -159.15 173.74 15.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.198 -0.939 . . . . 0.0 109.797 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.574 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -145.05 -176.74 0.58 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.574 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.1 Cg_endo -77.3 136.54 16.04 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.068 1.845 . . . . 0.0 110.118 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.413 ' HB3' HG13 ' A' ' 73' ' ' ILE . 36.2 Cg_endo -78.43 104.0 1.76 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.65 2.234 . . . . 0.0 111.221 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.466 HD11 HG21 ' A' ' 6' ' ' THR . 0.9 OUTLIER -80.99 90.52 5.97 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.069 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.517 ' CD1' ' HB2' ' A' ' 71' ' ' SER . 2.7 mt -92.93 159.8 2.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.146 -0.971 . . . . 0.0 110.703 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.509 ' N ' HG21 ' A' ' 85' ' ' ILE . . . -154.22 168.34 32.5 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -117.27 139.94 50.18 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.129 -1.218 . . . . 0.0 109.915 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.491 ' OE1' ' CB ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -139.68 -162.75 1.38 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.371 -0.831 . . . . 0.0 109.029 179.758 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.53 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -156.76 129.23 7.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.114 -0.991 . . . . 0.0 109.886 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.452 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -78.8 146.26 33.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.385 -0.822 . . . . 0.0 108.999 179.693 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 65' ' ' GLY . 1.4 t -74.06 163.17 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.506 -0.746 . . . . 0.0 110.114 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.465 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 3.0 p -67.48 146.26 54.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.427 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.528 ' HB2' ' CB ' ' A' ' 64' ' ' PRO . 1.6 t70 -97.06 -45.2 6.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.324 -0.86 . . . . 0.0 110.012 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.604 ' CD1' ' CB ' ' A' ' 176' ' ' LYS . 6.4 mt -91.64 142.99 27.31 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.059 -1.026 . . . . 0.0 109.719 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.492 ' HD2' ' CG2' ' A' ' 94' ' ' ILE . 36.2 Cg_endo -80.23 68.56 8.27 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.292 1.995 . . . . 0.0 108.63 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.468 ' O ' ' HB2' ' A' ' 112' ' ' TRP . 24.9 mtt180 -72.51 -163.65 0.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.665 0.745 . . . . 0.0 110.392 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 96' ' ' ARG . 8.4 m-20 64.64 9.48 5.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.614 -0.679 . . . . 0.0 109.588 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.488 ' CD2' HD22 ' A' ' 162' ' ' LEU . 25.1 tp -61.71 99.13 0.11 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.138 -0.976 . . . . 0.0 109.439 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -137.76 159.96 40.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.902 . . . . 0.0 109.673 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.7 p -81.35 139.78 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.362 -0.836 . . . . 0.0 109.716 -179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.512 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 41.6 pt -134.62 4.46 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.404 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.528 ' CB ' ' HB2' ' A' ' 109' ' ' LEU . . . -165.12 88.27 0.45 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.516 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 0.7 OUTLIER -82.72 96.44 8.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.417 -0.802 . . . . 0.0 110.609 -178.712 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.567 ' OG1' ' N ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -84.01 162.72 51.22 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.244 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 29.4 Cg_endo -67.82 -3.21 9.99 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.532 2.155 . . . . 0.0 111.138 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.501 ' C ' ' CG2' ' A' ' 152' ' ' ILE . 2.3 p -156.6 22.39 0.34 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.567 ' N ' ' OG1' ' A' ' 104' ' ' THR . 18.2 p -172.54 175.91 3.39 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.118 -1.033 . . . . 0.0 109.924 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.603 ' N ' ' CD1' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -153.69 154.48 34.2 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.484 -0.76 . . . . 0.0 109.203 -179.627 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.528 ' HB2' ' CB ' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -103.02 114.55 28.94 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.095 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.562 ' CD1' ' CD1' ' A' ' 149' ' ' ILE . 0.4 OUTLIER -103.61 131.62 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.113 -0.992 . . . . 0.0 109.954 -179.512 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 97' ' ' ASP . 3.3 m -123.52 132.53 53.94 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.572 ' CD2' ' O ' ' A' ' 145' ' ' SER . 49.0 p90 -135.99 169.52 17.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.935 . . . . 0.0 109.695 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.476 ' O ' ' HD3' ' A' ' 115' ' ' PRO . 0.5 OUTLIER -69.49 119.42 70.57 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.181 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.462 ' HG3' ' OG ' ' A' ' 145' ' ' SER . 35.9 Cg_endo -77.78 111.3 3.09 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.357 2.038 . . . . 0.0 110.333 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 113' ' ' GLU . 35.9 Cg_endo -78.24 177.47 8.73 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.419 2.08 . . . . 0.0 110.356 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.518 ' HB2' ' CG2' ' A' ' 91' ' ' VAL . . . -118.88 13.64 13.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.289 -0.882 . . . . 0.0 109.233 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.532 ' HA ' ' CG2' ' A' ' 14' ' ' THR . 4.9 m -74.75 170.53 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.279 -0.888 . . . . 0.0 109.245 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.6 m -69.91 63.33 0.21 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.233 -0.917 . . . . 0.0 109.2 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.52 ' CG2' HG21 ' A' ' 117' ' ' VAL . 2.0 t -74.9 115.21 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.326 -0.859 . . . . 0.0 109.557 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' A' ' 165' ' ' VAL . 0.1 OUTLIER -74.78 -52.66 10.88 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.457 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.584 ' CE1' ' CG2' ' A' ' 139' ' ' THR . 1.4 p90 -165.35 152.27 10.42 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.495 ' HA ' ' O ' ' A' ' 163' ' ' TYR . 32.2 m-85 -93.51 134.42 35.8 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.998 -1.064 . . . . 0.0 108.85 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 4.3 ttp-105 -101.19 94.83 6.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.246 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.587 HD13 ' CZ ' ' A' ' 138' ' ' PHE . 19.6 mt -85.79 141.52 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.299 -0.876 . . . . 0.0 109.96 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.609 ' HB ' ' CG1' ' A' ' 135' ' ' VAL . 5.1 p -113.79 127.44 56.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.372 -0.83 . . . . 0.0 109.507 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.664 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 3.4 m-30 -74.95 113.93 12.82 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.613 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -101.77 119.83 6.63 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 120.214 -0.994 . . . . 0.0 110.852 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 130' ' ' GLY . 2.3 mm-40 -80.19 -175.51 5.09 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.269 -1.136 . . . . 0.0 108.529 178.725 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 157' ' ' ASP . 1.4 p -41.49 -27.94 0.11 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.326 -0.859 . . . . 0.0 109.768 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 128' ' ' GLU . . . -104.01 -102.49 2.74 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.46 89.77 0.09 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.426 ' O ' ' CB ' ' A' ' 133' ' ' SER . 0.7 OUTLIER -93.94 -9.79 35.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -1.197 . . . . 0.0 109.67 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.59 ' CB ' ' HD3' ' A' ' 134' ' ' PRO . 0.6 OUTLIER 169.09 -57.62 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.358 -0.839 . . . . 0.0 109.159 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . 0.59 ' HD3' ' CB ' ' A' ' 133' ' ' SER . 36.5 Cg_endo -78.53 144.88 20.37 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.288 1.992 . . . . 0.0 109.039 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.613 ' CG1' ' N ' ' A' ' 136' ' ' GLN . 0.3 OUTLIER -178.48 -161.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.719 -1.238 . . . . 0.0 110.836 -179.563 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.613 ' N ' ' CG1' ' A' ' 135' ' ' VAL . 0.6 OUTLIER -79.11 148.7 32.29 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.525 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.589 ' CG ' ' CG2' ' A' ' 125' ' ' THR . 14.4 mp0 -142.79 157.76 44.3 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.902 -1.124 . . . . 0.0 110.985 -178.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.587 ' CZ ' HD13 ' A' ' 124' ' ' ILE . 6.0 p90 -155.51 135.14 12.59 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.584 ' CG2' ' CE1' ' A' ' 121' ' ' TYR . 12.2 p -74.37 165.29 25.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.083 -1.011 . . . . 0.0 110.905 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.535 ' CG2' HD13 ' A' ' 124' ' ' ILE . 2.8 t -136.07 140.96 34.63 Favored Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.481 ' HD2' HG11 ' A' ' 140' ' ' VAL . 34.3 Cg_endo -76.29 146.75 28.53 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.334 2.023 . . . . 0.0 110.142 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.33 37.33 3.14 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.4 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 89.4 p -105.12 -1.1 25.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.111 -1.229 . . . . 0.0 109.624 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 143' ' ' SER . 5.7 mttt -151.45 154.5 36.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.186 -0.946 . . . . 0.0 109.52 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.572 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 0.4 OUTLIER -91.8 2.24 56.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 109.552 179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.464 ' HA ' ' O ' ' A' ' 110' ' ' ILE . 2.0 p -124.56 151.41 44.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.054 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.546 ' HB1' ' CH2' ' A' ' 112' ' ' TRP . . . -118.12 178.14 4.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.141 -0.975 . . . . 0.0 109.409 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.454 HG23 ' OD1' ' A' ' 150' ' ' ASN . 57.4 m -133.2 97.31 3.95 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.252 -0.905 . . . . 0.0 109.568 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.664 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 1.0 OUTLIER -79.17 93.11 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.333 -0.855 . . . . 0.0 109.051 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.527 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 82.9 m-20 -101.29 178.23 4.71 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.935 . . . . 0.0 109.356 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 28.7 m120 57.67 55.92 5.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.892 . . . . 0.0 109.355 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.557 HG13 ' CE2' ' A' ' 158' ' ' TYR . 13.8 tt -111.63 164.4 7.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.268 -0.895 . . . . 0.0 109.699 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -95.03 110.26 49.0 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.134 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 152' ' ' ILE . 34.9 Cg_endo -76.77 139.66 20.06 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.355 2.036 . . . . 0.0 110.522 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . 0.474 ' O ' ' CB ' ' A' ' 156' ' ' ALA . . . 95.55 62.49 0.99 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.504 ' CB ' ' CG2' ' A' ' 129' ' ' THR . . . 164.6 132.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -1.136 . . . . 0.0 109.524 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 129' ' ' THR . 1.8 t70 -48.19 168.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.613 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -146.69 -164.7 2.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.837 -1.164 . . . . 0.0 110.275 -179.638 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 127' ' ' GLY . 9.2 m -174.79 105.21 0.1 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.439 HD13 HD23 ' A' ' 108' ' ' LEU . 54.8 mt -97.75 117.2 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.909 -1.119 . . . . 0.0 110.286 -178.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.533 ' CG2' ' HB2' ' A' ' 179' ' ' SER . 36.9 m -120.46 161.86 20.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.28 -0.888 . . . . 0.0 108.723 178.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 124' ' ' ILE . 0.5 OUTLIER -156.72 148.6 22.8 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 118.742 -1.183 . . . . 0.0 111.441 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.634 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.9 m-85 -120.54 161.87 20.57 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.524 ' CB ' ' OG ' ' A' ' 175' ' ' SER . . . -113.68 102.15 9.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.938 -1.102 . . . . 0.0 109.016 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.51 ' O ' ' N ' ' A' ' 120' ' ' ARG . 51.7 t -78.34 148.6 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.383 -0.823 . . . . 0.0 110.218 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.499 ' N ' HG11 ' A' ' 165' ' ' VAL . 80.7 p -135.1 -59.9 0.78 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.378 -0.826 . . . . 0.0 109.419 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 172' ' ' PRO . . . -53.42 168.42 1.19 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . 0.467 ' CG ' ' HD2' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -131.84 -162.43 1.23 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -1.15 . . . . 0.0 109.418 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 86.72 -106.32 3.11 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -145.25 13.48 1.42 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -1.124 . . . . 0.0 109.431 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.4 m -156.15 73.1 5.09 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.861 . . . . 0.0 109.197 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.473 ' HB3' ' O ' ' A' ' 167' ' ' GLY . 36.0 Cg_endo -78.3 -171.62 1.27 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.69 2.26 . . . . 0.0 110.61 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.432 ' O ' ' HA ' ' A' ' 165' ' ' VAL . . . -118.26 -165.58 1.13 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.385 -0.822 . . . . 0.0 109.097 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 2.4 p -165.14 106.16 0.79 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.17 -0.956 . . . . 0.0 109.669 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.524 ' OG ' ' CB ' ' A' ' 164' ' ' ALA . 0.7 OUTLIER -50.81 169.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.29 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.604 ' CB ' ' CD1' ' A' ' 94' ' ' ILE . 0.3 OUTLIER -44.36 123.68 4.47 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.286 -0.884 . . . . 0.0 109.274 179.705 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.634 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 33.7 Cg_endo -77.61 140.45 18.88 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.018 1.812 . . . . 0.0 110.902 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.37 135.48 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.533 ' HB2' ' CG2' ' A' ' 161' ' ' THR . 30.6 t -122.83 170.76 9.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.164 -0.96 . . . . 0.0 111.332 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.469 HG21 HD22 ' A' ' 98' ' ' LEU . 7.1 pt -152.21 152.65 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 159' ' ' THR . 67.0 m-80 -96.22 157.72 15.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.946 -1.096 . . . . 0.0 110.028 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.59 ' CE1' HD21 ' A' ' 108' ' ' LEU . 39.8 t80 -141.1 171.86 13.48 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.384 -0.823 . . . . 0.0 109.448 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . 0.462 ' HA ' ' HA ' ' A' ' 157' ' ' ASP . 3.4 tmtt? -145.05 108.09 4.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.532 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.452 ' OG1' ' N ' ' A' ' 155' ' ' GLY . 5.2 p . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.443 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.5 -162.83 0.91 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -1.145 . . . . 0.0 109.405 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 4.8 m-20 -91.25 132.46 36.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 109.439 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.524 ' OG ' ' CG ' ' A' ' 82' ' ' PRO . 15.2 m -95.79 150.05 36.86 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.305 -0.872 . . . . 0.0 109.808 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.563 ' HG3' ' CE1' ' A' ' 32' ' ' TYR . 36.2 Cg_endo -79.74 131.05 9.0 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.746 2.297 . . . . 0.0 109.873 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.447 ' HA ' HD23 ' A' ' 84' ' ' LEU . 0.8 OUTLIER -157.75 -167.62 2.31 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.053 -1.029 . . . . 0.0 109.591 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 46.25 27.06 2.54 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.056 -2.017 . . . . 0.0 108.056 -179.127 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PHE . . . . . 0.624 ' C ' ' CD1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -70.21 -170.33 0.36 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.74 -0.859 . . . . 0.0 109.57 -179.235 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.437 ' N ' ' CG ' ' A' ' 8' ' ' PHE . 21.3 t70 -165.55 110.19 0.86 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.229 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . 0.514 ' OG ' ' CG ' ' A' ' 88' ' ' GLN . 4.6 p -84.75 139.6 31.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.196 -0.94 . . . . 0.0 109.355 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.466 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 5.1 p -164.74 -157.96 0.38 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.185 -0.947 . . . . 0.0 109.623 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.505 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.6 OUTLIER 44.3 36.34 1.55 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -178.56 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ILE . . . . . 0.627 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.6 mt -74.63 145.29 11.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.862 -178.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.59 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -124.78 172.57 9.21 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.012 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.538 ' CB ' HG11 ' A' ' 117' ' ' VAL . . . -67.92 -65.11 0.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.704 -1.248 . . . . 0.0 109.419 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.471 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -90.5 27.44 1.71 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.06 -1.025 . . . . 0.0 109.323 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.59 ' O ' ' N ' ' A' ' 14' ' ' THR . 3.5 p -178.02 161.28 1.51 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.648 ' CE1' ' CD1' ' A' ' 59' ' ' LEU . 17.5 p90 -167.74 147.86 5.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.891 -1.131 . . . . 0.0 109.644 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 58' ' ' THR . 4.0 m -90.7 158.41 16.91 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.843 -1.16 . . . . 0.0 111.164 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.554 ' CG2' ' CD1' ' A' ' 59' ' ' LEU . 0.8 OUTLIER -139.23 104.26 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.38 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.466 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 7.9 m-70 -86.23 162.7 18.17 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.153 -0.967 . . . . 0.0 110.261 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' TRP . . . . . 0.526 ' CB ' ' HB2' ' A' ' 8' ' ' PHE . 16.3 p90 -175.08 136.4 0.38 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.469 -0.77 . . . . 0.0 109.305 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.425 HG11 ' N ' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -74.74 161.57 4.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 O-C-N 121.091 -1.006 . . . . 0.0 109.693 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.425 ' N ' HG11 ' A' ' 23' ' ' VAL . . . -96.74 160.96 28.13 Favored Pre-proline 0 C--N 1.298 -1.664 0 O-C-N 121.745 -0.597 . . . . 0.0 109.703 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.466 ' HB3' ' O ' ' A' ' 3' ' ' ASP . 36.1 Cg_endo -78.44 163.57 27.04 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.647 2.231 . . . . 0.0 110.326 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.49 28.76 1.89 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.427 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.443 ' HB2' ' HD2' ' A' ' 28' ' ' PRO . . . -118.92 161.32 36.88 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.456 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.455 ' O ' ' OD1' ' A' ' 76' ' ' ASN . 35.5 Cg_endo -78.18 89.9 1.31 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.612 2.208 . . . . 0.0 110.39 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.571 HD11 ' CD2' ' A' ' 32' ' ' TYR . 20.3 pt -97.45 171.59 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.506 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.1 p -100.57 -26.65 13.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.894 . . . . 0.0 109.433 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.08 -152.11 9.94 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.634 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -165.12 126.26 2.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -1.17 . . . . 0.0 109.647 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.529 ' CG2' ' HD2' ' A' ' 49' ' ' ARG . 6.1 mt -94.78 138.92 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.203 -0.936 . . . . 0.0 109.288 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.604 ' CG2' ' CE1' ' A' ' 36' ' ' HIS . 1.5 mm -119.85 117.91 55.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.298 -0.876 . . . . 0.0 109.077 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ARG . . . . . 0.534 ' CG ' ' OG ' ' A' ' 71' ' ' SER . 3.1 ptp180 -121.94 140.5 52.37 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.881 -1.137 . . . . 0.0 108.698 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.64 ' CD2' ' CD2' ' A' ' 59' ' ' LEU . 28.5 m-70 -137.43 167.21 22.07 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.055 -1.028 . . . . 0.0 110.496 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' HIS . . . . . 0.471 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 45.9 p-80 -173.37 149.46 1.73 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.594 ' HA ' ' CD2' ' A' ' 68' ' ' TYR . . . -56.15 -163.65 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.564 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.459 ' OE2' ' OE2' ' A' ' 67' ' ' GLU . 5.3 mm-40 -69.78 -90.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.955 . . . . 0.0 109.718 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -74.41 -1.0 19.15 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.51 -0.744 . . . . 0.0 109.798 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.521 ' OG ' ' CB ' ' A' ' 38' ' ' ALA . 25.6 p -76.94 88.45 3.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.124 -0.985 . . . . 0.0 109.39 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 8.2 p -120.5 -0.65 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.932 . . . . 0.0 109.591 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -50.66 -92.38 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.11 82.38 29.66 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.254 -1.145 . . . . 0.0 109.434 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.83 -169.63 0.79 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.672 2.248 . . . . 0.0 110.141 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.524 ' CZ ' ' HB2' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -124.3 154.31 40.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.114 -0.991 . . . . 0.0 109.557 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLN . . . . . 0.5 ' HB3' ' NE ' ' A' ' 49' ' ' ARG . 1.0 OUTLIER -126.66 109.52 12.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 110.174 -179.574 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.521 ' N ' ' O ' ' A' ' 34' ' ' ILE . 64.9 m-20 -92.68 111.54 23.18 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.42 -0.8 . . . . 0.0 108.928 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ARG . . . . . 0.537 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 9.6 mmt85 -90.58 137.82 32.05 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.16 -0.963 . . . . 0.0 109.339 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.473 ' HB ' ' HD2' ' A' ' 51' ' ' PRO . 5.5 m -126.66 160.19 59.82 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.296 -0.878 . . . . 0.0 109.432 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.476 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 34.9 Cg_endo -77.25 174.72 12.33 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.555 2.17 . . . . 0.0 110.343 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 34.8 Cg_endo -76.88 -15.4 16.75 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.513 2.142 . . . . 0.0 110.356 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 m -93.87 13.13 23.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.263 -0.898 . . . . 0.0 109.451 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.436 ' O ' ' CZ2' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -123.93 121.36 35.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.921 . . . . 0.0 109.499 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.498 ' O ' ' CE3' ' A' ' 22' ' ' TRP . 3.6 p30 -107.25 -0.86 22.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 109.523 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.7 p -132.55 129.76 39.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.648 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.522 HD11 ' CB ' ' A' ' 34' ' ' ILE . 2.3 tt -125.63 141.27 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.309 -0.869 . . . . 0.0 109.126 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 19.4 m -104.5 127.34 52.19 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.158 -0.964 . . . . 0.0 109.966 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.648 ' CD1' ' CE1' ' A' ' 18' ' ' PHE . 5.0 mp -84.39 160.73 20.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.341 -0.85 . . . . 0.0 109.674 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.492 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 0.8 OUTLIER -152.9 169.22 23.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.619 -0.676 . . . . 0.0 109.553 179.818 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.6 m120 60.07 48.28 8.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.886 . . . . 0.0 109.39 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.525 ' CD1' ' HB3' ' A' ' 59' ' ' LEU . 2.0 mt -127.7 157.19 40.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.292 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.499 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 1.4 m-20 -63.1 132.59 95.13 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.119 -0.988 . . . . 0.0 108.693 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.3 Cg_endo -77.49 125.4 7.62 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.288 1.992 . . . . 0.0 110.638 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 90' ' ' THR . . . 77.94 61.67 2.49 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.575 HG21 ' CE1' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -154.66 145.12 22.15 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.255 -1.144 . . . . 0.0 110.155 -179.164 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.558 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 23.4 tt0 -74.87 129.57 37.91 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.594 ' CD2' ' HA ' ' A' ' 38' ' ' ALA . 27.9 m-85 -125.42 164.56 20.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.997 -1.065 . . . . 0.0 110.251 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' VAL . . . . . 0.471 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 53.9 t -110.28 164.49 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 85' ' ' ILE . 4.6 t -149.67 144.07 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.832 -1.167 . . . . 0.0 110.168 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.556 ' CB ' HG12 ' A' ' 85' ' ' ILE . 1.3 p -142.09 118.76 11.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.2 -0.938 . . . . 0.0 109.897 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . 0.528 ' CD1' HG22 ' A' ' 34' ' ' ILE . 4.5 mm -91.38 131.85 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.493 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.583 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 5.4 mt -116.91 150.75 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 109.201 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.634 ' CB ' ' CZ ' ' A' ' 32' ' ' TYR . . . -123.21 147.09 47.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.361 -0.837 . . . . 0.0 109.642 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.432 HG11 ' HG2' ' A' ' 80' ' ' GLU . 0.1 OUTLIER -133.21 132.71 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 109.384 179.86 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASN . . . . . 0.468 ' HB3' ' HB2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -121.08 53.37 1.14 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 109.422 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.95 -69.85 3.17 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.407 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 17.8 tpp85 -126.08 -0.58 7.15 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -1.166 . . . . 0.0 109.647 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.525 ' O ' ' CG ' ' A' ' 80' ' ' GLU . 6.7 mm-40 -106.71 178.11 4.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.917 . . . . 0.0 109.399 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.525 ' CG ' ' O ' ' A' ' 79' ' ' GLU . 56.1 mt-10 -160.81 105.52 1.39 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.659 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.545 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -60.15 179.57 0.21 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 109.103 179.71 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.3 Cg_endo -77.43 149.25 27.3 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.35 2.033 . . . . 0.0 110.238 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.46 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 35.8 Cg_endo -77.96 106.24 2.14 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.65 2.233 . . . . 0.0 111.175 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.458 HD21 ' O ' ' A' ' 5' ' ' PRO . 12.3 tp -78.91 119.91 22.76 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . 0.556 HG12 ' CB ' ' A' ' 71' ' ' SER . 0.5 OUTLIER -106.88 163.95 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.008 -1.058 . . . . 0.0 110.292 -179.365 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.554 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -156.42 164.31 32.44 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -117.93 141.66 48.19 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.124 -1.221 . . . . 0.0 110.034 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.534 ' CG ' HD12 ' A' ' 13' ' ' ILE . 2.1 mm-40 -165.27 137.6 4.29 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.558 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -103.26 148.87 25.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 110.102 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.477 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.7 OUTLIER -74.75 139.83 43.66 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.55 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.528 ' CG2' ' HB2' ' A' ' 116' ' ' ALA . 2.3 t -64.77 176.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.486 0.66 . . . . 0.0 110.571 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 75.4 m -81.0 139.67 35.64 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . 0.539 ' HA ' ' CG1' ' A' ' 117' ' ' VAL . 49.3 t0 -74.78 -45.73 41.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.262 -0.899 . . . . 0.0 110.723 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.542 HD12 ' N ' ' A' ' 176' ' ' LYS . 1.4 mt -86.41 144.12 37.52 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 120.931 -1.106 . . . . 0.0 109.917 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . 0.526 ' HD2' ' CG2' ' A' ' 94' ' ' ILE . 35.9 Cg_endo -78.87 -159.32 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.735 2.29 . . . . 0.0 109.947 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -174.28 156.12 2.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.194 -0.941 . . . . 0.0 109.635 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 1.4 t0 78.38 25.5 0.58 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.396 -0.815 . . . . 0.0 109.928 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.506 ' CD2' ' CD2' ' A' ' 162' ' ' LEU . 27.9 tp -67.46 101.39 0.97 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.062 -1.023 . . . . 0.0 109.114 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -138.26 -171.92 3.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 109.642 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.5 p -107.14 144.24 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.227 -0.921 . . . . 0.0 109.837 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.519 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 22.8 pt -126.75 -4.32 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.373 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.522 ' CB ' ' HB2' ' A' ' 109' ' ' LEU . . . -152.38 91.38 1.58 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . 0.485 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 4.9 p -85.31 85.97 7.41 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.526 -0.733 . . . . 0.0 110.298 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' THR . . . . . 0.547 ' OG1' ' N ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -74.42 163.29 69.33 Favored Pre-proline 0 C--N 1.306 -1.307 0 O-C-N 121.045 -1.034 . . . . 0.0 108.462 179.215 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 29.7 Cg_endo -68.47 -3.1 10.36 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.437 2.091 . . . . 0.0 110.775 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.493 ' C ' ' CG2' ' A' ' 152' ' ' ILE . 21.7 p -153.68 20.1 0.53 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' SER . . . . . 0.547 ' N ' ' OG1' ' A' ' 104' ' ' THR . 6.3 p -170.84 165.58 7.83 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.999 -1.08 . . . . 0.0 110.281 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.64 ' CD2' ' CZ ' ' A' ' 182' ' ' TYR . 0.0 OUTLIER -139.42 153.36 47.58 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.884 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.522 ' HB2' ' CB ' ' A' ' 102' ' ' ALA . 0.3 OUTLIER -105.53 98.43 8.13 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.319 -0.863 . . . . 0.0 108.904 179.296 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 147' ' ' ALA . 1.3 pt -74.62 134.56 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.168 -0.958 . . . . 0.0 109.612 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . 0.448 ' HB2' HG22 ' A' ' 101' ' ' ILE . 12.8 t -134.05 111.15 10.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.554 -0.716 . . . . 0.0 109.237 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' TRP . . . . . 0.576 ' CD2' ' O ' ' A' ' 145' ' ' SER . 37.4 p90 -130.03 137.96 50.52 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.331 -0.855 . . . . 0.0 109.158 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.475 ' O ' ' HD3' ' A' ' 115' ' ' PRO . 2.4 mt-10 -44.65 131.73 4.97 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.187 -0.946 . . . . 0.0 108.944 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' PRO . . . . . 0.518 ' HB3' ' CB ' ' A' ' 145' ' ' SER . 35.4 Cg_endo -77.85 111.37 3.1 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.362 2.041 . . . . 0.0 110.364 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 113' ' ' GLU . 36.6 Cg_endo -78.65 152.16 25.67 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.308 2.005 . . . . 0.0 109.707 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ALA . . . . . 0.528 ' HB2' ' CG2' ' A' ' 91' ' ' VAL . . . -90.43 92.88 9.07 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.143 -0.973 . . . . 0.0 109.222 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.539 ' CG1' ' HA ' ' A' ' 93' ' ' ASP . 0.0 OUTLIER -140.42 -179.91 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 109.831 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 55.3 m -104.4 44.02 1.06 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' A' ' 165' ' ' VAL . 2.2 t -74.41 124.58 32.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.522 -0.736 . . . . 0.0 109.548 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.423 ' NE ' ' O ' ' A' ' 166' ' ' THR . 0.0 OUTLIER -74.86 -31.63 61.68 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.269 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . 0.505 ' HB2' ' O ' ' A' ' 140' ' ' VAL . 3.6 p90 -165.77 162.17 18.41 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.352 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' TYR . . . . . 0.553 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 3.6 m-85 -111.46 126.83 55.37 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.473 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 15.1 ttp180 -84.9 91.6 8.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.139 -0.976 . . . . 0.0 109.398 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ILE . . . . . 0.595 ' HB ' ' CZ ' ' A' ' 138' ' ' PHE . 19.2 mt -84.45 138.77 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.889 . . . . 0.0 109.59 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.485 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 25.9 p -112.7 129.63 56.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.411 -0.805 . . . . 0.0 109.889 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' TYR . . . . . 0.647 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 2.2 m-85 -75.36 131.75 40.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.449 -0.782 . . . . 0.0 109.091 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLY . . . . . 0.601 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -101.47 107.03 3.15 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.491 ' O ' ' C ' ' A' ' 129' ' ' THR . 3.9 mt-10 -107.21 141.14 38.98 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.115 -1.227 . . . . 0.0 108.932 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' THR . . . . . 0.592 ' CG2' ' CB ' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -32.55 -53.76 0.33 Allowed 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.344 0.592 . . . . 0.0 110.09 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.464 ' N ' ' OG1' ' A' ' 129' ' ' THR . . . 111.87 102.24 2.62 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 172.67 -28.22 0.1 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.454 ' O ' ' HB3' ' A' ' 133' ' ' SER . 2.6 p30 -121.99 -2.61 9.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.112 -1.228 . . . . 0.0 109.804 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.454 ' HB3' ' O ' ' A' ' 132' ' ' ASN . 1.1 p 175.84 160.65 0.43 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.166 -0.959 . . . . 0.0 109.611 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.42 -175.74 2.89 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.614 2.209 . . . . 0.0 110.318 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 126' ' ' TYR . 3.5 m -68.56 169.19 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.238 -0.914 . . . . 0.0 109.563 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' GLN . . . . . 0.545 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 0.1 OUTLIER -122.42 105.44 10.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.28 -0.888 . . . . 0.0 109.084 179.645 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.485 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 1.9 tm-20 -88.57 123.22 32.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 110.39 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.595 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 38.7 p90 -125.42 140.62 52.63 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 8.5 p -74.44 162.8 28.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.106 -0.996 . . . . 0.0 110.342 -178.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.524 HG13 ' CD1' ' A' ' 122' ' ' TYR . 2.4 t -131.44 142.37 45.13 Favored Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 121.602 -0.686 . . . . 0.0 109.625 -178.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PRO . . . . . 0.457 ' HD2' HG11 ' A' ' 140' ' ' VAL . 34.9 Cg_endo -77.48 140.54 19.23 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.408 2.072 . . . . 0.0 109.935 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.3 24.88 8.68 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.51 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 2.1 p -105.42 32.22 4.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.147 -1.207 . . . . 0.0 109.664 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.51 ' CG ' ' O ' ' A' ' 143' ' ' SER . 1.7 mttt -177.83 156.63 1.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.095 -1.003 . . . . 0.0 109.773 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.576 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 1.1 p -95.17 -14.52 24.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.884 . . . . 0.0 109.357 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.461 ' HB ' ' O ' ' A' ' 110' ' ' ILE . 6.5 p -118.92 137.88 53.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.118 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.462 ' O ' HG13 ' A' ' 110' ' ' ILE . . . -118.99 164.22 15.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.143 -0.973 . . . . 0.0 109.696 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.8 t -95.15 156.48 16.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.246 -0.909 . . . . 0.0 109.144 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.647 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 9.7 mm -134.96 68.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.202 -0.936 . . . . 0.0 109.577 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.534 ' O ' ' CB ' ' A' ' 151' ' ' ASN . 1.4 m-80 -83.44 166.39 18.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.46 -0.775 . . . . 0.0 109.496 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 2.0 t30 79.02 31.6 0.3 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.352 -0.843 . . . . 0.0 109.794 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.525 HG13 ' CE2' ' A' ' 158' ' ' TYR . 2.7 tt -94.04 159.96 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.169 -0.957 . . . . 0.0 109.47 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt -103.94 120.77 50.14 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.301 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.14 147.45 23.53 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.424 2.083 . . . . 0.0 110.507 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 72.52 61.59 3.55 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.592 ' CB ' ' CG2' ' A' ' 129' ' ' THR . . . 177.56 129.17 0.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -1.124 . . . . 0.0 109.582 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.486 ' O ' HG21 ' A' ' 129' ' ' THR . 4.4 t0 -46.05 160.69 0.06 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.129 -0.982 . . . . 0.0 108.455 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TYR . . . . . 0.601 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -148.39 178.46 8.57 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.736 -1.228 . . . . 0.0 110.242 -179.574 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' THR . . . . . 0.547 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 6.1 m -161.73 108.92 1.39 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.38 -0.825 . . . . 0.0 109.209 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.499 ' CD1' HD11 ' A' ' 108' ' ' LEU . 15.4 mt -98.85 133.21 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.608 -1.307 . . . . 0.0 109.824 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.573 ' CG2' ' CB ' ' A' ' 179' ' ' SER . 1.6 m -141.39 174.18 10.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.312 -0.867 . . . . 0.0 109.339 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 124' ' ' ILE . 0.7 OUTLIER -163.99 148.63 10.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.063 -1.023 . . . . 0.0 110.997 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' TYR . . . . . 0.6 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.6 m-85 -125.32 81.73 2.0 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.544 ' HB3' ' CE2' ' A' ' 122' ' ' TYR . . . -45.18 99.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.952 -1.093 . . . . 0.0 109.15 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . 0.524 ' O ' ' CG1' ' A' ' 119' ' ' VAL . 70.7 t -90.93 135.45 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.898 . . . . 0.0 109.917 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' THR . . . . . 0.472 ' CG2' ' HA ' ' A' ' 119' ' ' VAL . 45.3 p -115.3 -62.91 1.53 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.418 -0.801 . . . . 0.0 109.405 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 172' ' ' PRO . . . -81.86 135.09 13.82 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -137.19 125.44 23.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -1.134 . . . . 0.0 109.461 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 144.44 -122.75 1.84 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -82.38 8.59 10.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -1.16 . . . . 0.0 109.54 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.8 m -159.51 69.71 3.24 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.436 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.464 ' HA ' ' O ' ' A' ' 167' ' ' GLY . 35.5 Cg_endo -78.08 94.23 1.07 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.616 2.211 . . . . 0.0 110.405 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -107.67 143.4 36.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.227 -0.921 . . . . 0.0 109.542 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' SER . . . . . 0.461 ' HB3' HG21 ' A' ' 165' ' ' VAL . 0.9 OUTLIER -142.11 133.66 26.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 0.0 109.371 179.941 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.497 ' HB2' ' CG1' ' A' ' 94' ' ' ILE . 96.9 p -53.82 161.33 1.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.929 . . . . 0.0 109.351 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LYS . . . . . 0.542 ' N ' HD12 ' A' ' 94' ' ' ILE . 3.4 mttt -46.25 142.95 3.94 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.174 -0.954 . . . . 0.0 108.588 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.6 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 35.0 Cg_endo -77.88 141.52 19.2 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.345 2.03 . . . . 0.0 111.397 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.466 ' O ' HG21 ' A' ' 161' ' ' THR . 2.2 t -114.99 134.68 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' SER . . . . . 0.573 ' CB ' ' CG2' ' A' ' 161' ' ' THR . 1.1 p -133.29 162.25 32.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 111.02 -178.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . 0.465 HG21 ' O ' ' A' ' 179' ' ' SER . 13.5 pt -142.26 152.13 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -93.33 152.1 19.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.987 -1.071 . . . . 0.0 109.853 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.64 ' CZ ' ' CD2' ' A' ' 108' ' ' LEU . 53.6 t80 -146.53 130.03 16.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.399 -0.813 . . . . 0.0 109.468 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -106.34 119.34 39.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.444 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' THR . . . . . 0.488 ' OG1' ' N ' ' A' ' 156' ' ' ALA . 1.5 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.484 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.6 mt . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.501 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 1.0 OUTLIER -99.84 162.34 13.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.886 . . . . 0.0 109.084 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.478 ' HA ' ' HG2' ' A' ' 82' ' ' PRO . 79.6 p -95.15 136.62 22.54 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.109 -0.995 . . . . 0.0 109.762 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.862 ' O ' HD22 ' A' ' 84' ' ' LEU . 35.9 Cg_endo -79.27 119.07 4.1 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.602 2.201 . . . . 0.0 110.067 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.43 -163.21 1.52 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.021 -1.049 . . . . 0.0 109.746 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 60.29 22.46 58.54 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -178.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 1.005 ' HB3' HD21 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -82.28 168.05 17.99 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.863 -0.786 . . . . 0.0 109.538 -179.17 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.768 ' O ' HG12 ' A' ' 20' ' ' VAL . 3.6 t70 -165.28 -163.93 0.72 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.9 t -142.91 149.16 38.09 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.151 -0.968 . . . . 0.0 109.643 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.475 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 40.4 p -176.24 -163.52 0.1 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 109.286 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.571 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.6 OUTLIER 45.8 37.11 3.2 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -178.622 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.697 HG22 HG23 ' A' ' 91' ' ' VAL . 1.8 mt -85.5 165.03 2.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.65 -177.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 17' ' ' SER . 0.7 OUTLIER -154.41 -165.21 2.02 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.8 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.829 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -86.62 -44.96 11.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.022 -1.049 . . . . 0.0 109.875 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -110.32 11.15 23.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.91 -1.119 . . . . 0.0 109.486 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.937 ' HB3' HG22 ' A' ' 60' ' ' THR . 0.0 OUTLIER -160.9 150.11 16.85 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.767 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.677 ' HA ' ' HA ' ' A' ' 13' ' ' ILE . 2.1 p90 -165.51 143.35 5.91 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.009 -1.057 . . . . 0.0 108.855 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.907 ' OG1' HG23 ' A' ' 58' ' ' THR . 61.6 m -107.95 163.85 12.78 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.823 -1.173 . . . . 0.0 111.099 -178.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.768 HG12 ' O ' ' A' ' 9' ' ' ASP . 0.9 OUTLIER -132.09 170.88 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.475 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 18.1 m-70 -142.07 158.44 43.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.994 -1.066 . . . . 0.0 110.195 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.597 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 23.9 p90 -170.84 135.19 1.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.43 -0.794 . . . . 0.0 109.24 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.37 166.53 2.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.135 -0.978 . . . . 0.0 109.363 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.887 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -98.03 174.07 3.46 Favored Pre-proline 0 C--N 1.298 -1.639 0 O-C-N 121.666 -0.646 . . . . 0.0 109.772 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.887 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.6 Cg_endo -78.64 177.35 8.84 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.682 2.255 . . . . 0.0 110.457 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -86.73 9.13 19.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -0.932 . . . . 0.0 109.388 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.744 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -126.07 168.06 15.18 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.496 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.744 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.4 Cg_endo -78.12 133.04 11.94 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.695 2.264 . . . . 0.0 110.444 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.673 HD13 ' CE1' ' A' ' 32' ' ' TYR . 27.2 pt -118.18 -172.79 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.435 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.4 p -123.12 -10.24 8.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 109.555 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.501 ' O ' ' CG2' ' A' ' 75' ' ' VAL . . . 157.38 151.21 5.94 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.673 ' CE1' HD13 ' A' ' 29' ' ' ILE . 2.4 m-30 -114.07 139.09 49.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -1.133 . . . . 0.0 109.612 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.965 ' C ' HD13 ' A' ' 34' ' ' ILE . 1.7 mp -93.01 128.97 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.233 -0.917 . . . . 0.0 109.087 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.976 HG21 HG21 ' A' ' 57' ' ' ILE . 1.8 mm -115.86 109.25 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.214 -0.929 . . . . 0.0 109.76 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.48 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -109.86 137.11 48.11 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.13 -0.981 . . . . 0.0 109.012 179.36 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.872 ' HB3' HG22 ' A' ' 70' ' ' VAL . 5.4 p-80 -129.84 146.74 51.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.109 -0.994 . . . . 0.0 110.076 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.554 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 28.6 p-80 -168.24 133.34 1.76 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.339 -0.851 . . . . 0.0 109.87 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.936 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . -66.08 137.54 57.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 109.243 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.195 -0.941 . . . . 0.0 109.759 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.483 ' HB2' ' NE2' ' A' ' 36' ' ' HIS . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -123.14 117.16 24.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 109.958 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.593 ' HB3' HD11 ' A' ' 57' ' ' ILE . 1.3 m-20 -120.04 107.68 13.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.413 -0.804 . . . . 0.0 108.893 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.842 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -91.28 142.28 27.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.07 -1.019 . . . . 0.0 109.8 -179.504 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.74 HG13 HD12 ' A' ' 57' ' ' ILE . 5.8 m -119.3 161.97 34.35 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.44 -0.787 . . . . 0.0 109.107 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.531 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.5 Cg_endo -76.88 173.93 13.67 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.501 2.134 . . . . 0.0 110.293 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 35.4 Cg_endo -77.35 -15.32 15.93 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.648 2.232 . . . . 0.0 110.545 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.3 29.27 4.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.576 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.531 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 12.0 mmt85 -138.96 119.85 14.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 109.562 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.541 ' O ' ' CE3' ' A' ' 22' ' ' TRP . 10.2 p-10 -99.24 -3.66 33.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 109.468 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 74.8 p -135.14 158.59 43.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.175 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.976 HG21 HG21 ' A' ' 34' ' ' ILE . 3.5 tt -142.29 124.4 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.155 -0.966 . . . . 0.0 109.607 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.907 HG23 ' OG1' ' A' ' 19' ' ' THR . 0.3 OUTLIER -82.53 117.1 22.28 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.31 -0.868 . . . . 0.0 109.414 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.84 ' HB3' HD11 ' A' ' 62' ' ' LEU . 1.2 mt -95.93 143.37 27.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.893 . . . . 0.0 109.562 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.937 HG22 ' HB3' ' A' ' 17' ' ' SER . 39.2 p -134.61 -177.4 4.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 109.35 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.603 ' O ' HD23 ' A' ' 62' ' ' LEU . 4.4 m-80 53.03 56.37 7.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.385 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.84 HD11 ' HB3' ' A' ' 59' ' ' LEU . 6.0 mt -134.13 134.65 42.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.495 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.469 ' CB ' ' OH ' ' A' ' 68' ' ' TYR . 3.2 t30 -51.17 130.05 31.41 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 109.081 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.829 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -78.52 134.0 12.13 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.355 2.037 . . . . 0.0 110.712 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 82.83 60.95 1.99 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 90' ' ' THR . 2.4 m -163.73 154.26 15.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.323 -1.104 . . . . 0.0 109.924 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -88.92 127.1 35.64 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.936 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 23.5 m-85 -118.27 124.02 46.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.011 -1.055 . . . . 0.0 109.879 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.554 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 22.7 t -83.65 122.28 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 108.976 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.872 HG22 ' HB3' ' A' ' 36' ' ' HIS . 24.6 t -110.88 122.56 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -0.985 . . . . 0.0 109.55 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.541 ' HB2' ' CD1' ' A' ' 85' ' ' ILE . 82.3 p -103.54 117.13 33.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.192 -0.943 . . . . 0.0 109.903 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.803 HD13 HG23 ' A' ' 34' ' ' ILE . 11.2 mm -94.08 120.16 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.324 -0.86 . . . . 0.0 109.648 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.788 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.4 mp -112.11 132.74 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.165 -0.959 . . . . 0.0 109.124 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.58 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -95.94 154.48 17.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.557 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.501 ' CG2' ' O ' ' A' ' 31' ' ' GLY . 11.7 m -154.97 130.28 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 109.449 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -103.03 45.56 0.95 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.36 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.68 -85.21 0.99 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -111.64 -1.14 15.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -1.141 . . . . 0.0 109.404 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -97.09 -166.26 1.37 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 0.0 109.311 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -146.36 -167.07 2.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.14 -0.975 . . . . 0.0 109.854 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.592 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -172.44 -178.87 0.46 Allowed Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.592 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.1 Cg_endo -76.6 134.2 14.99 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.021 1.814 . . . . 0.0 109.69 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 35.2 Cg_endo -77.1 108.83 2.71 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.437 2.091 . . . . 0.0 111.129 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.005 HD21 ' HB3' ' A' ' 8' ' ' PHE . 9.7 tp -77.4 80.94 3.89 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.296 -0.878 . . . . 0.0 108.638 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 71' ' ' SER . 4.2 mt -86.06 151.47 3.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.184 -0.947 . . . . 0.0 110.216 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.44 ' C ' ' HG3' ' A' ' 87' ' ' GLN . . . -145.42 -169.13 13.47 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.483 ' HG2' HG13 ' A' ' 69' ' ' VAL . 30.8 mt-30 -150.73 126.89 10.55 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.168 -1.195 . . . . 0.0 109.676 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.665 ' NE2' ' N ' ' A' ' 88' ' ' GLN . 0.0 OUTLIER -129.3 -155.31 0.69 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.317 -0.864 . . . . 0.0 108.752 179.6 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -159.73 136.13 8.99 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.037 -1.04 . . . . 0.0 110.002 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.408 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.93 137.16 41.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.401 -0.812 . . . . 0.0 108.997 179.667 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.697 HG23 HG22 ' A' ' 13' ' ' ILE . 3.1 t . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.407 0.622 . . . . 0.0 110.092 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.481 ' HB2' ' HB2' ' A' ' 112' ' ' TRP . 36.3 Cg_endo . . . . . 0 C--O 1.215 -0.636 0 N-CA-C 109.656 -0.94 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.504 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -169.9 158.54 7.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.091 -1.006 . . . . 0.0 109.604 179.591 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 4.5 t0 78.13 26.83 0.57 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.435 -0.791 . . . . 0.0 109.715 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.818 ' CD1' HD23 ' A' ' 162' ' ' LEU . 1.7 tt -60.3 99.4 0.08 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.13 -0.981 . . . . 0.0 109.057 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -138.05 165.38 26.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.616 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 13.3 p -96.31 147.24 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.762 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.531 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 14.1 pt -127.99 -4.32 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 0.0 109.704 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.911 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -153.03 105.28 2.9 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.517 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 10.0 m -100.79 91.08 4.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -0.933 . . . . 0.0 110.588 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.541 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -83.35 163.28 50.81 Favored Pre-proline 0 C--N 1.306 -1.306 0 O-C-N 121.126 -0.983 . . . . 0.0 108.671 178.726 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -69.2 -2.12 9.21 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.296 1.997 . . . . 0.0 110.795 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.833 ' C ' HG22 ' A' ' 152' ' ' ILE . 23.2 p -147.56 12.58 1.03 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 109.497 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' SER . . . . . 1.053 ' O ' HD23 ' A' ' 108' ' ' LEU . 3.2 p -169.84 164.69 9.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.809 -1.182 . . . . 0.0 110.198 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.053 HD23 ' O ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -139.13 155.4 47.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.306 -0.871 . . . . 0.0 109.131 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.911 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 1.3 mt -105.41 116.23 31.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.295 -0.878 . . . . 0.0 109.329 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.65 HD11 ' HB3' ' A' ' 147' ' ' ALA . 1.6 pt -99.01 143.55 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 109.494 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.906 ' CB ' HG22 ' A' ' 146' ' ' THR . 41.3 p -140.24 131.2 26.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.352 -0.843 . . . . 0.0 109.58 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.644 ' HH2' ' HB2' ' A' ' 147' ' ' ALA . 47.0 p90 -135.85 151.69 50.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.358 -0.839 . . . . 0.0 109.35 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.474 ' HB2' ' HG3' ' A' ' 96' ' ' ARG . 14.2 mt-10 . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.485 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.683 ' CE2' HG22 ' A' ' 139' ' ' THR . 1.5 p90 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 121.214 0.53 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 1.4 m-85 -125.96 140.4 52.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.251 -0.906 . . . . 0.0 109.013 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.595 ' CG ' ' HB2' ' A' ' 163' ' ' TYR . 0.1 OUTLIER -113.12 98.95 7.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.655 -1.278 . . . . 0.0 108.214 178.665 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.841 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 20.8 mt -92.25 156.73 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.354 -0.841 . . . . 0.0 110.629 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 82.1 p -116.01 135.84 53.59 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.76 -0.588 . . . . 0.0 109.594 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.642 ' CE2' ' CG2' ' A' ' 149' ' ' ILE . 14.1 m-85 -74.17 143.62 45.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 109.368 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.581 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.86 94.02 0.94 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.224 -1.163 . . . . 0.0 109.427 179.634 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.495 ' HB2' ' HB2' ' A' ' 126' ' ' TYR . 1.9 tt0 . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 8.2 pt-20 -84.38 126.9 33.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 110.372 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.841 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 11.7 p90 -131.27 136.73 48.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.345 -0.847 . . . . 0.0 108.834 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.683 HG22 ' CE2' ' A' ' 121' ' ' TYR . 1.7 p -74.78 157.55 35.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.235 -0.916 . . . . 0.0 110.755 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.509 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 39.7 t -121.5 127.14 26.22 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 143' ' ' SER . 36.3 Cg_endo -79.01 42.11 1.22 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.282 1.988 . . . . 0.0 111.352 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 141' ' ' PRO . . . 35.49 31.86 0.03 OUTLIER Glycine 0 N--CA 1.498 2.804 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.9 OUTLIER -50.43 -41.22 52.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -1.102 . . . . 0.0 109.835 -179.354 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.456 ' HD2' ' OG1' ' A' ' 146' ' ' THR . 0.4 OUTLIER 179.43 -168.69 0.1 Allowed 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.609 -0.682 . . . . 0.0 109.628 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.564 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -71.98 -4.54 29.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.499 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.906 HG22 ' CB ' ' A' ' 111' ' ' SER . 75.7 p -124.37 133.09 53.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.178 -0.951 . . . . 0.0 109.396 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.65 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -117.54 169.87 9.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.608 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.408 ' C ' HG12 ' A' ' 149' ' ' ILE . 12.2 t -99.24 164.47 12.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.382 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.642 ' CG2' ' CE2' ' A' ' 126' ' ' TYR . 17.7 mm -143.59 65.86 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.448 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.579 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 0.8 OUTLIER -78.7 -152.23 0.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.479 -0.763 . . . . 0.0 109.792 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.539 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 0.1 OUTLIER 47.1 26.43 0.64 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 109.418 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.833 HG22 ' C ' ' A' ' 106' ' ' THR . 3.3 tt -92.19 160.74 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.304 -0.873 . . . . 0.0 109.637 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.416 ' HD2' ' HD2' ' A' ' 154' ' ' PRO . 0.0 OUTLIER -122.58 127.65 25.72 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.189 -0.945 . . . . 0.0 109.268 179.805 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.449 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 36.1 Cg_endo -78.59 155.87 27.96 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.467 2.111 . . . . 0.0 110.593 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.704 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 81.76 64.89 1.7 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.704 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 162.3 132.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.287 -1.125 . . . . 0.0 109.657 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.59 164.83 0.2 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.699 ' CD1' HG21 ' A' ' 184' ' ' THR . 0.2 OUTLIER -145.21 -175.87 4.87 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.705 -1.247 . . . . 0.0 110.519 -179.149 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.571 HG22 ' N ' ' A' ' 160' ' ' ILE . 2.9 m -162.97 168.16 21.51 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.571 ' N ' HG22 ' A' ' 159' ' ' THR . 67.0 mt -152.55 136.25 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.856 -1.152 . . . . 0.0 109.908 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.95 HG23 ' CB ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -138.74 131.25 28.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.316 -0.865 . . . . 0.0 109.081 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.818 HD23 ' CD1' ' A' ' 98' ' ' LEU . 3.7 pp -114.68 141.27 48.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.076 -1.015 . . . . 0.0 111.23 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.663 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 1.4 m-85 -122.56 72.49 1.07 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.548 ' CB ' ' CD2' ' A' ' 122' ' ' TYR . . . -45.5 120.12 2.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.864 -1.147 . . . . 0.0 109.284 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.461 HG11 ' CE1' ' A' ' 121' ' ' TYR . 74.0 t . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.285 -0.884 . . . . 0.0 109.722 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 175' ' ' SER . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 174' ' ' SER . 3.4 p -52.8 -171.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -0.852 . . . . 0.0 109.619 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.11 144.86 95.83 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.663 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.1 Cg_endo -77.86 128.88 9.53 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.446 2.097 . . . . 0.0 111.641 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.7 t -95.52 124.2 48.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.95 ' CB ' HG23 ' A' ' 161' ' ' THR . 0.0 OUTLIER -115.2 146.7 41.15 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 110.811 -178.372 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.589 HG23 HD13 ' A' ' 98' ' ' LEU . 5.2 pt -130.81 -164.92 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -126.16 164.86 20.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.961 -1.087 . . . . 0.0 109.491 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.748 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 63.4 t80 -165.08 132.87 3.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.205 -0.935 . . . . 0.0 109.461 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -103.21 129.84 50.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.208 -0.932 . . . . 0.0 109.613 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.699 HG21 ' CD1' ' A' ' 158' ' ' TYR . 30.8 p . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.494 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.79 HD11 ' HG2' ' A' ' 79' ' ' GLU . 4.9 mt . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 121.415 0.626 . . . . 0.0 109.616 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.843 ' CG ' HG22 ' A' ' 29' ' ' ILE . 1.1 m-20 -73.94 77.35 1.66 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.395 -0.816 . . . . 0.0 109.133 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.532 ' OG ' ' CG ' ' A' ' 82' ' ' PRO . 14.8 m -95.58 109.59 46.53 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.431 -0.793 . . . . 0.0 109.772 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.677 ' O ' HD22 ' A' ' 84' ' ' LEU . 36.7 Cg_endo -79.66 145.52 18.3 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.375 2.05 . . . . 0.0 110.077 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.668 HG23 ' O ' ' A' ' 5' ' ' PRO . 0.7 OUTLIER -161.43 -171.87 3.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.099 -1.0 . . . . 0.0 109.762 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 45.44 27.33 1.88 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.62 ' C ' ' CD1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -71.65 -161.63 0.07 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.598 -0.943 . . . . 0.0 109.867 -179.242 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.517 ' N ' ' CG ' ' A' ' 8' ' ' PHE . 1.5 t70 -165.58 -170.97 1.96 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.361 -0.837 . . . . 0.0 108.993 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 5.1 p -154.37 133.08 12.18 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.69 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.607 ' HG ' ' CD2' ' A' ' 21' ' ' HIS . 51.3 p -161.15 -159.64 0.67 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.253 -0.904 . . . . 0.0 109.42 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.524 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.8 OUTLIER 45.37 33.68 1.32 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -178.247 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.657 ' HA ' ' HA ' ' A' ' 18' ' ' PHE . 1.3 mt -75.71 163.43 3.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.485 -177.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.687 HG23 ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -149.71 -167.92 2.96 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.027 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.913 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -88.12 -47.55 8.4 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.901 -1.125 . . . . 0.0 109.361 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -105.59 19.72 20.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.915 -1.116 . . . . 0.0 109.001 179.623 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.822 ' HB3' HG22 ' A' ' 60' ' ' THR . 0.0 OUTLIER -172.64 153.33 2.76 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.741 ' CE1' HG22 ' A' ' 20' ' ' VAL . 4.7 p90 -166.19 140.73 4.43 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.955 -1.09 . . . . 0.0 108.985 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 2.3 m -89.07 160.34 17.1 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.922 -1.111 . . . . 0.0 111.252 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.741 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -137.46 122.39 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.607 ' CD2' ' HG ' ' A' ' 11' ' ' SER . 29.2 m-70 -99.31 153.09 19.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.097 -1.002 . . . . 0.0 110.104 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.803 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 22.3 p90 -161.5 133.48 5.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.382 -0.824 . . . . 0.0 109.523 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.548 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.41 170.54 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.234 -0.917 . . . . 0.0 109.295 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.548 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -100.76 159.58 29.18 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.623 -0.673 . . . . 0.0 109.378 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.543 ' CG ' ' HB3' ' A' ' 3' ' ' ASP . 36.2 Cg_endo -78.28 -159.11 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.7 2.266 . . . . 0.0 110.403 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -107.07 1.19 24.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.541 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.629 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -104.24 164.13 15.9 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.45 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.629 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.1 Cg_endo -77.5 141.4 19.93 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.669 2.246 . . . . 0.0 110.307 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.843 HG22 ' CG ' ' A' ' 3' ' ' ASP . 18.7 pt -133.69 163.33 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.763 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.2 p -117.73 1.78 12.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.406 -0.809 . . . . 0.0 109.234 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.575 ' O ' HG23 ' A' ' 75' ' ' VAL . . . 164.24 161.18 12.86 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.613 ' CD1' HD12 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -125.82 124.18 40.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.633 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.941 HG23 ' HG3' ' A' ' 49' ' ' ARG . 14.6 mm -87.64 118.61 33.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.198 -0.939 . . . . 0.0 109.318 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.071 HG23 HD13 ' A' ' 72' ' ' ILE . 1.5 mm -107.2 110.22 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.185 -0.947 . . . . 0.0 109.86 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.475 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 35.6 ttp180 -109.05 142.82 39.19 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.146 -0.971 . . . . 0.0 108.657 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.67 ' CG ' HD22 ' A' ' 59' ' ' LEU . 21.9 p-80 -132.06 151.75 51.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.986 -1.071 . . . . 0.0 110.187 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.456 ' O ' ' O ' ' A' ' 38' ' ' ALA . 15.8 p80 -168.55 126.66 1.09 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.512 -0.743 . . . . 0.0 109.023 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.724 ' HB2' ' CE2' ' A' ' 68' ' ' TYR . . . -47.55 174.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.15 -0.969 . . . . 0.0 109.6 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.45 ' HG2' HG23 ' A' ' 69' ' ' VAL . 1.3 mt-10 . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.101 -0.999 . . . . 0.0 109.582 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.576 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -123.27 103.91 8.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.943 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 1.003 ' HB3' HD11 ' A' ' 57' ' ' ILE . 4.8 m-20 -98.41 112.88 24.75 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.258 -0.901 . . . . 0.0 108.856 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.941 ' HG3' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -96.69 152.91 18.2 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.133 -0.979 . . . . 0.0 109.858 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.88 HG13 HD12 ' A' ' 57' ' ' ILE . 5.1 m -134.46 162.12 59.6 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.462 -0.774 . . . . 0.0 109.034 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.543 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.7 Cg_endo -77.02 174.16 13.29 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.481 2.12 . . . . 0.0 110.365 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 35.3 Cg_endo -77.63 -15.26 15.5 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.549 2.166 . . . . 0.0 110.419 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.39 29.73 3.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.477 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.543 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 4.5 mmt180 -139.17 132.89 30.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.569 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.412 ' O ' ' CE3' ' A' ' 22' ' ' TRP . 21.7 p-10 -112.61 -3.0 14.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 0.0 109.38 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 88.5 p -132.2 148.38 52.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.922 . . . . 0.0 109.35 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.003 HD11 ' HB3' ' A' ' 48' ' ' ASP . 5.9 tt -139.35 127.24 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 0.0 109.821 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.74 115.51 24.22 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.206 -0.934 . . . . 0.0 109.298 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.67 HD22 ' CG ' ' A' ' 36' ' ' HIS . 6.5 mt -88.31 160.47 17.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.738 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.822 HG22 ' HB3' ' A' ' 17' ' ' SER . 19.7 p -147.2 173.3 12.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.827 . . . . 0.0 109.609 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.66 ' O ' HD23 ' A' ' 62' ' ' LEU . 4.2 m-80 62.07 53.2 3.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.352 -0.843 . . . . 0.0 109.915 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.669 HD11 ' HB3' ' A' ' 59' ' ' LEU . 3.0 mt -132.69 135.61 45.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 109.315 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.469 ' CB ' ' OH ' ' A' ' 68' ' ' TYR . 3.2 t30 -47.24 131.54 9.68 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.094 -1.004 . . . . 0.0 108.889 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.913 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 36.6 Cg_endo -78.68 134.2 12.04 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.475 2.117 . . . . 0.0 111.258 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 78.95 62.03 2.29 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.606 HG22 ' CE1' ' A' ' 68' ' ' TYR . 1.2 m -161.99 144.04 11.28 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.275 -1.133 . . . . 0.0 110.2 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -79.19 133.37 36.7 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.652 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.724 ' CE2' ' HB2' ' A' ' 38' ' ' ALA . 50.7 m-85 -124.88 171.55 10.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.903 -1.123 . . . . 0.0 110.832 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.706 HG12 HG23 ' A' ' 85' ' ' ILE . 3.2 t -124.37 137.54 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.538 HG13 ' HB3' ' A' ' 36' ' ' HIS . 2.2 t -126.8 129.38 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.847 -1.158 . . . . 0.0 110.356 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.574 ' CB ' HG12 ' A' ' 85' ' ' ILE . 5.0 p -100.42 101.45 12.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.323 -0.86 . . . . 0.0 109.996 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.071 HD13 HG23 ' A' ' 34' ' ' ILE . 26.0 mm -80.91 84.2 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.094 -1.004 . . . . 0.0 109.317 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.475 ' HB ' ' HB ' ' A' ' 33' ' ' ILE . 9.1 mt -81.87 159.2 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -0.943 . . . . 0.0 109.587 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.556 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -121.05 169.87 10.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.9 . . . . 0.0 109.434 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -154.94 140.51 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 109.547 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.567 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 13.5 t30 -137.24 49.44 2.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 109.585 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.71 -96.15 1.44 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.44 ' CD ' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -112.37 1.7 16.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -1.096 . . . . 0.0 109.519 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.79 ' HG2' HD11 ' A' ' 2' ' ' LEU . 1.2 tt0 -98.29 170.08 9.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.266 -0.897 . . . . 0.0 109.387 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 2.3 mp0 -148.89 108.35 3.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.112 -0.993 . . . . 0.0 110.009 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.582 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -59.92 -178.34 0.14 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 108.649 179.245 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.582 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.0 Cg_endo -76.87 154.33 33.78 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.177 1.918 . . . . 0.0 110.127 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.2 103.8 1.8 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.66 2.24 . . . . 0.0 111.356 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.677 HD22 ' O ' ' A' ' 5' ' ' PRO . 5.6 tp -81.48 93.64 6.69 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.706 HG23 HG12 ' A' ' 69' ' ' VAL . 3.0 mt -100.09 126.69 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.177 -0.952 . . . . 0.0 110.157 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.552 ' O ' HG13 ' A' ' 69' ' ' VAL . . . -121.45 -164.71 12.39 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.401 ' HG2' HG13 ' A' ' 69' ' ' VAL . 60.7 mt-30 -143.99 123.85 13.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.947 -1.325 . . . . 0.0 110.198 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.446 ' NE2' ' HZ ' ' A' ' 8' ' ' PHE . 17.8 mm-40 -121.5 -152.79 0.52 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.4 143.36 6.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.089 -1.007 . . . . 0.0 109.904 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.501 ' HG1' ' HE1' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -87.81 138.13 31.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.411 -0.805 . . . . 0.0 109.196 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.541 HG23 HG22 ' A' ' 13' ' ' ILE . 2.9 t . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 121.592 0.711 . . . . 0.0 110.99 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.658 ' CB ' ' CD1' ' A' ' 112' ' ' TRP . 35.8 Cg_endo . . . . . 0 C--O 1.215 -0.67 0 N-CA-C 109.924 -0.837 . . . . 0.0 109.924 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.504 ' CG ' ' N ' ' A' ' 97' ' ' ASP . 32.5 ttt85 -77.5 164.56 25.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.321 -0.862 . . . . 0.0 109.752 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.532 ' HB2' ' CG ' ' A' ' 113' ' ' GLU . 2.8 t0 77.63 33.58 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.417 -0.802 . . . . 0.0 109.781 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.593 HD22 ' CD2' ' A' ' 162' ' ' LEU . 33.0 tp -77.15 102.53 6.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.959 . . . . 0.0 109.486 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -140.25 169.89 16.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -0.904 . . . . 0.0 109.392 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 7.9 p -94.17 138.86 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.922 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.483 HG13 ' HB3' ' A' ' 109' ' ' LEU . 1.3 pp -123.93 -7.97 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.395 -0.816 . . . . 0.0 109.312 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.732 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -158.54 99.08 1.57 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.528 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 0.1 OUTLIER -103.58 109.86 21.7 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.442 -0.786 . . . . 0.0 110.648 -178.52 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.46 ' HB ' ' HD2' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -91.3 166.39 18.56 Favored Pre-proline 0 C--N 1.306 -1.317 0 O-C-N 121.293 -0.88 . . . . 0.0 108.749 178.869 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.46 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 30.3 Cg_endo -69.55 -2.05 9.35 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.258 1.972 . . . . 0.0 110.617 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.829 ' C ' HG22 ' A' ' 152' ' ' ILE . 62.0 p -145.41 10.47 1.26 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.277 -0.889 . . . . 0.0 109.59 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' SER . . . . . 1.029 ' C ' HD23 ' A' ' 108' ' ' LEU . 3.1 p -167.3 153.69 8.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.826 -1.171 . . . . 0.0 109.992 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.029 HD23 ' C ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -120.9 151.38 39.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.256 -0.902 . . . . 0.0 109.422 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.732 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.7 OUTLIER -106.03 120.9 42.98 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.806 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.97 HD11 HD13 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -105.46 133.22 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.981 -1.074 . . . . 0.0 110.105 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.655 ' HA ' HG22 ' A' ' 146' ' ' THR . 4.9 t -130.82 121.51 25.46 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.658 ' CD1' ' CB ' ' A' ' 95' ' ' PRO . 41.8 p90 -138.28 163.93 30.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.834 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.532 ' CG ' ' HB2' ' A' ' 97' ' ' ASP . 1.8 mt-10 . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.901 . . . . 0.0 108.655 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.93 ' CE1' HG22 ' A' ' 139' ' ' THR . 1.2 p90 . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.518 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 11.5 m-85 -103.18 135.86 44.05 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 3.2 ttp-105 -90.98 82.85 5.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.997 -1.064 . . . . 0.0 109.889 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 1.033 ' CD1' HG21 ' A' ' 140' ' ' VAL . 78.9 mt -83.6 143.64 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 3.2 p -136.76 152.69 50.61 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.931 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 1.107 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 2.4 m-85 -86.21 134.84 33.75 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.607 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -106.19 119.49 6.04 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 C--N 1.299 -1.591 0 O-C-N 121.19 -1.182 . . . . 0.0 109.133 179.631 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.555 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 1.6 tm-20 -89.05 117.44 28.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.833 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.642 ' CE2' ' CG2' ' A' ' 124' ' ' ILE . 25.5 p90 -118.28 136.74 53.51 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.93 HG22 ' CE1' ' A' ' 121' ' ' TYR . 4.6 p -74.01 172.15 12.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.13 -0.981 . . . . 0.0 110.331 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 1.033 HG21 ' CD1' ' A' ' 124' ' ' ILE . 25.3 t -142.85 139.16 16.68 Favored Pre-proline 0 C--N 1.302 -1.464 0 O-C-N 121.494 -0.754 . . . . 0.0 109.884 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.525 ' HD2' HG13 ' A' ' 140' ' ' VAL . 35.4 Cg_endo -78.35 144.32 20.38 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.411 2.074 . . . . 0.0 109.943 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.27 40.87 3.06 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.9 m -105.45 -1.21 25.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -1.168 . . . . 0.0 109.847 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.3 158.6 39.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.976 . . . . 0.0 109.835 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.575 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -95.42 8.19 43.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.388 -0.82 . . . . 0.0 109.714 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.655 HG22 ' HA ' ' A' ' 111' ' ' SER . 54.7 p -133.39 147.55 51.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.193 -0.942 . . . . 0.0 109.442 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.495 ' N ' ' CH2' ' A' ' 112' ' ' TRP . . . -132.63 173.16 11.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.142 -0.974 . . . . 0.0 109.459 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.597 ' O ' HD12 ' A' ' 149' ' ' ILE . 1.9 t -125.77 138.88 53.87 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.188 -0.945 . . . . 0.0 109.698 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 1.107 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 1.0 OUTLIER -113.09 83.68 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.52 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 3.6 m-20 -92.96 175.23 6.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.313 -0.867 . . . . 0.0 110.153 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 151' ' ' ASN . 1.1 m120 70.21 30.46 3.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 108.912 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.829 HG22 ' C ' ' A' ' 106' ' ' THR . 9.4 tt -89.33 163.92 2.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.489 -0.757 . . . . 0.0 109.731 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -107.36 121.53 44.17 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.331 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.13 146.68 22.91 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.382 2.055 . . . . 0.0 110.507 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.699 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 87.37 65.57 1.36 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 164.23 130.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -1.149 . . . . 0.0 109.631 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -48.64 163.58 0.07 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.097 -1.002 . . . . 0.0 108.495 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.613 ' CD1' HG21 ' A' ' 184' ' ' THR . 0.2 OUTLIER -147.08 -176.11 5.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.823 -1.173 . . . . 0.0 110.147 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.505 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 4.8 m -163.69 115.55 1.42 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.482 HD12 HG12 ' A' ' 149' ' ' ILE . 39.5 mm -100.06 129.34 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.737 -1.227 . . . . 0.0 109.83 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . 1.021 HG23 ' CB ' ' A' ' 179' ' ' SER . 2.0 m -136.78 168.32 19.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.206 -0.933 . . . . 0.0 109.766 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.593 ' CD2' HD22 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -158.64 147.3 18.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.044 -1.035 . . . . 0.0 111.304 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.665 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 23.0 m-85 -121.15 105.86 10.99 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -70.64 93.7 0.95 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.911 -1.118 . . . . 0.0 109.158 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.598 HG22 ' HB3' ' A' ' 174' ' ' SER . 2.4 t . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 109.896 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.598 ' HB3' HG22 ' A' ' 165' ' ' VAL . 44.3 p . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.36 0.6 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 174' ' ' SER . 33.7 p 42.0 -164.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 176' ' ' LYS . 0.0 OUTLIER -86.58 148.51 46.61 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 120.993 -1.067 . . . . 0.0 108.559 179.276 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.665 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 31.3 Cg_endo -73.54 119.3 5.87 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.143 1.895 . . . . 0.0 111.058 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.85 124.33 63.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' SER . . . . . 1.021 ' CB ' HG23 ' A' ' 161' ' ' THR . 1.1 p -127.89 176.87 7.25 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.346 -0.846 . . . . 0.0 111.032 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.581 HG23 HD23 ' A' ' 98' ' ' LEU . 11.4 pt -157.31 152.02 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -85.78 158.58 19.97 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.926 -1.109 . . . . 0.0 109.674 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.764 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 47.0 t80 -158.25 127.69 5.79 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.358 -0.839 . . . . 0.0 109.328 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -101.86 128.52 48.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 109.527 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.613 HG21 ' CD1' ' A' ' 158' ' ' TYR . 7.5 p . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.505 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.472 ' HB2' ' OG ' ' A' ' 81' ' ' SER . 1.8 mt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 3.3 m-20 -106.33 153.22 22.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.473 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.541 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 0.3 OUTLIER -95.33 132.32 28.02 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.763 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.479 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 36.1 Cg_endo -79.54 102.13 1.46 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.515 2.143 . . . . 0.0 109.968 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.686 HG22 ' CD1' ' A' ' 84' ' ' LEU . 1.4 p -95.58 -110.58 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 109.792 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.443 ' HA3' ' HB ' ' A' ' 23' ' ' VAL . . . 44.3 27.39 1.17 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.576 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 28.2 t80 -51.54 124.5 12.28 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.55 -0.971 . . . . 0.0 110.011 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 0.7 OUTLIER -153.21 87.78 1.28 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 92.7 p -84.29 124.59 31.4 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 109.648 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 12' ' ' ASP . 13.2 p -153.55 -159.34 0.97 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.397 -0.814 . . . . 0.0 109.05 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.501 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 1.1 m-20 45.88 40.12 6.26 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.833 HG23 ' CB ' ' A' ' 18' ' ' PHE . 2.7 mt -85.14 131.76 33.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.721 0.772 . . . . 0.0 111.284 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -115.62 -167.13 1.21 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.161 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.62 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -78.48 -70.57 0.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.935 -1.103 . . . . 0.0 109.794 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 52.4 m-20 -83.06 14.21 3.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.127 -0.983 . . . . 0.0 110.156 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.777 ' HB2' HG22 ' A' ' 60' ' ' THR . 1.6 t -165.35 156.46 14.21 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.104 -0.998 . . . . 0.0 109.085 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.989 ' CE1' HG22 ' A' ' 20' ' ' VAL . 4.7 p90 -164.32 145.33 8.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.162 -0.962 . . . . 0.0 109.112 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.501 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 3.8 m -89.24 149.69 22.97 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.815 -1.178 . . . . 0.0 111.441 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.989 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -130.37 114.17 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.938 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 9' ' ' ASP . 4.4 m-70 -96.42 170.91 8.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.995 -1.066 . . . . 0.0 110.748 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.86 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 21.0 p90 178.23 136.43 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.48 164.85 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.011 -1.056 . . . . 0.0 109.789 -179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.687 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -97.53 167.3 12.05 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.71 -0.619 . . . . 0.0 109.595 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.687 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 36.3 Cg_endo -79.32 -159.28 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.607 2.205 . . . . 0.0 110.294 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -126.24 16.68 7.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.298 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.952 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -117.75 176.08 1.77 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.324 -0.86 . . . . 0.0 109.424 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.952 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.5 Cg_endo -78.16 136.57 14.61 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.635 2.224 . . . . 0.0 110.457 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.744 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 27.5 pt -150.06 -179.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.331 -0.856 . . . . 0.0 109.406 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.2 p -120.81 4.53 10.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.583 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.96 173.37 17.15 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.744 ' CZ ' HD11 ' A' ' 29' ' ' ILE . 16.6 m-85 -118.71 123.65 45.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -1.174 . . . . 0.0 109.634 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.83 ' C ' HD13 ' A' ' 34' ' ' ILE . 1.7 mp -79.69 135.18 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.215 -0.928 . . . . 0.0 108.768 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.83 HD13 ' C ' ' A' ' 33' ' ' ILE . 2.9 mm -115.47 107.02 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.069 -1.019 . . . . 0.0 110.064 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -109.18 117.02 33.03 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.942 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.674 ' HB3' HG13 ' A' ' 70' ' ' VAL . 24.0 p80 -126.83 176.19 7.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.009 -1.057 . . . . 0.0 110.682 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 38' ' ' ALA . 42.4 p-80 175.18 145.48 0.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.583 ' HA ' ' CD2' ' A' ' 68' ' ' TYR . . . -41.57 163.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.22 -0.925 . . . . 0.0 109.617 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.698 ' HA ' HG23 ' A' ' 69' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.08 -1.012 . . . . 0.0 109.567 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.467 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 121.364 0.602 . . . . 0.0 109.53 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.46 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -120.95 122.63 40.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.464 -0.772 . . . . 0.0 110.076 -179.569 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 34' ' ' ILE . 63.2 m-20 -144.54 120.04 10.36 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.752 ' CD ' HG23 ' A' ' 33' ' ' ILE . 5.1 mmt-85 -104.09 152.23 22.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.971 -1.081 . . . . 0.0 110.23 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.859 HG12 HD12 ' A' ' 57' ' ' ILE . 10.7 m -128.02 161.29 56.82 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.546 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 33.7 Cg_endo -76.36 174.13 13.34 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.358 2.039 . . . . 0.0 110.34 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.587 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 35.2 Cg_endo -77.07 -15.46 16.33 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.582 2.188 . . . . 0.0 110.604 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.2 t -101.97 17.84 22.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 0.0 109.652 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.546 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.5 OUTLIER -122.77 100.78 7.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.19 -0.944 . . . . 0.0 109.914 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -84.85 -3.0 58.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.14 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 56.5 p -137.52 149.02 46.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.432 -0.793 . . . . 0.0 109.031 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.86 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 5.2 tt -136.44 125.95 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.075 -1.016 . . . . 0.0 109.746 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.29 107.4 19.04 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.408 -0.807 . . . . 0.0 109.269 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.91 ' HB3' HD11 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -84.91 152.02 23.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.533 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.777 HG22 ' HB2' ' A' ' 17' ' ' SER . 29.2 p -137.98 -177.49 4.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.467 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.3 m120 55.7 29.67 14.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.356 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.91 HD11 ' HB3' ' A' ' 59' ' ' LEU . 5.1 mt -107.53 136.26 47.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 0.0 109.403 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.516 ' CB ' ' OH ' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -44.76 126.61 5.13 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.147 -0.97 . . . . 0.0 108.868 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.62 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 35.9 Cg_endo -77.42 131.41 11.59 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.29 1.994 . . . . 0.0 110.852 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 78.25 61.35 2.51 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.568 HG22 ' N ' ' A' ' 67' ' ' GLU . 13.2 m -157.16 165.79 35.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.258 -1.142 . . . . 0.0 109.93 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.568 ' N ' HG22 ' A' ' 66' ' ' THR . 1.8 mp0 -115.33 132.64 56.55 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.445 -0.784 . . . . 0.0 109.174 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.608 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 1.2 m-85 -130.57 173.83 10.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.93 . . . . 0.0 109.377 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.698 HG23 ' HA ' ' A' ' 39' ' ' GLU . 8.4 t -112.82 114.9 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.674 HG13 ' HB3' ' A' ' 36' ' ' HIS . 4.5 t -96.99 138.49 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.09 -1.006 . . . . 0.0 110.067 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.535 ' CB ' HG12 ' A' ' 85' ' ' ILE . 14.5 p -119.56 138.74 53.0 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.296 -0.878 . . . . 0.0 110.233 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.573 HD13 HG23 ' A' ' 34' ' ' ILE . 13.2 mm -111.78 95.11 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.397 -0.815 . . . . 0.0 109.397 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.621 HD12 ' N ' ' A' ' 73' ' ' ILE . 1.3 mp -85.24 122.84 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.339 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.915 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -97.34 137.62 36.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.924 . . . . 0.0 109.368 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.705 HG22 HD13 ' A' ' 33' ' ' ILE . 4.6 m -140.78 171.82 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.905 . . . . 0.0 109.471 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.447 ' OD1' ' HA ' ' A' ' 29' ' ' ILE . 49.2 t30 -146.39 43.23 1.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.915 . . . . 0.0 109.439 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 112.31 -87.03 0.44 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.04 -8.25 10.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -1.141 . . . . 0.0 109.625 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -84.81 -167.21 1.72 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.382 -0.824 . . . . 0.0 109.276 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.52 ' HG2' HG12 ' A' ' 75' ' ' VAL . 16.2 mt-10 -159.4 131.14 6.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.188 -0.945 . . . . 0.0 109.929 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.915 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -98.62 -178.33 0.69 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.393 -0.817 . . . . 0.0 108.882 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.591 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.4 Cg_endo -77.34 131.21 11.52 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.118 1.879 . . . . 0.0 109.908 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.452 ' HB3' HG13 ' A' ' 73' ' ' ILE . 35.7 Cg_endo -77.75 115.48 3.84 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.491 2.127 . . . . 0.0 111.117 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.686 ' CD1' HG22 ' A' ' 6' ' ' THR . 0.7 OUTLIER -88.53 106.5 18.33 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.187 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.535 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.8 mt -95.48 146.4 7.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.116 -0.99 . . . . 0.0 110.105 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.576 ' HA3' ' CZ ' ' A' ' 8' ' ' PHE . . . -142.75 161.37 27.46 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 108.134 -1.987 . . . . 0.0 108.134 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.475 ' HG2' ' N ' ' A' ' 88' ' ' GLN . 37.7 tt0 -102.05 148.38 25.45 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.18 -1.188 . . . . 0.0 110.028 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.57 ' HG2' ' CZ ' ' A' ' 18' ' ' PHE . 4.8 pp0? -149.82 -176.35 5.39 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.728 ' O ' HG21 ' A' ' 13' ' ' ILE . . . -160.2 134.61 7.49 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 109.969 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.5 143.36 36.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.358 -0.839 . . . . 0.0 109.019 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.559 HG23 HG22 ' A' ' 13' ' ' ILE . 2.0 t . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.512 -0.743 . . . . 0.0 109.888 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.548 ' HB2' ' CD1' ' A' ' 112' ' ' TRP . 36.0 Cg_endo . . . . . 0 C--O 1.215 -0.645 0 N-CA-C 110.162 -0.745 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.56 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 4.2 ttt180 -66.62 170.71 5.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.319 -0.863 . . . . 0.0 109.813 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 1.1 t0 81.87 34.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.736 . . . . 0.0 110.113 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.764 HD22 ' CD2' ' A' ' 162' ' ' LEU . 21.8 tp -76.46 101.56 5.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.134 -0.979 . . . . 0.0 109.288 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -151.85 -175.24 5.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 109.077 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 109' ' ' LEU . 47.8 t -119.23 149.37 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.0 -1.063 . . . . 0.0 110.164 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.644 ' CG1' HD23 ' A' ' 109' ' ' LEU . 6.9 pt -119.6 -17.14 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.737 0.779 . . . . 0.0 109.356 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 109' ' ' LEU . . . -150.84 142.12 23.27 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.532 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 51.5 p -150.49 132.09 14.85 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.695 -1.253 . . . . 0.0 111.299 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.579 ' HB ' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -98.02 171.38 5.94 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.527 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.579 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 29.9 Cg_endo -69.66 -1.05 7.73 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.918 1.746 . . . . 0.0 110.63 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.843 ' C ' HG22 ' A' ' 152' ' ' ILE . 19.2 p -143.02 8.23 1.65 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.194 -0.941 . . . . 0.0 109.655 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 149' ' ' ILE . 2.9 p -164.33 149.68 10.32 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.819 -1.152 . . . . 0.0 109.96 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.811 HD22 ' CZ ' ' A' ' 182' ' ' TYR . 0.9 OUTLIER -123.69 156.33 36.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.909 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.644 HD23 ' CG1' ' A' ' 101' ' ' ILE . 11.1 tp -105.27 108.81 20.52 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.963 ' CD1' ' HB3' ' A' ' 147' ' ' ALA . 3.1 pt -92.26 150.04 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.237 -0.914 . . . . 0.0 109.998 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 146' ' ' THR . 31.8 m -148.36 135.82 20.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.421 -0.799 . . . . 0.0 109.325 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.661 ' HH2' ' HB2' ' A' ' 147' ' ' ALA . 14.4 p90 -135.68 159.06 42.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 109.42 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.068 -1.02 . . . . 0.0 109.315 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.578 ' CE2' ' HB ' ' A' ' 165' ' ' VAL . 1.9 p90 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 121.267 0.556 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.621 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 2.2 m-85 -136.63 131.59 33.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -0.871 . . . . 0.0 109.097 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 4.6 ttt180 -84.69 154.4 22.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.019 -1.05 . . . . 0.0 108.541 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.845 HG23 ' O ' ' A' ' 161' ' ' THR . 17.6 mt -151.03 138.82 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.006 -1.059 . . . . 0.0 110.394 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 136' ' ' GLN . 2.2 p -106.28 141.77 37.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.607 -0.683 . . . . 0.0 109.721 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.648 ' CE1' HG23 ' A' ' 149' ' ' ILE . 1.6 m-85 -88.26 118.83 28.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.369 -0.832 . . . . 0.0 108.758 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.624 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.8 113.73 4.3 Favored Glycine 0 N--CA 1.487 2.073 0 C-N-CA 119.607 -1.282 . . . . 0.0 111.217 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 . . . . . 0 C--N 1.3 -1.566 0 O-C-N 121.173 -1.192 . . . . 0.0 108.384 178.494 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.583 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.56 ' HG3' HG22 ' A' ' 125' ' ' THR . 0.1 OUTLIER -156.71 152.16 26.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.144 -1.598 . . . . 0.0 111.702 -179.506 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.737 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 11.7 p90 -165.11 134.73 3.6 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.444 HG22 ' CE1' ' A' ' 121' ' ' TYR . 1.7 p -74.57 171.85 13.09 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.175 -0.953 . . . . 0.0 110.944 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.721 HG21 HD11 ' A' ' 124' ' ' ILE . 28.5 t -131.83 140.53 38.52 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.52 -0.738 . . . . 0.0 109.542 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.606 ' HD2' HG13 ' A' ' 140' ' ' VAL . 35.5 Cg_endo -77.99 125.47 7.31 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.428 2.086 . . . . 0.0 109.919 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.32 51.65 3.31 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.431 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 16.0 p -105.5 -4.71 20.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.194 -1.18 . . . . 0.0 109.551 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 143' ' ' SER . 0.6 OUTLIER -173.55 178.21 2.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.513 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.571 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 0.3 OUTLIER -95.12 15.33 19.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.584 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.531 ' C ' ' CH2' ' A' ' 112' ' ' TRP . 2.1 p -123.52 146.15 48.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.465 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.963 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -133.12 167.19 20.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.246 -0.909 . . . . 0.0 109.461 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.651 ' O ' HD13 ' A' ' 149' ' ' ILE . 14.0 m -108.49 164.07 12.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 109.465 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.651 HD13 ' O ' ' A' ' 148' ' ' THR . 11.7 mm -143.24 66.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.0 109.335 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.553 ' HA ' ' CB ' ' A' ' 107' ' ' SER . 4.3 m120 -78.28 -167.51 1.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.692 -0.63 . . . . 0.0 109.814 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 50.92 42.0 27.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.081 -1.012 . . . . 0.0 109.053 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.843 HG22 ' C ' ' A' ' 106' ' ' THR . 4.4 tt -106.18 160.03 5.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.422 -0.799 . . . . 0.0 109.915 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -93.58 125.22 54.63 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 109.17 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.463 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 35.8 Cg_endo -78.73 140.25 16.36 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.436 2.091 . . . . 0.0 110.859 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 75.09 63.23 2.58 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.452 ' N ' ' OG1' ' A' ' 184' ' ' THR . . . 178.13 127.2 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.174 -1.192 . . . . 0.0 110.147 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 9.7 t70 -48.58 167.94 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.64 ' CE2' HG13 ' A' ' 152' ' ' ILE . 0.4 OUTLIER -146.6 -167.88 2.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.973 -1.079 . . . . 0.0 109.991 -179.544 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' GLY . 4.4 m -168.41 96.39 0.4 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.744 HD11 HD12 ' A' ' 108' ' ' LEU . 7.1 mt -91.86 133.01 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.049 -1.032 . . . . 0.0 110.05 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . 1.04 HG23 ' CB ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -131.27 159.91 36.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.329 -0.857 . . . . 0.0 108.764 179.311 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.764 ' CD2' HD22 ' A' ' 98' ' ' LEU . 1.7 pp -150.82 150.08 30.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.734 -1.229 . . . . 0.0 111.714 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.641 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.3 m-85 -125.99 79.59 1.85 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -43.92 125.69 4.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.976 -1.077 . . . . 0.0 109.322 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.578 ' HB ' ' CE2' ' A' ' 121' ' ' TYR . 55.2 t . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 110.079 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.475 ' OG ' ' HB3' ' A' ' 163' ' ' TYR . 84.5 p . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.281 0.562 . . . . 0.0 109.706 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 176' ' ' LYS . 3.0 p -54.12 174.86 0.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.301 -0.874 . . . . 0.0 109.217 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 175' ' ' SER . 1.4 mmtp -45.81 136.87 6.06 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.16 -0.963 . . . . 0.0 108.618 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.641 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.2 Cg_endo -77.39 144.94 23.38 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.267 1.978 . . . . 0.0 110.885 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.593 HG12 HD23 ' A' ' 98' ' ' LEU . 3.1 t -120.62 130.79 74.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' SER . . . . . 1.04 ' CB ' HG23 ' A' ' 161' ' ' THR . 0.9 OUTLIER -122.84 158.32 30.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 110.704 -178.617 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.524 HG21 ' O ' ' A' ' 98' ' ' LEU . 29.3 pt -146.7 153.12 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.492 ' HA ' ' HA ' ' A' ' 159' ' ' THR . 33.6 m120 -93.15 153.98 18.33 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.035 -1.041 . . . . 0.0 109.41 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.811 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 92.1 t80 -141.81 123.9 15.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.282 -0.886 . . . . 0.0 109.721 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -87.69 111.45 21.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.066 -1.021 . . . . 0.0 109.477 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.485 HG22 ' CD2' ' A' ' 182' ' ' TYR . 21.9 p . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.485 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.85 HD13 ' HB3' ' A' ' 81' ' ' SER . 2.6 mp . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.321 0.581 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.506 ' HB2' ' CB ' ' A' ' 25' ' ' PRO . 1.3 m-20 -108.37 164.41 12.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.0 109.526 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.5 m -95.41 120.3 64.01 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.486 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.522 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 35.6 Cg_endo -78.41 95.56 1.07 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.394 2.063 . . . . 0.0 110.296 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.714 HG22 ' CD1' ' A' ' 84' ' ' LEU . 1.2 p -85.02 -107.72 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.959 . . . . 0.0 109.614 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 43.7 29.24 1.26 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.573 ' CE2' ' HA3' ' A' ' 86' ' ' GLY . 20.5 t80 -53.08 129.92 32.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.399 -1.059 . . . . 0.0 110.166 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 21' ' ' HIS . 1.9 t70 -165.29 134.2 3.36 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.54 ' CB ' ' HG2' ' A' ' 88' ' ' GLN . 4.7 m -118.19 139.38 51.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.923 -1.11 . . . . 0.0 110.276 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.481 ' O ' ' C ' ' A' ' 12' ' ' ASP . 8.9 p -153.43 -169.38 3.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.435 -0.791 . . . . 0.0 109.2 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.533 ' HB2' ' CB ' ' A' ' 19' ' ' THR . 0.8 OUTLIER 41.39 46.93 3.01 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.047 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.813 HG22 ' CG2' ' A' ' 91' ' ' VAL . 41.5 mm -77.67 130.73 35.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.622 0.725 . . . . 0.0 111.349 -178.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.572 ' CB ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -119.67 176.81 5.2 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.183 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.934 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -71.01 -70.03 0.33 Allowed 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.528 -1.358 . . . . 0.0 109.559 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 50.2 m-80 -81.2 -6.84 59.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.056 -1.027 . . . . 0.0 109.362 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.81 ' HB2' HG22 ' A' ' 60' ' ' THR . 3.4 t -137.42 158.01 45.33 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.037 ' CE1' HG22 ' A' ' 20' ' ' VAL . 2.2 p90 -167.76 139.88 3.11 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.991 -1.068 . . . . 0.0 108.494 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.533 ' CB ' ' HB2' ' A' ' 12' ' ' ASP . 23.0 m -84.48 154.88 22.46 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.785 -1.197 . . . . 0.0 110.898 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.037 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.5 t -128.6 177.76 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' A' ' 20' ' ' VAL . 55.6 m-70 -156.2 163.64 39.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.017 -1.052 . . . . 0.0 110.158 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.823 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 46.0 p90 179.87 142.94 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.447 -0.783 . . . . 0.0 109.239 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.537 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.43 169.79 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.113 -0.992 . . . . 0.0 109.145 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.671 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -102.38 165.89 13.0 Favored Pre-proline 0 C--N 1.299 -1.606 0 O-C-N 121.504 -0.747 . . . . 0.0 109.794 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.671 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.7 Cg_endo -78.26 -164.7 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.672 2.248 . . . . 0.0 110.38 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 -115.31 26.5 10.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.37 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.797 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -134.41 169.75 13.06 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.29 -0.881 . . . . 0.0 109.383 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.797 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.4 Cg_endo -77.78 136.62 15.3 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.612 2.208 . . . . 0.0 110.356 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.625 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 16.3 pt -145.52 -171.52 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.493 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 77' ' ' GLY . 60.5 p -126.56 6.38 6.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.87 . . . . 0.0 109.527 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.436 ' HA2' ' C ' ' A' ' 51' ' ' PRO . . . 139.8 172.92 12.96 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.625 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -123.76 125.26 44.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -1.165 . . . . 0.0 109.543 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.602 HG23 ' HE ' ' A' ' 49' ' ' ARG . 16.1 mm -74.8 120.51 24.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.231 -0.918 . . . . 0.0 109.289 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.688 HG23 HD13 ' A' ' 72' ' ' ILE . 2.3 mm -99.26 129.74 49.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.169 -0.957 . . . . 0.0 109.393 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.461 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 58.2 ttt180 -118.9 119.57 34.74 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.264 -0.898 . . . . 0.0 109.115 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.645 ' NE2' ' CG ' ' A' ' 68' ' ' TYR . 0.3 OUTLIER -93.46 149.14 21.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.32 -0.863 . . . . 0.0 109.472 -179.552 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.51 ' ND1' ' O ' ' A' ' 69' ' ' VAL . 44.3 p-80 178.27 133.64 0.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.54 -0.725 . . . . 0.0 109.408 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -56.65 -165.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.262 -0.899 . . . . 0.0 109.802 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 109.655 -179.874 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.654 ' CD ' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.36 0.6 . . . . 0.0 109.75 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -132.47 111.12 11.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.632 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.629 ' HB3' HD11 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -116.31 125.05 51.61 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.307 -0.87 . . . . 0.0 108.794 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.602 ' HE ' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -104.31 160.64 14.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.119 -0.988 . . . . 0.0 109.847 -179.087 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.766 HG21 ' CZ2' ' A' ' 22' ' ' TRP . 3.7 m -142.51 159.93 55.94 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.42 -0.8 . . . . 0.0 109.298 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.543 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 33.7 Cg_endo -76.37 174.27 13.11 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.484 2.123 . . . . 0.0 110.224 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.624 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.9 Cg_endo -76.81 -25.8 8.77 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.62 2.213 . . . . 0.0 111.07 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.8 p -89.35 -3.0 58.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.098 -1.002 . . . . 0.0 109.666 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.543 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -101.02 111.69 23.95 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.281 -0.887 . . . . 0.0 110.137 -179.54 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 40.6 p-10 -92.92 -8.82 42.18 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.446 -0.784 . . . . 0.0 109.084 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 18.2 p -124.3 150.51 45.33 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.823 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 4.6 tt -134.92 133.16 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.926 -1.109 . . . . 0.0 110.295 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.95 102.7 14.53 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.991 ' CB ' HD11 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -84.47 156.89 21.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.16 -0.963 . . . . 0.0 109.763 -179.532 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.81 HG22 ' HB2' ' A' ' 17' ' ' SER . 33.0 p -143.12 -179.65 6.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.403 -0.811 . . . . 0.0 109.35 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.451 ' O ' ' CZ ' ' A' ' 46' ' ' ARG . 17.5 m-80 55.28 19.26 2.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 109.395 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.991 HD11 ' CB ' ' A' ' 59' ' ' LEU . 4.9 mt -91.62 168.03 11.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 0.0 109.332 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.53 ' CB ' ' OH ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER -77.38 130.98 72.87 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.154 -0.966 . . . . 0.0 108.576 179.404 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.934 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 36.6 Cg_endo -78.84 133.87 11.6 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.371 2.048 . . . . 0.0 111.566 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 73.57 62.76 2.94 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 1.009 HG21 ' CZ ' ' A' ' 68' ' ' TYR . 3.3 m -159.22 145.73 16.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.179 -1.189 . . . . 0.0 110.698 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 1.4 mt-10 -87.66 99.24 11.92 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 1.009 ' CZ ' HG21 ' A' ' 66' ' ' THR . 29.1 m-85 -103.46 119.68 39.36 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.191 -0.943 . . . . 0.0 110.284 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.661 HG22 ' HG3' ' A' ' 87' ' ' GLN . 20.7 t -68.99 117.82 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.423 -0.798 . . . . 0.0 109.25 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.546 HG12 HG22 ' A' ' 34' ' ' ILE . 1.3 t -96.25 109.99 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.088 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -84.49 110.11 18.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.947 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.769 ' C ' HD12 ' A' ' 73' ' ' ILE . 15.5 mm -79.98 120.58 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.398 -0.814 . . . . 0.0 109.653 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.769 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.3 mp -112.59 144.12 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.04 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.713 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -104.43 128.69 52.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.415 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.539 ' CG2' HG12 ' A' ' 33' ' ' ILE . 16.9 m -133.55 130.56 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.47 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.501 ' OD1' HG23 ' A' ' 30' ' ' THR . 38.9 t30 -99.82 44.6 1.01 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.284 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.515 ' N ' ' OG1' ' A' ' 30' ' ' THR . . . 95.42 -63.32 1.39 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.02 3.22 3.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -1.141 . . . . 0.0 109.59 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -103.05 -164.39 1.07 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.437 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.413 ' C ' ' OG ' ' A' ' 81' ' ' SER . 32.8 mt-10 -144.13 -169.21 3.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.8 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.85 ' HB3' HD13 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -176.58 -178.8 0.31 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 109.066 -179.563 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.598 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.8 Cg_endo -77.08 116.13 4.13 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.212 1.941 . . . . 0.0 109.929 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.489 ' CA ' ' O ' ' A' ' 72' ' ' ILE . 36.2 Cg_endo -78.27 146.9 22.7 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.585 2.19 . . . . 0.0 111.272 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.714 ' CD1' HG22 ' A' ' 6' ' ' THR . 0.7 OUTLIER -108.97 107.74 18.22 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.544 HG23 HG12 ' A' ' 69' ' ' VAL . 2.1 mt -87.94 148.05 4.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.071 -1.018 . . . . 0.0 110.228 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.573 ' HA3' ' CE2' ' A' ' 8' ' ' PHE . . . -155.4 161.21 30.37 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.661 ' HG3' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -98.63 143.53 28.92 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.231 -1.158 . . . . 0.0 110.065 -179.486 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.582 ' HG3' ' CE1' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -142.41 137.5 30.45 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.278 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -107.6 124.25 49.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.027 -1.046 . . . . 0.0 110.982 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.76 138.11 42.46 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.139 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.813 ' CG2' HG22 ' A' ' 13' ' ' ILE . 1.2 t . . . . . 0 N--CA 1.491 1.609 0 C-N-CA 118.833 -1.147 . . . . 0.0 108.714 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.511 ' CB ' ' CD1' ' A' ' 112' ' ' TRP . 35.9 Cg_endo . . . . . 0 C--O 1.214 -0.678 0 N-CA-C 110.183 -0.737 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.533 ' CG ' ' HB2' ' A' ' 113' ' ' GLU . 13.2 ptp180 -174.67 160.13 2.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.257 -0.902 . . . . 0.0 109.373 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.2 OUTLIER 74.97 17.86 2.66 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.218 -0.926 . . . . 0.0 109.516 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.71 HD13 ' CD2' ' A' ' 162' ' ' LEU . 0.6 OUTLIER -51.58 103.7 0.07 Allowed 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.118 -0.989 . . . . 0.0 109.427 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -130.25 161.85 30.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.333 -0.854 . . . . 0.0 109.458 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 12.6 p -97.6 144.76 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.739 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.518 HG12 ' HB3' ' A' ' 109' ' ' LEU . 23.9 pt -127.72 -3.87 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.305 -0.872 . . . . 0.0 109.612 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.887 ' CB ' HD12 ' A' ' 109' ' ' LEU . . . -157.84 106.17 2.03 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.467 ' OG ' ' OH ' ' A' ' 182' ' ' TYR . 1.0 OUTLIER -103.94 106.65 17.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 0.0 110.592 -178.85 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -94.31 166.48 15.34 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.745 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 29.8 Cg_endo -68.97 -2.59 9.88 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.332 2.021 . . . . 0.0 110.665 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.869 ' C ' HG22 ' A' ' 152' ' ' ILE . 3.2 p -148.8 13.9 0.92 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.24 -0.912 . . . . 0.0 109.346 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' SER . . . . . 1.051 ' O ' HD23 ' A' ' 108' ' ' LEU . 3.3 p -172.31 168.43 5.58 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 118.764 -1.174 . . . . 0.0 109.989 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.051 HD23 ' O ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -144.35 155.17 43.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.329 -0.857 . . . . 0.0 109.375 -179.468 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.887 HD12 ' CB ' ' A' ' 102' ' ' ALA . 5.8 mt -97.11 140.12 32.09 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.573 ' CD1' HD11 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -122.58 132.62 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.946 -1.096 . . . . 0.0 110.663 -179.126 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.3 t -131.03 111.3 11.9 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.715 ' HH2' ' HB2' ' A' ' 147' ' ' ALA . 45.1 p90 -123.63 144.68 49.46 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.182 -0.949 . . . . 0.0 110.75 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.533 ' HB2' ' CG ' ' A' ' 96' ' ' ARG . 4.4 mm-40 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 1.091 ' CZ ' HG21 ' A' ' 165' ' ' VAL . 5.4 p90 . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.626 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 1.1 m-85 -136.65 161.56 35.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.19 -0.944 . . . . 0.0 109.494 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -120.67 98.9 6.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.929 . . . . 0.0 108.672 179.434 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.852 HG21 HD11 ' A' ' 149' ' ' ILE . 20.3 mt -84.3 146.47 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.139 -0.975 . . . . 0.0 110.012 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.659 HG22 ' HB3' ' A' ' 137' ' ' GLU . 21.6 p -120.9 153.04 37.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 0.0 110.415 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.657 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 2.6 m-85 -101.9 121.88 42.97 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.596 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.1 117.4 5.56 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.272 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 . . . . . 0 C--N 1.3 -1.573 0 O-C-N 121.226 -1.161 . . . . 0.0 108.988 179.164 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 126' ' ' TYR . 87.3 mm-40 . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.659 ' HB3' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -119.57 158.07 27.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.939 -1.101 . . . . 0.0 111.557 -178.332 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.595 ' CE1' ' HB ' ' A' ' 124' ' ' ILE . 33.8 p90 -140.7 162.86 34.4 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.643 HG22 ' CE2' ' A' ' 121' ' ' TYR . 0.7 OUTLIER -74.51 -171.14 1.15 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.752 -1.217 . . . . 0.0 110.164 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.586 ' CG2' HD12 ' A' ' 124' ' ' ILE . 40.0 t -149.88 133.98 9.02 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.213 -0.93 . . . . 0.0 109.86 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.33 117.34 4.05 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.357 2.038 . . . . 0.0 110.097 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -71.77 55.81 1.33 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.48 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 39.3 m -105.46 -1.62 24.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.164 -1.198 . . . . 0.0 109.492 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.48 ' CG ' ' O ' ' A' ' 143' ' ' SER . 3.0 mtmt -176.16 -179.75 1.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.919 . . . . 0.0 109.43 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.99 13.75 24.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.57 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 110' ' ' ILE . 18.0 p -125.36 152.84 44.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.912 . . . . 0.0 109.527 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.715 ' HB2' ' HH2' ' A' ' 112' ' ' TRP . . . -142.4 171.73 13.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.0 109.548 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.41 ' O ' ' CZ ' ' A' ' 138' ' ' PHE . 11.3 t -110.7 155.85 21.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.328 -0.858 . . . . 0.0 109.379 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.852 HD11 HG21 ' A' ' 124' ' ' ILE . 16.1 mm -133.26 81.9 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 109.506 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.543 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -92.69 167.64 11.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.389 -0.819 . . . . 0.0 109.979 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 0.3 OUTLIER 75.15 47.4 0.1 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 0.0 109.298 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.869 HG22 ' C ' ' A' ' 106' ' ' THR . 4.2 tt -110.67 158.85 10.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.35 -0.844 . . . . 0.0 109.922 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.422 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 1.7 tttp -97.77 112.45 61.59 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.351 -0.843 . . . . 0.0 108.944 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.457 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 34.7 Cg_endo -77.2 138.17 17.72 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.387 2.058 . . . . 0.0 110.692 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.696 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 87.99 67.7 1.3 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 163.26 130.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -1.117 . . . . 0.0 109.633 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 156' ' ' ALA . 1.2 t0 -46.36 158.92 0.1 Allowed 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.596 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -143.08 -179.47 6.39 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.0 -1.063 . . . . 0.0 109.884 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 127' ' ' GLY . 4.8 m -150.94 101.41 2.89 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 179' ' ' SER . 16.2 mm -84.84 136.55 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.117 -0.989 . . . . 0.0 110.118 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.798 HG23 ' HB3' ' A' ' 179' ' ' SER . 2.0 m -147.45 168.87 20.78 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.71 ' CD2' HD13 ' A' ' 98' ' ' LEU . 0.8 OUTLIER -163.54 147.64 10.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.871 -1.143 . . . . 0.0 110.859 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 177' ' ' PRO . 2.0 m-85 -116.08 103.42 10.55 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -61.32 167.25 3.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.007 -1.058 . . . . 0.0 109.459 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 1.091 HG21 ' CZ ' ' A' ' 121' ' ' TYR . 84.4 t . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.146 -0.971 . . . . 0.0 110.543 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.516 ' HA ' ' HA ' ' A' ' 165' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 176' ' ' LYS . 96.6 p -146.14 163.76 34.34 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.173 -0.954 . . . . 0.0 109.817 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 175' ' ' SER . 0.0 OUTLIER -47.0 139.99 6.58 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.278 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 163' ' ' TYR . 34.8 Cg_endo -77.39 117.49 4.36 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.204 1.936 . . . . 0.0 111.757 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 161' ' ' THR . 2.3 t -84.59 131.57 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.798 ' HB3' HG23 ' A' ' 161' ' ' THR . 54.4 p -128.14 149.37 50.45 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.05 -1.031 . . . . 0.0 111.218 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.655 HD13 HD23 ' A' ' 98' ' ' LEU . 18.8 pt -134.94 152.65 33.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -84.18 147.03 27.52 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.928 -1.108 . . . . 0.0 109.698 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.783 ' OH ' HD22 ' A' ' 108' ' ' LEU . 74.4 t80 -147.43 121.63 9.55 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.452 -0.78 . . . . 0.0 109.335 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 183' ' ' LYS . 8.0 pttm -96.04 121.86 38.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.994 . . . . 0.0 109.505 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.628 HG22 ' HE2' ' A' ' 182' ' ' TYR . 44.7 p . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.483 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.435 ' HA ' HD22 ' A' ' 2' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 121.384 0.612 . . . . 0.0 109.51 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.829 ' CG ' ' HB3' ' A' ' 27' ' ' ALA . 7.5 m-20 -74.62 90.13 2.25 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.422 -0.799 . . . . 0.0 110.134 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.6 m -96.71 106.72 32.09 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 3' ' ' ASP . 36.7 Cg_endo -79.61 159.66 25.2 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.322 2.015 . . . . 0.0 110.642 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.744 ' HA ' HD22 ' A' ' 84' ' ' LEU . 3.8 p -151.94 -121.1 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 109.074 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 43.33 28.14 0.85 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.568 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 7.6 t80 -48.68 133.57 16.94 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.705 -0.88 . . . . 0.0 110.327 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 9.2 t0 -165.05 94.1 0.64 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -84.4 118.32 24.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -0.885 . . . . 0.0 109.764 -179.345 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.464 ' O ' ' C ' ' A' ' 12' ' ' ASP . 96.3 p -151.86 -159.1 0.97 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.396 -0.815 . . . . 0.0 108.981 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.525 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.7 OUTLIER 46.46 33.58 2.0 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -178.305 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.679 ' HA ' ' HA ' ' A' ' 18' ' ' PHE . 1.2 mt -76.69 162.67 4.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.679 -177.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.679 HG23 ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -151.2 -175.27 5.1 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.081 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -78.37 -52.11 9.08 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.123 -0.986 . . . . 0.0 109.752 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 60' ' ' THR . 1.8 p-10 -97.83 -1.9 42.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.78 -1.2 . . . . 0.0 109.936 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.857 ' HB3' HG22 ' A' ' 60' ' ' THR . 3.4 p -150.98 157.33 42.75 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.32 -0.863 . . . . 0.0 108.825 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.798 ' CE1' HG22 ' A' ' 20' ' ' VAL . 2.1 p90 -165.71 141.45 5.07 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.17 -0.956 . . . . 0.0 108.559 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 1.7 m -94.82 155.68 16.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.855 -1.153 . . . . 0.0 111.7 -177.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.798 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -130.16 120.07 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.746 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.52 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 4.0 m-70 -101.26 148.91 24.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.118 -0.989 . . . . 0.0 110.81 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.743 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 11.9 p90 -171.47 129.94 0.7 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.536 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.53 169.07 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.985 -1.072 . . . . 0.0 109.566 -179.782 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.536 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -107.66 160.42 26.77 Favored Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.685 -0.634 . . . . 0.0 109.366 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.54 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 36.9 Cg_endo -78.38 -99.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.676 2.251 . . . . 0.0 110.371 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.54 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -174.57 -34.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.076 -1.015 . . . . 0.0 109.984 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.829 ' HB3' ' CG ' ' A' ' 3' ' ' ASP . . . -54.38 168.13 0.5 Allowed Pre-proline 0 C--N 1.296 -1.729 0 O-C-N 121.5 -0.75 . . . . 0.0 109.368 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.737 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.1 Cg_endo -77.52 142.18 20.57 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.529 2.153 . . . . 0.0 110.354 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.638 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 14.2 pt -148.11 176.98 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.921 . . . . 0.0 109.751 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.0 p -120.77 1.05 10.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.412 -0.805 . . . . 0.0 109.256 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.462 ' O ' ' CG2' ' A' ' 75' ' ' VAL . . . 139.3 150.97 5.61 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.723 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -100.63 135.56 41.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.254 -1.144 . . . . 0.0 109.322 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.88 HG23 ' HD2' ' A' ' 49' ' ' ARG . 1.2 mp -86.53 133.14 30.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.149 -0.969 . . . . 0.0 109.094 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.844 HD13 ' C ' ' A' ' 33' ' ' ILE . 2.9 mm -112.12 102.15 13.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.354 -0.841 . . . . 0.0 109.346 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.533 ' HG2' ' N ' ' A' ' 36' ' ' HIS . 5.4 ttt180 -100.62 158.1 16.18 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.145 -0.972 . . . . 0.0 109.218 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.952 ' CE1' HG22 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -140.07 144.59 36.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.165 -0.96 . . . . 0.0 109.635 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.718 ' CD2' ' O ' ' A' ' 69' ' ' VAL . 7.0 p80 -163.5 128.85 3.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.834 . . . . 0.0 109.533 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.572 ' HA ' ' HB3' ' A' ' 68' ' ' TYR . . . -40.32 163.6 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.415 -0.803 . . . . 0.0 110.03 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 1.016 ' HG2' HG23 ' A' ' 69' ' ' VAL . 2.1 mt-10 . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.168 -0.958 . . . . 0.0 109.481 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 36' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.366 0.603 . . . . 0.0 109.631 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -143.39 126.97 16.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.339 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.534 ' CG ' HD21 ' A' ' 59' ' ' LEU . 21.2 m-20 -138.21 159.22 42.61 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.88 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -139.18 159.03 43.11 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.286 -0.884 . . . . 0.0 109.85 -179.474 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 1.076 ' CG1' HD12 ' A' ' 57' ' ' ILE . 32.7 m -142.72 159.22 57.88 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.865 . . . . 0.0 109.189 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.544 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.4 Cg_endo -77.21 174.42 12.8 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.503 2.135 . . . . 0.0 110.324 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 35.3 Cg_endo -77.21 -15.5 16.08 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.596 2.198 . . . . 0.0 110.52 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 p -102.8 24.11 11.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.65 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.544 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 5.7 mmt180 -126.83 109.04 11.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.186 -0.946 . . . . 0.0 109.966 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 22' ' ' TRP . 16.5 p30 -94.09 -11.23 31.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.031 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 20.0 p -131.21 137.13 48.79 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.076 HD12 ' CG1' ' A' ' 50' ' ' VAL . 6.4 tt -131.35 129.65 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.982 -1.074 . . . . 0.0 110.264 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.63 111.09 23.1 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.876 ' HB3' HD11 ' A' ' 62' ' ' LEU . 2.0 mt -84.48 158.37 21.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.165 -0.959 . . . . 0.0 109.541 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.857 HG22 ' HB3' ' A' ' 17' ' ' SER . 19.4 p -145.65 177.6 8.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 109.394 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 50.93 46.6 26.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.517 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.876 HD11 ' HB3' ' A' ' 59' ' ' LEU . 3.7 mt -118.19 147.34 43.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 109.355 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.478 ' O ' ' OH ' ' A' ' 68' ' ' TYR . 28.3 m-80 -44.89 117.2 3.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.197 -0.939 . . . . 0.0 108.686 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.4 Cg_endo -77.47 125.72 7.84 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.144 1.896 . . . . 0.0 111.41 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.99 59.99 2.11 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.564 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 2.6 m -151.8 166.51 31.16 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.154 -1.204 . . . . 0.0 109.506 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.564 ' N ' ' CG2' ' A' ' 66' ' ' THR . 5.1 mt-10 -125.56 127.25 46.09 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.305 -0.872 . . . . 0.0 109.21 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -134.23 -159.53 0.97 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.139 -0.975 . . . . 0.0 109.773 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 1.016 HG23 ' HG2' ' A' ' 39' ' ' GLU . 41.7 t -137.36 116.68 15.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.952 HG22 ' CE1' ' A' ' 36' ' ' HIS . 3.7 t -88.58 127.73 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.031 -1.043 . . . . 0.0 109.621 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.539 ' HB3' ' CD1' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -101.0 104.72 15.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 110.065 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 84' ' ' LEU . 15.0 mm -79.4 154.56 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.341 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.549 HG22 ' N ' ' A' ' 74' ' ' ALA . 48.3 mt -153.1 165.03 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 0.0 109.593 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.645 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -132.57 120.62 22.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.298 -0.877 . . . . 0.0 109.389 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.735 HG12 ' HG2' ' A' ' 80' ' ' GLU . 2.4 m -112.63 144.52 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.524 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -135.94 45.23 2.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.892 . . . . 0.0 109.361 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.13 -96.46 1.15 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -109.72 -1.4 18.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.244 -1.15 . . . . 0.0 109.554 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.528 ' O ' ' CG ' ' A' ' 80' ' ' GLU . 19.8 mt-10 -106.52 172.89 6.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 0.0 109.121 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.735 ' HG2' HG12 ' A' ' 75' ' ' VAL . 46.0 mt-10 -158.33 115.75 2.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.125 -0.984 . . . . 0.0 110.022 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.695 ' HG ' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -60.29 -175.17 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.283 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.695 ' HD2' ' HG ' ' A' ' 81' ' ' SER . 33.1 Cg_endo -76.5 146.15 27.19 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.925 1.75 . . . . 0.0 110.107 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.489 ' HB3' HG12 ' A' ' 73' ' ' ILE . 35.6 Cg_endo -77.22 109.56 2.84 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.674 2.249 . . . . 0.0 111.357 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.744 HD22 ' HA ' ' A' ' 6' ' ' THR . 17.9 tp -84.21 94.54 8.42 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.586 ' CG2' ' CG1' ' A' ' 69' ' ' VAL . 2.2 mt -85.72 151.34 3.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.128 -0.983 . . . . 0.0 110.678 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.604 ' O ' HG13 ' A' ' 69' ' ' VAL . . . -142.62 179.25 20.47 Favored Glycine 0 N--CA 1.483 1.824 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.42 ' HG3' ' C ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -131.73 146.4 52.14 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.992 -1.299 . . . . 0.0 110.058 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.538 ' NE2' ' NE2' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -163.13 -167.69 1.54 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' A' ' 66' ' ' THR . . . -165.41 136.64 3.94 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.973 -1.079 . . . . 0.0 109.953 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.462 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.6 OUTLIER -74.59 162.18 29.01 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.193 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.522 HG23 ' C ' ' A' ' 14' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.612 0 O-C-N 121.142 -0.973 . . . . 0.0 110.201 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.945 ' HG3' HD11 ' A' ' 162' ' ' LEU . 36.4 Cg_endo . . . . . 0 C--O 1.216 -0.599 0 N-CA-C 109.886 -0.852 . . . . 0.0 109.886 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.471 ' CG ' ' HG3' ' A' ' 113' ' ' GLU . 5.9 ptm85 -60.05 179.15 0.15 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.403 -0.811 . . . . 0.0 109.569 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.1 t0 67.35 8.11 6.02 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.243 -0.911 . . . . 0.0 109.272 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.766 ' CD2' HD13 ' A' ' 180' ' ' ILE . 8.7 tt -53.59 99.98 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.216 -0.927 . . . . 0.0 109.13 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -124.98 157.29 36.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.306 -0.871 . . . . 0.0 109.532 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 8.1 p -91.1 139.67 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.381 -0.824 . . . . 0.0 109.606 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.826 HD11 HD22 ' A' ' 109' ' ' LEU . 20.0 pt -125.23 -5.86 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.503 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.999 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -149.4 97.77 2.7 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.488 ' HB2' ' OH ' ' A' ' 182' ' ' TYR . 17.4 p -90.0 90.56 8.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.368 -0.832 . . . . 0.0 110.293 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -80.37 157.49 72.79 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 121.237 -0.914 . . . . 0.0 108.776 179.059 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.483 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.2 Cg_endo -69.9 -2.73 10.77 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.397 2.065 . . . . 0.0 110.502 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.727 ' C ' HG22 ' A' ' 152' ' ' ILE . 1.4 p -150.53 18.38 0.82 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' SER . . . . . 1.067 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.7 OUTLIER -167.22 171.63 10.63 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.034 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.067 HD23 ' O ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -144.43 152.63 40.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.309 -0.869 . . . . 0.0 109.173 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.999 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -105.75 120.72 42.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 108.86 179.293 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.581 ' CD1' ' HB3' ' A' ' 147' ' ' ALA . 1.0 OUTLIER -106.29 138.06 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.115 -0.991 . . . . 0.0 110.024 -179.68 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.87 ' HB2' HG22 ' A' ' 146' ' ' THR . 0.0 OUTLIER -142.87 115.17 8.44 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.455 -0.778 . . . . 0.0 109.259 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.624 ' CD1' ' CB ' ' A' ' 95' ' ' PRO . 43.4 p90 -125.97 -177.43 3.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 109.561 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.471 ' HG3' ' CG ' ' A' ' 96' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.912 . . . . 0.0 109.424 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.829 ' CE1' HG22 ' A' ' 139' ' ' THR . 9.0 p90 . . . . . 0 N--CA 1.486 1.367 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.498 ' HB2' ' HB ' ' A' ' 140' ' ' VAL . 14.4 m-85 -103.74 129.59 51.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.03 -1.044 . . . . 0.0 108.589 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.555 ' HG3' ' CG ' ' A' ' 137' ' ' GLU . 1.5 ttm180 -95.34 85.94 4.39 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.286 -0.884 . . . . 0.0 109.518 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 1.065 HD12 ' CG2' ' A' ' 140' ' ' VAL . 21.6 mt -84.37 153.16 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.364 -0.835 . . . . 0.0 109.193 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.697 HG22 ' HA ' ' A' ' 137' ' ' GLU . 27.7 p -138.73 142.45 38.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.136 -0.978 . . . . 0.0 110.189 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.672 ' CE2' HG22 ' A' ' 149' ' ' ILE . 4.1 m-85 -79.59 126.68 31.21 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.577 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.35 120.42 6.49 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 C--N 1.3 -1.569 0 O-C-N 121.447 -1.031 . . . . 0.0 109.064 179.571 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.583 ' HB3' ' CD1' ' A' ' 126' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.697 ' HA ' HG22 ' A' ' 125' ' ' THR . 6.4 tm-20 -76.54 117.48 18.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 110.665 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.618 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 26.7 p90 -121.94 138.59 54.35 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.829 HG22 ' CE1' ' A' ' 121' ' ' TYR . 7.4 p -74.21 168.39 19.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.083 -1.01 . . . . 0.0 110.534 -178.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 1.065 ' CG2' HD12 ' A' ' 124' ' ' ILE . 50.9 t -138.31 141.5 31.92 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.523 -0.736 . . . . 0.0 109.647 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.643 ' HD2' HG13 ' A' ' 140' ' ' VAL . 35.0 Cg_endo -77.17 141.43 20.69 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.528 2.152 . . . . 0.0 110.657 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.82 53.55 3.33 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.505 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 28.4 t -103.7 -11.85 17.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.178 -1.189 . . . . 0.0 109.888 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 143' ' ' SER . 1.5 mmmt 179.54 175.81 0.7 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 109.777 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.581 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -95.26 -1.23 51.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.585 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.87 HG22 ' HB2' ' A' ' 111' ' ' SER . 41.4 p -102.0 129.79 48.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.09 -1.006 . . . . 0.0 108.913 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.581 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -126.81 156.5 41.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.118 -0.988 . . . . 0.0 109.78 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.588 ' O ' HD13 ' A' ' 149' ' ' ILE . 8.9 m -100.82 152.26 20.72 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.352 -0.843 . . . . 0.0 109.097 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.672 HG22 ' CE2' ' A' ' 126' ' ' TYR . 49.9 mm -127.93 107.95 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.252 -0.905 . . . . 0.0 109.199 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.586 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 2.9 m120 -116.0 166.1 12.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.418 -0.801 . . . . 0.0 109.929 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 4.1 m120 76.07 37.73 0.36 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 109.268 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.727 HG22 ' C ' ' A' ' 106' ' ' THR . 4.7 tt -96.93 156.17 3.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.392 -0.817 . . . . 0.0 109.795 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 184' ' ' THR . 9.0 mttp -84.64 117.57 69.06 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 109.349 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.483 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 36.4 Cg_endo -78.73 75.88 4.78 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.479 2.12 . . . . 0.0 110.684 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.717 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 143.08 73.05 0.03 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.717 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 162.25 134.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -1.107 . . . . 0.0 109.67 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.08 164.43 0.05 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.11 -0.994 . . . . 0.0 108.338 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.612 ' CE2' HG13 ' A' ' 152' ' ' ILE . 0.4 OUTLIER -144.97 -167.44 2.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.865 -1.147 . . . . 0.0 110.352 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.513 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 31.6 m -169.6 102.75 0.33 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.598 HD11 HD12 ' A' ' 108' ' ' LEU . 33.0 mm -88.11 118.6 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.025 -1.047 . . . . 0.0 109.785 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.985 HG23 ' CB ' ' A' ' 179' ' ' SER . 1.1 m -126.37 165.41 19.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.904 . . . . 0.0 109.19 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.945 HD11 ' HG3' ' A' ' 95' ' ' PRO . 1.9 pp -165.86 154.4 11.26 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.997 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.626 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 1.8 m-85 -122.69 160.38 25.97 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -127.26 101.68 6.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.865 -1.147 . . . . 0.0 109.342 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.934 HG22 ' HB3' ' A' ' 174' ' ' SER . 15.1 t . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.333 -0.854 . . . . 0.0 109.677 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.934 ' HB3' HG22 ' A' ' 165' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.382 0.61 . . . . 0.0 109.697 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.49 ' O ' ' O ' ' A' ' 174' ' ' SER . 0.7 OUTLIER 42.1 -166.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.19 139.71 23.1 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 120.999 -1.063 . . . . 0.0 108.229 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.626 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 33.8 Cg_endo -76.14 140.91 22.91 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.206 1.937 . . . . 0.0 111.158 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.2 t -122.11 138.22 53.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.985 ' CB ' HG23 ' A' ' 161' ' ' THR . 0.3 OUTLIER -131.36 155.45 47.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.088 -1.007 . . . . 0.0 110.821 -178.663 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.766 HD13 ' CD2' ' A' ' 98' ' ' LEU . 14.0 pt -136.96 153.3 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 159' ' ' THR . 23.6 m120 -91.67 156.67 17.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.0 -1.063 . . . . 0.0 110.051 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.764 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 51.9 t80 -143.98 169.78 17.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.405 -0.809 . . . . 0.0 109.296 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.477 ' N ' ' CD2' ' A' ' 182' ' ' TYR . 8.6 tttp -139.86 121.69 15.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.231 -0.918 . . . . 0.0 109.537 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.455 ' CB ' ' O ' ' A' ' 153' ' ' LYS . 14.7 p . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.46 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.817 HD12 ' N ' ' A' ' 2' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 26' ' ' ARG . 1.6 m-20 -96.62 167.61 11.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 0.0 109.344 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.548 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 4.8 p -94.52 133.62 26.64 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.491 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.921 ' O ' HD22 ' A' ' 84' ' ' LEU . 36.3 Cg_endo -79.14 86.72 1.64 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.54 2.16 . . . . 0.0 110.394 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.466 ' O ' ' C ' ' A' ' 7' ' ' GLY . 16.5 p -89.32 -126.87 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.04 -1.038 . . . . 0.0 109.304 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 44.48 28.42 1.51 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.039 -2.025 . . . . 0.0 108.039 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.569 ' HB3' HD21 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -92.34 152.32 19.83 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.851 -0.794 . . . . 0.0 109.879 -178.603 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.593 ' O ' HG12 ' A' ' 20' ' ' VAL . 2.5 t70 -165.0 -163.15 0.68 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.788 ' HB2' HD11 ' A' ' 13' ' ' ILE . 83.0 p -137.45 121.26 17.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.048 -1.032 . . . . 0.0 109.908 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.472 ' O ' ' C ' ' A' ' 12' ' ' ASP . 3.7 p -140.6 -171.01 3.13 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.356 -0.84 . . . . 0.0 108.847 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.547 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.9 OUTLIER 43.84 36.01 1.24 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -178.552 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.867 HG22 ' CG2' ' A' ' 91' ' ' VAL . 1.2 mt -79.52 132.69 31.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.729 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.543 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -122.83 -179.94 4.42 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.198 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -74.08 -63.39 1.23 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.751 -1.218 . . . . 0.0 109.75 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 3.4 m-20 -88.46 23.77 2.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.148 -0.97 . . . . 0.0 109.446 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.731 ' HA ' HD12 ' A' ' 62' ' ' LEU . 42.0 p -176.04 153.68 1.34 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.774 ' HB2' HG23 ' A' ' 13' ' ' ILE . 2.5 p90 -165.66 140.53 4.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 0.0 109.089 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.547 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 4.6 m -89.79 161.44 16.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.922 -1.111 . . . . 0.0 110.964 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.759 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -133.54 173.23 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.543 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 28.3 m-70 -147.68 170.6 17.17 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.89 -1.131 . . . . 0.0 110.541 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.66 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 16.3 p90 179.81 135.28 0.11 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.533 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.51 167.6 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.087 -1.008 . . . . 0.0 109.267 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.757 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -92.21 168.77 12.15 Favored Pre-proline 0 C--N 1.299 -1.606 0 O-C-N 121.647 -0.658 . . . . 0.0 109.796 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.757 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.9 Cg_endo -78.18 172.75 14.94 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.675 2.25 . . . . 0.0 110.387 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.455 ' HB2' ' OD1' ' A' ' 3' ' ' ASP . 45.5 mmt-85 -90.68 28.73 1.45 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.229 -0.92 . . . . 0.0 109.48 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.948 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -146.26 175.35 2.77 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 109.428 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.948 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.3 Cg_endo -77.83 142.38 20.01 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.647 2.231 . . . . 0.0 110.35 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.716 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 46.3 pt -145.68 -170.6 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.602 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.8 p -121.26 -8.64 9.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.278 -0.889 . . . . 0.0 109.416 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.04 -168.34 32.41 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.716 ' CZ ' HD11 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -138.64 131.54 29.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -1.178 . . . . 0.0 109.526 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.943 HG23 ' HD2' ' A' ' 49' ' ' ARG . 1.1 mp -83.48 133.05 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.21 -0.931 . . . . 0.0 108.835 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.845 HD13 ' C ' ' A' ' 33' ' ' ILE . 2.4 mm -111.97 101.03 11.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.185 -0.947 . . . . 0.0 109.829 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 71' ' ' SER . 0.2 OUTLIER -109.39 111.14 22.52 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 108.602 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.947 ' HB3' HG13 ' A' ' 70' ' ' VAL . 3.4 p80 -119.13 160.6 21.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.135 -0.978 . . . . 0.0 110.385 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.52 ' NE2' ' HB ' ' A' ' 69' ' ' VAL . 30.3 p-80 -167.25 136.02 2.67 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.576 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -47.51 177.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.922 . . . . 0.0 110.033 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.889 . . . . 0.0 109.767 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.1 mmt85 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.451 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 3.8 mt-30 -87.77 133.3 33.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.885 . . . . 0.0 109.95 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.486 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -155.21 117.08 4.1 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.582 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.943 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -105.64 165.02 11.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.982 -1.074 . . . . 0.0 110.205 -179.124 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.646 ' CG1' HD12 ' A' ' 57' ' ' ILE . 7.2 m -140.0 161.84 53.63 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.548 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.3 Cg_endo -76.37 174.1 13.39 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.324 2.016 . . . . 0.0 110.354 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.556 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.5 Cg_endo -76.86 -14.43 17.24 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.558 2.172 . . . . 0.0 110.273 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.12 23.39 13.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.349 -0.845 . . . . 0.0 109.513 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.548 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 10.5 mmt180 -124.77 97.99 5.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -0.953 . . . . 0.0 109.719 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 3.7 p30 -85.06 -0.97 56.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.181 -0.95 . . . . 0.0 109.305 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 63.5 p -136.52 149.1 47.97 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.406 -0.808 . . . . 0.0 109.028 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.66 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 3.4 tt -134.14 123.22 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.116 -0.99 . . . . 0.0 109.741 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 66.4 m -91.74 116.37 28.83 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.358 -0.838 . . . . 0.0 109.456 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.91 ' HB3' HD11 ' A' ' 62' ' ' LEU . 7.2 mt -92.51 151.4 20.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.203 -0.936 . . . . 0.0 109.618 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.487 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 1.2 p -133.12 169.66 16.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.382 -0.824 . . . . 0.0 109.561 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 59.4 39.85 21.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -0.879 . . . . 0.0 109.455 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.91 HD11 ' HB3' ' A' ' 59' ' ' LEU . 4.3 mt -108.89 157.64 18.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 0.0 109.293 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.475 ' O ' ' OH ' ' A' ' 68' ' ' TYR . 13.0 m-20 -60.87 134.74 92.59 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.142 -0.974 . . . . 0.0 108.819 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 37.0 Cg_endo -78.49 117.9 4.13 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.289 1.993 . . . . 0.0 110.502 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 77.46 60.51 2.81 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.552 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 2.1 m -146.58 166.67 25.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.535 -0.979 . . . . 0.0 109.895 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.552 ' N ' ' CG2' ' A' ' 66' ' ' THR . 7.5 pt-20 -121.18 136.46 54.97 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.418 -0.801 . . . . 0.0 109.303 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.576 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -132.49 176.97 7.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.19 -0.944 . . . . 0.0 109.577 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.646 HG22 ' HG3' ' A' ' 87' ' ' GLN . 74.9 t -108.69 97.02 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.947 HG13 ' HB3' ' A' ' 36' ' ' HIS . 1.9 t -84.76 124.51 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.863 . . . . 0.0 110.13 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.579 ' CB ' HG12 ' A' ' 85' ' ' ILE . 15.5 p -105.72 137.72 43.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.877 . . . . 0.0 110.295 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.79 ' CD1' HG23 ' A' ' 34' ' ' ILE . 30.9 mm -124.06 120.95 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.465 -0.772 . . . . 0.0 109.149 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 74' ' ' ALA . 49.2 mt -117.6 167.16 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 109.428 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -132.13 124.75 29.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.911 . . . . 0.0 109.393 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -116.03 136.21 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 109.588 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.415 ' CB ' ' HA ' ' A' ' 29' ' ' ILE . 48.3 t30 -121.31 50.14 1.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -0.94 . . . . 0.0 109.448 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.41 -82.12 0.95 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.432 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 20.0 tpt180 -117.35 2.01 12.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -1.166 . . . . 0.0 109.62 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 1.1 mt-10 -92.96 176.45 6.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.133 -0.979 . . . . 0.0 109.415 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 36.0 mt-10 -154.57 96.31 1.88 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.522 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.79 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -59.9 178.99 0.22 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.134 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.568 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.3 Cg_endo -77.3 152.22 30.43 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.352 2.035 . . . . 0.0 110.139 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.436 ' HA ' HG12 ' A' ' 73' ' ' ILE . 35.5 Cg_endo -77.8 105.49 2.03 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.532 2.155 . . . . 0.0 110.759 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.921 HD22 ' O ' ' A' ' 5' ' ' PRO . 23.1 tp -84.57 100.8 11.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -0.888 . . . . 0.0 108.941 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.579 HG12 ' CB ' ' A' ' 71' ' ' SER . 2.3 mt -110.1 149.92 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.126 -0.984 . . . . 0.0 110.09 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -153.47 160.5 29.26 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.646 ' HG3' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -104.19 105.09 15.12 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.127 -1.219 . . . . 0.0 109.792 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.462 ' OE1' ' CB ' ' A' ' 10' ' ' SER . 36.0 mm-40 -104.79 -165.92 1.18 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.74 145.39 6.43 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.902 -1.119 . . . . 0.0 110.929 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -78.26 140.09 38.87 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.144 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.867 ' CG2' HG22 ' A' ' 13' ' ' ILE . 2.1 t . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.585 ' HB3' ' CD1' ' A' ' 112' ' ' TRP . 34.7 Cg_endo . . . . . 0 C--O 1.215 -0.648 0 N-CA-C 109.097 -1.155 . . . . 0.0 109.097 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 9.2 ptm85 -158.81 147.6 18.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.871 -1.143 . . . . 0.0 109.682 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 4.4 t70 75.71 24.26 1.3 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.352 -0.843 . . . . 0.0 109.301 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 1.025 HD23 ' CG2' ' A' ' 180' ' ' ILE . 3.4 tp -54.96 99.81 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.186 -0.946 . . . . 0.0 109.207 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -142.8 161.78 37.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.906 . . . . 0.0 109.599 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 109' ' ' LEU . 38.4 t -103.72 150.54 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.273 -0.892 . . . . 0.0 109.592 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.753 ' CG1' HD21 ' A' ' 109' ' ' LEU . 1.2 pt -120.01 -16.06 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.378 -0.826 . . . . 0.0 109.44 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.78 ' HB3' HD23 ' A' ' 109' ' ' LEU . . . -135.99 143.1 44.63 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.532 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.8 p -135.31 93.22 2.95 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.94 -1.1 . . . . 0.0 110.531 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.575 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -75.77 165.95 49.21 Favored Pre-proline 0 C--N 1.306 -1.296 0 O-C-N 121.102 -0.999 . . . . 0.0 108.512 178.715 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 30.0 Cg_endo -69.34 -1.89 8.92 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.296 1.997 . . . . 0.0 110.58 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.748 ' C ' HG22 ' A' ' 152' ' ' ILE . 3.3 p -151.41 17.24 0.72 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.353 -0.842 . . . . 0.0 108.953 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' SER . . . . . 1.033 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.7 OUTLIER -169.93 161.54 8.91 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.768 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.033 HD23 ' O ' ' A' ' 107' ' ' SER . 0.4 OUTLIER -148.05 147.76 29.93 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.412 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.78 HD23 ' HB3' ' A' ' 102' ' ' ALA . 1.5 pp -106.99 135.93 47.72 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.149 -0.969 . . . . 0.0 109.222 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.614 ' H ' HD13 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -112.47 167.05 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.109 -0.994 . . . . 0.0 110.1 -179.659 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.584 ' CB ' HG22 ' A' ' 146' ' ' THR . 32.4 t -152.03 136.3 16.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.483 -0.761 . . . . 0.0 109.146 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.585 ' CD1' ' HB3' ' A' ' 95' ' ' PRO . 15.5 p90 -141.08 172.18 13.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.198 -0.939 . . . . 0.0 109.711 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.483 ' HB2' ' CG ' ' A' ' 96' ' ' ARG . 5.4 mt-10 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.299 -0.875 . . . . 0.0 109.52 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 1.076 ' CZ ' HG21 ' A' ' 165' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -125.74 171.98 10.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.034 -1.041 . . . . 0.0 109.908 -179.48 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -131.8 90.36 2.82 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.076 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.625 ' CD1' HG21 ' A' ' 140' ' ' VAL . 12.9 mt -83.48 164.37 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.339 -0.851 . . . . 0.0 110.021 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.553 HG22 ' CB ' ' A' ' 137' ' ' GLU . 1.9 p -141.14 151.4 43.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.372 -0.83 . . . . 0.0 109.697 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.756 ' CE2' HG22 ' A' ' 149' ' ' ILE . 2.9 m-85 -87.01 141.64 28.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 108.685 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.593 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -105.31 111.54 3.75 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.4 ' OE2' ' HD3' ' A' ' 153' ' ' LYS . 4.9 mt-10 . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.114 -1.227 . . . . 0.0 109.356 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.534 ' O ' ' HA ' ' A' ' 125' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.839 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.553 ' CB ' HG22 ' A' ' 125' ' ' THR . 32.5 tt0 -74.01 114.97 12.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.869 . . . . 0.0 111.349 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.613 ' CE1' ' HB ' ' A' ' 124' ' ' ILE . 44.0 p90 -117.48 156.74 27.48 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.675 HG22 ' HE1' ' A' ' 121' ' ' TYR . 0.7 OUTLIER -74.19 -171.76 1.24 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.824 -1.172 . . . . 0.0 110.744 -178.31 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.726 HG13 ' HD2' ' A' ' 141' ' ' PRO . 71.2 t -154.53 143.12 14.59 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.32 -0.862 . . . . 0.0 109.41 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.726 ' HD2' HG13 ' A' ' 140' ' ' VAL . 35.5 Cg_endo -78.48 140.55 17.11 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.451 2.101 . . . . 0.0 110.2 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.94 38.29 3.2 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.7 t -105.15 -0.74 26.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -1.166 . . . . 0.0 109.694 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.57 162.65 32.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.117 -0.989 . . . . 0.0 109.527 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.578 ' O ' ' CE3' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -90.9 9.17 31.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.559 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.584 HG22 ' CB ' ' A' ' 111' ' ' SER . 71.7 p -119.72 158.78 25.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.887 . . . . 0.0 109.281 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.596 ' CB ' ' CD1' ' A' ' 124' ' ' ILE . . . -135.51 153.32 51.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.193 -0.942 . . . . 0.0 109.633 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.3 t -98.94 151.26 21.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.193 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.756 HG22 ' CE2' ' A' ' 126' ' ' TYR . 12.4 mm -133.05 111.36 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.198 -0.939 . . . . 0.0 109.399 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.581 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 12.1 m-80 -122.32 169.18 11.19 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.311 -0.868 . . . . 0.0 109.955 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 2.0 m120 76.12 20.23 1.68 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.959 . . . . 0.0 109.041 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.748 HG22 ' C ' ' A' ' 106' ' ' THR . 7.4 tt -76.7 149.45 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.441 -0.787 . . . . 0.0 109.643 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.47 ' HB2' ' OH ' ' A' ' 158' ' ' TYR . 4.2 mtpm? -103.7 117.44 59.83 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.959 . . . . 0.0 109.487 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.537 ' HA ' ' CB ' ' A' ' 184' ' ' THR . 35.3 Cg_endo -77.83 166.67 24.93 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.407 2.072 . . . . 0.0 110.481 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.694 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 74.07 59.43 3.96 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 162.92 130.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -1.147 . . . . 0.0 109.599 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 156' ' ' ALA . 0.3 OUTLIER -47.22 161.72 0.07 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -141.78 176.58 8.8 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.773 -1.204 . . . . 0.0 110.44 -179.186 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.739 ' O ' HD13 ' A' ' 160' ' ' ILE . 0.6 OUTLIER -146.89 168.72 20.76 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 179.235 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.739 HD13 ' O ' ' A' ' 159' ' ' THR . 31.1 mm -147.47 120.5 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.668 -1.27 . . . . 0.0 109.707 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.733 HG23 ' CB ' ' A' ' 179' ' ' SER . 0.9 OUTLIER -126.89 163.7 23.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.244 -0.91 . . . . 0.0 109.119 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.944 HD23 HD13 ' A' ' 98' ' ' LEU . 2.5 pp -160.86 146.32 14.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.867 -1.146 . . . . 0.0 110.988 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.595 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 1.9 m-85 -115.71 90.7 3.4 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.18 135.37 56.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.933 -1.104 . . . . 0.0 109.437 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 1.076 HG21 ' CZ ' ' A' ' 121' ' ' TYR . 48.2 t . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 109.576 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 175' ' ' SER . 5.0 p . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.256 0.55 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 174' ' ' SER . 85.8 p -54.35 -168.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 109.439 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.47 151.91 89.67 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.942 . . . . 0.0 108.89 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.595 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 35.9 Cg_endo -79.24 118.92 4.08 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.427 2.085 . . . . 0.0 111.433 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 161' ' ' THR . 2.7 t -84.79 127.71 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.733 ' CB ' HG23 ' A' ' 161' ' ' THR . 0.0 OUTLIER -124.52 129.31 50.38 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.21 -0.932 . . . . 0.0 110.586 -178.779 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 1.025 ' CG2' HD23 ' A' ' 98' ' ' LEU . 40.3 pt -114.78 -162.79 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.474 ' OD1' ' N ' ' A' ' 181' ' ' ASN . 1.1 m120 -124.5 156.81 36.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.047 -1.033 . . . . 0.0 109.758 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.82 ' OH ' HD22 ' A' ' 108' ' ' LEU . 64.9 t80 -153.19 170.55 20.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.312 -0.868 . . . . 0.0 109.164 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.412 ' N ' ' CG ' ' A' ' 182' ' ' TYR . 19.2 mtpt -139.18 134.21 32.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 109.448 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.593 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 2.9 p . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.467 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.522 ' CD1' ' O ' ' A' ' 80' ' ' GLU . 1.3 mp . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.272 0.558 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 26' ' ' ARG . 1.1 m-20 -100.75 152.79 20.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 0.0 109.511 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -95.08 125.89 48.77 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.496 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.533 ' O ' ' CD2' ' A' ' 84' ' ' LEU . 36.2 Cg_endo -78.67 81.95 2.62 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.464 2.11 . . . . 0.0 110.322 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.544 ' HA ' ' CD2' ' A' ' 84' ' ' LEU . 2.7 p -74.68 -109.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.163 -0.96 . . . . 0.0 109.666 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 45.71 26.72 1.92 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.558 ' CE2' ' HA3' ' A' ' 86' ' ' GLY . 14.1 t80 -56.14 128.03 33.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.544 -0.974 . . . . 0.0 110.094 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.504 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 0.8 OUTLIER -147.75 -179.28 6.77 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.504 ' HB2' HD11 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -155.42 117.86 4.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.104 -0.997 . . . . 0.0 110.062 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.5 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 0.8 OUTLIER -145.73 -167.65 2.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.059 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.545 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 4.6 m-20 42.23 38.49 1.16 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.019 HG22 HG23 ' A' ' 91' ' ' VAL . 2.5 mt -80.45 149.84 5.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.775 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -140.48 169.15 18.2 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.446 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -65.43 -62.61 1.43 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.71 -1.244 . . . . 0.0 110.159 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 1.4 m120 -91.37 27.86 1.83 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.116 -0.99 . . . . 0.0 109.511 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 14' ' ' THR . 56.7 p 179.48 154.72 0.5 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.049 ' CE1' HG22 ' A' ' 20' ' ' VAL . 3.5 p90 -166.83 144.18 4.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.13 -0.981 . . . . 0.0 109.279 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 28.9 m -85.95 148.18 25.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.637 -1.289 . . . . 0.0 110.369 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.049 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.3 t -118.16 171.62 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.536 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 49.8 m-70 -151.76 165.02 35.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.004 -1.06 . . . . 0.0 110.006 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.819 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 42.6 p90 -171.98 145.42 1.84 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.442 -0.786 . . . . 0.0 109.152 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.521 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.51 169.21 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.054 -1.029 . . . . 0.0 109.189 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.52 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -98.65 161.05 26.41 Favored Pre-proline 0 C--N 1.298 -1.643 0 O-C-N 121.54 -0.725 . . . . 0.0 109.819 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.505 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.8 Cg_endo -78.79 159.78 27.85 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.687 2.258 . . . . 0.0 110.397 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.466 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 5.1 mmm180 -90.28 17.07 7.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.222 -0.924 . . . . 0.0 109.408 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.969 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -121.04 177.13 1.57 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 109.374 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.969 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.4 Cg_endo -77.83 140.03 18.09 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.52 2.147 . . . . 0.0 110.333 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.636 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 28.7 pt -153.86 -173.47 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.526 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 17.1 p -133.95 3.31 3.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 109.579 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.57 -172.19 30.34 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.636 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -144.25 127.95 17.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.237 -1.155 . . . . 0.0 109.668 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.874 HG23 ' CD ' ' A' ' 49' ' ' ARG . 1.6 mp -80.74 130.84 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.274 -0.891 . . . . 0.0 108.772 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.753 HD13 ' C ' ' A' ' 33' ' ' ILE . 2.5 mm -107.54 112.34 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.166 -0.959 . . . . 0.0 109.966 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.551 ' CG ' ' HG2' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -104.55 116.77 32.65 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.137 -0.977 . . . . 0.0 108.582 179.098 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.95 144.36 32.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.085 -1.01 . . . . 0.0 109.797 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.587 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 41.6 p-80 -169.5 114.47 0.54 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.586 -0.696 . . . . 0.0 109.91 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.924 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . -61.37 175.21 0.6 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.42 -0.8 . . . . 0.0 109.609 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.909 . . . . 0.0 109.323 179.779 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.51 ' CZ ' ' CB ' ' A' ' 46' ' ' ARG . 2.8 ptm85 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.297 0.57 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.551 ' HG2' ' CG ' ' A' ' 35' ' ' ARG . 30.1 mt-30 -139.18 119.58 13.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.276 -0.89 . . . . 0.0 109.701 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.868 ' HB3' HD11 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -111.58 118.22 35.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.358 -0.839 . . . . 0.0 108.822 179.503 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.874 ' CD ' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -92.99 140.31 29.6 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.013 -1.054 . . . . 0.0 109.546 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.666 ' CG2' HD11 ' A' ' 34' ' ' ILE . 1.8 m -117.58 163.16 25.15 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.277 -0.89 . . . . 0.0 109.555 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.497 ' HG2' ' HG3' ' A' ' 54' ' ' ARG . 34.5 Cg_endo -76.98 174.84 12.2 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.634 2.222 . . . . 0.0 110.486 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.61 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.9 Cg_endo -76.73 -15.8 16.84 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.562 2.175 . . . . 0.0 110.316 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.6 m -103.26 25.71 9.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.277 -0.889 . . . . 0.0 109.16 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.497 ' HG3' ' HG2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -127.14 126.22 42.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.37 -0.831 . . . . 0.0 109.509 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 25.2 p-10 -111.82 5.43 19.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.884 . . . . 0.0 109.528 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.516 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 89.3 p -146.12 150.05 35.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 0.0 109.313 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.868 HD11 ' HB3' ' A' ' 48' ' ' ASP . 4.2 tt -138.21 125.16 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -0.94 . . . . 0.0 109.586 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 0.3 OUTLIER -84.83 107.64 17.1 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.351 -0.843 . . . . 0.0 109.496 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.666 ' HB3' HD11 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -84.82 149.61 25.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.94 . . . . 0.0 109.259 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.485 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 6.3 p -134.61 166.15 23.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.139 -0.976 . . . . 0.0 109.703 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 60' ' ' THR . 3.7 m120 61.04 61.06 1.68 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.283 -0.886 . . . . 0.0 109.655 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.666 HD11 ' HB3' ' A' ' 59' ' ' LEU . 1.7 mt -132.92 138.18 46.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.352 -0.842 . . . . 0.0 109.166 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.542 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 3.0 m-20 -44.56 133.3 4.78 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.12 -0.988 . . . . 0.0 108.797 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 174' ' ' SER . 35.9 Cg_endo -77.74 135.22 14.17 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.333 2.022 . . . . 0.0 111.373 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 71.36 64.91 2.59 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.6 m -158.44 151.57 22.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.251 -1.146 . . . . 0.0 110.889 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 1.7 tt0 -84.43 133.95 34.48 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.924 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 28.0 m-85 -119.81 130.98 55.18 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.882 -1.136 . . . . 0.0 110.856 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.709 HG12 ' CG2' ' A' ' 85' ' ' ILE . 3.4 t -85.56 97.49 5.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.535 HG23 ' NE2' ' A' ' 88' ' ' GLN . 3.1 t -94.06 125.48 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.291 -0.88 . . . . 0.0 109.759 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.527 ' CB ' HG12 ' A' ' 85' ' ' ILE . 1.3 p -96.74 138.62 34.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 109.72 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.56 ' CD1' HG23 ' A' ' 34' ' ' ILE . 17.8 mm -114.45 77.35 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.332 -0.855 . . . . 0.0 109.27 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.555 HG22 ' N ' ' A' ' 74' ' ' ALA . 24.5 mt -75.04 163.71 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 109.46 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.845 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -121.89 160.2 25.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 0.0 109.583 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.446 ' O ' ' OG1' ' A' ' 30' ' ' THR . 0.4 OUTLIER -145.11 131.9 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -0.923 . . . . 0.0 109.318 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -116.63 50.47 1.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.278 -0.889 . . . . 0.0 109.395 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.05 -90.24 1.34 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -114.53 0.77 14.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -1.129 . . . . 0.0 109.638 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 0.8 OUTLIER -96.44 -164.54 1.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.136 -0.978 . . . . 0.0 109.262 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.522 ' O ' ' CD1' ' A' ' 2' ' ' LEU . 23.2 mt-10 -147.58 -169.56 3.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.171 -0.956 . . . . 0.0 109.571 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.845 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.6 OUTLIER -155.33 -177.41 0.73 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.371 -0.831 . . . . 0.0 109.062 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.598 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.1 Cg_endo -77.85 131.03 10.88 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.162 1.908 . . . . 0.0 109.963 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.467 ' HB3' HG12 ' A' ' 73' ' ' ILE . 36.0 Cg_endo -77.8 86.87 1.58 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.524 2.149 . . . . 0.0 111.179 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -75.26 131.28 40.25 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.096 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.709 ' CG2' HG12 ' A' ' 69' ' ' VAL . 3.8 mt -117.54 150.65 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.011 -1.055 . . . . 0.0 110.346 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.558 ' HA3' ' CE2' ' A' ' 8' ' ' PHE . . . -132.58 176.97 19.15 Favored Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.074 -2.011 . . . . 0.0 108.074 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -142.66 111.9 6.59 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.101 -1.234 . . . . 0.0 110.344 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.591 ' HG3' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -113.24 -158.82 0.66 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.014 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -148.07 130.06 15.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.716 -1.24 . . . . 0.0 110.525 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.508 ' OG1' ' CE2' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -74.45 134.83 42.32 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.909 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.019 HG23 HG22 ' A' ' 13' ' ' ILE . 7.5 t . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.54 ' CB ' ' O ' ' A' ' 113' ' ' GLU . 36.7 Cg_endo . . . . . 0 C--O 1.215 -0.637 0 N-CA-C 110.267 -0.705 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.476 ' O ' ' N ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -86.53 -168.27 2.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.155 -0.966 . . . . 0.0 109.511 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 111' ' ' SER . 11.5 t0 71.78 33.09 1.8 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 109.702 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.964 HD13 ' CD2' ' A' ' 162' ' ' LEU . 31.5 tp -71.95 92.77 1.3 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.912 . . . . 0.0 109.396 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -133.28 157.88 44.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -0.926 . . . . 0.0 109.668 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 9.5 p -96.96 141.77 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.81 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.865 HD11 ' CD2' ' A' ' 109' ' ' LEU . 12.1 pt -123.59 -8.55 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.532 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.617 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -147.12 112.83 5.69 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.488 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 12.9 m -112.72 96.44 5.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.136 -0.977 . . . . 0.0 110.599 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -83.11 165.92 38.3 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.243 -0.91 . . . . 0.0 108.653 178.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.464 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 30.0 Cg_endo -69.44 -3.83 12.58 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.275 1.984 . . . . 0.0 110.478 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.69 ' C ' HG22 ' A' ' 152' ' ' ILE . 4.9 p -149.08 16.67 0.95 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.396 -0.815 . . . . 0.0 108.94 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' SER . . . . . 1.044 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.7 OUTLIER -169.92 165.46 9.59 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.071 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.044 HD23 ' O ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -145.65 155.69 43.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.358 -0.839 . . . . 0.0 109.259 -179.706 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.865 ' CD2' HD11 ' A' ' 101' ' ' ILE . 21.1 tp -105.42 136.52 44.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.284 -0.885 . . . . 0.0 108.94 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.781 ' CD1' ' HB3' ' A' ' 147' ' ' ALA . 1.2 pt -124.82 140.72 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.055 -1.028 . . . . 0.0 110.369 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 97' ' ' ASP . 7.5 t -134.46 145.19 48.61 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.602 ' CH2' ' N ' ' A' ' 147' ' ' ALA . 11.9 p90 -134.56 -171.31 2.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.076 -1.015 . . . . 0.0 110.707 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 95' ' ' PRO . 4.4 mm-40 . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.591 -0.693 . . . . 0.0 109.668 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.893 ' CE1' HG22 ' A' ' 139' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.477 ' HB2' ' HB ' ' A' ' 140' ' ' VAL . 2.7 m-85 -111.76 147.89 34.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.965 -1.084 . . . . 0.0 109.83 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.582 ' O ' ' CD1' ' A' ' 163' ' ' TYR . 21.4 ttm180 -120.42 84.22 2.19 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.633 HG12 ' HB2' ' A' ' 162' ' ' LEU . 7.6 mt -84.42 168.72 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 110.274 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.511 ' N ' HG22 ' A' ' 124' ' ' ILE . 1.5 p -144.37 156.08 44.07 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.61 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.699 ' CE2' HG22 ' A' ' 149' ' ' ILE . 3.5 m-85 -91.24 137.43 32.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.519 -0.738 . . . . 0.0 109.034 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.615 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -102.69 111.52 4.02 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 . . . . . 0 C--N 1.298 -1.652 0 O-C-N 121.134 -1.215 . . . . 0.0 109.311 179.293 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' A' ' 125' ' ' THR . 1.2 tt0 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.498 ' HA ' HG22 ' A' ' 125' ' ' THR . 0.5 OUTLIER -74.72 133.18 42.07 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.346 -0.846 . . . . 0.0 110.89 -178.679 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.652 ' CZ ' HD13 ' A' ' 149' ' ' ILE . 43.6 p90 -134.69 145.19 48.28 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.893 HG22 ' CE1' ' A' ' 121' ' ' TYR . 1.2 p -74.05 -175.71 2.29 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.943 -1.098 . . . . 0.0 110.791 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.744 HG13 ' HD2' ' A' ' 141' ' ' PRO . 72.0 t -157.21 144.03 13.38 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.446 -0.784 . . . . 0.0 109.297 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.744 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.0 Cg_endo -76.17 140.89 22.81 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.379 2.052 . . . . 0.0 110.361 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -88.58 35.62 3.58 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.424 ' C ' ' HD3' ' A' ' 144' ' ' LYS . 0.3 OUTLIER -105.27 -22.01 13.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.096 -1.237 . . . . 0.0 109.463 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.424 ' HD3' ' C ' ' A' ' 143' ' ' SER . 2.3 mptt -116.44 150.77 37.29 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.522 -0.736 . . . . 0.0 110.03 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.56 4.01 50.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.351 -0.843 . . . . 0.0 109.108 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.543 ' C ' ' CH2' ' A' ' 112' ' ' TRP . 1.6 p -130.2 151.94 50.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.389 -0.819 . . . . 0.0 108.827 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.781 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -116.76 153.41 32.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.029 -1.045 . . . . 0.0 109.969 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.8 t -104.66 154.19 20.28 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.365 -0.834 . . . . 0.0 109.1 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.699 HG22 ' CE2' ' A' ' 126' ' ' TYR . 9.4 mm -134.75 114.25 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.482 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.58 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 3.2 m120 -122.28 170.95 9.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.287 -0.883 . . . . 0.0 109.984 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.435 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 4.3 m120 70.57 28.19 3.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 0.0 109.115 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.69 HG22 ' C ' ' A' ' 106' ' ' THR . 5.1 tt -84.56 147.13 5.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.393 -0.817 . . . . 0.0 109.713 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.468 ' HB2' ' OH ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -93.22 111.3 51.28 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.345 -0.847 . . . . 0.0 109.19 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.504 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 35.8 Cg_endo -77.29 141.51 20.5 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.319 2.013 . . . . 0.0 110.451 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.693 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 90.41 64.59 1.22 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.693 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 163.49 134.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -1.154 . . . . 0.0 109.491 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 6.9 t0 -49.31 151.62 1.43 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.645 ' CD1' HG21 ' A' ' 184' ' ' THR . 0.2 OUTLIER -135.29 178.66 6.86 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.847 -1.158 . . . . 0.0 110.246 -179.285 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.589 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 3.4 m -150.06 107.7 3.67 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.963 HD11 HD12 ' A' ' 108' ' ' LEU . 9.0 mt -94.39 130.08 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.617 -1.302 . . . . 0.0 109.966 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 179' ' ' SER . 1.8 m -132.15 113.67 13.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.356 -0.84 . . . . 0.0 109.265 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.964 ' CD2' HD13 ' A' ' 98' ' ' LEU . 2.1 pp -99.18 127.16 45.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.29 -0.881 . . . . 0.0 110.164 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.626 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 4.2 m-85 -100.39 171.94 7.45 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.486 ' HB3' ' OG ' ' A' ' 175' ' ' SER . . . -148.92 135.24 19.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.138 -0.976 . . . . 0.0 109.628 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.558 HG22 ' HA ' ' A' ' 174' ' ' SER . 97.0 t . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 109.399 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.558 ' HA ' HG22 ' A' ' 165' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.575 0.702 . . . . 0.0 110.062 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.486 ' OG ' ' HB3' ' A' ' 164' ' ' ALA . 0.6 OUTLIER -115.66 159.89 20.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.667 -0.646 . . . . 0.0 109.561 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 176' ' ' LYS . 1.7 ptmt -42.36 118.69 2.2 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.171 -0.955 . . . . 0.0 110.45 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.626 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 29.7 Cg_endo -70.96 122.1 8.48 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.368 2.045 . . . . 0.0 111.199 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 161' ' ' THR . 57.4 t -84.77 118.79 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 161' ' ' THR . 0.0 OUTLIER -109.9 126.52 53.95 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.132 -0.98 . . . . 0.0 110.551 -178.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.931 HG23 HD23 ' A' ' 98' ' ' LEU . 32.1 pt -117.55 151.16 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -79.5 163.33 24.8 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.006 -1.059 . . . . 0.0 109.8 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.792 ' OH ' HD22 ' A' ' 108' ' ' LEU . 46.2 t80 -159.19 114.98 2.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.437 -0.789 . . . . 0.0 109.122 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -87.14 116.87 25.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.113 -0.992 . . . . 0.0 109.447 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.645 HG21 ' CD1' ' A' ' 158' ' ' TYR . 9.2 p . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.481 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.673 HD12 ' HB3' ' A' ' 25' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.441 ' CG ' ' HB2' ' A' ' 26' ' ' ARG . 1.5 m-20 -81.04 161.53 24.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.235 -0.916 . . . . 0.0 109.459 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.1 t -95.2 112.01 57.0 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.513 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.49 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 35.1 Cg_endo -77.25 78.78 3.35 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.34 2.027 . . . . 0.0 110.134 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.822 ' HA ' HD22 ' A' ' 84' ' ' LEU . 0.9 OUTLIER -87.48 -104.6 0.07 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.238 -0.913 . . . . 0.0 109.565 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 9' ' ' ASP . . . 44.2 27.03 1.03 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.402 ' N ' ' C ' ' A' ' 6' ' ' THR . 12.7 t80 -49.06 93.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.44 -1.035 . . . . 0.0 109.688 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 7' ' ' GLY . 9.8 t0 -121.3 84.07 2.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.366 -0.833 . . . . 0.0 108.994 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 83.1 p -84.43 131.79 34.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.495 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.479 ' O ' ' HB ' ' A' ' 19' ' ' THR . 76.7 p -156.01 -156.36 0.63 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.336 -0.853 . . . . 0.0 109.537 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.55 ' HB2' ' CB ' ' A' ' 19' ' ' THR . 0.6 OUTLIER 45.0 34.59 1.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -178.537 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.851 HD13 ' HB2' ' A' ' 18' ' ' PHE . 13.6 mm -62.13 134.25 27.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.749 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.571 ' CB ' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -123.0 178.24 5.15 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 177.149 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 91' ' ' VAL . . . -74.07 -74.73 0.18 Allowed 'General case' 0 C--N 1.292 -1.902 0 O-C-N 120.605 -1.309 . . . . 0.0 109.155 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 4.7 p30 -75.68 -1.35 24.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.159 -0.963 . . . . 0.0 109.338 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.946 ' HB3' HG22 ' A' ' 60' ' ' THR . 14.4 p -146.54 162.08 39.11 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.281 -0.887 . . . . 0.0 109.096 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.023 ' CE1' HG22 ' A' ' 20' ' ' VAL . 4.9 p90 -167.38 137.72 2.92 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.907 -1.121 . . . . 0.0 108.419 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.55 ' CB ' ' HB2' ' A' ' 12' ' ' ASP . 11.9 m -80.99 150.01 29.08 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.77 -1.206 . . . . 0.0 111.172 -178.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.023 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -135.34 109.85 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.506 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 3.0 m-70 -102.01 166.31 10.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.032 -1.043 . . . . 0.0 110.509 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.67 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 38.9 p90 -175.71 147.72 0.83 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.49 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -74.51 159.27 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.966 -1.084 . . . . 0.0 110.083 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.75 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -100.79 168.97 8.46 Favored Pre-proline 0 C--N 1.299 -1.63 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.75 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.9 Cg_endo -78.61 -159.53 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.63 2.22 . . . . 0.0 110.196 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.441 ' HB2' ' CG ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -127.66 12.69 6.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.297 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.933 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -123.17 175.14 2.9 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 109.38 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.933 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.6 Cg_endo -78.24 112.05 3.15 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.586 2.19 . . . . 0.0 110.418 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.575 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 7.6 pt -116.0 -174.23 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.9 . . . . 0.0 109.388 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.5 p -114.88 2.87 14.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.567 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.528 ' HA2' ' N ' ' A' ' 52' ' ' PRO . . . 131.41 -173.04 20.59 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.63 ' CE1' ' HA ' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -134.26 145.3 48.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -1.111 . . . . 0.0 109.35 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.881 ' C ' HD13 ' A' ' 34' ' ' ILE . 1.8 mp -92.9 129.17 43.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.269 -0.895 . . . . 0.0 109.065 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.881 HD13 ' C ' ' A' ' 33' ' ' ILE . 1.7 mm -109.76 104.38 16.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.243 -0.91 . . . . 0.0 109.673 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.485 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 10.2 ttp85 -106.87 131.0 54.46 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.11 -0.994 . . . . 0.0 109.209 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 1.003 ' CD2' HD22 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -117.41 131.82 56.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.171 -0.956 . . . . 0.0 109.622 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.473 ' O ' ' N ' ' A' ' 69' ' ' VAL . 16.9 p80 -151.04 132.74 14.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.316 -0.865 . . . . 0.0 109.796 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -53.22 -168.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.356 -0.84 . . . . 0.0 109.87 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.047 -1.033 . . . . 0.0 110.4 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.725 ' HD2' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 35' ' ' ARG . 1.1 pt20 -127.77 126.78 42.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 109.993 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.634 ' HB2' HD21 ' A' ' 59' ' ' LEU . 0.8 OUTLIER -117.5 118.11 31.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.357 -0.84 . . . . 0.0 108.831 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.87 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -92.73 153.63 18.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.033 -1.042 . . . . 0.0 110.034 -179.407 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.992 ' CG1' HD12 ' A' ' 57' ' ' ILE . 1.1 m -129.03 163.75 43.66 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.824 . . . . 0.0 109.297 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.535 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.8 Cg_endo -77.43 174.8 12.15 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.593 2.195 . . . . 0.0 110.419 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.63 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 35.1 Cg_endo -77.06 -15.64 16.26 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.622 2.215 . . . . 0.0 110.582 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.19 28.71 6.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.244 -0.91 . . . . 0.0 109.555 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.535 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -128.87 103.33 6.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.93 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.68 -12.23 37.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.185 -0.947 . . . . 0.0 109.104 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 56.1 p -135.7 130.35 34.09 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.992 HD12 ' CG1' ' A' ' 50' ' ' VAL . 3.4 tt -126.65 133.78 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.075 -1.015 . . . . 0.0 110.083 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.49 106.12 18.1 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.003 HD22 ' CD2' ' A' ' 36' ' ' HIS . 1.5 mt -84.62 148.56 26.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.155 -0.965 . . . . 0.0 109.566 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.946 HG22 ' HB3' ' A' ' 17' ' ' SER . 27.6 p -142.24 -179.61 6.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.341 -0.849 . . . . 0.0 109.435 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 60' ' ' THR . 17.5 m-80 60.93 16.3 6.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.255 -0.903 . . . . 0.0 109.365 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.981 HD11 ' HB3' ' A' ' 59' ' ' LEU . 0.9 OUTLIER -94.86 143.57 26.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 109.261 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.485 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 2.5 t-20 -45.71 116.01 3.06 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 34.6 Cg_endo -75.86 136.63 18.93 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.214 1.943 . . . . 0.0 111.043 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 74.93 63.69 2.49 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.539 HG21 ' CZ ' ' A' ' 68' ' ' TYR . 2.0 m -162.88 146.25 10.99 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.071 -1.253 . . . . 0.0 110.138 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.557 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 2.2 tp10 -74.79 128.23 35.07 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 20.4 m-85 -136.45 110.59 8.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.967 -1.083 . . . . 0.0 110.041 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.946 HG13 ' O ' ' A' ' 86' ' ' GLY . 93.4 t -71.02 141.63 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 35' ' ' ARG . 1.3 t -117.57 126.5 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.993 -1.067 . . . . 0.0 110.022 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.507 ' HB2' HG12 ' A' ' 85' ' ' ILE . 3.1 p -102.76 112.14 24.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -0.861 . . . . 0.0 109.735 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.793 ' C ' HD12 ' A' ' 73' ' ' ILE . 24.8 mm -94.41 111.29 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 0.0 109.528 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.793 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.4 mp -112.3 122.44 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.961 . . . . 0.0 109.34 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.017 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -98.03 122.05 40.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.238 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.414 HG13 HG22 ' A' ' 73' ' ' ILE . 13.0 m -132.79 141.04 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 109.7 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.458 ' CB ' ' HA ' ' A' ' 29' ' ' ILE . 30.8 t30 -110.91 44.71 1.24 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 109.363 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.11 -95.94 0.86 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.45 ' CD ' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -75.42 -0.35 19.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -1.123 . . . . 0.0 109.624 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 1.2 tt0 -116.88 171.88 7.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.58 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 30.3 mt-10 -149.84 96.46 2.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.437 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . 1.017 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -59.77 179.62 0.2 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.265 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.575 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.4 Cg_endo -77.48 154.87 31.76 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.355 2.037 . . . . 0.0 110.348 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.52 143.73 21.95 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.636 2.224 . . . . 0.0 110.761 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.822 HD22 ' HA ' ' A' ' 6' ' ' THR . 23.7 tp -138.74 92.96 2.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.44 -0.788 . . . . 0.0 108.923 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.507 HG12 ' HB2' ' A' ' 71' ' ' SER . 1.9 mt -99.33 153.16 4.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.134 -0.979 . . . . 0.0 110.075 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.946 ' O ' HG13 ' A' ' 69' ' ' VAL . . . -148.37 -166.84 13.13 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -125.8 138.17 53.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.163 -1.198 . . . . 0.0 109.603 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.624 ' NE2' ' CD2' ' A' ' 18' ' ' PHE . 11.7 tm0? -154.5 115.09 3.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.293 -0.88 . . . . 0.0 109.197 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.557 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -98.55 134.3 41.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.315 -0.866 . . . . 0.0 109.714 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.436 HG23 HE22 ' A' ' 88' ' ' GLN . 0.1 OUTLIER -74.24 162.67 28.69 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.131 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.694 ' CG2' HG22 ' A' ' 13' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.132 -0.98 . . . . 0.0 110.982 -178.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.649 ' CB ' ' CD1' ' A' ' 112' ' ' TRP . 34.6 Cg_endo . . . . . 0 C--O 1.215 -0.656 0 N-CA-C 109.487 -1.005 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 112' ' ' TRP . 0.9 OUTLIER -49.96 -178.53 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.695 -0.628 . . . . 0.0 109.634 -179.502 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER 67.46 8.25 6.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.332 -0.855 . . . . 0.0 109.333 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.959 HD22 HD12 ' A' ' 162' ' ' LEU . 7.9 tp -57.27 90.21 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.221 -0.924 . . . . 0.0 108.923 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 97' ' ' ASP . 11.1 pt-20 -130.36 161.31 31.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.934 . . . . 0.0 109.523 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 10.7 p -95.76 144.27 10.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.29 -0.881 . . . . 0.0 109.638 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.52 ' N ' HD13 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -132.6 3.79 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.279 -0.888 . . . . 0.0 109.449 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.958 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -162.97 94.26 0.83 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.492 ' HB2' ' OH ' ' A' ' 182' ' ' TYR . 21.0 p -91.68 105.85 18.04 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.409 -0.807 . . . . 0.0 110.585 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.549 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -93.25 159.39 35.43 Favored Pre-proline 0 C--N 1.304 -1.373 0 O-C-N 121.371 -0.83 . . . . 0.0 108.889 178.886 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.413 ' O ' ' HG3' ' A' ' 154' ' ' PRO . 30.6 Cg_endo -70.22 -2.65 10.84 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.472 2.114 . . . . 0.0 110.455 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.833 ' C ' HG22 ' A' ' 152' ' ' ILE . 61.9 p -150.5 19.49 0.83 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.835 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -168.98 167.7 10.59 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.982 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.895 HD22 ' CE2' ' A' ' 182' ' ' TYR . 0.5 OUTLIER -140.37 151.77 45.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.335 -0.853 . . . . 0.0 109.224 -179.782 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.958 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -106.26 118.84 37.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.109 179.389 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.738 HD12 HD12 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -101.85 145.1 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.258 -0.901 . . . . 0.0 109.764 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.845 ' HA ' HG22 ' A' ' 146' ' ' THR . 0.4 OUTLIER -140.82 115.75 9.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.403 -0.811 . . . . 0.0 109.135 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.649 ' CD1' ' CB ' ' A' ' 95' ' ' PRO . 25.8 p90 -145.01 170.61 15.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.408 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.439 ' HG3' ' HG3' ' A' ' 96' ' ' ARG . 4.8 mt-10 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.15 -0.969 . . . . 0.0 109.495 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 1.051 ' CE2' HG22 ' A' ' 139' ' ' THR . 4.7 p90 . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.593 ' N ' ' CD2' ' A' ' 121' ' ' TYR . 4.2 m-85 -130.42 139.43 50.6 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.598 ' HG2' ' CE2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -96.73 102.88 14.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.785 -1.197 . . . . 0.0 110.035 -179.017 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.723 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 6.4 mt -84.57 106.07 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.741 HG22 ' HB3' ' A' ' 137' ' ' GLU . 32.3 p -93.05 141.96 27.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 110.549 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 1.113 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 4.8 m-30 -94.66 136.77 34.58 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.603 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -105.09 108.94 3.16 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.244 -1.151 . . . . 0.0 109.734 179.923 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.59 ' O ' ' CG ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.741 ' HB3' HG22 ' A' ' 125' ' ' THR . 7.3 pt-20 -112.38 145.62 39.77 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.918 -1.114 . . . . 0.0 110.774 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.723 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 6.3 p90 -135.23 150.52 50.09 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' THR . . . . . 1.051 HG22 ' CE2' ' A' ' 121' ' ' TYR . 2.0 p -74.61 142.69 44.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.988 -1.07 . . . . 0.0 111.106 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.571 HG21 HG13 ' A' ' 124' ' ' ILE . 2.0 t -110.61 146.24 33.94 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.558 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.5 Cg_endo -77.38 140.12 19.1 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.342 2.028 . . . . 0.0 109.761 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.401 ' HA2' ' CE1' ' A' ' 122' ' ' TYR . . . -83.08 13.63 43.44 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.451 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 7.6 t -105.25 23.59 13.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.034 -1.274 . . . . 0.0 109.855 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 143' ' ' SER . 1.6 mmtt -155.11 142.0 19.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.115 -0.991 . . . . 0.0 109.85 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.562 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -95.11 -8.74 35.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.349 -0.844 . . . . 0.0 109.404 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.845 HG22 ' HA ' ' A' ' 111' ' ' SER . 32.2 p -130.37 150.61 51.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.234 -0.916 . . . . 0.0 109.216 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.455 ' O ' HG12 ' A' ' 110' ' ' ILE . . . -145.89 -172.6 3.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.128 -0.982 . . . . 0.0 109.538 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 108' ' ' LEU . 51.8 m -144.95 134.94 23.81 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.217 -0.927 . . . . 0.0 109.577 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 1.113 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 1.0 OUTLIER -81.05 145.0 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.322 -0.861 . . . . 0.0 108.953 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.445 ' O ' ' C ' ' A' ' 151' ' ' ASN . 10.6 m-20 -130.49 169.56 15.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.332 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 150' ' ' ASN . 1.4 p-10 40.68 62.36 1.41 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.37 -0.831 . . . . 0.0 109.81 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.833 HG22 ' C ' ' A' ' 106' ' ' THR . 10.6 tt -106.95 165.77 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.301 -0.875 . . . . 0.0 109.334 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.5 ' N ' HG12 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -101.37 105.86 42.29 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.119 -0.988 . . . . 0.0 109.369 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.515 ' HA ' ' OG1' ' A' ' 184' ' ' THR . 35.6 Cg_endo -77.98 169.24 20.82 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.404 2.069 . . . . 0.0 110.456 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.697 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 70.17 60.69 4.66 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.697 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 164.48 131.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.318 -1.107 . . . . 0.0 109.628 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -47.56 162.25 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.096 -1.003 . . . . 0.0 108.387 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.652 ' CD1' HG21 ' A' ' 184' ' ' THR . 0.3 OUTLIER -140.53 -174.57 4.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.888 -1.133 . . . . 0.0 110.211 -179.524 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.577 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 2.6 m -158.1 110.36 2.32 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.502 ' HB ' HG13 ' A' ' 180' ' ' ILE . 40.6 mm -94.27 141.73 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.839 -1.163 . . . . 0.0 110.567 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.99 HG23 ' CB ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -141.57 133.61 27.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.459 -0.776 . . . . 0.0 109.137 179.455 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.959 HD12 HD22 ' A' ' 98' ' ' LEU . 1.8 mt -112.55 135.19 53.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 0.0 110.564 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.616 ' CD1' ' HB3' ' A' ' 177' ' ' PRO . 22.0 m-85 -117.94 164.87 14.42 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.94 ' HB3' ' OG ' ' A' ' 175' ' ' SER . . . -142.88 88.59 2.06 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.015 -1.053 . . . . 0.0 109.406 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.458 ' HA ' ' HB3' ' A' ' 174' ' ' SER . 47.9 t . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.378 -0.826 . . . . 0.0 109.72 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 95.4 p . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.94 ' OG ' ' HB3' ' A' ' 164' ' ' ALA . 0.6 OUTLIER -54.65 -168.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.188 -0.945 . . . . 0.0 109.476 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.476 ' HD2' ' HD2' ' A' ' 177' ' ' PRO . 0.0 OUTLIER -78.52 129.59 73.95 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.325 -0.859 . . . . 0.0 109.312 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.616 ' HB3' ' CD1' ' A' ' 163' ' ' TYR . 35.3 Cg_endo -77.53 127.14 8.72 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.07 1.847 . . . . 0.0 110.244 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.29 136.29 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.99 ' CB ' HG23 ' A' ' 161' ' ' THR . 4.7 t -119.62 165.47 14.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 110.476 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.502 HG13 ' HB ' ' A' ' 160' ' ' ILE . 11.8 pt -154.3 152.09 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -81.85 162.99 22.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.096 -1.003 . . . . 0.0 109.943 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.895 ' CE2' HD22 ' A' ' 108' ' ' LEU . 64.5 t80 -154.9 159.31 40.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.419 -0.801 . . . . 0.0 109.45 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.97 116.95 17.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.285 -0.884 . . . . 0.0 109.33 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.652 HG21 ' CD1' ' A' ' 158' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.521 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.544 HD11 ' HB3' ' A' ' 79' ' ' GLU . 72.5 mt . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.312 0.577 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 45.2 m-20 -156.11 125.49 6.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.572 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.559 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -95.26 178.3 1.51 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.0 109.309 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.839 ' C ' HD22 ' A' ' 84' ' ' LEU . 35.9 Cg_endo -78.9 164.03 25.5 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.593 2.195 . . . . 0.0 109.989 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 5' ' ' PRO . 4.0 p -162.08 174.63 12.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.068 -1.02 . . . . 0.0 109.711 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 44.54 27.16 1.2 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.585 ' C ' ' CD1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -72.29 -162.43 0.09 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.392 -1.064 . . . . 0.0 109.587 -179.766 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.76 -163.35 0.63 Allowed 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.112 -0.993 . . . . 0.0 109.592 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.532 ' CB ' ' HG2' ' A' ' 88' ' ' GLN . 0.3 OUTLIER -154.86 141.93 19.31 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.362 -0.836 . . . . 0.0 109.351 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.598 ' HG ' ' HE2' ' A' ' 21' ' ' HIS . 3.5 p -146.72 -163.29 1.72 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.304 -0.873 . . . . 0.0 109.498 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.533 ' HB2' ' CB ' ' A' ' 19' ' ' THR . 4.5 m-20 44.45 38.07 2.39 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.021 HG22 HG23 ' A' ' 91' ' ' VAL . 40.6 mm -70.1 125.7 28.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.587 0.708 . . . . 0.0 110.305 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.562 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -119.5 177.75 4.81 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.31 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -72.9 -69.59 0.4 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.722 -1.236 . . . . 0.0 109.457 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -83.06 8.6 12.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.973 -1.079 . . . . 0.0 109.414 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.785 ' HB2' HG22 ' A' ' 60' ' ' THR . 2.8 t -154.51 156.56 36.89 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.015 ' CE1' HG22 ' A' ' 20' ' ' VAL . 2.2 p90 -166.66 137.19 3.25 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.533 ' CB ' ' HB2' ' A' ' 12' ' ' ASP . 10.1 m -87.76 153.98 20.92 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.949 -1.095 . . . . 0.0 111.174 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 1.015 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -134.41 119.52 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.148 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.598 ' HE2' ' HG ' ' A' ' 11' ' ' SER . 20.1 m-70 -103.36 164.28 11.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.02 -1.05 . . . . 0.0 110.368 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.846 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 22.8 p90 -177.3 135.59 0.19 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.555 -0.715 . . . . 0.0 109.084 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.29 167.43 2.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.183 -0.948 . . . . 0.0 109.517 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -102.18 165.38 13.98 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.617 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 36.0 Cg_endo -78.23 -163.14 0.2 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.499 2.133 . . . . 0.0 110.299 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -120.59 28.33 8.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.925 . . . . 0.0 109.404 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.893 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -129.36 173.54 5.59 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 0.0 109.551 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.893 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 36.1 Cg_endo -78.4 130.44 10.0 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.615 2.21 . . . . 0.0 110.453 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.498 HD12 ' CE2' ' A' ' 32' ' ' TYR . 17.6 pt -135.98 169.93 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.918 . . . . 0.0 109.474 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.4 p -107.12 -19.95 13.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.476 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.08 -152.83 15.5 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.907 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 1.2 m-85 -162.08 123.23 2.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -1.123 . . . . 0.0 109.447 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.784 HD12 ' NE ' ' A' ' 49' ' ' ARG . 14.9 mm -85.41 122.65 38.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.189 -0.945 . . . . 0.0 109.624 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.077 HG23 ' CD1' ' A' ' 72' ' ' ILE . 2.6 mm -102.89 114.31 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.056 -1.028 . . . . 0.0 109.321 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.487 ' HG3' ' CG ' ' A' ' 47' ' ' GLN . 0.4 OUTLIER -105.58 144.86 31.75 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.103 -0.998 . . . . 0.0 108.912 179.361 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.804 ' HB3' HG13 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -143.53 140.14 30.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.056 -1.027 . . . . 0.0 110.032 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -176.17 144.39 0.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.32 -0.863 . . . . 0.0 109.665 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.571 ' HA ' ' CB ' ' A' ' 68' ' ' TYR . . . -64.99 170.48 4.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 109.605 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.33 -0.856 . . . . 0.0 109.453 -179.92 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.559 ' HD3' ' CE1' ' A' ' 36' ' ' HIS . 1.2 ptp85 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.489 0.661 . . . . 0.0 109.748 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.487 ' CG ' ' HG3' ' A' ' 35' ' ' ARG . 14.2 mp0 -126.91 118.1 23.89 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.312 -0.867 . . . . 0.0 109.568 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.628 ' OD2' HD23 ' A' ' 59' ' ' LEU . 65.8 m-20 -100.96 122.8 44.13 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.784 ' NE ' HD12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.18 140.53 32.35 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.031 -1.043 . . . . 0.0 109.493 -179.264 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.957 HG12 HD12 ' A' ' 57' ' ' ILE . 11.9 m -124.08 159.56 56.13 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.341 -0.849 . . . . 0.0 109.355 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.487 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 34.5 Cg_endo -77.14 174.37 12.92 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.581 2.187 . . . . 0.0 110.279 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.475 ' HB3' HG13 ' A' ' 29' ' ' ILE . 34.6 Cg_endo -76.96 -16.09 16.2 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.498 2.132 . . . . 0.0 110.486 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.7 t -100.85 27.86 5.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.351 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.464 ' HG3' ' HG2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -130.65 116.71 18.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.938 . . . . 0.0 109.677 -179.819 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -102.87 -6.01 22.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.394 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 62.7 p -139.2 130.84 27.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.357 -0.84 . . . . 0.0 109.018 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.957 HD12 HG12 ' A' ' 50' ' ' VAL . 5.4 tt -123.24 124.92 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.164 -0.96 . . . . 0.0 109.816 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.75 109.91 20.56 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.441 -0.787 . . . . 0.0 109.184 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.981 ' HB3' HD11 ' A' ' 62' ' ' LEU . 1.2 mp -84.83 158.65 20.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.164 -0.96 . . . . 0.0 109.778 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.785 HG22 ' HB2' ' A' ' 17' ' ' SER . 0.8 OUTLIER -150.86 175.29 12.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.654 -0.654 . . . . 0.0 109.332 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.499 ' O ' ' NH2' ' A' ' 46' ' ' ARG . 6.1 m120 52.57 37.8 24.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 0.0 109.496 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.981 HD11 ' HB3' ' A' ' 59' ' ' LEU . 5.2 mt -109.59 161.17 15.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 109.387 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -55.07 113.33 5.26 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 34.5 Cg_endo -74.19 123.64 8.43 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.984 1.79 . . . . 0.0 111.009 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 82.67 64.56 1.68 Allowed Glycine 0 N--CA 1.485 1.916 0 N-CA-C 108.186 -1.966 . . . . 0.0 108.186 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.0 m -152.27 118.9 5.69 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.126 -1.22 . . . . 0.0 110.821 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.559 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 11.6 tt0 -74.82 135.74 41.62 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.822 ' OH ' HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -153.44 176.54 11.9 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.79 -1.193 . . . . 0.0 111.076 -178.436 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.656 HG12 HG23 ' A' ' 85' ' ' ILE . 1.9 t -107.27 151.55 9.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.804 HG13 ' HB3' ' A' ' 36' ' ' HIS . 1.1 t -132.98 130.92 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.983 -1.073 . . . . 0.0 109.492 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.819 ' O ' HD13 ' A' ' 72' ' ' ILE . 10.5 p -108.44 156.43 19.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.254 -0.904 . . . . 0.0 110.484 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.077 ' CD1' HG23 ' A' ' 34' ' ' ILE . 28.4 mm -135.71 92.51 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.927 HD12 ' HB3' ' A' ' 83' ' ' PRO . 1.2 mm -83.71 140.85 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.106 -0.996 . . . . 0.0 109.928 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.907 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . . . -96.38 157.86 15.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 109.181 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.69 136.55 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 109.47 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 76' ' ' ASN . 12.6 t-20 -135.14 46.37 2.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 109.424 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.52 -91.57 0.84 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.51 1.36 13.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -1.167 . . . . 0.0 109.647 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.544 ' HB3' HD11 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -92.72 -171.66 2.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.97 . . . . 0.0 109.47 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 79' ' ' GLU . 4.9 mt-10 -171.16 91.49 0.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.487 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.593 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.6 OUTLIER -59.55 -179.18 0.15 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 108.987 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.593 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 31.4 Cg_endo -74.49 150.35 40.68 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.08 1.853 . . . . 0.0 110.348 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.927 ' HB3' HD12 ' A' ' 73' ' ' ILE . 36.1 Cg_endo -77.57 144.11 22.17 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.811 2.341 . . . . 0.0 111.62 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.839 HD22 ' C ' ' A' ' 5' ' ' PRO . 3.4 tp -109.7 93.65 4.61 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.656 HG23 HG12 ' A' ' 69' ' ' VAL . 3.3 mt -100.23 141.19 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.939 . . . . 0.0 110.15 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.54 ' O ' HG13 ' A' ' 69' ' ' VAL . . . -136.66 -165.06 10.38 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -129.94 140.0 51.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.985 -1.303 . . . . 0.0 109.77 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.532 ' HG2' ' CB ' ' A' ' 10' ' ' SER . 2.4 tp60 -154.29 -165.36 2.07 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.372 -0.83 . . . . 0.0 109.318 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.559 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.43 130.28 2.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.256 -0.903 . . . . 0.0 109.57 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.822 HG23 ' OH ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -73.16 138.35 45.66 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.281 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.021 HG23 HG22 ' A' ' 13' ' ' ILE . 2.3 t . . . . . 0 C--N 1.302 -1.48 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 1.12 ' CG ' HD11 ' A' ' 162' ' ' LEU . 35.7 Cg_endo . . . . . 0 C--O 1.215 -0.664 0 N-CA-C 109.891 -0.849 . . . . 0.0 109.891 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.576 ' CB ' ' CZ ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -65.9 -165.34 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.444 -0.785 . . . . 0.0 109.734 -179.648 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.41 ' CG ' ' HG3' ' A' ' 113' ' ' GLU . 0.2 OUTLIER 64.41 11.62 6.66 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.235 -0.915 . . . . 0.0 109.227 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.745 HD23 HG23 ' A' ' 180' ' ' ILE . 19.7 tp -59.25 92.77 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.281 -0.887 . . . . 0.0 109.213 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -126.5 160.53 30.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.264 -0.898 . . . . 0.0 109.335 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 8.5 p -104.64 138.47 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.402 -0.811 . . . . 0.0 109.818 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.796 ' CG1' HD23 ' A' ' 109' ' ' LEU . 8.7 pt -122.96 -11.23 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.389 -0.82 . . . . 0.0 109.407 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.807 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -134.73 82.12 1.94 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.526 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 6.4 m -85.81 95.4 9.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.816 . . . . 0.0 110.45 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.532 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -96.24 159.66 31.55 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 121.244 -0.91 . . . . 0.0 109.036 179.052 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.473 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.4 Cg_endo -70.47 -1.74 9.55 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.509 2.139 . . . . 0.0 110.738 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.817 ' C ' HG22 ' A' ' 152' ' ' ILE . 7.1 p -144.68 10.93 1.41 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 109.342 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.911 ' O ' HD23 ' A' ' 108' ' ' LEU . 3.2 p -169.01 166.6 11.02 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 118.907 -1.117 . . . . 0.0 109.767 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.011 HD22 ' CZ ' ' A' ' 182' ' ' TYR . 0.4 OUTLIER -141.75 150.77 42.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.137 -0.977 . . . . 0.0 109.091 -179.557 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.807 ' CB ' ' HB3' ' A' ' 102' ' ' ALA . 13.9 tp -106.26 116.33 31.74 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 108.824 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.96 ' CD1' ' HB3' ' A' ' 147' ' ' ALA . 3.2 pt -102.35 149.4 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.079 -1.013 . . . . 0.0 110.192 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.671 ' CB ' HG22 ' A' ' 146' ' ' THR . 5.1 t -153.1 125.18 7.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.516 -0.74 . . . . 0.0 109.382 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.578 ' CE2' ' O ' ' A' ' 145' ' ' SER . 3.1 p90 -124.21 -170.13 2.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.233 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.41 ' HG3' ' CG ' ' A' ' 97' ' ' ASP . 3.1 mt-10 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.14 -0.975 . . . . 0.0 109.914 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.777 ' CE1' HG22 ' A' ' 139' ' ' THR . 1.6 p90 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.596 ' HB3' HD13 ' A' ' 162' ' ' LEU . 3.0 m-85 -106.11 115.35 30.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.98 -1.075 . . . . 0.0 109.56 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 5.5 ttm180 -84.62 98.81 10.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.11 -0.994 . . . . 0.0 109.017 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 1.034 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 55.2 mt -84.25 151.42 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 0.0 110.045 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 46.2 p -123.92 133.27 53.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.46 -0.775 . . . . 0.0 109.901 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.689 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 4.9 m-85 -80.19 118.36 21.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.49 -0.756 . . . . 0.0 109.359 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 158' ' ' TYR . . . -91.94 105.74 3.32 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.285 -1.126 . . . . 0.0 108.876 179.08 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.545 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 2.6 mm100 . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 13.2 pt-20 -101.96 149.87 23.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -0.948 . . . . 0.0 110.743 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 1.034 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 34.1 p90 -143.07 145.75 33.17 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.777 HG22 ' CE1' ' A' ' 121' ' ' TYR . 3.0 p -75.01 149.69 39.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.99 -1.069 . . . . 0.0 110.589 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.657 HG13 ' HD2' ' A' ' 141' ' ' PRO . 53.7 t -112.31 141.6 25.4 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 121.762 -0.586 . . . . 0.0 109.443 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.657 ' HD2' HG13 ' A' ' 140' ' ' VAL . 35.6 Cg_endo -77.66 141.81 19.92 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.433 2.088 . . . . 0.0 110.307 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -88.03 23.0 15.68 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.42 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 1.9 m -104.42 -0.94 27.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -1.149 . . . . 0.0 109.576 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 143' ' ' SER . 15.2 mmtt -143.02 153.85 43.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 109.48 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.578 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 0.4 OUTLIER -93.35 -18.27 22.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 109.395 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.671 HG22 ' CB ' ' A' ' 111' ' ' SER . 66.1 p -107.77 152.79 23.89 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.199 -0.938 . . . . 0.0 108.941 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.96 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -130.96 148.17 52.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.064 -1.023 . . . . 0.0 109.635 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 8.2 t -91.08 147.42 23.09 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.184 -0.948 . . . . 0.0 109.347 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.689 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 13.9 mm -128.46 95.62 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.358 -0.839 . . . . 0.0 109.119 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.522 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 2.6 m-20 -104.54 -164.17 1.03 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.517 -0.74 . . . . 0.0 109.733 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.511 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 6.6 p-10 42.03 60.58 2.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.429 -0.794 . . . . 0.0 109.902 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.817 HG22 ' C ' ' A' ' 106' ' ' THR . 6.4 tt -116.52 155.28 18.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.269 -0.894 . . . . 0.0 109.568 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.07 117.19 67.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.753 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.473 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 35.9 Cg_endo -78.91 163.85 25.63 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.518 2.146 . . . . 0.0 110.562 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 61.8 51.47 57.07 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -177.37 130.45 0.16 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.223 -1.163 . . . . 0.0 109.699 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -51.62 165.93 0.15 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.597 ' CE2' HG13 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -144.98 172.68 12.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.881 -1.137 . . . . 0.0 110.255 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.553 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 1.8 m -145.7 96.74 2.86 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 179' ' ' SER . 51.5 mm -84.69 132.44 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.889 -1.132 . . . . 0.0 109.705 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.846 HG23 ' CB ' ' A' ' 179' ' ' SER . 1.1 m -142.26 165.33 27.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.309 -0.869 . . . . 0.0 109.24 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 1.12 HD11 ' CG ' ' A' ' 95' ' ' PRO . 1.3 pp -159.64 151.13 20.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.013 -1.054 . . . . 0.0 110.72 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.611 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 2.1 m-85 -122.03 90.45 3.31 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.434 ' HB2' ' HG3' ' A' ' 95' ' ' PRO . . . -54.0 117.47 3.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.864 -1.147 . . . . 0.0 109.039 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.545 HG21 ' CZ ' ' A' ' 121' ' ' TYR . 22.2 t . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.892 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 175' ' ' SER . 1.2 p . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 174' ' ' SER . 84.6 p -55.47 -166.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.168 -0.957 . . . . 0.0 109.21 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.436 ' N ' ' CD ' ' A' ' 176' ' ' LYS . 0.0 OUTLIER -74.59 145.78 82.58 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 108.829 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.611 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 34.9 Cg_endo -77.71 133.77 13.04 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.429 2.086 . . . . 0.0 111.019 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 161' ' ' THR . 2.2 t -105.82 134.47 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.846 ' CB ' HG23 ' A' ' 161' ' ' THR . 1.3 p -131.45 143.24 50.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 110.558 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.745 HG23 HD23 ' A' ' 98' ' ' LEU . 13.4 pt -129.89 152.44 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -82.57 168.71 17.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.082 -1.012 . . . . 0.0 109.7 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 1.011 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 44.2 t80 -165.21 124.32 1.75 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.323 -0.86 . . . . 0.0 109.415 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -95.19 112.13 23.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.009 -1.057 . . . . 0.0 109.443 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.433 ' HB ' ' HA ' ' A' ' 154' ' ' PRO . 28.9 p . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.524 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.775 HD11 ' CB ' ' A' ' 81' ' ' SER . 1.5 pp . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.546 ' O ' HD12 ' A' ' 2' ' ' LEU . 21.7 m-20 -74.91 148.12 40.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.391 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.491 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 18.0 p -84.5 159.97 57.49 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.591 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.634 ' HD3' ' HB2' ' A' ' 74' ' ' ALA . 35.5 Cg_endo -78.27 96.77 1.1 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.715 2.277 . . . . 0.0 109.943 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.678 ' HA ' HD22 ' A' ' 84' ' ' LEU . 2.1 p -83.89 -111.65 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.166 -0.959 . . . . 0.0 109.79 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 22' ' ' TRP . . . 45.53 26.12 1.58 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.443 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 13.5 t80 -55.59 107.76 0.37 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.485 -1.009 . . . . 0.0 110.003 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 6.3 t70 -133.52 100.21 4.74 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.405 -0.809 . . . . 0.0 108.841 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.884 ' OG ' HG13 ' A' ' 20' ' ' VAL . 4.7 m -84.63 128.27 34.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.216 -0.928 . . . . 0.0 109.578 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 19' ' ' THR . 5.5 p -164.0 -157.06 0.37 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.316 -0.865 . . . . 0.0 109.402 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.534 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 2.5 m-20 47.33 38.01 6.71 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.638 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.5 mt -87.07 163.84 2.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.761 0.791 . . . . 0.0 111.427 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.587 ' N ' HG22 ' A' ' 13' ' ' ILE . 0.7 OUTLIER -155.27 -172.83 4.31 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.945 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.581 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -81.02 -44.14 18.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.931 -1.106 . . . . 0.0 109.484 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 17' ' ' SER . 1.5 m120 -114.6 39.75 2.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.991 -1.068 . . . . 0.0 109.037 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 14' ' ' THR . 5.8 p 168.55 145.5 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.638 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 2.0 p90 -164.97 145.38 7.3 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.108 -0.995 . . . . 0.0 108.827 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.611 HG22 ' N ' ' A' ' 20' ' ' VAL . 52.3 m -112.34 164.23 13.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.737 -1.227 . . . . 0.0 111.132 -178.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.884 HG13 ' OG ' ' A' ' 10' ' ' SER . 1.6 t -130.43 168.42 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.588 ' CD2' ' HB3' ' A' ' 56' ' ' SER . 19.2 m80 -144.35 161.88 37.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.936 -1.102 . . . . 0.0 110.104 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.601 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 10.0 p90 -168.18 142.19 3.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.434 -0.791 . . . . 0.0 109.171 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.85 166.02 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.04 -1.037 . . . . 0.0 109.435 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.659 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -94.01 165.57 17.5 Favored Pre-proline 0 C--N 1.3 -1.585 0 O-C-N 121.634 -0.666 . . . . 0.0 109.632 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.659 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.7 Cg_endo -78.27 178.12 7.95 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.606 2.204 . . . . 0.0 110.384 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.08 12.82 26.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 109.442 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.984 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -118.13 176.71 1.52 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.409 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.984 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 34.9 Cg_endo -77.7 118.05 4.42 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.538 2.159 . . . . 0.0 110.285 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.633 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 47.3 pt -131.47 179.99 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 109.614 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.7 p -120.71 -22.11 6.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.864 . . . . 0.0 109.458 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 167.97 174.68 37.08 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.633 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -124.42 133.73 53.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.248 -1.148 . . . . 0.0 109.391 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.871 ' O ' HD13 ' A' ' 34' ' ' ILE . 44.8 mm -74.95 144.42 12.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.187 -0.945 . . . . 0.0 109.251 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.871 HD13 ' O ' ' A' ' 33' ' ' ILE . 7.9 mm -124.57 93.15 2.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.21 -0.931 . . . . 0.0 110.058 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.454 ' HB2' ' OG ' ' A' ' 71' ' ' SER . 1.0 OUTLIER -104.17 128.53 51.86 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.812 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.886 ' CB ' HG22 ' A' ' 70' ' ' VAL . 54.5 p-80 -148.33 176.85 9.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.727 -1.233 . . . . 0.0 110.845 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.472 ' HB3' ' O ' ' A' ' 36' ' ' HIS . 1.9 p80 176.9 -173.37 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.035 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . -112.55 132.17 55.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.165 -0.959 . . . . 0.0 109.175 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.484 ' HG2' ' HB2' ' A' ' 67' ' ' GLU . 1.3 pt-20 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 0.0 109.556 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.52 ' NE ' ' OD1' ' A' ' 48' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.454 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 47.0 mt-30 -100.43 134.63 43.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 110.589 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.52 ' OD1' ' NE ' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -149.24 147.82 28.84 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.967 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.585 ' HG3' HD13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -134.53 158.79 43.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.864 -1.147 . . . . 0.0 110.104 -179.055 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.803 HG22 ' CG1' ' A' ' 34' ' ' ILE . 12.3 m -136.87 161.08 63.64 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.468 -0.77 . . . . 0.0 109.076 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.53 ' HG2' ' CD ' ' A' ' 54' ' ' ARG . 33.5 Cg_endo -76.21 174.12 13.35 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.478 2.119 . . . . 0.0 110.333 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.623 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.2 Cg_endo -76.49 -29.51 5.91 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.587 2.192 . . . . 0.0 110.518 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -82.91 -7.78 59.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.398 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.53 ' CD ' ' HG2' ' A' ' 51' ' ' PRO . 3.4 mpt_? -93.96 109.34 21.08 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.412 -0.805 . . . . 0.0 109.838 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -97.27 -1.51 44.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.423 -0.798 . . . . 0.0 109.377 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.588 ' HB3' ' CD2' ' A' ' 21' ' ' HIS . 77.2 p -140.99 147.83 39.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.297 -0.877 . . . . 0.0 109.168 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.674 HD13 HG21 ' A' ' 34' ' ' ILE . 1.4 tt -131.95 119.49 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.119 -0.988 . . . . 0.0 109.388 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.585 HG23 ' OG1' ' A' ' 19' ' ' THR . 45.7 m -87.85 138.06 31.79 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.349 -0.845 . . . . 0.0 109.62 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.019 ' HB3' HD11 ' A' ' 62' ' ' LEU . 4.6 mt -111.23 159.46 17.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.512 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.5 p -144.37 173.37 11.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -0.882 . . . . 0.0 109.475 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m120 52.9 52.36 14.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -0.891 . . . . 0.0 109.546 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.019 HD11 ' HB3' ' A' ' 59' ' ' LEU . 7.7 mt -122.17 133.51 54.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.472 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.498 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 42.5 m-20 -48.66 128.15 13.77 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.056 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.581 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 36.1 Cg_endo -78.01 133.6 12.5 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.36 2.04 . . . . 0.0 110.665 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 82.89 61.24 1.96 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.462 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 4.5 m -162.37 159.86 25.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.392 -1.064 . . . . 0.0 109.734 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 2.0 mm-40 -90.77 134.5 34.38 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.369 -0.832 . . . . 0.0 108.839 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 1.035 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 15.0 m-85 -119.17 115.52 24.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.086 -1.009 . . . . 0.0 109.709 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.854 HG13 ' HG2' ' A' ' 87' ' ' GLN . 1.4 t -82.48 120.06 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.899 . . . . 0.0 108.99 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.886 HG22 ' CB ' ' A' ' 36' ' ' HIS . 27.1 t -117.92 138.61 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 109.443 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.546 ' CB ' HG12 ' A' ' 85' ' ' ILE . 80.2 p -116.84 139.1 51.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 110.13 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.7 mm -120.49 92.37 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.415 -0.803 . . . . 0.0 109.207 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.471 ' HB ' ' HB ' ' A' ' 33' ' ' ILE . 25.1 mm -90.78 137.52 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 109.634 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.869 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -99.54 137.79 37.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.423 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.23 150.21 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 0.0 109.444 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.441 ' HB3' ' HB2' ' A' ' 79' ' ' GLU . 28.1 t30 -137.53 49.82 1.98 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.43 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.91 -94.48 2.0 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.0 tpt85 -106.65 -0.76 23.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -1.153 . . . . 0.0 109.501 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 1.6 mt-10 -100.38 148.99 24.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.191 -0.943 . . . . 0.0 109.316 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.72 103.85 8.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.676 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.869 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -59.7 -178.41 0.13 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 108.931 179.687 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.603 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 32.7 Cg_endo -75.82 151.08 35.54 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.171 1.914 . . . . 0.0 110.204 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.0 Cg_endo -77.23 115.21 3.91 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.675 2.25 . . . . 0.0 111.379 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.678 HD22 ' HA ' ' A' ' 6' ' ' THR . 12.5 tp -106.08 104.25 13.91 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.546 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.8 mt -111.56 162.25 9.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.039 -1.038 . . . . 0.0 110.4 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.545 ' N ' HG22 ' A' ' 85' ' ' ILE . . . -155.77 162.91 31.49 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.854 ' HG2' HG13 ' A' ' 69' ' ' VAL . 4.0 mt-30 -136.66 118.56 15.22 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.119 -1.224 . . . . 0.0 110.042 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -110.59 -146.94 0.41 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.258 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.54 136.72 3.88 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.879 -1.138 . . . . 0.0 110.341 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.93 137.88 41.97 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.19 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.539 ' O ' ' N ' ' A' ' 65' ' ' GLY . 1.8 t . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.517 -0.739 . . . . 0.0 109.308 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.555 ' HB2' ' CD1' ' A' ' 112' ' ' TRP . 36.4 Cg_endo . . . . . 0 C--O 1.215 -0.671 0 N-CA-C 110.186 -0.736 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.6 OUTLIER -70.61 -176.62 1.32 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.63 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER 77.01 27.82 0.68 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 109.67 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.749 HD23 HG23 ' A' ' 180' ' ' ILE . 33.6 tp -76.97 101.88 6.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.148 -0.97 . . . . 0.0 109.394 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -137.15 170.2 16.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.561 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 11.8 p -93.75 147.97 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.197 -0.939 . . . . 0.0 109.665 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.554 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 11.7 pt -129.7 -2.41 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.369 -0.832 . . . . 0.0 109.552 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.552 ' CB ' HD12 ' A' ' 109' ' ' LEU . . . -165.33 116.26 1.11 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.318 -0.864 . . . . 0.0 108.68 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.504 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.8 t -104.48 93.23 4.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.114 -0.991 . . . . 0.0 110.221 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.56 ' OG1' ' N ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -78.41 163.48 61.5 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.314 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.478 ' O ' HG23 ' A' ' 106' ' ' THR . 29.6 Cg_endo -68.4 -2.44 9.12 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.4 2.067 . . . . 0.0 110.856 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.879 ' C ' HG22 ' A' ' 152' ' ' ILE . 11.6 p -155.26 20.75 0.42 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.294 -0.879 . . . . 0.0 108.723 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' SER . . . . . 1.068 ' O ' HD23 ' A' ' 108' ' ' LEU . 52.4 p -173.43 161.47 4.11 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.935 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.068 HD23 ' O ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -139.67 155.76 47.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.371 -0.83 . . . . 0.0 109.274 -179.665 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.554 ' HB3' ' CG1' ' A' ' 101' ' ' ILE . 19.8 mt -100.29 132.78 45.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.291 -0.881 . . . . 0.0 108.892 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.783 HD11 ' CD1' ' A' ' 149' ' ' ILE . 0.5 OUTLIER -119.63 141.27 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.168 -0.958 . . . . 0.0 109.809 -179.617 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 97' ' ' ASP . 37.8 t -133.75 135.17 43.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.411 -0.806 . . . . 0.0 109.385 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.619 ' HH2' ' HB2' ' A' ' 147' ' ' ALA . 43.4 p90 -140.28 143.21 35.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.399 -0.813 . . . . 0.0 109.288 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 8.9 mm-40 . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.944 . . . . 0.0 109.282 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.994 ' CE2' HG22 ' A' ' 139' ' ' THR . 2.8 p90 . . . . . 0 N--CA 1.487 1.389 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.484 ' HB2' ' HB ' ' A' ' 140' ' ' VAL . 5.5 m-85 -120.54 154.52 35.22 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.791 -1.193 . . . . 0.0 110.085 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.586 ' HG2' ' CE2' ' A' ' 121' ' ' TYR . 4.5 mmm-85 -112.07 88.08 2.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.389 -0.819 . . . . 0.0 109.032 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.629 ' CG2' ' CE2' ' A' ' 138' ' ' PHE . 88.9 mt -84.08 160.24 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 109.491 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 18.5 p -145.32 150.78 37.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.127 -0.983 . . . . 0.0 110.474 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 1.123 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 2.5 m-85 -87.31 139.72 30.27 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.598 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -105.74 107.48 2.8 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.11 -1.229 . . . . 0.0 109.475 179.609 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 126' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 0.8 OUTLIER -79.38 128.19 33.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 111.057 -178.6 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.629 ' CE2' ' CG2' ' A' ' 124' ' ' ILE . 17.8 p90 -128.11 140.04 52.16 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.994 HG22 ' CE2' ' A' ' 121' ' ' TYR . 1.2 p -74.44 153.52 39.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.046 -1.034 . . . . 0.0 111.103 -178.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.684 HG13 ' HD2' ' A' ' 141' ' ' PRO . 94.5 t -118.07 143.18 32.29 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.684 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.2 Cg_endo -76.81 119.65 5.21 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.332 2.021 . . . . 0.0 110.298 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -55.47 -17.13 11.94 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.3 t -83.84 12.32 6.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.157 -1.202 . . . . 0.0 109.696 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.452 ' HB2' ' HG2' ' A' ' 141' ' ' PRO . 43.1 mmtt -139.08 122.53 17.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.954 . . . . 0.0 109.552 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.568 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 11.9 p -82.28 -5.37 58.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.919 . . . . 0.0 109.506 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.54 ' C ' ' CH2' ' A' ' 112' ' ' TRP . 6.9 p -124.87 154.08 41.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.25 -0.906 . . . . 0.0 109.357 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.678 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -123.98 168.52 12.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.882 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' THR . . . . . 1.024 HG22 ' OD1' ' A' ' 150' ' ' ASN . 22.4 m -130.8 104.12 6.98 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.303 -0.873 . . . . 0.0 109.306 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 1.123 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -82.57 93.3 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.033 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 1.024 ' OD1' HG22 ' A' ' 148' ' ' THR . 1.7 m-20 -100.28 174.1 6.29 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.282 -0.886 . . . . 0.0 109.632 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 67.09 37.0 3.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 109.193 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.879 HG22 ' C ' ' A' ' 106' ' ' THR . 4.5 tt -95.45 161.8 2.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.445 -0.784 . . . . 0.0 109.733 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -98.27 108.85 49.6 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.222 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.457 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 36.2 Cg_endo -77.22 75.74 4.5 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.483 2.122 . . . . 0.0 110.568 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.708 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 168.48 59.36 0.03 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.708 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 163.59 136.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -1.109 . . . . 0.0 109.533 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 156' ' ' ALA . 22.8 t70 -46.34 158.01 0.12 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.735 ' CD1' HG21 ' A' ' 184' ' ' THR . 0.3 OUTLIER -140.6 -177.21 4.94 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.873 -1.142 . . . . 0.0 110.496 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.575 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 3.1 m -157.83 114.45 2.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.484 -0.76 . . . . 0.0 109.093 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.449 HG21 HG21 ' A' ' 110' ' ' ILE . 25.4 mm -97.03 126.71 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.567 -1.333 . . . . 0.0 109.73 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.997 HG23 ' CB ' ' A' ' 179' ' ' SER . 1.3 m -138.96 167.2 22.58 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.221 -0.924 . . . . 0.0 109.357 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.523 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 0.9 OUTLIER -162.95 150.35 13.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.912 -1.117 . . . . 0.0 111.109 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.622 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.3 m-85 -121.39 100.11 6.85 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -55.13 129.26 37.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.871 -1.143 . . . . 0.0 109.084 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.597 HG21 ' CZ ' ' A' ' 121' ' ' TYR . 65.1 t . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.931 . . . . 0.0 109.863 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 2.0 p . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.401 0.62 . . . . 0.0 110.011 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 174' ' ' SER . 16.8 p -54.85 -168.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.327 -0.858 . . . . 0.0 109.035 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt -68.16 144.27 96.69 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.0 -1.062 . . . . 0.0 108.706 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.622 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.1 Cg_endo -76.68 132.78 13.53 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.317 2.011 . . . . 0.0 111.437 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 3.7 t -106.01 130.64 57.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.997 ' CB ' HG23 ' A' ' 161' ' ' THR . 1.1 p -130.17 147.88 51.95 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.123 -0.986 . . . . 0.0 110.808 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.749 HG23 HD23 ' A' ' 98' ' ' LEU . 19.0 pt -131.55 151.84 36.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -86.04 156.58 20.36 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.046 -1.034 . . . . 0.0 109.672 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.753 ' CZ ' HD13 ' A' ' 108' ' ' LEU . 54.1 t80 -161.22 123.8 3.11 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.335 -0.853 . . . . 0.0 109.432 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.87 130.78 38.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.23 -0.919 . . . . 0.0 109.542 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.735 HG21 ' CD1' ' A' ' 158' ' ' TYR . 6.4 p . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.495 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.738 HD21 HD22 ' A' ' 76' ' ' ASN . 1.4 mp . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.548 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 3.2 m-20 -74.89 153.52 38.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.866 . . . . 0.0 108.954 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.502 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 89.9 p -96.53 107.81 38.49 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.344 -0.847 . . . . 0.0 110.115 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.608 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 36.4 Cg_endo -80.15 77.72 3.96 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.56 2.173 . . . . 0.0 109.893 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . 1.093 HG22 ' CD2' ' A' ' 84' ' ' LEU . 73.6 p -93.16 -104.74 0.12 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.154 -0.966 . . . . 0.0 110.112 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 55.81 20.73 26.96 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -44.68 127.67 6.28 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.749 -0.853 . . . . 0.0 109.929 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.478 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 4.7 t0 -162.81 105.81 1.07 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.362 -0.836 . . . . 0.0 109.047 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 16.1 m -84.89 127.29 34.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.908 . . . . 0.0 109.736 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.507 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 3.5 p -154.49 -163.17 1.54 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.562 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 2.4 m-20 44.9 38.59 3.03 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.671 HD12 ' OE1' ' A' ' 88' ' ' GLN . 1.6 mm -74.57 130.01 36.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.581 0.705 . . . . 0.0 110.851 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.549 ' CB ' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -119.35 175.63 5.73 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.923 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -67.01 -75.56 0.09 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.865 -1.147 . . . . 0.0 109.463 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 15.3 p-10 -78.66 -2.5 39.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.302 -0.874 . . . . 0.0 109.82 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.629 ' HB2' HG22 ' A' ' 60' ' ' THR . 6.4 t -143.27 160.83 39.76 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.245 -0.909 . . . . 0.0 109.058 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.694 ' HE1' HG22 ' A' ' 20' ' ' VAL . 3.5 p90 -167.33 145.66 4.85 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.722 ' OG1' HG23 ' A' ' 58' ' ' THR . 2.8 m -109.98 157.18 19.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.353 -1.467 . . . . 0.0 111.395 -178.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.694 HG22 ' HE1' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -123.11 166.63 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.017 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.507 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 26.1 m-70 -137.67 160.23 39.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.94 -1.1 . . . . 0.0 110.404 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.788 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 21.7 p90 177.56 139.61 0.08 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -74.34 159.19 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 120.946 -1.096 . . . . 0.0 110.116 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -96.82 165.58 15.66 Favored Pre-proline 0 C--N 1.3 -1.545 0 O-C-N 121.819 -0.551 . . . . 0.0 109.774 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 1.003 ' CG ' HD13 ' A' ' 29' ' ' ILE . 36.2 Cg_endo -79.56 145.38 18.41 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.604 2.203 . . . . 0.0 110.181 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.461 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 0.7 OUTLIER -80.21 5.52 14.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 0.0 109.493 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.901 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -108.23 173.68 2.89 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.935 . . . . 0.0 109.448 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.901 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.7 Cg_endo -78.03 88.57 1.42 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.657 2.238 . . . . 0.0 110.55 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.003 HD13 ' CG ' ' A' ' 25' ' ' PRO . 36.0 pt -98.13 -179.79 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.397 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.532 HG21 ' N ' ' A' ' 77' ' ' GLY . 2.3 p -102.13 -21.49 14.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.345 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.49 165.36 10.27 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 1.146 ' CD1' HG22 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -90.5 148.6 22.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -1.091 . . . . 0.0 110.314 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.777 HG23 ' HD2' ' A' ' 49' ' ' ARG . 0.5 OUTLIER -102.3 103.38 14.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.839 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.863 HD11 HG22 ' A' ' 50' ' ' VAL . 1.3 mm -88.28 117.59 32.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 O-C-N 121.314 -0.866 . . . . 0.0 109.885 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -122.72 111.77 17.13 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.374 -0.829 . . . . 0.0 108.879 179.407 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.91 ' CE1' HD21 ' A' ' 59' ' ' LEU . 1.4 p-80 -105.98 122.0 45.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.935 . . . . 0.0 110.11 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.574 ' CE1' ' O ' ' A' ' 69' ' ' VAL . 37.3 p-80 -140.71 127.68 20.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.423 -0.798 . . . . 0.0 109.008 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -39.4 151.5 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.803 . . . . 0.0 110.008 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.49 ' OE1' ' CG2' ' A' ' 69' ' ' VAL . 5.7 mm-40 . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.531 ' HB2' ' NE2' ' A' ' 36' ' ' HIS . 3.1 mmm180 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 47' ' ' GLN . 16.9 pt20 -113.2 102.44 10.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.248 -0.907 . . . . 0.0 109.482 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.495 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 1.7 m-20 -106.34 115.8 30.83 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -0.907 . . . . 0.0 109.254 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.777 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -92.6 140.54 29.44 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.194 -0.941 . . . . 0.0 109.476 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.863 HG22 HD11 ' A' ' 34' ' ' ILE . 26.8 m -115.54 151.65 46.3 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.301 -0.874 . . . . 0.0 109.309 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.476 ' HG2' ' HG2' ' A' ' 54' ' ' ARG . 35.3 Cg_endo -77.7 174.27 12.87 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.599 2.2 . . . . 0.0 110.373 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.497 ' HB3' HG13 ' A' ' 29' ' ' ILE . 34.0 Cg_endo -77.07 -15.59 16.27 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.573 2.182 . . . . 0.0 110.269 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -90.43 14.78 12.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.314 -0.867 . . . . 0.0 109.22 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.476 ' HG2' ' HG2' ' A' ' 51' ' ' PRO . 5.9 mmm-85 -133.48 126.33 30.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 109.575 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 2.8 p-10 -109.83 -4.96 15.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.93 . . . . 0.0 109.431 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 16.0 p -130.53 145.43 51.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 109.068 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.788 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 3.0 tt -129.12 118.89 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.953 . . . . 0.0 109.642 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.722 HG23 ' OG1' ' A' ' 19' ' ' THR . 0.3 OUTLIER -91.74 103.04 15.65 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.364 -0.835 . . . . 0.0 109.241 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.973 ' HB3' HD11 ' A' ' 62' ' ' LEU . 2.5 mt -84.92 144.82 28.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -0.922 . . . . 0.0 109.672 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.629 HG22 ' HB2' ' A' ' 17' ' ' SER . 63.7 p -137.69 -174.77 3.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 0.0 109.414 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 56.39 20.1 4.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.416 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.973 HD11 ' HB3' ' A' ' 59' ' ' LEU . 2.4 mt -96.49 156.85 16.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.929 . . . . 0.0 109.242 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.468 ' O ' ' OH ' ' A' ' 68' ' ' TYR . 2.3 t30 -61.44 132.71 92.93 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.097 -1.002 . . . . 0.0 108.485 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.3 Cg_endo -77.51 124.64 7.14 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.159 1.906 . . . . 0.0 110.767 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 77.8 60.98 2.64 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.636 ' HB ' ' HH ' ' A' ' 68' ' ' TYR . 3.0 m -145.88 167.0 24.32 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.242 -1.152 . . . . 0.0 110.084 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.8 OUTLIER -125.2 121.51 34.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.434 -0.791 . . . . 0.0 109.674 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.636 ' HH ' ' HB ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -124.89 -172.57 2.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 0.0 109.302 179.685 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.574 ' O ' ' CE1' ' A' ' 37' ' ' HIS . 41.7 t -122.28 110.62 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 35' ' ' ARG . 3.5 t -96.57 127.19 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.778 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.579 ' HB3' HD13 ' A' ' 85' ' ' ILE . 95.1 p -108.01 133.98 51.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.32 -0.862 . . . . 0.0 109.951 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.146 HG22 ' CD1' ' A' ' 32' ' ' TYR . 5.2 mm -115.57 104.16 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.892 . . . . 0.0 109.242 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.667 HD12 ' HB3' ' A' ' 83' ' ' PRO . 21.1 mm -109.81 109.49 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.13 -0.981 . . . . 0.0 109.57 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.737 ' HB3' ' CB ' ' A' ' 81' ' ' SER . . . -75.88 140.81 42.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -0.959 . . . . 0.0 109.299 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.551 HG21 HD11 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -131.43 176.35 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.289 -0.882 . . . . 0.0 109.561 -179.734 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.738 HD22 HD21 ' A' ' 2' ' ' LEU . 34.2 t30 -156.44 43.68 0.4 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.476 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.532 ' N ' HG21 ' A' ' 30' ' ' THR . . . 91.13 -77.12 1.45 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.441 ' HD2' ' C ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -125.18 3.22 7.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -1.164 . . . . 0.0 109.679 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.509 ' OE1' ' ND2' ' A' ' 76' ' ' ASN . 4.0 mt-10 -100.34 -174.9 2.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.182 -0.949 . . . . 0.0 109.486 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 0.8 OUTLIER -149.9 143.93 25.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.889 . . . . 0.0 109.596 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.737 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -110.34 -178.78 0.58 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.408 -0.807 . . . . 0.0 109.065 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.582 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.0 Cg_endo -77.66 131.11 11.12 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.21 1.94 . . . . 0.0 110.168 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.667 ' HB3' HD12 ' A' ' 73' ' ' ILE . 36.1 Cg_endo -78.25 152.43 27.24 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.483 2.122 . . . . 0.0 110.775 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.093 ' CD2' HG22 ' A' ' 6' ' ' THR . 0.0 OUTLIER -146.61 54.13 1.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 108.875 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.579 HD13 ' HB3' ' A' ' 71' ' ' SER . 6.4 mt -57.87 162.6 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.306 -0.871 . . . . 0.0 109.871 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.5 ' N ' HG22 ' A' ' 85' ' ' ILE . . . -164.98 160.85 34.2 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.525 ' HG3' HG22 ' A' ' 69' ' ' VAL . 0.7 OUTLIER -95.75 127.86 42.13 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.268 -1.136 . . . . 0.0 109.493 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.671 ' OE1' HD12 ' A' ' 13' ' ' ILE . 1.3 tm0? -125.31 128.26 47.95 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -107.44 130.39 54.83 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.198 -0.939 . . . . 0.0 110.235 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.458 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -74.41 135.9 42.39 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.145 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 65' ' ' GLY . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.212 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.621 ' HB2' ' CD1' ' A' ' 112' ' ' TRP . 35.3 Cg_endo . . . . . 0 C--O 1.215 -0.649 0 N-CA-C 109.997 -0.809 . . . . 0.0 109.997 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -64.38 -179.37 0.46 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.258 -0.901 . . . . 0.0 109.678 -179.655 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER 77.06 21.14 1.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.312 -0.868 . . . . 0.0 109.622 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.907 HD22 HD23 ' A' ' 162' ' ' LEU . 15.1 tp -69.87 102.6 2.0 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.162 -0.961 . . . . 0.0 109.291 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 97' ' ' ASP . 8.6 pt-20 -149.1 -174.04 4.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.134 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 109' ' ' LEU . 41.7 t -127.57 151.18 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.084 -1.01 . . . . 0.0 109.971 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.1 pt -119.13 -14.2 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.524 -0.735 . . . . 0.0 109.332 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.78 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -142.32 149.3 39.3 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.518 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 0.7 OUTLIER -134.88 106.07 6.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.993 -1.067 . . . . 0.0 110.234 -179.452 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.479 ' OG1' ' OG ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -91.73 158.18 40.57 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.4 -0.812 . . . . 0.0 108.97 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.462 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.3 Cg_endo -70.32 -2.51 10.69 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.383 2.055 . . . . 0.0 110.385 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.828 ' C ' HG22 ' A' ' 152' ' ' ILE . 64.7 p -150.34 19.08 0.85 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' SER . . . . . 1.075 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -168.0 168.56 11.9 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.801 179.742 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.075 HD23 ' O ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -141.33 154.2 45.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.67 -179.383 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.78 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.8 OUTLIER -105.31 106.66 17.26 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.921 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.858 HD12 HD13 ' A' ' 124' ' ' ILE . 0.0 OUTLIER -100.76 140.81 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.226 -0.921 . . . . 0.0 110.206 -179.117 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.477 ' HA ' ' HB ' ' A' ' 146' ' ' THR . 47.4 p -144.49 120.51 10.71 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.656 ' HH2' ' HB2' ' A' ' 147' ' ' ALA . 47.5 p90 -124.69 168.87 12.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.944 . . . . 0.0 109.662 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . 4.3 mt-10 . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.287 -0.883 . . . . 0.0 109.245 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.851 ' CE2' HG22 ' A' ' 139' ' ' THR . 1.5 p90 . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.459 ' HB2' ' HB ' ' A' ' 140' ' ' VAL . 5.5 m-85 -128.72 122.21 30.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.114 -0.991 . . . . 0.0 109.426 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.48 ' CD ' ' OE1' ' A' ' 137' ' ' GLU . 9.9 ttm180 -89.96 105.76 18.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.194 -0.942 . . . . 0.0 109.248 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 1.195 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 43.3 mt -84.7 166.46 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.677 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.664 HG22 ' HG2' ' A' ' 137' ' ' GLU . 1.3 p -141.8 137.22 31.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.866 . . . . 0.0 109.704 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 1.17 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 3.2 m-30 -92.04 132.4 36.59 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.597 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -103.42 112.31 4.18 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.287 -1.125 . . . . 0.0 109.136 179.348 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.61 ' HG2' ' CG ' ' A' ' 126' ' ' TYR . 1.8 pt20 . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.664 ' HG2' HG22 ' A' ' 125' ' ' THR . 84.0 mt-10 -96.76 152.23 18.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.105 -0.997 . . . . 0.0 111.434 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 1.195 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 1.7 p90 -143.88 139.89 29.47 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.851 HG22 ' CE2' ' A' ' 121' ' ' TYR . 1.6 p -74.2 144.37 44.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.029 -1.044 . . . . 0.0 111.317 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.807 HG13 ' HD2' ' A' ' 141' ' ' PRO . 48.5 t -108.78 145.77 32.36 Favored Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.807 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.3 Cg_endo -77.11 146.3 25.35 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.327 2.018 . . . . 0.0 110.011 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.17 19.62 25.77 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.425 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 0.5 OUTLIER -105.16 10.63 33.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.115 -1.226 . . . . 0.0 109.518 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 143' ' ' SER . 19.2 mmtp -152.42 135.93 16.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 109.616 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.572 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 7.2 p -83.53 1.72 40.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.921 . . . . 0.0 109.467 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.477 ' HB ' ' HA ' ' A' ' 111' ' ' SER . 11.7 p -137.38 146.51 44.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.914 . . . . 0.0 108.911 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.656 ' HB2' ' HH2' ' A' ' 112' ' ' TRP . . . -126.07 -171.42 2.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.07 -1.019 . . . . 0.0 109.593 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.606 HG22 ' N ' ' A' ' 149' ' ' ILE . 82.8 m -137.6 167.55 21.44 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.304 -0.872 . . . . 0.0 109.168 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 1.17 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 1.6 mt -126.36 141.41 45.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.251 -0.906 . . . . 0.0 109.134 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 151' ' ' ASN . 43.5 m-80 -134.5 176.09 8.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.325 -0.859 . . . . 0.0 109.539 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 150' ' ' ASN . 2.3 p-10 41.02 52.9 3.37 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.32 -0.862 . . . . 0.0 109.78 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.838 HD13 HD21 ' A' ' 108' ' ' LEU . 8.4 tt -101.66 164.07 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.322 -0.861 . . . . 0.0 109.216 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.464 ' N ' HG12 ' A' ' 152' ' ' ILE . 19.5 mmmt -99.89 108.01 49.46 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.113 -0.992 . . . . 0.0 109.806 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 152' ' ' ILE . 36.5 Cg_endo -79.38 174.69 11.62 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.571 2.181 . . . . 0.0 110.573 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.602 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 64.94 56.06 18.5 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 170.47 138.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -1.114 . . . . 0.0 109.654 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -54.79 161.05 1.68 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.597 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.3 OUTLIER -140.33 176.54 8.69 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.908 -1.12 . . . . 0.0 110.135 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.548 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 3.2 m -146.2 109.63 4.76 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.514 ' HB ' ' CG1' ' A' ' 180' ' ' ILE . 29.6 mm -89.86 143.19 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.953 -1.092 . . . . 0.0 110.349 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.949 HG23 ' CB ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -153.12 160.0 42.83 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.414 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.907 HD23 HD22 ' A' ' 98' ' ' LEU . 2.1 pp -161.48 148.45 14.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.914 -1.116 . . . . 0.0 110.632 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.604 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 2.4 m-85 -113.07 164.45 13.46 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -134.33 102.87 5.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.027 -1.045 . . . . 0.0 109.582 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.514 HG22 ' HB3' ' A' ' 174' ' ' SER . 51.5 t . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 109.725 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.514 ' HB3' HG22 ' A' ' 165' ' ' VAL . 14.2 p . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.453 0.644 . . . . 0.0 109.798 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 174' ' ' SER . 5.9 p 42.08 -165.54 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.06 140.58 29.03 Favored Pre-proline 0 C--N 1.305 -1.35 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.604 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 34.9 Cg_endo -77.51 130.23 10.69 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.354 2.036 . . . . 0.0 110.76 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.582 HG12 HD23 ' A' ' 98' ' ' LEU . 5.3 t -101.47 134.36 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.949 ' CB ' HG23 ' A' ' 161' ' ' THR . 1.3 p -126.61 155.63 42.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.172 -0.955 . . . . 0.0 110.191 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.514 ' CG1' ' HB ' ' A' ' 160' ' ' ILE . 24.6 pt -141.58 178.82 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -103.41 151.66 22.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.098 -1.001 . . . . 0.0 109.519 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.769 ' CE2' HD22 ' A' ' 108' ' ' LEU . 83.8 t80 -155.23 122.63 5.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.361 -0.837 . . . . 0.0 109.495 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.418 ' O ' ' CD ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -99.24 127.9 45.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.148 -0.97 . . . . 0.0 109.446 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.569 HG22 ' HE2' ' A' ' 182' ' ' TYR . 51.3 p . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.539 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.829 HD11 ' CB ' ' A' ' 81' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 25' ' ' PRO . 10.8 m-20 -84.93 123.08 30.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.425 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.559 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -95.73 177.5 1.75 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 109.528 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.665 ' O ' HG23 ' A' ' 6' ' ' THR . 36.2 Cg_endo -78.86 147.07 21.22 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.648 2.232 . . . . 0.0 110.096 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.665 HG23 ' O ' ' A' ' 5' ' ' PRO . 0.8 OUTLIER -161.25 -170.48 2.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.065 -1.022 . . . . 0.0 109.8 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 44.08 32.59 2.48 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.628 ' C ' ' CD1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -75.1 -167.68 0.65 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.51 -0.994 . . . . 0.0 109.99 -179.242 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -165.32 129.1 2.31 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.233 -0.917 . . . . 0.0 109.216 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.949 ' OG ' HG13 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -88.49 140.05 29.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.153 -0.967 . . . . 0.0 109.64 -179.728 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.507 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 60.2 p -148.16 -162.54 1.57 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.256 -0.903 . . . . 0.0 109.545 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.542 ' HB2' ' CB ' ' A' ' 19' ' ' THR . 4.4 m-20 45.34 39.77 4.7 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.077 HG22 HG22 ' A' ' 91' ' ' VAL . 24.5 mm -73.35 92.33 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.494 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.657 ' C ' HG23 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -93.04 166.38 12.39 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 176.702 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.62 ' N ' HG23 ' A' ' 91' ' ' VAL . . . -56.06 -77.81 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.961 -1.087 . . . . 0.0 111.106 -177.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -77.04 -0.08 23.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.109 -0.994 . . . . 0.0 110.177 -178.735 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.942 ' HB3' HG22 ' A' ' 60' ' ' THR . 20.8 p -144.67 123.58 12.73 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.164 -0.96 . . . . 0.0 109.237 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.935 ' CE1' HG22 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -135.09 136.05 41.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.119 -0.988 . . . . 0.0 108.335 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.582 ' OG1' HG23 ' A' ' 58' ' ' THR . 16.2 m -87.18 156.99 19.46 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.094 -1.004 . . . . 0.0 112.013 -177.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.949 HG13 ' OG ' ' A' ' 10' ' ' SER . 0.7 OUTLIER -135.58 97.94 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.673 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.507 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 15.5 m-70 -87.72 163.17 16.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.153 -0.967 . . . . 0.0 110.882 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.865 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 25.9 p90 -174.79 139.99 0.55 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.0 161.1 5.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.152 -0.967 . . . . 0.0 109.827 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.511 ' HB1' ' OH ' ' A' ' 32' ' ' TYR . . . -102.15 151.0 38.0 Favored Pre-proline 0 C--N 1.297 -1.691 0 O-C-N 121.779 -0.576 . . . . 0.0 109.511 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.528 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 36.2 Cg_endo -78.53 152.8 26.53 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.538 2.159 . . . . 0.0 110.247 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -92.69 27.06 2.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 109.627 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.958 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -105.34 175.32 2.18 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 109.271 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.958 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.2 Cg_endo -77.77 98.87 1.24 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.586 2.191 . . . . 0.0 110.363 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.635 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 39.4 pt -126.93 173.81 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 109.518 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.6 p -114.2 -18.83 11.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.262 -0.898 . . . . 0.0 109.346 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.28 170.68 26.27 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.635 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 1.2 m-85 -112.49 134.23 54.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -1.193 . . . . 0.0 109.492 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.814 ' C ' HD13 ' A' ' 34' ' ' ILE . 2.0 mt -88.54 126.8 41.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.303 -0.873 . . . . 0.0 109.069 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.062 HG23 ' CD1' ' A' ' 72' ' ' ILE . 1.1 mm -104.28 111.25 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.084 -1.01 . . . . 0.0 109.882 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.423 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 42.2 ttt-85 -121.7 108.16 13.21 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.301 -0.874 . . . . 0.0 108.898 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.938 ' HB3' HG13 ' A' ' 70' ' ' VAL . 18.3 p-80 -117.41 170.77 8.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 110.069 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.44 ' O ' ' O ' ' A' ' 38' ' ' ALA . 20.8 p80 -179.61 130.38 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.43 -0.794 . . . . 0.0 109.723 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -55.31 -168.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.262 -0.899 . . . . 0.0 109.318 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.124 -0.985 . . . . 0.0 109.329 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.577 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 3.7 mmt85 . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -110.23 85.26 2.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 0.0 109.63 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.512 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 29.7 m-20 -100.74 99.86 10.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.241 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.52 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -84.81 134.49 34.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.037 -1.039 . . . . 0.0 109.617 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.75 ' CG1' HD12 ' A' ' 57' ' ' ILE . 13.6 m -118.97 159.67 43.83 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.38 -0.825 . . . . 0.0 109.256 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.495 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 34.7 Cg_endo -77.0 174.16 13.3 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.528 2.152 . . . . 0.0 110.263 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.577 ' HA ' ' CE2' ' A' ' 32' ' ' TYR . 34.9 Cg_endo -76.89 -15.63 16.6 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.605 2.203 . . . . 0.0 110.43 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.87 23.53 2.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.473 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.435 ' O ' ' CZ2' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -137.52 109.47 7.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.923 . . . . 0.0 109.647 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 22' ' ' TRP . 5.2 p30 -95.13 -6.96 40.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 21' ' ' HIS . 64.9 p -139.1 129.49 25.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.318 -0.864 . . . . 0.0 109.057 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.865 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 3.4 tt -118.33 119.36 61.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.258 -0.902 . . . . 0.0 109.594 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.582 HG23 ' OG1' ' A' ' 19' ' ' THR . 0.3 OUTLIER -85.13 108.75 17.84 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.411 -0.806 . . . . 0.0 108.829 179.628 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.987 ' CB ' HD11 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -84.72 152.46 23.71 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.204 -0.935 . . . . 0.0 109.24 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.942 HG22 ' HB3' ' A' ' 17' ' ' SER . 21.5 p -142.93 -179.69 6.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.568 -0.708 . . . . 0.0 109.449 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 56.44 18.29 3.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 109.392 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.987 HD11 ' CB ' ' A' ' 59' ' ' LEU . 3.5 mt -92.68 142.8 26.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.246 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 62' ' ' LEU . 7.5 t-20 -45.86 123.99 6.4 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.204 -0.935 . . . . 0.0 108.651 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.421 ' HG3' ' OD1' ' A' ' 16' ' ' ASN . 35.2 Cg_endo -76.96 131.78 12.35 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.23 1.954 . . . . 0.0 110.32 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 71.89 61.6 3.71 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 90' ' ' THR . 3.3 m -154.91 149.3 26.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -1.136 . . . . 0.0 109.654 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.528 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 16.5 mt-10 -74.41 130.33 39.44 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.096 -1.002 . . . . 0.0 108.417 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 3.0 m-85 -126.0 115.97 20.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.093 -1.004 . . . . 0.0 110.377 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 36' ' ' HIS . 2.1 t -83.52 123.37 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.938 HG13 ' HB3' ' A' ' 36' ' ' HIS . 2.2 t -112.34 123.8 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.003 -1.061 . . . . 0.0 110.18 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.504 ' HB2' HG12 ' A' ' 85' ' ' ILE . 61.2 p -112.97 122.28 47.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.371 -0.831 . . . . 0.0 109.689 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.062 ' CD1' HG23 ' A' ' 34' ' ' ILE . 10.7 mm -107.19 136.49 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.273 -0.892 . . . . 0.0 109.54 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.91 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.7 mp -122.6 156.38 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 0.0 109.2 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.061 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -119.35 115.57 24.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.379 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.35 164.02 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.167 -0.958 . . . . 0.0 109.441 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -140.21 49.93 1.73 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.398 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.58 -82.24 1.65 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.44 ' HD3' ' C ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -120.19 -2.37 10.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -1.154 . . . . 0.0 109.564 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -92.96 -166.59 1.56 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.427 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 37.5 mt-10 -154.01 155.03 34.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.2 -0.938 . . . . 0.0 109.745 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . 1.061 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -129.49 179.89 1.19 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.385 -0.822 . . . . 0.0 108.978 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.576 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.3 Cg_endo -76.04 142.74 25.15 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.194 1.929 . . . . 0.0 109.855 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.8 Cg_endo -77.81 132.33 11.82 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.685 2.257 . . . . 0.0 111.529 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.64 HD22 ' O ' ' A' ' 5' ' ' PRO . 9.0 tp -108.16 100.75 10.03 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.504 HG12 ' HB2' ' A' ' 71' ' ' SER . 2.0 mt -105.63 157.35 6.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.065 -1.022 . . . . 0.0 110.486 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.478 ' N ' HG22 ' A' ' 85' ' ' ILE . . . -151.42 178.97 28.45 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -131.59 137.2 48.32 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.113 -1.228 . . . . 0.0 109.766 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.546 ' HG3' ' CB ' ' A' ' 10' ' ' SER . 1.8 mm100 -163.76 126.94 2.61 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.313 -0.867 . . . . 0.0 109.174 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.528 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -94.5 145.91 24.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.354 -0.841 . . . . 0.0 110.098 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.71 145.93 42.69 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.458 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.077 HG22 HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.462 -0.774 . . . . 0.0 109.096 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.463 ' HB2' ' HB2' ' A' ' 112' ' ' TRP . 36.2 Cg_endo . . . . . 0 C--O 1.214 -0.681 0 N-CA-C 109.499 -1.001 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 5.1 ptp180 -45.94 173.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.44 -0.788 . . . . 0.0 109.974 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 1.7 t70 82.38 15.34 0.43 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.68 -0.637 . . . . 0.0 110.004 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 1.059 HD23 HG12 ' A' ' 178' ' ' VAL . 20.7 tp -70.27 100.45 1.71 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.042 -1.037 . . . . 0.0 109.137 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 110' ' ' ILE . 0.7 OUTLIER -153.3 176.85 11.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.233 -0.917 . . . . 0.0 109.649 -179.797 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.564 HG22 ' N ' ' A' ' 101' ' ' ILE . 9.2 p -105.25 171.23 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.342 -0.849 . . . . 0.0 109.537 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.564 ' N ' HG22 ' A' ' 100' ' ' VAL . 3.6 pt -136.51 -42.69 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.277 -0.89 . . . . 0.0 109.166 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.899 ' HB3' ' CD1' ' A' ' 109' ' ' LEU . . . -121.99 114.29 20.75 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.569 ' CB ' ' HH ' ' A' ' 182' ' ' TYR . 1.2 t -99.94 99.16 9.88 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.24 -0.913 . . . . 0.0 110.5 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.516 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -89.38 160.74 41.67 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.639 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -69.64 -0.81 7.35 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.423 2.082 . . . . 0.0 110.937 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.867 ' C ' HG22 ' A' ' 152' ' ' ILE . 56.0 p -146.45 11.5 1.14 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.269 -0.894 . . . . 0.0 109.485 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' SER . . . . . 1.081 ' O ' HD23 ' A' ' 108' ' ' LEU . 85.3 p -172.48 165.52 5.67 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.682 -1.207 . . . . 0.0 110.41 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.081 HD23 ' O ' ' A' ' 107' ' ' SER . 0.4 OUTLIER -145.92 149.57 34.47 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.899 ' CD1' ' HB3' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -106.63 116.52 32.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.199 -0.938 . . . . 0.0 108.952 179.214 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.835 HD11 ' HB3' ' A' ' 147' ' ' ALA . 2.4 pt -100.03 -179.14 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.984 -1.072 . . . . 0.0 109.719 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 146' ' ' THR . 1.0 OUTLIER -168.42 150.96 5.26 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.551 -0.718 . . . . 0.0 109.778 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.655 ' CH2' ' HB2' ' A' ' 147' ' ' ALA . 24.2 p90 -154.03 -176.8 6.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.43 -0.794 . . . . 0.0 109.307 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 95' ' ' PRO . 19.1 mm-40 . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.095 -1.003 . . . . 0.0 109.742 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.959 ' CE1' HG22 ' A' ' 139' ' ' THR . 1.2 p90 . . . . . 0 N--CA 1.486 1.373 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.541 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 7.0 m-85 -107.58 123.43 48.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.013 -1.054 . . . . 0.0 109.331 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 4.2 ttp180 -86.11 106.11 17.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.206 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.832 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 26.1 mt -99.09 150.09 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.296 -0.878 . . . . 0.0 109.902 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 25.3 p -133.48 132.73 41.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.865 . . . . 0.0 109.932 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.702 ' CE2' HG22 ' A' ' 149' ' ' ILE . 30.5 m-85 -74.8 134.22 41.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.86 . . . . 0.0 109.225 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.586 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.32 106.73 2.71 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.198 -1.178 . . . . 0.0 109.529 179.882 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.58 ' HB3' ' CD1' ' A' ' 126' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 4.8 tt0 -85.82 111.75 20.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 110.372 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.832 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 13.3 p90 -122.39 132.18 54.25 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.959 HG22 ' CE1' ' A' ' 121' ' ' TYR . 1.7 p -74.29 174.48 8.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.225 -0.922 . . . . 0.0 110.741 -178.352 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.61 HG21 ' CD1' ' A' ' 124' ' ' ILE . 24.9 t -137.03 138.08 24.72 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.667 -0.646 . . . . 0.0 109.294 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.487 ' HD2' HG13 ' A' ' 140' ' ' VAL . 35.2 Cg_endo -76.95 132.72 13.12 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.346 2.031 . . . . 0.0 110.35 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.45 0.44 55.04 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -4.64 25.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.114 -1.227 . . . . 0.0 109.751 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.531 ' CD ' ' O ' ' A' ' 146' ' ' THR . 0.0 OUTLIER -154.71 157.67 38.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.935 . . . . 0.0 109.376 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.569 ' O ' ' CE3' ' A' ' 112' ' ' TRP . 0.1 OUTLIER -95.84 2.06 53.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.265 -0.897 . . . . 0.0 110.313 -179.348 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.531 ' O ' ' CD ' ' A' ' 144' ' ' LYS . 43.4 p -108.32 162.34 14.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.981 -1.075 . . . . 0.0 109.624 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.835 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -145.9 134.45 22.09 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.991 . . . . 0.0 109.749 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.2 t -83.91 153.47 23.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.328 -0.858 . . . . 0.0 109.031 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.702 HG22 ' CE2' ' A' ' 126' ' ' TYR . 14.3 mm -133.98 66.26 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.135 -0.978 . . . . 0.0 109.674 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.566 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 2.4 m-20 -84.2 -176.26 6.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.403 -0.811 . . . . 0.0 109.636 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 13.3 m120 68.47 21.4 8.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.22 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.867 HG22 ' C ' ' A' ' 106' ' ' THR . 2.8 tt -85.91 155.11 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.341 -0.849 . . . . 0.0 109.615 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.426 ' O ' ' OG1' ' A' ' 184' ' ' THR . 0.0 OUTLIER -103.88 123.81 39.79 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.231 -0.918 . . . . 0.0 109.298 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.46 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 35.9 Cg_endo -78.43 149.63 24.52 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.415 2.076 . . . . 0.0 110.402 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.698 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 78.43 66.16 1.77 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 163.97 131.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -1.162 . . . . 0.0 109.653 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.17 164.87 0.26 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.617 ' CD1' ' CG2' ' A' ' 184' ' ' THR . 0.2 OUTLIER -142.69 -179.36 6.27 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.846 -1.159 . . . . 0.0 110.363 -179.419 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.585 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 1.7 m -153.12 106.75 3.03 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.933 HD11 HD12 ' A' ' 108' ' ' LEU . 27.5 mt -97.72 116.79 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.805 -1.184 . . . . 0.0 109.754 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . 1.039 HG23 ' CB ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -125.04 153.52 42.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 109.165 179.68 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.828 ' CD2' HD13 ' A' ' 98' ' ' LEU . 2.3 pp -149.95 145.62 26.58 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.055 -1.028 . . . . 0.0 110.682 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.607 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 4.1 m-85 -114.11 177.39 4.66 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -140.53 110.09 6.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.231 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 95.7 t . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.276 -0.89 . . . . 0.0 109.639 -179.71 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.276 0.56 . . . . 0.0 109.589 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 73.5 p -64.07 -164.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.847 . . . . 0.0 109.365 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.24 144.84 51.06 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 108.91 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.607 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 35.7 Cg_endo -78.55 127.96 8.41 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.547 2.164 . . . . 0.0 110.931 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 1.059 HG12 HD23 ' A' ' 98' ' ' LEU . 69.1 t -96.5 123.51 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -0.91 . . . . 0.0 108.56 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' SER . . . . . 1.039 ' CB ' HG23 ' A' ' 161' ' ' THR . 0.4 OUTLIER -118.53 143.71 46.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.167 -0.958 . . . . 0.0 109.914 -179.537 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.5 pt -136.14 151.75 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -84.66 162.67 19.63 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.111 -0.993 . . . . 0.0 109.347 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.769 ' OH ' HD22 ' A' ' 108' ' ' LEU . 49.6 t80 -155.1 157.88 38.17 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.314 -0.867 . . . . 0.0 109.368 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.439 ' N ' ' CD1' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -126.57 119.06 26.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.18 -0.95 . . . . 0.0 109.474 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.617 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 10.8 p . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.54 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.845 HD22 HG22 ' A' ' 29' ' ' ILE . 1.9 mp . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.438 ' HB2' ' CB ' ' A' ' 25' ' ' PRO . 29.2 m-20 -115.34 169.84 8.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.43 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.481 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 37.1 p -94.8 119.22 66.37 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.541 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.554 ' O ' HD22 ' A' ' 84' ' ' LEU . 35.2 Cg_endo -77.85 88.13 1.45 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.367 2.045 . . . . 0.0 110.109 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 7' ' ' GLY . 1.8 p -80.87 -109.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.92 . . . . 0.0 109.682 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 22' ' ' TRP . . . 45.7 26.44 1.82 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.781 -1.727 . . . . 0.0 108.781 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.544 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 30.9 t80 -53.74 132.23 40.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.526 -0.985 . . . . 0.0 110.112 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 5.2 t0 -165.22 153.83 11.97 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.537 ' CB ' ' HG2' ' A' ' 88' ' ' GLN . 2.1 p -136.44 139.03 42.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.047 -1.033 . . . . 0.0 109.696 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.471 ' O ' ' HB ' ' A' ' 19' ' ' THR . 17.8 p -160.12 -165.6 1.51 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.249 -0.907 . . . . 0.0 109.579 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.556 ' HB2' ' CB ' ' A' ' 19' ' ' THR . 10.0 m-20 42.31 36.21 0.71 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.906 HG22 HG23 ' A' ' 91' ' ' VAL . 26.2 mm -66.32 134.2 30.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-O 121.418 0.628 . . . . 0.0 110.367 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.556 ' CB ' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -124.73 -179.8 4.66 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.328 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -72.4 -76.01 0.12 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.932 -1.105 . . . . 0.0 109.336 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 2.1 p-10 -76.69 0.78 19.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.87 . . . . 0.0 109.648 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.694 ' HB2' HG22 ' A' ' 60' ' ' THR . 3.6 t -150.47 162.47 40.52 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.246 -0.909 . . . . 0.0 109.139 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.904 ' CE1' HG22 ' A' ' 20' ' ' VAL . 7.7 p90 -166.69 139.87 3.81 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.556 ' CB ' ' HB2' ' A' ' 12' ' ' ASP . 23.6 m -83.02 158.74 22.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.738 -1.226 . . . . 0.0 111.447 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.904 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.5 t -136.89 166.58 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.503 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 14.2 m-70 -148.53 165.43 31.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.898 -1.126 . . . . 0.0 110.416 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.836 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 39.4 p90 -177.13 140.93 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.31 167.54 2.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 120.932 -1.105 . . . . 0.0 109.376 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.742 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -103.32 168.7 8.36 Favored Pre-proline 0 C--N 1.3 -1.581 0 O-C-N 121.671 -0.643 . . . . 0.0 109.936 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.742 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.5 Cg_endo -78.48 -158.73 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.703 2.269 . . . . 0.0 110.347 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.48 28.38 8.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.551 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.708 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -144.73 166.84 16.62 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.547 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.708 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.5 Cg_endo -78.25 89.88 1.31 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.633 2.222 . . . . 0.0 110.42 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.951 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 11.7 pt -87.83 -172.09 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -0.938 . . . . 0.0 109.457 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 2.8 p -112.33 -5.8 14.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.94 . . . . 0.0 109.563 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.06 172.35 12.49 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.951 ' CZ ' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -120.83 144.27 48.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -1.148 . . . . 0.0 109.375 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.547 HG23 ' HG3' ' A' ' 49' ' ' ARG . 22.6 mm -82.1 101.81 7.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.212 -0.93 . . . . 0.0 109.594 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.777 HD13 ' N ' ' A' ' 34' ' ' ILE . 1.5 mm -83.42 105.35 13.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.345 -0.847 . . . . 0.0 109.715 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.59 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -102.94 155.37 18.4 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.117 -0.989 . . . . 0.0 108.757 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.699 ' CE1' HD22 ' A' ' 62' ' ' LEU . 23.7 p80 -144.93 136.6 25.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.983 -1.073 . . . . 0.0 110.04 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.428 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 8.2 p80 -167.73 129.79 1.54 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.882 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -58.66 -172.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.401 -0.812 . . . . 0.0 109.436 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 179.968 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.531 ' HG2' ' NE2' ' A' ' 36' ' ' HIS . 6.2 ptm180 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 121.452 0.644 . . . . 0.0 109.798 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.505 ' HB3' ' HG3' ' A' ' 35' ' ' ARG . 3.8 pt20 -113.16 130.23 56.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.409 -0.807 . . . . 0.0 109.436 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.504 ' C ' ' CD ' ' A' ' 49' ' ' ARG . 9.0 m-20 -112.91 158.27 20.41 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.547 ' HG3' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -133.12 157.5 45.15 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.398 -0.814 . . . . 0.0 109.872 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 1.098 ' CG1' HD12 ' A' ' 57' ' ' ILE . 27.0 m -143.02 159.71 55.27 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.434 -0.791 . . . . 0.0 109.247 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.536 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 35.3 Cg_endo -77.6 173.93 13.43 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.567 2.178 . . . . 0.0 110.517 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 35.6 Cg_endo -77.86 -15.49 14.98 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.674 2.25 . . . . 0.0 110.518 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.3 t -97.8 18.41 15.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.493 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.536 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 15.4 mmm180 -127.31 109.35 11.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.802 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 13.3 p-10 -94.81 -7.12 41.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.219 -0.925 . . . . 0.0 109.199 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 42.0 p -134.56 130.62 36.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.42 -0.8 . . . . 0.0 108.987 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.098 HD12 ' CG1' ' A' ' 50' ' ' VAL . 1.5 tt -132.06 143.42 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.143 -0.973 . . . . 0.0 109.795 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 16.8 m -102.63 125.7 49.46 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.295 -0.878 . . . . 0.0 109.328 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.96 ' CB ' HD11 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -91.13 153.73 19.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.888 . . . . 0.0 109.329 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.694 HG22 ' HB2' ' A' ' 17' ' ' SER . 13.8 p -139.51 -178.79 5.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 109.462 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 54.69 27.38 8.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 109.364 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.96 HD11 ' CB ' ' A' ' 59' ' ' LEU . 2.1 mt -105.46 148.16 27.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.121 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -49.33 130.21 17.51 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.106 -0.996 . . . . 0.0 108.525 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.1 Cg_endo -76.85 129.18 10.54 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.33 2.02 . . . . 0.0 110.756 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 69.8 63.87 3.16 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 90' ' ' THR . 2.4 m -156.86 152.01 26.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.339 -1.095 . . . . 0.0 110.486 -178.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.6 OUTLIER -78.6 124.44 28.16 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.463 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.517 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 2.2 m-85 -119.19 119.42 34.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.983 -1.073 . . . . 0.0 110.319 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.511 HG13 ' HG3' ' A' ' 87' ' ' GLN . 16.3 t -78.67 122.37 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.59 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.8 t -107.08 136.35 42.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.11 -0.994 . . . . 0.0 110.188 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.526 ' OG ' ' CB ' ' A' ' 35' ' ' ARG . 10.5 p -110.91 108.43 18.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.363 -0.836 . . . . 0.0 109.67 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.814 ' C ' HD12 ' A' ' 73' ' ' ILE . 17.1 mm -91.87 110.1 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 109.959 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.814 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.5 mp -113.96 153.33 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.16 -0.962 . . . . 0.0 109.092 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.919 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -112.71 145.46 40.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.527 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.464 ' O ' ' OG1' ' A' ' 30' ' ' THR . 0.9 OUTLIER -147.13 142.19 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.294 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.664 ' OD1' HD21 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -112.96 50.13 0.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.214 -0.929 . . . . 0.0 109.472 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.41 -59.19 3.69 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.527 ' N ' ' HD2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -130.36 0.16 4.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -1.123 . . . . 0.0 109.63 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 7.3 mt-10 -100.9 -164.7 1.13 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 0.0 109.365 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 20.2 mt-10 -151.03 -170.44 3.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 109.592 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.919 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -167.74 -178.08 0.6 Allowed Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.595 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.7 Cg_endo -76.67 142.56 23.09 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.126 1.884 . . . . 0.0 110.151 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.4 Cg_endo -77.56 129.97 10.47 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.678 2.252 . . . . 0.0 110.967 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.554 HD22 ' O ' ' A' ' 5' ' ' PRO . 22.3 tp -120.13 84.04 2.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -0.825 . . . . 0.0 109.01 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 70' ' ' VAL . 3.0 mt -94.67 152.8 3.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.208 -0.933 . . . . 0.0 109.954 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.544 ' HA3' ' CZ ' ' A' ' 8' ' ' PHE . . . -143.95 -172.45 14.7 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.511 ' HG3' HG13 ' A' ' 69' ' ' VAL . 9.8 mt-30 -138.26 131.01 29.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -1.183 . . . . 0.0 109.766 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.537 ' HG2' ' CB ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -141.32 -152.0 0.39 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 108.962 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.28 145.54 7.01 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.878 -1.139 . . . . 0.0 110.59 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.461 ' CG2' ' O ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -84.85 142.43 29.74 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.906 HG23 HG22 ' A' ' 13' ' ' ILE . 1.9 t . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.416 -0.802 . . . . 0.0 109.307 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.993 ' HG3' HD11 ' A' ' 162' ' ' LEU . 33.9 Cg_endo . . . . . 0 C--O 1.215 -0.674 0 N-CA-C 109.886 -0.851 . . . . 0.0 109.886 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 13.9 tpp85 -61.76 158.86 14.74 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.538 -0.726 . . . . 0.0 109.516 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.9 OUTLIER 80.1 17.17 0.71 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.559 -0.713 . . . . 0.0 109.507 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.875 ' O ' HG21 ' A' ' 180' ' ' ILE . 26.7 tp -60.51 100.07 0.09 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.228 -0.92 . . . . 0.0 108.918 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -140.56 -171.75 3.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.206 -0.934 . . . . 0.0 109.173 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 109' ' ' LEU . 35.3 t -126.41 150.53 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.16 -0.963 . . . . 0.0 110.014 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.704 HG12 HD12 ' A' ' 109' ' ' LEU . 3.0 pt -121.21 -14.43 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.475 -0.766 . . . . 0.0 109.505 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.876 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -134.08 133.42 41.11 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.517 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.8 p -122.73 81.91 1.92 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.033 -1.042 . . . . 0.0 110.374 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.542 HG21 ' OG ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -73.76 163.52 67.82 Favored Pre-proline 0 C--N 1.305 -1.365 0 O-C-N 121.147 -0.971 . . . . 0.0 108.51 179.177 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.492 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 29.7 Cg_endo -68.56 -2.32 9.05 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.4 2.066 . . . . 0.0 110.777 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.879 ' C ' HG22 ' A' ' 152' ' ' ILE . 17.1 p -155.38 21.55 0.41 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.326 -0.859 . . . . 0.0 108.684 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' SER . . . . . 1.069 ' O ' HD23 ' A' ' 108' ' ' LEU . 49.6 p -173.24 158.88 3.71 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.467 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.069 HD23 ' O ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -143.91 151.82 40.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.149 -0.969 . . . . 0.0 109.514 -179.569 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 1.065 HD13 ' N ' ' A' ' 110' ' ' ILE . 2.8 tm? -86.9 144.76 26.83 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.433 -0.792 . . . . 0.0 109.091 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 1.065 ' N ' HD13 ' A' ' 109' ' ' LEU . 0.6 OUTLIER -127.09 150.71 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.083 -1.011 . . . . 0.0 109.953 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.6 t -156.1 139.99 16.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.45 -0.782 . . . . 0.0 109.32 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.617 ' CD1' ' HB3' ' A' ' 95' ' ' PRO . 28.5 p90 -150.63 160.69 43.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.512 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.474 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 59.4 mt-10 . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.0 109.498 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.687 ' CE2' HG22 ' A' ' 139' ' ' THR . 3.2 p90 . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.442 0.639 . . . . 0.0 109.887 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 1.6 m-85 -141.01 142.7 34.21 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.539 ' CD ' ' HB2' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -113.63 106.56 14.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.012 -1.055 . . . . 0.0 109.413 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.646 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 20.2 mt -84.62 164.99 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.355 -0.84 . . . . 0.0 109.141 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.917 HG22 ' HG2' ' A' ' 137' ' ' GLU . 3.0 p -135.39 140.83 45.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.914 . . . . 0.0 110.105 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 1.209 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 3.6 m-30 -85.9 124.01 31.89 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.625 ' HA3' ' HB ' ' A' ' 159' ' ' THR . . . -95.05 112.11 4.32 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 . . . . . 0 C--N 1.297 -1.688 0 O-C-N 121.228 -1.16 . . . . 0.0 109.295 179.258 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.529 ' HB3' ' HB2' ' A' ' 126' ' ' TYR . 1.5 tt0 . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.917 ' HG2' HG22 ' A' ' 125' ' ' THR . 0.5 OUTLIER -105.18 119.23 38.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.128 -0.983 . . . . 0.0 110.808 -179.045 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.646 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 26.5 p90 -118.89 149.49 41.48 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.687 HG22 ' CE2' ' A' ' 121' ' ' TYR . 1.3 p -73.97 -174.03 1.74 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.008 -1.057 . . . . 0.0 110.879 -177.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.661 HG13 ' HD2' ' A' ' 141' ' ' PRO . 55.7 t -153.0 141.16 13.78 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.239 -0.913 . . . . 0.0 109.715 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.661 ' HD2' HG13 ' A' ' 140' ' ' VAL . 36.0 Cg_endo -78.5 128.88 9.02 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.396 2.064 . . . . 0.0 110.052 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -81.96 47.28 3.66 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.3 p -105.42 -2.48 23.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -1.175 . . . . 0.0 109.747 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -166.2 170.03 13.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.142 -0.974 . . . . 0.0 109.683 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.05 21.2 8.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.321 -0.862 . . . . 0.0 109.642 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.565 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 70.0 p -139.01 152.32 47.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.175 -0.953 . . . . 0.0 109.504 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.483 ' C ' ' CG1' ' A' ' 110' ' ' ILE . . . -144.13 -164.29 1.86 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.213 -0.93 . . . . 0.0 109.239 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.639 HG22 ' N ' ' A' ' 149' ' ' ILE . 20.9 m -146.21 165.77 28.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 109.736 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 1.209 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -138.89 111.87 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.367 -0.833 . . . . 0.0 109.109 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.465 ' HA ' ' CB ' ' A' ' 107' ' ' SER . 13.6 m-80 -109.62 177.5 4.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.858 . . . . 0.0 109.369 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 30.0 m120 54.97 69.41 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 108.998 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.879 HG22 ' C ' ' A' ' 106' ' ' THR . 9.2 tt -129.34 163.86 33.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.385 -0.822 . . . . 0.0 109.897 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.471 ' N ' HG12 ' A' ' 152' ' ' ILE . 0.3 OUTLIER -94.37 110.77 50.6 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 109.177 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 152' ' ' ILE . 35.7 Cg_endo -78.35 153.37 27.53 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.4 2.067 . . . . 0.0 110.638 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 74.99 64.07 2.4 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.566 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 171.37 131.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -1.145 . . . . 0.0 109.659 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.78 133.9 42.3 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.606 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -116.22 177.28 4.74 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.904 -1.123 . . . . 0.0 110.23 -179.069 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.625 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 1.8 m -143.53 98.55 3.27 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.482 ' HB ' HG13 ' A' ' 180' ' ' ILE . 32.9 mm -84.94 125.45 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.933 -1.104 . . . . 0.0 110.213 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.623 HG23 ' CB ' ' A' ' 179' ' ' SER . 1.4 m -133.29 170.5 15.36 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.993 HD11 ' HG3' ' A' ' 95' ' ' PRO . 0.9 OUTLIER -167.79 150.68 5.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.792 -1.192 . . . . 0.0 111.048 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.6 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 1.2 m-85 -124.45 119.92 30.55 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -85.12 116.13 23.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.877 -1.139 . . . . 0.0 109.226 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.57 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 53.2 t . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 109.99 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 175' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 174' ' ' SER . 0.7 OUTLIER -54.39 -169.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.011 179.677 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.462 ' HG3' ' N ' ' A' ' 177' ' ' PRO . 0.5 OUTLIER -80.98 145.89 58.0 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.543 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.6 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 34.7 Cg_endo -77.21 139.12 18.59 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.474 2.116 . . . . 0.0 111.042 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 161' ' ' THR . 2.2 t -113.48 139.14 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.623 ' CB ' HG23 ' A' ' 161' ' ' THR . 0.4 OUTLIER -130.48 136.0 48.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 110.17 -179.282 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.875 HG21 ' O ' ' A' ' 98' ' ' LEU . 9.8 pt -125.16 152.08 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 29.5 m-20 -85.32 160.6 19.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.126 -0.984 . . . . 0.0 109.634 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.882 ' OH ' HD22 ' A' ' 108' ' ' LEU . 66.8 t80 -159.25 116.47 2.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 109.437 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -84.81 113.16 21.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.92 . . . . 0.0 109.549 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.704 HG22 ' CE2' ' A' ' 182' ' ' TYR . 21.6 p . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.489 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.83 HD12 ' O ' ' A' ' 80' ' ' GLU . 94.7 mt . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 28.5 m-20 -75.05 167.04 22.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.868 . . . . 0.0 109.447 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.536 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 22.7 t -94.82 124.15 55.52 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.952 . . . . 0.0 109.639 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 1.023 ' O ' HD22 ' A' ' 84' ' ' LEU . 35.6 Cg_endo -78.78 83.76 2.18 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.437 2.091 . . . . 0.0 110.161 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.448 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.9 p -75.92 -109.85 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 22' ' ' TRP . . . 45.46 26.16 1.53 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.411 ' N ' ' C ' ' A' ' 6' ' ' THR . 22.5 t80 -55.25 121.09 8.1 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.519 -0.989 . . . . 0.0 109.958 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 1.0 OUTLIER -149.26 103.42 3.31 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.425 -0.797 . . . . 0.0 108.853 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.501 ' HB3' ' NE2' ' A' ' 88' ' ' GLN . 3.8 p -84.54 124.78 31.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 109.586 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 19' ' ' THR . 3.6 p -155.34 -162.17 1.3 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.202 -0.936 . . . . 0.0 109.32 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.566 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.9 OUTLIER 44.9 38.15 2.77 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -178.796 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.113 HG22 HG22 ' A' ' 91' ' ' VAL . 2.3 mt -88.12 141.31 14.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.81 0.814 . . . . 0.0 111.417 -177.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.642 ' C ' HG23 ' A' ' 91' ' ' VAL . 1.5 p -127.43 156.87 41.4 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.84 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -58.95 -36.9 75.57 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.009 -1.057 . . . . 0.0 110.26 -178.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 17' ' ' SER . 0.5 OUTLIER -112.36 38.17 2.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.562 -1.336 . . . . 0.0 109.3 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.614 ' HA ' HD12 ' A' ' 62' ' ' LEU . 1.4 t 160.65 155.65 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.897 ' CB ' HG23 ' A' ' 13' ' ' ILE . 5.1 p90 -165.88 152.09 9.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.624 -1.298 . . . . 0.0 109.886 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.968 ' OG1' HG23 ' A' ' 58' ' ' THR . 25.4 m -109.09 153.6 23.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.766 -1.209 . . . . 0.0 110.86 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.784 HG22 ' HE1' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -118.43 169.43 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.431 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.536 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 17.7 m-70 -143.71 157.57 44.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.177 -0.952 . . . . 0.0 109.79 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.607 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 32.4 p90 -164.64 146.63 8.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.304 -0.873 . . . . 0.0 109.392 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.7 167.48 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.127 -0.983 . . . . 0.0 109.273 179.717 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.502 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -95.9 160.8 29.32 Favored Pre-proline 0 C--N 1.299 -1.63 0 O-C-N 121.584 -0.698 . . . . 0.0 109.541 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.489 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 36.0 Cg_endo -79.16 160.28 26.53 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.6 2.2 . . . . 0.0 110.377 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.423 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 1.2 mtm-85 -84.02 46.34 1.18 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.923 . . . . 0.0 109.487 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.91 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -158.31 173.32 5.1 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.374 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.91 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.8 Cg_endo -78.35 136.14 13.94 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.586 2.191 . . . . 0.0 110.445 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.639 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 21.0 pt -140.93 -170.39 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 46.2 p -132.44 2.44 3.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.584 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.5 -168.58 28.5 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.639 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -146.29 133.38 20.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -1.137 . . . . 0.0 109.516 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.876 ' C ' HD13 ' A' ' 34' ' ' ILE . 0.7 OUTLIER -87.29 123.57 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.179 -0.951 . . . . 0.0 108.766 179.581 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.011 HG23 ' CD1' ' A' ' 72' ' ' ILE . 1.1 mm -109.37 158.25 9.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.244 -0.91 . . . . 0.0 109.167 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.756 ' O ' HG13 ' A' ' 70' ' ' VAL . 50.7 ttp180 -155.49 146.62 22.58 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.537 ' NE2' ' HD2' ' A' ' 46' ' ' ARG . 1.1 p80 -128.9 151.99 49.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.926 -1.109 . . . . 0.0 109.964 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.628 ' CE1' ' CG1' ' A' ' 69' ' ' VAL . 55.9 p-80 -170.4 108.81 0.35 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.743 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -45.92 160.26 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.244 -0.91 . . . . 0.0 109.447 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.502 ' HG2' HG23 ' A' ' 69' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 109.56 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.537 ' HD2' ' NE2' ' A' ' 36' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -106.98 120.28 41.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.368 -0.832 . . . . 0.0 110.124 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 1.029 ' HB3' HD11 ' A' ' 57' ' ' ILE . 6.6 m-20 -102.48 117.98 35.88 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.717 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.1 155.25 17.23 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.095 -1.003 . . . . 0.0 110.054 -179.223 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.88 HG11 ' HB ' ' A' ' 57' ' ' ILE . 15.1 m -136.09 158.99 72.68 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.478 -0.764 . . . . 0.0 109.199 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.52 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.3 Cg_endo -76.49 174.08 13.43 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.552 2.168 . . . . 0.0 110.302 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.546 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 35.5 Cg_endo -77.17 -15.97 15.89 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.606 2.204 . . . . 0.0 110.448 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.3 p -97.86 8.47 44.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.442 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.52 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -115.74 106.21 13.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.206 -0.934 . . . . 0.0 109.759 -179.742 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -85.46 -2.58 58.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.168 -0.958 . . . . 0.0 109.245 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 61.4 p -137.96 144.62 41.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.868 . . . . 0.0 109.119 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.029 HD11 ' HB3' ' A' ' 48' ' ' ASP . 8.0 tt -118.58 127.73 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.112 -0.993 . . . . 0.0 109.792 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.968 HG23 ' OG1' ' A' ' 19' ' ' THR . 0.3 OUTLIER -90.31 113.95 25.91 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.411 -0.806 . . . . 0.0 109.458 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.794 HD13 ' CZ ' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -84.86 147.75 26.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.43 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.455 ' HA ' ' HB2' ' A' ' 17' ' ' SER . 0.9 OUTLIER -126.41 154.19 43.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 109.63 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.959 ' O ' HD23 ' A' ' 62' ' ' LEU . 1.1 m-80 61.85 79.57 0.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.362 -0.836 . . . . 0.0 109.595 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.959 HD23 ' O ' ' A' ' 61' ' ' ASN . 6.0 mt -143.33 134.68 26.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -0.879 . . . . 0.0 109.449 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -55.05 130.63 67.78 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.254 -0.904 . . . . 0.0 109.043 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.84 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 36.4 Cg_endo -78.1 128.36 9.02 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.389 2.059 . . . . 0.0 110.692 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.14 58.65 2.42 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 90' ' ' THR . 2.5 m -157.28 143.37 17.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.31 -1.112 . . . . 0.0 109.22 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.535 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 3.2 mt-10 -74.41 130.28 39.36 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.027 -1.046 . . . . 0.0 108.793 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 4.1 m-85 -121.5 101.17 7.45 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.16 -0.962 . . . . 0.0 110.046 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.628 ' CG1' ' CE1' ' A' ' 37' ' ' HIS . 58.9 t -67.98 130.08 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 35' ' ' ARG . 47.0 t -126.0 136.97 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.993 -1.067 . . . . 0.0 109.962 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.522 ' CB ' HG12 ' A' ' 85' ' ' ILE . 92.3 p -111.53 123.86 51.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 110.146 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.011 ' CD1' HG23 ' A' ' 34' ' ' ILE . 11.6 mm -100.65 131.86 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.373 -0.829 . . . . 0.0 109.621 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.954 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.7 mp -126.14 164.12 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -0.858 . . . . 0.0 108.919 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.884 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -128.36 141.88 51.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.284 -0.885 . . . . 0.0 109.595 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.41 134.13 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.343 -0.848 . . . . 0.0 109.347 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.681 ' HB2' HD11 ' A' ' 2' ' ' LEU . 37.0 t30 -108.93 46.46 0.97 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.522 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 87.03 -80.39 1.74 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.52 -1.97 13.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.179 -1.189 . . . . 0.0 109.6 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 1.3 mp0 -100.62 -165.75 1.24 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 109.27 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.83 ' O ' HD12 ' A' ' 2' ' ' LEU . 23.7 mt-10 -146.58 -168.66 3.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 109.665 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.884 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -159.37 -179.17 1.03 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.396 -0.815 . . . . 0.0 108.983 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.588 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.4 Cg_endo -77.36 141.93 20.72 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.23 1.954 . . . . 0.0 109.943 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.4 Cg_endo -77.71 88.83 1.38 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.524 2.15 . . . . 0.0 111.038 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 1.023 HD22 ' O ' ' A' ' 5' ' ' PRO . 4.6 tp -75.08 104.11 5.53 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.572 HG22 ' N ' ' A' ' 86' ' ' GLY . 2.5 mt -105.0 163.27 4.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.095 -1.003 . . . . 0.0 110.375 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.572 ' N ' HG22 ' A' ' 85' ' ' ILE . . . -159.36 159.24 30.3 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.481 -1.847 . . . . 0.0 108.481 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . 29.5 mt-30 -117.76 131.29 56.61 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.185 -1.185 . . . . 0.0 109.815 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.628 ' OE1' HG21 ' A' ' 70' ' ' VAL . 3.6 pt20 -136.37 -165.59 1.75 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.535 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -154.74 146.57 23.42 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.025 -1.047 . . . . 0.0 109.75 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.91 132.94 41.82 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.543 -0.863 . . . . 0.0 108.91 179.563 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.113 HG22 HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.826 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 113' ' ' GLU . 30.6 Cg_endo . . . . . 0 C--O 1.215 -0.632 0 N-CA-C 109.375 -1.048 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 17.9 ttt180 -60.27 177.09 0.29 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.389 0.614 . . . . 0.0 110.387 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.502 ' HB3' ' HA ' ' A' ' 112' ' ' TRP . 0.7 OUTLIER 66.4 24.79 10.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.513 -0.742 . . . . 0.0 109.256 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 1.097 HD21 ' CD1' ' A' ' 162' ' ' LEU . 0.2 OUTLIER -61.61 102.45 0.25 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.349 -0.844 . . . . 0.0 109.531 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 97' ' ' ASP . 3.8 pt-20 -153.78 171.57 18.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.209 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 109' ' ' LEU . 40.2 t -115.1 155.87 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.157 -0.964 . . . . 0.0 109.747 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.961 HD11 HD23 ' A' ' 109' ' ' LEU . 0.8 OUTLIER -127.91 -7.39 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.46 -0.775 . . . . 0.0 109.821 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.767 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -136.47 122.13 19.73 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.527 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.4 p -112.62 75.66 0.93 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.092 -1.005 . . . . 0.0 110.415 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 107' ' ' SER . 0.7 OUTLIER -74.0 159.59 83.73 Favored Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.15 -0.969 . . . . 0.0 108.622 179.225 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.453 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.1 Cg_endo -69.04 -1.85 8.62 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.493 2.129 . . . . 0.0 111.003 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.898 ' C ' HG22 ' A' ' 152' ' ' ILE . 70.7 p -152.33 19.13 0.65 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 108.893 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.97 ' C ' HD23 ' A' ' 108' ' ' LEU . 6.8 p -173.71 147.54 1.39 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.024 -1.071 . . . . 0.0 110.144 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.97 HD23 ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -124.29 154.72 39.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.404 -0.81 . . . . 0.0 109.294 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.961 HD23 HD11 ' A' ' 101' ' ' ILE . 13.0 tp -105.22 107.16 17.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.269 -0.894 . . . . 0.0 108.731 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.713 ' CD1' ' HB3' ' A' ' 147' ' ' ALA . 1.4 pt -85.8 129.48 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.221 -0.924 . . . . 0.0 110.262 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.609 ' HA ' HG22 ' A' ' 146' ' ' THR . 1.3 p -126.32 123.28 37.68 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.582 ' CE3' ' O ' ' A' ' 145' ' ' SER . 19.3 p90 -152.64 -175.73 5.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.947 -1.095 . . . . 0.0 110.464 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 45.2 mm-40 . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.753 ' CZ ' HG21 ' A' ' 165' ' ' VAL . 13.6 p90 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 121.408 0.623 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.624 ' N ' ' CD2' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -140.19 137.53 34.42 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.134 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.486 ' CB ' ' HB2' ' A' ' 163' ' ' TYR . 5.8 ttt180 -95.64 101.92 13.67 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.271 -0.893 . . . . 0.0 109.089 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.871 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 19.7 mt -85.35 117.64 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.209 -0.932 . . . . 0.0 109.013 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 43.3 p -93.55 130.11 39.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.413 -0.804 . . . . 0.0 110.488 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.695 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 3.0 m-85 -81.35 122.78 27.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.564 -0.71 . . . . 0.0 109.15 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.602 ' HA3' ' HB ' ' A' ' 159' ' ' THR . . . -102.32 99.18 1.82 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.492 ' HG2' ' CZ ' ' A' ' 158' ' ' TYR . 7.4 mt-10 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.16 -1.2 . . . . 0.0 109.474 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.558 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 1.9 tt0 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 4.8 pt-20 -92.25 137.13 32.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 110.762 -178.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.871 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 43.4 p90 -134.79 147.48 49.98 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.691 HG22 ' CE2' ' A' ' 121' ' ' TYR . 3.7 p -74.17 171.07 14.24 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.111 -0.993 . . . . 0.0 111.013 -177.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.611 HG21 HG13 ' A' ' 124' ' ' ILE . 25.1 t -143.19 140.45 17.82 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.423 -0.798 . . . . 0.0 110.102 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.561 ' HD2' HG13 ' A' ' 140' ' ' VAL . 36.4 Cg_endo -79.94 142.34 15.57 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.475 2.117 . . . . 0.0 110.201 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.449 ' HA2' ' OH ' ' A' ' 122' ' ' TYR . . . -84.06 45.76 3.54 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.59 -81.46 0.54 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -1.152 . . . . 0.0 110.096 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -78.98 157.67 28.09 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.545 0.688 . . . . 0.0 110.271 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.582 ' O ' ' CE3' ' A' ' 112' ' ' TRP . 0.1 OUTLIER -95.38 -3.17 47.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.473 -0.767 . . . . 0.0 109.577 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.609 HG22 ' HA ' ' A' ' 111' ' ' SER . 7.1 p -116.63 142.04 47.41 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.713 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -134.51 150.88 50.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.876 -1.14 . . . . 0.0 110.06 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 6.9 t -96.17 146.4 24.71 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.367 -0.833 . . . . 0.0 109.028 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.695 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 19.2 mm -126.07 73.18 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.233 -0.917 . . . . 0.0 109.513 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.536 ' HA ' ' CB ' ' A' ' 107' ' ' SER . 8.1 m120 -79.22 -165.03 0.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.711 -0.618 . . . . 0.0 109.597 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 25.2 m120 57.93 20.65 6.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.057 -1.027 . . . . 0.0 109.017 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.898 HG22 ' C ' ' A' ' 106' ' ' THR . 3.5 tt -89.69 161.04 2.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.478 -0.764 . . . . 0.0 109.67 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.58 122.89 40.44 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.166 -0.959 . . . . 0.0 109.221 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.488 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 36.3 Cg_endo -77.73 145.3 22.82 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.439 2.093 . . . . 0.0 110.563 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.654 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 81.12 65.69 1.67 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 167.14 130.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -1.208 . . . . 0.0 109.748 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.412 ' CG ' ' N ' ' A' ' 158' ' ' TYR . 2.0 t70 -50.34 165.78 0.09 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.613 ' CE2' HG13 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -144.53 173.07 12.12 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.804 -1.185 . . . . 0.0 110.248 -179.66 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.602 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 1.8 m -147.59 99.34 3.1 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.58 HD11 HD12 ' A' ' 108' ' ' LEU . 88.1 mt -97.39 129.62 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.701 -1.249 . . . . 0.0 109.403 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . 1.004 HG23 ' CB ' ' A' ' 179' ' ' SER . 1.7 m -133.8 139.2 46.15 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.099 -1.001 . . . . 0.0 110.428 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 1.097 ' CD1' HD21 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -110.79 145.6 37.86 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.529 -0.732 . . . . 0.0 110.478 -179.72 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.633 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 37.8 m-85 -131.33 83.73 2.12 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.538 ' HB2' ' HD2' ' A' ' 122' ' ' TYR . . . -63.73 123.25 18.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.128 -0.983 . . . . 0.0 109.726 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.753 HG21 ' CZ ' ' A' ' 121' ' ' TYR . 5.3 t . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 109.452 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 164' ' ' ALA . 1.7 p . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 174' ' ' SER . 0.9 OUTLIER -44.6 167.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 108.995 179.773 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 175' ' ' SER . 0.2 OUTLIER -47.98 133.4 11.8 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.987 -1.071 . . . . 0.0 108.491 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.633 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.8 Cg_endo -76.57 157.23 36.24 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.121 1.881 . . . . 0.0 110.324 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -140.35 137.04 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.317 -0.864 . . . . 0.0 108.829 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' SER . . . . . 1.004 ' CB ' HG23 ' A' ' 161' ' ' THR . 0.1 OUTLIER -126.73 -178.6 4.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 110.512 -178.891 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.905 ' CG2' HD12 ' A' ' 98' ' ' LEU . 27.8 pt -158.14 152.3 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -95.72 151.6 19.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.056 -1.028 . . . . 0.0 109.475 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.657 ' CD2' HD13 ' A' ' 108' ' ' LEU . 70.7 t80 -147.11 131.26 17.35 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.271 -0.893 . . . . 0.0 109.4 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.82 119.65 39.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.084 -1.01 . . . . 0.0 109.524 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.488 ' HB ' ' HA ' ' A' ' 154' ' ' PRO . 18.4 p . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.46 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 2' ' ' LEU . 1.1 mp . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.547 ' HB2' ' CB ' ' A' ' 25' ' ' PRO . 1.1 m-20 -94.17 144.06 25.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.338 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.552 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 10.3 m -78.15 145.33 68.88 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.509 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.822 ' O ' HD13 ' A' ' 84' ' ' LEU . 35.7 Cg_endo -78.52 125.77 7.1 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.68 2.253 . . . . 0.0 110.336 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.447 ' CG2' HD13 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -143.35 -164.96 1.97 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.905 . . . . 0.0 109.988 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 8' ' ' PHE . . . 83.13 16.89 68.37 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 107.691 -2.163 . . . . 0.0 107.691 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.415 ' C ' ' O ' ' A' ' 7' ' ' GLY . 2.4 t80 -40.49 140.32 0.67 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.794 -0.827 . . . . 0.0 110.28 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 15.1 t0 -165.26 97.68 0.71 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.627 ' OG ' HG13 ' A' ' 20' ' ' VAL . 5.4 m -84.59 128.44 34.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.159 -0.963 . . . . 0.0 109.651 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.494 ' O ' ' C ' ' A' ' 12' ' ' ASP . 3.5 p -146.87 -164.74 2.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.327 -0.858 . . . . 0.0 109.026 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.513 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.8 OUTLIER 41.61 35.92 0.52 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -178.935 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.807 HG23 ' CB ' ' A' ' 18' ' ' PHE . 2.3 mt -78.73 144.53 10.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.202 -177.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -123.5 -157.69 0.77 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.379 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.993 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -93.2 -48.65 6.36 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.887 -1.133 . . . . 0.0 109.167 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 15.2 p30 -99.63 -9.12 23.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.043 -1.036 . . . . 0.0 109.155 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.597 ' O ' HG23 ' A' ' 14' ' ' THR . 27.4 p -142.62 159.53 42.06 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.884 ' CE1' HG22 ' A' ' 20' ' ' VAL . 9.9 p90 -166.13 142.16 4.92 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.911 -1.118 . . . . 0.0 109.435 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.513 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 17.1 m -81.33 153.76 26.86 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.897 -1.127 . . . . 0.0 110.773 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.884 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -132.18 116.98 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.52 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.547 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 3.1 m-70 -103.07 161.95 13.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.053 -1.03 . . . . 0.0 110.34 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.678 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 23.4 p90 -171.42 137.47 1.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.484 -0.76 . . . . 0.0 109.083 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.35 163.14 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.073 -1.017 . . . . 0.0 109.652 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.874 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -98.62 173.45 3.86 Favored Pre-proline 0 C--N 1.299 -1.63 0 O-C-N 121.713 -0.617 . . . . 0.0 109.733 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.874 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.8 Cg_endo -78.42 -162.18 0.17 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.644 2.229 . . . . 0.0 110.307 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.515 ' HB2' ' NH2' ' A' ' 26' ' ' ARG . 0.5 OUTLIER -119.55 18.53 12.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.957 . . . . 0.0 109.426 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.89 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -121.83 172.7 4.76 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.886 . . . . 0.0 109.489 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.89 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.7 Cg_endo -78.0 88.25 1.45 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.653 2.236 . . . . 0.0 110.421 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.772 HD13 ' HE1' ' A' ' 32' ' ' TYR . 9.1 pt -80.12 -176.89 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 109.498 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.453 ' OG1' ' N ' ' A' ' 77' ' ' GLY . 59.6 p -131.72 -2.14 3.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 109.929 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.499 ' O ' ' CD1' ' A' ' 32' ' ' TYR . . . 162.51 -178.56 38.24 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.772 ' HE1' HD13 ' A' ' 29' ' ' ILE . 1.7 m-85 -149.53 131.66 15.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -1.168 . . . . 0.0 109.732 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.998 HG23 ' HD2' ' A' ' 49' ' ' ARG . 0.9 OUTLIER -99.38 130.4 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -0.892 . . . . 0.0 108.897 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.991 HD13 ' C ' ' A' ' 33' ' ' ILE . 1.4 mm -117.57 119.34 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.013 -1.054 . . . . 0.0 109.985 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.464 ' HB2' ' OG ' ' A' ' 71' ' ' SER . 34.8 mtp180 -119.35 138.91 52.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.19 -0.944 . . . . 0.0 108.508 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.753 ' CD2' HD22 ' A' ' 59' ' ' LEU . 8.4 p80 -129.88 160.26 34.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.905 -1.122 . . . . 0.0 110.688 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.519 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 28.6 p-80 -171.86 121.9 0.49 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.617 -0.677 . . . . 0.0 109.332 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.132 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . -50.58 -178.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.177 -0.952 . . . . 0.0 109.554 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 . . . . . 0 N--CA 1.488 1.428 0 O-C-N 121.227 -0.92 . . . . 0.0 109.403 179.902 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.586 ' CG ' ' NE2' ' A' ' 36' ' ' HIS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -109.94 103.52 12.3 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.341 -0.849 . . . . 0.0 109.881 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 1.05 ' HB3' HD11 ' A' ' 57' ' ' ILE . 70.8 m-20 -93.93 115.93 28.34 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.998 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -97.27 156.72 16.31 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.109 -0.995 . . . . 0.0 109.87 -179.47 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.671 HG11 ' HB ' ' A' ' 57' ' ' ILE . 15.8 m -141.9 160.54 55.38 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 109.113 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.549 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.4 Cg_endo -77.11 174.18 13.23 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.466 2.111 . . . . 0.0 110.03 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 35.3 Cg_endo -77.54 -15.42 15.56 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.443 2.096 . . . . 0.0 110.516 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.9 t -99.23 18.45 17.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.576 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.549 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -125.86 119.08 26.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 109.799 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 22' ' ' TRP . 0.8 OUTLIER -103.48 -0.39 29.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.321 -0.862 . . . . 0.0 109.283 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 21' ' ' HIS . 30.8 p -131.08 129.94 42.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 109.462 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.05 HD11 ' HB3' ' A' ' 48' ' ' ASP . 4.4 tt -125.05 140.12 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.254 -0.904 . . . . 0.0 109.361 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 8.8 m -102.75 136.68 42.13 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.264 -0.897 . . . . 0.0 109.302 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.753 HD22 ' CD2' ' A' ' 36' ' ' HIS . 1.1 mp -115.16 161.0 19.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.637 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.44 HG22 ' HB3' ' A' ' 17' ' ' SER . 23.5 p -139.12 -170.32 2.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.402 -0.811 . . . . 0.0 109.344 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.494 ' O ' HD23 ' A' ' 62' ' ' LEU . 50.8 m-20 51.93 54.62 10.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.195 -0.941 . . . . 0.0 109.51 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.636 ' CD2' ' CE1' ' A' ' 36' ' ' HIS . 6.8 mt -129.27 169.93 14.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.473 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -84.64 142.83 40.13 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.263 -0.898 . . . . 0.0 109.3 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.993 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 36.9 Cg_endo -78.78 122.29 5.37 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.556 2.171 . . . . 0.0 110.395 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 75.12 62.49 2.75 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.113 -1.995 . . . . 0.0 108.113 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.605 ' CG2' ' CE2' ' A' ' 68' ' ' TYR . 1.3 m -149.17 144.76 26.8 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.309 -1.112 . . . . 0.0 110.899 -178.64 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -81.38 105.63 12.71 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.468 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 1.132 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 13.5 m-85 -103.91 150.52 24.11 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.27 -0.894 . . . . 0.0 109.979 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.584 HG13 ' HB3' ' A' ' 87' ' ' GLN . 4.1 t -109.75 154.98 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.321 -0.862 . . . . 0.0 109.193 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.598 HG22 ' CB ' ' A' ' 36' ' ' HIS . 40.9 t -139.51 129.02 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.126 -0.984 . . . . 0.0 109.709 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 79.2 p -103.18 101.18 11.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.862 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.965 HD13 HG23 ' A' ' 34' ' ' ILE . 10.9 mm -74.98 153.12 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.094 -1.004 . . . . 0.0 109.702 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.572 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 15.5 mt -143.3 158.68 17.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.383 -0.823 . . . . 0.0 108.892 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.647 ' HB2' ' CZ ' ' A' ' 32' ' ' TYR . . . -131.21 153.02 49.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.437 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.9 m -141.12 135.61 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 109.389 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 79' ' ' GLU . 1.1 t30 -110.72 43.66 1.39 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 109.513 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.453 ' N ' ' OG1' ' A' ' 30' ' ' THR . . . 77.25 -57.1 3.67 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -126.19 -2.96 6.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -1.147 . . . . 0.0 109.737 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.512 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 0.5 OUTLIER -110.07 177.02 4.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.571 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -147.78 95.43 2.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.32 -0.863 . . . . 0.0 109.434 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.587 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.7 OUTLIER -59.64 -179.05 0.15 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.891 . . . . 0.0 109.084 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.587 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.5 Cg_endo -77.71 146.28 23.72 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.277 1.985 . . . . 0.0 110.365 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 36.1 Cg_endo -77.93 100.99 1.43 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.675 2.25 . . . . 0.0 110.896 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.822 HD13 ' O ' ' A' ' 5' ' ' PRO . 4.1 tp -75.0 103.83 5.34 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 1.9 mt -93.98 143.52 11.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 120.887 -1.133 . . . . 0.0 110.636 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -148.11 -163.22 10.61 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.584 ' HB3' HG13 ' A' ' 69' ' ' VAL . 8.2 pt20 -166.78 164.96 16.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.997 -1.296 . . . . 0.0 110.038 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.564 ' HG3' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -159.73 151.43 20.2 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.665 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.556 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -90.94 136.67 32.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.153 -0.967 . . . . 0.0 110.431 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.474 ' O ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.45 134.27 42.35 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.144 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.751 HG23 HG22 ' A' ' 13' ' ' ILE . 9.4 t . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.574 0.702 . . . . 0.0 110.599 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.613 ' HG2' HD11 ' A' ' 162' ' ' LEU . 36.5 Cg_endo . . . . . 0 C--O 1.216 -0.614 0 N-CA-C 109.496 -1.002 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -76.07 177.19 7.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.318 -0.864 . . . . 0.0 109.677 -179.366 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER 76.28 19.57 1.7 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -0.846 . . . . 0.0 109.64 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.779 HD13 HG23 ' A' ' 180' ' ' ILE . 0.5 OUTLIER -62.21 99.95 0.15 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.121 -0.987 . . . . 0.0 109.029 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 97' ' ' ASP . 0.1 OUTLIER -144.64 163.74 33.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 109.715 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.418 HG21 ' HB3' ' A' ' 108' ' ' LEU . 9.6 p -104.05 148.75 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.548 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.735 HD11 HD22 ' A' ' 109' ' ' LEU . 25.1 pt -125.44 -5.46 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -0.891 . . . . 0.0 109.589 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 1.042 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -150.49 108.46 3.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.371 -0.831 . . . . 0.0 108.783 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.521 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.7 t -101.7 93.95 5.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 110.229 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -80.01 164.28 53.58 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.339 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.489 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 30.1 Cg_endo -69.18 -2.95 10.66 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.425 2.083 . . . . 0.0 110.748 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.835 ' C ' HG22 ' A' ' 152' ' ' ILE . 7.5 p -152.48 19.24 0.63 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.988 ' O ' HD23 ' A' ' 108' ' ' LEU . 54.5 p -172.89 160.4 4.32 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.96 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.988 HD23 ' O ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -135.52 155.33 50.67 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.354 -0.841 . . . . 0.0 108.947 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 1.042 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.4 OUTLIER -105.04 95.41 5.83 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.239 -0.913 . . . . 0.0 109.346 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.779 HD11 ' HB3' ' A' ' 147' ' ' ALA . 15.7 pt -74.88 167.82 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.927 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 146' ' ' THR . 3.7 m -165.34 100.41 0.72 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.634 -0.666 . . . . 0.0 109.365 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.58 ' CD1' ' HB2' ' A' ' 95' ' ' PRO . 41.3 p90 -111.4 141.77 44.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.207 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 96' ' ' ARG . 11.3 mm-40 . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.168 -0.957 . . . . 0.0 109.352 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.89 ' CZ ' HG21 ' A' ' 165' ' ' VAL . 2.7 p90 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.643 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 1.6 m-85 -134.8 132.91 39.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.924 . . . . 0.0 109.282 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.485 ' HG2' ' N ' ' A' ' 124' ' ' ILE . 8.7 ttm180 -85.28 159.33 20.08 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.909 -1.12 . . . . 0.0 108.459 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.811 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 13.9 mt -148.85 119.75 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.033 -1.042 . . . . 0.0 109.779 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 64.9 p -91.39 128.99 37.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.595 -0.691 . . . . 0.0 109.94 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.821 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 2.4 m-85 -74.53 138.59 43.22 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.592 ' HA3' ' HB ' ' A' ' 159' ' ' THR . . . -105.91 89.23 0.6 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.583 ' HG2' ' CE2' ' A' ' 158' ' ' TYR . 6.8 mt-10 . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.218 -1.166 . . . . 0.0 109.735 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.574 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 1.1 mt-30 . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 0.9 OUTLIER -74.7 155.36 37.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.242 -0.911 . . . . 0.0 110.751 -178.94 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.811 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 3.2 p90 -161.4 139.19 9.16 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.845 HG22 ' CE1' ' A' ' 121' ' ' TYR . 2.6 p -74.81 149.74 39.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.068 -1.02 . . . . 0.0 111.145 -178.202 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.778 HG13 ' HD2' ' A' ' 141' ' ' PRO . 55.7 t -111.71 145.46 32.7 Favored Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.778 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.8 Cg_endo -77.54 132.23 12.05 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.395 2.063 . . . . 0.0 109.882 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -85.87 37.63 3.07 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.407 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 2.7 m -105.27 -1.46 25.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.096 -1.238 . . . . 0.0 109.595 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.407 ' CG ' ' O ' ' A' ' 143' ' ' SER . 12.3 mttp -163.01 172.29 15.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.917 . . . . 0.0 109.57 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.575 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 5.0 p -95.3 -23.82 17.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.221 -0.925 . . . . 0.0 109.899 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 111' ' ' SER . 3.3 p -102.23 163.77 12.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.079 -1.013 . . . . 0.0 109.483 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.779 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -153.7 173.34 15.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.95 . . . . 0.0 109.682 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.1 t -104.45 152.39 22.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 109.097 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.821 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 34.0 mm -131.29 73.52 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.137 -0.977 . . . . 0.0 109.49 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.536 ' HA ' ' CB ' ' A' ' 107' ' ' SER . 3.7 m120 -80.7 -146.62 0.05 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.551 -0.718 . . . . 0.0 109.731 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 150' ' ' ASN . 4.9 m120 43.38 26.88 0.11 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 109.523 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.835 HG22 ' C ' ' A' ' 106' ' ' THR . 4.5 tt -93.37 158.28 2.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.281 -0.887 . . . . 0.0 109.549 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 153' ' ' LYS . 26.2 mmtt -114.17 120.51 38.37 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.92 . . . . 0.0 109.234 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.525 ' HA ' ' OG1' ' A' ' 184' ' ' THR . 35.4 Cg_endo -78.04 146.31 22.85 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.413 2.075 . . . . 0.0 110.566 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.705 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 93.7 60.0 1.17 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 162.3 131.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.411 -1.052 . . . . 0.0 109.41 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 156' ' ' ALA . 24.6 t0 -46.83 166.52 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.594 ' CD1' ' CG2' ' A' ' 184' ' ' THR . 0.2 OUTLIER -145.04 -178.2 5.93 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.51 -1.369 . . . . 0.0 110.048 -179.464 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.592 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 2.5 m -157.98 165.23 35.66 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.546 HD11 HD12 ' A' ' 108' ' ' LEU . 22.5 mt -155.27 132.57 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.749 -1.22 . . . . 0.0 110.11 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . 1.021 HG23 ' CB ' ' A' ' 179' ' ' SER . 1.6 m -136.91 172.09 13.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.855 . . . . 0.0 108.844 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.613 HD11 ' HG2' ' A' ' 95' ' ' PRO . 0.6 OUTLIER -163.42 151.55 13.48 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.679 -1.208 . . . . 0.0 111.597 -179.481 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.636 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 4.2 m-85 -125.11 120.79 32.41 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.814 ' HB3' ' OG ' ' A' ' 175' ' ' SER . . . -81.57 99.75 9.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.847 -1.158 . . . . 0.0 109.532 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.89 HG21 ' CZ ' ' A' ' 121' ' ' TYR . 18.7 t . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.263 -0.898 . . . . 0.0 109.369 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.509 ' HB2' ' HB3' ' A' ' 163' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.281 0.562 . . . . 0.0 109.507 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.814 ' OG ' ' HB3' ' A' ' 164' ' ' ALA . 0.6 OUTLIER -46.96 166.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.611 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 175' ' ' SER . 0.0 OUTLIER -41.05 127.88 2.03 Favored Pre-proline 0 C--N 1.304 -1.383 0 O-C-N 121.595 -0.691 . . . . 0.0 109.878 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.636 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.2 Cg_endo -77.43 131.4 11.56 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.022 1.815 . . . . 0.0 110.492 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.34 137.48 47.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' SER . . . . . 1.021 ' CB ' HG23 ' A' ' 161' ' ' THR . 1.0 OUTLIER -129.53 165.67 21.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 110.811 -178.406 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.779 HG23 HD13 ' A' ' 98' ' ' LEU . 5.5 pt -144.2 -170.53 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -119.12 169.64 9.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.042 -1.036 . . . . 0.0 109.402 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.922 ' OH ' HD22 ' A' ' 108' ' ' LEU . 56.3 t80 -164.63 166.45 20.13 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.163 -0.961 . . . . 0.0 109.428 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -147.56 129.14 15.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.902 . . . . 0.0 109.455 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.594 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.48 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.625 HD11 ' CB ' ' A' ' 81' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.565 ' O ' HD12 ' A' ' 2' ' ' LEU . 1.1 m-20 -113.66 146.2 40.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.423 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.484 ' OG ' ' HG2' ' A' ' 82' ' ' PRO . 10.8 p -95.4 155.91 38.22 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 0.0 109.595 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.782 ' O ' HD22 ' A' ' 84' ' ' LEU . 36.3 Cg_endo -79.05 110.48 2.76 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.725 2.283 . . . . 0.0 110.128 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 8' ' ' PHE . 1.8 p -97.94 -113.21 0.15 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.131 -0.981 . . . . 0.0 109.472 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.457 ' HA3' ' HB ' ' A' ' 23' ' ' VAL . . . 44.14 27.08 1.02 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.426 ' N ' ' O ' ' A' ' 6' ' ' THR . 8.7 t80 -58.17 95.07 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.582 -0.952 . . . . 0.0 109.861 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.525 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 38.0 t70 -126.82 95.77 4.43 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.344 -0.848 . . . . 0.0 109.055 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.619 ' OG ' HG13 ' A' ' 20' ' ' VAL . 32.8 m -84.66 135.3 34.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.297 -0.877 . . . . 0.0 109.38 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.456 ' O ' ' C ' ' A' ' 12' ' ' ASP . 5.5 p -156.42 -159.78 0.92 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.407 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.535 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 1.2 m-20 45.96 40.7 7.18 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.61 ' HA ' ' HA ' ' A' ' 18' ' ' PHE . 1.5 mt -83.45 129.32 37.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.604 -177.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.594 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -115.91 174.1 6.21 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 178.194 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -67.63 -65.1 0.73 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.764 -1.21 . . . . 0.0 109.924 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.467 ' O ' ' OG ' ' A' ' 17' ' ' SER . 6.5 m-80 -86.66 17.15 4.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.012 -1.055 . . . . 0.0 110.017 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.749 ' HA ' HD12 ' A' ' 62' ' ' LEU . 21.8 m -168.46 156.37 8.18 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.933 ' CE1' HG22 ' A' ' 20' ' ' VAL . 4.3 p90 -165.89 143.05 5.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.143 -0.973 . . . . 0.0 109.281 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.535 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 8.5 m -89.55 156.17 18.79 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.849 -1.157 . . . . 0.0 111.293 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.933 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.3 t -132.58 134.34 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.536 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 2.1 m-70 -121.25 166.36 14.12 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.924 -1.11 . . . . 0.0 110.328 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.816 ' CH2' HG21 ' A' ' 50' ' ' VAL . 6.2 p90 -174.12 137.78 0.56 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.477 -0.765 . . . . 0.0 109.189 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -78.75 162.43 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.053 -1.029 . . . . 0.0 109.773 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.716 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -86.86 168.71 17.1 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.73 -0.606 . . . . 0.0 109.587 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.716 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 36.3 Cg_endo -79.45 -172.54 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.647 2.232 . . . . 0.0 110.459 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -113.87 16.09 18.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -0.871 . . . . 0.0 109.3 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.99 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -124.55 177.9 1.63 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.341 -0.849 . . . . 0.0 109.26 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.99 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 34.6 Cg_endo -77.84 135.84 14.54 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.476 2.117 . . . . 0.0 110.256 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.501 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 45.9 pt -152.04 -179.13 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.915 . . . . 0.0 109.546 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.8 p -114.32 -20.89 10.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 109.476 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.16 172.1 28.04 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.618 ' CE2' ' HA ' ' A' ' 52' ' ' PRO . 0.5 OUTLIER -112.17 150.25 31.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -1.154 . . . . 0.0 109.47 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.955 HG23 ' HD2' ' A' ' 49' ' ' ARG . 1.4 mp -95.08 137.23 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.158 -0.964 . . . . 0.0 108.858 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.847 HD13 ' C ' ' A' ' 33' ' ' ILE . 3.4 mm -116.94 95.05 3.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.4 -0.812 . . . . 0.0 109.937 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.507 ' HG3' ' HA ' ' A' ' 47' ' ' GLN . 54.7 ttp180 -106.28 117.01 32.93 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 108.522 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.535 ' NE2' ' HG2' ' A' ' 46' ' ' ARG . 3.1 p-80 -106.69 147.35 29.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.966 -1.084 . . . . 0.0 110.273 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.521 ' NE2' ' HB ' ' A' ' 69' ' ' VAL . 41.3 p-80 -162.05 124.43 2.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.45 -0.781 . . . . 0.0 109.577 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -56.58 -161.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.263 -0.898 . . . . 0.0 109.624 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.419 ' HG3' ' HB2' ' A' ' 67' ' ' GLU . 4.1 mm-40 . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.769 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.535 ' HG2' ' NE2' ' A' ' 36' ' ' HIS . 12.9 ptm180 . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.362 0.601 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.507 ' HA ' ' HG3' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -105.89 114.17 28.16 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.341 -0.849 . . . . 0.0 109.48 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.495 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 19.5 m-20 -107.42 168.81 8.98 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.955 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -136.4 164.07 28.99 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.509 -0.744 . . . . 0.0 109.587 -179.524 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.816 HG21 ' CH2' ' A' ' 22' ' ' TRP . 33.5 m -149.56 158.86 37.39 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.421 -0.799 . . . . 0.0 109.295 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 33.9 Cg_endo -75.72 174.25 13.13 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.529 2.153 . . . . 0.0 110.373 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.618 ' HA ' ' CE2' ' A' ' 32' ' ' TYR . 34.3 Cg_endo -76.63 -22.63 11.9 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.574 2.182 . . . . 0.0 110.68 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.95 -8.77 53.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.135 -0.978 . . . . 0.0 109.505 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.533 ' HD3' ' N ' ' A' ' 54' ' ' ARG . 1.6 mpt_? -94.78 112.13 23.88 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.291 -0.881 . . . . 0.0 109.593 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 7.9 p-10 -107.41 -2.29 20.68 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.448 -0.782 . . . . 0.0 109.725 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 27.0 p -136.17 129.83 32.3 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.111 -0.993 . . . . 0.0 109.815 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.608 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 1.9 tt -129.44 120.28 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -0.871 . . . . 0.0 109.045 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 0.3 OUTLIER -88.09 131.43 34.69 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.298 -0.876 . . . . 0.0 109.615 -179.601 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.817 ' HB3' HD11 ' A' ' 62' ' ' LEU . 1.3 mt -104.56 142.63 34.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 109.38 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.469 ' HA ' ' OG ' ' A' ' 17' ' ' SER . 6.7 p -130.02 178.12 6.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.949 . . . . 0.0 109.537 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.9 m120 54.78 40.95 32.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 109.497 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.817 HD11 ' HB3' ' A' ' 59' ' ' LEU . 4.6 mt -111.94 145.12 40.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.301 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.463 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 2.6 m120 -54.63 130.6 64.17 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.113 -0.992 . . . . 0.0 108.681 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.1 Cg_endo -77.4 125.36 7.66 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.217 1.944 . . . . 0.0 110.642 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 80.46 61.73 2.16 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 90' ' ' THR . 3.5 m -152.89 155.85 37.84 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.349 -1.089 . . . . 0.0 110.385 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 2.0 mp0 -85.43 116.95 24.05 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.552 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 9.8 m-85 -112.72 106.88 15.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.121 -0.987 . . . . 0.0 109.898 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.521 ' HB ' ' NE2' ' A' ' 37' ' ' HIS . 3.4 t -73.93 133.03 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.923 . . . . 0.0 108.839 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 19.4 t -122.36 117.72 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.096 -1.002 . . . . 0.0 109.837 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.543 ' CB ' HG12 ' A' ' 85' ' ' ILE . 1.8 p -92.84 133.37 36.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.0 110.282 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.501 ' HB ' HD23 ' A' ' 84' ' ' LEU . 21.4 mm -120.74 79.39 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.808 HD13 ' HA ' ' A' ' 83' ' ' PRO . 23.4 mm -76.75 163.87 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.943 . . . . 0.0 109.604 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.012 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -131.71 117.22 18.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.54 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -107.65 173.98 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.289 -0.882 . . . . 0.0 109.283 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.497 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 18.6 t30 -153.33 49.35 0.7 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 109.446 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.69 -80.72 1.73 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.433 ' NH2' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -119.74 -1.95 10.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -1.15 . . . . 0.0 109.59 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 1.2 mp0 -90.9 -173.44 3.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.371 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 16.8 mt-10 -156.65 93.56 1.39 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.19 -0.943 . . . . 0.0 109.584 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . 1.012 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -59.48 178.85 0.22 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.014 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.554 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.4 Cg_endo -76.8 158.16 35.15 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.289 1.992 . . . . 0.0 110.167 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.808 ' HA ' HD13 ' A' ' 73' ' ' ILE . 34.7 Cg_endo -77.15 145.25 24.29 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.621 2.214 . . . . 0.0 111.103 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.782 HD22 ' O ' ' A' ' 5' ' ' PRO . 25.5 tp -136.21 85.97 2.19 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.543 HG12 ' CB ' ' A' ' 71' ' ' SER . 2.3 mt -99.93 139.85 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.185 -0.947 . . . . 0.0 109.789 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -128.08 -171.13 12.95 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -148.59 125.04 10.97 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.14 -1.211 . . . . 0.0 109.691 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.563 ' HG3' ' CB ' ' A' ' 10' ' ' SER . 1.1 tm0? -135.81 114.61 12.02 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.321 -0.862 . . . . 0.0 109.006 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -74.9 133.53 41.78 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.295 -0.878 . . . . 0.0 110.02 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.15 138.12 43.63 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.336 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.603 ' CG2' HG22 ' A' ' 13' ' ' ILE . 1.4 t . . . . . 0 C--N 1.3 -1.571 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.432 ' CB ' ' O ' ' A' ' 113' ' ' GLU . 34.3 Cg_endo . . . . . 0 C--O 1.215 -0.645 0 N-CA-C 109.346 -1.059 . . . . 0.0 109.346 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 1.5 ptm85 -168.44 171.91 8.7 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.072 -1.018 . . . . 0.0 109.575 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 2.0 t70 79.47 17.86 0.8 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 0.0 109.661 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.818 HD12 ' CG2' ' A' ' 180' ' ' ILE . 0.8 OUTLIER -54.33 87.22 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.225 -0.922 . . . . 0.0 109.486 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 97' ' ' ASP . 0.6 OUTLIER -138.89 169.49 17.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.107 -0.996 . . . . 0.0 109.796 -179.748 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 7.0 p -102.84 144.01 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -0.878 . . . . 0.0 109.81 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.551 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 6.8 pt -126.1 -4.49 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.367 -0.833 . . . . 0.0 109.266 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.874 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -151.74 88.87 1.43 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.541 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 6.0 p -84.09 93.52 8.14 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.595 -0.69 . . . . 0.0 110.27 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.46 ' OG1' ' OG ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -84.42 161.38 54.41 Favored Pre-proline 0 C--N 1.306 -1.297 0 O-C-N 121.127 -0.983 . . . . 0.0 108.949 179.156 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.477 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.6 Cg_endo -69.65 -3.04 11.14 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.44 2.093 . . . . 0.0 110.56 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.771 ' C ' HG22 ' A' ' 152' ' ' ILE . 37.8 p -151.33 19.1 0.74 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.48 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 1.1 p -170.85 176.22 4.21 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.719 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.875 HD12 ' N ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -154.11 155.91 36.27 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.406 -0.809 . . . . 0.0 109.143 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.874 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.6 OUTLIER -102.33 123.73 46.65 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.248 -0.908 . . . . 0.0 108.572 179.122 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.701 HD13 ' CD1' ' A' ' 149' ' ' ILE . 0.0 OUTLIER -103.21 135.41 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.122 -0.987 . . . . 0.0 109.92 -179.33 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 97' ' ' ASP . 0.4 OUTLIER -131.0 128.57 40.64 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.505 -0.747 . . . . 0.0 108.997 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.578 ' CD2' ' O ' ' A' ' 145' ' ' SER . 28.2 p90 -151.55 145.36 25.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.403 -0.81 . . . . 0.0 109.325 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.474 ' HB2' ' HG2' ' A' ' 96' ' ' ARG . 29.2 mm-40 . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 0.0 109.408 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.998 ' CE1' HG22 ' A' ' 139' ' ' THR . 3.0 p90 . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 4.0 m-85 -115.18 145.98 41.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.035 -1.041 . . . . 0.0 109.737 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.6 ' HG2' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -108.39 95.8 5.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.459 -0.776 . . . . 0.0 109.197 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.882 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 45.1 mt -84.36 145.12 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.315 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 77.0 p -131.54 144.53 51.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.945 . . . . 0.0 110.451 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 1.22 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 2.8 m-30 -88.06 132.19 34.38 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.589 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.68 111.35 3.64 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.423 ' HG2' ' CZ ' ' A' ' 158' ' ' TYR . 14.1 mt-10 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.263 -1.139 . . . . 0.0 109.45 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.601 ' HB3' ' CG ' ' A' ' 126' ' ' TYR . 2.8 tt0 . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 18.7 tt0 -102.34 118.48 36.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.858 . . . . 0.0 111.076 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.882 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 35.9 p90 -121.92 142.49 50.23 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.998 HG22 ' CE1' ' A' ' 121' ' ' TYR . 1.5 p -74.15 175.06 7.86 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.966 -1.084 . . . . 0.0 110.834 -178.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.694 HG13 ' HD2' ' A' ' 141' ' ' PRO . 53.7 t -144.35 142.73 20.07 Favored Pre-proline 0 C--N 1.304 -1.392 0 O-C-N 121.553 -0.717 . . . . 0.0 109.321 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.694 ' HD2' HG13 ' A' ' 140' ' ' VAL . 35.2 Cg_endo -77.34 148.73 27.06 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.454 2.103 . . . . 0.0 110.331 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.06 17.88 39.31 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.4 p -105.25 27.81 7.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -1.151 . . . . 0.0 109.613 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.99 139.01 4.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 0.0 109.585 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.578 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 1.3 p -92.48 -15.56 26.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 109.404 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.5 p -123.12 132.39 54.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.292 -0.88 . . . . 0.0 109.185 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.478 ' HB2' ' HH2' ' A' ' 112' ' ' TRP . . . -120.91 -165.43 1.21 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.23 -0.918 . . . . 0.0 109.239 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.635 HG22 ' N ' ' A' ' 149' ' ' ILE . 23.8 m -145.13 166.08 26.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.151 -0.968 . . . . 0.0 109.646 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 1.22 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 1.2 mt -137.12 121.76 24.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.3 -0.875 . . . . 0.0 109.334 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.478 ' HA ' ' HB3' ' A' ' 107' ' ' SER . 6.8 m-80 -123.2 177.27 5.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.4 -0.812 . . . . 0.0 109.514 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 2.7 m-20 65.54 31.43 10.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 109.161 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.771 HG22 ' C ' ' A' ' 106' ' ' THR . 16.2 tt -89.86 166.9 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.397 -0.814 . . . . 0.0 109.714 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -107.14 112.17 63.14 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 109.445 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.525 ' HA ' ' OG1' ' A' ' 184' ' ' THR . 34.7 Cg_endo -77.26 167.12 25.24 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.454 2.103 . . . . 0.0 110.6 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.69 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 76.73 57.23 3.88 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 163.55 134.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -1.128 . . . . 0.0 109.516 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 0.6 OUTLIER -51.49 164.57 0.2 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.093 -1.004 . . . . 0.0 108.443 179.436 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.589 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.4 OUTLIER -142.0 177.06 8.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.8 -1.187 . . . . 0.0 110.381 -179.528 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.54 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 2.2 m -147.73 109.66 4.48 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.404 HG23 HD12 ' A' ' 160' ' ' ILE . 21.8 mm -97.59 134.87 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.789 -1.194 . . . . 0.0 109.994 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.614 HG23 ' HB3' ' A' ' 179' ' ' SER . 68.8 m -145.11 147.65 32.76 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.283 -0.886 . . . . 0.0 109.717 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.615 HD23 ' H ' ' A' ' 162' ' ' LEU . 2.6 pt? -140.26 150.61 44.29 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.177 -0.952 . . . . 0.0 110.112 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.615 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 4.1 m-85 -115.47 -176.15 2.86 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -147.02 104.32 3.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.862 . . . . 0.0 109.153 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.935 HG21 ' CE2' ' A' ' 121' ' ' TYR . 63.8 t . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 109.909 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 16.7 p . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.326 0.584 . . . . 0.0 109.698 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 51.9 p -53.91 -176.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.322 -0.861 . . . . 0.0 109.303 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.36 140.92 96.93 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.139 -0.975 . . . . 0.0 108.809 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.615 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 35.0 Cg_endo -78.18 136.47 14.48 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.335 2.023 . . . . 0.0 111.145 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.472 ' O ' HD23 ' A' ' 162' ' ' LEU . 2.1 t -108.12 138.14 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.614 ' HB3' HG23 ' A' ' 161' ' ' THR . 80.7 p -133.91 173.65 11.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.065 -1.022 . . . . 0.0 110.75 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.818 ' CG2' HD12 ' A' ' 98' ' ' LEU . 38.2 pt -154.53 169.08 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -98.49 178.29 5.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.042 -1.036 . . . . 0.0 109.686 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.83 ' CZ ' HD23 ' A' ' 108' ' ' LEU . 25.0 t80 -163.33 172.21 14.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -0.859 . . . . 0.0 109.605 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 157' ' ' ASP . 6.6 tttt -148.85 109.75 4.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 109.264 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.525 ' OG1' ' HA ' ' A' ' 154' ' ' PRO . 1.4 p . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.482 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.441 HD21 ' HG2' ' A' ' 79' ' ' GLU . 3.2 mt . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 1.6 m-20 -80.11 135.9 36.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.908 . . . . 0.0 109.363 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.87 111.42 55.94 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 109.964 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.763 ' O ' HD22 ' A' ' 84' ' ' LEU . 35.0 Cg_endo -77.05 112.26 3.38 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.471 2.114 . . . . 0.0 109.629 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 22' ' ' TRP . 1.7 p -110.31 -110.22 0.33 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.187 -0.945 . . . . 0.0 109.856 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 9' ' ' ASP . . . 46.5 25.23 1.99 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -46.24 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.426 -1.043 . . . . 0.0 109.855 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 7' ' ' GLY . 7.3 t0 -126.92 101.45 6.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.358 -0.839 . . . . 0.0 108.795 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.972 ' OG ' HG13 ' A' ' 20' ' ' VAL . 38.2 m -87.25 143.58 27.21 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.166 -0.959 . . . . 0.0 110.217 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.488 ' O ' ' HB ' ' A' ' 19' ' ' THR . 49.1 p -144.35 -161.34 1.26 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.512 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 1.4 m-20 42.73 35.95 0.77 Allowed 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -178.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.707 HG22 HG23 ' A' ' 91' ' ' VAL . 1.3 mt -77.21 156.48 5.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 122.582 1.182 . . . . 0.0 112.638 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.765 ' O ' HG22 ' A' ' 90' ' ' THR . 0.0 OUTLIER -150.57 161.74 41.97 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 177.226 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.603 ' HB1' ' HA ' ' A' ' 64' ' ' PRO . . . -73.98 -36.21 64.54 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.324 -1.485 . . . . 0.0 109.704 -178.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.6 OUTLIER -98.59 22.11 10.35 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.048 -1.032 . . . . 0.0 108.809 179.453 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.587 ' HA ' HD12 ' A' ' 62' ' ' LEU . 13.0 p 167.01 154.96 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.935 ' CE1' HG22 ' A' ' 20' ' ' VAL . 8.9 p90 -166.95 139.49 3.51 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.653 -1.279 . . . . 0.0 109.681 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 28.8 m -79.47 152.72 30.09 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.94 -1.1 . . . . 0.0 110.743 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.972 HG13 ' OG ' ' A' ' 10' ' ' SER . 2.5 t -126.04 135.07 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.569 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 2.6 m-70 -126.98 170.89 11.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.91 -1.119 . . . . 0.0 110.339 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.611 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 27.8 p90 -179.85 149.18 0.34 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -76.89 147.78 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 120.966 -1.084 . . . . 0.0 109.929 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.531 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -76.47 161.63 73.87 Favored Pre-proline 0 C--N 1.298 -1.66 0 O-C-N 121.835 -0.541 . . . . 0.0 109.57 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.557 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 35.9 Cg_endo -78.09 153.41 28.49 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.582 2.188 . . . . 0.0 110.478 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.459 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 17.0 mtt180 -75.35 -0.92 21.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 109.569 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.641 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -102.17 164.75 15.15 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 109.579 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.641 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.9 Cg_endo -78.38 105.66 2.01 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.729 2.286 . . . . 0.0 110.357 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.557 ' CG2' ' HG2' ' A' ' 25' ' ' PRO . 31.4 pt -100.37 168.61 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.425 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.637 HG23 ' HA ' ' A' ' 76' ' ' ASN . 59.8 p -113.23 -16.67 12.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.0 109.338 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.82 -165.23 35.25 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 1.098 ' CZ ' ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -165.42 120.72 1.31 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -1.151 . . . . 0.0 110.049 -179.818 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.878 ' O ' HD13 ' A' ' 34' ' ' ILE . 22.2 mm -75.33 147.89 7.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 121.104 -0.998 . . . . 0.0 108.658 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.988 ' CG1' HG22 ' A' ' 50' ' ' VAL . 14.7 mm -133.24 92.89 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.078 -1.014 . . . . 0.0 109.857 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.542 ' CG ' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -100.57 157.01 16.98 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.171 -0.955 . . . . 0.0 108.69 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.606 ' CG ' ' CD2' ' A' ' 59' ' ' LEU . 1.3 p-80 -143.15 143.27 31.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.004 -1.06 . . . . 0.0 110.055 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.579 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 37.2 p-80 -163.16 130.57 3.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.377 -0.827 . . . . 0.0 109.716 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 1.063 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . -75.28 130.84 39.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.258 -0.901 . . . . 0.0 109.256 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.166 -0.959 . . . . 0.0 109.359 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.539 ' HB2' ' NE2' ' A' ' 36' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.341 0.591 . . . . 0.0 109.747 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 35' ' ' ARG . 29.3 mt-30 -141.06 111.49 6.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -0.866 . . . . 0.0 109.979 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.534 ' O ' ' CD ' ' A' ' 49' ' ' ARG . 20.9 m-20 -110.78 178.59 4.31 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.604 HH11 HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -153.98 155.74 36.13 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.217 -0.927 . . . . 0.0 109.951 -179.736 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.988 HG22 ' CG1' ' A' ' 34' ' ' ILE . 15.9 m -142.46 160.9 52.56 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.477 -0.764 . . . . 0.0 108.989 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.537 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 33.7 Cg_endo -75.82 173.94 13.66 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.369 2.046 . . . . 0.0 110.211 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.494 ' HB3' HG13 ' A' ' 29' ' ' ILE . 35.0 Cg_endo -77.16 -17.44 15.04 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.491 2.127 . . . . 0.0 110.568 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.1 t -102.23 17.29 23.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 109.342 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.537 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -115.56 104.63 11.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -0.865 . . . . 0.0 109.454 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 2.7 p-10 -89.38 -6.17 56.83 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.923 . . . . 0.0 109.561 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 6.3 p -126.23 142.76 51.4 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.39 -0.819 . . . . 0.0 109.567 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.955 HD12 HG13 ' A' ' 50' ' ' VAL . 5.1 tt -137.11 134.72 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 109.391 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 87.8 m -96.63 125.49 41.14 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.194 -0.941 . . . . 0.0 109.6 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.638 ' HB3' HD11 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -102.99 142.24 34.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 109.354 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.494 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 0.9 OUTLIER -122.4 156.67 33.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 109.799 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.981 ' O ' HD23 ' A' ' 62' ' ' LEU . 9.0 m-80 62.27 79.83 0.24 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.364 -0.835 . . . . 0.0 109.905 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.981 HD23 ' O ' ' A' ' 61' ' ' ASN . 6.5 mt -143.24 138.88 29.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -0.881 . . . . 0.0 109.414 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 62' ' ' LEU . 4.9 m-80 -42.59 136.01 2.57 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 109.429 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.603 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . 36.6 Cg_endo -79.2 131.42 9.76 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.476 2.118 . . . . 0.0 110.732 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 63.47 64.15 3.95 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.249 -1.941 . . . . 0.0 108.249 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 m -156.72 151.72 26.14 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.391 -1.064 . . . . 0.0 110.667 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -85.38 123.92 31.39 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.633 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 1.063 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 3.1 m-85 -111.25 133.8 53.32 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.073 -1.017 . . . . 0.0 110.605 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.708 HG12 HG23 ' A' ' 85' ' ' ILE . 1.6 t -89.16 107.79 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.58 HG13 ' HB3' ' A' ' 36' ' ' HIS . 1.6 t -103.53 129.47 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.205 -0.935 . . . . 0.0 109.533 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.568 ' CB ' HG12 ' A' ' 85' ' ' ILE . 1.3 p -100.07 147.05 26.06 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.142 -0.974 . . . . 0.0 110.35 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.821 HG22 ' CD1' ' A' ' 32' ' ' TYR . 5.1 mm -131.62 94.22 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.664 HD12 ' N ' ' A' ' 73' ' ' ILE . 1.4 mp -90.62 135.86 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 109.716 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.098 ' HB2' ' CZ ' ' A' ' 32' ' ' TYR . . . -96.85 144.22 27.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -0.83 . . . . 0.0 109.522 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.423 ' O ' ' OG1' ' A' ' 30' ' ' THR . 1.7 m -130.99 133.18 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.275 -0.891 . . . . 0.0 109.058 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.637 ' HA ' HG23 ' A' ' 30' ' ' THR . 24.9 t30 -116.35 45.1 1.85 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.792 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.67 -81.55 1.71 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.42 -5.83 16.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -1.186 . . . . 0.0 109.816 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 76' ' ' ASN . 16.2 tp10 -107.34 155.92 19.47 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.242 -0.911 . . . . 0.0 109.247 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.485 ' N ' ' HG3' ' A' ' 79' ' ' GLU . 8.1 mt-10 -129.94 105.61 8.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.214 -0.928 . . . . 0.0 109.473 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.569 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -63.96 -179.87 0.31 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.218 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.569 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.4 Cg_endo -77.52 155.76 31.98 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.358 2.039 . . . . 0.0 110.513 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.6 Cg_endo -77.83 136.14 14.82 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.706 2.27 . . . . 0.0 111.099 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.763 HD22 ' O ' ' A' ' 5' ' ' PRO . 15.5 tp -117.71 93.27 4.09 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.708 HG23 HG12 ' A' ' 69' ' ' VAL . 2.5 mt -96.09 141.36 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.118 -0.989 . . . . 0.0 109.572 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 69' ' ' VAL . . . -130.43 -177.67 15.01 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.446 ' CG ' HG13 ' A' ' 69' ' ' VAL . 60.7 mt-30 -146.18 101.26 3.49 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.187 -1.184 . . . . 0.0 109.961 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.526 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 41.8 mm-40 -98.26 -161.17 0.85 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -144.65 130.93 19.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.916 -1.115 . . . . 0.0 110.37 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -74.37 139.01 43.79 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.224 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.707 HG23 HG22 ' A' ' 13' ' ' ILE . 12.1 t . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 121.557 0.694 . . . . 0.0 110.29 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.701 ' CG ' HD11 ' A' ' 162' ' ' LEU . 36.8 Cg_endo . . . . . 0 C--O 1.216 -0.612 0 N-CA-C 109.744 -0.906 . . . . 0.0 109.744 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 2.2 ptt180 -106.27 153.41 22.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.055 -1.028 . . . . 0.0 109.851 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.9 OUTLIER 76.98 25.82 0.79 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 109.853 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.902 HD22 ' CD2' ' A' ' 162' ' ' LEU . 31.1 tp -64.01 100.46 0.32 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.064 -1.022 . . . . 0.0 109.239 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 110' ' ' ILE . 18.4 pt-20 -128.22 170.15 13.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.95 . . . . 0.0 109.572 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.614 HG22 ' H ' ' A' ' 101' ' ' ILE . 9.1 p -109.24 172.66 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 109.766 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.736 HD11 ' HB3' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -150.3 -81.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.361 -0.837 . . . . 0.0 109.226 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 1.066 ' HB3' HD13 ' A' ' 109' ' ' LEU . . . -74.89 101.84 4.55 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.528 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 5.2 p -98.98 90.14 4.53 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.868 . . . . 0.0 110.479 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.612 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -76.5 165.71 50.57 Favored Pre-proline 0 C--N 1.306 -1.325 0 O-C-N 121.154 -0.966 . . . . 0.0 108.759 178.884 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 29.9 Cg_endo -69.42 -2.81 10.57 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.421 2.081 . . . . 0.0 110.602 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.774 ' C ' HG22 ' A' ' 152' ' ' ILE . 1.0 OUTLIER -150.64 17.49 0.8 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.394 -0.817 . . . . 0.0 108.805 179.002 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' SER . . . . . 1.034 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -169.05 159.33 9.13 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.127 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.034 HD23 ' O ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -143.87 154.69 43.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.324 -0.86 . . . . 0.0 109.263 -179.818 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 1.066 HD13 ' HB3' ' A' ' 102' ' ' ALA . 0.4 OUTLIER -105.58 132.97 51.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.318 -0.863 . . . . 0.0 108.833 179.32 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.757 HD11 HD13 ' A' ' 124' ' ' ILE . 1.1 pt -115.67 144.69 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.084 -1.01 . . . . 0.0 109.96 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' A' ' 146' ' ' THR . 32.6 t -143.31 126.55 16.57 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.585 ' CZ3' ' HA ' ' A' ' 146' ' ' THR . 3.3 p90 -123.33 171.33 9.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.947 . . . . 0.0 109.835 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 96' ' ' ARG . 6.0 mm-40 . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.388 -0.82 . . . . 0.0 109.338 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.619 ' CE2' HG22 ' A' ' 139' ' ' THR . 1.8 p90 . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.627 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.2 OUTLIER -135.01 150.37 50.31 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.692 -1.255 . . . . 0.0 110.69 -179.014 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.496 ' HG2' ' CE2' ' A' ' 121' ' ' TYR . 15.6 mtp180 -109.42 92.63 4.13 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.757 HD13 HD11 ' A' ' 110' ' ' ILE . 52.8 mt -84.2 163.83 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.926 . . . . 0.0 110.421 -178.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.596 ' N ' HG22 ' A' ' 124' ' ' ILE . 23.3 p -145.35 140.85 28.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.505 -0.747 . . . . 0.0 109.586 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.651 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 2.6 m-85 -82.06 134.24 35.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.876 . . . . 0.0 109.227 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.62 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -106.0 124.87 7.98 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 . . . . . 0 C--N 1.295 -1.786 0 O-C-N 121.213 -1.169 . . . . 0.0 109.201 179.472 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 126' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 2.1 pt-20 -92.8 154.0 18.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.379 -0.826 . . . . 0.0 110.918 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.612 ' CE1' ' HB ' ' A' ' 124' ' ' ILE . 31.7 p90 -164.74 147.39 8.53 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.619 HG22 ' CE2' ' A' ' 121' ' ' TYR . 0.8 OUTLIER -73.85 -176.6 2.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.011 -1.056 . . . . 0.0 110.553 -178.19 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.704 ' CG2' HD12 ' A' ' 124' ' ' ILE . 71.6 t -146.69 139.07 13.91 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.465 -0.772 . . . . 0.0 109.199 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.579 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.8 Cg_endo -76.97 127.88 9.63 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.419 2.079 . . . . 0.0 110.396 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -79.4 51.16 3.9 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.504 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 1.0 OUTLIER -104.65 -3.4 23.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.18 -1.188 . . . . 0.0 109.457 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.504 ' CG ' ' O ' ' A' ' 143' ' ' SER . 18.2 mttt -165.3 174.66 9.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 0.0 109.275 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.443 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 4.7 p -93.15 4.35 54.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.512 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.585 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 3.1 p -119.11 155.76 30.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.317 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.57 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -129.61 161.22 31.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.411 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.581 ' O ' HD13 ' A' ' 149' ' ' ILE . 12.6 m -107.69 153.63 22.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.269 -0.894 . . . . 0.0 109.521 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.651 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 7.5 mm -134.65 119.03 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.352 -0.842 . . . . 0.0 109.304 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.531 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 41.8 m-20 -124.72 173.79 8.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.323 -0.86 . . . . 0.0 109.825 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 15.2 m120 62.94 33.92 14.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.134 -0.979 . . . . 0.0 109.074 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.774 HG22 ' C ' ' A' ' 106' ' ' THR . 7.2 tt -89.32 147.68 5.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.519 -0.738 . . . . 0.0 109.739 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.4 ' HB2' ' OH ' ' A' ' 158' ' ' TYR . 25.3 mttt -82.67 113.87 47.98 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.175 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.493 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 35.8 Cg_endo -78.11 146.61 22.9 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.413 2.075 . . . . 0.0 110.606 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.661 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 78.2 65.28 1.89 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 166.7 128.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -1.163 . . . . 0.0 109.772 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -46.34 160.56 0.07 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.62 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -141.66 177.75 7.94 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.886 -1.134 . . . . 0.0 110.356 -179.346 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.548 ' CB ' ' HA3' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -146.42 108.15 4.32 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.295 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.53 ' HB ' ' CG1' ' A' ' 180' ' ' ILE . 43.3 mm -93.73 112.68 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.735 -1.228 . . . . 0.0 109.867 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.713 HG23 ' HB2' ' A' ' 179' ' ' SER . 7.5 m -123.37 148.79 45.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -0.87 . . . . 0.0 108.954 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.902 ' CD2' HD22 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -145.15 156.15 43.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.91 -1.118 . . . . 0.0 110.706 -179.779 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.596 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 1.8 m-85 -119.76 77.8 1.26 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 122' ' ' TYR . . . -47.41 150.01 0.99 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.959 -1.088 . . . . 0.0 109.456 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.887 HG22 ' HB3' ' A' ' 174' ' ' SER . 51.6 t . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.208 -0.932 . . . . 0.0 109.739 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.887 ' HB3' HG22 ' A' ' 165' ' ' VAL . 1.2 p . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 174' ' ' SER . 83.9 p -44.2 168.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.342 -0.849 . . . . 0.0 109.443 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.26 143.61 9.29 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.043 -1.035 . . . . 0.0 108.508 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.596 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 35.7 Cg_endo -78.44 136.49 14.07 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.407 2.071 . . . . 0.0 111.337 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.2 t -109.56 136.95 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.713 ' HB2' HG23 ' A' ' 161' ' ' THR . 33.0 t -124.67 160.33 28.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.058 -1.026 . . . . 0.0 110.951 -178.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.855 HG23 HD23 ' A' ' 98' ' ' LEU . 39.3 pt -140.95 171.86 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.473 ' OD1' ' N ' ' A' ' 181' ' ' ASN . 1.2 m120 -103.72 166.0 10.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.936 -1.102 . . . . 0.0 110.036 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 1.023 ' OH ' HD22 ' A' ' 108' ' ' LEU . 48.3 t80 -154.15 172.47 17.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.512 -0.743 . . . . 0.0 109.2 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -145.1 118.38 8.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.149 -0.969 . . . . 0.0 109.562 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.509 ' OG1' ' N ' ' A' ' 156' ' ' ALA . 8.0 p . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.42 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.403 HD21 ' ND2' ' A' ' 76' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.521 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 2.5 m-20 -76.04 97.44 4.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.351 -0.843 . . . . 0.0 109.152 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -40.59 101.34 0.24 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.597 -0.689 . . . . 0.0 109.888 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.716 ' HG2' ' HB2' ' A' ' 74' ' ' ALA . 34.9 Cg_endo -77.44 71.97 6.19 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.51 2.14 . . . . 0.0 109.733 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.875 ' HA ' HD22 ' A' ' 84' ' ' LEU . 16.7 p -91.16 -98.67 0.11 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.269 -0.894 . . . . 0.0 109.937 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 9' ' ' ASP . . . 48.64 24.72 4.22 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.402 ' N ' ' C ' ' A' ' 6' ' ' THR . 29.7 t80 -55.55 91.79 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.567 -0.961 . . . . 0.0 109.325 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 7' ' ' GLY . 7.8 t70 -137.36 111.99 8.76 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.552 ' CB ' ' HG3' ' A' ' 88' ' ' GLN . 0.3 OUTLIER -84.3 134.23 34.52 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.253 -0.904 . . . . 0.0 109.452 -179.573 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.471 ' O ' ' C ' ' A' ' 12' ' ' ASP . 86.8 p -150.33 -160.84 1.23 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.304 -0.873 . . . . 0.0 109.064 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.533 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 19.2 m-20 46.17 33.12 1.64 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 1.088 HG22 HG23 ' A' ' 91' ' ' VAL . 1.9 mt -86.97 111.02 21.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.317 -177.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -94.23 -177.04 4.15 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 177.568 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -88.58 -11.07 46.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.668 -1.27 . . . . 0.0 109.684 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 17' ' ' SER . 0.6 OUTLIER -131.95 22.14 4.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.887 -1.133 . . . . 0.0 108.115 178.605 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.529 ' CB ' ' HA ' ' A' ' 60' ' ' THR . 76.0 p 174.19 127.15 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.78 ' CB ' HG23 ' A' ' 13' ' ' ILE . 2.2 p90 -137.97 147.0 43.84 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.699 -1.251 . . . . 0.0 109.883 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . 1.008 ' OG1' HG23 ' A' ' 58' ' ' THR . 60.1 m -111.97 164.62 12.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.914 -1.116 . . . . 0.0 110.5 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.609 ' N ' HG22 ' A' ' 19' ' ' THR . 1.8 t -127.27 162.88 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.514 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 3.5 m-70 -151.77 137.45 17.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.926 -1.108 . . . . 0.0 110.155 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.778 ' CZ2' HG21 ' A' ' 50' ' ' VAL . 48.4 p90 -133.81 156.48 47.96 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.38 156.63 6.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 120.864 -1.147 . . . . 0.0 109.957 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . . . -101.64 153.31 37.99 Favored Pre-proline 0 C--N 1.298 -1.668 0 O-C-N 121.841 -0.537 . . . . 0.0 109.731 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 1.098 ' CG ' HD13 ' A' ' 29' ' ' ILE . 36.7 Cg_endo -79.65 133.78 10.61 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.623 2.216 . . . . 0.0 110.171 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -69.51 -5.74 26.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 109.574 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.914 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -97.25 173.8 3.75 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 0.0 109.384 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.914 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.3 Cg_endo -78.17 107.19 2.28 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.605 2.203 . . . . 0.0 110.484 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 1.098 HD13 ' CG ' ' A' ' 25' ' ' PRO . 18.6 pt -108.66 -171.72 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.411 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 7.9 p -115.63 -7.1 12.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.902 . . . . 0.0 109.568 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.24 -178.98 17.4 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.709 ' OH ' HD11 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -126.82 158.02 37.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -1.145 . . . . 0.0 109.488 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.008 ' C ' HD13 ' A' ' 34' ' ' ILE . 5.9 mt -111.56 136.32 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.241 -0.912 . . . . 0.0 108.898 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.008 HD13 ' C ' ' A' ' 33' ' ' ILE . 1.4 mm -119.08 125.4 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.109 -0.994 . . . . 0.0 110.283 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.528 ' CB ' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -122.6 129.71 52.2 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.555 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.603 ' CE1' ' HD2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -125.09 140.12 53.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.833 -1.167 . . . . 0.0 110.542 -178.819 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.735 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 25.3 p80 -166.32 122.29 1.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.424 -0.797 . . . . 0.0 109.753 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -55.22 -164.25 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.252 -0.905 . . . . 0.0 109.66 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 38' ' ' ALA . 1.4 mp0 . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.189 -0.944 . . . . 0.0 109.615 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.603 ' HD2' ' CE1' ' A' ' 36' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.597 0.713 . . . . 0.0 109.817 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.52 ' CB ' ' HG3' ' A' ' 35' ' ' ARG . 1.6 mt-30 -119.78 99.42 6.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.517 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -84.66 106.53 16.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.269 -0.894 . . . . 0.0 109.072 179.55 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.986 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -84.65 137.7 33.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.241 -0.912 . . . . 0.0 109.142 -179.803 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.778 HG21 ' CZ2' ' A' ' 22' ' ' TRP . 21.9 m -114.07 154.75 46.08 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 109.706 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.514 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 35.2 Cg_endo -77.99 175.3 11.34 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.76 2.307 . . . . 0.0 110.29 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.53 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.1 Cg_endo -76.26 -15.87 17.82 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.528 2.152 . . . . 0.0 110.121 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.72 11.13 18.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 0.0 109.25 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.402 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 6.2 mmt180 -137.98 134.89 35.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.306 -0.871 . . . . 0.0 109.21 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.5 ' HA ' ' CE2' ' A' ' 22' ' ' TRP . 2.1 p-10 -124.75 18.69 8.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 0.0 109.638 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 84.4 p -145.78 138.59 25.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 109.776 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.956 HG21 HG21 ' A' ' 34' ' ' ILE . 1.5 tt -119.1 120.03 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.359 -0.838 . . . . 0.0 108.988 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 1.008 HG23 ' OG1' ' A' ' 19' ' ' THR . 0.4 OUTLIER -91.03 133.05 35.62 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.269 -0.894 . . . . 0.0 110.405 -179.115 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.816 ' HB3' HD11 ' A' ' 62' ' ' LEU . 1.5 mt -117.29 140.45 49.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.0 109.112 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.529 ' HA ' ' CB ' ' A' ' 17' ' ' SER . 25.1 p -129.05 174.65 9.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.354 -0.841 . . . . 0.0 109.909 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.638 ' O ' HD23 ' A' ' 62' ' ' LEU . 8.9 m-20 51.63 66.43 1.2 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.377 -0.827 . . . . 0.0 109.515 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.816 HD11 ' HB3' ' A' ' 59' ' ' LEU . 9.0 mt -134.41 133.94 41.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.467 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -48.12 134.88 11.95 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 108.819 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.4 Cg_endo -77.97 128.21 9.03 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.362 2.041 . . . . 0.0 110.681 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 79.37 60.87 2.43 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 90' ' ' THR . 1.5 m -149.59 142.23 24.51 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.366 -1.079 . . . . 0.0 109.7 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.541 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 3.0 mt-10 -74.59 134.72 42.09 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.973 -1.079 . . . . 0.0 108.768 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.597 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 3.6 m-85 -123.23 98.1 5.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.125 -0.984 . . . . 0.0 109.761 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.735 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 6.6 t -59.6 133.67 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.157 -0.965 . . . . 0.0 108.874 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 35' ' ' ARG . 11.0 t -137.86 137.36 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.106 -0.996 . . . . 0.0 109.375 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.628 ' HB3' HD13 ' A' ' 85' ' ' ILE . 88.9 p -116.53 134.68 54.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.188 -0.945 . . . . 0.0 110.133 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.898 ' HB ' HD12 ' A' ' 84' ' ' LEU . 21.5 mm -120.21 143.0 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 109.334 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.552 HG22 ' N ' ' A' ' 74' ' ' ALA . 36.9 mm -138.5 162.11 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.148 -0.97 . . . . 0.0 109.704 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.716 ' HB2' ' HG2' ' A' ' 5' ' ' PRO . . . -134.61 98.23 4.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.357 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.465 ' O ' ' OG1' ' A' ' 30' ' ' THR . 2.5 m -96.65 154.69 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 109.399 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 28' ' ' PRO . 30.2 t30 -133.63 45.94 2.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 109.55 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.453 ' N ' HG21 ' A' ' 30' ' ' THR . . . 81.87 -97.2 1.84 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -94.14 2.61 55.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -1.164 . . . . 0.0 109.534 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.484 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 2.2 mt-10 -109.49 -173.39 2.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.162 -0.961 . . . . 0.0 109.552 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 0.6 OUTLIER -163.31 100.16 0.94 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.357 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.649 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -59.64 -179.7 0.17 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.899 . . . . 0.0 108.878 179.716 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.578 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.1 Cg_endo -77.16 138.35 17.98 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.2 1.933 . . . . 0.0 110.187 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.533 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 36.0 Cg_endo -77.9 139.94 17.86 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.572 2.182 . . . . 0.0 110.571 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.898 HD12 ' HB ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -136.1 91.87 2.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.318 -0.864 . . . . 0.0 109.565 179.755 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.628 HD13 ' HB3' ' A' ' 71' ' ' SER . 4.1 mt -97.09 159.1 3.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.373 -0.829 . . . . 0.0 109.341 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.477 ' N ' HG22 ' A' ' 85' ' ' ILE . . . -162.84 159.08 31.46 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -112.81 118.36 34.73 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.367 -1.078 . . . . 0.0 109.435 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.552 ' HG3' ' CB ' ' A' ' 10' ' ' SER . 1.7 mm-40 -109.64 -157.64 0.62 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.541 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -162.31 148.4 13.04 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.978 -1.076 . . . . 0.0 110.081 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.47 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.47 136.97 42.28 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 1.088 HG23 HG22 ' A' ' 13' ' ' ILE . 5.2 t . . . . . 0 C--N 1.298 -1.647 0 CA-C-O 121.741 0.782 . . . . 0.0 110.902 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.525 ' CB ' ' O ' ' A' ' 113' ' ' GLU . 34.2 Cg_endo . . . . . 0 C--O 1.214 -0.681 0 N-CA-C 109.293 -1.079 . . . . 0.0 109.293 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 1.7 ptp180 -163.37 164.77 24.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.912 -1.117 . . . . 0.0 110.064 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 21.0 t0 79.26 21.2 0.65 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.552 -0.718 . . . . 0.0 110.146 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.867 ' O ' HG21 ' A' ' 180' ' ' ILE . 0.3 OUTLIER -63.77 99.28 0.23 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.9 -1.125 . . . . 0.0 108.928 179.517 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.69 -174.95 4.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 109' ' ' LEU . 5.0 p -114.93 152.43 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.195 -0.941 . . . . 0.0 110.013 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.475 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 5.2 pt -119.08 -16.11 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.394 -0.816 . . . . 0.0 109.314 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.716 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -140.95 168.79 18.94 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.472 ' HG ' ' HH ' ' A' ' 182' ' ' TYR . 1.9 t -156.16 102.22 2.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.891 -1.131 . . . . 0.0 110.506 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.484 ' HB ' ' HD2' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -90.74 166.92 17.6 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.798 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.484 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 29.9 Cg_endo -69.41 -1.97 9.1 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.257 1.971 . . . . 0.0 110.579 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.746 ' C ' HG22 ' A' ' 152' ' ' ILE . 3.9 p -151.26 17.43 0.74 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.331 -0.856 . . . . 0.0 108.985 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' SER . . . . . 1.097 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -170.72 162.42 7.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.991 -1.068 . . . . 0.0 110.343 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.097 HD23 ' O ' ' A' ' 107' ' ' SER . 0.7 OUTLIER -141.84 156.85 45.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.464 -0.772 . . . . 0.0 109.099 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.716 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.3 OUTLIER -104.24 121.83 44.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 109.207 179.704 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.8 ' CD1' ' HB3' ' A' ' 147' ' ' ALA . 2.0 pt -103.35 148.23 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -0.903 . . . . 0.0 109.934 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.543 ' CB ' HG22 ' A' ' 146' ' ' THR . 84.9 p -146.16 137.46 24.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.4 -0.813 . . . . 0.0 109.052 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.57 ' CE3' ' O ' ' A' ' 145' ' ' SER . 37.1 p90 -158.87 -167.33 2.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.728 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 95' ' ' PRO . 2.1 mt-10 . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 108.959 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.654 ' OH ' HG21 ' A' ' 165' ' ' VAL . 5.2 p90 . . . . . 0 N--CA 1.485 1.279 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 2.6 m-85 -129.11 137.67 51.36 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -94.91 86.6 4.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 109.548 -179.479 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.975 ' CD1' HG21 ' A' ' 140' ' ' VAL . 77.1 mt -84.19 148.47 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.882 . . . . 0.0 109.192 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 2.5 p -131.44 150.59 52.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.92 . . . . 0.0 110.348 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.634 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 2.9 m-85 -85.33 133.51 34.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.436 -0.79 . . . . 0.0 108.942 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.592 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.83 116.57 5.21 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.227 -1.161 . . . . 0.0 109.316 179.695 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.597 ' HB2' ' CD1' ' A' ' 126' ' ' TYR . 19.7 mt-30 . . . . . 0 N--CA 1.496 1.84 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 7.2 pt-20 -76.54 130.24 37.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.448 -0.783 . . . . 0.0 111.103 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.599 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 38.1 p90 -137.27 143.66 42.31 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.652 HG22 ' CE1' ' A' ' 121' ' ' TYR . 12.7 p -74.28 165.62 24.86 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.996 -1.065 . . . . 0.0 110.69 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.975 HG21 ' CD1' ' A' ' 124' ' ' ILE . 8.2 t -137.33 139.63 28.34 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.603 -0.686 . . . . 0.0 109.773 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.486 ' HD2' HG13 ' A' ' 140' ' ' VAL . 33.7 Cg_endo -75.64 125.81 9.15 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.303 2.002 . . . . 0.0 110.364 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.61 -1.85 54.21 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 4.9 p -75.4 1.02 14.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.175 -1.191 . . . . 0.0 109.656 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 143' ' ' SER . 1.8 mmtp -152.39 149.68 28.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.152 -0.968 . . . . 0.0 109.67 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.57 ' O ' ' CE3' ' A' ' 112' ' ' TRP . 1.7 m -93.96 -13.17 27.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 109.296 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.543 HG22 ' CB ' ' A' ' 111' ' ' SER . 64.4 p -107.26 130.64 54.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.285 -0.884 . . . . 0.0 108.974 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.8 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -118.49 161.34 20.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.975 . . . . 0.0 109.905 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.456 ' O ' HD13 ' A' ' 149' ' ' ILE . 11.2 t -103.07 155.96 18.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.33 -0.856 . . . . 0.0 109.074 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.634 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 20.2 mm -133.07 113.68 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 109.725 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.547 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 3.3 m120 -120.79 173.34 7.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.384 -0.822 . . . . 0.0 109.705 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 0.5 OUTLIER 69.12 34.19 3.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.914 . . . . 0.0 109.291 -179.912 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.746 HG22 ' C ' ' A' ' 106' ' ' THR . 4.5 tt -93.89 158.7 2.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.37 -0.831 . . . . 0.0 109.788 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.42 115.65 65.71 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.262 -0.899 . . . . 0.0 109.121 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.463 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 35.4 Cg_endo -77.42 138.17 17.32 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.391 2.061 . . . . 0.0 110.743 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.702 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 86.41 68.06 1.35 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 163.73 130.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -1.155 . . . . 0.0 109.637 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -47.53 162.63 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.17 -0.956 . . . . 0.0 108.559 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.592 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.3 OUTLIER -142.94 -170.8 3.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.918 -1.114 . . . . 0.0 110.234 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.514 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 3.2 m -165.41 110.83 0.9 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.523 ' HB ' ' CG1' ' A' ' 180' ' ' ILE . 30.1 mm -95.82 120.23 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.995 -1.066 . . . . 0.0 109.843 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.674 HG23 ' CB ' ' A' ' 179' ' ' SER . 2.2 m -124.9 164.31 20.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.241 -0.912 . . . . 0.0 109.145 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.838 HD23 HD11 ' A' ' 98' ' ' LEU . 1.6 pp -159.53 142.88 14.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.933 -1.104 . . . . 0.0 111.135 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.62 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.2 m-85 -113.78 80.25 1.35 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 122' ' ' TYR . . . -43.79 96.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.14 -0.975 . . . . 0.0 109.328 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.654 HG21 ' OH ' ' A' ' 121' ' ' TYR . 58.0 t . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 109.494 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.41 ' HB3' ' HA ' ' A' ' 165' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.8 p -57.14 -167.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.171 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -66.71 146.45 99.07 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.149 -0.969 . . . . 0.0 108.808 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.62 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.6 Cg_endo -77.32 122.72 6.22 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.455 2.103 . . . . 0.0 111.158 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.83 HG12 HD12 ' A' ' 98' ' ' LEU . 2.2 t -91.41 133.63 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.674 ' CB ' HG23 ' A' ' 161' ' ' THR . 1.4 p -124.71 151.37 45.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.11 -0.994 . . . . 0.0 110.72 -178.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.867 HG21 ' O ' ' A' ' 98' ' ' LEU . 3.1 pt -138.84 152.19 24.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -88.45 162.79 16.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.002 -1.061 . . . . 0.0 109.824 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.977 ' OH ' HD22 ' A' ' 108' ' ' LEU . 74.9 t80 -152.8 167.33 29.41 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.414 -0.804 . . . . 0.0 109.268 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.412 ' N ' ' CG ' ' A' ' 182' ' ' TYR . 5.7 tttp -138.3 118.35 13.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.55 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 17.0 p . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.46 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' LEU . . . . . 0.454 ' O ' ' OG ' ' A' ' 81' ' ' SER . 96.4 mt . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 2.9 m-20 -74.87 140.11 43.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 109.545 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.534 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 2.4 t -95.08 149.52 36.36 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.555 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.603 ' HG3' ' CD1' ' A' ' 32' ' ' TYR . 36.4 Cg_endo -78.89 117.72 3.97 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.711 2.274 . . . . 0.0 110.347 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.772 HG22 HD13 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -101.92 -107.78 0.24 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.947 . . . . 0.0 109.382 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 22' ' ' TRP . . . 42.5 27.83 0.54 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.442 ' N ' ' O ' ' A' ' 6' ' ' THR . 25.8 t80 -48.36 124.75 8.43 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.431 -1.041 . . . . 0.0 109.849 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 21' ' ' HIS . 4.2 t70 -164.96 84.06 0.39 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.405 -0.809 . . . . 0.0 109.019 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.983 ' OG ' HG13 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -84.6 137.84 33.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.195 -0.941 . . . . 0.0 109.684 -179.63 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.474 ' O ' ' HB ' ' A' ' 19' ' ' THR . 82.6 p -159.19 -158.67 0.7 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.36 -0.837 . . . . 0.0 109.143 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.523 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.5 OUTLIER 44.62 34.75 1.2 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -178.417 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.749 HD11 ' HG2' ' A' ' 88' ' ' GLN . 1.3 mt -72.37 140.48 17.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.495 -177.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.568 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -122.93 -175.09 3.08 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.611 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 91' ' ' VAL . . . -75.18 -70.97 0.39 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.908 -1.12 . . . . 0.0 109.499 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 5.8 p-10 -83.74 9.16 12.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.168 -0.957 . . . . 0.0 109.459 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.799 ' HB3' HG22 ' A' ' 60' ' ' THR . 0.1 OUTLIER -157.82 159.33 36.6 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.995 ' CE1' HG22 ' A' ' 20' ' ' VAL . 5.8 p90 -166.01 140.72 4.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.207 -0.933 . . . . 0.0 108.839 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 9.3 m -79.37 153.8 29.49 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.814 -1.179 . . . . 0.0 111.209 -178.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.995 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.3 t -134.69 115.82 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 9' ' ' ASP . 17.2 m-70 -105.46 159.11 16.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.044 -1.035 . . . . 0.0 110.132 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.771 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 20.9 p90 -175.09 140.25 0.51 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.366 -0.834 . . . . 0.0 109.209 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.61 162.32 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.134 -0.979 . . . . 0.0 109.965 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.774 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -93.96 169.59 9.72 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.766 -0.584 . . . . 0.0 109.696 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.774 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.2 Cg_endo -78.12 -159.88 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.611 2.207 . . . . 0.0 110.346 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.82 8.05 4.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 109.592 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.991 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -110.47 176.98 1.32 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.335 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.991 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 34.8 Cg_endo -77.54 110.67 3.01 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.478 2.119 . . . . 0.0 110.294 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.619 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 50.2 pt -126.29 -173.01 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 0.0 109.557 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.409 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 32.0 p -125.32 -5.43 7.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.483 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.498 ' HA2' ' N ' ' A' ' 52' ' ' PRO . . . 149.62 -178.78 26.91 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.642 ' CE2' ' HA ' ' A' ' 52' ' ' PRO . 1.8 m-85 -124.28 145.93 49.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -1.189 . . . . 0.0 109.631 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.061 HG23 ' HD2' ' A' ' 49' ' ' ARG . 0.9 OUTLIER -99.76 130.43 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.329 -0.857 . . . . 0.0 108.727 179.753 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.846 HD13 ' C ' ' A' ' 33' ' ' ILE . 1.4 mm -109.08 108.76 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.935 -1.103 . . . . 0.0 110.08 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.523 ' CB ' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -112.61 108.65 17.79 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.752 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.843 ' HB3' HG13 ' A' ' 70' ' ' VAL . 1.7 p-80 -114.62 166.79 11.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.022 . . . . 0.0 110.355 -178.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.455 ' O ' ' O ' ' A' ' 38' ' ' ALA . 40.0 p-80 177.73 136.19 0.07 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.594 -0.691 . . . . 0.0 109.282 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -56.31 -163.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.926 . . . . 0.0 109.372 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.18 -0.95 . . . . 0.0 109.606 -179.999 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.601 ' HB2' ' CD2' ' A' ' 36' ' ' HIS . 12.7 mmm180 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.305 0.574 . . . . 0.0 109.637 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.407 ' HG3' ' C ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -130.01 90.07 2.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.684 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.546 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 9.5 m-20 -99.1 114.3 26.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.267 -0.896 . . . . 0.0 108.862 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 1.061 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -92.11 150.21 21.07 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.978 -1.076 . . . . 0.0 109.822 -179.469 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.914 HG12 HD12 ' A' ' 57' ' ' ILE . 10.3 m -133.4 160.1 69.96 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.431 -0.793 . . . . 0.0 109.3 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.501 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 33.6 Cg_endo -76.27 174.35 12.98 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.561 2.174 . . . . 0.0 110.381 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.642 ' HA ' ' CE2' ' A' ' 32' ' ' TYR . 35.1 Cg_endo -77.17 -21.74 11.76 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.672 2.248 . . . . 0.0 110.999 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.8 t -92.51 -4.51 53.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.074 -1.016 . . . . 0.0 109.716 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.536 ' HD3' ' N ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -97.8 111.42 23.72 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.286 -0.884 . . . . 0.0 109.895 -179.744 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -101.04 -6.43 24.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.447 -0.783 . . . . 0.0 109.46 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 53.1 p -135.69 129.84 33.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.384 -0.822 . . . . 0.0 109.189 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.914 HD12 HG12 ' A' ' 50' ' ' VAL . 6.1 tt -133.33 129.14 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.231 -0.918 . . . . 0.0 109.672 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.1 115.39 24.46 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.337 -0.852 . . . . 0.0 109.074 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.988 ' CB ' HD11 ' A' ' 62' ' ' LEU . 1.3 mt -84.74 156.22 21.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.14 -0.975 . . . . 0.0 109.642 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.799 HG22 ' HB3' ' A' ' 17' ' ' SER . 15.5 p -145.65 -178.2 5.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.404 -0.81 . . . . 0.0 109.33 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.9 m120 55.48 20.04 3.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.364 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 0.988 HD11 ' CB ' ' A' ' 59' ' ' LEU . 3.5 mt -96.15 138.69 33.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.872 . . . . 0.0 109.302 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 62' ' ' LEU . 45.5 t30 -45.72 126.41 6.56 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.191 -0.943 . . . . 0.0 108.804 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 35.8 Cg_endo -77.81 134.67 13.62 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.307 2.004 . . . . 0.0 110.699 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 68.16 62.6 4.09 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.0 m -160.67 153.01 20.46 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.264 -1.139 . . . . 0.0 110.134 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 1.2 tt0 -77.09 121.27 23.33 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.541 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 1.0 OUTLIER -116.71 114.54 24.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.085 -1.01 . . . . 0.0 110.019 -179.158 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.8 t -79.5 118.44 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 108.678 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.843 HG13 ' HB3' ' A' ' 36' ' ' HIS . 1.4 t -100.4 135.77 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.129 -0.982 . . . . 0.0 109.611 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.545 ' HB2' ' CD1' ' A' ' 85' ' ' ILE . 10.8 p -114.72 108.3 16.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.345 -0.847 . . . . 0.0 110.084 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 0.849 ' C ' HD12 ' A' ' 73' ' ' ILE . 17.0 mm -87.96 119.17 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 0.0 109.428 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.849 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.6 mp -116.74 158.63 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 109.256 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.624 ' HB3' ' CB ' ' A' ' 81' ' ' SER . . . -119.32 157.43 28.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.492 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.457 HG21 HD11 ' A' ' 33' ' ' ILE . 3.9 m -151.95 148.4 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 0.0 109.487 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.437 ' HB2' HD13 ' A' ' 2' ' ' LEU . 43.0 t30 -131.33 44.22 2.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.289 -0.882 . . . . 0.0 109.376 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.95 -88.13 0.67 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.95 -1.68 11.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.247 -1.149 . . . . 0.0 109.463 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.77 -162.59 0.92 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 109.394 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -159.15 173.74 15.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.198 -0.939 . . . . 0.0 109.797 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.624 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -145.05 -176.74 0.58 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.596 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.1 Cg_endo -77.3 136.54 16.04 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.068 1.845 . . . . 0.0 110.118 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.431 ' HB3' HG13 ' A' ' 73' ' ' ILE . 36.2 Cg_endo -78.43 104.0 1.76 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.65 2.234 . . . . 0.0 111.221 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.772 HD13 HG22 ' A' ' 6' ' ' THR . 0.9 OUTLIER -80.99 90.52 5.97 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.069 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.545 ' CD1' ' HB2' ' A' ' 71' ' ' SER . 2.7 mt -92.93 159.8 2.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.146 -0.971 . . . . 0.0 110.703 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.51 ' N ' HG22 ' A' ' 85' ' ' ILE . . . -154.22 168.34 32.5 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -117.27 139.94 50.18 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.129 -1.218 . . . . 0.0 109.915 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.749 ' HG2' HD11 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -139.68 -162.75 1.38 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.371 -0.831 . . . . 0.0 109.029 179.758 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -156.76 129.23 7.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.114 -0.991 . . . . 0.0 109.886 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.443 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -78.8 146.26 33.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.385 -0.822 . . . . 0.0 108.999 179.693 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.568 HG23 HG22 ' A' ' 13' ' ' ILE . 1.4 t . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.506 -0.746 . . . . 0.0 110.114 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PRO . . . . . 0.495 ' O ' ' HB2' ' A' ' 112' ' ' TRP . 36.2 Cg_endo . . . . . 0 C--O 1.214 -0.686 0 N-CA-C 108.63 -1.334 . . . . 0.0 108.63 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 112' ' ' TRP . 24.9 mtt180 -72.51 -163.65 0.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.665 0.745 . . . . 0.0 110.392 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 111' ' ' SER . 8.4 m-20 64.64 9.48 5.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.614 -0.679 . . . . 0.0 109.588 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.884 HD22 ' CD2' ' A' ' 162' ' ' LEU . 25.1 tp -61.71 99.13 0.11 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.138 -0.976 . . . . 0.0 109.439 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -137.76 159.96 40.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.902 . . . . 0.0 109.673 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.405 HG12 ' H ' ' A' ' 100' ' ' VAL . 2.7 p -81.35 139.78 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.362 -0.836 . . . . 0.0 109.716 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.535 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 41.6 pt -134.62 4.46 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.404 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.925 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -165.12 88.27 0.45 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.516 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 0.7 OUTLIER -82.72 96.44 8.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.417 -0.802 . . . . 0.0 110.609 -178.712 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.572 HG21 ' OG ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -84.01 162.72 51.22 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.244 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.515 ' O ' HG23 ' A' ' 106' ' ' THR . 29.4 Cg_endo -67.82 -3.21 9.99 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.532 2.155 . . . . 0.0 111.138 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.863 ' C ' HG22 ' A' ' 152' ' ' ILE . 2.3 p -156.6 22.39 0.34 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.572 ' OG ' HG21 ' A' ' 104' ' ' THR . 18.2 p -172.54 175.91 3.39 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.118 -1.033 . . . . 0.0 109.924 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.847 HD12 ' N ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -153.69 154.48 34.2 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.484 -0.76 . . . . 0.0 109.203 -179.627 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.925 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -103.02 114.55 28.94 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.095 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.976 HD11 ' CD1' ' A' ' 149' ' ' ILE . 0.4 OUTLIER -103.61 131.62 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.113 -0.992 . . . . 0.0 109.954 -179.512 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 97' ' ' ASP . 3.3 m -123.52 132.53 53.94 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.572 ' CD2' ' O ' ' A' ' 145' ' ' SER . 49.0 p90 -135.99 169.52 17.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.935 . . . . 0.0 109.695 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.181 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 1.118 ' CE1' HG22 ' A' ' 139' ' ' THR . 1.4 p90 . . . . . 0 N--CA 1.485 1.317 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 163' ' ' TYR . 32.2 m-85 -93.51 134.42 35.8 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.998 -1.064 . . . . 0.0 108.85 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 4.3 ttp-105 -101.19 94.83 6.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.246 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.631 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 19.6 mt -85.79 141.52 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.299 -0.876 . . . . 0.0 109.96 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . 1.1 HG22 ' CG ' ' A' ' 137' ' ' GLU . 5.1 p -113.79 127.44 56.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.372 -0.83 . . . . 0.0 109.507 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 1.162 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 3.4 m-30 -74.95 113.93 12.82 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.613 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -101.77 119.83 6.63 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 120.214 -0.994 . . . . 0.0 110.852 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 . . . . . 0 C--N 1.297 -1.697 0 O-C-N 121.269 -1.136 . . . . 0.0 108.529 178.725 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.559 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 4.5 mt-30 . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 1.1 ' CG ' HG22 ' A' ' 125' ' ' THR . 14.4 mp0 -142.79 157.76 44.3 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.902 -1.124 . . . . 0.0 110.985 -178.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.631 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 6.0 p90 -155.51 135.14 12.59 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' THR . . . . . 1.118 HG22 ' CE1' ' A' ' 121' ' ' TYR . 12.2 p -74.37 165.29 25.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.083 -1.011 . . . . 0.0 110.905 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.546 HG21 ' CD1' ' A' ' 124' ' ' ILE . 2.8 t -136.07 140.96 34.63 Favored Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.506 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.3 Cg_endo -76.29 146.75 28.53 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.334 2.023 . . . . 0.0 110.142 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.33 37.33 3.14 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.416 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 89.4 p -105.12 -1.1 25.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.111 -1.229 . . . . 0.0 109.624 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 143' ' ' SER . 5.7 mttt -151.45 154.5 36.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.186 -0.946 . . . . 0.0 109.52 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.572 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 0.4 OUTLIER -91.8 2.24 56.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 109.552 179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 110' ' ' ILE . 2.0 p -124.56 151.41 44.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.054 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.535 ' HB3' HG13 ' A' ' 110' ' ' ILE . . . -118.12 178.14 4.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.141 -0.975 . . . . 0.0 109.409 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.466 HG22 ' OD1' ' A' ' 150' ' ' ASN . 57.4 m -133.2 97.31 3.95 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.252 -0.905 . . . . 0.0 109.568 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 1.162 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 1.0 OUTLIER -79.17 93.11 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.333 -0.855 . . . . 0.0 109.051 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.539 ' HA ' ' CB ' ' A' ' 107' ' ' SER . 82.9 m-20 -101.29 178.23 4.71 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.935 . . . . 0.0 109.356 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 28.7 m120 57.67 55.92 5.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.892 . . . . 0.0 109.355 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.863 HG22 ' C ' ' A' ' 106' ' ' THR . 13.8 tt -111.63 164.4 7.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.268 -0.895 . . . . 0.0 109.699 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -95.03 110.26 49.0 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.134 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 152' ' ' ILE . 34.9 Cg_endo -76.77 139.66 20.06 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.355 2.036 . . . . 0.0 110.522 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.69 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 95.55 62.49 0.99 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 164.6 132.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -1.136 . . . . 0.0 109.524 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 1.8 t70 -48.19 168.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.613 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -146.69 -164.7 2.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.837 -1.164 . . . . 0.0 110.275 -179.638 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 127' ' ' GLY . 9.2 m -174.79 105.21 0.1 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.736 HD11 HD22 ' A' ' 108' ' ' LEU . 54.8 mt -97.75 117.2 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.909 -1.119 . . . . 0.0 110.286 -178.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.609 HG23 ' HB2' ' A' ' 179' ' ' SER . 36.9 m -120.46 161.86 20.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.28 -0.888 . . . . 0.0 108.723 178.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.884 ' CD2' HD22 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -156.72 148.6 22.8 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 118.742 -1.183 . . . . 0.0 111.441 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.648 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.9 m-85 -120.54 161.87 20.57 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.035 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 1.046 ' HB3' ' OG ' ' A' ' 175' ' ' SER . . . -113.68 102.15 9.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.938 -1.102 . . . . 0.0 109.016 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.508 HG21 ' CZ ' ' A' ' 121' ' ' TYR . 51.7 t . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.383 -0.823 . . . . 0.0 110.218 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 2.4 p . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.224 0.535 . . . . 0.0 109.669 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' SER . . . . . 1.046 ' OG ' ' HB3' ' A' ' 164' ' ' ALA . 0.7 OUTLIER -50.81 169.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.29 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 176' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 175' ' ' SER . 0.3 OUTLIER -44.36 123.68 4.47 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.286 -0.884 . . . . 0.0 109.274 179.705 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.648 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 33.7 Cg_endo -77.61 140.45 18.88 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.018 1.812 . . . . 0.0 110.902 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.37 135.48 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' SER . . . . . 0.609 ' HB2' HG23 ' A' ' 161' ' ' THR . 30.6 t -122.83 170.76 9.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.164 -0.96 . . . . 0.0 111.332 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.482 HG21 ' O ' ' A' ' 98' ' ' LEU . 7.1 pt -152.21 152.65 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 159' ' ' THR . 67.0 m-80 -96.22 157.72 15.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.946 -1.096 . . . . 0.0 110.028 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.725 ' CZ ' HD23 ' A' ' 108' ' ' LEU . 39.8 t80 -141.1 171.86 13.48 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.384 -0.823 . . . . 0.0 109.448 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 157' ' ' ASP . 3.4 tmtt? -145.05 108.09 4.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.532 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.452 ' OG1' ' N ' ' A' ' 155' ' ' GLY . 5.2 p . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.443 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ASP . . . . . 0.507 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 4.8 m-20 -91.25 132.46 36.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 109.439 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.524 ' OG ' ' CG ' ' A' ' 82' ' ' PRO . 15.2 m -95.79 150.05 36.86 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.305 -0.872 . . . . 0.0 109.808 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PRO . . . . . 0.714 ' O ' HD22 ' A' ' 84' ' ' LEU . 36.2 Cg_endo -79.74 131.05 9.0 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.746 2.297 . . . . 0.0 109.873 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 5' ' ' PRO . 0.8 OUTLIER -157.75 -167.62 2.31 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.053 -1.029 . . . . 0.0 109.591 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 46.25 27.06 2.54 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.056 -2.017 . . . . 0.0 108.056 -179.127 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PHE . . . . . 0.624 ' C ' ' CD1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -70.21 -170.33 0.36 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.74 -0.859 . . . . 0.0 109.57 -179.235 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.437 ' N ' ' CG ' ' A' ' 8' ' ' PHE . 21.3 t70 -165.55 110.19 0.86 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.229 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . 0.664 ' HB3' HG13 ' A' ' 20' ' ' VAL . 4.6 p -84.75 139.6 31.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.196 -0.94 . . . . 0.0 109.355 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.452 ' O ' ' C ' ' A' ' 12' ' ' ASP . 5.1 p -164.74 -157.96 0.38 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.185 -0.947 . . . . 0.0 109.623 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.538 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.6 OUTLIER 44.3 36.34 1.55 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -178.56 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ILE . . . . . 0.866 HG23 ' CB ' ' A' ' 18' ' ' PHE . 1.6 mt -74.63 145.29 11.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.862 -178.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.59 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -124.78 172.57 9.21 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.012 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.727 ' HB1' ' CB ' ' A' ' 64' ' ' PRO . . . -67.92 -65.11 0.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.704 -1.248 . . . . 0.0 109.419 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.482 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -90.5 27.44 1.71 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.06 -1.025 . . . . 0.0 109.323 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.59 ' O ' ' N ' ' A' ' 14' ' ' THR . 3.5 p -178.02 161.28 1.51 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 1.041 ' CE1' HD13 ' A' ' 59' ' ' LEU . 17.5 p90 -167.74 147.86 5.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.891 -1.131 . . . . 0.0 109.644 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.538 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 4.0 m -90.7 158.41 16.91 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.843 -1.16 . . . . 0.0 111.164 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.774 HG11 HG11 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -139.23 104.26 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.38 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' HIS . . . . . 0.412 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 7.9 m-70 -86.23 162.7 18.17 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.153 -0.967 . . . . 0.0 110.261 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' TRP . . . . . 0.787 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 16.3 p90 -175.08 136.4 0.38 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.469 -0.77 . . . . 0.0 109.305 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -74.74 161.57 4.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 O-C-N 121.091 -1.006 . . . . 0.0 109.693 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -96.74 160.96 28.13 Favored Pre-proline 0 C--N 1.298 -1.664 0 O-C-N 121.745 -0.597 . . . . 0.0 109.703 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.507 ' HB2' ' HB2' ' A' ' 3' ' ' ASP . 36.1 Cg_endo -78.44 163.57 27.04 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.647 2.231 . . . . 0.0 110.326 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.49 28.76 1.89 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.427 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.554 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -118.92 161.32 36.88 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.456 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.595 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 35.5 Cg_endo -78.18 89.9 1.31 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.612 2.208 . . . . 0.0 110.39 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.676 HD12 ' CD2' ' A' ' 32' ' ' TYR . 20.3 pt -97.45 171.59 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.506 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.499 HG23 ' HA ' ' A' ' 76' ' ' ASN . 64.1 p -100.57 -26.65 13.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.894 . . . . 0.0 109.433 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.08 -152.11 9.94 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 1.067 ' CZ ' ' HB2' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -165.12 126.26 2.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -1.17 . . . . 0.0 109.647 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.999 ' C ' HD13 ' A' ' 34' ' ' ILE . 6.1 mt -94.78 138.92 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.203 -0.936 . . . . 0.0 109.288 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.05 HG21 HG21 ' A' ' 57' ' ' ILE . 1.5 mm -119.85 117.91 55.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.298 -0.876 . . . . 0.0 109.077 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ARG . . . . . 0.534 ' CG ' ' OG ' ' A' ' 71' ' ' SER . 3.1 ptp180 -121.94 140.5 52.37 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.881 -1.137 . . . . 0.0 108.698 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 1.064 ' CG ' HD21 ' A' ' 59' ' ' LEU . 28.5 m-70 -137.43 167.21 22.07 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.055 -1.028 . . . . 0.0 110.496 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' HIS . . . . . 0.469 ' HA ' ' NH2' ' A' ' 46' ' ' ARG . 11.6 p80 -173.37 149.46 1.73 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.604 ' HA ' ' CD2' ' A' ' 68' ' ' TYR . . . -56.15 -163.65 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.564 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.459 ' OE2' ' OE2' ' A' ' 67' ' ' GLU . 5.3 mm-40 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.955 . . . . 0.0 109.718 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.792 HH11 HD23 ' A' ' 59' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.247 0.546 . . . . 0.0 109.557 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLN . . . . . 0.523 ' HB3' ' NE ' ' A' ' 49' ' ' ARG . 1.0 OUTLIER -126.66 109.52 12.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 110.174 -179.574 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.863 ' CB ' HD11 ' A' ' 57' ' ' ILE . 64.9 m-20 -92.68 111.54 23.18 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.42 -0.8 . . . . 0.0 108.928 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ARG . . . . . 0.817 ' HD2' HG23 ' A' ' 33' ' ' ILE . 9.6 mmt85 -90.58 137.82 32.05 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.16 -0.963 . . . . 0.0 109.339 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.78 HG13 HG12 ' A' ' 34' ' ' ILE . 5.5 m -126.66 160.19 59.82 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.296 -0.878 . . . . 0.0 109.432 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.5 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 34.9 Cg_endo -77.25 174.72 12.33 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.555 2.17 . . . . 0.0 110.343 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 34.8 Cg_endo -76.88 -15.4 16.75 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.513 2.142 . . . . 0.0 110.356 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 m -93.87 13.13 23.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.263 -0.898 . . . . 0.0 109.451 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.436 ' O ' ' CZ2' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -123.93 121.36 35.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.921 . . . . 0.0 109.499 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.498 ' O ' ' CE3' ' A' ' 22' ' ' TRP . 3.6 p30 -107.25 -0.86 22.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 109.523 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.7 p -132.55 129.76 39.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.648 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 1.05 HG21 HG21 ' A' ' 34' ' ' ILE . 2.3 tt -125.63 141.27 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.309 -0.869 . . . . 0.0 109.126 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 19.4 m -104.5 127.34 52.19 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.158 -0.964 . . . . 0.0 109.966 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.064 HD21 ' CG ' ' A' ' 36' ' ' HIS . 5.0 mp -84.39 160.73 20.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.341 -0.85 . . . . 0.0 109.674 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 0.8 OUTLIER -152.9 169.22 23.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.619 -0.676 . . . . 0.0 109.553 179.818 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASN . . . . . 0.463 ' O ' HD23 ' A' ' 62' ' ' LEU . 3.6 m120 60.07 48.28 8.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.886 . . . . 0.0 109.39 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . 1.008 HD11 ' HB3' ' A' ' 59' ' ' LEU . 2.0 mt -127.7 157.19 40.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.292 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASN . . . . . 0.499 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 1.4 m-20 -63.1 132.59 95.13 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.119 -0.988 . . . . 0.0 108.693 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.727 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . 36.3 Cg_endo -77.49 125.4 7.62 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.288 1.992 . . . . 0.0 110.638 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 90' ' ' THR . . . 77.94 61.67 2.49 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.638 HG22 ' CE1' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -154.66 145.12 22.15 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.255 -1.144 . . . . 0.0 110.155 -179.164 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 23.4 tt0 -74.87 129.57 37.91 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.638 ' CE1' HG22 ' A' ' 66' ' ' THR . 27.9 m-85 -125.42 164.56 20.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.997 -1.065 . . . . 0.0 110.251 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 70' ' ' VAL . 53.9 t -110.28 164.49 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.807 HG22 ' ND1' ' A' ' 36' ' ' HIS . 4.6 t -149.67 144.07 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.832 -1.167 . . . . 0.0 110.168 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.586 ' CB ' HG12 ' A' ' 85' ' ' ILE . 1.3 p -142.09 118.76 11.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.2 -0.938 . . . . 0.0 109.897 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . 1.039 HD13 HG23 ' A' ' 34' ' ' ILE . 4.5 mm -91.38 131.85 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.493 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.583 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 5.4 mt -116.91 150.75 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 109.201 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.067 ' HB2' ' CZ ' ' A' ' 32' ' ' TYR . . . -123.21 147.09 47.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.361 -0.837 . . . . 0.0 109.642 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.21 132.71 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 109.384 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 28' ' ' PRO . 5.9 t-20 -121.08 53.37 1.14 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 109.422 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.95 -69.85 3.17 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.8 tpp85 -126.08 -0.58 7.15 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -1.166 . . . . 0.0 109.647 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.525 ' O ' ' CG ' ' A' ' 80' ' ' GLU . 6.7 mm-40 -106.71 178.11 4.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.917 . . . . 0.0 109.399 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.525 ' CG ' ' O ' ' A' ' 79' ' ' GLU . 56.1 mt-10 -160.81 105.52 1.39 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.659 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.562 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -60.15 179.57 0.21 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 109.103 179.71 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.562 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.3 Cg_endo -77.43 149.25 27.3 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.35 2.033 . . . . 0.0 110.238 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 35.8 Cg_endo -77.96 106.24 2.14 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.65 2.233 . . . . 0.0 111.175 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.714 HD22 ' O ' ' A' ' 5' ' ' PRO . 12.3 tp -78.91 119.91 22.76 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ILE . . . . . 0.586 HG12 ' CB ' ' A' ' 71' ' ' SER . 0.5 OUTLIER -106.88 163.95 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.008 -1.058 . . . . 0.0 110.292 -179.365 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.554 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -156.42 164.31 32.44 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -117.93 141.66 48.19 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.124 -1.221 . . . . 0.0 110.034 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.573 ' CG ' HD11 ' A' ' 13' ' ' ILE . 2.1 mm-40 -165.27 137.6 4.29 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -103.26 148.87 25.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 110.102 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.471 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.7 OUTLIER -74.75 139.83 43.66 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.55 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.693 HG23 HG22 ' A' ' 13' ' ' ILE . 2.3 t . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.486 0.66 . . . . 0.0 110.571 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 C--O 1.215 -0.665 0 N-CA-C 109.947 -0.828 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -174.28 156.12 2.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.194 -0.941 . . . . 0.0 109.635 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 1.4 t0 78.38 25.5 0.58 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.396 -0.815 . . . . 0.0 109.928 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.897 HD22 ' CD2' ' A' ' 162' ' ' LEU . 27.9 tp -67.46 101.39 0.97 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.062 -1.023 . . . . 0.0 109.114 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -138.26 -171.92 3.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 109.642 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.5 p -107.14 144.24 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.227 -0.921 . . . . 0.0 109.837 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.923 HD11 HD22 ' A' ' 109' ' ' LEU . 22.8 pt -126.75 -4.32 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.373 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.978 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -152.38 91.38 1.58 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . 0.505 ' HB2' ' OH ' ' A' ' 182' ' ' TYR . 4.9 p -85.31 85.97 7.41 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.526 -0.733 . . . . 0.0 110.298 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' THR . . . . . 0.547 ' OG1' ' N ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -74.42 163.29 69.33 Favored Pre-proline 0 C--N 1.306 -1.307 0 O-C-N 121.045 -1.034 . . . . 0.0 108.462 179.215 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 29.7 Cg_endo -68.47 -3.1 10.36 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.437 2.091 . . . . 0.0 110.775 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.922 ' C ' HG22 ' A' ' 152' ' ' ILE . 21.7 p -153.68 20.1 0.53 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' SER . . . . . 0.547 ' N ' ' OG1' ' A' ' 104' ' ' THR . 6.3 p -170.84 165.58 7.83 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.999 -1.08 . . . . 0.0 110.281 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 1.021 HD13 HD11 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -139.42 153.36 47.58 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.884 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.978 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.3 OUTLIER -105.53 98.43 8.13 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.319 -0.863 . . . . 0.0 108.904 179.296 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ILE . . . . . 0.763 HD11 ' HB3' ' A' ' 147' ' ' ALA . 1.3 pt -74.62 134.56 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.168 -0.958 . . . . 0.0 109.612 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.406 ' HA ' HG22 ' A' ' 146' ' ' THR . 12.8 t -134.05 111.15 10.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.554 -0.716 . . . . 0.0 109.237 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' TRP . . . . . 0.576 ' CD2' ' O ' ' A' ' 145' ' ' SER . 37.4 p90 -130.03 137.96 50.52 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.331 -0.855 . . . . 0.0 109.158 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 112' ' ' TRP . 2.4 mt-10 . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.187 -0.946 . . . . 0.0 108.944 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.51 ' HB2' ' O ' ' A' ' 140' ' ' VAL . 3.6 p90 . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' TYR . . . . . 0.553 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 3.6 m-85 -111.46 126.83 55.37 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 15.1 ttp180 -84.9 91.6 8.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.139 -0.976 . . . . 0.0 109.398 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ILE . . . . . 0.788 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 19.2 mt -84.45 138.77 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.889 . . . . 0.0 109.59 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 25.9 p -112.7 129.63 56.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.411 -0.805 . . . . 0.0 109.889 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' TYR . . . . . 0.647 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 2.2 m-85 -75.36 131.75 40.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.449 -0.782 . . . . 0.0 109.091 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLY . . . . . 0.601 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -101.47 107.03 3.15 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 . . . . . 0 C--N 1.298 -1.647 0 O-C-N 121.115 -1.227 . . . . 0.0 108.932 179.111 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 136' ' ' GLN . . . . . 0.566 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 1.9 tm-20 -88.57 123.22 32.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 110.39 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.788 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 38.7 p90 -125.42 140.62 52.63 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.479 HG22 ' CE1' ' A' ' 121' ' ' TYR . 8.5 p -74.44 162.8 28.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.106 -0.996 . . . . 0.0 110.342 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.748 HG21 ' CD1' ' A' ' 124' ' ' ILE . 2.4 t -131.44 142.37 45.13 Favored Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 121.602 -0.686 . . . . 0.0 109.625 -178.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' PRO . . . . . 0.493 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.9 Cg_endo -77.48 140.54 19.23 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.408 2.072 . . . . 0.0 109.935 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.3 24.88 8.68 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.51 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 2.1 p -105.42 32.22 4.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.147 -1.207 . . . . 0.0 109.664 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.51 ' CG ' ' O ' ' A' ' 143' ' ' SER . 1.7 mttt -177.83 156.63 1.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.095 -1.003 . . . . 0.0 109.773 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.576 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 1.1 p -95.17 -14.52 24.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.884 . . . . 0.0 109.357 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 110' ' ' ILE . 6.5 p -118.92 137.88 53.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.118 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.763 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -118.99 164.22 15.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.143 -0.973 . . . . 0.0 109.696 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.8 t -95.15 156.48 16.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.246 -0.909 . . . . 0.0 109.144 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.647 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 9.7 mm -134.96 68.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.202 -0.936 . . . . 0.0 109.577 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.534 ' O ' ' CB ' ' A' ' 151' ' ' ASN . 1.9 m120 -83.44 166.39 18.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.46 -0.775 . . . . 0.0 109.496 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 2.0 t30 79.02 31.6 0.3 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.352 -0.843 . . . . 0.0 109.794 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.922 HG22 ' C ' ' A' ' 106' ' ' THR . 2.7 tt -94.04 159.96 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.169 -0.957 . . . . 0.0 109.47 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt -103.94 120.77 50.14 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.301 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.14 147.45 23.53 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.424 2.083 . . . . 0.0 110.507 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 72.52 61.59 3.55 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.488 ' N ' ' OG1' ' A' ' 184' ' ' THR . . . 177.56 129.17 0.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -1.124 . . . . 0.0 109.582 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -46.05 160.69 0.06 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.129 -0.982 . . . . 0.0 108.455 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TYR . . . . . 0.601 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -148.39 178.46 8.57 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.736 -1.228 . . . . 0.0 110.242 -179.574 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 159' ' ' THR . . . . . 0.557 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 6.1 m -161.73 108.92 1.39 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.38 -0.825 . . . . 0.0 109.209 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 1.021 HD11 HD13 ' A' ' 108' ' ' LEU . 15.4 mt -98.85 133.21 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.608 -1.307 . . . . 0.0 109.824 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' THR . . . . . 1.007 HG23 ' CB ' ' A' ' 179' ' ' SER . 1.6 m -141.39 174.18 10.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.312 -0.867 . . . . 0.0 109.339 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.897 ' CD2' HD22 ' A' ' 98' ' ' LEU . 0.7 OUTLIER -163.99 148.63 10.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.063 -1.023 . . . . 0.0 110.997 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 163' ' ' TYR . . . . . 0.617 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.6 m-85 -125.32 81.73 2.0 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.497 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . . . -45.18 99.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.952 -1.093 . . . . 0.0 109.15 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 163' ' ' TYR . 70.7 t . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.898 . . . . 0.0 109.917 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.371 -0.604 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 96.9 p -53.82 161.33 1.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.929 . . . . 0.0 109.351 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -46.25 142.95 3.94 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.174 -0.954 . . . . 0.0 108.588 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.617 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 35.0 Cg_endo -77.88 141.52 19.2 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.345 2.03 . . . . 0.0 111.397 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.2 t -114.99 134.68 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' SER . . . . . 1.007 ' CB ' HG23 ' A' ' 161' ' ' THR . 1.1 p -133.29 162.25 32.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 111.02 -178.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.886 HG21 ' O ' ' A' ' 98' ' ' LEU . 13.5 pt -142.26 152.13 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -93.33 152.1 19.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.987 -1.071 . . . . 0.0 109.853 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.667 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 53.6 t80 -146.53 130.03 16.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.399 -0.813 . . . . 0.0 109.468 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -106.34 119.34 39.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.444 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' THR . . . . . 0.488 ' OG1' ' N ' ' A' ' 156' ' ' ALA . 1.5 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.484 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.477 ' O ' HD23 ' A' ' 2' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.477 HD23 ' O ' ' A' ' 1' ' ' GLY . 2.6 mt -127.86 -164.44 1.37 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.297 -1.119 . . . . 0.0 109.245 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.501 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 1.0 OUTLIER -99.84 162.34 13.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.886 . . . . 0.0 109.084 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.478 ' HA ' ' HG2' ' A' ' 82' ' ' PRO . 79.6 p -95.15 136.62 22.54 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.109 -0.995 . . . . 0.0 109.762 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.862 ' O ' HD22 ' A' ' 84' ' ' LEU . 35.9 Cg_endo -79.27 119.07 4.1 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.602 2.201 . . . . 0.0 110.067 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.43 -163.21 1.52 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.021 -1.049 . . . . 0.0 109.746 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 60.29 22.46 58.54 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -178.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 1.005 ' HB3' HD21 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -82.28 168.05 17.99 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.863 -0.786 . . . . 0.0 109.538 -179.17 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.768 ' O ' HG12 ' A' ' 20' ' ' VAL . 3.6 t70 -165.28 -163.93 0.72 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.9 t -142.91 149.16 38.09 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.151 -0.968 . . . . 0.0 109.643 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.475 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 40.4 p -176.24 -163.52 0.1 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 109.286 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.571 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.6 OUTLIER 45.8 37.11 3.2 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -178.622 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.697 HG22 HG23 ' A' ' 91' ' ' VAL . 1.8 mt -85.5 165.03 2.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.65 -177.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 17' ' ' SER . 0.7 OUTLIER -154.41 -165.21 2.02 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.8 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.829 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -86.62 -44.96 11.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.022 -1.049 . . . . 0.0 109.875 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.508 ' OD1' ' NH1' ' A' ' 168' ' ' ARG . 1.6 p-10 -110.32 11.15 23.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.91 -1.119 . . . . 0.0 109.486 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.937 ' HB3' HG22 ' A' ' 60' ' ' THR . 0.0 OUTLIER -160.9 150.11 16.85 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.767 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.677 ' HA ' ' HA ' ' A' ' 13' ' ' ILE . 2.1 p90 -165.51 143.35 5.91 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.009 -1.057 . . . . 0.0 108.855 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.907 ' OG1' HG23 ' A' ' 58' ' ' THR . 61.6 m -107.95 163.85 12.78 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.823 -1.173 . . . . 0.0 111.099 -178.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.768 HG12 ' O ' ' A' ' 9' ' ' ASP . 0.9 OUTLIER -132.09 170.88 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.475 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 18.1 m-70 -142.07 158.44 43.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.994 -1.066 . . . . 0.0 110.195 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.597 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 23.9 p90 -170.84 135.19 1.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.43 -0.794 . . . . 0.0 109.24 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.37 166.53 2.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.135 -0.978 . . . . 0.0 109.363 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.887 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -98.03 174.07 3.46 Favored Pre-proline 0 C--N 1.298 -1.639 0 O-C-N 121.666 -0.646 . . . . 0.0 109.772 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.887 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.6 Cg_endo -78.64 177.35 8.84 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.682 2.255 . . . . 0.0 110.457 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -86.73 9.13 19.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -0.932 . . . . 0.0 109.388 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.744 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -126.07 168.06 15.18 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.496 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.744 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.4 Cg_endo -78.12 133.04 11.94 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.695 2.264 . . . . 0.0 110.444 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.673 HD13 ' CE1' ' A' ' 32' ' ' TYR . 27.2 pt -118.18 -172.79 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.435 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.4 p -123.12 -10.24 8.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 109.555 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.501 ' O ' ' CG2' ' A' ' 75' ' ' VAL . . . 157.38 151.21 5.94 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.673 ' CE1' HD13 ' A' ' 29' ' ' ILE . 2.4 m-30 -114.07 139.09 49.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -1.133 . . . . 0.0 109.612 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.965 ' C ' HD13 ' A' ' 34' ' ' ILE . 1.7 mp -93.01 128.97 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.233 -0.917 . . . . 0.0 109.087 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.976 HG21 HG21 ' A' ' 57' ' ' ILE . 1.8 mm -115.86 109.25 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.214 -0.929 . . . . 0.0 109.76 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.48 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -109.86 137.11 48.11 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.13 -0.981 . . . . 0.0 109.012 179.36 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.872 ' HB3' HG22 ' A' ' 70' ' ' VAL . 5.4 p-80 -129.84 146.74 51.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.109 -0.994 . . . . 0.0 110.076 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.554 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 28.6 p-80 -168.24 133.34 1.76 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.339 -0.851 . . . . 0.0 109.87 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.936 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . -66.08 137.54 57.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 109.243 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.03 -2.35 20.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.195 -0.941 . . . . 0.0 109.759 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -99.84 29.48 4.15 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.143 -0.973 . . . . 0.0 109.676 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.5 p -150.48 153.76 36.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.529 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.404 ' O ' HG22 ' A' ' 42' ' ' VAL . 9.9 p -117.35 -0.75 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.221 -0.925 . . . . 0.0 109.583 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.25 -168.06 0.71 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.416 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 5.2 mtm180 -80.51 134.54 54.39 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.278 -1.13 . . . . 0.0 109.368 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.504 ' HB3' ' HB3' ' A' ' 37' ' ' HIS . 36.3 Cg_endo -78.93 145.39 19.72 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.535 2.157 . . . . 0.0 110.468 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.483 ' HB2' ' NE2' ' A' ' 36' ' ' HIS . 0.6 OUTLIER -74.59 151.86 39.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.217 -0.927 . . . . 0.0 109.239 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -123.14 117.16 24.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 109.958 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.593 ' HB3' HD11 ' A' ' 57' ' ' ILE . 1.3 m-20 -120.04 107.68 13.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.413 -0.804 . . . . 0.0 108.893 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.842 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -91.28 142.28 27.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.07 -1.019 . . . . 0.0 109.8 -179.504 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.74 HG13 HD12 ' A' ' 57' ' ' ILE . 5.8 m -119.3 161.97 34.35 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.44 -0.787 . . . . 0.0 109.107 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.531 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.5 Cg_endo -76.88 173.93 13.67 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.501 2.134 . . . . 0.0 110.293 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 35.4 Cg_endo -77.35 -15.32 15.93 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.648 2.232 . . . . 0.0 110.545 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.3 29.27 4.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.576 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.531 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 12.0 mmt85 -138.96 119.85 14.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 109.562 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.541 ' O ' ' CE3' ' A' ' 22' ' ' TRP . 10.2 p-10 -99.24 -3.66 33.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 109.468 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 74.8 p -135.14 158.59 43.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.175 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.976 HG21 HG21 ' A' ' 34' ' ' ILE . 3.5 tt -142.29 124.4 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.155 -0.966 . . . . 0.0 109.607 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.907 HG23 ' OG1' ' A' ' 19' ' ' THR . 0.3 OUTLIER -82.53 117.1 22.28 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.31 -0.868 . . . . 0.0 109.414 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.84 ' HB3' HD11 ' A' ' 62' ' ' LEU . 1.2 mt -95.93 143.37 27.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.893 . . . . 0.0 109.562 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.937 HG22 ' HB3' ' A' ' 17' ' ' SER . 39.2 p -134.61 -177.4 4.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 109.35 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.603 ' O ' HD23 ' A' ' 62' ' ' LEU . 4.4 m-80 53.03 56.37 7.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.385 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.84 HD11 ' HB3' ' A' ' 59' ' ' LEU . 6.0 mt -134.13 134.65 42.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.495 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.469 ' CB ' ' OH ' ' A' ' 68' ' ' TYR . 3.2 t30 -51.17 130.05 31.41 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 109.081 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.829 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -78.52 134.0 12.13 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.355 2.037 . . . . 0.0 110.712 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 82.83 60.95 1.99 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 90' ' ' THR . 2.4 m -163.73 154.26 15.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.323 -1.104 . . . . 0.0 109.924 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -88.92 127.1 35.64 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.936 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 23.5 m-85 -118.27 124.02 46.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.011 -1.055 . . . . 0.0 109.879 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.554 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 22.7 t -83.65 122.28 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 108.976 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.872 HG22 ' HB3' ' A' ' 36' ' ' HIS . 24.6 t -110.88 122.56 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -0.985 . . . . 0.0 109.55 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.541 ' HB2' ' CD1' ' A' ' 85' ' ' ILE . 82.3 p -103.54 117.13 33.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.192 -0.943 . . . . 0.0 109.903 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.803 HD13 HG23 ' A' ' 34' ' ' ILE . 11.2 mm -94.08 120.16 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.324 -0.86 . . . . 0.0 109.648 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.788 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.4 mp -112.11 132.74 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.165 -0.959 . . . . 0.0 109.124 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.58 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -95.94 154.48 17.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.557 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.501 ' CG2' ' O ' ' A' ' 31' ' ' GLY . 11.7 m -154.97 130.28 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 109.449 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -103.03 45.56 0.95 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.36 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.68 -85.21 0.99 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -111.64 -1.14 15.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -1.141 . . . . 0.0 109.404 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -97.09 -166.26 1.37 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 0.0 109.311 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -146.36 -167.07 2.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.14 -0.975 . . . . 0.0 109.854 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.592 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -172.44 -178.87 0.46 Allowed Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.592 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.1 Cg_endo -76.6 134.2 14.99 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.021 1.814 . . . . 0.0 109.69 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 35.2 Cg_endo -77.1 108.83 2.71 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.437 2.091 . . . . 0.0 111.129 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.005 HD21 ' HB3' ' A' ' 8' ' ' PHE . 9.7 tp -77.4 80.94 3.89 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.296 -0.878 . . . . 0.0 108.638 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 71' ' ' SER . 4.2 mt -86.06 151.47 3.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.184 -0.947 . . . . 0.0 110.216 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.44 ' C ' ' HG3' ' A' ' 87' ' ' GLN . . . -145.42 -169.13 13.47 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.483 ' HG2' HG13 ' A' ' 69' ' ' VAL . 30.8 mt-30 -150.73 126.89 10.55 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.168 -1.195 . . . . 0.0 109.676 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.665 ' NE2' ' N ' ' A' ' 88' ' ' GLN . 0.0 OUTLIER -129.3 -155.31 0.69 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.317 -0.864 . . . . 0.0 108.752 179.6 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -159.73 136.13 8.99 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.037 -1.04 . . . . 0.0 110.002 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.408 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.93 137.16 41.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.401 -0.812 . . . . 0.0 108.997 179.667 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.697 HG23 HG22 ' A' ' 13' ' ' ILE . 3.1 t -53.92 164.87 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 121.407 0.622 . . . . 0.0 110.092 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.403 ' N ' HG12 ' A' ' 91' ' ' VAL . 1.9 t -90.95 154.29 19.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.471 -0.768 . . . . 0.0 108.984 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.525 ' OD1' ' CB ' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -97.25 -37.79 9.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.107 -0.996 . . . . 0.0 110.068 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.673 HG23 ' HD2' ' A' ' 95' ' ' PRO . 1.4 mt -76.27 140.84 69.59 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 121.002 -1.061 . . . . 0.0 109.557 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.673 ' HD2' HG23 ' A' ' 94' ' ' ILE . 36.3 Cg_endo -80.77 -159.28 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.597 2.198 . . . . 0.0 109.656 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.504 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -169.9 158.54 7.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.091 -1.006 . . . . 0.0 109.604 179.591 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 4.5 t0 78.13 26.83 0.57 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.435 -0.791 . . . . 0.0 109.715 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.818 ' CD1' HD23 ' A' ' 162' ' ' LEU . 1.7 tt -60.3 99.4 0.08 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.13 -0.981 . . . . 0.0 109.057 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -138.05 165.38 26.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.616 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 13.3 p -96.31 147.24 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.762 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.531 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 14.1 pt -127.99 -4.32 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 0.0 109.704 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.911 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -153.03 105.28 2.9 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.517 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 10.0 m -100.79 91.08 4.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -0.933 . . . . 0.0 110.588 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.541 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -83.35 163.28 50.81 Favored Pre-proline 0 C--N 1.306 -1.306 0 O-C-N 121.126 -0.983 . . . . 0.0 108.671 178.726 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -69.2 -2.12 9.21 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.296 1.997 . . . . 0.0 110.795 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.833 ' C ' HG22 ' A' ' 152' ' ' ILE . 23.2 p -147.56 12.58 1.03 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 109.497 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . 1.053 ' O ' HD23 ' A' ' 108' ' ' LEU . 3.2 p -169.84 164.69 9.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.809 -1.182 . . . . 0.0 110.198 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.053 HD23 ' O ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -139.13 155.4 47.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.306 -0.871 . . . . 0.0 109.131 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.911 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 1.3 mt -105.41 116.23 31.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.295 -0.878 . . . . 0.0 109.329 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.65 HD11 ' HB3' ' A' ' 147' ' ' ALA . 1.6 pt -99.01 143.55 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 109.494 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.906 ' CB ' HG22 ' A' ' 146' ' ' THR . 41.3 p -140.24 131.2 26.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.352 -0.843 . . . . 0.0 109.58 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.644 ' HH2' ' HB2' ' A' ' 147' ' ' ALA . 47.0 p90 -135.85 151.69 50.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.358 -0.839 . . . . 0.0 109.35 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.474 ' HB2' ' HG3' ' A' ' 96' ' ' ARG . 14.2 mt-10 -56.46 141.61 71.16 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.485 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 113' ' ' GLU . 36.3 Cg_endo -79.31 118.07 3.9 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.645 2.23 . . . . 0.0 110.459 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 117' ' ' VAL . 34.9 Cg_endo -78.04 138.05 16.03 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.379 2.053 . . . . 0.0 110.276 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.689 ' HB3' ' CG1' ' A' ' 91' ' ' VAL . . . -69.84 59.65 0.16 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.142 -0.974 . . . . 0.0 109.431 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.698 HG11 ' HB2' ' A' ' 15' ' ' ALA . 14.8 m -146.21 154.18 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.44 -0.787 . . . . 0.0 109.257 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.6 m -83.7 86.2 7.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -0.911 . . . . 0.0 109.515 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.859 HG11 ' CE2' ' A' ' 122' ' ' TYR . 1.7 t -74.92 125.76 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.909 . . . . 0.0 109.439 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 165' ' ' VAL . 0.2 OUTLIER -75.05 -45.98 37.92 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.121 -0.987 . . . . 0.0 108.746 179.39 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.683 ' CE2' HG22 ' A' ' 139' ' ' THR . 1.5 p90 -167.22 165.53 15.3 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.151 -0.968 . . . . 0.0 109.575 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.859 ' CE2' HG11 ' A' ' 119' ' ' VAL . 1.4 m-85 -125.96 140.4 52.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.251 -0.906 . . . . 0.0 109.013 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.595 ' CG ' ' HB2' ' A' ' 163' ' ' TYR . 0.1 OUTLIER -113.12 98.95 7.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.655 -1.278 . . . . 0.0 108.214 178.665 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.841 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 20.8 mt -92.25 156.73 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.354 -0.841 . . . . 0.0 110.629 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 82.1 p -116.01 135.84 53.59 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.76 -0.588 . . . . 0.0 109.594 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.642 ' CE2' ' CG2' ' A' ' 149' ' ' ILE . 14.1 m-85 -74.17 143.62 45.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 109.368 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.581 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.86 94.02 0.94 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -106.63 139.12 41.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -1.163 . . . . 0.0 109.427 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.579 HG21 ' CB ' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -81.34 -89.91 0.07 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.197 -0.939 . . . . 0.0 109.653 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -108.6 56.79 0.46 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -84.26 -83.02 0.98 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.471 ' O ' ' CB ' ' A' ' 133' ' ' SER . 19.5 p-10 -173.24 33.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -1.167 . . . . 0.0 109.436 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.537 ' CB ' ' HD2' ' A' ' 134' ' ' PRO . 0.3 OUTLIER 166.42 176.33 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.473 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 133' ' ' SER . 35.5 Cg_endo -77.72 -173.93 2.01 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.578 2.185 . . . . 0.0 110.384 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 126' ' ' TYR . 3.0 m -52.8 149.8 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.239 -0.913 . . . . 0.0 109.827 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.495 ' HB2' ' HB2' ' A' ' 126' ' ' TYR . 1.9 tt0 -105.32 113.96 27.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.91 . . . . 0.0 109.402 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 8.2 pt-20 -84.38 126.9 33.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 110.372 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.841 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 11.7 p90 -131.27 136.73 48.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.345 -0.847 . . . . 0.0 108.834 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.683 HG22 ' CE2' ' A' ' 121' ' ' TYR . 1.7 p -74.78 157.55 35.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.235 -0.916 . . . . 0.0 110.755 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.509 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 39.7 t -121.5 127.14 26.22 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 143' ' ' SER . 36.3 Cg_endo -79.01 42.11 1.22 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.282 1.988 . . . . 0.0 111.352 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 141' ' ' PRO . . . 35.49 31.86 0.03 OUTLIER Glycine 0 N--CA 1.498 2.804 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.9 OUTLIER -50.43 -41.22 52.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -1.102 . . . . 0.0 109.835 -179.354 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.456 ' HD2' ' OG1' ' A' ' 146' ' ' THR . 0.4 OUTLIER 179.43 -168.69 0.1 Allowed 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.609 -0.682 . . . . 0.0 109.628 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.564 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -71.98 -4.54 29.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.499 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.906 HG22 ' CB ' ' A' ' 111' ' ' SER . 75.7 p -124.37 133.09 53.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.178 -0.951 . . . . 0.0 109.396 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.65 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -117.54 169.87 9.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.608 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.408 ' C ' HG12 ' A' ' 149' ' ' ILE . 12.2 t -99.24 164.47 12.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.382 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.642 ' CG2' ' CE2' ' A' ' 126' ' ' TYR . 17.7 mm -143.59 65.86 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.448 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.579 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 0.8 OUTLIER -78.7 -152.23 0.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.479 -0.763 . . . . 0.0 109.792 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.539 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 0.1 OUTLIER 47.1 26.43 0.64 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 109.418 -179.913 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.833 HG22 ' C ' ' A' ' 106' ' ' THR . 3.3 tt -92.19 160.74 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.304 -0.873 . . . . 0.0 109.637 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.416 ' HD2' ' HD2' ' A' ' 154' ' ' PRO . 0.0 OUTLIER -122.58 127.65 25.72 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.189 -0.945 . . . . 0.0 109.268 179.805 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.449 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 36.1 Cg_endo -78.59 155.87 27.96 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.467 2.111 . . . . 0.0 110.593 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.704 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 81.76 64.89 1.7 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.704 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 162.3 132.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.287 -1.125 . . . . 0.0 109.657 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.579 ' CB ' HG21 ' A' ' 129' ' ' THR . 0.9 OUTLIER -51.59 164.83 0.2 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.877 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.699 ' CD1' HG21 ' A' ' 184' ' ' THR . 0.2 OUTLIER -145.21 -175.87 4.87 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.705 -1.247 . . . . 0.0 110.519 -179.149 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.571 HG22 ' N ' ' A' ' 160' ' ' ILE . 2.9 m -162.97 168.16 21.51 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.571 ' N ' HG22 ' A' ' 159' ' ' THR . 67.0 mt -152.55 136.25 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.856 -1.152 . . . . 0.0 109.908 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.95 HG23 ' CB ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -138.74 131.25 28.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.316 -0.865 . . . . 0.0 109.081 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.818 HD23 ' CD1' ' A' ' 98' ' ' LEU . 3.7 pp -114.68 141.27 48.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.076 -1.015 . . . . 0.0 111.23 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.663 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 1.4 m-85 -122.56 72.49 1.07 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.548 ' CB ' ' CD2' ' A' ' 122' ' ' TYR . . . -45.5 120.12 2.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.864 -1.147 . . . . 0.0 109.284 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.501 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 74.0 t -98.93 124.37 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.285 -0.884 . . . . 0.0 109.722 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 173' ' ' ALA . 69.8 p -114.52 130.81 56.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.45 -0.781 . . . . 0.0 108.929 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.527 ' O ' ' CD ' ' A' ' 168' ' ' ARG . . . -69.43 157.32 53.5 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.539 ' HG2' ' HA ' ' A' ' 172' ' ' PRO . 0.7 OUTLIER -140.97 13.0 2.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -1.104 . . . . 0.0 109.543 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 117.24 -116.67 3.58 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.8 -1.01 20.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -1.158 . . . . 0.0 109.468 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 168' ' ' ARG . 22.9 m -160.6 125.0 2.07 Favored Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.539 ' HA ' ' HG2' ' A' ' 168' ' ' ARG . 34.5 Cg_endo -76.15 -168.94 0.61 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.262 1.975 . . . . 0.0 110.636 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 166' ' ' THR . . . -155.29 164.25 39.03 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.248 -0.907 . . . . 0.0 110.062 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 175' ' ' SER . 0.7 OUTLIER -146.68 108.81 4.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.404 -0.81 . . . . 0.0 109.186 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.571 ' HB2' ' CG1' ' A' ' 94' ' ' ILE . 3.4 p -52.8 -171.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -0.852 . . . . 0.0 109.619 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.567 ' CB ' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -69.11 144.86 95.83 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.55 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.663 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.1 Cg_endo -77.86 128.88 9.53 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.446 2.097 . . . . 0.0 111.641 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.7 t -95.52 124.2 48.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.95 ' CB ' HG23 ' A' ' 161' ' ' THR . 0.0 OUTLIER -115.2 146.7 41.15 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 110.811 -178.372 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.589 HG23 HD13 ' A' ' 98' ' ' LEU . 5.2 pt -130.81 -164.92 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -126.16 164.86 20.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.961 -1.087 . . . . 0.0 109.491 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.748 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 63.4 t80 -165.08 132.87 3.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.205 -0.935 . . . . 0.0 109.461 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -103.21 129.84 50.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.208 -0.932 . . . . 0.0 109.613 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.699 HG21 ' CD1' ' A' ' 158' ' ' TYR . 30.8 p . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.494 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.79 HD11 ' HG2' ' A' ' 79' ' ' GLU . 4.9 mt -78.52 -160.87 0.24 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.286 -1.126 . . . . 0.0 109.616 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.843 ' CG ' HG22 ' A' ' 29' ' ' ILE . 1.1 m-20 -73.94 77.35 1.66 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.395 -0.816 . . . . 0.0 109.133 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.532 ' OG ' ' CG ' ' A' ' 82' ' ' PRO . 14.8 m -95.58 109.59 46.53 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.431 -0.793 . . . . 0.0 109.772 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.677 ' O ' HD22 ' A' ' 84' ' ' LEU . 36.7 Cg_endo -79.66 145.52 18.3 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.375 2.05 . . . . 0.0 110.077 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.668 HG23 ' O ' ' A' ' 5' ' ' PRO . 0.7 OUTLIER -161.43 -171.87 3.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.099 -1.0 . . . . 0.0 109.762 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 45.44 27.33 1.88 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.62 ' C ' ' CD1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -71.65 -161.63 0.07 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.598 -0.943 . . . . 0.0 109.867 -179.242 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.517 ' N ' ' CG ' ' A' ' 8' ' ' PHE . 1.5 t70 -165.58 -170.97 1.96 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.361 -0.837 . . . . 0.0 108.993 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.475 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 5.1 p -154.37 133.08 12.18 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.69 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.607 ' HG ' ' CD2' ' A' ' 21' ' ' HIS . 51.3 p -161.15 -159.64 0.67 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.253 -0.904 . . . . 0.0 109.42 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.524 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.8 OUTLIER 45.37 33.68 1.32 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -178.247 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.657 ' HA ' ' HA ' ' A' ' 18' ' ' PHE . 1.3 mt -75.71 163.43 3.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.485 -177.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.687 HG23 ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -149.71 -167.92 2.96 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.027 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.913 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -88.12 -47.55 8.4 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.901 -1.125 . . . . 0.0 109.361 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -105.59 19.72 20.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.915 -1.116 . . . . 0.0 109.001 179.623 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.822 ' HB3' HG22 ' A' ' 60' ' ' THR . 0.0 OUTLIER -172.64 153.33 2.76 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.741 ' CE1' HG22 ' A' ' 20' ' ' VAL . 4.7 p90 -166.19 140.73 4.43 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.955 -1.09 . . . . 0.0 108.985 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 2.3 m -89.07 160.34 17.1 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.922 -1.111 . . . . 0.0 111.252 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.741 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -137.46 122.39 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.607 ' CD2' ' HG ' ' A' ' 11' ' ' SER . 29.2 m-70 -99.31 153.09 19.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.097 -1.002 . . . . 0.0 110.104 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.803 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 22.3 p90 -161.5 133.48 5.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.382 -0.824 . . . . 0.0 109.523 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.548 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.41 170.54 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.234 -0.917 . . . . 0.0 109.295 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.548 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -100.76 159.58 29.18 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.623 -0.673 . . . . 0.0 109.378 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.543 ' CG ' ' HB3' ' A' ' 3' ' ' ASP . 36.2 Cg_endo -78.28 -159.11 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.7 2.266 . . . . 0.0 110.403 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -107.07 1.19 24.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.541 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.629 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -104.24 164.13 15.9 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.45 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.629 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.1 Cg_endo -77.5 141.4 19.93 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.669 2.246 . . . . 0.0 110.307 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.843 HG22 ' CG ' ' A' ' 3' ' ' ASP . 18.7 pt -133.69 163.33 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.763 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.2 p -117.73 1.78 12.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.406 -0.809 . . . . 0.0 109.234 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.575 ' O ' HG23 ' A' ' 75' ' ' VAL . . . 164.24 161.18 12.86 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.613 ' CD1' HD12 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -125.82 124.18 40.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.633 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.941 HG23 ' HG3' ' A' ' 49' ' ' ARG . 14.6 mm -87.64 118.61 33.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.198 -0.939 . . . . 0.0 109.318 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.071 HG23 HD13 ' A' ' 72' ' ' ILE . 1.5 mm -107.2 110.22 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.185 -0.947 . . . . 0.0 109.86 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.475 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 35.6 ttp180 -109.05 142.82 39.19 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.146 -0.971 . . . . 0.0 108.657 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.67 ' CG ' HD22 ' A' ' 59' ' ' LEU . 21.9 p-80 -132.06 151.75 51.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.986 -1.071 . . . . 0.0 110.187 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.539 ' CB ' ' HB3' ' A' ' 45' ' ' PRO . 15.8 p80 -168.55 126.66 1.09 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.512 -0.743 . . . . 0.0 109.023 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.724 ' HB2' ' CE2' ' A' ' 68' ' ' TYR . . . -47.55 174.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.15 -0.969 . . . . 0.0 109.6 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.45 ' HG2' HG23 ' A' ' 69' ' ' VAL . 1.3 mt-10 -89.12 -24.42 22.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.101 -0.999 . . . . 0.0 109.582 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -165.32 23.67 0.05 Allowed 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.509 -0.744 . . . . 0.0 109.867 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.6 p -83.23 165.09 19.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.328 -0.858 . . . . 0.0 109.554 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 42' ' ' VAL . 22.0 t -87.29 -0.54 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.617 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.44 -175.26 1.71 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.59 140.63 26.95 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.259 -1.141 . . . . 0.0 109.435 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.539 ' HB3' ' CB ' ' A' ' 37' ' ' HIS . 36.3 Cg_endo -78.79 120.09 4.59 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.508 2.138 . . . . 0.0 110.421 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.576 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 0.1 OUTLIER -106.59 174.64 5.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.946 . . . . 0.0 109.363 179.842 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -123.27 103.91 8.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.943 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 1.003 ' HB3' HD11 ' A' ' 57' ' ' ILE . 4.8 m-20 -98.41 112.88 24.75 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.258 -0.901 . . . . 0.0 108.856 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.941 ' HG3' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -96.69 152.91 18.2 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.133 -0.979 . . . . 0.0 109.858 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.88 HG13 HD12 ' A' ' 57' ' ' ILE . 5.1 m -134.46 162.12 59.6 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.462 -0.774 . . . . 0.0 109.034 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.543 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.7 Cg_endo -77.02 174.16 13.29 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.481 2.12 . . . . 0.0 110.365 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 35.3 Cg_endo -77.63 -15.26 15.5 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.549 2.166 . . . . 0.0 110.419 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.39 29.73 3.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.477 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.543 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 4.5 mmt180 -139.17 132.89 30.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.569 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.412 ' O ' ' CE3' ' A' ' 22' ' ' TRP . 21.7 p-10 -112.61 -3.0 14.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 0.0 109.38 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 88.5 p -132.2 148.38 52.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.922 . . . . 0.0 109.35 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.003 HD11 ' HB3' ' A' ' 48' ' ' ASP . 5.9 tt -139.35 127.24 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 0.0 109.821 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.74 115.51 24.22 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.206 -0.934 . . . . 0.0 109.298 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.67 HD22 ' CG ' ' A' ' 36' ' ' HIS . 6.5 mt -88.31 160.47 17.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.738 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.822 HG22 ' HB3' ' A' ' 17' ' ' SER . 19.7 p -147.2 173.3 12.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.827 . . . . 0.0 109.609 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.66 ' O ' HD23 ' A' ' 62' ' ' LEU . 4.2 m-80 62.07 53.2 3.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.352 -0.843 . . . . 0.0 109.915 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.669 HD11 ' HB3' ' A' ' 59' ' ' LEU . 3.0 mt -132.69 135.61 45.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 109.315 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.469 ' CB ' ' OH ' ' A' ' 68' ' ' TYR . 3.2 t30 -47.24 131.54 9.68 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.094 -1.004 . . . . 0.0 108.889 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.913 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 36.6 Cg_endo -78.68 134.2 12.04 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.475 2.117 . . . . 0.0 111.258 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 78.95 62.03 2.29 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.606 HG22 ' CE1' ' A' ' 68' ' ' TYR . 1.2 m -161.99 144.04 11.28 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.275 -1.133 . . . . 0.0 110.2 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -79.19 133.37 36.7 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.652 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.724 ' CE2' ' HB2' ' A' ' 38' ' ' ALA . 50.7 m-85 -124.88 171.55 10.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.903 -1.123 . . . . 0.0 110.832 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.706 HG12 HG23 ' A' ' 85' ' ' ILE . 3.2 t -124.37 137.54 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.538 HG13 ' HB3' ' A' ' 36' ' ' HIS . 2.2 t -126.8 129.38 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.847 -1.158 . . . . 0.0 110.356 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.574 ' CB ' HG12 ' A' ' 85' ' ' ILE . 5.0 p -100.42 101.45 12.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.323 -0.86 . . . . 0.0 109.996 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.071 HD13 HG23 ' A' ' 34' ' ' ILE . 26.0 mm -80.91 84.2 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.094 -1.004 . . . . 0.0 109.317 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.475 ' HB ' ' HB ' ' A' ' 33' ' ' ILE . 9.1 mt -81.87 159.2 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -0.943 . . . . 0.0 109.587 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.556 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -121.05 169.87 10.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.9 . . . . 0.0 109.434 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -154.94 140.51 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 109.547 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.567 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 13.5 t30 -137.24 49.44 2.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 109.585 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.71 -96.15 1.44 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.44 ' CD ' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -112.37 1.7 16.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -1.096 . . . . 0.0 109.519 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.79 ' HG2' HD11 ' A' ' 2' ' ' LEU . 1.2 tt0 -98.29 170.08 9.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.266 -0.897 . . . . 0.0 109.387 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 2.3 mp0 -148.89 108.35 3.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.112 -0.993 . . . . 0.0 110.009 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.582 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -59.92 -178.34 0.14 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 108.649 179.245 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.582 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.0 Cg_endo -76.87 154.33 33.78 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.177 1.918 . . . . 0.0 110.127 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.2 103.8 1.8 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.66 2.24 . . . . 0.0 111.356 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.677 HD22 ' O ' ' A' ' 5' ' ' PRO . 5.6 tp -81.48 93.64 6.69 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.706 HG23 HG12 ' A' ' 69' ' ' VAL . 3.0 mt -100.09 126.69 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.177 -0.952 . . . . 0.0 110.157 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.552 ' O ' HG13 ' A' ' 69' ' ' VAL . . . -121.45 -164.71 12.39 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.401 ' HG2' HG13 ' A' ' 69' ' ' VAL . 60.7 mt-30 -143.99 123.85 13.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.947 -1.325 . . . . 0.0 110.198 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.446 ' NE2' ' HZ ' ' A' ' 8' ' ' PHE . 17.8 mm-40 -121.5 -152.79 0.52 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.4 143.36 6.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.089 -1.007 . . . . 0.0 109.904 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.501 ' HG1' ' HE1' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -87.81 138.13 31.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.411 -0.805 . . . . 0.0 109.196 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.625 HG12 ' H ' ' A' ' 92' ' ' SER . 2.9 t -55.12 173.16 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.592 0.711 . . . . 0.0 110.99 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.625 ' H ' HG12 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -87.29 158.41 19.08 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.564 -0.71 . . . . 0.0 109.858 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.794 ' OD2' HG11 ' A' ' 117' ' ' VAL . 2.5 m-20 -86.07 -43.99 12.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.496 -0.753 . . . . 0.0 109.802 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.802 HG23 ' HD2' ' A' ' 95' ' ' PRO . 0.8 OUTLIER -90.34 144.2 30.58 Favored Pre-proline 0 N--CA 1.486 1.368 0 O-C-N 121.125 -0.984 . . . . 0.0 110.302 -179.058 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.802 ' HD2' HG23 ' A' ' 94' ' ' ILE . 35.8 Cg_endo -79.55 80.34 3.1 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.691 2.261 . . . . 0.0 109.924 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.504 ' CG ' ' N ' ' A' ' 97' ' ' ASP . 32.5 ttt85 -77.5 164.56 25.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.321 -0.862 . . . . 0.0 109.752 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.532 ' HB2' ' CG ' ' A' ' 113' ' ' GLU . 2.8 t0 77.63 33.58 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.417 -0.802 . . . . 0.0 109.781 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.593 HD22 ' CD2' ' A' ' 162' ' ' LEU . 33.0 tp -77.15 102.53 6.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.959 . . . . 0.0 109.486 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -140.25 169.89 16.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -0.904 . . . . 0.0 109.392 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 7.9 p -94.17 138.86 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.922 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.483 HG13 ' HB3' ' A' ' 109' ' ' LEU . 1.3 pp -123.93 -7.97 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.395 -0.816 . . . . 0.0 109.312 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.732 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -158.54 99.08 1.57 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.528 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 0.1 OUTLIER -103.58 109.86 21.7 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.442 -0.786 . . . . 0.0 110.648 -178.52 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.46 ' HB ' ' HD2' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -91.3 166.39 18.56 Favored Pre-proline 0 C--N 1.306 -1.317 0 O-C-N 121.293 -0.88 . . . . 0.0 108.749 178.869 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.46 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 30.3 Cg_endo -69.55 -2.05 9.35 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.258 1.972 . . . . 0.0 110.617 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.829 ' C ' HG22 ' A' ' 152' ' ' ILE . 62.0 p -145.41 10.47 1.26 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.277 -0.889 . . . . 0.0 109.59 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . 1.029 ' C ' HD23 ' A' ' 108' ' ' LEU . 3.1 p -167.3 153.69 8.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.826 -1.171 . . . . 0.0 109.992 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.029 HD23 ' C ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -120.9 151.38 39.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.256 -0.902 . . . . 0.0 109.422 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.732 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.7 OUTLIER -106.03 120.9 42.98 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.97 HD11 HD13 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -105.46 133.22 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.981 -1.074 . . . . 0.0 110.105 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.655 ' HA ' HG22 ' A' ' 146' ' ' THR . 4.9 t -130.82 121.51 25.46 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.658 ' CD1' ' CB ' ' A' ' 95' ' ' PRO . 41.8 p90 -138.28 163.93 30.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.834 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.532 ' CG ' ' HB2' ' A' ' 97' ' ' ASP . 1.8 mt-10 -55.55 135.76 70.73 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.901 . . . . 0.0 108.655 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.472 ' HB3' ' CB ' ' A' ' 145' ' ' SER . 36.2 Cg_endo -78.73 111.39 2.97 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.393 2.062 . . . . 0.0 111.238 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.492 ' HG2' ' OH ' ' A' ' 122' ' ' TYR . 35.8 Cg_endo -78.4 -166.7 0.42 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.37 2.047 . . . . 0.0 108.912 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.583 ' HB1' ' HA ' ' A' ' 14' ' ' THR . . . -170.35 22.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.659 -1.276 . . . . 0.0 111.162 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.88 HG12 ' CB ' ' A' ' 15' ' ' ALA . 6.8 m -80.49 -170.83 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.797 -1.189 . . . . 0.0 108.647 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.48 ' O ' ' HB ' ' A' ' 166' ' ' THR . 43.9 m -69.73 58.88 0.14 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.973 -1.08 . . . . 0.0 108.873 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.87 ' HA ' HG22 ' A' ' 166' ' ' THR . 2.7 t -87.56 111.2 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 0.0 109.963 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.457 ' NE ' ' HG2' ' A' ' 168' ' ' ARG . 0.3 OUTLIER -74.48 -41.38 60.84 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.045 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.93 ' CE1' HG22 ' A' ' 139' ' ' THR . 1.2 p90 -166.81 158.34 12.72 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.393 -0.817 . . . . 0.0 109.364 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.524 ' CZ ' HG11 ' A' ' 119' ' ' VAL . 11.5 m-85 -103.18 135.86 44.05 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 3.2 ttp-105 -90.98 82.85 5.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.997 -1.064 . . . . 0.0 109.889 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 1.033 ' CD1' HG21 ' A' ' 140' ' ' VAL . 78.9 mt -83.6 143.64 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 3.2 p -136.76 152.69 50.61 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.931 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 1.107 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 2.4 m-85 -86.21 134.84 33.75 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.607 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -106.19 119.49 6.04 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.505 ' O ' ' C ' ' A' ' 129' ' ' THR . 2.8 mt-10 -101.08 154.05 19.04 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.19 -1.182 . . . . 0.0 109.133 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' THR . . . . . 1.063 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 1.1 p -33.64 -47.9 0.25 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.302 0.573 . . . . 0.0 109.95 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 131' ' ' GLY . . . -94.8 -96.43 1.66 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 130' ' ' GLY . . . 45.44 76.55 0.12 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.489 ' O ' ' CB ' ' A' ' 133' ' ' SER . 8.4 t-20 -84.32 15.51 3.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.326 -1.102 . . . . 0.0 109.631 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.553 ' CB ' ' HD3' ' A' ' 134' ' ' PRO . 0.1 OUTLIER 166.3 -53.42 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.152 -0.967 . . . . 0.0 109.617 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.553 ' HD3' ' CB ' ' A' ' 133' ' ' SER . 36.1 Cg_endo -78.69 85.46 1.84 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.458 2.105 . . . . 0.0 110.597 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 126' ' ' TYR . 0.1 OUTLIER -108.09 -164.18 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 109.036 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.555 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 0.4 OUTLIER -104.28 91.84 4.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.05 -1.031 . . . . 0.0 109.042 179.704 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 1.6 tm-20 -89.05 117.44 28.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.833 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.642 ' CE2' ' CG2' ' A' ' 124' ' ' ILE . 25.5 p90 -118.28 136.74 53.51 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.93 HG22 ' CE1' ' A' ' 121' ' ' TYR . 4.6 p -74.01 172.15 12.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.13 -0.981 . . . . 0.0 110.331 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 1.033 HG21 ' CD1' ' A' ' 124' ' ' ILE . 25.3 t -142.85 139.16 16.68 Favored Pre-proline 0 C--N 1.302 -1.464 0 O-C-N 121.494 -0.754 . . . . 0.0 109.884 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.525 ' HD2' HG13 ' A' ' 140' ' ' VAL . 35.4 Cg_endo -78.35 144.32 20.38 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.411 2.074 . . . . 0.0 109.943 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.27 40.87 3.06 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.9 m -105.45 -1.21 25.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -1.168 . . . . 0.0 109.847 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.3 158.6 39.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.976 . . . . 0.0 109.835 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.575 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -95.42 8.19 43.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.388 -0.82 . . . . 0.0 109.714 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.655 HG22 ' HA ' ' A' ' 111' ' ' SER . 54.7 p -133.39 147.55 51.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.193 -0.942 . . . . 0.0 109.442 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.495 ' N ' ' CH2' ' A' ' 112' ' ' TRP . . . -132.63 173.16 11.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.142 -0.974 . . . . 0.0 109.459 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.597 ' O ' HD12 ' A' ' 149' ' ' ILE . 1.9 t -125.77 138.88 53.87 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.188 -0.945 . . . . 0.0 109.698 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 1.107 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 1.0 OUTLIER -113.09 83.68 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.52 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 3.6 m-20 -92.96 175.23 6.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.313 -0.867 . . . . 0.0 110.153 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 151' ' ' ASN . 1.1 m120 70.21 30.46 3.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 108.912 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.829 HG22 ' C ' ' A' ' 106' ' ' THR . 9.4 tt -89.33 163.92 2.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.489 -0.757 . . . . 0.0 109.731 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -107.36 121.53 44.17 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.331 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.13 146.68 22.91 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.382 2.055 . . . . 0.0 110.507 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.699 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 87.37 65.57 1.36 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 1.063 ' HB1' ' CG2' ' A' ' 129' ' ' THR . . . 164.23 130.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -1.149 . . . . 0.0 109.631 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.642 ' N ' HG22 ' A' ' 129' ' ' THR . 32.9 t70 -48.64 163.58 0.07 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.097 -1.002 . . . . 0.0 108.495 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.613 ' CD1' HG21 ' A' ' 184' ' ' THR . 0.2 OUTLIER -147.08 -176.11 5.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.823 -1.173 . . . . 0.0 110.147 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.505 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 4.8 m -163.69 115.55 1.42 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.482 HD12 HG12 ' A' ' 149' ' ' ILE . 39.5 mm -100.06 129.34 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.737 -1.227 . . . . 0.0 109.83 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . 1.021 HG23 ' CB ' ' A' ' 179' ' ' SER . 2.0 m -136.78 168.32 19.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.206 -0.933 . . . . 0.0 109.766 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.593 ' CD2' HD22 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -158.64 147.3 18.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.044 -1.035 . . . . 0.0 111.304 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.665 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 23.0 m-85 -121.15 105.86 10.99 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -70.64 93.7 0.95 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.911 -1.118 . . . . 0.0 109.158 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.598 HG22 ' HB3' ' A' ' 174' ' ' SER . 2.4 t -78.56 130.73 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 109.896 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.87 HG22 ' HA ' ' A' ' 119' ' ' VAL . 33.2 p -122.87 -59.6 1.58 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.502 -0.749 . . . . 0.0 109.575 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.519 ' O ' ' CG ' ' A' ' 168' ' ' ARG . . . -53.82 178.33 0.19 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.519 ' CG ' ' O ' ' A' ' 167' ' ' GLY . 14.8 mtm180 -159.43 111.91 2.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.326 -1.102 . . . . 0.0 109.415 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 160.99 -149.61 18.79 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -78.49 1.44 22.31 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.347 -1.09 . . . . 0.0 109.534 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.457 ' N ' ' HD3' ' A' ' 172' ' ' PRO . 0.7 OUTLIER -150.27 65.22 7.17 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.909 . . . . 0.0 109.392 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 171' ' ' SER . 35.5 Cg_endo -77.9 103.87 1.77 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.63 2.22 . . . . 0.0 110.394 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -87.72 132.18 34.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.343 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.598 ' HB3' HG22 ' A' ' 165' ' ' VAL . 44.3 p -112.53 62.39 0.63 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.56 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 174' ' ' SER . 33.7 p 42.0 -164.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.608 ' H ' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -86.58 148.51 46.61 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 120.993 -1.067 . . . . 0.0 108.559 179.276 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.665 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 31.3 Cg_endo -73.54 119.3 5.87 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.143 1.895 . . . . 0.0 111.058 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.85 124.33 63.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' SER . . . . . 1.021 ' CB ' HG23 ' A' ' 161' ' ' THR . 1.1 p -127.89 176.87 7.25 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.346 -0.846 . . . . 0.0 111.032 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.581 HG23 HD23 ' A' ' 98' ' ' LEU . 11.4 pt -157.31 152.02 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -85.78 158.58 19.97 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.926 -1.109 . . . . 0.0 109.674 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.764 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 47.0 t80 -158.25 127.69 5.79 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.358 -0.839 . . . . 0.0 109.328 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -101.86 128.52 48.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 109.527 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.613 HG21 ' CD1' ' A' ' 158' ' ' TYR . 7.5 p . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.505 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.586 ' O ' HD23 ' A' ' 2' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.586 HD23 ' O ' ' A' ' 1' ' ' GLY . 1.8 mt -129.31 -162.81 1.23 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -1.136 . . . . 0.0 109.325 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 3.3 m-20 -106.33 153.22 22.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.473 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.541 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 0.3 OUTLIER -95.33 132.32 28.02 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.763 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.479 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 36.1 Cg_endo -79.54 102.13 1.46 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.515 2.143 . . . . 0.0 109.968 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.686 HG22 ' CD1' ' A' ' 84' ' ' LEU . 1.4 p -95.58 -110.58 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 109.792 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.443 ' HA3' ' HB ' ' A' ' 23' ' ' VAL . . . 44.3 27.39 1.17 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.576 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 28.2 t80 -51.54 124.5 12.28 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.55 -0.971 . . . . 0.0 110.011 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 0.7 OUTLIER -153.21 87.78 1.28 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 92.7 p -84.29 124.59 31.4 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 109.648 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 12' ' ' ASP . 13.2 p -153.55 -159.34 0.97 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.397 -0.814 . . . . 0.0 109.05 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.501 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 1.1 m-20 45.88 40.12 6.26 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.833 HG23 ' CB ' ' A' ' 18' ' ' PHE . 2.7 mt -85.14 131.76 33.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.721 0.772 . . . . 0.0 111.284 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 1.011 HG22 ' O ' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -115.62 -167.13 1.21 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.161 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.62 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -78.48 -70.57 0.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.935 -1.103 . . . . 0.0 109.794 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 52.4 m-20 -83.06 14.21 3.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.127 -0.983 . . . . 0.0 110.156 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.777 ' HB2' HG22 ' A' ' 60' ' ' THR . 1.6 t -165.35 156.46 14.21 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.104 -0.998 . . . . 0.0 109.085 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.989 ' CE1' HG22 ' A' ' 20' ' ' VAL . 4.7 p90 -164.32 145.33 8.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.162 -0.962 . . . . 0.0 109.112 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.501 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 3.8 m -89.24 149.69 22.97 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.815 -1.178 . . . . 0.0 111.441 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.989 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -130.37 114.17 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.938 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 9' ' ' ASP . 4.4 m-70 -96.42 170.91 8.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.995 -1.066 . . . . 0.0 110.748 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.86 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 21.0 p90 178.23 136.43 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.48 164.85 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.011 -1.056 . . . . 0.0 109.789 -179.693 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.687 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -97.53 167.3 12.05 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.71 -0.619 . . . . 0.0 109.595 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.687 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 36.3 Cg_endo -79.32 -159.28 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.607 2.205 . . . . 0.0 110.294 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -126.24 16.68 7.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.298 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.952 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -117.75 176.08 1.77 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.324 -0.86 . . . . 0.0 109.424 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.952 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.5 Cg_endo -78.16 136.57 14.61 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.635 2.224 . . . . 0.0 110.457 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.744 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 27.5 pt -150.06 -179.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.331 -0.856 . . . . 0.0 109.406 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.2 p -120.81 4.53 10.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.583 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.96 173.37 17.15 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.744 ' CZ ' HD11 ' A' ' 29' ' ' ILE . 16.6 m-85 -118.71 123.65 45.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -1.174 . . . . 0.0 109.634 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.83 ' C ' HD13 ' A' ' 34' ' ' ILE . 1.7 mp -79.69 135.18 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.215 -0.928 . . . . 0.0 108.768 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.83 HD13 ' C ' ' A' ' 33' ' ' ILE . 2.9 mm -115.47 107.02 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.069 -1.019 . . . . 0.0 110.064 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -109.18 117.02 33.03 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.674 ' HB3' HG13 ' A' ' 70' ' ' VAL . 24.0 p80 -126.83 176.19 7.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.009 -1.057 . . . . 0.0 110.682 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 38' ' ' ALA . 42.4 p-80 175.18 145.48 0.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.583 ' HA ' ' CD2' ' A' ' 68' ' ' TYR . . . -41.57 163.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.22 -0.925 . . . . 0.0 109.617 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.698 ' HA ' HG23 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -82.55 -8.23 59.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.08 -1.012 . . . . 0.0 109.567 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.42 36.17 3.88 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.329 -0.857 . . . . 0.0 109.56 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.4 p -154.97 92.28 1.44 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.51 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.696 HG12 ' O ' ' A' ' 42' ' ' VAL . 79.6 t -87.81 6.48 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 109.486 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.434 ' O ' ' HD3' ' A' ' 45' ' ' PRO . . . -76.32 -160.56 10.23 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 43' ' ' GLY . 17.2 mtt85 -42.32 102.38 0.27 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.379 -1.071 . . . . 0.0 109.588 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 35.6 Cg_endo -78.1 161.42 29.51 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.451 2.101 . . . . 0.0 110.308 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.467 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -73.96 149.51 41.32 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.134 -0.979 . . . . 0.0 109.53 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.46 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 3.2 mp0 -120.95 122.63 40.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.464 -0.772 . . . . 0.0 110.076 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 34' ' ' ILE . 63.2 m-20 -144.54 120.04 10.36 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.752 ' CD ' HG23 ' A' ' 33' ' ' ILE . 5.1 mmt-85 -104.09 152.23 22.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.971 -1.081 . . . . 0.0 110.23 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.859 HG12 HD12 ' A' ' 57' ' ' ILE . 10.7 m -128.02 161.29 56.82 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.546 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 33.7 Cg_endo -76.36 174.13 13.34 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.358 2.039 . . . . 0.0 110.34 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.587 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 35.2 Cg_endo -77.07 -15.46 16.33 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.582 2.188 . . . . 0.0 110.604 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.2 t -101.97 17.84 22.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 0.0 109.652 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.546 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.5 OUTLIER -122.77 100.78 7.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.19 -0.944 . . . . 0.0 109.914 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -84.85 -3.0 58.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.14 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 56.5 p -137.52 149.02 46.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.432 -0.793 . . . . 0.0 109.031 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.86 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 5.2 tt -136.44 125.95 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.075 -1.016 . . . . 0.0 109.746 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.29 107.4 19.04 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.408 -0.807 . . . . 0.0 109.269 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.91 ' HB3' HD11 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -84.91 152.02 23.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.533 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.777 HG22 ' HB2' ' A' ' 17' ' ' SER . 29.2 p -137.98 -177.49 4.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.467 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.3 m120 55.7 29.67 14.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.356 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.91 HD11 ' HB3' ' A' ' 59' ' ' LEU . 5.1 mt -107.53 136.26 47.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 0.0 109.403 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.516 ' CB ' ' OH ' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -44.76 126.61 5.13 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.147 -0.97 . . . . 0.0 108.868 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.62 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 35.9 Cg_endo -77.42 131.41 11.59 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.29 1.994 . . . . 0.0 110.852 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 78.25 61.35 2.51 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.568 HG22 ' N ' ' A' ' 67' ' ' GLU . 13.2 m -157.16 165.79 35.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.258 -1.142 . . . . 0.0 109.93 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.568 ' N ' HG22 ' A' ' 66' ' ' THR . 1.8 mp0 -115.33 132.64 56.55 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.445 -0.784 . . . . 0.0 109.174 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.608 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 1.2 m-85 -130.57 173.83 10.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.93 . . . . 0.0 109.377 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.698 HG23 ' HA ' ' A' ' 39' ' ' GLU . 8.4 t -112.82 114.9 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.674 HG13 ' HB3' ' A' ' 36' ' ' HIS . 4.5 t -96.99 138.49 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.09 -1.006 . . . . 0.0 110.067 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.535 ' CB ' HG12 ' A' ' 85' ' ' ILE . 14.5 p -119.56 138.74 53.0 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.296 -0.878 . . . . 0.0 110.233 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.573 HD13 HG23 ' A' ' 34' ' ' ILE . 13.2 mm -111.78 95.11 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.397 -0.815 . . . . 0.0 109.397 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.621 HD12 ' N ' ' A' ' 73' ' ' ILE . 1.3 mp -85.24 122.84 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.339 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.915 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -97.34 137.62 36.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.924 . . . . 0.0 109.368 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.705 HG22 HD13 ' A' ' 33' ' ' ILE . 4.6 m -140.78 171.82 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.905 . . . . 0.0 109.471 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.447 ' OD1' ' HA ' ' A' ' 29' ' ' ILE . 49.2 t30 -146.39 43.23 1.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.915 . . . . 0.0 109.439 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 112.31 -87.03 0.44 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.04 -8.25 10.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -1.141 . . . . 0.0 109.625 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -84.81 -167.21 1.72 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.382 -0.824 . . . . 0.0 109.276 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.52 ' HG2' HG12 ' A' ' 75' ' ' VAL . 16.2 mt-10 -159.4 131.14 6.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.188 -0.945 . . . . 0.0 109.929 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.915 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -98.62 -178.33 0.69 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.393 -0.817 . . . . 0.0 108.882 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.591 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.4 Cg_endo -77.34 131.21 11.52 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.118 1.879 . . . . 0.0 109.908 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.452 ' HB3' HG13 ' A' ' 73' ' ' ILE . 35.7 Cg_endo -77.75 115.48 3.84 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.491 2.127 . . . . 0.0 111.117 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.686 ' CD1' HG22 ' A' ' 6' ' ' THR . 0.7 OUTLIER -88.53 106.5 18.33 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.187 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.535 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.8 mt -95.48 146.4 7.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.116 -0.99 . . . . 0.0 110.105 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.576 ' HA3' ' CZ ' ' A' ' 8' ' ' PHE . . . -142.75 161.37 27.46 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 108.134 -1.987 . . . . 0.0 108.134 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.475 ' HG2' ' N ' ' A' ' 88' ' ' GLN . 37.7 tt0 -102.05 148.38 25.45 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.18 -1.188 . . . . 0.0 110.028 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.57 ' HG2' ' CZ ' ' A' ' 18' ' ' PHE . 4.8 pp0? -149.82 -176.35 5.39 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.728 ' O ' HG21 ' A' ' 13' ' ' ILE . . . -160.2 134.61 7.49 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 109.969 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.5 143.36 36.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.358 -0.839 . . . . 0.0 109.019 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.578 HG11 ' HB2' ' A' ' 116' ' ' ALA . 2.0 t -64.13 163.17 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.512 -0.743 . . . . 0.0 109.888 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.0 t -69.33 169.06 13.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.383 -0.823 . . . . 0.0 109.699 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.456 ' HB3' ' HB2' ' A' ' 64' ' ' PRO . 1.4 p30 -115.07 -34.96 4.87 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.728 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.721 HG23 ' HD2' ' A' ' 95' ' ' PRO . 1.6 mt -83.96 143.08 42.44 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.136 -0.978 . . . . 0.0 109.486 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.721 ' HD2' HG23 ' A' ' 94' ' ' ILE . 36.0 Cg_endo -79.54 81.98 2.63 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.652 2.235 . . . . 0.0 110.162 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.56 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 4.2 ttt180 -66.62 170.71 5.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.319 -0.863 . . . . 0.0 109.813 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 1.1 t0 81.87 34.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.736 . . . . 0.0 110.113 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.764 HD22 ' CD2' ' A' ' 162' ' ' LEU . 21.8 tp -76.46 101.56 5.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.134 -0.979 . . . . 0.0 109.288 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -151.85 -175.24 5.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 109.077 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 109' ' ' LEU . 47.8 t -119.23 149.37 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.0 -1.063 . . . . 0.0 110.164 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.644 ' CG1' HD23 ' A' ' 109' ' ' LEU . 6.9 pt -119.6 -17.14 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.737 0.779 . . . . 0.0 109.356 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 109' ' ' LEU . . . -150.84 142.12 23.27 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.532 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 51.5 p -150.49 132.09 14.85 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.695 -1.253 . . . . 0.0 111.299 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.579 ' HB ' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -98.02 171.38 5.94 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.527 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.579 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 29.9 Cg_endo -69.66 -1.05 7.73 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.918 1.746 . . . . 0.0 110.63 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.843 ' C ' HG22 ' A' ' 152' ' ' ILE . 19.2 p -143.02 8.23 1.65 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.194 -0.941 . . . . 0.0 109.655 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 149' ' ' ILE . 2.9 p -164.33 149.68 10.32 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.819 -1.152 . . . . 0.0 109.96 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.811 HD22 ' CZ ' ' A' ' 182' ' ' TYR . 0.9 OUTLIER -123.69 156.33 36.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.909 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.644 HD23 ' CG1' ' A' ' 101' ' ' ILE . 11.1 tp -105.27 108.81 20.52 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.963 ' CD1' ' HB3' ' A' ' 147' ' ' ALA . 3.1 pt -92.26 150.04 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.237 -0.914 . . . . 0.0 109.998 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 146' ' ' THR . 31.8 m -148.36 135.82 20.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.421 -0.799 . . . . 0.0 109.325 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.661 ' HH2' ' HB2' ' A' ' 147' ' ' ALA . 14.4 p90 -135.68 159.06 42.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 109.42 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -65.32 142.19 98.37 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.068 -1.02 . . . . 0.0 109.315 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 113' ' ' GLU . 36.0 Cg_endo -78.65 119.15 4.35 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.575 2.183 . . . . 0.0 110.484 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.593 ' HB2' HG22 ' A' ' 117' ' ' VAL . 35.8 Cg_endo -78.1 148.93 24.97 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.422 2.081 . . . . 0.0 110.328 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.011 ' O ' HG22 ' A' ' 14' ' ' THR . . . -80.49 57.16 2.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 109.579 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.593 HG22 ' HB2' ' A' ' 115' ' ' PRO . 25.9 m -142.67 164.5 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.851 . . . . 0.0 109.459 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.4 m -92.18 93.86 8.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.445 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.47 HG11 ' CE2' ' A' ' 122' ' ' TYR . 1.9 t -93.69 144.71 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 109.598 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.531 ' CG ' ' O ' ' A' ' 166' ' ' THR . 2.4 mmt85 -95.44 -37.89 10.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 108.76 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.578 ' CE2' ' HB ' ' A' ' 165' ' ' VAL . 1.9 p90 -163.98 175.32 10.44 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.291 -0.88 . . . . 0.0 109.509 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.621 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 2.2 m-85 -136.63 131.59 33.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -0.871 . . . . 0.0 109.097 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 4.6 ttt180 -84.69 154.4 22.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.019 -1.05 . . . . 0.0 108.541 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.845 HG23 ' O ' ' A' ' 161' ' ' THR . 17.6 mt -151.03 138.82 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.006 -1.059 . . . . 0.0 110.394 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 136' ' ' GLN . 2.2 p -106.28 141.77 37.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.607 -0.683 . . . . 0.0 109.721 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.729 ' O ' HG22 ' A' ' 135' ' ' VAL . 1.6 m-85 -88.26 118.83 28.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.369 -0.832 . . . . 0.0 108.758 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.624 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.8 113.73 4.3 Favored Glycine 0 N--CA 1.487 2.073 0 C-N-CA 119.607 -1.282 . . . . 0.0 111.217 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.479 ' O ' ' C ' ' A' ' 129' ' ' THR . 25.4 mt-10 -90.21 175.35 7.17 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.173 -1.192 . . . . 0.0 108.384 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.578 HG23 ' HB1' ' A' ' 156' ' ' ALA . 0.7 OUTLIER -36.11 -93.04 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.603 -0.685 . . . . 0.0 110.517 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 153.06 97.18 0.14 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.411 ' C ' ' OD1' ' A' ' 132' ' ' ASN . . . -148.07 -39.15 0.04 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.417 ' N ' ' OD1' ' A' ' 132' ' ' ASN . 0.8 OUTLIER -171.01 57.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -1.162 . . . . 0.0 109.584 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 0.0 OUTLIER -173.64 142.92 0.96 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 109.449 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 133' ' ' SER . 36.2 Cg_endo -78.73 -161.64 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.597 2.198 . . . . 0.0 110.415 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.788 HG13 ' N ' ' A' ' 136' ' ' GLN . 0.3 OUTLIER -90.4 -166.28 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 122.098 0.952 . . . . 0.0 109.36 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.788 ' N ' HG13 ' A' ' 135' ' ' VAL . 0.7 OUTLIER -135.79 -166.95 1.94 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.373 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.56 ' HG3' HG22 ' A' ' 125' ' ' THR . 0.1 OUTLIER -156.71 152.16 26.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.144 -1.598 . . . . 0.0 111.702 -179.506 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.737 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 11.7 p90 -165.11 134.73 3.6 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.444 HG22 ' CE1' ' A' ' 121' ' ' TYR . 1.7 p -74.57 171.85 13.09 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.175 -0.953 . . . . 0.0 110.944 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.721 HG21 HD11 ' A' ' 124' ' ' ILE . 28.5 t -131.83 140.53 38.52 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.52 -0.738 . . . . 0.0 109.542 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.606 ' HD2' HG13 ' A' ' 140' ' ' VAL . 35.5 Cg_endo -77.99 125.47 7.31 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.428 2.086 . . . . 0.0 109.919 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.32 51.65 3.31 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.431 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 16.0 p -105.5 -4.71 20.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.194 -1.18 . . . . 0.0 109.551 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 143' ' ' SER . 0.6 OUTLIER -173.55 178.21 2.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.513 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.571 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 0.3 OUTLIER -95.12 15.33 19.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.584 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.531 ' C ' ' CH2' ' A' ' 112' ' ' TRP . 2.1 p -123.52 146.15 48.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.465 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.963 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -133.12 167.19 20.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.246 -0.909 . . . . 0.0 109.461 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.651 ' O ' HD13 ' A' ' 149' ' ' ILE . 14.0 m -108.49 164.07 12.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 109.465 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.651 HD13 ' O ' ' A' ' 148' ' ' THR . 11.7 mm -143.24 66.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.0 109.335 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.553 ' HA ' ' CB ' ' A' ' 107' ' ' SER . 4.3 m120 -78.28 -167.51 1.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.692 -0.63 . . . . 0.0 109.814 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 50.92 42.0 27.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.081 -1.012 . . . . 0.0 109.053 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.843 HG22 ' C ' ' A' ' 106' ' ' THR . 4.4 tt -106.18 160.03 5.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.422 -0.799 . . . . 0.0 109.915 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -93.58 125.22 54.63 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 109.17 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.463 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 35.8 Cg_endo -78.73 140.25 16.36 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.436 2.091 . . . . 0.0 110.859 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 75.09 63.23 2.58 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.578 ' HB1' HG23 ' A' ' 129' ' ' THR . . . 178.13 127.2 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.174 -1.192 . . . . 0.0 110.147 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.557 ' N ' HG23 ' A' ' 129' ' ' THR . 9.7 t70 -48.58 167.94 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.64 ' CE2' HG13 ' A' ' 152' ' ' ILE . 0.4 OUTLIER -146.6 -167.88 2.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.973 -1.079 . . . . 0.0 109.991 -179.544 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' GLY . 4.4 m -168.41 96.39 0.4 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.744 HD11 HD12 ' A' ' 108' ' ' LEU . 7.1 mt -91.86 133.01 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.049 -1.032 . . . . 0.0 110.05 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . 1.04 HG23 ' CB ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -131.27 159.91 36.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.329 -0.857 . . . . 0.0 108.764 179.311 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.764 ' CD2' HD22 ' A' ' 98' ' ' LEU . 1.7 pp -150.82 150.08 30.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.734 -1.229 . . . . 0.0 111.714 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.641 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.3 m-85 -125.99 79.59 1.85 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -43.92 125.69 4.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.976 -1.077 . . . . 0.0 109.322 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.578 ' HB ' ' CE2' ' A' ' 121' ' ' TYR . 55.2 t -113.16 135.66 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 110.079 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.531 ' O ' ' CG ' ' A' ' 120' ' ' ARG . 0.7 OUTLIER -105.96 -38.65 6.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.532 -0.73 . . . . 0.0 109.383 179.673 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -82.29 150.49 28.78 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -150.88 140.71 21.86 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.192 -1.181 . . . . 0.0 109.523 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 134.66 -72.87 0.46 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' A' ' 171' ' ' SER . 0.2 OUTLIER -146.94 42.13 1.12 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -1.138 . . . . 0.0 109.382 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 0.9 OUTLIER 163.73 69.88 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.316 -0.865 . . . . 0.0 109.291 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.87 102.5 1.59 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.639 2.226 . . . . 0.0 110.515 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.518 ' O ' HG22 ' A' ' 165' ' ' VAL . . . -84.82 175.83 8.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.187 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.475 ' OG ' ' HB3' ' A' ' 163' ' ' TYR . 84.5 p -164.61 127.82 2.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.145 -0.972 . . . . 0.0 109.706 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.481 ' HB2' HG12 ' A' ' 94' ' ' ILE . 3.0 p -54.12 174.86 0.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.301 -0.874 . . . . 0.0 109.217 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.5 ' HB2' HD11 ' A' ' 94' ' ' ILE . 1.4 mmtp -45.81 136.87 6.06 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.16 -0.963 . . . . 0.0 108.618 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.641 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.2 Cg_endo -77.39 144.94 23.38 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.267 1.978 . . . . 0.0 110.885 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.593 HG12 HD23 ' A' ' 98' ' ' LEU . 3.1 t -120.62 130.79 74.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' SER . . . . . 1.04 ' CB ' HG23 ' A' ' 161' ' ' THR . 0.9 OUTLIER -122.84 158.32 30.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 110.704 -178.617 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.524 HG21 ' O ' ' A' ' 98' ' ' LEU . 29.3 pt -146.7 153.12 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.492 ' HA ' ' HA ' ' A' ' 159' ' ' THR . 33.6 m120 -93.15 153.98 18.33 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.035 -1.041 . . . . 0.0 109.41 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.811 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 92.1 t80 -141.81 123.9 15.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.282 -0.886 . . . . 0.0 109.721 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -87.69 111.45 21.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.066 -1.021 . . . . 0.0 109.477 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.485 HG22 ' CD2' ' A' ' 182' ' ' TYR . 21.9 p . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.485 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.85 HD13 ' HB3' ' A' ' 81' ' ' SER . 2.6 mp -127.67 -162.59 1.18 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.243 -1.151 . . . . 0.0 109.511 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.506 ' HB2' ' CB ' ' A' ' 25' ' ' PRO . 1.3 m-20 -108.37 164.41 12.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.0 109.526 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.5 m -95.41 120.3 64.01 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.486 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.522 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 35.6 Cg_endo -78.41 95.56 1.07 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.394 2.063 . . . . 0.0 110.296 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.714 HG22 ' CD1' ' A' ' 84' ' ' LEU . 1.2 p -85.02 -107.72 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.959 . . . . 0.0 109.614 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 43.7 29.24 1.26 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.573 ' CE2' ' HA3' ' A' ' 86' ' ' GLY . 20.5 t80 -53.08 129.92 32.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.399 -1.059 . . . . 0.0 110.166 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 21' ' ' HIS . 1.9 t70 -165.29 134.2 3.36 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.54 ' CB ' ' HG2' ' A' ' 88' ' ' GLN . 4.7 m -118.19 139.38 51.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.923 -1.11 . . . . 0.0 110.276 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.481 ' O ' ' C ' ' A' ' 12' ' ' ASP . 8.9 p -153.43 -169.38 3.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.435 -0.791 . . . . 0.0 109.2 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.533 ' HB2' ' CB ' ' A' ' 19' ' ' THR . 0.8 OUTLIER 41.39 46.93 3.01 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.047 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.813 HG22 ' CG2' ' A' ' 91' ' ' VAL . 41.5 mm -77.67 130.73 35.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.622 0.725 . . . . 0.0 111.349 -178.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.572 ' CB ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -119.67 176.81 5.2 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.183 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.934 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -71.01 -70.03 0.33 Allowed 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.528 -1.358 . . . . 0.0 109.559 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 50.2 m-80 -81.2 -6.84 59.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.056 -1.027 . . . . 0.0 109.362 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.81 ' HB2' HG22 ' A' ' 60' ' ' THR . 3.4 t -137.42 158.01 45.33 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.037 ' CE1' HG22 ' A' ' 20' ' ' VAL . 2.2 p90 -167.76 139.88 3.11 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.991 -1.068 . . . . 0.0 108.494 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.533 ' CB ' ' HB2' ' A' ' 12' ' ' ASP . 23.0 m -84.48 154.88 22.46 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.785 -1.197 . . . . 0.0 110.898 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.037 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.5 t -128.6 177.76 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' A' ' 20' ' ' VAL . 55.6 m-70 -156.2 163.64 39.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.017 -1.052 . . . . 0.0 110.158 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.823 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 46.0 p90 179.87 142.94 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.447 -0.783 . . . . 0.0 109.239 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.537 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.43 169.79 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.113 -0.992 . . . . 0.0 109.145 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.671 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -102.38 165.89 13.0 Favored Pre-proline 0 C--N 1.299 -1.606 0 O-C-N 121.504 -0.747 . . . . 0.0 109.794 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.671 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.7 Cg_endo -78.26 -164.7 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.672 2.248 . . . . 0.0 110.38 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 -115.31 26.5 10.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.37 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.797 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -134.41 169.75 13.06 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.29 -0.881 . . . . 0.0 109.383 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.797 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.4 Cg_endo -77.78 136.62 15.3 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.612 2.208 . . . . 0.0 110.356 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.625 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 16.3 pt -145.52 -171.52 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.493 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.515 ' OG1' ' N ' ' A' ' 77' ' ' GLY . 60.5 p -126.56 6.38 6.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.87 . . . . 0.0 109.527 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.436 ' HA2' ' C ' ' A' ' 51' ' ' PRO . . . 139.8 172.92 12.96 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.625 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -123.76 125.26 44.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -1.165 . . . . 0.0 109.543 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.602 HG23 ' HE ' ' A' ' 49' ' ' ARG . 16.1 mm -74.8 120.51 24.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.231 -0.918 . . . . 0.0 109.289 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.688 HG23 HD13 ' A' ' 72' ' ' ILE . 2.3 mm -99.26 129.74 49.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.169 -0.957 . . . . 0.0 109.393 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.461 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 58.2 ttt180 -118.9 119.57 34.74 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.264 -0.898 . . . . 0.0 109.115 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.645 ' NE2' ' CG ' ' A' ' 68' ' ' TYR . 0.3 OUTLIER -93.46 149.14 21.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.32 -0.863 . . . . 0.0 109.472 -179.552 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.546 ' CB ' ' HB3' ' A' ' 45' ' ' PRO . 44.3 p-80 178.27 133.64 0.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.54 -0.725 . . . . 0.0 109.408 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -56.65 -165.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.262 -0.899 . . . . 0.0 109.802 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -95.37 -99.45 0.16 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 109.655 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 16.6 p-80 -74.53 -1.05 19.67 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.232 -0.917 . . . . 0.0 109.72 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.491 ' OG ' ' CB ' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -97.85 91.54 5.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.197 -0.94 . . . . 0.0 109.342 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 t -75.09 55.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.511 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.91 -114.94 0.03 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.0 mtm-85 -120.07 98.64 49.07 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.239 -1.154 . . . . 0.0 109.536 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.546 ' HB3' ' CB ' ' A' ' 37' ' ' HIS . 35.6 Cg_endo -77.65 125.33 7.45 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.581 2.187 . . . . 0.0 110.339 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.654 ' CD ' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -90.05 177.42 6.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 0.0 109.75 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -132.47 111.12 11.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.632 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.629 ' HB3' HD11 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -116.31 125.05 51.61 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.307 -0.87 . . . . 0.0 108.794 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.602 ' HE ' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -104.31 160.64 14.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.119 -0.988 . . . . 0.0 109.847 -179.087 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.766 HG21 ' CZ2' ' A' ' 22' ' ' TRP . 3.7 m -142.51 159.93 55.94 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.42 -0.8 . . . . 0.0 109.298 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.543 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 33.7 Cg_endo -76.37 174.27 13.11 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.484 2.123 . . . . 0.0 110.224 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.624 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.9 Cg_endo -76.81 -25.8 8.77 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.62 2.213 . . . . 0.0 111.07 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.8 p -89.35 -3.0 58.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.098 -1.002 . . . . 0.0 109.666 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.543 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -101.02 111.69 23.95 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.281 -0.887 . . . . 0.0 110.137 -179.54 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 40.6 p-10 -92.92 -8.82 42.18 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.446 -0.784 . . . . 0.0 109.084 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 18.2 p -124.3 150.51 45.33 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.823 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 4.6 tt -134.92 133.16 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.926 -1.109 . . . . 0.0 110.295 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.95 102.7 14.53 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.991 ' CB ' HD11 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -84.47 156.89 21.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.16 -0.963 . . . . 0.0 109.763 -179.532 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.81 HG22 ' HB2' ' A' ' 17' ' ' SER . 33.0 p -143.12 -179.65 6.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.403 -0.811 . . . . 0.0 109.35 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.451 ' O ' ' CZ ' ' A' ' 46' ' ' ARG . 17.5 m-80 55.28 19.26 2.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 109.395 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.991 HD11 ' CB ' ' A' ' 59' ' ' LEU . 4.9 mt -91.62 168.03 11.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 0.0 109.332 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.53 ' CB ' ' OH ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER -77.38 130.98 72.87 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.154 -0.966 . . . . 0.0 108.576 179.404 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.934 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 36.6 Cg_endo -78.84 133.87 11.6 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.371 2.048 . . . . 0.0 111.566 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 73.57 62.76 2.94 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 1.009 HG21 ' CZ ' ' A' ' 68' ' ' TYR . 3.3 m -159.22 145.73 16.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.179 -1.189 . . . . 0.0 110.698 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 1.4 mt-10 -87.66 99.24 11.92 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 1.009 ' CZ ' HG21 ' A' ' 66' ' ' THR . 29.1 m-85 -103.46 119.68 39.36 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.191 -0.943 . . . . 0.0 110.284 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.661 HG22 ' HG3' ' A' ' 87' ' ' GLN . 20.7 t -68.99 117.82 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.423 -0.798 . . . . 0.0 109.25 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.546 HG12 HG22 ' A' ' 34' ' ' ILE . 1.3 t -96.25 109.99 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.088 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -84.49 110.11 18.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.947 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.769 ' C ' HD12 ' A' ' 73' ' ' ILE . 15.5 mm -79.98 120.58 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.398 -0.814 . . . . 0.0 109.653 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.769 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.3 mp -112.59 144.12 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.04 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.713 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -104.43 128.69 52.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.415 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.539 ' CG2' HG12 ' A' ' 33' ' ' ILE . 16.9 m -133.55 130.56 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.47 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.501 ' OD1' HG23 ' A' ' 30' ' ' THR . 38.9 t30 -99.82 44.6 1.01 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.284 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.515 ' N ' ' OG1' ' A' ' 30' ' ' THR . . . 95.42 -63.32 1.39 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.02 3.22 3.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -1.141 . . . . 0.0 109.59 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -103.05 -164.39 1.07 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.437 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.413 ' C ' ' OG ' ' A' ' 81' ' ' SER . 32.8 mt-10 -144.13 -169.21 3.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.8 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.85 ' HB3' HD13 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -176.58 -178.8 0.31 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 109.066 -179.563 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.598 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.8 Cg_endo -77.08 116.13 4.13 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.212 1.941 . . . . 0.0 109.929 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.489 ' CA ' ' O ' ' A' ' 72' ' ' ILE . 36.2 Cg_endo -78.27 146.9 22.7 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.585 2.19 . . . . 0.0 111.272 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.714 ' CD1' HG22 ' A' ' 6' ' ' THR . 0.7 OUTLIER -108.97 107.74 18.22 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.544 HG23 HG12 ' A' ' 69' ' ' VAL . 2.1 mt -87.94 148.05 4.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.071 -1.018 . . . . 0.0 110.228 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.573 ' HA3' ' CE2' ' A' ' 8' ' ' PHE . . . -155.4 161.21 30.37 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.661 ' HG3' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -98.63 143.53 28.92 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.231 -1.158 . . . . 0.0 110.065 -179.486 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.582 ' HG3' ' CE1' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -142.41 137.5 30.45 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.278 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -107.6 124.25 49.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.027 -1.046 . . . . 0.0 110.982 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.76 138.11 42.46 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.139 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.813 ' CG2' HG22 ' A' ' 13' ' ' ILE . 1.2 t -47.43 147.55 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 118.833 -1.147 . . . . 0.0 108.714 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.572 ' O ' ' HB3' ' A' ' 175' ' ' SER . 5.4 t -107.85 64.47 0.63 Allowed 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.65 ' CG ' HG21 ' A' ' 166' ' ' THR . 0.0 OUTLIER 54.04 25.71 5.78 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.113 -0.992 . . . . 0.0 108.586 -179.168 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.718 HG23 ' HD2' ' A' ' 95' ' ' PRO . 1.4 mt -72.08 141.71 84.24 Favored Pre-proline 0 N--CA 1.487 1.407 0 O-C-N 121.32 -0.863 . . . . 0.0 109.02 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.718 ' HD2' HG23 ' A' ' 94' ' ' ILE . 35.9 Cg_endo -79.13 -163.08 0.2 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.513 2.142 . . . . 0.0 110.183 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.533 ' CG ' ' HB2' ' A' ' 113' ' ' GLU . 13.2 ptp180 -174.67 160.13 2.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.257 -0.902 . . . . 0.0 109.373 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.2 OUTLIER 74.97 17.86 2.66 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.218 -0.926 . . . . 0.0 109.516 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.71 HD13 ' CD2' ' A' ' 162' ' ' LEU . 0.6 OUTLIER -51.58 103.7 0.07 Allowed 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.118 -0.989 . . . . 0.0 109.427 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -130.25 161.85 30.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.333 -0.854 . . . . 0.0 109.458 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 12.6 p -97.6 144.76 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.739 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.518 HG12 ' HB3' ' A' ' 109' ' ' LEU . 23.9 pt -127.72 -3.87 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.305 -0.872 . . . . 0.0 109.612 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.887 ' CB ' HD12 ' A' ' 109' ' ' LEU . . . -157.84 106.17 2.03 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.467 ' OG ' ' OH ' ' A' ' 182' ' ' TYR . 1.0 OUTLIER -103.94 106.65 17.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 0.0 110.592 -178.85 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -94.31 166.48 15.34 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.745 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 29.8 Cg_endo -68.97 -2.59 9.88 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.332 2.021 . . . . 0.0 110.665 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.869 ' C ' HG22 ' A' ' 152' ' ' ILE . 3.2 p -148.8 13.9 0.92 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.24 -0.912 . . . . 0.0 109.346 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . 1.051 ' O ' HD23 ' A' ' 108' ' ' LEU . 3.3 p -172.31 168.43 5.58 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 118.764 -1.174 . . . . 0.0 109.989 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.051 HD23 ' O ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -144.35 155.17 43.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.329 -0.857 . . . . 0.0 109.375 -179.468 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.887 HD12 ' CB ' ' A' ' 102' ' ' ALA . 5.8 mt -97.11 140.12 32.09 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.573 ' CD1' HD11 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -122.58 132.62 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.946 -1.096 . . . . 0.0 110.663 -179.126 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.3 t -131.03 111.3 11.9 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.715 ' HH2' ' HB2' ' A' ' 147' ' ' ALA . 45.1 p90 -123.63 144.68 49.46 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.182 -0.949 . . . . 0.0 110.75 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.533 ' HB2' ' CG ' ' A' ' 96' ' ' ARG . 4.4 mm-40 -55.21 168.35 0.57 Allowed Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 113' ' ' GLU . 30.2 Cg_endo -72.94 146.37 41.82 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 122.297 1.998 . . . . 0.0 109.926 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.532 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 31.9 Cg_endo -75.24 -172.58 1.32 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.543 2.162 . . . . 0.0 111.99 -178.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.769 ' CB ' ' HB2' ' A' ' 15' ' ' ALA . . . -69.94 -12.04 61.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.647 -0.658 . . . . 0.0 110.38 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.581 HG13 ' CB ' ' A' ' 15' ' ' ALA . 6.1 m -159.59 -166.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.138 -0.976 . . . . 0.0 109.593 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.492 ' O ' HG22 ' A' ' 119' ' ' VAL . 0.1 OUTLIER -75.27 179.82 4.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.868 . . . . 0.0 109.047 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.577 ' HB ' ' CZ ' ' A' ' 122' ' ' TYR . 1.4 t -156.25 135.05 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.062 -1.024 . . . . 0.0 109.878 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -74.68 -42.98 57.44 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 1.091 ' CZ ' HG21 ' A' ' 165' ' ' VAL . 5.4 p90 -165.76 176.42 7.99 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.63 -0.669 . . . . 0.0 109.289 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.626 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 1.1 m-85 -136.65 161.56 35.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.19 -0.944 . . . . 0.0 109.494 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -120.67 98.9 6.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.929 . . . . 0.0 108.672 179.434 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.852 HG21 HD11 ' A' ' 149' ' ' ILE . 20.3 mt -84.3 146.47 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.139 -0.975 . . . . 0.0 110.012 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.659 HG22 ' HB3' ' A' ' 137' ' ' GLU . 21.6 p -120.9 153.04 37.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 0.0 110.415 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.657 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 2.6 m-85 -101.9 121.88 42.97 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.596 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.1 117.4 5.56 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.272 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 129' ' ' THR . 15.9 mt-10 -87.93 169.54 11.92 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.226 -1.161 . . . . 0.0 108.988 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.597 HG23 ' N ' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -36.74 -79.48 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.65 -0.656 . . . . 0.0 110.475 179.744 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 129' ' ' THR . . . -42.44 -71.53 0.37 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 96.51 -21.72 44.09 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -70.56 -5.34 28.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -1.174 . . . . 0.0 109.586 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.572 ' CB ' ' HD2' ' A' ' 134' ' ' PRO . 0.9 OUTLIER -90.14 -179.99 1.35 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.25 -0.906 . . . . 0.0 109.174 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.572 ' HD2' ' CB ' ' A' ' 133' ' ' SER . 34.6 Cg_endo -77.61 92.78 1.11 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.384 2.056 . . . . 0.0 110.137 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' ' 126' ' ' TYR . 3.4 m -46.67 161.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.443 -0.786 . . . . 0.0 110.132 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 126' ' ' TYR . 24.7 mm100 -107.27 115.83 30.86 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.659 ' HB3' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -119.57 158.07 27.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.939 -1.101 . . . . 0.0 111.557 -178.332 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.595 ' CE1' ' HB ' ' A' ' 124' ' ' ILE . 33.8 p90 -140.7 162.86 34.4 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.643 HG22 ' CE2' ' A' ' 121' ' ' TYR . 0.7 OUTLIER -74.51 -171.14 1.15 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.752 -1.217 . . . . 0.0 110.164 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.586 ' CG2' HD12 ' A' ' 124' ' ' ILE . 40.0 t -149.88 133.98 9.02 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.213 -0.93 . . . . 0.0 109.86 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.33 117.34 4.05 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.357 2.038 . . . . 0.0 110.097 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -71.77 55.81 1.33 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.48 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 39.3 m -105.46 -1.62 24.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.164 -1.198 . . . . 0.0 109.492 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.48 ' CG ' ' O ' ' A' ' 143' ' ' SER . 3.0 mtmt -176.16 -179.75 1.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.919 . . . . 0.0 109.43 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.99 13.75 24.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.57 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 110' ' ' ILE . 18.0 p -125.36 152.84 44.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.912 . . . . 0.0 109.527 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.715 ' HB2' ' HH2' ' A' ' 112' ' ' TRP . . . -142.4 171.73 13.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.0 109.548 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.41 ' O ' ' CZ ' ' A' ' 138' ' ' PHE . 11.3 t -110.7 155.85 21.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.328 -0.858 . . . . 0.0 109.379 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.852 HD11 HG21 ' A' ' 124' ' ' ILE . 16.1 mm -133.26 81.9 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 109.506 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.543 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -92.69 167.64 11.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.389 -0.819 . . . . 0.0 109.979 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 0.3 OUTLIER 75.15 47.4 0.1 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 0.0 109.298 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.869 HG22 ' C ' ' A' ' 106' ' ' THR . 4.2 tt -110.67 158.85 10.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.35 -0.844 . . . . 0.0 109.922 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.422 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 1.7 tttp -97.77 112.45 61.59 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.351 -0.843 . . . . 0.0 108.944 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.457 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 34.7 Cg_endo -77.2 138.17 17.72 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.387 2.058 . . . . 0.0 110.692 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.696 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 87.99 67.7 1.3 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 163.26 130.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -1.117 . . . . 0.0 109.633 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.597 ' N ' HG23 ' A' ' 129' ' ' THR . 1.2 t0 -46.36 158.92 0.1 Allowed 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.596 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -143.08 -179.47 6.39 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.0 -1.063 . . . . 0.0 109.884 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 127' ' ' GLY . 4.8 m -150.94 101.41 2.89 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 179' ' ' SER . 16.2 mm -84.84 136.55 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.117 -0.989 . . . . 0.0 110.118 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.798 HG23 ' HB3' ' A' ' 179' ' ' SER . 2.0 m -147.45 168.87 20.78 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.71 ' CD2' HD13 ' A' ' 98' ' ' LEU . 0.8 OUTLIER -163.54 147.64 10.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.871 -1.143 . . . . 0.0 110.859 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 177' ' ' PRO . 2.0 m-85 -116.08 103.42 10.55 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -61.32 167.25 3.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.007 -1.058 . . . . 0.0 109.459 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 1.091 HG21 ' CZ ' ' A' ' 121' ' ' TYR . 84.4 t -143.79 114.72 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.146 -0.971 . . . . 0.0 110.543 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.65 HG21 ' CG ' ' A' ' 93' ' ' ASP . 0.7 OUTLIER -109.93 131.88 54.66 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.634 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 172' ' ' PRO . . . -58.54 167.11 6.68 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.505 ' NE ' ' HB2' ' A' ' 173' ' ' ALA . 1.1 mtm180 -149.48 15.36 0.88 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -1.118 . . . . 0.0 109.795 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 113.25 -116.86 4.07 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -75.28 0.5 16.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -1.138 . . . . 0.0 109.536 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 168' ' ' ARG . 9.5 m -163.18 128.8 2.19 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.434 ' HA ' ' HA2' ' A' ' 167' ' ' GLY . 33.8 Cg_endo -75.27 -170.59 0.82 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.346 2.031 . . . . 0.0 110.557 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.505 ' HB2' ' NE ' ' A' ' 168' ' ' ARG . . . -155.3 150.99 27.46 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.235 -0.915 . . . . 0.0 109.821 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.516 ' HA ' ' HA ' ' A' ' 165' ' ' VAL . 0.6 OUTLIER -103.29 -165.97 1.22 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.368 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.572 ' HB3' ' O ' ' A' ' 92' ' ' SER . 96.6 p -146.14 163.76 34.34 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.173 -0.954 . . . . 0.0 109.817 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.559 ' CB ' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -47.0 139.99 6.58 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.278 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 163' ' ' TYR . 34.8 Cg_endo -77.39 117.49 4.36 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.204 1.936 . . . . 0.0 111.757 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 161' ' ' THR . 2.3 t -84.59 131.57 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.798 ' HB3' HG23 ' A' ' 161' ' ' THR . 54.4 p -128.14 149.37 50.45 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.05 -1.031 . . . . 0.0 111.218 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.655 HD13 HD23 ' A' ' 98' ' ' LEU . 18.8 pt -134.94 152.65 33.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -84.18 147.03 27.52 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.928 -1.108 . . . . 0.0 109.698 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.783 ' OH ' HD22 ' A' ' 108' ' ' LEU . 74.4 t80 -147.43 121.63 9.55 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.452 -0.78 . . . . 0.0 109.335 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 183' ' ' LYS . 8.0 pttm -96.04 121.86 38.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.994 . . . . 0.0 109.505 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.628 HG22 ' HE2' ' A' ' 182' ' ' TYR . 44.7 p . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.483 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.435 ' HA ' HD22 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -74.55 -163.17 0.19 Allowed 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.265 -1.138 . . . . 0.0 109.51 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.829 ' CG ' ' HB3' ' A' ' 27' ' ' ALA . 7.5 m-20 -74.62 90.13 2.25 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.422 -0.799 . . . . 0.0 110.134 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.6 m -96.71 106.72 32.09 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 3' ' ' ASP . 36.7 Cg_endo -79.61 159.66 25.2 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.322 2.015 . . . . 0.0 110.642 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.744 ' HA ' HD22 ' A' ' 84' ' ' LEU . 3.8 p -151.94 -121.1 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 109.074 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 43.33 28.14 0.85 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.568 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 7.6 t80 -48.68 133.57 16.94 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.705 -0.88 . . . . 0.0 110.327 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 9.2 t0 -165.05 94.1 0.64 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -84.4 118.32 24.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -0.885 . . . . 0.0 109.764 -179.345 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.464 ' O ' ' C ' ' A' ' 12' ' ' ASP . 96.3 p -151.86 -159.1 0.97 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.396 -0.815 . . . . 0.0 108.981 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.525 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.7 OUTLIER 46.46 33.58 2.0 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -178.305 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.679 ' HA ' ' HA ' ' A' ' 18' ' ' PHE . 1.2 mt -76.69 162.67 4.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.679 -177.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.679 HG23 ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -151.2 -175.27 5.1 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.081 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -78.37 -52.11 9.08 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.123 -0.986 . . . . 0.0 109.752 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 60' ' ' THR . 1.8 p-10 -97.83 -1.9 42.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.78 -1.2 . . . . 0.0 109.936 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.857 ' HB3' HG22 ' A' ' 60' ' ' THR . 3.4 p -150.98 157.33 42.75 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.32 -0.863 . . . . 0.0 108.825 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.798 ' CE1' HG22 ' A' ' 20' ' ' VAL . 2.1 p90 -165.71 141.45 5.07 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.17 -0.956 . . . . 0.0 108.559 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 1.7 m -94.82 155.68 16.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.855 -1.153 . . . . 0.0 111.7 -177.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.798 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -130.16 120.07 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.746 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.52 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 4.0 m-70 -101.26 148.91 24.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.118 -0.989 . . . . 0.0 110.81 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.743 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 11.9 p90 -171.47 129.94 0.7 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.536 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.53 169.07 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.985 -1.072 . . . . 0.0 109.566 -179.782 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.536 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -107.66 160.42 26.77 Favored Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.685 -0.634 . . . . 0.0 109.366 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.54 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 36.9 Cg_endo -78.38 -99.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.676 2.251 . . . . 0.0 110.371 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.54 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -174.57 -34.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.076 -1.015 . . . . 0.0 109.984 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.829 ' HB3' ' CG ' ' A' ' 3' ' ' ASP . . . -54.38 168.13 0.5 Allowed Pre-proline 0 C--N 1.296 -1.729 0 O-C-N 121.5 -0.75 . . . . 0.0 109.368 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.737 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.1 Cg_endo -77.52 142.18 20.57 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.529 2.153 . . . . 0.0 110.354 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.638 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 14.2 pt -148.11 176.98 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.921 . . . . 0.0 109.751 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.0 p -120.77 1.05 10.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.412 -0.805 . . . . 0.0 109.256 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.462 ' O ' ' CG2' ' A' ' 75' ' ' VAL . . . 139.3 150.97 5.61 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.723 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -100.63 135.56 41.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.254 -1.144 . . . . 0.0 109.322 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.88 HG23 ' HD2' ' A' ' 49' ' ' ARG . 1.2 mp -86.53 133.14 30.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.149 -0.969 . . . . 0.0 109.094 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.844 HD13 ' C ' ' A' ' 33' ' ' ILE . 2.9 mm -112.12 102.15 13.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.354 -0.841 . . . . 0.0 109.346 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.533 ' HG2' ' N ' ' A' ' 36' ' ' HIS . 5.4 ttt180 -100.62 158.1 16.18 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.145 -0.972 . . . . 0.0 109.218 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.952 ' CE1' HG22 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -140.07 144.59 36.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.165 -0.96 . . . . 0.0 109.635 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.718 ' CD2' ' O ' ' A' ' 69' ' ' VAL . 7.0 p80 -163.5 128.85 3.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.834 . . . . 0.0 109.533 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.88 ' HB1' ' OG ' ' A' ' 41' ' ' SER . . . -40.32 163.6 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.415 -0.803 . . . . 0.0 110.03 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 1.016 ' HG2' HG23 ' A' ' 69' ' ' VAL . 2.1 mt-10 -84.42 -98.04 0.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.168 -0.958 . . . . 0.0 109.481 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.2 p-80 -87.77 -3.22 58.96 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.349 -0.844 . . . . 0.0 109.714 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.88 ' OG ' ' HB1' ' A' ' 38' ' ' ALA . 22.9 p -84.98 -177.12 6.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 109.477 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 42' ' ' VAL . 4.9 t -101.46 29.6 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.245 -0.909 . . . . 0.0 109.492 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.655 ' HA3' ' HB2' ' A' ' 38' ' ' ALA . . . -64.2 125.85 32.65 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.9 OUTLIER -55.92 143.99 59.44 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.254 -1.145 . . . . 0.0 109.417 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 37' ' ' HIS . 35.8 Cg_endo -78.57 106.14 2.07 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.547 2.165 . . . . 0.0 110.352 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -74.82 179.68 4.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.631 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -143.39 126.97 16.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.339 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.534 ' CG ' HD21 ' A' ' 59' ' ' LEU . 21.2 m-20 -138.21 159.22 42.61 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.88 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -139.18 159.03 43.11 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.286 -0.884 . . . . 0.0 109.85 -179.474 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 1.076 ' CG1' HD12 ' A' ' 57' ' ' ILE . 32.7 m -142.72 159.22 57.88 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.865 . . . . 0.0 109.189 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.544 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.4 Cg_endo -77.21 174.42 12.8 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.503 2.135 . . . . 0.0 110.324 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 35.3 Cg_endo -77.21 -15.5 16.08 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.596 2.198 . . . . 0.0 110.52 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 p -102.8 24.11 11.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.65 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.544 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 5.7 mmt180 -126.83 109.04 11.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.186 -0.946 . . . . 0.0 109.966 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 22' ' ' TRP . 16.5 p30 -94.09 -11.23 31.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.031 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 20.0 p -131.21 137.13 48.79 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.076 HD12 ' CG1' ' A' ' 50' ' ' VAL . 6.4 tt -131.35 129.65 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.982 -1.074 . . . . 0.0 110.264 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.63 111.09 23.1 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.876 ' HB3' HD11 ' A' ' 62' ' ' LEU . 2.0 mt -84.48 158.37 21.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.165 -0.959 . . . . 0.0 109.541 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.857 HG22 ' HB3' ' A' ' 17' ' ' SER . 19.4 p -145.65 177.6 8.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 109.394 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.9 m-20 50.93 46.6 26.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.517 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.876 HD11 ' HB3' ' A' ' 59' ' ' LEU . 3.7 mt -118.19 147.34 43.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 109.355 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.478 ' O ' ' OH ' ' A' ' 68' ' ' TYR . 28.3 m-80 -44.89 117.2 3.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.197 -0.939 . . . . 0.0 108.686 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.4 Cg_endo -77.47 125.72 7.84 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.144 1.896 . . . . 0.0 111.41 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.99 59.99 2.11 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.564 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 2.6 m -151.8 166.51 31.16 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.154 -1.204 . . . . 0.0 109.506 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.564 ' N ' ' CG2' ' A' ' 66' ' ' THR . 5.1 mt-10 -125.56 127.25 46.09 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.305 -0.872 . . . . 0.0 109.21 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -134.23 -159.53 0.97 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.139 -0.975 . . . . 0.0 109.773 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 1.016 HG23 ' HG2' ' A' ' 39' ' ' GLU . 41.7 t -137.36 116.68 15.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.952 HG22 ' CE1' ' A' ' 36' ' ' HIS . 3.7 t -88.58 127.73 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.031 -1.043 . . . . 0.0 109.621 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.539 ' HB3' ' CD1' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -101.0 104.72 15.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 110.065 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 84' ' ' LEU . 15.0 mm -79.4 154.56 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.341 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.549 HG22 ' N ' ' A' ' 74' ' ' ALA . 48.3 mt -153.1 165.03 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 0.0 109.593 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.645 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -132.57 120.62 22.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.298 -0.877 . . . . 0.0 109.389 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.735 HG12 ' HG2' ' A' ' 80' ' ' GLU . 2.4 m -112.63 144.52 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.524 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -135.94 45.23 2.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.892 . . . . 0.0 109.361 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.13 -96.46 1.15 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -109.72 -1.4 18.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.244 -1.15 . . . . 0.0 109.554 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.528 ' O ' ' CG ' ' A' ' 80' ' ' GLU . 19.8 mt-10 -106.52 172.89 6.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 0.0 109.121 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.735 ' HG2' HG12 ' A' ' 75' ' ' VAL . 46.0 mt-10 -158.33 115.75 2.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.125 -0.984 . . . . 0.0 110.022 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.695 ' HG ' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -60.29 -175.17 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.283 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.695 ' HD2' ' HG ' ' A' ' 81' ' ' SER . 33.1 Cg_endo -76.5 146.15 27.19 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.925 1.75 . . . . 0.0 110.107 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.489 ' HB3' HG12 ' A' ' 73' ' ' ILE . 35.6 Cg_endo -77.22 109.56 2.84 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.674 2.249 . . . . 0.0 111.357 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.744 HD22 ' HA ' ' A' ' 6' ' ' THR . 17.9 tp -84.21 94.54 8.42 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.586 ' CG2' ' CG1' ' A' ' 69' ' ' VAL . 2.2 mt -85.72 151.34 3.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.128 -0.983 . . . . 0.0 110.678 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.604 ' O ' HG13 ' A' ' 69' ' ' VAL . . . -142.62 179.25 20.47 Favored Glycine 0 N--CA 1.483 1.824 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.42 ' HG3' ' C ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -131.73 146.4 52.14 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.992 -1.299 . . . . 0.0 110.058 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.538 ' NE2' ' NE2' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -163.13 -167.69 1.54 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' A' ' 66' ' ' THR . . . -165.41 136.64 3.94 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.973 -1.079 . . . . 0.0 109.953 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.462 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.6 OUTLIER -74.59 162.18 29.01 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.193 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.722 HG11 ' CB ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -99.05 154.79 4.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.142 -0.973 . . . . 0.0 110.201 -179.691 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 11.4 p -70.53 105.31 3.05 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.522 ' HB2' ' CB ' ' A' ' 15' ' ' ALA . 1.3 t0 -67.52 -56.86 7.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.623 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.72 HG23 ' HD2' ' A' ' 95' ' ' PRO . 1.2 mt -76.81 142.99 70.47 Favored Pre-proline 0 C--N 1.302 -1.464 0 O-C-N 121.216 -0.927 . . . . 0.0 109.605 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.945 ' HG3' HD11 ' A' ' 162' ' ' LEU . 36.4 Cg_endo -80.63 46.0 2.14 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.451 2.101 . . . . 0.0 109.886 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.471 ' CG ' ' HG3' ' A' ' 113' ' ' GLU . 5.9 ptm85 -60.05 179.15 0.15 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.403 -0.811 . . . . 0.0 109.569 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.1 t0 67.35 8.11 6.02 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.243 -0.911 . . . . 0.0 109.272 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.766 ' CD2' HD13 ' A' ' 180' ' ' ILE . 8.7 tt -53.59 99.98 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.216 -0.927 . . . . 0.0 109.13 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -124.98 157.29 36.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.306 -0.871 . . . . 0.0 109.532 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 8.1 p -91.1 139.67 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.381 -0.824 . . . . 0.0 109.606 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.826 HD11 HD22 ' A' ' 109' ' ' LEU . 20.0 pt -125.23 -5.86 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.503 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.999 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -149.4 97.77 2.7 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.488 ' HB2' ' OH ' ' A' ' 182' ' ' TYR . 17.4 p -90.0 90.56 8.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.368 -0.832 . . . . 0.0 110.293 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -80.37 157.49 72.79 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 121.237 -0.914 . . . . 0.0 108.776 179.059 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.483 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.2 Cg_endo -69.9 -2.73 10.77 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.397 2.065 . . . . 0.0 110.502 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.727 ' C ' HG22 ' A' ' 152' ' ' ILE . 1.4 p -150.53 18.38 0.82 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . 1.067 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.7 OUTLIER -167.22 171.63 10.63 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.034 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.067 HD23 ' O ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -144.43 152.63 40.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.309 -0.869 . . . . 0.0 109.173 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.999 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -105.75 120.72 42.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 108.86 179.293 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.581 ' CD1' ' HB3' ' A' ' 147' ' ' ALA . 1.0 OUTLIER -106.29 138.06 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.115 -0.991 . . . . 0.0 110.024 -179.68 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.87 ' HB2' HG22 ' A' ' 146' ' ' THR . 0.0 OUTLIER -142.87 115.17 8.44 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.455 -0.778 . . . . 0.0 109.259 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.624 ' CD1' ' CB ' ' A' ' 95' ' ' PRO . 43.4 p90 -125.97 -177.43 3.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 109.561 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.505 ' O ' ' HD3' ' A' ' 115' ' ' PRO . 1.0 OUTLIER -56.73 133.82 78.48 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.912 . . . . 0.0 109.424 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.462 ' HB3' ' OG ' ' A' ' 145' ' ' SER . 36.6 Cg_endo -79.98 109.92 2.47 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.788 2.325 . . . . 0.0 110.806 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 113' ' ' GLU . 36.3 Cg_endo -81.34 164.37 19.23 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.322 2.014 . . . . 0.0 110.243 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.722 ' CB ' HG11 ' A' ' 91' ' ' VAL . . . -142.59 14.22 1.96 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.631 HG22 ' CG2' ' A' ' 119' ' ' VAL . 3.0 m -79.38 179.83 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.477 ' O ' ' HB ' ' A' ' 166' ' ' THR . 11.1 m -69.52 59.35 0.13 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.054 -1.029 . . . . 0.0 108.786 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.89 ' HA ' HG22 ' A' ' 166' ' ' THR . 21.3 t -74.65 125.88 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.362 -0.836 . . . . 0.0 109.993 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER -74.93 -58.62 3.17 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.907 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.829 ' CE1' HG22 ' A' ' 139' ' ' THR . 9.0 p90 -166.93 163.4 16.1 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.498 ' CE1' HG11 ' A' ' 119' ' ' VAL . 14.4 m-85 -103.74 129.59 51.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.03 -1.044 . . . . 0.0 108.589 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.555 ' HG3' ' CG ' ' A' ' 137' ' ' GLU . 1.5 ttm180 -95.34 85.94 4.39 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.286 -0.884 . . . . 0.0 109.518 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 1.065 HD12 ' CG2' ' A' ' 140' ' ' VAL . 21.6 mt -84.37 153.16 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.364 -0.835 . . . . 0.0 109.193 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.697 HG22 ' HA ' ' A' ' 137' ' ' GLU . 27.7 p -138.73 142.45 38.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.136 -0.978 . . . . 0.0 110.189 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.672 ' CE2' HG22 ' A' ' 149' ' ' ILE . 4.1 m-85 -79.59 126.68 31.21 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.577 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.35 120.42 6.49 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 130' ' ' GLY . 2.3 mt-10 -90.52 170.12 10.46 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.447 -1.031 . . . . 0.0 109.064 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.946 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 1.2 p -39.81 -28.46 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.465 -0.772 . . . . 0.0 109.887 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 128' ' ' GLU . . . -59.41 -84.67 0.04 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 96.8 100.0 1.96 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -145.12 -71.71 0.26 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.327 -1.102 . . . . 0.0 109.348 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.56 ' CB ' ' HD3' ' A' ' 134' ' ' PRO . 0.5 OUTLIER 171.48 -55.48 0.0 OUTLIER Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.56 ' HD3' ' CB ' ' A' ' 133' ' ' SER . 35.7 Cg_endo -78.16 71.63 6.61 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.336 2.024 . . . . 0.0 109.995 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.554 ' CG1' ' O ' ' A' ' 126' ' ' TYR . 0.2 OUTLIER -109.64 -143.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.437 -0.789 . . . . 0.0 109.326 -179.655 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.583 ' HB3' ' CD1' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -80.96 76.1 7.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.846 -1.159 . . . . 0.0 109.14 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.697 ' HA ' HG22 ' A' ' 125' ' ' THR . 6.4 tm-20 -76.54 117.48 18.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 110.665 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.618 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 26.7 p90 -121.94 138.59 54.35 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.829 HG22 ' CE1' ' A' ' 121' ' ' TYR . 7.4 p -74.21 168.39 19.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.083 -1.01 . . . . 0.0 110.534 -178.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 1.065 ' CG2' HD12 ' A' ' 124' ' ' ILE . 50.9 t -138.31 141.5 31.92 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.523 -0.736 . . . . 0.0 109.647 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.643 ' HD2' HG13 ' A' ' 140' ' ' VAL . 35.0 Cg_endo -77.17 141.43 20.69 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.528 2.152 . . . . 0.0 110.657 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.82 53.55 3.33 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.505 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 28.4 t -103.7 -11.85 17.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.178 -1.189 . . . . 0.0 109.888 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 143' ' ' SER . 1.5 mmmt 179.54 175.81 0.7 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 109.777 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.581 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -95.26 -1.23 51.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.585 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.87 HG22 ' HB2' ' A' ' 111' ' ' SER . 41.4 p -102.0 129.79 48.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.09 -1.006 . . . . 0.0 108.913 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.581 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -126.81 156.5 41.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.118 -0.988 . . . . 0.0 109.78 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.588 ' O ' HD13 ' A' ' 149' ' ' ILE . 8.9 m -100.82 152.26 20.72 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.352 -0.843 . . . . 0.0 109.097 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.672 HG22 ' CE2' ' A' ' 126' ' ' TYR . 49.9 mm -127.93 107.95 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.252 -0.905 . . . . 0.0 109.199 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.586 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 2.9 m120 -116.0 166.1 12.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.418 -0.801 . . . . 0.0 109.929 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 4.1 m120 76.07 37.73 0.36 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 109.268 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.727 HG22 ' C ' ' A' ' 106' ' ' THR . 4.7 tt -96.93 156.17 3.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.392 -0.817 . . . . 0.0 109.795 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 184' ' ' THR . 9.0 mttp -84.64 117.57 69.06 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 109.349 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.483 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 36.4 Cg_endo -78.73 75.88 4.78 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.479 2.12 . . . . 0.0 110.684 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.717 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 143.08 73.05 0.03 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.946 ' HB1' ' CG2' ' A' ' 129' ' ' THR . . . 162.25 134.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -1.107 . . . . 0.0 109.67 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.673 ' N ' HG22 ' A' ' 129' ' ' THR . 1.0 OUTLIER -48.08 164.43 0.05 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.11 -0.994 . . . . 0.0 108.338 179.292 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.612 ' CE2' HG13 ' A' ' 152' ' ' ILE . 0.4 OUTLIER -144.97 -167.44 2.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.865 -1.147 . . . . 0.0 110.352 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.513 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 31.6 m -169.6 102.75 0.33 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.598 HD11 HD12 ' A' ' 108' ' ' LEU . 33.0 mm -88.11 118.6 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.025 -1.047 . . . . 0.0 109.785 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.985 HG23 ' CB ' ' A' ' 179' ' ' SER . 1.1 m -126.37 165.41 19.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.904 . . . . 0.0 109.19 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.945 HD11 ' HG3' ' A' ' 95' ' ' PRO . 1.9 pp -165.86 154.4 11.26 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.997 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.626 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 1.8 m-85 -122.69 160.38 25.97 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -127.26 101.68 6.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.865 -1.147 . . . . 0.0 109.342 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.934 HG22 ' HB3' ' A' ' 174' ' ' SER . 15.1 t -87.74 131.42 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.333 -0.854 . . . . 0.0 109.677 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.89 HG22 ' HA ' ' A' ' 119' ' ' VAL . 17.0 p -130.89 -66.97 0.73 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.768 -0.582 . . . . 0.0 109.512 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.51 ' N ' ' OG1' ' A' ' 166' ' ' THR . . . -43.18 139.28 3.09 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -141.22 104.53 4.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -1.149 . . . . 0.0 109.453 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 166.68 -122.49 1.06 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 170' ' ' ASP . 7.3 p-10 -93.29 12.07 25.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -1.155 . . . . 0.0 109.47 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.477 ' N ' ' HD3' ' A' ' 172' ' ' PRO . 64.8 m -158.58 64.8 2.85 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.355 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' A' ' 171' ' ' SER . 35.7 Cg_endo -78.18 98.84 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.658 2.239 . . . . 0.0 110.574 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -103.59 -179.29 3.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 109.307 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.934 ' HB3' HG22 ' A' ' 165' ' ' VAL . 0.7 OUTLIER -144.68 48.26 1.33 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.103 -0.998 . . . . 0.0 109.697 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.49 ' O ' ' O ' ' A' ' 174' ' ' SER . 0.7 OUTLIER 42.1 -166.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.641 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -93.19 139.71 23.1 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 120.999 -1.063 . . . . 0.0 108.229 179.165 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.626 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 33.8 Cg_endo -76.14 140.91 22.91 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.206 1.937 . . . . 0.0 111.158 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.2 t -122.11 138.22 53.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.985 ' CB ' HG23 ' A' ' 161' ' ' THR . 0.3 OUTLIER -131.36 155.45 47.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.088 -1.007 . . . . 0.0 110.821 -178.663 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.766 HD13 ' CD2' ' A' ' 98' ' ' LEU . 14.0 pt -136.96 153.3 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 159' ' ' THR . 23.6 m120 -91.67 156.67 17.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.0 -1.063 . . . . 0.0 110.051 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.764 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 51.9 t80 -143.98 169.78 17.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.405 -0.809 . . . . 0.0 109.296 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.477 ' N ' ' CD2' ' A' ' 182' ' ' TYR . 8.6 tttp -139.86 121.69 15.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.231 -0.918 . . . . 0.0 109.537 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.455 ' CB ' ' O ' ' A' ' 153' ' ' LYS . 14.7 p . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.46 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.817 HD12 ' N ' ' A' ' 2' ' ' LEU . 0.2 OUTLIER -119.58 -162.87 0.94 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.268 -1.137 . . . . 0.0 109.342 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 26' ' ' ARG . 1.6 m-20 -96.62 167.61 11.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 0.0 109.344 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.548 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 4.8 p -94.52 133.62 26.64 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.491 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.921 ' O ' HD22 ' A' ' 84' ' ' LEU . 36.3 Cg_endo -79.14 86.72 1.64 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.54 2.16 . . . . 0.0 110.394 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.466 ' O ' ' C ' ' A' ' 7' ' ' GLY . 16.5 p -89.32 -126.87 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.04 -1.038 . . . . 0.0 109.304 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 44.48 28.42 1.51 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.039 -2.025 . . . . 0.0 108.039 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.569 ' HB3' HD21 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -92.34 152.32 19.83 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.851 -0.794 . . . . 0.0 109.879 -178.603 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.593 ' O ' HG12 ' A' ' 20' ' ' VAL . 2.5 t70 -165.0 -163.15 0.68 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.788 ' HB2' HD11 ' A' ' 13' ' ' ILE . 83.0 p -137.45 121.26 17.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.048 -1.032 . . . . 0.0 109.908 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.472 ' O ' ' C ' ' A' ' 12' ' ' ASP . 3.7 p -140.6 -171.01 3.13 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.356 -0.84 . . . . 0.0 108.847 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.547 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.9 OUTLIER 43.84 36.01 1.24 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -178.552 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.867 HG22 ' CG2' ' A' ' 91' ' ' VAL . 1.2 mt -79.52 132.69 31.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.729 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.543 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -122.83 -179.94 4.42 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.198 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 1.055 ' HB2' HG11 ' A' ' 117' ' ' VAL . . . -74.08 -63.39 1.23 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.751 -1.218 . . . . 0.0 109.75 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 3.4 m-20 -88.46 23.77 2.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.148 -0.97 . . . . 0.0 109.446 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.731 ' HA ' HD12 ' A' ' 62' ' ' LEU . 42.0 p -176.04 153.68 1.34 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.774 ' HB2' HG23 ' A' ' 13' ' ' ILE . 2.5 p90 -165.66 140.53 4.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 0.0 109.089 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.547 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 4.6 m -89.79 161.44 16.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.922 -1.111 . . . . 0.0 110.964 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.759 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -133.54 173.23 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.543 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 28.3 m-70 -147.68 170.6 17.17 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.89 -1.131 . . . . 0.0 110.541 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.66 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 16.3 p90 179.81 135.28 0.11 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.533 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.51 167.6 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.087 -1.008 . . . . 0.0 109.267 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.757 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -92.21 168.77 12.15 Favored Pre-proline 0 C--N 1.299 -1.606 0 O-C-N 121.647 -0.658 . . . . 0.0 109.796 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.757 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.9 Cg_endo -78.18 172.75 14.94 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.675 2.25 . . . . 0.0 110.387 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.455 ' HB2' ' OD1' ' A' ' 3' ' ' ASP . 45.5 mmt-85 -90.68 28.73 1.45 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.229 -0.92 . . . . 0.0 109.48 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.948 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -146.26 175.35 2.77 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 109.428 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.948 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.3 Cg_endo -77.83 142.38 20.01 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.647 2.231 . . . . 0.0 110.35 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.716 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 46.3 pt -145.68 -170.6 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.602 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.8 p -121.26 -8.64 9.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.278 -0.889 . . . . 0.0 109.416 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.04 -168.34 32.41 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.716 ' CZ ' HD11 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -138.64 131.54 29.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -1.178 . . . . 0.0 109.526 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.943 HG23 ' HD2' ' A' ' 49' ' ' ARG . 1.1 mp -83.48 133.05 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.21 -0.931 . . . . 0.0 108.835 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.845 HD13 ' C ' ' A' ' 33' ' ' ILE . 2.4 mm -111.97 101.03 11.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.185 -0.947 . . . . 0.0 109.829 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 71' ' ' SER . 0.2 OUTLIER -109.39 111.14 22.52 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 108.602 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.947 ' HB3' HG13 ' A' ' 70' ' ' VAL . 3.4 p80 -119.13 160.6 21.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.135 -0.978 . . . . 0.0 110.385 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.536 ' HB3' ' CB ' ' A' ' 45' ' ' PRO . 30.3 p-80 -167.25 136.02 2.67 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.576 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -47.51 177.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.922 . . . . 0.0 110.033 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -42.96 -75.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.889 . . . . 0.0 109.767 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -149.06 47.68 0.99 Allowed 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.689 -0.632 . . . . 0.0 109.512 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.476 ' OG ' ' HB3' ' A' ' 38' ' ' ALA . 4.9 p -74.88 -94.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.579 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.684 HG12 ' H ' ' A' ' 43' ' ' GLY . 2.2 t -74.78 -179.35 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.36 -0.838 . . . . 0.0 109.536 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.684 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -84.81 -90.97 0.8 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.469 ' HD3' ' HD2' ' A' ' 45' ' ' PRO . 0.8 OUTLIER -51.95 139.32 33.04 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.28 -1.13 . . . . 0.0 109.396 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.536 ' CB ' ' HB3' ' A' ' 37' ' ' HIS . 36.4 Cg_endo -79.08 164.48 24.75 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.573 2.182 . . . . 0.0 110.6 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 4.1 mmt85 -75.64 128.61 35.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.868 . . . . 0.0 109.209 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.451 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 3.8 mt-30 -87.77 133.3 33.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.885 . . . . 0.0 109.95 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.486 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -155.21 117.08 4.1 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.582 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.943 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -105.64 165.02 11.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.982 -1.074 . . . . 0.0 110.205 -179.124 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.646 ' CG1' HD12 ' A' ' 57' ' ' ILE . 7.2 m -140.0 161.84 53.63 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.548 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.3 Cg_endo -76.37 174.1 13.39 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.324 2.016 . . . . 0.0 110.354 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.556 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.5 Cg_endo -76.86 -14.43 17.24 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.558 2.172 . . . . 0.0 110.273 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.12 23.39 13.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.349 -0.845 . . . . 0.0 109.513 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.548 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 10.5 mmt180 -124.77 97.99 5.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -0.953 . . . . 0.0 109.719 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 3.7 p30 -85.06 -0.97 56.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.181 -0.95 . . . . 0.0 109.305 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 63.5 p -136.52 149.1 47.97 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.406 -0.808 . . . . 0.0 109.028 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.66 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 3.4 tt -134.14 123.22 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.116 -0.99 . . . . 0.0 109.741 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 66.4 m -91.74 116.37 28.83 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.358 -0.838 . . . . 0.0 109.456 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.91 ' HB3' HD11 ' A' ' 62' ' ' LEU . 7.2 mt -92.51 151.4 20.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.203 -0.936 . . . . 0.0 109.618 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.487 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 1.2 p -133.12 169.66 16.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.382 -0.824 . . . . 0.0 109.561 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 23.3 m-20 59.4 39.85 21.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -0.879 . . . . 0.0 109.455 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.91 HD11 ' HB3' ' A' ' 59' ' ' LEU . 4.3 mt -108.89 157.64 18.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 0.0 109.293 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.475 ' O ' ' OH ' ' A' ' 68' ' ' TYR . 13.0 m-20 -60.87 134.74 92.59 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.142 -0.974 . . . . 0.0 108.819 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 37.0 Cg_endo -78.49 117.9 4.13 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.289 1.993 . . . . 0.0 110.502 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 77.46 60.51 2.81 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.552 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 2.1 m -146.58 166.67 25.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.535 -0.979 . . . . 0.0 109.895 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.552 ' N ' ' CG2' ' A' ' 66' ' ' THR . 7.5 pt-20 -121.18 136.46 54.97 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.418 -0.801 . . . . 0.0 109.303 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.576 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -132.49 176.97 7.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.19 -0.944 . . . . 0.0 109.577 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.646 HG22 ' HG3' ' A' ' 87' ' ' GLN . 74.9 t -108.69 97.02 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.947 HG13 ' HB3' ' A' ' 36' ' ' HIS . 1.9 t -84.76 124.51 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.863 . . . . 0.0 110.13 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.579 ' CB ' HG12 ' A' ' 85' ' ' ILE . 15.5 p -105.72 137.72 43.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.877 . . . . 0.0 110.295 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.79 ' CD1' HG23 ' A' ' 34' ' ' ILE . 30.9 mm -124.06 120.95 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.465 -0.772 . . . . 0.0 109.149 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 74' ' ' ALA . 49.2 mt -117.6 167.16 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 109.428 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -132.13 124.75 29.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.911 . . . . 0.0 109.393 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -116.03 136.21 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 109.588 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.415 ' CB ' ' HA ' ' A' ' 29' ' ' ILE . 48.3 t30 -121.31 50.14 1.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -0.94 . . . . 0.0 109.448 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.41 -82.12 0.95 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.432 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 20.0 tpt180 -117.35 2.01 12.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -1.166 . . . . 0.0 109.62 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 1.1 mt-10 -92.96 176.45 6.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.133 -0.979 . . . . 0.0 109.415 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 36.0 mt-10 -154.57 96.31 1.88 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.522 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.79 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -59.9 178.99 0.22 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.134 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.568 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.3 Cg_endo -77.3 152.22 30.43 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.352 2.035 . . . . 0.0 110.139 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.436 ' HA ' HG12 ' A' ' 73' ' ' ILE . 35.5 Cg_endo -77.8 105.49 2.03 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.532 2.155 . . . . 0.0 110.759 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.921 HD22 ' O ' ' A' ' 5' ' ' PRO . 23.1 tp -84.57 100.8 11.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -0.888 . . . . 0.0 108.941 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.579 HG12 ' CB ' ' A' ' 71' ' ' SER . 2.3 mt -110.1 149.92 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.126 -0.984 . . . . 0.0 110.09 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -153.47 160.5 29.26 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.646 ' HG3' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -104.19 105.09 15.12 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.127 -1.219 . . . . 0.0 109.792 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.462 ' OE1' ' CB ' ' A' ' 10' ' ' SER . 36.0 mm-40 -104.79 -165.92 1.18 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.74 145.39 6.43 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.902 -1.119 . . . . 0.0 110.929 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -78.26 140.09 38.87 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.144 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.08 HG11 ' CB ' ' A' ' 116' ' ' ALA . 2.1 t -42.35 158.67 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.532 ' HA ' ' CA ' ' A' ' 65' ' ' GLY . 0.3 OUTLIER -106.01 135.29 47.72 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.441 -0.787 . . . . 0.0 109.841 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.511 ' CB ' ' OG1' ' A' ' 166' ' ' THR . 0.7 OUTLIER -70.8 -4.51 24.37 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.441 -0.787 . . . . 0.0 108.878 179.302 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.974 HD11 ' HB2' ' A' ' 176' ' ' LYS . 5.3 mt -50.31 144.24 11.98 Favored Pre-proline 0 N--CA 1.484 1.231 0 O-C-N 121.307 -0.871 . . . . 0.0 109.673 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.763 ' HD2' HG23 ' A' ' 94' ' ' ILE . 34.7 Cg_endo -77.49 -163.83 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.163 1.909 . . . . 0.0 109.097 178.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 9.2 ptm85 -158.81 147.6 18.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.871 -1.143 . . . . 0.0 109.682 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 4.4 t70 75.71 24.26 1.3 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.352 -0.843 . . . . 0.0 109.301 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 1.025 HD23 ' CG2' ' A' ' 180' ' ' ILE . 3.4 tp -54.96 99.81 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.186 -0.946 . . . . 0.0 109.207 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -142.8 161.78 37.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.906 . . . . 0.0 109.599 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 109' ' ' LEU . 38.4 t -103.72 150.54 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.273 -0.892 . . . . 0.0 109.592 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.753 ' CG1' HD21 ' A' ' 109' ' ' LEU . 1.2 pt -120.01 -16.06 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.378 -0.826 . . . . 0.0 109.44 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.78 ' HB3' HD23 ' A' ' 109' ' ' LEU . . . -135.99 143.1 44.63 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.532 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.8 p -135.31 93.22 2.95 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.94 -1.1 . . . . 0.0 110.531 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.575 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -75.77 165.95 49.21 Favored Pre-proline 0 C--N 1.306 -1.296 0 O-C-N 121.102 -0.999 . . . . 0.0 108.512 178.715 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 30.0 Cg_endo -69.34 -1.89 8.92 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.296 1.997 . . . . 0.0 110.58 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.748 ' C ' HG22 ' A' ' 152' ' ' ILE . 3.3 p -151.41 17.24 0.72 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.353 -0.842 . . . . 0.0 108.953 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . 1.033 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.7 OUTLIER -169.93 161.54 8.91 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.768 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.033 HD23 ' O ' ' A' ' 107' ' ' SER . 0.4 OUTLIER -148.05 147.76 29.93 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.412 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.78 HD23 ' HB3' ' A' ' 102' ' ' ALA . 1.5 pp -106.99 135.93 47.72 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.149 -0.969 . . . . 0.0 109.222 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.614 ' H ' HD13 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -112.47 167.05 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.109 -0.994 . . . . 0.0 110.1 -179.659 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.584 ' CB ' HG22 ' A' ' 146' ' ' THR . 32.4 t -152.03 136.3 16.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.483 -0.761 . . . . 0.0 109.146 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.585 ' CD1' ' HB3' ' A' ' 95' ' ' PRO . 15.5 p90 -141.08 172.18 13.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.198 -0.939 . . . . 0.0 109.711 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.498 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 5.4 mt-10 -108.03 164.16 15.38 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.299 -0.875 . . . . 0.0 109.52 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 113' ' ' GLU . 34.7 Cg_endo -78.15 132.54 11.58 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.803 2.335 . . . . 0.0 110.771 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.506 ' HG3' ' O ' ' A' ' 93' ' ' ASP . 35.1 Cg_endo -79.23 -157.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.752 2.301 . . . . 0.0 110.813 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.08 ' CB ' HG11 ' A' ' 91' ' ' VAL . . . -69.29 -4.28 17.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.362 -0.836 . . . . 0.0 109.942 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 1.055 HG11 ' HB2' ' A' ' 15' ' ' ALA . 3.5 m -134.64 158.68 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.142 -0.974 . . . . 0.0 109.723 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.436 ' O ' ' CG2' ' A' ' 166' ' ' THR . 74.9 p -69.85 -161.68 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.925 . . . . 0.0 108.897 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 1.151 HG11 ' CE2' ' A' ' 122' ' ' TYR . 2.9 t -152.99 139.79 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.082 -1.011 . . . . 0.0 110.411 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.531 ' NH2' ' HG2' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -98.97 -43.39 6.72 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.689 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 1.076 ' CZ ' HG21 ' A' ' 165' ' ' VAL . 0.9 OUTLIER -165.4 161.13 18.7 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.046 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 1.151 ' CE2' HG11 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -125.74 171.98 10.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.034 -1.041 . . . . 0.0 109.908 -179.48 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -131.8 90.36 2.82 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.076 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.625 ' CD1' HG21 ' A' ' 140' ' ' VAL . 12.9 mt -83.48 164.37 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.339 -0.851 . . . . 0.0 110.021 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.553 HG22 ' CB ' ' A' ' 137' ' ' GLU . 1.9 p -141.14 151.4 43.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.372 -0.83 . . . . 0.0 109.697 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.756 ' CE2' HG22 ' A' ' 149' ' ' ILE . 2.9 m-85 -87.01 141.64 28.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 108.685 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.593 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -105.31 111.54 3.75 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.4 ' OE2' ' HD3' ' A' ' 153' ' ' LYS . 4.9 mt-10 -105.56 144.06 32.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.114 -1.227 . . . . 0.0 109.356 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -56.14 159.68 3.29 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.245 -0.909 . . . . 0.0 109.75 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 54.29 57.55 16.57 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.444 ' C ' ' HD2' ' A' ' 134' ' ' PRO . . . -154.39 -78.56 0.02 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.44 ' O ' ' CB ' ' A' ' 133' ' ' SER . 67.9 m-20 58.86 41.48 21.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.271 -1.135 . . . . 0.0 109.485 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.56 ' CB ' ' HD3' ' A' ' 134' ' ' PRO . 0.1 OUTLIER 169.17 -54.81 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.554 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.56 ' HD3' ' CB ' ' A' ' 133' ' ' SER . 35.7 Cg_endo -77.95 78.33 3.61 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.404 2.07 . . . . 0.0 110.004 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.751 HG12 ' O ' ' A' ' 126' ' ' TYR . 0.7 OUTLIER -109.47 170.35 3.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.378 -0.826 . . . . 0.0 109.618 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.534 ' O ' ' HA ' ' A' ' 125' ' ' THR . 1.3 mp0 -94.84 83.4 4.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.145 -0.972 . . . . 0.0 108.811 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.553 ' CB ' HG22 ' A' ' 125' ' ' THR . 32.5 tt0 -74.01 114.97 12.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.869 . . . . 0.0 111.349 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.613 ' CE1' ' HB ' ' A' ' 124' ' ' ILE . 44.0 p90 -117.48 156.74 27.48 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.675 HG22 ' HE1' ' A' ' 121' ' ' TYR . 0.7 OUTLIER -74.19 -171.76 1.24 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.824 -1.172 . . . . 0.0 110.744 -178.31 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.726 HG13 ' HD2' ' A' ' 141' ' ' PRO . 71.2 t -154.53 143.12 14.59 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.32 -0.862 . . . . 0.0 109.41 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.726 ' HD2' HG13 ' A' ' 140' ' ' VAL . 35.5 Cg_endo -78.48 140.55 17.11 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.451 2.101 . . . . 0.0 110.2 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.94 38.29 3.2 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.7 t -105.15 -0.74 26.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -1.166 . . . . 0.0 109.694 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.57 162.65 32.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.117 -0.989 . . . . 0.0 109.527 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.578 ' O ' ' CE3' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -90.9 9.17 31.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.559 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.584 HG22 ' CB ' ' A' ' 111' ' ' SER . 71.7 p -119.72 158.78 25.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.887 . . . . 0.0 109.281 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.596 ' CB ' ' CD1' ' A' ' 124' ' ' ILE . . . -135.51 153.32 51.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.193 -0.942 . . . . 0.0 109.633 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.3 t -98.94 151.26 21.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.193 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.756 HG22 ' CE2' ' A' ' 126' ' ' TYR . 12.4 mm -133.05 111.36 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.198 -0.939 . . . . 0.0 109.399 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.581 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 12.1 m-80 -122.32 169.18 11.19 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.311 -0.868 . . . . 0.0 109.955 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 2.0 m120 76.12 20.23 1.68 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.959 . . . . 0.0 109.041 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.748 HG22 ' C ' ' A' ' 106' ' ' THR . 7.4 tt -76.7 149.45 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.441 -0.787 . . . . 0.0 109.643 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.47 ' HB2' ' OH ' ' A' ' 158' ' ' TYR . 4.2 mtpm? -103.7 117.44 59.83 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.959 . . . . 0.0 109.487 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.537 ' HA ' ' CB ' ' A' ' 184' ' ' THR . 35.3 Cg_endo -77.83 166.67 24.93 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.407 2.072 . . . . 0.0 110.481 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.694 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 74.07 59.43 3.96 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 162.92 130.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -1.147 . . . . 0.0 109.599 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.612 ' O ' HG23 ' A' ' 129' ' ' THR . 0.3 OUTLIER -47.22 161.72 0.07 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -141.78 176.58 8.8 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.773 -1.204 . . . . 0.0 110.44 -179.186 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.739 ' O ' HD13 ' A' ' 160' ' ' ILE . 0.6 OUTLIER -146.89 168.72 20.76 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 179.235 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.739 HD13 ' O ' ' A' ' 159' ' ' THR . 31.1 mm -147.47 120.5 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.668 -1.27 . . . . 0.0 109.707 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.733 HG23 ' CB ' ' A' ' 179' ' ' SER . 0.9 OUTLIER -126.89 163.7 23.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.244 -0.91 . . . . 0.0 109.119 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.944 HD23 HD13 ' A' ' 98' ' ' LEU . 2.5 pp -160.86 146.32 14.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.867 -1.146 . . . . 0.0 110.988 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.595 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 1.9 m-85 -115.71 90.7 3.4 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.18 135.37 56.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.933 -1.104 . . . . 0.0 109.437 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 1.076 HG21 ' CZ ' ' A' ' 121' ' ' TYR . 48.2 t -107.56 124.65 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 109.576 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.698 HG22 ' HA ' ' A' ' 119' ' ' VAL . 0.7 OUTLIER -135.1 -38.22 0.78 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.665 -0.647 . . . . 0.0 109.744 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 166' ' ' THR . . . -37.91 139.12 0.58 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.531 ' HG2' ' NH2' ' A' ' 120' ' ' ARG . 1.4 mtp180 -150.17 16.38 0.84 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.335 -1.097 . . . . 0.0 109.572 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -82.15 -110.44 0.42 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.496 ' O ' ' CB ' ' A' ' 171' ' ' SER . 9.2 p-10 -89.34 21.06 3.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -1.137 . . . . 0.0 109.312 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 0.8 OUTLIER 162.97 139.15 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.349 -0.844 . . . . 0.0 109.175 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.66 96.6 1.1 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.502 2.135 . . . . 0.0 110.471 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -85.63 -166.53 1.55 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 109.432 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 175' ' ' SER . 5.0 p -155.14 126.97 7.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.227 -0.921 . . . . 0.0 109.536 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.499 ' HB2' HG13 ' A' ' 94' ' ' ILE . 85.8 p -54.35 -168.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 109.439 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.974 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.8 OUTLIER -73.47 151.91 89.67 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.942 . . . . 0.0 108.89 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.595 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 35.9 Cg_endo -79.24 118.92 4.08 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.427 2.085 . . . . 0.0 111.433 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.615 HG23 ' CG2' ' A' ' 94' ' ' ILE . 2.7 t -84.79 127.71 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.733 ' CB ' HG23 ' A' ' 161' ' ' THR . 0.0 OUTLIER -124.52 129.31 50.38 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.21 -0.932 . . . . 0.0 110.586 -178.779 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 1.025 ' CG2' HD23 ' A' ' 98' ' ' LEU . 40.3 pt -114.78 -162.79 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.474 ' OD1' ' N ' ' A' ' 181' ' ' ASN . 1.1 m120 -124.5 156.81 36.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.047 -1.033 . . . . 0.0 109.758 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.82 ' OH ' HD22 ' A' ' 108' ' ' LEU . 64.9 t80 -153.19 170.55 20.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.312 -0.868 . . . . 0.0 109.164 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.412 ' N ' ' CG ' ' A' ' 182' ' ' TYR . 19.2 mtpt -139.18 134.21 32.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 109.448 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.593 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 2.9 p . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.467 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.522 ' CD1' ' O ' ' A' ' 80' ' ' GLU . 1.3 mp -134.17 -162.87 1.29 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.234 -1.157 . . . . 0.0 109.534 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 26' ' ' ARG . 1.1 m-20 -100.75 152.79 20.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 0.0 109.511 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -95.08 125.89 48.77 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.496 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.533 ' O ' ' CD2' ' A' ' 84' ' ' LEU . 36.2 Cg_endo -78.67 81.95 2.62 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.464 2.11 . . . . 0.0 110.322 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.544 ' HA ' ' CD2' ' A' ' 84' ' ' LEU . 2.7 p -74.68 -109.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.163 -0.96 . . . . 0.0 109.666 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 45.71 26.72 1.92 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.558 ' CE2' ' HA3' ' A' ' 86' ' ' GLY . 14.1 t80 -56.14 128.03 33.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.544 -0.974 . . . . 0.0 110.094 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.504 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 0.8 OUTLIER -147.75 -179.28 6.77 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.504 ' HB2' HD11 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -155.42 117.86 4.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.104 -0.997 . . . . 0.0 110.062 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.5 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 0.8 OUTLIER -145.73 -167.65 2.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.059 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.545 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 4.6 m-20 42.23 38.49 1.16 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.019 HG22 HG23 ' A' ' 91' ' ' VAL . 2.5 mt -80.45 149.84 5.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.775 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -140.48 169.15 18.2 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.446 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.783 ' HB3' HG11 ' A' ' 117' ' ' VAL . . . -65.43 -62.61 1.43 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.71 -1.244 . . . . 0.0 110.159 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 1.4 m120 -91.37 27.86 1.83 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.116 -0.99 . . . . 0.0 109.511 -179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 14' ' ' THR . 56.7 p 179.48 154.72 0.5 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.049 ' CE1' HG22 ' A' ' 20' ' ' VAL . 3.5 p90 -166.83 144.18 4.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.13 -0.981 . . . . 0.0 109.279 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 28.9 m -85.95 148.18 25.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.637 -1.289 . . . . 0.0 110.369 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.049 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.3 t -118.16 171.62 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.536 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 49.8 m-70 -151.76 165.02 35.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.004 -1.06 . . . . 0.0 110.006 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.819 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 42.6 p90 -171.98 145.42 1.84 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.442 -0.786 . . . . 0.0 109.152 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.521 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.51 169.21 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.054 -1.029 . . . . 0.0 109.189 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.52 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -98.65 161.05 26.41 Favored Pre-proline 0 C--N 1.298 -1.643 0 O-C-N 121.54 -0.725 . . . . 0.0 109.819 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.505 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.8 Cg_endo -78.79 159.78 27.85 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.687 2.258 . . . . 0.0 110.397 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.466 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 5.1 mmm180 -90.28 17.07 7.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.222 -0.924 . . . . 0.0 109.408 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.969 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -121.04 177.13 1.57 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 109.374 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.969 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.4 Cg_endo -77.83 140.03 18.09 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.52 2.147 . . . . 0.0 110.333 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.636 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 28.7 pt -153.86 -173.47 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.526 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 17.1 p -133.95 3.31 3.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 109.579 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.57 -172.19 30.34 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.636 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -144.25 127.95 17.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.237 -1.155 . . . . 0.0 109.668 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.874 HG23 ' CD ' ' A' ' 49' ' ' ARG . 1.6 mp -80.74 130.84 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.274 -0.891 . . . . 0.0 108.772 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.753 HD13 ' C ' ' A' ' 33' ' ' ILE . 2.5 mm -107.54 112.34 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.166 -0.959 . . . . 0.0 109.966 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.551 ' CG ' ' HG2' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -104.55 116.77 32.65 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.137 -0.977 . . . . 0.0 108.582 179.098 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -105.95 144.36 32.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.085 -1.01 . . . . 0.0 109.797 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.587 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 41.6 p-80 -169.5 114.47 0.54 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.586 -0.696 . . . . 0.0 109.91 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.924 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . -61.37 175.21 0.6 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.42 -0.8 . . . . 0.0 109.609 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -54.86 -68.74 0.16 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.909 . . . . 0.0 109.323 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -165.25 50.06 0.1 Allowed 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.745 -0.597 . . . . 0.0 109.514 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.421 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 2.6 p -127.46 8.56 6.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.577 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.608 HG23 ' HB3' ' A' ' 38' ' ' ALA . 2.1 t -123.03 149.68 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.172 -0.955 . . . . 0.0 109.518 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -53.46 -88.63 0.01 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -117.22 146.26 37.79 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.292 -1.123 . . . . 0.0 109.421 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.561 ' HB3' ' CB ' ' A' ' 37' ' ' HIS . 36.2 Cg_endo -78.39 144.16 20.12 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.61 2.207 . . . . 0.0 110.534 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.51 ' CZ ' ' CB ' ' A' ' 46' ' ' ARG . 2.8 ptm85 -107.6 176.97 4.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 109.52 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.551 ' HG2' ' CG ' ' A' ' 35' ' ' ARG . 30.1 mt-30 -139.18 119.58 13.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.276 -0.89 . . . . 0.0 109.701 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.868 ' HB3' HD11 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -111.58 118.22 35.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.358 -0.839 . . . . 0.0 108.822 179.503 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.874 ' CD ' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -92.99 140.31 29.6 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.013 -1.054 . . . . 0.0 109.546 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.666 ' CG2' HD11 ' A' ' 34' ' ' ILE . 1.8 m -117.58 163.16 25.15 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.277 -0.89 . . . . 0.0 109.555 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.497 ' HG2' ' HG3' ' A' ' 54' ' ' ARG . 34.5 Cg_endo -76.98 174.84 12.2 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.634 2.222 . . . . 0.0 110.486 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.61 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.9 Cg_endo -76.73 -15.8 16.84 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.562 2.175 . . . . 0.0 110.316 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.6 m -103.26 25.71 9.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.277 -0.889 . . . . 0.0 109.16 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.497 ' HG3' ' HG2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -127.14 126.22 42.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.37 -0.831 . . . . 0.0 109.509 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 25.2 p-10 -111.82 5.43 19.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.884 . . . . 0.0 109.528 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.516 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 89.3 p -146.12 150.05 35.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 0.0 109.313 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.868 HD11 ' HB3' ' A' ' 48' ' ' ASP . 4.2 tt -138.21 125.16 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -0.94 . . . . 0.0 109.586 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 0.3 OUTLIER -84.83 107.64 17.1 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.351 -0.843 . . . . 0.0 109.496 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.666 ' HB3' HD11 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -84.82 149.61 25.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.94 . . . . 0.0 109.259 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.485 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 6.3 p -134.61 166.15 23.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.139 -0.976 . . . . 0.0 109.703 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 60' ' ' THR . 3.7 m120 61.04 61.06 1.68 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.283 -0.886 . . . . 0.0 109.655 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.666 HD11 ' HB3' ' A' ' 59' ' ' LEU . 1.7 mt -132.92 138.18 46.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.352 -0.842 . . . . 0.0 109.166 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.576 ' HB3' ' HB1' ' A' ' 173' ' ' ALA . 3.0 m-20 -44.56 133.3 4.78 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.12 -0.988 . . . . 0.0 108.797 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.508 ' HG2' ' OD2' ' A' ' 93' ' ' ASP . 35.9 Cg_endo -77.74 135.22 14.17 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.333 2.022 . . . . 0.0 111.373 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 71.36 64.91 2.59 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.6 m -158.44 151.57 22.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.251 -1.146 . . . . 0.0 110.889 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 1.7 tt0 -84.43 133.95 34.48 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.924 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 28.0 m-85 -119.81 130.98 55.18 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.882 -1.136 . . . . 0.0 110.856 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.709 HG12 ' CG2' ' A' ' 85' ' ' ILE . 3.4 t -85.56 97.49 5.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.535 HG23 ' NE2' ' A' ' 88' ' ' GLN . 3.1 t -94.06 125.48 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.291 -0.88 . . . . 0.0 109.759 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.527 ' CB ' HG12 ' A' ' 85' ' ' ILE . 1.3 p -96.74 138.62 34.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 109.72 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.56 ' CD1' HG23 ' A' ' 34' ' ' ILE . 17.8 mm -114.45 77.35 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.332 -0.855 . . . . 0.0 109.27 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.555 HG22 ' N ' ' A' ' 74' ' ' ALA . 24.5 mt -75.04 163.71 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 109.46 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.845 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -121.89 160.2 25.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 0.0 109.583 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.446 ' O ' ' OG1' ' A' ' 30' ' ' THR . 0.4 OUTLIER -145.11 131.9 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -0.923 . . . . 0.0 109.318 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -116.63 50.47 1.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.278 -0.889 . . . . 0.0 109.395 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.05 -90.24 1.34 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -114.53 0.77 14.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -1.129 . . . . 0.0 109.638 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 0.8 OUTLIER -96.44 -164.54 1.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.136 -0.978 . . . . 0.0 109.262 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.522 ' O ' ' CD1' ' A' ' 2' ' ' LEU . 23.2 mt-10 -147.58 -169.56 3.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.171 -0.956 . . . . 0.0 109.571 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.845 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.6 OUTLIER -155.33 -177.41 0.73 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.371 -0.831 . . . . 0.0 109.062 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.598 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.1 Cg_endo -77.85 131.03 10.88 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.162 1.908 . . . . 0.0 109.963 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.467 ' HB3' HG12 ' A' ' 73' ' ' ILE . 36.0 Cg_endo -77.8 86.87 1.58 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.524 2.149 . . . . 0.0 111.179 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -75.26 131.28 40.25 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.096 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.709 ' CG2' HG12 ' A' ' 69' ' ' VAL . 3.8 mt -117.54 150.65 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.011 -1.055 . . . . 0.0 110.346 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.558 ' HA3' ' CE2' ' A' ' 8' ' ' PHE . . . -132.58 176.97 19.15 Favored Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.074 -2.011 . . . . 0.0 108.074 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -142.66 111.9 6.59 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.101 -1.234 . . . . 0.0 110.344 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.591 ' HG3' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -113.24 -158.82 0.66 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.014 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -148.07 130.06 15.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.716 -1.24 . . . . 0.0 110.525 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.508 ' OG1' ' CE2' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -74.45 134.83 42.32 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.019 HG23 HG22 ' A' ' 13' ' ' ILE . 7.5 t -44.32 167.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.555 ' CB ' ' HD3' ' A' ' 176' ' ' LYS . 16.1 p -97.53 107.39 19.88 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 109.093 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.522 ' O ' ' HG3' ' A' ' 115' ' ' PRO . 1.0 OUTLIER -59.62 -12.25 6.41 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.162 -0.961 . . . . 0.0 109.19 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 1.044 HD12 ' O ' ' A' ' 176' ' ' LYS . 0.4 OUTLIER -60.88 138.44 93.76 Favored Pre-proline 0 N--CA 1.483 1.201 0 O-C-N 120.936 -1.103 . . . . 0.0 108.525 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.551 ' HD2' HG23 ' A' ' 94' ' ' ILE . 36.7 Cg_endo -82.58 137.82 9.26 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.502 2.135 . . . . 0.0 110.267 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.476 ' O ' ' N ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -86.53 -168.27 2.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.155 -0.966 . . . . 0.0 109.511 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 111' ' ' SER . 11.5 t0 71.78 33.09 1.8 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 109.702 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.964 HD13 ' CD2' ' A' ' 162' ' ' LEU . 31.5 tp -71.95 92.77 1.3 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.912 . . . . 0.0 109.396 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -133.28 157.88 44.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -0.926 . . . . 0.0 109.668 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 9.5 p -96.96 141.77 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.81 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.865 HD11 ' CD2' ' A' ' 109' ' ' LEU . 12.1 pt -123.59 -8.55 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.532 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.617 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -147.12 112.83 5.69 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.488 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 12.9 m -112.72 96.44 5.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.136 -0.977 . . . . 0.0 110.599 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -83.11 165.92 38.3 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.243 -0.91 . . . . 0.0 108.653 178.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.464 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 30.0 Cg_endo -69.44 -3.83 12.58 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.275 1.984 . . . . 0.0 110.478 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.69 ' C ' HG22 ' A' ' 152' ' ' ILE . 4.9 p -149.08 16.67 0.95 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.396 -0.815 . . . . 0.0 108.94 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . 1.044 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.7 OUTLIER -169.92 165.46 9.59 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.071 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.044 HD23 ' O ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -145.65 155.69 43.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.358 -0.839 . . . . 0.0 109.259 -179.706 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.865 ' CD2' HD11 ' A' ' 101' ' ' ILE . 21.1 tp -105.42 136.52 44.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.284 -0.885 . . . . 0.0 108.94 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.781 ' CD1' ' HB3' ' A' ' 147' ' ' ALA . 1.2 pt -124.82 140.72 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.055 -1.028 . . . . 0.0 110.369 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 97' ' ' ASP . 7.5 t -134.46 145.19 48.61 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.602 ' CH2' ' N ' ' A' ' 147' ' ' ALA . 11.9 p90 -134.56 -171.31 2.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.076 -1.015 . . . . 0.0 110.707 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 95' ' ' PRO . 4.4 mm-40 -119.58 169.52 8.18 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.591 -0.693 . . . . 0.0 109.668 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 113' ' ' GLU . 32.4 Cg_endo -76.04 119.95 5.55 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.817 2.345 . . . . 0.0 110.743 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.522 ' HG3' ' O ' ' A' ' 93' ' ' ASP . 35.7 Cg_endo -80.36 -158.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.97 2.446 . . . . 0.0 111.732 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.708 ' HB2' HG11 ' A' ' 91' ' ' VAL . . . -69.12 -5.4 22.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.5 -0.75 . . . . 0.0 109.927 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.783 HG11 ' HB3' ' A' ' 15' ' ' ALA . 2.4 m -155.84 -167.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.099 -1.001 . . . . 0.0 110.289 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.494 ' O ' HG23 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -89.44 -158.85 0.53 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.508 -0.745 . . . . 0.0 109.099 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.512 ' HA ' ' CG2' ' A' ' 166' ' ' THR . 2.1 t -154.94 131.37 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -0.941 . . . . 0.0 109.909 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.46 ' HB2' ' HA ' ' A' ' 166' ' ' THR . 12.6 ttt180 -78.08 -44.27 26.77 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.893 ' CE1' HG22 ' A' ' 139' ' ' THR . 0.8 OUTLIER -165.3 157.59 15.44 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.5 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.493 ' CE2' HG11 ' A' ' 119' ' ' VAL . 2.7 m-85 -111.76 147.89 34.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.965 -1.084 . . . . 0.0 109.83 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.582 ' O ' ' CD1' ' A' ' 163' ' ' TYR . 21.4 ttm180 -120.42 84.22 2.19 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.633 HG12 ' HB2' ' A' ' 162' ' ' LEU . 7.6 mt -84.42 168.72 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 110.274 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.511 ' N ' HG22 ' A' ' 124' ' ' ILE . 1.5 p -144.37 156.08 44.07 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.61 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.699 ' CE2' HG22 ' A' ' 149' ' ' ILE . 3.5 m-85 -91.24 137.43 32.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.519 -0.738 . . . . 0.0 109.034 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.615 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -102.69 111.52 4.02 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.474 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 5.8 mt-10 -107.92 75.11 0.98 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.134 -1.215 . . . . 0.0 109.311 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.95 141.62 57.91 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.052 -1.03 . . . . 0.0 109.644 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 152.28 -32.82 0.86 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -120.98 -103.69 1.9 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -102.33 -72.76 0.68 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -1.107 . . . . 0.0 109.414 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.546 ' N ' ' HD3' ' A' ' 134' ' ' PRO . 1.8 t -175.44 59.89 0.2 Allowed Pre-proline 0 C--N 1.294 -1.823 0 O-C-N 121.726 -0.609 . . . . 0.0 109.724 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.546 ' HD3' ' N ' ' A' ' 133' ' ' SER . 35.9 Cg_endo -77.61 112.72 3.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.582 2.188 . . . . 0.0 110.228 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -122.3 147.0 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.133 -0.979 . . . . 0.0 109.698 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' A' ' 125' ' ' THR . 1.2 tt0 -111.95 90.81 3.44 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.498 ' HA ' HG22 ' A' ' 125' ' ' THR . 0.5 OUTLIER -74.72 133.18 42.07 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.346 -0.846 . . . . 0.0 110.89 -178.679 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.652 ' CZ ' HD13 ' A' ' 149' ' ' ILE . 43.6 p90 -134.69 145.19 48.28 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.893 HG22 ' CE1' ' A' ' 121' ' ' TYR . 1.2 p -74.05 -175.71 2.29 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.943 -1.098 . . . . 0.0 110.791 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.744 HG13 ' HD2' ' A' ' 141' ' ' PRO . 72.0 t -157.21 144.03 13.38 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.446 -0.784 . . . . 0.0 109.297 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.744 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.0 Cg_endo -76.17 140.89 22.81 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.379 2.052 . . . . 0.0 110.361 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -88.58 35.62 3.58 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.424 ' C ' ' HD3' ' A' ' 144' ' ' LYS . 0.3 OUTLIER -105.27 -22.01 13.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.096 -1.237 . . . . 0.0 109.463 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.424 ' HD3' ' C ' ' A' ' 143' ' ' SER . 2.3 mptt -116.44 150.77 37.29 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.522 -0.736 . . . . 0.0 110.03 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.56 4.01 50.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.351 -0.843 . . . . 0.0 109.108 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.543 ' C ' ' CH2' ' A' ' 112' ' ' TRP . 1.6 p -130.2 151.94 50.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.389 -0.819 . . . . 0.0 108.827 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.781 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -116.76 153.41 32.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.029 -1.045 . . . . 0.0 109.969 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.8 t -104.66 154.19 20.28 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.365 -0.834 . . . . 0.0 109.1 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.699 HG22 ' CE2' ' A' ' 126' ' ' TYR . 9.4 mm -134.75 114.25 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.482 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.58 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 3.2 m120 -122.28 170.95 9.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.287 -0.883 . . . . 0.0 109.984 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.435 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 4.3 m120 70.57 28.19 3.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 0.0 109.115 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.69 HG22 ' C ' ' A' ' 106' ' ' THR . 5.1 tt -84.56 147.13 5.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.393 -0.817 . . . . 0.0 109.713 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.468 ' HB2' ' OH ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -93.22 111.3 51.28 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.345 -0.847 . . . . 0.0 109.19 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.504 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 35.8 Cg_endo -77.29 141.51 20.5 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.319 2.013 . . . . 0.0 110.451 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.693 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 90.41 64.59 1.22 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.693 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 163.49 134.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -1.154 . . . . 0.0 109.491 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 6.9 t0 -49.31 151.62 1.43 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.645 ' CD1' HG21 ' A' ' 184' ' ' THR . 0.2 OUTLIER -135.29 178.66 6.86 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.847 -1.158 . . . . 0.0 110.246 -179.285 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.589 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 3.4 m -150.06 107.7 3.67 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.963 HD11 HD12 ' A' ' 108' ' ' LEU . 9.0 mt -94.39 130.08 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.617 -1.302 . . . . 0.0 109.966 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 179' ' ' SER . 1.8 m -132.15 113.67 13.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.356 -0.84 . . . . 0.0 109.265 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.964 ' CD2' HD13 ' A' ' 98' ' ' LEU . 2.1 pp -99.18 127.16 45.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.29 -0.881 . . . . 0.0 110.164 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.677 ' HA ' HD11 ' A' ' 94' ' ' ILE . 4.2 m-85 -100.39 171.94 7.45 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.791 ' HB3' HG12 ' A' ' 94' ' ' ILE . . . -148.92 135.24 19.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.138 -0.976 . . . . 0.0 109.628 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 173' ' ' ALA . 97.0 t -131.02 162.18 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 109.399 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.535 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.8 OUTLIER -139.43 -40.06 0.47 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.325 -0.859 . . . . 0.0 109.409 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 166' ' ' THR . . . -53.2 -170.17 0.03 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.4 -147.98 0.39 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -1.148 . . . . 0.0 109.597 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -74.46 -27.07 66.31 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -74.87 -0.82 19.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.257 -1.143 . . . . 0.0 109.619 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.483 ' N ' ' HD3' ' A' ' 172' ' ' PRO . 3.0 m 177.33 63.97 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 108.989 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.483 ' HD3' ' N ' ' A' ' 171' ' ' SER . 34.8 Cg_endo -77.54 79.14 3.28 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.656 2.237 . . . . 0.0 110.885 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.762 ' O ' HG13 ' A' ' 165' ' ' VAL . . . -95.91 -165.96 1.36 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.313 -0.867 . . . . 0.0 108.806 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.558 ' HA ' HG22 ' A' ' 165' ' ' VAL . 0.7 OUTLIER -151.73 177.53 10.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.928 -1.107 . . . . 0.0 110.062 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.646 ' CB ' HG13 ' A' ' 94' ' ' ILE . 0.6 OUTLIER -115.66 159.89 20.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.667 -0.646 . . . . 0.0 109.561 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 1.044 ' O ' HD12 ' A' ' 94' ' ' ILE . 1.7 ptmt -42.36 118.69 2.2 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.171 -0.955 . . . . 0.0 110.45 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.626 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 29.7 Cg_endo -70.96 122.1 8.48 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.368 2.045 . . . . 0.0 111.199 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.839 HG23 HG21 ' A' ' 94' ' ' ILE . 57.4 t -84.77 118.79 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 161' ' ' THR . 0.0 OUTLIER -109.9 126.52 53.95 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.132 -0.98 . . . . 0.0 110.551 -178.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.931 HG23 HD23 ' A' ' 98' ' ' LEU . 32.1 pt -117.55 151.16 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -79.5 163.33 24.8 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.006 -1.059 . . . . 0.0 109.8 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.792 ' OH ' HD22 ' A' ' 108' ' ' LEU . 46.2 t80 -159.19 114.98 2.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.437 -0.789 . . . . 0.0 109.122 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -87.14 116.87 25.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.113 -0.992 . . . . 0.0 109.447 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.645 HG21 ' CD1' ' A' ' 158' ' ' TYR . 9.2 p . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.481 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.673 HD12 ' HB3' ' A' ' 25' ' ' PRO . 0.5 OUTLIER -140.54 -163.7 1.58 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -1.164 . . . . 0.0 109.449 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.441 ' CG ' ' HB2' ' A' ' 26' ' ' ARG . 1.5 m-20 -81.04 161.53 24.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.235 -0.916 . . . . 0.0 109.459 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.1 t -95.2 112.01 57.0 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.513 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.49 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 35.1 Cg_endo -77.25 78.78 3.35 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.34 2.027 . . . . 0.0 110.134 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.822 ' HA ' HD22 ' A' ' 84' ' ' LEU . 0.9 OUTLIER -87.48 -104.6 0.07 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.238 -0.913 . . . . 0.0 109.565 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 9' ' ' ASP . . . 44.2 27.03 1.03 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.402 ' N ' ' C ' ' A' ' 6' ' ' THR . 12.7 t80 -49.06 93.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.44 -1.035 . . . . 0.0 109.688 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 7' ' ' GLY . 9.8 t0 -121.3 84.07 2.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.366 -0.833 . . . . 0.0 108.994 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 83.1 p -84.43 131.79 34.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.495 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.479 ' O ' ' HB ' ' A' ' 19' ' ' THR . 76.7 p -156.01 -156.36 0.63 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.336 -0.853 . . . . 0.0 109.537 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.55 ' HB2' ' CB ' ' A' ' 19' ' ' THR . 0.6 OUTLIER 45.0 34.59 1.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -178.537 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.851 HD13 ' HB2' ' A' ' 18' ' ' PHE . 13.6 mm -62.13 134.25 27.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.749 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.571 ' CB ' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -123.0 178.24 5.15 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 177.149 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.596 ' N ' HG12 ' A' ' 117' ' ' VAL . . . -74.07 -74.73 0.18 Allowed 'General case' 0 C--N 1.292 -1.902 0 O-C-N 120.605 -1.309 . . . . 0.0 109.155 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.6 OUTLIER -75.68 -1.35 24.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.159 -0.963 . . . . 0.0 109.338 179.731 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.946 ' HB3' HG22 ' A' ' 60' ' ' THR . 14.4 p -146.54 162.08 39.11 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.281 -0.887 . . . . 0.0 109.096 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.023 ' CE1' HG22 ' A' ' 20' ' ' VAL . 4.9 p90 -167.38 137.72 2.92 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.907 -1.121 . . . . 0.0 108.419 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.55 ' CB ' ' HB2' ' A' ' 12' ' ' ASP . 11.9 m -80.99 150.01 29.08 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.77 -1.206 . . . . 0.0 111.172 -178.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.023 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -135.34 109.85 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.506 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 3.0 m-70 -102.01 166.31 10.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.032 -1.043 . . . . 0.0 110.509 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.67 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 38.9 p90 -175.71 147.72 0.83 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.49 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -74.51 159.27 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.966 -1.084 . . . . 0.0 110.083 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.75 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -100.79 168.97 8.46 Favored Pre-proline 0 C--N 1.299 -1.63 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.75 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.9 Cg_endo -78.61 -159.53 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.63 2.22 . . . . 0.0 110.196 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.441 ' HB2' ' CG ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -127.66 12.69 6.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.297 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.933 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -123.17 175.14 2.9 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 109.38 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.933 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.6 Cg_endo -78.24 112.05 3.15 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.586 2.19 . . . . 0.0 110.418 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.575 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 7.6 pt -116.0 -174.23 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.9 . . . . 0.0 109.388 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.5 p -114.88 2.87 14.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.567 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.528 ' HA2' ' N ' ' A' ' 52' ' ' PRO . . . 131.41 -173.04 20.59 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.63 ' CE1' ' HA ' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -134.26 145.3 48.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -1.111 . . . . 0.0 109.35 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.881 ' C ' HD13 ' A' ' 34' ' ' ILE . 1.8 mp -92.9 129.17 43.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.269 -0.895 . . . . 0.0 109.065 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.881 HD13 ' C ' ' A' ' 33' ' ' ILE . 1.7 mm -109.76 104.38 16.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.243 -0.91 . . . . 0.0 109.673 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.485 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 10.2 ttp85 -106.87 131.0 54.46 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.11 -0.994 . . . . 0.0 109.209 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 1.003 ' CD2' HD22 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -117.41 131.82 56.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.171 -0.956 . . . . 0.0 109.622 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.473 ' O ' ' N ' ' A' ' 69' ' ' VAL . 16.9 p80 -151.04 132.74 14.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.316 -0.865 . . . . 0.0 109.796 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.93 ' HB3' ' OG ' ' A' ' 41' ' ' SER . . . -53.22 -168.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.356 -0.84 . . . . 0.0 109.87 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.14 -99.06 0.16 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.047 -1.033 . . . . 0.0 110.4 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -74.31 -0.42 17.04 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.245 -0.909 . . . . 0.0 110.015 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.93 ' OG ' ' HB3' ' A' ' 38' ' ' ALA . 4.0 p -74.73 103.84 5.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.075 -1.016 . . . . 0.0 109.047 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 t -74.89 54.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.187 -0.946 . . . . 0.0 109.515 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' ' 45' ' ' PRO . . . -105.22 134.05 11.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -48.59 106.67 0.64 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.344 -1.091 . . . . 0.0 109.387 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 35.5 Cg_endo -77.53 160.23 31.9 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.417 2.078 . . . . 0.0 110.386 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.725 ' HD2' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -106.92 163.95 12.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.206 -0.934 . . . . 0.0 109.4 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 35' ' ' ARG . 1.1 pt20 -127.77 126.78 42.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 109.993 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.634 ' HB2' HD21 ' A' ' 59' ' ' LEU . 0.8 OUTLIER -117.5 118.11 31.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.357 -0.84 . . . . 0.0 108.831 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.87 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -92.73 153.63 18.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.033 -1.042 . . . . 0.0 110.034 -179.407 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.992 ' CG1' HD12 ' A' ' 57' ' ' ILE . 1.1 m -129.03 163.75 43.66 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.824 . . . . 0.0 109.297 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.535 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.8 Cg_endo -77.43 174.8 12.15 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.593 2.195 . . . . 0.0 110.419 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.63 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 35.1 Cg_endo -77.06 -15.64 16.26 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.622 2.215 . . . . 0.0 110.582 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.19 28.71 6.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.244 -0.91 . . . . 0.0 109.555 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.535 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -128.87 103.33 6.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.93 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.68 -12.23 37.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.185 -0.947 . . . . 0.0 109.104 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 56.1 p -135.7 130.35 34.09 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.992 HD12 ' CG1' ' A' ' 50' ' ' VAL . 3.4 tt -126.65 133.78 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.075 -1.015 . . . . 0.0 110.083 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.49 106.12 18.1 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.003 HD22 ' CD2' ' A' ' 36' ' ' HIS . 1.5 mt -84.62 148.56 26.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.155 -0.965 . . . . 0.0 109.566 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.946 HG22 ' HB3' ' A' ' 17' ' ' SER . 27.6 p -142.24 -179.61 6.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.341 -0.849 . . . . 0.0 109.435 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 60' ' ' THR . 17.5 m-80 60.93 16.3 6.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.255 -0.903 . . . . 0.0 109.365 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.981 HD11 ' HB3' ' A' ' 59' ' ' LEU . 0.9 OUTLIER -94.86 143.57 26.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 109.261 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.485 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 2.5 t-20 -45.71 116.01 3.06 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 34.6 Cg_endo -75.86 136.63 18.93 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.214 1.943 . . . . 0.0 111.043 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 74.93 63.69 2.49 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.539 HG21 ' CZ ' ' A' ' 68' ' ' TYR . 2.0 m -162.88 146.25 10.99 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.071 -1.253 . . . . 0.0 110.138 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.557 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 2.2 tp10 -74.79 128.23 35.07 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 20.4 m-85 -136.45 110.59 8.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.967 -1.083 . . . . 0.0 110.041 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.946 HG13 ' O ' ' A' ' 86' ' ' GLY . 93.4 t -71.02 141.63 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 35' ' ' ARG . 1.3 t -117.57 126.5 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.993 -1.067 . . . . 0.0 110.022 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.507 ' HB2' HG12 ' A' ' 85' ' ' ILE . 3.1 p -102.76 112.14 24.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -0.861 . . . . 0.0 109.735 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.793 ' C ' HD12 ' A' ' 73' ' ' ILE . 24.8 mm -94.41 111.29 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 0.0 109.528 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.793 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.4 mp -112.3 122.44 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.961 . . . . 0.0 109.34 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.017 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -98.03 122.05 40.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.238 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.414 HG13 HG22 ' A' ' 73' ' ' ILE . 13.0 m -132.79 141.04 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 109.7 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.458 ' CB ' ' HA ' ' A' ' 29' ' ' ILE . 30.8 t30 -110.91 44.71 1.24 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 109.363 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.11 -95.94 0.86 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.45 ' CD ' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -75.42 -0.35 19.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -1.123 . . . . 0.0 109.624 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 1.2 tt0 -116.88 171.88 7.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.58 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 30.3 mt-10 -149.84 96.46 2.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.437 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . 1.017 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -59.77 179.62 0.2 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.265 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.575 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.4 Cg_endo -77.48 154.87 31.76 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.355 2.037 . . . . 0.0 110.348 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.52 143.73 21.95 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.636 2.224 . . . . 0.0 110.761 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.822 HD22 ' HA ' ' A' ' 6' ' ' THR . 23.7 tp -138.74 92.96 2.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.44 -0.788 . . . . 0.0 108.923 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.507 HG12 ' HB2' ' A' ' 71' ' ' SER . 1.9 mt -99.33 153.16 4.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.134 -0.979 . . . . 0.0 110.075 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.946 ' O ' HG13 ' A' ' 69' ' ' VAL . . . -148.37 -166.84 13.13 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -125.8 138.17 53.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.163 -1.198 . . . . 0.0 109.603 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.624 ' NE2' ' CD2' ' A' ' 18' ' ' PHE . 11.7 tm0? -154.5 115.09 3.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.293 -0.88 . . . . 0.0 109.197 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.557 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -98.55 134.3 41.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.315 -0.866 . . . . 0.0 109.714 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.436 HG23 HE22 ' A' ' 88' ' ' GLN . 0.1 OUTLIER -74.24 162.67 28.69 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.131 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.701 HG11 ' HB3' ' A' ' 116' ' ' ALA . 0.2 OUTLIER -98.61 168.54 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.132 -0.98 . . . . 0.0 110.982 -178.718 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.531 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 17.0 p -79.62 110.26 14.78 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.53 ' HB2' ' CB ' ' A' ' 15' ' ' ALA . 2.0 t0 -68.48 -58.47 4.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.169 -0.957 . . . . 0.0 110.65 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.701 HD11 ' CB ' ' A' ' 176' ' ' LYS . 4.3 mt -80.12 140.56 53.46 Favored Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.15 -0.969 . . . . 0.0 110.305 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.649 ' CB ' ' CD1' ' A' ' 112' ' ' TRP . 34.6 Cg_endo -78.48 53.12 4.42 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.463 2.109 . . . . 0.0 109.487 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 112' ' ' TRP . 0.9 OUTLIER -49.96 -178.53 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.695 -0.628 . . . . 0.0 109.634 -179.502 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER 67.46 8.25 6.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.332 -0.855 . . . . 0.0 109.333 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.959 HD22 HD12 ' A' ' 162' ' ' LEU . 7.9 tp -57.27 90.21 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.221 -0.924 . . . . 0.0 108.923 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 97' ' ' ASP . 11.1 pt-20 -130.36 161.31 31.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.934 . . . . 0.0 109.523 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 10.7 p -95.76 144.27 10.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.29 -0.881 . . . . 0.0 109.638 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.52 ' N ' HD13 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -132.6 3.79 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.279 -0.888 . . . . 0.0 109.449 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.958 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -162.97 94.26 0.83 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.492 ' HB2' ' OH ' ' A' ' 182' ' ' TYR . 21.0 p -91.68 105.85 18.04 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.409 -0.807 . . . . 0.0 110.585 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.549 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -93.25 159.39 35.43 Favored Pre-proline 0 C--N 1.304 -1.373 0 O-C-N 121.371 -0.83 . . . . 0.0 108.889 178.886 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.413 ' O ' ' HG3' ' A' ' 154' ' ' PRO . 30.6 Cg_endo -70.22 -2.65 10.84 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.472 2.114 . . . . 0.0 110.455 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.833 ' C ' HG22 ' A' ' 152' ' ' ILE . 61.9 p -150.5 19.49 0.83 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.835 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -168.98 167.7 10.59 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.982 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.895 HD22 ' CE2' ' A' ' 182' ' ' TYR . 0.5 OUTLIER -140.37 151.77 45.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.335 -0.853 . . . . 0.0 109.224 -179.782 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.958 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -106.26 118.84 37.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.109 179.389 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.738 HD12 HD12 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -101.85 145.1 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.258 -0.901 . . . . 0.0 109.764 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.845 ' HA ' HG22 ' A' ' 146' ' ' THR . 0.4 OUTLIER -140.82 115.75 9.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.403 -0.811 . . . . 0.0 109.135 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.649 ' CD1' ' CB ' ' A' ' 95' ' ' PRO . 25.8 p90 -145.01 170.61 15.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.408 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.462 ' O ' ' HD3' ' A' ' 115' ' ' PRO . 4.8 mt-10 -71.06 139.98 85.47 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.15 -0.969 . . . . 0.0 109.495 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.515 ' HB3' ' CB ' ' A' ' 145' ' ' SER . 35.3 Cg_endo -78.41 111.24 2.99 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.507 2.138 . . . . 0.0 110.471 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.531 ' HB3' ' O ' ' A' ' 92' ' ' SER . 35.8 Cg_endo -78.84 99.16 1.24 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.334 2.023 . . . . 0.0 110.318 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.701 ' HB3' HG11 ' A' ' 91' ' ' VAL . . . -76.49 53.8 0.88 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.315 -0.865 . . . . 0.0 109.12 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.997 HG23 ' CG2' ' A' ' 119' ' ' VAL . 16.3 m -109.0 172.42 2.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.275 -0.891 . . . . 0.0 109.517 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.476 ' O ' ' HB ' ' A' ' 166' ' ' THR . 29.2 m -69.57 64.82 0.19 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.162 -0.961 . . . . 0.0 109.622 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.997 ' CG2' HG23 ' A' ' 117' ' ' VAL . 43.7 t -102.75 131.73 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.547 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.538 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -74.33 -42.71 58.97 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 1.051 ' CE2' HG22 ' A' ' 139' ' ' THR . 4.7 p90 -166.3 -174.91 3.06 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.562 -0.711 . . . . 0.0 109.385 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.593 ' N ' ' CD2' ' A' ' 121' ' ' TYR . 4.2 m-85 -130.42 139.43 50.6 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.598 ' HG2' ' CE2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -96.73 102.88 14.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.785 -1.197 . . . . 0.0 110.035 -179.017 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.723 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 6.4 mt -84.57 106.07 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.741 HG22 ' HB3' ' A' ' 137' ' ' GLU . 32.3 p -93.05 141.96 27.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 110.549 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 1.113 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 4.8 m-30 -94.66 136.77 34.58 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.603 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -105.09 108.94 3.16 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -107.26 136.78 46.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -1.151 . . . . 0.0 109.734 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.798 HG21 ' HB3' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -88.91 152.69 21.58 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.191 -0.943 . . . . 0.0 109.288 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 124.78 -38.23 2.39 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.33 7.6 60.7 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.454 ' O ' ' ND2' ' A' ' 132' ' ' ASN . 0.2 OUTLIER -96.84 23.97 6.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -1.153 . . . . 0.0 109.397 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.85 157.07 2.16 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.284 -0.885 . . . . 0.0 109.473 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.01 147.78 24.2 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.609 2.206 . . . . 0.0 110.334 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.453 HG22 ' H ' ' A' ' 135' ' ' VAL . 1.0 OUTLIER -54.85 170.89 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.288 -0.882 . . . . 0.0 109.585 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.59 ' O ' ' CG ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -123.41 100.85 7.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.34 -0.85 . . . . 0.0 108.958 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.741 ' HB3' HG22 ' A' ' 125' ' ' THR . 7.3 pt-20 -112.38 145.62 39.77 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.918 -1.114 . . . . 0.0 110.774 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.723 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 6.3 p90 -135.23 150.52 50.09 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . 1.051 HG22 ' CE2' ' A' ' 121' ' ' TYR . 2.0 p -74.61 142.69 44.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.988 -1.07 . . . . 0.0 111.106 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.571 HG21 HG13 ' A' ' 124' ' ' ILE . 2.0 t -110.61 146.24 33.94 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.558 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.5 Cg_endo -77.38 140.12 19.1 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.342 2.028 . . . . 0.0 109.761 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.401 ' HA2' ' CE1' ' A' ' 122' ' ' TYR . . . -83.08 13.63 43.44 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.451 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 7.6 t -105.25 23.59 13.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.034 -1.274 . . . . 0.0 109.855 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 143' ' ' SER . 1.6 mmtt -155.11 142.0 19.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.115 -0.991 . . . . 0.0 109.85 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.562 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -95.11 -8.74 35.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.349 -0.844 . . . . 0.0 109.404 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.845 HG22 ' HA ' ' A' ' 111' ' ' SER . 32.2 p -130.37 150.61 51.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.234 -0.916 . . . . 0.0 109.216 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.455 ' O ' HG12 ' A' ' 110' ' ' ILE . . . -145.89 -172.6 3.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.128 -0.982 . . . . 0.0 109.538 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 108' ' ' LEU . 51.8 m -144.95 134.94 23.81 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.217 -0.927 . . . . 0.0 109.577 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 1.113 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 1.0 OUTLIER -81.05 145.0 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.322 -0.861 . . . . 0.0 108.953 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.445 ' O ' ' C ' ' A' ' 151' ' ' ASN . 10.6 m-20 -130.49 169.56 15.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.332 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 150' ' ' ASN . 1.4 p-10 40.68 62.36 1.41 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.37 -0.831 . . . . 0.0 109.81 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.833 HG22 ' C ' ' A' ' 106' ' ' THR . 10.6 tt -106.95 165.77 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.301 -0.875 . . . . 0.0 109.334 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.5 ' N ' HG12 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -101.37 105.86 42.29 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.119 -0.988 . . . . 0.0 109.369 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.515 ' HA ' ' OG1' ' A' ' 184' ' ' THR . 35.6 Cg_endo -77.98 169.24 20.82 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.404 2.069 . . . . 0.0 110.456 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.697 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 70.17 60.69 4.66 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.697 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 164.48 131.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.318 -1.107 . . . . 0.0 109.628 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.798 ' HB3' HG21 ' A' ' 129' ' ' THR . 2.2 t0 -47.56 162.25 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.096 -1.003 . . . . 0.0 108.387 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.652 ' CD1' HG21 ' A' ' 184' ' ' THR . 0.3 OUTLIER -140.53 -174.57 4.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.888 -1.133 . . . . 0.0 110.211 -179.524 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.577 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 2.6 m -158.1 110.36 2.32 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.502 ' HB ' HG13 ' A' ' 180' ' ' ILE . 40.6 mm -94.27 141.73 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.839 -1.163 . . . . 0.0 110.567 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.99 HG23 ' CB ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -141.57 133.61 27.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.459 -0.776 . . . . 0.0 109.137 179.455 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.959 HD12 HD22 ' A' ' 98' ' ' LEU . 1.8 mt -112.55 135.19 53.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 0.0 110.564 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.616 ' CD1' ' HB3' ' A' ' 177' ' ' PRO . 22.0 m-85 -117.94 164.87 14.42 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.94 ' HB3' ' OG ' ' A' ' 175' ' ' SER . . . -142.88 88.59 2.06 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.015 -1.053 . . . . 0.0 109.406 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.458 ' HA ' ' HB3' ' A' ' 174' ' ' SER . 47.9 t -72.94 130.31 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.378 -0.826 . . . . 0.0 109.72 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.915 HG22 ' HA ' ' A' ' 119' ' ' VAL . 42.1 p -121.77 -67.79 0.94 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.427 -0.796 . . . . 0.0 109.387 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 172' ' ' PRO . . . -59.22 128.38 47.25 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.471 ' HG3' ' HG3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -147.67 15.24 1.1 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.273 -1.134 . . . . 0.0 109.532 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -126.35 -55.07 0.15 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.518 ' O ' ' CB ' ' A' ' 171' ' ' SER . 0.3 OUTLIER -99.29 1.05 44.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -1.133 . . . . 0.0 109.583 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 0.9 OUTLIER 163.49 138.08 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.252 -0.905 . . . . 0.0 109.296 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 167' ' ' GLY . 35.9 Cg_endo -78.21 102.02 1.53 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.499 2.133 . . . . 0.0 110.274 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -121.09 169.42 10.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.215 -0.928 . . . . 0.0 109.585 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 95.4 p -161.95 144.11 11.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.323 -0.861 . . . . 0.0 109.433 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.94 ' OG ' ' HB3' ' A' ' 164' ' ' ALA . 0.6 OUTLIER -54.65 -168.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.188 -0.945 . . . . 0.0 109.476 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.701 ' CB ' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -78.52 129.59 73.95 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.325 -0.859 . . . . 0.0 109.312 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.616 ' HB3' ' CD1' ' A' ' 163' ' ' TYR . 35.3 Cg_endo -77.53 127.14 8.72 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.07 1.847 . . . . 0.0 110.244 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.577 ' CG2' HG21 ' A' ' 94' ' ' ILE . 2.1 t -110.29 136.29 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.99 ' CB ' HG23 ' A' ' 161' ' ' THR . 4.7 t -119.62 165.47 14.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 110.476 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.502 HG13 ' HB ' ' A' ' 160' ' ' ILE . 11.8 pt -154.3 152.09 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -81.85 162.99 22.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.096 -1.003 . . . . 0.0 109.943 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.895 ' CE2' HD22 ' A' ' 108' ' ' LEU . 64.5 t80 -154.9 159.31 40.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.419 -0.801 . . . . 0.0 109.45 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.97 116.95 17.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.285 -0.884 . . . . 0.0 109.33 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.652 HG21 ' CD1' ' A' ' 158' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.521 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.544 HD11 ' HB3' ' A' ' 79' ' ' GLU . 72.5 mt -128.95 -162.85 1.23 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -1.157 . . . . 0.0 109.5 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 45.2 m-20 -156.11 125.49 6.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.572 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.559 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -95.26 178.3 1.51 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.0 109.309 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.839 ' C ' HD22 ' A' ' 84' ' ' LEU . 35.9 Cg_endo -78.9 164.03 25.5 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.593 2.195 . . . . 0.0 109.989 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 5' ' ' PRO . 4.0 p -162.08 174.63 12.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.068 -1.02 . . . . 0.0 109.711 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 44.54 27.16 1.2 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.585 ' C ' ' CD1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -72.29 -162.43 0.09 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.392 -1.064 . . . . 0.0 109.587 -179.766 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.76 -163.35 0.63 Allowed 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.112 -0.993 . . . . 0.0 109.592 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.532 ' CB ' ' HG2' ' A' ' 88' ' ' GLN . 0.3 OUTLIER -154.86 141.93 19.31 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.362 -0.836 . . . . 0.0 109.351 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.598 ' HG ' ' HE2' ' A' ' 21' ' ' HIS . 3.5 p -146.72 -163.29 1.72 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.304 -0.873 . . . . 0.0 109.498 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.533 ' HB2' ' CB ' ' A' ' 19' ' ' THR . 4.5 m-20 44.45 38.07 2.39 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.021 HG22 HG23 ' A' ' 91' ' ' VAL . 40.6 mm -70.1 125.7 28.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.587 0.708 . . . . 0.0 110.305 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.562 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -119.5 177.75 4.81 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.31 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -72.9 -69.59 0.4 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.722 -1.236 . . . . 0.0 109.457 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -83.06 8.6 12.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.973 -1.079 . . . . 0.0 109.414 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.785 ' HB2' HG22 ' A' ' 60' ' ' THR . 2.8 t -154.51 156.56 36.89 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.015 ' CE1' HG22 ' A' ' 20' ' ' VAL . 2.2 p90 -166.66 137.19 3.25 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.533 ' CB ' ' HB2' ' A' ' 12' ' ' ASP . 10.1 m -87.76 153.98 20.92 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.949 -1.095 . . . . 0.0 111.174 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 1.015 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -134.41 119.52 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.148 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.598 ' HE2' ' HG ' ' A' ' 11' ' ' SER . 20.1 m-70 -103.36 164.28 11.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.02 -1.05 . . . . 0.0 110.368 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.846 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 22.8 p90 -177.3 135.59 0.19 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.555 -0.715 . . . . 0.0 109.084 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.29 167.43 2.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.183 -0.948 . . . . 0.0 109.517 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -102.18 165.38 13.98 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.617 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 36.0 Cg_endo -78.23 -163.14 0.2 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.499 2.133 . . . . 0.0 110.299 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -120.59 28.33 8.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.925 . . . . 0.0 109.404 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.893 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -129.36 173.54 5.59 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 0.0 109.551 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.893 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 36.1 Cg_endo -78.4 130.44 10.0 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.615 2.21 . . . . 0.0 110.453 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.498 HD12 ' CE2' ' A' ' 32' ' ' TYR . 17.6 pt -135.98 169.93 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.918 . . . . 0.0 109.474 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.4 p -107.12 -19.95 13.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.476 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.08 -152.83 15.5 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.907 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 1.2 m-85 -162.08 123.23 2.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -1.123 . . . . 0.0 109.447 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.784 HD12 ' NE ' ' A' ' 49' ' ' ARG . 14.9 mm -85.41 122.65 38.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.189 -0.945 . . . . 0.0 109.624 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.077 HG23 ' CD1' ' A' ' 72' ' ' ILE . 2.6 mm -102.89 114.31 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.056 -1.028 . . . . 0.0 109.321 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.487 ' HG3' ' CG ' ' A' ' 47' ' ' GLN . 0.4 OUTLIER -105.58 144.86 31.75 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.103 -0.998 . . . . 0.0 108.912 179.361 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.804 ' HB3' HG13 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -143.53 140.14 30.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.056 -1.027 . . . . 0.0 110.032 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -176.17 144.39 0.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.32 -0.863 . . . . 0.0 109.665 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.93 ' HB3' ' CB ' ' A' ' 41' ' ' SER . . . -64.99 170.48 4.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 109.605 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -76.84 -27.45 55.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.33 -0.856 . . . . 0.0 109.453 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -120.01 10.9 11.6 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.93 ' CB ' ' HB3' ' A' ' 38' ' ' ALA . 20.6 p -106.41 93.46 4.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 109.668 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.708 HG12 ' O ' ' A' ' 42' ' ' VAL . 59.1 t -114.66 31.15 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.933 . . . . 0.0 109.114 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.54 ' C ' ' HD3' ' A' ' 45' ' ' PRO . . . -104.44 -42.16 1.92 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.563 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 45.9 mtm-85 -121.94 51.67 3.1 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.14 -1.212 . . . . 0.0 111.037 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.563 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 34.9 Cg_endo -75.3 121.98 6.79 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.052 1.835 . . . . 0.0 110.171 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.559 ' HD3' ' CE1' ' A' ' 36' ' ' HIS . 1.2 ptp85 -119.89 162.26 19.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.748 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.487 ' CG ' ' HG3' ' A' ' 35' ' ' ARG . 14.2 mp0 -126.91 118.1 23.89 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.312 -0.867 . . . . 0.0 109.568 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.628 ' OD2' HD23 ' A' ' 59' ' ' LEU . 65.8 m-20 -100.96 122.8 44.13 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.784 ' NE ' HD12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.18 140.53 32.35 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.031 -1.043 . . . . 0.0 109.493 -179.264 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.957 HG12 HD12 ' A' ' 57' ' ' ILE . 11.9 m -124.08 159.56 56.13 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.341 -0.849 . . . . 0.0 109.355 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.487 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 34.5 Cg_endo -77.14 174.37 12.92 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.581 2.187 . . . . 0.0 110.279 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.475 ' HB3' HG13 ' A' ' 29' ' ' ILE . 34.6 Cg_endo -76.96 -16.09 16.2 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.498 2.132 . . . . 0.0 110.486 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.7 t -100.85 27.86 5.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.351 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.464 ' HG3' ' HG2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -130.65 116.71 18.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.938 . . . . 0.0 109.677 -179.819 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -102.87 -6.01 22.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.394 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 62.7 p -139.2 130.84 27.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.357 -0.84 . . . . 0.0 109.018 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.957 HD12 HG12 ' A' ' 50' ' ' VAL . 5.4 tt -123.24 124.92 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.164 -0.96 . . . . 0.0 109.816 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.75 109.91 20.56 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.441 -0.787 . . . . 0.0 109.184 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.981 ' HB3' HD11 ' A' ' 62' ' ' LEU . 1.2 mp -84.83 158.65 20.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.164 -0.96 . . . . 0.0 109.778 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.785 HG22 ' HB2' ' A' ' 17' ' ' SER . 0.8 OUTLIER -150.86 175.29 12.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.654 -0.654 . . . . 0.0 109.332 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.499 ' O ' ' NH2' ' A' ' 46' ' ' ARG . 6.1 m120 52.57 37.8 24.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 0.0 109.496 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.981 HD11 ' HB3' ' A' ' 59' ' ' LEU . 5.2 mt -109.59 161.17 15.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 109.387 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -55.07 113.33 5.26 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 34.5 Cg_endo -74.19 123.64 8.43 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.984 1.79 . . . . 0.0 111.009 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 82.67 64.56 1.68 Allowed Glycine 0 N--CA 1.485 1.916 0 N-CA-C 108.186 -1.966 . . . . 0.0 108.186 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.0 m -152.27 118.9 5.69 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.126 -1.22 . . . . 0.0 110.821 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.559 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 11.6 tt0 -74.82 135.74 41.62 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.822 ' OH ' HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -153.44 176.54 11.9 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.79 -1.193 . . . . 0.0 111.076 -178.436 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.656 HG12 HG23 ' A' ' 85' ' ' ILE . 1.9 t -107.27 151.55 9.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.804 HG13 ' HB3' ' A' ' 36' ' ' HIS . 1.1 t -132.98 130.92 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.983 -1.073 . . . . 0.0 109.492 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.819 ' O ' HD13 ' A' ' 72' ' ' ILE . 10.5 p -108.44 156.43 19.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.254 -0.904 . . . . 0.0 110.484 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.077 ' CD1' HG23 ' A' ' 34' ' ' ILE . 28.4 mm -135.71 92.51 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.927 HD12 ' HB3' ' A' ' 83' ' ' PRO . 1.2 mm -83.71 140.85 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.106 -0.996 . . . . 0.0 109.928 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.907 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . . . -96.38 157.86 15.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 109.181 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.69 136.55 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 109.47 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 76' ' ' ASN . 12.6 t-20 -135.14 46.37 2.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 109.424 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.52 -91.57 0.84 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.51 1.36 13.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -1.167 . . . . 0.0 109.647 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.544 ' HB3' HD11 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -92.72 -171.66 2.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.97 . . . . 0.0 109.47 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 79' ' ' GLU . 4.9 mt-10 -171.16 91.49 0.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.487 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.593 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.6 OUTLIER -59.55 -179.18 0.15 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 108.987 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.593 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 31.4 Cg_endo -74.49 150.35 40.68 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.08 1.853 . . . . 0.0 110.348 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.927 ' HB3' HD12 ' A' ' 73' ' ' ILE . 36.1 Cg_endo -77.57 144.11 22.17 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.811 2.341 . . . . 0.0 111.62 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.839 HD22 ' C ' ' A' ' 5' ' ' PRO . 3.4 tp -109.7 93.65 4.61 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.656 HG23 HG12 ' A' ' 69' ' ' VAL . 3.3 mt -100.23 141.19 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.939 . . . . 0.0 110.15 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.54 ' O ' HG13 ' A' ' 69' ' ' VAL . . . -136.66 -165.06 10.38 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -129.94 140.0 51.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.985 -1.303 . . . . 0.0 109.77 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.532 ' HG2' ' CB ' ' A' ' 10' ' ' SER . 2.4 tp60 -154.29 -165.36 2.07 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.372 -0.83 . . . . 0.0 109.318 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.559 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.43 130.28 2.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.256 -0.903 . . . . 0.0 109.57 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.822 HG23 ' OH ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -73.16 138.35 45.66 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.281 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.021 HG23 HG22 ' A' ' 13' ' ' ILE . 2.3 t -56.94 -169.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 178.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.708 ' H ' HG12 ' A' ' 91' ' ' VAL . 20.9 t -133.35 176.69 8.3 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.196 -1.565 . . . . 0.0 110.925 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.535 ' HA ' HG21 ' A' ' 117' ' ' VAL . 0.5 OUTLIER -165.57 -46.05 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.82 HD11 ' HB2' ' A' ' 176' ' ' LYS . 8.1 mt -104.82 141.68 23.06 Favored Pre-proline 0 C--N 1.304 -1.38 0 O-C-N 121.485 -0.759 . . . . 0.0 109.102 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 1.12 ' CG ' HD11 ' A' ' 162' ' ' LEU . 35.7 Cg_endo -78.83 70.51 7.39 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.38 2.053 . . . . 0.0 109.891 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.576 ' CB ' ' CZ ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -65.9 -165.34 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.444 -0.785 . . . . 0.0 109.734 -179.648 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.41 ' CG ' ' HG3' ' A' ' 113' ' ' GLU . 0.2 OUTLIER 64.41 11.62 6.66 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.235 -0.915 . . . . 0.0 109.227 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.745 HD23 HG23 ' A' ' 180' ' ' ILE . 19.7 tp -59.25 92.77 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.281 -0.887 . . . . 0.0 109.213 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -126.5 160.53 30.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.264 -0.898 . . . . 0.0 109.335 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 8.5 p -104.64 138.47 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.402 -0.811 . . . . 0.0 109.818 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.796 ' CG1' HD23 ' A' ' 109' ' ' LEU . 8.7 pt -122.96 -11.23 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.389 -0.82 . . . . 0.0 109.407 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.807 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -134.73 82.12 1.94 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.526 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 6.4 m -85.81 95.4 9.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.816 . . . . 0.0 110.45 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.532 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -96.24 159.66 31.55 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 121.244 -0.91 . . . . 0.0 109.036 179.052 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.473 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.4 Cg_endo -70.47 -1.74 9.55 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.509 2.139 . . . . 0.0 110.738 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.817 ' C ' HG22 ' A' ' 152' ' ' ILE . 7.1 p -144.68 10.93 1.41 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 109.342 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.911 ' O ' HD23 ' A' ' 108' ' ' LEU . 3.2 p -169.01 166.6 11.02 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 118.907 -1.117 . . . . 0.0 109.767 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.011 HD22 ' CZ ' ' A' ' 182' ' ' TYR . 0.4 OUTLIER -141.75 150.77 42.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.137 -0.977 . . . . 0.0 109.091 -179.557 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.807 ' CB ' ' HB3' ' A' ' 102' ' ' ALA . 13.9 tp -106.26 116.33 31.74 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 108.824 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.96 ' CD1' ' HB3' ' A' ' 147' ' ' ALA . 3.2 pt -102.35 149.4 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.079 -1.013 . . . . 0.0 110.192 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.671 ' CB ' HG22 ' A' ' 146' ' ' THR . 5.1 t -153.1 125.18 7.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.516 -0.74 . . . . 0.0 109.382 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.578 ' CE2' ' O ' ' A' ' 145' ' ' SER . 3.1 p90 -124.21 -170.13 2.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.233 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.41 ' HG3' ' CG ' ' A' ' 97' ' ' ASP . 3.1 mt-10 -102.08 157.52 33.54 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.14 -0.975 . . . . 0.0 109.914 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.38 121.46 5.23 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.783 2.322 . . . . 0.0 110.164 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.582 ' HG2' HG21 ' A' ' 119' ' ' VAL . 35.8 Cg_endo -77.81 140.0 18.11 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.458 2.105 . . . . 0.0 110.881 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.95 -6.28 31.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.273 -0.892 . . . . 0.0 109.255 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.765 HG13 HG12 ' A' ' 91' ' ' VAL . 3.0 m -94.3 177.02 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.388 -0.82 . . . . 0.0 109.277 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.523 ' O ' ' CG2' ' A' ' 166' ' ' THR . 58.6 m -78.23 155.58 30.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 109.771 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 1.046 HG11 ' CZ ' ' A' ' 122' ' ' TYR . 19.5 t -144.69 129.68 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.362 -0.836 . . . . 0.0 109.566 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 166' ' ' THR . 2.8 tpm_? -95.01 -53.84 3.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.255 -0.903 . . . . 0.0 109.065 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.777 ' CE1' HG22 ' A' ' 139' ' ' THR . 1.6 p90 -165.36 151.15 9.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.371 -0.831 . . . . 0.0 108.995 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 1.046 ' CZ ' HG11 ' A' ' 119' ' ' VAL . 3.0 m-85 -106.11 115.35 30.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.98 -1.075 . . . . 0.0 109.56 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 5.5 ttm180 -84.62 98.81 10.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.11 -0.994 . . . . 0.0 109.017 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 1.034 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 55.2 mt -84.25 151.42 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 0.0 110.045 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 46.2 p -123.92 133.27 53.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.46 -0.775 . . . . 0.0 109.901 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 1.029 ' O ' HG12 ' A' ' 135' ' ' VAL . 4.9 m-85 -80.19 118.36 21.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.49 -0.756 . . . . 0.0 109.359 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 158' ' ' TYR . . . -91.94 105.74 3.32 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -107.47 96.61 6.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -1.126 . . . . 0.0 108.876 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -55.2 -80.59 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 O-C-N 120.948 -1.095 . . . . 0.0 109.544 -179.893 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -83.5 46.09 3.58 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -89.86 -77.36 1.32 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.521 ' O ' ' CB ' ' A' ' 133' ' ' SER . 5.3 t-20 -159.48 -44.31 0.05 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.211 -1.17 . . . . 0.0 109.769 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.565 ' N ' ' HD2' ' A' ' 134' ' ' PRO . 0.1 OUTLIER 162.01 -53.09 0.0 OUTLIER Pre-proline 0 C--N 1.297 -1.695 0 O-C-N 121.724 -0.61 . . . . 0.0 109.813 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 133' ' ' SER . 35.5 Cg_endo -77.44 160.34 32.14 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.517 2.145 . . . . 0.0 110.688 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 1.029 HG12 ' O ' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -108.98 170.92 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.362 -0.837 . . . . 0.0 109.25 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.545 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 2.6 mm100 -119.36 99.39 6.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.199 -0.938 . . . . 0.0 108.874 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 13.2 pt-20 -101.96 149.87 23.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -0.948 . . . . 0.0 110.743 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 1.034 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 34.1 p90 -143.07 145.75 33.17 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.777 HG22 ' CE1' ' A' ' 121' ' ' TYR . 3.0 p -75.01 149.69 39.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.99 -1.069 . . . . 0.0 110.589 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.657 HG13 ' HD2' ' A' ' 141' ' ' PRO . 53.7 t -112.31 141.6 25.4 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 121.762 -0.586 . . . . 0.0 109.443 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.657 ' HD2' HG13 ' A' ' 140' ' ' VAL . 35.6 Cg_endo -77.66 141.81 19.92 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.433 2.088 . . . . 0.0 110.307 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -88.03 23.0 15.68 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.42 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 1.9 m -104.42 -0.94 27.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -1.149 . . . . 0.0 109.576 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 143' ' ' SER . 15.2 mmtt -143.02 153.85 43.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 109.48 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.578 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 0.4 OUTLIER -93.35 -18.27 22.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 109.395 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.671 HG22 ' CB ' ' A' ' 111' ' ' SER . 66.1 p -107.77 152.79 23.89 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.199 -0.938 . . . . 0.0 108.941 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.96 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -130.96 148.17 52.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.064 -1.023 . . . . 0.0 109.635 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 8.2 t -91.08 147.42 23.09 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.184 -0.948 . . . . 0.0 109.347 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.689 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 13.9 mm -128.46 95.62 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.358 -0.839 . . . . 0.0 109.119 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.522 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 2.6 m-20 -104.54 -164.17 1.03 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.517 -0.74 . . . . 0.0 109.733 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.511 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 6.6 p-10 42.03 60.58 2.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.429 -0.794 . . . . 0.0 109.902 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.817 HG22 ' C ' ' A' ' 106' ' ' THR . 6.4 tt -116.52 155.28 18.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.269 -0.894 . . . . 0.0 109.568 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.07 117.19 67.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.753 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.473 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 35.9 Cg_endo -78.91 163.85 25.63 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.518 2.146 . . . . 0.0 110.562 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 61.8 51.47 57.07 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -177.37 130.45 0.16 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.223 -1.163 . . . . 0.0 109.699 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.486 ' O ' ' OG1' ' A' ' 129' ' ' THR . 1.1 t0 -51.62 165.93 0.15 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.597 ' CE2' HG13 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -144.98 172.68 12.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.881 -1.137 . . . . 0.0 110.255 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.553 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 1.8 m -145.7 96.74 2.86 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 179' ' ' SER . 51.5 mm -84.69 132.44 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.889 -1.132 . . . . 0.0 109.705 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.846 HG23 ' CB ' ' A' ' 179' ' ' SER . 1.1 m -142.26 165.33 27.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.309 -0.869 . . . . 0.0 109.24 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 1.12 HD11 ' CG ' ' A' ' 95' ' ' PRO . 1.3 pp -159.64 151.13 20.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.013 -1.054 . . . . 0.0 110.72 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.611 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 2.1 m-85 -122.03 90.45 3.31 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.434 ' HB2' ' HG3' ' A' ' 95' ' ' PRO . . . -54.0 117.47 3.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.864 -1.147 . . . . 0.0 109.039 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.58 HG12 ' N ' ' A' ' 166' ' ' THR . 22.2 t -102.76 168.57 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.892 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.58 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.8 OUTLIER -145.08 -40.41 0.24 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.332 -0.855 . . . . 0.0 109.548 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -99.97 138.93 14.15 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -146.72 88.57 1.77 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -1.121 . . . . 0.0 109.484 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -174.59 -81.9 0.05 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 2.4 m-20 -119.02 10.03 12.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.324 -1.104 . . . . 0.0 109.349 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 170' ' ' ASP . 75.5 m -168.63 81.27 0.75 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.275 -0.891 . . . . 0.0 109.552 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.86 98.83 1.23 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.643 2.228 . . . . 0.0 110.412 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -100.52 166.42 10.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.36 -0.838 . . . . 0.0 109.558 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 175' ' ' SER . 1.2 p -165.09 132.65 3.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.335 -0.853 . . . . 0.0 109.422 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.468 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 84.6 p -55.47 -166.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.168 -0.957 . . . . 0.0 109.21 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.82 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -74.59 145.78 82.58 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 108.829 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.611 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 34.9 Cg_endo -77.71 133.77 13.04 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.429 2.086 . . . . 0.0 111.019 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.64 HG23 HG21 ' A' ' 94' ' ' ILE . 2.2 t -105.82 134.47 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.846 ' CB ' HG23 ' A' ' 161' ' ' THR . 1.3 p -131.45 143.24 50.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 110.558 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.745 HG23 HD23 ' A' ' 98' ' ' LEU . 13.4 pt -129.89 152.44 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -82.57 168.71 17.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.082 -1.012 . . . . 0.0 109.7 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 1.011 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 44.2 t80 -165.21 124.32 1.75 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.323 -0.86 . . . . 0.0 109.415 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -95.19 112.13 23.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.009 -1.057 . . . . 0.0 109.443 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.433 ' HB ' ' HA ' ' A' ' 154' ' ' PRO . 28.9 p . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.524 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.775 HD11 ' CB ' ' A' ' 81' ' ' SER . 1.5 pp -161.71 143.74 11.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -1.144 . . . . 0.0 109.472 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.546 ' O ' HD12 ' A' ' 2' ' ' LEU . 21.7 m-20 -74.91 148.12 40.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.391 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.491 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 18.0 p -84.5 159.97 57.49 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.591 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.634 ' HD3' ' HB2' ' A' ' 74' ' ' ALA . 35.5 Cg_endo -78.27 96.77 1.1 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.715 2.277 . . . . 0.0 109.943 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.678 ' HA ' HD22 ' A' ' 84' ' ' LEU . 2.1 p -83.89 -111.65 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.166 -0.959 . . . . 0.0 109.79 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 22' ' ' TRP . . . 45.53 26.12 1.58 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.443 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 13.5 t80 -55.59 107.76 0.37 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.485 -1.009 . . . . 0.0 110.003 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 6.3 t70 -133.52 100.21 4.74 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.405 -0.809 . . . . 0.0 108.841 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.884 ' OG ' HG13 ' A' ' 20' ' ' VAL . 4.7 m -84.63 128.27 34.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.216 -0.928 . . . . 0.0 109.578 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 19' ' ' THR . 5.5 p -164.0 -157.06 0.37 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.316 -0.865 . . . . 0.0 109.402 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.534 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 2.5 m-20 47.33 38.01 6.71 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.638 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.5 mt -87.07 163.84 2.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.761 0.791 . . . . 0.0 111.427 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.587 ' N ' HG22 ' A' ' 13' ' ' ILE . 0.7 OUTLIER -155.27 -172.83 4.31 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.581 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -81.02 -44.14 18.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.931 -1.106 . . . . 0.0 109.484 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 17' ' ' SER . 1.5 m120 -114.6 39.75 2.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.991 -1.068 . . . . 0.0 109.037 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 14' ' ' THR . 5.8 p 168.55 145.5 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.638 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 2.0 p90 -164.97 145.38 7.3 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.108 -0.995 . . . . 0.0 108.827 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.611 HG22 ' N ' ' A' ' 20' ' ' VAL . 52.3 m -112.34 164.23 13.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.737 -1.227 . . . . 0.0 111.132 -178.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.884 HG13 ' OG ' ' A' ' 10' ' ' SER . 1.6 t -130.43 168.42 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.588 ' CD2' ' HB3' ' A' ' 56' ' ' SER . 19.2 m80 -144.35 161.88 37.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.936 -1.102 . . . . 0.0 110.104 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.601 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 10.0 p90 -168.18 142.19 3.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.434 -0.791 . . . . 0.0 109.171 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.85 166.02 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.04 -1.037 . . . . 0.0 109.435 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.659 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -94.01 165.57 17.5 Favored Pre-proline 0 C--N 1.3 -1.585 0 O-C-N 121.634 -0.666 . . . . 0.0 109.632 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.659 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.7 Cg_endo -78.27 178.12 7.95 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.606 2.204 . . . . 0.0 110.384 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.08 12.82 26.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 109.442 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.984 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -118.13 176.71 1.52 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.409 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.984 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 34.9 Cg_endo -77.7 118.05 4.42 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.538 2.159 . . . . 0.0 110.285 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.633 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 47.3 pt -131.47 179.99 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 109.614 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.7 p -120.71 -22.11 6.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.864 . . . . 0.0 109.458 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 167.97 174.68 37.08 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.633 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -124.42 133.73 53.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.248 -1.148 . . . . 0.0 109.391 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.871 ' O ' HD13 ' A' ' 34' ' ' ILE . 44.8 mm -74.95 144.42 12.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.187 -0.945 . . . . 0.0 109.251 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.871 HD13 ' O ' ' A' ' 33' ' ' ILE . 7.9 mm -124.57 93.15 2.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.21 -0.931 . . . . 0.0 110.058 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.454 ' HB2' ' OG ' ' A' ' 71' ' ' SER . 1.0 OUTLIER -104.17 128.53 51.86 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.812 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.886 ' CB ' HG22 ' A' ' 70' ' ' VAL . 54.5 p-80 -148.33 176.85 9.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.727 -1.233 . . . . 0.0 110.845 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.592 ' CG ' ' HB3' ' A' ' 45' ' ' PRO . 9.1 p-80 176.9 -173.37 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.035 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . -112.55 132.17 55.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.165 -0.959 . . . . 0.0 109.175 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.484 ' HG2' ' HB2' ' A' ' 67' ' ' GLU . 1.3 pt-20 -54.78 -18.55 4.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 0.0 109.556 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -104.74 14.17 30.15 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 109.469 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.726 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 60.3 p -99.91 -147.74 0.35 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.517 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.609 HG22 ' N ' ' A' ' 43' ' ' GLY . 11.2 p -74.92 167.56 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.187 -0.946 . . . . 0.0 109.563 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.609 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -54.58 -99.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.417 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 3.7 mmm180 -46.54 143.05 4.22 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.195 -1.179 . . . . 0.0 109.397 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.592 ' HB3' ' CG ' ' A' ' 37' ' ' HIS . 36.4 Cg_endo -79.39 171.55 15.82 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.571 2.181 . . . . 0.0 110.447 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.52 ' NE ' ' OD1' ' A' ' 48' ' ' ASP . 0.8 OUTLIER -84.38 159.59 20.82 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.197 -0.939 . . . . 0.0 108.986 179.49 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.454 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 47.0 mt-30 -100.43 134.63 43.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 110.589 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.52 ' OD1' ' NE ' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -149.24 147.82 28.84 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.967 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.585 ' HG3' HD13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -134.53 158.79 43.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.864 -1.147 . . . . 0.0 110.104 -179.055 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.803 HG22 ' CG1' ' A' ' 34' ' ' ILE . 12.3 m -136.87 161.08 63.64 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.468 -0.77 . . . . 0.0 109.076 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.53 ' HG2' ' CD ' ' A' ' 54' ' ' ARG . 33.5 Cg_endo -76.21 174.12 13.35 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.478 2.119 . . . . 0.0 110.333 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.623 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.2 Cg_endo -76.49 -29.51 5.91 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.587 2.192 . . . . 0.0 110.518 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -82.91 -7.78 59.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.398 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.53 ' CD ' ' HG2' ' A' ' 51' ' ' PRO . 3.4 mpt_? -93.96 109.34 21.08 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.412 -0.805 . . . . 0.0 109.838 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -97.27 -1.51 44.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.423 -0.798 . . . . 0.0 109.377 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.588 ' HB3' ' CD2' ' A' ' 21' ' ' HIS . 77.2 p -140.99 147.83 39.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.297 -0.877 . . . . 0.0 109.168 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.674 HD13 HG21 ' A' ' 34' ' ' ILE . 1.4 tt -131.95 119.49 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.119 -0.988 . . . . 0.0 109.388 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.585 HG23 ' OG1' ' A' ' 19' ' ' THR . 45.7 m -87.85 138.06 31.79 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.349 -0.845 . . . . 0.0 109.62 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.019 ' HB3' HD11 ' A' ' 62' ' ' LEU . 4.6 mt -111.23 159.46 17.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.512 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.5 p -144.37 173.37 11.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -0.882 . . . . 0.0 109.475 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m120 52.9 52.36 14.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -0.891 . . . . 0.0 109.546 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.019 HD11 ' HB3' ' A' ' 59' ' ' LEU . 7.7 mt -122.17 133.51 54.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.472 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.498 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 42.5 m-20 -48.66 128.15 13.77 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.056 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.581 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 36.1 Cg_endo -78.01 133.6 12.5 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.36 2.04 . . . . 0.0 110.665 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 82.89 61.24 1.96 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.462 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 4.5 m -162.37 159.86 25.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.392 -1.064 . . . . 0.0 109.734 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 2.0 mm-40 -90.77 134.5 34.38 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.369 -0.832 . . . . 0.0 108.839 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 1.035 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 15.0 m-85 -119.17 115.52 24.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.086 -1.009 . . . . 0.0 109.709 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.854 HG13 ' HG2' ' A' ' 87' ' ' GLN . 1.4 t -82.48 120.06 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.899 . . . . 0.0 108.99 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.886 HG22 ' CB ' ' A' ' 36' ' ' HIS . 27.1 t -117.92 138.61 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 109.443 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.546 ' CB ' HG12 ' A' ' 85' ' ' ILE . 80.2 p -116.84 139.1 51.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 110.13 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.7 mm -120.49 92.37 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.415 -0.803 . . . . 0.0 109.207 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.471 ' HB ' ' HB ' ' A' ' 33' ' ' ILE . 25.1 mm -90.78 137.52 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 109.634 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.869 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -99.54 137.79 37.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.423 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.23 150.21 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 0.0 109.444 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.441 ' HB3' ' HB2' ' A' ' 79' ' ' GLU . 28.1 t30 -137.53 49.82 1.98 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.43 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.91 -94.48 2.0 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.0 tpt85 -106.65 -0.76 23.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -1.153 . . . . 0.0 109.501 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 1.6 mt-10 -100.38 148.99 24.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.191 -0.943 . . . . 0.0 109.316 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.72 103.85 8.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.676 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.869 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -59.7 -178.41 0.13 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 108.931 179.687 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.603 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 32.7 Cg_endo -75.82 151.08 35.54 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.171 1.914 . . . . 0.0 110.204 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.0 Cg_endo -77.23 115.21 3.91 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.675 2.25 . . . . 0.0 111.379 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.678 HD22 ' HA ' ' A' ' 6' ' ' THR . 12.5 tp -106.08 104.25 13.91 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.546 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.8 mt -111.56 162.25 9.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.039 -1.038 . . . . 0.0 110.4 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.545 ' N ' HG22 ' A' ' 85' ' ' ILE . . . -155.77 162.91 31.49 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.854 ' HG2' HG13 ' A' ' 69' ' ' VAL . 4.0 mt-30 -136.66 118.56 15.22 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.119 -1.224 . . . . 0.0 110.042 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -110.59 -146.94 0.41 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.258 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.54 136.72 3.88 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.879 -1.138 . . . . 0.0 110.341 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.93 137.88 41.97 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.19 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.007 HG11 ' CB ' ' A' ' 116' ' ' ALA . 1.8 t -54.87 161.01 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.517 -0.739 . . . . 0.0 109.308 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.5 m -102.67 154.26 19.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 109.795 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -91.48 -40.65 11.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.355 -0.84 . . . . 0.0 109.416 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.666 HG23 ' HD2' ' A' ' 95' ' ' PRO . 2.7 mt -77.23 141.56 66.85 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.171 -0.956 . . . . 0.0 109.208 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.666 ' HD2' HG23 ' A' ' 94' ' ' ILE . 36.4 Cg_endo -80.61 82.95 2.33 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.592 2.195 . . . . 0.0 110.186 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.6 OUTLIER -70.61 -176.62 1.32 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.63 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER 77.01 27.82 0.68 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 109.67 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.749 HD23 HG23 ' A' ' 180' ' ' ILE . 33.6 tp -76.97 101.88 6.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.148 -0.97 . . . . 0.0 109.394 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -137.15 170.2 16.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.561 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 11.8 p -93.75 147.97 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.197 -0.939 . . . . 0.0 109.665 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.554 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 11.7 pt -129.7 -2.41 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.369 -0.832 . . . . 0.0 109.552 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.552 ' CB ' HD12 ' A' ' 109' ' ' LEU . . . -165.33 116.26 1.11 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.318 -0.864 . . . . 0.0 108.68 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.504 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.8 t -104.48 93.23 4.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.114 -0.991 . . . . 0.0 110.221 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.56 ' OG1' ' N ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -78.41 163.48 61.5 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.314 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.478 ' O ' HG23 ' A' ' 106' ' ' THR . 29.6 Cg_endo -68.4 -2.44 9.12 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.4 2.067 . . . . 0.0 110.856 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.879 ' C ' HG22 ' A' ' 152' ' ' ILE . 11.6 p -155.26 20.75 0.42 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.294 -0.879 . . . . 0.0 108.723 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . 1.068 ' O ' HD23 ' A' ' 108' ' ' LEU . 52.4 p -173.43 161.47 4.11 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.935 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.068 HD23 ' O ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -139.67 155.76 47.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.371 -0.83 . . . . 0.0 109.274 -179.665 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.554 ' HB3' ' CG1' ' A' ' 101' ' ' ILE . 19.8 mt -100.29 132.78 45.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.291 -0.881 . . . . 0.0 108.892 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.783 HD11 ' CD1' ' A' ' 149' ' ' ILE . 0.5 OUTLIER -119.63 141.27 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.168 -0.958 . . . . 0.0 109.809 -179.617 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 97' ' ' ASP . 37.8 t -133.75 135.17 43.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.411 -0.806 . . . . 0.0 109.385 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.619 ' HH2' ' HB2' ' A' ' 147' ' ' ALA . 43.4 p90 -140.28 143.21 35.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.399 -0.813 . . . . 0.0 109.288 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 8.9 mm-40 -69.88 136.67 87.54 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.944 . . . . 0.0 109.282 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 36.1 Cg_endo -78.74 142.84 18.23 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.425 2.083 . . . . 0.0 110.385 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.591 ' HB2' HG22 ' A' ' 117' ' ' VAL . 35.8 Cg_endo -78.48 175.87 10.57 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.525 2.15 . . . . 0.0 110.265 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.007 ' CB ' HG11 ' A' ' 91' ' ' VAL . . . -95.05 3.73 54.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 109.57 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.591 HG22 ' HB2' ' A' ' 115' ' ' PRO . 4.9 m -95.36 171.01 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.175 -0.953 . . . . 0.0 109.404 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.9 98.16 9.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.396 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.833 HG11 ' CE2' ' A' ' 122' ' ' TYR . 22.4 t -86.37 127.54 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 109.752 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -55.46 5.88 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.994 ' CE2' HG22 ' A' ' 139' ' ' THR . 2.8 p90 -165.61 174.76 9.5 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.833 ' CE2' HG11 ' A' ' 119' ' ' VAL . 5.5 m-85 -120.54 154.52 35.22 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.791 -1.193 . . . . 0.0 110.085 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.586 ' HG2' ' CE2' ' A' ' 121' ' ' TYR . 4.5 mmm-85 -112.07 88.08 2.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.389 -0.819 . . . . 0.0 109.032 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.629 ' CG2' ' CE2' ' A' ' 138' ' ' PHE . 88.9 mt -84.08 160.24 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 109.491 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 18.5 p -145.32 150.78 37.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.127 -0.983 . . . . 0.0 110.474 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 1.123 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 2.5 m-85 -87.31 139.72 30.27 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.598 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -105.74 107.48 2.8 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.474 ' O ' ' HD2' ' A' ' 134' ' ' PRO . 6.2 mt-10 -107.61 85.98 2.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.11 -1.229 . . . . 0.0 109.475 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.431 ' OG1' ' HB3' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -63.19 140.77 58.91 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.008 -1.057 . . . . 0.0 109.826 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 176.18 -89.62 0.08 OUTLIER Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 132' ' ' ASN . . . -154.39 64.83 0.33 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 131' ' ' GLY . 1.2 m-20 160.31 -22.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.467 -1.02 . . . . 0.0 109.3 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.575 ' N ' ' HD3' ' A' ' 134' ' ' PRO . 1.4 m 64.4 56.4 1.54 Allowed Pre-proline 0 C--N 1.298 -1.651 0 O-C-N 121.632 -0.668 . . . . 0.0 110.359 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.575 ' HD3' ' N ' ' A' ' 133' ' ' SER . 36.1 Cg_endo -77.74 118.53 4.53 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.423 2.082 . . . . 0.0 109.594 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.768 HG12 ' O ' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -113.01 141.7 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.116 -0.99 . . . . 0.0 110.13 -179.177 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 126' ' ' TYR . 0.1 OUTLIER -108.59 98.51 8.02 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.206 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 0.8 OUTLIER -79.38 128.19 33.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 111.057 -178.6 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.629 ' CE2' ' CG2' ' A' ' 124' ' ' ILE . 17.8 p90 -128.11 140.04 52.16 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.994 HG22 ' CE2' ' A' ' 121' ' ' TYR . 1.2 p -74.44 153.52 39.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.046 -1.034 . . . . 0.0 111.103 -178.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.684 HG13 ' HD2' ' A' ' 141' ' ' PRO . 94.5 t -118.07 143.18 32.29 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.684 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.2 Cg_endo -76.81 119.65 5.21 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.332 2.021 . . . . 0.0 110.298 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -55.47 -17.13 11.94 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.3 t -83.84 12.32 6.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.157 -1.202 . . . . 0.0 109.696 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.452 ' HB2' ' HG2' ' A' ' 141' ' ' PRO . 43.1 mmtt -139.08 122.53 17.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.954 . . . . 0.0 109.552 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.568 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 11.9 p -82.28 -5.37 58.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.919 . . . . 0.0 109.506 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.54 ' C ' ' CH2' ' A' ' 112' ' ' TRP . 6.9 p -124.87 154.08 41.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.25 -0.906 . . . . 0.0 109.357 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.678 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -123.98 168.52 12.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.882 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' THR . . . . . 1.024 HG22 ' OD1' ' A' ' 150' ' ' ASN . 22.4 m -130.8 104.12 6.98 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.303 -0.873 . . . . 0.0 109.306 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 1.123 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -82.57 93.3 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.033 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 1.024 ' OD1' HG22 ' A' ' 148' ' ' THR . 1.7 m-20 -100.28 174.1 6.29 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.282 -0.886 . . . . 0.0 109.632 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 67.09 37.0 3.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 109.193 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.879 HG22 ' C ' ' A' ' 106' ' ' THR . 4.5 tt -95.45 161.8 2.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.445 -0.784 . . . . 0.0 109.733 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -98.27 108.85 49.6 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.222 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.457 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 36.2 Cg_endo -77.22 75.74 4.5 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.483 2.122 . . . . 0.0 110.568 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.708 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 168.48 59.36 0.03 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.708 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 163.59 136.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -1.109 . . . . 0.0 109.533 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.431 ' HB3' ' OG1' ' A' ' 129' ' ' THR . 22.8 t70 -46.34 158.01 0.12 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.735 ' CD1' HG21 ' A' ' 184' ' ' THR . 0.3 OUTLIER -140.6 -177.21 4.94 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.873 -1.142 . . . . 0.0 110.496 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.575 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 3.1 m -157.83 114.45 2.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.484 -0.76 . . . . 0.0 109.093 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.449 HG21 HG21 ' A' ' 110' ' ' ILE . 25.4 mm -97.03 126.71 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.567 -1.333 . . . . 0.0 109.73 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.997 HG23 ' CB ' ' A' ' 179' ' ' SER . 1.3 m -138.96 167.2 22.58 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.221 -0.924 . . . . 0.0 109.357 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.523 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 0.9 OUTLIER -162.95 150.35 13.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.912 -1.117 . . . . 0.0 111.109 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.622 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.3 m-85 -121.39 100.11 6.85 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -55.13 129.26 37.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.871 -1.143 . . . . 0.0 109.084 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.597 HG21 ' CZ ' ' A' ' 121' ' ' TYR . 65.1 t -106.29 153.59 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.931 . . . . 0.0 109.863 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.694 HG22 ' HA ' ' A' ' 119' ' ' VAL . 0.7 OUTLIER -148.26 -38.88 0.18 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.443 -0.786 . . . . 0.0 109.608 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 166' ' ' THR . . . -59.11 -138.99 0.01 OUTLIER Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.516 ' N ' ' HB3' ' A' ' 172' ' ' PRO . 4.6 mmm180 -74.31 -131.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -1.115 . . . . 0.0 110.253 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -137.82 -44.78 0.08 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -74.69 -11.49 60.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -1.171 . . . . 0.0 109.258 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.561 ' N ' ' HD3' ' A' ' 172' ' ' PRO . 0.9 OUTLIER -176.6 59.84 0.18 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.492 -0.755 . . . . 0.0 109.279 179.582 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 171' ' ' SER . 36.2 Cg_endo -79.25 -171.44 1.25 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.507 2.138 . . . . 0.0 110.533 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -111.44 129.32 56.06 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 2.0 p -121.57 130.83 53.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.148 -0.97 . . . . 0.0 110.011 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.483 ' OG ' HG12 ' A' ' 94' ' ' ILE . 16.8 p -54.85 -168.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.327 -0.858 . . . . 0.0 109.035 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.566 ' CB ' HD11 ' A' ' 94' ' ' ILE . 1.8 mtmt -68.16 144.27 96.69 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.0 -1.062 . . . . 0.0 108.706 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.622 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.1 Cg_endo -76.68 132.78 13.53 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.317 2.011 . . . . 0.0 111.437 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 3.7 t -106.01 130.64 57.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.997 ' CB ' HG23 ' A' ' 161' ' ' THR . 1.1 p -130.17 147.88 51.95 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.123 -0.986 . . . . 0.0 110.808 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.749 HG23 HD23 ' A' ' 98' ' ' LEU . 19.0 pt -131.55 151.84 36.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -86.04 156.58 20.36 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.046 -1.034 . . . . 0.0 109.672 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.753 ' CZ ' HD13 ' A' ' 108' ' ' LEU . 54.1 t80 -161.22 123.8 3.11 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.335 -0.853 . . . . 0.0 109.432 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.87 130.78 38.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.23 -0.919 . . . . 0.0 109.542 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.735 HG21 ' CD1' ' A' ' 158' ' ' TYR . 6.4 p . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.495 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.439 ' C ' ' HG ' ' A' ' 2' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.738 HD21 HD22 ' A' ' 76' ' ' ASN . 1.4 mp -138.6 -167.96 2.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.185 -1.185 . . . . 0.0 109.298 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.548 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 3.2 m-20 -74.89 153.52 38.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.866 . . . . 0.0 108.954 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.502 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 89.9 p -96.53 107.81 38.49 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.344 -0.847 . . . . 0.0 110.115 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.608 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 36.4 Cg_endo -80.15 77.72 3.96 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.56 2.173 . . . . 0.0 109.893 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 1.093 HG22 ' CD2' ' A' ' 84' ' ' LEU . 73.6 p -93.16 -104.74 0.12 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.154 -0.966 . . . . 0.0 110.112 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 55.81 20.73 26.96 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -44.68 127.67 6.28 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.749 -0.853 . . . . 0.0 109.929 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.478 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 4.7 t0 -162.81 105.81 1.07 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.362 -0.836 . . . . 0.0 109.047 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 16.1 m -84.89 127.29 34.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.908 . . . . 0.0 109.736 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.507 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 3.5 p -154.49 -163.17 1.54 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.562 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 2.4 m-20 44.9 38.59 3.03 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.671 HD12 ' OE1' ' A' ' 88' ' ' GLN . 1.6 mm -74.57 130.01 36.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.581 0.705 . . . . 0.0 110.851 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.874 ' HA ' ' HB1' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -119.35 175.63 5.73 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.923 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' CB ' ' OD1' ' A' ' 93' ' ' ASP . . . -67.01 -75.56 0.09 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.865 -1.147 . . . . 0.0 109.463 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 15.3 p-10 -78.66 -2.5 39.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.302 -0.874 . . . . 0.0 109.82 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.629 ' HB2' HG22 ' A' ' 60' ' ' THR . 6.4 t -143.27 160.83 39.76 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.245 -0.909 . . . . 0.0 109.058 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.694 ' HE1' HG22 ' A' ' 20' ' ' VAL . 3.5 p90 -167.33 145.66 4.85 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.722 ' OG1' HG23 ' A' ' 58' ' ' THR . 2.8 m -109.98 157.18 19.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.353 -1.467 . . . . 0.0 111.395 -178.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.694 HG22 ' HE1' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -123.11 166.63 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.017 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.507 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 26.1 m-70 -137.67 160.23 39.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.94 -1.1 . . . . 0.0 110.404 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.788 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 21.7 p90 177.56 139.61 0.08 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -74.34 159.19 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 120.946 -1.096 . . . . 0.0 110.116 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -96.82 165.58 15.66 Favored Pre-proline 0 C--N 1.3 -1.545 0 O-C-N 121.819 -0.551 . . . . 0.0 109.774 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 1.003 ' CG ' HD13 ' A' ' 29' ' ' ILE . 36.2 Cg_endo -79.56 145.38 18.41 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.604 2.203 . . . . 0.0 110.181 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.461 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 0.7 OUTLIER -80.21 5.52 14.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 0.0 109.493 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.901 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -108.23 173.68 2.89 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.935 . . . . 0.0 109.448 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.901 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.7 Cg_endo -78.03 88.57 1.42 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.657 2.238 . . . . 0.0 110.55 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.003 HD13 ' CG ' ' A' ' 25' ' ' PRO . 36.0 pt -98.13 -179.79 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.397 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.532 HG21 ' N ' ' A' ' 77' ' ' GLY . 2.3 p -102.13 -21.49 14.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.345 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.49 165.36 10.27 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 1.146 ' CD1' HG22 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -90.5 148.6 22.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -1.091 . . . . 0.0 110.314 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.777 HG23 ' HD2' ' A' ' 49' ' ' ARG . 0.5 OUTLIER -102.3 103.38 14.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.839 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.863 HD11 HG22 ' A' ' 50' ' ' VAL . 1.3 mm -88.28 117.59 32.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 O-C-N 121.314 -0.866 . . . . 0.0 109.885 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -122.72 111.77 17.13 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.374 -0.829 . . . . 0.0 108.879 179.407 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.91 ' CE1' HD21 ' A' ' 59' ' ' LEU . 1.4 p-80 -105.98 122.0 45.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.935 . . . . 0.0 110.11 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.574 ' CE1' ' O ' ' A' ' 69' ' ' VAL . 37.3 p-80 -140.71 127.68 20.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.423 -0.798 . . . . 0.0 109.008 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -39.4 151.5 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.803 . . . . 0.0 110.008 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.49 ' OE1' ' CG2' ' A' ' 69' ' ' VAL . 5.7 mm-40 -55.76 -74.42 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -86.16 -68.18 0.76 Allowed 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.525 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -165.92 117.84 1.07 Allowed 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.205 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.74 HG11 ' CG2' ' A' ' 66' ' ' THR . 84.9 t -157.93 -100.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.509 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.55 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -60.29 -146.31 0.01 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.48 ' HB2' ' HD3' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -119.64 137.64 25.78 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.209 -1.171 . . . . 0.0 109.418 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 36.3 Cg_endo -78.68 85.2 1.88 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.536 2.157 . . . . 0.0 110.329 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.531 ' HB2' ' NE2' ' A' ' 36' ' ' HIS . 3.1 mmm180 -96.73 156.4 16.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.226 -0.922 . . . . 0.0 109.348 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 47' ' ' GLN . 16.9 pt20 -113.2 102.44 10.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.248 -0.907 . . . . 0.0 109.482 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.495 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 1.7 m-20 -106.34 115.8 30.83 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -0.907 . . . . 0.0 109.254 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.777 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -92.6 140.54 29.44 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.194 -0.941 . . . . 0.0 109.476 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.863 HG22 HD11 ' A' ' 34' ' ' ILE . 26.8 m -115.54 151.65 46.3 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.301 -0.874 . . . . 0.0 109.309 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.476 ' HG2' ' HG2' ' A' ' 54' ' ' ARG . 35.3 Cg_endo -77.7 174.27 12.87 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.599 2.2 . . . . 0.0 110.373 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.497 ' HB3' HG13 ' A' ' 29' ' ' ILE . 34.0 Cg_endo -77.07 -15.59 16.27 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.573 2.182 . . . . 0.0 110.269 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -90.43 14.78 12.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.314 -0.867 . . . . 0.0 109.22 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.476 ' HG2' ' HG2' ' A' ' 51' ' ' PRO . 5.9 mmm-85 -133.48 126.33 30.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 109.575 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 2.8 p-10 -109.83 -4.96 15.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.93 . . . . 0.0 109.431 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 16.0 p -130.53 145.43 51.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 109.068 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.788 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 3.0 tt -129.12 118.89 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.953 . . . . 0.0 109.642 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.722 HG23 ' OG1' ' A' ' 19' ' ' THR . 0.3 OUTLIER -91.74 103.04 15.65 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.364 -0.835 . . . . 0.0 109.241 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.973 ' HB3' HD11 ' A' ' 62' ' ' LEU . 2.5 mt -84.92 144.82 28.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -0.922 . . . . 0.0 109.672 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.629 HG22 ' HB2' ' A' ' 17' ' ' SER . 63.7 p -137.69 -174.77 3.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 0.0 109.414 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 56.39 20.1 4.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.416 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.973 HD11 ' HB3' ' A' ' 59' ' ' LEU . 2.4 mt -96.49 156.85 16.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.929 . . . . 0.0 109.242 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.468 ' O ' ' OH ' ' A' ' 68' ' ' TYR . 2.3 t30 -61.44 132.71 92.93 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.097 -1.002 . . . . 0.0 108.485 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.3 Cg_endo -77.51 124.64 7.14 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.159 1.906 . . . . 0.0 110.767 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.565 ' CA ' ' HA ' ' A' ' 92' ' ' SER . . . 77.8 60.98 2.64 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.74 ' CG2' HG11 ' A' ' 42' ' ' VAL . 3.0 m -145.88 167.0 24.32 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.242 -1.152 . . . . 0.0 110.084 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.8 OUTLIER -125.2 121.51 34.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.434 -0.791 . . . . 0.0 109.674 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.636 ' HH ' ' HB ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -124.89 -172.57 2.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 0.0 109.302 179.685 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.574 ' O ' ' CE1' ' A' ' 37' ' ' HIS . 41.7 t -122.28 110.62 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 35' ' ' ARG . 3.5 t -96.57 127.19 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.778 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.579 ' HB3' HD13 ' A' ' 85' ' ' ILE . 95.1 p -108.01 133.98 51.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.32 -0.862 . . . . 0.0 109.951 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.146 HG22 ' CD1' ' A' ' 32' ' ' TYR . 5.2 mm -115.57 104.16 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.892 . . . . 0.0 109.242 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.667 HD12 ' HB3' ' A' ' 83' ' ' PRO . 21.1 mm -109.81 109.49 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.13 -0.981 . . . . 0.0 109.57 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.737 ' HB3' ' CB ' ' A' ' 81' ' ' SER . . . -75.88 140.81 42.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -0.959 . . . . 0.0 109.299 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.551 HG21 HD11 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -131.43 176.35 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.289 -0.882 . . . . 0.0 109.561 -179.734 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.738 HD22 HD21 ' A' ' 2' ' ' LEU . 34.2 t30 -156.44 43.68 0.4 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.476 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.532 ' N ' HG21 ' A' ' 30' ' ' THR . . . 91.13 -77.12 1.45 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.441 ' HD2' ' C ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -125.18 3.22 7.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -1.164 . . . . 0.0 109.679 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.509 ' OE1' ' ND2' ' A' ' 76' ' ' ASN . 4.0 mt-10 -100.34 -174.9 2.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.182 -0.949 . . . . 0.0 109.486 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 0.8 OUTLIER -149.9 143.93 25.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.889 . . . . 0.0 109.596 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.737 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -110.34 -178.78 0.58 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.408 -0.807 . . . . 0.0 109.065 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.582 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.0 Cg_endo -77.66 131.11 11.12 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.21 1.94 . . . . 0.0 110.168 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.667 ' HB3' HD12 ' A' ' 73' ' ' ILE . 36.1 Cg_endo -78.25 152.43 27.24 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.483 2.122 . . . . 0.0 110.775 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.093 ' CD2' HG22 ' A' ' 6' ' ' THR . 0.0 OUTLIER -146.61 54.13 1.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 108.875 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.579 HD13 ' HB3' ' A' ' 71' ' ' SER . 6.4 mt -57.87 162.6 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.306 -0.871 . . . . 0.0 109.871 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.5 ' N ' HG22 ' A' ' 85' ' ' ILE . . . -164.98 160.85 34.2 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.525 ' HG3' HG22 ' A' ' 69' ' ' VAL . 0.7 OUTLIER -95.75 127.86 42.13 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.268 -1.136 . . . . 0.0 109.493 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.671 ' OE1' HD12 ' A' ' 13' ' ' ILE . 1.3 tm0? -125.31 128.26 47.95 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -107.44 130.39 54.83 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.198 -0.939 . . . . 0.0 110.235 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.458 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -74.41 135.9 42.39 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.145 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.024 HG21 ' HB2' ' A' ' 116' ' ' ALA . 1.0 OUTLIER -44.41 156.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.212 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.565 ' HA ' ' CA ' ' A' ' 65' ' ' GLY . 0.4 OUTLIER -105.52 31.72 4.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.235 -0.916 . . . . 0.0 109.248 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.511 ' OD1' ' CB ' ' A' ' 15' ' ' ALA . 0.6 OUTLIER 52.83 16.88 0.75 Allowed 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.718 -0.614 . . . . 0.0 110.121 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.767 HG23 ' HD2' ' A' ' 95' ' ' PRO . 6.7 mt -108.5 143.78 28.18 Favored Pre-proline 0 N--CA 1.484 1.259 0 O-C-N 120.99 -1.069 . . . . 0.0 109.623 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.767 ' HD2' HG23 ' A' ' 94' ' ' ILE . 35.3 Cg_endo -78.96 81.94 2.65 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.494 2.129 . . . . 0.0 109.997 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -64.38 -179.37 0.46 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.258 -0.901 . . . . 0.0 109.678 -179.655 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER 77.06 21.14 1.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.312 -0.868 . . . . 0.0 109.622 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.907 HD22 HD23 ' A' ' 162' ' ' LEU . 15.1 tp -69.87 102.6 2.0 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.162 -0.961 . . . . 0.0 109.291 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 97' ' ' ASP . 8.6 pt-20 -149.1 -174.04 4.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.134 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 109' ' ' LEU . 41.7 t -127.57 151.18 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.084 -1.01 . . . . 0.0 109.971 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.1 pt -119.13 -14.2 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.524 -0.735 . . . . 0.0 109.332 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.78 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -142.32 149.3 39.3 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.518 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 0.7 OUTLIER -134.88 106.07 6.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.993 -1.067 . . . . 0.0 110.234 -179.452 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.479 ' OG1' ' OG ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -91.73 158.18 40.57 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.4 -0.812 . . . . 0.0 108.97 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.462 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.3 Cg_endo -70.32 -2.51 10.69 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.383 2.055 . . . . 0.0 110.385 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.828 ' C ' HG22 ' A' ' 152' ' ' ILE . 64.7 p -150.34 19.08 0.85 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . 1.075 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -168.0 168.56 11.9 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.801 179.742 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.075 HD23 ' O ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -141.33 154.2 45.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.67 -179.383 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.78 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.8 OUTLIER -105.31 106.66 17.26 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.921 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.858 HD12 HD13 ' A' ' 124' ' ' ILE . 0.0 OUTLIER -100.76 140.81 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.226 -0.921 . . . . 0.0 110.206 -179.117 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.477 ' HA ' ' HB ' ' A' ' 146' ' ' THR . 47.4 p -144.49 120.51 10.71 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.656 ' HH2' ' HB2' ' A' ' 147' ' ' ALA . 47.5 p90 -124.69 168.87 12.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.944 . . . . 0.0 109.662 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . 4.3 mt-10 -90.67 159.99 39.68 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.287 -0.883 . . . . 0.0 109.245 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 34.8 Cg_endo -77.36 142.49 21.23 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.628 2.219 . . . . 0.0 110.242 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.51 ' HG2' ' CG2' ' A' ' 119' ' ' VAL . 35.0 Cg_endo -77.72 -171.21 1.12 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.588 2.192 . . . . 0.0 110.481 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.024 ' HB2' HG21 ' A' ' 91' ' ' VAL . . . -103.52 32.98 3.55 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.543 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 116' ' ' ALA . 27.7 m -159.49 163.42 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.908 . . . . 0.0 109.511 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.9 121.42 17.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.235 -0.916 . . . . 0.0 109.245 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 1.026 HG11 ' CE2' ' A' ' 122' ' ' TYR . 3.1 t -99.81 139.7 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.231 -0.918 . . . . 0.0 109.738 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.48 ' HG2' ' HD2' ' A' ' 168' ' ' ARG . 3.8 tpt180 -82.29 -48.92 10.64 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.851 ' CE2' HG22 ' A' ' 139' ' ' THR . 1.5 p90 -165.3 171.31 13.7 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.372 -0.83 . . . . 0.0 109.038 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 1.026 ' CE2' HG11 ' A' ' 119' ' ' VAL . 5.5 m-85 -128.72 122.21 30.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.114 -0.991 . . . . 0.0 109.426 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.48 ' CD ' ' OE1' ' A' ' 137' ' ' GLU . 9.9 ttm180 -89.96 105.76 18.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.194 -0.942 . . . . 0.0 109.248 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 1.195 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 43.3 mt -84.7 166.46 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.677 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.664 HG22 ' HG2' ' A' ' 137' ' ' GLU . 1.3 p -141.8 137.22 31.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.866 . . . . 0.0 109.704 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 1.17 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 3.2 m-30 -92.04 132.4 36.59 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.597 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -103.42 112.31 4.18 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -107.1 136.49 46.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -1.125 . . . . 0.0 109.136 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.799 HG21 ' HB3' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -86.65 149.48 24.88 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.114 -0.991 . . . . 0.0 109.765 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 160.8 -83.38 0.13 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -151.24 -87.24 0.06 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.95 -7.35 34.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -1.139 . . . . 0.0 109.37 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 21.7 t 45.1 79.22 0.35 Allowed Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.379 -0.826 . . . . 0.0 109.871 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.04 73.63 5.65 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.581 2.188 . . . . 0.0 109.949 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 126' ' ' TYR . 2.4 m -58.63 154.48 2.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.479 -0.763 . . . . 0.0 110.127 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.61 ' HG2' ' CG ' ' A' ' 126' ' ' TYR . 1.8 pt20 -125.05 117.6 24.32 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.664 ' HG2' HG22 ' A' ' 125' ' ' THR . 84.0 mt-10 -96.76 152.23 18.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.105 -0.997 . . . . 0.0 111.434 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 1.195 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 1.7 p90 -143.88 139.89 29.47 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.851 HG22 ' CE2' ' A' ' 121' ' ' TYR . 1.6 p -74.2 144.37 44.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.029 -1.044 . . . . 0.0 111.317 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.807 HG13 ' HD2' ' A' ' 141' ' ' PRO . 48.5 t -108.78 145.77 32.36 Favored Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.807 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.3 Cg_endo -77.11 146.3 25.35 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.327 2.018 . . . . 0.0 110.011 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.17 19.62 25.77 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.425 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 0.5 OUTLIER -105.16 10.63 33.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.115 -1.226 . . . . 0.0 109.518 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 143' ' ' SER . 19.2 mmtp -152.42 135.93 16.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 109.616 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.572 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 7.2 p -83.53 1.72 40.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.921 . . . . 0.0 109.467 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.477 ' HB ' ' HA ' ' A' ' 111' ' ' SER . 11.7 p -137.38 146.51 44.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.914 . . . . 0.0 108.911 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.656 ' HB2' ' HH2' ' A' ' 112' ' ' TRP . . . -126.07 -171.42 2.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.07 -1.019 . . . . 0.0 109.593 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.606 HG22 ' N ' ' A' ' 149' ' ' ILE . 82.8 m -137.6 167.55 21.44 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.304 -0.872 . . . . 0.0 109.168 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 1.17 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 1.6 mt -126.36 141.41 45.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.251 -0.906 . . . . 0.0 109.134 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 151' ' ' ASN . 43.5 m-80 -134.5 176.09 8.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.325 -0.859 . . . . 0.0 109.539 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 150' ' ' ASN . 2.3 p-10 41.02 52.9 3.37 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.32 -0.862 . . . . 0.0 109.78 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.838 HD13 HD21 ' A' ' 108' ' ' LEU . 8.4 tt -101.66 164.07 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.322 -0.861 . . . . 0.0 109.216 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.464 ' N ' HG12 ' A' ' 152' ' ' ILE . 19.5 mmmt -99.89 108.01 49.46 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.113 -0.992 . . . . 0.0 109.806 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 152' ' ' ILE . 36.5 Cg_endo -79.38 174.69 11.62 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.571 2.181 . . . . 0.0 110.573 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.602 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 64.94 56.06 18.5 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 170.47 138.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -1.114 . . . . 0.0 109.654 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.799 ' HB3' HG21 ' A' ' 129' ' ' THR . 4.0 t0 -54.79 161.05 1.68 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.597 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.3 OUTLIER -140.33 176.54 8.69 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.908 -1.12 . . . . 0.0 110.135 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.548 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 3.2 m -146.2 109.63 4.76 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.514 ' HB ' ' CG1' ' A' ' 180' ' ' ILE . 29.6 mm -89.86 143.19 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.953 -1.092 . . . . 0.0 110.349 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.949 HG23 ' CB ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -153.12 160.0 42.83 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.414 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.907 HD23 HD22 ' A' ' 98' ' ' LEU . 2.1 pp -161.48 148.45 14.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.914 -1.116 . . . . 0.0 110.632 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.604 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 2.4 m-85 -113.07 164.45 13.46 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -134.33 102.87 5.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.027 -1.045 . . . . 0.0 109.582 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.514 HG22 ' HB3' ' A' ' 174' ' ' SER . 51.5 t -97.38 156.11 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 109.725 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.998 HG22 ' HA ' ' A' ' 119' ' ' VAL . 62.9 p -135.88 -56.61 0.77 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.362 -0.836 . . . . 0.0 109.259 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -70.97 135.19 24.15 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.48 ' HD2' ' HG2' ' A' ' 120' ' ' ARG . 18.8 mtp180 -143.8 61.64 1.37 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -1.139 . . . . 0.0 109.515 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -178.85 -43.66 0.07 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.428 ' O ' ' OG ' ' A' ' 171' ' ' SER . 18.3 t70 -138.82 10.13 2.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -1.135 . . . . 0.0 109.494 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 170' ' ' ASP . 64.8 m -168.74 76.58 0.78 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.929 . . . . 0.0 109.413 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.1 84.45 2.0 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.675 2.25 . . . . 0.0 110.54 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.509 ' O ' HG13 ' A' ' 165' ' ' VAL . . . -108.49 166.02 11.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 109.186 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.514 ' HB3' HG22 ' A' ' 165' ' ' VAL . 14.2 p -146.46 29.27 1.05 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.975 . . . . 0.0 109.798 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 174' ' ' SER . 5.9 p 42.08 -165.54 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.577 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -89.06 140.58 29.03 Favored Pre-proline 0 C--N 1.305 -1.35 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.327 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.604 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 34.9 Cg_endo -77.51 130.23 10.69 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.354 2.036 . . . . 0.0 110.76 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.582 HG12 HD23 ' A' ' 98' ' ' LEU . 5.3 t -101.47 134.36 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.949 ' CB ' HG23 ' A' ' 161' ' ' THR . 1.3 p -126.61 155.63 42.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.172 -0.955 . . . . 0.0 110.191 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.514 ' CG1' ' HB ' ' A' ' 160' ' ' ILE . 24.6 pt -141.58 178.82 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -103.41 151.66 22.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.098 -1.001 . . . . 0.0 109.519 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.769 ' CE2' HD22 ' A' ' 108' ' ' LEU . 83.8 t80 -155.23 122.63 5.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.361 -0.837 . . . . 0.0 109.495 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.418 ' O ' ' CD ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -99.24 127.9 45.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.148 -0.97 . . . . 0.0 109.446 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.569 HG22 ' HE2' ' A' ' 182' ' ' TYR . 51.3 p . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.539 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.829 HD11 ' CB ' ' A' ' 81' ' ' SER . 0.6 OUTLIER -164.79 149.07 9.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -1.136 . . . . 0.0 109.354 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 25' ' ' PRO . 10.8 m-20 -84.93 123.08 30.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.425 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.559 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -95.73 177.5 1.75 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 109.528 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.665 ' O ' HG23 ' A' ' 6' ' ' THR . 36.2 Cg_endo -78.86 147.07 21.22 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.648 2.232 . . . . 0.0 110.096 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.665 HG23 ' O ' ' A' ' 5' ' ' PRO . 0.8 OUTLIER -161.25 -170.48 2.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.065 -1.022 . . . . 0.0 109.8 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 44.08 32.59 2.48 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.628 ' C ' ' CD1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -75.1 -167.68 0.65 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.51 -0.994 . . . . 0.0 109.99 -179.242 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -165.32 129.1 2.31 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.233 -0.917 . . . . 0.0 109.216 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.949 ' OG ' HG13 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -88.49 140.05 29.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.153 -0.967 . . . . 0.0 109.64 -179.728 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.507 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 60.2 p -148.16 -162.54 1.57 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.256 -0.903 . . . . 0.0 109.545 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.542 ' HB2' ' CB ' ' A' ' 19' ' ' THR . 4.4 m-20 45.34 39.77 4.7 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.077 HG22 HG22 ' A' ' 91' ' ' VAL . 24.5 mm -73.35 92.33 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.494 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.657 ' C ' HG23 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -93.04 166.38 12.39 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 176.702 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.791 ' HB1' ' HB2' ' A' ' 93' ' ' ASP . . . -56.06 -77.81 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.961 -1.087 . . . . 0.0 111.106 -177.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -77.04 -0.08 23.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.109 -0.994 . . . . 0.0 110.177 -178.735 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.942 ' HB3' HG22 ' A' ' 60' ' ' THR . 20.8 p -144.67 123.58 12.73 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.164 -0.96 . . . . 0.0 109.237 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.935 ' CE1' HG22 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -135.09 136.05 41.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.119 -0.988 . . . . 0.0 108.335 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.582 ' OG1' HG23 ' A' ' 58' ' ' THR . 16.2 m -87.18 156.99 19.46 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.094 -1.004 . . . . 0.0 112.013 -177.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.949 HG13 ' OG ' ' A' ' 10' ' ' SER . 0.7 OUTLIER -135.58 97.94 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.673 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.507 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 15.5 m-70 -87.72 163.17 16.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.153 -0.967 . . . . 0.0 110.882 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.865 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 25.9 p90 -174.79 139.99 0.55 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.0 161.1 5.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.152 -0.967 . . . . 0.0 109.827 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.511 ' HB1' ' OH ' ' A' ' 32' ' ' TYR . . . -102.15 151.0 38.0 Favored Pre-proline 0 C--N 1.297 -1.691 0 O-C-N 121.779 -0.576 . . . . 0.0 109.511 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.528 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 36.2 Cg_endo -78.53 152.8 26.53 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.538 2.159 . . . . 0.0 110.247 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -92.69 27.06 2.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 109.627 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.958 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -105.34 175.32 2.18 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 109.271 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.958 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.2 Cg_endo -77.77 98.87 1.24 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.586 2.191 . . . . 0.0 110.363 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.635 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 39.4 pt -126.93 173.81 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 109.518 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.6 p -114.2 -18.83 11.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.262 -0.898 . . . . 0.0 109.346 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.28 170.68 26.27 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.635 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 1.2 m-85 -112.49 134.23 54.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -1.193 . . . . 0.0 109.492 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.814 ' C ' HD13 ' A' ' 34' ' ' ILE . 2.0 mt -88.54 126.8 41.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.303 -0.873 . . . . 0.0 109.069 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.062 HG23 ' CD1' ' A' ' 72' ' ' ILE . 1.1 mm -104.28 111.25 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.084 -1.01 . . . . 0.0 109.882 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.423 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 42.2 ttt-85 -121.7 108.16 13.21 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.301 -0.874 . . . . 0.0 108.898 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.938 ' HB3' HG13 ' A' ' 70' ' ' VAL . 18.3 p-80 -117.41 170.77 8.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 110.069 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.44 ' O ' ' O ' ' A' ' 38' ' ' ALA . 20.8 p80 -179.61 130.38 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.43 -0.794 . . . . 0.0 109.723 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -55.31 -168.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.262 -0.899 . . . . 0.0 109.318 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -47.17 -79.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.124 -0.985 . . . . 0.0 109.329 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -164.8 55.33 0.13 Allowed 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.551 0.691 . . . . 0.0 109.313 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.1 p -101.4 10.57 40.38 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.506 -0.746 . . . . 0.0 109.575 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.587 HG22 ' N ' ' A' ' 43' ' ' GLY . 7.1 p -143.46 165.0 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.194 -0.941 . . . . 0.0 109.593 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.587 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -77.66 -72.1 1.16 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -93.55 145.69 30.42 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.256 -1.143 . . . . 0.0 109.33 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.402 ' HB3' ' HB3' ' A' ' 37' ' ' HIS . 34.9 Cg_endo -77.84 163.19 28.97 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.557 2.171 . . . . 0.0 110.312 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.577 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 3.7 mmt85 -74.89 127.8 34.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.198 -0.938 . . . . 0.0 109.27 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -110.23 85.26 2.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 0.0 109.63 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.512 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 29.7 m-20 -100.74 99.86 10.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.241 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.52 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -84.81 134.49 34.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.037 -1.039 . . . . 0.0 109.617 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.75 ' CG1' HD12 ' A' ' 57' ' ' ILE . 13.6 m -118.97 159.67 43.83 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.38 -0.825 . . . . 0.0 109.256 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.495 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 34.7 Cg_endo -77.0 174.16 13.3 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.528 2.152 . . . . 0.0 110.263 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.577 ' HA ' ' CE2' ' A' ' 32' ' ' TYR . 34.9 Cg_endo -76.89 -15.63 16.6 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.605 2.203 . . . . 0.0 110.43 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.87 23.53 2.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.473 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.435 ' O ' ' CZ2' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -137.52 109.47 7.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.923 . . . . 0.0 109.647 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 22' ' ' TRP . 5.2 p30 -95.13 -6.96 40.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 21' ' ' HIS . 64.9 p -139.1 129.49 25.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.318 -0.864 . . . . 0.0 109.057 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.865 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 3.4 tt -118.33 119.36 61.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.258 -0.902 . . . . 0.0 109.594 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.582 HG23 ' OG1' ' A' ' 19' ' ' THR . 0.3 OUTLIER -85.13 108.75 17.84 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.411 -0.806 . . . . 0.0 108.829 179.628 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.987 ' CB ' HD11 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -84.72 152.46 23.71 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.204 -0.935 . . . . 0.0 109.24 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.942 HG22 ' HB3' ' A' ' 17' ' ' SER . 21.5 p -142.93 -179.69 6.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.568 -0.708 . . . . 0.0 109.449 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 56.44 18.29 3.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 109.392 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.987 HD11 ' CB ' ' A' ' 59' ' ' LEU . 3.5 mt -92.68 142.8 26.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.246 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 62' ' ' LEU . 7.5 t-20 -45.86 123.99 6.4 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.204 -0.935 . . . . 0.0 108.651 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.547 ' CB ' ' HB2' ' A' ' 93' ' ' ASP . 35.2 Cg_endo -76.96 131.78 12.35 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.23 1.954 . . . . 0.0 110.32 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 71.89 61.6 3.71 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 90' ' ' THR . 3.3 m -154.91 149.3 26.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -1.136 . . . . 0.0 109.654 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.528 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 16.5 mt-10 -74.41 130.33 39.44 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.096 -1.002 . . . . 0.0 108.417 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 3.0 m-85 -126.0 115.97 20.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.093 -1.004 . . . . 0.0 110.377 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 36' ' ' HIS . 2.1 t -83.52 123.37 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.938 HG13 ' HB3' ' A' ' 36' ' ' HIS . 2.2 t -112.34 123.8 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.003 -1.061 . . . . 0.0 110.18 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.504 ' HB2' HG12 ' A' ' 85' ' ' ILE . 61.2 p -112.97 122.28 47.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.371 -0.831 . . . . 0.0 109.689 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.062 ' CD1' HG23 ' A' ' 34' ' ' ILE . 10.7 mm -107.19 136.49 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.273 -0.892 . . . . 0.0 109.54 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.91 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.7 mp -122.6 156.38 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 0.0 109.2 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.061 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -119.35 115.57 24.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.379 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.35 164.02 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.167 -0.958 . . . . 0.0 109.441 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -140.21 49.93 1.73 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.398 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.58 -82.24 1.65 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.44 ' HD3' ' C ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -120.19 -2.37 10.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -1.154 . . . . 0.0 109.564 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -92.96 -166.59 1.56 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.427 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 37.5 mt-10 -154.01 155.03 34.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.2 -0.938 . . . . 0.0 109.745 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . 1.061 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -129.49 179.89 1.19 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.385 -0.822 . . . . 0.0 108.978 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.576 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.3 Cg_endo -76.04 142.74 25.15 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.194 1.929 . . . . 0.0 109.855 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.8 Cg_endo -77.81 132.33 11.82 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.685 2.257 . . . . 0.0 111.529 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.64 HD22 ' O ' ' A' ' 5' ' ' PRO . 9.0 tp -108.16 100.75 10.03 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.504 HG12 ' HB2' ' A' ' 71' ' ' SER . 2.0 mt -105.63 157.35 6.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.065 -1.022 . . . . 0.0 110.486 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.478 ' N ' HG22 ' A' ' 85' ' ' ILE . . . -151.42 178.97 28.45 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -131.59 137.2 48.32 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.113 -1.228 . . . . 0.0 109.766 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.546 ' HG3' ' CB ' ' A' ' 10' ' ' SER . 1.8 mm100 -163.76 126.94 2.61 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.313 -0.867 . . . . 0.0 109.174 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.528 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -94.5 145.91 24.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.354 -0.841 . . . . 0.0 110.098 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.71 145.93 42.69 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.458 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.077 HG22 HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -70.21 159.31 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.462 -0.774 . . . . 0.0 109.096 179.426 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.542 ' HB2' ' CB ' ' A' ' 115' ' ' PRO . 12.3 m -76.18 139.13 41.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.001 -1.062 . . . . 0.0 108.803 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.791 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 3.3 t0 -103.14 -50.14 3.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.211 -0.93 . . . . 0.0 110.168 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 1.025 HD11 ' HB2' ' A' ' 176' ' ' LYS . 5.6 mt -98.39 140.46 21.86 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.238 -0.914 . . . . 0.0 110.176 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.63 ' HD2' HG23 ' A' ' 94' ' ' ILE . 36.2 Cg_endo -81.05 77.51 4.01 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.615 2.21 . . . . 0.0 109.499 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 5.1 ptp180 -45.94 173.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.44 -0.788 . . . . 0.0 109.974 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 1.7 t70 82.38 15.34 0.43 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.68 -0.637 . . . . 0.0 110.004 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 1.059 HD23 HG12 ' A' ' 178' ' ' VAL . 20.7 tp -70.27 100.45 1.71 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.042 -1.037 . . . . 0.0 109.137 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 110' ' ' ILE . 0.7 OUTLIER -153.3 176.85 11.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.233 -0.917 . . . . 0.0 109.649 -179.797 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.564 HG22 ' N ' ' A' ' 101' ' ' ILE . 9.2 p -105.25 171.23 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.342 -0.849 . . . . 0.0 109.537 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.564 ' N ' HG22 ' A' ' 100' ' ' VAL . 3.6 pt -136.51 -42.69 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.277 -0.89 . . . . 0.0 109.166 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.899 ' HB3' ' CD1' ' A' ' 109' ' ' LEU . . . -121.99 114.29 20.75 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.569 ' CB ' ' HH ' ' A' ' 182' ' ' TYR . 1.2 t -99.94 99.16 9.88 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.24 -0.913 . . . . 0.0 110.5 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.516 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -89.38 160.74 41.67 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.639 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -69.64 -0.81 7.35 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.423 2.082 . . . . 0.0 110.937 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.867 ' C ' HG22 ' A' ' 152' ' ' ILE . 56.0 p -146.45 11.5 1.14 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.269 -0.894 . . . . 0.0 109.485 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . 1.081 ' O ' HD23 ' A' ' 108' ' ' LEU . 85.3 p -172.48 165.52 5.67 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.682 -1.207 . . . . 0.0 110.41 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.081 HD23 ' O ' ' A' ' 107' ' ' SER . 0.4 OUTLIER -145.92 149.57 34.47 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.899 ' CD1' ' HB3' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -106.63 116.52 32.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.199 -0.938 . . . . 0.0 108.952 179.214 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.835 HD11 ' HB3' ' A' ' 147' ' ' ALA . 2.4 pt -100.03 -179.14 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.984 -1.072 . . . . 0.0 109.719 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 146' ' ' THR . 1.0 OUTLIER -168.42 150.96 5.26 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.551 -0.718 . . . . 0.0 109.778 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.655 ' CH2' ' HB2' ' A' ' 147' ' ' ALA . 24.2 p90 -154.03 -176.8 6.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.43 -0.794 . . . . 0.0 109.307 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 95' ' ' PRO . 19.1 mm-40 -120.21 150.39 51.37 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.095 -1.003 . . . . 0.0 109.742 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.79 132.63 10.89 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.725 2.283 . . . . 0.0 110.705 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.542 ' CB ' ' HB2' ' A' ' 92' ' ' SER . 36.4 Cg_endo -79.87 -167.68 0.54 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.705 2.27 . . . . 0.0 110.557 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.003 ' CB ' HG12 ' A' ' 91' ' ' VAL . . . -87.82 -12.15 45.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 109.273 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.532 HG13 ' HB ' ' A' ' 91' ' ' VAL . 30.0 m -88.54 161.84 2.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.397 -0.814 . . . . 0.0 109.332 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.639 ' O ' HG22 ' A' ' 166' ' ' THR . 9.0 m -76.41 122.92 25.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 109.561 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.937 HG11 ' CZ ' ' A' ' 122' ' ' TYR . 2.8 t -100.85 114.91 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.189 -0.944 . . . . 0.0 109.715 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.506 ' HA ' ' NE ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -74.85 -51.48 13.85 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.206 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.959 ' CE1' HG22 ' A' ' 139' ' ' THR . 1.2 p90 -165.49 158.09 15.5 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.937 ' CZ ' HG11 ' A' ' 119' ' ' VAL . 7.0 m-85 -107.58 123.43 48.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.013 -1.054 . . . . 0.0 109.331 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 4.2 ttp180 -86.11 106.11 17.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.206 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.832 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 26.1 mt -99.09 150.09 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.296 -0.878 . . . . 0.0 109.902 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 25.3 p -133.48 132.73 41.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.865 . . . . 0.0 109.932 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.702 ' CE2' HG22 ' A' ' 149' ' ' ILE . 30.5 m-85 -74.8 134.22 41.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.86 . . . . 0.0 109.225 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.586 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.32 106.73 2.71 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -106.01 140.7 38.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.198 -1.178 . . . . 0.0 109.529 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.822 ' OG1' ' HB1' ' A' ' 156' ' ' ALA . 0.7 OUTLIER -67.87 -82.53 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.24 -0.912 . . . . 0.0 109.674 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -134.04 69.61 0.53 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -100.98 25.45 28.31 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.403 ' O ' ' CG ' ' A' ' 132' ' ' ASN . 37.6 t30 55.91 34.38 23.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.334 -1.098 . . . . 0.0 109.453 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.61 153.79 26.94 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.24 -0.912 . . . . 0.0 109.425 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.22 173.61 13.64 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.609 2.206 . . . . 0.0 110.457 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.5 m -62.45 157.69 3.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.267 -0.896 . . . . 0.0 109.661 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.58 ' HB3' ' CD1' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -107.74 104.29 13.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 0.0 109.028 179.626 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 4.8 tt0 -85.82 111.75 20.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 110.372 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.832 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 13.3 p90 -122.39 132.18 54.25 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.959 HG22 ' CE1' ' A' ' 121' ' ' TYR . 1.7 p -74.29 174.48 8.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.225 -0.922 . . . . 0.0 110.741 -178.352 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.61 HG21 ' CD1' ' A' ' 124' ' ' ILE . 24.9 t -137.03 138.08 24.72 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.667 -0.646 . . . . 0.0 109.294 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.487 ' HD2' HG13 ' A' ' 140' ' ' VAL . 35.2 Cg_endo -76.95 132.72 13.12 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.346 2.031 . . . . 0.0 110.35 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.45 0.44 55.04 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -4.64 25.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.114 -1.227 . . . . 0.0 109.751 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.531 ' CD ' ' O ' ' A' ' 146' ' ' THR . 0.0 OUTLIER -154.71 157.67 38.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.935 . . . . 0.0 109.376 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.569 ' O ' ' CE3' ' A' ' 112' ' ' TRP . 0.1 OUTLIER -95.84 2.06 53.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.265 -0.897 . . . . 0.0 110.313 -179.348 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.531 ' O ' ' CD ' ' A' ' 144' ' ' LYS . 43.4 p -108.32 162.34 14.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.981 -1.075 . . . . 0.0 109.624 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.835 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -145.9 134.45 22.09 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.991 . . . . 0.0 109.749 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.2 t -83.91 153.47 23.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.328 -0.858 . . . . 0.0 109.031 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.702 HG22 ' CE2' ' A' ' 126' ' ' TYR . 14.3 mm -133.98 66.26 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.135 -0.978 . . . . 0.0 109.674 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.566 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 2.4 m-20 -84.2 -176.26 6.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.403 -0.811 . . . . 0.0 109.636 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 13.3 m120 68.47 21.4 8.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.22 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.867 HG22 ' C ' ' A' ' 106' ' ' THR . 2.8 tt -85.91 155.11 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.341 -0.849 . . . . 0.0 109.615 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.426 ' O ' ' OG1' ' A' ' 184' ' ' THR . 0.0 OUTLIER -103.88 123.81 39.79 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.231 -0.918 . . . . 0.0 109.298 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.46 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 35.9 Cg_endo -78.43 149.63 24.52 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.415 2.076 . . . . 0.0 110.402 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.698 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 78.43 66.16 1.77 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.822 ' HB1' ' OG1' ' A' ' 129' ' ' THR . . . 163.97 131.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -1.162 . . . . 0.0 109.653 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.558 ' HB3' ' CG2' ' A' ' 129' ' ' THR . 0.9 OUTLIER -52.17 164.87 0.26 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.346 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.617 ' CD1' ' CG2' ' A' ' 184' ' ' THR . 0.2 OUTLIER -142.69 -179.36 6.27 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.846 -1.159 . . . . 0.0 110.363 -179.419 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.585 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 1.7 m -153.12 106.75 3.03 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.933 HD11 HD12 ' A' ' 108' ' ' LEU . 27.5 mt -97.72 116.79 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.805 -1.184 . . . . 0.0 109.754 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . 1.039 HG23 ' CB ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -125.04 153.52 42.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 109.165 179.68 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.828 ' CD2' HD13 ' A' ' 98' ' ' LEU . 2.3 pp -149.95 145.62 26.58 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.055 -1.028 . . . . 0.0 110.682 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.607 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 4.1 m-85 -114.11 177.39 4.66 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -140.53 110.09 6.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.231 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 95.7 t -101.48 152.3 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -0.89 . . . . 0.0 109.639 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.639 HG22 ' O ' ' A' ' 118' ' ' SER . 21.8 p -122.73 -69.97 0.8 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 109.722 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.495 ' N ' ' OG1' ' A' ' 166' ' ' THR . . . -64.58 172.28 19.1 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.22 44.16 0.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.294 -1.121 . . . . 0.0 109.679 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 161.94 -39.77 0.39 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.524 ' O ' ' CB ' ' A' ' 171' ' ' SER . 10.3 p-10 -108.83 -2.26 18.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.147 -1.208 . . . . 0.0 109.697 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 1.0 OUTLIER 163.43 83.05 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 109.435 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.89 86.54 1.64 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.627 2.218 . . . . 0.0 110.431 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -96.99 174.8 6.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.327 -0.858 . . . . 0.0 109.34 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 0.6 OUTLIER -164.38 131.88 3.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.162 -0.961 . . . . 0.0 109.589 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 73.5 p -64.07 -164.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.847 . . . . 0.0 109.365 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 1.025 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -82.24 144.84 51.06 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 108.91 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.607 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 35.7 Cg_endo -78.55 127.96 8.41 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.547 2.164 . . . . 0.0 110.931 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 1.059 HG12 HD23 ' A' ' 98' ' ' LEU . 69.1 t -96.5 123.51 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -0.91 . . . . 0.0 108.56 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' SER . . . . . 1.039 ' CB ' HG23 ' A' ' 161' ' ' THR . 0.4 OUTLIER -118.53 143.71 46.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.167 -0.958 . . . . 0.0 109.914 -179.537 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.5 pt -136.14 151.75 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -84.66 162.67 19.63 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.111 -0.993 . . . . 0.0 109.347 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.769 ' OH ' HD22 ' A' ' 108' ' ' LEU . 49.6 t80 -155.1 157.88 38.17 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.314 -0.867 . . . . 0.0 109.368 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.439 ' N ' ' CD1' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -126.57 119.06 26.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.18 -0.95 . . . . 0.0 109.474 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.617 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 10.8 p . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.54 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.454 ' O ' ' HG ' ' A' ' 2' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.845 HD22 HG22 ' A' ' 29' ' ' ILE . 1.9 mp -141.2 -163.32 1.53 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.257 -1.143 . . . . 0.0 109.367 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.438 ' HB2' ' CB ' ' A' ' 25' ' ' PRO . 29.2 m-20 -115.34 169.84 8.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.43 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.481 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 37.1 p -94.8 119.22 66.37 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.541 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.554 ' O ' HD22 ' A' ' 84' ' ' LEU . 35.2 Cg_endo -77.85 88.13 1.45 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.367 2.045 . . . . 0.0 110.109 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 7' ' ' GLY . 1.8 p -80.87 -109.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.92 . . . . 0.0 109.682 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 22' ' ' TRP . . . 45.7 26.44 1.82 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.781 -1.727 . . . . 0.0 108.781 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.544 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 30.9 t80 -53.74 132.23 40.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.526 -0.985 . . . . 0.0 110.112 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 5.2 t0 -165.22 153.83 11.97 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.537 ' CB ' ' HG2' ' A' ' 88' ' ' GLN . 2.1 p -136.44 139.03 42.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.047 -1.033 . . . . 0.0 109.696 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.471 ' O ' ' HB ' ' A' ' 19' ' ' THR . 17.8 p -160.12 -165.6 1.51 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.249 -0.907 . . . . 0.0 109.579 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.556 ' HB2' ' CB ' ' A' ' 19' ' ' THR . 10.0 m-20 42.31 36.21 0.71 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.906 HG22 HG23 ' A' ' 91' ' ' VAL . 26.2 mm -66.32 134.2 30.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-O 121.418 0.628 . . . . 0.0 110.367 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.938 HG22 HG12 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -124.73 -179.8 4.66 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.328 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' CB ' ' HB3' ' A' ' 93' ' ' ASP . . . -72.4 -76.01 0.12 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.932 -1.105 . . . . 0.0 109.336 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 2.1 p-10 -76.69 0.78 19.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.87 . . . . 0.0 109.648 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.694 ' HB2' HG22 ' A' ' 60' ' ' THR . 3.6 t -150.47 162.47 40.52 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.246 -0.909 . . . . 0.0 109.139 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.904 ' CE1' HG22 ' A' ' 20' ' ' VAL . 7.7 p90 -166.69 139.87 3.81 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.556 ' CB ' ' HB2' ' A' ' 12' ' ' ASP . 23.6 m -83.02 158.74 22.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.738 -1.226 . . . . 0.0 111.447 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.904 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.5 t -136.89 166.58 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.503 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 14.2 m-70 -148.53 165.43 31.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.898 -1.126 . . . . 0.0 110.416 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.836 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 39.4 p90 -177.13 140.93 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.31 167.54 2.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 120.932 -1.105 . . . . 0.0 109.376 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.742 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -103.32 168.7 8.36 Favored Pre-proline 0 C--N 1.3 -1.581 0 O-C-N 121.671 -0.643 . . . . 0.0 109.936 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.742 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.5 Cg_endo -78.48 -158.73 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.703 2.269 . . . . 0.0 110.347 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.48 28.38 8.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.551 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.708 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -144.73 166.84 16.62 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.547 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.708 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.5 Cg_endo -78.25 89.88 1.31 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.633 2.222 . . . . 0.0 110.42 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.951 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 11.7 pt -87.83 -172.09 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -0.938 . . . . 0.0 109.457 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 2.8 p -112.33 -5.8 14.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.94 . . . . 0.0 109.563 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.06 172.35 12.49 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.951 ' CZ ' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -120.83 144.27 48.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -1.148 . . . . 0.0 109.375 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.547 HG23 ' HG3' ' A' ' 49' ' ' ARG . 22.6 mm -82.1 101.81 7.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.212 -0.93 . . . . 0.0 109.594 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.777 HD13 ' N ' ' A' ' 34' ' ' ILE . 1.5 mm -83.42 105.35 13.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.345 -0.847 . . . . 0.0 109.715 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.59 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -102.94 155.37 18.4 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.117 -0.989 . . . . 0.0 108.757 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.699 ' CE1' HD22 ' A' ' 62' ' ' LEU . 23.7 p80 -144.93 136.6 25.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.983 -1.073 . . . . 0.0 110.04 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.588 ' HA ' ' HB3' ' A' ' 45' ' ' PRO . 8.2 p80 -167.73 129.79 1.54 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.882 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -58.66 -172.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.401 -0.812 . . . . 0.0 109.436 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -94.64 -10.93 30.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -128.87 11.12 6.06 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.376 -0.828 . . . . 0.0 109.278 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.479 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 9.9 p -82.09 176.84 9.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.342 -0.849 . . . . 0.0 109.562 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.83 HG22 ' N ' ' A' ' 43' ' ' GLY . 0.6 OUTLIER -142.54 -91.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.729 -179.831 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.83 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -89.12 -21.39 42.11 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.604 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 2.1 mmp_? -51.07 -46.92 88.46 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.292 -1.123 . . . . 0.0 110.481 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 44' ' ' ARG . 36.2 Cg_endo -77.51 154.98 31.7 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.06 1.84 . . . . 0.0 110.434 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.531 ' HG2' ' NE2' ' A' ' 36' ' ' HIS . 6.2 ptm180 -139.77 -165.49 1.89 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.272 -0.892 . . . . 0.0 109.798 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.505 ' HB3' ' HG3' ' A' ' 35' ' ' ARG . 3.8 pt20 -113.16 130.23 56.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.409 -0.807 . . . . 0.0 109.436 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.504 ' C ' ' CD ' ' A' ' 49' ' ' ARG . 9.0 m-20 -112.91 158.27 20.41 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.547 ' HG3' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -133.12 157.5 45.15 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.398 -0.814 . . . . 0.0 109.872 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 1.098 ' CG1' HD12 ' A' ' 57' ' ' ILE . 27.0 m -143.02 159.71 55.27 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.434 -0.791 . . . . 0.0 109.247 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.536 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 35.3 Cg_endo -77.6 173.93 13.43 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.567 2.178 . . . . 0.0 110.517 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 35.6 Cg_endo -77.86 -15.49 14.98 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.674 2.25 . . . . 0.0 110.518 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.3 t -97.8 18.41 15.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.493 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.536 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 15.4 mmm180 -127.31 109.35 11.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.802 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 13.3 p-10 -94.81 -7.12 41.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.219 -0.925 . . . . 0.0 109.199 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 42.0 p -134.56 130.62 36.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.42 -0.8 . . . . 0.0 108.987 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.098 HD12 ' CG1' ' A' ' 50' ' ' VAL . 1.5 tt -132.06 143.42 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.143 -0.973 . . . . 0.0 109.795 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 16.8 m -102.63 125.7 49.46 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.295 -0.878 . . . . 0.0 109.328 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.96 ' CB ' HD11 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -91.13 153.73 19.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.888 . . . . 0.0 109.329 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.694 HG22 ' HB2' ' A' ' 17' ' ' SER . 13.8 p -139.51 -178.79 5.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 109.462 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 54.69 27.38 8.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 109.364 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.96 HD11 ' CB ' ' A' ' 59' ' ' LEU . 2.1 mt -105.46 148.16 27.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.121 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -49.33 130.21 17.51 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.106 -0.996 . . . . 0.0 108.525 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.1 Cg_endo -76.85 129.18 10.54 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.33 2.02 . . . . 0.0 110.756 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 69.8 63.87 3.16 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 90' ' ' THR . 2.4 m -156.86 152.01 26.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.339 -1.095 . . . . 0.0 110.486 -178.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.6 OUTLIER -78.6 124.44 28.16 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.463 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.517 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 2.2 m-85 -119.19 119.42 34.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.983 -1.073 . . . . 0.0 110.319 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.511 HG13 ' HG3' ' A' ' 87' ' ' GLN . 16.3 t -78.67 122.37 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.59 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.8 t -107.08 136.35 42.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.11 -0.994 . . . . 0.0 110.188 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.526 ' OG ' ' CB ' ' A' ' 35' ' ' ARG . 10.5 p -110.91 108.43 18.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.363 -0.836 . . . . 0.0 109.67 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.814 ' C ' HD12 ' A' ' 73' ' ' ILE . 17.1 mm -91.87 110.1 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 109.959 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.814 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.5 mp -113.96 153.33 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.16 -0.962 . . . . 0.0 109.092 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.919 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -112.71 145.46 40.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.527 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.464 ' O ' ' OG1' ' A' ' 30' ' ' THR . 0.9 OUTLIER -147.13 142.19 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.294 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.664 ' OD1' HD21 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -112.96 50.13 0.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.214 -0.929 . . . . 0.0 109.472 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.41 -59.19 3.69 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.527 ' N ' ' HD2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -130.36 0.16 4.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -1.123 . . . . 0.0 109.63 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 7.3 mt-10 -100.9 -164.7 1.13 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 0.0 109.365 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 20.2 mt-10 -151.03 -170.44 3.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 109.592 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.919 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -167.74 -178.08 0.6 Allowed Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.595 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.7 Cg_endo -76.67 142.56 23.09 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.126 1.884 . . . . 0.0 110.151 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.4 Cg_endo -77.56 129.97 10.47 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.678 2.252 . . . . 0.0 110.967 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.554 HD22 ' O ' ' A' ' 5' ' ' PRO . 22.3 tp -120.13 84.04 2.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -0.825 . . . . 0.0 109.01 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 70' ' ' VAL . 3.0 mt -94.67 152.8 3.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.208 -0.933 . . . . 0.0 109.954 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.544 ' HA3' ' CZ ' ' A' ' 8' ' ' PHE . . . -143.95 -172.45 14.7 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.511 ' HG3' HG13 ' A' ' 69' ' ' VAL . 9.8 mt-30 -138.26 131.01 29.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -1.183 . . . . 0.0 109.766 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.537 ' HG2' ' CB ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -141.32 -152.0 0.39 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 108.962 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.28 145.54 7.01 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.878 -1.139 . . . . 0.0 110.59 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.461 ' CG2' ' O ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -84.85 142.43 29.74 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.098 HG11 ' CB ' ' A' ' 116' ' ' ALA . 1.9 t -61.87 176.84 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.416 -0.802 . . . . 0.0 109.307 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.589 ' H ' HG12 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -106.68 106.79 17.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.164 -0.96 . . . . 0.0 109.645 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.511 ' HB3' ' CB ' ' A' ' 15' ' ' ALA . 7.5 p30 -78.82 -35.15 44.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.141 -0.974 . . . . 0.0 109.08 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.781 HG23 ' HD2' ' A' ' 95' ' ' PRO . 8.8 mt -58.53 144.36 79.22 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.371 -0.831 . . . . 0.0 109.205 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.993 ' HG3' HD11 ' A' ' 162' ' ' LEU . 33.9 Cg_endo -76.08 74.6 4.48 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.271 1.98 . . . . 0.0 109.886 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 13.9 tpp85 -61.76 158.86 14.74 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.538 -0.726 . . . . 0.0 109.516 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.9 OUTLIER 80.1 17.17 0.71 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.559 -0.713 . . . . 0.0 109.507 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.875 ' O ' HG21 ' A' ' 180' ' ' ILE . 26.7 tp -60.51 100.07 0.09 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.228 -0.92 . . . . 0.0 108.918 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -140.56 -171.75 3.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.206 -0.934 . . . . 0.0 109.173 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 109' ' ' LEU . 35.3 t -126.41 150.53 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.16 -0.963 . . . . 0.0 110.014 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.704 HG12 HD12 ' A' ' 109' ' ' LEU . 3.0 pt -121.21 -14.43 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.475 -0.766 . . . . 0.0 109.505 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.876 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -134.08 133.42 41.11 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.517 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.8 p -122.73 81.91 1.92 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.033 -1.042 . . . . 0.0 110.374 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.542 HG21 ' OG ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -73.76 163.52 67.82 Favored Pre-proline 0 C--N 1.305 -1.365 0 O-C-N 121.147 -0.971 . . . . 0.0 108.51 179.177 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.492 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 29.7 Cg_endo -68.56 -2.32 9.05 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.4 2.066 . . . . 0.0 110.777 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.879 ' C ' HG22 ' A' ' 152' ' ' ILE . 17.1 p -155.38 21.55 0.41 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.326 -0.859 . . . . 0.0 108.684 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . 1.069 ' O ' HD23 ' A' ' 108' ' ' LEU . 49.6 p -173.24 158.88 3.71 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.467 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.069 HD23 ' O ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -143.91 151.82 40.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.149 -0.969 . . . . 0.0 109.514 -179.569 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 1.065 HD13 ' N ' ' A' ' 110' ' ' ILE . 2.8 tm? -86.9 144.76 26.83 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.433 -0.792 . . . . 0.0 109.091 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 1.065 ' N ' HD13 ' A' ' 109' ' ' LEU . 0.6 OUTLIER -127.09 150.71 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.083 -1.011 . . . . 0.0 109.953 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.6 t -156.1 139.99 16.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.45 -0.782 . . . . 0.0 109.32 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.617 ' CD1' ' HB3' ' A' ' 95' ' ' PRO . 28.5 p90 -150.63 160.69 43.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.512 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.474 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 59.4 mt-10 -74.2 146.63 84.72 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.0 109.498 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.445 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 35.8 Cg_endo -78.72 141.12 17.03 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.586 2.19 . . . . 0.0 110.416 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.469 ' CB ' ' HA ' ' A' ' 93' ' ' ASP . 35.1 Cg_endo -78.45 173.0 14.38 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.582 2.188 . . . . 0.0 110.571 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 1.098 ' CB ' HG11 ' A' ' 91' ' ' VAL . . . -96.19 25.42 4.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.371 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.938 HG12 HG22 ' A' ' 14' ' ' THR . 3.7 m -134.93 158.09 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.256 -0.903 . . . . 0.0 109.492 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.5 ' O ' HG22 ' A' ' 119' ' ' VAL . 4.2 m -70.47 164.75 24.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.91 . . . . 0.0 109.391 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.575 ' HA ' HG22 ' A' ' 166' ' ' THR . 1.5 t -156.16 134.17 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 0.0 109.506 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.535 ' CG ' ' O ' ' A' ' 166' ' ' THR . 0.1 OUTLIER -78.3 -45.48 22.62 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.162 -0.961 . . . . 0.0 108.871 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.687 ' CE2' HG22 ' A' ' 139' ' ' THR . 3.2 p90 -165.21 -177.21 4.44 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.269 -0.894 . . . . 0.0 109.887 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 1.6 m-85 -141.01 142.7 34.21 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.539 ' CD ' ' HB2' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -113.63 106.56 14.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.012 -1.055 . . . . 0.0 109.413 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.646 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 20.2 mt -84.62 164.99 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.355 -0.84 . . . . 0.0 109.141 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.917 HG22 ' HG2' ' A' ' 137' ' ' GLU . 3.0 p -135.39 140.83 45.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.914 . . . . 0.0 110.105 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 1.209 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 3.6 m-30 -85.9 124.01 31.89 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.625 ' HA3' ' HB ' ' A' ' 159' ' ' THR . . . -95.05 112.11 4.32 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -107.35 134.14 50.85 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.228 -1.16 . . . . 0.0 109.295 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.739 HG21 ' HB3' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -82.47 -85.69 0.11 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.052 -1.03 . . . . 0.0 109.648 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -84.5 45.49 3.51 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.445 ' O ' ' OG ' ' A' ' 133' ' ' SER . . . -93.43 -14.24 53.98 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 48.85 23.87 0.75 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -1.15 . . . . 0.0 109.343 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 131' ' ' GLY . 0.0 OUTLIER -131.81 171.74 8.59 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.322 -0.861 . . . . 0.0 109.41 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 133' ' ' SER . 35.3 Cg_endo -78.27 132.88 11.65 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.62 2.213 . . . . 0.0 110.432 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.492 ' HB ' ' O ' ' A' ' 126' ' ' TYR . 3.3 m -45.97 165.26 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.229 -0.919 . . . . 0.0 109.596 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.529 ' HB3' ' HB2' ' A' ' 126' ' ' TYR . 1.5 tt0 -112.48 117.12 31.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.143 -0.973 . . . . 0.0 109.117 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.917 ' HG2' HG22 ' A' ' 125' ' ' THR . 0.5 OUTLIER -105.18 119.23 38.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.128 -0.983 . . . . 0.0 110.808 -179.045 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.646 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 26.5 p90 -118.89 149.49 41.48 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.687 HG22 ' CE2' ' A' ' 121' ' ' TYR . 1.3 p -73.97 -174.03 1.74 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.008 -1.057 . . . . 0.0 110.879 -177.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.661 HG13 ' HD2' ' A' ' 141' ' ' PRO . 55.7 t -153.0 141.16 13.78 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.239 -0.913 . . . . 0.0 109.715 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.661 ' HD2' HG13 ' A' ' 140' ' ' VAL . 36.0 Cg_endo -78.5 128.88 9.02 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.396 2.064 . . . . 0.0 110.052 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -81.96 47.28 3.66 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.3 p -105.42 -2.48 23.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -1.175 . . . . 0.0 109.747 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -166.2 170.03 13.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.142 -0.974 . . . . 0.0 109.683 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.05 21.2 8.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.321 -0.862 . . . . 0.0 109.642 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.565 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 70.0 p -139.01 152.32 47.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.175 -0.953 . . . . 0.0 109.504 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.483 ' C ' ' CG1' ' A' ' 110' ' ' ILE . . . -144.13 -164.29 1.86 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.213 -0.93 . . . . 0.0 109.239 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.639 HG22 ' N ' ' A' ' 149' ' ' ILE . 20.9 m -146.21 165.77 28.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 109.736 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 1.209 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -138.89 111.87 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.367 -0.833 . . . . 0.0 109.109 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.465 ' HA ' ' CB ' ' A' ' 107' ' ' SER . 13.6 m-80 -109.62 177.5 4.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.858 . . . . 0.0 109.369 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 30.0 m120 54.97 69.41 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 108.998 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.879 HG22 ' C ' ' A' ' 106' ' ' THR . 9.2 tt -129.34 163.86 33.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.385 -0.822 . . . . 0.0 109.897 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.471 ' N ' HG12 ' A' ' 152' ' ' ILE . 0.3 OUTLIER -94.37 110.77 50.6 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 109.177 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 152' ' ' ILE . 35.7 Cg_endo -78.35 153.37 27.53 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.4 2.067 . . . . 0.0 110.638 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 74.99 64.07 2.4 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.566 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 171.37 131.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -1.145 . . . . 0.0 109.659 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.739 ' HB3' HG21 ' A' ' 129' ' ' THR . 0.9 OUTLIER -53.78 133.9 42.3 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.266 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.606 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -116.22 177.28 4.74 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.904 -1.123 . . . . 0.0 110.23 -179.069 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.625 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 1.8 m -143.53 98.55 3.27 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.482 ' HB ' HG13 ' A' ' 180' ' ' ILE . 32.9 mm -84.94 125.45 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.933 -1.104 . . . . 0.0 110.213 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.623 HG23 ' CB ' ' A' ' 179' ' ' SER . 1.4 m -133.29 170.5 15.36 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.993 HD11 ' HG3' ' A' ' 95' ' ' PRO . 0.9 OUTLIER -167.79 150.68 5.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.792 -1.192 . . . . 0.0 111.048 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.6 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 1.2 m-85 -124.45 119.92 30.55 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -85.12 116.13 23.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.877 -1.139 . . . . 0.0 109.226 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.57 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 53.2 t -93.96 134.19 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 109.99 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.575 HG22 ' HA ' ' A' ' 119' ' ' VAL . 0.7 OUTLIER -112.88 -39.26 4.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.467 -0.771 . . . . 0.0 109.37 179.757 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 172' ' ' PRO . . . -101.01 139.37 14.36 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.35 58.33 1.46 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.224 -1.162 . . . . 0.0 109.529 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -160.09 -118.23 0.49 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -86.32 12.7 9.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -1.166 . . . . 0.0 109.47 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 73.7 m -164.49 69.52 1.51 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.391 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 167' ' ' GLY . 35.6 Cg_endo -78.0 107.27 2.31 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.713 2.275 . . . . 0.0 110.464 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -105.39 166.69 10.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.899 . . . . 0.0 109.538 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 175' ' ' SER . 0.6 OUTLIER -160.27 122.48 3.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.441 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 174' ' ' SER . 0.7 OUTLIER -54.39 -169.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.011 179.677 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.557 ' HG2' HD11 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -80.98 145.89 58.0 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.543 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.6 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 34.7 Cg_endo -77.21 139.12 18.59 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.474 2.116 . . . . 0.0 111.042 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.619 ' CG2' HG21 ' A' ' 94' ' ' ILE . 2.2 t -113.48 139.14 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.623 ' CB ' HG23 ' A' ' 161' ' ' THR . 0.4 OUTLIER -130.48 136.0 48.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 110.17 -179.282 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.875 HG21 ' O ' ' A' ' 98' ' ' LEU . 9.8 pt -125.16 152.08 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 29.5 m-20 -85.32 160.6 19.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.126 -0.984 . . . . 0.0 109.634 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.882 ' OH ' HD22 ' A' ' 108' ' ' LEU . 66.8 t80 -159.25 116.47 2.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 109.437 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -84.81 113.16 21.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.92 . . . . 0.0 109.549 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.704 HG22 ' CE2' ' A' ' 182' ' ' TYR . 21.6 p . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.489 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.414 ' O ' ' HG ' ' A' ' 2' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.83 HD12 ' O ' ' A' ' 80' ' ' GLU . 94.7 mt -152.53 143.93 23.33 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.225 -1.161 . . . . 0.0 109.435 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 28.5 m-20 -75.05 167.04 22.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.868 . . . . 0.0 109.447 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.536 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 22.7 t -94.82 124.15 55.52 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.952 . . . . 0.0 109.639 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 1.023 ' O ' HD22 ' A' ' 84' ' ' LEU . 35.6 Cg_endo -78.78 83.76 2.18 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.437 2.091 . . . . 0.0 110.161 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.448 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.9 p -75.92 -109.85 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 22' ' ' TRP . . . 45.46 26.16 1.53 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.411 ' N ' ' C ' ' A' ' 6' ' ' THR . 22.5 t80 -55.25 121.09 8.1 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.519 -0.989 . . . . 0.0 109.958 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 1.0 OUTLIER -149.26 103.42 3.31 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.425 -0.797 . . . . 0.0 108.853 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.501 ' HB3' ' NE2' ' A' ' 88' ' ' GLN . 3.8 p -84.54 124.78 31.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 109.586 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 19' ' ' THR . 3.6 p -155.34 -162.17 1.3 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.202 -0.936 . . . . 0.0 109.32 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.566 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.9 OUTLIER 44.9 38.15 2.77 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -178.796 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.113 HG22 HG22 ' A' ' 91' ' ' VAL . 2.3 mt -88.12 141.31 14.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.81 0.814 . . . . 0.0 111.417 -177.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.642 ' C ' HG23 ' A' ' 91' ' ' VAL . 1.5 p -127.43 156.87 41.4 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.84 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -58.95 -36.9 75.57 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.009 -1.057 . . . . 0.0 110.26 -178.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 17' ' ' SER . 0.5 OUTLIER -112.36 38.17 2.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.562 -1.336 . . . . 0.0 109.3 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.614 ' HA ' HD12 ' A' ' 62' ' ' LEU . 1.4 t 160.65 155.65 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.897 ' CB ' HG23 ' A' ' 13' ' ' ILE . 5.1 p90 -165.88 152.09 9.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.624 -1.298 . . . . 0.0 109.886 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.968 ' OG1' HG23 ' A' ' 58' ' ' THR . 25.4 m -109.09 153.6 23.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.766 -1.209 . . . . 0.0 110.86 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.784 HG22 ' HE1' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -118.43 169.43 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.431 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.536 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 17.7 m-70 -143.71 157.57 44.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.177 -0.952 . . . . 0.0 109.79 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.607 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 32.4 p90 -164.64 146.63 8.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.304 -0.873 . . . . 0.0 109.392 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.7 167.48 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.127 -0.983 . . . . 0.0 109.273 179.717 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.502 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -95.9 160.8 29.32 Favored Pre-proline 0 C--N 1.299 -1.63 0 O-C-N 121.584 -0.698 . . . . 0.0 109.541 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.489 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 36.0 Cg_endo -79.16 160.28 26.53 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.6 2.2 . . . . 0.0 110.377 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.423 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 1.2 mtm-85 -84.02 46.34 1.18 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.923 . . . . 0.0 109.487 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.91 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -158.31 173.32 5.1 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.374 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.91 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.8 Cg_endo -78.35 136.14 13.94 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.586 2.191 . . . . 0.0 110.445 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.639 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 21.0 pt -140.93 -170.39 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 46.2 p -132.44 2.44 3.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.584 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.5 -168.58 28.5 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.639 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -146.29 133.38 20.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -1.137 . . . . 0.0 109.516 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.876 ' C ' HD13 ' A' ' 34' ' ' ILE . 0.7 OUTLIER -87.29 123.57 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.179 -0.951 . . . . 0.0 108.766 179.581 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.011 HG23 ' CD1' ' A' ' 72' ' ' ILE . 1.1 mm -109.37 158.25 9.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.244 -0.91 . . . . 0.0 109.167 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.756 ' O ' HG13 ' A' ' 70' ' ' VAL . 50.7 ttp180 -155.49 146.62 22.58 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.537 ' NE2' ' HD2' ' A' ' 46' ' ' ARG . 1.1 p80 -128.9 151.99 49.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.926 -1.109 . . . . 0.0 109.964 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.628 ' CE1' ' CG1' ' A' ' 69' ' ' VAL . 55.9 p-80 -170.4 108.81 0.35 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.743 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -45.92 160.26 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.244 -0.91 . . . . 0.0 109.447 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.502 ' HG2' HG23 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -69.28 -8.4 45.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 109.56 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -108.23 18.05 21.53 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.306 -0.871 . . . . 0.0 109.516 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 37' ' ' HIS . 62.7 p -159.98 100.93 1.42 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 109.773 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 42' ' ' VAL . 9.8 p -130.97 5.06 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.397 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.542 ' C ' ' HD3' ' A' ' 45' ' ' PRO . . . -78.4 -53.49 4.72 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.585 ' CD ' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -122.29 62.66 16.35 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.079 -1.247 . . . . 0.0 110.712 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.542 ' HD3' ' C ' ' A' ' 43' ' ' GLY . 36.9 Cg_endo -77.85 155.57 30.64 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.393 2.062 . . . . 0.0 110.062 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.537 ' HD2' ' NE2' ' A' ' 36' ' ' HIS . 1.0 OUTLIER -97.29 149.86 21.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.015 -1.053 . . . . 0.0 109.417 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -106.98 120.28 41.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.368 -0.832 . . . . 0.0 110.124 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 1.029 ' HB3' HD11 ' A' ' 57' ' ' ILE . 6.6 m-20 -102.48 117.98 35.88 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.717 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.1 155.25 17.23 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.095 -1.003 . . . . 0.0 110.054 -179.223 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.88 HG11 ' HB ' ' A' ' 57' ' ' ILE . 15.1 m -136.09 158.99 72.68 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.478 -0.764 . . . . 0.0 109.199 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.52 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.3 Cg_endo -76.49 174.08 13.43 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.552 2.168 . . . . 0.0 110.302 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.546 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 35.5 Cg_endo -77.17 -15.97 15.89 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.606 2.204 . . . . 0.0 110.448 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.3 p -97.86 8.47 44.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.442 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.52 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -115.74 106.21 13.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.206 -0.934 . . . . 0.0 109.759 -179.742 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -85.46 -2.58 58.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.168 -0.958 . . . . 0.0 109.245 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 61.4 p -137.96 144.62 41.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.868 . . . . 0.0 109.119 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.029 HD11 ' HB3' ' A' ' 48' ' ' ASP . 8.0 tt -118.58 127.73 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.112 -0.993 . . . . 0.0 109.792 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.968 HG23 ' OG1' ' A' ' 19' ' ' THR . 0.3 OUTLIER -90.31 113.95 25.91 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.411 -0.806 . . . . 0.0 109.458 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.794 HD13 ' CZ ' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -84.86 147.75 26.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.43 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.455 ' HA ' ' HB2' ' A' ' 17' ' ' SER . 0.9 OUTLIER -126.41 154.19 43.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 109.63 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.959 ' O ' HD23 ' A' ' 62' ' ' LEU . 1.1 m-80 61.85 79.57 0.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.362 -0.836 . . . . 0.0 109.595 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.959 HD23 ' O ' ' A' ' 61' ' ' ASN . 6.0 mt -143.33 134.68 26.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -0.879 . . . . 0.0 109.449 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.6 t30 -55.05 130.63 67.78 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.254 -0.904 . . . . 0.0 109.043 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.84 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 36.4 Cg_endo -78.1 128.36 9.02 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.389 2.059 . . . . 0.0 110.692 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.49 ' HA3' ' OG ' ' A' ' 92' ' ' SER . . . 82.14 58.65 2.42 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 90' ' ' THR . 2.5 m -157.28 143.37 17.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.31 -1.112 . . . . 0.0 109.22 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.535 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 3.2 mt-10 -74.41 130.28 39.36 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.027 -1.046 . . . . 0.0 108.793 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 4.1 m-85 -121.5 101.17 7.45 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.16 -0.962 . . . . 0.0 110.046 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.628 ' CG1' ' CE1' ' A' ' 37' ' ' HIS . 58.9 t -67.98 130.08 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.067 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 35' ' ' ARG . 47.0 t -126.0 136.97 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.993 -1.067 . . . . 0.0 109.962 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.522 ' CB ' HG12 ' A' ' 85' ' ' ILE . 92.3 p -111.53 123.86 51.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 110.146 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.011 ' CD1' HG23 ' A' ' 34' ' ' ILE . 11.6 mm -100.65 131.86 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.373 -0.829 . . . . 0.0 109.621 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.954 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.7 mp -126.14 164.12 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -0.858 . . . . 0.0 108.919 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.884 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -128.36 141.88 51.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.284 -0.885 . . . . 0.0 109.595 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.41 134.13 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.343 -0.848 . . . . 0.0 109.347 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.681 ' HB2' HD11 ' A' ' 2' ' ' LEU . 37.0 t30 -108.93 46.46 0.97 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.522 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 87.03 -80.39 1.74 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.52 -1.97 13.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.179 -1.189 . . . . 0.0 109.6 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 1.3 mp0 -100.62 -165.75 1.24 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 109.27 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.83 ' O ' HD12 ' A' ' 2' ' ' LEU . 23.7 mt-10 -146.58 -168.66 3.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 109.665 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.884 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -159.37 -179.17 1.03 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.396 -0.815 . . . . 0.0 108.983 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.588 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.4 Cg_endo -77.36 141.93 20.72 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.23 1.954 . . . . 0.0 109.943 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.4 Cg_endo -77.71 88.83 1.38 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.524 2.15 . . . . 0.0 111.038 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 1.023 HD22 ' O ' ' A' ' 5' ' ' PRO . 4.6 tp -75.08 104.11 5.53 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.572 HG22 ' N ' ' A' ' 86' ' ' GLY . 2.5 mt -105.0 163.27 4.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.095 -1.003 . . . . 0.0 110.375 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.572 ' N ' HG22 ' A' ' 85' ' ' ILE . . . -159.36 159.24 30.3 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.481 -1.847 . . . . 0.0 108.481 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . 29.5 mt-30 -117.76 131.29 56.61 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.185 -1.185 . . . . 0.0 109.815 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.628 ' OE1' HG21 ' A' ' 70' ' ' VAL . 3.6 pt20 -136.37 -165.59 1.75 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.535 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -154.74 146.57 23.42 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.025 -1.047 . . . . 0.0 109.75 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.91 132.94 41.82 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.543 -0.863 . . . . 0.0 108.91 179.563 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.113 HG22 HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -47.09 136.4 2.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.57 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.49 ' OG ' ' HA3' ' A' ' 65' ' ' GLY . 1.5 t -107.27 151.88 24.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 109.621 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 6.6 p-10 -48.19 -25.34 1.46 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.208 -0.932 . . . . 0.0 108.846 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.87 HG23 ' HD2' ' A' ' 95' ' ' PRO . 2.6 mt -107.15 147.9 36.03 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.87 ' HD2' HG23 ' A' ' 94' ' ' ILE . 30.6 Cg_endo -72.03 59.16 2.91 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.783 1.655 . . . . 0.0 109.375 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 17.9 ttt180 -60.27 177.09 0.29 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.389 0.614 . . . . 0.0 110.387 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.502 ' HB3' ' HA ' ' A' ' 112' ' ' TRP . 0.7 OUTLIER 66.4 24.79 10.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.513 -0.742 . . . . 0.0 109.256 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 1.097 HD21 ' CD1' ' A' ' 162' ' ' LEU . 0.2 OUTLIER -61.61 102.45 0.25 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.349 -0.844 . . . . 0.0 109.531 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 97' ' ' ASP . 3.8 pt-20 -153.78 171.57 18.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.209 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 109' ' ' LEU . 40.2 t -115.1 155.87 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.157 -0.964 . . . . 0.0 109.747 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.961 HD11 HD23 ' A' ' 109' ' ' LEU . 0.8 OUTLIER -127.91 -7.39 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.46 -0.775 . . . . 0.0 109.821 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.767 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -136.47 122.13 19.73 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.527 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.4 p -112.62 75.66 0.93 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.092 -1.005 . . . . 0.0 110.415 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 107' ' ' SER . 0.7 OUTLIER -74.0 159.59 83.73 Favored Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.15 -0.969 . . . . 0.0 108.622 179.225 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.453 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.1 Cg_endo -69.04 -1.85 8.62 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.493 2.129 . . . . 0.0 111.003 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.898 ' C ' HG22 ' A' ' 152' ' ' ILE . 70.7 p -152.33 19.13 0.65 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 108.893 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.97 ' C ' HD23 ' A' ' 108' ' ' LEU . 6.8 p -173.71 147.54 1.39 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.024 -1.071 . . . . 0.0 110.144 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.97 HD23 ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -124.29 154.72 39.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.404 -0.81 . . . . 0.0 109.294 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.961 HD23 HD11 ' A' ' 101' ' ' ILE . 13.0 tp -105.22 107.16 17.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.269 -0.894 . . . . 0.0 108.731 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.713 ' CD1' ' HB3' ' A' ' 147' ' ' ALA . 1.4 pt -85.8 129.48 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.221 -0.924 . . . . 0.0 110.262 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.609 ' HA ' HG22 ' A' ' 146' ' ' THR . 1.3 p -126.32 123.28 37.68 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.582 ' CE3' ' O ' ' A' ' 145' ' ' SER . 19.3 p90 -152.64 -175.73 5.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.947 -1.095 . . . . 0.0 110.464 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 45.2 mm-40 -105.56 100.49 26.84 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.981 ' O ' HG12 ' A' ' 91' ' ' VAL . 34.0 Cg_endo -73.24 165.47 32.54 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.5 2.133 . . . . 0.0 111.364 -178.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.55 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 37.3 Cg_endo -81.98 85.61 1.67 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.76 2.307 . . . . 0.0 110.416 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.953 ' HB3' HG21 ' A' ' 91' ' ' VAL . . . -69.54 61.04 0.15 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.069 -1.019 . . . . 0.0 108.563 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -133.72 -162.39 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.585 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.8 m -68.91 70.99 0.21 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.883 -1.136 . . . . 0.0 109.207 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.957 ' HA ' HG22 ' A' ' 166' ' ' THR . 2.6 t -107.5 142.89 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.306 -0.871 . . . . 0.0 109.839 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.547 ' CD ' ' HG2' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -89.98 -51.67 5.35 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.225 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.753 ' CZ ' HG21 ' A' ' 165' ' ' VAL . 13.6 p90 -165.74 -168.71 1.36 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.508 -0.745 . . . . 0.0 109.53 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.624 ' N ' ' CD2' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -140.19 137.53 34.42 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.134 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.486 ' CB ' ' HB2' ' A' ' 163' ' ' TYR . 5.8 ttt180 -95.64 101.92 13.67 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.271 -0.893 . . . . 0.0 109.089 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.871 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 19.7 mt -85.35 117.64 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.209 -0.932 . . . . 0.0 109.013 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 43.3 p -93.55 130.11 39.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.413 -0.804 . . . . 0.0 110.488 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 1.014 ' O ' HG12 ' A' ' 135' ' ' VAL . 3.0 m-85 -81.35 122.78 27.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.564 -0.71 . . . . 0.0 109.15 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.602 ' HA3' ' HB ' ' A' ' 159' ' ' THR . . . -102.32 99.18 1.82 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.492 ' HG2' ' CZ ' ' A' ' 158' ' ' TYR . 7.4 mt-10 -107.36 89.86 3.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.16 -1.2 . . . . 0.0 109.474 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -72.51 145.07 47.75 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.029 -1.045 . . . . 0.0 109.605 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 161.17 -77.79 0.17 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -114.94 45.26 1.33 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 50.53 23.34 1.27 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -1.164 . . . . 0.0 109.502 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.438 ' CB ' ' HD2' ' A' ' 134' ' ' PRO . 0.1 OUTLIER -55.52 171.93 0.32 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.491 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 133' ' ' SER . 35.8 Cg_endo -78.58 177.22 8.99 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.674 2.249 . . . . 0.0 110.434 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 1.014 HG12 ' O ' ' A' ' 126' ' ' TYR . 0.1 OUTLIER -105.53 144.89 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.303 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.558 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 1.9 tt0 -102.61 98.49 8.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.924 . . . . 0.0 108.939 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 4.8 pt-20 -92.25 137.13 32.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 110.762 -178.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.871 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 43.4 p90 -134.79 147.48 49.98 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.691 HG22 ' CE2' ' A' ' 121' ' ' TYR . 3.7 p -74.17 171.07 14.24 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.111 -0.993 . . . . 0.0 111.013 -177.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.611 HG21 HG13 ' A' ' 124' ' ' ILE . 25.1 t -143.19 140.45 17.82 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.423 -0.798 . . . . 0.0 110.102 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.561 ' HD2' HG13 ' A' ' 140' ' ' VAL . 36.4 Cg_endo -79.94 142.34 15.57 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.475 2.117 . . . . 0.0 110.201 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.449 ' HA2' ' OH ' ' A' ' 122' ' ' TYR . . . -84.06 45.76 3.54 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.59 -81.46 0.54 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -1.152 . . . . 0.0 110.096 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -78.98 157.67 28.09 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.545 0.688 . . . . 0.0 110.271 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.582 ' O ' ' CE3' ' A' ' 112' ' ' TRP . 0.1 OUTLIER -95.38 -3.17 47.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.473 -0.767 . . . . 0.0 109.577 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.609 HG22 ' HA ' ' A' ' 111' ' ' SER . 7.1 p -116.63 142.04 47.41 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.713 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -134.51 150.88 50.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.876 -1.14 . . . . 0.0 110.06 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 6.9 t -96.17 146.4 24.71 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.367 -0.833 . . . . 0.0 109.028 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.695 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 19.2 mm -126.07 73.18 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.233 -0.917 . . . . 0.0 109.513 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.536 ' HA ' ' CB ' ' A' ' 107' ' ' SER . 8.1 m120 -79.22 -165.03 0.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.711 -0.618 . . . . 0.0 109.597 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 25.2 m120 57.93 20.65 6.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.057 -1.027 . . . . 0.0 109.017 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.898 HG22 ' C ' ' A' ' 106' ' ' THR . 3.5 tt -89.69 161.04 2.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.478 -0.764 . . . . 0.0 109.67 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.58 122.89 40.44 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.166 -0.959 . . . . 0.0 109.221 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.488 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 36.3 Cg_endo -77.73 145.3 22.82 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.439 2.093 . . . . 0.0 110.563 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.654 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 81.12 65.69 1.67 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 167.14 130.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -1.208 . . . . 0.0 109.748 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.436 ' O ' ' OG1' ' A' ' 129' ' ' THR . 2.0 t70 -50.34 165.78 0.09 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.613 ' CE2' HG13 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -144.53 173.07 12.12 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.804 -1.185 . . . . 0.0 110.248 -179.66 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.602 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 1.8 m -147.59 99.34 3.1 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.58 HD11 HD12 ' A' ' 108' ' ' LEU . 88.1 mt -97.39 129.62 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.701 -1.249 . . . . 0.0 109.403 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . 1.004 HG23 ' CB ' ' A' ' 179' ' ' SER . 1.7 m -133.8 139.2 46.15 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.099 -1.001 . . . . 0.0 110.428 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 1.097 ' CD1' HD21 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -110.79 145.6 37.86 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.529 -0.732 . . . . 0.0 110.478 -179.72 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.633 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 37.8 m-85 -131.33 83.73 2.12 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.538 ' HB2' ' HD2' ' A' ' 122' ' ' TYR . . . -63.73 123.25 18.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.128 -0.983 . . . . 0.0 109.726 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.753 HG21 ' CZ ' ' A' ' 121' ' ' TYR . 5.3 t -104.32 129.18 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 109.452 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.957 HG22 ' HA ' ' A' ' 119' ' ' VAL . 21.0 p -120.0 -52.25 2.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.405 -0.81 . . . . 0.0 109.617 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.468 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -42.66 157.32 0.09 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.547 ' HG2' ' CD ' ' A' ' 120' ' ' ARG . 3.3 mpt_? -141.5 106.06 4.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.309 -1.112 . . . . 0.0 109.489 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 162.13 -155.47 26.76 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -75.05 -2.05 25.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -1.15 . . . . 0.0 109.426 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 22.4 m -147.64 82.68 7.92 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.209 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.55 104.62 1.91 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.533 2.155 . . . . 0.0 110.397 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -85.78 129.86 34.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.376 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 164' ' ' ALA . 1.7 p -108.5 133.92 51.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -0.891 . . . . 0.0 109.405 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 174' ' ' SER . 0.9 OUTLIER -44.6 167.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 108.995 179.773 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.572 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -47.98 133.4 11.8 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.987 -1.071 . . . . 0.0 108.491 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.633 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.8 Cg_endo -76.57 157.23 36.24 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.121 1.881 . . . . 0.0 110.324 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -140.35 137.04 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.317 -0.864 . . . . 0.0 108.829 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' SER . . . . . 1.004 ' CB ' HG23 ' A' ' 161' ' ' THR . 0.1 OUTLIER -126.73 -178.6 4.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 110.512 -178.891 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.905 ' CG2' HD12 ' A' ' 98' ' ' LEU . 27.8 pt -158.14 152.3 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -95.72 151.6 19.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.056 -1.028 . . . . 0.0 109.475 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.657 ' CD2' HD13 ' A' ' 108' ' ' LEU . 70.7 t80 -147.11 131.26 17.35 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.271 -0.893 . . . . 0.0 109.4 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.82 119.65 39.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.084 -1.01 . . . . 0.0 109.524 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.488 ' HB ' ' HA ' ' A' ' 154' ' ' PRO . 18.4 p . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.46 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 2' ' ' LEU . 1.1 mp -139.15 -164.03 1.59 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -1.147 . . . . 0.0 109.425 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.547 ' HB2' ' CB ' ' A' ' 25' ' ' PRO . 1.1 m-20 -94.17 144.06 25.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.338 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.552 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 10.3 m -78.15 145.33 68.88 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.509 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.822 ' O ' HD13 ' A' ' 84' ' ' LEU . 35.7 Cg_endo -78.52 125.77 7.1 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.68 2.253 . . . . 0.0 110.336 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.447 ' CG2' HD13 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -143.35 -164.96 1.97 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.905 . . . . 0.0 109.988 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 8' ' ' PHE . . . 83.13 16.89 68.37 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 107.691 -2.163 . . . . 0.0 107.691 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.415 ' C ' ' O ' ' A' ' 7' ' ' GLY . 2.4 t80 -40.49 140.32 0.67 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.794 -0.827 . . . . 0.0 110.28 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 15.1 t0 -165.26 97.68 0.71 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.627 ' OG ' HG13 ' A' ' 20' ' ' VAL . 5.4 m -84.59 128.44 34.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.159 -0.963 . . . . 0.0 109.651 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.494 ' O ' ' C ' ' A' ' 12' ' ' ASP . 3.5 p -146.87 -164.74 2.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.327 -0.858 . . . . 0.0 109.026 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.513 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.8 OUTLIER 41.61 35.92 0.52 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -178.935 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.807 HG23 ' CB ' ' A' ' 18' ' ' PHE . 2.3 mt -78.73 144.53 10.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.202 -177.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -123.5 -157.69 0.77 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.379 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.993 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -93.2 -48.65 6.36 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.887 -1.133 . . . . 0.0 109.167 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 15.2 p30 -99.63 -9.12 23.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.043 -1.036 . . . . 0.0 109.155 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.597 ' O ' HG23 ' A' ' 14' ' ' THR . 27.4 p -142.62 159.53 42.06 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.884 ' CE1' HG22 ' A' ' 20' ' ' VAL . 9.9 p90 -166.13 142.16 4.92 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.911 -1.118 . . . . 0.0 109.435 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.513 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 17.1 m -81.33 153.76 26.86 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.897 -1.127 . . . . 0.0 110.773 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.884 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -132.18 116.98 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.52 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.547 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 3.1 m-70 -103.07 161.95 13.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.053 -1.03 . . . . 0.0 110.34 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.678 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 23.4 p90 -171.42 137.47 1.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.484 -0.76 . . . . 0.0 109.083 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.35 163.14 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.073 -1.017 . . . . 0.0 109.652 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.874 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -98.62 173.45 3.86 Favored Pre-proline 0 C--N 1.299 -1.63 0 O-C-N 121.713 -0.617 . . . . 0.0 109.733 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.874 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.8 Cg_endo -78.42 -162.18 0.17 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.644 2.229 . . . . 0.0 110.307 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.515 ' HB2' ' NH2' ' A' ' 26' ' ' ARG . 0.5 OUTLIER -119.55 18.53 12.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.957 . . . . 0.0 109.426 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.89 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -121.83 172.7 4.76 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.886 . . . . 0.0 109.489 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.89 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.7 Cg_endo -78.0 88.25 1.45 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.653 2.236 . . . . 0.0 110.421 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.772 HD13 ' HE1' ' A' ' 32' ' ' TYR . 9.1 pt -80.12 -176.89 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 109.498 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.453 ' OG1' ' N ' ' A' ' 77' ' ' GLY . 59.6 p -131.72 -2.14 3.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 109.929 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.499 ' O ' ' CD1' ' A' ' 32' ' ' TYR . . . 162.51 -178.56 38.24 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.772 ' HE1' HD13 ' A' ' 29' ' ' ILE . 1.7 m-85 -149.53 131.66 15.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -1.168 . . . . 0.0 109.732 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.998 HG23 ' HD2' ' A' ' 49' ' ' ARG . 0.9 OUTLIER -99.38 130.4 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -0.892 . . . . 0.0 108.897 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.991 HD13 ' C ' ' A' ' 33' ' ' ILE . 1.4 mm -117.57 119.34 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.013 -1.054 . . . . 0.0 109.985 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.464 ' HB2' ' OG ' ' A' ' 71' ' ' SER . 34.8 mtp180 -119.35 138.91 52.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.19 -0.944 . . . . 0.0 108.508 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.753 ' CD2' HD22 ' A' ' 59' ' ' LEU . 8.4 p80 -129.88 160.26 34.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.905 -1.122 . . . . 0.0 110.688 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 45' ' ' PRO . 28.6 p-80 -171.86 121.9 0.49 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.617 -0.677 . . . . 0.0 109.332 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.132 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . -50.58 -178.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.177 -0.952 . . . . 0.0 109.554 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -79.14 -95.12 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.227 -0.92 . . . . 0.0 109.403 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -100.32 28.96 4.6 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.308 -0.87 . . . . 0.0 109.586 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.586 ' OG ' ' HB3' ' A' ' 38' ' ' ALA . 6.0 p -75.87 -161.9 0.19 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.462 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 42' ' ' VAL . 8.0 p -127.32 -1.22 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.602 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.4 141.62 41.16 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.411 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 17.8 mtm180 -72.61 140.92 82.02 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.227 -1.161 . . . . 0.0 109.417 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 37' ' ' HIS . 36.3 Cg_endo -78.94 112.34 3.08 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.546 2.164 . . . . 0.0 110.423 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.586 ' CG ' ' NE2' ' A' ' 36' ' ' HIS . 0.7 OUTLIER -95.09 160.9 14.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.937 . . . . 0.0 109.356 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -109.94 103.52 12.3 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.341 -0.849 . . . . 0.0 109.881 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 1.05 ' HB3' HD11 ' A' ' 57' ' ' ILE . 70.8 m-20 -93.93 115.93 28.34 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.998 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -97.27 156.72 16.31 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.109 -0.995 . . . . 0.0 109.87 -179.47 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.671 HG11 ' HB ' ' A' ' 57' ' ' ILE . 15.8 m -141.9 160.54 55.38 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 109.113 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.549 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.4 Cg_endo -77.11 174.18 13.23 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.466 2.111 . . . . 0.0 110.03 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 35.3 Cg_endo -77.54 -15.42 15.56 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.443 2.096 . . . . 0.0 110.516 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.9 t -99.23 18.45 17.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.576 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.549 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -125.86 119.08 26.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 109.799 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 22' ' ' TRP . 0.8 OUTLIER -103.48 -0.39 29.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.321 -0.862 . . . . 0.0 109.283 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 21' ' ' HIS . 30.8 p -131.08 129.94 42.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 109.462 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.05 HD11 ' HB3' ' A' ' 48' ' ' ASP . 4.4 tt -125.05 140.12 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.254 -0.904 . . . . 0.0 109.361 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 8.8 m -102.75 136.68 42.13 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.264 -0.897 . . . . 0.0 109.302 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.753 HD22 ' CD2' ' A' ' 36' ' ' HIS . 1.1 mp -115.16 161.0 19.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.637 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.44 HG22 ' HB3' ' A' ' 17' ' ' SER . 23.5 p -139.12 -170.32 2.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.402 -0.811 . . . . 0.0 109.344 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.494 ' O ' HD23 ' A' ' 62' ' ' LEU . 50.8 m-20 51.93 54.62 10.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.195 -0.941 . . . . 0.0 109.51 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.636 ' CD2' ' CE1' ' A' ' 36' ' ' HIS . 6.8 mt -129.27 169.93 14.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.473 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -84.64 142.83 40.13 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.263 -0.898 . . . . 0.0 109.3 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.993 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 36.9 Cg_endo -78.78 122.29 5.37 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.556 2.171 . . . . 0.0 110.395 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 75.12 62.49 2.75 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.113 -1.995 . . . . 0.0 108.113 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.605 ' CG2' ' CE2' ' A' ' 68' ' ' TYR . 1.3 m -149.17 144.76 26.8 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.309 -1.112 . . . . 0.0 110.899 -178.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -81.38 105.63 12.71 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.468 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 1.132 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 13.5 m-85 -103.91 150.52 24.11 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.27 -0.894 . . . . 0.0 109.979 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.584 HG13 ' HB3' ' A' ' 87' ' ' GLN . 4.1 t -109.75 154.98 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.321 -0.862 . . . . 0.0 109.193 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.598 HG22 ' CB ' ' A' ' 36' ' ' HIS . 40.9 t -139.51 129.02 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.126 -0.984 . . . . 0.0 109.709 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 79.2 p -103.18 101.18 11.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.862 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.965 HD13 HG23 ' A' ' 34' ' ' ILE . 10.9 mm -74.98 153.12 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.094 -1.004 . . . . 0.0 109.702 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.572 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 15.5 mt -143.3 158.68 17.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.383 -0.823 . . . . 0.0 108.892 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.647 ' HB2' ' CZ ' ' A' ' 32' ' ' TYR . . . -131.21 153.02 49.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.437 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.9 m -141.12 135.61 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 109.389 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 79' ' ' GLU . 1.1 t30 -110.72 43.66 1.39 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 109.513 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.453 ' N ' ' OG1' ' A' ' 30' ' ' THR . . . 77.25 -57.1 3.67 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -126.19 -2.96 6.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -1.147 . . . . 0.0 109.737 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.512 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 0.5 OUTLIER -110.07 177.02 4.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.571 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -147.78 95.43 2.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.32 -0.863 . . . . 0.0 109.434 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.587 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.7 OUTLIER -59.64 -179.05 0.15 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.891 . . . . 0.0 109.084 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.587 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.5 Cg_endo -77.71 146.28 23.72 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.277 1.985 . . . . 0.0 110.365 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 36.1 Cg_endo -77.93 100.99 1.43 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.675 2.25 . . . . 0.0 110.896 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.822 HD13 ' O ' ' A' ' 5' ' ' PRO . 4.1 tp -75.0 103.83 5.34 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 1.9 mt -93.98 143.52 11.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 120.887 -1.133 . . . . 0.0 110.636 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -148.11 -163.22 10.61 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.584 ' HB3' HG13 ' A' ' 69' ' ' VAL . 8.2 pt20 -166.78 164.96 16.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.997 -1.296 . . . . 0.0 110.038 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.564 ' HG3' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -159.73 151.43 20.2 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.665 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.556 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -90.94 136.67 32.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.153 -0.967 . . . . 0.0 110.431 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.474 ' O ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.45 134.27 42.35 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.144 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.751 HG23 HG22 ' A' ' 13' ' ' ILE . 9.4 t -41.98 169.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.574 0.702 . . . . 0.0 110.599 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.547 ' N ' HG12 ' A' ' 91' ' ' VAL . 8.1 t -102.97 158.13 16.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.344 -0.848 . . . . 0.0 109.839 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.897 ' OD2' HG21 ' A' ' 117' ' ' VAL . 2.9 t70 -86.63 -33.4 20.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.443 -0.786 . . . . 0.0 110.527 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.857 HD11 ' CB ' ' A' ' 176' ' ' LYS . 2.5 mt -55.64 139.77 67.88 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 120.804 -1.185 . . . . 0.0 109.716 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.646 ' HD2' HG23 ' A' ' 94' ' ' ILE . 36.5 Cg_endo -80.89 78.05 3.81 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.571 2.181 . . . . 0.0 109.496 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -76.07 177.19 7.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.318 -0.864 . . . . 0.0 109.677 -179.366 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER 76.28 19.57 1.7 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -0.846 . . . . 0.0 109.64 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.779 HD13 HG23 ' A' ' 180' ' ' ILE . 0.5 OUTLIER -62.21 99.95 0.15 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.121 -0.987 . . . . 0.0 109.029 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 97' ' ' ASP . 0.1 OUTLIER -144.64 163.74 33.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 109.715 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.418 HG21 ' HB3' ' A' ' 108' ' ' LEU . 9.6 p -104.05 148.75 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.548 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.735 HD11 HD22 ' A' ' 109' ' ' LEU . 25.1 pt -125.44 -5.46 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -0.891 . . . . 0.0 109.589 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 1.042 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -150.49 108.46 3.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.371 -0.831 . . . . 0.0 108.783 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.521 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.7 t -101.7 93.95 5.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 110.229 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -80.01 164.28 53.58 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.339 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.489 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 30.1 Cg_endo -69.18 -2.95 10.66 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.425 2.083 . . . . 0.0 110.748 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.835 ' C ' HG22 ' A' ' 152' ' ' ILE . 7.5 p -152.48 19.24 0.63 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.988 ' O ' HD23 ' A' ' 108' ' ' LEU . 54.5 p -172.89 160.4 4.32 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.96 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.988 HD23 ' O ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -135.52 155.33 50.67 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.354 -0.841 . . . . 0.0 108.947 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 1.042 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.4 OUTLIER -105.04 95.41 5.83 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.239 -0.913 . . . . 0.0 109.346 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.779 HD11 ' HB3' ' A' ' 147' ' ' ALA . 15.7 pt -74.88 167.82 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.927 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 146' ' ' THR . 3.7 m -165.34 100.41 0.72 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.634 -0.666 . . . . 0.0 109.365 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.58 ' CD1' ' HB2' ' A' ' 95' ' ' PRO . 41.3 p90 -111.4 141.77 44.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.207 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 96' ' ' ARG . 11.3 mm-40 -48.84 145.52 6.21 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.168 -0.957 . . . . 0.0 109.352 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.471 ' HD2' ' OE1' ' A' ' 113' ' ' GLU . 35.2 Cg_endo -77.63 138.79 17.46 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.411 2.074 . . . . 0.0 109.987 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.51 ' CG ' HG21 ' A' ' 119' ' ' VAL . 35.8 Cg_endo -77.79 141.58 19.44 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.35 2.033 . . . . 0.0 110.115 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.538 ' HB1' ' CA ' ' A' ' 14' ' ' THR . . . -87.01 42.52 1.03 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.328 -0.858 . . . . 0.0 109.452 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.897 HG21 ' OD2' ' A' ' 93' ' ' ASP . 5.0 m -141.58 178.19 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 109.491 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.8 m -90.27 96.6 10.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.267 -0.896 . . . . 0.0 109.126 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.977 ' HA ' HG22 ' A' ' 166' ' ' THR . 1.5 t -100.08 133.51 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 109.811 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.549 ' HD3' HG12 ' A' ' 165' ' ' VAL . 8.8 ptm85 -75.21 -46.1 36.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.256 -0.903 . . . . 0.0 108.873 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.89 ' CZ ' HG21 ' A' ' 165' ' ' VAL . 2.7 p90 -165.8 177.16 7.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.896 . . . . 0.0 109.503 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.643 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 1.6 m-85 -134.8 132.91 39.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.924 . . . . 0.0 109.282 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.485 ' HG2' ' N ' ' A' ' 124' ' ' ILE . 8.7 ttm180 -85.28 159.33 20.08 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.909 -1.12 . . . . 0.0 108.459 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.811 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 13.9 mt -148.85 119.75 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.033 -1.042 . . . . 0.0 109.779 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 64.9 p -91.39 128.99 37.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.595 -0.691 . . . . 0.0 109.94 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.821 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 2.4 m-85 -74.53 138.59 43.22 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.592 ' HA3' ' HB ' ' A' ' 159' ' ' THR . . . -105.91 89.23 0.6 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.583 ' HG2' ' CE2' ' A' ' 158' ' ' TYR . 6.8 mt-10 -107.27 138.47 43.4 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.218 -1.166 . . . . 0.0 109.735 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.452 HG21 ' HB3' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -94.39 147.46 23.2 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.182 -0.949 . . . . 0.0 109.299 179.439 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' A' ' 134' ' ' PRO . . . 127.02 103.19 1.25 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 132' ' ' ASN . . . 117.94 -62.24 0.43 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 133' ' ' SER . 14.5 p30 169.95 -30.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.388 -1.066 . . . . 0.0 109.098 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.497 ' N ' ' OD1' ' A' ' 132' ' ' ASN . 0.6 OUTLIER 167.42 65.33 0.01 OUTLIER Pre-proline 0 C--N 1.297 -1.676 0 O-C-N 121.693 -0.629 . . . . 0.0 109.716 179.778 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.462 ' HG2' ' O ' ' A' ' 128' ' ' GLU . 36.3 Cg_endo -79.58 107.27 2.12 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.574 2.183 . . . . 0.0 109.871 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -112.69 146.26 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.104 -0.998 . . . . 0.0 109.897 -179.496 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.574 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 1.1 mt-30 -124.61 99.92 6.4 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.419 -0.801 . . . . 0.0 108.866 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 0.9 OUTLIER -74.7 155.36 37.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.242 -0.911 . . . . 0.0 110.751 -178.94 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.811 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 3.2 p90 -161.4 139.19 9.16 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.845 HG22 ' CE1' ' A' ' 121' ' ' TYR . 2.6 p -74.81 149.74 39.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.068 -1.02 . . . . 0.0 111.145 -178.202 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.778 HG13 ' HD2' ' A' ' 141' ' ' PRO . 55.7 t -111.71 145.46 32.7 Favored Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.778 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.8 Cg_endo -77.54 132.23 12.05 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.395 2.063 . . . . 0.0 109.882 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -85.87 37.63 3.07 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.407 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 2.7 m -105.27 -1.46 25.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.096 -1.238 . . . . 0.0 109.595 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.407 ' CG ' ' O ' ' A' ' 143' ' ' SER . 12.3 mttp -163.01 172.29 15.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.917 . . . . 0.0 109.57 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.575 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 5.0 p -95.3 -23.82 17.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.221 -0.925 . . . . 0.0 109.899 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 111' ' ' SER . 3.3 p -102.23 163.77 12.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.079 -1.013 . . . . 0.0 109.483 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.779 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -153.7 173.34 15.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.95 . . . . 0.0 109.682 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.1 t -104.45 152.39 22.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 109.097 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.821 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 34.0 mm -131.29 73.52 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.137 -0.977 . . . . 0.0 109.49 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.536 ' HA ' ' CB ' ' A' ' 107' ' ' SER . 3.7 m120 -80.7 -146.62 0.05 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.551 -0.718 . . . . 0.0 109.731 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 150' ' ' ASN . 4.9 m120 43.38 26.88 0.11 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 109.523 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.835 HG22 ' C ' ' A' ' 106' ' ' THR . 4.5 tt -93.37 158.28 2.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.281 -0.887 . . . . 0.0 109.549 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 153' ' ' LYS . 26.2 mmtt -114.17 120.51 38.37 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.92 . . . . 0.0 109.234 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.525 ' HA ' ' OG1' ' A' ' 184' ' ' THR . 35.4 Cg_endo -78.04 146.31 22.85 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.413 2.075 . . . . 0.0 110.566 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.705 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 93.7 60.0 1.17 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 162.3 131.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.411 -1.052 . . . . 0.0 109.41 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.452 ' HB3' HG21 ' A' ' 129' ' ' THR . 24.6 t0 -46.83 166.52 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.594 ' CD1' ' CG2' ' A' ' 184' ' ' THR . 0.2 OUTLIER -145.04 -178.2 5.93 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.51 -1.369 . . . . 0.0 110.048 -179.464 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.592 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 2.5 m -157.98 165.23 35.66 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.546 HD11 HD12 ' A' ' 108' ' ' LEU . 22.5 mt -155.27 132.57 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.749 -1.22 . . . . 0.0 110.11 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . 1.021 HG23 ' CB ' ' A' ' 179' ' ' SER . 1.6 m -136.91 172.09 13.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.855 . . . . 0.0 108.844 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.613 HD11 ' HG2' ' A' ' 95' ' ' PRO . 0.6 OUTLIER -163.42 151.55 13.48 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.679 -1.208 . . . . 0.0 111.597 -179.481 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.636 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 4.2 m-85 -125.11 120.79 32.41 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.814 ' HB3' ' OG ' ' A' ' 175' ' ' SER . . . -81.57 99.75 9.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.847 -1.158 . . . . 0.0 109.532 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.89 HG21 ' CZ ' ' A' ' 121' ' ' TYR . 18.7 t -78.46 142.98 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -0.898 . . . . 0.0 109.369 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.977 HG22 ' HA ' ' A' ' 119' ' ' VAL . 1.1 p -136.88 -42.68 0.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.394 -0.816 . . . . 0.0 109.732 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.527 ' HA3' ' HA ' ' A' ' 172' ' ' PRO . . . -53.33 -170.38 0.03 OUTLIER Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.405 ' O ' ' HB3' ' A' ' 172' ' ' PRO . 22.1 mtt180 -109.57 -158.22 0.64 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -1.17 . . . . 0.0 109.818 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -81.48 -35.49 22.8 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 2.4 m-20 -74.71 -1.13 20.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -1.173 . . . . 0.0 109.437 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 0.8 OUTLIER 168.93 75.16 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.282 -0.886 . . . . 0.0 108.963 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.527 ' HA ' ' HA3' ' A' ' 167' ' ' GLY . 35.3 Cg_endo -77.87 175.83 10.73 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.603 2.202 . . . . 0.0 110.339 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 165' ' ' VAL . . . -155.67 130.85 9.44 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.485 -0.759 . . . . 0.0 109.4 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.509 ' HB2' ' HB3' ' A' ' 163' ' ' TYR . 0.7 OUTLIER -112.33 104.71 12.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.814 ' OG ' ' HB3' ' A' ' 164' ' ' ALA . 0.6 OUTLIER -46.96 166.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.611 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.857 ' CB ' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -41.05 127.88 2.03 Favored Pre-proline 0 C--N 1.304 -1.383 0 O-C-N 121.595 -0.691 . . . . 0.0 109.878 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.636 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.2 Cg_endo -77.43 131.4 11.56 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.022 1.815 . . . . 0.0 110.492 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.34 137.48 47.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' SER . . . . . 1.021 ' CB ' HG23 ' A' ' 161' ' ' THR . 1.0 OUTLIER -129.53 165.67 21.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 110.811 -178.406 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.779 HG23 HD13 ' A' ' 98' ' ' LEU . 5.5 pt -144.2 -170.53 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -119.12 169.64 9.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.042 -1.036 . . . . 0.0 109.402 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.922 ' OH ' HD22 ' A' ' 108' ' ' LEU . 56.3 t80 -164.63 166.45 20.13 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.163 -0.961 . . . . 0.0 109.428 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -147.56 129.14 15.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.902 . . . . 0.0 109.455 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.594 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.48 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.625 HD11 ' CB ' ' A' ' 81' ' ' SER . 0.6 OUTLIER -157.21 -163.72 1.45 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.289 -1.124 . . . . 0.0 109.384 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.565 ' O ' HD12 ' A' ' 2' ' ' LEU . 1.1 m-20 -113.66 146.2 40.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.423 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.484 ' OG ' ' HG2' ' A' ' 82' ' ' PRO . 10.8 p -95.4 155.91 38.22 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 0.0 109.595 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.782 ' O ' HD22 ' A' ' 84' ' ' LEU . 36.3 Cg_endo -79.05 110.48 2.76 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.725 2.283 . . . . 0.0 110.128 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 8' ' ' PHE . 1.8 p -97.94 -113.21 0.15 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.131 -0.981 . . . . 0.0 109.472 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.457 ' HA3' ' HB ' ' A' ' 23' ' ' VAL . . . 44.14 27.08 1.02 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.426 ' N ' ' O ' ' A' ' 6' ' ' THR . 8.7 t80 -58.17 95.07 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.582 -0.952 . . . . 0.0 109.861 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.525 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 38.0 t70 -126.82 95.77 4.43 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.344 -0.848 . . . . 0.0 109.055 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.619 ' OG ' HG13 ' A' ' 20' ' ' VAL . 32.8 m -84.66 135.3 34.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.297 -0.877 . . . . 0.0 109.38 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.456 ' O ' ' C ' ' A' ' 12' ' ' ASP . 5.5 p -156.42 -159.78 0.92 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.407 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.535 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 1.2 m-20 45.96 40.7 7.18 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.61 ' HA ' ' HA ' ' A' ' 18' ' ' PHE . 1.5 mt -83.45 129.32 37.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.604 -177.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.594 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -115.91 174.1 6.21 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 178.194 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -67.63 -65.1 0.73 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.764 -1.21 . . . . 0.0 109.924 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.467 ' O ' ' OG ' ' A' ' 17' ' ' SER . 6.5 m-80 -86.66 17.15 4.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.012 -1.055 . . . . 0.0 110.017 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.749 ' HA ' HD12 ' A' ' 62' ' ' LEU . 21.8 m -168.46 156.37 8.18 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.933 ' CE1' HG22 ' A' ' 20' ' ' VAL . 4.3 p90 -165.89 143.05 5.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.143 -0.973 . . . . 0.0 109.281 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.535 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 8.5 m -89.55 156.17 18.79 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.849 -1.157 . . . . 0.0 111.293 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.933 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.3 t -132.58 134.34 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.536 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 2.1 m-70 -121.25 166.36 14.12 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.924 -1.11 . . . . 0.0 110.328 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.816 ' CH2' HG21 ' A' ' 50' ' ' VAL . 6.2 p90 -174.12 137.78 0.56 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.477 -0.765 . . . . 0.0 109.189 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -78.75 162.43 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.053 -1.029 . . . . 0.0 109.773 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.716 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -86.86 168.71 17.1 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.73 -0.606 . . . . 0.0 109.587 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.716 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 36.3 Cg_endo -79.45 -172.54 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.647 2.232 . . . . 0.0 110.459 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -113.87 16.09 18.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -0.871 . . . . 0.0 109.3 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.99 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -124.55 177.9 1.63 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.341 -0.849 . . . . 0.0 109.26 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.99 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 34.6 Cg_endo -77.84 135.84 14.54 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.476 2.117 . . . . 0.0 110.256 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.501 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 45.9 pt -152.04 -179.13 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.915 . . . . 0.0 109.546 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.8 p -114.32 -20.89 10.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 109.476 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.16 172.1 28.04 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.618 ' CE2' ' HA ' ' A' ' 52' ' ' PRO . 0.5 OUTLIER -112.17 150.25 31.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -1.154 . . . . 0.0 109.47 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.955 HG23 ' HD2' ' A' ' 49' ' ' ARG . 1.4 mp -95.08 137.23 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.158 -0.964 . . . . 0.0 108.858 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.847 HD13 ' C ' ' A' ' 33' ' ' ILE . 3.4 mm -116.94 95.05 3.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.4 -0.812 . . . . 0.0 109.937 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.507 ' HG3' ' HA ' ' A' ' 47' ' ' GLN . 54.7 ttp180 -106.28 117.01 32.93 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 108.522 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.535 ' NE2' ' HG2' ' A' ' 46' ' ' ARG . 3.1 p-80 -106.69 147.35 29.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.966 -1.084 . . . . 0.0 110.273 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.521 ' NE2' ' HB ' ' A' ' 69' ' ' VAL . 41.3 p-80 -162.05 124.43 2.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.45 -0.781 . . . . 0.0 109.577 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -56.58 -161.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.263 -0.898 . . . . 0.0 109.624 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.419 ' HG3' ' HB2' ' A' ' 67' ' ' GLU . 4.1 mm-40 -83.68 -97.17 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.769 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -105.32 -6.71 19.41 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.774 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.6 p -81.43 116.08 21.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.134 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 42' ' ' VAL . 1.5 p -74.91 92.81 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.171 -0.956 . . . . 0.0 109.448 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.546 ' C ' ' HD3' ' A' ' 45' ' ' PRO . . . -105.63 -105.18 3.0 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.516 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 12.9 mtt180 -122.3 55.93 7.08 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.256 -1.144 . . . . 0.0 110.41 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.546 ' HD3' ' C ' ' A' ' 43' ' ' GLY . 35.2 Cg_endo -75.04 81.78 2.15 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.204 1.936 . . . . 0.0 110.434 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.535 ' HG2' ' NE2' ' A' ' 36' ' ' HIS . 12.9 ptm180 -105.73 169.72 8.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.246 -0.909 . . . . 0.0 109.531 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.507 ' HA ' ' HG3' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -105.89 114.17 28.16 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.341 -0.849 . . . . 0.0 109.48 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.495 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 19.5 m-20 -107.42 168.81 8.98 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.955 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -136.4 164.07 28.99 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.509 -0.744 . . . . 0.0 109.587 -179.524 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.816 HG21 ' CH2' ' A' ' 22' ' ' TRP . 33.5 m -149.56 158.86 37.39 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.421 -0.799 . . . . 0.0 109.295 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 33.9 Cg_endo -75.72 174.25 13.13 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.529 2.153 . . . . 0.0 110.373 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.618 ' HA ' ' CE2' ' A' ' 32' ' ' TYR . 34.3 Cg_endo -76.63 -22.63 11.9 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.574 2.182 . . . . 0.0 110.68 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.95 -8.77 53.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.135 -0.978 . . . . 0.0 109.505 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.533 ' HD3' ' N ' ' A' ' 54' ' ' ARG . 1.6 mpt_? -94.78 112.13 23.88 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.291 -0.881 . . . . 0.0 109.593 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 7.9 p-10 -107.41 -2.29 20.68 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.448 -0.782 . . . . 0.0 109.725 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 27.0 p -136.17 129.83 32.3 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.111 -0.993 . . . . 0.0 109.815 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.608 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 1.9 tt -129.44 120.28 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -0.871 . . . . 0.0 109.045 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 0.3 OUTLIER -88.09 131.43 34.69 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.298 -0.876 . . . . 0.0 109.615 -179.601 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.817 ' HB3' HD11 ' A' ' 62' ' ' LEU . 1.3 mt -104.56 142.63 34.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 109.38 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.469 ' HA ' ' OG ' ' A' ' 17' ' ' SER . 6.7 p -130.02 178.12 6.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.949 . . . . 0.0 109.537 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.9 m120 54.78 40.95 32.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 109.497 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.817 HD11 ' HB3' ' A' ' 59' ' ' LEU . 4.6 mt -111.94 145.12 40.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.301 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.463 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 2.6 m120 -54.63 130.6 64.17 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.113 -0.992 . . . . 0.0 108.681 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.1 Cg_endo -77.4 125.36 7.66 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.217 1.944 . . . . 0.0 110.642 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 80.46 61.73 2.16 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 90' ' ' THR . 3.5 m -152.89 155.85 37.84 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.349 -1.089 . . . . 0.0 110.385 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 2.0 mp0 -85.43 116.95 24.05 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.552 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 9.8 m-85 -112.72 106.88 15.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.121 -0.987 . . . . 0.0 109.898 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.521 ' HB ' ' NE2' ' A' ' 37' ' ' HIS . 3.4 t -73.93 133.03 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.923 . . . . 0.0 108.839 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 19.4 t -122.36 117.72 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.096 -1.002 . . . . 0.0 109.837 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.543 ' CB ' HG12 ' A' ' 85' ' ' ILE . 1.8 p -92.84 133.37 36.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.0 110.282 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.501 ' HB ' HD23 ' A' ' 84' ' ' LEU . 21.4 mm -120.74 79.39 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.808 HD13 ' HA ' ' A' ' 83' ' ' PRO . 23.4 mm -76.75 163.87 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.943 . . . . 0.0 109.604 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.012 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -131.71 117.22 18.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.54 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -107.65 173.98 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.289 -0.882 . . . . 0.0 109.283 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.497 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 18.6 t30 -153.33 49.35 0.7 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 109.446 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.69 -80.72 1.73 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.433 ' NH2' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -119.74 -1.95 10.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -1.15 . . . . 0.0 109.59 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 1.2 mp0 -90.9 -173.44 3.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.371 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 16.8 mt-10 -156.65 93.56 1.39 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.19 -0.943 . . . . 0.0 109.584 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . 1.012 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -59.48 178.85 0.22 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.014 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.554 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.4 Cg_endo -76.8 158.16 35.15 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.289 1.992 . . . . 0.0 110.167 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.808 ' HA ' HD13 ' A' ' 73' ' ' ILE . 34.7 Cg_endo -77.15 145.25 24.29 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.621 2.214 . . . . 0.0 111.103 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.782 HD22 ' O ' ' A' ' 5' ' ' PRO . 25.5 tp -136.21 85.97 2.19 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.543 HG12 ' CB ' ' A' ' 71' ' ' SER . 2.3 mt -99.93 139.85 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.185 -0.947 . . . . 0.0 109.789 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -128.08 -171.13 12.95 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -148.59 125.04 10.97 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.14 -1.211 . . . . 0.0 109.691 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.563 ' HG3' ' CB ' ' A' ' 10' ' ' SER . 1.1 tm0? -135.81 114.61 12.02 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.321 -0.862 . . . . 0.0 109.006 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -74.9 133.53 41.78 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.295 -0.878 . . . . 0.0 110.02 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.15 138.12 43.63 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.336 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.938 HG13 ' HB3' ' A' ' 116' ' ' ALA . 1.4 t -50.37 155.09 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.891 ' O ' HG22 ' A' ' 117' ' ' VAL . 1.2 m -114.78 162.38 16.94 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.389 -0.82 . . . . 0.0 109.747 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.93 -45.35 3.33 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.818 HG23 ' HD2' ' A' ' 95' ' ' PRO . 3.1 mt -99.85 145.56 30.37 Favored Pre-proline 0 C--N 1.304 -1.373 0 O-C-N 121.382 -0.824 . . . . 0.0 109.518 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.818 ' HD2' HG23 ' A' ' 94' ' ' ILE . 34.3 Cg_endo -77.28 -161.53 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.319 2.013 . . . . 0.0 109.346 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 1.5 ptm85 -168.44 171.91 8.7 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.072 -1.018 . . . . 0.0 109.575 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 2.0 t70 79.47 17.86 0.8 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 0.0 109.661 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.818 HD12 ' CG2' ' A' ' 180' ' ' ILE . 0.8 OUTLIER -54.33 87.22 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.225 -0.922 . . . . 0.0 109.486 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 97' ' ' ASP . 0.6 OUTLIER -138.89 169.49 17.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.107 -0.996 . . . . 0.0 109.796 -179.748 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 7.0 p -102.84 144.01 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -0.878 . . . . 0.0 109.81 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.551 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 6.8 pt -126.1 -4.49 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.367 -0.833 . . . . 0.0 109.266 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.874 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -151.74 88.87 1.43 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.541 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 6.0 p -84.09 93.52 8.14 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.595 -0.69 . . . . 0.0 110.27 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.46 ' OG1' ' OG ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -84.42 161.38 54.41 Favored Pre-proline 0 C--N 1.306 -1.297 0 O-C-N 121.127 -0.983 . . . . 0.0 108.949 179.156 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.477 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.6 Cg_endo -69.65 -3.04 11.14 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.44 2.093 . . . . 0.0 110.56 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.771 ' C ' HG22 ' A' ' 152' ' ' ILE . 37.8 p -151.33 19.1 0.74 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.48 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 1.1 p -170.85 176.22 4.21 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.719 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.875 HD12 ' N ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -154.11 155.91 36.27 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.406 -0.809 . . . . 0.0 109.143 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.874 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.6 OUTLIER -102.33 123.73 46.65 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.248 -0.908 . . . . 0.0 108.572 179.122 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.701 HD13 ' CD1' ' A' ' 149' ' ' ILE . 0.0 OUTLIER -103.21 135.41 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.122 -0.987 . . . . 0.0 109.92 -179.33 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 97' ' ' ASP . 0.4 OUTLIER -131.0 128.57 40.64 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.505 -0.747 . . . . 0.0 108.997 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.578 ' CD2' ' O ' ' A' ' 145' ' ' SER . 28.2 p90 -151.55 145.36 25.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.403 -0.81 . . . . 0.0 109.325 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.474 ' HB2' ' HG2' ' A' ' 96' ' ' ARG . 29.2 mm-40 -81.4 130.48 61.98 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 0.0 109.408 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.466 ' HD3' ' HB3' ' A' ' 145' ' ' SER . 36.4 Cg_endo -78.92 151.22 24.09 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.458 2.105 . . . . 0.0 110.598 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.547 ' HG2' ' CG2' ' A' ' 119' ' ' VAL . 35.4 Cg_endo -78.37 -169.09 0.7 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.744 2.296 . . . . 0.0 110.148 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.938 ' HB3' HG13 ' A' ' 91' ' ' VAL . . . -113.68 -14.49 12.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.121 -0.987 . . . . 0.0 109.704 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.891 HG22 ' O ' ' A' ' 92' ' ' SER . 18.6 m -74.73 165.49 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.212 -0.93 . . . . 0.0 109.083 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.475 ' O ' HG22 ' A' ' 166' ' ' THR . 0.3 OUTLIER -69.5 106.08 2.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 109.684 -179.35 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.591 HG11 ' CZ ' ' A' ' 122' ' ' TYR . 58.2 t -95.26 132.41 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.334 -0.854 . . . . 0.0 109.535 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER -74.55 -64.5 1.02 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.236 -0.915 . . . . 0.0 108.684 179.494 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.998 ' CE1' HG22 ' A' ' 139' ' ' THR . 3.0 p90 -165.42 171.4 13.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.456 -0.778 . . . . 0.0 109.01 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 4.0 m-85 -115.18 145.98 41.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.035 -1.041 . . . . 0.0 109.737 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.6 ' HG2' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -108.39 95.8 5.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.459 -0.776 . . . . 0.0 109.197 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.882 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 45.1 mt -84.36 145.12 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.315 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 77.0 p -131.54 144.53 51.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.945 . . . . 0.0 110.451 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 1.22 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 2.8 m-30 -88.06 132.19 34.38 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.589 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.68 111.35 3.64 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.483 ' O ' ' HB3' ' A' ' 132' ' ' ASN . 14.1 mt-10 -106.16 141.97 36.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -1.139 . . . . 0.0 109.45 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.765 HG21 ' HB3' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -90.16 140.03 30.06 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.999 -1.063 . . . . 0.0 109.776 179.833 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.98 93.46 1.01 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 51.85 80.11 0.07 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' A' ' 128' ' ' GLU . 7.6 p30 -134.03 29.06 3.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -1.128 . . . . 0.0 109.735 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.567 ' CB ' ' HD3' ' A' ' 134' ' ' PRO . 0.1 OUTLIER -44.61 -54.05 13.54 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.114 -0.991 . . . . 0.0 109.32 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.567 ' HD3' ' CB ' ' A' ' 133' ' ' SER . 36.4 Cg_endo -79.39 77.18 4.19 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.426 2.084 . . . . 0.0 110.254 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 126' ' ' TYR . 3.2 m -66.1 176.93 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.266 -0.896 . . . . 0.0 109.376 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.601 ' HB3' ' CG ' ' A' ' 126' ' ' TYR . 2.8 tt0 -101.95 103.38 14.02 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.148 -0.97 . . . . 0.0 109.131 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 18.7 tt0 -102.34 118.48 36.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.858 . . . . 0.0 111.076 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.882 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 35.9 p90 -121.92 142.49 50.23 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.998 HG22 ' CE1' ' A' ' 121' ' ' TYR . 1.5 p -74.15 175.06 7.86 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.966 -1.084 . . . . 0.0 110.834 -178.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.694 HG13 ' HD2' ' A' ' 141' ' ' PRO . 53.7 t -144.35 142.73 20.07 Favored Pre-proline 0 C--N 1.304 -1.392 0 O-C-N 121.553 -0.717 . . . . 0.0 109.321 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.694 ' HD2' HG13 ' A' ' 140' ' ' VAL . 35.2 Cg_endo -77.34 148.73 27.06 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.454 2.103 . . . . 0.0 110.331 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.06 17.88 39.31 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.4 p -105.25 27.81 7.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -1.151 . . . . 0.0 109.613 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.99 139.01 4.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 0.0 109.585 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.578 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 1.3 p -92.48 -15.56 26.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 109.404 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.5 p -123.12 132.39 54.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.292 -0.88 . . . . 0.0 109.185 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.478 ' HB2' ' HH2' ' A' ' 112' ' ' TRP . . . -120.91 -165.43 1.21 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.23 -0.918 . . . . 0.0 109.239 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.635 HG22 ' N ' ' A' ' 149' ' ' ILE . 23.8 m -145.13 166.08 26.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.151 -0.968 . . . . 0.0 109.646 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 1.22 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 1.2 mt -137.12 121.76 24.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.3 -0.875 . . . . 0.0 109.334 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.478 ' HA ' ' HB3' ' A' ' 107' ' ' SER . 6.8 m-80 -123.2 177.27 5.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.4 -0.812 . . . . 0.0 109.514 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 2.7 m-20 65.54 31.43 10.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 109.161 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.771 HG22 ' C ' ' A' ' 106' ' ' THR . 16.2 tt -89.86 166.9 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.397 -0.814 . . . . 0.0 109.714 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -107.14 112.17 63.14 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 109.445 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.525 ' HA ' ' OG1' ' A' ' 184' ' ' THR . 34.7 Cg_endo -77.26 167.12 25.24 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.454 2.103 . . . . 0.0 110.6 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.69 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 76.73 57.23 3.88 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 163.55 134.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -1.128 . . . . 0.0 109.516 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.765 ' HB3' HG21 ' A' ' 129' ' ' THR . 0.6 OUTLIER -51.49 164.57 0.2 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.093 -1.004 . . . . 0.0 108.443 179.436 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.589 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.4 OUTLIER -142.0 177.06 8.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.8 -1.187 . . . . 0.0 110.381 -179.528 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.54 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 2.2 m -147.73 109.66 4.48 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.404 HG23 HD12 ' A' ' 160' ' ' ILE . 21.8 mm -97.59 134.87 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.789 -1.194 . . . . 0.0 109.994 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.614 HG23 ' HB3' ' A' ' 179' ' ' SER . 68.8 m -145.11 147.65 32.76 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.283 -0.886 . . . . 0.0 109.717 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.615 HD23 ' H ' ' A' ' 162' ' ' LEU . 2.6 pt? -140.26 150.61 44.29 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.177 -0.952 . . . . 0.0 110.112 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.615 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 4.1 m-85 -115.47 -176.15 2.86 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -147.02 104.32 3.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.862 . . . . 0.0 109.153 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.935 HG21 ' CE2' ' A' ' 121' ' ' TYR . 63.8 t -79.82 133.16 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 109.909 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.53 ' O ' ' CG ' ' A' ' 168' ' ' ARG . 0.7 OUTLIER -130.52 -49.83 1.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.558 -0.714 . . . . 0.0 109.526 179.812 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.489 ' C ' ' CG ' ' A' ' 168' ' ' ARG . . . -42.84 151.83 0.31 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.53 ' CG ' ' O ' ' A' ' 166' ' ' THR . 2.0 mtp180 -156.67 58.3 0.55 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.354 -1.086 . . . . 0.0 109.389 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -152.17 -100.89 0.2 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.515 ' O ' ' CB ' ' A' ' 171' ' ' SER . 12.5 t70 -77.13 2.79 14.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -1.126 . . . . 0.0 109.688 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 1.0 OUTLIER 163.94 138.07 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.216 -0.928 . . . . 0.0 109.164 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.63 102.58 1.61 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.5 2.133 . . . . 0.0 110.44 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 165' ' ' VAL . . . -84.66 -171.88 3.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.261 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 16.7 p -164.38 135.41 4.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 109.698 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.524 ' HB2' ' CG1' ' A' ' 94' ' ' ILE . 51.9 p -53.91 -176.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.322 -0.861 . . . . 0.0 109.303 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.553 ' CB ' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -66.36 140.92 96.93 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.139 -0.975 . . . . 0.0 108.809 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.615 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 35.0 Cg_endo -78.18 136.47 14.48 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.335 2.023 . . . . 0.0 111.145 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.472 ' O ' HD23 ' A' ' 162' ' ' LEU . 2.1 t -108.12 138.14 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.614 ' HB3' HG23 ' A' ' 161' ' ' THR . 80.7 p -133.91 173.65 11.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.065 -1.022 . . . . 0.0 110.75 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.818 ' CG2' HD12 ' A' ' 98' ' ' LEU . 38.2 pt -154.53 169.08 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -98.49 178.29 5.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.042 -1.036 . . . . 0.0 109.686 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.83 ' CZ ' HD23 ' A' ' 108' ' ' LEU . 25.0 t80 -163.33 172.21 14.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -0.859 . . . . 0.0 109.605 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 157' ' ' ASP . 6.6 tttt -148.85 109.75 4.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 109.264 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.525 ' OG1' ' HA ' ' A' ' 154' ' ' PRO . 1.4 p . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.482 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 1.006 ' O ' HD23 ' A' ' 2' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 1.006 HD23 ' O ' ' A' ' 1' ' ' GLY . 3.2 mt -142.45 -166.3 2.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -1.165 . . . . 0.0 109.246 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 1.6 m-20 -80.11 135.9 36.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.908 . . . . 0.0 109.363 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.87 111.42 55.94 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 109.964 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.763 ' O ' HD22 ' A' ' 84' ' ' LEU . 35.0 Cg_endo -77.05 112.26 3.38 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.471 2.114 . . . . 0.0 109.629 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 22' ' ' TRP . 1.7 p -110.31 -110.22 0.33 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.187 -0.945 . . . . 0.0 109.856 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 9' ' ' ASP . . . 46.5 25.23 1.99 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -46.24 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.426 -1.043 . . . . 0.0 109.855 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 7' ' ' GLY . 7.3 t0 -126.92 101.45 6.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.358 -0.839 . . . . 0.0 108.795 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.972 ' OG ' HG13 ' A' ' 20' ' ' VAL . 38.2 m -87.25 143.58 27.21 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.166 -0.959 . . . . 0.0 110.217 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.488 ' O ' ' HB ' ' A' ' 19' ' ' THR . 49.1 p -144.35 -161.34 1.26 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.512 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 1.4 m-20 42.73 35.95 0.77 Allowed 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -178.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.707 HG22 HG23 ' A' ' 91' ' ' VAL . 1.3 mt -77.21 156.48 5.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 122.582 1.182 . . . . 0.0 112.638 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.765 ' O ' HG22 ' A' ' 90' ' ' THR . 0.0 OUTLIER -150.57 161.74 41.97 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 177.226 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.944 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -73.98 -36.21 64.54 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.324 -1.485 . . . . 0.0 109.704 -178.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.6 OUTLIER -98.59 22.11 10.35 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.048 -1.032 . . . . 0.0 108.809 179.453 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.587 ' HA ' HD12 ' A' ' 62' ' ' LEU . 13.0 p 167.01 154.96 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.935 ' CE1' HG22 ' A' ' 20' ' ' VAL . 8.9 p90 -166.95 139.49 3.51 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.653 -1.279 . . . . 0.0 109.681 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 28.8 m -79.47 152.72 30.09 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.94 -1.1 . . . . 0.0 110.743 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.972 HG13 ' OG ' ' A' ' 10' ' ' SER . 2.5 t -126.04 135.07 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.569 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 2.6 m-70 -126.98 170.89 11.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.91 -1.119 . . . . 0.0 110.339 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.611 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 27.8 p90 -179.85 149.18 0.34 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -76.89 147.78 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 120.966 -1.084 . . . . 0.0 109.929 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.531 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -76.47 161.63 73.87 Favored Pre-proline 0 C--N 1.298 -1.66 0 O-C-N 121.835 -0.541 . . . . 0.0 109.57 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.557 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 35.9 Cg_endo -78.09 153.41 28.49 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.582 2.188 . . . . 0.0 110.478 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.459 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 17.0 mtt180 -75.35 -0.92 21.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 109.569 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.641 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -102.17 164.75 15.15 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 109.579 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.641 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.9 Cg_endo -78.38 105.66 2.01 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.729 2.286 . . . . 0.0 110.357 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.557 ' CG2' ' HG2' ' A' ' 25' ' ' PRO . 31.4 pt -100.37 168.61 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.425 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.637 HG23 ' HA ' ' A' ' 76' ' ' ASN . 59.8 p -113.23 -16.67 12.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.0 109.338 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.82 -165.23 35.25 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 1.098 ' CZ ' ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -165.42 120.72 1.31 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -1.151 . . . . 0.0 110.049 -179.818 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.878 ' O ' HD13 ' A' ' 34' ' ' ILE . 22.2 mm -75.33 147.89 7.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 121.104 -0.998 . . . . 0.0 108.658 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.988 ' CG1' HG22 ' A' ' 50' ' ' VAL . 14.7 mm -133.24 92.89 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.078 -1.014 . . . . 0.0 109.857 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.542 ' CG ' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -100.57 157.01 16.98 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.171 -0.955 . . . . 0.0 108.69 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.606 ' CG ' ' CD2' ' A' ' 59' ' ' LEU . 1.3 p-80 -143.15 143.27 31.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.004 -1.06 . . . . 0.0 110.055 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.579 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 37.2 p-80 -163.16 130.57 3.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.377 -0.827 . . . . 0.0 109.716 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 1.063 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . -75.28 130.84 39.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.258 -0.901 . . . . 0.0 109.256 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.15 -13.61 28.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.166 -0.959 . . . . 0.0 109.359 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -108.24 15.72 23.85 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.478 -0.764 . . . . 0.0 109.28 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.794 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 52.5 p -92.84 152.83 19.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.619 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.0 t -115.77 -0.27 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.253 -0.904 . . . . 0.0 109.586 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.88 156.01 19.26 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.47 ' HA ' ' NE ' ' A' ' 44' ' ' ARG . 5.8 mmp_? -45.54 147.16 1.54 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.207 -1.172 . . . . 0.0 109.463 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.517 ' HB3' ' CB ' ' A' ' 37' ' ' HIS . 36.0 Cg_endo -78.28 137.59 15.22 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.623 2.215 . . . . 0.0 110.293 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.539 ' HB2' ' NE2' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -74.86 169.25 18.3 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.166 -0.959 . . . . 0.0 109.747 -179.846 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 35' ' ' ARG . 29.3 mt-30 -141.06 111.49 6.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -0.866 . . . . 0.0 109.979 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.534 ' O ' ' CD ' ' A' ' 49' ' ' ARG . 20.9 m-20 -110.78 178.59 4.31 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.604 HH11 HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -153.98 155.74 36.13 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.217 -0.927 . . . . 0.0 109.951 -179.736 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.988 HG22 ' CG1' ' A' ' 34' ' ' ILE . 15.9 m -142.46 160.9 52.56 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.477 -0.764 . . . . 0.0 108.989 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.537 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 33.7 Cg_endo -75.82 173.94 13.66 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.369 2.046 . . . . 0.0 110.211 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.494 ' HB3' HG13 ' A' ' 29' ' ' ILE . 35.0 Cg_endo -77.16 -17.44 15.04 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.491 2.127 . . . . 0.0 110.568 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.1 t -102.23 17.29 23.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 109.342 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.537 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -115.56 104.63 11.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -0.865 . . . . 0.0 109.454 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 2.7 p-10 -89.38 -6.17 56.83 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.923 . . . . 0.0 109.561 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 6.3 p -126.23 142.76 51.4 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.39 -0.819 . . . . 0.0 109.567 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.955 HD12 HG13 ' A' ' 50' ' ' VAL . 5.1 tt -137.11 134.72 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 109.391 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 87.8 m -96.63 125.49 41.14 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.194 -0.941 . . . . 0.0 109.6 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.638 ' HB3' HD11 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -102.99 142.24 34.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 109.354 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.494 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 0.9 OUTLIER -122.4 156.67 33.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 109.799 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.981 ' O ' HD23 ' A' ' 62' ' ' LEU . 9.0 m-80 62.27 79.83 0.24 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.364 -0.835 . . . . 0.0 109.905 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.981 HD23 ' O ' ' A' ' 61' ' ' ASN . 6.5 mt -143.24 138.88 29.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -0.881 . . . . 0.0 109.414 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 62' ' ' LEU . 4.9 m-80 -42.59 136.01 2.57 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 109.429 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.678 ' HB3' HG11 ' A' ' 117' ' ' VAL . 36.6 Cg_endo -79.2 131.42 9.76 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.476 2.118 . . . . 0.0 110.732 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 63.47 64.15 3.95 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.249 -1.941 . . . . 0.0 108.249 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 m -156.72 151.72 26.14 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.391 -1.064 . . . . 0.0 110.667 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -85.38 123.92 31.39 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.633 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 1.063 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 3.1 m-85 -111.25 133.8 53.32 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.073 -1.017 . . . . 0.0 110.605 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.708 HG12 HG23 ' A' ' 85' ' ' ILE . 1.6 t -89.16 107.79 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.58 HG13 ' HB3' ' A' ' 36' ' ' HIS . 1.6 t -103.53 129.47 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.205 -0.935 . . . . 0.0 109.533 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.568 ' CB ' HG12 ' A' ' 85' ' ' ILE . 1.3 p -100.07 147.05 26.06 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.142 -0.974 . . . . 0.0 110.35 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.821 HG22 ' CD1' ' A' ' 32' ' ' TYR . 5.1 mm -131.62 94.22 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.664 HD12 ' N ' ' A' ' 73' ' ' ILE . 1.4 mp -90.62 135.86 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 109.716 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.098 ' HB2' ' CZ ' ' A' ' 32' ' ' TYR . . . -96.85 144.22 27.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -0.83 . . . . 0.0 109.522 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.423 ' O ' ' OG1' ' A' ' 30' ' ' THR . 1.7 m -130.99 133.18 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.275 -0.891 . . . . 0.0 109.058 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.637 ' HA ' HG23 ' A' ' 30' ' ' THR . 24.9 t30 -116.35 45.1 1.85 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.792 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.67 -81.55 1.71 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.42 -5.83 16.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -1.186 . . . . 0.0 109.816 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 76' ' ' ASN . 16.2 tp10 -107.34 155.92 19.47 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.242 -0.911 . . . . 0.0 109.247 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.485 ' N ' ' HG3' ' A' ' 79' ' ' GLU . 8.1 mt-10 -129.94 105.61 8.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.214 -0.928 . . . . 0.0 109.473 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.569 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -63.96 -179.87 0.31 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.218 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.569 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.4 Cg_endo -77.52 155.76 31.98 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.358 2.039 . . . . 0.0 110.513 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.6 Cg_endo -77.83 136.14 14.82 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.706 2.27 . . . . 0.0 111.099 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.763 HD22 ' O ' ' A' ' 5' ' ' PRO . 15.5 tp -117.71 93.27 4.09 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.708 HG23 HG12 ' A' ' 69' ' ' VAL . 2.5 mt -96.09 141.36 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.118 -0.989 . . . . 0.0 109.572 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 69' ' ' VAL . . . -130.43 -177.67 15.01 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.446 ' CG ' HG13 ' A' ' 69' ' ' VAL . 60.7 mt-30 -146.18 101.26 3.49 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.187 -1.184 . . . . 0.0 109.961 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.526 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 41.8 mm-40 -98.26 -161.17 0.85 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -144.65 130.93 19.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.916 -1.115 . . . . 0.0 110.37 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -74.37 139.01 43.79 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.224 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.707 HG23 HG22 ' A' ' 13' ' ' ILE . 12.1 t -41.68 169.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-O 121.557 0.694 . . . . 0.0 110.29 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.572 ' N ' HG12 ' A' ' 91' ' ' VAL . 64.7 p -110.22 168.26 9.58 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.251 -0.906 . . . . 0.0 109.685 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 1.007 ' OD2' HG13 ' A' ' 119' ' ' VAL . 16.2 t70 -84.97 22.37 1.41 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.494 -0.754 . . . . 0.0 110.236 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.887 HD11 ' HB2' ' A' ' 176' ' ' LYS . 1.1 mt -42.86 142.39 1.43 Allowed Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.75 -1.219 . . . . 0.0 109.501 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.701 ' CG ' HD11 ' A' ' 162' ' ' LEU . 36.8 Cg_endo -83.1 113.57 2.13 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.666 2.244 . . . . 0.0 109.744 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 2.2 ptt180 -106.27 153.41 22.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.055 -1.028 . . . . 0.0 109.851 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.9 OUTLIER 76.98 25.82 0.79 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 109.853 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.902 HD22 ' CD2' ' A' ' 162' ' ' LEU . 31.1 tp -64.01 100.46 0.32 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.064 -1.022 . . . . 0.0 109.239 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 110' ' ' ILE . 18.4 pt-20 -128.22 170.15 13.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.95 . . . . 0.0 109.572 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.614 HG22 ' H ' ' A' ' 101' ' ' ILE . 9.1 p -109.24 172.66 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 109.766 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.736 HD11 ' HB3' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -150.3 -81.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.361 -0.837 . . . . 0.0 109.226 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 1.066 ' HB3' HD13 ' A' ' 109' ' ' LEU . . . -74.89 101.84 4.55 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.528 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 5.2 p -98.98 90.14 4.53 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.868 . . . . 0.0 110.479 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.612 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -76.5 165.71 50.57 Favored Pre-proline 0 C--N 1.306 -1.325 0 O-C-N 121.154 -0.966 . . . . 0.0 108.759 178.884 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 29.9 Cg_endo -69.42 -2.81 10.57 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.421 2.081 . . . . 0.0 110.602 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.774 ' C ' HG22 ' A' ' 152' ' ' ILE . 1.0 OUTLIER -150.64 17.49 0.8 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.394 -0.817 . . . . 0.0 108.805 179.002 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' SER . . . . . 1.034 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -169.05 159.33 9.13 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.127 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.034 HD23 ' O ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -143.87 154.69 43.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.324 -0.86 . . . . 0.0 109.263 -179.818 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 1.066 HD13 ' HB3' ' A' ' 102' ' ' ALA . 0.4 OUTLIER -105.58 132.97 51.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.318 -0.863 . . . . 0.0 108.833 179.32 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.757 HD11 HD13 ' A' ' 124' ' ' ILE . 1.1 pt -115.67 144.69 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.084 -1.01 . . . . 0.0 109.96 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' A' ' 146' ' ' THR . 32.6 t -143.31 126.55 16.57 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.585 ' CZ3' ' HA ' ' A' ' 146' ' ' THR . 3.3 p90 -123.33 171.33 9.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.947 . . . . 0.0 109.835 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 96' ' ' ARG . 6.0 mm-40 -94.81 165.33 17.36 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.388 -0.82 . . . . 0.0 109.338 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 113' ' ' GLU . 34.6 Cg_endo -78.2 127.36 8.32 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.621 2.214 . . . . 0.0 110.564 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.515 ' HG2' ' OD1' ' A' ' 93' ' ' ASP . 34.6 Cg_endo -76.91 -152.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.608 2.205 . . . . 0.0 110.206 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.579 ' HB1' ' H ' ' A' ' 15' ' ' ALA . . . -69.05 -1.36 7.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -0.956 . . . . 0.0 109.817 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.944 ' CG1' ' HB3' ' A' ' 15' ' ' ALA . 1.8 m -150.24 -163.09 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.937 -1.102 . . . . 0.0 110.263 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.73 ' O ' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -97.69 -164.5 1.15 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.065 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 1.013 HG11 ' CE2' ' A' ' 122' ' ' TYR . 1.4 t -141.48 129.3 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.635 -1.29 . . . . 0.0 110.87 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.545 ' O ' ' NE ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -74.86 -49.42 20.53 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.467 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.619 ' CE2' HG22 ' A' ' 139' ' ' THR . 1.8 p90 -163.99 173.08 13.01 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 1.013 ' CE2' HG11 ' A' ' 119' ' ' VAL . 0.2 OUTLIER -135.01 150.37 50.31 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.692 -1.255 . . . . 0.0 110.69 -179.014 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.496 ' HG2' ' CE2' ' A' ' 121' ' ' TYR . 15.6 mtp180 -109.42 92.63 4.13 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.757 HD13 HD11 ' A' ' 110' ' ' ILE . 52.8 mt -84.2 163.83 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.926 . . . . 0.0 110.421 -178.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.596 ' N ' HG22 ' A' ' 124' ' ' ILE . 23.3 p -145.35 140.85 28.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.505 -0.747 . . . . 0.0 109.586 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.651 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 2.6 m-85 -82.06 134.24 35.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.876 . . . . 0.0 109.227 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.62 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -106.0 124.87 7.98 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 129' ' ' THR . 15.5 mt-10 -105.1 148.7 26.54 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.213 -1.169 . . . . 0.0 109.201 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.65 HG23 ' N ' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -40.89 -92.98 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.394 -0.816 . . . . 0.0 110.08 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -139.33 -102.04 0.53 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 46.84 24.68 1.99 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 51.77 20.97 1.26 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -1.17 . . . . 0.0 109.394 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.3 148.87 95.84 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.238 -0.914 . . . . 0.0 109.353 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.65 -162.15 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.542 2.162 . . . . 0.0 110.321 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 126' ' ' TYR . 0.7 OUTLIER -120.28 157.64 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.204 -0.935 . . . . 0.0 109.369 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -112.6 100.53 8.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 108.948 179.525 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 2.1 pt-20 -92.8 154.0 18.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.379 -0.826 . . . . 0.0 110.918 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.612 ' CE1' ' HB ' ' A' ' 124' ' ' ILE . 31.7 p90 -164.74 147.39 8.53 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.619 HG22 ' CE2' ' A' ' 121' ' ' TYR . 0.8 OUTLIER -73.85 -176.6 2.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.011 -1.056 . . . . 0.0 110.553 -178.19 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.704 ' CG2' HD12 ' A' ' 124' ' ' ILE . 71.6 t -146.69 139.07 13.91 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.465 -0.772 . . . . 0.0 109.199 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.579 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.8 Cg_endo -76.97 127.88 9.63 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.419 2.079 . . . . 0.0 110.396 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -79.4 51.16 3.9 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.504 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 1.0 OUTLIER -104.65 -3.4 23.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.18 -1.188 . . . . 0.0 109.457 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.504 ' CG ' ' O ' ' A' ' 143' ' ' SER . 18.2 mttt -165.3 174.66 9.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 0.0 109.275 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.443 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 4.7 p -93.15 4.35 54.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.512 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.585 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 3.1 p -119.11 155.76 30.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.317 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.57 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -129.61 161.22 31.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.411 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.581 ' O ' HD13 ' A' ' 149' ' ' ILE . 12.6 m -107.69 153.63 22.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.269 -0.894 . . . . 0.0 109.521 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.651 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 7.5 mm -134.65 119.03 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.352 -0.842 . . . . 0.0 109.304 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.531 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 41.8 m-20 -124.72 173.79 8.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.323 -0.86 . . . . 0.0 109.825 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 15.2 m120 62.94 33.92 14.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.134 -0.979 . . . . 0.0 109.074 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.774 HG22 ' C ' ' A' ' 106' ' ' THR . 7.2 tt -89.32 147.68 5.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.519 -0.738 . . . . 0.0 109.739 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.4 ' HB2' ' OH ' ' A' ' 158' ' ' TYR . 25.3 mttt -82.67 113.87 47.98 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.175 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.493 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 35.8 Cg_endo -78.11 146.61 22.9 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.413 2.075 . . . . 0.0 110.606 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.661 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 78.2 65.28 1.89 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 166.7 128.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -1.163 . . . . 0.0 109.772 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.65 ' N ' HG23 ' A' ' 129' ' ' THR . 0.6 OUTLIER -46.34 160.56 0.07 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.62 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -141.66 177.75 7.94 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.886 -1.134 . . . . 0.0 110.356 -179.346 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.548 ' CB ' ' HA3' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -146.42 108.15 4.32 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.295 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.53 ' HB ' ' CG1' ' A' ' 180' ' ' ILE . 43.3 mm -93.73 112.68 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.735 -1.228 . . . . 0.0 109.867 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.713 HG23 ' HB2' ' A' ' 179' ' ' SER . 7.5 m -123.37 148.79 45.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -0.87 . . . . 0.0 108.954 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.902 ' CD2' HD22 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -145.15 156.15 43.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.91 -1.118 . . . . 0.0 110.706 -179.779 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.596 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 1.8 m-85 -119.76 77.8 1.26 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 122' ' ' TYR . . . -47.41 150.01 0.99 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.959 -1.088 . . . . 0.0 109.456 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.887 HG22 ' HB3' ' A' ' 174' ' ' SER . 51.6 t -140.54 131.08 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.208 -0.932 . . . . 0.0 109.739 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.657 HG23 ' OD2' ' A' ' 93' ' ' ASP . 0.8 OUTLIER -119.24 -41.02 2.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.326 -0.859 . . . . 0.0 109.114 179.692 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.457 ' O ' ' HG2' ' A' ' 168' ' ' ARG . . . -54.26 156.62 6.72 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 167' ' ' GLY . 0.0 OUTLIER -164.59 90.36 0.54 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -1.121 . . . . 0.0 109.375 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -165.65 -125.69 0.78 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -89.54 23.21 2.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -1.157 . . . . 0.0 109.515 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 176.77 91.2 0.11 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 109.571 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.89 95.95 1.08 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.623 2.215 . . . . 0.0 110.27 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -92.1 131.09 37.63 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.915 . . . . 0.0 109.652 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.887 ' HB3' HG22 ' A' ' 165' ' ' VAL . 1.2 p -99.35 119.07 37.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.217 -0.927 . . . . 0.0 109.252 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.538 ' CB ' ' HB2' ' A' ' 92' ' ' SER . 83.9 p -44.2 168.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.342 -0.849 . . . . 0.0 109.443 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.887 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.4 OUTLIER -49.26 143.61 9.29 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.043 -1.035 . . . . 0.0 108.508 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.596 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 35.7 Cg_endo -78.44 136.49 14.07 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.407 2.071 . . . . 0.0 111.337 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.2 t -109.56 136.95 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.713 ' HB2' HG23 ' A' ' 161' ' ' THR . 33.0 t -124.67 160.33 28.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.058 -1.026 . . . . 0.0 110.951 -178.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.855 HG23 HD23 ' A' ' 98' ' ' LEU . 39.3 pt -140.95 171.86 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.473 ' OD1' ' N ' ' A' ' 181' ' ' ASN . 1.2 m120 -103.72 166.0 10.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.936 -1.102 . . . . 0.0 110.036 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 1.023 ' OH ' HD22 ' A' ' 108' ' ' LEU . 48.3 t80 -154.15 172.47 17.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.512 -0.743 . . . . 0.0 109.2 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -145.1 118.38 8.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.149 -0.969 . . . . 0.0 109.562 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.509 ' OG1' ' N ' ' A' ' 156' ' ' ALA . 8.0 p . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.42 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.403 HD21 ' ND2' ' A' ' 76' ' ' ASN . 0.9 OUTLIER -104.36 -162.13 0.87 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.265 -1.138 . . . . 0.0 109.228 179.863 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.521 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 2.5 m-20 -76.04 97.44 4.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.351 -0.843 . . . . 0.0 109.152 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -40.59 101.34 0.24 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.597 -0.689 . . . . 0.0 109.888 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.716 ' HG2' ' HB2' ' A' ' 74' ' ' ALA . 34.9 Cg_endo -77.44 71.97 6.19 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.51 2.14 . . . . 0.0 109.733 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.875 ' HA ' HD22 ' A' ' 84' ' ' LEU . 16.7 p -91.16 -98.67 0.11 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.269 -0.894 . . . . 0.0 109.937 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 9' ' ' ASP . . . 48.64 24.72 4.22 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.402 ' N ' ' C ' ' A' ' 6' ' ' THR . 29.7 t80 -55.55 91.79 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.567 -0.961 . . . . 0.0 109.325 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 7' ' ' GLY . 7.8 t70 -137.36 111.99 8.76 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.552 ' CB ' ' HG3' ' A' ' 88' ' ' GLN . 0.3 OUTLIER -84.3 134.23 34.52 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.253 -0.904 . . . . 0.0 109.452 -179.573 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.471 ' O ' ' C ' ' A' ' 12' ' ' ASP . 86.8 p -150.33 -160.84 1.23 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.304 -0.873 . . . . 0.0 109.064 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.533 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 19.2 m-20 46.17 33.12 1.64 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 1.088 HG22 HG23 ' A' ' 91' ' ' VAL . 1.9 mt -86.97 111.02 21.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.317 -177.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -94.23 -177.04 4.15 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 177.568 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -88.58 -11.07 46.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.668 -1.27 . . . . 0.0 109.684 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 17' ' ' SER . 0.6 OUTLIER -131.95 22.14 4.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.887 -1.133 . . . . 0.0 108.115 178.605 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.529 ' CB ' ' HA ' ' A' ' 60' ' ' THR . 76.0 p 174.19 127.15 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.78 ' CB ' HG23 ' A' ' 13' ' ' ILE . 2.2 p90 -137.97 147.0 43.84 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.699 -1.251 . . . . 0.0 109.883 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . 1.008 ' OG1' HG23 ' A' ' 58' ' ' THR . 60.1 m -111.97 164.62 12.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.914 -1.116 . . . . 0.0 110.5 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.609 ' N ' HG22 ' A' ' 19' ' ' THR . 1.8 t -127.27 162.88 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.514 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 3.5 m-70 -151.77 137.45 17.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.926 -1.108 . . . . 0.0 110.155 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.778 ' CZ2' HG21 ' A' ' 50' ' ' VAL . 48.4 p90 -133.81 156.48 47.96 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.38 156.63 6.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 120.864 -1.147 . . . . 0.0 109.957 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . . . -101.64 153.31 37.99 Favored Pre-proline 0 C--N 1.298 -1.668 0 O-C-N 121.841 -0.537 . . . . 0.0 109.731 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 1.098 ' CG ' HD13 ' A' ' 29' ' ' ILE . 36.7 Cg_endo -79.65 133.78 10.61 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.623 2.216 . . . . 0.0 110.171 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -69.51 -5.74 26.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 109.574 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.914 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -97.25 173.8 3.75 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 0.0 109.384 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.914 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.3 Cg_endo -78.17 107.19 2.28 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.605 2.203 . . . . 0.0 110.484 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 1.098 HD13 ' CG ' ' A' ' 25' ' ' PRO . 18.6 pt -108.66 -171.72 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.411 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 7.9 p -115.63 -7.1 12.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.902 . . . . 0.0 109.568 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.24 -178.98 17.4 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.709 ' OH ' HD11 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -126.82 158.02 37.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -1.145 . . . . 0.0 109.488 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.008 ' C ' HD13 ' A' ' 34' ' ' ILE . 5.9 mt -111.56 136.32 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.241 -0.912 . . . . 0.0 108.898 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.008 HD13 ' C ' ' A' ' 33' ' ' ILE . 1.4 mm -119.08 125.4 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.109 -0.994 . . . . 0.0 110.283 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.528 ' CB ' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -122.6 129.71 52.2 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.555 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.603 ' CE1' ' HD2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -125.09 140.12 53.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.833 -1.167 . . . . 0.0 110.542 -178.819 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.735 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 25.3 p80 -166.32 122.29 1.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.424 -0.797 . . . . 0.0 109.753 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -55.22 -164.25 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.252 -0.905 . . . . 0.0 109.66 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 38' ' ' ALA . 1.4 mp0 -44.44 -74.97 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.189 -0.944 . . . . 0.0 109.615 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -165.98 66.44 0.11 Allowed 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.589 -0.694 . . . . 0.0 109.414 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 85.7 p -74.55 161.6 29.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.41 -0.806 . . . . 0.0 109.568 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.8 p -74.91 -0.71 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.691 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 44' ' ' ARG . . . -90.57 109.94 3.73 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 43' ' ' GLY . 13.8 mmm180 -44.04 133.8 4.16 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.238 -1.154 . . . . 0.0 109.403 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.558 ' HB3' ' CB ' ' A' ' 37' ' ' HIS . 36.6 Cg_endo -79.11 154.65 25.5 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.502 2.135 . . . . 0.0 110.307 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.603 ' HD2' ' CE1' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -109.57 162.03 14.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.0 109.817 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.52 ' CB ' ' HG3' ' A' ' 35' ' ' ARG . 1.6 mt-30 -119.78 99.42 6.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.517 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -84.66 106.53 16.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.269 -0.894 . . . . 0.0 109.072 179.55 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.986 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -84.65 137.7 33.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.241 -0.912 . . . . 0.0 109.142 -179.803 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.778 HG21 ' CZ2' ' A' ' 22' ' ' TRP . 21.9 m -114.07 154.75 46.08 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 109.706 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.514 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 35.2 Cg_endo -77.99 175.3 11.34 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.76 2.307 . . . . 0.0 110.29 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.53 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.1 Cg_endo -76.26 -15.87 17.82 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.528 2.152 . . . . 0.0 110.121 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.72 11.13 18.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 0.0 109.25 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.402 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 6.2 mmt180 -137.98 134.89 35.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.306 -0.871 . . . . 0.0 109.21 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.5 ' HA ' ' CE2' ' A' ' 22' ' ' TRP . 2.1 p-10 -124.75 18.69 8.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 0.0 109.638 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 84.4 p -145.78 138.59 25.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 109.776 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.956 HG21 HG21 ' A' ' 34' ' ' ILE . 1.5 tt -119.1 120.03 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.359 -0.838 . . . . 0.0 108.988 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 1.008 HG23 ' OG1' ' A' ' 19' ' ' THR . 0.4 OUTLIER -91.03 133.05 35.62 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.269 -0.894 . . . . 0.0 110.405 -179.115 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.816 ' HB3' HD11 ' A' ' 62' ' ' LEU . 1.5 mt -117.29 140.45 49.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.0 109.112 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.529 ' HA ' ' CB ' ' A' ' 17' ' ' SER . 25.1 p -129.05 174.65 9.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.354 -0.841 . . . . 0.0 109.909 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.638 ' O ' HD23 ' A' ' 62' ' ' LEU . 8.9 m-20 51.63 66.43 1.2 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.377 -0.827 . . . . 0.0 109.515 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.816 HD11 ' HB3' ' A' ' 59' ' ' LEU . 9.0 mt -134.41 133.94 41.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.467 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -48.12 134.88 11.95 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 108.819 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.4 Cg_endo -77.97 128.21 9.03 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.362 2.041 . . . . 0.0 110.681 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 79.37 60.87 2.43 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 90' ' ' THR . 1.5 m -149.59 142.23 24.51 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.366 -1.079 . . . . 0.0 109.7 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.541 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 3.0 mt-10 -74.59 134.72 42.09 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.973 -1.079 . . . . 0.0 108.768 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.597 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 3.6 m-85 -123.23 98.1 5.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.125 -0.984 . . . . 0.0 109.761 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.735 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 6.6 t -59.6 133.67 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.157 -0.965 . . . . 0.0 108.874 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 35' ' ' ARG . 11.0 t -137.86 137.36 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.106 -0.996 . . . . 0.0 109.375 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.628 ' HB3' HD13 ' A' ' 85' ' ' ILE . 88.9 p -116.53 134.68 54.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.188 -0.945 . . . . 0.0 110.133 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.898 ' HB ' HD12 ' A' ' 84' ' ' LEU . 21.5 mm -120.21 143.0 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 109.334 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.552 HG22 ' N ' ' A' ' 74' ' ' ALA . 36.9 mm -138.5 162.11 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.148 -0.97 . . . . 0.0 109.704 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.716 ' HB2' ' HG2' ' A' ' 5' ' ' PRO . . . -134.61 98.23 4.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.357 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.465 ' O ' ' OG1' ' A' ' 30' ' ' THR . 2.5 m -96.65 154.69 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 109.399 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 28' ' ' PRO . 30.2 t30 -133.63 45.94 2.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 109.55 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.453 ' N ' HG21 ' A' ' 30' ' ' THR . . . 81.87 -97.2 1.84 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -94.14 2.61 55.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -1.164 . . . . 0.0 109.534 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.484 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 2.2 mt-10 -109.49 -173.39 2.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.162 -0.961 . . . . 0.0 109.552 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 0.6 OUTLIER -163.31 100.16 0.94 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.357 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.649 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -59.64 -179.7 0.17 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.899 . . . . 0.0 108.878 179.716 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.578 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.1 Cg_endo -77.16 138.35 17.98 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.2 1.933 . . . . 0.0 110.187 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.533 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 36.0 Cg_endo -77.9 139.94 17.86 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.572 2.182 . . . . 0.0 110.571 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.898 HD12 ' HB ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -136.1 91.87 2.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.318 -0.864 . . . . 0.0 109.565 179.755 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.628 HD13 ' HB3' ' A' ' 71' ' ' SER . 4.1 mt -97.09 159.1 3.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.373 -0.829 . . . . 0.0 109.341 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.477 ' N ' HG22 ' A' ' 85' ' ' ILE . . . -162.84 159.08 31.46 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -112.81 118.36 34.73 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.367 -1.078 . . . . 0.0 109.435 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.552 ' HG3' ' CB ' ' A' ' 10' ' ' SER . 1.7 mm-40 -109.64 -157.64 0.62 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.541 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -162.31 148.4 13.04 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.978 -1.076 . . . . 0.0 110.081 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.47 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.47 136.97 42.28 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 1.088 HG23 HG22 ' A' ' 13' ' ' ILE . 5.2 t -44.95 168.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-O 121.741 0.782 . . . . 0.0 110.902 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.527 ' N ' HG12 ' A' ' 91' ' ' VAL . 3.0 t -105.53 127.45 53.03 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.99 -52.95 12.51 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.031 -1.043 . . . . 0.0 109.912 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.841 HD11 ' HB2' ' A' ' 176' ' ' LYS . 3.1 mt -111.28 144.2 29.98 Favored Pre-proline 0 C--N 1.304 -1.372 0 O-C-N 121.169 -0.957 . . . . 0.0 110.34 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.749 ' HD2' HG23 ' A' ' 94' ' ' ILE . 34.2 Cg_endo -76.72 -161.46 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.406 2.071 . . . . 0.0 109.293 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 1.7 ptp180 -163.37 164.77 24.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.912 -1.117 . . . . 0.0 110.064 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 21.0 t0 79.26 21.2 0.65 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.552 -0.718 . . . . 0.0 110.146 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.867 ' O ' HG21 ' A' ' 180' ' ' ILE . 0.3 OUTLIER -63.77 99.28 0.23 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.9 -1.125 . . . . 0.0 108.928 179.517 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.69 -174.95 4.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 109' ' ' LEU . 5.0 p -114.93 152.43 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.195 -0.941 . . . . 0.0 110.013 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.475 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 5.2 pt -119.08 -16.11 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.394 -0.816 . . . . 0.0 109.314 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.716 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -140.95 168.79 18.94 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.472 ' HG ' ' HH ' ' A' ' 182' ' ' TYR . 1.9 t -156.16 102.22 2.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.891 -1.131 . . . . 0.0 110.506 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.484 ' HB ' ' HD2' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -90.74 166.92 17.6 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.798 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.484 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 29.9 Cg_endo -69.41 -1.97 9.1 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.257 1.971 . . . . 0.0 110.579 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.746 ' C ' HG22 ' A' ' 152' ' ' ILE . 3.9 p -151.26 17.43 0.74 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.331 -0.856 . . . . 0.0 108.985 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' SER . . . . . 1.097 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -170.72 162.42 7.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.991 -1.068 . . . . 0.0 110.343 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.097 HD23 ' O ' ' A' ' 107' ' ' SER . 0.7 OUTLIER -141.84 156.85 45.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.464 -0.772 . . . . 0.0 109.099 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.716 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.3 OUTLIER -104.24 121.83 44.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 109.207 179.704 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.8 ' CD1' ' HB3' ' A' ' 147' ' ' ALA . 2.0 pt -103.35 148.23 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -0.903 . . . . 0.0 109.934 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.543 ' CB ' HG22 ' A' ' 146' ' ' THR . 84.9 p -146.16 137.46 24.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.4 -0.813 . . . . 0.0 109.052 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.57 ' CE3' ' O ' ' A' ' 145' ' ' SER . 37.1 p90 -158.87 -167.33 2.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.728 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 95' ' ' PRO . 2.1 mt-10 -124.63 119.07 25.92 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 108.959 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 145' ' ' SER . 34.6 Cg_endo -76.8 152.3 32.48 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.309 2.006 . . . . 0.0 110.69 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.489 ' HB2' ' O ' ' A' ' 92' ' ' SER . 35.2 Cg_endo -77.53 -159.86 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.64 2.226 . . . . 0.0 110.413 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.617 ' HB3' HG13 ' A' ' 91' ' ' VAL . . . -120.39 11.27 11.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.306 -0.871 . . . . 0.0 109.791 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.941 HG13 ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -82.16 -179.47 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.006 -1.058 . . . . 0.0 109.381 -179.681 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' SER . . . . . 0.522 ' O ' ' CA ' ' A' ' 166' ' ' THR . 24.3 m -70.63 61.0 0.23 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.362 -0.836 . . . . 0.0 110.07 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.856 ' CA ' HG22 ' A' ' 166' ' ' THR . 1.5 t -76.96 97.22 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 109.438 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.522 ' CG ' ' O ' ' A' ' 166' ' ' THR . 0.1 OUTLIER -74.9 -32.26 61.77 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.208 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.654 ' OH ' HG21 ' A' ' 165' ' ' VAL . 5.2 p90 -165.85 178.58 6.43 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.612 -0.68 . . . . 0.0 109.364 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.799 ' CZ ' HG11 ' A' ' 119' ' ' VAL . 2.6 m-85 -129.11 137.67 51.36 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -94.91 86.6 4.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 109.548 -179.479 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.975 ' CD1' HG21 ' A' ' 140' ' ' VAL . 77.1 mt -84.19 148.47 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.882 . . . . 0.0 109.192 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 2.5 p -131.44 150.59 52.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.92 . . . . 0.0 110.348 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.911 ' O ' HG12 ' A' ' 135' ' ' VAL . 2.9 m-85 -85.33 133.51 34.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.436 -0.79 . . . . 0.0 108.942 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.592 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.83 116.57 5.21 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -105.46 146.83 29.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.227 -1.161 . . . . 0.0 109.316 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.591 ' CG2' ' CB ' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -47.18 142.97 3.45 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.178 -0.951 . . . . 0.0 109.777 179.723 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 50.96 77.25 0.14 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -138.42 -91.63 0.25 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.439 ' C ' ' OG ' ' A' ' 133' ' ' SER . 0.1 OUTLIER 66.5 32.35 7.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -1.142 . . . . 0.0 109.339 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.566 ' CB ' ' HD3' ' A' ' 134' ' ' PRO . 0.0 OUTLIER 177.57 -57.38 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.327 -0.858 . . . . 0.0 109.633 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.566 ' HD3' ' CB ' ' A' ' 133' ' ' SER . 35.1 Cg_endo -76.42 82.29 2.29 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.243 1.962 . . . . 0.0 110.3 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.911 HG12 ' O ' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -115.01 148.11 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.396 -0.815 . . . . 0.0 109.123 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.597 ' HB2' ' CD1' ' A' ' 126' ' ' TYR . 19.7 mt-30 -93.4 87.16 5.49 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.12 -0.987 . . . . 0.0 109.134 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 7.2 pt-20 -76.54 130.24 37.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.448 -0.783 . . . . 0.0 111.103 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.599 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 38.1 p90 -137.27 143.66 42.31 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.652 HG22 ' CE1' ' A' ' 121' ' ' TYR . 12.7 p -74.28 165.62 24.86 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.996 -1.065 . . . . 0.0 110.69 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.975 HG21 ' CD1' ' A' ' 124' ' ' ILE . 8.2 t -137.33 139.63 28.34 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.603 -0.686 . . . . 0.0 109.773 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.486 ' HD2' HG13 ' A' ' 140' ' ' VAL . 33.7 Cg_endo -75.64 125.81 9.15 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.303 2.002 . . . . 0.0 110.364 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.61 -1.85 54.21 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 4.9 p -75.4 1.02 14.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.175 -1.191 . . . . 0.0 109.656 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 143' ' ' SER . 1.8 mmtp -152.39 149.68 28.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.152 -0.968 . . . . 0.0 109.67 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.57 ' O ' ' CE3' ' A' ' 112' ' ' TRP . 1.7 m -93.96 -13.17 27.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 109.296 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.543 HG22 ' CB ' ' A' ' 111' ' ' SER . 64.4 p -107.26 130.64 54.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.285 -0.884 . . . . 0.0 108.974 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.8 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -118.49 161.34 20.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.975 . . . . 0.0 109.905 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.456 ' O ' HD13 ' A' ' 149' ' ' ILE . 11.2 t -103.07 155.96 18.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.33 -0.856 . . . . 0.0 109.074 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.634 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 20.2 mm -133.07 113.68 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 109.725 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.547 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 3.3 m120 -120.79 173.34 7.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.384 -0.822 . . . . 0.0 109.705 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 0.5 OUTLIER 69.12 34.19 3.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.914 . . . . 0.0 109.291 -179.912 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.746 HG22 ' C ' ' A' ' 106' ' ' THR . 4.5 tt -93.89 158.7 2.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.37 -0.831 . . . . 0.0 109.788 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.42 115.65 65.71 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.262 -0.899 . . . . 0.0 109.121 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.463 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 35.4 Cg_endo -77.42 138.17 17.32 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.391 2.061 . . . . 0.0 110.743 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.702 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 86.41 68.06 1.35 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 163.73 130.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -1.155 . . . . 0.0 109.637 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.591 ' CB ' ' CG2' ' A' ' 129' ' ' THR . 1.2 t0 -47.53 162.63 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.17 -0.956 . . . . 0.0 108.559 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.592 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.3 OUTLIER -142.94 -170.8 3.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.918 -1.114 . . . . 0.0 110.234 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.514 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 3.2 m -165.41 110.83 0.9 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.523 ' HB ' ' CG1' ' A' ' 180' ' ' ILE . 30.1 mm -95.82 120.23 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.995 -1.066 . . . . 0.0 109.843 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.674 HG23 ' CB ' ' A' ' 179' ' ' SER . 2.2 m -124.9 164.31 20.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.241 -0.912 . . . . 0.0 109.145 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.838 HD23 HD11 ' A' ' 98' ' ' LEU . 1.6 pp -159.53 142.88 14.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.933 -1.104 . . . . 0.0 111.135 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.62 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.2 m-85 -113.78 80.25 1.35 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 122' ' ' TYR . . . -43.79 96.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.14 -0.975 . . . . 0.0 109.328 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.654 HG21 ' OH ' ' A' ' 121' ' ' TYR . 58.0 t -83.64 135.15 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 109.494 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.856 HG22 ' CA ' ' A' ' 119' ' ' VAL . 19.3 p -116.05 -51.49 2.64 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.286 -0.884 . . . . 0.0 109.604 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 172' ' ' PRO . . . -69.36 149.08 48.23 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.464 ' HB2' ' HD3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -159.29 -166.09 1.73 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -1.187 . . . . 0.0 109.411 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 65.8 -79.94 0.09 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.14 13.51 4.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -1.162 . . . . 0.0 109.508 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' SER . . . . . 0.471 ' O ' ' HA3' ' A' ' 167' ' ' GLY . 66.6 m -155.2 86.52 3.35 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.368 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 167' ' ' GLY . 36.2 Cg_endo -78.74 108.41 2.42 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.726 2.284 . . . . 0.0 110.544 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -114.84 156.42 24.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.387 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.41 ' HB3' ' HA ' ' A' ' 165' ' ' VAL . 0.7 OUTLIER -164.8 119.63 1.37 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.541 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.8 p -57.14 -167.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.171 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.841 ' HB2' HD11 ' A' ' 94' ' ' ILE . 1.3 mttp -66.71 146.45 99.07 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.149 -0.969 . . . . 0.0 108.808 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.62 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.6 Cg_endo -77.32 122.72 6.22 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.455 2.103 . . . . 0.0 111.158 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.83 HG12 HD12 ' A' ' 98' ' ' LEU . 2.2 t -91.41 133.63 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.674 ' CB ' HG23 ' A' ' 161' ' ' THR . 1.4 p -124.71 151.37 45.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.11 -0.994 . . . . 0.0 110.72 -178.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.867 HG21 ' O ' ' A' ' 98' ' ' LEU . 3.1 pt -138.84 152.19 24.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -88.45 162.79 16.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.002 -1.061 . . . . 0.0 109.824 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.977 ' OH ' HD22 ' A' ' 108' ' ' LEU . 74.9 t80 -152.8 167.33 29.41 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.414 -0.804 . . . . 0.0 109.268 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.412 ' N ' ' CG ' ' A' ' 182' ' ' TYR . 5.7 tttp -138.3 118.35 13.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.55 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 17.0 p . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.46 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LEU . . . . . 0.454 ' O ' ' OG ' ' A' ' 81' ' ' SER . 96.4 mt -145.43 138.81 26.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.174 -1.192 . . . . 0.0 109.41 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 2.9 m-20 -74.87 140.11 43.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 109.545 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.534 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 2.4 t -95.08 149.52 36.36 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.555 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.603 ' HG3' ' CD1' ' A' ' 32' ' ' TYR . 36.4 Cg_endo -78.89 117.72 3.97 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.711 2.274 . . . . 0.0 110.347 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.772 HG22 HD13 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -101.92 -107.78 0.24 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.947 . . . . 0.0 109.382 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 22' ' ' TRP . . . 42.5 27.83 0.54 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.442 ' N ' ' O ' ' A' ' 6' ' ' THR . 25.8 t80 -48.36 124.75 8.43 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.431 -1.041 . . . . 0.0 109.849 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 21' ' ' HIS . 4.2 t70 -164.96 84.06 0.39 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.405 -0.809 . . . . 0.0 109.019 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.983 ' OG ' HG13 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -84.6 137.84 33.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.195 -0.941 . . . . 0.0 109.684 -179.63 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.474 ' O ' ' HB ' ' A' ' 19' ' ' THR . 82.6 p -159.19 -158.67 0.7 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.36 -0.837 . . . . 0.0 109.143 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.523 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.5 OUTLIER 44.62 34.75 1.2 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -178.417 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.749 HD11 ' HG2' ' A' ' 88' ' ' GLN . 1.3 mt -72.37 140.48 17.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.495 -177.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.974 HG22 ' HA ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -122.93 -175.09 3.08 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.611 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.588 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -75.18 -70.97 0.39 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.908 -1.12 . . . . 0.0 109.499 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 5.8 p-10 -83.74 9.16 12.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.168 -0.957 . . . . 0.0 109.459 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.799 ' HB3' HG22 ' A' ' 60' ' ' THR . 0.1 OUTLIER -157.82 159.33 36.6 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.995 ' CE1' HG22 ' A' ' 20' ' ' VAL . 5.8 p90 -166.01 140.72 4.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.207 -0.933 . . . . 0.0 108.839 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 9.3 m -79.37 153.8 29.49 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.814 -1.179 . . . . 0.0 111.209 -178.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.995 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.3 t -134.69 115.82 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 9' ' ' ASP . 17.2 m-70 -105.46 159.11 16.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.044 -1.035 . . . . 0.0 110.132 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.771 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 20.9 p90 -175.09 140.25 0.51 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.366 -0.834 . . . . 0.0 109.209 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.61 162.32 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.134 -0.979 . . . . 0.0 109.965 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.774 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -93.96 169.59 9.72 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.766 -0.584 . . . . 0.0 109.696 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.774 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.2 Cg_endo -78.12 -159.88 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.611 2.207 . . . . 0.0 110.346 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.82 8.05 4.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 109.592 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.991 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -110.47 176.98 1.32 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.335 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.991 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 34.8 Cg_endo -77.54 110.67 3.01 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.478 2.119 . . . . 0.0 110.294 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.619 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 50.2 pt -126.29 -173.01 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 0.0 109.557 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.409 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 32.0 p -125.32 -5.43 7.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.483 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.498 ' HA2' ' N ' ' A' ' 52' ' ' PRO . . . 149.62 -178.78 26.91 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.642 ' CE2' ' HA ' ' A' ' 52' ' ' PRO . 1.8 m-85 -124.28 145.93 49.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -1.189 . . . . 0.0 109.631 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.061 HG23 ' HD2' ' A' ' 49' ' ' ARG . 0.9 OUTLIER -99.76 130.43 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.329 -0.857 . . . . 0.0 108.727 179.753 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.846 HD13 ' C ' ' A' ' 33' ' ' ILE . 1.4 mm -109.08 108.76 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.935 -1.103 . . . . 0.0 110.08 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.523 ' CB ' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -112.61 108.65 17.79 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.752 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.843 ' HB3' HG13 ' A' ' 70' ' ' VAL . 1.7 p-80 -114.62 166.79 11.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.022 . . . . 0.0 110.355 -178.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.455 ' O ' ' O ' ' A' ' 38' ' ' ALA . 40.0 p-80 177.73 136.19 0.07 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.594 -0.691 . . . . 0.0 109.282 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -56.31 -163.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.926 . . . . 0.0 109.372 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -70.5 -92.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.18 -0.95 . . . . 0.0 109.606 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -126.17 29.91 5.73 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.502 -0.749 . . . . 0.0 109.526 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.1 p -75.24 -96.99 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 109.599 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.3 t -74.89 153.25 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.902 . . . . 0.0 109.474 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.447 ' O ' ' HD3' ' A' ' 45' ' ' PRO . . . -87.86 -63.88 1.38 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 43' ' ' GLY . 30.4 mtm180 -43.09 103.27 0.31 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.371 -1.076 . . . . 0.0 109.508 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 35.1 Cg_endo -77.17 137.2 16.89 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.394 2.063 . . . . 0.0 110.264 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.601 ' HB2' ' CD2' ' A' ' 36' ' ' HIS . 12.7 mmm180 -74.72 141.17 44.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.289 -0.882 . . . . 0.0 109.637 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.407 ' HG3' ' C ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -130.01 90.07 2.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.684 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.546 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 9.5 m-20 -99.1 114.3 26.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.267 -0.896 . . . . 0.0 108.862 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 1.061 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -92.11 150.21 21.07 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.978 -1.076 . . . . 0.0 109.822 -179.469 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.914 HG12 HD12 ' A' ' 57' ' ' ILE . 10.3 m -133.4 160.1 69.96 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.431 -0.793 . . . . 0.0 109.3 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.501 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 33.6 Cg_endo -76.27 174.35 12.98 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.561 2.174 . . . . 0.0 110.381 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.642 ' HA ' ' CE2' ' A' ' 32' ' ' TYR . 35.1 Cg_endo -77.17 -21.74 11.76 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.672 2.248 . . . . 0.0 110.999 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.8 t -92.51 -4.51 53.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.074 -1.016 . . . . 0.0 109.716 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.536 ' HD3' ' N ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -97.8 111.42 23.72 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.286 -0.884 . . . . 0.0 109.895 -179.744 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -101.04 -6.43 24.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.447 -0.783 . . . . 0.0 109.46 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 53.1 p -135.69 129.84 33.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.384 -0.822 . . . . 0.0 109.189 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.914 HD12 HG12 ' A' ' 50' ' ' VAL . 6.1 tt -133.33 129.14 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.231 -0.918 . . . . 0.0 109.672 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.1 115.39 24.46 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.337 -0.852 . . . . 0.0 109.074 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.988 ' CB ' HD11 ' A' ' 62' ' ' LEU . 1.3 mt -84.74 156.22 21.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.14 -0.975 . . . . 0.0 109.642 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.799 HG22 ' HB3' ' A' ' 17' ' ' SER . 15.5 p -145.65 -178.2 5.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.404 -0.81 . . . . 0.0 109.33 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.9 m120 55.48 20.04 3.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.364 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.988 HD11 ' CB ' ' A' ' 59' ' ' LEU . 3.5 mt -96.15 138.69 33.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.872 . . . . 0.0 109.302 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 62' ' ' LEU . 45.5 t30 -45.72 126.41 6.56 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.191 -0.943 . . . . 0.0 108.804 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.551 ' CB ' ' HB2' ' A' ' 93' ' ' ASP . 35.8 Cg_endo -77.81 134.67 13.62 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.307 2.004 . . . . 0.0 110.699 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 68.16 62.6 4.09 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.0 m -160.67 153.01 20.46 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.264 -1.139 . . . . 0.0 110.134 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 1.2 tt0 -77.09 121.27 23.33 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.541 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 1.0 OUTLIER -116.71 114.54 24.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.085 -1.01 . . . . 0.0 110.019 -179.158 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.8 t -79.5 118.44 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 108.678 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.843 HG13 ' HB3' ' A' ' 36' ' ' HIS . 1.4 t -100.4 135.77 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.129 -0.982 . . . . 0.0 109.611 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.545 ' HB2' ' CD1' ' A' ' 85' ' ' ILE . 10.8 p -114.72 108.3 16.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.345 -0.847 . . . . 0.0 110.084 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 0.849 ' C ' HD12 ' A' ' 73' ' ' ILE . 17.0 mm -87.96 119.17 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 0.0 109.428 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.849 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.6 mp -116.74 158.63 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 109.256 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.624 ' HB3' ' CB ' ' A' ' 81' ' ' SER . . . -119.32 157.43 28.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.492 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.457 HG21 HD11 ' A' ' 33' ' ' ILE . 3.9 m -151.95 148.4 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 0.0 109.487 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.437 ' HB2' HD13 ' A' ' 2' ' ' LEU . 43.0 t30 -131.33 44.22 2.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.289 -0.882 . . . . 0.0 109.376 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.95 -88.13 0.67 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.95 -1.68 11.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.247 -1.149 . . . . 0.0 109.463 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.77 -162.59 0.92 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 109.394 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -159.15 173.74 15.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.198 -0.939 . . . . 0.0 109.797 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.624 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -145.05 -176.74 0.58 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.596 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.1 Cg_endo -77.3 136.54 16.04 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.068 1.845 . . . . 0.0 110.118 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.431 ' HB3' HG13 ' A' ' 73' ' ' ILE . 36.2 Cg_endo -78.43 104.0 1.76 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.65 2.234 . . . . 0.0 111.221 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.772 HD13 HG22 ' A' ' 6' ' ' THR . 0.9 OUTLIER -80.99 90.52 5.97 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.069 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.545 ' CD1' ' HB2' ' A' ' 71' ' ' SER . 2.7 mt -92.93 159.8 2.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.146 -0.971 . . . . 0.0 110.703 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.51 ' N ' HG22 ' A' ' 85' ' ' ILE . . . -154.22 168.34 32.5 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -117.27 139.94 50.18 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.129 -1.218 . . . . 0.0 109.915 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.749 ' HG2' HD11 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -139.68 -162.75 1.38 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.371 -0.831 . . . . 0.0 109.029 179.758 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -156.76 129.23 7.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.114 -0.991 . . . . 0.0 109.886 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.443 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -78.8 146.26 33.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.385 -0.822 . . . . 0.0 108.999 179.693 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.945 HG21 ' HB3' ' A' ' 116' ' ' ALA . 1.4 t -74.06 163.17 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.506 -0.746 . . . . 0.0 110.114 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.497 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 3.0 p -67.48 146.26 54.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.427 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.551 ' HB2' ' CB ' ' A' ' 64' ' ' PRO . 1.6 t70 -97.06 -45.2 6.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.324 -0.86 . . . . 0.0 110.012 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.797 HD11 ' CB ' ' A' ' 176' ' ' LYS . 6.4 mt -91.64 142.99 27.31 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.059 -1.026 . . . . 0.0 109.719 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.726 ' HD2' HG23 ' A' ' 94' ' ' ILE . 36.2 Cg_endo -80.23 68.56 8.27 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.292 1.995 . . . . 0.0 108.63 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 112' ' ' TRP . 24.9 mtt180 -72.51 -163.65 0.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.665 0.745 . . . . 0.0 110.392 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 111' ' ' SER . 8.4 m-20 64.64 9.48 5.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.614 -0.679 . . . . 0.0 109.588 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.884 HD22 ' CD2' ' A' ' 162' ' ' LEU . 25.1 tp -61.71 99.13 0.11 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.138 -0.976 . . . . 0.0 109.439 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -137.76 159.96 40.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.902 . . . . 0.0 109.673 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.405 HG12 ' H ' ' A' ' 100' ' ' VAL . 2.7 p -81.35 139.78 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.362 -0.836 . . . . 0.0 109.716 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.535 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 41.6 pt -134.62 4.46 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.404 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.925 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -165.12 88.27 0.45 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.516 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 0.7 OUTLIER -82.72 96.44 8.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.417 -0.802 . . . . 0.0 110.609 -178.712 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.572 HG21 ' OG ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -84.01 162.72 51.22 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.244 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.515 ' O ' HG23 ' A' ' 106' ' ' THR . 29.4 Cg_endo -67.82 -3.21 9.99 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.532 2.155 . . . . 0.0 111.138 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.863 ' C ' HG22 ' A' ' 152' ' ' ILE . 2.3 p -156.6 22.39 0.34 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.572 ' OG ' HG21 ' A' ' 104' ' ' THR . 18.2 p -172.54 175.91 3.39 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.118 -1.033 . . . . 0.0 109.924 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.847 HD12 ' N ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -153.69 154.48 34.2 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.484 -0.76 . . . . 0.0 109.203 -179.627 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.925 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -103.02 114.55 28.94 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.095 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.976 HD11 ' CD1' ' A' ' 149' ' ' ILE . 0.4 OUTLIER -103.61 131.62 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.113 -0.992 . . . . 0.0 109.954 -179.512 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 97' ' ' ASP . 3.3 m -123.52 132.53 53.94 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.572 ' CD2' ' O ' ' A' ' 145' ' ' SER . 49.0 p90 -135.99 169.52 17.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.935 . . . . 0.0 109.695 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.475 ' O ' ' HD3' ' A' ' 115' ' ' PRO . 0.5 OUTLIER -69.49 119.42 70.57 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.181 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.45 ' HG3' ' OG ' ' A' ' 145' ' ' SER . 35.9 Cg_endo -77.78 111.3 3.09 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.357 2.038 . . . . 0.0 110.333 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.528 ' HB2' HG22 ' A' ' 117' ' ' VAL . 35.9 Cg_endo -78.24 177.47 8.73 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.419 2.08 . . . . 0.0 110.356 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.945 ' HB3' HG21 ' A' ' 91' ' ' VAL . . . -118.88 13.64 13.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.289 -0.882 . . . . 0.0 109.233 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.974 ' HA ' HG22 ' A' ' 14' ' ' THR . 4.9 m -74.75 170.53 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.279 -0.888 . . . . 0.0 109.245 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.6 m -69.91 63.33 0.21 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.233 -0.917 . . . . 0.0 109.2 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.892 HG22 HG23 ' A' ' 117' ' ' VAL . 2.0 t -74.9 115.21 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.326 -0.859 . . . . 0.0 109.557 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' A' ' 165' ' ' VAL . 0.1 OUTLIER -74.78 -52.66 10.88 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.457 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 1.118 ' CE1' HG22 ' A' ' 139' ' ' THR . 1.4 p90 -165.35 152.27 10.42 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.57 ' CZ ' HG11 ' A' ' 119' ' ' VAL . 32.2 m-85 -93.51 134.42 35.8 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.998 -1.064 . . . . 0.0 108.85 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 4.3 ttp-105 -101.19 94.83 6.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.246 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.631 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 19.6 mt -85.79 141.52 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.299 -0.876 . . . . 0.0 109.96 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . 1.1 HG22 ' CG ' ' A' ' 137' ' ' GLU . 5.1 p -113.79 127.44 56.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.372 -0.83 . . . . 0.0 109.507 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 1.162 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 3.4 m-30 -74.95 113.93 12.82 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.618 ' HA2' HG21 ' A' ' 135' ' ' VAL . . . -101.77 119.83 6.63 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 120.214 -0.994 . . . . 0.0 110.852 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 130' ' ' GLY . 2.3 mm-40 -80.19 -175.51 5.09 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.269 -1.136 . . . . 0.0 108.529 178.725 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' THR . . . . . 0.992 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 1.4 p -41.49 -27.94 0.11 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.326 -0.859 . . . . 0.0 109.768 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 128' ' ' GLU . . . -104.01 -102.49 2.74 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.46 89.77 0.09 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.426 ' O ' ' CB ' ' A' ' 133' ' ' SER . 0.7 OUTLIER -93.94 -9.79 35.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -1.197 . . . . 0.0 109.67 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.608 ' CB ' ' HD3' ' A' ' 134' ' ' PRO . 0.6 OUTLIER 169.09 -57.62 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.358 -0.839 . . . . 0.0 109.159 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PRO . . . . . 0.608 ' HD3' ' CB ' ' A' ' 133' ' ' SER . 36.5 Cg_endo -78.53 144.88 20.37 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.288 1.992 . . . . 0.0 109.039 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.857 HG13 ' N ' ' A' ' 136' ' ' GLN . 0.3 OUTLIER -178.48 -161.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.719 -1.238 . . . . 0.0 110.836 -179.563 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.857 ' N ' HG13 ' A' ' 135' ' ' VAL . 4.5 mt-30 -79.11 148.7 32.29 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 1.1 ' CG ' HG22 ' A' ' 125' ' ' THR . 14.4 mp0 -142.79 157.76 44.3 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.902 -1.124 . . . . 0.0 110.985 -178.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.631 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 6.0 p90 -155.51 135.14 12.59 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' THR . . . . . 1.118 HG22 ' CE1' ' A' ' 121' ' ' TYR . 12.2 p -74.37 165.29 25.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.083 -1.011 . . . . 0.0 110.905 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.546 HG21 ' CD1' ' A' ' 124' ' ' ILE . 2.8 t -136.07 140.96 34.63 Favored Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.506 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.3 Cg_endo -76.29 146.75 28.53 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.334 2.023 . . . . 0.0 110.142 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.33 37.33 3.14 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.416 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 89.4 p -105.12 -1.1 25.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.111 -1.229 . . . . 0.0 109.624 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 143' ' ' SER . 5.7 mttt -151.45 154.5 36.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.186 -0.946 . . . . 0.0 109.52 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.572 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 0.4 OUTLIER -91.8 2.24 56.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 109.552 179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 110' ' ' ILE . 2.0 p -124.56 151.41 44.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.054 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.535 ' HB3' HG13 ' A' ' 110' ' ' ILE . . . -118.12 178.14 4.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.141 -0.975 . . . . 0.0 109.409 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.466 HG22 ' OD1' ' A' ' 150' ' ' ASN . 57.4 m -133.2 97.31 3.95 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.252 -0.905 . . . . 0.0 109.568 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 1.162 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 1.0 OUTLIER -79.17 93.11 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.333 -0.855 . . . . 0.0 109.051 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.539 ' HA ' ' CB ' ' A' ' 107' ' ' SER . 82.9 m-20 -101.29 178.23 4.71 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.935 . . . . 0.0 109.356 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 28.7 m120 57.67 55.92 5.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.892 . . . . 0.0 109.355 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.863 HG22 ' C ' ' A' ' 106' ' ' THR . 13.8 tt -111.63 164.4 7.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.268 -0.895 . . . . 0.0 109.699 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -95.03 110.26 49.0 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.134 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 152' ' ' ILE . 34.9 Cg_endo -76.77 139.66 20.06 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.355 2.036 . . . . 0.0 110.522 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.69 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 95.55 62.49 0.99 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.992 ' HB1' ' CG2' ' A' ' 129' ' ' THR . . . 164.6 132.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -1.136 . . . . 0.0 109.524 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.72 ' N ' HG22 ' A' ' 129' ' ' THR . 1.8 t70 -48.19 168.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.613 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -146.69 -164.7 2.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.837 -1.164 . . . . 0.0 110.275 -179.638 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 127' ' ' GLY . 9.2 m -174.79 105.21 0.1 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.736 HD11 HD22 ' A' ' 108' ' ' LEU . 54.8 mt -97.75 117.2 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.909 -1.119 . . . . 0.0 110.286 -178.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.609 HG23 ' HB2' ' A' ' 179' ' ' SER . 36.9 m -120.46 161.86 20.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.28 -0.888 . . . . 0.0 108.723 178.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.884 ' CD2' HD22 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -156.72 148.6 22.8 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 118.742 -1.183 . . . . 0.0 111.441 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.648 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.9 m-85 -120.54 161.87 20.57 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.035 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 1.046 ' HB3' ' OG ' ' A' ' 175' ' ' SER . . . -113.68 102.15 9.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.938 -1.102 . . . . 0.0 109.016 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.937 HG13 ' HB2' ' A' ' 172' ' ' PRO . 51.7 t -78.34 148.6 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.383 -0.823 . . . . 0.0 110.218 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 119' ' ' VAL . 80.7 p -135.1 -59.9 0.78 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.378 -0.826 . . . . 0.0 109.419 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 172' ' ' PRO . . . -53.42 168.42 1.19 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ARG . . . . . 0.479 ' CG ' ' HD2' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -131.84 -162.43 1.23 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -1.15 . . . . 0.0 109.418 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 86.72 -106.32 3.11 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -145.25 13.48 1.42 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -1.124 . . . . 0.0 109.431 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.4 m -156.15 73.1 5.09 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.861 . . . . 0.0 109.197 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.937 ' HB2' HG13 ' A' ' 165' ' ' VAL . 36.0 Cg_endo -78.3 -171.62 1.27 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.69 2.26 . . . . 0.0 110.61 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 165' ' ' VAL . . . -118.26 -165.58 1.13 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.385 -0.822 . . . . 0.0 109.097 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 2.4 p -165.14 106.16 0.79 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.17 -0.956 . . . . 0.0 109.669 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' SER . . . . . 1.046 ' OG ' ' HB3' ' A' ' 164' ' ' ALA . 0.7 OUTLIER -50.81 169.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.29 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.797 ' CB ' HD11 ' A' ' 94' ' ' ILE . 0.3 OUTLIER -44.36 123.68 4.47 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.286 -0.884 . . . . 0.0 109.274 179.705 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.648 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 33.7 Cg_endo -77.61 140.45 18.88 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.018 1.812 . . . . 0.0 110.902 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.37 135.48 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' SER . . . . . 0.609 ' HB2' HG23 ' A' ' 161' ' ' THR . 30.6 t -122.83 170.76 9.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.164 -0.96 . . . . 0.0 111.332 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.482 HG21 ' O ' ' A' ' 98' ' ' LEU . 7.1 pt -152.21 152.65 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 159' ' ' THR . 67.0 m-80 -96.22 157.72 15.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.946 -1.096 . . . . 0.0 110.028 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.725 ' CZ ' HD23 ' A' ' 108' ' ' LEU . 39.8 t80 -141.1 171.86 13.48 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.384 -0.823 . . . . 0.0 109.448 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 157' ' ' ASP . 3.4 tmtt? -145.05 108.09 4.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.532 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.452 ' OG1' ' N ' ' A' ' 155' ' ' GLY . 5.2 p . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.443 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.5 -162.83 0.91 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -1.145 . . . . 0.0 109.405 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.507 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 4.8 m-20 -91.25 132.46 36.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 109.439 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.524 ' OG ' ' CG ' ' A' ' 82' ' ' PRO . 15.2 m -95.79 150.05 36.86 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.305 -0.872 . . . . 0.0 109.808 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.714 ' O ' HD22 ' A' ' 84' ' ' LEU . 36.2 Cg_endo -79.74 131.05 9.0 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.746 2.297 . . . . 0.0 109.873 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 5' ' ' PRO . 0.8 OUTLIER -157.75 -167.62 2.31 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.053 -1.029 . . . . 0.0 109.591 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 46.25 27.06 2.54 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.056 -2.017 . . . . 0.0 108.056 -179.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PHE . . . . . 0.624 ' C ' ' CD1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -70.21 -170.33 0.36 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.74 -0.859 . . . . 0.0 109.57 -179.235 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.437 ' N ' ' CG ' ' A' ' 8' ' ' PHE . 21.3 t70 -165.55 110.19 0.86 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.229 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . 0.664 ' HB3' HG13 ' A' ' 20' ' ' VAL . 4.6 p -84.75 139.6 31.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.196 -0.94 . . . . 0.0 109.355 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.452 ' O ' ' C ' ' A' ' 12' ' ' ASP . 5.1 p -164.74 -157.96 0.38 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.185 -0.947 . . . . 0.0 109.623 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.538 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.6 OUTLIER 44.3 36.34 1.55 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -178.56 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ILE . . . . . 0.866 HG23 ' CB ' ' A' ' 18' ' ' PHE . 1.6 mt -74.63 145.29 11.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.862 -178.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.83 HG22 ' CA ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -124.78 172.57 9.21 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.012 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.794 ' HB3' HG12 ' A' ' 117' ' ' VAL . . . -67.92 -65.11 0.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.704 -1.248 . . . . 0.0 109.419 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.482 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -90.5 27.44 1.71 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.06 -1.025 . . . . 0.0 109.323 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.59 ' O ' ' N ' ' A' ' 14' ' ' THR . 3.5 p -178.02 161.28 1.51 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 1.041 ' CE1' HD13 ' A' ' 59' ' ' LEU . 17.5 p90 -167.74 147.86 5.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.891 -1.131 . . . . 0.0 109.644 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.538 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 4.0 m -90.7 158.41 16.91 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.843 -1.16 . . . . 0.0 111.164 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.774 HG11 HG11 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -139.23 104.26 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.38 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' HIS . . . . . 0.412 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 7.9 m-70 -86.23 162.7 18.17 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.153 -0.967 . . . . 0.0 110.261 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' TRP . . . . . 0.787 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 16.3 p90 -175.08 136.4 0.38 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.469 -0.77 . . . . 0.0 109.305 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -74.74 161.57 4.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 O-C-N 121.091 -1.006 . . . . 0.0 109.693 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -96.74 160.96 28.13 Favored Pre-proline 0 C--N 1.298 -1.664 0 O-C-N 121.745 -0.597 . . . . 0.0 109.703 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.507 ' HB2' ' HB2' ' A' ' 3' ' ' ASP . 36.1 Cg_endo -78.44 163.57 27.04 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.647 2.231 . . . . 0.0 110.326 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.49 28.76 1.89 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.427 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.554 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -118.92 161.32 36.88 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.456 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.595 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 35.5 Cg_endo -78.18 89.9 1.31 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.612 2.208 . . . . 0.0 110.39 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.676 HD12 ' CD2' ' A' ' 32' ' ' TYR . 20.3 pt -97.45 171.59 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.506 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.499 HG23 ' HA ' ' A' ' 76' ' ' ASN . 64.1 p -100.57 -26.65 13.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.894 . . . . 0.0 109.433 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.08 -152.11 9.94 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 1.067 ' CZ ' ' HB2' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -165.12 126.26 2.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -1.17 . . . . 0.0 109.647 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.999 ' C ' HD13 ' A' ' 34' ' ' ILE . 6.1 mt -94.78 138.92 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.203 -0.936 . . . . 0.0 109.288 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.05 HG21 HG21 ' A' ' 57' ' ' ILE . 1.5 mm -119.85 117.91 55.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.298 -0.876 . . . . 0.0 109.077 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ARG . . . . . 0.534 ' CG ' ' OG ' ' A' ' 71' ' ' SER . 3.1 ptp180 -121.94 140.5 52.37 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.881 -1.137 . . . . 0.0 108.698 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 1.064 ' CG ' HD21 ' A' ' 59' ' ' LEU . 28.5 m-70 -137.43 167.21 22.07 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.055 -1.028 . . . . 0.0 110.496 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' HIS . . . . . 0.469 ' HA ' ' NH2' ' A' ' 46' ' ' ARG . 11.6 p80 -173.37 149.46 1.73 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.827 ' HB3' ' OG ' ' A' ' 41' ' ' SER . . . -56.15 -163.65 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.564 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.459 ' OE2' ' OE2' ' A' ' 67' ' ' GLU . 5.3 mm-40 -69.78 -90.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.955 . . . . 0.0 109.718 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -74.41 -1.0 19.15 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.51 -0.744 . . . . 0.0 109.798 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.827 ' OG ' ' HB3' ' A' ' 38' ' ' ALA . 25.6 p -76.94 88.45 3.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.124 -0.985 . . . . 0.0 109.39 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 42' ' ' VAL . 8.2 p -120.5 -0.65 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.932 . . . . 0.0 109.591 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -50.66 -92.38 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.11 82.38 29.66 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.254 -1.145 . . . . 0.0 109.434 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.83 -169.63 0.79 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.672 2.248 . . . . 0.0 110.141 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.792 HH11 HD23 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -124.3 154.31 40.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.114 -0.991 . . . . 0.0 109.557 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLN . . . . . 0.523 ' HB3' ' NE ' ' A' ' 49' ' ' ARG . 1.0 OUTLIER -126.66 109.52 12.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 110.174 -179.574 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.863 ' CB ' HD11 ' A' ' 57' ' ' ILE . 64.9 m-20 -92.68 111.54 23.18 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.42 -0.8 . . . . 0.0 108.928 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ARG . . . . . 0.817 ' HD2' HG23 ' A' ' 33' ' ' ILE . 9.6 mmt85 -90.58 137.82 32.05 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.16 -0.963 . . . . 0.0 109.339 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.78 HG13 HG12 ' A' ' 34' ' ' ILE . 5.5 m -126.66 160.19 59.82 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.296 -0.878 . . . . 0.0 109.432 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.5 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 34.9 Cg_endo -77.25 174.72 12.33 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.555 2.17 . . . . 0.0 110.343 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 34.8 Cg_endo -76.88 -15.4 16.75 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.513 2.142 . . . . 0.0 110.356 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 m -93.87 13.13 23.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.263 -0.898 . . . . 0.0 109.451 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.436 ' O ' ' CZ2' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -123.93 121.36 35.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.921 . . . . 0.0 109.499 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.498 ' O ' ' CE3' ' A' ' 22' ' ' TRP . 3.6 p30 -107.25 -0.86 22.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 109.523 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.7 p -132.55 129.76 39.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.648 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 1.05 HG21 HG21 ' A' ' 34' ' ' ILE . 2.3 tt -125.63 141.27 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.309 -0.869 . . . . 0.0 109.126 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 19.4 m -104.5 127.34 52.19 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.158 -0.964 . . . . 0.0 109.966 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.064 HD21 ' CG ' ' A' ' 36' ' ' HIS . 5.0 mp -84.39 160.73 20.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.341 -0.85 . . . . 0.0 109.674 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 0.8 OUTLIER -152.9 169.22 23.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.619 -0.676 . . . . 0.0 109.553 179.818 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASN . . . . . 0.463 ' O ' HD23 ' A' ' 62' ' ' LEU . 3.6 m120 60.07 48.28 8.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.886 . . . . 0.0 109.39 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 1.008 HD11 ' HB3' ' A' ' 59' ' ' LEU . 2.0 mt -127.7 157.19 40.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.292 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.499 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 1.4 m-20 -63.1 132.59 95.13 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.119 -0.988 . . . . 0.0 108.693 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.727 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . 36.3 Cg_endo -77.49 125.4 7.62 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.288 1.992 . . . . 0.0 110.638 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 90' ' ' THR . . . 77.94 61.67 2.49 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.638 HG22 ' CE1' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -154.66 145.12 22.15 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.255 -1.144 . . . . 0.0 110.155 -179.164 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 23.4 tt0 -74.87 129.57 37.91 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.638 ' CE1' HG22 ' A' ' 66' ' ' THR . 27.9 m-85 -125.42 164.56 20.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.997 -1.065 . . . . 0.0 110.251 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 70' ' ' VAL . 53.9 t -110.28 164.49 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.807 HG22 ' ND1' ' A' ' 36' ' ' HIS . 4.6 t -149.67 144.07 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.832 -1.167 . . . . 0.0 110.168 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.586 ' CB ' HG12 ' A' ' 85' ' ' ILE . 1.3 p -142.09 118.76 11.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.2 -0.938 . . . . 0.0 109.897 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . 1.039 HD13 HG23 ' A' ' 34' ' ' ILE . 4.5 mm -91.38 131.85 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.493 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.583 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 5.4 mt -116.91 150.75 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 109.201 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.067 ' HB2' ' CZ ' ' A' ' 32' ' ' TYR . . . -123.21 147.09 47.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.361 -0.837 . . . . 0.0 109.642 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.21 132.71 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 109.384 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASN . . . . . 0.595 ' ND2' ' O ' ' A' ' 28' ' ' PRO . 5.9 t-20 -121.08 53.37 1.14 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 109.422 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.95 -69.85 3.17 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.8 tpp85 -126.08 -0.58 7.15 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -1.166 . . . . 0.0 109.647 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.525 ' O ' ' CG ' ' A' ' 80' ' ' GLU . 6.7 mm-40 -106.71 178.11 4.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.917 . . . . 0.0 109.399 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.525 ' CG ' ' O ' ' A' ' 79' ' ' GLU . 56.1 mt-10 -160.81 105.52 1.39 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.659 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.562 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -60.15 179.57 0.21 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 109.103 179.71 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.562 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.3 Cg_endo -77.43 149.25 27.3 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.35 2.033 . . . . 0.0 110.238 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 35.8 Cg_endo -77.96 106.24 2.14 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.65 2.233 . . . . 0.0 111.175 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.714 HD22 ' O ' ' A' ' 5' ' ' PRO . 12.3 tp -78.91 119.91 22.76 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . 0.586 HG12 ' CB ' ' A' ' 71' ' ' SER . 0.5 OUTLIER -106.88 163.95 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.008 -1.058 . . . . 0.0 110.292 -179.365 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.554 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -156.42 164.31 32.44 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -117.93 141.66 48.19 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.124 -1.221 . . . . 0.0 110.034 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.573 ' CG ' HD11 ' A' ' 13' ' ' ILE . 2.1 mm-40 -165.27 137.6 4.29 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -103.26 148.87 25.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 110.102 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.471 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.7 OUTLIER -74.75 139.83 43.66 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.55 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.956 HG21 ' HB3' ' A' ' 116' ' ' ALA . 2.3 t -64.77 176.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.486 0.66 . . . . 0.0 110.571 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.645 ' H ' HG12 ' A' ' 91' ' ' VAL . 75.4 m -81.0 139.67 35.64 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . 0.545 ' HA ' ' CG1' ' A' ' 117' ' ' VAL . 49.3 t0 -74.78 -45.73 41.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.262 -0.899 . . . . 0.0 110.723 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.831 HG23 ' HD2' ' A' ' 95' ' ' PRO . 1.4 mt -86.41 144.12 37.52 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 120.931 -1.106 . . . . 0.0 109.917 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . 0.831 ' HD2' HG23 ' A' ' 94' ' ' ILE . 35.9 Cg_endo -78.87 -159.32 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.735 2.29 . . . . 0.0 109.947 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -174.28 156.12 2.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.194 -0.941 . . . . 0.0 109.635 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 1.4 t0 78.38 25.5 0.58 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.396 -0.815 . . . . 0.0 109.928 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.897 HD22 ' CD2' ' A' ' 162' ' ' LEU . 27.9 tp -67.46 101.39 0.97 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.062 -1.023 . . . . 0.0 109.114 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -138.26 -171.92 3.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 109.642 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.5 p -107.14 144.24 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.227 -0.921 . . . . 0.0 109.837 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.923 HD11 HD22 ' A' ' 109' ' ' LEU . 22.8 pt -126.75 -4.32 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.373 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.978 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -152.38 91.38 1.58 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.505 ' HB2' ' OH ' ' A' ' 182' ' ' TYR . 4.9 p -85.31 85.97 7.41 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.526 -0.733 . . . . 0.0 110.298 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' THR . . . . . 0.547 ' OG1' ' N ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -74.42 163.29 69.33 Favored Pre-proline 0 C--N 1.306 -1.307 0 O-C-N 121.045 -1.034 . . . . 0.0 108.462 179.215 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 29.7 Cg_endo -68.47 -3.1 10.36 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.437 2.091 . . . . 0.0 110.775 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.922 ' C ' HG22 ' A' ' 152' ' ' ILE . 21.7 p -153.68 20.1 0.53 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' SER . . . . . 0.547 ' N ' ' OG1' ' A' ' 104' ' ' THR . 6.3 p -170.84 165.58 7.83 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.999 -1.08 . . . . 0.0 110.281 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 1.021 HD13 HD11 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -139.42 153.36 47.58 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.884 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.978 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.3 OUTLIER -105.53 98.43 8.13 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.319 -0.863 . . . . 0.0 108.904 179.296 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.763 HD11 ' HB3' ' A' ' 147' ' ' ALA . 1.3 pt -74.62 134.56 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.168 -0.958 . . . . 0.0 109.612 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.406 ' HA ' HG22 ' A' ' 146' ' ' THR . 12.8 t -134.05 111.15 10.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.554 -0.716 . . . . 0.0 109.237 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' TRP . . . . . 0.576 ' CD2' ' O ' ' A' ' 145' ' ' SER . 37.4 p90 -130.03 137.96 50.52 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.331 -0.855 . . . . 0.0 109.158 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.475 ' O ' ' HD3' ' A' ' 115' ' ' PRO . 2.4 mt-10 -44.65 131.73 4.97 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.187 -0.946 . . . . 0.0 108.944 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' PRO . . . . . 0.5 ' HB3' ' CB ' ' A' ' 145' ' ' SER . 35.4 Cg_endo -77.85 111.37 3.1 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.362 2.041 . . . . 0.0 110.364 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 113' ' ' GLU . 36.6 Cg_endo -78.65 152.16 25.67 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.308 2.005 . . . . 0.0 109.707 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ALA . . . . . 0.956 ' HB3' HG21 ' A' ' 91' ' ' VAL . . . -90.43 92.88 9.07 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.143 -0.973 . . . . 0.0 109.222 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.83 ' CA ' HG22 ' A' ' 14' ' ' THR . 0.0 OUTLIER -140.42 -179.91 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 109.831 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 55.3 m -104.4 44.02 1.06 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.831 ' HA ' HG22 ' A' ' 166' ' ' THR . 2.2 t -74.41 124.58 32.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.522 -0.736 . . . . 0.0 109.548 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.423 ' NE ' ' O ' ' A' ' 166' ' ' THR . 0.0 OUTLIER -74.86 -31.63 61.68 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.269 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.51 ' HB2' ' O ' ' A' ' 140' ' ' VAL . 3.6 p90 -165.77 162.17 18.41 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.352 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' TYR . . . . . 0.553 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 3.6 m-85 -111.46 126.83 55.37 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 15.1 ttp180 -84.9 91.6 8.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.139 -0.976 . . . . 0.0 109.398 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ILE . . . . . 0.788 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 19.2 mt -84.45 138.77 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.889 . . . . 0.0 109.59 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 25.9 p -112.7 129.63 56.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.411 -0.805 . . . . 0.0 109.889 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' TYR . . . . . 0.647 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 2.2 m-85 -75.36 131.75 40.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.449 -0.782 . . . . 0.0 109.091 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLY . . . . . 0.601 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -101.47 107.03 3.15 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.491 ' O ' ' C ' ' A' ' 129' ' ' THR . 3.9 mt-10 -107.21 141.14 38.98 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.115 -1.227 . . . . 0.0 108.932 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' THR . . . . . 1.079 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -32.55 -53.76 0.33 Allowed 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.344 0.592 . . . . 0.0 110.09 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.464 ' N ' ' OG1' ' A' ' 129' ' ' THR . . . 111.87 102.24 2.62 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 172.67 -28.22 0.1 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.452 ' O ' ' HB3' ' A' ' 133' ' ' SER . 9.5 p-10 -121.99 -2.61 9.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.112 -1.228 . . . . 0.0 109.804 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.452 ' HB3' ' O ' ' A' ' 132' ' ' ASN . 1.1 p 175.84 160.65 0.43 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.166 -0.959 . . . . 0.0 109.611 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.42 -175.74 2.89 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.614 2.209 . . . . 0.0 110.318 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.442 ' H ' HG22 ' A' ' 135' ' ' VAL . 3.5 m -68.56 169.19 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.238 -0.914 . . . . 0.0 109.563 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' GLN . . . . . 0.566 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 0.1 OUTLIER -122.42 105.44 10.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.28 -0.888 . . . . 0.0 109.084 179.645 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 1.9 tm-20 -88.57 123.22 32.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 110.39 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.788 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 38.7 p90 -125.42 140.62 52.63 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.479 HG22 ' CE1' ' A' ' 121' ' ' TYR . 8.5 p -74.44 162.8 28.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.106 -0.996 . . . . 0.0 110.342 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.748 HG21 ' CD1' ' A' ' 124' ' ' ILE . 2.4 t -131.44 142.37 45.13 Favored Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 121.602 -0.686 . . . . 0.0 109.625 -178.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PRO . . . . . 0.493 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.9 Cg_endo -77.48 140.54 19.23 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.408 2.072 . . . . 0.0 109.935 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.3 24.88 8.68 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.51 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 2.1 p -105.42 32.22 4.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.147 -1.207 . . . . 0.0 109.664 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.51 ' CG ' ' O ' ' A' ' 143' ' ' SER . 1.7 mttt -177.83 156.63 1.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.095 -1.003 . . . . 0.0 109.773 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.576 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 1.1 p -95.17 -14.52 24.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.884 . . . . 0.0 109.357 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 110' ' ' ILE . 6.5 p -118.92 137.88 53.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.118 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.763 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -118.99 164.22 15.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.143 -0.973 . . . . 0.0 109.696 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.8 t -95.15 156.48 16.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.246 -0.909 . . . . 0.0 109.144 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.647 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 9.7 mm -134.96 68.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.202 -0.936 . . . . 0.0 109.577 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.534 ' O ' ' CB ' ' A' ' 151' ' ' ASN . 1.9 m120 -83.44 166.39 18.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.46 -0.775 . . . . 0.0 109.496 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 2.0 t30 79.02 31.6 0.3 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.352 -0.843 . . . . 0.0 109.794 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.922 HG22 ' C ' ' A' ' 106' ' ' THR . 2.7 tt -94.04 159.96 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.169 -0.957 . . . . 0.0 109.47 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt -103.94 120.77 50.14 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.301 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.14 147.45 23.53 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.424 2.083 . . . . 0.0 110.507 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 72.52 61.59 3.55 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 1.079 ' HB1' ' CG2' ' A' ' 129' ' ' THR . . . 177.56 129.17 0.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -1.124 . . . . 0.0 109.582 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.564 ' N ' HG22 ' A' ' 129' ' ' THR . 4.4 t0 -46.05 160.69 0.06 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.129 -0.982 . . . . 0.0 108.455 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TYR . . . . . 0.601 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -148.39 178.46 8.57 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.736 -1.228 . . . . 0.0 110.242 -179.574 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 159' ' ' THR . . . . . 0.557 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 6.1 m -161.73 108.92 1.39 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.38 -0.825 . . . . 0.0 109.209 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 1.021 HD11 HD13 ' A' ' 108' ' ' LEU . 15.4 mt -98.85 133.21 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.608 -1.307 . . . . 0.0 109.824 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' THR . . . . . 1.007 HG23 ' CB ' ' A' ' 179' ' ' SER . 1.6 m -141.39 174.18 10.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.312 -0.867 . . . . 0.0 109.339 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.897 ' CD2' HD22 ' A' ' 98' ' ' LEU . 0.7 OUTLIER -163.99 148.63 10.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.063 -1.023 . . . . 0.0 110.997 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 163' ' ' TYR . . . . . 0.617 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.6 m-85 -125.32 81.73 2.0 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.593 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -45.18 99.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.952 -1.093 . . . . 0.0 109.15 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 163' ' ' TYR . 70.7 t -90.93 135.45 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.898 . . . . 0.0 109.917 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' THR . . . . . 0.831 HG22 ' HA ' ' A' ' 119' ' ' VAL . 45.3 p -115.3 -62.91 1.53 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.418 -0.801 . . . . 0.0 109.405 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 172' ' ' PRO . . . -81.86 135.09 13.82 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -137.19 125.44 23.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -1.134 . . . . 0.0 109.461 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 144.44 -122.75 1.84 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -82.38 8.59 10.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -1.16 . . . . 0.0 109.54 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.8 m -159.51 69.71 3.24 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.436 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 167' ' ' GLY . 35.5 Cg_endo -78.08 94.23 1.07 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.616 2.211 . . . . 0.0 110.405 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -107.67 143.4 36.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.227 -0.921 . . . . 0.0 109.542 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.11 133.66 26.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 0.0 109.371 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.492 ' HB2' ' CG1' ' A' ' 94' ' ' ILE . 96.9 p -53.82 161.33 1.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.929 . . . . 0.0 109.351 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LYS . . . . . 0.548 ' N ' HD11 ' A' ' 94' ' ' ILE . 3.4 mttt -46.25 142.95 3.94 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.174 -0.954 . . . . 0.0 108.588 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.617 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 35.0 Cg_endo -77.88 141.52 19.2 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.345 2.03 . . . . 0.0 111.397 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.2 t -114.99 134.68 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' SER . . . . . 1.007 ' CB ' HG23 ' A' ' 161' ' ' THR . 1.1 p -133.29 162.25 32.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 111.02 -178.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.886 HG21 ' O ' ' A' ' 98' ' ' LEU . 13.5 pt -142.26 152.13 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -93.33 152.1 19.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.987 -1.071 . . . . 0.0 109.853 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.667 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 53.6 t80 -146.53 130.03 16.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.399 -0.813 . . . . 0.0 109.468 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -106.34 119.34 39.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.444 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' THR . . . . . 0.488 ' OG1' ' N ' ' A' ' 156' ' ' ALA . 1.5 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.484 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 2.6 mt . . . . . 0 N--CA 1.489 1.498 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.501 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 1.0 OUTLIER -99.84 162.34 13.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.886 . . . . 0.0 109.084 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.478 ' HA ' ' HG2' ' A' ' 82' ' ' PRO . 79.6 p -95.15 136.62 22.54 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.109 -0.995 . . . . 0.0 109.762 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.862 ' O ' HD22 ' A' ' 84' ' ' LEU . 35.9 Cg_endo -79.27 119.07 4.1 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.602 2.201 . . . . 0.0 110.067 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.43 -163.21 1.52 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.021 -1.049 . . . . 0.0 109.746 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 60.29 22.46 58.54 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -178.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 1.005 ' HB3' HD21 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -82.28 168.05 17.99 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.863 -0.786 . . . . 0.0 109.538 -179.17 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.768 ' O ' HG12 ' A' ' 20' ' ' VAL . 3.6 t70 -165.28 -163.93 0.72 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.9 t -142.91 149.16 38.09 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.151 -0.968 . . . . 0.0 109.643 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.475 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 40.4 p -176.24 -163.52 0.1 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 109.286 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.571 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.6 OUTLIER 45.8 37.11 3.2 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -178.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.697 HG22 HG23 ' A' ' 91' ' ' VAL . 1.8 mt -85.5 165.03 2.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.65 -177.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 17' ' ' SER . 0.7 OUTLIER -154.41 -165.21 2.02 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.829 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -86.62 -44.96 11.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.022 -1.049 . . . . 0.0 109.875 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -110.32 11.15 23.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.91 -1.119 . . . . 0.0 109.486 -179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.937 ' HB3' HG22 ' A' ' 60' ' ' THR . 0.0 OUTLIER -160.9 150.11 16.85 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.677 ' HA ' ' HA ' ' A' ' 13' ' ' ILE . 2.1 p90 -165.51 143.35 5.91 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.009 -1.057 . . . . 0.0 108.855 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.907 ' OG1' HG23 ' A' ' 58' ' ' THR . 61.6 m -107.95 163.85 12.78 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.823 -1.173 . . . . 0.0 111.099 -178.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.768 HG12 ' O ' ' A' ' 9' ' ' ASP . 0.9 OUTLIER -132.09 170.88 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.475 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 18.1 m-70 -142.07 158.44 43.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.994 -1.066 . . . . 0.0 110.195 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.597 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 23.9 p90 -170.84 135.19 1.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.43 -0.794 . . . . 0.0 109.24 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.37 166.53 2.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.135 -0.978 . . . . 0.0 109.363 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.887 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -98.03 174.07 3.46 Favored Pre-proline 0 C--N 1.298 -1.639 0 O-C-N 121.666 -0.646 . . . . 0.0 109.772 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.887 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.6 Cg_endo -78.64 177.35 8.84 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.682 2.255 . . . . 0.0 110.457 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -86.73 9.13 19.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -0.932 . . . . 0.0 109.388 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.744 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -126.07 168.06 15.18 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.496 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.744 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.4 Cg_endo -78.12 133.04 11.94 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.695 2.264 . . . . 0.0 110.444 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.673 HD13 ' CE1' ' A' ' 32' ' ' TYR . 27.2 pt -118.18 -172.79 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.435 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.4 p -123.12 -10.24 8.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 109.555 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.501 ' O ' ' CG2' ' A' ' 75' ' ' VAL . . . 157.38 151.21 5.94 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.673 ' CE1' HD13 ' A' ' 29' ' ' ILE . 2.4 m-30 -114.07 139.09 49.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -1.133 . . . . 0.0 109.612 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.965 ' C ' HD13 ' A' ' 34' ' ' ILE . 1.7 mp -93.01 128.97 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.233 -0.917 . . . . 0.0 109.087 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.976 HG21 HG21 ' A' ' 57' ' ' ILE . 1.8 mm -115.86 109.25 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.214 -0.929 . . . . 0.0 109.76 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.48 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -109.86 137.11 48.11 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.13 -0.981 . . . . 0.0 109.012 179.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.872 ' HB3' HG22 ' A' ' 70' ' ' VAL . 5.4 p-80 -129.84 146.74 51.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.109 -0.994 . . . . 0.0 110.076 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.554 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 28.6 p-80 -168.24 133.34 1.76 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.339 -0.851 . . . . 0.0 109.87 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.936 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . -66.08 137.54 57.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 109.243 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.195 -0.941 . . . . 0.0 109.759 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.483 ' HB2' ' NE2' ' A' ' 36' ' ' HIS . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -123.14 117.16 24.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 109.958 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.593 ' HB3' HD11 ' A' ' 57' ' ' ILE . 1.3 m-20 -120.04 107.68 13.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.413 -0.804 . . . . 0.0 108.893 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.842 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -91.28 142.28 27.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.07 -1.019 . . . . 0.0 109.8 -179.504 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.74 HG13 HD12 ' A' ' 57' ' ' ILE . 5.8 m -119.3 161.97 34.35 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.44 -0.787 . . . . 0.0 109.107 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.531 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.5 Cg_endo -76.88 173.93 13.67 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.501 2.134 . . . . 0.0 110.293 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 35.4 Cg_endo -77.35 -15.32 15.93 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.648 2.232 . . . . 0.0 110.545 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.3 29.27 4.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.576 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.531 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 12.0 mmt85 -138.96 119.85 14.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 109.562 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.541 ' O ' ' CE3' ' A' ' 22' ' ' TRP . 10.2 p-10 -99.24 -3.66 33.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 109.468 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 74.8 p -135.14 158.59 43.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.175 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.976 HG21 HG21 ' A' ' 34' ' ' ILE . 3.5 tt -142.29 124.4 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.155 -0.966 . . . . 0.0 109.607 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.907 HG23 ' OG1' ' A' ' 19' ' ' THR . 0.3 OUTLIER -82.53 117.1 22.28 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.31 -0.868 . . . . 0.0 109.414 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.84 ' HB3' HD11 ' A' ' 62' ' ' LEU . 1.2 mt -95.93 143.37 27.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.893 . . . . 0.0 109.562 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.937 HG22 ' HB3' ' A' ' 17' ' ' SER . 39.2 p -134.61 -177.4 4.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 109.35 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.603 ' O ' HD23 ' A' ' 62' ' ' LEU . 4.4 m-80 53.03 56.37 7.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.385 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.84 HD11 ' HB3' ' A' ' 59' ' ' LEU . 6.0 mt -134.13 134.65 42.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.495 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.469 ' CB ' ' OH ' ' A' ' 68' ' ' TYR . 3.2 t30 -51.17 130.05 31.41 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 109.081 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.829 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -78.52 134.0 12.13 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.355 2.037 . . . . 0.0 110.712 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 82.83 60.95 1.99 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 90' ' ' THR . 2.4 m -163.73 154.26 15.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.323 -1.104 . . . . 0.0 109.924 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -88.92 127.1 35.64 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.936 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 23.5 m-85 -118.27 124.02 46.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.011 -1.055 . . . . 0.0 109.879 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.554 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 22.7 t -83.65 122.28 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 108.976 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.872 HG22 ' HB3' ' A' ' 36' ' ' HIS . 24.6 t -110.88 122.56 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -0.985 . . . . 0.0 109.55 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.541 ' HB2' ' CD1' ' A' ' 85' ' ' ILE . 82.3 p -103.54 117.13 33.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.192 -0.943 . . . . 0.0 109.903 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.803 HD13 HG23 ' A' ' 34' ' ' ILE . 11.2 mm -94.08 120.16 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.324 -0.86 . . . . 0.0 109.648 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.788 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.4 mp -112.11 132.74 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.165 -0.959 . . . . 0.0 109.124 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.58 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -95.94 154.48 17.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.557 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.501 ' CG2' ' O ' ' A' ' 31' ' ' GLY . 11.7 m -154.97 130.28 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 109.449 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -103.03 45.56 0.95 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.36 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.68 -85.21 0.99 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -111.64 -1.14 15.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -1.141 . . . . 0.0 109.404 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -97.09 -166.26 1.37 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 0.0 109.311 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -146.36 -167.07 2.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.14 -0.975 . . . . 0.0 109.854 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.592 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -172.44 -178.87 0.46 Allowed Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.592 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.1 Cg_endo -76.6 134.2 14.99 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.021 1.814 . . . . 0.0 109.69 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 35.2 Cg_endo -77.1 108.83 2.71 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.437 2.091 . . . . 0.0 111.129 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.005 HD21 ' HB3' ' A' ' 8' ' ' PHE . 9.7 tp -77.4 80.94 3.89 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.296 -0.878 . . . . 0.0 108.638 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 71' ' ' SER . 4.2 mt -86.06 151.47 3.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.184 -0.947 . . . . 0.0 110.216 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.44 ' C ' ' HG3' ' A' ' 87' ' ' GLN . . . -145.42 -169.13 13.47 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.483 ' HG2' HG13 ' A' ' 69' ' ' VAL . 30.8 mt-30 -150.73 126.89 10.55 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.168 -1.195 . . . . 0.0 109.676 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.857 HE22 HG23 ' A' ' 70' ' ' VAL . 9.6 pm0 -129.3 -155.31 0.69 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.317 -0.864 . . . . 0.0 108.752 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -159.73 136.13 8.99 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.037 -1.04 . . . . 0.0 110.002 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.408 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.93 137.16 41.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.401 -0.812 . . . . 0.0 108.997 179.667 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.697 HG23 HG22 ' A' ' 13' ' ' ILE . 3.1 t . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.407 0.622 . . . . 0.0 110.092 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.481 ' HB2' ' HB2' ' A' ' 112' ' ' TRP . 36.3 Cg_endo . . . . . 0 C--O 1.215 -0.636 0 N-CA-C 109.656 -0.94 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.504 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -169.9 158.54 7.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.091 -1.006 . . . . 0.0 109.604 179.591 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 4.5 t0 78.13 26.83 0.57 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.435 -0.791 . . . . 0.0 109.715 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.818 ' CD1' HD23 ' A' ' 162' ' ' LEU . 1.7 tt -60.3 99.4 0.08 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.13 -0.981 . . . . 0.0 109.057 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -138.05 165.38 26.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.616 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 13.3 p -96.31 147.24 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.762 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.531 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 14.1 pt -127.99 -4.32 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 0.0 109.704 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.911 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -153.03 105.28 2.9 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.517 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 10.0 m -100.79 91.08 4.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -0.933 . . . . 0.0 110.588 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.541 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -83.35 163.28 50.81 Favored Pre-proline 0 C--N 1.306 -1.306 0 O-C-N 121.126 -0.983 . . . . 0.0 108.671 178.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -69.2 -2.12 9.21 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.296 1.997 . . . . 0.0 110.795 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.833 ' C ' HG22 ' A' ' 152' ' ' ILE . 23.2 p -147.56 12.58 1.03 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 109.497 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 1.053 ' O ' HD23 ' A' ' 108' ' ' LEU . 3.2 p -169.84 164.69 9.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.809 -1.182 . . . . 0.0 110.198 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.053 HD23 ' O ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -139.13 155.4 47.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.306 -0.871 . . . . 0.0 109.131 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.911 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 1.3 mt -105.41 116.23 31.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.295 -0.878 . . . . 0.0 109.329 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.65 HD11 ' HB3' ' A' ' 147' ' ' ALA . 1.6 pt -99.01 143.55 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 109.494 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.906 ' CB ' HG22 ' A' ' 146' ' ' THR . 41.3 p -140.24 131.2 26.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.352 -0.843 . . . . 0.0 109.58 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.644 ' HH2' ' HB2' ' A' ' 147' ' ' ALA . 47.0 p90 -135.85 151.69 50.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.358 -0.839 . . . . 0.0 109.35 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.474 ' HB2' ' HG3' ' A' ' 96' ' ' ARG . 14.2 mt-10 . . . . . 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.485 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.683 ' CE2' HG22 ' A' ' 139' ' ' THR . 1.5 p90 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 121.214 0.53 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 1.4 m-85 -125.96 140.4 52.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.251 -0.906 . . . . 0.0 109.013 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.595 ' CG ' ' HB2' ' A' ' 163' ' ' TYR . 0.1 OUTLIER -113.12 98.95 7.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.655 -1.278 . . . . 0.0 108.214 178.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.841 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 20.8 mt -92.25 156.73 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.354 -0.841 . . . . 0.0 110.629 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 82.1 p -116.01 135.84 53.59 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.76 -0.588 . . . . 0.0 109.594 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.642 ' CE2' ' CG2' ' A' ' 149' ' ' ILE . 14.1 m-85 -74.17 143.62 45.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 109.368 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.581 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.86 94.02 0.94 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.224 -1.163 . . . . 0.0 109.427 179.634 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.495 ' HB2' ' HB2' ' A' ' 126' ' ' TYR . 1.9 tt0 . . . . . 0 N--CA 1.492 1.627 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 8.2 pt-20 -84.38 126.9 33.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 110.372 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.841 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 11.7 p90 -131.27 136.73 48.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.345 -0.847 . . . . 0.0 108.834 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.683 HG22 ' CE2' ' A' ' 121' ' ' TYR . 1.7 p -74.78 157.55 35.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.235 -0.916 . . . . 0.0 110.755 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.509 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 39.7 t -121.5 127.14 26.22 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 143' ' ' SER . 36.3 Cg_endo -79.01 42.11 1.22 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.282 1.988 . . . . 0.0 111.352 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 141' ' ' PRO . . . 35.49 31.86 0.03 OUTLIER Glycine 0 N--CA 1.498 2.804 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.9 OUTLIER -50.43 -41.22 52.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -1.102 . . . . 0.0 109.835 -179.354 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.456 ' HD2' ' OG1' ' A' ' 146' ' ' THR . 0.4 OUTLIER 179.43 -168.69 0.1 Allowed 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.609 -0.682 . . . . 0.0 109.628 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.564 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -71.98 -4.54 29.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.499 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.906 HG22 ' CB ' ' A' ' 111' ' ' SER . 75.7 p -124.37 133.09 53.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.178 -0.951 . . . . 0.0 109.396 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.65 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -117.54 169.87 9.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.608 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.408 ' C ' HG12 ' A' ' 149' ' ' ILE . 12.2 t -99.24 164.47 12.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.382 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.642 ' CG2' ' CE2' ' A' ' 126' ' ' TYR . 17.7 mm -143.59 65.86 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.448 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.579 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 0.8 OUTLIER -78.7 -152.23 0.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.479 -0.763 . . . . 0.0 109.792 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.4 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 24.0 t-20 47.1 26.43 0.64 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 109.418 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.833 HG22 ' C ' ' A' ' 106' ' ' THR . 3.3 tt -92.19 160.74 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.304 -0.873 . . . . 0.0 109.637 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.416 ' HD2' ' HD2' ' A' ' 154' ' ' PRO . 0.0 OUTLIER -122.58 127.65 25.72 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.189 -0.945 . . . . 0.0 109.268 179.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.449 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 36.1 Cg_endo -78.59 155.87 27.96 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.467 2.111 . . . . 0.0 110.593 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.704 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 81.76 64.89 1.7 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.704 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 162.3 132.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.287 -1.125 . . . . 0.0 109.657 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -51.59 164.83 0.2 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.699 ' CD1' HG21 ' A' ' 184' ' ' THR . 0.2 OUTLIER -145.21 -175.87 4.87 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.705 -1.247 . . . . 0.0 110.519 -179.149 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.571 HG22 ' N ' ' A' ' 160' ' ' ILE . 2.9 m -162.97 168.16 21.51 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.571 ' N ' HG22 ' A' ' 159' ' ' THR . 67.0 mt -152.55 136.25 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.856 -1.152 . . . . 0.0 109.908 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.95 HG23 ' CB ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -138.74 131.25 28.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.316 -0.865 . . . . 0.0 109.081 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.818 HD23 ' CD1' ' A' ' 98' ' ' LEU . 3.7 pp -114.68 141.27 48.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.076 -1.015 . . . . 0.0 111.23 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.663 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 1.4 m-85 -122.56 72.49 1.07 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.548 ' CB ' ' CD2' ' A' ' 122' ' ' TYR . . . -45.5 120.12 2.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.864 -1.147 . . . . 0.0 109.284 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.461 HG11 ' CE1' ' A' ' 121' ' ' TYR . 74.0 t . . . . . 0 N--CA 1.489 1.481 0 O-C-N 121.285 -0.884 . . . . 0.0 109.722 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 175' ' ' SER . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 174' ' ' SER . 3.4 p -52.8 -171.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -0.852 . . . . 0.0 109.619 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.11 144.86 95.83 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.663 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.1 Cg_endo -77.86 128.88 9.53 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.446 2.097 . . . . 0.0 111.641 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.7 t -95.52 124.2 48.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.95 ' CB ' HG23 ' A' ' 161' ' ' THR . 0.0 OUTLIER -115.2 146.7 41.15 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 110.811 -178.372 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.589 HG23 HD13 ' A' ' 98' ' ' LEU . 5.2 pt -130.81 -164.92 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -126.16 164.86 20.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.961 -1.087 . . . . 0.0 109.491 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.748 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 63.4 t80 -165.08 132.87 3.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.205 -0.935 . . . . 0.0 109.461 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -103.21 129.84 50.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.208 -0.932 . . . . 0.0 109.613 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.699 HG21 ' CD1' ' A' ' 158' ' ' TYR . 30.8 p . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.494 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.79 HD11 ' HG2' ' A' ' 79' ' ' GLU . 4.9 mt . . . . . 0 N--CA 1.484 1.238 0 CA-C-O 121.415 0.626 . . . . 0.0 109.616 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.843 ' CG ' HG22 ' A' ' 29' ' ' ILE . 1.1 m-20 -73.94 77.35 1.66 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.395 -0.816 . . . . 0.0 109.133 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.532 ' OG ' ' CG ' ' A' ' 82' ' ' PRO . 14.8 m -95.58 109.59 46.53 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.431 -0.793 . . . . 0.0 109.772 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.677 ' O ' HD22 ' A' ' 84' ' ' LEU . 36.7 Cg_endo -79.66 145.52 18.3 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.375 2.05 . . . . 0.0 110.077 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.668 HG23 ' O ' ' A' ' 5' ' ' PRO . 0.7 OUTLIER -161.43 -171.87 3.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.099 -1.0 . . . . 0.0 109.762 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 45.44 27.33 1.88 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.62 ' C ' ' CD1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -71.65 -161.63 0.07 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.598 -0.943 . . . . 0.0 109.867 -179.242 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.517 ' N ' ' CG ' ' A' ' 8' ' ' PHE . 1.5 t70 -165.58 -170.97 1.96 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.361 -0.837 . . . . 0.0 108.993 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.506 ' OG ' ' NE2' ' A' ' 88' ' ' GLN . 5.1 p -154.37 133.08 12.18 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.69 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.607 ' HG ' ' CD2' ' A' ' 21' ' ' HIS . 51.3 p -161.15 -159.64 0.67 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.253 -0.904 . . . . 0.0 109.42 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.524 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.8 OUTLIER 45.37 33.68 1.32 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -178.247 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.657 ' HA ' ' HA ' ' A' ' 18' ' ' PHE . 1.3 mt -75.71 163.43 3.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.485 -177.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.687 HG23 ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -149.71 -167.92 2.96 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.027 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.913 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -88.12 -47.55 8.4 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.901 -1.125 . . . . 0.0 109.361 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -105.59 19.72 20.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.915 -1.116 . . . . 0.0 109.001 179.623 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.822 ' HB3' HG22 ' A' ' 60' ' ' THR . 0.0 OUTLIER -172.64 153.33 2.76 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.741 ' CE1' HG22 ' A' ' 20' ' ' VAL . 4.7 p90 -166.19 140.73 4.43 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.955 -1.09 . . . . 0.0 108.985 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 2.3 m -89.07 160.34 17.1 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.922 -1.111 . . . . 0.0 111.252 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.741 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -137.46 122.39 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.607 ' CD2' ' HG ' ' A' ' 11' ' ' SER . 29.2 m-70 -99.31 153.09 19.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.097 -1.002 . . . . 0.0 110.104 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.803 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 22.3 p90 -161.5 133.48 5.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.382 -0.824 . . . . 0.0 109.523 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.548 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.41 170.54 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.234 -0.917 . . . . 0.0 109.295 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.548 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -100.76 159.58 29.18 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.623 -0.673 . . . . 0.0 109.378 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.543 ' CG ' ' HB3' ' A' ' 3' ' ' ASP . 36.2 Cg_endo -78.28 -159.11 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.7 2.266 . . . . 0.0 110.403 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -107.07 1.19 24.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.541 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.629 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -104.24 164.13 15.9 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.45 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.629 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.1 Cg_endo -77.5 141.4 19.93 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.669 2.246 . . . . 0.0 110.307 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.843 HG22 ' CG ' ' A' ' 3' ' ' ASP . 18.7 pt -133.69 163.33 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.763 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.2 p -117.73 1.78 12.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.406 -0.809 . . . . 0.0 109.234 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.575 ' O ' HG23 ' A' ' 75' ' ' VAL . . . 164.24 161.18 12.86 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.613 ' CD1' HD12 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -125.82 124.18 40.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.633 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.941 HG23 ' HG3' ' A' ' 49' ' ' ARG . 14.6 mm -87.64 118.61 33.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.198 -0.939 . . . . 0.0 109.318 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.071 HG23 HD13 ' A' ' 72' ' ' ILE . 1.5 mm -107.2 110.22 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.185 -0.947 . . . . 0.0 109.86 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.475 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 35.6 ttp180 -109.05 142.82 39.19 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.146 -0.971 . . . . 0.0 108.657 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.67 ' CG ' HD22 ' A' ' 59' ' ' LEU . 21.9 p-80 -132.06 151.75 51.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.986 -1.071 . . . . 0.0 110.187 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.456 ' O ' ' O ' ' A' ' 38' ' ' ALA . 54.6 p-80 -168.55 126.66 1.09 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.512 -0.743 . . . . 0.0 109.023 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.724 ' HB2' ' CE2' ' A' ' 68' ' ' TYR . . . -47.55 174.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.15 -0.969 . . . . 0.0 109.6 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.45 ' HG2' HG23 ' A' ' 69' ' ' VAL . 1.3 mt-10 . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.101 -0.999 . . . . 0.0 109.582 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.576 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -123.27 103.91 8.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.943 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 1.003 ' HB3' HD11 ' A' ' 57' ' ' ILE . 4.8 m-20 -98.41 112.88 24.75 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.258 -0.901 . . . . 0.0 108.856 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.941 ' HG3' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -96.69 152.91 18.2 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.133 -0.979 . . . . 0.0 109.858 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.88 HG13 HD12 ' A' ' 57' ' ' ILE . 5.1 m -134.46 162.12 59.6 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.462 -0.774 . . . . 0.0 109.034 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.543 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.7 Cg_endo -77.02 174.16 13.29 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.481 2.12 . . . . 0.0 110.365 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 35.3 Cg_endo -77.63 -15.26 15.5 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.549 2.166 . . . . 0.0 110.419 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.39 29.73 3.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.477 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.543 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 4.5 mmt180 -139.17 132.89 30.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.569 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.412 ' O ' ' CE3' ' A' ' 22' ' ' TRP . 21.7 p-10 -112.61 -3.0 14.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 0.0 109.38 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 88.5 p -132.2 148.38 52.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.922 . . . . 0.0 109.35 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.003 HD11 ' HB3' ' A' ' 48' ' ' ASP . 5.9 tt -139.35 127.24 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 0.0 109.821 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.74 115.51 24.22 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.206 -0.934 . . . . 0.0 109.298 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.67 HD22 ' CG ' ' A' ' 36' ' ' HIS . 6.5 mt -88.31 160.47 17.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.738 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.822 HG22 ' HB3' ' A' ' 17' ' ' SER . 19.7 p -147.2 173.3 12.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.827 . . . . 0.0 109.609 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.66 ' O ' HD23 ' A' ' 62' ' ' LEU . 4.2 m-80 62.07 53.2 3.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.352 -0.843 . . . . 0.0 109.915 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.669 HD11 ' HB3' ' A' ' 59' ' ' LEU . 3.0 mt -132.69 135.61 45.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 109.315 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.469 ' CB ' ' OH ' ' A' ' 68' ' ' TYR . 3.2 t30 -47.24 131.54 9.68 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.094 -1.004 . . . . 0.0 108.889 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.913 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 36.6 Cg_endo -78.68 134.2 12.04 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.475 2.117 . . . . 0.0 111.258 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 78.95 62.03 2.29 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.606 HG22 ' CE1' ' A' ' 68' ' ' TYR . 1.2 m -161.99 144.04 11.28 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.275 -1.133 . . . . 0.0 110.2 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -79.19 133.37 36.7 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.724 ' CE2' ' HB2' ' A' ' 38' ' ' ALA . 50.7 m-85 -124.88 171.55 10.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.903 -1.123 . . . . 0.0 110.832 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.706 HG12 HG23 ' A' ' 85' ' ' ILE . 3.2 t -124.37 137.54 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.538 HG13 ' HB3' ' A' ' 36' ' ' HIS . 2.2 t -126.8 129.38 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.847 -1.158 . . . . 0.0 110.356 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.574 ' CB ' HG12 ' A' ' 85' ' ' ILE . 5.0 p -100.42 101.45 12.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.323 -0.86 . . . . 0.0 109.996 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.071 HD13 HG23 ' A' ' 34' ' ' ILE . 26.0 mm -80.91 84.2 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.094 -1.004 . . . . 0.0 109.317 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.475 ' HB ' ' HB ' ' A' ' 33' ' ' ILE . 9.1 mt -81.87 159.2 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -0.943 . . . . 0.0 109.587 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.556 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -121.05 169.87 10.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.9 . . . . 0.0 109.434 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -154.94 140.51 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 109.547 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.429 ' O ' ' CG ' ' A' ' 76' ' ' ASN . 27.1 t-20 -137.24 49.44 2.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 109.585 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.71 -96.15 1.44 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.44 ' CD ' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -112.37 1.7 16.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -1.096 . . . . 0.0 109.519 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.79 ' HG2' HD11 ' A' ' 2' ' ' LEU . 1.2 tt0 -98.29 170.08 9.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.266 -0.897 . . . . 0.0 109.387 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 2.3 mp0 -148.89 108.35 3.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.112 -0.993 . . . . 0.0 110.009 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.582 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -59.92 -178.34 0.14 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 108.649 179.245 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.582 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.0 Cg_endo -76.87 154.33 33.78 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.177 1.918 . . . . 0.0 110.127 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.2 103.8 1.8 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.66 2.24 . . . . 0.0 111.356 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.677 HD22 ' O ' ' A' ' 5' ' ' PRO . 5.6 tp -81.48 93.64 6.69 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.706 HG23 HG12 ' A' ' 69' ' ' VAL . 3.0 mt -100.09 126.69 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.177 -0.952 . . . . 0.0 110.157 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.552 ' O ' HG13 ' A' ' 69' ' ' VAL . . . -121.45 -164.71 12.39 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.401 ' HG2' HG13 ' A' ' 69' ' ' VAL . 31.9 mt-30 -143.99 123.85 13.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.947 -1.325 . . . . 0.0 110.198 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.506 ' NE2' ' OG ' ' A' ' 10' ' ' SER . 3.9 mm100 -121.5 -152.79 0.52 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.4 143.36 6.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.089 -1.007 . . . . 0.0 109.904 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.501 ' HG1' ' HE1' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -87.81 138.13 31.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.411 -0.805 . . . . 0.0 109.196 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.541 HG23 HG22 ' A' ' 13' ' ' ILE . 2.9 t . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 121.592 0.711 . . . . 0.0 110.99 -179.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.658 ' CB ' ' CD1' ' A' ' 112' ' ' TRP . 35.8 Cg_endo . . . . . 0 C--O 1.215 -0.67 0 N-CA-C 109.924 -0.837 . . . . 0.0 109.924 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.504 ' CG ' ' N ' ' A' ' 97' ' ' ASP . 32.5 ttt85 -77.5 164.56 25.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.321 -0.862 . . . . 0.0 109.752 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.532 ' HB2' ' CG ' ' A' ' 113' ' ' GLU . 2.8 t0 77.63 33.58 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.417 -0.802 . . . . 0.0 109.781 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.593 HD22 ' CD2' ' A' ' 162' ' ' LEU . 33.0 tp -77.15 102.53 6.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.959 . . . . 0.0 109.486 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -140.25 169.89 16.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -0.904 . . . . 0.0 109.392 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 7.9 p -94.17 138.86 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.922 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.483 HG13 ' HB3' ' A' ' 109' ' ' LEU . 1.3 pp -123.93 -7.97 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.395 -0.816 . . . . 0.0 109.312 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.732 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -158.54 99.08 1.57 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.528 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 0.1 OUTLIER -103.58 109.86 21.7 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.442 -0.786 . . . . 0.0 110.648 -178.52 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.46 ' HB ' ' HD2' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -91.3 166.39 18.56 Favored Pre-proline 0 C--N 1.306 -1.317 0 O-C-N 121.293 -0.88 . . . . 0.0 108.749 178.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.46 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 30.3 Cg_endo -69.55 -2.05 9.35 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.258 1.972 . . . . 0.0 110.617 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.829 ' C ' HG22 ' A' ' 152' ' ' ILE . 62.0 p -145.41 10.47 1.26 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.277 -0.889 . . . . 0.0 109.59 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 1.029 ' C ' HD23 ' A' ' 108' ' ' LEU . 3.1 p -167.3 153.69 8.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.826 -1.171 . . . . 0.0 109.992 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.029 HD23 ' C ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -120.9 151.38 39.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.256 -0.902 . . . . 0.0 109.422 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.732 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.7 OUTLIER -106.03 120.9 42.98 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.97 HD11 HD13 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -105.46 133.22 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.981 -1.074 . . . . 0.0 110.105 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.655 ' HA ' HG22 ' A' ' 146' ' ' THR . 4.9 t -130.82 121.51 25.46 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.658 ' CD1' ' CB ' ' A' ' 95' ' ' PRO . 41.8 p90 -138.28 163.93 30.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.834 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.532 ' CG ' ' HB2' ' A' ' 97' ' ' ASP . 1.8 mt-10 . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.901 . . . . 0.0 108.655 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.93 ' CE1' HG22 ' A' ' 139' ' ' THR . 1.2 p90 . . . . . 0 N--CA 1.488 1.435 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.518 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 11.5 m-85 -103.18 135.86 44.05 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 3.2 ttp-105 -90.98 82.85 5.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.997 -1.064 . . . . 0.0 109.889 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 1.033 ' CD1' HG21 ' A' ' 140' ' ' VAL . 78.9 mt -83.6 143.64 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 3.2 p -136.76 152.69 50.61 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.931 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 1.107 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 2.4 m-85 -86.21 134.84 33.75 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.607 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -106.19 119.49 6.04 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 . . . . . 0 C--N 1.299 -1.591 0 O-C-N 121.19 -1.182 . . . . 0.0 109.133 179.631 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.555 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 1.6 tm-20 -89.05 117.44 28.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.833 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.642 ' CE2' ' CG2' ' A' ' 124' ' ' ILE . 25.5 p90 -118.28 136.74 53.51 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.93 HG22 ' CE1' ' A' ' 121' ' ' TYR . 4.6 p -74.01 172.15 12.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.13 -0.981 . . . . 0.0 110.331 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 1.033 HG21 ' CD1' ' A' ' 124' ' ' ILE . 25.3 t -142.85 139.16 16.68 Favored Pre-proline 0 C--N 1.302 -1.464 0 O-C-N 121.494 -0.754 . . . . 0.0 109.884 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.525 ' HD2' HG13 ' A' ' 140' ' ' VAL . 35.4 Cg_endo -78.35 144.32 20.38 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.411 2.074 . . . . 0.0 109.943 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.27 40.87 3.06 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.9 m -105.45 -1.21 25.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -1.168 . . . . 0.0 109.847 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.3 158.6 39.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.976 . . . . 0.0 109.835 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.575 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -95.42 8.19 43.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.388 -0.82 . . . . 0.0 109.714 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.655 HG22 ' HA ' ' A' ' 111' ' ' SER . 54.7 p -133.39 147.55 51.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.193 -0.942 . . . . 0.0 109.442 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.495 ' N ' ' CH2' ' A' ' 112' ' ' TRP . . . -132.63 173.16 11.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.142 -0.974 . . . . 0.0 109.459 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.597 ' O ' HD12 ' A' ' 149' ' ' ILE . 1.9 t -125.77 138.88 53.87 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.188 -0.945 . . . . 0.0 109.698 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 1.107 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 1.0 OUTLIER -113.09 83.68 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.52 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 3.6 m-20 -92.96 175.23 6.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.313 -0.867 . . . . 0.0 110.153 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 151' ' ' ASN . 1.1 m120 70.21 30.46 3.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 108.912 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.829 HG22 ' C ' ' A' ' 106' ' ' THR . 9.4 tt -89.33 163.92 2.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.489 -0.757 . . . . 0.0 109.731 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -107.36 121.53 44.17 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.331 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.13 146.68 22.91 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.382 2.055 . . . . 0.0 110.507 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.699 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 87.37 65.57 1.36 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 164.23 130.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -1.149 . . . . 0.0 109.631 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -48.64 163.58 0.07 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.097 -1.002 . . . . 0.0 108.495 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.613 ' CD1' HG21 ' A' ' 184' ' ' THR . 0.2 OUTLIER -147.08 -176.11 5.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.823 -1.173 . . . . 0.0 110.147 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.505 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 4.8 m -163.69 115.55 1.42 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.482 HD12 HG12 ' A' ' 149' ' ' ILE . 39.5 mm -100.06 129.34 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.737 -1.227 . . . . 0.0 109.83 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 1.021 HG23 ' CB ' ' A' ' 179' ' ' SER . 2.0 m -136.78 168.32 19.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.206 -0.933 . . . . 0.0 109.766 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.593 ' CD2' HD22 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -158.64 147.3 18.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.044 -1.035 . . . . 0.0 111.304 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.665 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 23.0 m-85 -121.15 105.86 10.99 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -70.64 93.7 0.95 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.911 -1.118 . . . . 0.0 109.158 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.598 HG22 ' HB3' ' A' ' 174' ' ' SER . 2.4 t . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 109.896 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.598 ' HB3' HG22 ' A' ' 165' ' ' VAL . 44.3 p . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.36 0.6 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 174' ' ' SER . 33.7 p 42.0 -164.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 176' ' ' LYS . 0.0 OUTLIER -86.58 148.51 46.61 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 120.993 -1.067 . . . . 0.0 108.559 179.276 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.665 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 31.3 Cg_endo -73.54 119.3 5.87 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.143 1.895 . . . . 0.0 111.058 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.85 124.33 63.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 1.021 ' CB ' HG23 ' A' ' 161' ' ' THR . 1.1 p -127.89 176.87 7.25 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.346 -0.846 . . . . 0.0 111.032 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.581 HG23 HD23 ' A' ' 98' ' ' LEU . 11.4 pt -157.31 152.02 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -85.78 158.58 19.97 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.926 -1.109 . . . . 0.0 109.674 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.764 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 47.0 t80 -158.25 127.69 5.79 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.358 -0.839 . . . . 0.0 109.328 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -101.86 128.52 48.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 109.527 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.613 HG21 ' CD1' ' A' ' 158' ' ' TYR . 7.5 p . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.505 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.472 ' HB2' ' OG ' ' A' ' 81' ' ' SER . 1.8 mt . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 3.3 m-20 -106.33 153.22 22.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.473 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.541 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 0.3 OUTLIER -95.33 132.32 28.02 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.763 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.479 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 36.1 Cg_endo -79.54 102.13 1.46 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.515 2.143 . . . . 0.0 109.968 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.686 HG22 ' CD1' ' A' ' 84' ' ' LEU . 1.4 p -95.58 -110.58 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 109.792 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.443 ' HA3' ' HB ' ' A' ' 23' ' ' VAL . . . 44.3 27.39 1.17 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.576 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 28.2 t80 -51.54 124.5 12.28 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.55 -0.971 . . . . 0.0 110.011 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 0.7 OUTLIER -153.21 87.78 1.28 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 92.7 p -84.29 124.59 31.4 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 109.648 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 12' ' ' ASP . 13.2 p -153.55 -159.34 0.97 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.397 -0.814 . . . . 0.0 109.05 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.501 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 1.1 m-20 45.88 40.12 6.26 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.833 HG23 ' CB ' ' A' ' 18' ' ' PHE . 2.7 mt -85.14 131.76 33.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.721 0.772 . . . . 0.0 111.284 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.52 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -115.62 -167.13 1.21 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.161 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.62 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -78.48 -70.57 0.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.935 -1.103 . . . . 0.0 109.794 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 52.4 m-20 -83.06 14.21 3.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.127 -0.983 . . . . 0.0 110.156 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.777 ' HB2' HG22 ' A' ' 60' ' ' THR . 1.6 t -165.35 156.46 14.21 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.104 -0.998 . . . . 0.0 109.085 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.989 ' CE1' HG22 ' A' ' 20' ' ' VAL . 4.7 p90 -164.32 145.33 8.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.162 -0.962 . . . . 0.0 109.112 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.501 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 3.8 m -89.24 149.69 22.97 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.815 -1.178 . . . . 0.0 111.441 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.989 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -130.37 114.17 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 9' ' ' ASP . 4.4 m-70 -96.42 170.91 8.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.995 -1.066 . . . . 0.0 110.748 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.86 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 21.0 p90 178.23 136.43 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.48 164.85 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.011 -1.056 . . . . 0.0 109.789 -179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.687 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -97.53 167.3 12.05 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.71 -0.619 . . . . 0.0 109.595 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.687 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 36.3 Cg_endo -79.32 -159.28 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.607 2.205 . . . . 0.0 110.294 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -126.24 16.68 7.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.298 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.952 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -117.75 176.08 1.77 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.324 -0.86 . . . . 0.0 109.424 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.952 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.5 Cg_endo -78.16 136.57 14.61 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.635 2.224 . . . . 0.0 110.457 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.744 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 27.5 pt -150.06 -179.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.331 -0.856 . . . . 0.0 109.406 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.2 p -120.81 4.53 10.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.583 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.96 173.37 17.15 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.744 ' CZ ' HD11 ' A' ' 29' ' ' ILE . 16.6 m-85 -118.71 123.65 45.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -1.174 . . . . 0.0 109.634 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.83 ' C ' HD13 ' A' ' 34' ' ' ILE . 1.7 mp -79.69 135.18 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.215 -0.928 . . . . 0.0 108.768 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.83 HD13 ' C ' ' A' ' 33' ' ' ILE . 2.9 mm -115.47 107.02 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.069 -1.019 . . . . 0.0 110.064 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -109.18 117.02 33.03 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.674 ' HB3' HG13 ' A' ' 70' ' ' VAL . 51.2 p-80 -126.83 176.19 7.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.009 -1.057 . . . . 0.0 110.682 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 38' ' ' ALA . 42.4 p-80 175.18 145.48 0.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.583 ' HA ' ' CD2' ' A' ' 68' ' ' TYR . . . -41.57 163.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.22 -0.925 . . . . 0.0 109.617 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.698 ' HA ' HG23 ' A' ' 69' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.08 -1.012 . . . . 0.0 109.567 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.594 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.423 0 CA-C-O 121.364 0.602 . . . . 0.0 109.53 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.46 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -120.95 122.63 40.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.464 -0.772 . . . . 0.0 110.076 -179.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 34' ' ' ILE . 63.2 m-20 -144.54 120.04 10.36 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.752 ' CD ' HG23 ' A' ' 33' ' ' ILE . 5.1 mmt-85 -104.09 152.23 22.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.971 -1.081 . . . . 0.0 110.23 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.859 HG12 HD12 ' A' ' 57' ' ' ILE . 10.7 m -128.02 161.29 56.82 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.546 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 33.7 Cg_endo -76.36 174.13 13.34 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.358 2.039 . . . . 0.0 110.34 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.587 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 35.2 Cg_endo -77.07 -15.46 16.33 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.582 2.188 . . . . 0.0 110.604 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.2 t -101.97 17.84 22.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 0.0 109.652 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.546 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.5 OUTLIER -122.77 100.78 7.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.19 -0.944 . . . . 0.0 109.914 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -84.85 -3.0 58.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.14 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 56.5 p -137.52 149.02 46.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.432 -0.793 . . . . 0.0 109.031 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.86 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 5.2 tt -136.44 125.95 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.075 -1.016 . . . . 0.0 109.746 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.29 107.4 19.04 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.408 -0.807 . . . . 0.0 109.269 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.91 ' HB3' HD11 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -84.91 152.02 23.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.533 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.777 HG22 ' HB2' ' A' ' 17' ' ' SER . 29.2 p -137.98 -177.49 4.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.467 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.3 m120 55.7 29.67 14.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.356 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.91 HD11 ' HB3' ' A' ' 59' ' ' LEU . 5.1 mt -107.53 136.26 47.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 0.0 109.403 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.516 ' CB ' ' OH ' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -44.76 126.61 5.13 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.147 -0.97 . . . . 0.0 108.868 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.62 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 35.9 Cg_endo -77.42 131.41 11.59 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.29 1.994 . . . . 0.0 110.852 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 78.25 61.35 2.51 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.568 HG22 ' N ' ' A' ' 67' ' ' GLU . 13.2 m -157.16 165.79 35.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.258 -1.142 . . . . 0.0 109.93 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.568 ' N ' HG22 ' A' ' 66' ' ' THR . 1.8 mp0 -115.33 132.64 56.55 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.445 -0.784 . . . . 0.0 109.174 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.608 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 1.2 m-85 -130.57 173.83 10.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.93 . . . . 0.0 109.377 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.698 HG23 ' HA ' ' A' ' 39' ' ' GLU . 8.4 t -112.82 114.9 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.674 HG13 ' HB3' ' A' ' 36' ' ' HIS . 4.5 t -96.99 138.49 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.09 -1.006 . . . . 0.0 110.067 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.535 ' CB ' HG12 ' A' ' 85' ' ' ILE . 14.5 p -119.56 138.74 53.0 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.296 -0.878 . . . . 0.0 110.233 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.573 HD13 HG23 ' A' ' 34' ' ' ILE . 13.2 mm -111.78 95.11 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.397 -0.815 . . . . 0.0 109.397 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.621 HD12 ' N ' ' A' ' 73' ' ' ILE . 1.3 mp -85.24 122.84 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.339 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.915 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -97.34 137.62 36.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.924 . . . . 0.0 109.368 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.705 HG22 HD13 ' A' ' 33' ' ' ILE . 4.6 m -140.78 171.82 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.905 . . . . 0.0 109.471 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.447 ' OD1' ' HA ' ' A' ' 29' ' ' ILE . 49.2 t30 -146.39 43.23 1.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.915 . . . . 0.0 109.439 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 112.31 -87.03 0.44 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.04 -8.25 10.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -1.141 . . . . 0.0 109.625 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -84.81 -167.21 1.72 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.382 -0.824 . . . . 0.0 109.276 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.52 ' HG2' HG12 ' A' ' 75' ' ' VAL . 16.2 mt-10 -159.4 131.14 6.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.188 -0.945 . . . . 0.0 109.929 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.915 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -98.62 -178.33 0.69 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.393 -0.817 . . . . 0.0 108.882 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.591 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.4 Cg_endo -77.34 131.21 11.52 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.118 1.879 . . . . 0.0 109.908 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.452 ' HB3' HG13 ' A' ' 73' ' ' ILE . 35.7 Cg_endo -77.75 115.48 3.84 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.491 2.127 . . . . 0.0 111.117 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.686 ' CD1' HG22 ' A' ' 6' ' ' THR . 0.7 OUTLIER -88.53 106.5 18.33 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.187 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.535 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.8 mt -95.48 146.4 7.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.116 -0.99 . . . . 0.0 110.105 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.576 ' HA3' ' CZ ' ' A' ' 8' ' ' PHE . . . -142.75 161.37 27.46 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 108.134 -1.987 . . . . 0.0 108.134 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.475 ' HG2' ' N ' ' A' ' 88' ' ' GLN . 5.8 tt0 -102.05 148.38 25.45 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.18 -1.188 . . . . 0.0 110.028 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.619 ' NE2' ' CE2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -149.82 -176.35 5.39 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.728 ' O ' HG21 ' A' ' 13' ' ' ILE . . . -160.2 134.61 7.49 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 109.969 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.5 143.36 36.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.358 -0.839 . . . . 0.0 109.019 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.559 HG23 HG22 ' A' ' 13' ' ' ILE . 2.0 t . . . . . 0 N--CA 1.492 1.635 0 O-C-N 121.512 -0.743 . . . . 0.0 109.888 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.548 ' HB2' ' CD1' ' A' ' 112' ' ' TRP . 36.0 Cg_endo . . . . . 0 C--O 1.215 -0.645 0 N-CA-C 110.162 -0.745 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.56 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 4.2 ttt180 -66.62 170.71 5.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.319 -0.863 . . . . 0.0 109.813 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 1.1 t0 81.87 34.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.736 . . . . 0.0 110.113 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.764 HD22 ' CD2' ' A' ' 162' ' ' LEU . 21.8 tp -76.46 101.56 5.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.134 -0.979 . . . . 0.0 109.288 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -151.85 -175.24 5.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 109.077 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 109' ' ' LEU . 47.8 t -119.23 149.37 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.0 -1.063 . . . . 0.0 110.164 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.644 ' CG1' HD23 ' A' ' 109' ' ' LEU . 6.9 pt -119.6 -17.14 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.737 0.779 . . . . 0.0 109.356 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 109' ' ' LEU . . . -150.84 142.12 23.27 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.532 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 51.5 p -150.49 132.09 14.85 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.695 -1.253 . . . . 0.0 111.299 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.579 ' HB ' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -98.02 171.38 5.94 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.579 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 29.9 Cg_endo -69.66 -1.05 7.73 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.918 1.746 . . . . 0.0 110.63 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.843 ' C ' HG22 ' A' ' 152' ' ' ILE . 19.2 p -143.02 8.23 1.65 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.194 -0.941 . . . . 0.0 109.655 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 149' ' ' ILE . 2.9 p -164.33 149.68 10.32 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.819 -1.152 . . . . 0.0 109.96 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.811 HD22 ' CZ ' ' A' ' 182' ' ' TYR . 0.9 OUTLIER -123.69 156.33 36.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.909 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.644 HD23 ' CG1' ' A' ' 101' ' ' ILE . 11.1 tp -105.27 108.81 20.52 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.963 ' CD1' ' HB3' ' A' ' 147' ' ' ALA . 3.1 pt -92.26 150.04 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.237 -0.914 . . . . 0.0 109.998 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 146' ' ' THR . 31.8 m -148.36 135.82 20.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.421 -0.799 . . . . 0.0 109.325 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.661 ' HH2' ' HB2' ' A' ' 147' ' ' ALA . 14.4 p90 -135.68 159.06 42.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 109.42 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.068 -1.02 . . . . 0.0 109.315 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.578 ' CE2' ' HB ' ' A' ' 165' ' ' VAL . 1.9 p90 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 121.267 0.556 . . . . 0.0 109.509 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.621 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 2.2 m-85 -136.63 131.59 33.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -0.871 . . . . 0.0 109.097 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 4.6 ttt180 -84.69 154.4 22.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.019 -1.05 . . . . 0.0 108.541 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.845 HG23 ' O ' ' A' ' 161' ' ' THR . 17.6 mt -151.03 138.82 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.006 -1.059 . . . . 0.0 110.394 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 136' ' ' GLN . 2.2 p -106.28 141.77 37.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.607 -0.683 . . . . 0.0 109.721 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.648 ' CE1' HG23 ' A' ' 149' ' ' ILE . 1.6 m-85 -88.26 118.83 28.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.369 -0.832 . . . . 0.0 108.758 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.624 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.8 113.73 4.3 Favored Glycine 0 N--CA 1.487 2.073 0 C-N-CA 119.607 -1.282 . . . . 0.0 111.217 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 . . . . . 0 C--N 1.3 -1.566 0 O-C-N 121.173 -1.192 . . . . 0.0 108.384 178.494 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.583 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.56 ' HG3' HG22 ' A' ' 125' ' ' THR . 0.1 OUTLIER -156.71 152.16 26.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.144 -1.598 . . . . 0.0 111.702 -179.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.737 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 11.7 p90 -165.11 134.73 3.6 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.444 HG22 ' CE1' ' A' ' 121' ' ' TYR . 1.7 p -74.57 171.85 13.09 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.175 -0.953 . . . . 0.0 110.944 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.721 HG21 HD11 ' A' ' 124' ' ' ILE . 28.5 t -131.83 140.53 38.52 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.52 -0.738 . . . . 0.0 109.542 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.606 ' HD2' HG13 ' A' ' 140' ' ' VAL . 35.5 Cg_endo -77.99 125.47 7.31 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.428 2.086 . . . . 0.0 109.919 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.32 51.65 3.31 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.431 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 16.0 p -105.5 -4.71 20.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.194 -1.18 . . . . 0.0 109.551 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 143' ' ' SER . 0.6 OUTLIER -173.55 178.21 2.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.513 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.571 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 0.3 OUTLIER -95.12 15.33 19.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.584 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.531 ' C ' ' CH2' ' A' ' 112' ' ' TRP . 2.1 p -123.52 146.15 48.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.465 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.963 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -133.12 167.19 20.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.246 -0.909 . . . . 0.0 109.461 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.651 ' O ' HD13 ' A' ' 149' ' ' ILE . 14.0 m -108.49 164.07 12.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 109.465 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.651 HD13 ' O ' ' A' ' 148' ' ' THR . 11.7 mm -143.24 66.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.0 109.335 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.553 ' HA ' ' CB ' ' A' ' 107' ' ' SER . 4.3 m120 -78.28 -167.51 1.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.692 -0.63 . . . . 0.0 109.814 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 50.92 42.0 27.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.081 -1.012 . . . . 0.0 109.053 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.843 HG22 ' C ' ' A' ' 106' ' ' THR . 4.4 tt -106.18 160.03 5.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.422 -0.799 . . . . 0.0 109.915 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -93.58 125.22 54.63 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 109.17 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.463 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 35.8 Cg_endo -78.73 140.25 16.36 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.436 2.091 . . . . 0.0 110.859 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 75.09 63.23 2.58 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.452 ' N ' ' OG1' ' A' ' 184' ' ' THR . . . 178.13 127.2 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.174 -1.192 . . . . 0.0 110.147 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 9.7 t70 -48.58 167.94 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.64 ' CE2' HG13 ' A' ' 152' ' ' ILE . 0.4 OUTLIER -146.6 -167.88 2.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.973 -1.079 . . . . 0.0 109.991 -179.544 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' GLY . 4.4 m -168.41 96.39 0.4 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.744 HD11 HD12 ' A' ' 108' ' ' LEU . 7.1 mt -91.86 133.01 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.049 -1.032 . . . . 0.0 110.05 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 1.04 HG23 ' CB ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -131.27 159.91 36.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.329 -0.857 . . . . 0.0 108.764 179.311 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.764 ' CD2' HD22 ' A' ' 98' ' ' LEU . 1.7 pp -150.82 150.08 30.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.734 -1.229 . . . . 0.0 111.714 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.641 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.3 m-85 -125.99 79.59 1.85 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -43.92 125.69 4.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.976 -1.077 . . . . 0.0 109.322 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.578 ' HB ' ' CE2' ' A' ' 121' ' ' TYR . 55.2 t . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 110.079 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.475 ' OG ' ' HB3' ' A' ' 163' ' ' TYR . 84.5 p . . . . . 0 N--CA 1.49 1.527 0 CA-C-O 121.281 0.562 . . . . 0.0 109.706 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.426 ' O ' ' C ' ' A' ' 176' ' ' LYS . 3.0 p -54.12 174.86 0.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.301 -0.874 . . . . 0.0 109.217 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 175' ' ' SER . 1.4 mmtp -45.81 136.87 6.06 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.16 -0.963 . . . . 0.0 108.618 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.641 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.2 Cg_endo -77.39 144.94 23.38 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.267 1.978 . . . . 0.0 110.885 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.593 HG12 HD23 ' A' ' 98' ' ' LEU . 3.1 t -120.62 130.79 74.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 1.04 ' CB ' HG23 ' A' ' 161' ' ' THR . 0.9 OUTLIER -122.84 158.32 30.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 110.704 -178.617 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.524 HG21 ' O ' ' A' ' 98' ' ' LEU . 29.3 pt -146.7 153.12 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.492 ' HA ' ' HA ' ' A' ' 159' ' ' THR . 73.7 m-80 -93.15 153.98 18.33 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.035 -1.041 . . . . 0.0 109.41 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.811 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 92.1 t80 -141.81 123.9 15.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.282 -0.886 . . . . 0.0 109.721 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -87.69 111.45 21.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.066 -1.021 . . . . 0.0 109.477 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.485 HG22 ' CD2' ' A' ' 182' ' ' TYR . 21.9 p . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.485 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.85 HD13 ' HB3' ' A' ' 81' ' ' SER . 2.6 mp . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 121.321 0.581 . . . . 0.0 109.511 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.506 ' HB2' ' CB ' ' A' ' 25' ' ' PRO . 1.3 m-20 -108.37 164.41 12.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.0 109.526 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.5 m -95.41 120.3 64.01 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.486 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.522 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 35.6 Cg_endo -78.41 95.56 1.07 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.394 2.063 . . . . 0.0 110.296 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.714 HG22 ' CD1' ' A' ' 84' ' ' LEU . 1.2 p -85.02 -107.72 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.959 . . . . 0.0 109.614 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 43.7 29.24 1.26 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.573 ' CE2' ' HA3' ' A' ' 86' ' ' GLY . 20.5 t80 -53.08 129.92 32.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.399 -1.059 . . . . 0.0 110.166 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 21' ' ' HIS . 1.9 t70 -165.29 134.2 3.36 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.54 ' CB ' ' HG2' ' A' ' 88' ' ' GLN . 4.7 m -118.19 139.38 51.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.923 -1.11 . . . . 0.0 110.276 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.481 ' O ' ' C ' ' A' ' 12' ' ' ASP . 8.9 p -153.43 -169.38 3.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.435 -0.791 . . . . 0.0 109.2 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.533 ' HB2' ' CB ' ' A' ' 19' ' ' THR . 0.8 OUTLIER 41.39 46.93 3.01 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.047 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.813 HG22 ' CG2' ' A' ' 91' ' ' VAL . 41.5 mm -77.67 130.73 35.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.622 0.725 . . . . 0.0 111.349 -178.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.572 ' CB ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -119.67 176.81 5.2 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.183 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.934 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -71.01 -70.03 0.33 Allowed 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.528 -1.358 . . . . 0.0 109.559 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 50.2 m-80 -81.2 -6.84 59.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.056 -1.027 . . . . 0.0 109.362 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.81 ' HB2' HG22 ' A' ' 60' ' ' THR . 3.4 t -137.42 158.01 45.33 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.037 ' CE1' HG22 ' A' ' 20' ' ' VAL . 2.2 p90 -167.76 139.88 3.11 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.991 -1.068 . . . . 0.0 108.494 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.533 ' CB ' ' HB2' ' A' ' 12' ' ' ASP . 23.0 m -84.48 154.88 22.46 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.785 -1.197 . . . . 0.0 110.898 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.037 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.5 t -128.6 177.76 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' A' ' 20' ' ' VAL . 55.6 m-70 -156.2 163.64 39.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.017 -1.052 . . . . 0.0 110.158 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.823 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 46.0 p90 179.87 142.94 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.447 -0.783 . . . . 0.0 109.239 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.537 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.43 169.79 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.113 -0.992 . . . . 0.0 109.145 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.671 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -102.38 165.89 13.0 Favored Pre-proline 0 C--N 1.299 -1.606 0 O-C-N 121.504 -0.747 . . . . 0.0 109.794 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.671 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.7 Cg_endo -78.26 -164.7 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.672 2.248 . . . . 0.0 110.38 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 -115.31 26.5 10.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.37 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.797 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -134.41 169.75 13.06 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.29 -0.881 . . . . 0.0 109.383 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.797 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.4 Cg_endo -77.78 136.62 15.3 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.612 2.208 . . . . 0.0 110.356 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.625 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 16.3 pt -145.52 -171.52 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.493 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.645 HG23 ' ND2' ' A' ' 76' ' ' ASN . 60.5 p -126.56 6.38 6.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.87 . . . . 0.0 109.527 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.436 ' HA2' ' C ' ' A' ' 51' ' ' PRO . . . 139.8 172.92 12.96 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.625 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -123.76 125.26 44.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -1.165 . . . . 0.0 109.543 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.602 HG23 ' HE ' ' A' ' 49' ' ' ARG . 16.1 mm -74.8 120.51 24.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.231 -0.918 . . . . 0.0 109.289 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.688 HG23 HD13 ' A' ' 72' ' ' ILE . 2.3 mm -99.26 129.74 49.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.169 -0.957 . . . . 0.0 109.393 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.461 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 58.2 ttt180 -118.9 119.57 34.74 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.264 -0.898 . . . . 0.0 109.115 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.645 ' NE2' ' CG ' ' A' ' 68' ' ' TYR . 0.3 OUTLIER -93.46 149.14 21.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.32 -0.863 . . . . 0.0 109.472 -179.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.51 ' ND1' ' O ' ' A' ' 69' ' ' VAL . 44.3 p-80 178.27 133.64 0.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.54 -0.725 . . . . 0.0 109.408 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -56.65 -165.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.262 -0.899 . . . . 0.0 109.802 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 . . . . . 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 109.655 -179.874 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.654 ' CD ' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 121.36 0.6 . . . . 0.0 109.75 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -132.47 111.12 11.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.632 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.629 ' HB3' HD11 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -116.31 125.05 51.61 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.307 -0.87 . . . . 0.0 108.794 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.602 ' HE ' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -104.31 160.64 14.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.119 -0.988 . . . . 0.0 109.847 -179.087 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.766 HG21 ' CZ2' ' A' ' 22' ' ' TRP . 3.7 m -142.51 159.93 55.94 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.42 -0.8 . . . . 0.0 109.298 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.543 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 33.7 Cg_endo -76.37 174.27 13.11 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.484 2.123 . . . . 0.0 110.224 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.624 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.9 Cg_endo -76.81 -25.8 8.77 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.62 2.213 . . . . 0.0 111.07 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.8 p -89.35 -3.0 58.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.098 -1.002 . . . . 0.0 109.666 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.543 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -101.02 111.69 23.95 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.281 -0.887 . . . . 0.0 110.137 -179.54 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 40.6 p-10 -92.92 -8.82 42.18 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.446 -0.784 . . . . 0.0 109.084 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 18.2 p -124.3 150.51 45.33 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.823 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 4.6 tt -134.92 133.16 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.926 -1.109 . . . . 0.0 110.295 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.95 102.7 14.53 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.991 ' CB ' HD11 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -84.47 156.89 21.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.16 -0.963 . . . . 0.0 109.763 -179.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.81 HG22 ' HB2' ' A' ' 17' ' ' SER . 33.0 p -143.12 -179.65 6.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.403 -0.811 . . . . 0.0 109.35 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.451 ' O ' ' CZ ' ' A' ' 46' ' ' ARG . 17.5 m-80 55.28 19.26 2.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 109.395 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.991 HD11 ' CB ' ' A' ' 59' ' ' LEU . 4.9 mt -91.62 168.03 11.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 0.0 109.332 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.53 ' CB ' ' OH ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER -77.38 130.98 72.87 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.154 -0.966 . . . . 0.0 108.576 179.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.934 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 36.6 Cg_endo -78.84 133.87 11.6 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.371 2.048 . . . . 0.0 111.566 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 73.57 62.76 2.94 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 1.009 HG21 ' CZ ' ' A' ' 68' ' ' TYR . 3.3 m -159.22 145.73 16.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.179 -1.189 . . . . 0.0 110.698 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 1.4 mt-10 -87.66 99.24 11.92 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 1.009 ' CZ ' HG21 ' A' ' 66' ' ' THR . 29.1 m-85 -103.46 119.68 39.36 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.191 -0.943 . . . . 0.0 110.284 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.661 HG22 ' HG3' ' A' ' 87' ' ' GLN . 20.7 t -68.99 117.82 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.423 -0.798 . . . . 0.0 109.25 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.546 HG12 HG22 ' A' ' 34' ' ' ILE . 1.3 t -96.25 109.99 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.088 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -84.49 110.11 18.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.947 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.769 ' C ' HD12 ' A' ' 73' ' ' ILE . 15.5 mm -79.98 120.58 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.398 -0.814 . . . . 0.0 109.653 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.769 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.3 mp -112.59 144.12 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.04 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.713 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -104.43 128.69 52.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.415 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.539 ' CG2' HG12 ' A' ' 33' ' ' ILE . 16.9 m -133.55 130.56 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.47 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.645 ' ND2' HG23 ' A' ' 30' ' ' THR . 3.1 t-20 -99.82 44.6 1.01 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.284 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.515 ' N ' ' OG1' ' A' ' 30' ' ' THR . . . 95.42 -63.32 1.39 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.02 3.22 3.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -1.141 . . . . 0.0 109.59 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -103.05 -164.39 1.07 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.437 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.413 ' C ' ' OG ' ' A' ' 81' ' ' SER . 32.8 mt-10 -144.13 -169.21 3.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.8 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.85 ' HB3' HD13 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -176.58 -178.8 0.31 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 109.066 -179.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.598 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.8 Cg_endo -77.08 116.13 4.13 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.212 1.941 . . . . 0.0 109.929 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.489 ' CA ' ' O ' ' A' ' 72' ' ' ILE . 36.2 Cg_endo -78.27 146.9 22.7 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.585 2.19 . . . . 0.0 111.272 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.714 ' CD1' HG22 ' A' ' 6' ' ' THR . 0.7 OUTLIER -108.97 107.74 18.22 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.544 HG23 HG12 ' A' ' 69' ' ' VAL . 2.1 mt -87.94 148.05 4.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.071 -1.018 . . . . 0.0 110.228 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.573 ' HA3' ' CE2' ' A' ' 8' ' ' PHE . . . -155.4 161.21 30.37 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.661 ' HG3' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -98.63 143.53 28.92 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.231 -1.158 . . . . 0.0 110.065 -179.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.582 ' HG3' ' CE1' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -142.41 137.5 30.45 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.278 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -107.6 124.25 49.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.027 -1.046 . . . . 0.0 110.982 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.76 138.11 42.46 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.139 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.813 ' CG2' HG22 ' A' ' 13' ' ' ILE . 1.2 t . . . . . 0 N--CA 1.491 1.609 0 C-N-CA 118.833 -1.147 . . . . 0.0 108.714 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.511 ' CB ' ' CD1' ' A' ' 112' ' ' TRP . 35.9 Cg_endo . . . . . 0 C--O 1.214 -0.678 0 N-CA-C 110.183 -0.737 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.533 ' CG ' ' HB2' ' A' ' 113' ' ' GLU . 13.2 ptp180 -174.67 160.13 2.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.257 -0.902 . . . . 0.0 109.373 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.2 OUTLIER 74.97 17.86 2.66 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.218 -0.926 . . . . 0.0 109.516 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.71 HD13 ' CD2' ' A' ' 162' ' ' LEU . 0.6 OUTLIER -51.58 103.7 0.07 Allowed 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.118 -0.989 . . . . 0.0 109.427 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -130.25 161.85 30.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.333 -0.854 . . . . 0.0 109.458 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 12.6 p -97.6 144.76 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.739 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.518 HG12 ' HB3' ' A' ' 109' ' ' LEU . 23.9 pt -127.72 -3.87 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.305 -0.872 . . . . 0.0 109.612 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.887 ' CB ' HD12 ' A' ' 109' ' ' LEU . . . -157.84 106.17 2.03 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.467 ' OG ' ' OH ' ' A' ' 182' ' ' TYR . 1.0 OUTLIER -103.94 106.65 17.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 0.0 110.592 -178.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -94.31 166.48 15.34 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 29.8 Cg_endo -68.97 -2.59 9.88 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.332 2.021 . . . . 0.0 110.665 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.869 ' C ' HG22 ' A' ' 152' ' ' ILE . 3.2 p -148.8 13.9 0.92 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.24 -0.912 . . . . 0.0 109.346 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 1.051 ' O ' HD23 ' A' ' 108' ' ' LEU . 3.3 p -172.31 168.43 5.58 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 118.764 -1.174 . . . . 0.0 109.989 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.051 HD23 ' O ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -144.35 155.17 43.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.329 -0.857 . . . . 0.0 109.375 -179.468 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.887 HD12 ' CB ' ' A' ' 102' ' ' ALA . 5.8 mt -97.11 140.12 32.09 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.573 ' CD1' HD11 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -122.58 132.62 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.946 -1.096 . . . . 0.0 110.663 -179.126 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.3 t -131.03 111.3 11.9 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.715 ' HH2' ' HB2' ' A' ' 147' ' ' ALA . 45.1 p90 -123.63 144.68 49.46 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.182 -0.949 . . . . 0.0 110.75 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.533 ' HB2' ' CG ' ' A' ' 96' ' ' ARG . 4.4 mm-40 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 1.091 ' CZ ' HG21 ' A' ' 165' ' ' VAL . 5.4 p90 . . . . . 0 N--CA 1.487 1.397 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.626 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 1.1 m-85 -136.65 161.56 35.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.19 -0.944 . . . . 0.0 109.494 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -120.67 98.9 6.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.929 . . . . 0.0 108.672 179.434 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.852 HG21 HD11 ' A' ' 149' ' ' ILE . 20.3 mt -84.3 146.47 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.139 -0.975 . . . . 0.0 110.012 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.659 HG22 ' HB3' ' A' ' 137' ' ' GLU . 21.6 p -120.9 153.04 37.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 0.0 110.415 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.657 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 2.6 m-85 -101.9 121.88 42.97 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.596 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.1 117.4 5.56 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.272 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 . . . . . 0 C--N 1.3 -1.573 0 O-C-N 121.226 -1.161 . . . . 0.0 108.988 179.164 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.469 ' O ' ' N ' ' A' ' 126' ' ' TYR . 87.3 mm-40 . . . . . 0 N--CA 1.492 1.665 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.659 ' HB3' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -119.57 158.07 27.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.939 -1.101 . . . . 0.0 111.557 -178.332 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.595 ' CE1' ' HB ' ' A' ' 124' ' ' ILE . 33.8 p90 -140.7 162.86 34.4 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.643 HG22 ' CE2' ' A' ' 121' ' ' TYR . 0.7 OUTLIER -74.51 -171.14 1.15 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.752 -1.217 . . . . 0.0 110.164 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.586 ' CG2' HD12 ' A' ' 124' ' ' ILE . 40.0 t -149.88 133.98 9.02 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.213 -0.93 . . . . 0.0 109.86 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.33 117.34 4.05 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.357 2.038 . . . . 0.0 110.097 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -71.77 55.81 1.33 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.48 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 39.3 m -105.46 -1.62 24.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.164 -1.198 . . . . 0.0 109.492 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.48 ' CG ' ' O ' ' A' ' 143' ' ' SER . 3.0 mtmt -176.16 -179.75 1.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.919 . . . . 0.0 109.43 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.99 13.75 24.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.57 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 110' ' ' ILE . 18.0 p -125.36 152.84 44.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.912 . . . . 0.0 109.527 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.715 ' HB2' ' HH2' ' A' ' 112' ' ' TRP . . . -142.4 171.73 13.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.0 109.548 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.41 ' O ' ' CZ ' ' A' ' 138' ' ' PHE . 11.3 t -110.7 155.85 21.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.328 -0.858 . . . . 0.0 109.379 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.852 HD11 HG21 ' A' ' 124' ' ' ILE . 16.1 mm -133.26 81.9 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 109.506 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.543 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -92.69 167.64 11.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.389 -0.819 . . . . 0.0 109.979 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 0.3 OUTLIER 75.15 47.4 0.1 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 0.0 109.298 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.869 HG22 ' C ' ' A' ' 106' ' ' THR . 4.2 tt -110.67 158.85 10.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.35 -0.844 . . . . 0.0 109.922 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.422 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 1.7 tttp -97.77 112.45 61.59 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.351 -0.843 . . . . 0.0 108.944 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.457 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 34.7 Cg_endo -77.2 138.17 17.72 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.387 2.058 . . . . 0.0 110.692 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.696 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 87.99 67.7 1.3 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 163.26 130.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -1.117 . . . . 0.0 109.633 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 156' ' ' ALA . 1.2 t0 -46.36 158.92 0.1 Allowed 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.596 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -143.08 -179.47 6.39 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.0 -1.063 . . . . 0.0 109.884 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 127' ' ' GLY . 4.8 m -150.94 101.41 2.89 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 179' ' ' SER . 16.2 mm -84.84 136.55 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.117 -0.989 . . . . 0.0 110.118 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.798 HG23 ' HB3' ' A' ' 179' ' ' SER . 2.0 m -147.45 168.87 20.78 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.71 ' CD2' HD13 ' A' ' 98' ' ' LEU . 0.8 OUTLIER -163.54 147.64 10.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.871 -1.143 . . . . 0.0 110.859 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 177' ' ' PRO . 2.0 m-85 -116.08 103.42 10.55 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -61.32 167.25 3.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.007 -1.058 . . . . 0.0 109.459 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 1.091 HG21 ' CZ ' ' A' ' 121' ' ' TYR . 84.4 t . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.146 -0.971 . . . . 0.0 110.543 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.516 ' HA ' ' HA ' ' A' ' 165' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.421 ' O ' ' C ' ' A' ' 176' ' ' LYS . 96.6 p -146.14 163.76 34.34 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.173 -0.954 . . . . 0.0 109.817 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 175' ' ' SER . 0.0 OUTLIER -47.0 139.99 6.58 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.278 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 163' ' ' TYR . 34.8 Cg_endo -77.39 117.49 4.36 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.204 1.936 . . . . 0.0 111.757 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 161' ' ' THR . 2.3 t -84.59 131.57 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.798 ' HB3' HG23 ' A' ' 161' ' ' THR . 54.4 p -128.14 149.37 50.45 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.05 -1.031 . . . . 0.0 111.218 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.655 HD13 HD23 ' A' ' 98' ' ' LEU . 18.8 pt -134.94 152.65 33.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -84.18 147.03 27.52 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.928 -1.108 . . . . 0.0 109.698 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.783 ' OH ' HD22 ' A' ' 108' ' ' LEU . 74.4 t80 -147.43 121.63 9.55 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.452 -0.78 . . . . 0.0 109.335 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 183' ' ' LYS . 8.0 pttm -96.04 121.86 38.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.994 . . . . 0.0 109.505 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.628 HG22 ' HE2' ' A' ' 182' ' ' TYR . 44.7 p . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.483 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.435 ' HA ' HD22 ' A' ' 2' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.482 1.148 0 CA-C-O 121.384 0.612 . . . . 0.0 109.51 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.829 ' CG ' ' HB3' ' A' ' 27' ' ' ALA . 7.5 m-20 -74.62 90.13 2.25 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.422 -0.799 . . . . 0.0 110.134 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.6 m -96.71 106.72 32.09 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 3' ' ' ASP . 36.7 Cg_endo -79.61 159.66 25.2 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.322 2.015 . . . . 0.0 110.642 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.744 ' HA ' HD22 ' A' ' 84' ' ' LEU . 3.8 p -151.94 -121.1 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 109.074 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 43.33 28.14 0.85 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.568 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 7.6 t80 -48.68 133.57 16.94 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.705 -0.88 . . . . 0.0 110.327 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 9.2 t0 -165.05 94.1 0.64 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -84.4 118.32 24.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -0.885 . . . . 0.0 109.764 -179.345 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.464 ' O ' ' C ' ' A' ' 12' ' ' ASP . 96.3 p -151.86 -159.1 0.97 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.396 -0.815 . . . . 0.0 108.981 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.525 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.7 OUTLIER 46.46 33.58 2.0 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -178.305 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.679 ' HA ' ' HA ' ' A' ' 18' ' ' PHE . 1.2 mt -76.69 162.67 4.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.679 -177.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.679 HG23 ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -151.2 -175.27 5.1 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.081 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -78.37 -52.11 9.08 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.123 -0.986 . . . . 0.0 109.752 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 60' ' ' THR . 1.8 p-10 -97.83 -1.9 42.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.78 -1.2 . . . . 0.0 109.936 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.857 ' HB3' HG22 ' A' ' 60' ' ' THR . 3.4 p -150.98 157.33 42.75 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.32 -0.863 . . . . 0.0 108.825 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.798 ' CE1' HG22 ' A' ' 20' ' ' VAL . 2.1 p90 -165.71 141.45 5.07 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.17 -0.956 . . . . 0.0 108.559 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 1.7 m -94.82 155.68 16.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.855 -1.153 . . . . 0.0 111.7 -177.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.798 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -130.16 120.07 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.52 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 4.0 m-70 -101.26 148.91 24.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.118 -0.989 . . . . 0.0 110.81 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.743 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 11.9 p90 -171.47 129.94 0.7 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.536 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.53 169.07 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.985 -1.072 . . . . 0.0 109.566 -179.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.536 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -107.66 160.42 26.77 Favored Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.685 -0.634 . . . . 0.0 109.366 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.54 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 36.9 Cg_endo -78.38 -99.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.676 2.251 . . . . 0.0 110.371 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.54 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -174.57 -34.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.076 -1.015 . . . . 0.0 109.984 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.829 ' HB3' ' CG ' ' A' ' 3' ' ' ASP . . . -54.38 168.13 0.5 Allowed Pre-proline 0 C--N 1.296 -1.729 0 O-C-N 121.5 -0.75 . . . . 0.0 109.368 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.737 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.1 Cg_endo -77.52 142.18 20.57 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.529 2.153 . . . . 0.0 110.354 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.638 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 14.2 pt -148.11 176.98 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.921 . . . . 0.0 109.751 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.0 p -120.77 1.05 10.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.412 -0.805 . . . . 0.0 109.256 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.462 ' O ' ' CG2' ' A' ' 75' ' ' VAL . . . 139.3 150.97 5.61 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.723 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -100.63 135.56 41.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.254 -1.144 . . . . 0.0 109.322 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.88 HG23 ' HD2' ' A' ' 49' ' ' ARG . 1.2 mp -86.53 133.14 30.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.149 -0.969 . . . . 0.0 109.094 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.844 HD13 ' C ' ' A' ' 33' ' ' ILE . 2.9 mm -112.12 102.15 13.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.354 -0.841 . . . . 0.0 109.346 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.533 ' HG2' ' N ' ' A' ' 36' ' ' HIS . 5.4 ttt180 -100.62 158.1 16.18 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.145 -0.972 . . . . 0.0 109.218 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.952 ' CE1' HG22 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -140.07 144.59 36.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.165 -0.96 . . . . 0.0 109.635 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.587 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 35.6 p-80 -163.5 128.85 3.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.834 . . . . 0.0 109.533 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.572 ' HA ' ' HB3' ' A' ' 68' ' ' TYR . . . -40.32 163.6 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.415 -0.803 . . . . 0.0 110.03 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 1.016 ' HG2' HG23 ' A' ' 69' ' ' VAL . 2.1 mt-10 . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.168 -0.958 . . . . 0.0 109.481 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 36' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.366 0.603 . . . . 0.0 109.631 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -143.39 126.97 16.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.339 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.534 ' CG ' HD21 ' A' ' 59' ' ' LEU . 21.2 m-20 -138.21 159.22 42.61 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.88 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -139.18 159.03 43.11 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.286 -0.884 . . . . 0.0 109.85 -179.474 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 1.076 ' CG1' HD12 ' A' ' 57' ' ' ILE . 32.7 m -142.72 159.22 57.88 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.865 . . . . 0.0 109.189 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.544 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.4 Cg_endo -77.21 174.42 12.8 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.503 2.135 . . . . 0.0 110.324 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 35.3 Cg_endo -77.21 -15.5 16.08 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.596 2.198 . . . . 0.0 110.52 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 p -102.8 24.11 11.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.65 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.544 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 5.7 mmt180 -126.83 109.04 11.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.186 -0.946 . . . . 0.0 109.966 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 22' ' ' TRP . 16.5 p30 -94.09 -11.23 31.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.031 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 20.0 p -131.21 137.13 48.79 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.076 HD12 ' CG1' ' A' ' 50' ' ' VAL . 6.4 tt -131.35 129.65 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.982 -1.074 . . . . 0.0 110.264 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.63 111.09 23.1 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.876 ' HB3' HD11 ' A' ' 62' ' ' LEU . 2.0 mt -84.48 158.37 21.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.165 -0.959 . . . . 0.0 109.541 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.857 HG22 ' HB3' ' A' ' 17' ' ' SER . 19.4 p -145.65 177.6 8.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 109.394 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 50.93 46.6 26.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.517 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.876 HD11 ' HB3' ' A' ' 59' ' ' LEU . 3.7 mt -118.19 147.34 43.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 109.355 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.478 ' O ' ' OH ' ' A' ' 68' ' ' TYR . 28.3 m-80 -44.89 117.2 3.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.197 -0.939 . . . . 0.0 108.686 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.4 Cg_endo -77.47 125.72 7.84 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.144 1.896 . . . . 0.0 111.41 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.99 59.99 2.11 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.564 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 2.6 m -151.8 166.51 31.16 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.154 -1.204 . . . . 0.0 109.506 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.564 ' N ' ' CG2' ' A' ' 66' ' ' THR . 5.1 mt-10 -125.56 127.25 46.09 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.305 -0.872 . . . . 0.0 109.21 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -134.23 -159.53 0.97 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.139 -0.975 . . . . 0.0 109.773 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 1.016 HG23 ' HG2' ' A' ' 39' ' ' GLU . 41.7 t -137.36 116.68 15.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.952 HG22 ' CE1' ' A' ' 36' ' ' HIS . 3.7 t -88.58 127.73 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.031 -1.043 . . . . 0.0 109.621 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.539 ' HB3' ' CD1' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -101.0 104.72 15.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 110.065 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 84' ' ' LEU . 15.0 mm -79.4 154.56 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.341 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.549 HG22 ' N ' ' A' ' 74' ' ' ALA . 48.3 mt -153.1 165.03 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 0.0 109.593 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.645 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -132.57 120.62 22.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.298 -0.877 . . . . 0.0 109.389 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.735 HG12 ' HG2' ' A' ' 80' ' ' GLU . 2.4 m -112.63 144.52 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.524 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -135.94 45.23 2.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.892 . . . . 0.0 109.361 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.13 -96.46 1.15 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -109.72 -1.4 18.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.244 -1.15 . . . . 0.0 109.554 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.528 ' O ' ' CG ' ' A' ' 80' ' ' GLU . 19.8 mt-10 -106.52 172.89 6.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 0.0 109.121 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.735 ' HG2' HG12 ' A' ' 75' ' ' VAL . 46.0 mt-10 -158.33 115.75 2.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.125 -0.984 . . . . 0.0 110.022 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.695 ' HG ' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -60.29 -175.17 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.283 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.695 ' HD2' ' HG ' ' A' ' 81' ' ' SER . 33.1 Cg_endo -76.5 146.15 27.19 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.925 1.75 . . . . 0.0 110.107 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.489 ' HB3' HG12 ' A' ' 73' ' ' ILE . 35.6 Cg_endo -77.22 109.56 2.84 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.674 2.249 . . . . 0.0 111.357 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.744 HD22 ' HA ' ' A' ' 6' ' ' THR . 17.9 tp -84.21 94.54 8.42 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.586 ' CG2' ' CG1' ' A' ' 69' ' ' VAL . 2.2 mt -85.72 151.34 3.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.128 -0.983 . . . . 0.0 110.678 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.604 ' O ' HG13 ' A' ' 69' ' ' VAL . . . -142.62 179.25 20.47 Favored Glycine 0 N--CA 1.483 1.824 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.42 ' HG3' ' C ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -131.73 146.4 52.14 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.992 -1.299 . . . . 0.0 110.058 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.538 ' NE2' ' NE2' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -163.13 -167.69 1.54 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' A' ' 66' ' ' THR . . . -165.41 136.64 3.94 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.973 -1.079 . . . . 0.0 109.953 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.462 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.6 OUTLIER -74.59 162.18 29.01 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.193 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.522 HG23 ' C ' ' A' ' 14' ' ' THR . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.612 0 O-C-N 121.142 -0.973 . . . . 0.0 110.201 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.945 ' HG3' HD11 ' A' ' 162' ' ' LEU . 36.4 Cg_endo . . . . . 0 C--O 1.216 -0.599 0 N-CA-C 109.886 -0.852 . . . . 0.0 109.886 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.471 ' CG ' ' HG3' ' A' ' 113' ' ' GLU . 5.9 ptm85 -60.05 179.15 0.15 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.403 -0.811 . . . . 0.0 109.569 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.1 t0 67.35 8.11 6.02 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.243 -0.911 . . . . 0.0 109.272 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.766 ' CD2' HD13 ' A' ' 180' ' ' ILE . 8.7 tt -53.59 99.98 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.216 -0.927 . . . . 0.0 109.13 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -124.98 157.29 36.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.306 -0.871 . . . . 0.0 109.532 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 8.1 p -91.1 139.67 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.381 -0.824 . . . . 0.0 109.606 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.826 HD11 HD22 ' A' ' 109' ' ' LEU . 20.0 pt -125.23 -5.86 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.503 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.999 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -149.4 97.77 2.7 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.488 ' HB2' ' OH ' ' A' ' 182' ' ' TYR . 17.4 p -90.0 90.56 8.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.368 -0.832 . . . . 0.0 110.293 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -80.37 157.49 72.79 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 121.237 -0.914 . . . . 0.0 108.776 179.059 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.483 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.2 Cg_endo -69.9 -2.73 10.77 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.397 2.065 . . . . 0.0 110.502 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.727 ' C ' HG22 ' A' ' 152' ' ' ILE . 1.4 p -150.53 18.38 0.82 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 1.067 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.7 OUTLIER -167.22 171.63 10.63 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.034 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.067 HD23 ' O ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -144.43 152.63 40.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.309 -0.869 . . . . 0.0 109.173 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.999 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -105.75 120.72 42.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 108.86 179.293 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.581 ' CD1' ' HB3' ' A' ' 147' ' ' ALA . 1.0 OUTLIER -106.29 138.06 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.115 -0.991 . . . . 0.0 110.024 -179.68 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.87 ' HB2' HG22 ' A' ' 146' ' ' THR . 0.0 OUTLIER -142.87 115.17 8.44 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.455 -0.778 . . . . 0.0 109.259 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.624 ' CD1' ' CB ' ' A' ' 95' ' ' PRO . 43.4 p90 -125.97 -177.43 3.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 109.561 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.471 ' HG3' ' CG ' ' A' ' 96' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.912 . . . . 0.0 109.424 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.829 ' CE1' HG22 ' A' ' 139' ' ' THR . 9.0 p90 . . . . . 0 N--CA 1.486 1.367 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.498 ' HB2' ' HB ' ' A' ' 140' ' ' VAL . 14.4 m-85 -103.74 129.59 51.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.03 -1.044 . . . . 0.0 108.589 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.555 ' HG3' ' CG ' ' A' ' 137' ' ' GLU . 1.5 ttm180 -95.34 85.94 4.39 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.286 -0.884 . . . . 0.0 109.518 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 1.065 HD12 ' CG2' ' A' ' 140' ' ' VAL . 21.6 mt -84.37 153.16 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.364 -0.835 . . . . 0.0 109.193 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.697 HG22 ' HA ' ' A' ' 137' ' ' GLU . 27.7 p -138.73 142.45 38.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.136 -0.978 . . . . 0.0 110.189 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.672 ' CE2' HG22 ' A' ' 149' ' ' ILE . 4.1 m-85 -79.59 126.68 31.21 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.577 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.35 120.42 6.49 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 C--N 1.3 -1.569 0 O-C-N 121.447 -1.031 . . . . 0.0 109.064 179.571 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.583 ' HB3' ' CD1' ' A' ' 126' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.697 ' HA ' HG22 ' A' ' 125' ' ' THR . 6.4 tm-20 -76.54 117.48 18.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 110.665 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.618 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 26.7 p90 -121.94 138.59 54.35 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.829 HG22 ' CE1' ' A' ' 121' ' ' TYR . 7.4 p -74.21 168.39 19.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.083 -1.01 . . . . 0.0 110.534 -178.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 1.065 ' CG2' HD12 ' A' ' 124' ' ' ILE . 50.9 t -138.31 141.5 31.92 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.523 -0.736 . . . . 0.0 109.647 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.643 ' HD2' HG13 ' A' ' 140' ' ' VAL . 35.0 Cg_endo -77.17 141.43 20.69 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.528 2.152 . . . . 0.0 110.657 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.82 53.55 3.33 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.505 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 28.4 t -103.7 -11.85 17.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.178 -1.189 . . . . 0.0 109.888 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 143' ' ' SER . 1.5 mmmt 179.54 175.81 0.7 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 109.777 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.581 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -95.26 -1.23 51.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.585 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.87 HG22 ' HB2' ' A' ' 111' ' ' SER . 41.4 p -102.0 129.79 48.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.09 -1.006 . . . . 0.0 108.913 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.581 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -126.81 156.5 41.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.118 -0.988 . . . . 0.0 109.78 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.588 ' O ' HD13 ' A' ' 149' ' ' ILE . 8.9 m -100.82 152.26 20.72 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.352 -0.843 . . . . 0.0 109.097 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.672 HG22 ' CE2' ' A' ' 126' ' ' TYR . 49.9 mm -127.93 107.95 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.252 -0.905 . . . . 0.0 109.199 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.586 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 2.9 m120 -116.0 166.1 12.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.418 -0.801 . . . . 0.0 109.929 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 150' ' ' ASN . 4.0 m-80 76.07 37.73 0.36 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 109.268 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.727 HG22 ' C ' ' A' ' 106' ' ' THR . 4.7 tt -96.93 156.17 3.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.392 -0.817 . . . . 0.0 109.795 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 184' ' ' THR . 9.0 mttp -84.64 117.57 69.06 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 109.349 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.483 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 36.4 Cg_endo -78.73 75.88 4.78 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.479 2.12 . . . . 0.0 110.684 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.717 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 143.08 73.05 0.03 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.717 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 162.25 134.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -1.107 . . . . 0.0 109.67 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -48.08 164.43 0.05 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.11 -0.994 . . . . 0.0 108.338 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.612 ' CE2' HG13 ' A' ' 152' ' ' ILE . 0.4 OUTLIER -144.97 -167.44 2.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.865 -1.147 . . . . 0.0 110.352 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.513 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 31.6 m -169.6 102.75 0.33 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.598 HD11 HD12 ' A' ' 108' ' ' LEU . 33.0 mm -88.11 118.6 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.025 -1.047 . . . . 0.0 109.785 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.985 HG23 ' CB ' ' A' ' 179' ' ' SER . 1.1 m -126.37 165.41 19.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.904 . . . . 0.0 109.19 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.945 HD11 ' HG3' ' A' ' 95' ' ' PRO . 1.9 pp -165.86 154.4 11.26 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.997 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.626 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 1.8 m-85 -122.69 160.38 25.97 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -127.26 101.68 6.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.865 -1.147 . . . . 0.0 109.342 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.934 HG22 ' HB3' ' A' ' 174' ' ' SER . 15.1 t . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.333 -0.854 . . . . 0.0 109.677 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.934 ' HB3' HG22 ' A' ' 165' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.382 0.61 . . . . 0.0 109.697 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.49 ' O ' ' O ' ' A' ' 174' ' ' SER . 0.7 OUTLIER 42.1 -166.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.19 139.71 23.1 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 120.999 -1.063 . . . . 0.0 108.229 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.626 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 33.8 Cg_endo -76.14 140.91 22.91 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.206 1.937 . . . . 0.0 111.158 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.2 t -122.11 138.22 53.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.985 ' CB ' HG23 ' A' ' 161' ' ' THR . 0.3 OUTLIER -131.36 155.45 47.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.088 -1.007 . . . . 0.0 110.821 -178.663 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.766 HD13 ' CD2' ' A' ' 98' ' ' LEU . 14.0 pt -136.96 153.3 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 159' ' ' THR . 23.6 m120 -91.67 156.67 17.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.0 -1.063 . . . . 0.0 110.051 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.764 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 51.9 t80 -143.98 169.78 17.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.405 -0.809 . . . . 0.0 109.296 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.477 ' N ' ' CD2' ' A' ' 182' ' ' TYR . 8.6 tttp -139.86 121.69 15.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.231 -0.918 . . . . 0.0 109.537 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.455 ' CB ' ' O ' ' A' ' 153' ' ' LYS . 14.7 p . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.46 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.817 HD12 ' N ' ' A' ' 2' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 26' ' ' ARG . 1.6 m-20 -96.62 167.61 11.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 0.0 109.344 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.548 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 4.8 p -94.52 133.62 26.64 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.491 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.921 ' O ' HD22 ' A' ' 84' ' ' LEU . 36.3 Cg_endo -79.14 86.72 1.64 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.54 2.16 . . . . 0.0 110.394 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.466 ' O ' ' C ' ' A' ' 7' ' ' GLY . 16.5 p -89.32 -126.87 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.04 -1.038 . . . . 0.0 109.304 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 44.48 28.42 1.51 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.039 -2.025 . . . . 0.0 108.039 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.569 ' HB3' HD21 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -92.34 152.32 19.83 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.851 -0.794 . . . . 0.0 109.879 -178.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.593 ' O ' HG12 ' A' ' 20' ' ' VAL . 2.5 t70 -165.0 -163.15 0.68 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.788 ' HB2' HD11 ' A' ' 13' ' ' ILE . 83.0 p -137.45 121.26 17.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.048 -1.032 . . . . 0.0 109.908 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.472 ' O ' ' C ' ' A' ' 12' ' ' ASP . 3.7 p -140.6 -171.01 3.13 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.356 -0.84 . . . . 0.0 108.847 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.547 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.9 OUTLIER 43.84 36.01 1.24 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -178.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.867 HG22 ' CG2' ' A' ' 91' ' ' VAL . 1.2 mt -79.52 132.69 31.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.729 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.543 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -122.83 -179.94 4.42 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.198 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -74.08 -63.39 1.23 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.751 -1.218 . . . . 0.0 109.75 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 3.4 m-20 -88.46 23.77 2.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.148 -0.97 . . . . 0.0 109.446 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.731 ' HA ' HD12 ' A' ' 62' ' ' LEU . 42.0 p -176.04 153.68 1.34 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.774 ' HB2' HG23 ' A' ' 13' ' ' ILE . 2.5 p90 -165.66 140.53 4.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 0.0 109.089 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.547 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 4.6 m -89.79 161.44 16.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.922 -1.111 . . . . 0.0 110.964 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.759 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -133.54 173.23 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.543 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 28.3 m-70 -147.68 170.6 17.17 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.89 -1.131 . . . . 0.0 110.541 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.66 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 16.3 p90 179.81 135.28 0.11 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.533 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.51 167.6 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.087 -1.008 . . . . 0.0 109.267 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.757 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -92.21 168.77 12.15 Favored Pre-proline 0 C--N 1.299 -1.606 0 O-C-N 121.647 -0.658 . . . . 0.0 109.796 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.757 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.9 Cg_endo -78.18 172.75 14.94 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.675 2.25 . . . . 0.0 110.387 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.455 ' HB2' ' OD1' ' A' ' 3' ' ' ASP . 45.5 mmt-85 -90.68 28.73 1.45 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.229 -0.92 . . . . 0.0 109.48 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.948 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -146.26 175.35 2.77 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 109.428 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.948 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.3 Cg_endo -77.83 142.38 20.01 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.647 2.231 . . . . 0.0 110.35 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.716 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 46.3 pt -145.68 -170.6 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.602 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.8 p -121.26 -8.64 9.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.278 -0.889 . . . . 0.0 109.416 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.04 -168.34 32.41 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.716 ' CZ ' HD11 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -138.64 131.54 29.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -1.178 . . . . 0.0 109.526 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.943 HG23 ' HD2' ' A' ' 49' ' ' ARG . 1.1 mp -83.48 133.05 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.21 -0.931 . . . . 0.0 108.835 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.845 HD13 ' C ' ' A' ' 33' ' ' ILE . 2.4 mm -111.97 101.03 11.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.185 -0.947 . . . . 0.0 109.829 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 71' ' ' SER . 0.2 OUTLIER -109.39 111.14 22.52 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 108.602 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.991 ' CE1' HD21 ' A' ' 59' ' ' LEU . 2.1 p-80 -119.13 160.6 21.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.135 -0.978 . . . . 0.0 110.385 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.52 ' NE2' ' HB ' ' A' ' 69' ' ' VAL . 30.3 p-80 -167.25 136.02 2.67 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.576 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -47.51 177.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.922 . . . . 0.0 110.033 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.889 . . . . 0.0 109.767 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.577 ' HB2' ' CD2' ' A' ' 36' ' ' HIS . 4.1 mmt85 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.451 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 3.8 mt-30 -87.77 133.3 33.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.885 . . . . 0.0 109.95 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.529 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 1.0 OUTLIER -155.21 117.08 4.1 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.943 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -105.64 165.02 11.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.982 -1.074 . . . . 0.0 110.205 -179.124 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.646 ' CG1' HD12 ' A' ' 57' ' ' ILE . 7.2 m -140.0 161.84 53.63 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.548 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.3 Cg_endo -76.37 174.1 13.39 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.324 2.016 . . . . 0.0 110.354 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.556 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.5 Cg_endo -76.86 -14.43 17.24 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.558 2.172 . . . . 0.0 110.273 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.12 23.39 13.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.349 -0.845 . . . . 0.0 109.513 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.548 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 10.5 mmt180 -124.77 97.99 5.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -0.953 . . . . 0.0 109.719 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 3.7 p30 -85.06 -0.97 56.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.181 -0.95 . . . . 0.0 109.305 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 63.5 p -136.52 149.1 47.97 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.406 -0.808 . . . . 0.0 109.028 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.66 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 3.4 tt -134.14 123.22 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.116 -0.99 . . . . 0.0 109.741 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 66.4 m -91.74 116.37 28.83 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.358 -0.838 . . . . 0.0 109.456 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.991 HD21 ' CE1' ' A' ' 36' ' ' HIS . 7.2 mt -92.51 151.4 20.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.203 -0.936 . . . . 0.0 109.618 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.487 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 1.2 p -133.12 169.66 16.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.382 -0.824 . . . . 0.0 109.561 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.6 m120 59.4 39.85 21.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -0.879 . . . . 0.0 109.455 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.91 HD11 ' HB3' ' A' ' 59' ' ' LEU . 4.3 mt -108.89 157.64 18.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 0.0 109.293 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.475 ' O ' ' OH ' ' A' ' 68' ' ' TYR . 13.0 m-20 -60.87 134.74 92.59 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.142 -0.974 . . . . 0.0 108.819 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 37.0 Cg_endo -78.49 117.9 4.13 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.289 1.993 . . . . 0.0 110.502 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 77.46 60.51 2.81 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.552 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 2.1 m -146.58 166.67 25.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.535 -0.979 . . . . 0.0 109.895 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.552 ' N ' ' CG2' ' A' ' 66' ' ' THR . 7.5 pt-20 -121.18 136.46 54.97 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.418 -0.801 . . . . 0.0 109.303 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.576 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -132.49 176.97 7.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.19 -0.944 . . . . 0.0 109.577 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.646 HG22 ' HG3' ' A' ' 87' ' ' GLN . 74.9 t -108.69 97.02 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.947 HG13 ' HB3' ' A' ' 36' ' ' HIS . 1.9 t -84.76 124.51 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.863 . . . . 0.0 110.13 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.579 ' CB ' HG12 ' A' ' 85' ' ' ILE . 15.5 p -105.72 137.72 43.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.877 . . . . 0.0 110.295 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.79 ' CD1' HG23 ' A' ' 34' ' ' ILE . 30.9 mm -124.06 120.95 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.465 -0.772 . . . . 0.0 109.149 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 74' ' ' ALA . 49.2 mt -117.6 167.16 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 109.428 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -132.13 124.75 29.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.911 . . . . 0.0 109.393 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -116.03 136.21 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 109.588 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.415 ' CB ' ' HA ' ' A' ' 29' ' ' ILE . 48.3 t30 -121.31 50.14 1.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -0.94 . . . . 0.0 109.448 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.41 -82.12 0.95 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.432 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 20.0 tpt180 -117.35 2.01 12.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -1.166 . . . . 0.0 109.62 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 1.1 mt-10 -92.96 176.45 6.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.133 -0.979 . . . . 0.0 109.415 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 36.0 mt-10 -154.57 96.31 1.88 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.522 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.79 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -59.9 178.99 0.22 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.134 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.568 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.3 Cg_endo -77.3 152.22 30.43 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.352 2.035 . . . . 0.0 110.139 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.436 ' HA ' HG12 ' A' ' 73' ' ' ILE . 35.5 Cg_endo -77.8 105.49 2.03 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.532 2.155 . . . . 0.0 110.759 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.921 HD22 ' O ' ' A' ' 5' ' ' PRO . 23.1 tp -84.57 100.8 11.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -0.888 . . . . 0.0 108.941 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.579 HG12 ' CB ' ' A' ' 71' ' ' SER . 2.3 mt -110.1 149.92 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.126 -0.984 . . . . 0.0 110.09 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -153.47 160.5 29.26 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.646 ' HG3' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -104.19 105.09 15.12 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.127 -1.219 . . . . 0.0 109.792 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.462 ' OE1' ' CB ' ' A' ' 10' ' ' SER . 36.0 mm-40 -104.79 -165.92 1.18 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.74 145.39 6.43 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.902 -1.119 . . . . 0.0 110.929 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -78.26 140.09 38.87 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.144 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.867 ' CG2' HG22 ' A' ' 13' ' ' ILE . 2.1 t . . . . . 0 N--CA 1.493 1.675 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.585 ' HB3' ' CD1' ' A' ' 112' ' ' TRP . 34.7 Cg_endo . . . . . 0 C--O 1.215 -0.648 0 N-CA-C 109.097 -1.155 . . . . 0.0 109.097 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 9.2 ptm85 -158.81 147.6 18.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.871 -1.143 . . . . 0.0 109.682 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 4.4 t70 75.71 24.26 1.3 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.352 -0.843 . . . . 0.0 109.301 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 1.025 HD23 ' CG2' ' A' ' 180' ' ' ILE . 3.4 tp -54.96 99.81 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.186 -0.946 . . . . 0.0 109.207 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -142.8 161.78 37.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.906 . . . . 0.0 109.599 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 109' ' ' LEU . 38.4 t -103.72 150.54 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.273 -0.892 . . . . 0.0 109.592 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.753 ' CG1' HD21 ' A' ' 109' ' ' LEU . 1.2 pt -120.01 -16.06 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.378 -0.826 . . . . 0.0 109.44 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.78 ' HB3' HD23 ' A' ' 109' ' ' LEU . . . -135.99 143.1 44.63 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.532 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.8 p -135.31 93.22 2.95 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.94 -1.1 . . . . 0.0 110.531 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.575 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -75.77 165.95 49.21 Favored Pre-proline 0 C--N 1.306 -1.296 0 O-C-N 121.102 -0.999 . . . . 0.0 108.512 178.715 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 30.0 Cg_endo -69.34 -1.89 8.92 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.296 1.997 . . . . 0.0 110.58 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.748 ' C ' HG22 ' A' ' 152' ' ' ILE . 3.3 p -151.41 17.24 0.72 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.353 -0.842 . . . . 0.0 108.953 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 1.033 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.7 OUTLIER -169.93 161.54 8.91 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.768 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.033 HD23 ' O ' ' A' ' 107' ' ' SER . 0.4 OUTLIER -148.05 147.76 29.93 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.412 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.78 HD23 ' HB3' ' A' ' 102' ' ' ALA . 1.5 pp -106.99 135.93 47.72 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.149 -0.969 . . . . 0.0 109.222 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.614 ' H ' HD13 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -112.47 167.05 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.109 -0.994 . . . . 0.0 110.1 -179.659 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.584 ' CB ' HG22 ' A' ' 146' ' ' THR . 32.4 t -152.03 136.3 16.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.483 -0.761 . . . . 0.0 109.146 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.585 ' CD1' ' HB3' ' A' ' 95' ' ' PRO . 15.5 p90 -141.08 172.18 13.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.198 -0.939 . . . . 0.0 109.711 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.483 ' HB2' ' CG ' ' A' ' 96' ' ' ARG . 5.4 mt-10 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.299 -0.875 . . . . 0.0 109.52 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 1.076 ' CZ ' HG21 ' A' ' 165' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.633 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.3 OUTLIER -125.74 171.98 10.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.034 -1.041 . . . . 0.0 109.908 -179.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -131.8 90.36 2.82 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.076 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.625 ' CD1' HG21 ' A' ' 140' ' ' VAL . 12.9 mt -83.48 164.37 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.339 -0.851 . . . . 0.0 110.021 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.553 HG22 ' CB ' ' A' ' 137' ' ' GLU . 1.9 p -141.14 151.4 43.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.372 -0.83 . . . . 0.0 109.697 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.756 ' CE2' HG22 ' A' ' 149' ' ' ILE . 2.9 m-85 -87.01 141.64 28.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 108.685 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.593 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -105.31 111.54 3.75 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.4 ' OE2' ' HD3' ' A' ' 153' ' ' LYS . 4.9 mt-10 . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.114 -1.227 . . . . 0.0 109.356 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.534 ' O ' ' HA ' ' A' ' 125' ' ' THR . 1.3 mp0 . . . . . 0 N--CA 1.496 1.839 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.553 ' CB ' HG22 ' A' ' 125' ' ' THR . 32.5 tt0 -74.01 114.97 12.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.869 . . . . 0.0 111.349 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.613 ' CE1' ' HB ' ' A' ' 124' ' ' ILE . 44.0 p90 -117.48 156.74 27.48 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.675 HG22 ' HE1' ' A' ' 121' ' ' TYR . 0.7 OUTLIER -74.19 -171.76 1.24 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.824 -1.172 . . . . 0.0 110.744 -178.31 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.726 HG13 ' HD2' ' A' ' 141' ' ' PRO . 71.2 t -154.53 143.12 14.59 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.32 -0.862 . . . . 0.0 109.41 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.726 ' HD2' HG13 ' A' ' 140' ' ' VAL . 35.5 Cg_endo -78.48 140.55 17.11 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.451 2.101 . . . . 0.0 110.2 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.94 38.29 3.2 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.7 t -105.15 -0.74 26.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -1.166 . . . . 0.0 109.694 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.57 162.65 32.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.117 -0.989 . . . . 0.0 109.527 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.578 ' O ' ' CE3' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -90.9 9.17 31.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.559 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.584 HG22 ' CB ' ' A' ' 111' ' ' SER . 71.7 p -119.72 158.78 25.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.887 . . . . 0.0 109.281 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.596 ' CB ' ' CD1' ' A' ' 124' ' ' ILE . . . -135.51 153.32 51.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.193 -0.942 . . . . 0.0 109.633 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.3 t -98.94 151.26 21.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.193 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.756 HG22 ' CE2' ' A' ' 126' ' ' TYR . 12.4 mm -133.05 111.36 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.198 -0.939 . . . . 0.0 109.399 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.581 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 9.8 m120 -122.32 169.18 11.19 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.311 -0.868 . . . . 0.0 109.955 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 2.0 m120 76.12 20.23 1.68 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.959 . . . . 0.0 109.041 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.748 HG22 ' C ' ' A' ' 106' ' ' THR . 7.4 tt -76.7 149.45 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.441 -0.787 . . . . 0.0 109.643 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.47 ' HB2' ' OH ' ' A' ' 158' ' ' TYR . 4.2 mtpm? -103.7 117.44 59.83 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.959 . . . . 0.0 109.487 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.537 ' HA ' ' CB ' ' A' ' 184' ' ' THR . 35.3 Cg_endo -77.83 166.67 24.93 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.407 2.072 . . . . 0.0 110.481 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.694 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 74.07 59.43 3.96 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 162.92 130.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -1.147 . . . . 0.0 109.599 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.421 ' C ' ' O ' ' A' ' 156' ' ' ALA . 0.3 OUTLIER -47.22 161.72 0.07 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -141.78 176.58 8.8 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.773 -1.204 . . . . 0.0 110.44 -179.186 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.739 ' O ' HD13 ' A' ' 160' ' ' ILE . 0.6 OUTLIER -146.89 168.72 20.76 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 179.235 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.739 HD13 ' O ' ' A' ' 159' ' ' THR . 31.1 mm -147.47 120.5 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.668 -1.27 . . . . 0.0 109.707 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.733 HG23 ' CB ' ' A' ' 179' ' ' SER . 0.9 OUTLIER -126.89 163.7 23.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.244 -0.91 . . . . 0.0 109.119 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.944 HD23 HD13 ' A' ' 98' ' ' LEU . 2.5 pp -160.86 146.32 14.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.867 -1.146 . . . . 0.0 110.988 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.595 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 1.9 m-85 -115.71 90.7 3.4 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.18 135.37 56.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.933 -1.104 . . . . 0.0 109.437 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 1.076 HG21 ' CZ ' ' A' ' 121' ' ' TYR . 48.2 t . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 109.576 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 175' ' ' SER . 5.0 p . . . . . 0 N--CA 1.489 1.522 0 CA-C-O 121.256 0.55 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 174' ' ' SER . 85.8 p -54.35 -168.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 109.439 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -73.47 151.91 89.67 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.942 . . . . 0.0 108.89 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.595 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 35.9 Cg_endo -79.24 118.92 4.08 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.427 2.085 . . . . 0.0 111.433 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 161' ' ' THR . 2.7 t -84.79 127.71 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.733 ' CB ' HG23 ' A' ' 161' ' ' THR . 0.0 OUTLIER -124.52 129.31 50.38 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.21 -0.932 . . . . 0.0 110.586 -178.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 1.025 ' CG2' HD23 ' A' ' 98' ' ' LEU . 40.3 pt -114.78 -162.79 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.474 ' OD1' ' N ' ' A' ' 181' ' ' ASN . 1.1 m120 -124.5 156.81 36.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.047 -1.033 . . . . 0.0 109.758 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.82 ' OH ' HD22 ' A' ' 108' ' ' LEU . 64.9 t80 -153.19 170.55 20.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.312 -0.868 . . . . 0.0 109.164 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.412 ' N ' ' CG ' ' A' ' 182' ' ' TYR . 19.2 mtpt -139.18 134.21 32.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 109.448 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.593 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 2.9 p . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.467 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.522 ' CD1' ' O ' ' A' ' 80' ' ' GLU . 1.3 mp . . . . . 0 N--CA 1.489 1.491 0 CA-C-O 121.272 0.558 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 26' ' ' ARG . 1.1 m-20 -100.75 152.79 20.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 0.0 109.511 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -95.08 125.89 48.77 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.496 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.533 ' O ' ' CD2' ' A' ' 84' ' ' LEU . 36.2 Cg_endo -78.67 81.95 2.62 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.464 2.11 . . . . 0.0 110.322 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.544 ' HA ' ' CD2' ' A' ' 84' ' ' LEU . 2.7 p -74.68 -109.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.163 -0.96 . . . . 0.0 109.666 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 45.71 26.72 1.92 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.558 ' CE2' ' HA3' ' A' ' 86' ' ' GLY . 14.1 t80 -56.14 128.03 33.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.544 -0.974 . . . . 0.0 110.094 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.504 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 0.8 OUTLIER -147.75 -179.28 6.77 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.504 ' HB2' HD11 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -155.42 117.86 4.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.104 -0.997 . . . . 0.0 110.062 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.5 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 0.8 OUTLIER -145.73 -167.65 2.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.059 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.545 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 4.6 m-20 42.23 38.49 1.16 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.019 HG22 HG23 ' A' ' 91' ' ' VAL . 2.5 mt -80.45 149.84 5.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.775 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -140.48 169.15 18.2 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.431 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -65.43 -62.61 1.43 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.71 -1.244 . . . . 0.0 110.159 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.9 OUTLIER -91.37 27.86 1.83 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.116 -0.99 . . . . 0.0 109.511 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 14' ' ' THR . 56.7 p 179.48 154.72 0.5 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.049 ' CE1' HG22 ' A' ' 20' ' ' VAL . 3.5 p90 -166.83 144.18 4.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.13 -0.981 . . . . 0.0 109.279 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 28.9 m -85.95 148.18 25.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.637 -1.289 . . . . 0.0 110.369 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.049 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.3 t -118.16 171.62 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.536 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 49.8 m-70 -151.76 165.02 35.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.004 -1.06 . . . . 0.0 110.006 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.819 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 42.6 p90 -171.98 145.42 1.84 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.442 -0.786 . . . . 0.0 109.152 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.521 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.51 169.21 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.054 -1.029 . . . . 0.0 109.189 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.52 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -98.65 161.05 26.41 Favored Pre-proline 0 C--N 1.298 -1.643 0 O-C-N 121.54 -0.725 . . . . 0.0 109.819 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.505 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.8 Cg_endo -78.79 159.78 27.85 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.687 2.258 . . . . 0.0 110.397 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.466 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 5.1 mmm180 -90.28 17.07 7.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.222 -0.924 . . . . 0.0 109.408 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.969 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -121.04 177.13 1.57 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 109.374 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.969 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.4 Cg_endo -77.83 140.03 18.09 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.52 2.147 . . . . 0.0 110.333 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.636 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 28.7 pt -153.86 -173.47 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.526 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 17.1 p -133.95 3.31 3.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 109.579 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.57 -172.19 30.34 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.636 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -144.25 127.95 17.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.237 -1.155 . . . . 0.0 109.668 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.874 HG23 ' CD ' ' A' ' 49' ' ' ARG . 1.6 mp -80.74 130.84 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.274 -0.891 . . . . 0.0 108.772 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.753 HD13 ' C ' ' A' ' 33' ' ' ILE . 2.5 mm -107.54 112.34 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.166 -0.959 . . . . 0.0 109.966 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.551 ' CG ' ' HG2' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -104.55 116.77 32.65 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.137 -0.977 . . . . 0.0 108.582 179.098 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.553 ' CD2' ' C ' ' A' ' 36' ' ' HIS . 0.1 OUTLIER -105.95 144.36 32.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.085 -1.01 . . . . 0.0 109.797 -179.11 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.587 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 41.6 p-80 -169.5 114.47 0.54 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.586 -0.696 . . . . 0.0 109.91 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.924 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . -61.37 175.21 0.6 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.42 -0.8 . . . . 0.0 109.609 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.909 . . . . 0.0 109.323 179.779 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.51 ' CZ ' ' CB ' ' A' ' 46' ' ' ARG . 2.8 ptm85 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 121.297 0.57 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.551 ' HG2' ' CG ' ' A' ' 35' ' ' ARG . 30.1 mt-30 -139.18 119.58 13.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.276 -0.89 . . . . 0.0 109.701 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.868 ' HB3' HD11 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -111.58 118.22 35.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.358 -0.839 . . . . 0.0 108.822 179.503 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.874 ' CD ' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -92.99 140.31 29.6 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.013 -1.054 . . . . 0.0 109.546 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.666 ' CG2' HD11 ' A' ' 34' ' ' ILE . 1.8 m -117.58 163.16 25.15 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.277 -0.89 . . . . 0.0 109.555 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.497 ' HG2' ' HG3' ' A' ' 54' ' ' ARG . 34.5 Cg_endo -76.98 174.84 12.2 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.634 2.222 . . . . 0.0 110.486 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.61 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.9 Cg_endo -76.73 -15.8 16.84 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.562 2.175 . . . . 0.0 110.316 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.6 m -103.26 25.71 9.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.277 -0.889 . . . . 0.0 109.16 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.497 ' HG3' ' HG2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -127.14 126.22 42.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.37 -0.831 . . . . 0.0 109.509 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 25.2 p-10 -111.82 5.43 19.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.884 . . . . 0.0 109.528 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.516 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 89.3 p -146.12 150.05 35.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 0.0 109.313 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.868 HD11 ' HB3' ' A' ' 48' ' ' ASP . 4.2 tt -138.21 125.16 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -0.94 . . . . 0.0 109.586 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 0.3 OUTLIER -84.83 107.64 17.1 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.351 -0.843 . . . . 0.0 109.496 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.666 ' HB3' HD11 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -84.82 149.61 25.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.94 . . . . 0.0 109.259 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.485 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 6.3 p -134.61 166.15 23.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.139 -0.976 . . . . 0.0 109.703 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 60' ' ' THR . 3.7 m120 61.04 61.06 1.68 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.283 -0.886 . . . . 0.0 109.655 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.666 HD11 ' HB3' ' A' ' 59' ' ' LEU . 1.7 mt -132.92 138.18 46.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.352 -0.842 . . . . 0.0 109.166 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.542 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 3.0 m-20 -44.56 133.3 4.78 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.12 -0.988 . . . . 0.0 108.797 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.452 ' O ' ' O ' ' A' ' 174' ' ' SER . 35.9 Cg_endo -77.74 135.22 14.17 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.333 2.022 . . . . 0.0 111.373 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 71.36 64.91 2.59 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.6 m -158.44 151.57 22.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.251 -1.146 . . . . 0.0 110.889 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 1.7 tt0 -84.43 133.95 34.48 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.924 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 28.0 m-85 -119.81 130.98 55.18 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.882 -1.136 . . . . 0.0 110.856 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.709 HG12 ' CG2' ' A' ' 85' ' ' ILE . 3.4 t -85.56 97.49 5.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.535 HG23 ' NE2' ' A' ' 88' ' ' GLN . 3.1 t -94.06 125.48 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.291 -0.88 . . . . 0.0 109.759 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.527 ' CB ' HG12 ' A' ' 85' ' ' ILE . 1.3 p -96.74 138.62 34.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 109.72 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.56 ' CD1' HG23 ' A' ' 34' ' ' ILE . 17.8 mm -114.45 77.35 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.332 -0.855 . . . . 0.0 109.27 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.555 HG22 ' N ' ' A' ' 74' ' ' ALA . 24.5 mt -75.04 163.71 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 109.46 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.845 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -121.89 160.2 25.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 0.0 109.583 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.446 ' O ' ' OG1' ' A' ' 30' ' ' THR . 0.4 OUTLIER -145.11 131.9 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -0.923 . . . . 0.0 109.318 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -116.63 50.47 1.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.278 -0.889 . . . . 0.0 109.395 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.05 -90.24 1.34 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -114.53 0.77 14.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -1.129 . . . . 0.0 109.638 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 0.8 OUTLIER -96.44 -164.54 1.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.136 -0.978 . . . . 0.0 109.262 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.522 ' O ' ' CD1' ' A' ' 2' ' ' LEU . 23.2 mt-10 -147.58 -169.56 3.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.171 -0.956 . . . . 0.0 109.571 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.845 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.6 OUTLIER -155.33 -177.41 0.73 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.371 -0.831 . . . . 0.0 109.062 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.598 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.1 Cg_endo -77.85 131.03 10.88 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.162 1.908 . . . . 0.0 109.963 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.467 ' HB3' HG12 ' A' ' 73' ' ' ILE . 36.0 Cg_endo -77.8 86.87 1.58 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.524 2.149 . . . . 0.0 111.179 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -75.26 131.28 40.25 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.096 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.709 ' CG2' HG12 ' A' ' 69' ' ' VAL . 3.8 mt -117.54 150.65 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.011 -1.055 . . . . 0.0 110.346 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.558 ' HA3' ' CE2' ' A' ' 8' ' ' PHE . . . -132.58 176.97 19.15 Favored Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.074 -2.011 . . . . 0.0 108.074 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -142.66 111.9 6.59 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.101 -1.234 . . . . 0.0 110.344 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.591 ' HG3' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -113.24 -158.82 0.66 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.014 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -148.07 130.06 15.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.716 -1.24 . . . . 0.0 110.525 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.508 ' OG1' ' CE2' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -74.45 134.83 42.32 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.019 HG23 HG22 ' A' ' 13' ' ' ILE . 7.5 t . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.54 ' CB ' ' O ' ' A' ' 113' ' ' GLU . 36.7 Cg_endo . . . . . 0 C--O 1.215 -0.637 0 N-CA-C 110.267 -0.705 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.476 ' O ' ' N ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -86.53 -168.27 2.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.155 -0.966 . . . . 0.0 109.511 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 111' ' ' SER . 11.5 t0 71.78 33.09 1.8 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 109.702 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.964 HD13 ' CD2' ' A' ' 162' ' ' LEU . 31.5 tp -71.95 92.77 1.3 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.912 . . . . 0.0 109.396 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -133.28 157.88 44.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -0.926 . . . . 0.0 109.668 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 9.5 p -96.96 141.77 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.81 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.865 HD11 ' CD2' ' A' ' 109' ' ' LEU . 12.1 pt -123.59 -8.55 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.532 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.617 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -147.12 112.83 5.69 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.488 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 12.9 m -112.72 96.44 5.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.136 -0.977 . . . . 0.0 110.599 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -83.11 165.92 38.3 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.243 -0.91 . . . . 0.0 108.653 178.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.464 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 30.0 Cg_endo -69.44 -3.83 12.58 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.275 1.984 . . . . 0.0 110.478 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.69 ' C ' HG22 ' A' ' 152' ' ' ILE . 4.9 p -149.08 16.67 0.95 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.396 -0.815 . . . . 0.0 108.94 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 1.044 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.7 OUTLIER -169.92 165.46 9.59 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.071 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.044 HD23 ' O ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -145.65 155.69 43.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.358 -0.839 . . . . 0.0 109.259 -179.706 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.865 ' CD2' HD11 ' A' ' 101' ' ' ILE . 21.1 tp -105.42 136.52 44.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.284 -0.885 . . . . 0.0 108.94 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.781 ' CD1' ' HB3' ' A' ' 147' ' ' ALA . 1.2 pt -124.82 140.72 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.055 -1.028 . . . . 0.0 110.369 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 97' ' ' ASP . 7.5 t -134.46 145.19 48.61 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.602 ' CH2' ' N ' ' A' ' 147' ' ' ALA . 11.9 p90 -134.56 -171.31 2.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.076 -1.015 . . . . 0.0 110.707 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 95' ' ' PRO . 4.4 mm-40 . . . . . 0 N--CA 1.494 1.748 0 O-C-N 121.591 -0.693 . . . . 0.0 109.668 -179.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.893 ' CE1' HG22 ' A' ' 139' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.418 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.477 ' HB2' ' HB ' ' A' ' 140' ' ' VAL . 2.7 m-85 -111.76 147.89 34.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.965 -1.084 . . . . 0.0 109.83 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.582 ' O ' ' CD1' ' A' ' 163' ' ' TYR . 21.4 ttm180 -120.42 84.22 2.19 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.633 HG12 ' HB2' ' A' ' 162' ' ' LEU . 7.6 mt -84.42 168.72 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 110.274 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.511 ' N ' HG22 ' A' ' 124' ' ' ILE . 1.5 p -144.37 156.08 44.07 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.61 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.699 ' CE2' HG22 ' A' ' 149' ' ' ILE . 3.5 m-85 -91.24 137.43 32.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.519 -0.738 . . . . 0.0 109.034 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.615 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -102.69 111.52 4.02 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 . . . . . 0 C--N 1.298 -1.652 0 O-C-N 121.134 -1.215 . . . . 0.0 109.311 179.293 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' A' ' 125' ' ' THR . 1.2 tt0 . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.498 ' HA ' HG22 ' A' ' 125' ' ' THR . 0.5 OUTLIER -74.72 133.18 42.07 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.346 -0.846 . . . . 0.0 110.89 -178.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.652 ' CZ ' HD13 ' A' ' 149' ' ' ILE . 43.6 p90 -134.69 145.19 48.28 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.893 HG22 ' CE1' ' A' ' 121' ' ' TYR . 1.2 p -74.05 -175.71 2.29 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.943 -1.098 . . . . 0.0 110.791 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.744 HG13 ' HD2' ' A' ' 141' ' ' PRO . 72.0 t -157.21 144.03 13.38 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.446 -0.784 . . . . 0.0 109.297 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.744 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.0 Cg_endo -76.17 140.89 22.81 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.379 2.052 . . . . 0.0 110.361 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -88.58 35.62 3.58 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.424 ' C ' ' HD3' ' A' ' 144' ' ' LYS . 0.3 OUTLIER -105.27 -22.01 13.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.096 -1.237 . . . . 0.0 109.463 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.424 ' HD3' ' C ' ' A' ' 143' ' ' SER . 2.3 mptt -116.44 150.77 37.29 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.522 -0.736 . . . . 0.0 110.03 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.56 4.01 50.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.351 -0.843 . . . . 0.0 109.108 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.543 ' C ' ' CH2' ' A' ' 112' ' ' TRP . 1.6 p -130.2 151.94 50.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.389 -0.819 . . . . 0.0 108.827 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.781 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -116.76 153.41 32.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.029 -1.045 . . . . 0.0 109.969 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.8 t -104.66 154.19 20.28 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.365 -0.834 . . . . 0.0 109.1 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.699 HG22 ' CE2' ' A' ' 126' ' ' TYR . 9.4 mm -134.75 114.25 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.482 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.58 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 3.2 m120 -122.28 170.95 9.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.287 -0.883 . . . . 0.0 109.984 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.435 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 4.3 m120 70.57 28.19 3.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 0.0 109.115 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.69 HG22 ' C ' ' A' ' 106' ' ' THR . 5.1 tt -84.56 147.13 5.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.393 -0.817 . . . . 0.0 109.713 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.468 ' HB2' ' OH ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -93.22 111.3 51.28 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.345 -0.847 . . . . 0.0 109.19 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.504 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 35.8 Cg_endo -77.29 141.51 20.5 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.319 2.013 . . . . 0.0 110.451 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.693 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 90.41 64.59 1.22 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.693 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 163.49 134.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -1.154 . . . . 0.0 109.491 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 6.9 t0 -49.31 151.62 1.43 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.645 ' CD1' HG21 ' A' ' 184' ' ' THR . 0.2 OUTLIER -135.29 178.66 6.86 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.847 -1.158 . . . . 0.0 110.246 -179.285 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.589 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 3.4 m -150.06 107.7 3.67 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.963 HD11 HD12 ' A' ' 108' ' ' LEU . 9.0 mt -94.39 130.08 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.617 -1.302 . . . . 0.0 109.966 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 179' ' ' SER . 1.8 m -132.15 113.67 13.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.356 -0.84 . . . . 0.0 109.265 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.964 ' CD2' HD13 ' A' ' 98' ' ' LEU . 2.1 pp -99.18 127.16 45.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.29 -0.881 . . . . 0.0 110.164 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.626 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 4.2 m-85 -100.39 171.94 7.45 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.486 ' HB3' ' OG ' ' A' ' 175' ' ' SER . . . -148.92 135.24 19.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.138 -0.976 . . . . 0.0 109.628 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.558 HG22 ' HA ' ' A' ' 174' ' ' SER . 97.0 t . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 109.399 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.558 ' HA ' HG22 ' A' ' 165' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.575 0.702 . . . . 0.0 110.062 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.486 ' OG ' ' HB3' ' A' ' 164' ' ' ALA . 0.6 OUTLIER -115.66 159.89 20.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.667 -0.646 . . . . 0.0 109.561 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.412 ' HE3' ' HB2' ' A' ' 176' ' ' LYS . 1.7 ptmt -42.36 118.69 2.2 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.171 -0.955 . . . . 0.0 110.45 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.626 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 29.7 Cg_endo -70.96 122.1 8.48 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.368 2.045 . . . . 0.0 111.199 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.463 ' O ' ' HA ' ' A' ' 161' ' ' THR . 57.4 t -84.77 118.79 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 161' ' ' THR . 0.0 OUTLIER -109.9 126.52 53.95 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.132 -0.98 . . . . 0.0 110.551 -178.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.931 HG23 HD23 ' A' ' 98' ' ' LEU . 32.1 pt -117.55 151.16 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -79.5 163.33 24.8 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.006 -1.059 . . . . 0.0 109.8 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.792 ' OH ' HD22 ' A' ' 108' ' ' LEU . 46.2 t80 -159.19 114.98 2.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.437 -0.789 . . . . 0.0 109.122 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -87.14 116.87 25.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.113 -0.992 . . . . 0.0 109.447 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.645 HG21 ' CD1' ' A' ' 158' ' ' TYR . 9.2 p . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.481 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.673 HD12 ' HB3' ' A' ' 25' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.535 0 N-CA-C 109.449 -0.575 . . . . 0.0 109.449 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.441 ' CG ' ' HB2' ' A' ' 26' ' ' ARG . 1.5 m-20 -81.04 161.53 24.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.235 -0.916 . . . . 0.0 109.459 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.1 t -95.2 112.01 57.0 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.513 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.49 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 35.1 Cg_endo -77.25 78.78 3.35 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.34 2.027 . . . . 0.0 110.134 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.822 ' HA ' HD22 ' A' ' 84' ' ' LEU . 0.9 OUTLIER -87.48 -104.6 0.07 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.238 -0.913 . . . . 0.0 109.565 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 9' ' ' ASP . . . 44.2 27.03 1.03 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.402 ' N ' ' C ' ' A' ' 6' ' ' THR . 12.7 t80 -49.06 93.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.44 -1.035 . . . . 0.0 109.688 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 7' ' ' GLY . 9.8 t0 -121.3 84.07 2.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.366 -0.833 . . . . 0.0 108.994 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 83.1 p -84.43 131.79 34.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.495 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.479 ' O ' ' HB ' ' A' ' 19' ' ' THR . 76.7 p -156.01 -156.36 0.63 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.336 -0.853 . . . . 0.0 109.537 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.55 ' HB2' ' CB ' ' A' ' 19' ' ' THR . 0.6 OUTLIER 45.0 34.59 1.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -178.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.851 HD13 ' HB2' ' A' ' 18' ' ' PHE . 13.6 mm -62.13 134.25 27.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.749 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.571 ' CB ' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -123.0 178.24 5.15 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 177.149 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.542 ' HA ' ' O ' ' A' ' 91' ' ' VAL . . . -74.07 -74.73 0.18 Allowed 'General case' 0 C--N 1.292 -1.902 0 O-C-N 120.605 -1.309 . . . . 0.0 109.155 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.6 OUTLIER -75.68 -1.35 24.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.159 -0.963 . . . . 0.0 109.338 179.731 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.946 ' HB3' HG22 ' A' ' 60' ' ' THR . 14.4 p -146.54 162.08 39.11 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.281 -0.887 . . . . 0.0 109.096 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.023 ' CE1' HG22 ' A' ' 20' ' ' VAL . 4.9 p90 -167.38 137.72 2.92 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.907 -1.121 . . . . 0.0 108.419 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.55 ' CB ' ' HB2' ' A' ' 12' ' ' ASP . 11.9 m -80.99 150.01 29.08 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.77 -1.206 . . . . 0.0 111.172 -178.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.023 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -135.34 109.85 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.506 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 3.0 m-70 -102.01 166.31 10.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.032 -1.043 . . . . 0.0 110.509 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.67 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 38.9 p90 -175.71 147.72 0.83 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.49 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -74.51 159.27 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.966 -1.084 . . . . 0.0 110.083 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.75 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -100.79 168.97 8.46 Favored Pre-proline 0 C--N 1.299 -1.63 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.75 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.9 Cg_endo -78.61 -159.53 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.63 2.22 . . . . 0.0 110.196 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.441 ' HB2' ' CG ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -127.66 12.69 6.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.297 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.933 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -123.17 175.14 2.9 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 109.38 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.933 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.6 Cg_endo -78.24 112.05 3.15 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.586 2.19 . . . . 0.0 110.418 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.575 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 7.6 pt -116.0 -174.23 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.9 . . . . 0.0 109.388 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.5 p -114.88 2.87 14.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.567 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.528 ' HA2' ' N ' ' A' ' 52' ' ' PRO . . . 131.41 -173.04 20.59 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.63 ' CE1' ' HA ' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -134.26 145.3 48.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -1.111 . . . . 0.0 109.35 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.881 ' C ' HD13 ' A' ' 34' ' ' ILE . 1.8 mp -92.9 129.17 43.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.269 -0.895 . . . . 0.0 109.065 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.881 HD13 ' C ' ' A' ' 33' ' ' ILE . 1.7 mm -109.76 104.38 16.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.243 -0.91 . . . . 0.0 109.673 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.485 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 10.2 ttp85 -106.87 131.0 54.46 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.11 -0.994 . . . . 0.0 109.209 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 1.003 ' CD2' HD22 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -117.41 131.82 56.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.171 -0.956 . . . . 0.0 109.622 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.567 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 41.9 p-80 -151.04 132.74 14.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.316 -0.865 . . . . 0.0 109.796 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -53.22 -168.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.356 -0.84 . . . . 0.0 109.87 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.047 -1.033 . . . . 0.0 110.4 -179.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.725 ' HD2' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.637 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 35' ' ' ARG . 1.1 pt20 -127.77 126.78 42.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 109.993 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.634 ' HB2' HD21 ' A' ' 59' ' ' LEU . 0.8 OUTLIER -117.5 118.11 31.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.357 -0.84 . . . . 0.0 108.831 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.87 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -92.73 153.63 18.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.033 -1.042 . . . . 0.0 110.034 -179.407 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.992 ' CG1' HD12 ' A' ' 57' ' ' ILE . 1.1 m -129.03 163.75 43.66 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.824 . . . . 0.0 109.297 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.535 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.8 Cg_endo -77.43 174.8 12.15 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.593 2.195 . . . . 0.0 110.419 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.63 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 35.1 Cg_endo -77.06 -15.64 16.26 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.622 2.215 . . . . 0.0 110.582 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.19 28.71 6.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.244 -0.91 . . . . 0.0 109.555 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.535 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -128.87 103.33 6.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.93 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.68 -12.23 37.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.185 -0.947 . . . . 0.0 109.104 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 56.1 p -135.7 130.35 34.09 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.992 HD12 ' CG1' ' A' ' 50' ' ' VAL . 3.4 tt -126.65 133.78 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.075 -1.015 . . . . 0.0 110.083 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.49 106.12 18.1 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.003 HD22 ' CD2' ' A' ' 36' ' ' HIS . 1.5 mt -84.62 148.56 26.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.155 -0.965 . . . . 0.0 109.566 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.946 HG22 ' HB3' ' A' ' 17' ' ' SER . 27.6 p -142.24 -179.61 6.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.341 -0.849 . . . . 0.0 109.435 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 60' ' ' THR . 17.5 m-80 60.93 16.3 6.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.255 -0.903 . . . . 0.0 109.365 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.981 HD11 ' HB3' ' A' ' 59' ' ' LEU . 0.9 OUTLIER -94.86 143.57 26.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 109.261 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.485 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 2.5 t-20 -45.71 116.01 3.06 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 34.6 Cg_endo -75.86 136.63 18.93 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.214 1.943 . . . . 0.0 111.043 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 74.93 63.69 2.49 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.539 HG21 ' CZ ' ' A' ' 68' ' ' TYR . 2.0 m -162.88 146.25 10.99 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.071 -1.253 . . . . 0.0 110.138 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.557 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 2.2 tp10 -74.79 128.23 35.07 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 20.4 m-85 -136.45 110.59 8.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.967 -1.083 . . . . 0.0 110.041 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.946 HG13 ' O ' ' A' ' 86' ' ' GLY . 93.4 t -71.02 141.63 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 35' ' ' ARG . 1.3 t -117.57 126.5 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.993 -1.067 . . . . 0.0 110.022 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.507 ' HB2' HG12 ' A' ' 85' ' ' ILE . 3.1 p -102.76 112.14 24.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -0.861 . . . . 0.0 109.735 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.793 ' C ' HD12 ' A' ' 73' ' ' ILE . 24.8 mm -94.41 111.29 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 0.0 109.528 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.793 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.4 mp -112.3 122.44 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.961 . . . . 0.0 109.34 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.017 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -98.03 122.05 40.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.238 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.414 HG13 HG22 ' A' ' 73' ' ' ILE . 13.0 m -132.79 141.04 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 109.7 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.458 ' CB ' ' HA ' ' A' ' 29' ' ' ILE . 30.8 t30 -110.91 44.71 1.24 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 109.363 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.11 -95.94 0.86 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.45 ' CD ' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -75.42 -0.35 19.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -1.123 . . . . 0.0 109.624 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 1.2 tt0 -116.88 171.88 7.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.58 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 30.3 mt-10 -149.84 96.46 2.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.437 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 1.017 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -59.77 179.62 0.2 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.265 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.575 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.4 Cg_endo -77.48 154.87 31.76 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.355 2.037 . . . . 0.0 110.348 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.52 143.73 21.95 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.636 2.224 . . . . 0.0 110.761 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.822 HD22 ' HA ' ' A' ' 6' ' ' THR . 23.7 tp -138.74 92.96 2.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.44 -0.788 . . . . 0.0 108.923 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.507 HG12 ' HB2' ' A' ' 71' ' ' SER . 1.9 mt -99.33 153.16 4.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.134 -0.979 . . . . 0.0 110.075 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.946 ' O ' HG13 ' A' ' 69' ' ' VAL . . . -148.37 -166.84 13.13 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -125.8 138.17 53.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.163 -1.198 . . . . 0.0 109.603 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.624 ' NE2' ' CD2' ' A' ' 18' ' ' PHE . 11.7 tm0? -154.5 115.09 3.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.293 -0.88 . . . . 0.0 109.197 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.557 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -98.55 134.3 41.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.315 -0.866 . . . . 0.0 109.714 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.436 HG23 HE22 ' A' ' 88' ' ' GLN . 0.1 OUTLIER -74.24 162.67 28.69 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.131 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.694 ' CG2' HG22 ' A' ' 13' ' ' ILE . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.132 -0.98 . . . . 0.0 110.982 -178.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.649 ' CB ' ' CD1' ' A' ' 112' ' ' TRP . 34.6 Cg_endo . . . . . 0 C--O 1.215 -0.656 0 N-CA-C 109.487 -1.005 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 112' ' ' TRP . 0.9 OUTLIER -49.96 -178.53 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.695 -0.628 . . . . 0.0 109.634 -179.502 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER 67.46 8.25 6.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.332 -0.855 . . . . 0.0 109.333 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.959 HD22 HD12 ' A' ' 162' ' ' LEU . 7.9 tp -57.27 90.21 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.221 -0.924 . . . . 0.0 108.923 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 97' ' ' ASP . 11.1 pt-20 -130.36 161.31 31.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.934 . . . . 0.0 109.523 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 10.7 p -95.76 144.27 10.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.29 -0.881 . . . . 0.0 109.638 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.52 ' N ' HD13 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -132.6 3.79 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.279 -0.888 . . . . 0.0 109.449 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.958 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -162.97 94.26 0.83 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.492 ' HB2' ' OH ' ' A' ' 182' ' ' TYR . 21.0 p -91.68 105.85 18.04 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.409 -0.807 . . . . 0.0 110.585 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.549 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -93.25 159.39 35.43 Favored Pre-proline 0 C--N 1.304 -1.373 0 O-C-N 121.371 -0.83 . . . . 0.0 108.889 178.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.413 ' O ' ' HG3' ' A' ' 154' ' ' PRO . 30.6 Cg_endo -70.22 -2.65 10.84 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.472 2.114 . . . . 0.0 110.455 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.833 ' C ' HG22 ' A' ' 152' ' ' ILE . 61.9 p -150.5 19.49 0.83 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.835 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -168.98 167.7 10.59 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.982 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.895 HD22 ' CE2' ' A' ' 182' ' ' TYR . 0.5 OUTLIER -140.37 151.77 45.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.335 -0.853 . . . . 0.0 109.224 -179.782 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.958 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -106.26 118.84 37.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.109 179.389 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.738 HD12 HD12 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -101.85 145.1 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.258 -0.901 . . . . 0.0 109.764 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.845 ' HA ' HG22 ' A' ' 146' ' ' THR . 0.4 OUTLIER -140.82 115.75 9.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.403 -0.811 . . . . 0.0 109.135 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.649 ' CD1' ' CB ' ' A' ' 95' ' ' PRO . 25.8 p90 -145.01 170.61 15.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.408 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.439 ' HG3' ' HG3' ' A' ' 96' ' ' ARG . 4.8 mt-10 . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.15 -0.969 . . . . 0.0 109.495 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 1.051 ' CE2' HG22 ' A' ' 139' ' ' THR . 4.7 p90 . . . . . 0 N--CA 1.486 1.326 0 N-CA-C 109.385 -0.598 . . . . 0.0 109.385 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.593 ' N ' ' CD2' ' A' ' 121' ' ' TYR . 4.2 m-85 -130.42 139.43 50.6 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.598 ' HG2' ' CE2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -96.73 102.88 14.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.785 -1.197 . . . . 0.0 110.035 -179.017 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.723 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 6.4 mt -84.57 106.07 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.741 HG22 ' HB3' ' A' ' 137' ' ' GLU . 32.3 p -93.05 141.96 27.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 110.549 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 1.113 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 4.8 m-30 -94.66 136.77 34.58 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.603 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -105.09 108.94 3.16 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.244 -1.151 . . . . 0.0 109.734 179.923 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.59 ' O ' ' CG ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.493 1.677 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.741 ' HB3' HG22 ' A' ' 125' ' ' THR . 7.3 pt-20 -112.38 145.62 39.77 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.918 -1.114 . . . . 0.0 110.774 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.723 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 6.3 p90 -135.23 150.52 50.09 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 1.051 HG22 ' CE2' ' A' ' 121' ' ' TYR . 2.0 p -74.61 142.69 44.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.988 -1.07 . . . . 0.0 111.106 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.571 HG21 HG13 ' A' ' 124' ' ' ILE . 2.0 t -110.61 146.24 33.94 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.558 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.5 Cg_endo -77.38 140.12 19.1 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.342 2.028 . . . . 0.0 109.761 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.401 ' HA2' ' CE1' ' A' ' 122' ' ' TYR . . . -83.08 13.63 43.44 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.451 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 7.6 t -105.25 23.59 13.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.034 -1.274 . . . . 0.0 109.855 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 143' ' ' SER . 1.6 mmtt -155.11 142.0 19.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.115 -0.991 . . . . 0.0 109.85 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.562 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -95.11 -8.74 35.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.349 -0.844 . . . . 0.0 109.404 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.845 HG22 ' HA ' ' A' ' 111' ' ' SER . 32.2 p -130.37 150.61 51.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.234 -0.916 . . . . 0.0 109.216 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.455 ' O ' HG12 ' A' ' 110' ' ' ILE . . . -145.89 -172.6 3.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.128 -0.982 . . . . 0.0 109.538 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 108' ' ' LEU . 51.8 m -144.95 134.94 23.81 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.217 -0.927 . . . . 0.0 109.577 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 1.113 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 1.0 OUTLIER -81.05 145.0 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.322 -0.861 . . . . 0.0 108.953 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.445 ' O ' ' C ' ' A' ' 151' ' ' ASN . 10.6 m-20 -130.49 169.56 15.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.332 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 150' ' ' ASN . 3.0 p30 40.68 62.36 1.41 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.37 -0.831 . . . . 0.0 109.81 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.833 HG22 ' C ' ' A' ' 106' ' ' THR . 10.6 tt -106.95 165.77 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.301 -0.875 . . . . 0.0 109.334 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.5 ' N ' HG12 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -101.37 105.86 42.29 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.119 -0.988 . . . . 0.0 109.369 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.515 ' HA ' ' OG1' ' A' ' 184' ' ' THR . 35.6 Cg_endo -77.98 169.24 20.82 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.404 2.069 . . . . 0.0 110.456 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.697 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 70.17 60.69 4.66 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.697 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 164.48 131.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.318 -1.107 . . . . 0.0 109.628 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -47.56 162.25 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.096 -1.003 . . . . 0.0 108.387 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.652 ' CD1' HG21 ' A' ' 184' ' ' THR . 0.3 OUTLIER -140.53 -174.57 4.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.888 -1.133 . . . . 0.0 110.211 -179.524 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.577 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 2.6 m -158.1 110.36 2.32 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.502 ' HB ' HG13 ' A' ' 180' ' ' ILE . 40.6 mm -94.27 141.73 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.839 -1.163 . . . . 0.0 110.567 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.99 HG23 ' CB ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -141.57 133.61 27.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.459 -0.776 . . . . 0.0 109.137 179.455 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.959 HD12 HD22 ' A' ' 98' ' ' LEU . 1.8 mt -112.55 135.19 53.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 0.0 110.564 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.616 ' CD1' ' HB3' ' A' ' 177' ' ' PRO . 22.0 m-85 -117.94 164.87 14.42 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.94 ' HB3' ' OG ' ' A' ' 175' ' ' SER . . . -142.88 88.59 2.06 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.015 -1.053 . . . . 0.0 109.406 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.458 ' HA ' ' HB3' ' A' ' 174' ' ' SER . 47.9 t . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.378 -0.826 . . . . 0.0 109.72 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 95.4 p . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.433 -0.581 . . . . 0.0 109.433 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.94 ' OG ' ' HB3' ' A' ' 164' ' ' ALA . 0.6 OUTLIER -54.65 -168.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.188 -0.945 . . . . 0.0 109.476 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.476 ' HD2' ' HD2' ' A' ' 177' ' ' PRO . 0.0 OUTLIER -78.52 129.59 73.95 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.325 -0.859 . . . . 0.0 109.312 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.616 ' HB3' ' CD1' ' A' ' 163' ' ' TYR . 35.3 Cg_endo -77.53 127.14 8.72 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.07 1.847 . . . . 0.0 110.244 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -110.29 136.29 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.99 ' CB ' HG23 ' A' ' 161' ' ' THR . 4.7 t -119.62 165.47 14.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 110.476 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.502 HG13 ' HB ' ' A' ' 160' ' ' ILE . 11.8 pt -154.3 152.09 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -81.85 162.99 22.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.096 -1.003 . . . . 0.0 109.943 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.895 ' CE2' HD22 ' A' ' 108' ' ' LEU . 64.5 t80 -154.9 159.31 40.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.419 -0.801 . . . . 0.0 109.45 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.97 116.95 17.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.285 -0.884 . . . . 0.0 109.33 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.652 HG21 ' CD1' ' A' ' 158' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.521 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.544 HD11 ' HB3' ' A' ' 79' ' ' GLU . 72.5 mt . . . . . 0 N--CA 1.49 1.529 0 CA-C-O 121.312 0.577 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 45.2 m-20 -156.11 125.49 6.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.572 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.559 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -95.26 178.3 1.51 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.0 109.309 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.839 ' C ' HD22 ' A' ' 84' ' ' LEU . 35.9 Cg_endo -78.9 164.03 25.5 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.593 2.195 . . . . 0.0 109.989 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 5' ' ' PRO . 4.0 p -162.08 174.63 12.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.068 -1.02 . . . . 0.0 109.711 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 44.54 27.16 1.2 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.585 ' C ' ' CD1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -72.29 -162.43 0.09 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.392 -1.064 . . . . 0.0 109.587 -179.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.76 -163.35 0.63 Allowed 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.112 -0.993 . . . . 0.0 109.592 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.532 ' CB ' ' HG2' ' A' ' 88' ' ' GLN . 0.3 OUTLIER -154.86 141.93 19.31 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.362 -0.836 . . . . 0.0 109.351 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.598 ' HG ' ' HE2' ' A' ' 21' ' ' HIS . 3.5 p -146.72 -163.29 1.72 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.304 -0.873 . . . . 0.0 109.498 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.533 ' HB2' ' CB ' ' A' ' 19' ' ' THR . 4.5 m-20 44.45 38.07 2.39 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.021 HG22 HG23 ' A' ' 91' ' ' VAL . 40.6 mm -70.1 125.7 28.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.587 0.708 . . . . 0.0 110.305 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.562 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -119.5 177.75 4.81 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.31 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -72.9 -69.59 0.4 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.722 -1.236 . . . . 0.0 109.457 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -83.06 8.6 12.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.973 -1.079 . . . . 0.0 109.414 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.785 ' HB2' HG22 ' A' ' 60' ' ' THR . 2.8 t -154.51 156.56 36.89 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.015 ' CE1' HG22 ' A' ' 20' ' ' VAL . 2.2 p90 -166.66 137.19 3.25 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.533 ' CB ' ' HB2' ' A' ' 12' ' ' ASP . 10.1 m -87.76 153.98 20.92 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.949 -1.095 . . . . 0.0 111.174 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 1.015 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -134.41 119.52 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.148 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.598 ' HE2' ' HG ' ' A' ' 11' ' ' SER . 20.1 m-70 -103.36 164.28 11.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.02 -1.05 . . . . 0.0 110.368 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.846 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 22.8 p90 -177.3 135.59 0.19 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.555 -0.715 . . . . 0.0 109.084 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.29 167.43 2.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.183 -0.948 . . . . 0.0 109.517 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -102.18 165.38 13.98 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.617 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 36.0 Cg_endo -78.23 -163.14 0.2 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.499 2.133 . . . . 0.0 110.299 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -120.59 28.33 8.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.925 . . . . 0.0 109.404 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.893 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -129.36 173.54 5.59 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 0.0 109.551 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.893 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 36.1 Cg_endo -78.4 130.44 10.0 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.615 2.21 . . . . 0.0 110.453 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.498 HD12 ' CE2' ' A' ' 32' ' ' TYR . 17.6 pt -135.98 169.93 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.918 . . . . 0.0 109.474 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.4 p -107.12 -19.95 13.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.476 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.08 -152.83 15.5 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.907 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 1.2 m-85 -162.08 123.23 2.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -1.123 . . . . 0.0 109.447 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.784 HD12 ' NE ' ' A' ' 49' ' ' ARG . 14.9 mm -85.41 122.65 38.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.189 -0.945 . . . . 0.0 109.624 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.077 HG23 ' CD1' ' A' ' 72' ' ' ILE . 2.6 mm -102.89 114.31 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.056 -1.028 . . . . 0.0 109.321 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.487 ' HG3' ' CG ' ' A' ' 47' ' ' GLN . 0.4 OUTLIER -105.58 144.86 31.75 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.103 -0.998 . . . . 0.0 108.912 179.361 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.804 ' HB3' HG13 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -143.53 140.14 30.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.056 -1.027 . . . . 0.0 110.032 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -176.17 144.39 0.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.32 -0.863 . . . . 0.0 109.665 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.571 ' HA ' ' CB ' ' A' ' 68' ' ' TYR . . . -64.99 170.48 4.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 109.605 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.33 -0.856 . . . . 0.0 109.453 -179.92 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.559 ' HD3' ' CE1' ' A' ' 36' ' ' HIS . 1.2 ptp85 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.489 0.661 . . . . 0.0 109.748 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.487 ' CG ' ' HG3' ' A' ' 35' ' ' ARG . 14.2 mp0 -126.91 118.1 23.89 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.312 -0.867 . . . . 0.0 109.568 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.628 ' OD2' HD23 ' A' ' 59' ' ' LEU . 65.8 m-20 -100.96 122.8 44.13 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.784 ' NE ' HD12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.18 140.53 32.35 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.031 -1.043 . . . . 0.0 109.493 -179.264 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.957 HG12 HD12 ' A' ' 57' ' ' ILE . 11.9 m -124.08 159.56 56.13 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.341 -0.849 . . . . 0.0 109.355 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.487 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 34.5 Cg_endo -77.14 174.37 12.92 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.581 2.187 . . . . 0.0 110.279 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.475 ' HB3' HG13 ' A' ' 29' ' ' ILE . 34.6 Cg_endo -76.96 -16.09 16.2 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.498 2.132 . . . . 0.0 110.486 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.7 t -100.85 27.86 5.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.351 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.464 ' HG3' ' HG2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -130.65 116.71 18.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.938 . . . . 0.0 109.677 -179.819 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -102.87 -6.01 22.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.394 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 62.7 p -139.2 130.84 27.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.357 -0.84 . . . . 0.0 109.018 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.957 HD12 HG12 ' A' ' 50' ' ' VAL . 5.4 tt -123.24 124.92 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.164 -0.96 . . . . 0.0 109.816 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.75 109.91 20.56 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.441 -0.787 . . . . 0.0 109.184 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.981 ' HB3' HD11 ' A' ' 62' ' ' LEU . 1.2 mp -84.83 158.65 20.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.164 -0.96 . . . . 0.0 109.778 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.785 HG22 ' HB2' ' A' ' 17' ' ' SER . 0.8 OUTLIER -150.86 175.29 12.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.654 -0.654 . . . . 0.0 109.332 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.499 ' O ' ' NH2' ' A' ' 46' ' ' ARG . 6.1 m120 52.57 37.8 24.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 0.0 109.496 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.981 HD11 ' HB3' ' A' ' 59' ' ' LEU . 5.2 mt -109.59 161.17 15.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 109.387 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -55.07 113.33 5.26 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 34.5 Cg_endo -74.19 123.64 8.43 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.984 1.79 . . . . 0.0 111.009 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 82.67 64.56 1.68 Allowed Glycine 0 N--CA 1.485 1.916 0 N-CA-C 108.186 -1.966 . . . . 0.0 108.186 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.0 m -152.27 118.9 5.69 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.126 -1.22 . . . . 0.0 110.821 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.559 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 11.6 tt0 -74.82 135.74 41.62 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.822 ' OH ' HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -153.44 176.54 11.9 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.79 -1.193 . . . . 0.0 111.076 -178.436 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.656 HG12 HG23 ' A' ' 85' ' ' ILE . 1.9 t -107.27 151.55 9.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.804 HG13 ' HB3' ' A' ' 36' ' ' HIS . 1.1 t -132.98 130.92 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.983 -1.073 . . . . 0.0 109.492 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.819 ' O ' HD13 ' A' ' 72' ' ' ILE . 10.5 p -108.44 156.43 19.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.254 -0.904 . . . . 0.0 110.484 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.077 ' CD1' HG23 ' A' ' 34' ' ' ILE . 28.4 mm -135.71 92.51 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.927 HD12 ' HB3' ' A' ' 83' ' ' PRO . 1.2 mm -83.71 140.85 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.106 -0.996 . . . . 0.0 109.928 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.907 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . . . -96.38 157.86 15.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 109.181 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.69 136.55 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 109.47 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 76' ' ' ASN . 12.6 t-20 -135.14 46.37 2.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 109.424 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.52 -91.57 0.84 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.51 1.36 13.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -1.167 . . . . 0.0 109.647 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.544 ' HB3' HD11 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -92.72 -171.66 2.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.97 . . . . 0.0 109.47 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 79' ' ' GLU . 4.9 mt-10 -171.16 91.49 0.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.487 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.593 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.6 OUTLIER -59.55 -179.18 0.15 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 108.987 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.593 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 31.4 Cg_endo -74.49 150.35 40.68 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.08 1.853 . . . . 0.0 110.348 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.927 ' HB3' HD12 ' A' ' 73' ' ' ILE . 36.1 Cg_endo -77.57 144.11 22.17 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.811 2.341 . . . . 0.0 111.62 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.839 HD22 ' C ' ' A' ' 5' ' ' PRO . 3.4 tp -109.7 93.65 4.61 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.656 HG23 HG12 ' A' ' 69' ' ' VAL . 3.3 mt -100.23 141.19 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.939 . . . . 0.0 110.15 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.54 ' O ' HG13 ' A' ' 69' ' ' VAL . . . -136.66 -165.06 10.38 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -129.94 140.0 51.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.985 -1.303 . . . . 0.0 109.77 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.532 ' HG2' ' CB ' ' A' ' 10' ' ' SER . 2.4 tp60 -154.29 -165.36 2.07 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.372 -0.83 . . . . 0.0 109.318 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.559 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.43 130.28 2.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.256 -0.903 . . . . 0.0 109.57 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.822 HG23 ' OH ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -73.16 138.35 45.66 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.281 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.021 HG23 HG22 ' A' ' 13' ' ' ILE . 2.3 t . . . . . 0 C--N 1.302 -1.48 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 178.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 1.12 ' CG ' HD11 ' A' ' 162' ' ' LEU . 35.7 Cg_endo . . . . . 0 C--O 1.215 -0.664 0 N-CA-C 109.891 -0.849 . . . . 0.0 109.891 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.576 ' CB ' ' CZ ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -65.9 -165.34 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.444 -0.785 . . . . 0.0 109.734 -179.648 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.41 ' CG ' ' HG3' ' A' ' 113' ' ' GLU . 0.2 OUTLIER 64.41 11.62 6.66 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.235 -0.915 . . . . 0.0 109.227 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.745 HD23 HG23 ' A' ' 180' ' ' ILE . 19.7 tp -59.25 92.77 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.281 -0.887 . . . . 0.0 109.213 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -126.5 160.53 30.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.264 -0.898 . . . . 0.0 109.335 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 8.5 p -104.64 138.47 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.402 -0.811 . . . . 0.0 109.818 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.796 ' CG1' HD23 ' A' ' 109' ' ' LEU . 8.7 pt -122.96 -11.23 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.389 -0.82 . . . . 0.0 109.407 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.807 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -134.73 82.12 1.94 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.526 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 6.4 m -85.81 95.4 9.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.816 . . . . 0.0 110.45 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.532 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -96.24 159.66 31.55 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 121.244 -0.91 . . . . 0.0 109.036 179.052 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.473 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.4 Cg_endo -70.47 -1.74 9.55 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.509 2.139 . . . . 0.0 110.738 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.817 ' C ' HG22 ' A' ' 152' ' ' ILE . 7.1 p -144.68 10.93 1.41 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 109.342 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.911 ' O ' HD23 ' A' ' 108' ' ' LEU . 3.2 p -169.01 166.6 11.02 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 118.907 -1.117 . . . . 0.0 109.767 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.011 HD22 ' CZ ' ' A' ' 182' ' ' TYR . 0.4 OUTLIER -141.75 150.77 42.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.137 -0.977 . . . . 0.0 109.091 -179.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.807 ' CB ' ' HB3' ' A' ' 102' ' ' ALA . 13.9 tp -106.26 116.33 31.74 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 108.824 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.96 ' CD1' ' HB3' ' A' ' 147' ' ' ALA . 3.2 pt -102.35 149.4 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.079 -1.013 . . . . 0.0 110.192 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.671 ' CB ' HG22 ' A' ' 146' ' ' THR . 5.1 t -153.1 125.18 7.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.516 -0.74 . . . . 0.0 109.382 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.578 ' CE2' ' O ' ' A' ' 145' ' ' SER . 3.1 p90 -124.21 -170.13 2.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.233 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.41 ' HG3' ' CG ' ' A' ' 97' ' ' ASP . 3.1 mt-10 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.14 -0.975 . . . . 0.0 109.914 -179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.777 ' CE1' HG22 ' A' ' 139' ' ' THR . 1.6 p90 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.596 ' HB3' HD13 ' A' ' 162' ' ' LEU . 3.0 m-85 -106.11 115.35 30.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.98 -1.075 . . . . 0.0 109.56 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 5.5 ttm180 -84.62 98.81 10.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.11 -0.994 . . . . 0.0 109.017 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 1.034 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 55.2 mt -84.25 151.42 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 0.0 110.045 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 46.2 p -123.92 133.27 53.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.46 -0.775 . . . . 0.0 109.901 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.689 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 4.9 m-85 -80.19 118.36 21.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.49 -0.756 . . . . 0.0 109.359 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 158' ' ' TYR . . . -91.94 105.74 3.32 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.285 -1.126 . . . . 0.0 108.876 179.08 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.545 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 2.6 mm100 . . . . . 0 N--CA 1.494 1.734 0 N-CA-C 108.874 -0.787 . . . . 0.0 108.874 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 13.2 pt-20 -101.96 149.87 23.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -0.948 . . . . 0.0 110.743 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 1.034 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 34.1 p90 -143.07 145.75 33.17 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.777 HG22 ' CE1' ' A' ' 121' ' ' TYR . 3.0 p -75.01 149.69 39.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.99 -1.069 . . . . 0.0 110.589 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.657 HG13 ' HD2' ' A' ' 141' ' ' PRO . 53.7 t -112.31 141.6 25.4 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 121.762 -0.586 . . . . 0.0 109.443 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.657 ' HD2' HG13 ' A' ' 140' ' ' VAL . 35.6 Cg_endo -77.66 141.81 19.92 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.433 2.088 . . . . 0.0 110.307 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -88.03 23.0 15.68 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.42 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 1.9 m -104.42 -0.94 27.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -1.149 . . . . 0.0 109.576 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 143' ' ' SER . 15.2 mmtt -143.02 153.85 43.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 109.48 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.578 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 0.4 OUTLIER -93.35 -18.27 22.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 109.395 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.671 HG22 ' CB ' ' A' ' 111' ' ' SER . 66.1 p -107.77 152.79 23.89 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.199 -0.938 . . . . 0.0 108.941 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.96 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -130.96 148.17 52.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.064 -1.023 . . . . 0.0 109.635 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 8.2 t -91.08 147.42 23.09 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.184 -0.948 . . . . 0.0 109.347 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.689 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 13.9 mm -128.46 95.62 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.358 -0.839 . . . . 0.0 109.119 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.522 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 2.6 m-20 -104.54 -164.17 1.03 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.517 -0.74 . . . . 0.0 109.733 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.511 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 6.6 p-10 42.03 60.58 2.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.429 -0.794 . . . . 0.0 109.902 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.817 HG22 ' C ' ' A' ' 106' ' ' THR . 6.4 tt -116.52 155.28 18.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.269 -0.894 . . . . 0.0 109.568 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.07 117.19 67.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.753 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.473 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 35.9 Cg_endo -78.91 163.85 25.63 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.518 2.146 . . . . 0.0 110.562 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 61.8 51.47 57.07 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -177.37 130.45 0.16 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.223 -1.163 . . . . 0.0 109.699 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -51.62 165.93 0.15 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.597 ' CE2' HG13 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -144.98 172.68 12.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.881 -1.137 . . . . 0.0 110.255 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.553 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 1.8 m -145.7 96.74 2.86 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 179' ' ' SER . 51.5 mm -84.69 132.44 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.889 -1.132 . . . . 0.0 109.705 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.846 HG23 ' CB ' ' A' ' 179' ' ' SER . 1.1 m -142.26 165.33 27.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.309 -0.869 . . . . 0.0 109.24 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 1.12 HD11 ' CG ' ' A' ' 95' ' ' PRO . 1.3 pp -159.64 151.13 20.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.013 -1.054 . . . . 0.0 110.72 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.611 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 2.1 m-85 -122.03 90.45 3.31 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.434 ' HB2' ' HG3' ' A' ' 95' ' ' PRO . . . -54.0 117.47 3.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.864 -1.147 . . . . 0.0 109.039 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.545 HG21 ' CZ ' ' A' ' 121' ' ' TYR . 22.2 t . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.892 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 175' ' ' SER . 1.2 p . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 174' ' ' SER . 84.6 p -55.47 -166.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.168 -0.957 . . . . 0.0 109.21 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.436 ' N ' ' CD ' ' A' ' 176' ' ' LYS . 0.0 OUTLIER -74.59 145.78 82.58 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 108.829 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.611 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 34.9 Cg_endo -77.71 133.77 13.04 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.429 2.086 . . . . 0.0 111.019 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 161' ' ' THR . 2.2 t -105.82 134.47 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.846 ' CB ' HG23 ' A' ' 161' ' ' THR . 1.3 p -131.45 143.24 50.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 110.558 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.745 HG23 HD23 ' A' ' 98' ' ' LEU . 13.4 pt -129.89 152.44 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -82.57 168.71 17.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.082 -1.012 . . . . 0.0 109.7 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 1.011 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 44.2 t80 -165.21 124.32 1.75 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.323 -0.86 . . . . 0.0 109.415 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -95.19 112.13 23.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.009 -1.057 . . . . 0.0 109.443 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.433 ' HB ' ' HA ' ' A' ' 154' ' ' PRO . 28.9 p . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.524 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.775 HD11 ' CB ' ' A' ' 81' ' ' SER . 1.5 pp . . . . . 0 N--CA 1.49 1.537 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.546 ' O ' HD12 ' A' ' 2' ' ' LEU . 21.7 m-20 -74.91 148.12 40.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.391 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.491 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 18.0 p -84.5 159.97 57.49 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.591 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.634 ' HD3' ' HB2' ' A' ' 74' ' ' ALA . 35.5 Cg_endo -78.27 96.77 1.1 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.715 2.277 . . . . 0.0 109.943 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.678 ' HA ' HD22 ' A' ' 84' ' ' LEU . 2.1 p -83.89 -111.65 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.166 -0.959 . . . . 0.0 109.79 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 22' ' ' TRP . . . 45.53 26.12 1.58 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.443 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 13.5 t80 -55.59 107.76 0.37 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.485 -1.009 . . . . 0.0 110.003 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 6.3 t70 -133.52 100.21 4.74 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.405 -0.809 . . . . 0.0 108.841 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.884 ' OG ' HG13 ' A' ' 20' ' ' VAL . 4.7 m -84.63 128.27 34.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.216 -0.928 . . . . 0.0 109.578 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 19' ' ' THR . 5.5 p -164.0 -157.06 0.37 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.316 -0.865 . . . . 0.0 109.402 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.534 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 2.5 m-20 47.33 38.01 6.71 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.638 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.5 mt -87.07 163.84 2.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.761 0.791 . . . . 0.0 111.427 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.587 ' N ' HG22 ' A' ' 13' ' ' ILE . 0.7 OUTLIER -155.27 -172.83 4.31 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.581 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -81.02 -44.14 18.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.931 -1.106 . . . . 0.0 109.484 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 17' ' ' SER . 1.5 m120 -114.6 39.75 2.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.991 -1.068 . . . . 0.0 109.037 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 14' ' ' THR . 5.8 p 168.55 145.5 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.638 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 2.0 p90 -164.97 145.38 7.3 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.108 -0.995 . . . . 0.0 108.827 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.611 HG22 ' N ' ' A' ' 20' ' ' VAL . 52.3 m -112.34 164.23 13.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.737 -1.227 . . . . 0.0 111.132 -178.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.884 HG13 ' OG ' ' A' ' 10' ' ' SER . 1.6 t -130.43 168.42 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.516 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 19.9 m-70 -144.35 161.88 37.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.936 -1.102 . . . . 0.0 110.104 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.601 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 10.0 p90 -168.18 142.19 3.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.434 -0.791 . . . . 0.0 109.171 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.85 166.02 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.04 -1.037 . . . . 0.0 109.435 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.659 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -94.01 165.57 17.5 Favored Pre-proline 0 C--N 1.3 -1.585 0 O-C-N 121.634 -0.666 . . . . 0.0 109.632 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.659 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.7 Cg_endo -78.27 178.12 7.95 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.606 2.204 . . . . 0.0 110.384 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.08 12.82 26.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 109.442 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.984 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -118.13 176.71 1.52 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.409 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.984 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 34.9 Cg_endo -77.7 118.05 4.42 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.538 2.159 . . . . 0.0 110.285 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.633 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 47.3 pt -131.47 179.99 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 109.614 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.7 p -120.71 -22.11 6.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.864 . . . . 0.0 109.458 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 167.97 174.68 37.08 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.633 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -124.42 133.73 53.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.248 -1.148 . . . . 0.0 109.391 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.871 ' O ' HD13 ' A' ' 34' ' ' ILE . 44.8 mm -74.95 144.42 12.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.187 -0.945 . . . . 0.0 109.251 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.871 HD13 ' O ' ' A' ' 33' ' ' ILE . 7.9 mm -124.57 93.15 2.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.21 -0.931 . . . . 0.0 110.058 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.454 ' HB2' ' OG ' ' A' ' 71' ' ' SER . 1.0 OUTLIER -104.17 128.53 51.86 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.886 ' CB ' HG22 ' A' ' 70' ' ' VAL . 54.5 p-80 -148.33 176.85 9.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.727 -1.233 . . . . 0.0 110.845 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.591 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 9.1 p-80 176.9 -173.37 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.035 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . -112.55 132.17 55.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.165 -0.959 . . . . 0.0 109.175 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.484 ' HG2' ' HB2' ' A' ' 67' ' ' GLU . 1.3 pt-20 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 0.0 109.556 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.52 ' NE ' ' OD1' ' A' ' 48' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.454 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 47.0 mt-30 -100.43 134.63 43.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 110.589 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.52 ' OD1' ' NE ' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -149.24 147.82 28.84 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.585 ' HG3' HD13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -134.53 158.79 43.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.864 -1.147 . . . . 0.0 110.104 -179.055 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.803 HG22 ' CG1' ' A' ' 34' ' ' ILE . 12.3 m -136.87 161.08 63.64 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.468 -0.77 . . . . 0.0 109.076 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.53 ' HG2' ' CD ' ' A' ' 54' ' ' ARG . 33.5 Cg_endo -76.21 174.12 13.35 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.478 2.119 . . . . 0.0 110.333 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.623 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.2 Cg_endo -76.49 -29.51 5.91 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.587 2.192 . . . . 0.0 110.518 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -82.91 -7.78 59.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.398 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.53 ' CD ' ' HG2' ' A' ' 51' ' ' PRO . 3.4 mpt_? -93.96 109.34 21.08 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.412 -0.805 . . . . 0.0 109.838 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -97.27 -1.51 44.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.423 -0.798 . . . . 0.0 109.377 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 77.2 p -140.99 147.83 39.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.297 -0.877 . . . . 0.0 109.168 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.674 HD13 HG21 ' A' ' 34' ' ' ILE . 1.4 tt -131.95 119.49 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.119 -0.988 . . . . 0.0 109.388 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.585 HG23 ' OG1' ' A' ' 19' ' ' THR . 45.7 m -87.85 138.06 31.79 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.349 -0.845 . . . . 0.0 109.62 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.019 ' HB3' HD11 ' A' ' 62' ' ' LEU . 4.6 mt -111.23 159.46 17.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.512 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.5 p -144.37 173.37 11.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -0.882 . . . . 0.0 109.475 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m120 52.9 52.36 14.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -0.891 . . . . 0.0 109.546 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.019 HD11 ' HB3' ' A' ' 59' ' ' LEU . 7.7 mt -122.17 133.51 54.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.472 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.498 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 42.5 m-20 -48.66 128.15 13.77 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.056 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.581 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 36.1 Cg_endo -78.01 133.6 12.5 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.36 2.04 . . . . 0.0 110.665 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 82.89 61.24 1.96 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.462 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 4.5 m -162.37 159.86 25.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.392 -1.064 . . . . 0.0 109.734 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 2.0 mm-40 -90.77 134.5 34.38 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.369 -0.832 . . . . 0.0 108.839 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 1.035 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 15.0 m-85 -119.17 115.52 24.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.086 -1.009 . . . . 0.0 109.709 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.854 HG13 ' HG2' ' A' ' 87' ' ' GLN . 1.4 t -82.48 120.06 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.899 . . . . 0.0 108.99 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.886 HG22 ' CB ' ' A' ' 36' ' ' HIS . 27.1 t -117.92 138.61 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 109.443 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.546 ' CB ' HG12 ' A' ' 85' ' ' ILE . 80.2 p -116.84 139.1 51.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 110.13 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.7 mm -120.49 92.37 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.415 -0.803 . . . . 0.0 109.207 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.471 ' HB ' ' HB ' ' A' ' 33' ' ' ILE . 25.1 mm -90.78 137.52 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 109.634 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.869 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -99.54 137.79 37.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.423 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.23 150.21 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 0.0 109.444 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.441 ' HB3' ' HB2' ' A' ' 79' ' ' GLU . 1.8 t-20 -137.53 49.82 1.98 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.43 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.91 -94.48 2.0 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.0 tpt85 -106.65 -0.76 23.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -1.153 . . . . 0.0 109.501 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 1.6 mt-10 -100.38 148.99 24.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.191 -0.943 . . . . 0.0 109.316 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.72 103.85 8.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.676 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.869 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -59.7 -178.41 0.13 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 108.931 179.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.603 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 32.7 Cg_endo -75.82 151.08 35.54 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.171 1.914 . . . . 0.0 110.204 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.0 Cg_endo -77.23 115.21 3.91 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.675 2.25 . . . . 0.0 111.379 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.678 HD22 ' HA ' ' A' ' 6' ' ' THR . 12.5 tp -106.08 104.25 13.91 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.546 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.8 mt -111.56 162.25 9.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.039 -1.038 . . . . 0.0 110.4 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.545 ' N ' HG22 ' A' ' 85' ' ' ILE . . . -155.77 162.91 31.49 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.854 ' HG2' HG13 ' A' ' 69' ' ' VAL . 4.0 mt-30 -136.66 118.56 15.22 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.119 -1.224 . . . . 0.0 110.042 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -110.59 -146.94 0.41 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.54 136.72 3.88 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.879 -1.138 . . . . 0.0 110.341 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.93 137.88 41.97 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.19 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.539 ' O ' ' N ' ' A' ' 65' ' ' GLY . 1.8 t . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.517 -0.739 . . . . 0.0 109.308 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.555 ' HB2' ' CD1' ' A' ' 112' ' ' TRP . 36.4 Cg_endo . . . . . 0 C--O 1.215 -0.671 0 N-CA-C 110.186 -0.736 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.6 OUTLIER -70.61 -176.62 1.32 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.63 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER 77.01 27.82 0.68 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 109.67 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.749 HD23 HG23 ' A' ' 180' ' ' ILE . 33.6 tp -76.97 101.88 6.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.148 -0.97 . . . . 0.0 109.394 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -137.15 170.2 16.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.561 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 11.8 p -93.75 147.97 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.197 -0.939 . . . . 0.0 109.665 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.554 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 11.7 pt -129.7 -2.41 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.369 -0.832 . . . . 0.0 109.552 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.552 ' CB ' HD12 ' A' ' 109' ' ' LEU . . . -165.33 116.26 1.11 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.318 -0.864 . . . . 0.0 108.68 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.504 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.8 t -104.48 93.23 4.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.114 -0.991 . . . . 0.0 110.221 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.56 ' OG1' ' N ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -78.41 163.48 61.5 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.314 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.478 ' O ' HG23 ' A' ' 106' ' ' THR . 29.6 Cg_endo -68.4 -2.44 9.12 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.4 2.067 . . . . 0.0 110.856 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.879 ' C ' HG22 ' A' ' 152' ' ' ILE . 11.6 p -155.26 20.75 0.42 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.294 -0.879 . . . . 0.0 108.723 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 1.068 ' O ' HD23 ' A' ' 108' ' ' LEU . 52.4 p -173.43 161.47 4.11 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.935 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.068 HD23 ' O ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -139.67 155.76 47.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.371 -0.83 . . . . 0.0 109.274 -179.665 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.554 ' HB3' ' CG1' ' A' ' 101' ' ' ILE . 19.8 mt -100.29 132.78 45.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.291 -0.881 . . . . 0.0 108.892 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.783 HD11 ' CD1' ' A' ' 149' ' ' ILE . 0.5 OUTLIER -119.63 141.27 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.168 -0.958 . . . . 0.0 109.809 -179.617 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 97' ' ' ASP . 37.8 t -133.75 135.17 43.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.411 -0.806 . . . . 0.0 109.385 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.619 ' HH2' ' HB2' ' A' ' 147' ' ' ALA . 43.4 p90 -140.28 143.21 35.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.399 -0.813 . . . . 0.0 109.288 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 8.9 mm-40 . . . . . 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.944 . . . . 0.0 109.282 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.994 ' CE2' HG22 ' A' ' 139' ' ' THR . 2.8 p90 . . . . . 0 N--CA 1.487 1.389 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.484 ' HB2' ' HB ' ' A' ' 140' ' ' VAL . 5.5 m-85 -120.54 154.52 35.22 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.791 -1.193 . . . . 0.0 110.085 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.586 ' HG2' ' CE2' ' A' ' 121' ' ' TYR . 4.5 mmm-85 -112.07 88.08 2.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.389 -0.819 . . . . 0.0 109.032 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.629 ' CG2' ' CE2' ' A' ' 138' ' ' PHE . 88.9 mt -84.08 160.24 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 109.491 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 18.5 p -145.32 150.78 37.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.127 -0.983 . . . . 0.0 110.474 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 1.123 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 2.5 m-85 -87.31 139.72 30.27 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.598 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -105.74 107.48 2.8 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.11 -1.229 . . . . 0.0 109.475 179.609 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 126' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 0.8 OUTLIER -79.38 128.19 33.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 111.057 -178.6 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.629 ' CE2' ' CG2' ' A' ' 124' ' ' ILE . 17.8 p90 -128.11 140.04 52.16 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.994 HG22 ' CE2' ' A' ' 121' ' ' TYR . 1.2 p -74.44 153.52 39.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.046 -1.034 . . . . 0.0 111.103 -178.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.684 HG13 ' HD2' ' A' ' 141' ' ' PRO . 94.5 t -118.07 143.18 32.29 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.684 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.2 Cg_endo -76.81 119.65 5.21 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.332 2.021 . . . . 0.0 110.298 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -55.47 -17.13 11.94 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.3 t -83.84 12.32 6.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.157 -1.202 . . . . 0.0 109.696 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.452 ' HB2' ' HG2' ' A' ' 141' ' ' PRO . 43.1 mmtt -139.08 122.53 17.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.954 . . . . 0.0 109.552 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.568 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 11.9 p -82.28 -5.37 58.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.919 . . . . 0.0 109.506 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.54 ' C ' ' CH2' ' A' ' 112' ' ' TRP . 6.9 p -124.87 154.08 41.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.25 -0.906 . . . . 0.0 109.357 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.678 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -123.98 168.52 12.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.882 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 1.024 HG22 ' OD1' ' A' ' 150' ' ' ASN . 22.4 m -130.8 104.12 6.98 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.303 -0.873 . . . . 0.0 109.306 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 1.123 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -82.57 93.3 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.033 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 1.024 ' OD1' HG22 ' A' ' 148' ' ' THR . 1.7 m-20 -100.28 174.1 6.29 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.282 -0.886 . . . . 0.0 109.632 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 67.09 37.0 3.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 109.193 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.879 HG22 ' C ' ' A' ' 106' ' ' THR . 4.5 tt -95.45 161.8 2.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.445 -0.784 . . . . 0.0 109.733 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -98.27 108.85 49.6 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.222 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.457 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 36.2 Cg_endo -77.22 75.74 4.5 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.483 2.122 . . . . 0.0 110.568 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.708 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 168.48 59.36 0.03 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.708 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 163.59 136.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -1.109 . . . . 0.0 109.533 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 156' ' ' ALA . 22.8 t70 -46.34 158.01 0.12 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.735 ' CD1' HG21 ' A' ' 184' ' ' THR . 0.3 OUTLIER -140.6 -177.21 4.94 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.873 -1.142 . . . . 0.0 110.496 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.575 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 3.1 m -157.83 114.45 2.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.484 -0.76 . . . . 0.0 109.093 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.449 HG21 HG21 ' A' ' 110' ' ' ILE . 25.4 mm -97.03 126.71 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.567 -1.333 . . . . 0.0 109.73 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.997 HG23 ' CB ' ' A' ' 179' ' ' SER . 1.3 m -138.96 167.2 22.58 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.221 -0.924 . . . . 0.0 109.357 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.523 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 0.9 OUTLIER -162.95 150.35 13.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.912 -1.117 . . . . 0.0 111.109 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.622 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.3 m-85 -121.39 100.11 6.85 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -55.13 129.26 37.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.871 -1.143 . . . . 0.0 109.084 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.597 HG21 ' CZ ' ' A' ' 121' ' ' TYR . 65.1 t . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.931 . . . . 0.0 109.863 -179.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 2.0 p . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.401 0.62 . . . . 0.0 110.011 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.448 ' O ' ' O ' ' A' ' 174' ' ' SER . 16.8 p -54.85 -168.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.327 -0.858 . . . . 0.0 109.035 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.8 mtmt -68.16 144.27 96.69 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.0 -1.062 . . . . 0.0 108.706 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.622 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.1 Cg_endo -76.68 132.78 13.53 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.317 2.011 . . . . 0.0 111.437 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 3.7 t -106.01 130.64 57.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.997 ' CB ' HG23 ' A' ' 161' ' ' THR . 1.1 p -130.17 147.88 51.95 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.123 -0.986 . . . . 0.0 110.808 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.749 HG23 HD23 ' A' ' 98' ' ' LEU . 19.0 pt -131.55 151.84 36.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -86.04 156.58 20.36 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.046 -1.034 . . . . 0.0 109.672 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.753 ' CZ ' HD13 ' A' ' 108' ' ' LEU . 54.1 t80 -161.22 123.8 3.11 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.335 -0.853 . . . . 0.0 109.432 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.87 130.78 38.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.23 -0.919 . . . . 0.0 109.542 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.735 HG21 ' CD1' ' A' ' 158' ' ' TYR . 6.4 p . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.495 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.738 HD21 HD22 ' A' ' 76' ' ' ASN . 1.4 mp . . . . . 0 N--CA 1.488 1.46 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.548 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 3.2 m-20 -74.89 153.52 38.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.866 . . . . 0.0 108.954 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.502 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 89.9 p -96.53 107.81 38.49 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.344 -0.847 . . . . 0.0 110.115 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.608 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 36.4 Cg_endo -80.15 77.72 3.96 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.56 2.173 . . . . 0.0 109.893 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 1.093 HG22 ' CD2' ' A' ' 84' ' ' LEU . 73.6 p -93.16 -104.74 0.12 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.154 -0.966 . . . . 0.0 110.112 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 55.81 20.73 26.96 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -44.68 127.67 6.28 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.749 -0.853 . . . . 0.0 109.929 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.478 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 4.7 t0 -162.81 105.81 1.07 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.362 -0.836 . . . . 0.0 109.047 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 16.1 m -84.89 127.29 34.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.908 . . . . 0.0 109.736 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.507 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 3.5 p -154.49 -163.17 1.54 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.562 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 2.4 m-20 44.9 38.59 3.03 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.671 HD12 ' OE1' ' A' ' 88' ' ' GLN . 1.6 mm -74.57 130.01 36.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.581 0.705 . . . . 0.0 110.851 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.549 ' CB ' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -119.35 175.63 5.73 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.485 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -67.01 -75.56 0.09 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.865 -1.147 . . . . 0.0 109.463 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 15.3 p-10 -78.66 -2.5 39.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.302 -0.874 . . . . 0.0 109.82 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.629 ' HB2' HG22 ' A' ' 60' ' ' THR . 6.4 t -143.27 160.83 39.76 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.245 -0.909 . . . . 0.0 109.058 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.694 ' HE1' HG22 ' A' ' 20' ' ' VAL . 3.5 p90 -167.33 145.66 4.85 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.722 ' OG1' HG23 ' A' ' 58' ' ' THR . 2.8 m -109.98 157.18 19.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.353 -1.467 . . . . 0.0 111.395 -178.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.694 HG22 ' HE1' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -123.11 166.63 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.017 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.507 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 26.1 m-70 -137.67 160.23 39.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.94 -1.1 . . . . 0.0 110.404 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.788 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 21.7 p90 177.56 139.61 0.08 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -74.34 159.19 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 120.946 -1.096 . . . . 0.0 110.116 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -96.82 165.58 15.66 Favored Pre-proline 0 C--N 1.3 -1.545 0 O-C-N 121.819 -0.551 . . . . 0.0 109.774 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 1.003 ' CG ' HD13 ' A' ' 29' ' ' ILE . 36.2 Cg_endo -79.56 145.38 18.41 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.604 2.203 . . . . 0.0 110.181 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.461 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 0.7 OUTLIER -80.21 5.52 14.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 0.0 109.493 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.901 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -108.23 173.68 2.89 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.935 . . . . 0.0 109.448 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.901 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.7 Cg_endo -78.03 88.57 1.42 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.657 2.238 . . . . 0.0 110.55 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.003 HD13 ' CG ' ' A' ' 25' ' ' PRO . 36.0 pt -98.13 -179.79 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.397 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.532 HG21 ' N ' ' A' ' 77' ' ' GLY . 2.3 p -102.13 -21.49 14.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.345 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.49 165.36 10.27 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 1.146 ' CD1' HG22 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -90.5 148.6 22.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -1.091 . . . . 0.0 110.314 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.777 HG23 ' HD2' ' A' ' 49' ' ' ARG . 0.5 OUTLIER -102.3 103.38 14.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.839 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.863 HD11 HG22 ' A' ' 50' ' ' VAL . 1.3 mm -88.28 117.59 32.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 O-C-N 121.314 -0.866 . . . . 0.0 109.885 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -122.72 111.77 17.13 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.374 -0.829 . . . . 0.0 108.879 179.407 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.91 ' CE1' HD21 ' A' ' 59' ' ' LEU . 1.4 p-80 -105.98 122.0 45.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.935 . . . . 0.0 110.11 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.574 ' CE1' ' O ' ' A' ' 69' ' ' VAL . 37.3 p-80 -140.71 127.68 20.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.423 -0.798 . . . . 0.0 109.008 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -39.4 151.5 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.803 . . . . 0.0 110.008 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.49 ' OE1' ' CG2' ' A' ' 69' ' ' VAL . 5.7 mm-40 . . . . . 0 N--CA 1.488 1.438 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.531 ' HB2' ' NE2' ' A' ' 36' ' ' HIS . 3.1 mmm180 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 47' ' ' GLN . 16.9 pt20 -113.2 102.44 10.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.248 -0.907 . . . . 0.0 109.482 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.495 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 1.7 m-20 -106.34 115.8 30.83 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -0.907 . . . . 0.0 109.254 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.777 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -92.6 140.54 29.44 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.194 -0.941 . . . . 0.0 109.476 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.863 HG22 HD11 ' A' ' 34' ' ' ILE . 26.8 m -115.54 151.65 46.3 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.301 -0.874 . . . . 0.0 109.309 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.476 ' HG2' ' HG2' ' A' ' 54' ' ' ARG . 35.3 Cg_endo -77.7 174.27 12.87 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.599 2.2 . . . . 0.0 110.373 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.497 ' HB3' HG13 ' A' ' 29' ' ' ILE . 34.0 Cg_endo -77.07 -15.59 16.27 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.573 2.182 . . . . 0.0 110.269 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -90.43 14.78 12.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.314 -0.867 . . . . 0.0 109.22 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.476 ' HG2' ' HG2' ' A' ' 51' ' ' PRO . 5.9 mmm-85 -133.48 126.33 30.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 109.575 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 2.8 p-10 -109.83 -4.96 15.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.93 . . . . 0.0 109.431 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 16.0 p -130.53 145.43 51.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 109.068 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.788 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 3.0 tt -129.12 118.89 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.953 . . . . 0.0 109.642 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.722 HG23 ' OG1' ' A' ' 19' ' ' THR . 0.3 OUTLIER -91.74 103.04 15.65 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.364 -0.835 . . . . 0.0 109.241 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.973 ' HB3' HD11 ' A' ' 62' ' ' LEU . 2.5 mt -84.92 144.82 28.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -0.922 . . . . 0.0 109.672 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.629 HG22 ' HB2' ' A' ' 17' ' ' SER . 63.7 p -137.69 -174.77 3.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 0.0 109.414 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 56.39 20.1 4.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.416 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.973 HD11 ' HB3' ' A' ' 59' ' ' LEU . 2.4 mt -96.49 156.85 16.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.929 . . . . 0.0 109.242 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.468 ' O ' ' OH ' ' A' ' 68' ' ' TYR . 2.3 t30 -61.44 132.71 92.93 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.097 -1.002 . . . . 0.0 108.485 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.3 Cg_endo -77.51 124.64 7.14 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.159 1.906 . . . . 0.0 110.767 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 77.8 60.98 2.64 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.636 ' HB ' ' HH ' ' A' ' 68' ' ' TYR . 3.0 m -145.88 167.0 24.32 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.242 -1.152 . . . . 0.0 110.084 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.8 OUTLIER -125.2 121.51 34.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.434 -0.791 . . . . 0.0 109.674 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.636 ' HH ' ' HB ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -124.89 -172.57 2.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 0.0 109.302 179.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.574 ' O ' ' CE1' ' A' ' 37' ' ' HIS . 41.7 t -122.28 110.62 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 35' ' ' ARG . 3.5 t -96.57 127.19 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.778 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.579 ' HB3' HD13 ' A' ' 85' ' ' ILE . 95.1 p -108.01 133.98 51.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.32 -0.862 . . . . 0.0 109.951 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.146 HG22 ' CD1' ' A' ' 32' ' ' TYR . 5.2 mm -115.57 104.16 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.892 . . . . 0.0 109.242 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.667 HD12 ' HB3' ' A' ' 83' ' ' PRO . 21.1 mm -109.81 109.49 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.13 -0.981 . . . . 0.0 109.57 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.737 ' HB3' ' CB ' ' A' ' 81' ' ' SER . . . -75.88 140.81 42.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -0.959 . . . . 0.0 109.299 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.551 HG21 HD11 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -131.43 176.35 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.289 -0.882 . . . . 0.0 109.561 -179.734 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.738 HD22 HD21 ' A' ' 2' ' ' LEU . 34.2 t30 -156.44 43.68 0.4 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.476 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.532 ' N ' HG21 ' A' ' 30' ' ' THR . . . 91.13 -77.12 1.45 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.441 ' HD2' ' C ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -125.18 3.22 7.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -1.164 . . . . 0.0 109.679 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.509 ' OE1' ' ND2' ' A' ' 76' ' ' ASN . 4.0 mt-10 -100.34 -174.9 2.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.182 -0.949 . . . . 0.0 109.486 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 0.8 OUTLIER -149.9 143.93 25.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.889 . . . . 0.0 109.596 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.737 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -110.34 -178.78 0.58 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.408 -0.807 . . . . 0.0 109.065 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.582 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.0 Cg_endo -77.66 131.11 11.12 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.21 1.94 . . . . 0.0 110.168 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.667 ' HB3' HD12 ' A' ' 73' ' ' ILE . 36.1 Cg_endo -78.25 152.43 27.24 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.483 2.122 . . . . 0.0 110.775 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.093 ' CD2' HG22 ' A' ' 6' ' ' THR . 0.0 OUTLIER -146.61 54.13 1.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 108.875 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.579 HD13 ' HB3' ' A' ' 71' ' ' SER . 6.4 mt -57.87 162.6 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.306 -0.871 . . . . 0.0 109.871 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.5 ' N ' HG22 ' A' ' 85' ' ' ILE . . . -164.98 160.85 34.2 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.525 ' HG3' HG22 ' A' ' 69' ' ' VAL . 0.7 OUTLIER -95.75 127.86 42.13 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.268 -1.136 . . . . 0.0 109.493 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.671 ' OE1' HD12 ' A' ' 13' ' ' ILE . 1.3 tm0? -125.31 128.26 47.95 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -107.44 130.39 54.83 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.198 -0.939 . . . . 0.0 110.235 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.458 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -74.41 135.9 42.39 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.145 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.527 ' O ' ' N ' ' A' ' 65' ' ' GLY . 1.0 OUTLIER . . . . . 0 N--CA 1.494 1.753 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.212 -179.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.621 ' HB2' ' CD1' ' A' ' 112' ' ' TRP . 35.3 Cg_endo . . . . . 0 C--O 1.215 -0.649 0 N-CA-C 109.997 -0.809 . . . . 0.0 109.997 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -64.38 -179.37 0.46 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.258 -0.901 . . . . 0.0 109.678 -179.655 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER 77.06 21.14 1.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.312 -0.868 . . . . 0.0 109.622 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.907 HD22 HD23 ' A' ' 162' ' ' LEU . 15.1 tp -69.87 102.6 2.0 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.162 -0.961 . . . . 0.0 109.291 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 97' ' ' ASP . 8.6 pt-20 -149.1 -174.04 4.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.134 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 109' ' ' LEU . 41.7 t -127.57 151.18 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.084 -1.01 . . . . 0.0 109.971 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.1 pt -119.13 -14.2 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.524 -0.735 . . . . 0.0 109.332 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.78 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -142.32 149.3 39.3 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.518 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 0.7 OUTLIER -134.88 106.07 6.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.993 -1.067 . . . . 0.0 110.234 -179.452 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.479 ' OG1' ' OG ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -91.73 158.18 40.57 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.4 -0.812 . . . . 0.0 108.97 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.462 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.3 Cg_endo -70.32 -2.51 10.69 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.383 2.055 . . . . 0.0 110.385 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.828 ' C ' HG22 ' A' ' 152' ' ' ILE . 64.7 p -150.34 19.08 0.85 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 1.075 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -168.0 168.56 11.9 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.801 179.742 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.075 HD23 ' O ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -141.33 154.2 45.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.67 -179.383 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.78 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.8 OUTLIER -105.31 106.66 17.26 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.858 HD12 HD13 ' A' ' 124' ' ' ILE . 0.0 OUTLIER -100.76 140.81 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.226 -0.921 . . . . 0.0 110.206 -179.117 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.477 ' HA ' ' HB ' ' A' ' 146' ' ' THR . 47.4 p -144.49 120.51 10.71 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.656 ' HH2' ' HB2' ' A' ' 147' ' ' ALA . 47.5 p90 -124.69 168.87 12.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.944 . . . . 0.0 109.662 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . 4.3 mt-10 . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.287 -0.883 . . . . 0.0 109.245 179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.851 ' CE2' HG22 ' A' ' 139' ' ' THR . 1.5 p90 . . . . . 0 N--CA 1.488 1.456 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.459 ' HB2' ' HB ' ' A' ' 140' ' ' VAL . 5.5 m-85 -128.72 122.21 30.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.114 -0.991 . . . . 0.0 109.426 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.48 ' CD ' ' OE1' ' A' ' 137' ' ' GLU . 9.9 ttm180 -89.96 105.76 18.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.194 -0.942 . . . . 0.0 109.248 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 1.195 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 43.3 mt -84.7 166.46 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.677 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.664 HG22 ' HG2' ' A' ' 137' ' ' GLU . 1.3 p -141.8 137.22 31.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.866 . . . . 0.0 109.704 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 1.17 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 3.2 m-30 -92.04 132.4 36.59 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.597 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -103.42 112.31 4.18 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.287 -1.125 . . . . 0.0 109.136 179.348 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.61 ' HG2' ' CG ' ' A' ' 126' ' ' TYR . 4.7 pt20 . . . . . 0 N--CA 1.493 1.69 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.664 ' HG2' HG22 ' A' ' 125' ' ' THR . 84.0 mt-10 -96.76 152.23 18.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.105 -0.997 . . . . 0.0 111.434 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 1.195 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 1.7 p90 -143.88 139.89 29.47 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.851 HG22 ' CE2' ' A' ' 121' ' ' TYR . 1.6 p -74.2 144.37 44.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.029 -1.044 . . . . 0.0 111.317 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.807 HG13 ' HD2' ' A' ' 141' ' ' PRO . 48.5 t -108.78 145.77 32.36 Favored Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.807 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.3 Cg_endo -77.11 146.3 25.35 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.327 2.018 . . . . 0.0 110.011 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.17 19.62 25.77 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.425 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 0.5 OUTLIER -105.16 10.63 33.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.115 -1.226 . . . . 0.0 109.518 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 143' ' ' SER . 19.2 mmtp -152.42 135.93 16.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 109.616 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.572 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 7.2 p -83.53 1.72 40.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.921 . . . . 0.0 109.467 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.477 ' HB ' ' HA ' ' A' ' 111' ' ' SER . 11.7 p -137.38 146.51 44.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.914 . . . . 0.0 108.911 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.656 ' HB2' ' HH2' ' A' ' 112' ' ' TRP . . . -126.07 -171.42 2.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.07 -1.019 . . . . 0.0 109.593 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.606 HG22 ' N ' ' A' ' 149' ' ' ILE . 82.8 m -137.6 167.55 21.44 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.304 -0.872 . . . . 0.0 109.168 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 1.17 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 1.6 mt -126.36 141.41 45.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.251 -0.906 . . . . 0.0 109.134 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 151' ' ' ASN . 43.5 m-80 -134.5 176.09 8.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.325 -0.859 . . . . 0.0 109.539 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 150' ' ' ASN . 1.3 p30 41.02 52.9 3.37 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.32 -0.862 . . . . 0.0 109.78 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.838 HD13 HD21 ' A' ' 108' ' ' LEU . 8.4 tt -101.66 164.07 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.322 -0.861 . . . . 0.0 109.216 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.464 ' N ' HG12 ' A' ' 152' ' ' ILE . 19.5 mmmt -99.89 108.01 49.46 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.113 -0.992 . . . . 0.0 109.806 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 152' ' ' ILE . 36.5 Cg_endo -79.38 174.69 11.62 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.571 2.181 . . . . 0.0 110.573 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.602 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 64.94 56.06 18.5 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 170.47 138.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -1.114 . . . . 0.0 109.654 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -54.79 161.05 1.68 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.597 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.3 OUTLIER -140.33 176.54 8.69 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.908 -1.12 . . . . 0.0 110.135 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.548 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 3.2 m -146.2 109.63 4.76 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.514 ' HB ' ' CG1' ' A' ' 180' ' ' ILE . 29.6 mm -89.86 143.19 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.953 -1.092 . . . . 0.0 110.349 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.949 HG23 ' CB ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -153.12 160.0 42.83 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.414 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.907 HD23 HD22 ' A' ' 98' ' ' LEU . 2.1 pp -161.48 148.45 14.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.914 -1.116 . . . . 0.0 110.632 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.604 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 2.4 m-85 -113.07 164.45 13.46 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -134.33 102.87 5.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.027 -1.045 . . . . 0.0 109.582 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.514 HG22 ' HB3' ' A' ' 174' ' ' SER . 51.5 t . . . . . 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 109.725 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.514 ' HB3' HG22 ' A' ' 165' ' ' VAL . 14.2 p . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.453 0.644 . . . . 0.0 109.798 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 174' ' ' SER . 5.9 p 42.08 -165.54 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.06 140.58 29.03 Favored Pre-proline 0 C--N 1.305 -1.35 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.604 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 34.9 Cg_endo -77.51 130.23 10.69 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.354 2.036 . . . . 0.0 110.76 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.582 HG12 HD23 ' A' ' 98' ' ' LEU . 5.3 t -101.47 134.36 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.949 ' CB ' HG23 ' A' ' 161' ' ' THR . 1.3 p -126.61 155.63 42.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.172 -0.955 . . . . 0.0 110.191 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.514 ' CG1' ' HB ' ' A' ' 160' ' ' ILE . 24.6 pt -141.58 178.82 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -103.41 151.66 22.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.098 -1.001 . . . . 0.0 109.519 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.769 ' CE2' HD22 ' A' ' 108' ' ' LEU . 83.8 t80 -155.23 122.63 5.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.361 -0.837 . . . . 0.0 109.495 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.418 ' O ' ' CD ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -99.24 127.9 45.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.148 -0.97 . . . . 0.0 109.446 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.569 HG22 ' HE2' ' A' ' 182' ' ' TYR . 51.3 p . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.539 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.829 HD11 ' CB ' ' A' ' 81' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 25' ' ' PRO . 10.8 m-20 -84.93 123.08 30.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.425 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.559 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -95.73 177.5 1.75 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 109.528 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.665 ' O ' HG23 ' A' ' 6' ' ' THR . 36.2 Cg_endo -78.86 147.07 21.22 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.648 2.232 . . . . 0.0 110.096 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.665 HG23 ' O ' ' A' ' 5' ' ' PRO . 0.8 OUTLIER -161.25 -170.48 2.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.065 -1.022 . . . . 0.0 109.8 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 44.08 32.59 2.48 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.628 ' C ' ' CD1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -75.1 -167.68 0.65 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.51 -0.994 . . . . 0.0 109.99 -179.242 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -165.32 129.1 2.31 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.233 -0.917 . . . . 0.0 109.216 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.949 ' OG ' HG13 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -88.49 140.05 29.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.153 -0.967 . . . . 0.0 109.64 -179.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.507 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 60.2 p -148.16 -162.54 1.57 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.256 -0.903 . . . . 0.0 109.545 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.542 ' HB2' ' CB ' ' A' ' 19' ' ' THR . 4.4 m-20 45.34 39.77 4.7 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.077 HG22 HG22 ' A' ' 91' ' ' VAL . 24.5 mm -73.35 92.33 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.494 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.657 ' C ' HG23 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -93.04 166.38 12.39 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 176.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.62 ' N ' HG23 ' A' ' 91' ' ' VAL . . . -56.06 -77.81 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.961 -1.087 . . . . 0.0 111.106 -177.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -77.04 -0.08 23.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.109 -0.994 . . . . 0.0 110.177 -178.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.942 ' HB3' HG22 ' A' ' 60' ' ' THR . 20.8 p -144.67 123.58 12.73 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.164 -0.96 . . . . 0.0 109.237 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.935 ' CE1' HG22 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -135.09 136.05 41.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.119 -0.988 . . . . 0.0 108.335 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.582 ' OG1' HG23 ' A' ' 58' ' ' THR . 16.2 m -87.18 156.99 19.46 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.094 -1.004 . . . . 0.0 112.013 -177.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.949 HG13 ' OG ' ' A' ' 10' ' ' SER . 0.7 OUTLIER -135.58 97.94 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.507 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 15.5 m-70 -87.72 163.17 16.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.153 -0.967 . . . . 0.0 110.882 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.865 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 25.9 p90 -174.79 139.99 0.55 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.0 161.1 5.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.152 -0.967 . . . . 0.0 109.827 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.511 ' HB1' ' OH ' ' A' ' 32' ' ' TYR . . . -102.15 151.0 38.0 Favored Pre-proline 0 C--N 1.297 -1.691 0 O-C-N 121.779 -0.576 . . . . 0.0 109.511 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.528 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 36.2 Cg_endo -78.53 152.8 26.53 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.538 2.159 . . . . 0.0 110.247 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -92.69 27.06 2.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 109.627 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.958 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -105.34 175.32 2.18 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 109.271 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.958 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.2 Cg_endo -77.77 98.87 1.24 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.586 2.191 . . . . 0.0 110.363 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.635 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 39.4 pt -126.93 173.81 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 109.518 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.6 p -114.2 -18.83 11.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.262 -0.898 . . . . 0.0 109.346 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.28 170.68 26.27 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.635 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 1.2 m-85 -112.49 134.23 54.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -1.193 . . . . 0.0 109.492 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.814 ' C ' HD13 ' A' ' 34' ' ' ILE . 2.0 mt -88.54 126.8 41.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.303 -0.873 . . . . 0.0 109.069 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.062 HG23 ' CD1' ' A' ' 72' ' ' ILE . 1.1 mm -104.28 111.25 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.084 -1.01 . . . . 0.0 109.882 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.423 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 42.2 ttt-85 -121.7 108.16 13.21 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.301 -0.874 . . . . 0.0 108.898 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.938 ' HB3' HG13 ' A' ' 70' ' ' VAL . 18.3 p-80 -117.41 170.77 8.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 110.069 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.44 ' O ' ' O ' ' A' ' 38' ' ' ALA . 54.7 p-80 -179.61 130.38 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.43 -0.794 . . . . 0.0 109.723 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -55.31 -168.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.262 -0.899 . . . . 0.0 109.318 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.124 -0.985 . . . . 0.0 109.329 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.577 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 3.7 mmt85 . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -110.23 85.26 2.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 0.0 109.63 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.512 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 29.7 m-20 -100.74 99.86 10.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.241 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.52 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -84.81 134.49 34.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.037 -1.039 . . . . 0.0 109.617 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.75 ' CG1' HD12 ' A' ' 57' ' ' ILE . 13.6 m -118.97 159.67 43.83 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.38 -0.825 . . . . 0.0 109.256 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.495 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 34.7 Cg_endo -77.0 174.16 13.3 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.528 2.152 . . . . 0.0 110.263 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.577 ' HA ' ' CE2' ' A' ' 32' ' ' TYR . 34.9 Cg_endo -76.89 -15.63 16.6 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.605 2.203 . . . . 0.0 110.43 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.87 23.53 2.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.473 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.435 ' O ' ' CZ2' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -137.52 109.47 7.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.923 . . . . 0.0 109.647 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 22' ' ' TRP . 5.2 p30 -95.13 -6.96 40.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 21' ' ' HIS . 64.9 p -139.1 129.49 25.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.318 -0.864 . . . . 0.0 109.057 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.865 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 3.4 tt -118.33 119.36 61.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.258 -0.902 . . . . 0.0 109.594 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.582 HG23 ' OG1' ' A' ' 19' ' ' THR . 0.3 OUTLIER -85.13 108.75 17.84 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.411 -0.806 . . . . 0.0 108.829 179.628 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.987 ' CB ' HD11 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -84.72 152.46 23.71 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.204 -0.935 . . . . 0.0 109.24 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.942 HG22 ' HB3' ' A' ' 17' ' ' SER . 21.5 p -142.93 -179.69 6.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.568 -0.708 . . . . 0.0 109.449 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.44 18.29 3.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 109.392 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.987 HD11 ' CB ' ' A' ' 59' ' ' LEU . 3.5 mt -92.68 142.8 26.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.246 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 62' ' ' LEU . 7.5 t-20 -45.86 123.99 6.4 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.204 -0.935 . . . . 0.0 108.651 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.421 ' HG3' ' OD1' ' A' ' 16' ' ' ASN . 35.2 Cg_endo -76.96 131.78 12.35 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.23 1.954 . . . . 0.0 110.32 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 71.89 61.6 3.71 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 90' ' ' THR . 3.3 m -154.91 149.3 26.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -1.136 . . . . 0.0 109.654 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.528 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 16.5 mt-10 -74.41 130.33 39.44 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.096 -1.002 . . . . 0.0 108.417 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 3.0 m-85 -126.0 115.97 20.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.093 -1.004 . . . . 0.0 110.377 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 36' ' ' HIS . 2.1 t -83.52 123.37 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.938 HG13 ' HB3' ' A' ' 36' ' ' HIS . 2.2 t -112.34 123.8 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.003 -1.061 . . . . 0.0 110.18 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.504 ' HB2' HG12 ' A' ' 85' ' ' ILE . 61.2 p -112.97 122.28 47.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.371 -0.831 . . . . 0.0 109.689 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.062 ' CD1' HG23 ' A' ' 34' ' ' ILE . 10.7 mm -107.19 136.49 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.273 -0.892 . . . . 0.0 109.54 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.91 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.7 mp -122.6 156.38 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 0.0 109.2 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.061 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -119.35 115.57 24.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.379 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.35 164.02 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.167 -0.958 . . . . 0.0 109.441 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -140.21 49.93 1.73 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.398 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.58 -82.24 1.65 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.44 ' HD3' ' C ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -120.19 -2.37 10.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -1.154 . . . . 0.0 109.564 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -92.96 -166.59 1.56 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.427 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 37.5 mt-10 -154.01 155.03 34.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.2 -0.938 . . . . 0.0 109.745 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 1.061 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -129.49 179.89 1.19 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.385 -0.822 . . . . 0.0 108.978 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.576 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.3 Cg_endo -76.04 142.74 25.15 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.194 1.929 . . . . 0.0 109.855 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.8 Cg_endo -77.81 132.33 11.82 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.685 2.257 . . . . 0.0 111.529 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.64 HD22 ' O ' ' A' ' 5' ' ' PRO . 9.0 tp -108.16 100.75 10.03 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.504 HG12 ' HB2' ' A' ' 71' ' ' SER . 2.0 mt -105.63 157.35 6.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.065 -1.022 . . . . 0.0 110.486 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.478 ' N ' HG22 ' A' ' 85' ' ' ILE . . . -151.42 178.97 28.45 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -131.59 137.2 48.32 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.113 -1.228 . . . . 0.0 109.766 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.546 ' HG3' ' CB ' ' A' ' 10' ' ' SER . 1.8 mm100 -163.76 126.94 2.61 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.313 -0.867 . . . . 0.0 109.174 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.528 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -94.5 145.91 24.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.354 -0.841 . . . . 0.0 110.098 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.71 145.93 42.69 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.458 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.077 HG22 HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 O-C-N 121.462 -0.774 . . . . 0.0 109.096 179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.463 ' HB2' ' HB2' ' A' ' 112' ' ' TRP . 36.2 Cg_endo . . . . . 0 C--O 1.214 -0.681 0 N-CA-C 109.499 -1.001 . . . . 0.0 109.499 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 5.1 ptp180 -45.94 173.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.44 -0.788 . . . . 0.0 109.974 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 1.7 t70 82.38 15.34 0.43 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.68 -0.637 . . . . 0.0 110.004 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 1.059 HD23 HG12 ' A' ' 178' ' ' VAL . 20.7 tp -70.27 100.45 1.71 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.042 -1.037 . . . . 0.0 109.137 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 110' ' ' ILE . 0.7 OUTLIER -153.3 176.85 11.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.233 -0.917 . . . . 0.0 109.649 -179.797 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.564 HG22 ' N ' ' A' ' 101' ' ' ILE . 9.2 p -105.25 171.23 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.342 -0.849 . . . . 0.0 109.537 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.564 ' N ' HG22 ' A' ' 100' ' ' VAL . 3.6 pt -136.51 -42.69 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.277 -0.89 . . . . 0.0 109.166 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.899 ' HB3' ' CD1' ' A' ' 109' ' ' LEU . . . -121.99 114.29 20.75 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.569 ' CB ' ' HH ' ' A' ' 182' ' ' TYR . 1.2 t -99.94 99.16 9.88 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.24 -0.913 . . . . 0.0 110.5 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.516 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -89.38 160.74 41.67 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.639 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -69.64 -0.81 7.35 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.423 2.082 . . . . 0.0 110.937 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.867 ' C ' HG22 ' A' ' 152' ' ' ILE . 56.0 p -146.45 11.5 1.14 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.269 -0.894 . . . . 0.0 109.485 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 1.081 ' O ' HD23 ' A' ' 108' ' ' LEU . 85.3 p -172.48 165.52 5.67 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.682 -1.207 . . . . 0.0 110.41 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.081 HD23 ' O ' ' A' ' 107' ' ' SER . 0.4 OUTLIER -145.92 149.57 34.47 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.899 ' CD1' ' HB3' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -106.63 116.52 32.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.199 -0.938 . . . . 0.0 108.952 179.214 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.835 HD11 ' HB3' ' A' ' 147' ' ' ALA . 2.4 pt -100.03 -179.14 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.984 -1.072 . . . . 0.0 109.719 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 146' ' ' THR . 1.0 OUTLIER -168.42 150.96 5.26 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.551 -0.718 . . . . 0.0 109.778 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.655 ' CH2' ' HB2' ' A' ' 147' ' ' ALA . 24.2 p90 -154.03 -176.8 6.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.43 -0.794 . . . . 0.0 109.307 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 95' ' ' PRO . 19.1 mm-40 . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.095 -1.003 . . . . 0.0 109.742 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.959 ' CE1' HG22 ' A' ' 139' ' ' THR . 1.2 p90 . . . . . 0 N--CA 1.486 1.373 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.541 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 7.0 m-85 -107.58 123.43 48.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.013 -1.054 . . . . 0.0 109.331 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 4.2 ttp180 -86.11 106.11 17.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.206 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.832 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 26.1 mt -99.09 150.09 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.296 -0.878 . . . . 0.0 109.902 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 25.3 p -133.48 132.73 41.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.865 . . . . 0.0 109.932 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.702 ' CE2' HG22 ' A' ' 149' ' ' ILE . 30.5 m-85 -74.8 134.22 41.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.86 . . . . 0.0 109.225 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.586 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.32 106.73 2.71 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.198 -1.178 . . . . 0.0 109.529 179.882 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.58 ' HB3' ' CD1' ' A' ' 126' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 4.8 tt0 -85.82 111.75 20.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 110.372 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.832 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 13.3 p90 -122.39 132.18 54.25 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.959 HG22 ' CE1' ' A' ' 121' ' ' TYR . 1.7 p -74.29 174.48 8.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.225 -0.922 . . . . 0.0 110.741 -178.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.61 HG21 ' CD1' ' A' ' 124' ' ' ILE . 24.9 t -137.03 138.08 24.72 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.667 -0.646 . . . . 0.0 109.294 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.487 ' HD2' HG13 ' A' ' 140' ' ' VAL . 35.2 Cg_endo -76.95 132.72 13.12 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.346 2.031 . . . . 0.0 110.35 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.45 0.44 55.04 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -4.64 25.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.114 -1.227 . . . . 0.0 109.751 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.531 ' CD ' ' O ' ' A' ' 146' ' ' THR . 0.0 OUTLIER -154.71 157.67 38.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.935 . . . . 0.0 109.376 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.569 ' O ' ' CE3' ' A' ' 112' ' ' TRP . 0.1 OUTLIER -95.84 2.06 53.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.265 -0.897 . . . . 0.0 110.313 -179.348 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.531 ' O ' ' CD ' ' A' ' 144' ' ' LYS . 43.4 p -108.32 162.34 14.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.981 -1.075 . . . . 0.0 109.624 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.835 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -145.9 134.45 22.09 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.991 . . . . 0.0 109.749 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.2 t -83.91 153.47 23.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.328 -0.858 . . . . 0.0 109.031 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.702 HG22 ' CE2' ' A' ' 126' ' ' TYR . 14.3 mm -133.98 66.26 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.135 -0.978 . . . . 0.0 109.674 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.566 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 2.4 m-20 -84.2 -176.26 6.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.403 -0.811 . . . . 0.0 109.636 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 13.3 m120 68.47 21.4 8.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.22 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.867 HG22 ' C ' ' A' ' 106' ' ' THR . 2.8 tt -85.91 155.11 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.341 -0.849 . . . . 0.0 109.615 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.426 ' O ' ' OG1' ' A' ' 184' ' ' THR . 0.0 OUTLIER -103.88 123.81 39.79 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.231 -0.918 . . . . 0.0 109.298 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.46 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 35.9 Cg_endo -78.43 149.63 24.52 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.415 2.076 . . . . 0.0 110.402 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.698 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 78.43 66.16 1.77 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 163.97 131.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -1.162 . . . . 0.0 109.653 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.17 164.87 0.26 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.617 ' CD1' ' CG2' ' A' ' 184' ' ' THR . 0.2 OUTLIER -142.69 -179.36 6.27 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.846 -1.159 . . . . 0.0 110.363 -179.419 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.585 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 1.7 m -153.12 106.75 3.03 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.933 HD11 HD12 ' A' ' 108' ' ' LEU . 27.5 mt -97.72 116.79 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.805 -1.184 . . . . 0.0 109.754 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 1.039 HG23 ' CB ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -125.04 153.52 42.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 109.165 179.68 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.828 ' CD2' HD13 ' A' ' 98' ' ' LEU . 2.3 pp -149.95 145.62 26.58 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.055 -1.028 . . . . 0.0 110.682 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.607 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 4.1 m-85 -114.11 177.39 4.66 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -140.53 110.09 6.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.231 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 95.7 t . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.276 -0.89 . . . . 0.0 109.639 -179.71 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.276 0.56 . . . . 0.0 109.589 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 73.5 p -64.07 -164.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.847 . . . . 0.0 109.365 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.24 144.84 51.06 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 108.91 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.607 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 35.7 Cg_endo -78.55 127.96 8.41 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.547 2.164 . . . . 0.0 110.931 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 1.059 HG12 HD23 ' A' ' 98' ' ' LEU . 69.1 t -96.5 123.51 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -0.91 . . . . 0.0 108.56 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 1.039 ' CB ' HG23 ' A' ' 161' ' ' THR . 0.4 OUTLIER -118.53 143.71 46.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.167 -0.958 . . . . 0.0 109.914 -179.537 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.5 pt -136.14 151.75 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -84.66 162.67 19.63 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.111 -0.993 . . . . 0.0 109.347 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.769 ' OH ' HD22 ' A' ' 108' ' ' LEU . 49.6 t80 -155.1 157.88 38.17 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.314 -0.867 . . . . 0.0 109.368 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.439 ' N ' ' CD1' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -126.57 119.06 26.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.18 -0.95 . . . . 0.0 109.474 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.617 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 10.8 p . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.54 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.845 HD22 HG22 ' A' ' 29' ' ' ILE . 1.9 mp . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.438 ' HB2' ' CB ' ' A' ' 25' ' ' PRO . 29.2 m-20 -115.34 169.84 8.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.43 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.481 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 37.1 p -94.8 119.22 66.37 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.541 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.554 ' O ' HD22 ' A' ' 84' ' ' LEU . 35.2 Cg_endo -77.85 88.13 1.45 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.367 2.045 . . . . 0.0 110.109 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 7' ' ' GLY . 1.8 p -80.87 -109.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.92 . . . . 0.0 109.682 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 22' ' ' TRP . . . 45.7 26.44 1.82 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.781 -1.727 . . . . 0.0 108.781 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.544 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 30.9 t80 -53.74 132.23 40.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.526 -0.985 . . . . 0.0 110.112 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 5.2 t0 -165.22 153.83 11.97 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.537 ' CB ' ' HG2' ' A' ' 88' ' ' GLN . 2.1 p -136.44 139.03 42.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.047 -1.033 . . . . 0.0 109.696 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.471 ' O ' ' HB ' ' A' ' 19' ' ' THR . 17.8 p -160.12 -165.6 1.51 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.249 -0.907 . . . . 0.0 109.579 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.556 ' HB2' ' CB ' ' A' ' 19' ' ' THR . 10.0 m-20 42.31 36.21 0.71 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.906 HG22 HG23 ' A' ' 91' ' ' VAL . 26.2 mm -66.32 134.2 30.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-O 121.418 0.628 . . . . 0.0 110.367 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.556 ' CB ' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -124.73 -179.8 4.66 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.495 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -72.4 -76.01 0.12 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.932 -1.105 . . . . 0.0 109.336 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 2.1 p-10 -76.69 0.78 19.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.87 . . . . 0.0 109.648 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.694 ' HB2' HG22 ' A' ' 60' ' ' THR . 3.6 t -150.47 162.47 40.52 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.246 -0.909 . . . . 0.0 109.139 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.904 ' CE1' HG22 ' A' ' 20' ' ' VAL . 7.7 p90 -166.69 139.87 3.81 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.556 ' CB ' ' HB2' ' A' ' 12' ' ' ASP . 23.6 m -83.02 158.74 22.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.738 -1.226 . . . . 0.0 111.447 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.904 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.5 t -136.89 166.58 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.503 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 14.2 m-70 -148.53 165.43 31.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.898 -1.126 . . . . 0.0 110.416 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.836 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 39.4 p90 -177.13 140.93 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.31 167.54 2.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 120.932 -1.105 . . . . 0.0 109.376 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.742 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -103.32 168.7 8.36 Favored Pre-proline 0 C--N 1.3 -1.581 0 O-C-N 121.671 -0.643 . . . . 0.0 109.936 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.742 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.5 Cg_endo -78.48 -158.73 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.703 2.269 . . . . 0.0 110.347 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.48 28.38 8.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.551 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.708 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -144.73 166.84 16.62 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.547 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.708 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.5 Cg_endo -78.25 89.88 1.31 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.633 2.222 . . . . 0.0 110.42 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.951 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 11.7 pt -87.83 -172.09 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -0.938 . . . . 0.0 109.457 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 2.8 p -112.33 -5.8 14.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.94 . . . . 0.0 109.563 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.06 172.35 12.49 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.951 ' CZ ' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -120.83 144.27 48.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -1.148 . . . . 0.0 109.375 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.547 HG23 ' HG3' ' A' ' 49' ' ' ARG . 22.6 mm -82.1 101.81 7.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.212 -0.93 . . . . 0.0 109.594 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.777 HD13 ' N ' ' A' ' 34' ' ' ILE . 1.5 mm -83.42 105.35 13.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.345 -0.847 . . . . 0.0 109.715 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.59 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -102.94 155.37 18.4 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.117 -0.989 . . . . 0.0 108.757 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.699 ' CE1' HD22 ' A' ' 62' ' ' LEU . 23.7 p80 -144.93 136.6 25.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.983 -1.073 . . . . 0.0 110.04 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.574 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 27.9 p-80 -167.73 129.79 1.54 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.882 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -58.66 -172.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.401 -0.812 . . . . 0.0 109.436 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 179.968 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.531 ' HG2' ' NE2' ' A' ' 36' ' ' HIS . 6.2 ptm180 . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 121.452 0.644 . . . . 0.0 109.798 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.505 ' HB3' ' HG3' ' A' ' 35' ' ' ARG . 3.8 pt20 -113.16 130.23 56.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.409 -0.807 . . . . 0.0 109.436 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.504 ' C ' ' CD ' ' A' ' 49' ' ' ARG . 9.0 m-20 -112.91 158.27 20.41 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.547 ' HG3' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -133.12 157.5 45.15 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.398 -0.814 . . . . 0.0 109.872 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 1.098 ' CG1' HD12 ' A' ' 57' ' ' ILE . 27.0 m -143.02 159.71 55.27 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.434 -0.791 . . . . 0.0 109.247 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.536 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 35.3 Cg_endo -77.6 173.93 13.43 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.567 2.178 . . . . 0.0 110.517 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 35.6 Cg_endo -77.86 -15.49 14.98 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.674 2.25 . . . . 0.0 110.518 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.3 t -97.8 18.41 15.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.493 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.536 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 15.4 mmm180 -127.31 109.35 11.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.802 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 13.3 p-10 -94.81 -7.12 41.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.219 -0.925 . . . . 0.0 109.199 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 42.0 p -134.56 130.62 36.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.42 -0.8 . . . . 0.0 108.987 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.098 HD12 ' CG1' ' A' ' 50' ' ' VAL . 1.5 tt -132.06 143.42 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.143 -0.973 . . . . 0.0 109.795 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 16.8 m -102.63 125.7 49.46 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.295 -0.878 . . . . 0.0 109.328 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.96 ' CB ' HD11 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -91.13 153.73 19.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.888 . . . . 0.0 109.329 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.694 HG22 ' HB2' ' A' ' 17' ' ' SER . 13.8 p -139.51 -178.79 5.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 109.462 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 54.69 27.38 8.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 109.364 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.96 HD11 ' CB ' ' A' ' 59' ' ' LEU . 2.1 mt -105.46 148.16 27.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.121 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -49.33 130.21 17.51 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.106 -0.996 . . . . 0.0 108.525 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.1 Cg_endo -76.85 129.18 10.54 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.33 2.02 . . . . 0.0 110.756 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 69.8 63.87 3.16 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 90' ' ' THR . 2.4 m -156.86 152.01 26.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.339 -1.095 . . . . 0.0 110.486 -178.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.6 OUTLIER -78.6 124.44 28.16 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.463 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.517 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 2.2 m-85 -119.19 119.42 34.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.983 -1.073 . . . . 0.0 110.319 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.574 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 16.3 t -78.67 122.37 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.59 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.8 t -107.08 136.35 42.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.11 -0.994 . . . . 0.0 110.188 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.526 ' OG ' ' CB ' ' A' ' 35' ' ' ARG . 10.5 p -110.91 108.43 18.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.363 -0.836 . . . . 0.0 109.67 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.814 ' C ' HD12 ' A' ' 73' ' ' ILE . 17.1 mm -91.87 110.1 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 109.959 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.814 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.5 mp -113.96 153.33 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.16 -0.962 . . . . 0.0 109.092 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.919 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -112.71 145.46 40.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.527 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.464 ' O ' ' OG1' ' A' ' 30' ' ' THR . 0.9 OUTLIER -147.13 142.19 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.294 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.664 ' OD1' HD21 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -112.96 50.13 0.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.214 -0.929 . . . . 0.0 109.472 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.41 -59.19 3.69 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.527 ' N ' ' HD2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -130.36 0.16 4.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -1.123 . . . . 0.0 109.63 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 7.3 mt-10 -100.9 -164.7 1.13 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 0.0 109.365 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 20.2 mt-10 -151.03 -170.44 3.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 109.592 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.919 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -167.74 -178.08 0.6 Allowed Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.595 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.7 Cg_endo -76.67 142.56 23.09 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.126 1.884 . . . . 0.0 110.151 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.4 Cg_endo -77.56 129.97 10.47 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.678 2.252 . . . . 0.0 110.967 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.554 HD22 ' O ' ' A' ' 5' ' ' PRO . 22.3 tp -120.13 84.04 2.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -0.825 . . . . 0.0 109.01 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 70' ' ' VAL . 3.0 mt -94.67 152.8 3.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.208 -0.933 . . . . 0.0 109.954 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.544 ' HA3' ' CZ ' ' A' ' 8' ' ' PHE . . . -143.95 -172.45 14.7 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.511 ' HG3' HG13 ' A' ' 69' ' ' VAL . 9.8 mt-30 -138.26 131.01 29.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -1.183 . . . . 0.0 109.766 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.537 ' HG2' ' CB ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -141.32 -152.0 0.39 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 108.962 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.28 145.54 7.01 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.878 -1.139 . . . . 0.0 110.59 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.461 ' CG2' ' O ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -84.85 142.43 29.74 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.906 HG23 HG22 ' A' ' 13' ' ' ILE . 1.9 t . . . . . 0 N--CA 1.493 1.713 0 O-C-N 121.416 -0.802 . . . . 0.0 109.307 179.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.993 ' HG3' HD11 ' A' ' 162' ' ' LEU . 33.9 Cg_endo . . . . . 0 C--O 1.215 -0.674 0 N-CA-C 109.886 -0.851 . . . . 0.0 109.886 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 13.9 tpp85 -61.76 158.86 14.74 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.538 -0.726 . . . . 0.0 109.516 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.9 OUTLIER 80.1 17.17 0.71 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.559 -0.713 . . . . 0.0 109.507 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.875 ' O ' HG21 ' A' ' 180' ' ' ILE . 26.7 tp -60.51 100.07 0.09 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.228 -0.92 . . . . 0.0 108.918 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -140.56 -171.75 3.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.206 -0.934 . . . . 0.0 109.173 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 109' ' ' LEU . 35.3 t -126.41 150.53 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.16 -0.963 . . . . 0.0 110.014 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.704 HG12 HD12 ' A' ' 109' ' ' LEU . 3.0 pt -121.21 -14.43 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.475 -0.766 . . . . 0.0 109.505 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.876 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -134.08 133.42 41.11 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.517 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.8 p -122.73 81.91 1.92 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.033 -1.042 . . . . 0.0 110.374 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.542 HG21 ' OG ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -73.76 163.52 67.82 Favored Pre-proline 0 C--N 1.305 -1.365 0 O-C-N 121.147 -0.971 . . . . 0.0 108.51 179.177 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.492 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 29.7 Cg_endo -68.56 -2.32 9.05 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.4 2.066 . . . . 0.0 110.777 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.879 ' C ' HG22 ' A' ' 152' ' ' ILE . 17.1 p -155.38 21.55 0.41 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.326 -0.859 . . . . 0.0 108.684 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 1.069 ' O ' HD23 ' A' ' 108' ' ' LEU . 49.6 p -173.24 158.88 3.71 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.467 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.069 HD23 ' O ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -143.91 151.82 40.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.149 -0.969 . . . . 0.0 109.514 -179.569 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 1.065 HD13 ' N ' ' A' ' 110' ' ' ILE . 2.8 tm? -86.9 144.76 26.83 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.433 -0.792 . . . . 0.0 109.091 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 1.065 ' N ' HD13 ' A' ' 109' ' ' LEU . 0.6 OUTLIER -127.09 150.71 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.083 -1.011 . . . . 0.0 109.953 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.6 t -156.1 139.99 16.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.45 -0.782 . . . . 0.0 109.32 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.617 ' CD1' ' HB3' ' A' ' 95' ' ' PRO . 28.5 p90 -150.63 160.69 43.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.512 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.474 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 59.4 mt-10 . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.0 109.498 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.687 ' CE2' HG22 ' A' ' 139' ' ' THR . 3.2 p90 . . . . . 0 N--CA 1.489 1.484 0 CA-C-O 121.442 0.639 . . . . 0.0 109.887 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 1.6 m-85 -141.01 142.7 34.21 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.539 ' CD ' ' HB2' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -113.63 106.56 14.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.012 -1.055 . . . . 0.0 109.413 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.646 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 20.2 mt -84.62 164.99 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.355 -0.84 . . . . 0.0 109.141 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.917 HG22 ' HG2' ' A' ' 137' ' ' GLU . 3.0 p -135.39 140.83 45.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.914 . . . . 0.0 110.105 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 1.209 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 3.6 m-30 -85.9 124.01 31.89 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.625 ' HA3' ' HB ' ' A' ' 159' ' ' THR . . . -95.05 112.11 4.32 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 . . . . . 0 C--N 1.297 -1.688 0 O-C-N 121.228 -1.16 . . . . 0.0 109.295 179.258 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.529 ' HB3' ' HB2' ' A' ' 126' ' ' TYR . 1.5 tt0 . . . . . 0 N--CA 1.493 1.708 0 N-CA-C 109.117 -0.698 . . . . 0.0 109.117 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.917 ' HG2' HG22 ' A' ' 125' ' ' THR . 0.5 OUTLIER -105.18 119.23 38.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.128 -0.983 . . . . 0.0 110.808 -179.045 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.646 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 26.5 p90 -118.89 149.49 41.48 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.687 HG22 ' CE2' ' A' ' 121' ' ' TYR . 1.3 p -73.97 -174.03 1.74 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.008 -1.057 . . . . 0.0 110.879 -177.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.661 HG13 ' HD2' ' A' ' 141' ' ' PRO . 55.7 t -153.0 141.16 13.78 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.239 -0.913 . . . . 0.0 109.715 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.661 ' HD2' HG13 ' A' ' 140' ' ' VAL . 36.0 Cg_endo -78.5 128.88 9.02 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.396 2.064 . . . . 0.0 110.052 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -81.96 47.28 3.66 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.3 p -105.42 -2.48 23.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -1.175 . . . . 0.0 109.747 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -166.2 170.03 13.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.142 -0.974 . . . . 0.0 109.683 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.05 21.2 8.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.321 -0.862 . . . . 0.0 109.642 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.565 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 70.0 p -139.01 152.32 47.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.175 -0.953 . . . . 0.0 109.504 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.483 ' C ' ' CG1' ' A' ' 110' ' ' ILE . . . -144.13 -164.29 1.86 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.213 -0.93 . . . . 0.0 109.239 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.639 HG22 ' N ' ' A' ' 149' ' ' ILE . 20.9 m -146.21 165.77 28.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 109.736 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 1.209 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -138.89 111.87 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.367 -0.833 . . . . 0.0 109.109 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.465 ' HA ' ' CB ' ' A' ' 107' ' ' SER . 13.6 m-80 -109.62 177.5 4.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.858 . . . . 0.0 109.369 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 30.0 m120 54.97 69.41 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 108.998 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.879 HG22 ' C ' ' A' ' 106' ' ' THR . 9.2 tt -129.34 163.86 33.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.385 -0.822 . . . . 0.0 109.897 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.471 ' N ' HG12 ' A' ' 152' ' ' ILE . 0.3 OUTLIER -94.37 110.77 50.6 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 109.177 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 152' ' ' ILE . 35.7 Cg_endo -78.35 153.37 27.53 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.4 2.067 . . . . 0.0 110.638 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 74.99 64.07 2.4 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.566 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 171.37 131.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -1.145 . . . . 0.0 109.659 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.78 133.9 42.3 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.606 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -116.22 177.28 4.74 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.904 -1.123 . . . . 0.0 110.23 -179.069 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.625 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 1.8 m -143.53 98.55 3.27 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.482 ' HB ' HG13 ' A' ' 180' ' ' ILE . 32.9 mm -84.94 125.45 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.933 -1.104 . . . . 0.0 110.213 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.623 HG23 ' CB ' ' A' ' 179' ' ' SER . 1.4 m -133.29 170.5 15.36 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.993 HD11 ' HG3' ' A' ' 95' ' ' PRO . 0.9 OUTLIER -167.79 150.68 5.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.792 -1.192 . . . . 0.0 111.048 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.6 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 1.2 m-85 -124.45 119.92 30.55 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -85.12 116.13 23.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.877 -1.139 . . . . 0.0 109.226 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.57 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 53.2 t . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 109.99 -179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 175' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 174' ' ' SER . 0.7 OUTLIER -54.39 -169.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.011 179.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.462 ' HG3' ' N ' ' A' ' 177' ' ' PRO . 0.5 OUTLIER -80.98 145.89 58.0 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.6 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 34.7 Cg_endo -77.21 139.12 18.59 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.474 2.116 . . . . 0.0 111.042 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 161' ' ' THR . 2.2 t -113.48 139.14 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.623 ' CB ' HG23 ' A' ' 161' ' ' THR . 0.4 OUTLIER -130.48 136.0 48.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 110.17 -179.282 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.875 HG21 ' O ' ' A' ' 98' ' ' LEU . 9.8 pt -125.16 152.08 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 29.5 m-20 -85.32 160.6 19.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.126 -0.984 . . . . 0.0 109.634 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.882 ' OH ' HD22 ' A' ' 108' ' ' LEU . 66.8 t80 -159.25 116.47 2.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 109.437 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -84.81 113.16 21.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.92 . . . . 0.0 109.549 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.704 HG22 ' CE2' ' A' ' 182' ' ' TYR . 21.6 p . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.489 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.83 HD12 ' O ' ' A' ' 80' ' ' GLU . 94.7 mt . . . . . 0 N--CA 1.489 1.497 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 28.5 m-20 -75.05 167.04 22.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.868 . . . . 0.0 109.447 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.536 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 22.7 t -94.82 124.15 55.52 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.952 . . . . 0.0 109.639 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 1.023 ' O ' HD22 ' A' ' 84' ' ' LEU . 35.6 Cg_endo -78.78 83.76 2.18 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.437 2.091 . . . . 0.0 110.161 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.448 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.9 p -75.92 -109.85 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 22' ' ' TRP . . . 45.46 26.16 1.53 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.411 ' N ' ' C ' ' A' ' 6' ' ' THR . 22.5 t80 -55.25 121.09 8.1 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.519 -0.989 . . . . 0.0 109.958 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 1.0 OUTLIER -149.26 103.42 3.31 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.425 -0.797 . . . . 0.0 108.853 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.501 ' HB3' ' NE2' ' A' ' 88' ' ' GLN . 3.8 p -84.54 124.78 31.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 109.586 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 19' ' ' THR . 3.6 p -155.34 -162.17 1.3 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.202 -0.936 . . . . 0.0 109.32 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.566 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.9 OUTLIER 44.9 38.15 2.77 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -178.796 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.113 HG22 HG22 ' A' ' 91' ' ' VAL . 2.3 mt -88.12 141.31 14.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.81 0.814 . . . . 0.0 111.417 -177.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.642 ' C ' HG23 ' A' ' 91' ' ' VAL . 1.5 p -127.43 156.87 41.4 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.84 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -58.95 -36.9 75.57 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.009 -1.057 . . . . 0.0 110.26 -178.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 17' ' ' SER . 0.5 OUTLIER -112.36 38.17 2.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.562 -1.336 . . . . 0.0 109.3 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.614 ' HA ' HD12 ' A' ' 62' ' ' LEU . 1.4 t 160.65 155.65 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.897 ' CB ' HG23 ' A' ' 13' ' ' ILE . 5.1 p90 -165.88 152.09 9.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.624 -1.298 . . . . 0.0 109.886 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.968 ' OG1' HG23 ' A' ' 58' ' ' THR . 25.4 m -109.09 153.6 23.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.766 -1.209 . . . . 0.0 110.86 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.784 HG22 ' HE1' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -118.43 169.43 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.431 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.536 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 17.7 m-70 -143.71 157.57 44.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.177 -0.952 . . . . 0.0 109.79 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.607 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 32.4 p90 -164.64 146.63 8.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.304 -0.873 . . . . 0.0 109.392 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.7 167.48 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.127 -0.983 . . . . 0.0 109.273 179.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.502 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -95.9 160.8 29.32 Favored Pre-proline 0 C--N 1.299 -1.63 0 O-C-N 121.584 -0.698 . . . . 0.0 109.541 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.489 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 36.0 Cg_endo -79.16 160.28 26.53 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.6 2.2 . . . . 0.0 110.377 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.423 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 1.2 mtm-85 -84.02 46.34 1.18 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.923 . . . . 0.0 109.487 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.91 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -158.31 173.32 5.1 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.374 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.91 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.8 Cg_endo -78.35 136.14 13.94 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.586 2.191 . . . . 0.0 110.445 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.639 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 21.0 pt -140.93 -170.39 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.616 HG23 HD22 ' A' ' 76' ' ' ASN . 46.2 p -132.44 2.44 3.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.584 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.5 -168.58 28.5 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.639 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -146.29 133.38 20.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -1.137 . . . . 0.0 109.516 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.876 ' C ' HD13 ' A' ' 34' ' ' ILE . 0.7 OUTLIER -87.29 123.57 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.179 -0.951 . . . . 0.0 108.766 179.581 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.011 HG23 ' CD1' ' A' ' 72' ' ' ILE . 1.1 mm -109.37 158.25 9.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.244 -0.91 . . . . 0.0 109.167 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.756 ' O ' HG13 ' A' ' 70' ' ' VAL . 50.7 ttp180 -155.49 146.62 22.58 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.537 ' NE2' ' HD2' ' A' ' 46' ' ' ARG . 1.1 p80 -128.9 151.99 49.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.926 -1.109 . . . . 0.0 109.964 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.628 ' CE1' ' CG1' ' A' ' 69' ' ' VAL . 55.9 p-80 -170.4 108.81 0.35 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.743 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -45.92 160.26 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.244 -0.91 . . . . 0.0 109.447 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.502 ' HG2' HG23 ' A' ' 69' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 109.56 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.537 ' HD2' ' NE2' ' A' ' 36' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -106.98 120.28 41.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.368 -0.832 . . . . 0.0 110.124 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 1.029 ' HB3' HD11 ' A' ' 57' ' ' ILE . 6.6 m-20 -102.48 117.98 35.88 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.717 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.1 155.25 17.23 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.095 -1.003 . . . . 0.0 110.054 -179.223 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.88 HG11 ' HB ' ' A' ' 57' ' ' ILE . 15.1 m -136.09 158.99 72.68 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.478 -0.764 . . . . 0.0 109.199 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.52 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.3 Cg_endo -76.49 174.08 13.43 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.552 2.168 . . . . 0.0 110.302 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.546 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 35.5 Cg_endo -77.17 -15.97 15.89 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.606 2.204 . . . . 0.0 110.448 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.3 p -97.86 8.47 44.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.442 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.52 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -115.74 106.21 13.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.206 -0.934 . . . . 0.0 109.759 -179.742 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -85.46 -2.58 58.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.168 -0.958 . . . . 0.0 109.245 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 61.4 p -137.96 144.62 41.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.868 . . . . 0.0 109.119 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.029 HD11 ' HB3' ' A' ' 48' ' ' ASP . 8.0 tt -118.58 127.73 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.112 -0.993 . . . . 0.0 109.792 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.968 HG23 ' OG1' ' A' ' 19' ' ' THR . 0.3 OUTLIER -90.31 113.95 25.91 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.411 -0.806 . . . . 0.0 109.458 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.794 HD13 ' CZ ' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -84.86 147.75 26.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.43 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.455 ' HA ' ' HB2' ' A' ' 17' ' ' SER . 0.9 OUTLIER -126.41 154.19 43.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 109.63 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.959 ' O ' HD23 ' A' ' 62' ' ' LEU . 1.1 m-80 61.85 79.57 0.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.362 -0.836 . . . . 0.0 109.595 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.959 HD23 ' O ' ' A' ' 61' ' ' ASN . 6.0 mt -143.33 134.68 26.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -0.879 . . . . 0.0 109.449 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -55.05 130.63 67.78 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.254 -0.904 . . . . 0.0 109.043 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.84 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 36.4 Cg_endo -78.1 128.36 9.02 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.389 2.059 . . . . 0.0 110.692 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.14 58.65 2.42 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 90' ' ' THR . 2.5 m -157.28 143.37 17.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.31 -1.112 . . . . 0.0 109.22 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.535 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 3.2 mt-10 -74.41 130.28 39.36 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.027 -1.046 . . . . 0.0 108.793 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 4.1 m-85 -121.5 101.17 7.45 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.16 -0.962 . . . . 0.0 110.046 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.628 ' CG1' ' CE1' ' A' ' 37' ' ' HIS . 58.9 t -67.98 130.08 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 35' ' ' ARG . 47.0 t -126.0 136.97 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.993 -1.067 . . . . 0.0 109.962 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.522 ' CB ' HG12 ' A' ' 85' ' ' ILE . 92.3 p -111.53 123.86 51.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 110.146 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.011 ' CD1' HG23 ' A' ' 34' ' ' ILE . 11.6 mm -100.65 131.86 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.373 -0.829 . . . . 0.0 109.621 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.954 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.7 mp -126.14 164.12 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -0.858 . . . . 0.0 108.919 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.884 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -128.36 141.88 51.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.284 -0.885 . . . . 0.0 109.595 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.41 134.13 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.343 -0.848 . . . . 0.0 109.347 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.681 ' HB2' HD11 ' A' ' 2' ' ' LEU . 2.9 t-20 -108.93 46.46 0.97 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.522 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 87.03 -80.39 1.74 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.52 -1.97 13.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.179 -1.189 . . . . 0.0 109.6 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 1.3 mp0 -100.62 -165.75 1.24 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 109.27 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.83 ' O ' HD12 ' A' ' 2' ' ' LEU . 23.7 mt-10 -146.58 -168.66 3.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 109.665 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.884 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -159.37 -179.17 1.03 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.396 -0.815 . . . . 0.0 108.983 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.588 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.4 Cg_endo -77.36 141.93 20.72 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.23 1.954 . . . . 0.0 109.943 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.4 Cg_endo -77.71 88.83 1.38 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.524 2.15 . . . . 0.0 111.038 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 1.023 HD22 ' O ' ' A' ' 5' ' ' PRO . 4.6 tp -75.08 104.11 5.53 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.572 HG22 ' N ' ' A' ' 86' ' ' GLY . 2.5 mt -105.0 163.27 4.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.095 -1.003 . . . . 0.0 110.375 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.572 ' N ' HG22 ' A' ' 85' ' ' ILE . . . -159.36 159.24 30.3 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.481 -1.847 . . . . 0.0 108.481 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . 29.5 mt-30 -117.76 131.29 56.61 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.185 -1.185 . . . . 0.0 109.815 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.628 ' OE1' HG21 ' A' ' 70' ' ' VAL . 3.6 pt20 -136.37 -165.59 1.75 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.535 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -154.74 146.57 23.42 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.025 -1.047 . . . . 0.0 109.75 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.91 132.94 41.82 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.543 -0.863 . . . . 0.0 108.91 179.563 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.113 HG22 HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.294 -1.826 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.581 ' HA ' ' O ' ' A' ' 113' ' ' GLU . 30.6 Cg_endo . . . . . 0 C--O 1.215 -0.632 0 N-CA-C 109.375 -1.048 . . . . 0.0 109.375 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 17.9 ttt180 -60.27 177.09 0.29 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.389 0.614 . . . . 0.0 110.387 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.502 ' HB3' ' HA ' ' A' ' 112' ' ' TRP . 0.7 OUTLIER 66.4 24.79 10.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.513 -0.742 . . . . 0.0 109.256 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 1.097 HD21 ' CD1' ' A' ' 162' ' ' LEU . 0.2 OUTLIER -61.61 102.45 0.25 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.349 -0.844 . . . . 0.0 109.531 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 97' ' ' ASP . 3.8 pt-20 -153.78 171.57 18.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.209 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 109' ' ' LEU . 40.2 t -115.1 155.87 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.157 -0.964 . . . . 0.0 109.747 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.961 HD11 HD23 ' A' ' 109' ' ' LEU . 0.8 OUTLIER -127.91 -7.39 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.46 -0.775 . . . . 0.0 109.821 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.767 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -136.47 122.13 19.73 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.527 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.4 p -112.62 75.66 0.93 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.092 -1.005 . . . . 0.0 110.415 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 107' ' ' SER . 0.7 OUTLIER -74.0 159.59 83.73 Favored Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.15 -0.969 . . . . 0.0 108.622 179.225 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.453 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.1 Cg_endo -69.04 -1.85 8.62 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.493 2.129 . . . . 0.0 111.003 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.898 ' C ' HG22 ' A' ' 152' ' ' ILE . 70.7 p -152.33 19.13 0.65 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 108.893 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.97 ' C ' HD23 ' A' ' 108' ' ' LEU . 6.8 p -173.71 147.54 1.39 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.024 -1.071 . . . . 0.0 110.144 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.97 HD23 ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -124.29 154.72 39.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.404 -0.81 . . . . 0.0 109.294 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.961 HD23 HD11 ' A' ' 101' ' ' ILE . 13.0 tp -105.22 107.16 17.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.269 -0.894 . . . . 0.0 108.731 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.713 ' CD1' ' HB3' ' A' ' 147' ' ' ALA . 1.4 pt -85.8 129.48 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.221 -0.924 . . . . 0.0 110.262 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.609 ' HA ' HG22 ' A' ' 146' ' ' THR . 1.3 p -126.32 123.28 37.68 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.582 ' CE3' ' O ' ' A' ' 145' ' ' SER . 19.3 p90 -152.64 -175.73 5.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.947 -1.095 . . . . 0.0 110.464 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 45.2 mm-40 . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.753 ' CZ ' HG21 ' A' ' 165' ' ' VAL . 13.6 p90 . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 121.408 0.623 . . . . 0.0 109.53 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.624 ' N ' ' CD2' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -140.19 137.53 34.42 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.134 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.486 ' CB ' ' HB2' ' A' ' 163' ' ' TYR . 5.8 ttt180 -95.64 101.92 13.67 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.271 -0.893 . . . . 0.0 109.089 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.871 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 19.7 mt -85.35 117.64 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.209 -0.932 . . . . 0.0 109.013 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 43.3 p -93.55 130.11 39.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.413 -0.804 . . . . 0.0 110.488 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.695 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 3.0 m-85 -81.35 122.78 27.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.564 -0.71 . . . . 0.0 109.15 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.602 ' HA3' ' HB ' ' A' ' 159' ' ' THR . . . -102.32 99.18 1.82 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.492 ' HG2' ' CZ ' ' A' ' 158' ' ' TYR . 7.4 mt-10 . . . . . 0 N--CA 1.491 1.596 0 O-C-N 121.16 -1.2 . . . . 0.0 109.474 179.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.558 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 1.9 tt0 . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 4.8 pt-20 -92.25 137.13 32.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 110.762 -178.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.871 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 43.4 p90 -134.79 147.48 49.98 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.691 HG22 ' CE2' ' A' ' 121' ' ' TYR . 3.7 p -74.17 171.07 14.24 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.111 -0.993 . . . . 0.0 111.013 -177.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.611 HG21 HG13 ' A' ' 124' ' ' ILE . 25.1 t -143.19 140.45 17.82 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.423 -0.798 . . . . 0.0 110.102 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.561 ' HD2' HG13 ' A' ' 140' ' ' VAL . 36.4 Cg_endo -79.94 142.34 15.57 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.475 2.117 . . . . 0.0 110.201 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.449 ' HA2' ' OH ' ' A' ' 122' ' ' TYR . . . -84.06 45.76 3.54 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.59 -81.46 0.54 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -1.152 . . . . 0.0 110.096 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -78.98 157.67 28.09 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.545 0.688 . . . . 0.0 110.271 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.582 ' O ' ' CE3' ' A' ' 112' ' ' TRP . 0.1 OUTLIER -95.38 -3.17 47.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.473 -0.767 . . . . 0.0 109.577 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.609 HG22 ' HA ' ' A' ' 111' ' ' SER . 7.1 p -116.63 142.04 47.41 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.713 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -134.51 150.88 50.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.876 -1.14 . . . . 0.0 110.06 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 6.9 t -96.17 146.4 24.71 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.367 -0.833 . . . . 0.0 109.028 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.695 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 19.2 mm -126.07 73.18 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.233 -0.917 . . . . 0.0 109.513 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.536 ' HA ' ' CB ' ' A' ' 107' ' ' SER . 4.9 m-80 -79.22 -165.03 0.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.711 -0.618 . . . . 0.0 109.597 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 25.2 m120 57.93 20.65 6.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.057 -1.027 . . . . 0.0 109.017 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.898 HG22 ' C ' ' A' ' 106' ' ' THR . 3.5 tt -89.69 161.04 2.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.478 -0.764 . . . . 0.0 109.67 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.58 122.89 40.44 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.166 -0.959 . . . . 0.0 109.221 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.488 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 36.3 Cg_endo -77.73 145.3 22.82 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.439 2.093 . . . . 0.0 110.563 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.654 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 81.12 65.69 1.67 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 167.14 130.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -1.208 . . . . 0.0 109.748 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.412 ' CG ' ' N ' ' A' ' 158' ' ' TYR . 2.0 t70 -50.34 165.78 0.09 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.613 ' CE2' HG13 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -144.53 173.07 12.12 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.804 -1.185 . . . . 0.0 110.248 -179.66 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.602 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 1.8 m -147.59 99.34 3.1 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.58 HD11 HD12 ' A' ' 108' ' ' LEU . 88.1 mt -97.39 129.62 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.701 -1.249 . . . . 0.0 109.403 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 1.004 HG23 ' CB ' ' A' ' 179' ' ' SER . 1.7 m -133.8 139.2 46.15 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.099 -1.001 . . . . 0.0 110.428 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 1.097 ' CD1' HD21 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -110.79 145.6 37.86 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.529 -0.732 . . . . 0.0 110.478 -179.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.633 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 37.8 m-85 -131.33 83.73 2.12 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.538 ' HB2' ' HD2' ' A' ' 122' ' ' TYR . . . -63.73 123.25 18.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.128 -0.983 . . . . 0.0 109.726 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.753 HG21 ' CZ ' ' A' ' 121' ' ' TYR . 5.3 t . . . . . 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 109.452 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 164' ' ' ALA . 1.7 p . . . . . 0 N--CA 1.489 1.507 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 174' ' ' SER . 0.9 OUTLIER -44.6 167.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 108.995 179.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.406 ' C ' ' O ' ' A' ' 175' ' ' SER . 0.2 OUTLIER -47.98 133.4 11.8 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.987 -1.071 . . . . 0.0 108.491 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.633 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.8 Cg_endo -76.57 157.23 36.24 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.121 1.881 . . . . 0.0 110.324 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -140.35 137.04 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.317 -0.864 . . . . 0.0 108.829 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 1.004 ' CB ' HG23 ' A' ' 161' ' ' THR . 0.1 OUTLIER -126.73 -178.6 4.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 110.512 -178.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.905 ' CG2' HD12 ' A' ' 98' ' ' LEU . 27.8 pt -158.14 152.3 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -95.72 151.6 19.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.056 -1.028 . . . . 0.0 109.475 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.657 ' CD2' HD13 ' A' ' 108' ' ' LEU . 70.7 t80 -147.11 131.26 17.35 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.271 -0.893 . . . . 0.0 109.4 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.82 119.65 39.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.084 -1.01 . . . . 0.0 109.524 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.488 ' HB ' ' HA ' ' A' ' 154' ' ' PRO . 18.4 p . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.46 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 2' ' ' LEU . 1.1 mp . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.547 ' HB2' ' CB ' ' A' ' 25' ' ' PRO . 1.1 m-20 -94.17 144.06 25.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.338 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.552 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 10.3 m -78.15 145.33 68.88 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.509 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.822 ' O ' HD13 ' A' ' 84' ' ' LEU . 35.7 Cg_endo -78.52 125.77 7.1 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.68 2.253 . . . . 0.0 110.336 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.447 ' CG2' HD13 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -143.35 -164.96 1.97 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.905 . . . . 0.0 109.988 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 8' ' ' PHE . . . 83.13 16.89 68.37 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 107.691 -2.163 . . . . 0.0 107.691 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.415 ' C ' ' O ' ' A' ' 7' ' ' GLY . 2.4 t80 -40.49 140.32 0.67 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.794 -0.827 . . . . 0.0 110.28 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 15.1 t0 -165.26 97.68 0.71 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.627 ' OG ' HG13 ' A' ' 20' ' ' VAL . 5.4 m -84.59 128.44 34.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.159 -0.963 . . . . 0.0 109.651 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.494 ' O ' ' C ' ' A' ' 12' ' ' ASP . 3.5 p -146.87 -164.74 2.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.327 -0.858 . . . . 0.0 109.026 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.513 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.8 OUTLIER 41.61 35.92 0.52 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -178.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.807 HG23 ' CB ' ' A' ' 18' ' ' PHE . 2.3 mt -78.73 144.53 10.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.202 -177.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -123.5 -157.69 0.77 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.379 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.993 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -93.2 -48.65 6.36 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.887 -1.133 . . . . 0.0 109.167 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 15.2 p30 -99.63 -9.12 23.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.043 -1.036 . . . . 0.0 109.155 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.597 ' O ' HG23 ' A' ' 14' ' ' THR . 27.4 p -142.62 159.53 42.06 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.884 ' CE1' HG22 ' A' ' 20' ' ' VAL . 9.9 p90 -166.13 142.16 4.92 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.911 -1.118 . . . . 0.0 109.435 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.513 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 17.1 m -81.33 153.76 26.86 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.897 -1.127 . . . . 0.0 110.773 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.884 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -132.18 116.98 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.52 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.547 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 3.1 m-70 -103.07 161.95 13.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.053 -1.03 . . . . 0.0 110.34 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.678 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 23.4 p90 -171.42 137.47 1.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.484 -0.76 . . . . 0.0 109.083 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.35 163.14 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.073 -1.017 . . . . 0.0 109.652 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.874 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -98.62 173.45 3.86 Favored Pre-proline 0 C--N 1.299 -1.63 0 O-C-N 121.713 -0.617 . . . . 0.0 109.733 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.874 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.8 Cg_endo -78.42 -162.18 0.17 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.644 2.229 . . . . 0.0 110.307 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.515 ' HB2' ' NH2' ' A' ' 26' ' ' ARG . 0.5 OUTLIER -119.55 18.53 12.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.957 . . . . 0.0 109.426 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.89 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -121.83 172.7 4.76 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.886 . . . . 0.0 109.489 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.89 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.7 Cg_endo -78.0 88.25 1.45 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.653 2.236 . . . . 0.0 110.421 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.772 HD13 ' HE1' ' A' ' 32' ' ' TYR . 9.1 pt -80.12 -176.89 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 109.498 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.453 ' OG1' ' N ' ' A' ' 77' ' ' GLY . 59.6 p -131.72 -2.14 3.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 109.929 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.499 ' O ' ' CD1' ' A' ' 32' ' ' TYR . . . 162.51 -178.56 38.24 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.772 ' HE1' HD13 ' A' ' 29' ' ' ILE . 1.7 m-85 -149.53 131.66 15.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -1.168 . . . . 0.0 109.732 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.998 HG23 ' HD2' ' A' ' 49' ' ' ARG . 0.9 OUTLIER -99.38 130.4 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -0.892 . . . . 0.0 108.897 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.991 HD13 ' C ' ' A' ' 33' ' ' ILE . 1.4 mm -117.57 119.34 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.013 -1.054 . . . . 0.0 109.985 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.464 ' HB2' ' OG ' ' A' ' 71' ' ' SER . 34.8 mtp180 -119.35 138.91 52.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.19 -0.944 . . . . 0.0 108.508 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.753 ' CD2' HD22 ' A' ' 59' ' ' LEU . 8.4 p80 -129.88 160.26 34.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.905 -1.122 . . . . 0.0 110.688 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.519 ' O ' ' CG ' ' A' ' 37' ' ' HIS . 28.6 p-80 -171.86 121.9 0.49 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.617 -0.677 . . . . 0.0 109.332 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.132 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . -50.58 -178.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.177 -0.952 . . . . 0.0 109.554 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 . . . . . 0 N--CA 1.488 1.428 0 O-C-N 121.227 -0.92 . . . . 0.0 109.403 179.902 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.586 ' CG ' ' NE2' ' A' ' 36' ' ' HIS . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -109.94 103.52 12.3 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.341 -0.849 . . . . 0.0 109.881 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 1.05 ' HB3' HD11 ' A' ' 57' ' ' ILE . 70.8 m-20 -93.93 115.93 28.34 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.998 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -97.27 156.72 16.31 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.109 -0.995 . . . . 0.0 109.87 -179.47 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.671 HG11 ' HB ' ' A' ' 57' ' ' ILE . 15.8 m -141.9 160.54 55.38 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 109.113 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.549 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.4 Cg_endo -77.11 174.18 13.23 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.466 2.111 . . . . 0.0 110.03 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 35.3 Cg_endo -77.54 -15.42 15.56 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.443 2.096 . . . . 0.0 110.516 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.9 t -99.23 18.45 17.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.576 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.549 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -125.86 119.08 26.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 109.799 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 22' ' ' TRP . 0.8 OUTLIER -103.48 -0.39 29.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.321 -0.862 . . . . 0.0 109.283 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 21' ' ' HIS . 30.8 p -131.08 129.94 42.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 109.462 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.05 HD11 ' HB3' ' A' ' 48' ' ' ASP . 4.4 tt -125.05 140.12 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.254 -0.904 . . . . 0.0 109.361 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 8.8 m -102.75 136.68 42.13 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.264 -0.897 . . . . 0.0 109.302 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.753 HD22 ' CD2' ' A' ' 36' ' ' HIS . 1.1 mp -115.16 161.0 19.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.637 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.44 HG22 ' HB3' ' A' ' 17' ' ' SER . 23.5 p -139.12 -170.32 2.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.402 -0.811 . . . . 0.0 109.344 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.494 ' O ' HD23 ' A' ' 62' ' ' LEU . 50.8 m-20 51.93 54.62 10.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.195 -0.941 . . . . 0.0 109.51 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.636 ' CD2' ' CE1' ' A' ' 36' ' ' HIS . 6.8 mt -129.27 169.93 14.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.473 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -84.64 142.83 40.13 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.263 -0.898 . . . . 0.0 109.3 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.993 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 36.9 Cg_endo -78.78 122.29 5.37 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.556 2.171 . . . . 0.0 110.395 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 75.12 62.49 2.75 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.113 -1.995 . . . . 0.0 108.113 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.605 ' CG2' ' CE2' ' A' ' 68' ' ' TYR . 1.3 m -149.17 144.76 26.8 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.309 -1.112 . . . . 0.0 110.899 -178.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -81.38 105.63 12.71 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.468 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 1.132 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 13.5 m-85 -103.91 150.52 24.11 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.27 -0.894 . . . . 0.0 109.979 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.584 HG13 ' HB3' ' A' ' 87' ' ' GLN . 4.1 t -109.75 154.98 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.321 -0.862 . . . . 0.0 109.193 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.598 HG22 ' CB ' ' A' ' 36' ' ' HIS . 40.9 t -139.51 129.02 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.126 -0.984 . . . . 0.0 109.709 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 79.2 p -103.18 101.18 11.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.862 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.965 HD13 HG23 ' A' ' 34' ' ' ILE . 10.9 mm -74.98 153.12 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.094 -1.004 . . . . 0.0 109.702 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.572 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 15.5 mt -143.3 158.68 17.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.383 -0.823 . . . . 0.0 108.892 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.647 ' HB2' ' CZ ' ' A' ' 32' ' ' TYR . . . -131.21 153.02 49.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.437 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.9 m -141.12 135.61 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 109.389 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 79' ' ' GLU . 1.1 t30 -110.72 43.66 1.39 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 109.513 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.453 ' N ' ' OG1' ' A' ' 30' ' ' THR . . . 77.25 -57.1 3.67 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -126.19 -2.96 6.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -1.147 . . . . 0.0 109.737 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.512 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 0.5 OUTLIER -110.07 177.02 4.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.571 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -147.78 95.43 2.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.32 -0.863 . . . . 0.0 109.434 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.587 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.7 OUTLIER -59.64 -179.05 0.15 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.891 . . . . 0.0 109.084 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.587 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.5 Cg_endo -77.71 146.28 23.72 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.277 1.985 . . . . 0.0 110.365 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 36.1 Cg_endo -77.93 100.99 1.43 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.675 2.25 . . . . 0.0 110.896 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.822 HD13 ' O ' ' A' ' 5' ' ' PRO . 4.1 tp -75.0 103.83 5.34 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 1.9 mt -93.98 143.52 11.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 120.887 -1.133 . . . . 0.0 110.636 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -148.11 -163.22 10.61 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.584 ' HB3' HG13 ' A' ' 69' ' ' VAL . 8.2 pt20 -166.78 164.96 16.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.997 -1.296 . . . . 0.0 110.038 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.564 ' HG3' ' CE1' ' A' ' 18' ' ' PHE . 1.9 pm0 -159.73 151.43 20.2 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.556 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -90.94 136.67 32.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.153 -0.967 . . . . 0.0 110.431 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.474 ' O ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.45 134.27 42.35 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.144 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.751 HG23 HG22 ' A' ' 13' ' ' ILE . 9.4 t . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.574 0.702 . . . . 0.0 110.599 -179.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.613 ' HG2' HD11 ' A' ' 162' ' ' LEU . 36.5 Cg_endo . . . . . 0 C--O 1.216 -0.614 0 N-CA-C 109.496 -1.002 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -76.07 177.19 7.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.318 -0.864 . . . . 0.0 109.677 -179.366 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER 76.28 19.57 1.7 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -0.846 . . . . 0.0 109.64 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.779 HD13 HG23 ' A' ' 180' ' ' ILE . 0.5 OUTLIER -62.21 99.95 0.15 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.121 -0.987 . . . . 0.0 109.029 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 97' ' ' ASP . 0.1 OUTLIER -144.64 163.74 33.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 109.715 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.418 HG21 ' HB3' ' A' ' 108' ' ' LEU . 9.6 p -104.05 148.75 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.548 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.735 HD11 HD22 ' A' ' 109' ' ' LEU . 25.1 pt -125.44 -5.46 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -0.891 . . . . 0.0 109.589 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 1.042 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -150.49 108.46 3.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.371 -0.831 . . . . 0.0 108.783 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.521 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.7 t -101.7 93.95 5.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 110.229 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -80.01 164.28 53.58 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.339 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.489 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 30.1 Cg_endo -69.18 -2.95 10.66 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.425 2.083 . . . . 0.0 110.748 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.835 ' C ' HG22 ' A' ' 152' ' ' ILE . 7.5 p -152.48 19.24 0.63 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.988 ' O ' HD23 ' A' ' 108' ' ' LEU . 54.5 p -172.89 160.4 4.32 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.96 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.988 HD23 ' O ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -135.52 155.33 50.67 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.354 -0.841 . . . . 0.0 108.947 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 1.042 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.4 OUTLIER -105.04 95.41 5.83 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.239 -0.913 . . . . 0.0 109.346 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.779 HD11 ' HB3' ' A' ' 147' ' ' ALA . 15.7 pt -74.88 167.82 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.927 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 146' ' ' THR . 3.7 m -165.34 100.41 0.72 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.634 -0.666 . . . . 0.0 109.365 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.58 ' CD1' ' HB2' ' A' ' 95' ' ' PRO . 41.3 p90 -111.4 141.77 44.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.207 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 96' ' ' ARG . 11.3 mm-40 . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.168 -0.957 . . . . 0.0 109.352 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.89 ' CZ ' HG21 ' A' ' 165' ' ' VAL . 2.7 p90 . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.643 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 1.6 m-85 -134.8 132.91 39.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.924 . . . . 0.0 109.282 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.485 ' HG2' ' N ' ' A' ' 124' ' ' ILE . 8.7 ttm180 -85.28 159.33 20.08 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.909 -1.12 . . . . 0.0 108.459 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.811 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 13.9 mt -148.85 119.75 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.033 -1.042 . . . . 0.0 109.779 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 64.9 p -91.39 128.99 37.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.595 -0.691 . . . . 0.0 109.94 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.821 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 2.4 m-85 -74.53 138.59 43.22 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.592 ' HA3' ' HB ' ' A' ' 159' ' ' THR . . . -105.91 89.23 0.6 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.583 ' HG2' ' CE2' ' A' ' 158' ' ' TYR . 6.8 mt-10 . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.218 -1.166 . . . . 0.0 109.735 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.574 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 1.1 mt-30 . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 108.866 -0.791 . . . . 0.0 108.866 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 0.9 OUTLIER -74.7 155.36 37.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.242 -0.911 . . . . 0.0 110.751 -178.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.811 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 3.2 p90 -161.4 139.19 9.16 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.845 HG22 ' CE1' ' A' ' 121' ' ' TYR . 2.6 p -74.81 149.74 39.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.068 -1.02 . . . . 0.0 111.145 -178.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.778 HG13 ' HD2' ' A' ' 141' ' ' PRO . 55.7 t -111.71 145.46 32.7 Favored Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.778 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.8 Cg_endo -77.54 132.23 12.05 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.395 2.063 . . . . 0.0 109.882 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -85.87 37.63 3.07 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.407 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 2.7 m -105.27 -1.46 25.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.096 -1.238 . . . . 0.0 109.595 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.407 ' CG ' ' O ' ' A' ' 143' ' ' SER . 12.3 mttp -163.01 172.29 15.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.917 . . . . 0.0 109.57 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.575 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 5.0 p -95.3 -23.82 17.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.221 -0.925 . . . . 0.0 109.899 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 111' ' ' SER . 3.3 p -102.23 163.77 12.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.079 -1.013 . . . . 0.0 109.483 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.779 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -153.7 173.34 15.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.95 . . . . 0.0 109.682 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.1 t -104.45 152.39 22.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 109.097 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.821 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 34.0 mm -131.29 73.52 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.137 -0.977 . . . . 0.0 109.49 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.536 ' HA ' ' CB ' ' A' ' 107' ' ' SER . 3.7 m120 -80.7 -146.62 0.05 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.551 -0.718 . . . . 0.0 109.731 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 150' ' ' ASN . 4.9 m120 43.38 26.88 0.11 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 109.523 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.835 HG22 ' C ' ' A' ' 106' ' ' THR . 4.5 tt -93.37 158.28 2.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.281 -0.887 . . . . 0.0 109.549 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 153' ' ' LYS . 26.2 mmtt -114.17 120.51 38.37 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.92 . . . . 0.0 109.234 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.525 ' HA ' ' OG1' ' A' ' 184' ' ' THR . 35.4 Cg_endo -78.04 146.31 22.85 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.413 2.075 . . . . 0.0 110.566 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.705 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 93.7 60.0 1.17 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 162.3 131.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.411 -1.052 . . . . 0.0 109.41 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.44 ' C ' ' O ' ' A' ' 156' ' ' ALA . 24.6 t0 -46.83 166.52 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.594 ' CD1' ' CG2' ' A' ' 184' ' ' THR . 0.2 OUTLIER -145.04 -178.2 5.93 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.51 -1.369 . . . . 0.0 110.048 -179.464 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.592 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 2.5 m -157.98 165.23 35.66 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.546 HD11 HD12 ' A' ' 108' ' ' LEU . 22.5 mt -155.27 132.57 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.749 -1.22 . . . . 0.0 110.11 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 1.021 HG23 ' CB ' ' A' ' 179' ' ' SER . 1.6 m -136.91 172.09 13.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.855 . . . . 0.0 108.844 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.613 HD11 ' HG2' ' A' ' 95' ' ' PRO . 0.6 OUTLIER -163.42 151.55 13.48 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.679 -1.208 . . . . 0.0 111.597 -179.481 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.636 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 4.2 m-85 -125.11 120.79 32.41 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.814 ' HB3' ' OG ' ' A' ' 175' ' ' SER . . . -81.57 99.75 9.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.847 -1.158 . . . . 0.0 109.532 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.89 HG21 ' CZ ' ' A' ' 121' ' ' TYR . 18.7 t . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.263 -0.898 . . . . 0.0 109.369 179.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.509 ' HB2' ' HB3' ' A' ' 163' ' ' TYR . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.281 0.562 . . . . 0.0 109.507 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.814 ' OG ' ' HB3' ' A' ' 164' ' ' ALA . 0.6 OUTLIER -46.96 166.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.611 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 175' ' ' SER . 0.0 OUTLIER -41.05 127.88 2.03 Favored Pre-proline 0 C--N 1.304 -1.383 0 O-C-N 121.595 -0.691 . . . . 0.0 109.878 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.636 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.2 Cg_endo -77.43 131.4 11.56 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.022 1.815 . . . . 0.0 110.492 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.34 137.48 47.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 1.021 ' CB ' HG23 ' A' ' 161' ' ' THR . 1.0 OUTLIER -129.53 165.67 21.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 110.811 -178.406 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.779 HG23 HD13 ' A' ' 98' ' ' LEU . 5.5 pt -144.2 -170.53 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -119.12 169.64 9.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.042 -1.036 . . . . 0.0 109.402 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.922 ' OH ' HD22 ' A' ' 108' ' ' LEU . 56.3 t80 -164.63 166.45 20.13 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.163 -0.961 . . . . 0.0 109.428 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -147.56 129.14 15.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.902 . . . . 0.0 109.455 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.594 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.48 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.625 HD11 ' CB ' ' A' ' 81' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.384 -0.598 . . . . 0.0 109.384 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.565 ' O ' HD12 ' A' ' 2' ' ' LEU . 1.1 m-20 -113.66 146.2 40.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.423 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.484 ' OG ' ' HG2' ' A' ' 82' ' ' PRO . 10.8 p -95.4 155.91 38.22 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 0.0 109.595 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.782 ' O ' HD22 ' A' ' 84' ' ' LEU . 36.3 Cg_endo -79.05 110.48 2.76 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.725 2.283 . . . . 0.0 110.128 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 8' ' ' PHE . 1.8 p -97.94 -113.21 0.15 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.131 -0.981 . . . . 0.0 109.472 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.457 ' HA3' ' HB ' ' A' ' 23' ' ' VAL . . . 44.14 27.08 1.02 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.426 ' N ' ' O ' ' A' ' 6' ' ' THR . 8.7 t80 -58.17 95.07 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.582 -0.952 . . . . 0.0 109.861 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.525 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 38.0 t70 -126.82 95.77 4.43 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.344 -0.848 . . . . 0.0 109.055 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.619 ' OG ' HG13 ' A' ' 20' ' ' VAL . 32.8 m -84.66 135.3 34.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.297 -0.877 . . . . 0.0 109.38 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.456 ' O ' ' C ' ' A' ' 12' ' ' ASP . 5.5 p -156.42 -159.78 0.92 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.407 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.535 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 1.2 m-20 45.96 40.7 7.18 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.61 ' HA ' ' HA ' ' A' ' 18' ' ' PHE . 1.5 mt -83.45 129.32 37.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.604 -177.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.594 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -115.91 174.1 6.21 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 178.194 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -67.63 -65.1 0.73 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.764 -1.21 . . . . 0.0 109.924 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.467 ' O ' ' OG ' ' A' ' 17' ' ' SER . 6.5 m-80 -86.66 17.15 4.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.012 -1.055 . . . . 0.0 110.017 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.749 ' HA ' HD12 ' A' ' 62' ' ' LEU . 21.8 m -168.46 156.37 8.18 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.933 ' CE1' HG22 ' A' ' 20' ' ' VAL . 4.3 p90 -165.89 143.05 5.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.143 -0.973 . . . . 0.0 109.281 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.535 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 8.5 m -89.55 156.17 18.79 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.849 -1.157 . . . . 0.0 111.293 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.933 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.3 t -132.58 134.34 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.536 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 2.1 m-70 -121.25 166.36 14.12 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.924 -1.11 . . . . 0.0 110.328 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.816 ' CH2' HG21 ' A' ' 50' ' ' VAL . 6.2 p90 -174.12 137.78 0.56 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.477 -0.765 . . . . 0.0 109.189 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -78.75 162.43 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.053 -1.029 . . . . 0.0 109.773 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.716 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -86.86 168.71 17.1 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.73 -0.606 . . . . 0.0 109.587 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.716 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 36.3 Cg_endo -79.45 -172.54 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.647 2.232 . . . . 0.0 110.459 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -113.87 16.09 18.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -0.871 . . . . 0.0 109.3 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.99 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -124.55 177.9 1.63 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.341 -0.849 . . . . 0.0 109.26 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.99 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 34.6 Cg_endo -77.84 135.84 14.54 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.476 2.117 . . . . 0.0 110.256 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.501 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 45.9 pt -152.04 -179.13 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.915 . . . . 0.0 109.546 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.8 p -114.32 -20.89 10.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 109.476 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.16 172.1 28.04 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.618 ' CE2' ' HA ' ' A' ' 52' ' ' PRO . 0.5 OUTLIER -112.17 150.25 31.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -1.154 . . . . 0.0 109.47 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.955 HG23 ' HD2' ' A' ' 49' ' ' ARG . 1.4 mp -95.08 137.23 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.158 -0.964 . . . . 0.0 108.858 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.847 HD13 ' C ' ' A' ' 33' ' ' ILE . 3.4 mm -116.94 95.05 3.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.4 -0.812 . . . . 0.0 109.937 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.507 ' HG3' ' HA ' ' A' ' 47' ' ' GLN . 54.7 ttp180 -106.28 117.01 32.93 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 108.522 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.535 ' NE2' ' HG2' ' A' ' 46' ' ' ARG . 3.1 p-80 -106.69 147.35 29.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.966 -1.084 . . . . 0.0 110.273 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.521 ' NE2' ' HB ' ' A' ' 69' ' ' VAL . 41.3 p-80 -162.05 124.43 2.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.45 -0.781 . . . . 0.0 109.577 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -56.58 -161.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.263 -0.898 . . . . 0.0 109.624 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.419 ' HG3' ' HB2' ' A' ' 67' ' ' GLU . 4.1 mm-40 . . . . . 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.769 -179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.535 ' HG2' ' NE2' ' A' ' 36' ' ' HIS . 12.9 ptm180 . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 121.362 0.601 . . . . 0.0 109.531 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.507 ' HA ' ' HG3' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -105.89 114.17 28.16 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.341 -0.849 . . . . 0.0 109.48 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.495 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 19.5 m-20 -107.42 168.81 8.98 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.955 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -136.4 164.07 28.99 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.509 -0.744 . . . . 0.0 109.587 -179.524 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.816 HG21 ' CH2' ' A' ' 22' ' ' TRP . 33.5 m -149.56 158.86 37.39 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.421 -0.799 . . . . 0.0 109.295 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 33.9 Cg_endo -75.72 174.25 13.13 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.529 2.153 . . . . 0.0 110.373 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.618 ' HA ' ' CE2' ' A' ' 32' ' ' TYR . 34.3 Cg_endo -76.63 -22.63 11.9 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.574 2.182 . . . . 0.0 110.68 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.95 -8.77 53.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.135 -0.978 . . . . 0.0 109.505 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.533 ' HD3' ' N ' ' A' ' 54' ' ' ARG . 1.6 mpt_? -94.78 112.13 23.88 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.291 -0.881 . . . . 0.0 109.593 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 7.9 p-10 -107.41 -2.29 20.68 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.448 -0.782 . . . . 0.0 109.725 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 27.0 p -136.17 129.83 32.3 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.111 -0.993 . . . . 0.0 109.815 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.608 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 1.9 tt -129.44 120.28 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -0.871 . . . . 0.0 109.045 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 0.3 OUTLIER -88.09 131.43 34.69 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.298 -0.876 . . . . 0.0 109.615 -179.601 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.817 ' HB3' HD11 ' A' ' 62' ' ' LEU . 1.3 mt -104.56 142.63 34.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 109.38 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.469 ' HA ' ' OG ' ' A' ' 17' ' ' SER . 6.7 p -130.02 178.12 6.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.949 . . . . 0.0 109.537 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.9 m120 54.78 40.95 32.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 109.497 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.817 HD11 ' HB3' ' A' ' 59' ' ' LEU . 4.6 mt -111.94 145.12 40.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.301 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.463 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 2.6 m120 -54.63 130.6 64.17 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.113 -0.992 . . . . 0.0 108.681 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.1 Cg_endo -77.4 125.36 7.66 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.217 1.944 . . . . 0.0 110.642 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 80.46 61.73 2.16 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 90' ' ' THR . 3.5 m -152.89 155.85 37.84 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.349 -1.089 . . . . 0.0 110.385 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 2.0 mp0 -85.43 116.95 24.05 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.552 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 9.8 m-85 -112.72 106.88 15.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.121 -0.987 . . . . 0.0 109.898 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.521 ' HB ' ' NE2' ' A' ' 37' ' ' HIS . 3.4 t -73.93 133.03 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.923 . . . . 0.0 108.839 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 19.4 t -122.36 117.72 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.096 -1.002 . . . . 0.0 109.837 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.543 ' CB ' HG12 ' A' ' 85' ' ' ILE . 1.8 p -92.84 133.37 36.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.0 110.282 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.501 ' HB ' HD23 ' A' ' 84' ' ' LEU . 21.4 mm -120.74 79.39 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.808 HD13 ' HA ' ' A' ' 83' ' ' PRO . 23.4 mm -76.75 163.87 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.943 . . . . 0.0 109.604 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.012 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -131.71 117.22 18.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.54 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -107.65 173.98 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.289 -0.882 . . . . 0.0 109.283 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.497 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 18.6 t30 -153.33 49.35 0.7 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 109.446 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.69 -80.72 1.73 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.433 ' NH2' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -119.74 -1.95 10.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -1.15 . . . . 0.0 109.59 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 1.2 mp0 -90.9 -173.44 3.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.371 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 16.8 mt-10 -156.65 93.56 1.39 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.19 -0.943 . . . . 0.0 109.584 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 1.012 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -59.48 178.85 0.22 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.014 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.554 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.4 Cg_endo -76.8 158.16 35.15 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.289 1.992 . . . . 0.0 110.167 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.808 ' HA ' HD13 ' A' ' 73' ' ' ILE . 34.7 Cg_endo -77.15 145.25 24.29 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.621 2.214 . . . . 0.0 111.103 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.782 HD22 ' O ' ' A' ' 5' ' ' PRO . 25.5 tp -136.21 85.97 2.19 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.543 HG12 ' CB ' ' A' ' 71' ' ' SER . 2.3 mt -99.93 139.85 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.185 -0.947 . . . . 0.0 109.789 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -128.08 -171.13 12.95 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -148.59 125.04 10.97 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.14 -1.211 . . . . 0.0 109.691 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.563 ' HG3' ' CB ' ' A' ' 10' ' ' SER . 1.1 tm0? -135.81 114.61 12.02 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.321 -0.862 . . . . 0.0 109.006 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -74.9 133.53 41.78 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.295 -0.878 . . . . 0.0 110.02 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.15 138.12 43.63 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.336 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.603 ' CG2' HG22 ' A' ' 13' ' ' ILE . 1.4 t . . . . . 0 C--N 1.3 -1.571 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.432 ' CB ' ' O ' ' A' ' 113' ' ' GLU . 34.3 Cg_endo . . . . . 0 C--O 1.215 -0.645 0 N-CA-C 109.346 -1.059 . . . . 0.0 109.346 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 1.5 ptm85 -168.44 171.91 8.7 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.072 -1.018 . . . . 0.0 109.575 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 2.0 t70 79.47 17.86 0.8 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 0.0 109.661 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.818 HD12 ' CG2' ' A' ' 180' ' ' ILE . 0.8 OUTLIER -54.33 87.22 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.225 -0.922 . . . . 0.0 109.486 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 97' ' ' ASP . 0.6 OUTLIER -138.89 169.49 17.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.107 -0.996 . . . . 0.0 109.796 -179.748 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 7.0 p -102.84 144.01 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -0.878 . . . . 0.0 109.81 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.551 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 6.8 pt -126.1 -4.49 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.367 -0.833 . . . . 0.0 109.266 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.874 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -151.74 88.87 1.43 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.541 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 6.0 p -84.09 93.52 8.14 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.595 -0.69 . . . . 0.0 110.27 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.46 ' OG1' ' OG ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -84.42 161.38 54.41 Favored Pre-proline 0 C--N 1.306 -1.297 0 O-C-N 121.127 -0.983 . . . . 0.0 108.949 179.156 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.477 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.6 Cg_endo -69.65 -3.04 11.14 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.44 2.093 . . . . 0.0 110.56 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.771 ' C ' HG22 ' A' ' 152' ' ' ILE . 37.8 p -151.33 19.1 0.74 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.48 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 1.1 p -170.85 176.22 4.21 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.719 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.875 HD12 ' N ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -154.11 155.91 36.27 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.406 -0.809 . . . . 0.0 109.143 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.874 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.6 OUTLIER -102.33 123.73 46.65 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.248 -0.908 . . . . 0.0 108.572 179.122 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.701 HD13 ' CD1' ' A' ' 149' ' ' ILE . 0.0 OUTLIER -103.21 135.41 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.122 -0.987 . . . . 0.0 109.92 -179.33 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 97' ' ' ASP . 0.4 OUTLIER -131.0 128.57 40.64 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.505 -0.747 . . . . 0.0 108.997 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.578 ' CD2' ' O ' ' A' ' 145' ' ' SER . 28.2 p90 -151.55 145.36 25.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.403 -0.81 . . . . 0.0 109.325 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.474 ' HB2' ' HG2' ' A' ' 96' ' ' ARG . 29.2 mm-40 . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 0.0 109.408 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.998 ' CE1' HG22 ' A' ' 139' ' ' THR . 3.0 p90 . . . . . 0 N--CA 1.489 1.479 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 4.0 m-85 -115.18 145.98 41.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.035 -1.041 . . . . 0.0 109.737 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.6 ' HG2' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -108.39 95.8 5.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.459 -0.776 . . . . 0.0 109.197 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.882 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 45.1 mt -84.36 145.12 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.315 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 77.0 p -131.54 144.53 51.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.945 . . . . 0.0 110.451 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 1.22 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 2.8 m-30 -88.06 132.19 34.38 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.589 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.68 111.35 3.64 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.423 ' HG2' ' CZ ' ' A' ' 158' ' ' TYR . 14.1 mt-10 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.263 -1.139 . . . . 0.0 109.45 179.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.601 ' HB3' ' CG ' ' A' ' 126' ' ' TYR . 2.8 tt0 . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 18.7 tt0 -102.34 118.48 36.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.858 . . . . 0.0 111.076 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.882 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 35.9 p90 -121.92 142.49 50.23 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.998 HG22 ' CE1' ' A' ' 121' ' ' TYR . 1.5 p -74.15 175.06 7.86 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.966 -1.084 . . . . 0.0 110.834 -178.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.694 HG13 ' HD2' ' A' ' 141' ' ' PRO . 53.7 t -144.35 142.73 20.07 Favored Pre-proline 0 C--N 1.304 -1.392 0 O-C-N 121.553 -0.717 . . . . 0.0 109.321 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.694 ' HD2' HG13 ' A' ' 140' ' ' VAL . 35.2 Cg_endo -77.34 148.73 27.06 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.454 2.103 . . . . 0.0 110.331 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.06 17.88 39.31 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.4 p -105.25 27.81 7.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -1.151 . . . . 0.0 109.613 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.99 139.01 4.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 0.0 109.585 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.578 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 1.3 p -92.48 -15.56 26.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 109.404 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.5 p -123.12 132.39 54.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.292 -0.88 . . . . 0.0 109.185 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.478 ' HB2' ' HH2' ' A' ' 112' ' ' TRP . . . -120.91 -165.43 1.21 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.23 -0.918 . . . . 0.0 109.239 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.635 HG22 ' N ' ' A' ' 149' ' ' ILE . 23.8 m -145.13 166.08 26.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.151 -0.968 . . . . 0.0 109.646 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 1.22 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 1.2 mt -137.12 121.76 24.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.3 -0.875 . . . . 0.0 109.334 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.478 ' HA ' ' HB3' ' A' ' 107' ' ' SER . 6.8 m-80 -123.2 177.27 5.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.4 -0.812 . . . . 0.0 109.514 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 2.7 m-20 65.54 31.43 10.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 109.161 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.771 HG22 ' C ' ' A' ' 106' ' ' THR . 16.2 tt -89.86 166.9 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.397 -0.814 . . . . 0.0 109.714 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -107.14 112.17 63.14 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 109.445 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.525 ' HA ' ' OG1' ' A' ' 184' ' ' THR . 34.7 Cg_endo -77.26 167.12 25.24 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.454 2.103 . . . . 0.0 110.6 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.69 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 76.73 57.23 3.88 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 163.55 134.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -1.128 . . . . 0.0 109.516 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.468 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 0.6 OUTLIER -51.49 164.57 0.2 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.093 -1.004 . . . . 0.0 108.443 179.436 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.589 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.4 OUTLIER -142.0 177.06 8.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.8 -1.187 . . . . 0.0 110.381 -179.528 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.54 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 2.2 m -147.73 109.66 4.48 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.404 HG23 HD12 ' A' ' 160' ' ' ILE . 21.8 mm -97.59 134.87 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.789 -1.194 . . . . 0.0 109.994 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.614 HG23 ' HB3' ' A' ' 179' ' ' SER . 68.8 m -145.11 147.65 32.76 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.283 -0.886 . . . . 0.0 109.717 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.615 HD23 ' H ' ' A' ' 162' ' ' LEU . 2.6 pt? -140.26 150.61 44.29 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.177 -0.952 . . . . 0.0 110.112 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.615 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 4.1 m-85 -115.47 -176.15 2.86 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -147.02 104.32 3.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.862 . . . . 0.0 109.153 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.935 HG21 ' CE2' ' A' ' 121' ' ' TYR . 63.8 t . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 109.909 -179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 16.7 p . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 121.326 0.584 . . . . 0.0 109.698 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 51.9 p -53.91 -176.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.322 -0.861 . . . . 0.0 109.303 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.36 140.92 96.93 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.139 -0.975 . . . . 0.0 108.809 179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.615 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 35.0 Cg_endo -78.18 136.47 14.48 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.335 2.023 . . . . 0.0 111.145 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.472 ' O ' HD23 ' A' ' 162' ' ' LEU . 2.1 t -108.12 138.14 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.614 ' HB3' HG23 ' A' ' 161' ' ' THR . 80.7 p -133.91 173.65 11.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.065 -1.022 . . . . 0.0 110.75 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.818 ' CG2' HD12 ' A' ' 98' ' ' LEU . 38.2 pt -154.53 169.08 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -98.49 178.29 5.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.042 -1.036 . . . . 0.0 109.686 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.83 ' CZ ' HD23 ' A' ' 108' ' ' LEU . 25.0 t80 -163.33 172.21 14.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -0.859 . . . . 0.0 109.605 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 157' ' ' ASP . 6.6 tttt -148.85 109.75 4.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 109.264 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.525 ' OG1' ' HA ' ' A' ' 154' ' ' PRO . 1.4 p . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.482 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.441 HD21 ' HG2' ' A' ' 79' ' ' GLU . 3.2 mt . . . . . 0 N--CA 1.489 1.513 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 1.6 m-20 -80.11 135.9 36.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.908 . . . . 0.0 109.363 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.87 111.42 55.94 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 109.964 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.763 ' O ' HD22 ' A' ' 84' ' ' LEU . 35.0 Cg_endo -77.05 112.26 3.38 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.471 2.114 . . . . 0.0 109.629 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 22' ' ' TRP . 1.7 p -110.31 -110.22 0.33 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.187 -0.945 . . . . 0.0 109.856 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 9' ' ' ASP . . . 46.5 25.23 1.99 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -46.24 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.426 -1.043 . . . . 0.0 109.855 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 7' ' ' GLY . 7.3 t0 -126.92 101.45 6.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.358 -0.839 . . . . 0.0 108.795 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.972 ' OG ' HG13 ' A' ' 20' ' ' VAL . 38.2 m -87.25 143.58 27.21 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.166 -0.959 . . . . 0.0 110.217 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.488 ' O ' ' HB ' ' A' ' 19' ' ' THR . 49.1 p -144.35 -161.34 1.26 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.512 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 1.4 m-20 42.73 35.95 0.77 Allowed 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -178.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.707 HG22 HG23 ' A' ' 91' ' ' VAL . 1.3 mt -77.21 156.48 5.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 122.582 1.182 . . . . 0.0 112.638 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.765 ' O ' HG22 ' A' ' 90' ' ' THR . 0.0 OUTLIER -150.57 161.74 41.97 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 177.226 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.603 ' HB1' ' HA ' ' A' ' 64' ' ' PRO . . . -73.98 -36.21 64.54 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.324 -1.485 . . . . 0.0 109.704 -178.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.6 OUTLIER -98.59 22.11 10.35 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.048 -1.032 . . . . 0.0 108.809 179.453 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.587 ' HA ' HD12 ' A' ' 62' ' ' LEU . 13.0 p 167.01 154.96 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.935 ' CE1' HG22 ' A' ' 20' ' ' VAL . 8.9 p90 -166.95 139.49 3.51 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.653 -1.279 . . . . 0.0 109.681 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 28.8 m -79.47 152.72 30.09 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.94 -1.1 . . . . 0.0 110.743 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.972 HG13 ' OG ' ' A' ' 10' ' ' SER . 2.5 t -126.04 135.07 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.569 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 2.6 m-70 -126.98 170.89 11.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.91 -1.119 . . . . 0.0 110.339 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.611 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 27.8 p90 -179.85 149.18 0.34 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -76.89 147.78 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 120.966 -1.084 . . . . 0.0 109.929 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.531 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -76.47 161.63 73.87 Favored Pre-proline 0 C--N 1.298 -1.66 0 O-C-N 121.835 -0.541 . . . . 0.0 109.57 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.557 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 35.9 Cg_endo -78.09 153.41 28.49 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.582 2.188 . . . . 0.0 110.478 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.459 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 17.0 mtt180 -75.35 -0.92 21.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 109.569 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.641 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -102.17 164.75 15.15 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 109.579 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.641 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.9 Cg_endo -78.38 105.66 2.01 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.729 2.286 . . . . 0.0 110.357 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.557 ' CG2' ' HG2' ' A' ' 25' ' ' PRO . 31.4 pt -100.37 168.61 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.425 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.637 HG23 ' HA ' ' A' ' 76' ' ' ASN . 59.8 p -113.23 -16.67 12.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.0 109.338 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.82 -165.23 35.25 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 1.098 ' CZ ' ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -165.42 120.72 1.31 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -1.151 . . . . 0.0 110.049 -179.818 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.878 ' O ' HD13 ' A' ' 34' ' ' ILE . 22.2 mm -75.33 147.89 7.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 121.104 -0.998 . . . . 0.0 108.658 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.988 ' CG1' HG22 ' A' ' 50' ' ' VAL . 14.7 mm -133.24 92.89 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.078 -1.014 . . . . 0.0 109.857 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.542 ' CG ' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -100.57 157.01 16.98 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.171 -0.955 . . . . 0.0 108.69 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.606 ' CG ' ' CD2' ' A' ' 59' ' ' LEU . 1.3 p-80 -143.15 143.27 31.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.004 -1.06 . . . . 0.0 110.055 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.579 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 37.2 p-80 -163.16 130.57 3.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.377 -0.827 . . . . 0.0 109.716 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 1.063 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . -75.28 130.84 39.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.258 -0.901 . . . . 0.0 109.256 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.166 -0.959 . . . . 0.0 109.359 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.539 ' HB2' ' NE2' ' A' ' 36' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.475 0 CA-C-O 121.341 0.591 . . . . 0.0 109.747 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 35' ' ' ARG . 29.3 mt-30 -141.06 111.49 6.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -0.866 . . . . 0.0 109.979 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.534 ' O ' ' CD ' ' A' ' 49' ' ' ARG . 20.9 m-20 -110.78 178.59 4.31 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.604 HH11 HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -153.98 155.74 36.13 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.217 -0.927 . . . . 0.0 109.951 -179.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.988 HG22 ' CG1' ' A' ' 34' ' ' ILE . 15.9 m -142.46 160.9 52.56 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.477 -0.764 . . . . 0.0 108.989 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.537 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 33.7 Cg_endo -75.82 173.94 13.66 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.369 2.046 . . . . 0.0 110.211 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.494 ' HB3' HG13 ' A' ' 29' ' ' ILE . 35.0 Cg_endo -77.16 -17.44 15.04 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.491 2.127 . . . . 0.0 110.568 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.1 t -102.23 17.29 23.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 109.342 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.537 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -115.56 104.63 11.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -0.865 . . . . 0.0 109.454 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 2.7 p-10 -89.38 -6.17 56.83 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.923 . . . . 0.0 109.561 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 6.3 p -126.23 142.76 51.4 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.39 -0.819 . . . . 0.0 109.567 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.955 HD12 HG13 ' A' ' 50' ' ' VAL . 5.1 tt -137.11 134.72 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 109.391 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 87.8 m -96.63 125.49 41.14 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.194 -0.941 . . . . 0.0 109.6 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.638 ' HB3' HD11 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -102.99 142.24 34.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 109.354 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.494 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 0.9 OUTLIER -122.4 156.67 33.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 109.799 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.981 ' O ' HD23 ' A' ' 62' ' ' LEU . 9.0 m-80 62.27 79.83 0.24 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.364 -0.835 . . . . 0.0 109.905 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.981 HD23 ' O ' ' A' ' 61' ' ' ASN . 6.5 mt -143.24 138.88 29.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -0.881 . . . . 0.0 109.414 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 62' ' ' LEU . 3.4 m120 -42.59 136.01 2.57 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 109.429 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.603 ' HA ' ' HB1' ' A' ' 15' ' ' ALA . 36.6 Cg_endo -79.2 131.42 9.76 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.476 2.118 . . . . 0.0 110.732 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 63.47 64.15 3.95 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.249 -1.941 . . . . 0.0 108.249 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 m -156.72 151.72 26.14 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.391 -1.064 . . . . 0.0 110.667 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -85.38 123.92 31.39 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.633 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 1.063 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 3.1 m-85 -111.25 133.8 53.32 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.073 -1.017 . . . . 0.0 110.605 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.708 HG12 HG23 ' A' ' 85' ' ' ILE . 1.6 t -89.16 107.79 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.58 HG13 ' HB3' ' A' ' 36' ' ' HIS . 1.6 t -103.53 129.47 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.205 -0.935 . . . . 0.0 109.533 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.568 ' CB ' HG12 ' A' ' 85' ' ' ILE . 1.3 p -100.07 147.05 26.06 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.142 -0.974 . . . . 0.0 110.35 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.821 HG22 ' CD1' ' A' ' 32' ' ' TYR . 5.1 mm -131.62 94.22 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.664 HD12 ' N ' ' A' ' 73' ' ' ILE . 1.4 mp -90.62 135.86 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 109.716 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.098 ' HB2' ' CZ ' ' A' ' 32' ' ' TYR . . . -96.85 144.22 27.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -0.83 . . . . 0.0 109.522 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.423 ' O ' ' OG1' ' A' ' 30' ' ' THR . 1.7 m -130.99 133.18 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.275 -0.891 . . . . 0.0 109.058 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.637 ' HA ' HG23 ' A' ' 30' ' ' THR . 24.9 t30 -116.35 45.1 1.85 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.792 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.67 -81.55 1.71 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.42 -5.83 16.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -1.186 . . . . 0.0 109.816 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 76' ' ' ASN . 16.2 tp10 -107.34 155.92 19.47 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.242 -0.911 . . . . 0.0 109.247 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.485 ' N ' ' HG3' ' A' ' 79' ' ' GLU . 8.1 mt-10 -129.94 105.61 8.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.214 -0.928 . . . . 0.0 109.473 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.569 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -63.96 -179.87 0.31 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.218 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.569 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.4 Cg_endo -77.52 155.76 31.98 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.358 2.039 . . . . 0.0 110.513 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.6 Cg_endo -77.83 136.14 14.82 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.706 2.27 . . . . 0.0 111.099 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.763 HD22 ' O ' ' A' ' 5' ' ' PRO . 15.5 tp -117.71 93.27 4.09 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.708 HG23 HG12 ' A' ' 69' ' ' VAL . 2.5 mt -96.09 141.36 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.118 -0.989 . . . . 0.0 109.572 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 69' ' ' VAL . . . -130.43 -177.67 15.01 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.446 ' CG ' HG13 ' A' ' 69' ' ' VAL . 60.7 mt-30 -146.18 101.26 3.49 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.187 -1.184 . . . . 0.0 109.961 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.526 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 41.8 mm-40 -98.26 -161.17 0.85 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -144.65 130.93 19.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.916 -1.115 . . . . 0.0 110.37 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -74.37 139.01 43.79 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.224 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.707 HG23 HG22 ' A' ' 13' ' ' ILE . 12.1 t . . . . . 0 N--CA 1.498 1.935 0 CA-C-O 121.557 0.694 . . . . 0.0 110.29 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.701 ' CG ' HD11 ' A' ' 162' ' ' LEU . 36.8 Cg_endo . . . . . 0 C--O 1.216 -0.612 0 N-CA-C 109.744 -0.906 . . . . 0.0 109.744 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 2.2 ptt180 -106.27 153.41 22.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.055 -1.028 . . . . 0.0 109.851 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.9 OUTLIER 76.98 25.82 0.79 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 109.853 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.902 HD22 ' CD2' ' A' ' 162' ' ' LEU . 31.1 tp -64.01 100.46 0.32 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.064 -1.022 . . . . 0.0 109.239 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 110' ' ' ILE . 18.4 pt-20 -128.22 170.15 13.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.95 . . . . 0.0 109.572 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.614 HG22 ' H ' ' A' ' 101' ' ' ILE . 9.1 p -109.24 172.66 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 109.766 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.736 HD11 ' HB3' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -150.3 -81.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.361 -0.837 . . . . 0.0 109.226 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 1.066 ' HB3' HD13 ' A' ' 109' ' ' LEU . . . -74.89 101.84 4.55 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.528 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 5.2 p -98.98 90.14 4.53 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.868 . . . . 0.0 110.479 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.612 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -76.5 165.71 50.57 Favored Pre-proline 0 C--N 1.306 -1.325 0 O-C-N 121.154 -0.966 . . . . 0.0 108.759 178.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 29.9 Cg_endo -69.42 -2.81 10.57 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.421 2.081 . . . . 0.0 110.602 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.774 ' C ' HG22 ' A' ' 152' ' ' ILE . 1.0 OUTLIER -150.64 17.49 0.8 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.394 -0.817 . . . . 0.0 108.805 179.002 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 1.034 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -169.05 159.33 9.13 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.127 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.034 HD23 ' O ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -143.87 154.69 43.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.324 -0.86 . . . . 0.0 109.263 -179.818 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 1.066 HD13 ' HB3' ' A' ' 102' ' ' ALA . 0.4 OUTLIER -105.58 132.97 51.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.318 -0.863 . . . . 0.0 108.833 179.32 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.757 HD11 HD13 ' A' ' 124' ' ' ILE . 1.1 pt -115.67 144.69 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.084 -1.01 . . . . 0.0 109.96 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' A' ' 146' ' ' THR . 32.6 t -143.31 126.55 16.57 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.585 ' CZ3' ' HA ' ' A' ' 146' ' ' THR . 3.3 p90 -123.33 171.33 9.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.947 . . . . 0.0 109.835 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 96' ' ' ARG . 6.0 mm-40 . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.388 -0.82 . . . . 0.0 109.338 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.619 ' CE2' HG22 ' A' ' 139' ' ' THR . 1.8 p90 . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.627 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 0.2 OUTLIER -135.01 150.37 50.31 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.692 -1.255 . . . . 0.0 110.69 -179.014 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.496 ' HG2' ' CE2' ' A' ' 121' ' ' TYR . 15.6 mtp180 -109.42 92.63 4.13 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.757 HD13 HD11 ' A' ' 110' ' ' ILE . 52.8 mt -84.2 163.83 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.926 . . . . 0.0 110.421 -178.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.596 ' N ' HG22 ' A' ' 124' ' ' ILE . 23.3 p -145.35 140.85 28.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.505 -0.747 . . . . 0.0 109.586 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.651 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 2.6 m-85 -82.06 134.24 35.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.876 . . . . 0.0 109.227 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.62 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -106.0 124.87 7.98 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 . . . . . 0 C--N 1.295 -1.786 0 O-C-N 121.213 -1.169 . . . . 0.0 109.201 179.472 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 126' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 2.1 pt-20 -92.8 154.0 18.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.379 -0.826 . . . . 0.0 110.918 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.612 ' CE1' ' HB ' ' A' ' 124' ' ' ILE . 31.7 p90 -164.74 147.39 8.53 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.619 HG22 ' CE2' ' A' ' 121' ' ' TYR . 0.8 OUTLIER -73.85 -176.6 2.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.011 -1.056 . . . . 0.0 110.553 -178.19 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.704 ' CG2' HD12 ' A' ' 124' ' ' ILE . 71.6 t -146.69 139.07 13.91 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.465 -0.772 . . . . 0.0 109.199 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.579 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.8 Cg_endo -76.97 127.88 9.63 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.419 2.079 . . . . 0.0 110.396 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -79.4 51.16 3.9 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.504 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 1.0 OUTLIER -104.65 -3.4 23.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.18 -1.188 . . . . 0.0 109.457 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.504 ' CG ' ' O ' ' A' ' 143' ' ' SER . 18.2 mttt -165.3 174.66 9.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 0.0 109.275 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.443 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 4.7 p -93.15 4.35 54.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.512 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.585 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 3.1 p -119.11 155.76 30.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.317 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.57 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -129.61 161.22 31.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.411 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.581 ' O ' HD13 ' A' ' 149' ' ' ILE . 12.6 m -107.69 153.63 22.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.269 -0.894 . . . . 0.0 109.521 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.651 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 7.5 mm -134.65 119.03 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.352 -0.842 . . . . 0.0 109.304 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.531 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 41.8 m-20 -124.72 173.79 8.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.323 -0.86 . . . . 0.0 109.825 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 15.2 m120 62.94 33.92 14.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.134 -0.979 . . . . 0.0 109.074 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.774 HG22 ' C ' ' A' ' 106' ' ' THR . 7.2 tt -89.32 147.68 5.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.519 -0.738 . . . . 0.0 109.739 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.4 ' HB2' ' OH ' ' A' ' 158' ' ' TYR . 25.3 mttt -82.67 113.87 47.98 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.175 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.493 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 35.8 Cg_endo -78.11 146.61 22.9 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.413 2.075 . . . . 0.0 110.606 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.661 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 78.2 65.28 1.89 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 166.7 128.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -1.163 . . . . 0.0 109.772 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.417 ' C ' ' O ' ' A' ' 156' ' ' ALA . 0.6 OUTLIER -46.34 160.56 0.07 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.62 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -141.66 177.75 7.94 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.886 -1.134 . . . . 0.0 110.356 -179.346 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.548 ' CB ' ' HA3' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -146.42 108.15 4.32 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.295 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.53 ' HB ' ' CG1' ' A' ' 180' ' ' ILE . 43.3 mm -93.73 112.68 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.735 -1.228 . . . . 0.0 109.867 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.713 HG23 ' HB2' ' A' ' 179' ' ' SER . 7.5 m -123.37 148.79 45.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -0.87 . . . . 0.0 108.954 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.902 ' CD2' HD22 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -145.15 156.15 43.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.91 -1.118 . . . . 0.0 110.706 -179.779 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.596 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 1.8 m-85 -119.76 77.8 1.26 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 122' ' ' TYR . . . -47.41 150.01 0.99 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.959 -1.088 . . . . 0.0 109.456 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.887 HG22 ' HB3' ' A' ' 174' ' ' SER . 51.6 t . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.208 -0.932 . . . . 0.0 109.739 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.887 ' HB3' HG22 ' A' ' 165' ' ' VAL . 1.2 p . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 174' ' ' SER . 83.9 p -44.2 168.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.342 -0.849 . . . . 0.0 109.443 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.26 143.61 9.29 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.043 -1.035 . . . . 0.0 108.508 -179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.596 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 35.7 Cg_endo -78.44 136.49 14.07 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.407 2.071 . . . . 0.0 111.337 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.2 t -109.56 136.95 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.713 ' HB2' HG23 ' A' ' 161' ' ' THR . 33.0 t -124.67 160.33 28.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.058 -1.026 . . . . 0.0 110.951 -178.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.855 HG23 HD23 ' A' ' 98' ' ' LEU . 39.3 pt -140.95 171.86 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.473 ' OD1' ' N ' ' A' ' 181' ' ' ASN . 1.2 m120 -103.72 166.0 10.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.936 -1.102 . . . . 0.0 110.036 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 1.023 ' OH ' HD22 ' A' ' 108' ' ' LEU . 48.3 t80 -154.15 172.47 17.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.512 -0.743 . . . . 0.0 109.2 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -145.1 118.38 8.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.149 -0.969 . . . . 0.0 109.562 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.509 ' OG1' ' N ' ' A' ' 156' ' ' ALA . 8.0 p . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.42 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.403 HD21 ' ND2' ' A' ' 76' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.433 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.521 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 2.5 m-20 -76.04 97.44 4.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.351 -0.843 . . . . 0.0 109.152 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -40.59 101.34 0.24 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.597 -0.689 . . . . 0.0 109.888 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.716 ' HG2' ' HB2' ' A' ' 74' ' ' ALA . 34.9 Cg_endo -77.44 71.97 6.19 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.51 2.14 . . . . 0.0 109.733 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.875 ' HA ' HD22 ' A' ' 84' ' ' LEU . 16.7 p -91.16 -98.67 0.11 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.269 -0.894 . . . . 0.0 109.937 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 9' ' ' ASP . . . 48.64 24.72 4.22 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.402 ' N ' ' C ' ' A' ' 6' ' ' THR . 29.7 t80 -55.55 91.79 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.567 -0.961 . . . . 0.0 109.325 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 7' ' ' GLY . 7.8 t70 -137.36 111.99 8.76 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.552 ' CB ' ' HG3' ' A' ' 88' ' ' GLN . 0.3 OUTLIER -84.3 134.23 34.52 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.253 -0.904 . . . . 0.0 109.452 -179.573 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.471 ' O ' ' C ' ' A' ' 12' ' ' ASP . 86.8 p -150.33 -160.84 1.23 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.304 -0.873 . . . . 0.0 109.064 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.533 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 19.2 m-20 46.17 33.12 1.64 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 1.088 HG22 HG23 ' A' ' 91' ' ' VAL . 1.9 mt -86.97 111.02 21.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.317 -177.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -94.23 -177.04 4.15 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 177.568 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -88.58 -11.07 46.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.668 -1.27 . . . . 0.0 109.684 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 17' ' ' SER . 0.6 OUTLIER -131.95 22.14 4.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.887 -1.133 . . . . 0.0 108.115 178.605 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.529 ' CB ' ' HA ' ' A' ' 60' ' ' THR . 76.0 p 174.19 127.15 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.78 ' CB ' HG23 ' A' ' 13' ' ' ILE . 2.2 p90 -137.97 147.0 43.84 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.699 -1.251 . . . . 0.0 109.883 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 1.008 ' OG1' HG23 ' A' ' 58' ' ' THR . 60.1 m -111.97 164.62 12.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.914 -1.116 . . . . 0.0 110.5 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.609 ' N ' HG22 ' A' ' 19' ' ' THR . 1.8 t -127.27 162.88 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.514 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 3.5 m-70 -151.77 137.45 17.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.926 -1.108 . . . . 0.0 110.155 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.778 ' CZ2' HG21 ' A' ' 50' ' ' VAL . 48.4 p90 -133.81 156.48 47.96 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.38 156.63 6.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 120.864 -1.147 . . . . 0.0 109.957 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . . . -101.64 153.31 37.99 Favored Pre-proline 0 C--N 1.298 -1.668 0 O-C-N 121.841 -0.537 . . . . 0.0 109.731 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 1.098 ' CG ' HD13 ' A' ' 29' ' ' ILE . 36.7 Cg_endo -79.65 133.78 10.61 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.623 2.216 . . . . 0.0 110.171 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -69.51 -5.74 26.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 109.574 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.914 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -97.25 173.8 3.75 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 0.0 109.384 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.914 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.3 Cg_endo -78.17 107.19 2.28 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.605 2.203 . . . . 0.0 110.484 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 1.098 HD13 ' CG ' ' A' ' 25' ' ' PRO . 18.6 pt -108.66 -171.72 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.411 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 7.9 p -115.63 -7.1 12.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.902 . . . . 0.0 109.568 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.24 -178.98 17.4 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.709 ' OH ' HD11 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -126.82 158.02 37.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -1.145 . . . . 0.0 109.488 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.008 ' C ' HD13 ' A' ' 34' ' ' ILE . 5.9 mt -111.56 136.32 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.241 -0.912 . . . . 0.0 108.898 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.008 HD13 ' C ' ' A' ' 33' ' ' ILE . 1.4 mm -119.08 125.4 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.109 -0.994 . . . . 0.0 110.283 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.528 ' CB ' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -122.6 129.71 52.2 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.555 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.603 ' CE1' ' HD2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -125.09 140.12 53.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.833 -1.167 . . . . 0.0 110.542 -178.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.584 ' CE1' ' CG1' ' A' ' 69' ' ' VAL . 38.5 p-80 -166.32 122.29 1.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.424 -0.797 . . . . 0.0 109.753 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -55.22 -164.25 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.252 -0.905 . . . . 0.0 109.66 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 38' ' ' ALA . 1.4 mp0 . . . . . 0 N--CA 1.493 1.7 0 O-C-N 121.189 -0.944 . . . . 0.0 109.615 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.603 ' HD2' ' CE1' ' A' ' 36' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.597 0.713 . . . . 0.0 109.817 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.52 ' CB ' ' HG3' ' A' ' 35' ' ' ARG . 1.6 mt-30 -119.78 99.42 6.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.517 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -84.66 106.53 16.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.269 -0.894 . . . . 0.0 109.072 179.55 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.986 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -84.65 137.7 33.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.241 -0.912 . . . . 0.0 109.142 -179.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.778 HG21 ' CZ2' ' A' ' 22' ' ' TRP . 21.9 m -114.07 154.75 46.08 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 109.706 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.514 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 35.2 Cg_endo -77.99 175.3 11.34 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.76 2.307 . . . . 0.0 110.29 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.53 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.1 Cg_endo -76.26 -15.87 17.82 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.528 2.152 . . . . 0.0 110.121 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.72 11.13 18.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 0.0 109.25 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.402 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 6.2 mmt180 -137.98 134.89 35.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.306 -0.871 . . . . 0.0 109.21 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.5 ' HA ' ' CE2' ' A' ' 22' ' ' TRP . 2.1 p-10 -124.75 18.69 8.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 0.0 109.638 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 84.4 p -145.78 138.59 25.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 109.776 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.956 HG21 HG21 ' A' ' 34' ' ' ILE . 1.5 tt -119.1 120.03 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.359 -0.838 . . . . 0.0 108.988 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 1.008 HG23 ' OG1' ' A' ' 19' ' ' THR . 0.4 OUTLIER -91.03 133.05 35.62 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.269 -0.894 . . . . 0.0 110.405 -179.115 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.816 ' HB3' HD11 ' A' ' 62' ' ' LEU . 1.5 mt -117.29 140.45 49.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.0 109.112 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.529 ' HA ' ' CB ' ' A' ' 17' ' ' SER . 25.1 p -129.05 174.65 9.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.354 -0.841 . . . . 0.0 109.909 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.638 ' O ' HD23 ' A' ' 62' ' ' LEU . 8.9 m-20 51.63 66.43 1.2 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.377 -0.827 . . . . 0.0 109.515 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.816 HD11 ' HB3' ' A' ' 59' ' ' LEU . 9.0 mt -134.41 133.94 41.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.467 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -48.12 134.88 11.95 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 108.819 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.4 Cg_endo -77.97 128.21 9.03 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.362 2.041 . . . . 0.0 110.681 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 79.37 60.87 2.43 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 90' ' ' THR . 1.5 m -149.59 142.23 24.51 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.366 -1.079 . . . . 0.0 109.7 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.541 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 3.0 mt-10 -74.59 134.72 42.09 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.973 -1.079 . . . . 0.0 108.768 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.597 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 3.6 m-85 -123.23 98.1 5.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.125 -0.984 . . . . 0.0 109.761 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.584 ' CG1' ' CE1' ' A' ' 37' ' ' HIS . 6.6 t -59.6 133.67 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.157 -0.965 . . . . 0.0 108.874 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 35' ' ' ARG . 11.0 t -137.86 137.36 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.106 -0.996 . . . . 0.0 109.375 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.628 ' HB3' HD13 ' A' ' 85' ' ' ILE . 88.9 p -116.53 134.68 54.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.188 -0.945 . . . . 0.0 110.133 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.898 ' HB ' HD12 ' A' ' 84' ' ' LEU . 21.5 mm -120.21 143.0 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 109.334 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.552 HG22 ' N ' ' A' ' 74' ' ' ALA . 36.9 mm -138.5 162.11 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.148 -0.97 . . . . 0.0 109.704 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.716 ' HB2' ' HG2' ' A' ' 5' ' ' PRO . . . -134.61 98.23 4.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.357 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.465 ' O ' ' OG1' ' A' ' 30' ' ' THR . 2.5 m -96.65 154.69 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 109.399 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 28' ' ' PRO . 30.2 t30 -133.63 45.94 2.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 109.55 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.453 ' N ' HG21 ' A' ' 30' ' ' THR . . . 81.87 -97.2 1.84 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -94.14 2.61 55.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -1.164 . . . . 0.0 109.534 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.484 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 2.2 mt-10 -109.49 -173.39 2.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.162 -0.961 . . . . 0.0 109.552 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 0.6 OUTLIER -163.31 100.16 0.94 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.357 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.649 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -59.64 -179.7 0.17 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.899 . . . . 0.0 108.878 179.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.578 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.1 Cg_endo -77.16 138.35 17.98 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.2 1.933 . . . . 0.0 110.187 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.533 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 36.0 Cg_endo -77.9 139.94 17.86 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.572 2.182 . . . . 0.0 110.571 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.898 HD12 ' HB ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -136.1 91.87 2.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.318 -0.864 . . . . 0.0 109.565 179.755 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.628 HD13 ' HB3' ' A' ' 71' ' ' SER . 4.1 mt -97.09 159.1 3.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.373 -0.829 . . . . 0.0 109.341 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.477 ' N ' HG22 ' A' ' 85' ' ' ILE . . . -162.84 159.08 31.46 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -112.81 118.36 34.73 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.367 -1.078 . . . . 0.0 109.435 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.552 ' HG3' ' CB ' ' A' ' 10' ' ' SER . 1.7 mm-40 -109.64 -157.64 0.62 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.541 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -162.31 148.4 13.04 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.978 -1.076 . . . . 0.0 110.081 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.47 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.47 136.97 42.28 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 1.088 HG23 HG22 ' A' ' 13' ' ' ILE . 5.2 t . . . . . 0 C--N 1.298 -1.647 0 CA-C-O 121.741 0.782 . . . . 0.0 110.902 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.525 ' CB ' ' O ' ' A' ' 113' ' ' GLU . 34.2 Cg_endo . . . . . 0 C--O 1.214 -0.681 0 N-CA-C 109.293 -1.079 . . . . 0.0 109.293 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 1.7 ptp180 -163.37 164.77 24.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.912 -1.117 . . . . 0.0 110.064 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 21.0 t0 79.26 21.2 0.65 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.552 -0.718 . . . . 0.0 110.146 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.867 ' O ' HG21 ' A' ' 180' ' ' ILE . 0.3 OUTLIER -63.77 99.28 0.23 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.9 -1.125 . . . . 0.0 108.928 179.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.69 -174.95 4.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 109' ' ' LEU . 5.0 p -114.93 152.43 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.195 -0.941 . . . . 0.0 110.013 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.475 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 5.2 pt -119.08 -16.11 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.394 -0.816 . . . . 0.0 109.314 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.716 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -140.95 168.79 18.94 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.472 ' HG ' ' HH ' ' A' ' 182' ' ' TYR . 1.9 t -156.16 102.22 2.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.891 -1.131 . . . . 0.0 110.506 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.484 ' HB ' ' HD2' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -90.74 166.92 17.6 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.484 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 29.9 Cg_endo -69.41 -1.97 9.1 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.257 1.971 . . . . 0.0 110.579 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.746 ' C ' HG22 ' A' ' 152' ' ' ILE . 3.9 p -151.26 17.43 0.74 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.331 -0.856 . . . . 0.0 108.985 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 1.097 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -170.72 162.42 7.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.991 -1.068 . . . . 0.0 110.343 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.097 HD23 ' O ' ' A' ' 107' ' ' SER . 0.7 OUTLIER -141.84 156.85 45.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.464 -0.772 . . . . 0.0 109.099 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.716 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.3 OUTLIER -104.24 121.83 44.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 109.207 179.704 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.8 ' CD1' ' HB3' ' A' ' 147' ' ' ALA . 2.0 pt -103.35 148.23 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -0.903 . . . . 0.0 109.934 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.543 ' CB ' HG22 ' A' ' 146' ' ' THR . 84.9 p -146.16 137.46 24.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.4 -0.813 . . . . 0.0 109.052 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.57 ' CE3' ' O ' ' A' ' 145' ' ' SER . 37.1 p90 -158.87 -167.33 2.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.728 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 95' ' ' PRO . 2.1 mt-10 . . . . . 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 108.959 179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.654 ' OH ' HG21 ' A' ' 165' ' ' VAL . 5.2 p90 . . . . . 0 N--CA 1.485 1.279 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 2.6 m-85 -129.11 137.67 51.36 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -94.91 86.6 4.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 109.548 -179.479 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.975 ' CD1' HG21 ' A' ' 140' ' ' VAL . 77.1 mt -84.19 148.47 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.882 . . . . 0.0 109.192 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 2.5 p -131.44 150.59 52.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.92 . . . . 0.0 110.348 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.634 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 2.9 m-85 -85.33 133.51 34.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.436 -0.79 . . . . 0.0 108.942 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.592 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.83 116.57 5.21 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.227 -1.161 . . . . 0.0 109.316 179.695 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.597 ' HB2' ' CD1' ' A' ' 126' ' ' TYR . 39.3 mt-30 . . . . . 0 N--CA 1.496 1.84 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 7.2 pt-20 -76.54 130.24 37.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.448 -0.783 . . . . 0.0 111.103 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.599 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 38.1 p90 -137.27 143.66 42.31 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.652 HG22 ' CE1' ' A' ' 121' ' ' TYR . 12.7 p -74.28 165.62 24.86 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.996 -1.065 . . . . 0.0 110.69 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.975 HG21 ' CD1' ' A' ' 124' ' ' ILE . 8.2 t -137.33 139.63 28.34 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.603 -0.686 . . . . 0.0 109.773 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.486 ' HD2' HG13 ' A' ' 140' ' ' VAL . 33.7 Cg_endo -75.64 125.81 9.15 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.303 2.002 . . . . 0.0 110.364 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.61 -1.85 54.21 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 4.9 p -75.4 1.02 14.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.175 -1.191 . . . . 0.0 109.656 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 143' ' ' SER . 1.8 mmtp -152.39 149.68 28.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.152 -0.968 . . . . 0.0 109.67 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.57 ' O ' ' CE3' ' A' ' 112' ' ' TRP . 1.7 m -93.96 -13.17 27.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 109.296 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.543 HG22 ' CB ' ' A' ' 111' ' ' SER . 64.4 p -107.26 130.64 54.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.285 -0.884 . . . . 0.0 108.974 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.8 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -118.49 161.34 20.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.975 . . . . 0.0 109.905 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.456 ' O ' HD13 ' A' ' 149' ' ' ILE . 11.2 t -103.07 155.96 18.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.33 -0.856 . . . . 0.0 109.074 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.634 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 20.2 mm -133.07 113.68 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 109.725 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.547 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 3.3 m120 -120.79 173.34 7.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.384 -0.822 . . . . 0.0 109.705 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 0.5 OUTLIER 69.12 34.19 3.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.914 . . . . 0.0 109.291 -179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.746 HG22 ' C ' ' A' ' 106' ' ' THR . 4.5 tt -93.89 158.7 2.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.37 -0.831 . . . . 0.0 109.788 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.42 115.65 65.71 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.262 -0.899 . . . . 0.0 109.121 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.463 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 35.4 Cg_endo -77.42 138.17 17.32 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.391 2.061 . . . . 0.0 110.743 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.702 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 86.41 68.06 1.35 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 163.73 130.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -1.155 . . . . 0.0 109.637 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -47.53 162.63 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.17 -0.956 . . . . 0.0 108.559 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.592 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.3 OUTLIER -142.94 -170.8 3.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.918 -1.114 . . . . 0.0 110.234 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.514 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 3.2 m -165.41 110.83 0.9 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.523 ' HB ' ' CG1' ' A' ' 180' ' ' ILE . 30.1 mm -95.82 120.23 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.995 -1.066 . . . . 0.0 109.843 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.674 HG23 ' CB ' ' A' ' 179' ' ' SER . 2.2 m -124.9 164.31 20.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.241 -0.912 . . . . 0.0 109.145 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.838 HD23 HD11 ' A' ' 98' ' ' LEU . 1.6 pp -159.53 142.88 14.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.933 -1.104 . . . . 0.0 111.135 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.62 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.2 m-85 -113.78 80.25 1.35 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 122' ' ' TYR . . . -43.79 96.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.14 -0.975 . . . . 0.0 109.328 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.654 HG21 ' OH ' ' A' ' 121' ' ' TYR . 58.0 t . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 109.494 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.41 ' HB3' ' HA ' ' A' ' 165' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.8 p -57.14 -167.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.171 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -66.71 146.45 99.07 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.149 -0.969 . . . . 0.0 108.808 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.62 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.6 Cg_endo -77.32 122.72 6.22 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.455 2.103 . . . . 0.0 111.158 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.83 HG12 HD12 ' A' ' 98' ' ' LEU . 2.2 t -91.41 133.63 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.674 ' CB ' HG23 ' A' ' 161' ' ' THR . 1.4 p -124.71 151.37 45.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.11 -0.994 . . . . 0.0 110.72 -178.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.867 HG21 ' O ' ' A' ' 98' ' ' LEU . 3.1 pt -138.84 152.19 24.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.45 162.79 16.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.002 -1.061 . . . . 0.0 109.824 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.977 ' OH ' HD22 ' A' ' 108' ' ' LEU . 74.9 t80 -152.8 167.33 29.41 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.414 -0.804 . . . . 0.0 109.268 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.412 ' N ' ' CG ' ' A' ' 182' ' ' TYR . 5.7 tttp -138.3 118.35 13.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.55 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 17.0 p . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.46 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . 0.454 ' O ' ' OG ' ' A' ' 81' ' ' SER . 96.4 mt . . . . . 0 N--CA 1.489 1.505 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 2.9 m-20 -74.87 140.11 43.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 109.545 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.534 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 2.4 t -95.08 149.52 36.36 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.555 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.603 ' HG3' ' CD1' ' A' ' 32' ' ' TYR . 36.4 Cg_endo -78.89 117.72 3.97 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.711 2.274 . . . . 0.0 110.347 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.772 HG22 HD13 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -101.92 -107.78 0.24 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.947 . . . . 0.0 109.382 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 22' ' ' TRP . . . 42.5 27.83 0.54 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.442 ' N ' ' O ' ' A' ' 6' ' ' THR . 25.8 t80 -48.36 124.75 8.43 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.431 -1.041 . . . . 0.0 109.849 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 21' ' ' HIS . 4.2 t70 -164.96 84.06 0.39 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.405 -0.809 . . . . 0.0 109.019 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.983 ' OG ' HG13 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -84.6 137.84 33.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.195 -0.941 . . . . 0.0 109.684 -179.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.474 ' O ' ' HB ' ' A' ' 19' ' ' THR . 82.6 p -159.19 -158.67 0.7 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.36 -0.837 . . . . 0.0 109.143 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.523 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.5 OUTLIER 44.62 34.75 1.2 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -178.417 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.749 HD11 ' HG2' ' A' ' 88' ' ' GLN . 1.3 mt -72.37 140.48 17.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.495 -177.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.568 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -122.93 -175.09 3.08 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.611 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 91' ' ' VAL . . . -75.18 -70.97 0.39 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.908 -1.12 . . . . 0.0 109.499 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 5.8 p-10 -83.74 9.16 12.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.168 -0.957 . . . . 0.0 109.459 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.799 ' HB3' HG22 ' A' ' 60' ' ' THR . 0.1 OUTLIER -157.82 159.33 36.6 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.995 ' CE1' HG22 ' A' ' 20' ' ' VAL . 5.8 p90 -166.01 140.72 4.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.207 -0.933 . . . . 0.0 108.839 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 9.3 m -79.37 153.8 29.49 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.814 -1.179 . . . . 0.0 111.209 -178.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.995 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.3 t -134.69 115.82 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 9' ' ' ASP . 17.2 m-70 -105.46 159.11 16.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.044 -1.035 . . . . 0.0 110.132 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.771 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 20.9 p90 -175.09 140.25 0.51 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.366 -0.834 . . . . 0.0 109.209 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.61 162.32 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.134 -0.979 . . . . 0.0 109.965 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.774 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -93.96 169.59 9.72 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.766 -0.584 . . . . 0.0 109.696 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.774 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.2 Cg_endo -78.12 -159.88 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.611 2.207 . . . . 0.0 110.346 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.82 8.05 4.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 109.592 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.991 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -110.47 176.98 1.32 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.335 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.991 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 34.8 Cg_endo -77.54 110.67 3.01 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.478 2.119 . . . . 0.0 110.294 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.619 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 50.2 pt -126.29 -173.01 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 0.0 109.557 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.409 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 32.0 p -125.32 -5.43 7.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.483 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.498 ' HA2' ' N ' ' A' ' 52' ' ' PRO . . . 149.62 -178.78 26.91 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.642 ' CE2' ' HA ' ' A' ' 52' ' ' PRO . 1.8 m-85 -124.28 145.93 49.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -1.189 . . . . 0.0 109.631 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.061 HG23 ' HD2' ' A' ' 49' ' ' ARG . 0.9 OUTLIER -99.76 130.43 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.329 -0.857 . . . . 0.0 108.727 179.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.846 HD13 ' C ' ' A' ' 33' ' ' ILE . 1.4 mm -109.08 108.76 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.935 -1.103 . . . . 0.0 110.08 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.523 ' CB ' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -112.61 108.65 17.79 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.752 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.843 ' HB3' HG13 ' A' ' 70' ' ' VAL . 1.7 p-80 -114.62 166.79 11.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.022 . . . . 0.0 110.355 -178.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.455 ' O ' ' O ' ' A' ' 38' ' ' ALA . 40.0 p-80 177.73 136.19 0.07 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.594 -0.691 . . . . 0.0 109.282 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -56.31 -163.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.926 . . . . 0.0 109.372 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.18 -0.95 . . . . 0.0 109.606 -179.999 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.601 ' HB2' ' CD2' ' A' ' 36' ' ' HIS . 12.7 mmm180 . . . . . 0 N--CA 1.49 1.526 0 CA-C-O 121.305 0.574 . . . . 0.0 109.637 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.407 ' HG3' ' C ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -130.01 90.07 2.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.684 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.546 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 9.5 m-20 -99.1 114.3 26.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.267 -0.896 . . . . 0.0 108.862 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 1.061 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -92.11 150.21 21.07 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.978 -1.076 . . . . 0.0 109.822 -179.469 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.914 HG12 HD12 ' A' ' 57' ' ' ILE . 10.3 m -133.4 160.1 69.96 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.431 -0.793 . . . . 0.0 109.3 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.501 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 33.6 Cg_endo -76.27 174.35 12.98 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.561 2.174 . . . . 0.0 110.381 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.642 ' HA ' ' CE2' ' A' ' 32' ' ' TYR . 35.1 Cg_endo -77.17 -21.74 11.76 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.672 2.248 . . . . 0.0 110.999 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.8 t -92.51 -4.51 53.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.074 -1.016 . . . . 0.0 109.716 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.536 ' HD3' ' N ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -97.8 111.42 23.72 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.286 -0.884 . . . . 0.0 109.895 -179.744 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -101.04 -6.43 24.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.447 -0.783 . . . . 0.0 109.46 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 53.1 p -135.69 129.84 33.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.384 -0.822 . . . . 0.0 109.189 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.914 HD12 HG12 ' A' ' 50' ' ' VAL . 6.1 tt -133.33 129.14 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.231 -0.918 . . . . 0.0 109.672 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.1 115.39 24.46 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.337 -0.852 . . . . 0.0 109.074 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.988 ' CB ' HD11 ' A' ' 62' ' ' LEU . 1.3 mt -84.74 156.22 21.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.14 -0.975 . . . . 0.0 109.642 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.799 HG22 ' HB3' ' A' ' 17' ' ' SER . 15.5 p -145.65 -178.2 5.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.404 -0.81 . . . . 0.0 109.33 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.9 m120 55.48 20.04 3.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.364 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 0.988 HD11 ' CB ' ' A' ' 59' ' ' LEU . 3.5 mt -96.15 138.69 33.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.872 . . . . 0.0 109.302 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 62' ' ' LEU . 6.2 t-20 -45.72 126.41 6.56 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.191 -0.943 . . . . 0.0 108.804 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.459 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 35.8 Cg_endo -77.81 134.67 13.62 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.307 2.004 . . . . 0.0 110.699 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 68.16 62.6 4.09 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.0 m -160.67 153.01 20.46 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.264 -1.139 . . . . 0.0 110.134 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 1.2 tt0 -77.09 121.27 23.33 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.541 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 1.0 OUTLIER -116.71 114.54 24.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.085 -1.01 . . . . 0.0 110.019 -179.158 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.8 t -79.5 118.44 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 108.678 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.843 HG13 ' HB3' ' A' ' 36' ' ' HIS . 1.4 t -100.4 135.77 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.129 -0.982 . . . . 0.0 109.611 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.545 ' HB2' ' CD1' ' A' ' 85' ' ' ILE . 10.8 p -114.72 108.3 16.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.345 -0.847 . . . . 0.0 110.084 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 0.849 ' C ' HD12 ' A' ' 73' ' ' ILE . 17.0 mm -87.96 119.17 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 0.0 109.428 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.849 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.6 mp -116.74 158.63 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 109.256 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.624 ' HB3' ' CB ' ' A' ' 81' ' ' SER . . . -119.32 157.43 28.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.492 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.457 HG21 HD11 ' A' ' 33' ' ' ILE . 3.9 m -151.95 148.4 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 0.0 109.487 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.437 ' HB2' HD13 ' A' ' 2' ' ' LEU . 43.0 t30 -131.33 44.22 2.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.289 -0.882 . . . . 0.0 109.376 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.95 -88.13 0.67 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.95 -1.68 11.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.247 -1.149 . . . . 0.0 109.463 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.77 -162.59 0.92 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 109.394 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -159.15 173.74 15.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.198 -0.939 . . . . 0.0 109.797 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.624 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -145.05 -176.74 0.58 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.596 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.1 Cg_endo -77.3 136.54 16.04 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.068 1.845 . . . . 0.0 110.118 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.431 ' HB3' HG13 ' A' ' 73' ' ' ILE . 36.2 Cg_endo -78.43 104.0 1.76 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.65 2.234 . . . . 0.0 111.221 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.772 HD13 HG22 ' A' ' 6' ' ' THR . 0.9 OUTLIER -80.99 90.52 5.97 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.069 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.545 ' CD1' ' HB2' ' A' ' 71' ' ' SER . 2.7 mt -92.93 159.8 2.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.146 -0.971 . . . . 0.0 110.703 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.51 ' N ' HG22 ' A' ' 85' ' ' ILE . . . -154.22 168.34 32.5 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -117.27 139.94 50.18 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.129 -1.218 . . . . 0.0 109.915 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.749 ' HG2' HD11 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -139.68 -162.75 1.38 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.371 -0.831 . . . . 0.0 109.029 179.758 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -156.76 129.23 7.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.114 -0.991 . . . . 0.0 109.886 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.443 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -78.8 146.26 33.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.385 -0.822 . . . . 0.0 108.999 179.693 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.568 HG23 HG22 ' A' ' 13' ' ' ILE . 1.4 t . . . . . 0 N--CA 1.493 1.686 0 O-C-N 121.506 -0.746 . . . . 0.0 110.114 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . 0.495 ' O ' ' HB2' ' A' ' 112' ' ' TRP . 36.2 Cg_endo . . . . . 0 C--O 1.214 -0.686 0 N-CA-C 108.63 -1.334 . . . . 0.0 108.63 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 112' ' ' TRP . 24.9 mtt180 -72.51 -163.65 0.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.665 0.745 . . . . 0.0 110.392 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 111' ' ' SER . 8.4 m-20 64.64 9.48 5.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.614 -0.679 . . . . 0.0 109.588 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.884 HD22 ' CD2' ' A' ' 162' ' ' LEU . 25.1 tp -61.71 99.13 0.11 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.138 -0.976 . . . . 0.0 109.439 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -137.76 159.96 40.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.902 . . . . 0.0 109.673 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.405 HG12 ' H ' ' A' ' 100' ' ' VAL . 2.7 p -81.35 139.78 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.362 -0.836 . . . . 0.0 109.716 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.535 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 41.6 pt -134.62 4.46 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.404 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.925 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -165.12 88.27 0.45 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.516 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 0.7 OUTLIER -82.72 96.44 8.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.417 -0.802 . . . . 0.0 110.609 -178.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.572 HG21 ' OG ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -84.01 162.72 51.22 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.244 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.515 ' O ' HG23 ' A' ' 106' ' ' THR . 29.4 Cg_endo -67.82 -3.21 9.99 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.532 2.155 . . . . 0.0 111.138 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.863 ' C ' HG22 ' A' ' 152' ' ' ILE . 2.3 p -156.6 22.39 0.34 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.572 ' OG ' HG21 ' A' ' 104' ' ' THR . 18.2 p -172.54 175.91 3.39 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.118 -1.033 . . . . 0.0 109.924 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.847 HD12 ' N ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -153.69 154.48 34.2 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.484 -0.76 . . . . 0.0 109.203 -179.627 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.925 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -103.02 114.55 28.94 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.095 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.976 HD11 ' CD1' ' A' ' 149' ' ' ILE . 0.4 OUTLIER -103.61 131.62 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.113 -0.992 . . . . 0.0 109.954 -179.512 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 97' ' ' ASP . 3.3 m -123.52 132.53 53.94 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.572 ' CD2' ' O ' ' A' ' 145' ' ' SER . 49.0 p90 -135.99 169.52 17.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.935 . . . . 0.0 109.695 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.181 179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 1.118 ' CE1' HG22 ' A' ' 139' ' ' THR . 1.4 p90 . . . . . 0 N--CA 1.485 1.317 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.507 ' HA ' ' O ' ' A' ' 163' ' ' TYR . 32.2 m-85 -93.51 134.42 35.8 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.998 -1.064 . . . . 0.0 108.85 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 4.3 ttp-105 -101.19 94.83 6.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.246 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.631 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 19.6 mt -85.79 141.52 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.299 -0.876 . . . . 0.0 109.96 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 1.1 HG22 ' CG ' ' A' ' 137' ' ' GLU . 5.1 p -113.79 127.44 56.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.372 -0.83 . . . . 0.0 109.507 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 1.162 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 3.4 m-30 -74.95 113.93 12.82 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.613 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -101.77 119.83 6.63 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 120.214 -0.994 . . . . 0.0 110.852 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 . . . . . 0 C--N 1.297 -1.697 0 O-C-N 121.269 -1.136 . . . . 0.0 108.529 178.725 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.559 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 0.6 OUTLIER . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 1.1 ' CG ' HG22 ' A' ' 125' ' ' THR . 14.4 mp0 -142.79 157.76 44.3 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.902 -1.124 . . . . 0.0 110.985 -178.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.631 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 6.0 p90 -155.51 135.14 12.59 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 1.118 HG22 ' CE1' ' A' ' 121' ' ' TYR . 12.2 p -74.37 165.29 25.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.083 -1.011 . . . . 0.0 110.905 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.546 HG21 ' CD1' ' A' ' 124' ' ' ILE . 2.8 t -136.07 140.96 34.63 Favored Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.506 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.3 Cg_endo -76.29 146.75 28.53 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.334 2.023 . . . . 0.0 110.142 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.33 37.33 3.14 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.416 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 89.4 p -105.12 -1.1 25.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.111 -1.229 . . . . 0.0 109.624 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 143' ' ' SER . 5.7 mttt -151.45 154.5 36.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.186 -0.946 . . . . 0.0 109.52 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.572 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 0.4 OUTLIER -91.8 2.24 56.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 109.552 179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 110' ' ' ILE . 2.0 p -124.56 151.41 44.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.054 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.535 ' HB3' HG13 ' A' ' 110' ' ' ILE . . . -118.12 178.14 4.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.141 -0.975 . . . . 0.0 109.409 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.466 HG22 ' OD1' ' A' ' 150' ' ' ASN . 57.4 m -133.2 97.31 3.95 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.252 -0.905 . . . . 0.0 109.568 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 1.162 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 1.0 OUTLIER -79.17 93.11 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.333 -0.855 . . . . 0.0 109.051 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.539 ' HA ' ' CB ' ' A' ' 107' ' ' SER . 82.9 m-20 -101.29 178.23 4.71 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.935 . . . . 0.0 109.356 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 28.7 m120 57.67 55.92 5.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.892 . . . . 0.0 109.355 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.863 HG22 ' C ' ' A' ' 106' ' ' THR . 13.8 tt -111.63 164.4 7.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.268 -0.895 . . . . 0.0 109.699 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -95.03 110.26 49.0 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.134 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 152' ' ' ILE . 34.9 Cg_endo -76.77 139.66 20.06 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.355 2.036 . . . . 0.0 110.522 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.69 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 95.55 62.49 0.99 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 164.6 132.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -1.136 . . . . 0.0 109.524 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.478 ' HA ' ' HA ' ' A' ' 183' ' ' LYS . 1.8 t70 -48.19 168.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.613 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -146.69 -164.7 2.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.837 -1.164 . . . . 0.0 110.275 -179.638 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 127' ' ' GLY . 9.2 m -174.79 105.21 0.1 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.736 HD11 HD22 ' A' ' 108' ' ' LEU . 54.8 mt -97.75 117.2 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.909 -1.119 . . . . 0.0 110.286 -178.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.609 HG23 ' HB2' ' A' ' 179' ' ' SER . 36.9 m -120.46 161.86 20.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.28 -0.888 . . . . 0.0 108.723 178.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.884 ' CD2' HD22 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -156.72 148.6 22.8 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 118.742 -1.183 . . . . 0.0 111.441 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.648 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.9 m-85 -120.54 161.87 20.57 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 1.046 ' HB3' ' OG ' ' A' ' 175' ' ' SER . . . -113.68 102.15 9.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.938 -1.102 . . . . 0.0 109.016 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.508 HG21 ' CZ ' ' A' ' 121' ' ' TYR . 51.7 t . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.383 -0.823 . . . . 0.0 110.218 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 2.4 p . . . . . 0 N--CA 1.489 1.502 0 CA-C-O 121.224 0.535 . . . . 0.0 109.669 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 1.046 ' OG ' ' HB3' ' A' ' 164' ' ' ALA . 0.7 OUTLIER -50.81 169.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.29 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . 0.407 ' C ' ' O ' ' A' ' 175' ' ' SER . 0.3 OUTLIER -44.36 123.68 4.47 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.286 -0.884 . . . . 0.0 109.274 179.705 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.648 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 33.7 Cg_endo -77.61 140.45 18.88 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.018 1.812 . . . . 0.0 110.902 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.37 135.48 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 0.609 ' HB2' HG23 ' A' ' 161' ' ' THR . 30.6 t -122.83 170.76 9.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.164 -0.96 . . . . 0.0 111.332 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.482 HG21 ' O ' ' A' ' 98' ' ' LEU . 7.1 pt -152.21 152.65 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 159' ' ' THR . 67.0 m-80 -96.22 157.72 15.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.946 -1.096 . . . . 0.0 110.028 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.725 ' CZ ' HD23 ' A' ' 108' ' ' LEU . 39.8 t80 -141.1 171.86 13.48 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.384 -0.823 . . . . 0.0 109.448 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 157' ' ' ASP . 3.4 tmtt? -145.05 108.09 4.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.532 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.452 ' OG1' ' N ' ' A' ' 155' ' ' GLY . 5.2 p . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.443 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ASP . . . . . 0.507 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 4.8 m-20 -91.25 132.46 36.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 109.439 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.524 ' OG ' ' CG ' ' A' ' 82' ' ' PRO . 15.2 m -95.79 150.05 36.86 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.305 -0.872 . . . . 0.0 109.808 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PRO . . . . . 0.714 ' O ' HD22 ' A' ' 84' ' ' LEU . 36.2 Cg_endo -79.74 131.05 9.0 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.746 2.297 . . . . 0.0 109.873 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 5' ' ' PRO . 0.8 OUTLIER -157.75 -167.62 2.31 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.053 -1.029 . . . . 0.0 109.591 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 46.25 27.06 2.54 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.056 -2.017 . . . . 0.0 108.056 -179.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PHE . . . . . 0.624 ' C ' ' CD1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -70.21 -170.33 0.36 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.74 -0.859 . . . . 0.0 109.57 -179.235 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.437 ' N ' ' CG ' ' A' ' 8' ' ' PHE . 21.3 t70 -165.55 110.19 0.86 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.229 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . 0.664 ' HB3' HG13 ' A' ' 20' ' ' VAL . 4.6 p -84.75 139.6 31.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.196 -0.94 . . . . 0.0 109.355 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.452 ' O ' ' C ' ' A' ' 12' ' ' ASP . 5.1 p -164.74 -157.96 0.38 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.185 -0.947 . . . . 0.0 109.623 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.538 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.6 OUTLIER 44.3 36.34 1.55 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -178.56 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ILE . . . . . 0.866 HG23 ' CB ' ' A' ' 18' ' ' PHE . 1.6 mt -74.63 145.29 11.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.862 -178.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.59 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -124.78 172.57 9.21 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.012 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.727 ' HB1' ' CB ' ' A' ' 64' ' ' PRO . . . -67.92 -65.11 0.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.704 -1.248 . . . . 0.0 109.419 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.482 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -90.5 27.44 1.71 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.06 -1.025 . . . . 0.0 109.323 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.59 ' O ' ' N ' ' A' ' 14' ' ' THR . 3.5 p -178.02 161.28 1.51 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 1.041 ' CE1' HD13 ' A' ' 59' ' ' LEU . 17.5 p90 -167.74 147.86 5.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.891 -1.131 . . . . 0.0 109.644 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.538 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 4.0 m -90.7 158.41 16.91 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.843 -1.16 . . . . 0.0 111.164 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.774 HG11 HG11 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -139.23 104.26 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.38 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.412 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 7.9 m-70 -86.23 162.7 18.17 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.153 -0.967 . . . . 0.0 110.261 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' TRP . . . . . 0.787 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 16.3 p90 -175.08 136.4 0.38 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.469 -0.77 . . . . 0.0 109.305 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -74.74 161.57 4.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 O-C-N 121.091 -1.006 . . . . 0.0 109.693 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -96.74 160.96 28.13 Favored Pre-proline 0 C--N 1.298 -1.664 0 O-C-N 121.745 -0.597 . . . . 0.0 109.703 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.507 ' HB2' ' HB2' ' A' ' 3' ' ' ASP . 36.1 Cg_endo -78.44 163.57 27.04 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.647 2.231 . . . . 0.0 110.326 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.49 28.76 1.89 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.427 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.554 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -118.92 161.32 36.88 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.456 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.554 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.5 Cg_endo -78.18 89.9 1.31 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.612 2.208 . . . . 0.0 110.39 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.676 HD12 ' CD2' ' A' ' 32' ' ' TYR . 20.3 pt -97.45 171.59 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.506 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.499 HG23 ' HA ' ' A' ' 76' ' ' ASN . 64.1 p -100.57 -26.65 13.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.894 . . . . 0.0 109.433 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.08 -152.11 9.94 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 1.067 ' CZ ' ' HB2' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -165.12 126.26 2.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -1.17 . . . . 0.0 109.647 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.999 ' C ' HD13 ' A' ' 34' ' ' ILE . 6.1 mt -94.78 138.92 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.203 -0.936 . . . . 0.0 109.288 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.05 HG21 HG21 ' A' ' 57' ' ' ILE . 1.5 mm -119.85 117.91 55.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.298 -0.876 . . . . 0.0 109.077 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ARG . . . . . 0.534 ' CG ' ' OG ' ' A' ' 71' ' ' SER . 3.1 ptp180 -121.94 140.5 52.37 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.881 -1.137 . . . . 0.0 108.698 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 1.064 ' CG ' HD21 ' A' ' 59' ' ' LEU . 28.5 m-70 -137.43 167.21 22.07 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.055 -1.028 . . . . 0.0 110.496 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' HIS . . . . . 0.479 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 45.9 p-80 -173.37 149.46 1.73 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.604 ' HA ' ' CD2' ' A' ' 68' ' ' TYR . . . -56.15 -163.65 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.564 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.459 ' OE2' ' OE2' ' A' ' 67' ' ' GLU . 5.3 mm-40 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.955 . . . . 0.0 109.718 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.792 HH11 HD23 ' A' ' 59' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.247 0.546 . . . . 0.0 109.557 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLN . . . . . 0.523 ' HB3' ' NE ' ' A' ' 49' ' ' ARG . 1.0 OUTLIER -126.66 109.52 12.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 110.174 -179.574 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.863 ' CB ' HD11 ' A' ' 57' ' ' ILE . 64.9 m-20 -92.68 111.54 23.18 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.42 -0.8 . . . . 0.0 108.928 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ARG . . . . . 0.817 ' HD2' HG23 ' A' ' 33' ' ' ILE . 9.6 mmt85 -90.58 137.82 32.05 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.16 -0.963 . . . . 0.0 109.339 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.78 HG13 HG12 ' A' ' 34' ' ' ILE . 5.5 m -126.66 160.19 59.82 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.296 -0.878 . . . . 0.0 109.432 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.5 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 34.9 Cg_endo -77.25 174.72 12.33 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.555 2.17 . . . . 0.0 110.343 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 34.8 Cg_endo -76.88 -15.4 16.75 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.513 2.142 . . . . 0.0 110.356 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 m -93.87 13.13 23.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.263 -0.898 . . . . 0.0 109.451 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.436 ' O ' ' CZ2' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -123.93 121.36 35.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.921 . . . . 0.0 109.499 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.498 ' O ' ' CE3' ' A' ' 22' ' ' TRP . 3.6 p30 -107.25 -0.86 22.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 109.523 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.7 p -132.55 129.76 39.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.648 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 1.05 HG21 HG21 ' A' ' 34' ' ' ILE . 2.3 tt -125.63 141.27 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.309 -0.869 . . . . 0.0 109.126 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 19.4 m -104.5 127.34 52.19 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.158 -0.964 . . . . 0.0 109.966 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.064 HD21 ' CG ' ' A' ' 36' ' ' HIS . 5.0 mp -84.39 160.73 20.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.341 -0.85 . . . . 0.0 109.674 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 0.8 OUTLIER -152.9 169.22 23.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.619 -0.676 . . . . 0.0 109.553 179.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASN . . . . . 0.463 ' O ' HD23 ' A' ' 62' ' ' LEU . 3.6 m120 60.07 48.28 8.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.886 . . . . 0.0 109.39 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . 1.008 HD11 ' HB3' ' A' ' 59' ' ' LEU . 2.0 mt -127.7 157.19 40.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.292 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASN . . . . . 0.499 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 1.4 m-20 -63.1 132.59 95.13 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.119 -0.988 . . . . 0.0 108.693 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.727 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . 36.3 Cg_endo -77.49 125.4 7.62 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.288 1.992 . . . . 0.0 110.638 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 90' ' ' THR . . . 77.94 61.67 2.49 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.638 HG22 ' CE1' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -154.66 145.12 22.15 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.255 -1.144 . . . . 0.0 110.155 -179.164 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 23.4 tt0 -74.87 129.57 37.91 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.638 ' CE1' HG22 ' A' ' 66' ' ' THR . 27.9 m-85 -125.42 164.56 20.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.997 -1.065 . . . . 0.0 110.251 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 70' ' ' VAL . 53.9 t -110.28 164.49 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.807 HG22 ' ND1' ' A' ' 36' ' ' HIS . 4.6 t -149.67 144.07 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.832 -1.167 . . . . 0.0 110.168 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.586 ' CB ' HG12 ' A' ' 85' ' ' ILE . 1.3 p -142.09 118.76 11.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.2 -0.938 . . . . 0.0 109.897 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . 1.039 HD13 HG23 ' A' ' 34' ' ' ILE . 4.5 mm -91.38 131.85 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.493 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.583 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 5.4 mt -116.91 150.75 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 109.201 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.067 ' HB2' ' CZ ' ' A' ' 32' ' ' TYR . . . -123.21 147.09 47.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.361 -0.837 . . . . 0.0 109.642 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.21 132.71 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 109.384 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASN . . . . . 0.506 ' HB3' ' HB2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -121.08 53.37 1.14 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 109.422 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.95 -69.85 3.17 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.8 tpp85 -126.08 -0.58 7.15 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -1.166 . . . . 0.0 109.647 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.525 ' O ' ' CG ' ' A' ' 80' ' ' GLU . 6.7 mm-40 -106.71 178.11 4.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.917 . . . . 0.0 109.399 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.525 ' CG ' ' O ' ' A' ' 79' ' ' GLU . 56.1 mt-10 -160.81 105.52 1.39 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.659 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.562 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -60.15 179.57 0.21 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 109.103 179.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.562 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.3 Cg_endo -77.43 149.25 27.3 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.35 2.033 . . . . 0.0 110.238 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 35.8 Cg_endo -77.96 106.24 2.14 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.65 2.233 . . . . 0.0 111.175 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.714 HD22 ' O ' ' A' ' 5' ' ' PRO . 12.3 tp -78.91 119.91 22.76 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ILE . . . . . 0.586 HG12 ' CB ' ' A' ' 71' ' ' SER . 0.5 OUTLIER -106.88 163.95 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.008 -1.058 . . . . 0.0 110.292 -179.365 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.554 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -156.42 164.31 32.44 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -117.93 141.66 48.19 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.124 -1.221 . . . . 0.0 110.034 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.573 ' CG ' HD11 ' A' ' 13' ' ' ILE . 2.1 mm-40 -165.27 137.6 4.29 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -103.26 148.87 25.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 110.102 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.471 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.7 OUTLIER -74.75 139.83 43.66 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.55 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.693 HG23 HG22 ' A' ' 13' ' ' ILE . 2.3 t . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.486 0.66 . . . . 0.0 110.571 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo . . . . . 0 C--O 1.215 -0.665 0 N-CA-C 109.947 -0.828 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -174.28 156.12 2.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.194 -0.941 . . . . 0.0 109.635 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 1.4 t0 78.38 25.5 0.58 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.396 -0.815 . . . . 0.0 109.928 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.897 HD22 ' CD2' ' A' ' 162' ' ' LEU . 27.9 tp -67.46 101.39 0.97 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.062 -1.023 . . . . 0.0 109.114 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -138.26 -171.92 3.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 109.642 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.5 p -107.14 144.24 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.227 -0.921 . . . . 0.0 109.837 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.923 HD11 HD22 ' A' ' 109' ' ' LEU . 22.8 pt -126.75 -4.32 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.373 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.978 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -152.38 91.38 1.58 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . 0.505 ' HB2' ' OH ' ' A' ' 182' ' ' TYR . 4.9 p -85.31 85.97 7.41 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.526 -0.733 . . . . 0.0 110.298 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' THR . . . . . 0.547 ' OG1' ' N ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -74.42 163.29 69.33 Favored Pre-proline 0 C--N 1.306 -1.307 0 O-C-N 121.045 -1.034 . . . . 0.0 108.462 179.215 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 29.7 Cg_endo -68.47 -3.1 10.36 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.437 2.091 . . . . 0.0 110.775 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.922 ' C ' HG22 ' A' ' 152' ' ' ILE . 21.7 p -153.68 20.1 0.53 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' SER . . . . . 0.547 ' N ' ' OG1' ' A' ' 104' ' ' THR . 6.3 p -170.84 165.58 7.83 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.999 -1.08 . . . . 0.0 110.281 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 1.021 HD13 HD11 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -139.42 153.36 47.58 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.978 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.3 OUTLIER -105.53 98.43 8.13 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.319 -0.863 . . . . 0.0 108.904 179.296 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ILE . . . . . 0.763 HD11 ' HB3' ' A' ' 147' ' ' ALA . 1.3 pt -74.62 134.56 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.168 -0.958 . . . . 0.0 109.612 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.406 ' HA ' HG22 ' A' ' 146' ' ' THR . 12.8 t -134.05 111.15 10.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.554 -0.716 . . . . 0.0 109.237 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' TRP . . . . . 0.576 ' CD2' ' O ' ' A' ' 145' ' ' SER . 37.4 p90 -130.03 137.96 50.52 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.331 -0.855 . . . . 0.0 109.158 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.437 ' C ' ' O ' ' A' ' 112' ' ' TRP . 2.4 mt-10 . . . . . 0 N--CA 1.489 1.51 0 O-C-N 121.187 -0.946 . . . . 0.0 108.944 180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.51 ' HB2' ' O ' ' A' ' 140' ' ' VAL . 3.6 p90 . . . . . 0 N--CA 1.485 1.281 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' TYR . . . . . 0.553 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 3.6 m-85 -111.46 126.83 55.37 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 15.1 ttp180 -84.9 91.6 8.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.139 -0.976 . . . . 0.0 109.398 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ILE . . . . . 0.788 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 19.2 mt -84.45 138.77 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.889 . . . . 0.0 109.59 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 25.9 p -112.7 129.63 56.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.411 -0.805 . . . . 0.0 109.889 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' TYR . . . . . 0.647 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 2.2 m-85 -75.36 131.75 40.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.449 -0.782 . . . . 0.0 109.091 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLY . . . . . 0.601 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -101.47 107.03 3.15 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 . . . . . 0 C--N 1.298 -1.647 0 O-C-N 121.115 -1.227 . . . . 0.0 108.932 179.111 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' GLN . . . . . 0.566 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 N-CA-C 109.084 -0.71 . . . . 0.0 109.084 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 1.9 tm-20 -88.57 123.22 32.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 110.39 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.788 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 38.7 p90 -125.42 140.62 52.63 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.479 HG22 ' CE1' ' A' ' 121' ' ' TYR . 8.5 p -74.44 162.8 28.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.106 -0.996 . . . . 0.0 110.342 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.748 HG21 ' CD1' ' A' ' 124' ' ' ILE . 2.4 t -131.44 142.37 45.13 Favored Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 121.602 -0.686 . . . . 0.0 109.625 -178.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' PRO . . . . . 0.493 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.9 Cg_endo -77.48 140.54 19.23 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.408 2.072 . . . . 0.0 109.935 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.3 24.88 8.68 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.51 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 2.1 p -105.42 32.22 4.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.147 -1.207 . . . . 0.0 109.664 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.51 ' CG ' ' O ' ' A' ' 143' ' ' SER . 1.7 mttt -177.83 156.63 1.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.095 -1.003 . . . . 0.0 109.773 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.576 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 1.1 p -95.17 -14.52 24.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.884 . . . . 0.0 109.357 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 110' ' ' ILE . 6.5 p -118.92 137.88 53.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.118 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.763 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -118.99 164.22 15.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.143 -0.973 . . . . 0.0 109.696 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.8 t -95.15 156.48 16.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.246 -0.909 . . . . 0.0 109.144 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.647 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 9.7 mm -134.96 68.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.202 -0.936 . . . . 0.0 109.577 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.534 ' O ' ' CB ' ' A' ' 151' ' ' ASN . 1.4 m-80 -83.44 166.39 18.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.46 -0.775 . . . . 0.0 109.496 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 2.0 t30 79.02 31.6 0.3 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.352 -0.843 . . . . 0.0 109.794 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.922 HG22 ' C ' ' A' ' 106' ' ' THR . 2.7 tt -94.04 159.96 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.169 -0.957 . . . . 0.0 109.47 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt -103.94 120.77 50.14 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.301 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.14 147.45 23.53 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.424 2.083 . . . . 0.0 110.507 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 72.52 61.59 3.55 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.488 ' N ' ' OG1' ' A' ' 184' ' ' THR . . . 177.56 129.17 0.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -1.124 . . . . 0.0 109.582 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -46.05 160.69 0.06 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.129 -0.982 . . . . 0.0 108.455 179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TYR . . . . . 0.601 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -148.39 178.46 8.57 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.736 -1.228 . . . . 0.0 110.242 -179.574 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' THR . . . . . 0.557 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 6.1 m -161.73 108.92 1.39 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.38 -0.825 . . . . 0.0 109.209 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 1.021 HD11 HD13 ' A' ' 108' ' ' LEU . 15.4 mt -98.85 133.21 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.608 -1.307 . . . . 0.0 109.824 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 1.007 HG23 ' CB ' ' A' ' 179' ' ' SER . 1.6 m -141.39 174.18 10.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.312 -0.867 . . . . 0.0 109.339 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.897 ' CD2' HD22 ' A' ' 98' ' ' LEU . 0.7 OUTLIER -163.99 148.63 10.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.063 -1.023 . . . . 0.0 110.997 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' TYR . . . . . 0.617 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.6 m-85 -125.32 81.73 2.0 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.497 ' HB2' ' CD2' ' A' ' 122' ' ' TYR . . . -45.18 99.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.952 -1.093 . . . . 0.0 109.15 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 163' ' ' TYR . 70.7 t . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.898 . . . . 0.0 109.917 -179.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.371 -0.604 . . . . 0.0 109.371 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 96.9 p -53.82 161.33 1.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.929 . . . . 0.0 109.351 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -46.25 142.95 3.94 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.174 -0.954 . . . . 0.0 108.588 179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.617 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 35.0 Cg_endo -77.88 141.52 19.2 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.345 2.03 . . . . 0.0 111.397 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.2 t -114.99 134.68 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' SER . . . . . 1.007 ' CB ' HG23 ' A' ' 161' ' ' THR . 1.1 p -133.29 162.25 32.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 111.02 -178.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.886 HG21 ' O ' ' A' ' 98' ' ' LEU . 13.5 pt -142.26 152.13 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -93.33 152.1 19.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.987 -1.071 . . . . 0.0 109.853 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.667 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 53.6 t80 -146.53 130.03 16.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.399 -0.813 . . . . 0.0 109.468 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -106.34 119.34 39.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.444 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' THR . . . . . 0.488 ' OG1' ' N ' ' A' ' 156' ' ' ALA . 1.5 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.484 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.477 ' O ' HD23 ' A' ' 2' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.477 HD23 ' O ' ' A' ' 1' ' ' GLY . 2.6 mt -127.86 -164.44 1.37 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.297 -1.119 . . . . 0.0 109.245 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.501 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 1.0 OUTLIER -99.84 162.34 13.06 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.283 -0.886 . . . . 0.0 109.084 179.649 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.478 ' HA ' ' HG2' ' A' ' 82' ' ' PRO . 79.6 p -95.15 136.62 22.54 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.109 -0.995 . . . . 0.0 109.762 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.862 ' O ' HD22 ' A' ' 84' ' ' LEU . 35.9 Cg_endo -79.27 119.07 4.1 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 C-N-CA 122.602 2.201 . . . . 0.0 110.067 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -141.43 -163.21 1.52 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.021 -1.049 . . . . 0.0 109.746 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 60.29 22.46 58.54 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -178.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 1.005 ' HB3' HD21 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -82.28 168.05 17.99 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.863 -0.786 . . . . 0.0 109.538 -179.17 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.768 ' O ' HG12 ' A' ' 20' ' ' VAL . 3.6 t70 -165.28 -163.93 0.72 Allowed 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 9.9 t -142.91 149.16 38.09 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.151 -0.968 . . . . 0.0 109.643 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.475 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 40.4 p -176.24 -163.52 0.1 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.334 -0.854 . . . . 0.0 109.286 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.571 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.6 OUTLIER 45.8 37.11 3.2 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 106.873 -1.529 . . . . 0.0 106.873 -178.622 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.697 HG22 HG23 ' A' ' 91' ' ' VAL . 1.8 mt -85.5 165.03 2.34 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.554 0 CA-C-N 115.218 -0.901 . . . . 0.0 111.65 -177.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.626 HG23 ' O ' ' A' ' 17' ' ' SER . 0.7 OUTLIER -154.41 -165.21 2.02 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.829 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -86.62 -44.96 11.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.022 -1.049 . . . . 0.0 109.875 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.508 ' OD1' ' NH1' ' A' ' 168' ' ' ARG . 1.6 p-10 -110.32 11.15 23.46 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.91 -1.119 . . . . 0.0 109.486 -179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.937 ' HB3' HG22 ' A' ' 60' ' ' THR . 0.0 OUTLIER -160.9 150.11 16.85 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 179.767 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.677 ' HA ' ' HA ' ' A' ' 13' ' ' ILE . 2.1 p90 -165.51 143.35 5.91 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.009 -1.057 . . . . 0.0 108.855 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.907 ' OG1' HG23 ' A' ' 58' ' ' THR . 61.6 m -107.95 163.85 12.78 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.823 -1.173 . . . . 0.0 111.099 -178.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.768 HG12 ' O ' ' A' ' 9' ' ' ASP . 0.9 OUTLIER -132.09 170.88 19.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.449 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.475 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 18.1 m-70 -142.07 158.44 43.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.994 -1.066 . . . . 0.0 110.195 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.597 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 23.9 p90 -170.84 135.19 1.06 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.43 -0.794 . . . . 0.0 109.24 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.48 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.37 166.53 2.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.135 -0.978 . . . . 0.0 109.363 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.887 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -98.03 174.07 3.46 Favored Pre-proline 0 C--N 1.298 -1.639 0 O-C-N 121.666 -0.646 . . . . 0.0 109.772 -179.401 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.887 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.6 Cg_endo -78.64 177.35 8.84 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.682 2.255 . . . . 0.0 110.457 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 45.6 mtp180 -86.73 9.13 19.84 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.208 -0.932 . . . . 0.0 109.388 179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.744 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -126.07 168.06 15.18 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.286 -0.884 . . . . 0.0 109.496 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.744 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.4 Cg_endo -78.12 133.04 11.94 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.695 2.264 . . . . 0.0 110.444 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.673 HD13 ' CE1' ' A' ' 32' ' ' TYR . 27.2 pt -118.18 -172.79 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.241 -0.912 . . . . 0.0 109.435 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 44.4 p -123.12 -10.24 8.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.218 -0.926 . . . . 0.0 109.555 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.501 ' O ' ' CG2' ' A' ' 75' ' ' VAL . . . 157.38 151.21 5.94 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.588 -1.405 . . . . 0.0 109.588 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.673 ' CE1' HD13 ' A' ' 29' ' ' ILE . 2.4 m-30 -114.07 139.09 49.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.274 -1.133 . . . . 0.0 109.612 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.965 ' C ' HD13 ' A' ' 34' ' ' ILE . 1.7 mp -93.01 128.97 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.233 -0.917 . . . . 0.0 109.087 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.976 HG21 HG21 ' A' ' 57' ' ' ILE . 1.8 mm -115.86 109.25 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.214 -0.929 . . . . 0.0 109.76 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.48 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -109.86 137.11 48.11 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.13 -0.981 . . . . 0.0 109.012 179.36 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.872 ' HB3' HG22 ' A' ' 70' ' ' VAL . 5.4 p-80 -129.84 146.74 51.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.109 -0.994 . . . . 0.0 110.076 -179.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.554 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 28.6 p-80 -168.24 133.34 1.76 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.339 -0.851 . . . . 0.0 109.87 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.936 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . -66.08 137.54 57.13 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 109.243 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.03 -2.35 20.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.195 -0.941 . . . . 0.0 109.759 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -99.84 29.48 4.15 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.143 -0.973 . . . . 0.0 109.676 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.5 p -150.48 153.76 36.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.212 -0.93 . . . . 0.0 109.529 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.404 ' O ' HG22 ' A' ' 42' ' ' VAL . 9.9 p -117.35 -0.75 8.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.221 -0.925 . . . . 0.0 109.583 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -62.25 -168.06 0.71 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.416 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 5.2 mtm180 -80.51 134.54 54.39 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.278 -1.13 . . . . 0.0 109.368 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.504 ' HB3' ' HB3' ' A' ' 37' ' ' HIS . 36.3 Cg_endo -78.93 145.39 19.72 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.535 2.157 . . . . 0.0 110.468 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.483 ' HB2' ' NE2' ' A' ' 36' ' ' HIS . 0.6 OUTLIER -74.59 151.86 39.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.217 -0.927 . . . . 0.0 109.239 179.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -123.14 117.16 24.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.197 -0.939 . . . . 0.0 109.958 -179.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.593 ' HB3' HD11 ' A' ' 57' ' ' ILE . 1.3 m-20 -120.04 107.68 13.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.413 -0.804 . . . . 0.0 108.893 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.842 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -91.28 142.28 27.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.07 -1.019 . . . . 0.0 109.8 -179.504 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.74 HG13 HD12 ' A' ' 57' ' ' ILE . 5.8 m -119.3 161.97 34.35 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.44 -0.787 . . . . 0.0 109.107 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.531 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.5 Cg_endo -76.88 173.93 13.67 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.501 2.134 . . . . 0.0 110.293 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 35.4 Cg_endo -77.35 -15.32 15.93 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.648 2.232 . . . . 0.0 110.545 -179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.3 29.27 4.03 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.576 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.531 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 12.0 mmt85 -138.96 119.85 14.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.228 -0.92 . . . . 0.0 109.562 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.541 ' O ' ' CE3' ' A' ' 22' ' ' TRP . 10.2 p-10 -99.24 -3.66 33.73 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.27 -0.894 . . . . 0.0 109.468 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 74.8 p -135.14 158.59 43.97 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 0.0 109.175 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.976 HG21 HG21 ' A' ' 34' ' ' ILE . 3.5 tt -142.29 124.4 13.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.155 -0.966 . . . . 0.0 109.607 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.907 HG23 ' OG1' ' A' ' 19' ' ' THR . 0.3 OUTLIER -82.53 117.1 22.28 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.31 -0.868 . . . . 0.0 109.414 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.84 ' HB3' HD11 ' A' ' 62' ' ' LEU . 1.2 mt -95.93 143.37 27.17 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.27 -0.893 . . . . 0.0 109.562 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.937 HG22 ' HB3' ' A' ' 17' ' ' SER . 39.2 p -134.61 -177.4 4.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -0.911 . . . . 0.0 109.35 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.603 ' O ' HD23 ' A' ' 62' ' ' LEU . 4.4 m-80 53.03 56.37 7.64 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.226 -0.921 . . . . 0.0 109.385 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.84 HD11 ' HB3' ' A' ' 59' ' ' LEU . 6.0 mt -134.13 134.65 42.46 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.495 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.469 ' CB ' ' OH ' ' A' ' 68' ' ' TYR . 3.2 t30 -51.17 130.05 31.41 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.0 109.081 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.829 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 36.2 Cg_endo -78.52 134.0 12.13 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 C-N-CA 122.355 2.037 . . . . 0.0 110.712 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 82.83 60.95 1.99 Allowed Glycine 0 N--CA 1.487 2.092 0 N-CA-C 109.033 -1.627 . . . . 0.0 109.033 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.408 ' O ' ' N ' ' A' ' 90' ' ' THR . 2.4 m -163.73 154.26 15.66 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.323 -1.104 . . . . 0.0 109.924 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.2 OUTLIER -88.92 127.1 35.64 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.936 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 23.5 m-85 -118.27 124.02 46.81 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.011 -1.055 . . . . 0.0 109.879 -179.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.554 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 22.7 t -83.65 122.28 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.303 -0.873 . . . . 0.0 108.976 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.872 HG22 ' HB3' ' A' ' 36' ' ' HIS . 24.6 t -110.88 122.56 65.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.125 -0.985 . . . . 0.0 109.55 -179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.541 ' HB2' ' CD1' ' A' ' 85' ' ' ILE . 82.3 p -103.54 117.13 33.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.192 -0.943 . . . . 0.0 109.903 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.803 HD13 HG23 ' A' ' 34' ' ' ILE . 11.2 mm -94.08 120.16 43.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.324 -0.86 . . . . 0.0 109.648 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.788 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.4 mp -112.11 132.74 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.165 -0.959 . . . . 0.0 109.124 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.58 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -95.94 154.48 17.21 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.242 -0.911 . . . . 0.0 109.557 -179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.501 ' CG2' ' O ' ' A' ' 31' ' ' GLY . 11.7 m -154.97 130.28 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.27 -0.894 . . . . 0.0 109.449 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -103.03 45.56 0.95 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.257 -0.902 . . . . 0.0 109.36 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.68 -85.21 0.99 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.294 -1.522 . . . . 0.0 109.294 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -111.64 -1.14 15.83 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.261 -1.141 . . . . 0.0 109.404 179.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -97.09 -166.26 1.37 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -0.89 . . . . 0.0 109.311 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -146.36 -167.07 2.64 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.14 -0.975 . . . . 0.0 109.854 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.592 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.0 OUTLIER -172.44 -178.87 0.46 Allowed Pre-proline 0 N--CA 1.489 1.52 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 -179.676 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.592 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.1 Cg_endo -76.6 134.2 14.99 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.021 1.814 . . . . 0.0 109.69 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.534 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 35.2 Cg_endo -77.1 108.83 2.71 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.437 2.091 . . . . 0.0 111.129 -178.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.005 HD21 ' HB3' ' A' ' 8' ' ' PHE . 9.7 tp -77.4 80.94 3.89 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.296 -0.878 . . . . 0.0 108.638 179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.541 ' CD1' ' HB2' ' A' ' 71' ' ' SER . 4.2 mt -86.06 151.47 3.66 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.184 -0.947 . . . . 0.0 110.216 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.44 ' C ' ' HG3' ' A' ' 87' ' ' GLN . . . -145.42 -169.13 13.47 Favored Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.82 -1.712 . . . . 0.0 108.82 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.483 ' HG2' HG13 ' A' ' 69' ' ' VAL . 30.8 mt-30 -150.73 126.89 10.55 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.168 -1.195 . . . . 0.0 109.676 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.857 HE22 HG23 ' A' ' 70' ' ' VAL . 9.6 pm0 -129.3 -155.31 0.69 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.317 -0.864 . . . . 0.0 108.752 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.539 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -159.73 136.13 8.99 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.037 -1.04 . . . . 0.0 110.002 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.408 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.93 137.16 41.49 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.401 -0.812 . . . . 0.0 108.997 179.667 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.697 HG23 HG22 ' A' ' 13' ' ' ILE . 3.1 t -53.92 164.87 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 CA-C-O 121.407 0.622 . . . . 0.0 110.092 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.403 ' N ' HG12 ' A' ' 91' ' ' VAL . 1.9 t -90.95 154.29 19.56 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.471 -0.768 . . . . 0.0 108.984 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.525 ' OD1' ' CB ' ' A' ' 15' ' ' ALA . 0.2 OUTLIER -97.25 -37.79 9.93 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.107 -0.996 . . . . 0.0 110.068 -179.641 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.673 HG23 ' HD2' ' A' ' 95' ' ' PRO . 1.4 mt -76.27 140.84 69.59 Favored Pre-proline 0 N--CA 1.487 1.399 0 O-C-N 121.002 -1.061 . . . . 0.0 109.557 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.673 ' HD2' HG23 ' A' ' 94' ' ' ILE . 36.3 Cg_endo -80.77 -159.28 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.597 2.198 . . . . 0.0 109.656 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.504 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -169.9 158.54 7.34 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.091 -1.006 . . . . 0.0 109.604 179.591 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.504 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 4.5 t0 78.13 26.83 0.57 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.435 -0.791 . . . . 0.0 109.715 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.818 ' CD1' HD23 ' A' ' 162' ' ' LEU . 1.7 tt -60.3 99.4 0.08 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.13 -0.981 . . . . 0.0 109.057 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -138.05 165.38 26.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.239 -0.913 . . . . 0.0 109.616 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 13.3 p -96.31 147.24 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.294 -0.879 . . . . 0.0 109.762 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.531 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 14.1 pt -127.99 -4.32 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.29 -0.881 . . . . 0.0 109.704 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.911 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -153.03 105.28 2.9 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.517 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 10.0 m -100.79 91.08 4.45 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.207 -0.933 . . . . 0.0 110.588 -178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.541 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -83.35 163.28 50.81 Favored Pre-proline 0 C--N 1.306 -1.306 0 O-C-N 121.126 -0.983 . . . . 0.0 108.671 178.726 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -69.2 -2.12 9.21 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 C-N-CA 122.296 1.997 . . . . 0.0 110.795 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.833 ' C ' HG22 ' A' ' 152' ' ' ILE . 23.2 p -147.56 12.58 1.03 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.29 -0.881 . . . . 0.0 109.497 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 1.053 ' O ' HD23 ' A' ' 108' ' ' LEU . 3.2 p -169.84 164.69 9.82 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.809 -1.182 . . . . 0.0 110.198 179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.053 HD23 ' O ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -139.13 155.4 47.9 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.306 -0.871 . . . . 0.0 109.131 -179.722 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.911 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 1.3 mt -105.41 116.23 31.59 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.295 -0.878 . . . . 0.0 109.329 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.65 HD11 ' HB3' ' A' ' 147' ' ' ALA . 1.6 pt -99.01 143.55 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 109.494 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.906 ' CB ' HG22 ' A' ' 146' ' ' THR . 41.3 p -140.24 131.2 26.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.352 -0.843 . . . . 0.0 109.58 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.644 ' HH2' ' HB2' ' A' ' 147' ' ' ALA . 47.0 p90 -135.85 151.69 50.29 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.358 -0.839 . . . . 0.0 109.35 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.474 ' HB2' ' HG3' ' A' ' 96' ' ' ARG . 14.2 mt-10 -56.46 141.61 71.16 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.485 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 113' ' ' GLU . 36.3 Cg_endo -79.31 118.07 3.9 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.645 2.23 . . . . 0.0 110.459 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.454 ' O ' ' N ' ' A' ' 117' ' ' VAL . 34.9 Cg_endo -78.04 138.05 16.03 Favored 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.379 2.053 . . . . 0.0 110.276 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.689 ' HB3' ' CG1' ' A' ' 91' ' ' VAL . . . -69.84 59.65 0.16 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.142 -0.974 . . . . 0.0 109.431 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.698 HG11 ' HB2' ' A' ' 15' ' ' ALA . 14.8 m -146.21 154.18 12.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.44 -0.787 . . . . 0.0 109.257 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 10.6 m -83.7 86.2 7.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.242 -0.911 . . . . 0.0 109.515 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.859 HG11 ' CE2' ' A' ' 122' ' ' TYR . 1.7 t -74.92 125.76 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.909 . . . . 0.0 109.439 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 165' ' ' VAL . 0.2 OUTLIER -75.05 -45.98 37.92 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.121 -0.987 . . . . 0.0 108.746 179.39 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.683 ' CE2' HG22 ' A' ' 139' ' ' THR . 1.5 p90 -167.22 165.53 15.3 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.151 -0.968 . . . . 0.0 109.575 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.859 ' CE2' HG11 ' A' ' 119' ' ' VAL . 1.4 m-85 -125.96 140.4 52.65 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.251 -0.906 . . . . 0.0 109.013 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.595 ' CG ' ' HB2' ' A' ' 163' ' ' TYR . 0.1 OUTLIER -113.12 98.95 7.47 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.655 -1.278 . . . . 0.0 108.214 178.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.841 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 20.8 mt -92.25 156.73 3.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.354 -0.841 . . . . 0.0 110.629 -178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 82.1 p -116.01 135.84 53.59 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.76 -0.588 . . . . 0.0 109.594 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.642 ' CE2' ' CG2' ' A' ' 149' ' ' ILE . 14.1 m-85 -74.17 143.62 45.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 109.368 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.581 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.86 94.02 0.94 Allowed Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -106.63 139.12 41.59 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.224 -1.163 . . . . 0.0 109.427 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.579 HG21 ' CB ' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -81.34 -89.91 0.07 Allowed 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.197 -0.939 . . . . 0.0 109.653 179.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -108.6 56.79 0.46 Allowed Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -84.26 -83.02 0.98 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.471 ' O ' ' CB ' ' A' ' 133' ' ' SER . 19.5 p-10 -173.24 33.6 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.216 -1.167 . . . . 0.0 109.436 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.537 ' CB ' ' HD2' ' A' ' 134' ' ' PRO . 0.3 OUTLIER 166.42 176.33 0.05 OUTLIER Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.274 -0.891 . . . . 0.0 109.473 -179.945 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 133' ' ' SER . 35.5 Cg_endo -77.72 -173.93 2.01 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.578 2.185 . . . . 0.0 110.384 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 126' ' ' TYR . 3.0 m -52.8 149.8 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.337 0 O-C-N 121.239 -0.913 . . . . 0.0 109.827 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.495 ' HB2' ' HB2' ' A' ' 126' ' ' TYR . 1.9 tt0 -105.32 113.96 27.85 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.91 . . . . 0.0 109.402 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 8.2 pt-20 -84.38 126.9 33.65 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.193 -0.942 . . . . 0.0 110.372 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.841 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 11.7 p90 -131.27 136.73 48.43 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.345 -0.847 . . . . 0.0 108.834 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.683 HG22 ' CE2' ' A' ' 121' ' ' TYR . 1.7 p -74.78 157.55 35.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.235 -0.916 . . . . 0.0 110.755 -178.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.509 ' O ' ' HB2' ' A' ' 121' ' ' TYR . 39.7 t -121.5 127.14 26.22 Favored Pre-proline 0 C--N 1.303 -1.422 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 -179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.522 ' O ' ' N ' ' A' ' 143' ' ' SER . 36.3 Cg_endo -79.01 42.11 1.22 Allowed 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.282 1.988 . . . . 0.0 111.352 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.491 ' C ' ' O ' ' A' ' 141' ' ' PRO . . . 35.49 31.86 0.03 OUTLIER Glycine 0 N--CA 1.498 2.804 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.522 ' N ' ' O ' ' A' ' 141' ' ' PRO . 0.9 OUTLIER -50.43 -41.22 52.18 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.326 -1.102 . . . . 0.0 109.835 -179.354 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.456 ' HD2' ' OG1' ' A' ' 146' ' ' THR . 0.4 OUTLIER 179.43 -168.69 0.1 Allowed 'General case' 0 C--N 1.293 -1.862 0 O-C-N 121.609 -0.682 . . . . 0.0 109.628 -179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.564 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -71.98 -4.54 29.1 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.319 -0.863 . . . . 0.0 109.499 179.878 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.906 HG22 ' CB ' ' A' ' 111' ' ' SER . 75.7 p -124.37 133.09 53.52 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.178 -0.951 . . . . 0.0 109.396 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.65 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -117.54 169.87 9.2 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.228 -0.92 . . . . 0.0 109.608 -179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.408 ' C ' HG12 ' A' ' 149' ' ' ILE . 12.2 t -99.24 164.47 12.12 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.382 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.642 ' CG2' ' CE2' ' A' ' 126' ' ' TYR . 17.7 mm -143.59 65.86 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 109.448 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.579 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 0.8 OUTLIER -78.7 -152.23 0.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.479 -0.763 . . . . 0.0 109.792 -179.918 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.4 ' O ' ' OD1' ' A' ' 151' ' ' ASN . 24.0 t-20 47.1 26.43 0.64 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.25 -0.906 . . . . 0.0 109.418 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.833 HG22 ' C ' ' A' ' 106' ' ' THR . 3.3 tt -92.19 160.74 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 O-C-N 121.304 -0.873 . . . . 0.0 109.637 -179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.416 ' HD2' ' HD2' ' A' ' 154' ' ' PRO . 0.0 OUTLIER -122.58 127.65 25.72 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.189 -0.945 . . . . 0.0 109.268 179.805 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.449 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 36.1 Cg_endo -78.59 155.87 27.96 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.467 2.111 . . . . 0.0 110.593 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.704 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 81.76 64.89 1.7 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.746 -1.341 . . . . 0.0 109.746 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.704 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 162.3 132.15 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.287 -1.125 . . . . 0.0 109.657 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.579 ' CB ' HG21 ' A' ' 129' ' ' THR . 0.9 OUTLIER -51.59 164.83 0.2 Allowed 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.699 ' CD1' HG21 ' A' ' 184' ' ' THR . 0.2 OUTLIER -145.21 -175.87 4.87 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.705 -1.247 . . . . 0.0 110.519 -179.149 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.571 HG22 ' N ' ' A' ' 160' ' ' ILE . 2.9 m -162.97 168.16 21.51 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.571 ' N ' HG22 ' A' ' 159' ' ' THR . 67.0 mt -152.55 136.25 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.856 -1.152 . . . . 0.0 109.908 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.95 HG23 ' CB ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -138.74 131.25 28.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.316 -0.865 . . . . 0.0 109.081 179.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.818 HD23 ' CD1' ' A' ' 98' ' ' LEU . 3.7 pp -114.68 141.27 48.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.076 -1.015 . . . . 0.0 111.23 -178.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.663 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 1.4 m-85 -122.56 72.49 1.07 Allowed 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.548 ' CB ' ' CD2' ' A' ' 122' ' ' TYR . . . -45.5 120.12 2.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.864 -1.147 . . . . 0.0 109.284 -179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.501 ' O ' ' HG3' ' A' ' 120' ' ' ARG . 74.0 t -98.93 124.37 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.285 -0.884 . . . . 0.0 109.722 -179.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.511 ' O ' ' N ' ' A' ' 173' ' ' ALA . 69.8 p -114.52 130.81 56.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.45 -0.781 . . . . 0.0 108.929 179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.527 ' O ' ' CD ' ' A' ' 168' ' ' ARG . . . -69.43 157.32 53.5 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 -179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.539 ' HG2' ' HA ' ' A' ' 172' ' ' PRO . 0.7 OUTLIER -140.97 13.0 2.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.324 -1.104 . . . . 0.0 109.543 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 117.24 -116.67 3.58 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.8 -1.01 20.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -1.158 . . . . 0.0 109.468 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 168' ' ' ARG . 22.9 m -160.6 125.0 2.07 Favored Pre-proline 0 N--CA 1.488 1.433 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.539 ' HA ' ' HG2' ' A' ' 168' ' ' ARG . 34.5 Cg_endo -76.15 -168.94 0.61 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.262 1.975 . . . . 0.0 110.636 -179.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.511 ' N ' ' O ' ' A' ' 166' ' ' THR . . . -155.29 164.25 39.03 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.248 -0.907 . . . . 0.0 110.062 -179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 175' ' ' SER . 0.7 OUTLIER -146.68 108.81 4.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.404 -0.81 . . . . 0.0 109.186 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.571 ' HB2' ' CG1' ' A' ' 94' ' ' ILE . 3.4 p -52.8 -171.43 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.337 -0.852 . . . . 0.0 109.619 -179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.567 ' CB ' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -69.11 144.86 95.83 Favored Pre-proline 0 C--N 1.306 -1.315 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 179.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.663 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.1 Cg_endo -77.86 128.88 9.53 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.446 2.097 . . . . 0.0 111.641 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.7 t -95.52 124.2 48.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 178.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.95 ' CB ' HG23 ' A' ' 161' ' ' THR . 0.0 OUTLIER -115.2 146.7 41.15 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 110.811 -178.372 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.589 HG23 HD13 ' A' ' 98' ' ' LEU . 5.2 pt -130.81 -164.92 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 5.5 m120 -126.16 164.86 20.0 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.961 -1.087 . . . . 0.0 109.491 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.748 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 63.4 t80 -165.08 132.87 3.13 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.205 -0.935 . . . . 0.0 109.461 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.5 mmmt -103.21 129.84 50.25 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.208 -0.932 . . . . 0.0 109.613 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.699 HG21 ' CD1' ' A' ' 158' ' ' TYR . 30.8 p . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 117.963 -1.018 . . . . 0.0 109.494 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.79 HD11 ' HG2' ' A' ' 79' ' ' GLU . 4.9 mt -78.52 -160.87 0.24 Allowed 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.286 -1.126 . . . . 0.0 109.616 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.843 ' CG ' HG22 ' A' ' 29' ' ' ILE . 1.1 m-20 -73.94 77.35 1.66 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.395 -0.816 . . . . 0.0 109.133 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.532 ' OG ' ' CG ' ' A' ' 82' ' ' PRO . 14.8 m -95.58 109.59 46.53 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.431 -0.793 . . . . 0.0 109.772 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.677 ' O ' HD22 ' A' ' 84' ' ' LEU . 36.7 Cg_endo -79.66 145.52 18.3 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.375 2.05 . . . . 0.0 110.077 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.668 HG23 ' O ' ' A' ' 5' ' ' PRO . 0.7 OUTLIER -161.43 -171.87 3.15 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.099 -1.0 . . . . 0.0 109.762 179.857 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 45.44 27.33 1.88 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 108.322 -1.911 . . . . 0.0 108.322 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.62 ' C ' ' CD1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -71.65 -161.63 0.07 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.598 -0.943 . . . . 0.0 109.867 -179.242 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.517 ' N ' ' CG ' ' A' ' 8' ' ' PHE . 1.5 t70 -165.58 -170.97 1.96 Allowed 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.361 -0.837 . . . . 0.0 108.993 179.281 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.506 ' OG ' ' NE2' ' A' ' 88' ' ' GLN . 5.1 p -154.37 133.08 12.18 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.138 -0.976 . . . . 0.0 109.69 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.607 ' HG ' ' CD2' ' A' ' 21' ' ' HIS . 51.3 p -161.15 -159.64 0.67 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.253 -0.904 . . . . 0.0 109.42 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.524 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.8 OUTLIER 45.37 33.68 1.32 Allowed 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 -178.247 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.657 ' HA ' ' HA ' ' A' ' 18' ' ' PHE . 1.3 mt -75.71 163.43 3.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.485 -177.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.687 HG23 ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -149.71 -167.92 2.96 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.027 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.913 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -88.12 -47.55 8.4 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.901 -1.125 . . . . 0.0 109.361 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.454 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.2 OUTLIER -105.59 19.72 20.1 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.915 -1.116 . . . . 0.0 109.001 179.623 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.822 ' HB3' HG22 ' A' ' 60' ' ' THR . 0.0 OUTLIER -172.64 153.33 2.76 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.741 ' CE1' HG22 ' A' ' 20' ' ' VAL . 4.7 p90 -166.19 140.73 4.43 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.955 -1.09 . . . . 0.0 108.985 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 2.3 m -89.07 160.34 17.1 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.922 -1.111 . . . . 0.0 111.252 -178.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.741 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -137.46 122.39 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 179.444 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.607 ' CD2' ' HG ' ' A' ' 11' ' ' SER . 29.2 m-70 -99.31 153.09 19.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.097 -1.002 . . . . 0.0 110.104 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.803 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 22.3 p90 -161.5 133.48 5.72 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.382 -0.824 . . . . 0.0 109.523 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.548 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.41 170.54 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.234 -0.917 . . . . 0.0 109.295 179.844 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.548 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -100.76 159.58 29.18 Favored Pre-proline 0 C--N 1.298 -1.647 0 O-C-N 121.623 -0.673 . . . . 0.0 109.378 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.543 ' CG ' ' HB3' ' A' ' 3' ' ' ASP . 36.2 Cg_endo -78.28 -159.11 0.1 OUTLIER 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.7 2.266 . . . . 0.0 110.403 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -107.07 1.19 24.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.541 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.629 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -104.24 164.13 15.9 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.21 -0.931 . . . . 0.0 109.45 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.629 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.1 Cg_endo -77.5 141.4 19.93 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.669 2.246 . . . . 0.0 110.307 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.843 HG22 ' CG ' ' A' ' 3' ' ' ASP . 18.7 pt -133.69 163.33 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.268 -0.895 . . . . 0.0 109.763 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.2 p -117.73 1.78 12.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.406 -0.809 . . . . 0.0 109.234 179.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.575 ' O ' HG23 ' A' ' 75' ' ' VAL . . . 164.24 161.18 12.86 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.613 ' CD1' HD12 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -125.82 124.18 40.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.226 -1.161 . . . . 0.0 109.633 -179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.941 HG23 ' HG3' ' A' ' 49' ' ' ARG . 14.6 mm -87.64 118.61 33.79 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.198 -0.939 . . . . 0.0 109.318 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.071 HG23 HD13 ' A' ' 72' ' ' ILE . 1.5 mm -107.2 110.22 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.185 -0.947 . . . . 0.0 109.86 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.475 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 35.6 ttp180 -109.05 142.82 39.19 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.146 -0.971 . . . . 0.0 108.657 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.67 ' CG ' HD22 ' A' ' 59' ' ' LEU . 21.9 p-80 -132.06 151.75 51.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.986 -1.071 . . . . 0.0 110.187 -179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.539 ' CB ' ' HB3' ' A' ' 45' ' ' PRO . 54.6 p-80 -168.55 126.66 1.09 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.512 -0.743 . . . . 0.0 109.023 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.724 ' HB2' ' CE2' ' A' ' 68' ' ' TYR . . . -47.55 174.48 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.15 -0.969 . . . . 0.0 109.6 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.519 ' HB2' ' CD2' ' A' ' 40' ' ' HIS . 1.3 mt-10 -89.12 -24.42 22.24 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.101 -0.999 . . . . 0.0 109.582 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.519 ' CD2' ' HB2' ' A' ' 39' ' ' GLU . 6.8 p80 -165.32 23.67 0.05 Allowed 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.509 -0.744 . . . . 0.0 109.867 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.6 p -83.23 165.09 19.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.328 -0.858 . . . . 0.0 109.554 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.475 HG12 ' O ' ' A' ' 42' ' ' VAL . 22.0 t -87.29 -0.54 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.267 -0.896 . . . . 0.0 109.617 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -61.44 -175.26 1.71 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.59 140.63 26.95 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.259 -1.141 . . . . 0.0 109.435 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.539 ' HB3' ' CB ' ' A' ' 37' ' ' HIS . 36.3 Cg_endo -78.79 120.09 4.59 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 C-N-CA 122.508 2.138 . . . . 0.0 110.421 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.576 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 0.1 OUTLIER -106.59 174.64 5.8 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.186 -0.946 . . . . 0.0 109.363 179.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -123.27 103.91 8.81 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.236 -0.915 . . . . 0.0 109.943 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 1.003 ' HB3' HD11 ' A' ' 57' ' ' ILE . 4.8 m-20 -98.41 112.88 24.75 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.258 -0.901 . . . . 0.0 108.856 179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.941 ' HG3' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -96.69 152.91 18.2 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.133 -0.979 . . . . 0.0 109.858 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.88 HG13 HD12 ' A' ' 57' ' ' ILE . 5.1 m -134.46 162.12 59.6 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.462 -0.774 . . . . 0.0 109.034 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.543 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.7 Cg_endo -77.02 174.16 13.29 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.481 2.12 . . . . 0.0 110.365 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 35.3 Cg_endo -77.63 -15.26 15.5 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.549 2.166 . . . . 0.0 110.419 -179.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -99.39 29.73 3.86 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.292 -0.88 . . . . 0.0 109.477 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.543 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 4.5 mmt180 -139.17 132.89 30.65 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.254 -0.904 . . . . 0.0 109.569 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.412 ' O ' ' CE3' ' A' ' 22' ' ' TRP . 21.7 p-10 -112.61 -3.0 14.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.272 -0.893 . . . . 0.0 109.38 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 88.5 p -132.2 148.38 52.46 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.226 -0.922 . . . . 0.0 109.35 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.003 HD11 ' HB3' ' A' ' 48' ' ' ASP . 5.9 tt -139.35 127.24 26.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.177 -0.952 . . . . 0.0 109.821 -179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.74 115.51 24.22 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.206 -0.934 . . . . 0.0 109.298 179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.67 HD22 ' CG ' ' A' ' 36' ' ' HIS . 6.5 mt -88.31 160.47 17.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.212 -0.93 . . . . 0.0 109.738 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.822 HG22 ' HB3' ' A' ' 17' ' ' SER . 19.7 p -147.2 173.3 12.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.376 -0.827 . . . . 0.0 109.609 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.66 ' O ' HD23 ' A' ' 62' ' ' LEU . 4.2 m-80 62.07 53.2 3.04 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.352 -0.843 . . . . 0.0 109.915 179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.669 HD11 ' HB3' ' A' ' 59' ' ' LEU . 3.0 mt -132.69 135.61 45.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.24 -0.913 . . . . 0.0 109.315 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.469 ' CB ' ' OH ' ' A' ' 68' ' ' TYR . 3.2 t30 -47.24 131.54 9.68 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.094 -1.004 . . . . 0.0 108.889 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.913 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 36.6 Cg_endo -78.68 134.2 12.04 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.475 2.117 . . . . 0.0 111.258 -179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 78.95 62.03 2.29 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.151 -1.579 . . . . 0.0 109.151 179.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.606 HG22 ' CE1' ' A' ' 68' ' ' TYR . 1.2 m -161.99 144.04 11.28 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.275 -1.133 . . . . 0.0 110.2 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.523 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -79.19 133.37 36.7 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.652 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.724 ' CE2' ' HB2' ' A' ' 38' ' ' ALA . 50.7 m-85 -124.88 171.55 10.08 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.903 -1.123 . . . . 0.0 110.832 -178.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.706 HG12 HG23 ' A' ' 85' ' ' ILE . 3.2 t -124.37 137.54 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.538 HG13 ' HB3' ' A' ' 36' ' ' HIS . 2.2 t -126.8 129.38 71.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.847 -1.158 . . . . 0.0 110.356 -178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.574 ' CB ' HG12 ' A' ' 85' ' ' ILE . 5.0 p -100.42 101.45 12.41 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.323 -0.86 . . . . 0.0 109.996 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.071 HD13 HG23 ' A' ' 34' ' ' ILE . 26.0 mm -80.91 84.2 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.094 -1.004 . . . . 0.0 109.317 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.475 ' HB ' ' HB ' ' A' ' 33' ' ' ILE . 9.1 mt -81.87 159.2 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.191 -0.943 . . . . 0.0 109.587 -179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.556 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -121.05 169.87 10.08 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.259 -0.9 . . . . 0.0 109.434 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -154.94 140.51 10.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.218 -0.926 . . . . 0.0 109.547 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.429 ' O ' ' CG ' ' A' ' 76' ' ' ASN . 27.1 t-20 -137.24 49.44 2.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 109.585 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.71 -96.15 1.44 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.44 ' CD ' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -112.37 1.7 16.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.337 -1.096 . . . . 0.0 109.519 179.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.79 ' HG2' HD11 ' A' ' 2' ' ' LEU . 1.2 tt0 -98.29 170.08 9.12 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.266 -0.897 . . . . 0.0 109.387 -179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 2.3 mp0 -148.89 108.35 3.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.112 -0.993 . . . . 0.0 110.009 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.582 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -59.92 -178.34 0.14 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 108.649 179.245 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.582 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.0 Cg_endo -76.87 154.33 33.78 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.177 1.918 . . . . 0.0 110.127 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.2 103.8 1.8 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.66 2.24 . . . . 0.0 111.356 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.677 HD22 ' O ' ' A' ' 5' ' ' PRO . 5.6 tp -81.48 93.64 6.69 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.706 HG23 HG12 ' A' ' 69' ' ' VAL . 3.0 mt -100.09 126.69 53.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.177 -0.952 . . . . 0.0 110.157 -179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.552 ' O ' HG13 ' A' ' 69' ' ' VAL . . . -121.45 -164.71 12.39 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.401 ' HG2' HG13 ' A' ' 69' ' ' VAL . 31.9 mt-30 -143.99 123.85 13.48 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.947 -1.325 . . . . 0.0 110.198 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.506 ' NE2' ' OG ' ' A' ' 10' ' ' SER . 3.9 mm100 -121.5 -152.79 0.52 Allowed 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.4 143.36 6.02 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.089 -1.007 . . . . 0.0 109.904 179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.501 ' HG1' ' HE1' ' A' ' 68' ' ' TYR . 0.6 OUTLIER -87.81 138.13 31.73 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.411 -0.805 . . . . 0.0 109.196 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.625 HG12 ' H ' ' A' ' 92' ' ' SER . 2.9 t -55.12 173.16 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.592 0.711 . . . . 0.0 110.99 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.625 ' H ' HG12 ' A' ' 91' ' ' VAL . 0.1 OUTLIER -87.29 158.41 19.08 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.564 -0.71 . . . . 0.0 109.858 -179.987 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.794 ' OD2' HG11 ' A' ' 117' ' ' VAL . 2.5 m-20 -86.07 -43.99 12.64 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.496 -0.753 . . . . 0.0 109.802 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.802 HG23 ' HD2' ' A' ' 95' ' ' PRO . 0.8 OUTLIER -90.34 144.2 30.58 Favored Pre-proline 0 N--CA 1.486 1.368 0 O-C-N 121.125 -0.984 . . . . 0.0 110.302 -179.058 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.802 ' HD2' HG23 ' A' ' 94' ' ' ILE . 35.8 Cg_endo -79.55 80.34 3.1 Favored 'Trans proline' 0 C--N 1.312 -1.392 0 C-N-CA 122.691 2.261 . . . . 0.0 109.924 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.504 ' CG ' ' N ' ' A' ' 97' ' ' ASP . 32.5 ttt85 -77.5 164.56 25.3 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.321 -0.862 . . . . 0.0 109.752 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.532 ' HB2' ' CG ' ' A' ' 113' ' ' GLU . 2.8 t0 77.63 33.58 0.38 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.417 -0.802 . . . . 0.0 109.781 179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.593 HD22 ' CD2' ' A' ' 162' ' ' LEU . 33.0 tp -77.15 102.53 6.63 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.166 -0.959 . . . . 0.0 109.486 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -140.25 169.89 16.84 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.253 -0.904 . . . . 0.0 109.392 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 7.9 p -94.17 138.86 19.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.268 -0.895 . . . . 0.0 109.922 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.483 HG13 ' HB3' ' A' ' 109' ' ' LEU . 1.3 pp -123.93 -7.97 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.395 -0.816 . . . . 0.0 109.312 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.732 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -158.54 99.08 1.57 Allowed 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.161 -1.052 . . . . 0.0 108.161 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.528 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 0.1 OUTLIER -103.58 109.86 21.7 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.442 -0.786 . . . . 0.0 110.648 -178.52 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.46 ' HB ' ' HD2' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -91.3 166.39 18.56 Favored Pre-proline 0 C--N 1.306 -1.317 0 O-C-N 121.293 -0.88 . . . . 0.0 108.749 178.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.46 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 30.3 Cg_endo -69.55 -2.05 9.35 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.258 1.972 . . . . 0.0 110.617 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.829 ' C ' HG22 ' A' ' 152' ' ' ILE . 62.0 p -145.41 10.47 1.26 Allowed 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.277 -0.889 . . . . 0.0 109.59 179.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 1.029 ' C ' HD23 ' A' ' 108' ' ' LEU . 3.1 p -167.3 153.69 8.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.826 -1.171 . . . . 0.0 109.992 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.029 HD23 ' C ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -120.9 151.38 39.74 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.256 -0.902 . . . . 0.0 109.422 -179.353 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.732 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.7 OUTLIER -106.03 120.9 42.98 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.408 -0.96 . . . . 0.0 108.408 178.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.97 HD11 HD13 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -105.46 133.22 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 120.981 -1.074 . . . . 0.0 110.105 -179.418 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.655 ' HA ' HG22 ' A' ' 146' ' ' THR . 4.9 t -130.82 121.51 25.46 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.658 ' CD1' ' CB ' ' A' ' 95' ' ' PRO . 41.8 p90 -138.28 163.93 30.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.209 -0.932 . . . . 0.0 109.834 -179.344 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.532 ' CG ' ' HB2' ' A' ' 97' ' ' ASP . 1.8 mt-10 -55.55 135.76 70.73 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.259 -0.901 . . . . 0.0 108.655 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.472 ' HB3' ' CB ' ' A' ' 145' ' ' SER . 36.2 Cg_endo -78.73 111.39 2.97 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.393 2.062 . . . . 0.0 111.238 -179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.492 ' HG2' ' OH ' ' A' ' 122' ' ' TYR . 35.8 Cg_endo -78.4 -166.7 0.42 Allowed 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.37 2.047 . . . . 0.0 108.912 178.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.583 ' HB1' ' HA ' ' A' ' 14' ' ' THR . . . -170.35 22.62 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.659 -1.276 . . . . 0.0 111.162 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.88 HG12 ' CB ' ' A' ' 15' ' ' ALA . 6.8 m -80.49 -170.83 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 120.797 -1.189 . . . . 0.0 108.647 179.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.48 ' O ' ' HB ' ' A' ' 166' ' ' THR . 43.9 m -69.73 58.88 0.14 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.973 -1.08 . . . . 0.0 108.873 179.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.87 ' HA ' HG22 ' A' ' 166' ' ' THR . 2.7 t -87.56 111.2 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.356 -0.84 . . . . 0.0 109.963 -179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.457 ' NE ' ' HG2' ' A' ' 168' ' ' ARG . 0.3 OUTLIER -74.48 -41.38 60.84 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.045 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.93 ' CE1' HG22 ' A' ' 139' ' ' THR . 1.2 p90 -166.81 158.34 12.72 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.393 -0.817 . . . . 0.0 109.364 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.524 ' CZ ' HG11 ' A' ' 119' ' ' VAL . 11.5 m-85 -103.18 135.86 44.05 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 178.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 3.2 ttp-105 -90.98 82.85 5.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.997 -1.064 . . . . 0.0 109.889 -179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 1.033 ' CD1' HG21 ' A' ' 140' ' ' VAL . 78.9 mt -83.6 143.64 11.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 179.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 3.2 p -136.76 152.69 50.61 Favored 'General case' 0 N--CA 1.489 1.494 0 C-N-CA 119.069 -1.053 . . . . 0.0 110.931 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 1.107 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 2.4 m-85 -86.21 134.84 33.75 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.607 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -106.19 119.49 6.04 Favored Glycine 0 N--CA 1.485 1.92 0 N-CA-C 109.429 -1.469 . . . . 0.0 109.429 179.059 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.505 ' O ' ' C ' ' A' ' 129' ' ' THR . 2.8 mt-10 -101.08 154.05 19.04 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.19 -1.182 . . . . 0.0 109.133 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 1.063 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 1.1 p -33.64 -47.9 0.25 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.302 0.573 . . . . 0.0 109.95 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.407 ' O ' ' C ' ' A' ' 131' ' ' GLY . . . -94.8 -96.43 1.66 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.038 -1.625 . . . . 0.0 109.038 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 130' ' ' GLY . . . 45.44 76.55 0.12 Allowed Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.506 -1.437 . . . . 0.0 109.506 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.489 ' O ' ' CB ' ' A' ' 133' ' ' SER . 8.4 t-20 -84.32 15.51 3.57 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.326 -1.102 . . . . 0.0 109.631 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.553 ' CB ' ' HD3' ' A' ' 134' ' ' PRO . 0.1 OUTLIER 166.3 -53.42 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.152 -0.967 . . . . 0.0 109.617 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.553 ' HD3' ' CB ' ' A' ' 133' ' ' SER . 36.1 Cg_endo -78.69 85.46 1.84 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.458 2.105 . . . . 0.0 110.597 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.523 ' CG1' ' O ' ' A' ' 126' ' ' TYR . 0.1 OUTLIER -108.09 -164.18 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.202 -0.936 . . . . 0.0 109.036 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.555 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 0.4 OUTLIER -104.28 91.84 4.09 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.05 -1.031 . . . . 0.0 109.042 179.704 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 1.6 tm-20 -89.05 117.44 28.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.289 -0.882 . . . . 0.0 110.833 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.642 ' CE2' ' CG2' ' A' ' 124' ' ' ILE . 25.5 p90 -118.28 136.74 53.51 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.93 HG22 ' CE1' ' A' ' 121' ' ' TYR . 4.6 p -74.01 172.15 12.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.13 -0.981 . . . . 0.0 110.331 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 1.033 HG21 ' CD1' ' A' ' 124' ' ' ILE . 25.3 t -142.85 139.16 16.68 Favored Pre-proline 0 C--N 1.302 -1.464 0 O-C-N 121.494 -0.754 . . . . 0.0 109.884 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.525 ' HD2' HG13 ' A' ' 140' ' ' VAL . 35.4 Cg_endo -78.35 144.32 20.38 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.411 2.074 . . . . 0.0 109.943 179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.27 40.87 3.06 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 48.9 m -105.45 -1.21 25.21 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.215 -1.168 . . . . 0.0 109.847 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -155.3 158.6 39.02 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.139 -0.976 . . . . 0.0 109.835 -179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.575 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -95.42 8.19 43.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.388 -0.82 . . . . 0.0 109.714 -179.902 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.655 HG22 ' HA ' ' A' ' 111' ' ' SER . 54.7 p -133.39 147.55 51.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.193 -0.942 . . . . 0.0 109.442 -179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.495 ' N ' ' CH2' ' A' ' 112' ' ' TRP . . . -132.63 173.16 11.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.142 -0.974 . . . . 0.0 109.459 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.597 ' O ' HD12 ' A' ' 149' ' ' ILE . 1.9 t -125.77 138.88 53.87 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 121.188 -0.945 . . . . 0.0 109.698 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 1.107 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 1.0 OUTLIER -113.09 83.68 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 179.362 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.52 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 3.6 m-20 -92.96 175.23 6.87 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.313 -0.867 . . . . 0.0 110.153 -179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.476 ' OD1' ' N ' ' A' ' 151' ' ' ASN . 1.1 m120 70.21 30.46 3.43 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.222 -0.924 . . . . 0.0 108.912 -179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.829 HG22 ' C ' ' A' ' 106' ' ' THR . 9.4 tt -89.33 163.92 2.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.489 -0.757 . . . . 0.0 109.731 -179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -107.36 121.53 44.17 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.242 -0.911 . . . . 0.0 109.331 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.13 146.68 22.91 Favored 'Trans proline' 0 C--N 1.312 -1.382 0 C-N-CA 122.382 2.055 . . . . 0.0 110.507 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.699 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 87.37 65.57 1.36 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.611 -1.396 . . . . 0.0 109.611 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 1.063 ' HB1' ' CG2' ' A' ' 129' ' ' THR . . . 164.23 130.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.246 -1.149 . . . . 0.0 109.631 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.642 ' N ' HG22 ' A' ' 129' ' ' THR . 32.9 t70 -48.64 163.58 0.07 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.097 -1.002 . . . . 0.0 108.495 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.613 ' CD1' HG21 ' A' ' 184' ' ' THR . 0.2 OUTLIER -147.08 -176.11 5.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.823 -1.173 . . . . 0.0 110.147 -179.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.505 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 4.8 m -163.69 115.55 1.42 Allowed 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.482 HD12 HG12 ' A' ' 149' ' ' ILE . 39.5 mm -100.06 129.34 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.737 -1.227 . . . . 0.0 109.83 -179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 1.021 HG23 ' CB ' ' A' ' 179' ' ' SER . 2.0 m -136.78 168.32 19.76 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.206 -0.933 . . . . 0.0 109.766 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.593 ' CD2' HD22 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -158.64 147.3 18.63 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.044 -1.035 . . . . 0.0 111.304 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.665 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 23.0 m-85 -121.15 105.86 10.99 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -70.64 93.7 0.95 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.911 -1.118 . . . . 0.0 109.158 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.598 HG22 ' HB3' ' A' ' 174' ' ' SER . 2.4 t -78.56 130.73 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 109.896 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.87 HG22 ' HA ' ' A' ' 119' ' ' VAL . 33.2 p -122.87 -59.6 1.58 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.502 -0.749 . . . . 0.0 109.575 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.519 ' O ' ' CG ' ' A' ' 168' ' ' ARG . . . -53.82 178.33 0.19 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 -179.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.519 ' CG ' ' O ' ' A' ' 167' ' ' GLY . 14.8 mtm180 -159.43 111.91 2.16 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.326 -1.102 . . . . 0.0 109.415 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 160.99 -149.61 18.79 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.534 -1.427 . . . . 0.0 109.534 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -78.49 1.44 22.31 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.347 -1.09 . . . . 0.0 109.534 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.457 ' N ' ' HD3' ' A' ' 172' ' ' PRO . 0.7 OUTLIER -150.27 65.22 7.17 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.246 -0.909 . . . . 0.0 109.392 -179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.457 ' HD3' ' N ' ' A' ' 171' ' ' SER . 35.5 Cg_endo -77.9 103.87 1.77 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.63 2.22 . . . . 0.0 110.394 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -87.72 132.18 34.22 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.343 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.598 ' HB3' HG22 ' A' ' 165' ' ' VAL . 44.3 p -112.53 62.39 0.63 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.234 -0.916 . . . . 0.0 109.56 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 174' ' ' SER . 33.7 p 42.0 -164.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.608 ' H ' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -86.58 148.51 46.61 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 120.993 -1.067 . . . . 0.0 108.559 179.276 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.665 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 31.3 Cg_endo -73.54 119.3 5.87 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 C-N-CA 122.143 1.895 . . . . 0.0 111.058 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -107.85 124.33 63.92 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 1.021 ' CB ' HG23 ' A' ' 161' ' ' THR . 1.1 p -127.89 176.87 7.25 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.346 -0.846 . . . . 0.0 111.032 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.581 HG23 HD23 ' A' ' 98' ' ' LEU . 11.4 pt -157.31 152.02 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 24.9 m-20 -85.78 158.58 19.97 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 120.926 -1.109 . . . . 0.0 109.674 -179.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.764 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 47.0 t80 -158.25 127.69 5.79 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.358 -0.839 . . . . 0.0 109.328 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 1.7 tttm -101.86 128.52 48.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.195 -0.941 . . . . 0.0 109.527 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.613 HG21 ' CD1' ' A' ' 158' ' ' TYR . 7.5 p . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.505 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.586 ' O ' HD23 ' A' ' 2' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.305 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.586 HD23 ' O ' ' A' ' 1' ' ' GLY . 1.8 mt -129.31 -162.81 1.23 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -1.136 . . . . 0.0 109.325 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.414 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 3.3 m-20 -106.33 153.22 22.51 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.473 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.541 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 0.3 OUTLIER -95.33 132.32 28.02 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.926 . . . . 0.0 109.763 -179.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.479 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 36.1 Cg_endo -79.54 102.13 1.46 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 C-N-CA 122.515 2.143 . . . . 0.0 109.968 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.686 HG22 ' CD1' ' A' ' 84' ' ' LEU . 1.4 p -95.58 -110.58 0.14 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.137 -0.977 . . . . 0.0 109.792 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.443 ' HA3' ' HB ' ' A' ' 23' ' ' VAL . . . 44.3 27.39 1.17 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 108.713 -1.755 . . . . 0.0 108.713 -179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.576 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 28.2 t80 -51.54 124.5 12.28 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.55 -0.971 . . . . 0.0 110.011 -179.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 0.7 OUTLIER -153.21 87.78 1.28 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.47 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 92.7 p -84.29 124.59 31.4 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.185 -0.947 . . . . 0.0 109.648 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.436 ' O ' ' C ' ' A' ' 12' ' ' ASP . 13.2 p -153.55 -159.34 0.97 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.397 -0.814 . . . . 0.0 109.05 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.501 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 1.1 m-20 45.88 40.12 6.26 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.833 HG23 ' CB ' ' A' ' 18' ' ' PHE . 2.7 mt -85.14 131.76 33.37 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.721 0.772 . . . . 0.0 111.284 -177.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 1.011 HG22 ' O ' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -115.62 -167.13 1.21 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.161 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.62 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -78.48 -70.57 0.48 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.935 -1.103 . . . . 0.0 109.794 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.477 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 52.4 m-20 -83.06 14.21 3.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.127 -0.983 . . . . 0.0 110.156 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.777 ' HB2' HG22 ' A' ' 60' ' ' THR . 1.6 t -165.35 156.46 14.21 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.104 -0.998 . . . . 0.0 109.085 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.989 ' CE1' HG22 ' A' ' 20' ' ' VAL . 4.7 p90 -164.32 145.33 8.28 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.162 -0.962 . . . . 0.0 109.112 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.501 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 3.8 m -89.24 149.69 22.97 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 120.815 -1.178 . . . . 0.0 111.441 -178.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.989 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -130.37 114.17 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.938 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 9' ' ' ASP . 4.4 m-70 -96.42 170.91 8.9 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.995 -1.066 . . . . 0.0 110.748 -178.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.86 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 21.0 p90 178.23 136.43 0.08 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.48 164.85 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.011 -1.056 . . . . 0.0 109.789 -179.693 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.687 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -97.53 167.3 12.05 Favored Pre-proline 0 C--N 1.301 -1.524 0 O-C-N 121.71 -0.619 . . . . 0.0 109.595 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.687 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 36.3 Cg_endo -79.32 -159.28 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.607 2.205 . . . . 0.0 110.294 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -126.24 16.68 7.78 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.298 179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.952 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -117.75 176.08 1.77 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.324 -0.86 . . . . 0.0 109.424 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.952 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.5 Cg_endo -78.16 136.57 14.61 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.635 2.224 . . . . 0.0 110.457 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.744 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 27.5 pt -150.06 -179.85 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.331 -0.856 . . . . 0.0 109.406 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.2 p -120.81 4.53 10.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.202 -0.936 . . . . 0.0 109.583 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 145.96 173.37 17.15 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.579 -1.409 . . . . 0.0 109.579 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.744 ' CZ ' HD11 ' A' ' 29' ' ' ILE . 16.6 m-85 -118.71 123.65 45.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.205 -1.174 . . . . 0.0 109.634 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.83 ' C ' HD13 ' A' ' 34' ' ' ILE . 1.7 mp -79.69 135.18 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.215 -0.928 . . . . 0.0 108.768 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.83 HD13 ' C ' ' A' ' 33' ' ' ILE . 2.9 mm -115.47 107.02 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.069 -1.019 . . . . 0.0 110.064 -179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.457 ' O ' ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -109.18 117.02 33.03 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 178.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.674 ' HB3' HG13 ' A' ' 70' ' ' VAL . 51.2 p-80 -126.83 176.19 7.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.009 -1.057 . . . . 0.0 110.682 -178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 38' ' ' ALA . 42.4 p-80 175.18 145.48 0.07 Allowed 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.583 ' HA ' ' CD2' ' A' ' 68' ' ' TYR . . . -41.57 163.24 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.22 -0.925 . . . . 0.0 109.617 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.698 ' HA ' HG23 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -82.55 -8.23 59.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.08 -1.012 . . . . 0.0 109.567 179.884 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -114.42 36.17 3.88 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.329 -0.857 . . . . 0.0 109.56 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 99.4 p -154.97 92.28 1.44 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.51 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.696 HG12 ' O ' ' A' ' 42' ' ' VAL . 79.6 t -87.81 6.48 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.22 -0.925 . . . . 0.0 109.486 -179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.434 ' O ' ' HD3' ' A' ' 45' ' ' PRO . . . -76.32 -160.56 10.23 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.426 ' C ' ' O ' ' A' ' 43' ' ' GLY . 17.2 mtt85 -42.32 102.38 0.27 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.379 -1.071 . . . . 0.0 109.588 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 35.6 Cg_endo -78.1 161.42 29.51 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 C-N-CA 122.451 2.101 . . . . 0.0 110.308 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.594 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -73.96 149.51 41.32 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.134 -0.979 . . . . 0.0 109.53 -179.674 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.46 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -120.95 122.63 40.59 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.464 -0.772 . . . . 0.0 110.076 -179.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 34' ' ' ILE . 63.2 m-20 -144.54 120.04 10.36 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.752 ' CD ' HG23 ' A' ' 33' ' ' ILE . 5.1 mmt-85 -104.09 152.23 22.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.971 -1.081 . . . . 0.0 110.23 -179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.859 HG12 HD12 ' A' ' 57' ' ' ILE . 10.7 m -128.02 161.29 56.82 Favored Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.546 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 33.7 Cg_endo -76.36 174.13 13.34 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 122.358 2.039 . . . . 0.0 110.34 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.587 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 35.2 Cg_endo -77.07 -15.46 16.33 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.582 2.188 . . . . 0.0 110.604 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.2 t -101.97 17.84 22.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.194 -0.941 . . . . 0.0 109.652 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.546 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.5 OUTLIER -122.77 100.78 7.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.19 -0.944 . . . . 0.0 109.914 -179.822 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -84.85 -3.0 58.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 109.14 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 56.5 p -137.52 149.02 46.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.432 -0.793 . . . . 0.0 109.031 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.86 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 5.2 tt -136.44 125.95 38.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.075 -1.016 . . . . 0.0 109.746 -179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -89.29 107.4 19.04 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.408 -0.807 . . . . 0.0 109.269 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.91 ' HB3' HD11 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -84.91 152.02 23.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.225 -0.922 . . . . 0.0 109.533 -179.904 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.777 HG22 ' HB2' ' A' ' 17' ' ' SER . 29.2 p -137.98 -177.49 4.84 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.294 -0.879 . . . . 0.0 109.467 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.3 m120 55.7 29.67 14.16 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.229 -0.919 . . . . 0.0 109.356 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.91 HD11 ' HB3' ' A' ' 59' ' ' LEU . 5.1 mt -107.53 136.26 47.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.28 -0.888 . . . . 0.0 109.403 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.516 ' CB ' ' OH ' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -44.76 126.61 5.13 Favored Pre-proline 0 N--CA 1.489 1.484 0 O-C-N 121.147 -0.97 . . . . 0.0 108.868 179.784 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.62 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 35.9 Cg_endo -77.42 131.41 11.59 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.29 1.994 . . . . 0.0 110.852 -179.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 78.25 61.35 2.51 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.568 HG22 ' N ' ' A' ' 67' ' ' GLU . 13.2 m -157.16 165.79 35.0 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.258 -1.142 . . . . 0.0 109.93 -179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.568 ' N ' HG22 ' A' ' 66' ' ' THR . 1.8 mp0 -115.33 132.64 56.55 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.445 -0.784 . . . . 0.0 109.174 179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.608 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 1.2 m-85 -130.57 173.83 10.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.213 -0.93 . . . . 0.0 109.377 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.698 HG23 ' HA ' ' A' ' 39' ' ' GLU . 8.4 t -112.82 114.9 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.674 HG13 ' HB3' ' A' ' 36' ' ' HIS . 4.5 t -96.99 138.49 21.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.09 -1.006 . . . . 0.0 110.067 -178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.535 ' CB ' HG12 ' A' ' 85' ' ' ILE . 14.5 p -119.56 138.74 53.0 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.296 -0.878 . . . . 0.0 110.233 -179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.573 HD13 HG23 ' A' ' 34' ' ' ILE . 13.2 mm -111.78 95.11 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.397 -0.815 . . . . 0.0 109.397 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.621 HD12 ' N ' ' A' ' 73' ' ' ILE . 1.3 mp -85.24 122.84 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 0.0 109.339 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.915 ' HB3' ' HB3' ' A' ' 81' ' ' SER . . . -97.34 137.62 36.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.924 . . . . 0.0 109.368 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.705 HG22 HD13 ' A' ' 33' ' ' ILE . 4.6 m -140.78 171.82 12.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.253 -0.905 . . . . 0.0 109.471 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.447 ' OD1' ' HA ' ' A' ' 29' ' ' ILE . 49.2 t30 -146.39 43.23 1.2 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.237 -0.915 . . . . 0.0 109.439 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 112.31 -87.03 0.44 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.04 -8.25 10.74 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.26 -1.141 . . . . 0.0 109.625 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -84.81 -167.21 1.72 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.382 -0.824 . . . . 0.0 109.276 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.52 ' HG2' HG12 ' A' ' 75' ' ' VAL . 16.2 mt-10 -159.4 131.14 6.3 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.188 -0.945 . . . . 0.0 109.929 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.915 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -98.62 -178.33 0.69 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.393 -0.817 . . . . 0.0 108.882 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.591 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.4 Cg_endo -77.34 131.21 11.52 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.118 1.879 . . . . 0.0 109.908 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.452 ' HB3' HG13 ' A' ' 73' ' ' ILE . 35.7 Cg_endo -77.75 115.48 3.84 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.491 2.127 . . . . 0.0 111.117 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.686 ' CD1' HG22 ' A' ' 6' ' ' THR . 0.7 OUTLIER -88.53 106.5 18.33 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.187 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.535 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.8 mt -95.48 146.4 7.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.116 -0.99 . . . . 0.0 110.105 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.576 ' HA3' ' CZ ' ' A' ' 8' ' ' PHE . . . -142.75 161.37 27.46 Favored Glycine 0 N--CA 1.483 1.773 0 N-CA-C 108.134 -1.987 . . . . 0.0 108.134 179.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.475 ' HG2' ' N ' ' A' ' 88' ' ' GLN . 5.8 tt0 -102.05 148.38 25.45 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 121.18 -1.188 . . . . 0.0 110.028 -179.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.619 ' NE2' ' CE2' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -149.82 -176.35 5.39 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.677 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.728 ' O ' HG21 ' A' ' 13' ' ' ILE . . . -160.2 134.61 7.49 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.156 -0.965 . . . . 0.0 109.969 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.5 143.36 36.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.358 -0.839 . . . . 0.0 109.019 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.578 HG11 ' HB2' ' A' ' 116' ' ' ALA . 2.0 t -64.13 163.17 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.512 -0.743 . . . . 0.0 109.888 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.0 t -69.33 169.06 13.0 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.383 -0.823 . . . . 0.0 109.699 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.456 ' HB3' ' HB2' ' A' ' 64' ' ' PRO . 1.4 p30 -115.07 -34.96 4.87 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.353 -0.842 . . . . 0.0 109.728 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.721 HG23 ' HD2' ' A' ' 95' ' ' PRO . 1.6 mt -83.96 143.08 42.44 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.136 -0.978 . . . . 0.0 109.486 -179.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.721 ' HD2' HG23 ' A' ' 94' ' ' ILE . 36.0 Cg_endo -79.54 81.98 2.63 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.652 2.235 . . . . 0.0 110.162 179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.56 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 4.2 ttt180 -66.62 170.71 5.93 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.319 -0.863 . . . . 0.0 109.813 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.56 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 1.1 t0 81.87 34.19 0.09 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.736 . . . . 0.0 110.113 179.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.764 HD22 ' CD2' ' A' ' 162' ' ' LEU . 21.8 tp -76.46 101.56 5.65 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.134 -0.979 . . . . 0.0 109.288 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -151.85 -175.24 5.14 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.253 -0.904 . . . . 0.0 109.077 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.584 HG13 ' O ' ' A' ' 109' ' ' LEU . 47.8 t -119.23 149.37 21.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.0 -1.063 . . . . 0.0 110.164 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.644 ' CG1' HD23 ' A' ' 109' ' ' LEU . 6.9 pt -119.6 -17.14 6.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 CA-C-O 121.737 0.779 . . . . 0.0 109.356 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.472 ' O ' ' HB3' ' A' ' 109' ' ' LEU . . . -150.84 142.12 23.27 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.532 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 51.5 p -150.49 132.09 14.85 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 120.695 -1.253 . . . . 0.0 111.299 -178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.579 ' HB ' ' HD2' ' A' ' 105' ' ' PRO . 0.2 OUTLIER -98.02 171.38 5.94 Favored Pre-proline 0 C--N 1.303 -1.446 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.527 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.579 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 29.9 Cg_endo -69.66 -1.05 7.73 Favored 'Trans proline' 0 C--N 1.308 -1.603 0 C-N-CA 121.918 1.746 . . . . 0.0 110.63 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.843 ' C ' HG22 ' A' ' 152' ' ' ILE . 19.2 p -143.02 8.23 1.65 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.194 -0.941 . . . . 0.0 109.655 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 149' ' ' ILE . 2.9 p -164.33 149.68 10.32 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 118.819 -1.152 . . . . 0.0 109.96 179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.811 HD22 ' CZ ' ' A' ' 182' ' ' TYR . 0.9 OUTLIER -123.69 156.33 36.14 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.228 -0.92 . . . . 0.0 109.909 -179.665 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.644 HD23 ' CG1' ' A' ' 101' ' ' ILE . 11.1 tp -105.27 108.81 20.52 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.963 ' CD1' ' HB3' ' A' ' 147' ' ' ALA . 3.1 pt -92.26 150.04 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.237 -0.914 . . . . 0.0 109.998 -179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 146' ' ' THR . 31.8 m -148.36 135.82 20.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.421 -0.799 . . . . 0.0 109.325 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.661 ' HH2' ' HB2' ' A' ' 147' ' ' ALA . 14.4 p90 -135.68 159.06 42.82 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.21 -0.931 . . . . 0.0 109.42 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -65.32 142.19 98.37 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.068 -1.02 . . . . 0.0 109.315 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 113' ' ' GLU . 36.0 Cg_endo -78.65 119.15 4.35 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.575 2.183 . . . . 0.0 110.484 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.593 ' HB2' HG22 ' A' ' 117' ' ' VAL . 35.8 Cg_endo -78.1 148.93 24.97 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.422 2.081 . . . . 0.0 110.328 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.011 ' O ' HG22 ' A' ' 14' ' ' THR . . . -80.49 57.16 2.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.191 -0.943 . . . . 0.0 109.579 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.593 HG22 ' HB2' ' A' ' 115' ' ' PRO . 25.9 m -142.67 164.5 17.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.339 -0.851 . . . . 0.0 109.459 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 17.4 m -92.18 93.86 8.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.305 -0.872 . . . . 0.0 109.445 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.47 HG11 ' CE2' ' A' ' 122' ' ' TYR . 1.9 t -93.69 144.71 8.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.271 -0.893 . . . . 0.0 109.598 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.531 ' CG ' ' O ' ' A' ' 166' ' ' THR . 2.4 mmt85 -95.44 -37.89 10.72 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.289 -0.882 . . . . 0.0 108.76 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.578 ' CE2' ' HB ' ' A' ' 165' ' ' VAL . 1.9 p90 -163.98 175.32 10.44 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.291 -0.88 . . . . 0.0 109.509 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.621 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 2.2 m-85 -136.63 131.59 33.88 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.307 -0.871 . . . . 0.0 109.097 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.493 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 4.6 ttt180 -84.69 154.4 22.51 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.019 -1.05 . . . . 0.0 108.541 179.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.845 HG23 ' O ' ' A' ' 161' ' ' THR . 17.6 mt -151.03 138.82 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 121.006 -1.059 . . . . 0.0 110.394 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.572 HG22 ' O ' ' A' ' 136' ' ' GLN . 2.2 p -106.28 141.77 37.07 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.607 -0.683 . . . . 0.0 109.721 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.729 ' O ' HG22 ' A' ' 135' ' ' VAL . 1.6 m-85 -88.26 118.83 28.14 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.369 -0.832 . . . . 0.0 108.758 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.624 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.8 113.73 4.3 Favored Glycine 0 N--CA 1.487 2.073 0 C-N-CA 119.607 -1.282 . . . . 0.0 111.217 -179.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.479 ' O ' ' C ' ' A' ' 129' ' ' THR . 25.4 mt-10 -90.21 175.35 7.17 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.173 -1.192 . . . . 0.0 108.384 178.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.578 HG23 ' HB1' ' A' ' 156' ' ' ALA . 0.7 OUTLIER -36.11 -93.04 0.0 OUTLIER 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.603 -0.685 . . . . 0.0 110.517 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 153.06 97.18 0.14 Allowed Glycine 0 N--CA 1.487 2.058 0 N-CA-C 109.497 -1.441 . . . . 0.0 109.497 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.411 ' C ' ' OD1' ' A' ' 132' ' ' ASN . . . -148.07 -39.15 0.04 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.417 ' N ' ' OD1' ' A' ' 132' ' ' ASN . 0.8 OUTLIER -171.01 57.92 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.224 -1.162 . . . . 0.0 109.584 179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.41 ' HA ' ' HD3' ' A' ' 134' ' ' PRO . 0.0 OUTLIER -173.64 142.92 0.96 Allowed Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 109.449 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 133' ' ' SER . 36.2 Cg_endo -78.73 -161.64 0.15 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.597 2.198 . . . . 0.0 110.415 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.788 HG13 ' N ' ' A' ' 136' ' ' GLN . 0.3 OUTLIER -90.4 -166.28 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 CA-C-O 122.098 0.952 . . . . 0.0 109.36 179.886 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.788 ' N ' HG13 ' A' ' 135' ' ' VAL . 0.7 OUTLIER -135.79 -166.95 1.94 Allowed 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 178.373 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.56 ' HG3' HG22 ' A' ' 125' ' ' THR . 0.1 OUTLIER -156.71 152.16 26.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.144 -1.598 . . . . 0.0 111.702 -179.506 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.737 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 11.7 p90 -165.11 134.73 3.6 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 178.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.444 HG22 ' CE1' ' A' ' 121' ' ' TYR . 1.7 p -74.57 171.85 13.09 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.175 -0.953 . . . . 0.0 110.944 -178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.721 HG21 HD11 ' A' ' 124' ' ' ILE . 28.5 t -131.83 140.53 38.52 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.52 -0.738 . . . . 0.0 109.542 -179.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.606 ' HD2' HG13 ' A' ' 140' ' ' VAL . 35.5 Cg_endo -77.99 125.47 7.31 Favored 'Trans proline' 0 C--N 1.308 -1.581 0 C-N-CA 122.428 2.086 . . . . 0.0 109.919 179.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -77.32 51.65 3.31 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.431 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 16.0 p -105.5 -4.71 20.96 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.194 -1.18 . . . . 0.0 109.551 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 143' ' ' SER . 0.6 OUTLIER -173.55 178.21 2.37 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.265 -0.897 . . . . 0.0 109.513 -179.949 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.571 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 0.3 OUTLIER -95.12 15.33 19.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.329 -0.857 . . . . 0.0 109.584 -179.959 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.531 ' C ' ' CH2' ' A' ' 112' ' ' TRP . 2.1 p -123.52 146.15 48.32 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.191 -0.943 . . . . 0.0 109.465 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.963 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -133.12 167.19 20.79 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.246 -0.909 . . . . 0.0 109.461 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.651 ' O ' HD13 ' A' ' 149' ' ' ILE . 14.0 m -108.49 164.07 12.66 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.207 -0.933 . . . . 0.0 109.465 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.651 HD13 ' O ' ' A' ' 148' ' ' THR . 11.7 mm -143.24 66.65 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.0 109.335 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.553 ' HA ' ' CB ' ' A' ' 107' ' ' SER . 4.3 m120 -78.28 -167.51 1.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.692 -0.63 . . . . 0.0 109.814 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 50.92 42.0 27.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.081 -1.012 . . . . 0.0 109.053 -179.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.843 HG22 ' C ' ' A' ' 106' ' ' THR . 4.4 tt -106.18 160.03 5.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.422 -0.799 . . . . 0.0 109.915 -179.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -93.58 125.22 54.63 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.931 . . . . 0.0 109.17 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.463 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 35.8 Cg_endo -78.73 140.25 16.36 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.436 2.091 . . . . 0.0 110.859 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.449 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 75.09 63.23 2.58 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.578 ' HB1' HG23 ' A' ' 129' ' ' THR . . . 178.13 127.2 0.05 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.174 -1.192 . . . . 0.0 110.147 179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.557 ' N ' HG23 ' A' ' 129' ' ' THR . 9.7 t70 -48.58 167.94 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.64 ' CE2' HG13 ' A' ' 152' ' ' ILE . 0.4 OUTLIER -146.6 -167.88 2.87 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.973 -1.079 . . . . 0.0 109.991 -179.544 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.516 ' N ' ' O ' ' A' ' 127' ' ' GLY . 4.4 m -168.41 96.39 0.4 Allowed 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.744 HD11 HD12 ' A' ' 108' ' ' LEU . 7.1 mt -91.86 133.01 34.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.049 -1.032 . . . . 0.0 110.05 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 1.04 HG23 ' CB ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -131.27 159.91 36.44 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.329 -0.857 . . . . 0.0 108.764 179.311 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.764 ' CD2' HD22 ' A' ' 98' ' ' LEU . 1.7 pp -150.82 150.08 30.5 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.734 -1.229 . . . . 0.0 111.714 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.641 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.3 m-85 -125.99 79.59 1.85 Allowed 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.468 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -43.92 125.69 4.41 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.976 -1.077 . . . . 0.0 109.322 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.578 ' HB ' ' CE2' ' A' ' 121' ' ' TYR . 55.2 t -113.16 135.66 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.245 -0.909 . . . . 0.0 110.079 -179.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.531 ' O ' ' CG ' ' A' ' 120' ' ' ARG . 0.7 OUTLIER -105.96 -38.65 6.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.532 -0.73 . . . . 0.0 109.383 179.673 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -82.29 150.49 28.78 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 3.9 mtm180 -150.88 140.71 21.86 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.192 -1.181 . . . . 0.0 109.523 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 134.66 -72.87 0.46 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.507 ' O ' ' CB ' ' A' ' 171' ' ' SER . 0.2 OUTLIER -146.94 42.13 1.12 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.265 -1.138 . . . . 0.0 109.382 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.507 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 0.9 OUTLIER 163.73 69.88 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.316 -0.865 . . . . 0.0 109.291 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.87 102.5 1.59 Allowed 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.639 2.226 . . . . 0.0 110.515 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.518 ' O ' HG22 ' A' ' 165' ' ' VAL . . . -84.82 175.83 8.89 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.238 -0.914 . . . . 0.0 109.187 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.475 ' OG ' ' HB3' ' A' ' 163' ' ' TYR . 84.5 p -164.61 127.82 2.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.145 -0.972 . . . . 0.0 109.706 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.481 ' HB2' HG12 ' A' ' 94' ' ' ILE . 3.0 p -54.12 174.86 0.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.301 -0.874 . . . . 0.0 109.217 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.5 ' HB2' HD11 ' A' ' 94' ' ' ILE . 1.4 mmtp -45.81 136.87 6.06 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.16 -0.963 . . . . 0.0 108.618 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.641 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.2 Cg_endo -77.39 144.94 23.38 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.267 1.978 . . . . 0.0 110.885 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.593 HG12 HD23 ' A' ' 98' ' ' LEU . 3.1 t -120.62 130.79 74.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 1.04 ' CB ' HG23 ' A' ' 161' ' ' THR . 0.9 OUTLIER -122.84 158.32 30.55 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.247 -0.908 . . . . 0.0 110.704 -178.617 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.524 HG21 ' O ' ' A' ' 98' ' ' LEU . 29.3 pt -146.7 153.12 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.492 ' HA ' ' HA ' ' A' ' 159' ' ' THR . 73.7 m-80 -93.15 153.98 18.33 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.035 -1.041 . . . . 0.0 109.41 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.811 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 92.1 t80 -141.81 123.9 15.46 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.282 -0.886 . . . . 0.0 109.721 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -87.69 111.45 21.32 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.066 -1.021 . . . . 0.0 109.477 179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.485 HG22 ' CD2' ' A' ' 182' ' ' TYR . 21.9 p . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 117.976 -1.011 . . . . 0.0 109.485 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.85 HD13 ' HB3' ' A' ' 81' ' ' SER . 2.6 mp -127.67 -162.59 1.18 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.243 -1.151 . . . . 0.0 109.511 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.506 ' HB2' ' CB ' ' A' ' 25' ' ' PRO . 1.3 m-20 -108.37 164.41 12.35 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.295 -0.878 . . . . 0.0 109.526 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 54.5 m -95.41 120.3 64.01 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 109.486 -179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.522 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 35.6 Cg_endo -78.41 95.56 1.07 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.394 2.063 . . . . 0.0 110.296 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.714 HG22 ' CD1' ' A' ' 84' ' ' LEU . 1.2 p -85.02 -107.72 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.165 -0.959 . . . . 0.0 109.614 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 43.7 29.24 1.26 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.115 -1.594 . . . . 0.0 109.115 -179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.573 ' CE2' ' HA3' ' A' ' 86' ' ' GLY . 20.5 t80 -53.08 129.92 32.43 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.399 -1.059 . . . . 0.0 110.166 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.484 ' O ' ' N ' ' A' ' 21' ' ' HIS . 1.9 t70 -165.29 134.2 3.36 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 179.55 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.54 ' CB ' ' HG2' ' A' ' 88' ' ' GLN . 4.7 m -118.19 139.38 51.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.923 -1.11 . . . . 0.0 110.276 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.481 ' O ' ' C ' ' A' ' 12' ' ' ASP . 8.9 p -153.43 -169.38 3.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.435 -0.791 . . . . 0.0 109.2 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.533 ' HB2' ' CB ' ' A' ' 19' ' ' THR . 0.8 OUTLIER 41.39 46.93 3.01 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 -179.047 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.813 HG22 ' CG2' ' A' ' 91' ' ' VAL . 41.5 mm -77.67 130.73 35.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.622 0.725 . . . . 0.0 111.349 -178.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.572 ' CB ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -119.67 176.81 5.2 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 106.762 -1.57 . . . . 0.0 106.762 177.183 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.934 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -71.01 -70.03 0.33 Allowed 'General case' 0 C--N 1.297 -1.712 0 O-C-N 120.528 -1.358 . . . . 0.0 109.559 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.478 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 50.2 m-80 -81.2 -6.84 59.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.056 -1.027 . . . . 0.0 109.362 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.81 ' HB2' HG22 ' A' ' 60' ' ' THR . 3.4 t -137.42 158.01 45.33 Favored 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 179.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.037 ' CE1' HG22 ' A' ' 20' ' ' VAL . 2.2 p90 -167.76 139.88 3.11 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.991 -1.068 . . . . 0.0 108.494 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.533 ' CB ' ' HB2' ' A' ' 12' ' ' ASP . 23.0 m -84.48 154.88 22.46 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.785 -1.197 . . . . 0.0 110.898 -178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.037 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.5 t -128.6 177.76 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.53 ' CG ' ' O ' ' A' ' 20' ' ' VAL . 55.6 m-70 -156.2 163.64 39.34 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.017 -1.052 . . . . 0.0 110.158 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.823 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 46.0 p90 179.87 142.94 0.16 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.447 -0.783 . . . . 0.0 109.239 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.537 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.43 169.79 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.113 -0.992 . . . . 0.0 109.145 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.671 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -102.38 165.89 13.0 Favored Pre-proline 0 C--N 1.299 -1.606 0 O-C-N 121.504 -0.747 . . . . 0.0 109.794 -179.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.671 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.7 Cg_endo -78.26 -164.7 0.29 Allowed 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.672 2.248 . . . . 0.0 110.38 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 22.0 mtt180 -115.31 26.5 10.04 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.242 -0.911 . . . . 0.0 109.37 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.797 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -134.41 169.75 13.06 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.29 -0.881 . . . . 0.0 109.383 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.797 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.4 Cg_endo -77.78 136.62 15.3 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.612 2.208 . . . . 0.0 110.356 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.625 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 16.3 pt -145.52 -171.52 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.886 . . . . 0.0 109.493 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.645 HG23 ' ND2' ' A' ' 76' ' ' ASN . 60.5 p -126.56 6.38 6.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.309 -0.87 . . . . 0.0 109.527 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.436 ' HA2' ' C ' ' A' ' 51' ' ' PRO . . . 139.8 172.92 12.96 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.625 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -123.76 125.26 44.42 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.22 -1.165 . . . . 0.0 109.543 -179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.602 HG23 ' HE ' ' A' ' 49' ' ' ARG . 16.1 mm -74.8 120.51 24.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.359 0 O-C-N 121.231 -0.918 . . . . 0.0 109.289 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.688 HG23 HD13 ' A' ' 72' ' ' ILE . 2.3 mm -99.26 129.74 49.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.169 -0.957 . . . . 0.0 109.393 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.461 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 58.2 ttt180 -118.9 119.57 34.74 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.264 -0.898 . . . . 0.0 109.115 179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.645 ' NE2' ' CG ' ' A' ' 68' ' ' TYR . 0.3 OUTLIER -93.46 149.14 21.46 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.32 -0.863 . . . . 0.0 109.472 -179.552 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.546 ' CB ' ' HB3' ' A' ' 45' ' ' PRO . 44.3 p-80 178.27 133.64 0.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.54 -0.725 . . . . 0.0 109.408 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.607 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -56.65 -165.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.262 -0.899 . . . . 0.0 109.802 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -95.37 -99.45 0.16 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.21 -0.931 . . . . 0.0 109.655 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.4 p80 -74.53 -1.05 19.67 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.232 -0.917 . . . . 0.0 109.72 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.491 ' OG ' ' CB ' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -97.85 91.54 5.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.197 -0.94 . . . . 0.0 109.342 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.8 t -75.09 55.85 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.236 -0.915 . . . . 0.0 109.511 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -69.91 -114.94 0.03 OUTLIER Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.0 mtm-85 -120.07 98.64 49.07 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.239 -1.154 . . . . 0.0 109.536 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.546 ' HB3' ' CB ' ' A' ' 37' ' ' HIS . 35.6 Cg_endo -77.65 125.33 7.45 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.581 2.187 . . . . 0.0 110.339 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.654 ' CD ' HD23 ' A' ' 62' ' ' LEU . 0.2 OUTLIER -90.05 177.42 6.46 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.259 -0.901 . . . . 0.0 109.75 -179.748 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 59.9 mt-30 -132.47 111.12 11.01 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.289 -0.882 . . . . 0.0 109.632 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.629 ' HB3' HD11 ' A' ' 57' ' ' ILE . 0.8 OUTLIER -116.31 125.05 51.61 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.307 -0.87 . . . . 0.0 108.794 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.602 ' HE ' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -104.31 160.64 14.72 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.119 -0.988 . . . . 0.0 109.847 -179.087 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.766 HG21 ' CZ2' ' A' ' 22' ' ' TRP . 3.7 m -142.51 159.93 55.94 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.42 -0.8 . . . . 0.0 109.298 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.543 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 33.7 Cg_endo -76.37 174.27 13.11 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.484 2.123 . . . . 0.0 110.224 179.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.624 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.9 Cg_endo -76.81 -25.8 8.77 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.62 2.213 . . . . 0.0 111.07 -179.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 57.8 p -89.35 -3.0 58.64 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.098 -1.002 . . . . 0.0 109.666 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.543 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -101.02 111.69 23.95 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.281 -0.887 . . . . 0.0 110.137 -179.54 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.498 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 40.6 p-10 -92.92 -8.82 42.18 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.446 -0.784 . . . . 0.0 109.084 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 18.2 p -124.3 150.51 45.33 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 179.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.823 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 4.6 tt -134.92 133.16 53.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.926 -1.109 . . . . 0.0 110.295 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.95 102.7 14.53 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.991 ' CB ' HD11 ' A' ' 62' ' ' LEU . 1.0 OUTLIER -84.47 156.89 21.53 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.16 -0.963 . . . . 0.0 109.763 -179.532 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.81 HG22 ' HB2' ' A' ' 17' ' ' SER . 33.0 p -143.12 -179.65 6.51 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.403 -0.811 . . . . 0.0 109.35 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.451 ' O ' ' CZ ' ' A' ' 46' ' ' ARG . 17.5 m-80 55.28 19.26 2.88 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.231 -0.918 . . . . 0.0 109.395 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.991 HD11 ' CB ' ' A' ' 59' ' ' LEU . 4.9 mt -91.62 168.03 11.79 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.326 -0.859 . . . . 0.0 109.332 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.53 ' CB ' ' OH ' ' A' ' 68' ' ' TYR . 0.4 OUTLIER -77.38 130.98 72.87 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.154 -0.966 . . . . 0.0 108.576 179.404 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.934 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 36.6 Cg_endo -78.84 133.87 11.6 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.371 2.048 . . . . 0.0 111.566 -178.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.553 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 73.57 62.76 2.94 Favored Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.243 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 1.009 HG21 ' CZ ' ' A' ' 68' ' ' TYR . 3.3 m -159.22 145.73 16.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.179 -1.189 . . . . 0.0 110.698 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 1.4 mt-10 -87.66 99.24 11.92 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 177.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 1.009 ' CZ ' HG21 ' A' ' 66' ' ' THR . 29.1 m-85 -103.46 119.68 39.36 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.191 -0.943 . . . . 0.0 110.284 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.661 HG22 ' HG3' ' A' ' 87' ' ' GLN . 20.7 t -68.99 117.82 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.423 -0.798 . . . . 0.0 109.25 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.546 HG12 HG22 ' A' ' 34' ' ' ILE . 1.3 t -96.25 109.99 23.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.271 -0.893 . . . . 0.0 109.088 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -84.49 110.11 18.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.182 -0.949 . . . . 0.0 109.947 -179.568 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.769 ' C ' HD12 ' A' ' 73' ' ' ILE . 15.5 mm -79.98 120.58 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.398 -0.814 . . . . 0.0 109.653 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.769 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.3 mp -112.59 144.12 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.04 179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.713 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -104.43 128.69 52.36 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -0.926 . . . . 0.0 109.415 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.539 ' CG2' HG12 ' A' ' 33' ' ' ILE . 16.9 m -133.55 130.56 56.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.252 -0.905 . . . . 0.0 109.47 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.645 ' ND2' HG23 ' A' ' 30' ' ' THR . 3.1 t-20 -99.82 44.6 1.01 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.222 -0.924 . . . . 0.0 109.284 179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.515 ' N ' ' OG1' ' A' ' 30' ' ' THR . . . 95.42 -63.32 1.39 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.02 3.22 3.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.26 -1.141 . . . . 0.0 109.59 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -103.05 -164.39 1.07 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.177 -0.952 . . . . 0.0 109.437 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.413 ' C ' ' OG ' ' A' ' 81' ' ' SER . 32.8 mt-10 -144.13 -169.21 3.06 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.26 -0.9 . . . . 0.0 109.8 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.85 ' HB3' HD13 ' A' ' 2' ' ' LEU . 0.0 OUTLIER -176.58 -178.8 0.31 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.349 -0.844 . . . . 0.0 109.066 -179.563 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.598 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.8 Cg_endo -77.08 116.13 4.13 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.212 1.941 . . . . 0.0 109.929 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.489 ' CA ' ' O ' ' A' ' 72' ' ' ILE . 36.2 Cg_endo -78.27 146.9 22.7 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 C-N-CA 122.585 2.19 . . . . 0.0 111.272 -178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.714 ' CD1' HG22 ' A' ' 6' ' ' THR . 0.7 OUTLIER -108.97 107.74 18.22 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.246 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.544 HG23 HG12 ' A' ' 69' ' ' VAL . 2.1 mt -87.94 148.05 4.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.071 -1.018 . . . . 0.0 110.228 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.573 ' HA3' ' CE2' ' A' ' 8' ' ' PHE . . . -155.4 161.21 30.37 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 108.624 -1.79 . . . . 0.0 108.624 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.661 ' HG3' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -98.63 143.53 28.92 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.231 -1.158 . . . . 0.0 110.065 -179.486 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.582 ' HG3' ' CE1' ' A' ' 18' ' ' PHE . 0.6 OUTLIER -142.41 137.5 30.45 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 179.278 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -107.6 124.25 49.67 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.027 -1.046 . . . . 0.0 110.982 -178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.76 138.11 42.46 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 178.139 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.813 ' CG2' HG22 ' A' ' 13' ' ' ILE . 1.2 t -47.43 147.55 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 118.833 -1.147 . . . . 0.0 108.714 -179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.572 ' O ' ' HB3' ' A' ' 175' ' ' SER . 5.4 t -107.85 64.47 0.63 Allowed 'General case' 0 C--N 1.294 -1.837 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.65 ' CG ' HG21 ' A' ' 166' ' ' THR . 0.0 OUTLIER 54.04 25.71 5.78 Favored 'General case' 0 C--N 1.298 -1.655 0 O-C-N 121.113 -0.992 . . . . 0.0 108.586 -179.168 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.718 HG23 ' HD2' ' A' ' 95' ' ' PRO . 1.4 mt -72.08 141.71 84.24 Favored Pre-proline 0 N--CA 1.487 1.407 0 O-C-N 121.32 -0.863 . . . . 0.0 109.02 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.718 ' HD2' HG23 ' A' ' 94' ' ' ILE . 35.9 Cg_endo -79.13 -163.08 0.2 Allowed 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.513 2.142 . . . . 0.0 110.183 179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.533 ' CG ' ' HB2' ' A' ' 113' ' ' GLU . 13.2 ptp180 -174.67 160.13 2.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.257 -0.902 . . . . 0.0 109.373 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.503 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.2 OUTLIER 74.97 17.86 2.66 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.218 -0.926 . . . . 0.0 109.516 179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.71 HD13 ' CD2' ' A' ' 162' ' ' LEU . 0.6 OUTLIER -51.58 103.7 0.07 Allowed 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.118 -0.989 . . . . 0.0 109.427 -179.908 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -130.25 161.85 30.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.333 -0.854 . . . . 0.0 109.458 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 12.6 p -97.6 144.76 10.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.739 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.518 HG12 ' HB3' ' A' ' 109' ' ' LEU . 23.9 pt -127.72 -3.87 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.305 -0.872 . . . . 0.0 109.612 179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.887 ' CB ' HD12 ' A' ' 109' ' ' LEU . . . -157.84 106.17 2.03 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.467 ' OG ' ' OH ' ' A' ' 182' ' ' TYR . 1.0 OUTLIER -103.94 106.65 17.22 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.198 -0.939 . . . . 0.0 110.592 -178.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -94.31 166.48 15.34 Favored Pre-proline 0 C--N 1.304 -1.399 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.475 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 29.8 Cg_endo -68.97 -2.59 9.88 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.332 2.021 . . . . 0.0 110.665 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.869 ' C ' HG22 ' A' ' 152' ' ' ILE . 3.2 p -148.8 13.9 0.92 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.24 -0.912 . . . . 0.0 109.346 179.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 1.051 ' O ' HD23 ' A' ' 108' ' ' LEU . 3.3 p -172.31 168.43 5.58 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 118.764 -1.174 . . . . 0.0 109.989 179.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.051 HD23 ' O ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -144.35 155.17 43.68 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.329 -0.857 . . . . 0.0 109.375 -179.468 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.887 HD12 ' CB ' ' A' ' 102' ' ' ALA . 5.8 mt -97.11 140.12 32.09 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 178.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.573 ' CD1' HD11 ' A' ' 149' ' ' ILE . 0.3 OUTLIER -122.58 132.62 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.946 -1.096 . . . . 0.0 110.663 -179.126 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.3 t -131.03 111.3 11.9 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 179.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.715 ' HH2' ' HB2' ' A' ' 147' ' ' ALA . 45.1 p90 -123.63 144.68 49.46 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.182 -0.949 . . . . 0.0 110.75 -178.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.533 ' HB2' ' CG ' ' A' ' 96' ' ' ARG . 4.4 mm-40 -55.21 168.35 0.57 Allowed Pre-proline 0 N--CA 1.489 1.515 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 113' ' ' GLU . 30.2 Cg_endo -72.94 146.37 41.82 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 C-N-CA 122.297 1.998 . . . . 0.0 109.926 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.532 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 31.9 Cg_endo -75.24 -172.58 1.32 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.543 2.162 . . . . 0.0 111.99 -178.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.769 ' CB ' ' HB2' ' A' ' 15' ' ' ALA . . . -69.94 -12.04 61.32 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.647 -0.658 . . . . 0.0 110.38 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.581 HG13 ' CB ' ' A' ' 15' ' ' ALA . 6.1 m -159.59 -166.04 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 O-C-N 121.138 -0.976 . . . . 0.0 109.593 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.492 ' O ' HG22 ' A' ' 119' ' ' VAL . 0.1 OUTLIER -75.27 179.82 4.91 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.868 . . . . 0.0 109.047 179.73 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.577 ' HB ' ' CZ ' ' A' ' 122' ' ' TYR . 1.4 t -156.25 135.05 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.062 -1.024 . . . . 0.0 109.878 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 1.9 mmm180 -74.68 -42.98 57.44 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 1.091 ' CZ ' HG21 ' A' ' 165' ' ' VAL . 5.4 p90 -165.76 176.42 7.99 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.63 -0.669 . . . . 0.0 109.289 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.626 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 1.1 m-85 -136.65 161.56 35.57 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.19 -0.944 . . . . 0.0 109.494 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -120.67 98.9 6.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.213 -0.929 . . . . 0.0 108.672 179.434 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.852 HG21 HD11 ' A' ' 149' ' ' ILE . 20.3 mt -84.3 146.47 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.139 -0.975 . . . . 0.0 110.012 -179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.659 HG22 ' HB3' ' A' ' 137' ' ' GLU . 21.6 p -120.9 153.04 37.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 0.0 110.415 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.657 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 2.6 m-85 -101.9 121.88 42.97 Favored 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.596 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.1 117.4 5.56 Favored Glycine 0 N--CA 1.486 2.012 0 C-N-CA 119.913 -1.137 . . . . 0.0 110.272 -179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.443 ' O ' ' C ' ' A' ' 129' ' ' THR . 15.9 mt-10 -87.93 169.54 11.92 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.226 -1.161 . . . . 0.0 108.988 179.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.597 HG23 ' N ' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -36.74 -79.48 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.324 0 O-C-N 121.65 -0.656 . . . . 0.0 110.475 179.744 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 129' ' ' THR . . . -42.44 -71.53 0.37 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 96.51 -21.72 44.09 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -70.56 -5.34 28.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.205 -1.174 . . . . 0.0 109.586 179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.572 ' CB ' ' HD2' ' A' ' 134' ' ' PRO . 0.9 OUTLIER -90.14 -179.99 1.35 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.25 -0.906 . . . . 0.0 109.174 179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.572 ' HD2' ' CB ' ' A' ' 133' ' ' SER . 34.6 Cg_endo -77.61 92.78 1.11 Allowed 'Trans proline' 0 C--N 1.31 -1.48 0 C-N-CA 122.384 2.056 . . . . 0.0 110.137 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' ' 126' ' ' TYR . 3.4 m -46.67 161.29 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.351 0 O-C-N 121.443 -0.786 . . . . 0.0 110.132 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 134' ' ' PRO . 87.3 mm-40 -107.27 115.83 30.86 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.393 -0.965 . . . . 0.0 108.393 179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.659 ' HB3' HG22 ' A' ' 125' ' ' THR . 0.0 OUTLIER -119.57 158.07 27.09 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.939 -1.101 . . . . 0.0 111.557 -178.332 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.595 ' CE1' ' HB ' ' A' ' 124' ' ' ILE . 33.8 p90 -140.7 162.86 34.4 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.643 HG22 ' CE2' ' A' ' 121' ' ' TYR . 0.7 OUTLIER -74.51 -171.14 1.15 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.752 -1.217 . . . . 0.0 110.164 -179.051 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.586 ' CG2' HD12 ' A' ' 124' ' ' ILE . 40.0 t -149.88 133.98 9.02 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.213 -0.93 . . . . 0.0 109.86 -178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.33 117.34 4.05 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.357 2.038 . . . . 0.0 110.097 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -71.77 55.81 1.33 Allowed Glycine 0 N--CA 1.493 2.441 0 N-CA-C 109.754 -1.339 . . . . 0.0 109.754 -179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.48 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 39.3 m -105.46 -1.62 24.72 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.164 -1.198 . . . . 0.0 109.492 179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.48 ' CG ' ' O ' ' A' ' 143' ' ' SER . 3.0 mtmt -176.16 -179.75 1.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.229 -0.919 . . . . 0.0 109.43 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -94.99 13.75 24.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.248 -0.907 . . . . 0.0 109.57 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.442 ' HA ' ' O ' ' A' ' 110' ' ' ILE . 18.0 p -125.36 152.84 44.23 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.242 -0.912 . . . . 0.0 109.527 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.715 ' HB2' ' HH2' ' A' ' 112' ' ' TRP . . . -142.4 171.73 13.65 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.0 109.548 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.41 ' O ' ' CZ ' ' A' ' 138' ' ' PHE . 11.3 t -110.7 155.85 21.86 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.328 -0.858 . . . . 0.0 109.379 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.852 HD11 HG21 ' A' ' 124' ' ' ILE . 16.1 mm -133.26 81.9 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.238 -0.914 . . . . 0.0 109.506 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.543 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -92.69 167.64 11.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.389 -0.819 . . . . 0.0 109.979 -179.76 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.5 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 0.3 OUTLIER 75.15 47.4 0.1 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.866 . . . . 0.0 109.298 -179.951 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.869 HG22 ' C ' ' A' ' 106' ' ' THR . 4.2 tt -110.67 158.85 10.91 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.35 -0.844 . . . . 0.0 109.922 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.422 ' HB3' ' OH ' ' A' ' 158' ' ' TYR . 1.7 tttp -97.77 112.45 61.59 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.351 -0.843 . . . . 0.0 108.944 179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.457 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 34.7 Cg_endo -77.2 138.17 17.72 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 122.387 2.058 . . . . 0.0 110.692 -179.665 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.696 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 87.99 67.7 1.3 Allowed Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.696 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 163.26 130.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -1.117 . . . . 0.0 109.633 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.597 ' N ' HG23 ' A' ' 129' ' ' THR . 1.2 t0 -46.36 158.92 0.1 Allowed 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.596 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -143.08 -179.47 6.39 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.0 -1.063 . . . . 0.0 109.884 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.506 ' N ' ' O ' ' A' ' 127' ' ' GLY . 4.8 m -150.94 101.41 2.89 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 179.144 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 179' ' ' SER . 16.2 mm -84.84 136.55 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.117 -0.989 . . . . 0.0 110.118 -178.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.798 HG23 ' HB3' ' A' ' 179' ' ' SER . 2.0 m -147.45 168.87 20.78 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 108.785 -0.821 . . . . 0.0 108.785 179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.71 ' CD2' HD13 ' A' ' 98' ' ' LEU . 0.8 OUTLIER -163.54 147.64 10.57 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.871 -1.143 . . . . 0.0 110.859 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 177' ' ' PRO . 2.0 m-85 -116.08 103.42 10.55 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.44 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -61.32 167.25 3.32 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.007 -1.058 . . . . 0.0 109.459 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 1.091 HG21 ' CZ ' ' A' ' 121' ' ' TYR . 84.4 t -143.79 114.72 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.146 -0.971 . . . . 0.0 110.543 -179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.65 HG21 ' CG ' ' A' ' 93' ' ' ASP . 0.7 OUTLIER -109.93 131.88 54.66 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.634 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.434 ' HA2' ' HA ' ' A' ' 172' ' ' PRO . . . -58.54 167.11 6.68 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.017 -1.233 . . . . 0.0 110.017 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.505 ' NE ' ' HB2' ' A' ' 173' ' ' ALA . 1.1 mtm180 -149.48 15.36 0.88 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.299 -1.118 . . . . 0.0 109.795 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 113.25 -116.86 4.07 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -75.28 0.5 16.41 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.266 -1.138 . . . . 0.0 109.536 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.488 ' O ' ' HB2' ' A' ' 168' ' ' ARG . 9.5 m -163.18 128.8 2.19 Favored Pre-proline 0 C--N 1.305 -1.329 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.434 ' HA ' ' HA2' ' A' ' 167' ' ' GLY . 33.8 Cg_endo -75.27 -170.59 0.82 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.346 2.031 . . . . 0.0 110.557 -179.643 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.505 ' HB2' ' NE ' ' A' ' 168' ' ' ARG . . . -155.3 150.99 27.46 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.235 -0.915 . . . . 0.0 109.821 -179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.516 ' HA ' ' HA ' ' A' ' 165' ' ' VAL . 0.6 OUTLIER -103.29 -165.97 1.22 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.0 109.368 179.68 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.572 ' HB3' ' O ' ' A' ' 92' ' ' SER . 96.6 p -146.14 163.76 34.34 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.173 -0.954 . . . . 0.0 109.817 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.559 ' CB ' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -47.0 139.99 6.58 Favored Pre-proline 0 N--CA 1.49 1.547 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 179.278 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 163' ' ' TYR . 34.8 Cg_endo -77.39 117.49 4.36 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.204 1.936 . . . . 0.0 111.757 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 161' ' ' THR . 2.3 t -84.59 131.57 33.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.798 ' HB3' HG23 ' A' ' 161' ' ' THR . 54.4 p -128.14 149.37 50.45 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.05 -1.031 . . . . 0.0 111.218 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.655 HD13 HD23 ' A' ' 98' ' ' LEU . 18.8 pt -134.94 152.65 33.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 178.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.2 m120 -84.18 147.03 27.52 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.928 -1.108 . . . . 0.0 109.698 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.783 ' OH ' HD22 ' A' ' 108' ' ' LEU . 74.4 t80 -147.43 121.63 9.55 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.452 -0.78 . . . . 0.0 109.335 -179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 183' ' ' LYS . 8.0 pttm -96.04 121.86 38.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.994 . . . . 0.0 109.505 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.628 HG22 ' HE2' ' A' ' 182' ' ' TYR . 44.7 p . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.483 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.435 ' HA ' HD22 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -74.55 -163.17 0.19 Allowed 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.265 -1.138 . . . . 0.0 109.51 -179.851 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.829 ' CG ' ' HB3' ' A' ' 27' ' ' ALA . 7.5 m-20 -74.62 90.13 2.25 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.422 -0.799 . . . . 0.0 110.134 -179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 5.6 m -96.71 106.72 32.09 Favored Pre-proline 0 N--CA 1.491 1.619 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 3' ' ' ASP . 36.7 Cg_endo -79.61 159.66 25.2 Favored 'Trans proline' 0 C--N 1.31 -1.477 0 C-N-CA 122.322 2.015 . . . . 0.0 110.642 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.744 ' HA ' HD22 ' A' ' 84' ' ' LEU . 3.8 p -151.94 -121.1 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 109.074 179.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.47 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 43.33 28.14 0.85 Allowed Glycine 0 N--CA 1.493 2.472 0 N-CA-C 108.377 -1.889 . . . . 0.0 108.377 -179.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.568 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 7.6 t80 -48.68 133.57 16.94 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.705 -0.88 . . . . 0.0 110.327 -178.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 9.2 t0 -165.05 94.1 0.64 Allowed 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 0.4 OUTLIER -84.4 118.32 24.18 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.285 -0.885 . . . . 0.0 109.764 -179.345 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.464 ' O ' ' C ' ' A' ' 12' ' ' ASP . 96.3 p -151.86 -159.1 0.97 Allowed 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.396 -0.815 . . . . 0.0 108.981 179.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.525 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.7 OUTLIER 46.46 33.58 2.0 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -178.305 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.679 ' HA ' ' HA ' ' A' ' 18' ' ' PHE . 1.2 mt -76.69 162.67 4.2 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 CA-C-N 114.837 -1.074 . . . . 0.0 111.679 -177.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.679 HG23 ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -151.2 -175.27 5.1 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 178.081 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.553 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -78.37 -52.11 9.08 Favored 'General case' 0 C--N 1.295 -1.8 0 O-C-N 121.123 -0.986 . . . . 0.0 109.752 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 60' ' ' THR . 1.8 p-10 -97.83 -1.9 42.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.78 -1.2 . . . . 0.0 109.936 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.857 ' HB3' HG22 ' A' ' 60' ' ' THR . 3.4 p -150.98 157.33 42.75 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.32 -0.863 . . . . 0.0 108.825 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.798 ' CE1' HG22 ' A' ' 20' ' ' VAL . 2.1 p90 -165.71 141.45 5.07 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.17 -0.956 . . . . 0.0 108.559 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 1.7 m -94.82 155.68 16.69 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.855 -1.153 . . . . 0.0 111.7 -177.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.798 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -130.16 120.07 48.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.52 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 4.0 m-70 -101.26 148.91 24.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.118 -0.989 . . . . 0.0 110.81 -178.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.743 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 11.9 p90 -171.47 129.94 0.7 Allowed 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.536 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.53 169.07 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 O-C-N 120.985 -1.072 . . . . 0.0 109.566 -179.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.536 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -107.66 160.42 26.77 Favored Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.685 -0.634 . . . . 0.0 109.366 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.54 ' O ' ' CG ' ' A' ' 26' ' ' ARG . 36.9 Cg_endo -78.38 -99.02 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.676 2.251 . . . . 0.0 110.371 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.54 ' CG ' ' O ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -174.57 -34.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.076 -1.015 . . . . 0.0 109.984 179.865 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.829 ' HB3' ' CG ' ' A' ' 3' ' ' ASP . . . -54.38 168.13 0.5 Allowed Pre-proline 0 C--N 1.296 -1.729 0 O-C-N 121.5 -0.75 . . . . 0.0 109.368 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.737 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.1 Cg_endo -77.52 142.18 20.57 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.529 2.153 . . . . 0.0 110.354 179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.638 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 14.2 pt -148.11 176.98 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.226 -0.921 . . . . 0.0 109.751 -179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.0 p -120.77 1.05 10.48 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.412 -0.805 . . . . 0.0 109.256 179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.462 ' O ' ' CG2' ' A' ' 75' ' ' VAL . . . 139.3 150.97 5.61 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.723 ' O ' HG22 ' A' ' 50' ' ' VAL . 0.4 OUTLIER -100.63 135.56 41.88 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.254 -1.144 . . . . 0.0 109.322 179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.88 HG23 ' HD2' ' A' ' 49' ' ' ARG . 1.2 mp -86.53 133.14 30.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.149 -0.969 . . . . 0.0 109.094 179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.844 HD13 ' C ' ' A' ' 33' ' ' ILE . 2.9 mm -112.12 102.15 13.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.354 -0.841 . . . . 0.0 109.346 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.533 ' HG2' ' N ' ' A' ' 36' ' ' HIS . 5.4 ttt180 -100.62 158.1 16.18 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.145 -0.972 . . . . 0.0 109.218 179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.952 ' CE1' HG22 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -140.07 144.59 36.9 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.165 -0.96 . . . . 0.0 109.635 -179.614 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.587 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 35.6 p-80 -163.5 128.85 3.04 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.365 -0.834 . . . . 0.0 109.533 179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.88 ' HB1' ' OG ' ' A' ' 41' ' ' SER . . . -40.32 163.6 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.415 -0.803 . . . . 0.0 110.03 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 1.016 ' HG2' HG23 ' A' ' 69' ' ' VAL . 2.1 mt-10 -84.42 -98.04 0.06 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.168 -0.958 . . . . 0.0 109.481 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -87.77 -3.22 58.96 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.349 -0.844 . . . . 0.0 109.714 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.88 ' OG ' ' HB1' ' A' ' 38' ' ' ALA . 22.9 p -84.98 -177.12 6.48 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.245 -0.909 . . . . 0.0 109.477 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.417 HG12 ' O ' ' A' ' 42' ' ' VAL . 4.9 t -101.46 29.6 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.245 -0.909 . . . . 0.0 109.492 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.655 ' HA3' ' HB2' ' A' ' 38' ' ' ALA . . . -64.2 125.85 32.65 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 0.9 OUTLIER -55.92 143.99 59.44 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.254 -1.145 . . . . 0.0 109.417 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 37' ' ' HIS . 35.8 Cg_endo -78.57 106.14 2.07 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.547 2.165 . . . . 0.0 110.352 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.512 ' N ' ' O ' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -74.82 179.68 4.71 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 0.0 109.631 -179.785 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -143.39 126.97 16.94 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.278 -0.889 . . . . 0.0 109.339 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.534 ' CG ' HD21 ' A' ' 59' ' ' LEU . 21.2 m-20 -138.21 159.22 42.61 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.88 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -139.18 159.03 43.11 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.286 -0.884 . . . . 0.0 109.85 -179.474 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 1.076 ' CG1' HD12 ' A' ' 57' ' ' ILE . 32.7 m -142.72 159.22 57.88 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.315 -0.865 . . . . 0.0 109.189 179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.544 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.4 Cg_endo -77.21 174.42 12.8 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.503 2.135 . . . . 0.0 110.324 179.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.605 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 35.3 Cg_endo -77.21 -15.5 16.08 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.596 2.198 . . . . 0.0 110.52 -179.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 p -102.8 24.11 11.11 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.236 -0.915 . . . . 0.0 109.65 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.544 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 5.7 mmt180 -126.83 109.04 11.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.186 -0.946 . . . . 0.0 109.966 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.441 ' HB2' ' O ' ' A' ' 22' ' ' TRP . 16.5 p30 -94.09 -11.23 31.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 109.031 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 20.0 p -131.21 137.13 48.79 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 179.46 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.076 HD12 ' CG1' ' A' ' 50' ' ' VAL . 6.4 tt -131.35 129.65 62.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.982 -1.074 . . . . 0.0 110.264 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -95.63 111.09 23.1 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.876 ' HB3' HD11 ' A' ' 62' ' ' LEU . 2.0 mt -84.48 158.37 21.03 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.165 -0.959 . . . . 0.0 109.541 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.857 HG22 ' HB3' ' A' ' 17' ' ' SER . 19.4 p -145.65 177.6 8.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.327 -0.858 . . . . 0.0 109.394 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 50.93 46.6 26.06 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.517 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.876 HD11 ' HB3' ' A' ' 59' ' ' LEU . 3.7 mt -118.19 147.34 43.46 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.226 -0.921 . . . . 0.0 109.355 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.478 ' O ' ' OH ' ' A' ' 68' ' ' TYR . 28.3 m-80 -44.89 117.2 3.07 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.197 -0.939 . . . . 0.0 108.686 179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.553 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.4 Cg_endo -77.47 125.72 7.84 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.144 1.896 . . . . 0.0 111.41 -179.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 82.99 59.99 2.11 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.564 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 2.6 m -151.8 166.51 31.16 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.154 -1.204 . . . . 0.0 109.506 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.564 ' N ' ' CG2' ' A' ' 66' ' ' THR . 5.1 mt-10 -125.56 127.25 46.09 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.305 -0.872 . . . . 0.0 109.21 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.623 ' N ' ' CD1' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -134.23 -159.53 0.97 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.139 -0.975 . . . . 0.0 109.773 -179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 1.016 HG23 ' HG2' ' A' ' 39' ' ' GLU . 41.7 t -137.36 116.68 15.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 178.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.952 HG22 ' CE1' ' A' ' 36' ' ' HIS . 3.7 t -88.58 127.73 41.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.031 -1.043 . . . . 0.0 109.621 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.539 ' HB3' ' CD1' ' A' ' 85' ' ' ILE . 0.2 OUTLIER -101.0 104.72 15.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.233 -0.917 . . . . 0.0 110.065 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.466 ' HB ' ' O ' ' A' ' 84' ' ' LEU . 15.0 mm -79.4 154.56 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.234 -0.916 . . . . 0.0 109.341 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.549 HG22 ' N ' ' A' ' 74' ' ' ALA . 48.3 mt -153.1 165.03 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 0.0 109.593 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.645 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -132.57 120.62 22.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.298 -0.877 . . . . 0.0 109.389 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.735 HG12 ' HG2' ' A' ' 80' ' ' GLU . 2.4 m -112.63 144.52 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.166 -0.959 . . . . 0.0 109.524 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -135.94 45.23 2.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.892 . . . . 0.0 109.361 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 106.13 -96.46 1.15 Allowed Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.391 -1.484 . . . . 0.0 109.391 -179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -109.72 -1.4 18.03 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.244 -1.15 . . . . 0.0 109.554 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.528 ' O ' ' CG ' ' A' ' 80' ' ' GLU . 19.8 mt-10 -106.52 172.89 6.57 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.208 -0.933 . . . . 0.0 109.121 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.735 ' HG2' HG12 ' A' ' 75' ' ' VAL . 46.0 mt-10 -158.33 115.75 2.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.125 -0.984 . . . . 0.0 110.022 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.695 ' HG ' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -60.29 -175.17 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.572 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 179.283 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.695 ' HD2' ' HG ' ' A' ' 81' ' ' SER . 33.1 Cg_endo -76.5 146.15 27.19 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 121.925 1.75 . . . . 0.0 110.107 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.489 ' HB3' HG12 ' A' ' 73' ' ' ILE . 35.6 Cg_endo -77.22 109.56 2.84 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.674 2.249 . . . . 0.0 111.357 -178.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.744 HD22 ' HA ' ' A' ' 6' ' ' THR . 17.9 tp -84.21 94.54 8.42 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.586 ' CG2' ' CG1' ' A' ' 69' ' ' VAL . 2.2 mt -85.72 151.34 3.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.128 -0.983 . . . . 0.0 110.678 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.604 ' O ' HG13 ' A' ' 69' ' ' VAL . . . -142.62 179.25 20.47 Favored Glycine 0 N--CA 1.483 1.824 0 N-CA-C 108.161 -1.975 . . . . 0.0 108.161 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.42 ' HG3' ' C ' ' A' ' 86' ' ' GLY . 0.0 OUTLIER -131.73 146.4 52.14 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.992 -1.299 . . . . 0.0 110.058 -179.774 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.538 ' NE2' ' NE2' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -163.13 -167.69 1.54 Allowed 'General case' 0 C--N 1.303 -1.418 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.546 ' HB1' ' O ' ' A' ' 66' ' ' THR . . . -165.41 136.64 3.94 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.973 -1.079 . . . . 0.0 109.953 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.462 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.6 OUTLIER -74.59 162.18 29.01 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 179.193 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.722 HG11 ' CB ' ' A' ' 116' ' ' ALA . 0.0 OUTLIER -99.05 154.79 4.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 121.142 -0.973 . . . . 0.0 110.201 -179.691 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 11.4 p -70.53 105.31 3.05 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.522 ' HB2' ' CB ' ' A' ' 15' ' ' ALA . 1.3 t0 -67.52 -56.86 7.83 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.201 -0.937 . . . . 0.0 109.623 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.72 HG23 ' HD2' ' A' ' 95' ' ' PRO . 1.2 mt -76.81 142.99 70.47 Favored Pre-proline 0 C--N 1.302 -1.464 0 O-C-N 121.216 -0.927 . . . . 0.0 109.605 -179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.945 ' HG3' HD11 ' A' ' 162' ' ' LEU . 36.4 Cg_endo -80.63 46.0 2.14 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.451 2.101 . . . . 0.0 109.886 178.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.471 ' CG ' ' HG3' ' A' ' 113' ' ' GLU . 5.9 ptm85 -60.05 179.15 0.15 Allowed 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.403 -0.811 . . . . 0.0 109.569 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 2.1 t0 67.35 8.11 6.02 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.243 -0.911 . . . . 0.0 109.272 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.766 ' CD2' HD13 ' A' ' 180' ' ' ILE . 8.7 tt -53.59 99.98 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.216 -0.927 . . . . 0.0 109.13 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -124.98 157.29 36.47 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.306 -0.871 . . . . 0.0 109.532 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.494 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 8.1 p -91.1 139.67 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.381 -0.824 . . . . 0.0 109.606 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.826 HD11 HD22 ' A' ' 109' ' ' LEU . 20.0 pt -125.23 -5.86 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.313 -0.867 . . . . 0.0 109.503 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.999 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -149.4 97.77 2.7 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.488 ' HB2' ' OH ' ' A' ' 182' ' ' TYR . 17.4 p -90.0 90.56 8.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.368 -0.832 . . . . 0.0 110.293 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.476 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -80.37 157.49 72.79 Favored Pre-proline 0 C--N 1.305 -1.354 0 O-C-N 121.237 -0.914 . . . . 0.0 108.776 179.059 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.483 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.2 Cg_endo -69.9 -2.73 10.77 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.397 2.065 . . . . 0.0 110.502 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.727 ' C ' HG22 ' A' ' 152' ' ' ILE . 1.4 p -150.53 18.38 0.82 Allowed 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 1.067 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.7 OUTLIER -167.22 171.63 10.63 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.275 -0.97 . . . . 0.0 110.034 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.067 HD23 ' O ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -144.43 152.63 40.93 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.309 -0.869 . . . . 0.0 109.173 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.999 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -105.75 120.72 42.43 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.275 -0.891 . . . . 0.0 108.86 179.293 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.581 ' CD1' ' HB3' ' A' ' 147' ' ' ALA . 1.0 OUTLIER -106.29 138.06 33.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.115 -0.991 . . . . 0.0 110.024 -179.68 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.87 ' HB2' HG22 ' A' ' 146' ' ' THR . 0.0 OUTLIER -142.87 115.17 8.44 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.455 -0.778 . . . . 0.0 109.259 179.768 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.624 ' CD1' ' CB ' ' A' ' 95' ' ' PRO . 43.4 p90 -125.97 -177.43 3.94 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.182 -0.949 . . . . 0.0 109.561 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.505 ' O ' ' HD3' ' A' ' 115' ' ' PRO . 1.0 OUTLIER -56.73 133.82 78.48 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.242 -0.912 . . . . 0.0 109.424 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.462 ' HB3' ' OG ' ' A' ' 145' ' ' SER . 36.6 Cg_endo -79.98 109.92 2.47 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 C-N-CA 122.788 2.325 . . . . 0.0 110.806 -179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 113' ' ' GLU . 36.3 Cg_endo -81.34 164.37 19.23 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.322 2.014 . . . . 0.0 110.243 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.722 ' CB ' HG11 ' A' ' 91' ' ' VAL . . . -142.59 14.22 1.96 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.631 HG22 ' CG2' ' A' ' 119' ' ' VAL . 3.0 m -79.38 179.83 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.477 ' O ' ' HB ' ' A' ' 166' ' ' THR . 11.1 m -69.52 59.35 0.13 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.054 -1.029 . . . . 0.0 108.786 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.89 ' HA ' HG22 ' A' ' 166' ' ' THR . 21.3 t -74.65 125.88 34.66 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.362 -0.836 . . . . 0.0 109.993 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.477 ' N ' ' O ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER -74.93 -58.62 3.17 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.829 ' CE1' HG22 ' A' ' 139' ' ' THR . 9.0 p90 -166.93 163.4 16.1 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.498 ' CE1' HG11 ' A' ' 119' ' ' VAL . 14.4 m-85 -103.74 129.59 51.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.03 -1.044 . . . . 0.0 108.589 178.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.555 ' HG3' ' CG ' ' A' ' 137' ' ' GLU . 1.5 ttm180 -95.34 85.94 4.39 Favored 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.286 -0.884 . . . . 0.0 109.518 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 1.065 HD12 ' CG2' ' A' ' 140' ' ' VAL . 21.6 mt -84.37 153.16 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.364 -0.835 . . . . 0.0 109.193 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.697 HG22 ' HA ' ' A' ' 137' ' ' GLU . 27.7 p -138.73 142.45 38.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.136 -0.978 . . . . 0.0 110.189 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.672 ' CE2' HG22 ' A' ' 149' ' ' ILE . 4.1 m-85 -79.59 126.68 31.21 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 178.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.577 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.35 120.42 6.49 Favored Glycine 0 N--CA 1.485 1.965 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 130' ' ' GLY . 2.3 mt-10 -90.52 170.12 10.46 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.447 -1.031 . . . . 0.0 109.064 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.946 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 1.2 p -39.81 -28.46 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.465 -0.772 . . . . 0.0 109.887 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.475 ' N ' ' O ' ' A' ' 128' ' ' GLU . . . -59.41 -84.67 0.04 OUTLIER Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 96.8 100.0 1.96 Allowed Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.661 -1.375 . . . . 0.0 109.661 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 18.6 m-80 -145.12 -71.71 0.26 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.327 -1.102 . . . . 0.0 109.348 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.56 ' CB ' ' HD3' ' A' ' 134' ' ' PRO . 0.5 OUTLIER 171.48 -55.48 0.0 OUTLIER Pre-proline 0 C--N 1.293 -1.855 0 N-CA-C 109.243 -0.651 . . . . 0.0 109.243 179.814 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.56 ' HD3' ' CB ' ' A' ' 133' ' ' SER . 35.7 Cg_endo -78.16 71.63 6.61 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.336 2.024 . . . . 0.0 109.995 179.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.554 ' CG1' ' O ' ' A' ' 126' ' ' TYR . 0.2 OUTLIER -109.64 -143.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.437 -0.789 . . . . 0.0 109.326 -179.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.583 ' HB3' ' CD1' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -80.96 76.1 7.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.846 -1.159 . . . . 0.0 109.14 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.697 ' HA ' HG22 ' A' ' 125' ' ' THR . 6.4 tm-20 -76.54 117.48 18.23 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 110.665 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.618 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 26.7 p90 -121.94 138.59 54.35 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 178.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.829 HG22 ' CE1' ' A' ' 121' ' ' TYR . 7.4 p -74.21 168.39 19.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.083 -1.01 . . . . 0.0 110.534 -178.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 1.065 ' CG2' HD12 ' A' ' 124' ' ' ILE . 50.9 t -138.31 141.5 31.92 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.523 -0.736 . . . . 0.0 109.647 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.643 ' HD2' HG13 ' A' ' 140' ' ' VAL . 35.0 Cg_endo -77.17 141.43 20.69 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.528 2.152 . . . . 0.0 110.657 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -76.82 53.55 3.33 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.505 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 28.4 t -103.7 -11.85 17.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.178 -1.189 . . . . 0.0 109.888 -179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.505 ' CG ' ' O ' ' A' ' 143' ' ' SER . 1.5 mmmt 179.54 175.81 0.7 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.249 -0.907 . . . . 0.0 109.777 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.581 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -95.26 -1.23 51.95 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.585 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.87 HG22 ' HB2' ' A' ' 111' ' ' SER . 41.4 p -102.0 129.79 48.39 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.09 -1.006 . . . . 0.0 108.913 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.581 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -126.81 156.5 41.19 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.118 -0.988 . . . . 0.0 109.78 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.588 ' O ' HD13 ' A' ' 149' ' ' ILE . 8.9 m -100.82 152.26 20.72 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.352 -0.843 . . . . 0.0 109.097 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.672 HG22 ' CE2' ' A' ' 126' ' ' TYR . 49.9 mm -127.93 107.95 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.252 -0.905 . . . . 0.0 109.199 -179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.586 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 2.9 m120 -116.0 166.1 12.37 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.418 -0.801 . . . . 0.0 109.929 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 150' ' ' ASN . 4.0 m-80 76.07 37.73 0.36 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.266 -0.896 . . . . 0.0 109.268 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.727 HG22 ' C ' ' A' ' 106' ' ' THR . 4.7 tt -96.93 156.17 3.44 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.348 0 O-C-N 121.392 -0.817 . . . . 0.0 109.795 -179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.455 ' O ' ' CB ' ' A' ' 184' ' ' THR . 9.0 mttp -84.64 117.57 69.06 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.253 -0.904 . . . . 0.0 109.349 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.483 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 36.4 Cg_endo -78.73 75.88 4.78 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.479 2.12 . . . . 0.0 110.684 -179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.717 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 143.08 73.05 0.03 OUTLIER Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.946 ' HB1' ' CG2' ' A' ' 129' ' ' THR . . . 162.25 134.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.319 -1.107 . . . . 0.0 109.67 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.673 ' N ' HG22 ' A' ' 129' ' ' THR . 1.0 OUTLIER -48.08 164.43 0.05 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.11 -0.994 . . . . 0.0 108.338 179.292 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.612 ' CE2' HG13 ' A' ' 152' ' ' ILE . 0.4 OUTLIER -144.97 -167.44 2.67 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.865 -1.147 . . . . 0.0 110.352 -179.558 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.513 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 31.6 m -169.6 102.75 0.33 Allowed 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.598 HD11 HD12 ' A' ' 108' ' ' LEU . 33.0 mm -88.11 118.6 34.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.025 -1.047 . . . . 0.0 109.785 -179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.985 HG23 ' CB ' ' A' ' 179' ' ' SER . 1.1 m -126.37 165.41 19.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.904 . . . . 0.0 109.19 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.945 HD11 ' HG3' ' A' ' 95' ' ' PRO . 1.9 pp -165.86 154.4 11.26 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.01 -1.076 . . . . 0.0 110.997 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.626 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 1.8 m-85 -122.69 160.38 25.97 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 179.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.472 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -127.26 101.68 6.59 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.865 -1.147 . . . . 0.0 109.342 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.934 HG22 ' HB3' ' A' ' 174' ' ' SER . 15.1 t -87.74 131.42 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.333 -0.854 . . . . 0.0 109.677 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.89 HG22 ' HA ' ' A' ' 119' ' ' VAL . 17.0 p -130.89 -66.97 0.73 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.768 -0.582 . . . . 0.0 109.512 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.51 ' N ' ' OG1' ' A' ' 166' ' ' THR . . . -43.18 139.28 3.09 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.666 -1.374 . . . . 0.0 109.666 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 8.1 mmm180 -141.22 104.53 4.64 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.247 -1.149 . . . . 0.0 109.453 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 166.68 -122.49 1.06 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 170' ' ' ASP . 7.3 p-10 -93.29 12.07 25.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.236 -1.155 . . . . 0.0 109.47 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.477 ' N ' ' HD3' ' A' ' 172' ' ' PRO . 64.8 m -158.58 64.8 2.85 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.0 109.355 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.477 ' HD3' ' N ' ' A' ' 171' ' ' SER . 35.7 Cg_endo -78.18 98.84 1.23 Allowed 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.658 2.239 . . . . 0.0 110.574 -179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -103.59 -179.29 3.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.274 -0.891 . . . . 0.0 109.307 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.934 ' HB3' HG22 ' A' ' 165' ' ' VAL . 0.7 OUTLIER -144.68 48.26 1.33 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.103 -0.998 . . . . 0.0 109.697 -179.99 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.49 ' O ' ' O ' ' A' ' 174' ' ' SER . 0.7 OUTLIER 42.1 -166.23 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 179.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.641 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -93.19 139.71 23.1 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 120.999 -1.063 . . . . 0.0 108.229 179.165 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.626 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 33.8 Cg_endo -76.14 140.91 22.91 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 C-N-CA 122.206 1.937 . . . . 0.0 111.158 -179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.2 t -122.11 138.22 53.07 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.985 ' CB ' HG23 ' A' ' 161' ' ' THR . 0.3 OUTLIER -131.36 155.45 47.23 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.088 -1.007 . . . . 0.0 110.821 -178.663 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.766 HD13 ' CD2' ' A' ' 98' ' ' LEU . 14.0 pt -136.96 153.3 29.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 159' ' ' THR . 23.6 m120 -91.67 156.67 17.43 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.0 -1.063 . . . . 0.0 110.051 -179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.764 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 51.9 t80 -143.98 169.78 17.17 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.405 -0.809 . . . . 0.0 109.296 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.477 ' N ' ' CD2' ' A' ' 182' ' ' TYR . 8.6 tttp -139.86 121.69 15.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.231 -0.918 . . . . 0.0 109.537 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.455 ' CB ' ' O ' ' A' ' 153' ' ' LYS . 14.7 p . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 117.971 -1.014 . . . . 0.0 109.46 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.817 HD12 ' N ' ' A' ' 2' ' ' LEU . 0.2 OUTLIER -119.58 -162.87 0.94 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.268 -1.137 . . . . 0.0 109.342 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 26' ' ' ARG . 1.6 m-20 -96.62 167.61 11.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.271 -0.893 . . . . 0.0 109.344 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.548 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 4.8 p -94.52 133.62 26.64 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.191 -0.943 . . . . 0.0 109.491 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.921 ' O ' HD22 ' A' ' 84' ' ' LEU . 36.3 Cg_endo -79.14 86.72 1.64 Allowed 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.54 2.16 . . . . 0.0 110.394 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.466 ' O ' ' C ' ' A' ' 7' ' ' GLY . 16.5 p -89.32 -126.87 0.06 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.04 -1.038 . . . . 0.0 109.304 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.466 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 44.48 28.42 1.51 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 108.039 -2.025 . . . . 0.0 108.039 -179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.569 ' HB3' HD21 ' A' ' 84' ' ' LEU . 0.0 OUTLIER -92.34 152.32 19.83 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.851 -0.794 . . . . 0.0 109.879 -178.603 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.593 ' O ' HG12 ' A' ' 20' ' ' VAL . 2.5 t70 -165.0 -163.15 0.68 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.788 ' HB2' HD11 ' A' ' 13' ' ' ILE . 83.0 p -137.45 121.26 17.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.048 -1.032 . . . . 0.0 109.908 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.472 ' O ' ' C ' ' A' ' 12' ' ' ASP . 3.7 p -140.6 -171.01 3.13 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.356 -0.84 . . . . 0.0 108.847 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.547 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.9 OUTLIER 43.84 36.01 1.24 Allowed 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 -178.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.867 HG22 ' CG2' ' A' ' 91' ' ' VAL . 1.2 mt -79.52 132.69 31.43 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 CA-C-N 115.083 -0.962 . . . . 0.0 111.729 -177.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.543 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -122.83 -179.94 4.42 Favored 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.198 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 1.055 ' HB2' HG11 ' A' ' 117' ' ' VAL . . . -74.08 -63.39 1.23 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.751 -1.218 . . . . 0.0 109.75 -179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 3.4 m-20 -88.46 23.77 2.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.148 -0.97 . . . . 0.0 109.446 -179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.731 ' HA ' HD12 ' A' ' 62' ' ' LEU . 42.0 p -176.04 153.68 1.34 Allowed 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.774 ' HB2' HG23 ' A' ' 13' ' ' ILE . 2.5 p90 -165.66 140.53 4.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 0.0 109.089 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.547 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 4.6 m -89.79 161.44 16.02 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.922 -1.111 . . . . 0.0 110.964 -178.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.759 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -133.54 173.23 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.543 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 28.3 m-70 -147.68 170.6 17.17 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.89 -1.131 . . . . 0.0 110.541 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.66 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 16.3 p90 179.81 135.28 0.11 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.207 -0.664 . . . . 0.0 109.207 179.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.533 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.51 167.6 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.087 -1.008 . . . . 0.0 109.267 179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.757 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -92.21 168.77 12.15 Favored Pre-proline 0 C--N 1.299 -1.606 0 O-C-N 121.647 -0.658 . . . . 0.0 109.796 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.757 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.9 Cg_endo -78.18 172.75 14.94 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.675 2.25 . . . . 0.0 110.387 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.455 ' HB2' ' OD1' ' A' ' 3' ' ' ASP . 45.5 mmt-85 -90.68 28.73 1.45 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.229 -0.92 . . . . 0.0 109.48 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.948 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -146.26 175.35 2.77 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.229 -0.919 . . . . 0.0 109.428 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.948 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.3 Cg_endo -77.83 142.38 20.01 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.647 2.231 . . . . 0.0 110.35 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.716 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 46.3 pt -145.68 -170.6 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.262 -0.899 . . . . 0.0 109.602 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 35.8 p -121.26 -8.64 9.2 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.278 -0.889 . . . . 0.0 109.416 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 154.04 -168.34 32.41 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.716 ' CZ ' HD11 ' A' ' 29' ' ' ILE . 0.2 OUTLIER -138.64 131.54 29.53 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.197 -1.178 . . . . 0.0 109.526 -179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.943 HG23 ' HD2' ' A' ' 49' ' ' ARG . 1.1 mp -83.48 133.05 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.21 -0.931 . . . . 0.0 108.835 179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.845 HD13 ' C ' ' A' ' 33' ' ' ILE . 2.4 mm -111.97 101.03 11.95 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 121.185 -0.947 . . . . 0.0 109.829 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.41 ' O ' ' N ' ' A' ' 71' ' ' SER . 0.2 OUTLIER -109.39 111.14 22.52 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.167 -0.958 . . . . 0.0 108.602 179.347 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.991 ' CE1' HD21 ' A' ' 59' ' ' LEU . 2.1 p-80 -119.13 160.6 21.8 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.135 -0.978 . . . . 0.0 110.385 -179.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.536 ' HB3' ' CB ' ' A' ' 45' ' ' PRO . 30.3 p-80 -167.25 136.02 2.67 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.576 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -47.51 177.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.922 . . . . 0.0 110.033 -179.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.426 ' C ' ' O ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -42.96 -75.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.277 -0.889 . . . . 0.0 109.767 179.804 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -149.06 47.68 0.99 Allowed 'General case' 0 C--N 1.293 -1.863 0 O-C-N 121.689 -0.632 . . . . 0.0 109.512 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.476 ' OG ' ' HB3' ' A' ' 38' ' ' ALA . 4.9 p -74.88 -94.34 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.295 -0.878 . . . . 0.0 109.579 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.684 HG12 ' H ' ' A' ' 43' ' ' GLY . 2.2 t -74.78 -179.35 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 O-C-N 121.36 -0.838 . . . . 0.0 109.536 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.684 ' H ' HG12 ' A' ' 42' ' ' VAL . . . -84.81 -90.97 0.8 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.469 ' HD3' ' HD2' ' A' ' 45' ' ' PRO . 0.8 OUTLIER -51.95 139.32 33.04 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.28 -1.13 . . . . 0.0 109.396 -179.909 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.536 ' CB ' ' HB3' ' A' ' 37' ' ' HIS . 36.4 Cg_endo -79.08 164.48 24.75 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.573 2.182 . . . . 0.0 110.6 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.577 ' HB2' ' CD2' ' A' ' 36' ' ' HIS . 4.1 mmt85 -75.64 128.61 35.6 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.312 -0.868 . . . . 0.0 109.209 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.451 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 3.8 mt-30 -87.77 133.3 33.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.283 -0.885 . . . . 0.0 109.95 -179.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.529 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 1.0 OUTLIER -155.21 117.08 4.1 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.582 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.943 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -105.64 165.02 11.46 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.982 -1.074 . . . . 0.0 110.205 -179.124 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.646 ' CG1' HD12 ' A' ' 57' ' ' ILE . 7.2 m -140.0 161.84 53.63 Favored Pre-proline 0 N--CA 1.489 1.492 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.548 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.3 Cg_endo -76.37 174.1 13.39 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 C-N-CA 122.324 2.016 . . . . 0.0 110.354 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.556 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.5 Cg_endo -76.86 -14.43 17.24 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.558 2.172 . . . . 0.0 110.273 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -105.12 23.39 13.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.349 -0.845 . . . . 0.0 109.513 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.548 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 10.5 mmt180 -124.77 97.99 5.52 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -0.953 . . . . 0.0 109.719 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 3.7 p30 -85.06 -0.97 56.24 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.181 -0.95 . . . . 0.0 109.305 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 63.5 p -136.52 149.1 47.97 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.406 -0.808 . . . . 0.0 109.028 179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.66 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 3.4 tt -134.14 123.22 43.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.116 -0.99 . . . . 0.0 109.741 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.494 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 66.4 m -91.74 116.37 28.83 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.358 -0.838 . . . . 0.0 109.456 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.991 HD21 ' CE1' ' A' ' 36' ' ' HIS . 7.2 mt -92.51 151.4 20.2 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.203 -0.936 . . . . 0.0 109.618 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.487 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 1.2 p -133.12 169.66 16.53 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.382 -0.824 . . . . 0.0 109.561 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 2.6 m120 59.4 39.85 21.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.293 -0.879 . . . . 0.0 109.455 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.91 HD11 ' HB3' ' A' ' 59' ' ' LEU . 4.3 mt -108.89 157.64 18.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.255 -0.903 . . . . 0.0 109.293 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.475 ' O ' ' OH ' ' A' ' 68' ' ' TYR . 13.0 m-20 -60.87 134.74 92.59 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 121.142 -0.974 . . . . 0.0 108.819 179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 37.0 Cg_endo -78.49 117.9 4.13 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.289 1.993 . . . . 0.0 110.502 -179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 77.46 60.51 2.81 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 108.693 -1.763 . . . . 0.0 108.693 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.552 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 2.1 m -146.58 166.67 25.8 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.535 -0.979 . . . . 0.0 109.895 -179.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.552 ' N ' ' CG2' ' A' ' 66' ' ' THR . 7.5 pt-20 -121.18 136.46 54.97 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.418 -0.801 . . . . 0.0 109.303 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.576 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 0.2 OUTLIER -132.49 176.97 7.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.19 -0.944 . . . . 0.0 109.577 -179.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.646 HG22 ' HG3' ' A' ' 87' ' ' GLN . 74.9 t -108.69 97.02 5.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.947 HG13 ' HB3' ' A' ' 36' ' ' HIS . 1.9 t -84.76 124.51 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.32 -0.863 . . . . 0.0 110.13 -178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.579 ' CB ' HG12 ' A' ' 85' ' ' ILE . 15.5 p -105.72 137.72 43.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.298 -0.877 . . . . 0.0 110.295 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.79 ' CD1' HG23 ' A' ' 34' ' ' ILE . 30.9 mm -124.06 120.95 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.465 -0.772 . . . . 0.0 109.149 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 74' ' ' ALA . 49.2 mt -117.6 167.16 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.264 -0.898 . . . . 0.0 109.428 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.79 ' HB3' ' HB2' ' A' ' 81' ' ' SER . . . -132.13 124.75 29.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.911 . . . . 0.0 109.393 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -116.03 136.21 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 109.588 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.415 ' CB ' ' HA ' ' A' ' 29' ' ' ILE . 48.3 t30 -121.31 50.14 1.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -0.94 . . . . 0.0 109.448 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.41 -82.12 0.95 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.541 -1.424 . . . . 0.0 109.541 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.432 ' O ' ' HG3' ' A' ' 78' ' ' ARG . 20.0 tpt180 -117.35 2.01 12.46 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.218 -1.166 . . . . 0.0 109.62 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 1.1 mt-10 -92.96 176.45 6.42 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.133 -0.979 . . . . 0.0 109.415 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 36.0 mt-10 -154.57 96.31 1.88 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 109.522 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.79 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -59.9 178.99 0.22 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.134 179.749 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.568 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.3 Cg_endo -77.3 152.22 30.43 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.352 2.035 . . . . 0.0 110.139 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.436 ' HA ' HG12 ' A' ' 73' ' ' ILE . 35.5 Cg_endo -77.8 105.49 2.03 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.532 2.155 . . . . 0.0 110.759 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.921 HD22 ' O ' ' A' ' 5' ' ' PRO . 23.1 tp -84.57 100.8 11.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.28 -0.888 . . . . 0.0 108.941 179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.579 HG12 ' CB ' ' A' ' 71' ' ' SER . 2.3 mt -110.1 149.92 12.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.126 -0.984 . . . . 0.0 110.09 -179.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -153.47 160.5 29.26 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 107.97 -2.052 . . . . 0.0 107.97 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.646 ' HG3' HG22 ' A' ' 69' ' ' VAL . 0.0 OUTLIER -104.19 105.09 15.12 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.127 -1.219 . . . . 0.0 109.792 -179.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.462 ' OE1' ' CB ' ' A' ' 10' ' ' SER . 36.0 mm-40 -104.79 -165.92 1.18 Allowed 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.55 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.74 145.39 6.43 Favored 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 118.902 -1.119 . . . . 0.0 110.929 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -78.26 140.09 38.87 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 179.144 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.08 HG11 ' CB ' ' A' ' 116' ' ' ALA . 2.1 t -42.35 158.67 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.532 ' HA ' ' CA ' ' A' ' 65' ' ' GLY . 0.3 OUTLIER -106.01 135.29 47.72 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.441 -0.787 . . . . 0.0 109.841 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.511 ' CB ' ' OG1' ' A' ' 166' ' ' THR . 0.7 OUTLIER -70.8 -4.51 24.37 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.441 -0.787 . . . . 0.0 108.878 179.302 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.974 HD11 ' HB2' ' A' ' 176' ' ' LYS . 5.3 mt -50.31 144.24 11.98 Favored Pre-proline 0 N--CA 1.484 1.231 0 O-C-N 121.307 -0.871 . . . . 0.0 109.673 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.763 ' HD2' HG23 ' A' ' 94' ' ' ILE . 34.7 Cg_endo -77.49 -163.83 0.23 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.163 1.909 . . . . 0.0 109.097 178.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 9.2 ptm85 -158.81 147.6 18.58 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.871 -1.143 . . . . 0.0 109.682 179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 4.4 t70 75.71 24.26 1.3 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.352 -0.843 . . . . 0.0 109.301 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 1.025 HD23 ' CG2' ' A' ' 180' ' ' ILE . 3.4 tp -54.96 99.81 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.268 0 O-C-N 121.186 -0.946 . . . . 0.0 109.207 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 -142.8 161.78 37.19 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.906 . . . . 0.0 109.599 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.497 HG13 ' O ' ' A' ' 109' ' ' LEU . 38.4 t -103.72 150.54 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.273 -0.892 . . . . 0.0 109.592 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.753 ' CG1' HD21 ' A' ' 109' ' ' LEU . 1.2 pt -120.01 -16.06 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.378 -0.826 . . . . 0.0 109.44 179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.78 ' HB3' HD23 ' A' ' 109' ' ' LEU . . . -135.99 143.1 44.63 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 179.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.532 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.8 p -135.31 93.22 2.95 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.94 -1.1 . . . . 0.0 110.531 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.575 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -75.77 165.95 49.21 Favored Pre-proline 0 C--N 1.306 -1.296 0 O-C-N 121.102 -0.999 . . . . 0.0 108.512 178.715 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.456 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 30.0 Cg_endo -69.34 -1.89 8.92 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.296 1.997 . . . . 0.0 110.58 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.748 ' C ' HG22 ' A' ' 152' ' ' ILE . 3.3 p -151.41 17.24 0.72 Allowed 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.353 -0.842 . . . . 0.0 108.953 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 1.033 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.7 OUTLIER -169.93 161.54 8.91 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 118.802 -1.159 . . . . 0.0 110.768 -179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.033 HD23 ' O ' ' A' ' 107' ' ' SER . 0.4 OUTLIER -148.05 147.76 29.93 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 179.412 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.78 HD23 ' HB3' ' A' ' 102' ' ' ALA . 1.5 pp -106.99 135.93 47.72 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.149 -0.969 . . . . 0.0 109.222 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.614 ' H ' HD13 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -112.47 167.05 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.109 -0.994 . . . . 0.0 110.1 -179.659 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.584 ' CB ' HG22 ' A' ' 146' ' ' THR . 32.4 t -152.03 136.3 16.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.483 -0.761 . . . . 0.0 109.146 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.585 ' CD1' ' HB3' ' A' ' 95' ' ' PRO . 15.5 p90 -141.08 172.18 13.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.198 -0.939 . . . . 0.0 109.711 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.498 ' HB3' ' HD2' ' A' ' 114' ' ' PRO . 5.4 mt-10 -108.03 164.16 15.38 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.299 -0.875 . . . . 0.0 109.52 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.498 ' HD2' ' HB3' ' A' ' 113' ' ' GLU . 34.7 Cg_endo -78.15 132.54 11.58 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.803 2.335 . . . . 0.0 110.771 -179.61 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.506 ' HG3' ' O ' ' A' ' 93' ' ' ASP . 35.1 Cg_endo -79.23 -157.29 0.08 OUTLIER 'Trans proline' 0 C--N 1.313 -1.301 0 C-N-CA 122.752 2.301 . . . . 0.0 110.813 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.08 ' CB ' HG11 ' A' ' 91' ' ' VAL . . . -69.29 -4.28 17.38 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.362 -0.836 . . . . 0.0 109.942 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 1.055 HG11 ' HB2' ' A' ' 15' ' ' ALA . 3.5 m -134.64 158.68 41.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.142 -0.974 . . . . 0.0 109.723 -179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.436 ' O ' ' CG2' ' A' ' 166' ' ' THR . 74.9 p -69.85 -161.68 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.925 . . . . 0.0 108.897 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 1.151 HG11 ' CE2' ' A' ' 122' ' ' TYR . 2.9 t -152.99 139.79 12.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.082 -1.011 . . . . 0.0 110.411 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.531 ' NH2' ' HG2' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -98.97 -43.39 6.72 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 178.689 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 1.076 ' CZ ' HG21 ' A' ' 165' ' ' VAL . 0.9 OUTLIER -165.4 161.13 18.7 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 179.046 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 1.151 ' CE2' HG11 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -125.74 171.98 10.19 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.034 -1.041 . . . . 0.0 109.908 -179.48 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -131.8 90.36 2.82 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.076 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.625 ' CD1' HG21 ' A' ' 140' ' ' VAL . 12.9 mt -83.48 164.37 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.339 -0.851 . . . . 0.0 110.021 -179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.553 HG22 ' CB ' ' A' ' 137' ' ' GLU . 1.9 p -141.14 151.4 43.86 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.372 -0.83 . . . . 0.0 109.697 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.756 ' CE2' HG22 ' A' ' 149' ' ' ILE . 2.9 m-85 -87.01 141.64 28.52 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.257 -0.902 . . . . 0.0 108.685 179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.593 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -105.31 111.54 3.75 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 110.388 -1.085 . . . . 0.0 110.388 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.4 ' OE2' ' HD3' ' A' ' 153' ' ' LYS . 4.9 mt-10 -105.56 144.06 32.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.114 -1.227 . . . . 0.0 109.356 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.612 HG23 ' O ' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -56.14 159.68 3.29 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.245 -0.909 . . . . 0.0 109.75 179.904 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 54.29 57.55 16.57 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.444 ' C ' ' HD2' ' A' ' 134' ' ' PRO . . . -154.39 -78.56 0.02 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.44 ' O ' ' CB ' ' A' ' 133' ' ' SER . 67.9 m-20 58.86 41.48 21.32 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.271 -1.135 . . . . 0.0 109.485 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.56 ' CB ' ' HD3' ' A' ' 134' ' ' PRO . 0.1 OUTLIER 169.17 -54.81 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.554 179.854 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.56 ' HD3' ' CB ' ' A' ' 133' ' ' SER . 35.7 Cg_endo -77.95 78.33 3.61 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.404 2.07 . . . . 0.0 110.004 179.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.751 HG12 ' O ' ' A' ' 126' ' ' TYR . 0.7 OUTLIER -109.47 170.35 3.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.378 -0.826 . . . . 0.0 109.618 -179.295 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.534 ' O ' ' HA ' ' A' ' 125' ' ' THR . 1.3 mp0 -94.84 83.4 4.0 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.145 -0.972 . . . . 0.0 108.811 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.553 ' CB ' HG22 ' A' ' 125' ' ' THR . 32.5 tt0 -74.01 114.97 12.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.869 . . . . 0.0 111.349 -178.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.613 ' CE1' ' HB ' ' A' ' 124' ' ' ILE . 44.0 p90 -117.48 156.74 27.48 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 178.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.675 HG22 ' HE1' ' A' ' 121' ' ' TYR . 0.7 OUTLIER -74.19 -171.76 1.24 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.824 -1.172 . . . . 0.0 110.744 -178.31 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.726 HG13 ' HD2' ' A' ' 141' ' ' PRO . 71.2 t -154.53 143.12 14.59 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.32 -0.862 . . . . 0.0 109.41 -179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.726 ' HD2' HG13 ' A' ' 140' ' ' VAL . 35.5 Cg_endo -78.48 140.55 17.11 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 C-N-CA 122.451 2.101 . . . . 0.0 110.2 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -92.94 38.29 3.2 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.7 t -105.15 -0.74 26.27 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -1.166 . . . . 0.0 109.694 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.57 162.65 32.95 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.117 -0.989 . . . . 0.0 109.527 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.578 ' O ' ' CE3' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -90.9 9.17 31.51 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.271 -0.893 . . . . 0.0 109.559 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.584 HG22 ' CB ' ' A' ' 111' ' ' SER . 71.7 p -119.72 158.78 25.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.887 . . . . 0.0 109.281 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.596 ' CB ' ' CD1' ' A' ' 124' ' ' ILE . . . -135.51 153.32 51.77 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.193 -0.942 . . . . 0.0 109.633 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.3 t -98.94 151.26 21.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.316 -0.865 . . . . 0.0 109.193 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.756 HG22 ' CE2' ' A' ' 126' ' ' TYR . 12.4 mm -133.05 111.36 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.198 -0.939 . . . . 0.0 109.399 -179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.581 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 9.8 m120 -122.32 169.18 11.19 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.311 -0.868 . . . . 0.0 109.955 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.518 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 2.0 m120 76.12 20.23 1.68 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.165 -0.959 . . . . 0.0 109.041 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.748 HG22 ' C ' ' A' ' 106' ' ' THR . 7.4 tt -76.7 149.45 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.441 -0.787 . . . . 0.0 109.643 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.47 ' HB2' ' OH ' ' A' ' 158' ' ' TYR . 4.2 mtpm? -103.7 117.44 59.83 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.165 -0.959 . . . . 0.0 109.487 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.537 ' HA ' ' CB ' ' A' ' 184' ' ' THR . 35.3 Cg_endo -77.83 166.67 24.93 Favored 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.407 2.072 . . . . 0.0 110.481 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.694 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 74.07 59.43 3.96 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.694 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 162.92 130.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -1.147 . . . . 0.0 109.599 -179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.612 ' O ' HG23 ' A' ' 129' ' ' THR . 0.3 OUTLIER -47.22 161.72 0.07 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 179.031 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.593 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -141.78 176.58 8.8 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 120.773 -1.204 . . . . 0.0 110.44 -179.186 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.739 ' O ' HD13 ' A' ' 160' ' ' ILE . 0.6 OUTLIER -146.89 168.72 20.76 Favored 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 107.813 -1.181 . . . . 0.0 107.813 179.235 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.739 HD13 ' O ' ' A' ' 159' ' ' THR . 31.1 mm -147.47 120.5 1.88 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.668 -1.27 . . . . 0.0 109.707 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.733 HG23 ' CB ' ' A' ' 179' ' ' SER . 0.9 OUTLIER -126.89 163.7 23.05 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.244 -0.91 . . . . 0.0 109.119 179.658 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.944 HD23 HD13 ' A' ' 98' ' ' LEU . 2.5 pp -160.86 146.32 14.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.867 -1.146 . . . . 0.0 110.988 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.595 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 1.9 m-85 -115.71 90.7 3.4 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -57.18 135.37 56.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.933 -1.104 . . . . 0.0 109.437 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 1.076 HG21 ' CZ ' ' A' ' 121' ' ' TYR . 48.2 t -107.56 124.65 63.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 109.576 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.698 HG22 ' HA ' ' A' ' 119' ' ' VAL . 0.7 OUTLIER -135.1 -38.22 0.78 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.665 -0.647 . . . . 0.0 109.744 -179.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 166' ' ' THR . . . -37.91 139.12 0.58 Allowed Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 -179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.531 ' HG2' ' NH2' ' A' ' 120' ' ' ARG . 1.4 mtp180 -150.17 16.38 0.84 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.335 -1.097 . . . . 0.0 109.572 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -82.15 -110.44 0.42 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.496 ' O ' ' CB ' ' A' ' 171' ' ' SER . 9.2 p-10 -89.34 21.06 3.47 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.267 -1.137 . . . . 0.0 109.312 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.496 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 0.8 OUTLIER 162.97 139.15 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.349 -0.844 . . . . 0.0 109.175 -179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.66 96.6 1.1 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.502 2.135 . . . . 0.0 110.471 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -85.63 -166.53 1.55 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.225 -0.922 . . . . 0.0 109.432 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.46 ' O ' ' O ' ' A' ' 175' ' ' SER . 5.0 p -155.14 126.97 7.52 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.227 -0.921 . . . . 0.0 109.536 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.499 ' HB2' HG13 ' A' ' 94' ' ' ILE . 85.8 p -54.35 -168.71 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.278 -0.889 . . . . 0.0 109.439 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.974 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.8 OUTLIER -73.47 151.91 89.67 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.942 . . . . 0.0 108.89 179.733 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.595 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 35.9 Cg_endo -79.24 118.92 4.08 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 C-N-CA 122.427 2.085 . . . . 0.0 111.433 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.615 HG23 ' CG2' ' A' ' 94' ' ' ILE . 2.7 t -84.79 127.71 39.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 178.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.733 ' CB ' HG23 ' A' ' 161' ' ' THR . 0.0 OUTLIER -124.52 129.31 50.38 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.21 -0.932 . . . . 0.0 110.586 -178.779 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 1.025 ' CG2' HD23 ' A' ' 98' ' ' LEU . 40.3 pt -114.78 -162.79 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.474 ' OD1' ' N ' ' A' ' 181' ' ' ASN . 1.1 m120 -124.5 156.81 36.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.047 -1.033 . . . . 0.0 109.758 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.82 ' OH ' HD22 ' A' ' 108' ' ' LEU . 64.9 t80 -153.19 170.55 20.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.312 -0.868 . . . . 0.0 109.164 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.412 ' N ' ' CG ' ' A' ' 182' ' ' TYR . 19.2 mtpt -139.18 134.21 32.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.191 -0.943 . . . . 0.0 109.448 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.593 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 2.9 p . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 118.065 -0.969 . . . . 0.0 109.467 -179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.36 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.522 ' CD1' ' O ' ' A' ' 80' ' ' GLU . 1.3 mp -134.17 -162.87 1.29 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.234 -1.157 . . . . 0.0 109.534 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 26' ' ' ARG . 1.1 m-20 -100.75 152.79 20.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.249 -0.907 . . . . 0.0 109.511 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -95.08 125.89 48.77 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.228 -0.92 . . . . 0.0 109.496 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.533 ' O ' ' CD2' ' A' ' 84' ' ' LEU . 36.2 Cg_endo -78.67 81.95 2.62 Favored 'Trans proline' 0 C--N 1.312 -1.387 0 C-N-CA 122.464 2.11 . . . . 0.0 110.322 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.544 ' HA ' ' CD2' ' A' ' 84' ' ' LEU . 2.7 p -74.68 -109.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.163 -0.96 . . . . 0.0 109.666 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 45.71 26.72 1.92 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 -179.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.558 ' CE2' ' HA3' ' A' ' 86' ' ' GLY . 14.1 t80 -56.14 128.03 33.52 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.544 -0.974 . . . . 0.0 110.094 -179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.504 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 0.8 OUTLIER -147.75 -179.28 6.77 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.504 ' HB2' HD11 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -155.42 117.86 4.21 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.104 -0.997 . . . . 0.0 110.062 -179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.5 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 0.8 OUTLIER -145.73 -167.65 2.76 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 0.0 109.059 179.184 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.545 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 4.6 m-20 42.23 38.49 1.16 Allowed 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -178.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.019 HG22 HG23 ' A' ' 91' ' ' VAL . 2.5 mt -80.45 149.84 5.01 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.775 -177.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.563 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -140.48 169.15 18.2 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 178.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.783 ' HB3' HG11 ' A' ' 117' ' ' VAL . . . -65.43 -62.61 1.43 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.71 -1.244 . . . . 0.0 110.159 -179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.504 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.9 OUTLIER -91.37 27.86 1.83 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.116 -0.99 . . . . 0.0 109.511 -179.66 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.563 ' O ' ' N ' ' A' ' 14' ' ' THR . 56.7 p 179.48 154.72 0.5 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.049 ' CE1' HG22 ' A' ' 20' ' ' VAL . 3.5 p90 -166.83 144.18 4.86 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.13 -0.981 . . . . 0.0 109.279 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 28.9 m -85.95 148.18 25.89 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.637 -1.289 . . . . 0.0 110.369 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.049 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.3 t -118.16 171.62 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.536 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 49.8 m-70 -151.76 165.02 35.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.004 -1.06 . . . . 0.0 110.006 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.819 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 42.6 p90 -171.98 145.42 1.84 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.442 -0.786 . . . . 0.0 109.152 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.521 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.51 169.21 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.054 -1.029 . . . . 0.0 109.189 179.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.52 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -98.65 161.05 26.41 Favored Pre-proline 0 C--N 1.298 -1.643 0 O-C-N 121.54 -0.725 . . . . 0.0 109.819 -179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.505 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.8 Cg_endo -78.79 159.78 27.85 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 C-N-CA 122.687 2.258 . . . . 0.0 110.397 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.466 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 5.1 mmm180 -90.28 17.07 7.57 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.222 -0.924 . . . . 0.0 109.408 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.969 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -121.04 177.13 1.57 Allowed Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.307 -0.871 . . . . 0.0 109.374 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.969 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.4 Cg_endo -77.83 140.03 18.09 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.52 2.147 . . . . 0.0 110.333 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.636 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 28.7 pt -153.86 -173.47 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.316 -0.865 . . . . 0.0 109.526 -179.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 17.1 p -133.95 3.31 3.45 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.229 -0.919 . . . . 0.0 109.579 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 150.57 -172.19 30.34 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.636 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -144.25 127.95 17.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.237 -1.155 . . . . 0.0 109.668 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.874 HG23 ' CD ' ' A' ' 49' ' ' ARG . 1.6 mp -80.74 130.84 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 O-C-N 121.274 -0.891 . . . . 0.0 108.772 179.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.753 HD13 ' C ' ' A' ' 33' ' ' ILE . 2.5 mm -107.54 112.34 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.166 -0.959 . . . . 0.0 109.966 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.551 ' CG ' ' HG2' ' A' ' 47' ' ' GLN . 0.0 OUTLIER -104.55 116.77 32.65 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.137 -0.977 . . . . 0.0 108.582 179.098 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.553 ' CD2' ' C ' ' A' ' 36' ' ' HIS . 0.1 OUTLIER -105.95 144.36 32.78 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.085 -1.01 . . . . 0.0 109.797 -179.11 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.587 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 41.6 p-80 -169.5 114.47 0.54 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.586 -0.696 . . . . 0.0 109.91 179.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.924 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . -61.37 175.21 0.6 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.42 -0.8 . . . . 0.0 109.609 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -54.86 -68.74 0.16 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.245 -0.909 . . . . 0.0 109.323 179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -165.25 50.06 0.1 Allowed 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.745 -0.597 . . . . 0.0 109.514 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.421 ' O ' ' ND2' ' A' ' 63' ' ' ASN . 2.6 p -127.46 8.56 6.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.258 -0.901 . . . . 0.0 109.577 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.608 HG23 ' HB3' ' A' ' 38' ' ' ALA . 2.1 t -123.03 149.68 26.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.172 -0.955 . . . . 0.0 109.518 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -53.46 -88.63 0.01 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.0 mmt180 -117.22 146.26 37.79 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.292 -1.123 . . . . 0.0 109.421 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.561 ' HB3' ' CB ' ' A' ' 37' ' ' HIS . 36.2 Cg_endo -78.39 144.16 20.12 Favored 'Trans proline' 0 C--N 1.31 -1.487 0 C-N-CA 122.61 2.207 . . . . 0.0 110.534 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.51 ' CZ ' ' CB ' ' A' ' 46' ' ' ARG . 2.8 ptm85 -107.6 176.97 4.97 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.271 -0.893 . . . . 0.0 109.52 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.551 ' HG2' ' CG ' ' A' ' 35' ' ' ARG . 30.1 mt-30 -139.18 119.58 13.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.276 -0.89 . . . . 0.0 109.701 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.868 ' HB3' HD11 ' A' ' 57' ' ' ILE . 0.6 OUTLIER -111.58 118.22 35.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.358 -0.839 . . . . 0.0 108.822 179.503 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.874 ' CD ' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -92.99 140.31 29.6 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.013 -1.054 . . . . 0.0 109.546 -179.307 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.666 ' CG2' HD11 ' A' ' 34' ' ' ILE . 1.8 m -117.58 163.16 25.15 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.277 -0.89 . . . . 0.0 109.555 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.497 ' HG2' ' HG3' ' A' ' 54' ' ' ARG . 34.5 Cg_endo -76.98 174.84 12.2 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.634 2.222 . . . . 0.0 110.486 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.61 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.9 Cg_endo -76.73 -15.8 16.84 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.562 2.175 . . . . 0.0 110.316 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.6 m -103.26 25.71 9.2 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.277 -0.889 . . . . 0.0 109.16 179.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.497 ' HG3' ' HG2' ' A' ' 51' ' ' PRO . 0.1 OUTLIER -127.14 126.22 42.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.37 -0.831 . . . . 0.0 109.509 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.474 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 25.2 p-10 -111.82 5.43 19.02 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.286 -0.884 . . . . 0.0 109.528 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.516 ' HB3' ' ND1' ' A' ' 21' ' ' HIS . 89.3 p -146.12 150.05 35.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.29 -0.881 . . . . 0.0 109.313 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.868 HD11 ' HB3' ' A' ' 48' ' ' ASP . 4.2 tt -138.21 125.16 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.195 -0.94 . . . . 0.0 109.586 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 0.3 OUTLIER -84.83 107.64 17.1 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.351 -0.843 . . . . 0.0 109.496 -179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.666 ' HB3' HD11 ' A' ' 62' ' ' LEU . 0.4 OUTLIER -84.82 149.61 25.6 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.195 -0.94 . . . . 0.0 109.259 179.829 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.485 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 6.3 p -134.61 166.15 23.57 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.139 -0.976 . . . . 0.0 109.703 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 60' ' ' THR . 3.7 m120 61.04 61.06 1.68 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.283 -0.886 . . . . 0.0 109.655 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.666 HD11 ' HB3' ' A' ' 59' ' ' LEU . 1.7 mt -132.92 138.18 46.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.352 -0.842 . . . . 0.0 109.166 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.576 ' HB3' ' HB1' ' A' ' 173' ' ' ALA . 3.0 m-20 -44.56 133.3 4.78 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.12 -0.988 . . . . 0.0 108.797 179.219 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.508 ' HG2' ' OD2' ' A' ' 93' ' ' ASP . 35.9 Cg_endo -77.74 135.22 14.17 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 C-N-CA 122.333 2.022 . . . . 0.0 111.373 -179.197 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.554 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 71.36 64.91 2.59 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.108 -1.597 . . . . 0.0 109.108 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.6 m -158.44 151.57 22.74 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.251 -1.146 . . . . 0.0 110.889 -179.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 1.7 tt0 -84.43 133.95 34.48 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 178.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.924 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 28.0 m-85 -119.81 130.98 55.18 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.882 -1.136 . . . . 0.0 110.856 -178.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.709 HG12 ' CG2' ' A' ' 85' ' ' ILE . 3.4 t -85.56 97.49 5.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.535 HG23 ' NE2' ' A' ' 88' ' ' GLN . 3.1 t -94.06 125.48 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.291 -0.88 . . . . 0.0 109.759 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.527 ' CB ' HG12 ' A' ' 85' ' ' ILE . 1.3 p -96.74 138.62 34.03 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.304 -0.872 . . . . 0.0 109.72 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.56 ' CD1' HG23 ' A' ' 34' ' ' ILE . 17.8 mm -114.45 77.35 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.332 -0.855 . . . . 0.0 109.27 179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.555 HG22 ' N ' ' A' ' 74' ' ' ALA . 24.5 mt -75.04 163.71 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 109.46 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.845 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -121.89 160.2 25.26 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.228 -0.92 . . . . 0.0 109.583 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.446 ' O ' ' OG1' ' A' ' 30' ' ' THR . 0.4 OUTLIER -145.11 131.9 15.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.222 -0.923 . . . . 0.0 109.318 179.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.464 ' OD1' ' O ' ' A' ' 28' ' ' PRO . 0.2 OUTLIER -116.63 50.47 1.06 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.278 -0.889 . . . . 0.0 109.395 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.05 -90.24 1.34 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.4 tpp180 -114.53 0.77 14.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -1.129 . . . . 0.0 109.638 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 0.8 OUTLIER -96.44 -164.54 1.16 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.136 -0.978 . . . . 0.0 109.262 179.892 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.522 ' O ' ' CD1' ' A' ' 2' ' ' LEU . 23.2 mt-10 -147.58 -169.56 3.35 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.171 -0.956 . . . . 0.0 109.571 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.845 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.6 OUTLIER -155.33 -177.41 0.73 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.371 -0.831 . . . . 0.0 109.062 -179.625 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.598 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.1 Cg_endo -77.85 131.03 10.88 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.162 1.908 . . . . 0.0 109.963 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.467 ' HB3' HG12 ' A' ' 73' ' ' ILE . 36.0 Cg_endo -77.8 86.87 1.58 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.524 2.149 . . . . 0.0 111.179 -179.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 85' ' ' ILE . 0.1 OUTLIER -75.26 131.28 40.25 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 179.096 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.709 ' CG2' HG12 ' A' ' 69' ' ' VAL . 3.8 mt -117.54 150.65 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.011 -1.055 . . . . 0.0 110.346 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.558 ' HA3' ' CE2' ' A' ' 8' ' ' PHE . . . -132.58 176.97 19.15 Favored Glycine 0 N--CA 1.483 1.829 0 N-CA-C 108.074 -2.011 . . . . 0.0 108.074 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -142.66 111.9 6.59 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.101 -1.234 . . . . 0.0 110.344 -179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.591 ' HG3' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -113.24 -158.82 0.66 Allowed 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 179.014 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.559 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -148.07 130.06 15.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.716 -1.24 . . . . 0.0 110.525 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.508 ' OG1' ' CE2' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -74.45 134.83 42.32 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.019 HG23 HG22 ' A' ' 13' ' ' ILE . 7.5 t -44.32 167.67 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.555 ' CB ' ' HD3' ' A' ' 176' ' ' LYS . 16.1 p -97.53 107.39 19.88 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.268 -0.895 . . . . 0.0 109.093 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.522 ' O ' ' HG3' ' A' ' 115' ' ' PRO . 1.0 OUTLIER -59.62 -12.25 6.41 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.162 -0.961 . . . . 0.0 109.19 179.82 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 1.044 HD12 ' O ' ' A' ' 176' ' ' LYS . 0.4 OUTLIER -60.88 138.44 93.76 Favored Pre-proline 0 N--CA 1.483 1.201 0 O-C-N 120.936 -1.103 . . . . 0.0 108.525 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.551 ' HD2' HG23 ' A' ' 94' ' ' ILE . 36.7 Cg_endo -82.58 137.82 9.26 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 122.502 2.135 . . . . 0.0 110.267 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.476 ' O ' ' N ' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -86.53 -168.27 2.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.155 -0.966 . . . . 0.0 109.511 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.468 ' O ' ' O ' ' A' ' 111' ' ' SER . 11.5 t0 71.78 33.09 1.8 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.294 -0.879 . . . . 0.0 109.702 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.964 HD13 ' CD2' ' A' ' 162' ' ' LEU . 31.5 tp -71.95 92.77 1.3 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.242 -0.912 . . . . 0.0 109.396 179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -133.28 157.88 44.35 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.218 -0.926 . . . . 0.0 109.668 -179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.466 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 9.5 p -96.96 141.77 15.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.209 -0.932 . . . . 0.0 109.81 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.865 HD11 ' CD2' ' A' ' 109' ' ' LEU . 12.1 pt -123.59 -8.55 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.227 -0.921 . . . . 0.0 109.532 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.617 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -147.12 112.83 5.69 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.239 -1.023 . . . . 0.0 108.239 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.488 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 12.9 m -112.72 96.44 5.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.136 -0.977 . . . . 0.0 110.599 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.479 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -83.11 165.92 38.3 Favored Pre-proline 0 C--N 1.306 -1.288 0 O-C-N 121.243 -0.91 . . . . 0.0 108.653 178.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.464 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 30.0 Cg_endo -69.44 -3.83 12.58 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.275 1.984 . . . . 0.0 110.478 -179.356 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.69 ' C ' HG22 ' A' ' 152' ' ' ILE . 4.9 p -149.08 16.67 0.95 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.396 -0.815 . . . . 0.0 108.94 179.027 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 1.044 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.7 OUTLIER -169.92 165.46 9.59 Favored 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 119.149 -1.02 . . . . 0.0 110.071 179.913 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.044 HD23 ' O ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -145.65 155.69 43.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.358 -0.839 . . . . 0.0 109.259 -179.706 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.865 ' CD2' HD11 ' A' ' 101' ' ' ILE . 21.1 tp -105.42 136.52 44.82 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.284 -0.885 . . . . 0.0 108.94 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.781 ' CD1' ' HB3' ' A' ' 147' ' ' ALA . 1.2 pt -124.82 140.72 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.055 -1.028 . . . . 0.0 110.369 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 97' ' ' ASP . 7.5 t -134.46 145.19 48.61 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.602 ' CH2' ' N ' ' A' ' 147' ' ' ALA . 11.9 p90 -134.56 -171.31 2.74 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.076 -1.015 . . . . 0.0 110.707 -179.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.54 ' O ' ' CB ' ' A' ' 95' ' ' PRO . 4.4 mm-40 -119.58 169.52 8.18 Favored Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.591 -0.693 . . . . 0.0 109.668 -179.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 113' ' ' GLU . 32.4 Cg_endo -76.04 119.95 5.55 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.817 2.345 . . . . 0.0 110.743 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.522 ' HG3' ' O ' ' A' ' 93' ' ' ASP . 35.7 Cg_endo -80.36 -158.53 0.09 OUTLIER 'Trans proline' 0 C--N 1.315 -1.192 0 C-N-CA 122.97 2.446 . . . . 0.0 111.732 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.708 ' HB2' HG11 ' A' ' 91' ' ' VAL . . . -69.12 -5.4 22.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.5 -0.75 . . . . 0.0 109.927 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.783 HG11 ' HB3' ' A' ' 15' ' ' ALA . 2.4 m -155.84 -167.82 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.099 -1.001 . . . . 0.0 110.289 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.494 ' O ' HG23 ' A' ' 117' ' ' VAL . 0.6 OUTLIER -89.44 -158.85 0.53 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.508 -0.745 . . . . 0.0 109.099 179.621 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.512 ' HA ' ' CG2' ' A' ' 166' ' ' THR . 2.1 t -154.94 131.37 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.195 -0.941 . . . . 0.0 109.909 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.46 ' HB2' ' HA ' ' A' ' 166' ' ' THR . 12.6 ttt180 -78.08 -44.27 26.77 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.893 ' CE1' HG22 ' A' ' 139' ' ' THR . 0.8 OUTLIER -165.3 157.59 15.44 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.5 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.493 ' CE2' HG11 ' A' ' 119' ' ' VAL . 2.7 m-85 -111.76 147.89 34.68 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.965 -1.084 . . . . 0.0 109.83 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.582 ' O ' ' CD1' ' A' ' 163' ' ' TYR . 21.4 ttm180 -120.42 84.22 2.19 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.633 HG12 ' HB2' ' A' ' 162' ' ' LEU . 7.6 mt -84.42 168.72 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.257 -0.902 . . . . 0.0 110.274 -178.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.511 ' N ' HG22 ' A' ' 124' ' ' ILE . 1.5 p -144.37 156.08 44.07 Favored 'General case' 0 N--CA 1.492 1.673 0 C-N-CA 119.665 -0.814 . . . . 0.0 110.61 -179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.699 ' CE2' HG22 ' A' ' 149' ' ' ILE . 3.5 m-85 -91.24 137.43 32.37 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.519 -0.738 . . . . 0.0 109.034 179.375 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.615 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -102.69 111.52 4.02 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.474 ' HB2' ' HG2' ' A' ' 134' ' ' PRO . 5.8 mt-10 -107.92 75.11 0.98 Allowed 'General case' 0 C--N 1.298 -1.652 0 O-C-N 121.134 -1.215 . . . . 0.0 109.311 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -61.95 141.62 57.91 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.052 -1.03 . . . . 0.0 109.644 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 152.28 -32.82 0.86 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.795 -1.322 . . . . 0.0 109.795 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -120.98 -103.69 1.9 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -102.33 -72.76 0.68 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -1.107 . . . . 0.0 109.414 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.546 ' N ' ' HD3' ' A' ' 134' ' ' PRO . 1.8 t -175.44 59.89 0.2 Allowed Pre-proline 0 C--N 1.294 -1.823 0 O-C-N 121.726 -0.609 . . . . 0.0 109.724 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.546 ' HD3' ' N ' ' A' ' 133' ' ' SER . 35.9 Cg_endo -77.61 112.72 3.38 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.582 2.188 . . . . 0.0 110.228 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -122.3 147.0 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.133 -0.979 . . . . 0.0 109.698 -179.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.486 ' O ' ' HA ' ' A' ' 125' ' ' THR . 1.2 tt0 -111.95 90.81 3.44 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.498 ' HA ' HG22 ' A' ' 125' ' ' THR . 0.5 OUTLIER -74.72 133.18 42.07 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.346 -0.846 . . . . 0.0 110.89 -178.679 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.652 ' CZ ' HD13 ' A' ' 149' ' ' ILE . 43.6 p90 -134.69 145.19 48.28 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.893 HG22 ' CE1' ' A' ' 121' ' ' TYR . 1.2 p -74.05 -175.71 2.29 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.943 -1.098 . . . . 0.0 110.791 -178.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.744 HG13 ' HD2' ' A' ' 141' ' ' PRO . 72.0 t -157.21 144.03 13.38 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.446 -0.784 . . . . 0.0 109.297 -179.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.744 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.0 Cg_endo -76.17 140.89 22.81 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.379 2.052 . . . . 0.0 110.361 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -88.58 35.62 3.58 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.424 ' C ' ' HD3' ' A' ' 144' ' ' LYS . 0.3 OUTLIER -105.27 -22.01 13.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.096 -1.237 . . . . 0.0 109.463 179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.424 ' HD3' ' C ' ' A' ' 143' ' ' SER . 2.3 mptt -116.44 150.77 37.29 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.522 -0.736 . . . . 0.0 110.03 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -89.56 4.01 50.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.351 -0.843 . . . . 0.0 109.108 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.543 ' C ' ' CH2' ' A' ' 112' ' ' TRP . 1.6 p -130.2 151.94 50.17 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.389 -0.819 . . . . 0.0 108.827 179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.781 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -116.76 153.41 32.47 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.029 -1.045 . . . . 0.0 109.969 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.8 t -104.66 154.19 20.28 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.365 -0.834 . . . . 0.0 109.1 179.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.699 HG22 ' CE2' ' A' ' 126' ' ' TYR . 9.4 mm -134.75 114.25 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.215 -0.928 . . . . 0.0 109.482 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.58 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 3.2 m120 -122.28 170.95 9.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.287 -0.883 . . . . 0.0 109.984 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.435 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 4.3 m120 70.57 28.19 3.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.255 -0.903 . . . . 0.0 109.115 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.69 HG22 ' C ' ' A' ' 106' ' ' THR . 5.1 tt -84.56 147.13 5.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 O-C-N 121.393 -0.817 . . . . 0.0 109.713 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.468 ' HB2' ' OH ' ' A' ' 158' ' ' TYR . 0.0 OUTLIER -93.22 111.3 51.28 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.345 -0.847 . . . . 0.0 109.19 179.866 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.504 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 35.8 Cg_endo -77.29 141.51 20.5 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.319 2.013 . . . . 0.0 110.451 -179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.693 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 90.41 64.59 1.22 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.693 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 163.49 134.1 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.238 -1.154 . . . . 0.0 109.491 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.457 ' OD1' ' N ' ' A' ' 158' ' ' TYR . 6.9 t0 -49.31 151.62 1.43 Allowed 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 179.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.645 ' CD1' HG21 ' A' ' 184' ' ' THR . 0.2 OUTLIER -135.29 178.66 6.86 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.847 -1.158 . . . . 0.0 110.246 -179.285 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.589 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 3.4 m -150.06 107.7 3.67 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.963 HD11 HD12 ' A' ' 108' ' ' LEU . 9.0 mt -94.39 130.08 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.617 -1.302 . . . . 0.0 109.966 -179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 179' ' ' SER . 1.8 m -132.15 113.67 13.59 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.356 -0.84 . . . . 0.0 109.265 179.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.964 ' CD2' HD13 ' A' ' 98' ' ' LEU . 2.1 pp -99.18 127.16 45.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.29 -0.881 . . . . 0.0 110.164 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.677 ' HA ' HD11 ' A' ' 94' ' ' ILE . 4.2 m-85 -100.39 171.94 7.45 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.791 ' HB3' HG12 ' A' ' 94' ' ' ILE . . . -148.92 135.24 19.34 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.138 -0.976 . . . . 0.0 109.628 179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.762 HG13 ' O ' ' A' ' 173' ' ' ALA . 97.0 t -131.02 162.18 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.327 -0.858 . . . . 0.0 109.399 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.535 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.8 OUTLIER -139.43 -40.06 0.47 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.325 -0.859 . . . . 0.0 109.409 -179.904 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 166' ' ' THR . . . -53.2 -170.17 0.03 OUTLIER Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.863 -1.295 . . . . 0.0 109.863 -179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.4 -147.98 0.39 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -1.148 . . . . 0.0 109.597 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -74.46 -27.07 66.31 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.0 p-10 -74.87 -0.82 19.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.257 -1.143 . . . . 0.0 109.619 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.483 ' N ' ' HD3' ' A' ' 172' ' ' PRO . 3.0 m 177.33 63.97 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.265 -0.897 . . . . 0.0 108.989 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.483 ' HD3' ' N ' ' A' ' 171' ' ' SER . 34.8 Cg_endo -77.54 79.14 3.28 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.656 2.237 . . . . 0.0 110.885 -179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.762 ' O ' HG13 ' A' ' 165' ' ' VAL . . . -95.91 -165.96 1.36 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.313 -0.867 . . . . 0.0 108.806 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.558 ' HA ' HG22 ' A' ' 165' ' ' VAL . 0.7 OUTLIER -151.73 177.53 10.29 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.928 -1.107 . . . . 0.0 110.062 179.905 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.646 ' CB ' HG13 ' A' ' 94' ' ' ILE . 0.6 OUTLIER -115.66 159.89 20.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.667 -0.646 . . . . 0.0 109.561 -179.807 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 1.044 ' O ' HD12 ' A' ' 94' ' ' ILE . 1.7 ptmt -42.36 118.69 2.2 Favored Pre-proline 0 N--CA 1.499 1.997 0 O-C-N 121.171 -0.955 . . . . 0.0 110.45 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.626 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 29.7 Cg_endo -70.96 122.1 8.48 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.368 2.045 . . . . 0.0 111.199 179.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.839 HG23 HG21 ' A' ' 94' ' ' ILE . 57.4 t -84.77 118.79 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.528 ' HA ' ' HA ' ' A' ' 161' ' ' THR . 0.0 OUTLIER -109.9 126.52 53.95 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.132 -0.98 . . . . 0.0 110.551 -178.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.931 HG23 HD23 ' A' ' 98' ' ' LEU . 32.1 pt -117.55 151.16 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -79.5 163.33 24.8 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.006 -1.059 . . . . 0.0 109.8 -179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.792 ' OH ' HD22 ' A' ' 108' ' ' LEU . 46.2 t80 -159.19 114.98 2.55 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.437 -0.789 . . . . 0.0 109.122 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -87.14 116.87 25.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.113 -0.992 . . . . 0.0 109.447 -179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.645 HG21 ' CD1' ' A' ' 158' ' ' TYR . 9.2 p . . . . . 0 N--CA 1.489 1.493 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.481 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.673 HD12 ' HB3' ' A' ' 25' ' ' PRO . 0.5 OUTLIER -140.54 -163.7 1.58 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -1.164 . . . . 0.0 109.449 179.999 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.441 ' CG ' ' HB2' ' A' ' 26' ' ' ARG . 1.5 m-20 -81.04 161.53 24.16 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.235 -0.916 . . . . 0.0 109.459 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 47.1 t -95.2 112.01 57.0 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.291 -0.881 . . . . 0.0 109.513 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.49 ' CB ' ' O ' ' A' ' 23' ' ' VAL . 35.1 Cg_endo -77.25 78.78 3.35 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.34 2.027 . . . . 0.0 110.134 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.822 ' HA ' HD22 ' A' ' 84' ' ' LEU . 0.9 OUTLIER -87.48 -104.6 0.07 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.238 -0.913 . . . . 0.0 109.565 -179.847 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.481 ' O ' ' N ' ' A' ' 9' ' ' ASP . . . 44.2 27.03 1.03 Allowed Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 -179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.402 ' N ' ' C ' ' A' ' 6' ' ' THR . 12.7 t80 -49.06 93.35 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.44 -1.035 . . . . 0.0 109.688 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.481 ' N ' ' O ' ' A' ' 7' ' ' GLY . 9.8 t0 -121.3 84.07 2.18 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.366 -0.833 . . . . 0.0 108.994 179.724 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.473 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 83.1 p -84.43 131.79 34.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.258 -0.901 . . . . 0.0 109.495 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.479 ' O ' ' HB ' ' A' ' 19' ' ' THR . 76.7 p -156.01 -156.36 0.63 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.336 -0.853 . . . . 0.0 109.537 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.55 ' HB2' ' CB ' ' A' ' 19' ' ' THR . 0.6 OUTLIER 45.0 34.59 1.29 Allowed 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 107.51 -1.293 . . . . 0.0 107.51 -178.537 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.851 HD13 ' HB2' ' A' ' 18' ' ' PHE . 13.6 mm -62.13 134.25 27.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.749 -178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.571 ' CB ' ' O ' ' A' ' 17' ' ' SER . 0.1 OUTLIER -123.0 178.24 5.15 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 177.149 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.596 ' N ' HG12 ' A' ' 117' ' ' VAL . . . -74.07 -74.73 0.18 Allowed 'General case' 0 C--N 1.292 -1.902 0 O-C-N 120.605 -1.309 . . . . 0.0 109.155 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.6 OUTLIER -75.68 -1.35 24.35 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.159 -0.963 . . . . 0.0 109.338 179.731 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.946 ' HB3' HG22 ' A' ' 60' ' ' THR . 14.4 p -146.54 162.08 39.11 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.281 -0.887 . . . . 0.0 109.096 179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.023 ' CE1' HG22 ' A' ' 20' ' ' VAL . 4.9 p90 -167.38 137.72 2.92 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.907 -1.121 . . . . 0.0 108.419 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.55 ' CB ' ' HB2' ' A' ' 12' ' ' ASP . 11.9 m -80.99 150.01 29.08 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.77 -1.206 . . . . 0.0 111.172 -178.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.023 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.2 OUTLIER -135.34 109.85 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 179.22 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.506 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 3.0 m-70 -102.01 166.31 10.7 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.032 -1.043 . . . . 0.0 110.509 -178.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.67 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 38.9 p90 -175.71 147.72 0.83 Allowed 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.49 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -74.51 159.27 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.367 0 O-C-N 120.966 -1.084 . . . . 0.0 110.083 -179.575 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.75 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -100.79 168.97 8.46 Favored Pre-proline 0 C--N 1.299 -1.63 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.75 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.9 Cg_endo -78.61 -159.53 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.63 2.22 . . . . 0.0 110.196 179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.441 ' HB2' ' CG ' ' A' ' 3' ' ' ASP . 0.1 OUTLIER -127.66 12.69 6.89 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.241 -0.912 . . . . 0.0 109.297 179.747 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.933 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -123.17 175.14 2.9 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 109.38 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.933 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.6 Cg_endo -78.24 112.05 3.15 Favored 'Trans proline' 0 C--N 1.307 -1.607 0 C-N-CA 122.586 2.19 . . . . 0.0 110.418 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.575 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 7.6 pt -116.0 -174.23 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.261 -0.9 . . . . 0.0 109.388 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.5 p -114.88 2.87 14.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.236 -0.915 . . . . 0.0 109.567 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.528 ' HA2' ' N ' ' A' ' 52' ' ' PRO . . . 131.41 -173.04 20.59 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.63 ' CE1' ' HA ' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -134.26 145.3 48.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.311 -1.111 . . . . 0.0 109.35 -179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.881 ' C ' HD13 ' A' ' 34' ' ' ILE . 1.8 mp -92.9 129.17 43.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.269 -0.895 . . . . 0.0 109.065 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.881 HD13 ' C ' ' A' ' 33' ' ' ILE . 1.7 mm -109.76 104.38 16.99 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.243 -0.91 . . . . 0.0 109.673 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.485 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 10.2 ttp85 -106.87 131.0 54.46 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.11 -0.994 . . . . 0.0 109.209 179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 1.003 ' CD2' HD22 ' A' ' 59' ' ' LEU . 0.2 OUTLIER -117.41 131.82 56.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.171 -0.956 . . . . 0.0 109.622 -179.685 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.567 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 41.9 p-80 -151.04 132.74 14.9 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.316 -0.865 . . . . 0.0 109.796 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.93 ' HB3' ' OG ' ' A' ' 41' ' ' SER . . . -53.22 -168.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.356 -0.84 . . . . 0.0 109.87 179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.14 -99.06 0.16 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.047 -1.033 . . . . 0.0 110.4 -179.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 31.3 m-70 -74.31 -0.42 17.04 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.245 -0.909 . . . . 0.0 110.015 -179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.93 ' OG ' ' HB3' ' A' ' 38' ' ' ALA . 4.0 p -74.73 103.84 5.15 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.075 -1.016 . . . . 0.0 109.047 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.9 t -74.89 54.83 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.187 -0.946 . . . . 0.0 109.515 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.428 ' O ' ' HD3' ' A' ' 45' ' ' PRO . . . -105.22 134.05 11.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.5 mmm180 -48.59 106.67 0.64 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.344 -1.091 . . . . 0.0 109.387 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 35.5 Cg_endo -77.53 160.23 31.9 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 C-N-CA 122.417 2.078 . . . . 0.0 110.386 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.725 ' HD2' HD23 ' A' ' 62' ' ' LEU . 0.0 OUTLIER -106.92 163.95 12.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.206 -0.934 . . . . 0.0 109.4 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 35' ' ' ARG . 1.1 pt20 -127.77 126.78 42.41 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.251 -0.906 . . . . 0.0 109.993 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.634 ' HB2' HD21 ' A' ' 59' ' ' LEU . 0.8 OUTLIER -117.5 118.11 31.27 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.357 -0.84 . . . . 0.0 108.831 179.443 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.87 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -92.73 153.63 18.8 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.033 -1.042 . . . . 0.0 110.034 -179.407 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.992 ' CG1' HD12 ' A' ' 57' ' ' ILE . 1.1 m -129.03 163.75 43.66 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.381 -0.824 . . . . 0.0 109.297 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.535 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.8 Cg_endo -77.43 174.8 12.15 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.593 2.195 . . . . 0.0 110.419 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.63 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 35.1 Cg_endo -77.06 -15.64 16.26 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.622 2.215 . . . . 0.0 110.582 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.19 28.71 6.57 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.244 -0.91 . . . . 0.0 109.555 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.535 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.6 OUTLIER -128.87 103.33 6.98 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.172 -0.955 . . . . 0.0 109.93 -179.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -90.68 -12.23 37.39 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.185 -0.947 . . . . 0.0 109.104 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 56.1 p -135.7 130.35 34.09 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.536 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.992 HD12 ' CG1' ' A' ' 50' ' ' VAL . 3.4 tt -126.65 133.78 67.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.075 -1.015 . . . . 0.0 110.083 -179.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -94.49 106.12 18.1 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.003 HD22 ' CD2' ' A' ' 36' ' ' HIS . 1.5 mt -84.62 148.56 26.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.155 -0.965 . . . . 0.0 109.566 -179.496 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.946 HG22 ' HB3' ' A' ' 17' ' ' SER . 27.6 p -142.24 -179.61 6.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.341 -0.849 . . . . 0.0 109.435 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.412 ' HB2' ' O ' ' A' ' 60' ' ' THR . 17.5 m-80 60.93 16.3 6.81 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.255 -0.903 . . . . 0.0 109.365 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.981 HD11 ' HB3' ' A' ' 59' ' ' LEU . 0.9 OUTLIER -94.86 143.57 26.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.301 -0.874 . . . . 0.0 109.261 -179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.485 ' HB2' ' OH ' ' A' ' 68' ' ' TYR . 2.5 t-20 -45.71 116.01 3.06 Favored Pre-proline 0 N--CA 1.489 1.521 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 34.6 Cg_endo -75.86 136.63 18.93 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.214 1.943 . . . . 0.0 111.043 -178.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 74.93 63.69 2.49 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 109.019 -1.632 . . . . 0.0 109.019 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.539 HG21 ' CZ ' ' A' ' 68' ' ' TYR . 2.0 m -162.88 146.25 10.99 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.071 -1.253 . . . . 0.0 110.138 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.557 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 2.2 tp10 -74.79 128.23 35.07 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.559 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 20.4 m-85 -136.45 110.59 8.34 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.967 -1.083 . . . . 0.0 110.041 -178.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.946 HG13 ' O ' ' A' ' 86' ' ' GLY . 93.4 t -71.02 141.63 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 35' ' ' ARG . 1.3 t -117.57 126.5 74.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 120.993 -1.067 . . . . 0.0 110.022 -179.333 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.507 ' HB2' HG12 ' A' ' 85' ' ' ILE . 3.1 p -102.76 112.14 24.79 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.323 -0.861 . . . . 0.0 109.735 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.793 ' C ' HD12 ' A' ' 73' ' ' ILE . 24.8 mm -94.41 111.29 25.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -0.886 . . . . 0.0 109.528 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.793 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.4 mp -112.3 122.44 66.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.163 -0.961 . . . . 0.0 109.34 179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.017 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -98.03 122.05 40.68 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.255 -0.903 . . . . 0.0 109.238 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.414 HG13 HG22 ' A' ' 73' ' ' ILE . 13.0 m -132.79 141.04 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.187 -0.946 . . . . 0.0 109.7 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.458 ' CB ' ' HA ' ' A' ' 29' ' ' ILE . 30.8 t30 -110.91 44.71 1.24 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.318 -0.864 . . . . 0.0 109.363 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 74.11 -95.94 0.86 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.45 ' CD ' ' H ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -75.42 -0.35 19.69 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.291 -1.123 . . . . 0.0 109.624 -179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.436 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 1.2 tt0 -116.88 171.88 7.61 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.58 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.436 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 30.3 mt-10 -149.84 96.46 2.46 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.437 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 1.017 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -59.77 179.62 0.2 Allowed Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.259 -0.901 . . . . 0.0 109.265 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.575 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.4 Cg_endo -77.48 154.87 31.76 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.355 2.037 . . . . 0.0 110.348 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.52 143.73 21.95 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.636 2.224 . . . . 0.0 110.761 -179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.822 HD22 ' HA ' ' A' ' 6' ' ' THR . 23.7 tp -138.74 92.96 2.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.44 -0.788 . . . . 0.0 108.923 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.507 HG12 ' HB2' ' A' ' 71' ' ' SER . 1.9 mt -99.33 153.16 4.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.334 0 O-C-N 121.134 -0.979 . . . . 0.0 110.075 -179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.946 ' O ' HG13 ' A' ' 69' ' ' VAL . . . -148.37 -166.84 13.13 Favored Glycine 0 N--CA 1.489 2.168 0 N-CA-C 109.037 -1.625 . . . . 0.0 109.037 179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -125.8 138.17 53.82 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.163 -1.198 . . . . 0.0 109.603 179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.624 ' NE2' ' CD2' ' A' ' 18' ' ' PHE . 11.7 tm0? -154.5 115.09 3.94 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.293 -0.88 . . . . 0.0 109.197 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.557 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -98.55 134.3 41.69 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.315 -0.866 . . . . 0.0 109.714 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.436 HG23 HE22 ' A' ' 88' ' ' GLN . 0.1 OUTLIER -74.24 162.67 28.69 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 107.801 -1.185 . . . . 0.0 107.801 179.131 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.701 HG11 ' HB3' ' A' ' 116' ' ' ALA . 0.2 OUTLIER -98.61 168.54 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.132 -0.98 . . . . 0.0 110.982 -178.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.531 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 17.0 p -79.62 110.26 14.78 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 178.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.53 ' HB2' ' CB ' ' A' ' 15' ' ' ALA . 2.0 t0 -68.48 -58.47 4.27 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.169 -0.957 . . . . 0.0 110.65 -178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.701 HD11 ' CB ' ' A' ' 176' ' ' LYS . 4.3 mt -80.12 140.56 53.46 Favored Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.15 -0.969 . . . . 0.0 110.305 -178.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.649 ' CB ' ' CD1' ' A' ' 112' ' ' TRP . 34.6 Cg_endo -78.48 53.12 4.42 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.463 2.109 . . . . 0.0 109.487 178.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 112' ' ' TRP . 0.9 OUTLIER -49.96 -178.53 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.695 -0.628 . . . . 0.0 109.634 -179.502 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER 67.46 8.25 6.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.332 -0.855 . . . . 0.0 109.333 -179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.959 HD22 HD12 ' A' ' 162' ' ' LEU . 7.9 tp -57.27 90.21 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.221 -0.924 . . . . 0.0 108.923 179.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.456 ' N ' ' O ' ' A' ' 97' ' ' ASP . 11.1 pt-20 -130.36 161.31 31.59 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.934 . . . . 0.0 109.523 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 10.7 p -95.76 144.27 10.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.29 -0.881 . . . . 0.0 109.638 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.52 ' N ' HD13 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -132.6 3.79 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.279 -0.888 . . . . 0.0 109.449 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.958 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -162.97 94.26 0.83 Allowed 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.492 ' HB2' ' OH ' ' A' ' 182' ' ' TYR . 21.0 p -91.68 105.85 18.04 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.409 -0.807 . . . . 0.0 110.585 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.549 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -93.25 159.39 35.43 Favored Pre-proline 0 C--N 1.304 -1.373 0 O-C-N 121.371 -0.83 . . . . 0.0 108.889 178.886 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.413 ' O ' ' HG3' ' A' ' 154' ' ' PRO . 30.6 Cg_endo -70.22 -2.65 10.84 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.472 2.114 . . . . 0.0 110.455 -179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.833 ' C ' HG22 ' A' ' 152' ' ' ILE . 61.9 p -150.5 19.49 0.83 Allowed 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.835 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -168.98 167.7 10.59 Favored 'General case' 0 N--CA 1.487 1.411 0 C-N-CA 119.26 -0.976 . . . . 0.0 109.982 179.67 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.895 HD22 ' CE2' ' A' ' 182' ' ' TYR . 0.5 OUTLIER -140.37 151.77 45.24 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.335 -0.853 . . . . 0.0 109.224 -179.782 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.958 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.1 OUTLIER -106.26 118.84 37.67 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.234 -0.916 . . . . 0.0 109.109 179.389 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.738 HD12 HD12 ' A' ' 149' ' ' ILE . 0.0 OUTLIER -101.85 145.1 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.258 -0.901 . . . . 0.0 109.764 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.845 ' HA ' HG22 ' A' ' 146' ' ' THR . 0.4 OUTLIER -140.82 115.75 9.74 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.403 -0.811 . . . . 0.0 109.135 179.85 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.649 ' CD1' ' CB ' ' A' ' 95' ' ' PRO . 25.8 p90 -145.01 170.61 15.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.278 -0.889 . . . . 0.0 109.408 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.462 ' O ' ' HD3' ' A' ' 115' ' ' PRO . 4.8 mt-10 -71.06 139.98 85.47 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.15 -0.969 . . . . 0.0 109.495 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.515 ' HB3' ' CB ' ' A' ' 145' ' ' SER . 35.3 Cg_endo -78.41 111.24 2.99 Favored 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.507 2.138 . . . . 0.0 110.471 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.531 ' HB3' ' O ' ' A' ' 92' ' ' SER . 35.8 Cg_endo -78.84 99.16 1.24 Allowed 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.334 2.023 . . . . 0.0 110.318 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.701 ' HB3' HG11 ' A' ' 91' ' ' VAL . . . -76.49 53.8 0.88 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.315 -0.865 . . . . 0.0 109.12 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.997 HG23 ' CG2' ' A' ' 119' ' ' VAL . 16.3 m -109.0 172.42 2.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.275 -0.891 . . . . 0.0 109.517 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.476 ' O ' ' HB ' ' A' ' 166' ' ' THR . 29.2 m -69.57 64.82 0.19 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.162 -0.961 . . . . 0.0 109.622 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.997 ' CG2' HG23 ' A' ' 117' ' ' VAL . 43.7 t -102.75 131.73 50.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.263 -0.898 . . . . 0.0 109.547 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.538 ' N ' ' CD ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -74.33 -42.71 58.97 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 178.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 1.051 ' CE2' HG22 ' A' ' 139' ' ' THR . 4.7 p90 -166.3 -174.91 3.06 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.562 -0.711 . . . . 0.0 109.385 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.593 ' N ' ' CD2' ' A' ' 121' ' ' TYR . 4.2 m-85 -130.42 139.43 50.6 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.598 ' HG2' ' CE2' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -96.73 102.88 14.74 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.785 -1.197 . . . . 0.0 110.035 -179.017 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.723 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 6.4 mt -84.57 106.07 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.741 HG22 ' HB3' ' A' ' 137' ' ' GLU . 32.3 p -93.05 141.96 27.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.282 -0.886 . . . . 0.0 110.549 -178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 1.113 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 4.8 m-30 -94.66 136.77 34.58 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 179.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.603 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -105.09 108.94 3.16 Favored Glycine 0 N--CA 1.486 1.969 0 N-CA-C 109.667 -1.373 . . . . 0.0 109.667 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -107.26 136.78 46.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.244 -1.151 . . . . 0.0 109.734 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.798 HG21 ' HB3' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -88.91 152.69 21.58 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.191 -0.943 . . . . 0.0 109.288 179.473 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 124.78 -38.23 2.39 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.33 7.6 60.7 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.454 ' O ' ' ND2' ' A' ' 132' ' ' ASN . 0.2 OUTLIER -96.84 23.97 6.59 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.24 -1.153 . . . . 0.0 109.397 179.99 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -174.85 157.07 2.16 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.284 -0.885 . . . . 0.0 109.473 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.01 147.78 24.2 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.609 2.206 . . . . 0.0 110.334 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.453 HG22 ' H ' ' A' ' 135' ' ' VAL . 1.0 OUTLIER -54.85 170.89 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 O-C-N 121.288 -0.882 . . . . 0.0 109.585 179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.59 ' O ' ' CG ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -123.41 100.85 7.03 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.34 -0.85 . . . . 0.0 108.958 179.809 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.741 ' HB3' HG22 ' A' ' 125' ' ' THR . 7.3 pt-20 -112.38 145.62 39.77 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.918 -1.114 . . . . 0.0 110.774 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.723 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 6.3 p90 -135.23 150.52 50.09 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 1.051 HG22 ' CE2' ' A' ' 121' ' ' TYR . 2.0 p -74.61 142.69 44.58 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.988 -1.07 . . . . 0.0 111.106 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.571 HG21 HG13 ' A' ' 124' ' ' ILE . 2.0 t -110.61 146.24 33.94 Favored Pre-proline 0 C--N 1.304 -1.41 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.558 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.5 Cg_endo -77.38 140.12 19.1 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.342 2.028 . . . . 0.0 109.761 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.401 ' HA2' ' CE1' ' A' ' 122' ' ' TYR . . . -83.08 13.63 43.44 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.451 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 7.6 t -105.25 23.59 13.45 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.034 -1.274 . . . . 0.0 109.855 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.451 ' HG2' ' O ' ' A' ' 143' ' ' SER . 1.6 mmtt -155.11 142.0 19.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.115 -0.991 . . . . 0.0 109.85 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.562 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 0.0 OUTLIER -95.11 -8.74 35.65 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.349 -0.844 . . . . 0.0 109.404 179.805 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.845 HG22 ' HA ' ' A' ' 111' ' ' SER . 32.2 p -130.37 150.61 51.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.234 -0.916 . . . . 0.0 109.216 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.455 ' O ' HG12 ' A' ' 110' ' ' ILE . . . -145.89 -172.6 3.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.128 -0.982 . . . . 0.0 109.538 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.409 ' HA ' ' O ' ' A' ' 108' ' ' LEU . 51.8 m -144.95 134.94 23.81 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.217 -0.927 . . . . 0.0 109.577 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 1.113 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 1.0 OUTLIER -81.05 145.0 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.322 -0.861 . . . . 0.0 108.953 179.782 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.445 ' O ' ' C ' ' A' ' 151' ' ' ASN . 10.6 m-20 -130.49 169.56 15.38 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 109.332 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.445 ' C ' ' O ' ' A' ' 150' ' ' ASN . 3.0 p30 40.68 62.36 1.41 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.37 -0.831 . . . . 0.0 109.81 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.833 HG22 ' C ' ' A' ' 106' ' ' THR . 10.6 tt -106.95 165.77 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.301 -0.875 . . . . 0.0 109.334 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.5 ' N ' HG12 ' A' ' 152' ' ' ILE . 0.0 OUTLIER -101.37 105.86 42.29 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.119 -0.988 . . . . 0.0 109.369 179.849 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.515 ' HA ' ' OG1' ' A' ' 184' ' ' THR . 35.6 Cg_endo -77.98 169.24 20.82 Favored 'Trans proline' 0 C--N 1.312 -1.381 0 C-N-CA 122.404 2.069 . . . . 0.0 110.456 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.697 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 70.17 60.69 4.66 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.286 -1.526 . . . . 0.0 109.286 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.697 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 164.48 131.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.318 -1.107 . . . . 0.0 109.628 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.798 ' HB3' HG21 ' A' ' 129' ' ' THR . 2.2 t0 -47.56 162.25 0.07 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.096 -1.003 . . . . 0.0 108.387 179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.652 ' CD1' HG21 ' A' ' 184' ' ' THR . 0.3 OUTLIER -140.53 -174.57 4.0 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.888 -1.133 . . . . 0.0 110.211 -179.524 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.577 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 2.6 m -158.1 110.36 2.32 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.502 ' HB ' HG13 ' A' ' 180' ' ' ILE . 40.6 mm -94.27 141.73 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.839 -1.163 . . . . 0.0 110.567 -178.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.99 HG23 ' CB ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -141.57 133.61 27.62 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.459 -0.776 . . . . 0.0 109.137 179.455 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.959 HD12 HD22 ' A' ' 98' ' ' LEU . 1.8 mt -112.55 135.19 53.55 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.15 -0.969 . . . . 0.0 110.564 -179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.616 ' CD1' ' HB3' ' A' ' 177' ' ' PRO . 22.0 m-85 -117.94 164.87 14.42 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.94 ' HB3' ' OG ' ' A' ' 175' ' ' SER . . . -142.88 88.59 2.06 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.015 -1.053 . . . . 0.0 109.406 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.458 ' HA ' ' HB3' ' A' ' 174' ' ' SER . 47.9 t -72.94 130.31 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.378 -0.826 . . . . 0.0 109.72 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.915 HG22 ' HA ' ' A' ' 119' ' ' VAL . 42.1 p -121.77 -67.79 0.94 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.427 -0.796 . . . . 0.0 109.387 179.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.481 ' O ' ' HA ' ' A' ' 172' ' ' PRO . . . -59.22 128.38 47.25 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.471 ' HG3' ' HG3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -147.67 15.24 1.1 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.273 -1.134 . . . . 0.0 109.532 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -126.35 -55.07 0.15 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.518 ' O ' ' CB ' ' A' ' 171' ' ' SER . 0.3 OUTLIER -99.29 1.05 44.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.273 -1.133 . . . . 0.0 109.583 -179.944 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.518 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 0.9 OUTLIER 163.49 138.08 0.03 OUTLIER Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.252 -0.905 . . . . 0.0 109.296 179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.481 ' HA ' ' O ' ' A' ' 167' ' ' GLY . 35.9 Cg_endo -78.21 102.02 1.53 Allowed 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.499 2.133 . . . . 0.0 110.274 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -121.09 169.42 10.53 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.215 -0.928 . . . . 0.0 109.585 -179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 95.4 p -161.95 144.11 11.39 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.323 -0.861 . . . . 0.0 109.433 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.94 ' OG ' ' HB3' ' A' ' 164' ' ' ALA . 0.6 OUTLIER -54.65 -168.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.188 -0.945 . . . . 0.0 109.476 179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.701 ' CB ' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -78.52 129.59 73.95 Favored Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.325 -0.859 . . . . 0.0 109.312 179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.616 ' HB3' ' CD1' ' A' ' 163' ' ' TYR . 35.3 Cg_endo -77.53 127.14 8.72 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.07 1.847 . . . . 0.0 110.244 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.577 ' CG2' HG21 ' A' ' 94' ' ' ILE . 2.1 t -110.29 136.29 46.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.99 ' CB ' HG23 ' A' ' 161' ' ' THR . 4.7 t -119.62 165.47 14.42 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.296 -0.877 . . . . 0.0 110.476 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.502 HG13 ' HB ' ' A' ' 160' ' ' ILE . 11.8 pt -154.3 152.09 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.254 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 6.8 m120 -81.85 162.99 22.61 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.096 -1.003 . . . . 0.0 109.943 -179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.895 ' CE2' HD22 ' A' ' 108' ' ' LEU . 64.5 t80 -154.9 159.31 40.38 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.419 -0.801 . . . . 0.0 109.45 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -132.97 116.95 17.05 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.285 -0.884 . . . . 0.0 109.33 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.652 HG21 ' CD1' ' A' ' 158' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 117.983 -1.008 . . . . 0.0 109.521 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.544 HD11 ' HB3' ' A' ' 79' ' ' GLU . 72.5 mt -128.95 -162.85 1.23 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.234 -1.157 . . . . 0.0 109.5 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.486 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 45.2 m-20 -156.11 125.49 6.22 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.295 -0.878 . . . . 0.0 109.572 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.559 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -95.26 178.3 1.51 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.303 -0.873 . . . . 0.0 109.309 179.919 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.839 ' C ' HD22 ' A' ' 84' ' ' LEU . 35.9 Cg_endo -78.9 164.03 25.5 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.593 2.195 . . . . 0.0 109.989 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.734 HG23 ' O ' ' A' ' 5' ' ' PRO . 4.0 p -162.08 174.63 12.71 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.068 -1.02 . . . . 0.0 109.711 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 44.54 27.16 1.2 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.911 -1.676 . . . . 0.0 108.911 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.585 ' C ' ' CD1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -72.29 -162.43 0.09 Allowed 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.392 -1.064 . . . . 0.0 109.587 -179.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -165.76 -163.35 0.63 Allowed 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.112 -0.993 . . . . 0.0 109.592 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.532 ' CB ' ' HG2' ' A' ' 88' ' ' GLN . 0.3 OUTLIER -154.86 141.93 19.31 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.362 -0.836 . . . . 0.0 109.351 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.598 ' HG ' ' HE2' ' A' ' 21' ' ' HIS . 3.5 p -146.72 -163.29 1.72 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.304 -0.873 . . . . 0.0 109.498 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.533 ' HB2' ' CB ' ' A' ' 19' ' ' THR . 4.5 m-20 44.45 38.07 2.39 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.021 HG22 HG23 ' A' ' 91' ' ' VAL . 40.6 mm -70.1 125.7 28.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 CA-C-O 121.587 0.708 . . . . 0.0 110.305 -179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.562 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -119.5 177.75 4.81 Favored 'General case' 0 C--N 1.299 -1.622 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 178.31 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.519 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -72.9 -69.59 0.4 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.722 -1.236 . . . . 0.0 109.457 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -83.06 8.6 12.42 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.973 -1.079 . . . . 0.0 109.414 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.785 ' HB2' HG22 ' A' ' 60' ' ' THR . 2.8 t -154.51 156.56 36.89 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.015 ' CE1' HG22 ' A' ' 20' ' ' VAL . 2.2 p90 -166.66 137.19 3.25 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.533 ' CB ' ' HB2' ' A' ' 12' ' ' ASP . 10.1 m -87.76 153.98 20.92 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.949 -1.095 . . . . 0.0 111.174 -178.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 1.015 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.5 OUTLIER -134.41 119.52 30.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 179.148 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.598 ' HE2' ' HG ' ' A' ' 11' ' ' SER . 20.1 m-70 -103.36 164.28 11.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.02 -1.05 . . . . 0.0 110.368 -179.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.846 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 22.8 p90 -177.3 135.59 0.19 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.555 -0.715 . . . . 0.0 109.084 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.517 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.29 167.43 2.32 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.183 -0.948 . . . . 0.0 109.517 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -102.18 165.38 13.98 Favored Pre-proline 0 C--N 1.298 -1.651 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.617 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 36.0 Cg_endo -78.23 -163.14 0.2 Allowed 'Trans proline' 0 C--N 1.306 -1.676 0 C-N-CA 122.499 2.133 . . . . 0.0 110.299 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -120.59 28.33 8.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -0.925 . . . . 0.0 109.404 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.893 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -129.36 173.54 5.59 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.273 -0.892 . . . . 0.0 109.551 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.893 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 36.1 Cg_endo -78.4 130.44 10.0 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.615 2.21 . . . . 0.0 110.453 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.498 HD12 ' CE2' ' A' ' 32' ' ' TYR . 17.6 pt -135.98 169.93 19.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.232 -0.918 . . . . 0.0 109.474 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.4 p -107.12 -19.95 13.45 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.255 -0.903 . . . . 0.0 109.476 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 174.08 -152.83 15.5 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.907 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 1.2 m-85 -162.08 123.23 2.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -1.123 . . . . 0.0 109.447 -179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.784 HD12 ' NE ' ' A' ' 49' ' ' ARG . 14.9 mm -85.41 122.65 38.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 121.189 -0.945 . . . . 0.0 109.624 -179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.077 HG23 ' CD1' ' A' ' 72' ' ' ILE . 2.6 mm -102.89 114.31 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.056 -1.028 . . . . 0.0 109.321 179.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.487 ' HG3' ' CG ' ' A' ' 47' ' ' GLN . 0.4 OUTLIER -105.58 144.86 31.75 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.103 -0.998 . . . . 0.0 108.912 179.361 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.804 ' HB3' HG13 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -143.53 140.14 30.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.056 -1.027 . . . . 0.0 110.032 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . . . . . . . . . 50.6 p-80 -176.17 144.39 0.57 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.32 -0.863 . . . . 0.0 109.665 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.93 ' HB3' ' CB ' ' A' ' 41' ' ' SER . . . -64.99 170.48 4.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.137 -0.977 . . . . 0.0 109.605 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -76.84 -27.45 55.13 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.33 -0.856 . . . . 0.0 109.453 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 35.9 m-70 -120.01 10.9 11.6 Favored 'General case' 0 C--N 1.295 -1.804 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.93 ' CB ' ' HB3' ' A' ' 38' ' ' ALA . 20.6 p -106.41 93.46 4.61 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.34 -0.85 . . . . 0.0 109.668 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.708 HG12 ' O ' ' A' ' 42' ' ' VAL . 59.1 t -114.66 31.15 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.208 -0.933 . . . . 0.0 109.114 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.54 ' C ' ' HD3' ' A' ' 45' ' ' PRO . . . -104.44 -42.16 1.92 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.563 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 45.9 mtm-85 -121.94 51.67 3.1 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.14 -1.212 . . . . 0.0 111.037 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.563 ' HD3' ' N ' ' A' ' 44' ' ' ARG . 34.9 Cg_endo -75.3 121.98 6.79 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 C-N-CA 122.052 1.835 . . . . 0.0 110.171 179.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.559 ' HD3' ' CE1' ' A' ' 36' ' ' HIS . 1.2 ptp85 -119.89 162.26 19.46 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.18 -0.95 . . . . 0.0 109.748 -179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.487 ' CG ' ' HG3' ' A' ' 35' ' ' ARG . 14.2 mp0 -126.91 118.1 23.89 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.312 -0.867 . . . . 0.0 109.568 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.628 ' OD2' HD23 ' A' ' 59' ' ' LEU . 65.8 m-20 -100.96 122.8 44.13 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.784 ' NE ' HD12 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.18 140.53 32.35 Favored 'General case' 0 C--N 1.295 -1.782 0 O-C-N 121.031 -1.043 . . . . 0.0 109.493 -179.264 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.957 HG12 HD12 ' A' ' 57' ' ' ILE . 11.9 m -124.08 159.56 56.13 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.341 -0.849 . . . . 0.0 109.355 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.487 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 34.5 Cg_endo -77.14 174.37 12.92 Favored 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.581 2.187 . . . . 0.0 110.279 179.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.475 ' HB3' HG13 ' A' ' 29' ' ' ILE . 34.6 Cg_endo -76.96 -16.09 16.2 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.498 2.132 . . . . 0.0 110.486 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.7 t -100.85 27.86 5.65 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.282 -0.886 . . . . 0.0 109.351 179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.464 ' HG3' ' HG2' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -130.65 116.71 18.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.2 -0.938 . . . . 0.0 109.677 -179.819 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -102.87 -6.01 22.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.225 -0.922 . . . . 0.0 109.394 179.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 62.7 p -139.2 130.84 27.31 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.357 -0.84 . . . . 0.0 109.018 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.957 HD12 HG12 ' A' ' 50' ' ' VAL . 5.4 tt -123.24 124.92 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.164 -0.96 . . . . 0.0 109.816 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -88.75 109.91 20.56 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.441 -0.787 . . . . 0.0 109.184 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.981 ' HB3' HD11 ' A' ' 62' ' ' LEU . 1.2 mp -84.83 158.65 20.6 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.164 -0.96 . . . . 0.0 109.778 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.785 HG22 ' HB2' ' A' ' 17' ' ' SER . 0.8 OUTLIER -150.86 175.29 12.17 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.654 -0.654 . . . . 0.0 109.332 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.499 ' O ' ' NH2' ' A' ' 46' ' ' ARG . 6.1 m120 52.57 37.8 24.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 0.0 109.496 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.981 HD11 ' HB3' ' A' ' 59' ' ' LEU . 5.2 mt -109.59 161.17 15.62 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 109.387 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -55.07 113.33 5.26 Favored Pre-proline 0 N--CA 1.487 1.416 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 178.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 34.5 Cg_endo -74.19 123.64 8.43 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.984 1.79 . . . . 0.0 111.009 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.598 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 82.67 64.56 1.68 Allowed Glycine 0 N--CA 1.485 1.916 0 N-CA-C 108.186 -1.966 . . . . 0.0 108.186 -179.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 5.0 m -152.27 118.9 5.69 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.126 -1.22 . . . . 0.0 110.821 -178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.559 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 11.6 tt0 -74.82 135.74 41.62 Favored 'General case' 0 C--N 1.304 -1.407 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 177.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.822 ' OH ' HG23 ' A' ' 90' ' ' THR . 0.0 OUTLIER -153.44 176.54 11.9 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 120.79 -1.193 . . . . 0.0 111.076 -178.436 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.656 HG12 HG23 ' A' ' 85' ' ' ILE . 1.9 t -107.27 151.55 9.17 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.804 HG13 ' HB3' ' A' ' 36' ' ' HIS . 1.1 t -132.98 130.92 58.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 120.983 -1.073 . . . . 0.0 109.492 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.819 ' O ' HD13 ' A' ' 72' ' ' ILE . 10.5 p -108.44 156.43 19.46 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.254 -0.904 . . . . 0.0 110.484 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.077 ' CD1' HG23 ' A' ' 34' ' ' ILE . 28.4 mm -135.71 92.51 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.927 HD12 ' HB3' ' A' ' 83' ' ' PRO . 1.2 mm -83.71 140.85 15.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.106 -0.996 . . . . 0.0 109.928 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.907 ' HB2' ' CE1' ' A' ' 32' ' ' TYR . . . -96.38 157.86 15.7 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.319 -0.863 . . . . 0.0 109.181 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.69 136.55 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 0.0 109.47 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.417 ' O ' ' CG ' ' A' ' 76' ' ' ASN . 12.6 t-20 -135.14 46.37 2.42 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.215 -0.928 . . . . 0.0 109.424 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 103.52 -91.57 0.84 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.51 1.36 13.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.216 -1.167 . . . . 0.0 109.647 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.544 ' HB3' HD11 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -92.72 -171.66 2.8 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.97 . . . . 0.0 109.47 179.923 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' A' ' 79' ' ' GLU . 4.9 mt-10 -171.16 91.49 0.15 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.0 109.487 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.593 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.6 OUTLIER -59.55 -179.18 0.15 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.258 -0.901 . . . . 0.0 108.987 179.809 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.593 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 31.4 Cg_endo -74.49 150.35 40.68 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.08 1.853 . . . . 0.0 110.348 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.927 ' HB3' HD12 ' A' ' 73' ' ' ILE . 36.1 Cg_endo -77.57 144.11 22.17 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.811 2.341 . . . . 0.0 111.62 -178.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.839 HD22 ' C ' ' A' ' 5' ' ' PRO . 3.4 tp -109.7 93.65 4.61 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.656 HG23 HG12 ' A' ' 69' ' ' VAL . 3.3 mt -100.23 141.19 17.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.197 -0.939 . . . . 0.0 110.15 -179.174 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.54 ' O ' HG13 ' A' ' 69' ' ' VAL . . . -136.66 -165.06 10.38 Favored Glycine 0 N--CA 1.487 2.039 0 N-CA-C 108.416 -1.874 . . . . 0.0 108.416 179.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 34.9 mt-30 -129.94 140.0 51.01 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.985 -1.303 . . . . 0.0 109.77 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.532 ' HG2' ' CB ' ' A' ' 10' ' ' SER . 2.4 tp60 -154.29 -165.36 2.07 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.372 -0.83 . . . . 0.0 109.318 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.559 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.43 130.28 2.46 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.256 -0.903 . . . . 0.0 109.57 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.822 HG23 ' OH ' ' A' ' 68' ' ' TYR . 0.0 OUTLIER -73.16 138.35 45.66 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.281 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.021 HG23 HG22 ' A' ' 13' ' ' ILE . 2.3 t -56.94 -169.87 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 178.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.708 ' H ' HG12 ' A' ' 91' ' ' VAL . 20.9 t -133.35 176.69 8.3 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.196 -1.565 . . . . 0.0 110.925 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.535 ' HA ' HG21 ' A' ' 117' ' ' VAL . 0.5 OUTLIER -165.57 -46.05 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.82 HD11 ' HB2' ' A' ' 176' ' ' LYS . 8.1 mt -104.82 141.68 23.06 Favored Pre-proline 0 C--N 1.304 -1.38 0 O-C-N 121.485 -0.759 . . . . 0.0 109.102 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 1.12 ' CG ' HD11 ' A' ' 162' ' ' LEU . 35.7 Cg_endo -78.83 70.51 7.39 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 122.38 2.053 . . . . 0.0 109.891 179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.576 ' CB ' ' CZ ' ' A' ' 96' ' ' ARG . 0.0 OUTLIER -65.9 -165.34 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.444 -0.785 . . . . 0.0 109.734 -179.648 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.41 ' CG ' ' HG3' ' A' ' 113' ' ' GLU . 0.2 OUTLIER 64.41 11.62 6.66 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.235 -0.915 . . . . 0.0 109.227 -179.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.745 HD23 HG23 ' A' ' 180' ' ' ILE . 19.7 tp -59.25 92.77 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.281 -0.887 . . . . 0.0 109.213 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -126.5 160.53 30.31 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.264 -0.898 . . . . 0.0 109.335 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.482 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 8.5 p -104.64 138.47 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.402 -0.811 . . . . 0.0 109.818 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.796 ' CG1' HD23 ' A' ' 109' ' ' LEU . 8.7 pt -122.96 -11.23 7.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.389 -0.82 . . . . 0.0 109.407 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.807 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -134.73 82.12 1.94 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.526 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 6.4 m -85.81 95.4 9.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.395 -0.816 . . . . 0.0 110.45 -178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.532 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -96.24 159.66 31.55 Favored Pre-proline 0 C--N 1.305 -1.361 0 O-C-N 121.244 -0.91 . . . . 0.0 109.036 179.052 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.473 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.4 Cg_endo -70.47 -1.74 9.55 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.509 2.139 . . . . 0.0 110.738 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.817 ' C ' HG22 ' A' ' 152' ' ' ILE . 7.1 p -144.68 10.93 1.41 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.25 -0.906 . . . . 0.0 109.342 179.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.911 ' O ' HD23 ' A' ' 108' ' ' LEU . 3.2 p -169.01 166.6 11.02 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 118.907 -1.117 . . . . 0.0 109.767 179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.011 HD22 ' CZ ' ' A' ' 182' ' ' TYR . 0.4 OUTLIER -141.75 150.77 42.2 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.137 -0.977 . . . . 0.0 109.091 -179.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.807 ' CB ' ' HB3' ' A' ' 102' ' ' ALA . 13.9 tp -106.26 116.33 31.74 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.27 -0.894 . . . . 0.0 108.824 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.96 ' CD1' ' HB3' ' A' ' 147' ' ' ALA . 3.2 pt -102.35 149.4 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.079 -1.013 . . . . 0.0 110.192 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.671 ' CB ' HG22 ' A' ' 146' ' ' THR . 5.1 t -153.1 125.18 7.96 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.516 -0.74 . . . . 0.0 109.382 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.578 ' CE2' ' O ' ' A' ' 145' ' ' SER . 3.1 p90 -124.21 -170.13 2.09 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.26 -0.9 . . . . 0.0 109.233 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.41 ' HG3' ' CG ' ' A' ' 97' ' ' ASP . 3.1 mt-10 -102.08 157.52 33.54 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.14 -0.975 . . . . 0.0 109.914 -179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.38 121.46 5.23 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.783 2.322 . . . . 0.0 110.164 179.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.582 ' HG2' HG21 ' A' ' 119' ' ' VAL . 35.8 Cg_endo -77.81 140.0 18.11 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.458 2.105 . . . . 0.0 110.881 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . . . . . . . . . . . -69.95 -6.28 31.98 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.273 -0.892 . . . . 0.0 109.255 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.765 HG13 HG12 ' A' ' 91' ' ' VAL . 3.0 m -94.3 177.02 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.388 -0.82 . . . . 0.0 109.277 179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.523 ' O ' ' CG2' ' A' ' 166' ' ' THR . 58.6 m -78.23 155.58 30.24 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.193 -0.942 . . . . 0.0 109.771 -179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 1.046 HG11 ' CZ ' ' A' ' 122' ' ' TYR . 19.5 t -144.69 129.68 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.362 -0.836 . . . . 0.0 109.566 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.492 ' HB2' ' O ' ' A' ' 166' ' ' THR . 2.8 tpm_? -95.01 -53.84 3.67 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.255 -0.903 . . . . 0.0 109.065 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.777 ' CE1' HG22 ' A' ' 139' ' ' THR . 1.6 p90 -165.36 151.15 9.53 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.371 -0.831 . . . . 0.0 108.995 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 1.046 ' CZ ' HG11 ' A' ' 119' ' ' VAL . 3.0 m-85 -106.11 115.35 30.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.98 -1.075 . . . . 0.0 109.56 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 5.5 ttm180 -84.62 98.81 10.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.11 -0.994 . . . . 0.0 109.017 179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 1.034 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 55.2 mt -84.25 151.42 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.321 -0.862 . . . . 0.0 110.045 -179.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 46.2 p -123.92 133.27 53.76 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.46 -0.775 . . . . 0.0 109.901 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 1.029 ' O ' HG12 ' A' ' 135' ' ' VAL . 4.9 m-85 -80.19 118.36 21.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.49 -0.756 . . . . 0.0 109.359 179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.561 ' O ' ' HA ' ' A' ' 158' ' ' TYR . . . -91.94 105.74 3.32 Favored Glycine 0 N--CA 1.486 2.006 0 N-CA-C 110.058 -1.217 . . . . 0.0 110.058 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -107.47 96.61 6.52 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.285 -1.126 . . . . 0.0 108.876 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.486 ' OG1' ' O ' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -55.2 -80.59 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 O-C-N 120.948 -1.095 . . . . 0.0 109.544 -179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -83.5 46.09 3.58 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -89.86 -77.36 1.32 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.521 ' O ' ' CB ' ' A' ' 133' ' ' SER . 5.3 t-20 -159.48 -44.31 0.05 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.211 -1.17 . . . . 0.0 109.769 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.565 ' N ' ' HD2' ' A' ' 134' ' ' PRO . 0.1 OUTLIER 162.01 -53.09 0.0 OUTLIER Pre-proline 0 C--N 1.297 -1.695 0 O-C-N 121.724 -0.61 . . . . 0.0 109.813 -179.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 133' ' ' SER . 35.5 Cg_endo -77.44 160.34 32.14 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.517 2.145 . . . . 0.0 110.688 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 1.029 HG12 ' O ' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -108.98 170.92 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 O-C-N 121.362 -0.837 . . . . 0.0 109.25 -179.907 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.545 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 2.6 mm100 -119.36 99.39 6.66 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.199 -0.938 . . . . 0.0 108.874 179.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 13.2 pt-20 -101.96 149.87 23.79 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.183 -0.948 . . . . 0.0 110.743 -179.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 1.034 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 34.1 p90 -143.07 145.75 33.17 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 179.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.777 HG22 ' CE1' ' A' ' 121' ' ' TYR . 3.0 p -75.01 149.69 39.18 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.99 -1.069 . . . . 0.0 110.589 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.657 HG13 ' HD2' ' A' ' 141' ' ' PRO . 53.7 t -112.31 141.6 25.4 Favored Pre-proline 0 C--N 1.303 -1.432 0 O-C-N 121.762 -0.586 . . . . 0.0 109.443 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.657 ' HD2' HG13 ' A' ' 140' ' ' VAL . 35.6 Cg_endo -77.66 141.81 19.92 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.433 2.088 . . . . 0.0 110.307 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -88.03 23.0 15.68 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.42 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 1.9 m -104.42 -0.94 27.44 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.248 -1.149 . . . . 0.0 109.576 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.42 ' HG2' ' O ' ' A' ' 143' ' ' SER . 15.2 mmtt -143.02 153.85 43.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.188 -0.945 . . . . 0.0 109.48 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.578 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 0.4 OUTLIER -93.35 -18.27 22.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 109.395 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.671 HG22 ' CB ' ' A' ' 111' ' ' SER . 66.1 p -107.77 152.79 23.89 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.199 -0.938 . . . . 0.0 108.941 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.96 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -130.96 148.17 52.69 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.064 -1.023 . . . . 0.0 109.635 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 8.2 t -91.08 147.42 23.09 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.184 -0.948 . . . . 0.0 109.347 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.689 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 13.9 mm -128.46 95.62 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.358 -0.839 . . . . 0.0 109.119 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.522 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 2.6 m-20 -104.54 -164.17 1.03 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.517 -0.74 . . . . 0.0 109.733 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.511 ' O ' ' ND2' ' A' ' 151' ' ' ASN . 6.6 p-10 42.03 60.58 2.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.429 -0.794 . . . . 0.0 109.902 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.817 HG22 ' C ' ' A' ' 106' ' ' THR . 6.4 tt -116.52 155.28 18.0 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.272 0 O-C-N 121.269 -0.894 . . . . 0.0 109.568 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.07 117.19 67.14 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.305 -0.872 . . . . 0.0 109.753 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.473 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 35.9 Cg_endo -78.91 163.85 25.63 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.518 2.146 . . . . 0.0 110.562 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 61.8 51.47 57.07 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -177.37 130.45 0.16 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.223 -1.163 . . . . 0.0 109.699 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.486 ' O ' ' OG1' ' A' ' 129' ' ' THR . 1.1 t0 -51.62 165.93 0.15 Allowed 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.597 ' CE2' HG13 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -144.98 172.68 12.7 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 120.881 -1.137 . . . . 0.0 110.255 -179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.553 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 1.8 m -145.7 96.74 2.86 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 179' ' ' SER . 51.5 mm -84.69 132.44 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 120.889 -1.132 . . . . 0.0 109.705 -179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.846 HG23 ' CB ' ' A' ' 179' ' ' SER . 1.1 m -142.26 165.33 27.72 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.309 -0.869 . . . . 0.0 109.24 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 1.12 HD11 ' CG ' ' A' ' 95' ' ' PRO . 1.3 pp -159.64 151.13 20.0 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.013 -1.054 . . . . 0.0 110.72 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.611 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 2.1 m-85 -122.03 90.45 3.31 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.161 -0.681 . . . . 0.0 109.161 179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.434 ' HB2' ' HG3' ' A' ' 95' ' ' PRO . . . -54.0 117.47 3.24 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.864 -1.147 . . . . 0.0 109.039 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.58 HG12 ' N ' ' A' ' 166' ' ' THR . 22.2 t -102.76 168.57 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.202 -0.936 . . . . 0.0 109.892 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.58 ' N ' HG12 ' A' ' 165' ' ' VAL . 0.8 OUTLIER -145.08 -40.41 0.24 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.332 -0.855 . . . . 0.0 109.548 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -99.97 138.93 14.15 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -146.72 88.57 1.77 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.294 -1.121 . . . . 0.0 109.484 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -174.59 -81.9 0.05 OUTLIER Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 2.4 m-20 -119.02 10.03 12.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.324 -1.104 . . . . 0.0 109.349 179.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 170' ' ' ASP . 75.5 m -168.63 81.27 0.75 Allowed Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.275 -0.891 . . . . 0.0 109.552 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.86 98.83 1.23 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.643 2.228 . . . . 0.0 110.412 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -100.52 166.42 10.93 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.36 -0.838 . . . . 0.0 109.558 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.463 ' O ' ' O ' ' A' ' 175' ' ' SER . 1.2 p -165.09 132.65 3.07 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.335 -0.853 . . . . 0.0 109.422 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.468 ' HB3' ' OD1' ' A' ' 93' ' ' ASP . 84.6 p -55.47 -166.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.168 -0.957 . . . . 0.0 109.21 179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.82 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -74.59 145.78 82.58 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.196 -0.94 . . . . 0.0 108.829 179.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.611 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 34.9 Cg_endo -77.71 133.77 13.04 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.429 2.086 . . . . 0.0 111.019 -179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.64 HG23 HG21 ' A' ' 94' ' ' ILE . 2.2 t -105.82 134.47 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.846 ' CB ' HG23 ' A' ' 161' ' ' THR . 1.3 p -131.45 143.24 50.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.28 -0.887 . . . . 0.0 110.558 -179.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.745 HG23 HD23 ' A' ' 98' ' ' LEU . 13.4 pt -129.89 152.44 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 179.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 32.6 m120 -82.57 168.71 17.08 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.082 -1.012 . . . . 0.0 109.7 -179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 1.011 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 44.2 t80 -165.21 124.32 1.75 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.323 -0.86 . . . . 0.0 109.415 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -95.19 112.13 23.88 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.009 -1.057 . . . . 0.0 109.443 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.433 ' HB ' ' HA ' ' A' ' 154' ' ' PRO . 28.9 p . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.524 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.775 HD11 ' CB ' ' A' ' 81' ' ' SER . 1.5 pp -161.71 143.74 11.57 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -1.144 . . . . 0.0 109.472 -179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.546 ' O ' HD12 ' A' ' 2' ' ' LEU . 21.7 m-20 -74.91 148.12 40.37 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.221 -0.924 . . . . 0.0 109.391 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.491 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 18.0 p -84.5 159.97 57.49 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.265 -0.897 . . . . 0.0 109.591 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.634 ' HD3' ' HB2' ' A' ' 74' ' ' ALA . 35.5 Cg_endo -78.27 96.77 1.1 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.715 2.277 . . . . 0.0 109.943 179.708 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.678 ' HA ' HD22 ' A' ' 84' ' ' LEU . 2.1 p -83.89 -111.65 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.166 -0.959 . . . . 0.0 109.79 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 22' ' ' TRP . . . 45.53 26.12 1.58 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 108.644 -1.782 . . . . 0.0 108.644 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.443 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 13.5 t80 -55.59 107.76 0.37 Allowed 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.485 -1.009 . . . . 0.0 110.003 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 6.3 t70 -133.52 100.21 4.74 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.405 -0.809 . . . . 0.0 108.841 179.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.884 ' OG ' HG13 ' A' ' 20' ' ' VAL . 4.7 m -84.63 128.27 34.51 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.216 -0.928 . . . . 0.0 109.578 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.446 ' O ' ' O ' ' A' ' 19' ' ' THR . 5.5 p -164.0 -157.06 0.37 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.316 -0.865 . . . . 0.0 109.402 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.534 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 2.5 m-20 47.33 38.01 6.71 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.638 ' HA ' ' HB2' ' A' ' 18' ' ' PHE . 1.5 mt -87.07 163.84 2.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 121.761 0.791 . . . . 0.0 111.427 -177.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.587 ' N ' HG22 ' A' ' 13' ' ' ILE . 0.7 OUTLIER -155.27 -172.83 4.31 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 178.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.581 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -81.02 -44.14 18.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.931 -1.106 . . . . 0.0 109.484 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.433 ' O ' ' CB ' ' A' ' 17' ' ' SER . 1.5 m120 -114.6 39.75 2.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.991 -1.068 . . . . 0.0 109.037 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 14' ' ' THR . 5.8 p 168.55 145.5 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.528 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.638 ' HB2' ' HA ' ' A' ' 13' ' ' ILE . 2.0 p90 -164.97 145.38 7.3 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.108 -0.995 . . . . 0.0 108.827 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.611 HG22 ' N ' ' A' ' 20' ' ' VAL . 52.3 m -112.34 164.23 13.48 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.737 -1.227 . . . . 0.0 111.132 -178.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.884 HG13 ' OG ' ' A' ' 10' ' ' SER . 1.6 t -130.43 168.42 23.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.516 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 19.9 m-70 -144.35 161.88 37.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.936 -1.102 . . . . 0.0 110.104 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.601 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 10.0 p90 -168.18 142.19 3.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.434 -0.791 . . . . 0.0 109.171 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.525 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.85 166.02 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.04 -1.037 . . . . 0.0 109.435 179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.659 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -94.01 165.57 17.5 Favored Pre-proline 0 C--N 1.3 -1.585 0 O-C-N 121.634 -0.666 . . . . 0.0 109.632 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.659 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.7 Cg_endo -78.27 178.12 7.95 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.606 2.204 . . . . 0.0 110.384 179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -108.08 12.82 26.51 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.273 -0.892 . . . . 0.0 109.442 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.984 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -118.13 176.71 1.52 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.276 -0.89 . . . . 0.0 109.409 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.984 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 34.9 Cg_endo -77.7 118.05 4.42 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.538 2.159 . . . . 0.0 110.285 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.633 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 47.3 pt -131.47 179.99 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.267 -0.895 . . . . 0.0 109.614 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.7 p -120.71 -22.11 6.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.864 . . . . 0.0 109.458 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 167.97 174.68 37.08 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.633 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -124.42 133.73 53.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.248 -1.148 . . . . 0.0 109.391 179.995 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.871 ' O ' HD13 ' A' ' 34' ' ' ILE . 44.8 mm -74.95 144.42 12.19 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.187 -0.945 . . . . 0.0 109.251 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.871 HD13 ' O ' ' A' ' 33' ' ' ILE . 7.9 mm -124.57 93.15 2.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 121.21 -0.931 . . . . 0.0 110.058 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.454 ' HB2' ' OG ' ' A' ' 71' ' ' SER . 1.0 OUTLIER -104.17 128.53 51.86 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 107.802 -1.184 . . . . 0.0 107.802 178.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.886 ' CB ' HG22 ' A' ' 70' ' ' VAL . 54.5 p-80 -148.33 176.85 9.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.727 -1.233 . . . . 0.0 110.845 -178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.592 ' CG ' ' HB3' ' A' ' 45' ' ' PRO . 9.1 p-80 176.9 -173.37 0.1 Allowed 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.035 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . -112.55 132.17 55.24 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.165 -0.959 . . . . 0.0 109.175 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.484 ' HG2' ' HB2' ' A' ' 67' ' ' GLU . 1.3 pt-20 -54.78 -18.55 4.88 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.201 -0.937 . . . . 0.0 109.556 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 -104.74 14.17 30.15 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.391 -0.818 . . . . 0.0 109.469 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.726 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 60.3 p -99.91 -147.74 0.35 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.276 -0.89 . . . . 0.0 109.517 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.609 HG22 ' N ' ' A' ' 43' ' ' GLY . 11.2 p -74.92 167.56 2.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.187 -0.946 . . . . 0.0 109.563 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.609 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -54.58 -99.03 0.01 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.417 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 3.7 mmm180 -46.54 143.05 4.22 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.195 -1.179 . . . . 0.0 109.397 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.592 ' HB3' ' CG ' ' A' ' 37' ' ' HIS . 36.4 Cg_endo -79.39 171.55 15.82 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.571 2.181 . . . . 0.0 110.447 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.52 ' NE ' ' OD1' ' A' ' 48' ' ' ASP . 0.8 OUTLIER -84.38 159.59 20.82 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.197 -0.939 . . . . 0.0 108.986 179.49 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.454 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 47.0 mt-30 -100.43 134.63 43.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 110.589 -179.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.52 ' OD1' ' NE ' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -149.24 147.82 28.84 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 178.967 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.585 ' HG3' HD13 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -134.53 158.79 43.06 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.864 -1.147 . . . . 0.0 110.104 -179.055 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.803 HG22 ' CG1' ' A' ' 34' ' ' ILE . 12.3 m -136.87 161.08 63.64 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.468 -0.77 . . . . 0.0 109.076 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.53 ' HG2' ' CD ' ' A' ' 54' ' ' ARG . 33.5 Cg_endo -76.21 174.12 13.35 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.478 2.119 . . . . 0.0 110.333 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.623 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.2 Cg_endo -76.49 -29.51 5.91 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.587 2.192 . . . . 0.0 110.518 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.2 m -82.91 -7.78 59.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.228 -0.92 . . . . 0.0 109.398 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.53 ' CD ' ' HG2' ' A' ' 51' ' ' PRO . 3.4 mpt_? -93.96 109.34 21.08 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.412 -0.805 . . . . 0.0 109.838 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.6 p30 -97.27 -1.51 44.61 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.423 -0.798 . . . . 0.0 109.377 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 77.2 p -140.99 147.83 39.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.297 -0.877 . . . . 0.0 109.168 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.674 HD13 HG21 ' A' ' 34' ' ' ILE . 1.4 tt -131.95 119.49 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.119 -0.988 . . . . 0.0 109.388 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.585 HG23 ' OG1' ' A' ' 19' ' ' THR . 45.7 m -87.85 138.06 31.79 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.349 -0.845 . . . . 0.0 109.62 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.019 ' HB3' HD11 ' A' ' 62' ' ' LEU . 4.6 mt -111.23 159.46 17.88 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.26 -0.9 . . . . 0.0 109.512 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.5 p -144.37 173.37 11.84 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.289 -0.882 . . . . 0.0 109.475 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 6.7 m120 52.9 52.36 14.05 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.274 -0.891 . . . . 0.0 109.546 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.019 HD11 ' HB3' ' A' ' 59' ' ' LEU . 7.7 mt -122.17 133.51 54.73 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.23 -0.919 . . . . 0.0 109.472 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.498 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 42.5 m-20 -48.66 128.15 13.77 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.223 -0.923 . . . . 0.0 109.056 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.581 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 36.1 Cg_endo -78.01 133.6 12.5 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.36 2.04 . . . . 0.0 110.665 -179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 82.89 61.24 1.96 Allowed Glycine 0 N--CA 1.489 2.188 0 N-CA-C 108.935 -1.666 . . . . 0.0 108.935 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.462 ' CG2' ' N ' ' A' ' 67' ' ' GLU . 4.5 m -162.37 159.86 25.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.392 -1.064 . . . . 0.0 109.734 -179.531 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.536 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 2.0 mm-40 -90.77 134.5 34.38 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.369 -0.832 . . . . 0.0 108.839 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 1.035 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 15.0 m-85 -119.17 115.52 24.41 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.086 -1.009 . . . . 0.0 109.709 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.854 HG13 ' HG2' ' A' ' 87' ' ' GLN . 1.4 t -82.48 120.06 33.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.899 . . . . 0.0 108.99 179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.886 HG22 ' CB ' ' A' ' 36' ' ' HIS . 27.1 t -117.92 138.61 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.188 -0.945 . . . . 0.0 109.443 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.546 ' CB ' HG12 ' A' ' 85' ' ' ILE . 80.2 p -116.84 139.1 51.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.213 -0.929 . . . . 0.0 110.13 -179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 5.7 mm -120.49 92.37 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.415 -0.803 . . . . 0.0 109.207 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.471 ' HB ' ' HB ' ' A' ' 33' ' ' ILE . 25.1 mm -90.78 137.52 21.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 109.634 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.869 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -99.54 137.79 37.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.26 -0.9 . . . . 0.0 109.423 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -127.23 150.21 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.259 -0.901 . . . . 0.0 109.444 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.441 ' HB3' ' HB2' ' A' ' 79' ' ' GLU . 1.8 t-20 -137.53 49.82 1.98 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.268 -0.895 . . . . 0.0 109.43 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 88.91 -94.48 2.0 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.419 -1.473 . . . . 0.0 109.419 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 15.0 tpt85 -106.65 -0.76 23.45 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.239 -1.153 . . . . 0.0 109.501 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.441 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 1.6 mt-10 -100.38 148.99 24.1 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.191 -0.943 . . . . 0.0 109.316 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -123.72 103.85 8.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.242 -0.911 . . . . 0.0 109.676 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.869 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -59.7 -178.41 0.13 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.354 -0.841 . . . . 0.0 108.931 179.687 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.603 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 32.7 Cg_endo -75.82 151.08 35.54 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.171 1.914 . . . . 0.0 110.204 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.0 Cg_endo -77.23 115.21 3.91 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.675 2.25 . . . . 0.0 111.379 -178.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.678 HD22 ' HA ' ' A' ' 6' ' ' THR . 12.5 tp -106.08 104.25 13.91 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.546 HG12 ' CB ' ' A' ' 71' ' ' SER . 1.8 mt -111.56 162.25 9.44 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.039 -1.038 . . . . 0.0 110.4 -179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.545 ' N ' HG22 ' A' ' 85' ' ' ILE . . . -155.77 162.91 31.49 Favored Glycine 0 N--CA 1.485 1.966 0 N-CA-C 108.275 -1.93 . . . . 0.0 108.275 179.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.854 ' HG2' HG13 ' A' ' 69' ' ' VAL . 4.0 mt-30 -136.66 118.56 15.22 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.119 -1.224 . . . . 0.0 110.042 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.444 ' NE2' ' O ' ' A' ' 68' ' ' TYR . 0.5 OUTLIER -110.59 -146.94 0.41 Allowed 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.54 136.72 3.88 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.879 -1.138 . . . . 0.0 110.341 179.844 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.93 137.88 41.97 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.19 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.007 HG11 ' CB ' ' A' ' 116' ' ' ALA . 1.8 t -54.87 161.01 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.517 -0.739 . . . . 0.0 109.308 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.5 m -102.67 154.26 19.32 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.308 -0.87 . . . . 0.0 109.795 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -91.48 -40.65 11.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.355 -0.84 . . . . 0.0 109.416 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.666 HG23 ' HD2' ' A' ' 95' ' ' PRO . 2.7 mt -77.23 141.56 66.85 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.171 -0.956 . . . . 0.0 109.208 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.666 ' HD2' HG23 ' A' ' 94' ' ' ILE . 36.4 Cg_endo -80.61 82.95 2.33 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.592 2.195 . . . . 0.0 110.186 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.6 OUTLIER -70.61 -176.62 1.32 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.289 -0.882 . . . . 0.0 109.63 -179.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER 77.01 27.82 0.68 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.362 -0.836 . . . . 0.0 109.67 179.898 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.749 HD23 HG23 ' A' ' 180' ' ' ILE . 33.6 tp -76.97 101.88 6.18 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.148 -0.97 . . . . 0.0 109.394 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -137.15 170.2 16.5 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.26 -0.9 . . . . 0.0 109.561 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.458 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 11.8 p -93.75 147.97 5.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.197 -0.939 . . . . 0.0 109.665 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.554 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 11.7 pt -129.7 -2.41 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.369 -0.832 . . . . 0.0 109.552 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.552 ' CB ' HD12 ' A' ' 109' ' ' LEU . . . -165.33 116.26 1.11 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.318 -0.864 . . . . 0.0 108.68 179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.504 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.8 t -104.48 93.23 4.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.114 -0.991 . . . . 0.0 110.221 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.56 ' OG1' ' N ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -78.41 163.48 61.5 Favored Pre-proline 0 C--N 1.301 -1.541 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 179.314 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.478 ' O ' HG23 ' A' ' 106' ' ' THR . 29.6 Cg_endo -68.4 -2.44 9.12 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.4 2.067 . . . . 0.0 110.856 -179.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.879 ' C ' HG22 ' A' ' 152' ' ' ILE . 11.6 p -155.26 20.75 0.42 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.294 -0.879 . . . . 0.0 108.723 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 1.068 ' O ' HD23 ' A' ' 108' ' ' LEU . 52.4 p -173.43 161.47 4.11 Favored 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 119.191 -1.004 . . . . 0.0 109.935 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.068 HD23 ' O ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -139.67 155.76 47.21 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.371 -0.83 . . . . 0.0 109.274 -179.665 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.554 ' HB3' ' CG1' ' A' ' 101' ' ' ILE . 19.8 mt -100.29 132.78 45.47 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.291 -0.881 . . . . 0.0 108.892 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.783 HD11 ' CD1' ' A' ' 149' ' ' ILE . 0.5 OUTLIER -119.63 141.27 40.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.168 -0.958 . . . . 0.0 109.809 -179.617 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.459 ' O ' ' O ' ' A' ' 97' ' ' ASP . 37.8 t -133.75 135.17 43.77 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.411 -0.806 . . . . 0.0 109.385 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.619 ' HH2' ' HB2' ' A' ' 147' ' ' ALA . 43.4 p90 -140.28 143.21 35.78 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.399 -0.813 . . . . 0.0 109.288 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 8.9 mm-40 -69.88 136.67 87.54 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.19 -0.944 . . . . 0.0 109.282 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.401 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 36.1 Cg_endo -78.74 142.84 18.23 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.425 2.083 . . . . 0.0 110.385 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.591 ' HB2' HG22 ' A' ' 117' ' ' VAL . 35.8 Cg_endo -78.48 175.87 10.57 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.525 2.15 . . . . 0.0 110.265 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.007 ' CB ' HG11 ' A' ' 91' ' ' VAL . . . -95.05 3.73 54.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -0.917 . . . . 0.0 109.57 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.591 HG22 ' HB2' ' A' ' 115' ' ' PRO . 4.9 m -95.36 171.01 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.175 -0.953 . . . . 0.0 109.404 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -82.9 98.16 9.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.916 . . . . 0.0 109.396 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.833 HG11 ' CE2' ' A' ' 122' ' ' TYR . 22.4 t -86.37 127.54 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 109.752 -179.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.61 -55.46 5.88 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.994 ' CE2' HG22 ' A' ' 139' ' ' THR . 2.8 p90 -165.61 174.76 9.5 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.49 -0.929 . . . . 0.0 108.49 179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.833 ' CE2' HG11 ' A' ' 119' ' ' VAL . 5.5 m-85 -120.54 154.52 35.22 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.791 -1.193 . . . . 0.0 110.085 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.586 ' HG2' ' CE2' ' A' ' 121' ' ' TYR . 4.5 mmm-85 -112.07 88.08 2.72 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.389 -0.819 . . . . 0.0 109.032 179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.629 ' CG2' ' CE2' ' A' ' 138' ' ' PHE . 88.9 mt -84.08 160.24 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.249 -0.907 . . . . 0.0 109.491 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.56 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 18.5 p -145.32 150.78 37.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.127 -0.983 . . . . 0.0 110.474 -179.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 1.123 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 2.5 m-85 -87.31 139.72 30.27 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 179.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.598 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -105.74 107.48 2.8 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.474 ' O ' ' HD2' ' A' ' 134' ' ' PRO . 6.2 mt-10 -107.61 85.98 2.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.11 -1.229 . . . . 0.0 109.475 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.431 ' OG1' ' HB3' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -63.19 140.77 58.91 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.008 -1.057 . . . . 0.0 109.826 179.98 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 176.18 -89.62 0.08 OUTLIER Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.739 -1.344 . . . . 0.0 109.739 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.547 ' O ' ' CB ' ' A' ' 132' ' ' ASN . . . -154.39 64.83 0.33 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.547 ' CB ' ' O ' ' A' ' 131' ' ' GLY . 0.3 OUTLIER 160.31 -22.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.467 -1.02 . . . . 0.0 109.3 179.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.575 ' N ' ' HD3' ' A' ' 134' ' ' PRO . 1.4 m 64.4 56.4 1.54 Allowed Pre-proline 0 C--N 1.298 -1.651 0 O-C-N 121.632 -0.668 . . . . 0.0 110.359 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.575 ' HD3' ' N ' ' A' ' 133' ' ' SER . 36.1 Cg_endo -77.74 118.53 4.53 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.423 2.082 . . . . 0.0 109.594 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.768 HG12 ' O ' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -113.01 141.7 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.116 -0.99 . . . . 0.0 110.13 -179.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.493 ' HB2' ' HB2' ' A' ' 126' ' ' TYR . 0.1 OUTLIER -108.59 98.51 8.02 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 179.206 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 0.8 OUTLIER -79.38 128.19 33.03 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 111.057 -178.6 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.629 ' CE2' ' CG2' ' A' ' 124' ' ' ILE . 17.8 p90 -128.11 140.04 52.16 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 178.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.994 HG22 ' CE2' ' A' ' 121' ' ' TYR . 1.2 p -74.44 153.52 39.15 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.046 -1.034 . . . . 0.0 111.103 -178.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.684 HG13 ' HD2' ' A' ' 141' ' ' PRO . 94.5 t -118.07 143.18 32.29 Favored Pre-proline 0 N--CA 1.487 1.409 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.684 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.2 Cg_endo -76.81 119.65 5.21 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.332 2.021 . . . . 0.0 110.298 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -55.47 -17.13 11.94 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.804 -1.319 . . . . 0.0 109.804 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 35.3 t -83.84 12.32 6.25 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.157 -1.202 . . . . 0.0 109.696 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.452 ' HB2' ' HG2' ' A' ' 141' ' ' PRO . 43.1 mmtt -139.08 122.53 17.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.173 -0.954 . . . . 0.0 109.552 -179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.568 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 11.9 p -82.28 -5.37 58.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.229 -0.919 . . . . 0.0 109.506 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.54 ' C ' ' CH2' ' A' ' 112' ' ' TRP . 6.9 p -124.87 154.08 41.6 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.25 -0.906 . . . . 0.0 109.357 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.678 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -123.98 168.52 12.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.29 -0.882 . . . . 0.0 109.513 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 1.024 HG22 ' OD1' ' A' ' 150' ' ' ASN . 22.4 m -130.8 104.12 6.98 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.303 -0.873 . . . . 0.0 109.306 179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 1.123 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -82.57 93.3 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.31 -0.869 . . . . 0.0 109.033 -179.993 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 1.024 ' OD1' HG22 ' A' ' 148' ' ' THR . 1.7 m-20 -100.28 174.1 6.29 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.282 -0.886 . . . . 0.0 109.632 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 67.09 37.0 3.91 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.207 -0.933 . . . . 0.0 109.193 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.879 HG22 ' C ' ' A' ' 106' ' ' THR . 4.5 tt -95.45 161.8 2.57 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.381 0 O-C-N 121.445 -0.784 . . . . 0.0 109.733 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -98.27 108.85 49.6 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.222 179.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.457 ' HB3' ' O ' ' A' ' 105' ' ' PRO . 36.2 Cg_endo -77.22 75.74 4.5 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 122.483 2.122 . . . . 0.0 110.568 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.708 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 168.48 59.36 0.03 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.708 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 163.59 136.78 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.314 -1.109 . . . . 0.0 109.533 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.431 ' HB3' ' OG1' ' A' ' 129' ' ' THR . 22.8 t70 -46.34 158.01 0.12 Allowed 'General case' 0 N--CA 1.489 1.48 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.735 ' CD1' HG21 ' A' ' 184' ' ' THR . 0.3 OUTLIER -140.6 -177.21 4.94 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.873 -1.142 . . . . 0.0 110.496 -179.429 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.575 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 3.1 m -157.83 114.45 2.89 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.484 -0.76 . . . . 0.0 109.093 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.449 HG21 HG21 ' A' ' 110' ' ' ILE . 25.4 mm -97.03 126.71 49.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.567 -1.333 . . . . 0.0 109.73 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.997 HG23 ' CB ' ' A' ' 179' ' ' SER . 1.3 m -138.96 167.2 22.58 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.221 -0.924 . . . . 0.0 109.357 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.523 ' HA ' ' O ' ' A' ' 123' ' ' ARG . 0.9 OUTLIER -162.95 150.35 13.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.912 -1.117 . . . . 0.0 111.109 -179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.622 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.3 m-85 -121.39 100.11 6.85 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.451 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -55.13 129.26 37.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.871 -1.143 . . . . 0.0 109.084 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.597 HG21 ' CZ ' ' A' ' 121' ' ' TYR . 65.1 t -106.29 153.59 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.931 . . . . 0.0 109.863 -179.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.694 HG22 ' HA ' ' A' ' 119' ' ' VAL . 0.7 OUTLIER -148.26 -38.88 0.18 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.443 -0.786 . . . . 0.0 109.608 -179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.471 ' O ' ' O ' ' A' ' 166' ' ' THR . . . -59.11 -138.99 0.01 OUTLIER Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.341 -1.104 . . . . 0.0 110.341 -179.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.516 ' N ' ' HB3' ' A' ' 172' ' ' PRO . 4.6 mmm180 -74.31 -131.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.304 -1.115 . . . . 0.0 110.253 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -137.82 -44.78 0.08 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -74.69 -11.49 60.19 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -1.171 . . . . 0.0 109.258 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.561 ' N ' ' HD3' ' A' ' 172' ' ' PRO . 0.9 OUTLIER -176.6 59.84 0.18 Allowed Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.492 -0.755 . . . . 0.0 109.279 179.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.561 ' HD3' ' N ' ' A' ' 171' ' ' SER . 36.2 Cg_endo -79.25 -171.44 1.25 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.507 2.138 . . . . 0.0 110.533 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -111.44 129.32 56.06 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 2.0 p -121.57 130.83 53.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.148 -0.97 . . . . 0.0 110.011 -179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.483 ' OG ' HG12 ' A' ' 94' ' ' ILE . 16.8 p -54.85 -168.87 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.327 -0.858 . . . . 0.0 109.035 179.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.566 ' CB ' HD11 ' A' ' 94' ' ' ILE . 1.8 mtmt -68.16 144.27 96.69 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.0 -1.062 . . . . 0.0 108.706 179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.622 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.1 Cg_endo -76.68 132.78 13.53 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 C-N-CA 122.317 2.011 . . . . 0.0 111.437 -179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 3.7 t -106.01 130.64 57.26 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.997 ' CB ' HG23 ' A' ' 161' ' ' THR . 1.1 p -130.17 147.88 51.95 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.123 -0.986 . . . . 0.0 110.808 -178.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.749 HG23 HD23 ' A' ' 98' ' ' LEU . 19.0 pt -131.55 151.84 36.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -86.04 156.58 20.36 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.046 -1.034 . . . . 0.0 109.672 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.753 ' CZ ' HD13 ' A' ' 108' ' ' LEU . 54.1 t80 -161.22 123.8 3.11 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.335 -0.853 . . . . 0.0 109.432 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -92.87 130.78 38.36 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.23 -0.919 . . . . 0.0 109.542 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.735 HG21 ' CD1' ' A' ' 158' ' ' TYR . 6.4 p . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.495 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.439 ' C ' ' HG ' ' A' ' 2' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.301 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.738 HD21 HD22 ' A' ' 76' ' ' ASN . 1.4 mp -138.6 -167.96 2.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.185 -1.185 . . . . 0.0 109.298 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.548 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 3.2 m-20 -74.89 153.52 38.6 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.315 -0.866 . . . . 0.0 108.954 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.502 ' HB2' ' HG2' ' A' ' 82' ' ' PRO . 89.9 p -96.53 107.81 38.49 Favored Pre-proline 0 N--CA 1.493 1.711 0 O-C-N 121.344 -0.847 . . . . 0.0 110.115 -179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.608 ' HG2' ' CE2' ' A' ' 32' ' ' TYR . 36.4 Cg_endo -80.15 77.72 3.96 Favored 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.56 2.173 . . . . 0.0 109.893 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 1.093 HG22 ' CD2' ' A' ' 84' ' ' LEU . 73.6 p -93.16 -104.74 0.12 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.154 -0.966 . . . . 0.0 110.112 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 55.81 20.73 26.96 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 107.964 -2.054 . . . . 0.0 107.964 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 15.6 t80 -44.68 127.67 6.28 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.749 -0.853 . . . . 0.0 109.929 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.478 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 4.7 t0 -162.81 105.81 1.07 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.362 -0.836 . . . . 0.0 109.047 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.492 ' HA ' ' HA ' ' A' ' 20' ' ' VAL . 16.1 m -84.89 127.29 34.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.246 -0.908 . . . . 0.0 109.736 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.507 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 3.5 p -154.49 -163.17 1.54 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 0.0 109.483 179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.562 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 2.4 m-20 44.9 38.59 3.03 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -179.044 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.671 HD12 ' OE1' ' A' ' 88' ' ' GLN . 1.6 mm -74.57 130.01 36.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.581 0.705 . . . . 0.0 110.851 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.874 ' HA ' ' HB1' ' A' ' 116' ' ' ALA . 0.1 OUTLIER -119.35 175.63 5.73 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 177.923 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' CB ' ' OD1' ' A' ' 93' ' ' ASP . . . -67.01 -75.56 0.09 Allowed 'General case' 0 C--N 1.298 -1.662 0 O-C-N 120.865 -1.147 . . . . 0.0 109.463 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 15.3 p-10 -78.66 -2.5 39.45 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.302 -0.874 . . . . 0.0 109.82 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.629 ' HB2' HG22 ' A' ' 60' ' ' THR . 6.4 t -143.27 160.83 39.76 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.245 -0.909 . . . . 0.0 109.058 179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.694 ' HE1' HG22 ' A' ' 20' ' ' VAL . 3.5 p90 -167.33 145.66 4.85 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.722 ' OG1' HG23 ' A' ' 58' ' ' THR . 2.8 m -109.98 157.18 19.55 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.353 -1.467 . . . . 0.0 111.395 -178.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.694 HG22 ' HE1' ' A' ' 18' ' ' PHE . 1.0 OUTLIER -123.11 166.63 17.74 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.017 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.507 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 26.1 m-70 -137.67 160.23 39.78 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.94 -1.1 . . . . 0.0 110.404 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.788 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 21.7 p90 177.56 139.61 0.08 Allowed 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.479 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -74.34 159.19 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.405 0 O-C-N 120.946 -1.096 . . . . 0.0 110.116 -179.437 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -96.82 165.58 15.66 Favored Pre-proline 0 C--N 1.3 -1.545 0 O-C-N 121.819 -0.551 . . . . 0.0 109.774 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 1.003 ' CG ' HD13 ' A' ' 29' ' ' ILE . 36.2 Cg_endo -79.56 145.38 18.41 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.604 2.203 . . . . 0.0 110.181 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.461 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 0.7 OUTLIER -80.21 5.52 14.32 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.184 -0.948 . . . . 0.0 109.493 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.901 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -108.23 173.68 2.89 Favored Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.205 -0.935 . . . . 0.0 109.448 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.901 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.7 Cg_endo -78.03 88.57 1.42 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.657 2.238 . . . . 0.0 110.55 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.003 HD13 ' CG ' ' A' ' 25' ' ' PRO . 36.0 pt -98.13 -179.79 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.175 -0.953 . . . . 0.0 109.397 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.532 HG21 ' N ' ' A' ' 77' ' ' GLY . 2.3 p -102.13 -21.49 14.41 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.287 -0.883 . . . . 0.0 109.345 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 138.49 165.36 10.27 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.917 -1.273 . . . . 0.0 109.917 179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 1.146 ' CD1' HG22 ' A' ' 72' ' ' ILE . 0.1 OUTLIER -90.5 148.6 22.63 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.345 -1.091 . . . . 0.0 110.314 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.777 HG23 ' HD2' ' A' ' 49' ' ' ARG . 0.5 OUTLIER -102.3 103.38 14.91 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.399 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 178.839 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.863 HD11 HG22 ' A' ' 50' ' ' VAL . 1.3 mm -88.28 117.59 32.23 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 O-C-N 121.314 -0.866 . . . . 0.0 109.885 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.477 ' O ' ' HA ' ' A' ' 70' ' ' VAL . 0.0 OUTLIER -122.72 111.77 17.13 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.374 -0.829 . . . . 0.0 108.879 179.407 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.91 ' CE1' HD21 ' A' ' 59' ' ' LEU . 1.4 p-80 -105.98 122.0 45.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.203 -0.935 . . . . 0.0 110.11 -179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.574 ' CE1' ' O ' ' A' ' 69' ' ' VAL . 37.3 p-80 -140.71 127.68 20.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.423 -0.798 . . . . 0.0 109.008 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.582 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -39.4 151.5 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.416 -0.803 . . . . 0.0 110.008 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.49 ' OE1' ' CG2' ' A' ' 69' ' ' VAL . 5.7 mm-40 -55.76 -74.42 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.8 m170 -86.16 -68.18 0.76 Allowed 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.525 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -165.92 117.84 1.07 Allowed 'General case' 0 C--N 1.295 -1.79 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.205 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.74 HG11 ' CG2' ' A' ' 66' ' ' THR . 84.9 t -157.93 -100.92 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.239 -0.913 . . . . 0.0 109.509 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.55 ' N ' HG12 ' A' ' 42' ' ' VAL . . . -60.29 -146.31 0.01 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.48 ' HB2' ' HD3' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -119.64 137.64 25.78 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.209 -1.171 . . . . 0.0 109.418 -179.982 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.507 ' HA ' ' O ' ' A' ' 36' ' ' HIS . 36.3 Cg_endo -78.68 85.2 1.88 Allowed 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.536 2.157 . . . . 0.0 110.329 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.531 ' HB2' ' NE2' ' A' ' 36' ' ' HIS . 3.1 mmm180 -96.73 156.4 16.36 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.226 -0.922 . . . . 0.0 109.348 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.437 ' HG3' ' O ' ' A' ' 47' ' ' GLN . 16.9 pt20 -113.2 102.44 10.37 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.248 -0.907 . . . . 0.0 109.482 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.495 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 1.7 m-20 -106.34 115.8 30.83 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.248 -0.907 . . . . 0.0 109.254 179.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.777 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -92.6 140.54 29.44 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.194 -0.941 . . . . 0.0 109.476 -179.813 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.863 HG22 HD11 ' A' ' 34' ' ' ILE . 26.8 m -115.54 151.65 46.3 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.301 -0.874 . . . . 0.0 109.309 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.476 ' HG2' ' HG2' ' A' ' 54' ' ' ARG . 35.3 Cg_endo -77.7 174.27 12.87 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.599 2.2 . . . . 0.0 110.373 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.497 ' HB3' HG13 ' A' ' 29' ' ' ILE . 34.0 Cg_endo -77.07 -15.59 16.27 Favored 'Trans proline' 0 C--N 1.308 -1.571 0 C-N-CA 122.573 2.182 . . . . 0.0 110.269 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.4 m -90.43 14.78 12.07 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.314 -0.867 . . . . 0.0 109.22 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.476 ' HG2' ' HG2' ' A' ' 51' ' ' PRO . 5.9 mmm-85 -133.48 126.33 30.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.327 -0.858 . . . . 0.0 109.575 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.487 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 2.8 p-10 -109.83 -4.96 15.7 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.211 -0.93 . . . . 0.0 109.431 179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 16.0 p -130.53 145.43 51.86 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.318 -0.864 . . . . 0.0 109.068 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.788 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 3.0 tt -129.12 118.89 47.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.174 -0.953 . . . . 0.0 109.642 180.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.722 HG23 ' OG1' ' A' ' 19' ' ' THR . 0.3 OUTLIER -91.74 103.04 15.65 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.364 -0.835 . . . . 0.0 109.241 179.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.973 ' HB3' HD11 ' A' ' 62' ' ' LEU . 2.5 mt -84.92 144.82 28.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.224 -0.922 . . . . 0.0 109.672 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.629 HG22 ' HB2' ' A' ' 17' ' ' SER . 63.7 p -137.69 -174.77 3.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.302 -0.874 . . . . 0.0 109.414 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 36.7 m-20 56.39 20.1 4.49 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.217 -0.927 . . . . 0.0 109.416 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.973 HD11 ' HB3' ' A' ' 59' ' ' LEU . 2.4 mt -96.49 156.85 16.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.213 -0.929 . . . . 0.0 109.242 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.468 ' O ' ' OH ' ' A' ' 68' ' ' TYR . 2.3 t30 -61.44 132.71 92.93 Favored Pre-proline 0 N--CA 1.488 1.463 0 O-C-N 121.097 -1.002 . . . . 0.0 108.485 179.339 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.485 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.3 Cg_endo -77.51 124.64 7.14 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.159 1.906 . . . . 0.0 110.767 -179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.565 ' CA ' ' HA ' ' A' ' 92' ' ' SER . . . 77.8 60.98 2.64 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 109.049 -1.621 . . . . 0.0 109.049 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.74 ' CG2' HG11 ' A' ' 42' ' ' VAL . 3.0 m -145.88 167.0 24.32 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.242 -1.152 . . . . 0.0 110.084 -179.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.57 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.8 OUTLIER -125.2 121.51 34.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.434 -0.791 . . . . 0.0 109.674 -179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.636 ' HH ' ' HB ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -124.89 -172.57 2.6 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.241 -0.912 . . . . 0.0 109.302 179.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.574 ' O ' ' CE1' ' A' ' 37' ' ' HIS . 41.7 t -122.28 110.62 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.008 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 35' ' ' ARG . 3.5 t -96.57 127.19 48.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.778 -179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.579 ' HB3' HD13 ' A' ' 85' ' ' ILE . 95.1 p -108.01 133.98 51.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.32 -0.862 . . . . 0.0 109.951 -179.661 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.146 HG22 ' CD1' ' A' ' 32' ' ' TYR . 5.2 mm -115.57 104.16 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.272 -0.892 . . . . 0.0 109.242 179.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.667 HD12 ' HB3' ' A' ' 83' ' ' PRO . 21.1 mm -109.81 109.49 28.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.13 -0.981 . . . . 0.0 109.57 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.737 ' HB3' ' CB ' ' A' ' 81' ' ' SER . . . -75.88 140.81 42.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.166 -0.959 . . . . 0.0 109.299 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.551 HG21 HD11 ' A' ' 33' ' ' ILE . 0.2 OUTLIER -131.43 176.35 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.289 -0.882 . . . . 0.0 109.561 -179.734 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.738 HD22 HD21 ' A' ' 2' ' ' LEU . 34.2 t30 -156.44 43.68 0.4 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.476 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.532 ' N ' HG21 ' A' ' 30' ' ' THR . . . 91.13 -77.12 1.45 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.441 ' HD2' ' C ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -125.18 3.22 7.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.222 -1.164 . . . . 0.0 109.679 -179.952 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.509 ' OE1' ' ND2' ' A' ' 76' ' ' ASN . 4.0 mt-10 -100.34 -174.9 2.78 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.182 -0.949 . . . . 0.0 109.486 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.459 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 0.8 OUTLIER -149.9 143.93 25.59 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.277 -0.889 . . . . 0.0 109.596 -179.992 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.737 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -110.34 -178.78 0.58 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.408 -0.807 . . . . 0.0 109.065 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.582 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.0 Cg_endo -77.66 131.11 11.12 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 C-N-CA 122.21 1.94 . . . . 0.0 110.168 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.667 ' HB3' HD12 ' A' ' 73' ' ' ILE . 36.1 Cg_endo -78.25 152.43 27.24 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.483 2.122 . . . . 0.0 110.775 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.093 ' CD2' HG22 ' A' ' 6' ' ' THR . 0.0 OUTLIER -146.61 54.13 1.12 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.293 -0.88 . . . . 0.0 108.875 179.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.579 HD13 ' HB3' ' A' ' 71' ' ' SER . 6.4 mt -57.87 162.6 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.306 -0.871 . . . . 0.0 109.871 -179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.5 ' N ' HG22 ' A' ' 85' ' ' ILE . . . -164.98 160.85 34.2 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.004 -1.638 . . . . 0.0 109.004 179.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.525 ' HG3' HG22 ' A' ' 69' ' ' VAL . 0.7 OUTLIER -95.75 127.86 42.13 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.268 -1.136 . . . . 0.0 109.493 -179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.671 ' OE1' HD12 ' A' ' 13' ' ' ILE . 1.3 tm0? -125.31 128.26 47.95 Favored 'General case' 0 N--CA 1.488 1.43 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -107.44 130.39 54.83 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.198 -0.939 . . . . 0.0 110.235 -179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.458 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -74.41 135.9 42.39 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 179.145 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.024 HG21 ' HB2' ' A' ' 116' ' ' ALA . 1.0 OUTLIER -44.41 156.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 C-N-CA 119.902 -0.719 . . . . 0.0 109.212 -179.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.565 ' HA ' ' CA ' ' A' ' 65' ' ' GLY . 0.4 OUTLIER -105.52 31.72 4.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.235 -0.916 . . . . 0.0 109.248 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.511 ' OD1' ' CB ' ' A' ' 15' ' ' ALA . 0.6 OUTLIER 52.83 16.88 0.75 Allowed 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.718 -0.614 . . . . 0.0 110.121 179.831 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.767 HG23 ' HD2' ' A' ' 95' ' ' PRO . 6.7 mt -108.5 143.78 28.18 Favored Pre-proline 0 N--CA 1.484 1.259 0 O-C-N 120.99 -1.069 . . . . 0.0 109.623 -179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.767 ' HD2' HG23 ' A' ' 94' ' ' ILE . 35.3 Cg_endo -78.96 81.94 2.65 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.494 2.129 . . . . 0.0 109.997 179.266 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -64.38 -179.37 0.46 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.258 -0.901 . . . . 0.0 109.678 -179.655 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.518 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER 77.06 21.14 1.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.312 -0.868 . . . . 0.0 109.622 179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.907 HD22 HD23 ' A' ' 162' ' ' LEU . 15.1 tp -69.87 102.6 2.0 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.162 -0.961 . . . . 0.0 109.291 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 97' ' ' ASP . 8.6 pt-20 -149.1 -174.04 4.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.269 -0.894 . . . . 0.0 109.134 -179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.545 HG13 ' O ' ' A' ' 109' ' ' LEU . 41.7 t -127.57 151.18 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.084 -1.01 . . . . 0.0 109.971 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 4.1 pt -119.13 -14.2 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.524 -0.735 . . . . 0.0 109.332 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.78 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -142.32 149.3 39.3 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.518 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 0.7 OUTLIER -134.88 106.07 6.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.993 -1.067 . . . . 0.0 110.234 -179.452 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.479 ' OG1' ' OG ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -91.73 158.18 40.57 Favored Pre-proline 0 C--N 1.303 -1.453 0 O-C-N 121.4 -0.812 . . . . 0.0 108.97 179.144 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.462 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.3 Cg_endo -70.32 -2.51 10.69 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.383 2.055 . . . . 0.0 110.385 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.828 ' C ' HG22 ' A' ' 152' ' ' ILE . 64.7 p -150.34 19.08 0.85 Allowed 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 1.075 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -168.0 168.56 11.9 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.32 -0.952 . . . . 0.0 109.801 179.742 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.075 HD23 ' O ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -141.33 154.2 45.56 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.236 -0.915 . . . . 0.0 109.67 -179.383 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.78 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.8 OUTLIER -105.31 106.66 17.26 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 178.921 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.858 HD12 HD13 ' A' ' 124' ' ' ILE . 0.0 OUTLIER -100.76 140.81 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.226 -0.921 . . . . 0.0 110.206 -179.117 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.477 ' HA ' ' HB ' ' A' ' 146' ' ' THR . 47.4 p -144.49 120.51 10.71 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.656 ' HH2' ' HB2' ' A' ' 147' ' ' ALA . 47.5 p90 -124.69 168.87 12.58 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -0.944 . . . . 0.0 109.662 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.468 ' HB2' ' HB2' ' A' ' 97' ' ' ASP . 4.3 mt-10 -90.67 159.99 39.68 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.287 -0.883 . . . . 0.0 109.245 179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 34.8 Cg_endo -77.36 142.49 21.23 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.628 2.219 . . . . 0.0 110.242 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.51 ' HG2' ' CG2' ' A' ' 119' ' ' VAL . 35.0 Cg_endo -77.72 -171.21 1.12 Allowed 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.588 2.192 . . . . 0.0 110.481 -179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.024 ' HB2' HG21 ' A' ' 91' ' ' VAL . . . -103.52 32.98 3.55 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.241 -0.912 . . . . 0.0 109.543 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.546 HG13 ' O ' ' A' ' 116' ' ' ALA . 27.7 m -159.49 163.42 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.908 . . . . 0.0 109.511 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.9 121.42 17.31 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.235 -0.916 . . . . 0.0 109.245 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 1.026 HG11 ' CE2' ' A' ' 122' ' ' TYR . 3.1 t -99.81 139.7 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.231 -0.918 . . . . 0.0 109.738 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.48 ' HG2' ' HD2' ' A' ' 168' ' ' ARG . 3.8 tpt180 -82.29 -48.92 10.64 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.851 ' CE2' HG22 ' A' ' 139' ' ' THR . 1.5 p90 -165.3 171.31 13.7 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.372 -0.83 . . . . 0.0 109.038 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 1.026 ' CE2' HG11 ' A' ' 119' ' ' VAL . 5.5 m-85 -128.72 122.21 30.17 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.114 -0.991 . . . . 0.0 109.426 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.48 ' CD ' ' OE1' ' A' ' 137' ' ' GLU . 9.9 ttm180 -89.96 105.76 18.02 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.194 -0.942 . . . . 0.0 109.248 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 1.195 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 43.3 mt -84.7 166.46 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.277 -0.889 . . . . 0.0 109.677 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.664 HG22 ' HG2' ' A' ' 137' ' ' GLU . 1.3 p -141.8 137.22 31.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.315 -0.866 . . . . 0.0 109.704 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 1.17 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 3.2 m-30 -92.04 132.4 36.59 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.597 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -103.42 112.31 4.18 Favored Glycine 0 N--CA 1.485 1.927 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -107.1 136.49 46.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -1.125 . . . . 0.0 109.136 179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.799 HG21 ' HB3' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -86.65 149.48 24.88 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.114 -0.991 . . . . 0.0 109.765 179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 160.8 -83.38 0.13 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -151.24 -87.24 0.06 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.386 -1.486 . . . . 0.0 109.386 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -68.95 -7.35 34.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -1.139 . . . . 0.0 109.37 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 21.7 t 45.1 79.22 0.35 Allowed Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.379 -0.826 . . . . 0.0 109.871 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.04 73.63 5.65 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.581 2.188 . . . . 0.0 109.949 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 126' ' ' TYR . 2.4 m -58.63 154.48 2.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.479 -0.763 . . . . 0.0 110.127 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.61 ' HG2' ' CG ' ' A' ' 126' ' ' TYR . 4.7 pt20 -125.05 117.6 24.32 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.664 ' HG2' HG22 ' A' ' 125' ' ' THR . 84.0 mt-10 -96.76 152.23 18.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.105 -0.997 . . . . 0.0 111.434 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 1.195 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 1.7 p90 -143.88 139.89 29.47 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.851 HG22 ' CE2' ' A' ' 121' ' ' TYR . 1.6 p -74.2 144.37 44.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.029 -1.044 . . . . 0.0 111.317 -177.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.807 HG13 ' HD2' ' A' ' 141' ' ' PRO . 48.5 t -108.78 145.77 32.36 Favored Pre-proline 0 N--CA 1.488 1.444 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.807 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.3 Cg_endo -77.11 146.3 25.35 Favored 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.327 2.018 . . . . 0.0 110.011 179.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.17 19.62 25.77 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.425 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 0.5 OUTLIER -105.16 10.63 33.75 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.115 -1.226 . . . . 0.0 109.518 179.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 143' ' ' SER . 19.2 mmtp -152.42 135.93 16.03 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.226 -0.921 . . . . 0.0 109.616 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.572 ' O ' ' CE2' ' A' ' 112' ' ' TRP . 7.2 p -83.53 1.72 40.57 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.226 -0.921 . . . . 0.0 109.467 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.477 ' HB ' ' HA ' ' A' ' 111' ' ' SER . 11.7 p -137.38 146.51 44.57 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.237 -0.914 . . . . 0.0 108.911 179.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.656 ' HB2' ' HH2' ' A' ' 112' ' ' TRP . . . -126.07 -171.42 2.39 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.07 -1.019 . . . . 0.0 109.593 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.606 HG22 ' N ' ' A' ' 149' ' ' ILE . 82.8 m -137.6 167.55 21.44 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.304 -0.872 . . . . 0.0 109.168 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 1.17 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 1.6 mt -126.36 141.41 45.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.48 0 O-C-N 121.251 -0.906 . . . . 0.0 109.134 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.437 ' O ' ' C ' ' A' ' 151' ' ' ASN . 43.5 m-80 -134.5 176.09 8.94 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.325 -0.859 . . . . 0.0 109.539 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.437 ' C ' ' O ' ' A' ' 150' ' ' ASN . 1.3 p30 41.02 52.9 3.37 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.32 -0.862 . . . . 0.0 109.78 179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.838 HD13 HD21 ' A' ' 108' ' ' LEU . 8.4 tt -101.66 164.07 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.322 -0.861 . . . . 0.0 109.216 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.464 ' N ' HG12 ' A' ' 152' ' ' ILE . 19.5 mmmt -99.89 108.01 49.46 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.113 -0.992 . . . . 0.0 109.806 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 152' ' ' ILE . 36.5 Cg_endo -79.38 174.69 11.62 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 C-N-CA 122.571 2.181 . . . . 0.0 110.573 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.602 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 64.94 56.06 18.5 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.602 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 170.47 138.74 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.306 -1.114 . . . . 0.0 109.654 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.799 ' HB3' HG21 ' A' ' 129' ' ' THR . 4.0 t0 -54.79 161.05 1.68 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 179.252 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.597 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.3 OUTLIER -140.33 176.54 8.69 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.908 -1.12 . . . . 0.0 110.135 -179.454 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.548 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 3.2 m -146.2 109.63 4.76 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 179.12 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.514 ' HB ' ' CG1' ' A' ' 180' ' ' ILE . 29.6 mm -89.86 143.19 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.953 -1.092 . . . . 0.0 110.349 -178.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.949 HG23 ' CB ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -153.12 160.0 42.83 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 179.414 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.907 HD23 HD22 ' A' ' 98' ' ' LEU . 2.1 pp -161.48 148.45 14.57 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.914 -1.116 . . . . 0.0 110.632 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.604 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 2.4 m-85 -113.07 164.45 13.46 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -134.33 102.87 5.5 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.027 -1.045 . . . . 0.0 109.582 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.514 HG22 ' HB3' ' A' ' 174' ' ' SER . 51.5 t -97.38 156.11 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.353 -0.842 . . . . 0.0 109.725 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.998 HG22 ' HA ' ' A' ' 119' ' ' VAL . 62.9 p -135.88 -56.61 0.77 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.362 -0.836 . . . . 0.0 109.259 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . . . . . . . . . . . -70.97 135.19 24.15 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.48 ' HD2' ' HG2' ' A' ' 120' ' ' ARG . 18.8 mtp180 -143.8 61.64 1.37 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -1.139 . . . . 0.0 109.515 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -178.85 -43.66 0.07 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.428 ' O ' ' OG ' ' A' ' 171' ' ' SER . 18.3 t70 -138.82 10.13 2.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -1.135 . . . . 0.0 109.494 -179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.428 ' OG ' ' O ' ' A' ' 170' ' ' ASP . 64.8 m -168.74 76.58 0.78 Allowed Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.213 -0.929 . . . . 0.0 109.413 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.1 84.45 2.0 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.675 2.25 . . . . 0.0 110.54 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.509 ' O ' HG13 ' A' ' 165' ' ' VAL . . . -108.49 166.02 11.09 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.295 -0.878 . . . . 0.0 109.186 179.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.514 ' HB3' HG22 ' A' ' 165' ' ' VAL . 14.2 p -146.46 29.27 1.05 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.975 . . . . 0.0 109.798 179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.482 ' O ' ' O ' ' A' ' 174' ' ' SER . 5.9 p 42.08 -165.54 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.577 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -89.06 140.58 29.03 Favored Pre-proline 0 C--N 1.305 -1.35 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 179.327 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.604 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 34.9 Cg_endo -77.51 130.23 10.69 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.354 2.036 . . . . 0.0 110.76 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.582 HG12 HD23 ' A' ' 98' ' ' LEU . 5.3 t -101.47 134.36 42.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.949 ' CB ' HG23 ' A' ' 161' ' ' THR . 1.3 p -126.61 155.63 42.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.172 -0.955 . . . . 0.0 110.191 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.514 ' CG1' ' HB ' ' A' ' 160' ' ' ILE . 24.6 pt -141.58 178.82 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 22.5 m120 -103.41 151.66 22.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.098 -1.001 . . . . 0.0 109.519 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.769 ' CE2' HD22 ' A' ' 108' ' ' LEU . 83.8 t80 -155.23 122.63 5.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.361 -0.837 . . . . 0.0 109.495 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.418 ' O ' ' CD ' ' A' ' 183' ' ' LYS . 0.0 OUTLIER -99.24 127.9 45.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.148 -0.97 . . . . 0.0 109.446 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.569 HG22 ' HE2' ' A' ' 182' ' ' TYR . 51.3 p . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 118.041 -0.98 . . . . 0.0 109.539 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.283 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.829 HD11 ' CB ' ' A' ' 81' ' ' SER . 0.6 OUTLIER -164.79 149.07 9.15 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.27 -1.136 . . . . 0.0 109.354 -179.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.528 ' O ' ' CB ' ' A' ' 25' ' ' PRO . 10.8 m-20 -84.93 123.08 30.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.235 -0.916 . . . . 0.0 109.425 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.559 ' CB ' ' HD2' ' A' ' 5' ' ' PRO . 0.2 OUTLIER -95.73 177.5 1.75 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.247 -0.908 . . . . 0.0 109.528 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.665 ' O ' HG23 ' A' ' 6' ' ' THR . 36.2 Cg_endo -78.86 147.07 21.22 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.648 2.232 . . . . 0.0 110.096 179.65 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.665 HG23 ' O ' ' A' ' 5' ' ' PRO . 0.8 OUTLIER -161.25 -170.48 2.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.065 -1.022 . . . . 0.0 109.8 -179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.436 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 44.08 32.59 2.48 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 108.71 -1.756 . . . . 0.0 108.71 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.628 ' C ' ' CD1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -75.1 -167.68 0.65 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.51 -0.994 . . . . 0.0 109.99 -179.242 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -165.32 129.1 2.31 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.233 -0.917 . . . . 0.0 109.216 179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.949 ' OG ' HG13 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -88.49 140.05 29.86 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.153 -0.967 . . . . 0.0 109.64 -179.728 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.507 ' OG ' ' NE2' ' A' ' 21' ' ' HIS . 60.2 p -148.16 -162.54 1.57 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.256 -0.903 . . . . 0.0 109.545 179.784 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.542 ' HB2' ' CB ' ' A' ' 19' ' ' THR . 4.4 m-20 45.34 39.77 4.7 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 -178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.077 HG22 HG22 ' A' ' 91' ' ' VAL . 24.5 mm -73.35 92.33 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.494 -178.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.657 ' C ' HG23 ' A' ' 91' ' ' VAL . 0.2 OUTLIER -93.04 166.38 12.39 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 176.702 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.791 ' HB1' ' HB2' ' A' ' 93' ' ' ASP . . . -56.06 -77.81 0.03 OUTLIER 'General case' 0 C--N 1.294 -1.819 0 O-C-N 120.961 -1.087 . . . . 0.0 111.106 -177.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.446 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.7 OUTLIER -77.04 -0.08 23.26 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.109 -0.994 . . . . 0.0 110.177 -178.735 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.942 ' HB3' HG22 ' A' ' 60' ' ' THR . 20.8 p -144.67 123.58 12.73 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.164 -0.96 . . . . 0.0 109.237 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.935 ' CE1' HG22 ' A' ' 20' ' ' VAL . 0.7 OUTLIER -135.09 136.05 41.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.119 -0.988 . . . . 0.0 108.335 179.842 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.582 ' OG1' HG23 ' A' ' 58' ' ' THR . 16.2 m -87.18 156.99 19.46 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.094 -1.004 . . . . 0.0 112.013 -177.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.949 HG13 ' OG ' ' A' ' 10' ' ' SER . 0.7 OUTLIER -135.58 97.94 1.93 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 178.673 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.507 ' NE2' ' OG ' ' A' ' 11' ' ' SER . 15.5 m-70 -87.72 163.17 16.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.153 -0.967 . . . . 0.0 110.882 -178.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.865 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 25.9 p90 -174.79 139.99 0.55 Allowed 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.513 ' O ' ' HB3' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.0 161.1 5.01 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.361 0 O-C-N 121.152 -0.967 . . . . 0.0 109.827 -179.571 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.511 ' HB1' ' OH ' ' A' ' 32' ' ' TYR . . . -102.15 151.0 38.0 Favored Pre-proline 0 C--N 1.297 -1.691 0 O-C-N 121.779 -0.576 . . . . 0.0 109.511 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.528 ' CB ' ' O ' ' A' ' 3' ' ' ASP . 36.2 Cg_endo -78.53 152.8 26.53 Favored 'Trans proline' 0 C--N 1.307 -1.622 0 C-N-CA 122.538 2.159 . . . . 0.0 110.247 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.7 mmm180 -92.69 27.06 2.45 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.2 -0.938 . . . . 0.0 109.627 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.958 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -105.34 175.32 2.18 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.254 -0.904 . . . . 0.0 109.271 179.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.958 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.2 Cg_endo -77.77 98.87 1.24 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.586 2.191 . . . . 0.0 110.363 -179.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.635 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 39.4 pt -126.93 173.81 11.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.308 -0.87 . . . . 0.0 109.518 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.6 p -114.2 -18.83 11.53 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.262 -0.898 . . . . 0.0 109.346 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.28 170.68 26.27 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.635 ' CE1' ' CD1' ' A' ' 29' ' ' ILE . 1.2 m-85 -112.49 134.23 54.13 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.172 -1.193 . . . . 0.0 109.492 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.814 ' C ' HD13 ' A' ' 34' ' ' ILE . 2.0 mt -88.54 126.8 41.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.303 -0.873 . . . . 0.0 109.069 179.691 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.062 HG23 ' CD1' ' A' ' 72' ' ' ILE . 1.1 mm -104.28 111.25 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.084 -1.01 . . . . 0.0 109.882 -179.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.423 ' HB3' ' OG ' ' A' ' 71' ' ' SER . 42.2 ttt-85 -121.7 108.16 13.21 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.301 -0.874 . . . . 0.0 108.898 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.938 ' HB3' HG13 ' A' ' 70' ' ' VAL . 18.3 p-80 -117.41 170.77 8.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.226 -0.921 . . . . 0.0 110.069 -179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.44 ' O ' ' O ' ' A' ' 38' ' ' ALA . 54.7 p-80 -179.61 130.38 0.1 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.43 -0.794 . . . . 0.0 109.723 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -55.31 -168.63 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.262 -0.899 . . . . 0.0 109.318 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.513 ' HB2' ' CD2' ' A' ' 40' ' ' HIS . 0.7 OUTLIER -47.17 -79.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.124 -0.985 . . . . 0.0 109.329 179.925 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.526 ' CD2' ' N ' ' A' ' 40' ' ' HIS . 0.1 OUTLIER -164.8 55.33 0.13 Allowed 'General case' 0 C--N 1.293 -1.854 0 CA-C-O 121.551 0.691 . . . . 0.0 109.313 179.741 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.1 p -101.4 10.57 40.38 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.506 -0.746 . . . . 0.0 109.575 -179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.587 HG22 ' N ' ' A' ' 43' ' ' GLY . 7.1 p -143.46 165.0 15.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.194 -0.941 . . . . 0.0 109.593 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.587 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -77.66 -72.1 1.16 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 mtt85 -93.55 145.69 30.42 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.256 -1.143 . . . . 0.0 109.33 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.402 ' HB3' ' HB3' ' A' ' 37' ' ' HIS . 34.9 Cg_endo -77.84 163.19 28.97 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.557 2.171 . . . . 0.0 110.312 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.577 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . 3.7 mmt85 -74.89 127.8 34.07 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.198 -0.938 . . . . 0.0 109.27 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -110.23 85.26 2.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.203 -0.936 . . . . 0.0 109.63 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.512 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 29.7 m-20 -100.74 99.86 10.46 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.201 -0.937 . . . . 0.0 109.241 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.52 ' HD3' ' N ' ' A' ' 49' ' ' ARG . 0.1 OUTLIER -84.81 134.49 34.3 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.037 -1.039 . . . . 0.0 109.617 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.75 ' CG1' HD12 ' A' ' 57' ' ' ILE . 13.6 m -118.97 159.67 43.83 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.38 -0.825 . . . . 0.0 109.256 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.495 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 34.7 Cg_endo -77.0 174.16 13.3 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.528 2.152 . . . . 0.0 110.263 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.577 ' HA ' ' CE2' ' A' ' 32' ' ' TYR . 34.9 Cg_endo -76.89 -15.63 16.6 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.605 2.203 . . . . 0.0 110.43 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.87 23.53 2.71 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.255 -0.903 . . . . 0.0 109.473 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.435 ' O ' ' CZ2' ' A' ' 22' ' ' TRP . 0.0 OUTLIER -137.52 109.47 7.17 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.222 -0.923 . . . . 0.0 109.647 -180.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.483 ' HB2' ' O ' ' A' ' 22' ' ' TRP . 5.2 p30 -95.13 -6.96 40.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.242 -0.911 . . . . 0.0 109.437 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 21' ' ' HIS . 64.9 p -139.1 129.49 25.63 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.318 -0.864 . . . . 0.0 109.057 179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.865 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 3.4 tt -118.33 119.36 61.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.258 -0.902 . . . . 0.0 109.594 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.582 HG23 ' OG1' ' A' ' 19' ' ' THR . 0.3 OUTLIER -85.13 108.75 17.84 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.411 -0.806 . . . . 0.0 108.829 179.628 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.987 ' CB ' HD11 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -84.72 152.46 23.71 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.204 -0.935 . . . . 0.0 109.24 -179.648 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.942 HG22 ' HB3' ' A' ' 17' ' ' SER . 21.5 p -142.93 -179.69 6.5 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.568 -0.708 . . . . 0.0 109.449 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 56.44 18.29 3.4 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.27 -0.894 . . . . 0.0 109.392 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.987 HD11 ' CB ' ' A' ' 59' ' ' LEU . 3.5 mt -92.68 142.8 26.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.246 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 62' ' ' LEU . 7.5 t-20 -45.86 123.99 6.4 Favored Pre-proline 0 N--CA 1.487 1.424 0 O-C-N 121.204 -0.935 . . . . 0.0 108.651 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.547 ' CB ' ' HB2' ' A' ' 93' ' ' ASP . 35.2 Cg_endo -76.96 131.78 12.35 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.23 1.954 . . . . 0.0 110.32 -179.607 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 71.89 61.6 3.71 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 108.868 -1.693 . . . . 0.0 108.868 -179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.472 ' O ' ' N ' ' A' ' 90' ' ' THR . 3.3 m -154.91 149.3 26.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -1.136 . . . . 0.0 109.654 -179.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.528 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 16.5 mt-10 -74.41 130.33 39.44 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.096 -1.002 . . . . 0.0 108.417 179.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 3.0 m-85 -126.0 115.97 20.72 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.093 -1.004 . . . . 0.0 110.377 -178.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 36' ' ' HIS . 2.1 t -83.52 123.37 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.432 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 178.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.938 HG13 ' HB3' ' A' ' 36' ' ' HIS . 2.2 t -112.34 123.8 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.003 -1.061 . . . . 0.0 110.18 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.504 ' HB2' HG12 ' A' ' 85' ' ' ILE . 61.2 p -112.97 122.28 47.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.371 -0.831 . . . . 0.0 109.689 179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.062 ' CD1' HG23 ' A' ' 34' ' ' ILE . 10.7 mm -107.19 136.49 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.273 -0.892 . . . . 0.0 109.54 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.91 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.7 mp -122.6 156.38 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.253 -0.905 . . . . 0.0 109.2 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.061 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -119.35 115.57 24.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.284 -0.885 . . . . 0.0 109.379 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -109.35 164.02 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.167 -0.958 . . . . 0.0 109.441 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -140.21 49.93 1.73 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 109.398 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.58 -82.24 1.65 Allowed Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.421 -1.471 . . . . 0.0 109.421 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.44 ' HD3' ' C ' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -120.19 -2.37 10.16 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -1.154 . . . . 0.0 109.564 179.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 0.0 OUTLIER -92.96 -166.59 1.56 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.241 -0.912 . . . . 0.0 109.427 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.479 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 37.5 mt-10 -154.01 155.03 34.78 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.2 -0.938 . . . . 0.0 109.745 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 1.061 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -129.49 179.89 1.19 Allowed Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.385 -0.822 . . . . 0.0 108.978 179.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.576 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.3 Cg_endo -76.04 142.74 25.15 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.194 1.929 . . . . 0.0 109.855 179.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.8 Cg_endo -77.81 132.33 11.82 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.685 2.257 . . . . 0.0 111.529 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.64 HD22 ' O ' ' A' ' 5' ' ' PRO . 9.0 tp -108.16 100.75 10.03 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 179.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.504 HG12 ' HB2' ' A' ' 71' ' ' SER . 2.0 mt -105.63 157.35 6.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.323 0 O-C-N 121.065 -1.022 . . . . 0.0 110.486 -178.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.478 ' N ' HG22 ' A' ' 85' ' ' ILE . . . -151.42 178.97 28.45 Favored Glycine 0 N--CA 1.485 1.95 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 179.566 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -131.59 137.2 48.32 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.113 -1.228 . . . . 0.0 109.766 -179.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.546 ' HG3' ' CB ' ' A' ' 10' ' ' SER . 1.8 mm100 -163.76 126.94 2.61 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.313 -0.867 . . . . 0.0 109.174 179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.528 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -94.5 145.91 24.47 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.354 -0.841 . . . . 0.0 110.098 -179.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.472 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.71 145.93 42.69 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.458 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.077 HG22 HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -70.21 159.31 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.462 -0.774 . . . . 0.0 109.096 179.426 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.542 ' HB2' ' CB ' ' A' ' 115' ' ' PRO . 12.3 m -76.18 139.13 41.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.001 -1.062 . . . . 0.0 108.803 179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.791 ' HB2' ' HB1' ' A' ' 15' ' ' ALA . 3.3 t0 -103.14 -50.14 3.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.211 -0.93 . . . . 0.0 110.168 -179.334 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 1.025 HD11 ' HB2' ' A' ' 176' ' ' LYS . 5.6 mt -98.39 140.46 21.86 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.238 -0.914 . . . . 0.0 110.176 -178.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.63 ' HD2' HG23 ' A' ' 94' ' ' ILE . 36.2 Cg_endo -81.05 77.51 4.01 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.615 2.21 . . . . 0.0 109.499 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.547 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 5.1 ptp180 -45.94 173.83 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.44 -0.788 . . . . 0.0 109.974 -179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.547 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 1.7 t70 82.38 15.34 0.43 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.68 -0.637 . . . . 0.0 110.004 179.693 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 1.059 HD23 HG12 ' A' ' 178' ' ' VAL . 20.7 tp -70.27 100.45 1.71 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.042 -1.037 . . . . 0.0 109.137 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 110' ' ' ILE . 0.7 OUTLIER -153.3 176.85 11.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.233 -0.917 . . . . 0.0 109.649 -179.797 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.564 HG22 ' N ' ' A' ' 101' ' ' ILE . 9.2 p -105.25 171.23 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.342 -0.849 . . . . 0.0 109.537 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.564 ' N ' HG22 ' A' ' 100' ' ' VAL . 3.6 pt -136.51 -42.69 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.277 -0.89 . . . . 0.0 109.166 179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.899 ' HB3' ' CD1' ' A' ' 109' ' ' LEU . . . -121.99 114.29 20.75 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 179.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.569 ' CB ' ' HH ' ' A' ' 182' ' ' TYR . 1.2 t -99.94 99.16 9.88 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.24 -0.913 . . . . 0.0 110.5 -178.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.516 ' OG1' ' O ' ' A' ' 107' ' ' SER . 0.2 OUTLIER -89.38 160.74 41.67 Favored Pre-proline 0 C--N 1.302 -1.491 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.639 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -69.64 -0.81 7.35 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.423 2.082 . . . . 0.0 110.937 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.867 ' C ' HG22 ' A' ' 152' ' ' ILE . 56.0 p -146.45 11.5 1.14 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.269 -0.894 . . . . 0.0 109.485 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 1.081 ' O ' HD23 ' A' ' 108' ' ' LEU . 85.3 p -172.48 165.52 5.67 Favored 'General case' 0 N--CA 1.491 1.62 0 C-N-CA 118.682 -1.207 . . . . 0.0 110.41 179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.081 HD23 ' O ' ' A' ' 107' ' ' SER . 0.4 OUTLIER -145.92 149.57 34.47 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.796 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.899 ' CD1' ' HB3' ' A' ' 102' ' ' ALA . 0.0 OUTLIER -106.63 116.52 32.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.199 -0.938 . . . . 0.0 108.952 179.214 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.835 HD11 ' HB3' ' A' ' 147' ' ' ALA . 2.4 pt -100.03 -179.14 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 120.984 -1.072 . . . . 0.0 109.719 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.502 ' HA ' ' HA ' ' A' ' 146' ' ' THR . 1.0 OUTLIER -168.42 150.96 5.26 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.551 -0.718 . . . . 0.0 109.778 -179.894 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.655 ' CH2' ' HB2' ' A' ' 147' ' ' ALA . 24.2 p90 -154.03 -176.8 6.02 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.43 -0.794 . . . . 0.0 109.307 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.462 ' O ' ' CB ' ' A' ' 95' ' ' PRO . 19.1 mm-40 -120.21 150.39 51.37 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.095 -1.003 . . . . 0.0 109.742 -179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.79 132.63 10.89 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.725 2.283 . . . . 0.0 110.705 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.542 ' CB ' ' HB2' ' A' ' 92' ' ' SER . 36.4 Cg_endo -79.87 -167.68 0.54 Allowed 'Trans proline' 0 C--N 1.312 -1.369 0 C-N-CA 122.705 2.27 . . . . 0.0 110.557 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.003 ' CB ' HG12 ' A' ' 91' ' ' VAL . . . -87.82 -12.15 45.81 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.909 . . . . 0.0 109.273 179.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.532 HG13 ' HB ' ' A' ' 91' ' ' VAL . 30.0 m -88.54 161.84 2.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 O-C-N 121.397 -0.814 . . . . 0.0 109.332 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.639 ' O ' HG22 ' A' ' 166' ' ' THR . 9.0 m -76.41 122.92 25.2 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.284 -0.885 . . . . 0.0 109.561 -179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.937 HG11 ' CZ ' ' A' ' 122' ' ' TYR . 2.8 t -100.85 114.91 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.189 -0.944 . . . . 0.0 109.715 -179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.506 ' HA ' ' NE ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -74.85 -51.48 13.85 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 179.206 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.959 ' CE1' HG22 ' A' ' 139' ' ' THR . 1.2 p90 -165.49 158.09 15.5 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 179.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.937 ' CZ ' HG11 ' A' ' 119' ' ' VAL . 7.0 m-85 -107.58 123.43 48.45 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.013 -1.054 . . . . 0.0 109.331 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 4.2 ttp180 -86.11 106.11 17.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.228 -0.92 . . . . 0.0 109.206 -179.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.832 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 26.1 mt -99.09 150.09 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.296 -0.878 . . . . 0.0 109.902 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.491 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 25.3 p -133.48 132.73 41.37 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.317 -0.865 . . . . 0.0 109.932 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.702 ' CE2' HG22 ' A' ' 149' ' ' ILE . 30.5 m-85 -74.8 134.22 41.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.323 -0.86 . . . . 0.0 109.225 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.586 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.32 106.73 2.71 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.519 -1.433 . . . . 0.0 109.519 179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.5 mt-10 -106.01 140.7 38.6 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.198 -1.178 . . . . 0.0 109.529 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.822 ' OG1' ' HB1' ' A' ' 156' ' ' ALA . 0.7 OUTLIER -67.87 -82.53 0.03 OUTLIER 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.24 -0.912 . . . . 0.0 109.674 179.723 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -134.04 69.61 0.53 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -100.98 25.45 28.31 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.403 ' O ' ' CG ' ' A' ' 132' ' ' ASN . 37.6 t30 55.91 34.38 23.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.334 -1.098 . . . . 0.0 109.453 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.61 153.79 26.94 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.24 -0.912 . . . . 0.0 109.425 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.22 173.61 13.64 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.609 2.206 . . . . 0.0 110.457 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.5 m -62.45 157.69 3.64 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 O-C-N 121.267 -0.896 . . . . 0.0 109.661 -179.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.58 ' HB3' ' CD1' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -107.74 104.29 13.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.266 -0.896 . . . . 0.0 109.028 179.626 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.491 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 4.8 tt0 -85.82 111.75 20.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 0.0 110.372 -179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.832 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 13.3 p90 -122.39 132.18 54.25 Favored 'General case' 0 N--CA 1.491 1.596 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.959 HG22 ' CE1' ' A' ' 121' ' ' TYR . 1.7 p -74.29 174.48 8.75 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.225 -0.922 . . . . 0.0 110.741 -178.352 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.61 HG21 ' CD1' ' A' ' 124' ' ' ILE . 24.9 t -137.03 138.08 24.72 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.667 -0.646 . . . . 0.0 109.294 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.487 ' HD2' HG13 ' A' ' 140' ' ' VAL . 35.2 Cg_endo -76.95 132.72 13.12 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.346 2.031 . . . . 0.0 110.35 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -74.45 0.44 55.04 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.88 -1.288 . . . . 0.0 109.88 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.94 -4.64 25.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.114 -1.227 . . . . 0.0 109.751 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.531 ' CD ' ' O ' ' A' ' 146' ' ' THR . 0.0 OUTLIER -154.71 157.67 38.42 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.935 . . . . 0.0 109.376 179.907 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.569 ' O ' ' CE3' ' A' ' 112' ' ' TRP . 0.1 OUTLIER -95.84 2.06 53.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.265 -0.897 . . . . 0.0 110.313 -179.348 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.531 ' O ' ' CD ' ' A' ' 144' ' ' LYS . 43.4 p -108.32 162.34 14.19 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.981 -1.075 . . . . 0.0 109.624 -179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.835 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -145.9 134.45 22.09 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.115 -0.991 . . . . 0.0 109.749 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 12.2 t -83.91 153.47 23.94 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.328 -0.858 . . . . 0.0 109.031 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.702 HG22 ' CE2' ' A' ' 126' ' ' TYR . 14.3 mm -133.98 66.26 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.135 -0.978 . . . . 0.0 109.674 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.566 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 2.4 m-20 -84.2 -176.26 6.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.403 -0.811 . . . . 0.0 109.636 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 13.3 m120 68.47 21.4 8.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.177 -0.952 . . . . 0.0 109.22 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.867 HG22 ' C ' ' A' ' 106' ' ' THR . 2.8 tt -85.91 155.11 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.341 -0.849 . . . . 0.0 109.615 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.426 ' O ' ' OG1' ' A' ' 184' ' ' THR . 0.0 OUTLIER -103.88 123.81 39.79 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.231 -0.918 . . . . 0.0 109.298 -179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.46 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 35.9 Cg_endo -78.43 149.63 24.52 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.415 2.076 . . . . 0.0 110.402 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.698 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 78.43 66.16 1.77 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.564 -1.414 . . . . 0.0 109.564 179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.822 ' HB1' ' OG1' ' A' ' 129' ' ' THR . . . 163.97 131.25 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.224 -1.162 . . . . 0.0 109.653 179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.558 ' HB3' ' CG2' ' A' ' 129' ' ' THR . 0.9 OUTLIER -52.17 164.87 0.26 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.346 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.617 ' CD1' ' CG2' ' A' ' 184' ' ' THR . 0.2 OUTLIER -142.69 -179.36 6.27 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.846 -1.159 . . . . 0.0 110.363 -179.419 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.585 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 1.7 m -153.12 106.75 3.03 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.933 HD11 HD12 ' A' ' 108' ' ' LEU . 27.5 mt -97.72 116.79 41.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.805 -1.184 . . . . 0.0 109.754 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 1.039 HG23 ' CB ' ' A' ' 179' ' ' SER . 0.2 OUTLIER -125.04 153.52 42.73 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.217 -0.927 . . . . 0.0 109.165 179.68 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.828 ' CD2' HD13 ' A' ' 98' ' ' LEU . 2.3 pp -149.95 145.62 26.58 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.055 -1.028 . . . . 0.0 110.682 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.607 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 4.1 m-85 -114.11 177.39 4.66 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -140.53 110.09 6.33 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 109.231 179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 95.7 t -101.48 152.3 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.276 -0.89 . . . . 0.0 109.639 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.639 HG22 ' O ' ' A' ' 118' ' ' SER . 21.8 p -122.73 -69.97 0.8 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -0.838 . . . . 0.0 109.722 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.495 ' N ' ' OG1' ' A' ' 166' ' ' THR . . . -64.58 172.28 19.1 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -165.22 44.16 0.08 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.294 -1.121 . . . . 0.0 109.679 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 161.94 -39.77 0.39 Allowed Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.524 ' O ' ' CB ' ' A' ' 171' ' ' SER . 10.3 p-10 -108.83 -2.26 18.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.147 -1.208 . . . . 0.0 109.697 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.524 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 1.0 OUTLIER 163.43 83.05 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.3 -0.875 . . . . 0.0 109.435 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.89 86.54 1.64 Allowed 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 122.627 2.218 . . . . 0.0 110.431 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -96.99 174.8 6.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.327 -0.858 . . . . 0.0 109.34 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 0.6 OUTLIER -164.38 131.88 3.28 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.162 -0.961 . . . . 0.0 109.589 -179.938 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.514 ' CB ' ' O ' ' A' ' 93' ' ' ASP . 73.5 p -64.07 -164.45 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -0.847 . . . . 0.0 109.365 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 1.025 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -82.24 144.84 51.06 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 0.0 108.91 179.784 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.607 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 35.7 Cg_endo -78.55 127.96 8.41 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.547 2.164 . . . . 0.0 110.931 -179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 1.059 HG12 HD23 ' A' ' 98' ' ' LEU . 69.1 t -96.5 123.51 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -0.91 . . . . 0.0 108.56 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 1.039 ' CB ' HG23 ' A' ' 161' ' ' THR . 0.4 OUTLIER -118.53 143.71 46.56 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.167 -0.958 . . . . 0.0 109.914 -179.537 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 15.5 pt -136.14 151.75 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 N-CA-C 108.729 -0.841 . . . . 0.0 108.729 179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 7.6 m120 -84.66 162.67 19.63 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.111 -0.993 . . . . 0.0 109.347 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.769 ' OH ' HD22 ' A' ' 108' ' ' LEU . 49.6 t80 -155.1 157.88 38.17 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.314 -0.867 . . . . 0.0 109.368 -179.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.439 ' N ' ' CD1' ' A' ' 182' ' ' TYR . 0.2 OUTLIER -126.57 119.06 26.15 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.18 -0.95 . . . . 0.0 109.474 -179.957 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.617 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 10.8 p . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.54 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.454 ' O ' ' HG ' ' A' ' 2' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.308 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.845 HD22 HG22 ' A' ' 29' ' ' ILE . 1.9 mp -141.2 -163.32 1.53 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.257 -1.143 . . . . 0.0 109.367 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.438 ' HB2' ' CB ' ' A' ' 25' ' ' PRO . 29.2 m-20 -115.34 169.84 8.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.287 -0.883 . . . . 0.0 109.43 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.481 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 37.1 p -94.8 119.22 66.37 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.231 -0.918 . . . . 0.0 109.541 -179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.554 ' O ' HD22 ' A' ' 84' ' ' LEU . 35.2 Cg_endo -77.85 88.13 1.45 Allowed 'Trans proline' 0 C--N 1.312 -1.345 0 C-N-CA 122.367 2.045 . . . . 0.0 110.109 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.424 ' O ' ' C ' ' A' ' 7' ' ' GLY . 1.8 p -80.87 -109.75 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.229 -0.92 . . . . 0.0 109.682 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 22' ' ' TRP . . . 45.7 26.44 1.82 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 108.781 -1.727 . . . . 0.0 108.781 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.544 ' CZ ' ' HA3' ' A' ' 86' ' ' GLY . 30.9 t80 -53.74 132.23 40.81 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.526 -0.985 . . . . 0.0 110.112 -179.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 5.2 t0 -165.22 153.83 11.97 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.537 ' CB ' ' HG2' ' A' ' 88' ' ' GLN . 2.1 p -136.44 139.03 42.09 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.047 -1.033 . . . . 0.0 109.696 -179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.471 ' O ' ' HB ' ' A' ' 19' ' ' THR . 17.8 p -160.12 -165.6 1.51 Allowed 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.249 -0.907 . . . . 0.0 109.579 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.556 ' HB2' ' CB ' ' A' ' 19' ' ' THR . 10.0 m-20 42.31 36.21 0.71 Allowed 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 -178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.906 HG22 HG23 ' A' ' 91' ' ' VAL . 26.2 mm -66.32 134.2 30.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 CA-C-O 121.418 0.628 . . . . 0.0 110.367 -178.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.938 HG22 HG12 ' A' ' 117' ' ' VAL . 0.1 OUTLIER -124.73 -179.8 4.66 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 178.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.511 ' CB ' ' HB3' ' A' ' 93' ' ' ASP . . . -72.4 -76.01 0.12 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 120.932 -1.105 . . . . 0.0 109.336 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 2.1 p-10 -76.69 0.78 19.13 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.307 -0.87 . . . . 0.0 109.648 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.694 ' HB2' HG22 ' A' ' 60' ' ' THR . 3.6 t -150.47 162.47 40.52 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.246 -0.909 . . . . 0.0 109.139 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.904 ' CE1' HG22 ' A' ' 20' ' ' VAL . 7.7 p90 -166.69 139.87 3.81 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.556 ' CB ' ' HB2' ' A' ' 12' ' ' ASP . 23.6 m -83.02 158.74 22.38 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.738 -1.226 . . . . 0.0 111.447 -178.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.904 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.5 t -136.89 166.58 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 178.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.503 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 14.2 m-70 -148.53 165.43 31.24 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.898 -1.126 . . . . 0.0 110.416 -179.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.836 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 39.4 p90 -177.13 140.93 0.31 Allowed 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 179.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.508 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.31 167.54 2.28 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 O-C-N 120.932 -1.105 . . . . 0.0 109.376 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.742 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -103.32 168.7 8.36 Favored Pre-proline 0 C--N 1.3 -1.581 0 O-C-N 121.671 -0.643 . . . . 0.0 109.936 -179.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.742 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.5 Cg_endo -78.48 -158.73 0.09 OUTLIER 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.703 2.269 . . . . 0.0 110.347 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.48 28.38 8.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.225 -0.922 . . . . 0.0 109.551 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.708 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -144.73 166.84 16.62 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.222 -0.924 . . . . 0.0 109.547 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.708 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.5 Cg_endo -78.25 89.88 1.31 Allowed 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.633 2.222 . . . . 0.0 110.42 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.951 HD11 ' CZ ' ' A' ' 32' ' ' TYR . 11.7 pt -87.83 -172.09 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.198 -0.938 . . . . 0.0 109.457 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 2.8 p -112.33 -5.8 14.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.197 -0.94 . . . . 0.0 109.563 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 137.06 172.35 12.49 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.951 ' CZ ' HD11 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -120.83 144.27 48.43 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -1.148 . . . . 0.0 109.375 179.937 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.547 HG23 ' HG3' ' A' ' 49' ' ' ARG . 22.6 mm -82.1 101.81 7.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.212 -0.93 . . . . 0.0 109.594 179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.777 HD13 ' N ' ' A' ' 34' ' ' ILE . 1.5 mm -83.42 105.35 13.0 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 O-C-N 121.345 -0.847 . . . . 0.0 109.715 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.59 ' O ' HG13 ' A' ' 70' ' ' VAL . 0.6 OUTLIER -102.94 155.37 18.4 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.117 -0.989 . . . . 0.0 108.757 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.699 ' CE1' HD22 ' A' ' 62' ' ' LEU . 23.7 p80 -144.93 136.6 25.49 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.983 -1.073 . . . . 0.0 110.04 -179.658 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.588 ' HA ' ' HB3' ' A' ' 45' ' ' PRO . 27.9 p-80 -167.73 129.79 1.54 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.273 -0.892 . . . . 0.0 109.882 179.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.483 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -58.66 -172.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.401 -0.812 . . . . 0.0 109.436 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -94.64 -10.93 30.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.241 -0.912 . . . . 0.0 109.517 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -128.87 11.12 6.06 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.376 -0.828 . . . . 0.0 109.278 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.479 ' HB2' ' HD3' ' A' ' 45' ' ' PRO . 9.9 p -82.09 176.84 9.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.342 -0.849 . . . . 0.0 109.562 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.83 HG22 ' N ' ' A' ' 43' ' ' GLY . 0.6 OUTLIER -142.54 -91.27 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.217 -0.927 . . . . 0.0 109.729 -179.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.83 ' N ' HG22 ' A' ' 42' ' ' VAL . . . -89.12 -21.39 42.11 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.604 ' N ' ' CD ' ' A' ' 45' ' ' PRO . 2.1 mmp_? -51.07 -46.92 88.46 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.292 -1.123 . . . . 0.0 110.481 179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 44' ' ' ARG . 36.2 Cg_endo -77.51 154.98 31.7 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.06 1.84 . . . . 0.0 110.434 -179.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.531 ' HG2' ' NE2' ' A' ' 36' ' ' HIS . 6.2 ptm180 -139.77 -165.49 1.89 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.272 -0.892 . . . . 0.0 109.798 -179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.505 ' HB3' ' HG3' ' A' ' 35' ' ' ARG . 3.8 pt20 -113.16 130.23 56.27 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.409 -0.807 . . . . 0.0 109.436 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.504 ' C ' ' CD ' ' A' ' 49' ' ' ARG . 9.0 m-20 -112.91 158.27 20.41 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.547 ' HG3' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -133.12 157.5 45.15 Favored 'General case' 0 C--N 1.295 -1.789 0 O-C-N 121.398 -0.814 . . . . 0.0 109.872 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 1.098 ' CG1' HD12 ' A' ' 57' ' ' ILE . 27.0 m -143.02 159.71 55.27 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.434 -0.791 . . . . 0.0 109.247 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.536 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 35.3 Cg_endo -77.6 173.93 13.43 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.567 2.178 . . . . 0.0 110.517 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 35.6 Cg_endo -77.86 -15.49 14.98 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.674 2.25 . . . . 0.0 110.518 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.3 t -97.8 18.41 15.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.237 -0.914 . . . . 0.0 109.493 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.536 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 15.4 mmm180 -127.31 109.35 11.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.241 -0.912 . . . . 0.0 109.802 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.471 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 13.3 p-10 -94.81 -7.12 41.28 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.219 -0.925 . . . . 0.0 109.199 179.432 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 42.0 p -134.56 130.62 36.81 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.42 -0.8 . . . . 0.0 108.987 179.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.098 HD12 ' CG1' ' A' ' 50' ' ' VAL . 1.5 tt -132.06 143.42 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.143 -0.973 . . . . 0.0 109.795 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.514 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 16.8 m -102.63 125.7 49.46 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.295 -0.878 . . . . 0.0 109.328 179.883 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.96 ' CB ' HD11 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -91.13 153.73 19.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.28 -0.888 . . . . 0.0 109.329 179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.694 HG22 ' HB2' ' A' ' 17' ' ' SER . 13.8 p -139.51 -178.79 5.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.309 -0.869 . . . . 0.0 109.462 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 16.8 m-20 54.69 27.38 8.63 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.18 -0.95 . . . . 0.0 109.364 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.96 HD11 ' CB ' ' A' ' 59' ' ' LEU . 2.1 mt -105.46 148.16 27.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.289 -0.882 . . . . 0.0 109.121 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -49.33 130.21 17.51 Favored Pre-proline 0 N--CA 1.488 1.467 0 O-C-N 121.106 -0.996 . . . . 0.0 108.525 179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.1 Cg_endo -76.85 129.18 10.54 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.33 2.02 . . . . 0.0 110.756 -179.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 69.8 63.87 3.16 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.447 -1.861 . . . . 0.0 108.447 -179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.404 ' O ' ' N ' ' A' ' 90' ' ' THR . 2.4 m -156.86 152.01 26.28 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.339 -1.095 . . . . 0.0 110.486 -178.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.6 OUTLIER -78.6 124.44 28.16 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.463 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.517 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 2.2 m-85 -119.19 119.42 34.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.983 -1.073 . . . . 0.0 110.319 -178.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.574 ' HB ' ' CE1' ' A' ' 37' ' ' HIS . 16.3 t -78.67 122.37 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 108.367 -0.975 . . . . 0.0 108.367 178.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.59 HG13 ' O ' ' A' ' 35' ' ' ARG . 2.8 t -107.08 136.35 42.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 O-C-N 121.11 -0.994 . . . . 0.0 110.188 -178.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.526 ' OG ' ' CB ' ' A' ' 35' ' ' ARG . 10.5 p -110.91 108.43 18.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.363 -0.836 . . . . 0.0 109.67 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.814 ' C ' HD12 ' A' ' 73' ' ' ILE . 17.1 mm -91.87 110.1 22.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.267 -0.896 . . . . 0.0 109.959 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.814 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.5 mp -113.96 153.33 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.16 -0.962 . . . . 0.0 109.092 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.919 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -112.71 145.46 40.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.199 -0.938 . . . . 0.0 109.527 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.464 ' O ' ' OG1' ' A' ' 30' ' ' THR . 0.9 OUTLIER -147.13 142.19 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 0.0 109.294 179.947 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.664 ' OD1' HD21 ' A' ' 2' ' ' LEU . 0.1 OUTLIER -112.96 50.13 0.9 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.214 -0.929 . . . . 0.0 109.472 179.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.41 -59.19 3.69 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.527 ' N ' ' HD2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -130.36 0.16 4.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.291 -1.123 . . . . 0.0 109.63 179.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.484 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 7.3 mt-10 -100.9 -164.7 1.13 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.193 -0.942 . . . . 0.0 109.365 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 20.2 mt-10 -151.03 -170.44 3.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.184 -0.948 . . . . 0.0 109.592 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.919 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -167.74 -178.08 0.6 Allowed Pre-proline 0 N--CA 1.489 1.486 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 -179.842 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.595 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.7 Cg_endo -76.67 142.56 23.09 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.126 1.884 . . . . 0.0 110.151 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.4 Cg_endo -77.56 129.97 10.47 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.678 2.252 . . . . 0.0 110.967 -179.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.554 HD22 ' O ' ' A' ' 5' ' ' PRO . 22.3 tp -120.13 84.04 2.15 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.38 -0.825 . . . . 0.0 109.01 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 70' ' ' VAL . 3.0 mt -94.67 152.8 3.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.344 0 O-C-N 121.208 -0.933 . . . . 0.0 109.954 -179.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.544 ' HA3' ' CZ ' ' A' ' 8' ' ' PHE . . . -143.95 -172.45 14.7 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.511 ' HG3' HG13 ' A' ' 69' ' ' VAL . 9.8 mt-30 -138.26 131.01 29.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.189 -1.183 . . . . 0.0 109.766 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.537 ' HG2' ' CB ' ' A' ' 10' ' ' SER . 0.0 OUTLIER -141.32 -152.0 0.39 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.257 -0.902 . . . . 0.0 108.962 179.696 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -165.28 145.54 7.01 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.878 -1.139 . . . . 0.0 110.59 -179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.461 ' CG2' ' O ' ' A' ' 15' ' ' ALA . 0.1 OUTLIER -84.85 142.43 29.74 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 179.342 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.098 HG11 ' CB ' ' A' ' 116' ' ' ALA . 1.9 t -61.87 176.84 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.416 -0.802 . . . . 0.0 109.307 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.589 ' H ' HG12 ' A' ' 91' ' ' VAL . 0.0 OUTLIER -106.68 106.79 17.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.164 -0.96 . . . . 0.0 109.645 179.94 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.511 ' HB3' ' CB ' ' A' ' 15' ' ' ALA . 7.5 p30 -78.82 -35.15 44.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.141 -0.974 . . . . 0.0 109.08 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.781 HG23 ' HD2' ' A' ' 95' ' ' PRO . 8.8 mt -58.53 144.36 79.22 Favored Pre-proline 0 C--N 1.303 -1.434 0 O-C-N 121.371 -0.831 . . . . 0.0 109.205 179.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.993 ' HG3' HD11 ' A' ' 162' ' ' LEU . 33.9 Cg_endo -76.08 74.6 4.48 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.271 1.98 . . . . 0.0 109.886 179.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 13.9 tpp85 -61.76 158.86 14.74 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.538 -0.726 . . . . 0.0 109.516 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.9 OUTLIER 80.1 17.17 0.71 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.559 -0.713 . . . . 0.0 109.507 -179.922 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.875 ' O ' HG21 ' A' ' 180' ' ' ILE . 26.7 tp -60.51 100.07 0.09 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.228 -0.92 . . . . 0.0 108.918 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -140.56 -171.75 3.29 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.206 -0.934 . . . . 0.0 109.173 -179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 109' ' ' LEU . 35.3 t -126.41 150.53 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.16 -0.963 . . . . 0.0 110.014 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.704 HG12 HD12 ' A' ' 109' ' ' LEU . 3.0 pt -121.21 -14.43 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.475 -0.766 . . . . 0.0 109.505 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.876 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -134.08 133.42 41.11 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.517 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.8 p -122.73 81.91 1.92 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.033 -1.042 . . . . 0.0 110.374 -179.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.542 HG21 ' OG ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -73.76 163.52 67.82 Favored Pre-proline 0 C--N 1.305 -1.365 0 O-C-N 121.147 -0.971 . . . . 0.0 108.51 179.177 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.492 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 29.7 Cg_endo -68.56 -2.32 9.05 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.4 2.066 . . . . 0.0 110.777 -179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.879 ' C ' HG22 ' A' ' 152' ' ' ILE . 17.1 p -155.38 21.55 0.41 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.326 -0.859 . . . . 0.0 108.684 178.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 1.069 ' O ' HD23 ' A' ' 108' ' ' LEU . 49.6 p -173.24 158.88 3.71 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 119.287 -0.965 . . . . 0.0 109.467 179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.069 HD23 ' O ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -143.91 151.82 40.31 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.149 -0.969 . . . . 0.0 109.514 -179.569 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 1.065 HD13 ' N ' ' A' ' 110' ' ' ILE . 2.8 tm? -86.9 144.76 26.83 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.433 -0.792 . . . . 0.0 109.091 179.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 1.065 ' N ' HD13 ' A' ' 109' ' ' LEU . 0.6 OUTLIER -127.09 150.71 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.083 -1.011 . . . . 0.0 109.953 -179.699 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.6 t -156.1 139.99 16.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.45 -0.782 . . . . 0.0 109.32 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.617 ' CD1' ' HB3' ' A' ' 95' ' ' PRO . 28.5 p90 -150.63 160.69 43.65 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.211 -0.931 . . . . 0.0 109.512 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.474 ' HG3' ' HB2' ' A' ' 97' ' ' ASP . 59.4 mt-10 -74.2 146.63 84.72 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.194 -0.941 . . . . 0.0 109.498 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.445 ' HA ' ' HD3' ' A' ' 115' ' ' PRO . 35.8 Cg_endo -78.72 141.12 17.03 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.586 2.19 . . . . 0.0 110.416 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.469 ' CB ' ' HA ' ' A' ' 93' ' ' ASP . 35.1 Cg_endo -78.45 173.0 14.38 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.582 2.188 . . . . 0.0 110.571 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 1.098 ' CB ' HG11 ' A' ' 91' ' ' VAL . . . -96.19 25.42 4.9 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.289 -0.882 . . . . 0.0 109.371 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.938 HG12 HG22 ' A' ' 14' ' ' THR . 3.7 m -134.93 158.09 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.256 -0.903 . . . . 0.0 109.492 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.5 ' O ' HG22 ' A' ' 119' ' ' VAL . 4.2 m -70.47 164.75 24.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.91 . . . . 0.0 109.391 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.575 ' HA ' HG22 ' A' ' 166' ' ' THR . 1.5 t -156.16 134.17 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.278 -0.889 . . . . 0.0 109.506 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.535 ' CG ' ' O ' ' A' ' 166' ' ' THR . 0.1 OUTLIER -78.3 -45.48 22.62 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.162 -0.961 . . . . 0.0 108.871 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.687 ' CE2' HG22 ' A' ' 139' ' ' THR . 3.2 p90 -165.21 -177.21 4.44 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.269 -0.894 . . . . 0.0 109.887 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 1.6 m-85 -141.01 142.7 34.21 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.539 ' CD ' ' HB2' ' A' ' 163' ' ' TYR . 0.0 OUTLIER -113.63 106.56 14.66 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.012 -1.055 . . . . 0.0 109.413 179.885 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.646 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 20.2 mt -84.62 164.99 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.355 -0.84 . . . . 0.0 109.141 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.917 HG22 ' HG2' ' A' ' 137' ' ' GLU . 3.0 p -135.39 140.83 45.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.238 -0.914 . . . . 0.0 110.105 -179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 1.209 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 3.6 m-30 -85.9 124.01 31.89 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.686 -0.857 . . . . 0.0 108.686 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.625 ' HA3' ' HB ' ' A' ' 159' ' ' THR . . . -95.05 112.11 4.32 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 19.2 mt-10 -107.35 134.14 50.85 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.228 -1.16 . . . . 0.0 109.295 179.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.739 HG21 ' HB3' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -82.47 -85.69 0.11 Allowed 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.052 -1.03 . . . . 0.0 109.648 179.912 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -84.5 45.49 3.51 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.445 ' O ' ' OG ' ' A' ' 133' ' ' SER . . . -93.43 -14.24 53.98 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 48.85 23.87 0.75 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -1.15 . . . . 0.0 109.343 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.445 ' OG ' ' O ' ' A' ' 131' ' ' GLY . 0.0 OUTLIER -131.81 171.74 8.59 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.322 -0.861 . . . . 0.0 109.41 -179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 133' ' ' SER . 35.3 Cg_endo -78.27 132.88 11.65 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.62 2.213 . . . . 0.0 110.432 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.492 ' HB ' ' O ' ' A' ' 126' ' ' TYR . 3.3 m -45.97 165.26 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.331 0 O-C-N 121.229 -0.919 . . . . 0.0 109.596 179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.529 ' HB3' ' HB2' ' A' ' 126' ' ' TYR . 1.5 tt0 -112.48 117.12 31.51 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.143 -0.973 . . . . 0.0 109.117 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.917 ' HG2' HG22 ' A' ' 125' ' ' THR . 0.5 OUTLIER -105.18 119.23 38.53 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.128 -0.983 . . . . 0.0 110.808 -179.045 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.646 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 26.5 p90 -118.89 149.49 41.48 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 178.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.687 HG22 ' CE2' ' A' ' 121' ' ' TYR . 1.3 p -73.97 -174.03 1.74 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.008 -1.057 . . . . 0.0 110.879 -177.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.661 HG13 ' HD2' ' A' ' 141' ' ' PRO . 55.7 t -153.0 141.16 13.78 Favored Pre-proline 0 N--CA 1.488 1.443 0 O-C-N 121.239 -0.913 . . . . 0.0 109.715 -179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.661 ' HD2' HG13 ' A' ' 140' ' ' VAL . 36.0 Cg_endo -78.5 128.88 9.02 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.396 2.064 . . . . 0.0 110.052 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -81.96 47.28 3.66 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 5.3 p -105.42 -2.48 23.73 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.202 -1.175 . . . . 0.0 109.747 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -166.2 170.03 13.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.142 -0.974 . . . . 0.0 109.683 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.05 21.2 8.0 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.321 -0.862 . . . . 0.0 109.642 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.565 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 70.0 p -139.01 152.32 47.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.175 -0.953 . . . . 0.0 109.504 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.483 ' C ' ' CG1' ' A' ' 110' ' ' ILE . . . -144.13 -164.29 1.86 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.213 -0.93 . . . . 0.0 109.239 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.639 HG22 ' N ' ' A' ' 149' ' ' ILE . 20.9 m -146.21 165.77 28.2 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.221 -0.924 . . . . 0.0 109.736 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 1.209 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 0.9 OUTLIER -138.89 111.87 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.367 -0.833 . . . . 0.0 109.109 -179.887 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.465 ' HA ' ' CB ' ' A' ' 107' ' ' SER . 13.6 m-80 -109.62 177.5 4.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.328 -0.858 . . . . 0.0 109.369 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 30.0 m120 54.97 69.41 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 0.0 108.998 -179.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.879 HG22 ' C ' ' A' ' 106' ' ' THR . 9.2 tt -129.34 163.86 33.39 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.385 -0.822 . . . . 0.0 109.897 -178.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.471 ' N ' HG12 ' A' ' 152' ' ' ILE . 0.3 OUTLIER -94.37 110.77 50.6 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.234 -0.916 . . . . 0.0 109.177 179.665 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 152' ' ' ILE . 35.7 Cg_endo -78.35 153.37 27.53 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.4 2.067 . . . . 0.0 110.638 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.566 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 74.99 64.07 2.4 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.566 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 171.37 131.79 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.254 -1.145 . . . . 0.0 109.659 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.739 ' HB3' HG21 ' A' ' 129' ' ' THR . 0.9 OUTLIER -53.78 133.9 42.3 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 179.266 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.606 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -116.22 177.28 4.74 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.904 -1.123 . . . . 0.0 110.23 -179.069 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.625 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 1.8 m -143.53 98.55 3.27 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.482 ' HB ' HG13 ' A' ' 180' ' ' ILE . 32.9 mm -84.94 125.45 40.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.933 -1.104 . . . . 0.0 110.213 -178.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.623 HG23 ' CB ' ' A' ' 179' ' ' SER . 1.4 m -133.29 170.5 15.36 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.993 HD11 ' HG3' ' A' ' 95' ' ' PRO . 0.9 OUTLIER -167.79 150.68 5.86 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.792 -1.192 . . . . 0.0 111.048 -179.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.6 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 1.2 m-85 -124.45 119.92 30.55 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -85.12 116.13 23.31 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.877 -1.139 . . . . 0.0 109.226 179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.57 ' HB ' ' CE1' ' A' ' 121' ' ' TYR . 53.2 t -93.96 134.19 32.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 109.99 -179.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.575 HG22 ' HA ' ' A' ' 119' ' ' VAL . 0.7 OUTLIER -112.88 -39.26 4.3 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.467 -0.771 . . . . 0.0 109.37 179.757 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.433 ' O ' ' HA ' ' A' ' 172' ' ' PRO . . . -101.01 139.37 14.36 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -142.35 58.33 1.46 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.224 -1.162 . . . . 0.0 109.529 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -160.09 -118.23 0.49 Allowed Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -86.32 12.7 9.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.217 -1.166 . . . . 0.0 109.47 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 73.7 m -164.49 69.52 1.51 Allowed Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.217 -0.927 . . . . 0.0 109.391 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.433 ' HA ' ' O ' ' A' ' 167' ' ' GLY . 35.6 Cg_endo -78.0 107.27 2.31 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.713 2.275 . . . . 0.0 110.464 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -105.39 166.69 10.25 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.899 . . . . 0.0 109.538 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 175' ' ' SER . 0.6 OUTLIER -160.27 122.48 3.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.262 -0.899 . . . . 0.0 109.441 -179.936 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 174' ' ' SER . 0.7 OUTLIER -54.39 -169.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.205 -0.934 . . . . 0.0 109.011 179.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.557 ' HG2' HD11 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -80.98 145.89 58.0 Favored Pre-proline 0 C--N 1.304 -1.386 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 179.543 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.6 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 34.7 Cg_endo -77.21 139.12 18.59 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.474 2.116 . . . . 0.0 111.042 -179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.619 ' CG2' HG21 ' A' ' 94' ' ' ILE . 2.2 t -113.48 139.14 40.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.623 ' CB ' HG23 ' A' ' 161' ' ' THR . 0.4 OUTLIER -130.48 136.0 48.54 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.226 -0.921 . . . . 0.0 110.17 -179.282 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.875 HG21 ' O ' ' A' ' 98' ' ' LEU . 9.8 pt -125.16 152.08 31.41 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 179.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 29.5 m-20 -85.32 160.6 19.78 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.126 -0.984 . . . . 0.0 109.634 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.882 ' OH ' HD22 ' A' ' 108' ' ' LEU . 66.8 t80 -159.25 116.47 2.71 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.254 -0.904 . . . . 0.0 109.437 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 11.7 ttmm -84.81 113.16 21.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.227 -0.92 . . . . 0.0 109.549 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.704 HG22 ' CE2' ' A' ' 182' ' ' TYR . 21.6 p . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.489 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.414 ' O ' ' HG ' ' A' ' 2' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.307 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.83 HD12 ' O ' ' A' ' 80' ' ' GLU . 94.7 mt -152.53 143.93 23.33 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.225 -1.161 . . . . 0.0 109.435 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 28.5 m-20 -75.05 167.04 22.7 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.312 -0.868 . . . . 0.0 109.447 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.536 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 22.7 t -94.82 124.15 55.52 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.176 -0.952 . . . . 0.0 109.639 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 1.023 ' O ' HD22 ' A' ' 84' ' ' LEU . 35.6 Cg_endo -78.78 83.76 2.18 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.437 2.091 . . . . 0.0 110.161 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.448 ' HA ' ' CD1' ' A' ' 84' ' ' LEU . 1.9 p -75.92 -109.85 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.236 -0.915 . . . . 0.0 109.607 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.477 ' O ' ' HA ' ' A' ' 22' ' ' TRP . . . 45.46 26.16 1.53 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 -179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.411 ' N ' ' C ' ' A' ' 6' ' ' THR . 22.5 t80 -55.25 121.09 8.1 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.519 -0.989 . . . . 0.0 109.958 -179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 1.0 OUTLIER -149.26 103.42 3.31 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.425 -0.797 . . . . 0.0 108.853 179.665 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.501 ' HB3' ' NE2' ' A' ' 88' ' ' GLN . 3.8 p -84.54 124.78 31.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 109.586 -179.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 19' ' ' THR . 3.6 p -155.34 -162.17 1.3 Allowed 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.202 -0.936 . . . . 0.0 109.32 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.566 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.9 OUTLIER 44.9 38.15 2.77 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 -178.796 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.113 HG22 HG22 ' A' ' 91' ' ' VAL . 2.3 mt -88.12 141.31 14.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 CA-C-O 121.81 0.814 . . . . 0.0 111.417 -177.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.642 ' C ' HG23 ' A' ' 91' ' ' VAL . 1.5 p -127.43 156.87 41.4 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.84 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -58.95 -36.9 75.57 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.009 -1.057 . . . . 0.0 110.26 -178.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.513 ' O ' ' CB ' ' A' ' 17' ' ' SER . 0.5 OUTLIER -112.36 38.17 2.81 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.562 -1.336 . . . . 0.0 109.3 179.878 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.614 ' HA ' HD12 ' A' ' 62' ' ' LEU . 1.4 t 160.65 155.65 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.897 ' CB ' HG23 ' A' ' 13' ' ' ILE . 5.1 p90 -165.88 152.09 9.37 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.624 -1.298 . . . . 0.0 109.886 -179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.968 ' OG1' HG23 ' A' ' 58' ' ' THR . 25.4 m -109.09 153.6 23.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.766 -1.209 . . . . 0.0 110.86 -178.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.784 HG22 ' HE1' ' A' ' 18' ' ' PHE . 0.7 OUTLIER -118.43 169.43 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.431 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.536 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 17.7 m-70 -143.71 157.57 44.3 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.177 -0.952 . . . . 0.0 109.79 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.607 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 32.4 p90 -164.64 146.63 8.36 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.304 -0.873 . . . . 0.0 109.392 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.504 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.7 167.48 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.127 -0.983 . . . . 0.0 109.273 179.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.502 ' N ' ' CG1' ' A' ' 23' ' ' VAL . . . -95.9 160.8 29.32 Favored Pre-proline 0 C--N 1.299 -1.63 0 O-C-N 121.584 -0.698 . . . . 0.0 109.541 -179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.489 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 36.0 Cg_endo -79.16 160.28 26.53 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.6 2.2 . . . . 0.0 110.377 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.423 ' HB2' ' OD2' ' A' ' 3' ' ' ASP . 1.2 mtm-85 -84.02 46.34 1.18 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.923 . . . . 0.0 109.487 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.91 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -158.31 173.32 5.1 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.265 -0.897 . . . . 0.0 109.374 -179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.91 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.8 Cg_endo -78.35 136.14 13.94 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.586 2.191 . . . . 0.0 110.445 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.639 ' CD1' ' CE2' ' A' ' 32' ' ' TYR . 21.0 pt -140.93 -170.39 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.236 -0.915 . . . . 0.0 109.493 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.616 HG23 HD22 ' A' ' 76' ' ' ASN . 46.2 p -132.44 2.44 3.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.25 -0.906 . . . . 0.0 109.584 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.5 -168.58 28.5 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.639 ' CE2' ' CD1' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -146.29 133.38 20.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.267 -1.137 . . . . 0.0 109.516 -179.936 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.876 ' C ' HD13 ' A' ' 34' ' ' ILE . 0.7 OUTLIER -87.29 123.57 40.15 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 O-C-N 121.179 -0.951 . . . . 0.0 108.766 179.581 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.011 HG23 ' CD1' ' A' ' 72' ' ' ILE . 1.1 mm -109.37 158.25 9.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.244 -0.91 . . . . 0.0 109.167 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.756 ' O ' HG13 ' A' ' 70' ' ' VAL . 50.7 ttp180 -155.49 146.62 22.58 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 108.558 -0.905 . . . . 0.0 108.558 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.537 ' NE2' ' HD2' ' A' ' 46' ' ' ARG . 1.1 p80 -128.9 151.99 49.04 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.926 -1.109 . . . . 0.0 109.964 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.628 ' CE1' ' CG1' ' A' ' 69' ' ' VAL . 55.9 p-80 -170.4 108.81 0.35 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.268 -0.895 . . . . 0.0 109.743 179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -45.92 160.26 0.06 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.244 -0.91 . . . . 0.0 109.447 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.502 ' HG2' HG23 ' A' ' 69' ' ' VAL . 1.0 OUTLIER -69.28 -8.4 45.74 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.229 -0.919 . . . . 0.0 109.56 -179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 18.0 m-70 -108.23 18.05 21.53 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.306 -0.871 . . . . 0.0 109.516 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 37' ' ' HIS . 62.7 p -159.98 100.93 1.42 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.204 -0.935 . . . . 0.0 109.773 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 42' ' ' VAL . 9.8 p -130.97 5.06 1.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.311 -0.868 . . . . 0.0 109.397 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.542 ' C ' ' HD3' ' A' ' 45' ' ' PRO . . . -78.4 -53.49 4.72 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 -179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.585 ' CD ' ' N ' ' A' ' 44' ' ' ARG . 0.0 OUTLIER -122.29 62.66 16.35 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.079 -1.247 . . . . 0.0 110.712 -179.87 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.542 ' HD3' ' C ' ' A' ' 43' ' ' GLY . 36.9 Cg_endo -77.85 155.57 30.64 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.393 2.062 . . . . 0.0 110.062 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.537 ' HD2' ' NE2' ' A' ' 36' ' ' HIS . 1.0 OUTLIER -97.29 149.86 21.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.015 -1.053 . . . . 0.0 109.417 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -106.98 120.28 41.65 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.368 -0.832 . . . . 0.0 110.124 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 1.029 ' HB3' HD11 ' A' ' 57' ' ' ILE . 6.6 m-20 -102.48 117.98 35.88 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 178.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.717 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.1 155.25 17.23 Favored 'General case' 0 C--N 1.299 -1.616 0 O-C-N 121.095 -1.003 . . . . 0.0 110.054 -179.223 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.88 HG11 ' HB ' ' A' ' 57' ' ' ILE . 15.1 m -136.09 158.99 72.68 Favored Pre-proline 0 N--CA 1.488 1.447 0 O-C-N 121.478 -0.764 . . . . 0.0 109.199 -179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.52 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.3 Cg_endo -76.49 174.08 13.43 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.552 2.168 . . . . 0.0 110.302 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.546 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 35.5 Cg_endo -77.17 -15.97 15.89 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.606 2.204 . . . . 0.0 110.448 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 53.3 p -97.86 8.47 44.67 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.284 -0.885 . . . . 0.0 109.442 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.52 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.3 OUTLIER -115.74 106.21 13.61 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.206 -0.934 . . . . 0.0 109.759 -179.742 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -85.46 -2.58 58.27 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.168 -0.958 . . . . 0.0 109.245 179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 61.4 p -137.96 144.62 41.28 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.31 -0.868 . . . . 0.0 109.119 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.029 HD11 ' HB3' ' A' ' 48' ' ' ASP . 8.0 tt -118.58 127.73 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.112 -0.993 . . . . 0.0 109.792 -179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.968 HG23 ' OG1' ' A' ' 19' ' ' THR . 0.3 OUTLIER -90.31 113.95 25.91 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.411 -0.806 . . . . 0.0 109.458 179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.794 HD13 ' CZ ' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -84.86 147.75 26.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.217 -0.927 . . . . 0.0 109.43 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.455 ' HA ' ' HB2' ' A' ' 17' ' ' SER . 0.9 OUTLIER -126.41 154.19 43.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.237 -0.914 . . . . 0.0 109.63 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.959 ' O ' HD23 ' A' ' 62' ' ' LEU . 1.1 m-80 61.85 79.57 0.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.362 -0.836 . . . . 0.0 109.595 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.959 HD23 ' O ' ' A' ' 61' ' ' ASN . 6.0 mt -143.33 134.68 26.04 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.293 -0.879 . . . . 0.0 109.449 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 15.8 t-20 -55.05 130.63 67.78 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.254 -0.904 . . . . 0.0 109.043 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.84 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 36.4 Cg_endo -78.1 128.36 9.02 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.389 2.059 . . . . 0.0 110.692 -179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.49 ' HA3' ' OG ' ' A' ' 92' ' ' SER . . . 82.14 58.65 2.42 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.275 -1.53 . . . . 0.0 109.275 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.424 ' O ' ' N ' ' A' ' 90' ' ' THR . 2.5 m -157.28 143.37 17.78 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.31 -1.112 . . . . 0.0 109.22 -179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.535 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 3.2 mt-10 -74.41 130.28 39.36 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.027 -1.046 . . . . 0.0 108.793 179.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 38' ' ' ALA . 4.1 m-85 -121.5 101.17 7.45 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.16 -0.962 . . . . 0.0 110.046 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.628 ' CG1' ' CE1' ' A' ' 37' ' ' HIS . 58.9 t -67.98 130.08 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 179.067 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.756 HG13 ' O ' ' A' ' 35' ' ' ARG . 47.0 t -126.0 136.97 59.21 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 120.993 -1.067 . . . . 0.0 109.962 -179.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.522 ' CB ' HG12 ' A' ' 85' ' ' ILE . 92.3 p -111.53 123.86 51.09 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 110.146 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.011 ' CD1' HG23 ' A' ' 34' ' ' ILE . 11.6 mm -100.65 131.86 47.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.373 -0.829 . . . . 0.0 109.621 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.954 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.7 mp -126.14 164.12 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.327 -0.858 . . . . 0.0 108.919 179.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.884 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -128.36 141.88 51.29 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.284 -0.885 . . . . 0.0 109.595 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.6 m -135.41 134.13 52.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.343 -0.848 . . . . 0.0 109.347 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.681 ' HB2' HD11 ' A' ' 2' ' ' LEU . 2.9 t-20 -108.93 46.46 0.97 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.266 -0.896 . . . . 0.0 109.522 -179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 87.03 -80.39 1.74 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.52 -1.97 13.99 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.179 -1.189 . . . . 0.0 109.6 -179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.483 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 1.3 mp0 -100.62 -165.75 1.24 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.251 -0.906 . . . . 0.0 109.27 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.83 ' O ' HD12 ' A' ' 2' ' ' LEU . 23.7 mt-10 -146.58 -168.66 3.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.205 -0.934 . . . . 0.0 109.665 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.884 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -159.37 -179.17 1.03 Allowed Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.396 -0.815 . . . . 0.0 108.983 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.588 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.4 Cg_endo -77.36 141.93 20.72 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.23 1.954 . . . . 0.0 109.943 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.4 Cg_endo -77.71 88.83 1.38 Allowed 'Trans proline' 0 C--N 1.308 -1.558 0 C-N-CA 122.524 2.15 . . . . 0.0 111.038 -179.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 1.023 HD22 ' O ' ' A' ' 5' ' ' PRO . 4.6 tp -75.08 104.11 5.53 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 179.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.572 HG22 ' N ' ' A' ' 86' ' ' GLY . 2.5 mt -105.0 163.27 4.33 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 O-C-N 121.095 -1.003 . . . . 0.0 110.375 -179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.572 ' N ' HG22 ' A' ' 85' ' ' ILE . . . -159.36 159.24 30.3 Favored Glycine 0 N--CA 1.485 1.949 0 N-CA-C 108.481 -1.847 . . . . 0.0 108.481 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . 29.5 mt-30 -117.76 131.29 56.61 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.185 -1.185 . . . . 0.0 109.815 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.628 ' OE1' HG21 ' A' ' 70' ' ' VAL . 3.6 pt20 -136.37 -165.59 1.75 Allowed 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.535 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -154.74 146.57 23.42 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.025 -1.047 . . . . 0.0 109.75 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.424 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.91 132.94 41.82 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.543 -0.863 . . . . 0.0 108.91 179.563 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.113 HG22 HG22 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -47.09 136.4 2.97 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.826 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 179.57 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.49 ' OG ' ' HA3' ' A' ' 65' ' ' GLY . 1.5 t -107.27 151.88 24.86 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 109.621 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 6.6 p-10 -48.19 -25.34 1.46 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.208 -0.932 . . . . 0.0 108.846 179.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.87 HG23 ' HD2' ' A' ' 95' ' ' PRO . 2.6 mt -107.15 147.9 36.03 Favored Pre-proline 0 C--N 1.305 -1.353 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.87 ' HD2' HG23 ' A' ' 94' ' ' ILE . 30.6 Cg_endo -72.03 59.16 2.91 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 121.783 1.655 . . . . 0.0 109.375 178.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.477 ' O ' ' HB2' ' A' ' 97' ' ' ASP . 17.9 ttt180 -60.27 177.09 0.29 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-O 121.389 0.614 . . . . 0.0 110.387 -179.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.502 ' HB3' ' HA ' ' A' ' 112' ' ' TRP . 0.7 OUTLIER 66.4 24.79 10.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.513 -0.742 . . . . 0.0 109.256 -179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 1.097 HD21 ' CD1' ' A' ' 162' ' ' LEU . 0.2 OUTLIER -61.61 102.45 0.25 Allowed 'General case' 0 C--N 1.304 -1.387 0 O-C-N 121.349 -0.844 . . . . 0.0 109.531 179.855 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.474 ' HG2' ' O ' ' A' ' 97' ' ' ASP . 3.8 pt-20 -153.78 171.57 18.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.233 -0.917 . . . . 0.0 109.209 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.522 HG13 ' O ' ' A' ' 109' ' ' LEU . 40.2 t -115.1 155.87 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 O-C-N 121.157 -0.964 . . . . 0.0 109.747 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.961 HD11 HD23 ' A' ' 109' ' ' LEU . 0.8 OUTLIER -127.91 -7.39 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.46 -0.775 . . . . 0.0 109.821 -179.771 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.767 ' HB3' ' CB ' ' A' ' 109' ' ' LEU . . . -136.47 122.13 19.73 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.527 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.4 p -112.62 75.66 0.93 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.092 -1.005 . . . . 0.0 110.415 -179.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.566 ' OG1' ' N ' ' A' ' 107' ' ' SER . 0.7 OUTLIER -74.0 159.59 83.73 Favored Pre-proline 0 C--N 1.304 -1.393 0 O-C-N 121.15 -0.969 . . . . 0.0 108.622 179.225 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.453 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.1 Cg_endo -69.04 -1.85 8.62 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.493 2.129 . . . . 0.0 111.003 -178.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.898 ' C ' HG22 ' A' ' 152' ' ' ILE . 70.7 p -152.33 19.13 0.65 Allowed 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.266 -0.896 . . . . 0.0 108.893 178.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.97 ' C ' HD23 ' A' ' 108' ' ' LEU . 6.8 p -173.71 147.54 1.39 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.024 -1.071 . . . . 0.0 110.144 179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.97 HD23 ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -124.29 154.72 39.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.404 -0.81 . . . . 0.0 109.294 179.821 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.961 HD23 HD11 ' A' ' 101' ' ' ILE . 13.0 tp -105.22 107.16 17.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.269 -0.894 . . . . 0.0 108.731 179.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.713 ' CD1' ' HB3' ' A' ' 147' ' ' ALA . 1.4 pt -85.8 129.48 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.221 -0.924 . . . . 0.0 110.262 -179.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.609 ' HA ' HG22 ' A' ' 146' ' ' THR . 1.3 p -126.32 123.28 37.68 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.582 ' CE3' ' O ' ' A' ' 145' ' ' SER . 19.3 p90 -152.64 -175.73 5.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.947 -1.095 . . . . 0.0 110.464 -178.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.581 ' O ' ' HA ' ' A' ' 95' ' ' PRO . 45.2 mm-40 -105.56 100.49 26.84 Favored Pre-proline 0 N--CA 1.488 1.441 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 178.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.981 ' O ' HG12 ' A' ' 91' ' ' VAL . 34.0 Cg_endo -73.24 165.47 32.54 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.5 2.133 . . . . 0.0 111.364 -178.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.55 ' HB3' ' O ' ' A' ' 93' ' ' ASP . 37.3 Cg_endo -81.98 85.61 1.67 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.76 2.307 . . . . 0.0 110.416 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.953 ' HB3' HG21 ' A' ' 91' ' ' VAL . . . -69.54 61.04 0.15 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.069 -1.019 . . . . 0.0 108.563 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.522 ' N ' ' O ' ' A' ' 115' ' ' PRO . 0.2 OUTLIER -133.72 -162.39 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -179.585 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 7.8 m -68.91 70.99 0.21 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.883 -1.136 . . . . 0.0 109.207 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.957 ' HA ' HG22 ' A' ' 166' ' ' THR . 2.6 t -107.5 142.89 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.306 -0.871 . . . . 0.0 109.839 -179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.547 ' CD ' ' HG2' ' A' ' 168' ' ' ARG . 0.0 OUTLIER -89.98 -51.67 5.35 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 179.225 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.753 ' CZ ' HG21 ' A' ' 165' ' ' VAL . 13.6 p90 -165.74 -168.71 1.36 Allowed 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.508 -0.745 . . . . 0.0 109.53 -179.731 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.624 ' N ' ' CD2' ' A' ' 121' ' ' TYR . 0.2 OUTLIER -140.19 137.53 34.42 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.134 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.486 ' CB ' ' HB2' ' A' ' 163' ' ' TYR . 5.8 ttt180 -95.64 101.92 13.67 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.271 -0.893 . . . . 0.0 109.089 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.871 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 19.7 mt -85.35 117.64 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.209 -0.932 . . . . 0.0 109.013 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 43.3 p -93.55 130.11 39.54 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.413 -0.804 . . . . 0.0 110.488 -179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 1.014 ' O ' HG12 ' A' ' 135' ' ' VAL . 3.0 m-85 -81.35 122.78 27.89 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.564 -0.71 . . . . 0.0 109.15 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.602 ' HA3' ' HB ' ' A' ' 159' ' ' THR . . . -102.32 99.18 1.82 Allowed Glycine 0 N--CA 1.488 2.11 0 N-CA-C 110.109 -1.196 . . . . 0.0 110.109 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.492 ' HG2' ' CZ ' ' A' ' 158' ' ' TYR . 7.4 mt-10 -107.36 89.86 3.12 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.16 -1.2 . . . . 0.0 109.474 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.436 ' OG1' ' O ' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -72.51 145.07 47.75 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.029 -1.045 . . . . 0.0 109.605 179.826 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 161.17 -77.79 0.17 Allowed Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.75 -1.34 . . . . 0.0 109.75 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -114.94 45.26 1.33 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 50.53 23.34 1.27 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.221 -1.164 . . . . 0.0 109.502 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.438 ' CB ' ' HD2' ' A' ' 134' ' ' PRO . 0.1 OUTLIER -55.52 171.93 0.32 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.491 -179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.438 ' HD2' ' CB ' ' A' ' 133' ' ' SER . 35.8 Cg_endo -78.58 177.22 8.99 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.674 2.249 . . . . 0.0 110.434 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 1.014 HG12 ' O ' ' A' ' 126' ' ' TYR . 0.1 OUTLIER -105.53 144.89 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 0.0 109.303 -180.0 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.558 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 1.9 tt0 -102.61 98.49 8.54 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.221 -0.924 . . . . 0.0 108.939 179.539 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 4.8 pt-20 -92.25 137.13 32.62 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.146 -0.971 . . . . 0.0 110.762 -178.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.871 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 43.4 p90 -134.79 147.48 49.98 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.691 HG22 ' CE2' ' A' ' 121' ' ' TYR . 3.7 p -74.17 171.07 14.24 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.111 -0.993 . . . . 0.0 111.013 -177.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.611 HG21 HG13 ' A' ' 124' ' ' ILE . 25.1 t -143.19 140.45 17.82 Favored Pre-proline 0 N--CA 1.488 1.433 0 O-C-N 121.423 -0.798 . . . . 0.0 110.102 -178.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.561 ' HD2' HG13 ' A' ' 140' ' ' VAL . 36.4 Cg_endo -79.94 142.34 15.57 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.475 2.117 . . . . 0.0 110.201 179.367 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.449 ' HA2' ' OH ' ' A' ' 122' ' ' TYR . . . -84.06 45.76 3.54 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.59 -81.46 0.54 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -1.152 . . . . 0.0 110.096 -179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -78.98 157.67 28.09 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.545 0.688 . . . . 0.0 110.271 -179.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.582 ' O ' ' CE3' ' A' ' 112' ' ' TRP . 0.1 OUTLIER -95.38 -3.17 47.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.473 -0.767 . . . . 0.0 109.577 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.609 HG22 ' HA ' ' A' ' 111' ' ' SER . 7.1 p -116.63 142.04 47.41 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.713 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -134.51 150.88 50.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.876 -1.14 . . . . 0.0 110.06 -179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 6.9 t -96.17 146.4 24.71 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.367 -0.833 . . . . 0.0 109.028 179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.695 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 19.2 mm -126.07 73.18 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.233 -0.917 . . . . 0.0 109.513 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.536 ' HA ' ' CB ' ' A' ' 107' ' ' SER . 4.9 m-80 -79.22 -165.03 0.7 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.711 -0.618 . . . . 0.0 109.597 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 25.2 m120 57.93 20.65 6.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.057 -1.027 . . . . 0.0 109.017 -179.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.898 HG22 ' C ' ' A' ' 106' ' ' THR . 3.5 tt -89.69 161.04 2.71 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 O-C-N 121.478 -0.764 . . . . 0.0 109.67 -179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.58 122.89 40.44 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.166 -0.959 . . . . 0.0 109.221 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.488 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 36.3 Cg_endo -77.73 145.3 22.82 Favored 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.439 2.093 . . . . 0.0 110.563 -179.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.654 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 81.12 65.69 1.67 Allowed Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.654 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 167.14 130.16 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.146 -1.208 . . . . 0.0 109.748 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.436 ' O ' ' OG1' ' A' ' 129' ' ' THR . 2.0 t70 -50.34 165.78 0.09 Allowed 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.613 ' CE2' HG13 ' A' ' 152' ' ' ILE . 0.2 OUTLIER -144.53 173.07 12.12 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.804 -1.185 . . . . 0.0 110.248 -179.66 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.602 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 1.8 m -147.59 99.34 3.1 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.58 HD11 HD12 ' A' ' 108' ' ' LEU . 88.1 mt -97.39 129.62 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.701 -1.249 . . . . 0.0 109.403 -179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 1.004 HG23 ' CB ' ' A' ' 179' ' ' SER . 1.7 m -133.8 139.2 46.15 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.099 -1.001 . . . . 0.0 110.428 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 1.097 ' CD1' HD21 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -110.79 145.6 37.86 Favored 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.529 -0.732 . . . . 0.0 110.478 -179.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.633 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 37.8 m-85 -131.33 83.73 2.12 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 109.26 -0.645 . . . . 0.0 109.26 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.538 ' HB2' ' HD2' ' A' ' 122' ' ' TYR . . . -63.73 123.25 18.39 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.128 -0.983 . . . . 0.0 109.726 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.753 HG21 ' CZ ' ' A' ' 121' ' ' TYR . 5.3 t -104.32 129.18 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.261 -0.899 . . . . 0.0 109.452 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.957 HG22 ' HA ' ' A' ' 119' ' ' VAL . 21.0 p -120.0 -52.25 2.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.405 -0.81 . . . . 0.0 109.617 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.468 ' O ' ' HG3' ' A' ' 168' ' ' ARG . . . -42.66 157.32 0.09 OUTLIER Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.876 -1.29 . . . . 0.0 109.876 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.547 ' HG2' ' CD ' ' A' ' 120' ' ' ARG . 3.3 mpt_? -141.5 106.06 4.87 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.309 -1.112 . . . . 0.0 109.489 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 162.13 -155.47 26.76 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.326 -1.509 . . . . 0.0 109.326 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -75.05 -2.05 25.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -1.15 . . . . 0.0 109.426 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 22.4 m -147.64 82.68 7.92 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.257 -0.902 . . . . 0.0 109.209 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.55 104.62 1.91 Allowed 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.533 2.155 . . . . 0.0 110.397 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -85.78 129.86 34.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.307 -0.871 . . . . 0.0 109.376 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.528 ' CB ' ' O ' ' A' ' 164' ' ' ALA . 1.7 p -108.5 133.92 51.98 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.274 -0.891 . . . . 0.0 109.405 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.455 ' O ' ' O ' ' A' ' 174' ' ' SER . 0.9 OUTLIER -44.6 167.9 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.22 -0.925 . . . . 0.0 108.995 179.773 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.572 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -47.98 133.4 11.8 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.987 -1.071 . . . . 0.0 108.491 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.633 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.8 Cg_endo -76.57 157.23 36.24 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.121 1.881 . . . . 0.0 110.324 -179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -140.35 137.04 37.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.317 -0.864 . . . . 0.0 108.829 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 1.004 ' CB ' HG23 ' A' ' 161' ' ' THR . 0.1 OUTLIER -126.73 -178.6 4.44 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 110.512 -178.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.905 ' CG2' HD12 ' A' ' 98' ' ' LEU . 27.8 pt -158.14 152.3 6.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -95.72 151.6 19.22 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.056 -1.028 . . . . 0.0 109.475 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.657 ' CD2' HD13 ' A' ' 108' ' ' LEU . 70.7 t80 -147.11 131.26 17.35 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.271 -0.893 . . . . 0.0 109.4 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -103.82 119.65 39.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.084 -1.01 . . . . 0.0 109.524 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.488 ' HB ' ' HA ' ' A' ' 154' ' ' PRO . 18.4 p . . . . . 0 N--CA 1.49 1.566 0 CA-C-O 118.007 -0.997 . . . . 0.0 109.46 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 2' ' ' LEU . 1.1 mp -139.15 -164.03 1.59 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.251 -1.147 . . . . 0.0 109.425 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.547 ' HB2' ' CB ' ' A' ' 25' ' ' PRO . 1.1 m-20 -94.17 144.06 25.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.302 -0.874 . . . . 0.0 109.338 179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.552 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 10.3 m -78.15 145.33 68.88 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.26 -0.9 . . . . 0.0 109.509 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.822 ' O ' HD13 ' A' ' 84' ' ' LEU . 35.7 Cg_endo -78.52 125.77 7.1 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.68 2.253 . . . . 0.0 110.336 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.447 ' CG2' HD13 ' A' ' 84' ' ' LEU . 0.7 OUTLIER -143.35 -164.96 1.97 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -0.905 . . . . 0.0 109.988 179.73 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.415 ' O ' ' C ' ' A' ' 8' ' ' PHE . . . 83.13 16.89 68.37 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 107.691 -2.163 . . . . 0.0 107.691 -178.102 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.415 ' C ' ' O ' ' A' ' 7' ' ' GLY . 2.4 t80 -40.49 140.32 0.67 Allowed 'General case' 0 N--CA 1.485 1.308 0 O-C-N 121.794 -0.827 . . . . 0.0 110.28 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 21' ' ' HIS . 15.1 t0 -165.26 97.68 0.71 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 179.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.627 ' OG ' HG13 ' A' ' 20' ' ' VAL . 5.4 m -84.59 128.44 34.6 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.159 -0.963 . . . . 0.0 109.651 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.494 ' O ' ' C ' ' A' ' 12' ' ' ASP . 3.5 p -146.87 -164.74 2.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.327 -0.858 . . . . 0.0 109.026 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.513 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.8 OUTLIER 41.61 35.92 0.52 Allowed 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 107.641 -1.244 . . . . 0.0 107.641 -178.935 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.807 HG23 ' CB ' ' A' ' 18' ' ' PHE . 2.3 mt -78.73 144.53 10.96 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.202 -177.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.597 HG23 ' O ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -123.5 -157.69 0.77 Allowed 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 178.379 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.993 ' HB1' ' HB3' ' A' ' 64' ' ' PRO . . . -93.2 -48.65 6.36 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.887 -1.133 . . . . 0.0 109.167 179.618 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 15.2 p30 -99.63 -9.12 23.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.043 -1.036 . . . . 0.0 109.155 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.597 ' O ' HG23 ' A' ' 14' ' ' THR . 27.4 p -142.62 159.53 42.06 Favored 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.884 ' CE1' HG22 ' A' ' 20' ' ' VAL . 9.9 p90 -166.13 142.16 4.92 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.911 -1.118 . . . . 0.0 109.435 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.513 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 17.1 m -81.33 153.76 26.86 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.897 -1.127 . . . . 0.0 110.773 -178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.884 HG22 ' CE1' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -132.18 116.98 30.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 179.52 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.547 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 3.1 m-70 -103.07 161.95 13.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.053 -1.03 . . . . 0.0 110.34 -179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.678 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 23.4 p90 -171.42 137.47 1.09 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.484 -0.76 . . . . 0.0 109.083 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.44 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 0.9 OUTLIER -74.35 163.14 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 O-C-N 121.073 -1.017 . . . . 0.0 109.652 -179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.874 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -98.62 173.45 3.86 Favored Pre-proline 0 C--N 1.299 -1.63 0 O-C-N 121.713 -0.617 . . . . 0.0 109.733 -179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.874 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.8 Cg_endo -78.42 -162.18 0.17 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.644 2.229 . . . . 0.0 110.307 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.515 ' HB2' ' NH2' ' A' ' 26' ' ' ARG . 0.5 OUTLIER -119.55 18.53 12.76 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.168 -0.957 . . . . 0.0 109.426 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.89 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -121.83 172.7 4.76 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 121.283 -0.886 . . . . 0.0 109.489 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.89 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.7 Cg_endo -78.0 88.25 1.45 Allowed 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.653 2.236 . . . . 0.0 110.421 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.772 HD13 ' HE1' ' A' ' 32' ' ' TYR . 9.1 pt -80.12 -176.89 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.293 -0.879 . . . . 0.0 109.498 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.453 ' OG1' ' N ' ' A' ' 77' ' ' GLY . 59.6 p -131.72 -2.14 3.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -0.947 . . . . 0.0 109.929 -179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.499 ' O ' ' CD1' ' A' ' 32' ' ' TYR . . . 162.51 -178.56 38.24 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.784 -1.327 . . . . 0.0 109.784 179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.772 ' HE1' HD13 ' A' ' 29' ' ' ILE . 1.7 m-85 -149.53 131.66 15.39 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.215 -1.168 . . . . 0.0 109.732 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.998 HG23 ' HD2' ' A' ' 49' ' ' ARG . 0.9 OUTLIER -99.38 130.4 48.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.274 -0.892 . . . . 0.0 108.897 179.826 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.991 HD13 ' C ' ' A' ' 33' ' ' ILE . 1.4 mm -117.57 119.34 61.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.013 -1.054 . . . . 0.0 109.985 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.464 ' HB2' ' OG ' ' A' ' 71' ' ' SER . 34.8 mtp180 -119.35 138.91 52.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.19 -0.944 . . . . 0.0 108.508 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.753 ' CD2' HD22 ' A' ' 59' ' ' LEU . 8.4 p80 -129.88 160.26 34.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.905 -1.122 . . . . 0.0 110.688 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.52 ' HB3' ' HB3' ' A' ' 45' ' ' PRO . 28.6 p-80 -171.86 121.9 0.49 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.617 -0.677 . . . . 0.0 109.332 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.132 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . -50.58 -178.62 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.177 -0.952 . . . . 0.0 109.554 -179.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -79.14 -95.12 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.227 -0.92 . . . . 0.0 109.403 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -100.32 28.96 4.6 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.308 -0.87 . . . . 0.0 109.586 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.586 ' OG ' ' HB3' ' A' ' 38' ' ' ALA . 6.0 p -75.87 -161.9 0.19 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.191 -0.943 . . . . 0.0 109.462 -179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.449 HG22 ' O ' ' A' ' 42' ' ' VAL . 8.0 p -127.32 -1.22 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.199 -0.938 . . . . 0.0 109.602 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -66.4 141.62 41.16 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.411 ' HA ' ' HD3' ' A' ' 45' ' ' PRO . 17.8 mtm180 -72.61 140.92 82.02 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.227 -1.161 . . . . 0.0 109.417 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.52 ' HB3' ' HB3' ' A' ' 37' ' ' HIS . 36.3 Cg_endo -78.94 112.34 3.08 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.546 2.164 . . . . 0.0 110.423 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.586 ' CG ' ' NE2' ' A' ' 36' ' ' HIS . 0.7 OUTLIER -95.09 160.9 14.35 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -0.937 . . . . 0.0 109.356 179.799 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -109.94 103.52 12.3 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.341 -0.849 . . . . 0.0 109.881 -179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 1.05 ' HB3' HD11 ' A' ' 57' ' ' ILE . 70.8 m-20 -93.93 115.93 28.34 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.282 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.998 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -97.27 156.72 16.31 Favored 'General case' 0 C--N 1.298 -1.673 0 O-C-N 121.109 -0.995 . . . . 0.0 109.87 -179.47 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.671 HG11 ' HB ' ' A' ' 57' ' ' ILE . 15.8 m -141.9 160.54 55.38 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.404 -0.81 . . . . 0.0 109.113 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.549 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 34.4 Cg_endo -77.11 174.18 13.23 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.466 2.111 . . . . 0.0 110.03 179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 35.3 Cg_endo -77.54 -15.42 15.56 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.443 2.096 . . . . 0.0 110.516 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 14.9 t -99.23 18.45 17.53 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.206 -0.934 . . . . 0.0 109.576 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.549 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -125.86 119.08 26.87 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.236 -0.915 . . . . 0.0 109.799 -179.88 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 22' ' ' TRP . 0.8 OUTLIER -103.48 -0.39 29.96 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.321 -0.862 . . . . 0.0 109.283 179.543 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.486 ' HA ' ' HA ' ' A' ' 21' ' ' HIS . 30.8 p -131.08 129.94 42.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.294 -0.879 . . . . 0.0 109.462 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.05 HD11 ' HB3' ' A' ' 48' ' ' ASP . 4.4 tt -125.05 140.12 49.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.254 -0.904 . . . . 0.0 109.361 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.48 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 8.8 m -102.75 136.68 42.13 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.264 -0.897 . . . . 0.0 109.302 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.753 HD22 ' CD2' ' A' ' 36' ' ' HIS . 1.1 mp -115.16 161.0 19.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.225 -0.922 . . . . 0.0 109.637 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.44 HG22 ' HB3' ' A' ' 17' ' ' SER . 23.5 p -139.12 -170.32 2.85 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.402 -0.811 . . . . 0.0 109.344 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.494 ' O ' HD23 ' A' ' 62' ' ' LEU . 50.8 m-20 51.93 54.62 10.57 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.195 -0.941 . . . . 0.0 109.51 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.636 ' CD2' ' CE1' ' A' ' 36' ' ' HIS . 6.8 mt -129.27 169.93 14.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.207 -0.933 . . . . 0.0 109.473 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 11.8 m-20 -84.64 142.83 40.13 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.263 -0.898 . . . . 0.0 109.3 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.993 ' HB3' ' HB1' ' A' ' 15' ' ' ALA . 36.9 Cg_endo -78.78 122.29 5.37 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.556 2.171 . . . . 0.0 110.395 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.542 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 75.12 62.49 2.75 Favored Glycine 0 N--CA 1.487 2.089 0 N-CA-C 108.113 -1.995 . . . . 0.0 108.113 -179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.605 ' CG2' ' CE2' ' A' ' 68' ' ' TYR . 1.3 m -149.17 144.76 26.8 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.309 -1.112 . . . . 0.0 110.899 -178.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.556 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.9 OUTLIER -81.38 105.63 12.71 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.468 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 1.132 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 13.5 m-85 -103.91 150.52 24.11 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.27 -0.894 . . . . 0.0 109.979 -179.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.584 HG13 ' HB3' ' A' ' 87' ' ' GLN . 4.1 t -109.75 154.98 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.321 -0.862 . . . . 0.0 109.193 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.598 HG22 ' CB ' ' A' ' 36' ' ' HIS . 40.9 t -139.51 129.02 29.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.126 -0.984 . . . . 0.0 109.709 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 85' ' ' ILE . 79.2 p -103.18 101.18 11.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 0.0 109.862 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.965 HD13 HG23 ' A' ' 34' ' ' ILE . 10.9 mm -74.98 153.12 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.094 -1.004 . . . . 0.0 109.702 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.572 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 15.5 mt -143.3 158.68 17.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 O-C-N 121.383 -0.823 . . . . 0.0 108.892 179.382 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.647 ' HB2' ' CZ ' ' A' ' 32' ' ' TYR . . . -131.21 153.02 49.91 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.437 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 9.9 m -141.12 135.61 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.0 109.389 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.512 ' HB3' ' HB2' ' A' ' 79' ' ' GLU . 1.1 t30 -110.72 43.66 1.39 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.268 -0.895 . . . . 0.0 109.513 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.453 ' N ' ' OG1' ' A' ' 30' ' ' THR . . . 77.25 -57.1 3.67 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -126.19 -2.96 6.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.25 -1.147 . . . . 0.0 109.737 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.512 ' HB2' ' HB3' ' A' ' 76' ' ' ASN . 0.5 OUTLIER -110.07 177.02 4.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.571 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -147.78 95.43 2.5 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.32 -0.863 . . . . 0.0 109.434 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.587 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.7 OUTLIER -59.64 -179.05 0.15 Allowed Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.275 -0.891 . . . . 0.0 109.084 179.883 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.587 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.5 Cg_endo -77.71 146.28 23.72 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.277 1.985 . . . . 0.0 110.365 -179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 36.1 Cg_endo -77.93 100.99 1.43 Allowed 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.675 2.25 . . . . 0.0 110.896 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.822 HD13 ' O ' ' A' ' 5' ' ' PRO . 4.1 tp -75.0 103.83 5.34 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 1.9 mt -93.98 143.52 11.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 120.887 -1.133 . . . . 0.0 110.636 -178.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -148.11 -163.22 10.61 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 108.64 -1.784 . . . . 0.0 108.64 179.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.584 ' HB3' HG13 ' A' ' 69' ' ' VAL . 8.2 pt20 -166.78 164.96 16.55 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.997 -1.296 . . . . 0.0 110.038 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.564 ' HG3' ' CE1' ' A' ' 18' ' ' PHE . 1.9 pm0 -159.73 151.43 20.2 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.556 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -90.94 136.67 32.92 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.153 -0.967 . . . . 0.0 110.431 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.474 ' O ' ' O ' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -74.45 134.27 42.35 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 179.144 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.751 HG23 HG22 ' A' ' 13' ' ' ILE . 9.4 t -41.98 169.26 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 CA-C-O 121.574 0.702 . . . . 0.0 110.599 -179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.547 ' N ' HG12 ' A' ' 91' ' ' VAL . 8.1 t -102.97 158.13 16.5 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.344 -0.848 . . . . 0.0 109.839 -179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.897 ' OD2' HG21 ' A' ' 117' ' ' VAL . 2.9 t70 -86.63 -33.4 20.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.443 -0.786 . . . . 0.0 110.527 -179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.857 HD11 ' CB ' ' A' ' 176' ' ' LYS . 2.5 mt -55.64 139.77 67.88 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 120.804 -1.185 . . . . 0.0 109.716 -179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.646 ' HD2' HG23 ' A' ' 94' ' ' ILE . 36.5 Cg_endo -80.89 78.05 3.81 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 C-N-CA 122.571 2.181 . . . . 0.0 109.496 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.52 ' O ' ' N ' ' A' ' 113' ' ' GLU . 0.0 OUTLIER -76.07 177.19 7.3 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.318 -0.864 . . . . 0.0 109.677 -179.366 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.497 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.4 OUTLIER 76.28 19.57 1.7 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.346 -0.846 . . . . 0.0 109.64 179.875 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.779 HD13 HG23 ' A' ' 180' ' ' ILE . 0.5 OUTLIER -62.21 99.95 0.15 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.121 -0.987 . . . . 0.0 109.029 179.743 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.483 ' HG2' ' O ' ' A' ' 97' ' ' ASP . 0.1 OUTLIER -144.64 163.74 33.04 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.201 -0.937 . . . . 0.0 109.715 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.418 HG21 ' HB3' ' A' ' 108' ' ' LEU . 9.6 p -104.05 148.75 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.291 -0.881 . . . . 0.0 109.548 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.735 HD11 HD22 ' A' ' 109' ' ' LEU . 25.1 pt -125.44 -5.46 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.275 -0.891 . . . . 0.0 109.589 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 1.042 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -150.49 108.46 3.72 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.371 -0.831 . . . . 0.0 108.783 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.521 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 1.7 t -101.7 93.95 5.6 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.191 -0.943 . . . . 0.0 110.229 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.542 ' OG1' ' N ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -80.01 164.28 53.58 Favored Pre-proline 0 C--N 1.3 -1.56 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 179.339 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.489 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 30.1 Cg_endo -69.18 -2.95 10.66 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.425 2.083 . . . . 0.0 110.748 -179.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.835 ' C ' HG22 ' A' ' 152' ' ' ILE . 7.5 p -152.48 19.24 0.63 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 178.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.988 ' O ' HD23 ' A' ' 108' ' ' LEU . 54.5 p -172.89 160.4 4.32 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.144 -1.022 . . . . 0.0 109.96 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.988 HD23 ' O ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -135.52 155.33 50.67 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.354 -0.841 . . . . 0.0 108.947 179.86 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 1.042 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.4 OUTLIER -105.04 95.41 5.83 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.239 -0.913 . . . . 0.0 109.346 179.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.779 HD11 ' HB3' ' A' ' 147' ' ' ALA . 15.7 pt -74.88 167.82 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.242 -0.911 . . . . 0.0 109.927 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.484 ' HA ' ' HA ' ' A' ' 146' ' ' THR . 3.7 m -165.34 100.41 0.72 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.634 -0.666 . . . . 0.0 109.365 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.58 ' CD1' ' HB2' ' A' ' 95' ' ' PRO . 41.3 p90 -111.4 141.77 44.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.279 -0.888 . . . . 0.0 109.207 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 96' ' ' ARG . 11.3 mm-40 -48.84 145.52 6.21 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.168 -0.957 . . . . 0.0 109.352 -179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.471 ' HD2' ' OE1' ' A' ' 113' ' ' GLU . 35.2 Cg_endo -77.63 138.79 17.46 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.411 2.074 . . . . 0.0 109.987 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.51 ' CG ' HG21 ' A' ' 119' ' ' VAL . 35.8 Cg_endo -77.79 141.58 19.44 Favored 'Trans proline' 0 C--N 1.308 -1.594 0 C-N-CA 122.35 2.033 . . . . 0.0 110.115 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.538 ' HB1' ' CA ' ' A' ' 14' ' ' THR . . . -87.01 42.52 1.03 Allowed 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.328 -0.858 . . . . 0.0 109.452 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.897 HG21 ' OD2' ' A' ' 93' ' ' ASP . 5.0 m -141.58 178.19 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.331 -0.856 . . . . 0.0 109.491 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 68.8 m -90.27 96.6 10.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.267 -0.896 . . . . 0.0 109.126 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.977 ' HA ' HG22 ' A' ' 166' ' ' THR . 1.5 t -100.08 133.51 42.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.241 -0.912 . . . . 0.0 109.811 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.549 ' HD3' HG12 ' A' ' 165' ' ' VAL . 8.8 ptm85 -75.21 -46.1 36.13 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.256 -0.903 . . . . 0.0 108.873 179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.89 ' CZ ' HG21 ' A' ' 165' ' ' VAL . 2.7 p90 -165.8 177.16 7.39 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.267 -0.896 . . . . 0.0 109.503 179.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.643 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 1.6 m-85 -134.8 132.91 39.24 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.221 -0.924 . . . . 0.0 109.282 -179.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.485 ' HG2' ' N ' ' A' ' 124' ' ' ILE . 8.7 ttm180 -85.28 159.33 20.08 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.909 -1.12 . . . . 0.0 108.459 179.395 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.811 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 13.9 mt -148.85 119.75 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.033 -1.042 . . . . 0.0 109.779 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.531 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 64.9 p -91.39 128.99 37.43 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.595 -0.691 . . . . 0.0 109.94 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.821 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 2.4 m-85 -74.53 138.59 43.22 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.592 ' HA3' ' HB ' ' A' ' 159' ' ' THR . . . -105.91 89.23 0.6 Allowed Glycine 0 N--CA 1.489 2.198 0 N-CA-C 110.339 -1.104 . . . . 0.0 110.339 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.583 ' HG2' ' CE2' ' A' ' 158' ' ' TYR . 6.8 mt-10 -107.27 138.47 43.4 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.218 -1.166 . . . . 0.0 109.735 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.452 HG21 ' HB3' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -94.39 147.46 23.2 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.182 -0.949 . . . . 0.0 109.299 179.439 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.41 ' O ' ' HG3' ' A' ' 134' ' ' PRO . . . 127.02 103.19 1.25 Allowed Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.915 -1.274 . . . . 0.0 109.915 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 132' ' ' ASN . . . 117.94 -62.24 0.43 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.497 ' OD1' ' N ' ' A' ' 133' ' ' SER . 14.5 p30 169.95 -30.4 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.388 -1.066 . . . . 0.0 109.098 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.497 ' N ' ' OD1' ' A' ' 132' ' ' ASN . 0.6 OUTLIER 167.42 65.33 0.01 OUTLIER Pre-proline 0 C--N 1.297 -1.676 0 O-C-N 121.693 -0.629 . . . . 0.0 109.716 179.778 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.462 ' HG2' ' O ' ' A' ' 128' ' ' GLU . 36.3 Cg_endo -79.58 107.27 2.12 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.574 2.183 . . . . 0.0 109.871 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.542 HG12 ' O ' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -112.69 146.26 17.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.104 -0.998 . . . . 0.0 109.897 -179.496 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.574 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 1.1 mt-30 -124.61 99.92 6.4 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.419 -0.801 . . . . 0.0 108.866 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 0.9 OUTLIER -74.7 155.36 37.8 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.242 -0.911 . . . . 0.0 110.751 -178.94 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.811 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 3.2 p90 -161.4 139.19 9.16 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.845 HG22 ' CE1' ' A' ' 121' ' ' TYR . 2.6 p -74.81 149.74 39.54 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.068 -1.02 . . . . 0.0 111.145 -178.202 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.778 HG13 ' HD2' ' A' ' 141' ' ' PRO . 55.7 t -111.71 145.46 32.7 Favored Pre-proline 0 N--CA 1.488 1.466 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.778 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.8 Cg_endo -77.54 132.23 12.05 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.395 2.063 . . . . 0.0 109.882 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -85.87 37.63 3.07 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.407 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 2.7 m -105.27 -1.46 25.24 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.096 -1.238 . . . . 0.0 109.595 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.407 ' CG ' ' O ' ' A' ' 143' ' ' SER . 12.3 mttp -163.01 172.29 15.22 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.234 -0.917 . . . . 0.0 109.57 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.575 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 5.0 p -95.3 -23.82 17.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.221 -0.925 . . . . 0.0 109.899 -179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.484 ' HA ' ' HA ' ' A' ' 111' ' ' SER . 3.3 p -102.23 163.77 12.05 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.079 -1.013 . . . . 0.0 109.483 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.779 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -153.7 173.34 15.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.95 . . . . 0.0 109.682 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.1 t -104.45 152.39 22.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 109.097 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.821 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 34.0 mm -131.29 73.52 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.137 -0.977 . . . . 0.0 109.49 -179.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.536 ' HA ' ' CB ' ' A' ' 107' ' ' SER . 3.7 m120 -80.7 -146.62 0.05 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.551 -0.718 . . . . 0.0 109.731 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 150' ' ' ASN . 4.9 m120 43.38 26.88 0.11 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -0.936 . . . . 0.0 109.523 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.835 HG22 ' C ' ' A' ' 106' ' ' THR . 4.5 tt -93.37 158.28 2.9 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.319 0 O-C-N 121.281 -0.887 . . . . 0.0 109.549 -179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 153' ' ' LYS . 26.2 mmtt -114.17 120.51 38.37 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.92 . . . . 0.0 109.234 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.525 ' HA ' ' OG1' ' A' ' 184' ' ' THR . 35.4 Cg_endo -78.04 146.31 22.85 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.413 2.075 . . . . 0.0 110.566 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.705 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 93.7 60.0 1.17 Allowed Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.705 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 162.3 131.07 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.411 -1.052 . . . . 0.0 109.41 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.452 ' HB3' HG21 ' A' ' 129' ' ' THR . 24.6 t0 -46.83 166.52 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.594 ' CD1' ' CG2' ' A' ' 184' ' ' THR . 0.2 OUTLIER -145.04 -178.2 5.93 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 120.51 -1.369 . . . . 0.0 110.048 -179.464 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.592 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 2.5 m -157.98 165.23 35.66 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.546 HD11 HD12 ' A' ' 108' ' ' LEU . 22.5 mt -155.27 132.57 2.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.749 -1.22 . . . . 0.0 110.11 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 1.021 HG23 ' CB ' ' A' ' 179' ' ' SER . 1.6 m -136.91 172.09 13.53 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.331 -0.855 . . . . 0.0 108.844 179.231 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.613 HD11 ' HG2' ' A' ' 95' ' ' PRO . 0.6 OUTLIER -163.42 151.55 13.48 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.679 -1.208 . . . . 0.0 111.597 -179.481 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.636 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 4.2 m-85 -125.11 120.79 32.41 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.814 ' HB3' ' OG ' ' A' ' 175' ' ' SER . . . -81.57 99.75 9.0 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.847 -1.158 . . . . 0.0 109.532 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.89 HG21 ' CZ ' ' A' ' 121' ' ' TYR . 18.7 t -78.46 142.98 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -0.898 . . . . 0.0 109.369 179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.977 HG22 ' HA ' ' A' ' 119' ' ' VAL . 1.1 p -136.88 -42.68 0.59 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.394 -0.816 . . . . 0.0 109.732 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.527 ' HA3' ' HA ' ' A' ' 172' ' ' PRO . . . -53.33 -170.38 0.03 OUTLIER Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.405 ' O ' ' HB3' ' A' ' 172' ' ' PRO . 22.1 mtt180 -109.57 -158.22 0.64 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.21 -1.17 . . . . 0.0 109.818 -179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -81.48 -35.49 22.8 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 170' ' ' ASP . 2.4 m-20 -74.71 -1.13 20.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.206 -1.173 . . . . 0.0 109.437 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.431 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 0.8 OUTLIER 168.93 75.16 0.02 OUTLIER Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.282 -0.886 . . . . 0.0 108.963 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.527 ' HA ' ' HA3' ' A' ' 167' ' ' GLY . 35.3 Cg_endo -77.87 175.83 10.73 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.603 2.202 . . . . 0.0 110.339 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 165' ' ' VAL . . . -155.67 130.85 9.44 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.485 -0.759 . . . . 0.0 109.4 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.509 ' HB2' ' HB3' ' A' ' 163' ' ' TYR . 0.7 OUTLIER -112.33 104.71 12.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.23 -0.919 . . . . 0.0 109.507 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.814 ' OG ' ' HB3' ' A' ' 164' ' ' ALA . 0.6 OUTLIER -46.96 166.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.255 -0.903 . . . . 0.0 109.611 179.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.857 ' CB ' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -41.05 127.88 2.03 Favored Pre-proline 0 C--N 1.304 -1.383 0 O-C-N 121.595 -0.691 . . . . 0.0 109.878 179.638 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.636 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.2 Cg_endo -77.43 131.4 11.56 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.022 1.815 . . . . 0.0 110.492 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -114.34 137.48 47.52 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 108.17 -1.048 . . . . 0.0 108.17 179.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 1.021 ' CB ' HG23 ' A' ' 161' ' ' THR . 1.0 OUTLIER -129.53 165.67 21.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.228 -0.92 . . . . 0.0 110.811 -178.406 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.779 HG23 HD13 ' A' ' 98' ' ' LEU . 5.5 pt -144.2 -170.53 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -119.12 169.64 9.76 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.042 -1.036 . . . . 0.0 109.402 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.922 ' OH ' HD22 ' A' ' 108' ' ' LEU . 56.3 t80 -164.63 166.45 20.13 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.163 -0.961 . . . . 0.0 109.428 -179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 3.2 ptmt -147.56 129.14 15.04 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.256 -0.902 . . . . 0.0 109.455 -179.851 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.594 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 1.7 p . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.48 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.625 HD11 ' CB ' ' A' ' 81' ' ' SER . 0.6 OUTLIER -157.21 -163.72 1.45 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.289 -1.124 . . . . 0.0 109.384 179.991 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.565 ' O ' HD12 ' A' ' 2' ' ' LEU . 1.1 m-20 -113.66 146.2 40.15 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.423 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.484 ' OG ' ' HG2' ' A' ' 82' ' ' PRO . 10.8 p -95.4 155.91 38.22 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.212 -0.93 . . . . 0.0 109.595 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.782 ' O ' HD22 ' A' ' 84' ' ' LEU . 36.3 Cg_endo -79.05 110.48 2.76 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.725 2.283 . . . . 0.0 110.128 179.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.426 ' O ' ' N ' ' A' ' 8' ' ' PHE . 1.8 p -97.94 -113.21 0.15 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.131 -0.981 . . . . 0.0 109.472 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.457 ' HA3' ' HB ' ' A' ' 23' ' ' VAL . . . 44.14 27.08 1.02 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 -179.293 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.426 ' N ' ' O ' ' A' ' 6' ' ' THR . 8.7 t80 -58.17 95.07 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.582 -0.952 . . . . 0.0 109.861 -179.325 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.525 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 38.0 t70 -126.82 95.77 4.43 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.344 -0.848 . . . . 0.0 109.055 179.68 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.619 ' OG ' HG13 ' A' ' 20' ' ' VAL . 32.8 m -84.66 135.3 34.23 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.297 -0.877 . . . . 0.0 109.38 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.456 ' O ' ' C ' ' A' ' 12' ' ' ASP . 5.5 p -156.42 -159.78 0.92 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.231 -0.918 . . . . 0.0 109.407 179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.535 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 1.2 m-20 45.96 40.7 7.18 Favored 'General case' 0 N--CA 1.492 1.657 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 -178.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.61 ' HA ' ' HA ' ' A' ' 18' ' ' PHE . 1.5 mt -83.45 129.32 37.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.604 -177.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.594 ' N ' ' O ' ' A' ' 17' ' ' SER . 0.0 OUTLIER -115.91 174.1 6.21 Favored 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 178.194 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.471 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -67.63 -65.1 0.73 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.764 -1.21 . . . . 0.0 109.924 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.467 ' O ' ' OG ' ' A' ' 17' ' ' SER . 6.5 m-80 -86.66 17.15 4.1 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.012 -1.055 . . . . 0.0 110.017 -179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.749 ' HA ' HD12 ' A' ' 62' ' ' LEU . 21.8 m -168.46 156.37 8.18 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.933 ' CE1' HG22 ' A' ' 20' ' ' VAL . 4.3 p90 -165.89 143.05 5.43 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.143 -0.973 . . . . 0.0 109.281 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.535 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 8.5 m -89.55 156.17 18.79 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.849 -1.157 . . . . 0.0 111.293 -178.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.933 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.3 t -132.58 134.34 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.536 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 2.1 m-70 -121.25 166.36 14.12 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.924 -1.11 . . . . 0.0 110.328 -179.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.816 ' CH2' HG21 ' A' ' 50' ' ' VAL . 6.2 p90 -174.12 137.78 0.56 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.477 -0.765 . . . . 0.0 109.189 179.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.469 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -78.75 162.43 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 O-C-N 121.053 -1.029 . . . . 0.0 109.773 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.716 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -86.86 168.71 17.1 Favored Pre-proline 0 C--N 1.3 -1.549 0 O-C-N 121.73 -0.606 . . . . 0.0 109.587 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.716 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 36.3 Cg_endo -79.45 -172.54 1.56 Allowed 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.647 2.232 . . . . 0.0 110.459 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.2 mtt85 -113.87 16.09 18.46 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.306 -0.871 . . . . 0.0 109.3 179.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.99 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -124.55 177.9 1.63 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.341 -0.849 . . . . 0.0 109.26 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.99 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 34.6 Cg_endo -77.84 135.84 14.54 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.476 2.117 . . . . 0.0 110.256 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.501 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 45.9 pt -152.04 -179.13 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.915 . . . . 0.0 109.546 -179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 30.8 p -114.32 -20.89 10.67 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.258 -0.901 . . . . 0.0 109.476 179.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.16 172.1 28.04 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.641 -1.383 . . . . 0.0 109.641 179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.618 ' CE2' ' HA ' ' A' ' 52' ' ' PRO . 0.5 OUTLIER -112.17 150.25 31.08 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.239 -1.154 . . . . 0.0 109.47 -179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.955 HG23 ' HD2' ' A' ' 49' ' ' ARG . 1.4 mp -95.08 137.23 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 O-C-N 121.158 -0.964 . . . . 0.0 108.858 179.522 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.847 HD13 ' C ' ' A' ' 33' ' ' ILE . 3.4 mm -116.94 95.05 3.46 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.355 0 O-C-N 121.4 -0.812 . . . . 0.0 109.937 -179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.507 ' HG3' ' HA ' ' A' ' 47' ' ' GLN . 54.7 ttp180 -106.28 117.01 32.93 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.192 -0.943 . . . . 0.0 108.522 179.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.535 ' NE2' ' HG2' ' A' ' 46' ' ' ARG . 3.1 p-80 -106.69 147.35 29.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.966 -1.084 . . . . 0.0 110.273 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.521 ' NE2' ' HB ' ' A' ' 69' ' ' VAL . 41.3 p-80 -162.05 124.43 2.88 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.45 -0.781 . . . . 0.0 109.577 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.52 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -56.58 -161.4 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.263 -0.898 . . . . 0.0 109.624 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.419 ' HG3' ' HB2' ' A' ' 67' ' ' GLU . 4.1 mm-40 -83.68 -97.17 0.06 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.272 -0.892 . . . . 0.0 109.769 -179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -105.32 -6.71 19.41 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.271 -0.893 . . . . 0.0 109.774 -179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 35.6 p -81.43 116.08 21.07 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.134 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.48 HG22 ' O ' ' A' ' 42' ' ' VAL . 1.5 p -74.91 92.81 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.171 -0.956 . . . . 0.0 109.448 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.546 ' C ' ' HD3' ' A' ' 45' ' ' PRO . . . -105.63 -105.18 3.0 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.165 -1.574 . . . . 0.0 109.165 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.516 ' N ' ' HD3' ' A' ' 45' ' ' PRO . 12.9 mtt180 -122.3 55.93 7.08 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.256 -1.144 . . . . 0.0 110.41 179.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.546 ' HD3' ' C ' ' A' ' 43' ' ' GLY . 35.2 Cg_endo -75.04 81.78 2.15 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 122.204 1.936 . . . . 0.0 110.434 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.535 ' HG2' ' NE2' ' A' ' 36' ' ' HIS . 12.9 ptm180 -105.73 169.72 8.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.246 -0.909 . . . . 0.0 109.531 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.507 ' HA ' ' HG3' ' A' ' 35' ' ' ARG . 0.4 OUTLIER -105.89 114.17 28.16 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.341 -0.849 . . . . 0.0 109.48 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.495 ' O ' ' HD2' ' A' ' 49' ' ' ARG . 19.5 m-20 -107.42 168.81 8.98 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.955 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -136.4 164.07 28.99 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 121.509 -0.744 . . . . 0.0 109.587 -179.524 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.816 HG21 ' CH2' ' A' ' 22' ' ' TRP . 33.5 m -149.56 158.86 37.39 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.421 -0.799 . . . . 0.0 109.295 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 33.9 Cg_endo -75.72 174.25 13.13 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.529 2.153 . . . . 0.0 110.373 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.618 ' HA ' ' CE2' ' A' ' 32' ' ' TYR . 34.3 Cg_endo -76.63 -22.63 11.9 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.574 2.182 . . . . 0.0 110.68 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.95 -8.77 53.52 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.135 -0.978 . . . . 0.0 109.505 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.533 ' HD3' ' N ' ' A' ' 54' ' ' ARG . 1.6 mpt_? -94.78 112.13 23.88 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.291 -0.881 . . . . 0.0 109.593 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.491 ' OD1' ' N ' ' A' ' 55' ' ' ASN . 7.9 p-10 -107.41 -2.29 20.68 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.448 -0.782 . . . . 0.0 109.725 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 27.0 p -136.17 129.83 32.3 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.111 -0.993 . . . . 0.0 109.815 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.608 HG22 ' HZ3' ' A' ' 22' ' ' TRP . 1.9 tt -129.44 120.28 50.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.306 -0.871 . . . . 0.0 109.045 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.449 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 0.3 OUTLIER -88.09 131.43 34.69 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.298 -0.876 . . . . 0.0 109.615 -179.601 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.817 ' HB3' HD11 ' A' ' 62' ' ' LEU . 1.3 mt -104.56 142.63 34.29 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.183 -0.948 . . . . 0.0 109.38 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.469 ' HA ' ' OG ' ' A' ' 17' ' ' SER . 6.7 p -130.02 178.12 6.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.181 -0.949 . . . . 0.0 109.537 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 5.9 m120 54.78 40.95 32.22 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.245 -0.91 . . . . 0.0 109.497 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.817 HD11 ' HB3' ' A' ' 59' ' ' LEU . 4.6 mt -111.94 145.12 40.13 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.231 -0.918 . . . . 0.0 109.301 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.463 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 2.6 m120 -54.63 130.6 64.17 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.113 -0.992 . . . . 0.0 108.681 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.471 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.1 Cg_endo -77.4 125.36 7.66 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 C-N-CA 122.217 1.944 . . . . 0.0 110.642 -179.621 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.556 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 80.46 61.73 2.16 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.61 -1.796 . . . . 0.0 108.61 -179.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.437 ' O ' ' N ' ' A' ' 90' ' ' THR . 3.5 m -152.89 155.85 37.84 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.349 -1.089 . . . . 0.0 110.385 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 2.0 mp0 -85.43 116.95 24.05 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.552 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 9.8 m-85 -112.72 106.88 15.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.121 -0.987 . . . . 0.0 109.898 -179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.521 ' HB ' ' NE2' ' A' ' 37' ' ' HIS . 3.4 t -73.93 133.03 32.46 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.224 -0.923 . . . . 0.0 108.839 179.321 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 19.4 t -122.36 117.72 53.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.096 -1.002 . . . . 0.0 109.837 -179.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.543 ' CB ' HG12 ' A' ' 85' ' ' ILE . 1.8 p -92.84 133.37 36.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.0 110.282 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.501 ' HB ' HD23 ' A' ' 84' ' ' LEU . 21.4 mm -120.74 79.39 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.808 HD13 ' HA ' ' A' ' 83' ' ' PRO . 23.4 mm -76.75 163.87 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.19 -0.943 . . . . 0.0 109.604 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.012 ' HB3' ' OG ' ' A' ' 81' ' ' SER . . . -131.71 117.22 18.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.258 -0.901 . . . . 0.0 109.54 -179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -107.65 173.98 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.289 -0.882 . . . . 0.0 109.283 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.497 ' O ' ' ND2' ' A' ' 76' ' ' ASN . 18.6 t30 -153.33 49.35 0.7 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 109.446 179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 86.69 -80.72 1.73 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.433 ' NH2' ' HG2' ' A' ' 78' ' ' ARG . 0.0 OUTLIER -119.74 -1.95 10.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.246 -1.15 . . . . 0.0 109.59 179.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 1.2 mp0 -90.9 -173.44 3.69 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.371 179.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.477 ' HG3' ' O ' ' A' ' 79' ' ' GLU . 16.8 mt-10 -156.65 93.56 1.39 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.19 -0.943 . . . . 0.0 109.584 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 1.012 ' OG ' ' HB3' ' A' ' 74' ' ' ALA . 0.9 OUTLIER -59.48 178.85 0.22 Allowed Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.316 -0.865 . . . . 0.0 109.014 179.825 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.554 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.4 Cg_endo -76.8 158.16 35.15 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.289 1.992 . . . . 0.0 110.167 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.808 ' HA ' HD13 ' A' ' 73' ' ' ILE . 34.7 Cg_endo -77.15 145.25 24.29 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.621 2.214 . . . . 0.0 111.103 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.782 HD22 ' O ' ' A' ' 5' ' ' PRO . 25.5 tp -136.21 85.97 2.19 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.543 HG12 ' CB ' ' A' ' 71' ' ' SER . 2.3 mt -99.93 139.85 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 O-C-N 121.185 -0.947 . . . . 0.0 109.789 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -128.08 -171.13 12.95 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 108.573 -1.811 . . . . 0.0 108.573 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 10.7 mt-30 -148.59 125.04 10.97 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.14 -1.211 . . . . 0.0 109.691 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.563 ' HG3' ' CB ' ' A' ' 10' ' ' SER . 1.1 tm0? -135.81 114.61 12.02 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.321 -0.862 . . . . 0.0 109.006 179.673 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -74.9 133.53 41.78 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.295 -0.878 . . . . 0.0 110.02 -179.364 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.437 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.15 138.12 43.63 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 179.336 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.938 HG13 ' HB3' ' A' ' 116' ' ' ALA . 1.4 t -50.37 155.09 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.891 ' O ' HG22 ' A' ' 117' ' ' VAL . 1.2 m -114.78 162.38 16.94 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.389 -0.82 . . . . 0.0 109.747 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.93 -45.35 3.33 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.818 HG23 ' HD2' ' A' ' 95' ' ' PRO . 3.1 mt -99.85 145.56 30.37 Favored Pre-proline 0 C--N 1.304 -1.373 0 O-C-N 121.382 -0.824 . . . . 0.0 109.518 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.818 ' HD2' HG23 ' A' ' 94' ' ' ILE . 34.3 Cg_endo -77.28 -161.53 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.319 2.013 . . . . 0.0 109.346 178.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.546 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 1.5 ptm85 -168.44 171.91 8.7 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.072 -1.018 . . . . 0.0 109.575 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.546 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 2.0 t70 79.47 17.86 0.8 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.492 -0.755 . . . . 0.0 109.661 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.818 HD12 ' CG2' ' A' ' 180' ' ' ILE . 0.8 OUTLIER -54.33 87.22 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.323 0 O-C-N 121.225 -0.922 . . . . 0.0 109.486 179.677 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.504 ' N ' ' O ' ' A' ' 97' ' ' ASP . 0.6 OUTLIER -138.89 169.49 17.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.107 -0.996 . . . . 0.0 109.796 -179.748 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 109' ' ' LEU . 7.0 p -102.84 144.01 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.295 -0.878 . . . . 0.0 109.81 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.551 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 6.8 pt -126.1 -4.49 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.367 -0.833 . . . . 0.0 109.266 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.874 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -151.74 88.87 1.43 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.541 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 6.0 p -84.09 93.52 8.14 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.595 -0.69 . . . . 0.0 110.27 -179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.46 ' OG1' ' OG ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -84.42 161.38 54.41 Favored Pre-proline 0 C--N 1.306 -1.297 0 O-C-N 121.127 -0.983 . . . . 0.0 108.949 179.156 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.477 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 30.6 Cg_endo -69.65 -3.04 11.14 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.44 2.093 . . . . 0.0 110.56 -179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.771 ' C ' HG22 ' A' ' 152' ' ' ILE . 37.8 p -151.33 19.1 0.74 Allowed 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 178.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.48 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 1.1 p -170.85 176.22 4.21 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.418 -0.913 . . . . 0.0 109.719 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.875 HD12 ' N ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -154.11 155.91 36.27 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.406 -0.809 . . . . 0.0 109.143 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.874 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.6 OUTLIER -102.33 123.73 46.65 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.248 -0.908 . . . . 0.0 108.572 179.122 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.701 HD13 ' CD1' ' A' ' 149' ' ' ILE . 0.0 OUTLIER -103.21 135.41 40.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.122 -0.987 . . . . 0.0 109.92 -179.33 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.464 ' O ' ' O ' ' A' ' 97' ' ' ASP . 0.4 OUTLIER -131.0 128.57 40.64 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.505 -0.747 . . . . 0.0 108.997 179.63 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.578 ' CD2' ' O ' ' A' ' 145' ' ' SER . 28.2 p90 -151.55 145.36 25.09 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.403 -0.81 . . . . 0.0 109.325 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.474 ' HB2' ' HG2' ' A' ' 96' ' ' ARG . 29.2 mm-40 -81.4 130.48 61.98 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 0.0 109.408 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.466 ' HD3' ' HB3' ' A' ' 145' ' ' SER . 36.4 Cg_endo -78.92 151.22 24.09 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.458 2.105 . . . . 0.0 110.598 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.547 ' HG2' ' CG2' ' A' ' 119' ' ' VAL . 35.4 Cg_endo -78.37 -169.09 0.7 Allowed 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.744 2.296 . . . . 0.0 110.148 179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.938 ' HB3' HG13 ' A' ' 91' ' ' VAL . . . -113.68 -14.49 12.6 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.121 -0.987 . . . . 0.0 109.704 179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.891 HG22 ' O ' ' A' ' 92' ' ' SER . 18.6 m -74.73 165.49 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.212 -0.93 . . . . 0.0 109.083 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.475 ' O ' HG22 ' A' ' 166' ' ' THR . 0.3 OUTLIER -69.5 106.08 2.86 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 0.0 109.684 -179.35 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.591 HG11 ' CZ ' ' A' ' 122' ' ' TYR . 58.2 t -95.26 132.41 39.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.334 -0.854 . . . . 0.0 109.535 179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 165' ' ' VAL . 0.0 OUTLIER -74.55 -64.5 1.02 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.236 -0.915 . . . . 0.0 108.684 179.494 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.998 ' CE1' HG22 ' A' ' 139' ' ' THR . 3.0 p90 -165.42 171.4 13.42 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.456 -0.778 . . . . 0.0 109.01 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.597 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 4.0 m-85 -115.18 145.98 41.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.035 -1.041 . . . . 0.0 109.737 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.6 ' HG2' ' CE1' ' A' ' 121' ' ' TYR . 0.0 OUTLIER -108.39 95.8 5.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.459 -0.776 . . . . 0.0 109.197 179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.882 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 45.1 mt -84.36 145.12 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.213 -0.929 . . . . 0.0 109.315 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.53 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 77.0 p -131.54 144.53 51.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.187 -0.945 . . . . 0.0 110.451 -179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 1.22 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 2.8 m-30 -88.06 132.19 34.38 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.589 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.68 111.35 3.64 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.483 ' O ' ' HB3' ' A' ' 132' ' ' ASN . 14.1 mt-10 -106.16 141.97 36.63 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.263 -1.139 . . . . 0.0 109.45 179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.765 HG21 ' HB3' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -90.16 140.03 30.06 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.999 -1.063 . . . . 0.0 109.776 179.833 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 87.98 93.46 1.01 Allowed Glycine 0 N--CA 1.491 2.35 0 N-CA-C 110.018 -1.233 . . . . 0.0 110.018 179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 51.85 80.11 0.07 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' A' ' 128' ' ' GLU . 3.0 p-10 -134.03 29.06 3.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.282 -1.128 . . . . 0.0 109.735 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.567 ' CB ' ' HD3' ' A' ' 134' ' ' PRO . 0.1 OUTLIER -44.61 -54.05 13.54 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.114 -0.991 . . . . 0.0 109.32 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.567 ' HD3' ' CB ' ' A' ' 133' ' ' SER . 36.4 Cg_endo -79.39 77.18 4.19 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.426 2.084 . . . . 0.0 110.254 179.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 126' ' ' TYR . 3.2 m -66.1 176.93 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.451 0 O-C-N 121.266 -0.896 . . . . 0.0 109.376 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.601 ' HB3' ' CG ' ' A' ' 126' ' ' TYR . 2.8 tt0 -101.95 103.38 14.02 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.148 -0.97 . . . . 0.0 109.131 179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 18.7 tt0 -102.34 118.48 36.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.328 -0.858 . . . . 0.0 111.076 -178.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.882 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 35.9 p90 -121.92 142.49 50.23 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 178.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.998 HG22 ' CE1' ' A' ' 121' ' ' TYR . 1.5 p -74.15 175.06 7.86 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.966 -1.084 . . . . 0.0 110.834 -178.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.694 HG13 ' HD2' ' A' ' 141' ' ' PRO . 53.7 t -144.35 142.73 20.07 Favored Pre-proline 0 C--N 1.304 -1.392 0 O-C-N 121.553 -0.717 . . . . 0.0 109.321 -179.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.694 ' HD2' HG13 ' A' ' 140' ' ' VAL . 35.2 Cg_endo -77.34 148.73 27.06 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.454 2.103 . . . . 0.0 110.331 179.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.06 17.88 39.31 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 2.4 p -105.25 27.81 7.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.242 -1.151 . . . . 0.0 109.613 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -164.99 139.01 4.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.177 -0.952 . . . . 0.0 109.585 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.578 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 1.3 p -92.48 -15.56 26.93 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.289 -0.882 . . . . 0.0 109.404 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 7.5 p -123.12 132.39 54.06 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.292 -0.88 . . . . 0.0 109.185 179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.478 ' HB2' ' HH2' ' A' ' 112' ' ' TRP . . . -120.91 -165.43 1.21 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.23 -0.918 . . . . 0.0 109.239 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.635 HG22 ' N ' ' A' ' 149' ' ' ILE . 23.8 m -145.13 166.08 26.43 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.151 -0.968 . . . . 0.0 109.646 179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 1.22 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 1.2 mt -137.12 121.76 24.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.3 -0.875 . . . . 0.0 109.334 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.478 ' HA ' ' HB3' ' A' ' 107' ' ' SER . 6.8 m-80 -123.2 177.27 5.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.4 -0.812 . . . . 0.0 109.514 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 150' ' ' ASN . 2.7 m-20 65.54 31.43 10.07 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.248 -0.907 . . . . 0.0 109.161 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.771 HG22 ' C ' ' A' ' 106' ' ' THR . 16.2 tt -89.86 166.9 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.397 -0.814 . . . . 0.0 109.714 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 13.0 mtpt -107.14 112.17 63.14 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.231 -0.918 . . . . 0.0 109.445 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.525 ' HA ' ' OG1' ' A' ' 184' ' ' THR . 34.7 Cg_endo -77.26 167.12 25.24 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.454 2.103 . . . . 0.0 110.6 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.69 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 76.73 57.23 3.88 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.69 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 163.55 134.59 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -1.128 . . . . 0.0 109.516 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.765 ' HB3' HG21 ' A' ' 129' ' ' THR . 0.6 OUTLIER -51.49 164.57 0.2 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.093 -1.004 . . . . 0.0 108.443 179.436 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.589 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.4 OUTLIER -142.0 177.06 8.47 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.8 -1.187 . . . . 0.0 110.381 -179.528 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.54 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 2.2 m -147.73 109.66 4.48 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.404 HG23 HD12 ' A' ' 160' ' ' ILE . 21.8 mm -97.59 134.87 34.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.789 -1.194 . . . . 0.0 109.994 -178.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.614 HG23 ' HB3' ' A' ' 179' ' ' SER . 68.8 m -145.11 147.65 32.76 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.283 -0.886 . . . . 0.0 109.717 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.615 HD23 ' H ' ' A' ' 162' ' ' LEU . 2.6 pt? -140.26 150.61 44.29 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.177 -0.952 . . . . 0.0 110.112 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.615 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 4.1 m-85 -115.47 -176.15 2.86 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.476 ' O ' ' HA ' ' A' ' 174' ' ' SER . . . -147.02 104.32 3.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.32 -0.862 . . . . 0.0 109.153 179.466 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.935 HG21 ' CE2' ' A' ' 121' ' ' TYR . 63.8 t -79.82 133.16 30.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 109.909 -179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.53 ' O ' ' CG ' ' A' ' 168' ' ' ARG . 0.7 OUTLIER -130.52 -49.83 1.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.558 -0.714 . . . . 0.0 109.526 179.812 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.489 ' C ' ' CG ' ' A' ' 168' ' ' ARG . . . -42.84 151.83 0.31 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.924 -1.27 . . . . 0.0 109.924 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.53 ' CG ' ' O ' ' A' ' 166' ' ' THR . 2.0 mtp180 -156.67 58.3 0.55 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.354 -1.086 . . . . 0.0 109.389 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -152.17 -100.89 0.2 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.515 ' O ' ' CB ' ' A' ' 171' ' ' SER . 12.5 t70 -77.13 2.79 14.21 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.285 -1.126 . . . . 0.0 109.688 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.515 ' CB ' ' O ' ' A' ' 170' ' ' ASP . 1.0 OUTLIER 163.94 138.07 0.03 OUTLIER Pre-proline 0 N--CA 1.488 1.461 0 O-C-N 121.216 -0.928 . . . . 0.0 109.164 179.965 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.63 102.58 1.61 Allowed 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.5 2.133 . . . . 0.0 110.44 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 165' ' ' VAL . . . -84.66 -171.88 3.87 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.295 -0.878 . . . . 0.0 109.261 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 16.7 p -164.38 135.41 4.32 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.161 -0.962 . . . . 0.0 109.698 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.524 ' HB2' ' CG1' ' A' ' 94' ' ' ILE . 51.9 p -53.91 -176.15 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.322 -0.861 . . . . 0.0 109.303 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.553 ' CB ' HD11 ' A' ' 94' ' ' ILE . 0.1 OUTLIER -66.36 140.92 96.93 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.139 -0.975 . . . . 0.0 108.809 179.621 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.615 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 35.0 Cg_endo -78.18 136.47 14.48 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.335 2.023 . . . . 0.0 111.145 -179.674 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.472 ' O ' HD23 ' A' ' 162' ' ' LEU . 2.1 t -108.12 138.14 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 178.819 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.614 ' HB3' HG23 ' A' ' 161' ' ' THR . 80.7 p -133.91 173.65 11.33 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.065 -1.022 . . . . 0.0 110.75 -178.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.818 ' CG2' HD12 ' A' ' 98' ' ' LEU . 38.2 pt -154.53 169.08 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 17.6 m120 -98.49 178.29 5.07 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.042 -1.036 . . . . 0.0 109.686 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.83 ' CZ ' HD23 ' A' ' 108' ' ' LEU . 25.0 t80 -163.33 172.21 14.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.325 -0.859 . . . . 0.0 109.605 -179.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.468 ' HA ' ' HA ' ' A' ' 157' ' ' ASP . 6.6 tttt -148.85 109.75 4.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 109.264 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.525 ' OG1' ' HA ' ' A' ' 154' ' ' PRO . 1.4 p . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.482 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 1.006 ' O ' HD23 ' A' ' 2' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.346 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 1.006 HD23 ' O ' ' A' ' 1' ' ' GLY . 3.2 mt -142.45 -166.3 2.23 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.22 -1.165 . . . . 0.0 109.246 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.507 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 1.6 m-20 -80.11 135.9 36.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.246 -0.908 . . . . 0.0 109.363 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -95.87 111.42 55.94 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.314 -0.866 . . . . 0.0 109.964 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.763 ' O ' HD22 ' A' ' 84' ' ' LEU . 35.0 Cg_endo -77.05 112.26 3.38 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.471 2.114 . . . . 0.0 109.629 179.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.463 ' O ' ' HB2' ' A' ' 22' ' ' TRP . 1.7 p -110.31 -110.22 0.33 Allowed 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.187 -0.945 . . . . 0.0 109.856 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 9' ' ' ASP . . . 46.5 25.23 1.99 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 108.746 -1.742 . . . . 0.0 108.746 -179.238 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -46.24 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.426 -1.043 . . . . 0.0 109.855 -179.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.518 ' N ' ' O ' ' A' ' 7' ' ' GLY . 7.3 t0 -126.92 101.45 6.58 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.358 -0.839 . . . . 0.0 108.795 179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.972 ' OG ' HG13 ' A' ' 20' ' ' VAL . 38.2 m -87.25 143.58 27.21 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.166 -0.959 . . . . 0.0 110.217 -179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.488 ' O ' ' HB ' ' A' ' 19' ' ' THR . 49.1 p -144.35 -161.34 1.26 Allowed 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 179.198 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.512 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 1.4 m-20 42.73 35.95 0.77 Allowed 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 -178.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.707 HG22 HG23 ' A' ' 91' ' ' VAL . 1.3 mt -77.21 156.48 5.42 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 122.582 1.182 . . . . 0.0 112.638 -176.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.765 ' O ' HG22 ' A' ' 90' ' ' THR . 0.0 OUTLIER -150.57 161.74 41.97 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 106.16 -1.793 . . . . 0.0 106.16 177.226 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.944 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -73.98 -36.21 64.54 Favored 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.324 -1.485 . . . . 0.0 109.704 -178.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.502 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.6 OUTLIER -98.59 22.11 10.35 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.048 -1.032 . . . . 0.0 108.809 179.453 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.587 ' HA ' HD12 ' A' ' 62' ' ' LEU . 13.0 p 167.01 154.96 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.935 ' CE1' HG22 ' A' ' 20' ' ' VAL . 8.9 p90 -166.95 139.49 3.51 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.653 -1.279 . . . . 0.0 109.681 -179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.512 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 28.8 m -79.47 152.72 30.09 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.94 -1.1 . . . . 0.0 110.743 -178.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.972 HG13 ' OG ' ' A' ' 10' ' ' SER . 2.5 t -126.04 135.07 64.96 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.569 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 2.6 m-70 -126.98 170.89 11.82 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.91 -1.119 . . . . 0.0 110.339 -179.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.611 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 27.8 p90 -179.85 149.18 0.34 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 1.0 OUTLIER -76.89 147.78 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 O-C-N 120.966 -1.084 . . . . 0.0 109.929 -179.947 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.531 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -76.47 161.63 73.87 Favored Pre-proline 0 C--N 1.298 -1.66 0 O-C-N 121.835 -0.541 . . . . 0.0 109.57 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.557 ' HG2' ' CG2' ' A' ' 29' ' ' ILE . 35.9 Cg_endo -78.09 153.41 28.49 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.582 2.188 . . . . 0.0 110.478 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.459 ' HD2' ' OD1' ' A' ' 3' ' ' ASP . 17.0 mtt180 -75.35 -0.92 21.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.252 -0.905 . . . . 0.0 109.569 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.641 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -102.17 164.75 15.15 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.199 -0.938 . . . . 0.0 109.579 -179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.641 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.9 Cg_endo -78.38 105.66 2.01 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.729 2.286 . . . . 0.0 110.357 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.557 ' CG2' ' HG2' ' A' ' 25' ' ' PRO . 31.4 pt -100.37 168.61 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.202 -0.936 . . . . 0.0 109.425 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.637 HG23 ' HA ' ' A' ' 76' ' ' ASN . 59.8 p -113.23 -16.67 12.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.259 -0.901 . . . . 0.0 109.338 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 176.82 -165.23 35.25 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 1.098 ' CZ ' ' HB2' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -165.42 120.72 1.31 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.243 -1.151 . . . . 0.0 110.049 -179.818 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.878 ' O ' HD13 ' A' ' 34' ' ' ILE . 22.2 mm -75.33 147.89 7.94 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 O-C-N 121.104 -0.998 . . . . 0.0 108.658 179.141 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.988 ' CG1' HG22 ' A' ' 50' ' ' VAL . 14.7 mm -133.24 92.89 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.078 -1.014 . . . . 0.0 109.857 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.542 ' CG ' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -100.57 157.01 16.98 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.171 -0.955 . . . . 0.0 108.69 179.249 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.606 ' CG ' ' CD2' ' A' ' 59' ' ' LEU . 1.3 p-80 -143.15 143.27 31.74 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.004 -1.06 . . . . 0.0 110.055 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.579 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 37.2 p-80 -163.16 130.57 3.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.377 -0.827 . . . . 0.0 109.716 179.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 1.063 ' HB2' ' CE1' ' A' ' 68' ' ' TYR . . . -75.28 130.84 39.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.258 -0.901 . . . . 0.0 109.256 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.15 -13.61 28.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.166 -0.959 . . . . 0.0 109.359 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.2 m170 -108.24 15.72 23.85 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.478 -0.764 . . . . 0.0 109.28 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.794 ' HB3' ' HB3' ' A' ' 38' ' ' ALA . 52.5 p -92.84 152.83 19.2 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.314 -0.866 . . . . 0.0 109.619 -179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.0 t -115.77 -0.27 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.253 -0.904 . . . . 0.0 109.586 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -100.88 156.01 19.26 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.47 ' HA ' ' NE ' ' A' ' 44' ' ' ARG . 5.8 mmp_? -45.54 147.16 1.54 Allowed Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.207 -1.172 . . . . 0.0 109.463 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.517 ' HB3' ' CB ' ' A' ' 37' ' ' HIS . 36.0 Cg_endo -78.28 137.59 15.22 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.623 2.215 . . . . 0.0 110.293 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.539 ' HB2' ' NE2' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -74.86 169.25 18.3 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.166 -0.959 . . . . 0.0 109.747 -179.846 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 35' ' ' ARG . 29.3 mt-30 -141.06 111.49 6.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.314 -0.866 . . . . 0.0 109.979 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.534 ' O ' ' CD ' ' A' ' 49' ' ' ARG . 20.9 m-20 -110.78 178.59 4.31 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.604 HH11 HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -153.98 155.74 36.13 Favored 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.217 -0.927 . . . . 0.0 109.951 -179.736 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.988 HG22 ' CG1' ' A' ' 34' ' ' ILE . 15.9 m -142.46 160.9 52.56 Favored Pre-proline 0 N--CA 1.488 1.459 0 O-C-N 121.477 -0.764 . . . . 0.0 108.989 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.537 ' HG2' ' CG ' ' A' ' 54' ' ' ARG . 33.7 Cg_endo -75.82 173.94 13.66 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.369 2.046 . . . . 0.0 110.211 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.494 ' HB3' HG13 ' A' ' 29' ' ' ILE . 35.0 Cg_endo -77.16 -17.44 15.04 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.491 2.127 . . . . 0.0 110.568 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.1 t -102.23 17.29 23.76 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.206 -0.934 . . . . 0.0 109.342 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.537 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 0.4 OUTLIER -115.56 104.63 11.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.315 -0.865 . . . . 0.0 109.454 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.509 ' O ' ' HA ' ' A' ' 21' ' ' HIS . 2.7 p-10 -89.38 -6.17 56.83 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.224 -0.923 . . . . 0.0 109.561 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 6.3 p -126.23 142.76 51.4 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.39 -0.819 . . . . 0.0 109.567 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.955 HD12 HG13 ' A' ' 50' ' ' VAL . 5.1 tt -137.11 134.72 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.204 -0.935 . . . . 0.0 109.391 179.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 87.8 m -96.63 125.49 41.14 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.194 -0.941 . . . . 0.0 109.6 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.638 ' HB3' HD11 ' A' ' 62' ' ' LEU . 0.9 OUTLIER -102.99 142.24 34.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.27 -0.894 . . . . 0.0 109.354 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.494 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 0.9 OUTLIER -122.4 156.67 33.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.248 -0.908 . . . . 0.0 109.799 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.981 ' O ' HD23 ' A' ' 62' ' ' LEU . 9.0 m-80 62.27 79.83 0.24 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.364 -0.835 . . . . 0.0 109.905 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.981 HD23 ' O ' ' A' ' 61' ' ' ASN . 6.5 mt -143.24 138.88 29.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -0.881 . . . . 0.0 109.414 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.441 ' C ' ' O ' ' A' ' 62' ' ' LEU . 3.4 m120 -42.59 136.01 2.57 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.236 -0.915 . . . . 0.0 109.429 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.678 ' HB3' HG11 ' A' ' 117' ' ' VAL . 36.6 Cg_endo -79.2 131.42 9.76 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 C-N-CA 122.476 2.118 . . . . 0.0 110.732 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.547 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 63.47 64.15 3.95 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 108.249 -1.941 . . . . 0.0 108.249 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.5 m -156.72 151.72 26.14 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.391 -1.064 . . . . 0.0 110.667 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.547 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 0.0 OUTLIER -85.38 123.92 31.39 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.633 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 1.063 ' CE1' ' HB2' ' A' ' 38' ' ' ALA . 3.1 m-85 -111.25 133.8 53.32 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.073 -1.017 . . . . 0.0 110.605 -178.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.708 HG12 HG23 ' A' ' 85' ' ' ILE . 1.6 t -89.16 107.79 18.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.58 HG13 ' HB3' ' A' ' 36' ' ' HIS . 1.6 t -103.53 129.47 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.205 -0.935 . . . . 0.0 109.533 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.568 ' CB ' HG12 ' A' ' 85' ' ' ILE . 1.3 p -100.07 147.05 26.06 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.142 -0.974 . . . . 0.0 110.35 -179.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.821 HG22 ' CD1' ' A' ' 32' ' ' TYR . 5.1 mm -131.62 94.22 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.664 HD12 ' N ' ' A' ' 73' ' ' ILE . 1.4 mp -90.62 135.86 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.142 -0.974 . . . . 0.0 109.716 -179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.098 ' HB2' ' CZ ' ' A' ' 32' ' ' TYR . . . -96.85 144.22 27.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.372 -0.83 . . . . 0.0 109.522 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.423 ' O ' ' OG1' ' A' ' 30' ' ' THR . 1.7 m -130.99 133.18 63.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.275 -0.891 . . . . 0.0 109.058 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.637 ' HA ' HG23 ' A' ' 30' ' ' THR . 24.9 t30 -116.35 45.1 1.85 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.228 -0.92 . . . . 0.0 109.792 -179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 82.67 -81.55 1.71 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.42 -5.83 16.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.184 -1.186 . . . . 0.0 109.816 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.492 ' HB3' ' HB3' ' A' ' 76' ' ' ASN . 16.2 tp10 -107.34 155.92 19.47 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.242 -0.911 . . . . 0.0 109.247 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.485 ' N ' ' HG3' ' A' ' 79' ' ' GLU . 8.1 mt-10 -129.94 105.61 8.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.214 -0.928 . . . . 0.0 109.473 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.569 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.1 OUTLIER -63.96 -179.87 0.31 Allowed Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.232 -0.917 . . . . 0.0 109.218 179.759 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.569 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.4 Cg_endo -77.52 155.76 31.98 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.358 2.039 . . . . 0.0 110.513 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 82' ' ' PRO . 35.6 Cg_endo -77.83 136.14 14.82 Favored 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.706 2.27 . . . . 0.0 111.099 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.763 HD22 ' O ' ' A' ' 5' ' ' PRO . 15.5 tp -117.71 93.27 4.09 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 179.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.708 HG23 HG12 ' A' ' 69' ' ' VAL . 2.5 mt -96.09 141.36 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 O-C-N 121.118 -0.989 . . . . 0.0 109.572 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.414 ' O ' ' HA ' ' A' ' 69' ' ' VAL . . . -130.43 -177.67 15.01 Favored Glycine 0 N--CA 1.484 1.836 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 179.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.446 ' CG ' HG13 ' A' ' 69' ' ' VAL . 60.7 mt-30 -146.18 101.26 3.49 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.187 -1.184 . . . . 0.0 109.961 -179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.526 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 41.8 mm-40 -98.26 -161.17 0.85 Allowed 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -144.65 130.93 19.62 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.916 -1.115 . . . . 0.0 110.37 -179.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.765 HG22 ' O ' ' A' ' 14' ' ' THR . 0.0 OUTLIER -74.37 139.01 43.79 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.224 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.707 HG23 HG22 ' A' ' 13' ' ' ILE . 12.1 t -41.68 169.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-O 121.557 0.694 . . . . 0.0 110.29 -179.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.572 ' N ' HG12 ' A' ' 91' ' ' VAL . 64.7 p -110.22 168.26 9.58 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.251 -0.906 . . . . 0.0 109.685 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 1.007 ' OD2' HG13 ' A' ' 119' ' ' VAL . 16.2 t70 -84.97 22.37 1.41 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.494 -0.754 . . . . 0.0 110.236 -179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.887 HD11 ' HB2' ' A' ' 176' ' ' LYS . 1.1 mt -42.86 142.39 1.43 Allowed Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.75 -1.219 . . . . 0.0 109.501 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.701 ' CG ' HD11 ' A' ' 162' ' ' LEU . 36.8 Cg_endo -83.1 113.57 2.13 Favored 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.666 2.244 . . . . 0.0 109.744 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.512 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 2.2 ptt180 -106.27 153.41 22.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.055 -1.028 . . . . 0.0 109.851 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.512 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 0.9 OUTLIER 76.98 25.82 0.79 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.324 -0.86 . . . . 0.0 109.853 179.656 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.902 HD22 ' CD2' ' A' ' 162' ' ' LEU . 31.1 tp -64.01 100.46 0.32 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.064 -1.022 . . . . 0.0 109.239 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.426 ' O ' ' HA ' ' A' ' 110' ' ' ILE . 18.4 pt-20 -128.22 170.15 13.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.179 -0.95 . . . . 0.0 109.572 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.614 HG22 ' H ' ' A' ' 101' ' ' ILE . 9.1 p -109.24 172.66 2.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.262 -0.899 . . . . 0.0 109.766 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.736 HD11 ' HB3' ' A' ' 109' ' ' LEU . 0.4 OUTLIER -150.3 -81.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 O-C-N 121.361 -0.837 . . . . 0.0 109.226 179.59 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 1.066 ' HB3' HD13 ' A' ' 109' ' ' LEU . . . -74.89 101.84 4.55 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.528 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 5.2 p -98.98 90.14 4.53 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.312 -0.868 . . . . 0.0 110.479 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.612 ' HG1' ' C ' ' A' ' 107' ' ' SER . 0.3 OUTLIER -76.5 165.71 50.57 Favored Pre-proline 0 C--N 1.306 -1.325 0 O-C-N 121.154 -0.966 . . . . 0.0 108.759 178.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 154' ' ' PRO . 29.9 Cg_endo -69.42 -2.81 10.57 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 122.421 2.081 . . . . 0.0 110.602 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.774 ' C ' HG22 ' A' ' 152' ' ' ILE . 1.0 OUTLIER -150.64 17.49 0.8 Allowed 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.394 -0.817 . . . . 0.0 108.805 179.002 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 1.034 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.5 OUTLIER -169.05 159.33 9.13 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 119.142 -1.023 . . . . 0.0 110.127 179.881 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.034 HD23 ' O ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -143.87 154.69 43.63 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.324 -0.86 . . . . 0.0 109.263 -179.818 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 1.066 HD13 ' HB3' ' A' ' 102' ' ' ALA . 0.4 OUTLIER -105.58 132.97 51.07 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.318 -0.863 . . . . 0.0 108.833 179.32 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.757 HD11 HD13 ' A' ' 124' ' ' ILE . 1.1 pt -115.67 144.69 22.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.084 -1.01 . . . . 0.0 109.96 -179.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.415 ' HA ' ' HA ' ' A' ' 146' ' ' THR . 32.6 t -143.31 126.55 16.57 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.585 ' CZ3' ' HA ' ' A' ' 146' ' ' THR . 3.3 p90 -123.33 171.33 9.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.947 . . . . 0.0 109.835 -179.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 96' ' ' ARG . 6.0 mm-40 -94.81 165.33 17.36 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.388 -0.82 . . . . 0.0 109.338 179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 113' ' ' GLU . 34.6 Cg_endo -78.2 127.36 8.32 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.621 2.214 . . . . 0.0 110.564 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.515 ' HG2' ' OD1' ' A' ' 93' ' ' ASP . 34.6 Cg_endo -76.91 -152.88 0.04 OUTLIER 'Trans proline' 0 C--N 1.313 -1.335 0 C-N-CA 122.608 2.205 . . . . 0.0 110.206 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.579 ' HB1' ' H ' ' A' ' 15' ' ' ALA . . . -69.05 -1.36 7.38 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -0.956 . . . . 0.0 109.817 -179.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.944 ' CG1' ' HB3' ' A' ' 15' ' ' ALA . 1.8 m -150.24 -163.09 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 120.937 -1.102 . . . . 0.0 110.263 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.73 ' O ' HG23 ' A' ' 117' ' ' VAL . 0.0 OUTLIER -97.69 -164.5 1.15 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 107.577 -1.268 . . . . 0.0 107.577 178.065 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 1.013 HG11 ' CE2' ' A' ' 122' ' ' TYR . 1.4 t -141.48 129.3 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.635 -1.29 . . . . 0.0 110.87 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.545 ' O ' ' NE ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -74.86 -49.42 20.53 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 178.467 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.619 ' CE2' HG22 ' A' ' 139' ' ' THR . 1.8 p90 -163.99 173.08 13.01 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 179.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 1.013 ' CE2' HG11 ' A' ' 119' ' ' VAL . 0.2 OUTLIER -135.01 150.37 50.31 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.692 -1.255 . . . . 0.0 110.69 -179.014 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.496 ' HG2' ' CE2' ' A' ' 121' ' ' TYR . 15.6 mtp180 -109.42 92.63 4.13 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 178.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.757 HD13 HD11 ' A' ' 110' ' ' ILE . 52.8 mt -84.2 163.83 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.926 . . . . 0.0 110.421 -178.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.596 ' N ' HG22 ' A' ' 124' ' ' ILE . 23.3 p -145.35 140.85 28.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.505 -0.747 . . . . 0.0 109.586 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.651 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 2.6 m-85 -82.06 134.24 35.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.876 . . . . 0.0 109.227 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.62 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -106.0 124.87 7.98 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 129' ' ' THR . 15.5 mt-10 -105.1 148.7 26.54 Favored 'General case' 0 C--N 1.295 -1.786 0 O-C-N 121.213 -1.169 . . . . 0.0 109.201 179.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.65 HG23 ' N ' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -40.89 -92.98 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.394 -0.816 . . . . 0.0 110.08 179.856 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -139.33 -102.04 0.53 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 46.84 24.68 1.99 Allowed Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 51.77 20.97 1.26 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.211 -1.17 . . . . 0.0 109.394 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.3 148.87 95.84 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.238 -0.914 . . . . 0.0 109.353 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.65 -162.15 0.16 Allowed 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.542 2.162 . . . . 0.0 110.321 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 126' ' ' TYR . 0.7 OUTLIER -120.28 157.64 22.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.204 -0.935 . . . . 0.0 109.369 -179.878 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.532 ' HB2' ' HB2' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -112.6 100.53 8.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.273 -0.892 . . . . 0.0 108.948 179.525 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.559 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 2.1 pt-20 -92.8 154.0 18.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.379 -0.826 . . . . 0.0 110.918 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.612 ' CE1' ' HB ' ' A' ' 124' ' ' ILE . 31.7 p90 -164.74 147.39 8.53 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 178.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.619 HG22 ' CE2' ' A' ' 121' ' ' TYR . 0.8 OUTLIER -73.85 -176.6 2.5 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.011 -1.056 . . . . 0.0 110.553 -178.19 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.704 ' CG2' HD12 ' A' ' 124' ' ' ILE . 71.6 t -146.69 139.07 13.91 Favored Pre-proline 0 N--CA 1.487 1.415 0 O-C-N 121.465 -0.772 . . . . 0.0 109.199 -179.364 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.579 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.8 Cg_endo -76.97 127.88 9.63 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.419 2.079 . . . . 0.0 110.396 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -79.4 51.16 3.9 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.504 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 1.0 OUTLIER -104.65 -3.4 23.78 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.18 -1.188 . . . . 0.0 109.457 179.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.504 ' CG ' ' O ' ' A' ' 143' ' ' SER . 18.2 mttt -165.3 174.66 9.92 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.264 -0.897 . . . . 0.0 109.275 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.443 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 4.7 p -93.15 4.35 54.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.212 -0.93 . . . . 0.0 109.512 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.585 ' HA ' ' CZ3' ' A' ' 112' ' ' TRP . 3.1 p -119.11 155.76 30.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.21 -0.931 . . . . 0.0 109.317 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.57 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -129.61 161.22 31.04 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.226 -0.921 . . . . 0.0 109.411 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.581 ' O ' HD13 ' A' ' 149' ' ' ILE . 12.6 m -107.69 153.63 22.65 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.269 -0.894 . . . . 0.0 109.521 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.651 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 7.5 mm -134.65 119.03 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.352 -0.842 . . . . 0.0 109.304 179.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.531 ' N ' ' OH ' ' A' ' 126' ' ' TYR . 41.8 m-20 -124.72 173.79 8.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.323 -0.86 . . . . 0.0 109.825 -179.751 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 15.2 m120 62.94 33.92 14.57 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.134 -0.979 . . . . 0.0 109.074 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.774 HG22 ' C ' ' A' ' 106' ' ' THR . 7.2 tt -89.32 147.68 5.04 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.519 -0.738 . . . . 0.0 109.739 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.4 ' HB2' ' OH ' ' A' ' 158' ' ' TYR . 25.3 mttt -82.67 113.87 47.98 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.221 -0.924 . . . . 0.0 109.175 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.493 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 35.8 Cg_endo -78.11 146.61 22.9 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.413 2.075 . . . . 0.0 110.606 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.661 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 78.2 65.28 1.89 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.661 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 166.7 128.56 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.222 -1.163 . . . . 0.0 109.772 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.65 ' N ' HG23 ' A' ' 129' ' ' THR . 0.6 OUTLIER -46.34 160.56 0.07 Allowed 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 179.216 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.62 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -141.66 177.75 7.94 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.886 -1.134 . . . . 0.0 110.356 -179.346 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.548 ' CB ' ' HA3' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -146.42 108.15 4.32 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 179.295 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.53 ' HB ' ' CG1' ' A' ' 180' ' ' ILE . 43.3 mm -93.73 112.68 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.735 -1.228 . . . . 0.0 109.867 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.713 HG23 ' HB2' ' A' ' 179' ' ' SER . 7.5 m -123.37 148.79 45.71 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.308 -0.87 . . . . 0.0 108.954 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.902 ' CD2' HD22 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -145.15 156.15 43.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.91 -1.118 . . . . 0.0 110.706 -179.779 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.596 ' CE2' ' HB3' ' A' ' 177' ' ' PRO . 1.8 m-85 -119.76 77.8 1.26 Allowed 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 -179.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 122' ' ' TYR . . . -47.41 150.01 0.99 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.959 -1.088 . . . . 0.0 109.456 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.887 HG22 ' HB3' ' A' ' 174' ' ' SER . 51.6 t -140.54 131.08 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.208 -0.932 . . . . 0.0 109.739 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.657 HG23 ' OD2' ' A' ' 93' ' ' ASP . 0.8 OUTLIER -119.24 -41.02 2.76 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.326 -0.859 . . . . 0.0 109.114 179.692 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.457 ' O ' ' HG2' ' A' ' 168' ' ' ARG . . . -54.26 156.62 6.72 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 167' ' ' GLY . 0.0 OUTLIER -164.59 90.36 0.54 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -1.121 . . . . 0.0 109.375 179.966 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . -165.65 -125.69 0.78 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.694 -1.363 . . . . 0.0 109.694 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -89.54 23.21 2.68 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.233 -1.157 . . . . 0.0 109.515 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 176.77 91.2 0.11 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 109.571 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.89 95.95 1.08 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.623 2.215 . . . . 0.0 110.27 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -92.1 131.09 37.63 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.235 -0.915 . . . . 0.0 109.652 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.887 ' HB3' HG22 ' A' ' 165' ' ' VAL . 1.2 p -99.35 119.07 37.35 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.217 -0.927 . . . . 0.0 109.252 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.538 ' CB ' ' HB2' ' A' ' 92' ' ' SER . 83.9 p -44.2 168.44 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.342 -0.849 . . . . 0.0 109.443 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.887 ' HB2' HD11 ' A' ' 94' ' ' ILE . 0.4 OUTLIER -49.26 143.61 9.29 Favored Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.043 -1.035 . . . . 0.0 108.508 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.596 ' HB3' ' CE2' ' A' ' 163' ' ' TYR . 35.7 Cg_endo -78.44 136.49 14.07 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 C-N-CA 122.407 2.071 . . . . 0.0 111.337 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.2 t -109.56 136.95 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 178.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.713 ' HB2' HG23 ' A' ' 161' ' ' THR . 33.0 t -124.67 160.33 28.77 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.058 -1.026 . . . . 0.0 110.951 -178.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.855 HG23 HD23 ' A' ' 98' ' ' LEU . 39.3 pt -140.95 171.86 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.473 ' OD1' ' N ' ' A' ' 181' ' ' ASN . 1.2 m120 -103.72 166.0 10.69 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.936 -1.102 . . . . 0.0 110.036 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 1.023 ' OH ' HD22 ' A' ' 108' ' ' LEU . 48.3 t80 -154.15 172.47 17.51 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.512 -0.743 . . . . 0.0 109.2 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 16.7 tptm -145.1 118.38 8.97 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.149 -0.969 . . . . 0.0 109.562 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.509 ' OG1' ' N ' ' A' ' 156' ' ' ALA . 8.0 p . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.018 -0.992 . . . . 0.0 109.42 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.34 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.403 HD21 ' ND2' ' A' ' 76' ' ' ASN . 0.9 OUTLIER -104.36 -162.13 0.87 Allowed 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.265 -1.138 . . . . 0.0 109.228 179.863 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.521 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . 2.5 m-20 -76.04 97.44 4.04 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.351 -0.843 . . . . 0.0 109.152 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.442 ' C ' ' O ' ' A' ' 3' ' ' ASP . 0.0 OUTLIER -40.59 101.34 0.24 Allowed Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.597 -0.689 . . . . 0.0 109.888 -179.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.716 ' HG2' ' HB2' ' A' ' 74' ' ' ALA . 34.9 Cg_endo -77.44 71.97 6.19 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.51 2.14 . . . . 0.0 109.733 179.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.875 ' HA ' HD22 ' A' ' 84' ' ' LEU . 16.7 p -91.16 -98.67 0.11 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.269 -0.894 . . . . 0.0 109.937 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.429 ' O ' ' N ' ' A' ' 9' ' ' ASP . . . 48.64 24.72 4.22 Favored Glycine 0 N--CA 1.487 2.049 0 N-CA-C 108.145 -1.982 . . . . 0.0 108.145 -178.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.402 ' N ' ' C ' ' A' ' 6' ' ' THR . 29.7 t80 -55.55 91.79 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.567 -0.961 . . . . 0.0 109.325 -179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 7' ' ' GLY . 7.8 t70 -137.36 111.99 8.76 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.552 ' CB ' ' HG3' ' A' ' 88' ' ' GLN . 0.3 OUTLIER -84.3 134.23 34.52 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.253 -0.904 . . . . 0.0 109.452 -179.573 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.471 ' O ' ' C ' ' A' ' 12' ' ' ASP . 86.8 p -150.33 -160.84 1.23 Allowed 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.304 -0.873 . . . . 0.0 109.064 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.533 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 19.2 m-20 46.17 33.12 1.64 Allowed 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 106.706 -1.59 . . . . 0.0 106.706 -178.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 1.088 HG22 HG23 ' A' ' 91' ' ' VAL . 1.9 mt -86.97 111.02 21.08 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.317 -177.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.497 ' OG1' ' O ' ' A' ' 17' ' ' SER . 0.2 OUTLIER -94.23 -177.04 4.15 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 177.568 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.467 ' O ' ' HA ' ' A' ' 64' ' ' PRO . . . -88.58 -11.07 46.61 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.668 -1.27 . . . . 0.0 109.684 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.433 ' O ' ' HB3' ' A' ' 17' ' ' SER . 0.6 OUTLIER -131.95 22.14 4.55 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.887 -1.133 . . . . 0.0 108.115 178.605 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.529 ' CB ' ' HA ' ' A' ' 60' ' ' THR . 76.0 p 174.19 127.15 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -179.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.78 ' CB ' HG23 ' A' ' 13' ' ' ILE . 2.2 p90 -137.97 147.0 43.84 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.699 -1.251 . . . . 0.0 109.883 -178.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 1.008 ' OG1' HG23 ' A' ' 58' ' ' THR . 60.1 m -111.97 164.62 12.91 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.914 -1.116 . . . . 0.0 110.5 -178.653 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.609 ' N ' HG22 ' A' ' 19' ' ' THR . 1.8 t -127.27 162.88 31.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.514 ' CD2' ' C ' ' A' ' 20' ' ' VAL . 3.5 m-70 -151.77 137.45 17.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.926 -1.108 . . . . 0.0 110.155 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.778 ' CZ2' HG21 ' A' ' 50' ' ' VAL . 48.4 p90 -133.81 156.48 47.96 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -74.38 156.63 6.33 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 O-C-N 120.864 -1.147 . . . . 0.0 109.957 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 25' ' ' PRO . . . -101.64 153.31 37.99 Favored Pre-proline 0 C--N 1.298 -1.668 0 O-C-N 121.841 -0.537 . . . . 0.0 109.731 -179.546 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 1.098 ' CG ' HD13 ' A' ' 29' ' ' ILE . 36.7 Cg_endo -79.65 133.78 10.61 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.623 2.216 . . . . 0.0 110.171 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.1 mtm180 -69.51 -5.74 26.09 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.18 -0.95 . . . . 0.0 109.574 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.914 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -97.25 173.8 3.75 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.246 -0.909 . . . . 0.0 109.384 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.914 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.3 Cg_endo -78.17 107.19 2.28 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.605 2.203 . . . . 0.0 110.484 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 1.098 HD13 ' CG ' ' A' ' 25' ' ' PRO . 18.6 pt -108.66 -171.72 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.247 -0.908 . . . . 0.0 109.411 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.465 ' OG1' ' O ' ' A' ' 75' ' ' VAL . 7.9 p -115.63 -7.1 12.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.256 -0.902 . . . . 0.0 109.568 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 131.24 -178.98 17.4 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.709 ' OH ' HD11 ' A' ' 29' ' ' ILE . 0.8 OUTLIER -126.82 158.02 37.73 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -1.145 . . . . 0.0 109.488 -179.977 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.008 ' C ' HD13 ' A' ' 34' ' ' ILE . 5.9 mt -111.56 136.32 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.241 -0.912 . . . . 0.0 108.898 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.008 HD13 ' C ' ' A' ' 33' ' ' ILE . 1.4 mm -119.08 125.4 74.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 O-C-N 121.109 -0.994 . . . . 0.0 110.283 -179.201 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.528 ' CB ' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -122.6 129.71 52.2 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 178.555 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.603 ' CE1' ' HD2' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -125.09 140.12 53.17 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.833 -1.167 . . . . 0.0 110.542 -178.819 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.584 ' CE1' ' CG1' ' A' ' 69' ' ' VAL . 38.5 p-80 -166.32 122.29 1.25 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.424 -0.797 . . . . 0.0 109.753 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -55.22 -164.25 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.252 -0.905 . . . . 0.0 109.66 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 38' ' ' ALA . 1.4 mp0 -44.44 -74.97 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.189 -0.944 . . . . 0.0 109.615 -179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -165.98 66.44 0.11 Allowed 'General case' 0 C--N 1.294 -1.823 0 O-C-N 121.589 -0.694 . . . . 0.0 109.414 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 85.7 p -74.55 161.6 29.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.41 -0.806 . . . . 0.0 109.568 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.8 p -74.91 -0.71 2.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.316 -0.865 . . . . 0.0 109.691 -179.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.417 ' O ' ' C ' ' A' ' 44' ' ' ARG . . . -90.57 109.94 3.73 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.427 -1.469 . . . . 0.0 109.427 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.417 ' C ' ' O ' ' A' ' 43' ' ' GLY . 13.8 mmm180 -44.04 133.8 4.16 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.238 -1.154 . . . . 0.0 109.403 -179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.558 ' HB3' ' CB ' ' A' ' 37' ' ' HIS . 36.6 Cg_endo -79.11 154.65 25.5 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.502 2.135 . . . . 0.0 110.307 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.603 ' HD2' ' CE1' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -109.57 162.03 14.79 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.0 109.817 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.52 ' CB ' ' HG3' ' A' ' 35' ' ' ARG . 1.6 mt-30 -119.78 99.42 6.63 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.326 -0.859 . . . . 0.0 109.517 -179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -84.66 106.53 16.28 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.269 -0.894 . . . . 0.0 109.072 179.55 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.986 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -84.65 137.7 33.11 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.241 -0.912 . . . . 0.0 109.142 -179.803 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.778 HG21 ' CZ2' ' A' ' 22' ' ' TRP . 21.9 m -114.07 154.75 46.08 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.194 -0.941 . . . . 0.0 109.706 -179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.514 ' HB2' ' HD2' ' A' ' 52' ' ' PRO . 35.2 Cg_endo -77.99 175.3 11.34 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.76 2.307 . . . . 0.0 110.29 179.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.53 ' HA ' ' CE1' ' A' ' 32' ' ' TYR . 34.1 Cg_endo -76.26 -15.87 17.82 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.528 2.152 . . . . 0.0 110.121 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -88.72 11.13 18.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.303 -0.873 . . . . 0.0 109.25 179.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.402 ' CG ' ' HG2' ' A' ' 51' ' ' PRO . 6.2 mmt180 -137.98 134.89 35.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.306 -0.871 . . . . 0.0 109.21 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.5 ' HA ' ' CE2' ' A' ' 22' ' ' TRP . 2.1 p-10 -124.75 18.69 8.66 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.23 -0.919 . . . . 0.0 109.638 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 84.4 p -145.78 138.59 25.84 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.185 -0.947 . . . . 0.0 109.776 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.956 HG21 HG21 ' A' ' 34' ' ' ILE . 1.5 tt -119.1 120.03 62.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.359 -0.838 . . . . 0.0 108.988 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 1.008 HG23 ' OG1' ' A' ' 19' ' ' THR . 0.4 OUTLIER -91.03 133.05 35.62 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.269 -0.894 . . . . 0.0 110.405 -179.115 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.816 ' HB3' HD11 ' A' ' 62' ' ' LEU . 1.5 mt -117.29 140.45 49.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.0 109.112 179.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.529 ' HA ' ' CB ' ' A' ' 17' ' ' SER . 25.1 p -129.05 174.65 9.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.354 -0.841 . . . . 0.0 109.909 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.638 ' O ' HD23 ' A' ' 62' ' ' LEU . 8.9 m-20 51.63 66.43 1.2 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.377 -0.827 . . . . 0.0 109.515 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.816 HD11 ' HB3' ' A' ' 59' ' ' LEU . 9.0 mt -134.41 133.94 41.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.274 -0.891 . . . . 0.0 109.467 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -48.12 134.88 11.95 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.175 -0.953 . . . . 0.0 108.819 179.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 15' ' ' ALA . 36.4 Cg_endo -77.97 128.21 9.03 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.362 2.041 . . . . 0.0 110.681 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 79.37 60.87 2.43 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 -179.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.47 ' O ' ' N ' ' A' ' 90' ' ' THR . 1.5 m -149.59 142.23 24.51 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.366 -1.079 . . . . 0.0 109.7 -179.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.541 ' HA ' ' CB ' ' A' ' 89' ' ' ALA . 3.0 mt-10 -74.59 134.72 42.09 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 120.973 -1.079 . . . . 0.0 108.768 179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.597 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 3.6 m-85 -123.23 98.1 5.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.125 -0.984 . . . . 0.0 109.761 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.584 ' CG1' ' CE1' ' A' ' 37' ' ' HIS . 6.6 t -59.6 133.67 24.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.157 -0.965 . . . . 0.0 108.874 179.575 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.506 ' HA ' ' O ' ' A' ' 35' ' ' ARG . 11.0 t -137.86 137.36 45.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.106 -0.996 . . . . 0.0 109.375 -179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.628 ' HB3' HD13 ' A' ' 85' ' ' ILE . 88.9 p -116.53 134.68 54.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.188 -0.945 . . . . 0.0 110.133 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.898 ' HB ' HD12 ' A' ' 84' ' ' LEU . 21.5 mm -120.21 143.0 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.279 -0.888 . . . . 0.0 109.334 179.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.552 HG22 ' N ' ' A' ' 74' ' ' ALA . 36.9 mm -138.5 162.11 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.148 -0.97 . . . . 0.0 109.704 179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.716 ' HB2' ' HG2' ' A' ' 5' ' ' PRO . . . -134.61 98.23 4.01 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.287 -0.883 . . . . 0.0 109.357 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.465 ' O ' ' OG1' ' A' ' 30' ' ' THR . 2.5 m -96.65 154.69 3.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.231 -0.918 . . . . 0.0 109.399 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.45 ' OD1' ' O ' ' A' ' 28' ' ' PRO . 30.2 t30 -133.63 45.94 2.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.19 -0.944 . . . . 0.0 109.55 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.453 ' N ' HG21 ' A' ' 30' ' ' THR . . . 81.87 -97.2 1.84 Allowed Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -94.14 2.61 55.95 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -1.164 . . . . 0.0 109.534 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.484 ' O ' ' HG2' ' A' ' 80' ' ' GLU . 2.2 mt-10 -109.49 -173.39 2.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.162 -0.961 . . . . 0.0 109.552 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.484 ' HG2' ' O ' ' A' ' 79' ' ' GLU . 0.6 OUTLIER -163.31 100.16 0.94 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.329 -0.857 . . . . 0.0 109.357 -179.92 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.649 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -59.64 -179.7 0.17 Allowed Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.261 -0.899 . . . . 0.0 108.878 179.716 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.578 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.1 Cg_endo -77.16 138.35 17.98 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.2 1.933 . . . . 0.0 110.187 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.533 ' HB3' ' CD1' ' A' ' 73' ' ' ILE . 36.0 Cg_endo -77.9 139.94 17.86 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.572 2.182 . . . . 0.0 110.571 -179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.898 HD12 ' HB ' ' A' ' 72' ' ' ILE . 0.1 OUTLIER -136.1 91.87 2.73 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.318 -0.864 . . . . 0.0 109.565 179.755 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.628 HD13 ' HB3' ' A' ' 71' ' ' SER . 4.1 mt -97.09 159.1 3.11 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 O-C-N 121.373 -0.829 . . . . 0.0 109.341 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.477 ' N ' HG22 ' A' ' 85' ' ' ILE . . . -162.84 159.08 31.46 Favored Glycine 0 N--CA 1.486 1.975 0 N-CA-C 109.021 -1.632 . . . . 0.0 109.021 179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 69' ' ' VAL . 0.0 OUTLIER -112.81 118.36 34.73 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 121.367 -1.078 . . . . 0.0 109.435 -179.981 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.552 ' HG3' ' CB ' ' A' ' 10' ' ' SER . 1.7 mm-40 -109.64 -157.64 0.62 Allowed 'General case' 0 C--N 1.302 -1.471 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.541 ' CB ' ' HA ' ' A' ' 67' ' ' GLU . . . -162.31 148.4 13.04 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.978 -1.076 . . . . 0.0 110.081 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.47 ' N ' ' O ' ' A' ' 66' ' ' THR . 0.0 OUTLIER -74.47 136.97 42.28 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 1.088 HG23 HG22 ' A' ' 13' ' ' ILE . 5.2 t -44.95 168.23 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-O 121.741 0.782 . . . . 0.0 110.902 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.527 ' N ' HG12 ' A' ' 91' ' ' VAL . 3.0 t -105.53 127.45 53.03 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.055 -1.091 . . . . 0.0 108.055 178.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -72.99 -52.95 12.51 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.031 -1.043 . . . . 0.0 109.912 -179.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.841 HD11 ' HB2' ' A' ' 176' ' ' LYS . 3.1 mt -111.28 144.2 29.98 Favored Pre-proline 0 C--N 1.304 -1.372 0 O-C-N 121.169 -0.957 . . . . 0.0 110.34 -178.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.749 ' HD2' HG23 ' A' ' 94' ' ' ILE . 34.2 Cg_endo -76.72 -161.46 0.14 Allowed 'Trans proline' 0 C--N 1.311 -1.441 0 C-N-CA 122.406 2.071 . . . . 0.0 109.293 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.539 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 1.7 ptp180 -163.37 164.77 24.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.912 -1.117 . . . . 0.0 110.064 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.539 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 21.0 t0 79.26 21.2 0.65 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.552 -0.718 . . . . 0.0 110.146 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.867 ' O ' HG21 ' A' ' 180' ' ' ILE . 0.3 OUTLIER -63.77 99.28 0.23 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.9 -1.125 . . . . 0.0 108.928 179.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.69 -174.95 4.93 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.209 -0.932 . . . . 0.0 109.448 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 109' ' ' LEU . 5.0 p -114.93 152.43 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.195 -0.941 . . . . 0.0 110.013 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.475 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 5.2 pt -119.08 -16.11 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.394 -0.816 . . . . 0.0 109.314 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.716 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -140.95 168.79 18.94 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 179.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.472 ' HG ' ' HH ' ' A' ' 182' ' ' TYR . 1.9 t -156.16 102.22 2.12 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.891 -1.131 . . . . 0.0 110.506 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.484 ' HB ' ' HD2' ' A' ' 105' ' ' PRO . 0.3 OUTLIER -90.74 166.92 17.6 Favored Pre-proline 0 C--N 1.302 -1.481 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.798 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.484 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 29.9 Cg_endo -69.41 -1.97 9.1 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.257 1.971 . . . . 0.0 110.579 -179.468 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.746 ' C ' HG22 ' A' ' 152' ' ' ILE . 3.9 p -151.26 17.43 0.74 Allowed 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.331 -0.856 . . . . 0.0 108.985 178.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 1.097 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.6 OUTLIER -170.72 162.42 7.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.991 -1.068 . . . . 0.0 110.343 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.097 HD23 ' O ' ' A' ' 107' ' ' SER . 0.7 OUTLIER -141.84 156.85 45.53 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.464 -0.772 . . . . 0.0 109.099 -179.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.716 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.3 OUTLIER -104.24 121.83 44.12 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -0.945 . . . . 0.0 109.207 179.704 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.8 ' CD1' ' HB3' ' A' ' 147' ' ' ALA . 2.0 pt -103.35 148.23 8.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.256 -0.903 . . . . 0.0 109.934 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.543 ' CB ' HG22 ' A' ' 146' ' ' THR . 84.9 p -146.16 137.46 24.64 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.4 -0.813 . . . . 0.0 109.052 179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.57 ' CE3' ' O ' ' A' ' 145' ' ' SER . 37.1 p90 -158.87 -167.33 2.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.178 -0.951 . . . . 0.0 109.728 -179.728 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' A' ' 95' ' ' PRO . 2.1 mt-10 -124.63 119.07 25.92 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 108.959 179.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.477 ' HD3' ' HB3' ' A' ' 145' ' ' SER . 34.6 Cg_endo -76.8 152.3 32.48 Favored 'Trans proline' 0 C--N 1.311 -1.405 0 C-N-CA 122.309 2.006 . . . . 0.0 110.69 -179.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.489 ' HB2' ' O ' ' A' ' 92' ' ' SER . 35.2 Cg_endo -77.53 -159.86 0.11 Allowed 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.64 2.226 . . . . 0.0 110.413 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.617 ' HB3' HG13 ' A' ' 91' ' ' VAL . . . -120.39 11.27 11.41 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.306 -0.871 . . . . 0.0 109.791 -179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.941 HG13 ' CG1' ' A' ' 91' ' ' VAL . 0.0 OUTLIER -82.16 -179.47 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.006 -1.058 . . . . 0.0 109.381 -179.681 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . 0.522 ' O ' ' CA ' ' A' ' 166' ' ' THR . 24.3 m -70.63 61.0 0.23 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.362 -0.836 . . . . 0.0 110.07 -179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.856 ' CA ' HG22 ' A' ' 166' ' ' THR . 1.5 t -76.96 97.22 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.245 -0.909 . . . . 0.0 109.438 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.522 ' CG ' ' O ' ' A' ' 166' ' ' THR . 0.1 OUTLIER -74.9 -32.26 61.77 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 179.208 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.654 ' OH ' HG21 ' A' ' 165' ' ' VAL . 5.2 p90 -165.85 178.58 6.43 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.612 -0.68 . . . . 0.0 109.364 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.799 ' CZ ' HG11 ' A' ' 119' ' ' VAL . 2.6 m-85 -129.11 137.67 51.36 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 178.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 0.0 OUTLIER -94.91 86.6 4.71 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.226 -0.921 . . . . 0.0 109.548 -179.479 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.975 ' CD1' HG21 ' A' ' 140' ' ' VAL . 77.1 mt -84.19 148.47 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.288 -0.882 . . . . 0.0 109.192 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 2.5 p -131.44 150.59 52.09 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.227 -0.92 . . . . 0.0 110.348 -179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.911 ' O ' HG12 ' A' ' 135' ' ' VAL . 2.9 m-85 -85.33 133.51 34.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.436 -0.79 . . . . 0.0 108.942 179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.592 ' O ' ' CD2' ' A' ' 158' ' ' TYR . . . -105.83 116.57 5.21 Favored Glycine 0 N--CA 1.486 2.033 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -105.46 146.83 29.0 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.227 -1.161 . . . . 0.0 109.316 179.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.591 ' CG2' ' CB ' ' A' ' 157' ' ' ASP . 0.7 OUTLIER -47.18 142.97 3.45 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.178 -0.951 . . . . 0.0 109.777 179.723 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 50.96 77.25 0.14 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . -138.42 -91.63 0.25 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.439 ' C ' ' OG ' ' A' ' 133' ' ' SER . 0.1 OUTLIER 66.5 32.35 7.42 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.259 -1.142 . . . . 0.0 109.339 -179.867 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.566 ' CB ' ' HD3' ' A' ' 134' ' ' PRO . 0.0 OUTLIER 177.57 -57.38 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.327 -0.858 . . . . 0.0 109.633 179.805 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.566 ' HD3' ' CB ' ' A' ' 133' ' ' SER . 35.1 Cg_endo -76.42 82.29 2.29 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 C-N-CA 122.243 1.962 . . . . 0.0 110.3 179.658 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.911 HG12 ' O ' ' A' ' 126' ' ' TYR . 0.0 OUTLIER -115.01 148.11 17.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.396 -0.815 . . . . 0.0 109.123 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.597 ' HB2' ' CD1' ' A' ' 126' ' ' TYR . 39.3 mt-30 -93.4 87.16 5.49 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.12 -0.987 . . . . 0.0 109.134 179.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.528 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 7.2 pt-20 -76.54 130.24 37.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.448 -0.783 . . . . 0.0 111.103 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.599 ' CZ ' ' HB ' ' A' ' 124' ' ' ILE . 38.1 p90 -137.27 143.66 42.31 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 178.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.652 HG22 ' CE1' ' A' ' 121' ' ' TYR . 12.7 p -74.28 165.62 24.86 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.996 -1.065 . . . . 0.0 110.69 -178.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.975 HG21 ' CD1' ' A' ' 124' ' ' ILE . 8.2 t -137.33 139.63 28.34 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.603 -0.686 . . . . 0.0 109.773 -178.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.486 ' HD2' HG13 ' A' ' 140' ' ' VAL . 33.7 Cg_endo -75.64 125.81 9.15 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.303 2.002 . . . . 0.0 110.364 179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -72.61 -1.85 54.21 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 -179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.434 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 4.9 p -75.4 1.02 14.98 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.175 -1.191 . . . . 0.0 109.656 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 143' ' ' SER . 1.8 mmtp -152.39 149.68 28.87 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.152 -0.968 . . . . 0.0 109.67 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.57 ' O ' ' CE3' ' A' ' 112' ' ' TRP . 1.7 m -93.96 -13.17 27.34 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.334 -0.854 . . . . 0.0 109.296 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.543 HG22 ' CB ' ' A' ' 111' ' ' SER . 64.4 p -107.26 130.64 54.72 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.285 -0.884 . . . . 0.0 108.974 179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.8 ' HB3' ' CD1' ' A' ' 110' ' ' ILE . . . -118.49 161.34 20.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.975 . . . . 0.0 109.905 -179.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.456 ' O ' HD13 ' A' ' 149' ' ' ILE . 11.2 t -103.07 155.96 18.02 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.33 -0.856 . . . . 0.0 109.074 179.683 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.634 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 20.2 mm -133.07 113.68 20.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.169 -0.957 . . . . 0.0 109.725 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.547 ' O ' ' CE2' ' A' ' 126' ' ' TYR . 3.3 m120 -120.79 173.34 7.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.384 -0.822 . . . . 0.0 109.705 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.412 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 0.5 OUTLIER 69.12 34.19 3.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.914 . . . . 0.0 109.291 -179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.746 HG22 ' C ' ' A' ' 106' ' ' THR . 4.5 tt -93.89 158.7 2.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.37 -0.831 . . . . 0.0 109.788 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -98.42 115.65 65.71 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.262 -0.899 . . . . 0.0 109.121 179.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.463 ' HA ' ' HB ' ' A' ' 184' ' ' THR . 35.4 Cg_endo -77.42 138.17 17.32 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 C-N-CA 122.391 2.061 . . . . 0.0 110.743 -179.667 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.702 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 86.41 68.06 1.35 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.702 ' HB2' ' O ' ' A' ' 155' ' ' GLY . . . 163.73 130.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -1.155 . . . . 0.0 109.637 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.591 ' CB ' ' CG2' ' A' ' 129' ' ' THR . 1.2 t0 -47.53 162.63 0.06 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.17 -0.956 . . . . 0.0 108.559 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.592 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.3 OUTLIER -142.94 -170.8 3.32 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.918 -1.114 . . . . 0.0 110.234 -179.682 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.514 ' O ' ' HA3' ' A' ' 127' ' ' GLY . 3.2 m -165.41 110.83 0.9 Allowed 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.523 ' HB ' ' CG1' ' A' ' 180' ' ' ILE . 30.1 mm -95.82 120.23 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.995 -1.066 . . . . 0.0 109.843 -179.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.674 HG23 ' CB ' ' A' ' 179' ' ' SER . 2.2 m -124.9 164.31 20.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.241 -0.912 . . . . 0.0 109.145 179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.838 HD23 HD11 ' A' ' 98' ' ' LEU . 1.6 pp -159.53 142.88 14.4 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.933 -1.104 . . . . 0.0 111.135 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.62 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.2 m-85 -113.78 80.25 1.35 Allowed 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.803 -0.814 . . . . 0.0 108.803 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.455 ' HA ' ' HA ' ' A' ' 122' ' ' TYR . . . -43.79 96.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.14 -0.975 . . . . 0.0 109.328 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.654 HG21 ' OH ' ' A' ' 121' ' ' TYR . 58.0 t -83.64 135.15 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.351 -0.843 . . . . 0.0 109.494 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.856 HG22 ' CA ' ' A' ' 119' ' ' VAL . 19.3 p -116.05 -51.49 2.64 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.286 -0.884 . . . . 0.0 109.604 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.49 ' O ' ' HA ' ' A' ' 172' ' ' PRO . . . -69.36 149.08 48.23 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.464 ' HB2' ' HD3' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -159.29 -166.09 1.73 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.181 -1.187 . . . . 0.0 109.411 -179.971 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 65.8 -79.94 0.09 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -132.14 13.51 4.69 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.225 -1.162 . . . . 0.0 109.508 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . 0.471 ' O ' ' HA3' ' A' ' 167' ' ' GLY . 66.6 m -155.2 86.52 3.35 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.223 -0.923 . . . . 0.0 109.368 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.49 ' HA ' ' O ' ' A' ' 167' ' ' GLY . 36.2 Cg_endo -78.74 108.41 2.42 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.726 2.284 . . . . 0.0 110.544 -179.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -114.84 156.42 24.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -0.881 . . . . 0.0 109.387 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.41 ' HB3' ' HA ' ' A' ' 165' ' ' VAL . 0.7 OUTLIER -164.8 119.63 1.37 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.204 -0.935 . . . . 0.0 109.541 -179.902 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 2.8 p -57.14 -167.81 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.257 -0.902 . . . . 0.0 109.171 179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.841 ' HB2' HD11 ' A' ' 94' ' ' ILE . 1.3 mttp -66.71 146.45 99.07 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.149 -0.969 . . . . 0.0 108.808 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.62 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 34.6 Cg_endo -77.32 122.72 6.22 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.455 2.103 . . . . 0.0 111.158 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.83 HG12 HD12 ' A' ' 98' ' ' LEU . 2.2 t -91.41 133.63 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 178.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.674 ' CB ' HG23 ' A' ' 161' ' ' THR . 1.4 p -124.71 151.37 45.11 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.11 -0.994 . . . . 0.0 110.72 -178.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.867 HG21 ' O ' ' A' ' 98' ' ' LEU . 3.1 pt -138.84 152.19 24.26 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.45 162.79 16.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.002 -1.061 . . . . 0.0 109.824 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.977 ' OH ' HD22 ' A' ' 108' ' ' LEU . 74.9 t80 -152.8 167.33 29.41 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.414 -0.804 . . . . 0.0 109.268 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.412 ' N ' ' CG ' ' A' ' 182' ' ' TYR . 5.7 tttp -138.3 118.35 13.44 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.247 -0.908 . . . . 0.0 109.495 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.55 ' CG2' ' CD1' ' A' ' 158' ' ' TYR . 17.0 p . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.46 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . 0.454 ' O ' ' OG ' ' A' ' 81' ' ' SER . 96.4 mt -145.43 138.81 26.46 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.174 -1.192 . . . . 0.0 109.41 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.437 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 2.9 m-20 -74.87 140.11 43.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.262 -0.899 . . . . 0.0 109.545 -179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.534 ' CB ' ' HG2' ' A' ' 82' ' ' PRO . 2.4 t -95.08 149.52 36.36 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.239 -0.913 . . . . 0.0 109.555 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.603 ' HG3' ' CD1' ' A' ' 32' ' ' TYR . 36.4 Cg_endo -78.89 117.72 3.97 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.711 2.274 . . . . 0.0 110.347 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.772 HG22 HD13 ' A' ' 84' ' ' LEU . 1.0 OUTLIER -101.92 -107.78 0.24 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.186 -0.947 . . . . 0.0 109.382 179.843 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 22' ' ' TRP . . . 42.5 27.83 0.54 Allowed Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.131 -1.588 . . . . 0.0 109.131 -179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.442 ' N ' ' O ' ' A' ' 6' ' ' THR . 25.8 t80 -48.36 124.75 8.43 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.431 -1.041 . . . . 0.0 109.849 -179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 21' ' ' HIS . 4.2 t70 -164.96 84.06 0.39 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.405 -0.809 . . . . 0.0 109.019 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.983 ' OG ' HG13 ' A' ' 20' ' ' VAL . 0.4 OUTLIER -84.6 137.84 33.06 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.195 -0.941 . . . . 0.0 109.684 -179.63 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.474 ' O ' ' HB ' ' A' ' 19' ' ' THR . 82.6 p -159.19 -158.67 0.7 Allowed 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.36 -0.837 . . . . 0.0 109.143 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.523 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.5 OUTLIER 44.62 34.75 1.2 Allowed 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 -178.417 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.749 HD11 ' HG2' ' A' ' 88' ' ' GLN . 1.3 mt -72.37 140.48 17.95 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 CA-C-N 114.942 -1.026 . . . . 0.0 111.495 -177.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.974 HG22 ' HA ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -122.93 -175.09 3.08 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 178.611 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.588 ' HB3' ' CG1' ' A' ' 117' ' ' VAL . . . -75.18 -70.97 0.39 Allowed 'General case' 0 C--N 1.3 -1.554 0 O-C-N 120.908 -1.12 . . . . 0.0 109.499 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.473 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 5.8 p-10 -83.74 9.16 12.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.168 -0.957 . . . . 0.0 109.459 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.799 ' HB3' HG22 ' A' ' 60' ' ' THR . 0.1 OUTLIER -157.82 159.33 36.6 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.891 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.995 ' CE1' HG22 ' A' ' 20' ' ' VAL . 5.8 p90 -166.01 140.72 4.59 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.207 -0.933 . . . . 0.0 108.839 179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 9.3 m -79.37 153.8 29.49 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 120.814 -1.179 . . . . 0.0 111.209 -178.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.995 HG22 ' CE1' ' A' ' 18' ' ' PHE . 1.3 t -134.69 115.82 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.452 ' HB2' ' O ' ' A' ' 9' ' ' ASP . 17.2 m-70 -105.46 159.11 16.18 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.044 -1.035 . . . . 0.0 110.132 -179.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.771 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 20.9 p90 -175.09 140.25 0.51 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.366 -0.834 . . . . 0.0 109.209 179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 5' ' ' PRO . 0.9 OUTLIER -74.61 162.32 4.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 O-C-N 121.134 -0.979 . . . . 0.0 109.965 -179.695 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.774 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -93.96 169.59 9.72 Favored Pre-proline 0 C--N 1.3 -1.548 0 O-C-N 121.766 -0.584 . . . . 0.0 109.696 -179.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.774 ' HD2' ' HB1' ' A' ' 24' ' ' ALA . 35.2 Cg_endo -78.12 -159.88 0.11 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.611 2.207 . . . . 0.0 110.346 179.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.82 8.05 4.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 0.0 109.592 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.991 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -110.47 176.98 1.32 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.268 -0.895 . . . . 0.0 109.335 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.991 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 34.8 Cg_endo -77.54 110.67 3.01 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.478 2.119 . . . . 0.0 110.294 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.619 ' CD1' ' CE1' ' A' ' 32' ' ' TYR . 50.2 pt -126.29 -173.01 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.311 -0.868 . . . . 0.0 109.557 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.409 ' O ' ' HD3' ' A' ' 52' ' ' PRO . 32.0 p -125.32 -5.43 7.19 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.337 -0.852 . . . . 0.0 109.483 179.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.498 ' HA2' ' N ' ' A' ' 52' ' ' PRO . . . 149.62 -178.78 26.91 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.642 ' CE2' ' HA ' ' A' ' 52' ' ' PRO . 1.8 m-85 -124.28 145.93 49.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.179 -1.189 . . . . 0.0 109.631 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.061 HG23 ' HD2' ' A' ' 49' ' ' ARG . 0.9 OUTLIER -99.76 130.43 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.329 -0.857 . . . . 0.0 108.727 179.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.846 HD13 ' C ' ' A' ' 33' ' ' ILE . 1.4 mm -109.08 108.76 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 120.935 -1.103 . . . . 0.0 110.08 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.523 ' CB ' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -112.61 108.65 17.79 Favored 'General case' 0 C--N 1.302 -1.484 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 178.752 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.843 ' HB3' HG13 ' A' ' 70' ' ' VAL . 1.7 p-80 -114.62 166.79 11.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.064 -1.022 . . . . 0.0 110.355 -178.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.455 ' O ' ' O ' ' A' ' 38' ' ' ALA . 40.0 p-80 177.73 136.19 0.07 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.594 -0.691 . . . . 0.0 109.282 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' A' ' 68' ' ' TYR . . . -56.31 -163.04 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.218 -0.926 . . . . 0.0 109.372 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -70.5 -92.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.18 -0.95 . . . . 0.0 109.606 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -126.17 29.91 5.73 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.502 -0.749 . . . . 0.0 109.526 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 38.1 p -75.24 -96.99 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.272 -0.893 . . . . 0.0 109.599 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 10.3 t -74.89 153.25 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.256 -0.902 . . . . 0.0 109.474 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.447 ' O ' ' HD3' ' A' ' 45' ' ' PRO . . . -87.86 -63.88 1.38 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.544 -1.423 . . . . 0.0 109.544 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.423 ' C ' ' O ' ' A' ' 43' ' ' GLY . 30.4 mtm180 -43.09 103.27 0.31 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.371 -1.076 . . . . 0.0 109.508 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.447 ' HD3' ' O ' ' A' ' 43' ' ' GLY . 35.1 Cg_endo -77.17 137.2 16.89 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.394 2.063 . . . . 0.0 110.264 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.601 ' HB2' ' CD2' ' A' ' 36' ' ' HIS . 12.7 mmm180 -74.72 141.17 44.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.289 -0.882 . . . . 0.0 109.637 -179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.407 ' HG3' ' C ' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -130.01 90.07 2.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.274 -0.891 . . . . 0.0 109.684 -179.942 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.546 ' O ' ' HB ' ' A' ' 34' ' ' ILE . 9.5 m-20 -99.1 114.3 26.95 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.267 -0.896 . . . . 0.0 108.862 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 1.061 ' HD2' HG23 ' A' ' 33' ' ' ILE . 0.0 OUTLIER -92.11 150.21 21.07 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 120.978 -1.076 . . . . 0.0 109.822 -179.469 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.914 HG12 HD12 ' A' ' 57' ' ' ILE . 10.3 m -133.4 160.1 69.96 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.431 -0.793 . . . . 0.0 109.3 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.501 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 33.6 Cg_endo -76.27 174.35 12.98 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.561 2.174 . . . . 0.0 110.381 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.642 ' HA ' ' CE2' ' A' ' 32' ' ' TYR . 35.1 Cg_endo -77.17 -21.74 11.76 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 C-N-CA 122.672 2.248 . . . . 0.0 110.999 -179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 38.8 t -92.51 -4.51 53.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.074 -1.016 . . . . 0.0 109.716 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.536 ' HD3' ' N ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -97.8 111.42 23.72 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.286 -0.884 . . . . 0.0 109.895 -179.744 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.6 p30 -101.04 -6.43 24.42 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.447 -0.783 . . . . 0.0 109.46 179.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 53.1 p -135.69 129.84 33.34 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.384 -0.822 . . . . 0.0 109.189 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.914 HD12 HG12 ' A' ' 50' ' ' VAL . 6.1 tt -133.33 129.14 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 O-C-N 121.231 -0.918 . . . . 0.0 109.672 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.1 115.39 24.46 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.337 -0.852 . . . . 0.0 109.074 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.988 ' CB ' HD11 ' A' ' 62' ' ' LEU . 1.3 mt -84.74 156.22 21.53 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.14 -0.975 . . . . 0.0 109.642 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.799 HG22 ' HB3' ' A' ' 17' ' ' SER . 15.5 p -145.65 -178.2 5.97 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.404 -0.81 . . . . 0.0 109.33 179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . . . . . . . . . 4.9 m120 55.48 20.04 3.5 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.241 -0.912 . . . . 0.0 109.364 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.988 HD11 ' CB ' ' A' ' 59' ' ' LEU . 3.5 mt -96.15 138.69 33.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.304 -0.872 . . . . 0.0 109.302 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.421 ' C ' ' O ' ' A' ' 62' ' ' LEU . 6.2 t-20 -45.72 126.41 6.56 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.191 -0.943 . . . . 0.0 108.804 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.551 ' CB ' ' HB2' ' A' ' 93' ' ' ASP . 35.8 Cg_endo -77.81 134.67 13.62 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.307 2.004 . . . . 0.0 110.699 -179.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.527 ' N ' ' O ' ' A' ' 91' ' ' VAL . . . 68.16 62.6 4.09 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 108.937 -1.665 . . . . 0.0 108.937 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.0 m -160.67 153.01 20.46 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.264 -1.139 . . . . 0.0 110.134 -179.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 1.2 tt0 -77.09 121.27 23.33 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.541 ' CE2' ' HB3' ' A' ' 62' ' ' LEU . 1.0 OUTLIER -116.71 114.54 24.17 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.085 -1.01 . . . . 0.0 110.019 -179.158 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . . . . . . . . . 15.8 t -79.5 118.44 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.256 -0.902 . . . . 0.0 108.678 179.244 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.843 HG13 ' HB3' ' A' ' 36' ' ' HIS . 1.4 t -100.4 135.77 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.129 -0.982 . . . . 0.0 109.611 -179.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.545 ' HB2' ' CD1' ' A' ' 85' ' ' ILE . 10.8 p -114.72 108.3 16.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.345 -0.847 . . . . 0.0 110.084 -179.509 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 0.849 ' C ' HD12 ' A' ' 73' ' ' ILE . 17.0 mm -87.96 119.17 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.3 -0.875 . . . . 0.0 109.428 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.849 HD12 ' C ' ' A' ' 72' ' ' ILE . 1.6 mp -116.74 158.63 17.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.238 -0.914 . . . . 0.0 109.256 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.624 ' HB3' ' CB ' ' A' ' 81' ' ' SER . . . -119.32 157.43 28.11 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.23 -0.919 . . . . 0.0 109.492 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.457 HG21 HD11 ' A' ' 33' ' ' ILE . 3.9 m -151.95 148.4 14.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 0.0 109.487 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.437 ' HB2' HD13 ' A' ' 2' ' ' LEU . 43.0 t30 -131.33 44.22 2.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.289 -0.882 . . . . 0.0 109.376 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 101.95 -88.13 0.67 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.292 -1.523 . . . . 0.0 109.292 -179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.95 -1.68 11.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.247 -1.149 . . . . 0.0 109.463 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.77 -162.59 0.92 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.27 -0.894 . . . . 0.0 109.394 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -159.15 173.74 15.92 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.198 -0.939 . . . . 0.0 109.797 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.624 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 0.1 OUTLIER -145.05 -176.74 0.58 Allowed Pre-proline 0 N--CA 1.49 1.549 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.596 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 33.1 Cg_endo -77.3 136.54 16.04 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 C-N-CA 122.068 1.845 . . . . 0.0 110.118 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.431 ' HB3' HG13 ' A' ' 73' ' ' ILE . 36.2 Cg_endo -78.43 104.0 1.76 Allowed 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.65 2.234 . . . . 0.0 111.221 -179.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.772 HD13 HG22 ' A' ' 6' ' ' THR . 0.9 OUTLIER -80.99 90.52 5.97 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 179.069 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.545 ' CD1' ' HB2' ' A' ' 71' ' ' SER . 2.7 mt -92.93 159.8 2.74 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.146 -0.971 . . . . 0.0 110.703 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.51 ' N ' HG22 ' A' ' 85' ' ' ILE . . . -154.22 168.34 32.5 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 108.433 -1.867 . . . . 0.0 108.433 179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 -117.27 139.94 50.18 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.129 -1.218 . . . . 0.0 109.915 -179.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.749 ' HG2' HD11 ' A' ' 13' ' ' ILE . 0.0 OUTLIER -139.68 -162.75 1.38 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.371 -0.831 . . . . 0.0 109.029 179.758 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -156.76 129.23 7.55 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.114 -0.991 . . . . 0.0 109.886 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.443 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.0 OUTLIER -78.8 146.26 33.86 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.385 -0.822 . . . . 0.0 108.999 179.693 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.945 HG21 ' HB3' ' A' ' 116' ' ' ALA . 1.4 t -74.06 163.17 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.506 -0.746 . . . . 0.0 110.114 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.497 ' O ' ' HB3' ' A' ' 115' ' ' PRO . 3.0 p -67.48 146.26 54.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.282 -0.886 . . . . 0.0 109.427 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.551 ' HB2' ' CB ' ' A' ' 64' ' ' PRO . 1.6 t70 -97.06 -45.2 6.66 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.324 -0.86 . . . . 0.0 110.012 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.797 HD11 ' CB ' ' A' ' 176' ' ' LYS . 6.4 mt -91.64 142.99 27.31 Favored Pre-proline 0 N--CA 1.488 1.439 0 O-C-N 121.059 -1.026 . . . . 0.0 109.719 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.726 ' HD2' HG23 ' A' ' 94' ' ' ILE . 36.2 Cg_endo -80.23 68.56 8.27 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.292 1.995 . . . . 0.0 108.63 177.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.474 ' O ' ' HB2' ' A' ' 112' ' ' TRP . 24.9 mtt180 -72.51 -163.65 0.13 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 121.665 0.745 . . . . 0.0 110.392 -178.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 111' ' ' SER . 8.4 m-20 64.64 9.48 5.18 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.614 -0.679 . . . . 0.0 109.588 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.884 HD22 ' CD2' ' A' ' 162' ' ' LEU . 25.1 tp -61.71 99.13 0.11 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.138 -0.976 . . . . 0.0 109.439 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -137.76 159.96 40.55 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.256 -0.902 . . . . 0.0 109.673 -179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.405 HG12 ' H ' ' A' ' 100' ' ' VAL . 2.7 p -81.35 139.78 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.362 -0.836 . . . . 0.0 109.716 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.535 ' CG1' ' HB3' ' A' ' 109' ' ' LEU . 41.6 pt -134.62 4.46 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.266 -0.896 . . . . 0.0 109.404 179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.925 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -165.12 88.27 0.45 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.192 -1.04 . . . . 0.0 108.192 179.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.516 ' CB ' ' OH ' ' A' ' 182' ' ' TYR . 0.7 OUTLIER -82.72 96.44 8.16 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.417 -0.802 . . . . 0.0 110.609 -178.712 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.572 HG21 ' OG ' ' A' ' 107' ' ' SER . 0.5 OUTLIER -84.01 162.72 51.22 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.244 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.515 ' O ' HG23 ' A' ' 106' ' ' THR . 29.4 Cg_endo -67.82 -3.21 9.99 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.532 2.155 . . . . 0.0 111.138 -178.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.863 ' C ' HG22 ' A' ' 152' ' ' ILE . 2.3 p -156.6 22.39 0.34 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.431 -0.952 . . . . 0.0 108.431 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.572 ' OG ' HG21 ' A' ' 104' ' ' THR . 18.2 p -172.54 175.91 3.39 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 119.118 -1.033 . . . . 0.0 109.924 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.847 HD12 ' N ' ' A' ' 108' ' ' LEU . 0.0 OUTLIER -153.69 154.48 34.2 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.484 -0.76 . . . . 0.0 109.203 -179.627 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.925 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.2 OUTLIER -103.02 114.55 28.94 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.095 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.976 HD11 ' CD1' ' A' ' 149' ' ' ILE . 0.4 OUTLIER -103.61 131.62 51.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.113 -0.992 . . . . 0.0 109.954 -179.512 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.467 ' O ' ' O ' ' A' ' 97' ' ' ASP . 3.3 m -123.52 132.53 53.94 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 179.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.572 ' CD2' ' O ' ' A' ' 145' ' ' SER . 49.0 p90 -135.99 169.52 17.47 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.935 . . . . 0.0 109.695 -179.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.475 ' O ' ' HD3' ' A' ' 115' ' ' PRO . 0.5 OUTLIER -69.49 119.42 70.57 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 121.286 -0.884 . . . . 0.0 109.181 179.856 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.45 ' HG3' ' OG ' ' A' ' 145' ' ' SER . 35.9 Cg_endo -77.78 111.3 3.09 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 C-N-CA 122.357 2.038 . . . . 0.0 110.333 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.528 ' HB2' HG22 ' A' ' 117' ' ' VAL . 35.9 Cg_endo -78.24 177.47 8.73 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.419 2.08 . . . . 0.0 110.356 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.945 ' HB3' HG21 ' A' ' 91' ' ' VAL . . . -118.88 13.64 13.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.289 -0.882 . . . . 0.0 109.233 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.974 ' HA ' HG22 ' A' ' 14' ' ' THR . 4.9 m -74.75 170.53 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.279 -0.888 . . . . 0.0 109.245 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 46.6 m -69.91 63.33 0.21 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.233 -0.917 . . . . 0.0 109.2 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.892 HG22 HG23 ' A' ' 117' ' ' VAL . 2.0 t -74.9 115.21 15.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.326 -0.859 . . . . 0.0 109.557 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.51 ' N ' ' O ' ' A' ' 165' ' ' VAL . 0.1 OUTLIER -74.78 -52.66 10.88 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 179.457 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 1.118 ' CE1' HG22 ' A' ' 139' ' ' THR . 1.4 p90 -165.35 152.27 10.42 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.57 ' CZ ' HG11 ' A' ' 119' ' ' VAL . 32.2 m-85 -93.51 134.42 35.8 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.998 -1.064 . . . . 0.0 108.85 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 4.3 ttp-105 -101.19 94.83 6.17 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 0.0 109.246 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.631 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 19.6 mt -85.79 141.52 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.299 -0.876 . . . . 0.0 109.96 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 1.1 HG22 ' CG ' ' A' ' 137' ' ' GLU . 5.1 p -113.79 127.44 56.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.372 -0.83 . . . . 0.0 109.507 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 1.162 ' CZ ' HG23 ' A' ' 149' ' ' ILE . 3.4 m-30 -74.95 113.93 12.82 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.618 ' HA2' HG21 ' A' ' 135' ' ' VAL . . . -101.77 119.83 6.63 Favored Glycine 0 N--CA 1.486 1.987 0 C-N-CA 120.214 -0.994 . . . . 0.0 110.852 -179.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 130' ' ' GLY . 2.3 mm-40 -80.19 -175.51 5.09 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 121.269 -1.136 . . . . 0.0 108.529 178.725 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 0.992 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 1.4 p -41.49 -27.94 0.11 Allowed 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.326 -0.859 . . . . 0.0 109.768 -179.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 128' ' ' GLU . . . -104.01 -102.49 2.74 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 70.46 89.77 0.09 OUTLIER Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.426 ' O ' ' CB ' ' A' ' 133' ' ' SER . 0.7 OUTLIER -93.94 -9.79 35.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.166 -1.197 . . . . 0.0 109.67 179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.608 ' CB ' ' HD3' ' A' ' 134' ' ' PRO . 0.6 OUTLIER 169.09 -57.62 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.358 -0.839 . . . . 0.0 109.159 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . 0.608 ' HD3' ' CB ' ' A' ' 133' ' ' SER . 36.5 Cg_endo -78.53 144.88 20.37 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.288 1.992 . . . . 0.0 109.039 178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.857 HG13 ' N ' ' A' ' 136' ' ' GLN . 0.3 OUTLIER -178.48 -161.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 120.719 -1.238 . . . . 0.0 110.836 -179.563 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.857 ' N ' HG13 ' A' ' 135' ' ' VAL . 0.6 OUTLIER -79.11 148.7 32.29 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.525 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 1.1 ' CG ' HG22 ' A' ' 125' ' ' THR . 14.4 mp0 -142.79 157.76 44.3 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 120.902 -1.124 . . . . 0.0 110.985 -178.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.631 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 6.0 p90 -155.51 135.14 12.59 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 1.118 HG22 ' CE1' ' A' ' 121' ' ' TYR . 12.2 p -74.37 165.29 25.43 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.083 -1.011 . . . . 0.0 110.905 -178.105 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.546 HG21 ' CD1' ' A' ' 124' ' ' ILE . 2.8 t -136.07 140.96 34.63 Favored Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.506 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.3 Cg_endo -76.29 146.75 28.53 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 C-N-CA 122.334 2.023 . . . . 0.0 110.142 179.44 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -86.33 37.33 3.14 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.821 -1.311 . . . . 0.0 109.821 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.416 ' O ' ' HG2' ' A' ' 144' ' ' LYS . 89.4 p -105.12 -1.1 25.96 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.111 -1.229 . . . . 0.0 109.624 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.416 ' HG2' ' O ' ' A' ' 143' ' ' SER . 5.7 mttt -151.45 154.5 36.72 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.186 -0.946 . . . . 0.0 109.52 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.572 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 0.4 OUTLIER -91.8 2.24 56.63 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 109.552 179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 110' ' ' ILE . 2.0 p -124.56 151.41 44.78 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.242 -0.911 . . . . 0.0 109.054 179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.535 ' HB3' HG13 ' A' ' 110' ' ' ILE . . . -118.12 178.14 4.54 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.141 -0.975 . . . . 0.0 109.409 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.466 HG22 ' OD1' ' A' ' 150' ' ' ASN . 57.4 m -133.2 97.31 3.95 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.252 -0.905 . . . . 0.0 109.568 -179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 1.162 HG23 ' CZ ' ' A' ' 126' ' ' TYR . 1.0 OUTLIER -79.17 93.11 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.333 -0.855 . . . . 0.0 109.051 179.928 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.539 ' HA ' ' CB ' ' A' ' 107' ' ' SER . 82.9 m-20 -101.29 178.23 4.71 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.935 . . . . 0.0 109.356 179.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . . . . . . . . . 28.7 m120 57.67 55.92 5.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.272 -0.892 . . . . 0.0 109.355 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.863 HG22 ' C ' ' A' ' 106' ' ' THR . 13.8 tt -111.63 164.4 7.59 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 O-C-N 121.268 -0.895 . . . . 0.0 109.699 -179.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.5 tttm -95.03 110.26 49.0 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.134 179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 152' ' ' ILE . 34.9 Cg_endo -76.77 139.66 20.06 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 C-N-CA 122.355 2.036 . . . . 0.0 110.522 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.69 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 95.55 62.49 0.99 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 -179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.992 ' HB1' ' CG2' ' A' ' 129' ' ' THR . . . 164.6 132.85 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.268 -1.136 . . . . 0.0 109.524 -179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.72 ' N ' HG22 ' A' ' 129' ' ' THR . 1.8 t70 -48.19 168.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.613 ' CD2' ' O ' ' A' ' 127' ' ' GLY . 0.5 OUTLIER -146.69 -164.7 2.05 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.837 -1.164 . . . . 0.0 110.275 -179.638 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.526 ' N ' ' O ' ' A' ' 127' ' ' GLY . 9.2 m -174.79 105.21 0.1 Allowed 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.736 HD11 HD22 ' A' ' 108' ' ' LEU . 54.8 mt -97.75 117.2 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.909 -1.119 . . . . 0.0 110.286 -178.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.609 HG23 ' HB2' ' A' ' 179' ' ' SER . 36.9 m -120.46 161.86 20.53 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.28 -0.888 . . . . 0.0 108.723 178.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.884 ' CD2' HD22 ' A' ' 98' ' ' LEU . 0.5 OUTLIER -156.72 148.6 22.8 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 118.742 -1.183 . . . . 0.0 111.441 -179.456 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.648 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.9 m-85 -120.54 161.87 20.57 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 179.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 1.046 ' HB3' ' OG ' ' A' ' 175' ' ' SER . . . -113.68 102.15 9.99 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.938 -1.102 . . . . 0.0 109.016 179.27 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.937 HG13 ' HB2' ' A' ' 172' ' ' PRO . 51.7 t -78.34 148.6 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.383 -0.823 . . . . 0.0 110.218 -179.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.59 HG22 ' HA ' ' A' ' 119' ' ' VAL . 80.7 p -135.1 -59.9 0.78 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.378 -0.826 . . . . 0.0 109.419 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 172' ' ' PRO . . . -53.42 168.42 1.19 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . 0.479 ' CG ' ' HD2' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -131.84 -162.43 1.23 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.245 -1.15 . . . . 0.0 109.418 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 86.72 -106.32 3.11 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.58 -1.408 . . . . 0.0 109.58 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -145.25 13.48 1.42 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.289 -1.124 . . . . 0.0 109.431 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 2.4 m -156.15 73.1 5.09 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.322 -0.861 . . . . 0.0 109.197 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.937 ' HB2' HG13 ' A' ' 165' ' ' VAL . 36.0 Cg_endo -78.3 -171.62 1.27 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.69 2.26 . . . . 0.0 110.61 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 165' ' ' VAL . . . -118.26 -165.58 1.13 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.385 -0.822 . . . . 0.0 109.097 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 164' ' ' ALA . 2.4 p -165.14 106.16 0.79 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.17 -0.956 . . . . 0.0 109.669 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 1.046 ' OG ' ' HB3' ' A' ' 164' ' ' ALA . 0.7 OUTLIER -50.81 169.56 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.204 -0.935 . . . . 0.0 109.29 179.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.797 ' CB ' HD11 ' A' ' 94' ' ' ILE . 0.3 OUTLIER -44.36 123.68 4.47 Favored Pre-proline 0 N--CA 1.488 1.442 0 O-C-N 121.286 -0.884 . . . . 0.0 109.274 179.705 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.648 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 33.7 Cg_endo -77.61 140.45 18.88 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 C-N-CA 122.018 1.812 . . . . 0.0 110.902 179.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -125.37 135.48 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 0.609 ' HB2' HG23 ' A' ' 161' ' ' THR . 30.6 t -122.83 170.76 9.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.164 -0.96 . . . . 0.0 111.332 -178.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.482 HG21 ' O ' ' A' ' 98' ' ' LEU . 7.1 pt -152.21 152.65 10.49 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . 0.439 ' HA ' ' HA ' ' A' ' 159' ' ' THR . 67.0 m-80 -96.22 157.72 15.77 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.946 -1.096 . . . . 0.0 110.028 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.725 ' CZ ' HD23 ' A' ' 108' ' ' LEU . 39.8 t80 -141.1 171.86 13.48 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.384 -0.823 . . . . 0.0 109.448 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . 0.478 ' HA ' ' HA ' ' A' ' 157' ' ' ASP . 3.4 tmtt? -145.05 108.09 4.53 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.183 -0.948 . . . . 0.0 109.532 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.452 ' OG1' ' N ' ' A' ' 155' ' ' GLY . 5.2 p . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 118.0 -1.0 . . . . 0.0 109.443 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -118.5 -162.83 0.91 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -1.145 . . . . 0.0 109.405 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.507 ' HB2' ' HB2' ' A' ' 25' ' ' PRO . 4.8 m-20 -91.25 132.46 36.11 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 109.439 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.524 ' OG ' ' CG ' ' A' ' 82' ' ' PRO . 15.2 m -95.79 150.05 36.86 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.305 -0.872 . . . . 0.0 109.808 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.714 ' O ' HD22 ' A' ' 84' ' ' LEU . 36.2 Cg_endo -79.74 131.05 9.0 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.746 2.297 . . . . 0.0 109.873 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.56 HG23 ' O ' ' A' ' 5' ' ' PRO . 0.8 OUTLIER -157.75 -167.62 2.31 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.053 -1.029 . . . . 0.0 109.591 -179.986 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 6' ' ' THR . . . 46.25 27.06 2.54 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 108.056 -2.017 . . . . 0.0 108.056 -179.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PHE . . . . . 0.624 ' C ' ' CD1' ' A' ' 8' ' ' PHE . 0.0 OUTLIER -70.21 -170.33 0.36 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.74 -0.859 . . . . 0.0 109.57 -179.235 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.437 ' N ' ' CG ' ' A' ' 8' ' ' PHE . 21.3 t70 -165.55 110.19 0.86 Allowed 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.229 179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . 0.664 ' HB3' HG13 ' A' ' 20' ' ' VAL . 4.6 p -84.75 139.6 31.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.196 -0.94 . . . . 0.0 109.355 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.452 ' O ' ' C ' ' A' ' 12' ' ' ASP . 5.1 p -164.74 -157.96 0.38 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.185 -0.947 . . . . 0.0 109.623 -179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.538 ' HB2' ' HB ' ' A' ' 19' ' ' THR . 0.6 OUTLIER 44.3 36.34 1.55 Allowed 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 -178.56 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ILE . . . . . 0.866 HG23 ' CB ' ' A' ' 18' ' ' PHE . 1.6 mt -74.63 145.29 11.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.862 -178.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.83 HG22 ' CA ' ' A' ' 117' ' ' VAL . 0.0 OUTLIER -124.78 172.57 9.21 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 179.012 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.794 ' HB3' HG12 ' A' ' 117' ' ' VAL . . . -67.92 -65.11 0.73 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.704 -1.248 . . . . 0.0 109.419 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.482 ' HA ' ' O ' ' A' ' 62' ' ' LEU . 0.8 OUTLIER -90.5 27.44 1.71 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.06 -1.025 . . . . 0.0 109.323 179.825 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.59 ' O ' ' N ' ' A' ' 14' ' ' THR . 3.5 p -178.02 161.28 1.51 Allowed 'General case' 0 C--N 1.3 -1.564 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 1.041 ' CE1' HD13 ' A' ' 59' ' ' LEU . 17.5 p90 -167.74 147.86 5.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.891 -1.131 . . . . 0.0 109.644 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.538 ' HB ' ' HB2' ' A' ' 12' ' ' ASP . 4.0 m -90.7 158.41 16.91 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.843 -1.16 . . . . 0.0 111.164 -178.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.774 HG11 HG11 ' A' ' 70' ' ' VAL . 0.8 OUTLIER -139.23 104.26 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 179.38 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.412 ' CD2' ' N ' ' A' ' 21' ' ' HIS . 7.9 m-70 -86.23 162.7 18.17 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.153 -0.967 . . . . 0.0 110.261 -179.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' TRP . . . . . 0.787 ' HZ3' HG22 ' A' ' 57' ' ' ILE . 16.3 p90 -175.08 136.4 0.38 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.469 -0.77 . . . . 0.0 109.305 179.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.411 ' CG1' ' N ' ' A' ' 24' ' ' ALA . 1.0 OUTLIER -74.74 161.57 4.79 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 O-C-N 121.091 -1.006 . . . . 0.0 109.693 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.503 ' HB1' ' HD2' ' A' ' 25' ' ' PRO . . . -96.74 160.96 28.13 Favored Pre-proline 0 C--N 1.298 -1.664 0 O-C-N 121.745 -0.597 . . . . 0.0 109.703 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.507 ' HB2' ' HB2' ' A' ' 3' ' ' ASP . 36.1 Cg_endo -78.44 163.57 27.04 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.647 2.231 . . . . 0.0 110.326 179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.49 28.76 1.89 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.218 -0.926 . . . . 0.0 109.427 179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.554 ' HB1' ' HD2' ' A' ' 28' ' ' PRO . . . -118.92 161.32 36.88 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.27 -0.894 . . . . 0.0 109.456 179.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.554 ' HD2' ' HB1' ' A' ' 27' ' ' ALA . 35.5 Cg_endo -78.18 89.9 1.31 Allowed 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.612 2.208 . . . . 0.0 110.39 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.676 HD12 ' CD2' ' A' ' 32' ' ' TYR . 20.3 pt -97.45 171.59 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 109.506 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.499 HG23 ' HA ' ' A' ' 76' ' ' ASN . 64.1 p -100.57 -26.65 13.76 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.269 -0.894 . . . . 0.0 109.433 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -178.08 -152.11 9.94 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 1.067 ' CZ ' ' HB2' ' A' ' 74' ' ' ALA . 0.3 OUTLIER -165.12 126.26 2.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.211 -1.17 . . . . 0.0 109.647 -179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.999 ' C ' HD13 ' A' ' 34' ' ' ILE . 6.1 mt -94.78 138.92 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.203 -0.936 . . . . 0.0 109.288 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.05 HG21 HG21 ' A' ' 57' ' ' ILE . 1.5 mm -119.85 117.91 55.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.298 -0.876 . . . . 0.0 109.077 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ARG . . . . . 0.534 ' CG ' ' OG ' ' A' ' 71' ' ' SER . 3.1 ptp180 -121.94 140.5 52.37 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 120.881 -1.137 . . . . 0.0 108.698 179.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 1.064 ' CG ' HD21 ' A' ' 59' ' ' LEU . 28.5 m-70 -137.43 167.21 22.07 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.055 -1.028 . . . . 0.0 110.496 -179.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' HIS . . . . . 0.479 ' CE1' ' HB ' ' A' ' 69' ' ' VAL . 45.9 p-80 -173.37 149.46 1.73 Allowed 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.827 ' HB3' ' OG ' ' A' ' 41' ' ' SER . . . -56.15 -163.65 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.194 -0.941 . . . . 0.0 109.564 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.459 ' OE2' ' OE2' ' A' ' 67' ' ' GLU . 5.3 mm-40 -69.78 -90.88 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.955 . . . . 0.0 109.718 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -74.41 -1.0 19.15 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.51 -0.744 . . . . 0.0 109.798 -179.661 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.827 ' OG ' ' HB3' ' A' ' 38' ' ' ALA . 25.6 p -76.94 88.45 3.49 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.124 -0.985 . . . . 0.0 109.39 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.435 HG22 ' O ' ' A' ' 42' ' ' VAL . 8.2 p -120.5 -0.65 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.208 -0.932 . . . . 0.0 109.591 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -50.66 -92.38 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -120.11 82.38 29.66 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.254 -1.145 . . . . 0.0 109.434 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.83 -169.63 0.79 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.672 2.248 . . . . 0.0 110.141 179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.792 HH11 HD23 ' A' ' 59' ' ' LEU . 0.0 OUTLIER -124.3 154.31 40.45 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.114 -0.991 . . . . 0.0 109.557 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLN . . . . . 0.523 ' HB3' ' NE ' ' A' ' 49' ' ' ARG . 1.0 OUTLIER -126.66 109.52 12.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.896 . . . . 0.0 110.174 -179.574 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.863 ' CB ' HD11 ' A' ' 57' ' ' ILE . 64.9 m-20 -92.68 111.54 23.18 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.42 -0.8 . . . . 0.0 108.928 179.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ARG . . . . . 0.817 ' HD2' HG23 ' A' ' 33' ' ' ILE . 9.6 mmt85 -90.58 137.82 32.05 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.16 -0.963 . . . . 0.0 109.339 -179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.78 HG13 HG12 ' A' ' 34' ' ' ILE . 5.5 m -126.66 160.19 59.82 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.296 -0.878 . . . . 0.0 109.432 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.5 ' HD2' ' HB ' ' A' ' 50' ' ' VAL . 34.9 Cg_endo -77.25 174.72 12.33 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.555 2.17 . . . . 0.0 110.343 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 51' ' ' PRO . 34.8 Cg_endo -76.88 -15.4 16.75 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.513 2.142 . . . . 0.0 110.356 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.5 m -93.87 13.13 23.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.263 -0.898 . . . . 0.0 109.451 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.436 ' O ' ' CZ2' ' A' ' 22' ' ' TRP . 0.1 OUTLIER -123.93 121.36 35.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.227 -0.921 . . . . 0.0 109.499 -179.854 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.498 ' O ' ' CE3' ' A' ' 22' ' ' TRP . 3.6 p30 -107.25 -0.86 22.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.256 -0.903 . . . . 0.0 109.523 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 25.7 p -132.55 129.76 39.46 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.205 -0.934 . . . . 0.0 109.648 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 1.05 HG21 HG21 ' A' ' 34' ' ' ILE . 2.3 tt -125.63 141.27 45.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.309 -0.869 . . . . 0.0 109.126 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.532 ' HA ' ' HA ' ' A' ' 19' ' ' THR . 19.4 m -104.5 127.34 52.19 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.158 -0.964 . . . . 0.0 109.966 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.064 HD21 ' CG ' ' A' ' 36' ' ' HIS . 5.0 mp -84.39 160.73 20.57 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.341 -0.85 . . . . 0.0 109.674 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.504 ' HA ' ' HB3' ' A' ' 17' ' ' SER . 0.8 OUTLIER -152.9 169.22 23.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.619 -0.676 . . . . 0.0 109.553 179.818 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASN . . . . . 0.463 ' O ' HD23 ' A' ' 62' ' ' LEU . 3.6 m120 60.07 48.28 8.7 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.282 -0.886 . . . . 0.0 109.39 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 1.008 HD11 ' HB3' ' A' ' 59' ' ' LEU . 2.0 mt -127.7 157.19 40.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.239 -0.913 . . . . 0.0 109.292 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.499 ' N ' ' OH ' ' A' ' 68' ' ' TYR . 1.4 m-20 -63.1 132.59 95.13 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.119 -0.988 . . . . 0.0 108.693 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.727 ' CB ' ' HB1' ' A' ' 15' ' ' ALA . 36.3 Cg_endo -77.49 125.4 7.62 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.288 1.992 . . . . 0.0 110.638 -179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 90' ' ' THR . . . 77.94 61.67 2.49 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 108.662 -1.775 . . . . 0.0 108.662 -179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.638 HG22 ' CE1' ' A' ' 68' ' ' TYR . 1.0 OUTLIER -154.66 145.12 22.15 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.255 -1.144 . . . . 0.0 110.155 -179.164 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 89' ' ' ALA . 23.4 tt0 -74.87 129.57 37.91 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.638 ' CE1' HG22 ' A' ' 66' ' ' THR . 27.9 m-85 -125.42 164.56 20.17 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.997 -1.065 . . . . 0.0 110.251 -179.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 70' ' ' VAL . 53.9 t -110.28 164.49 6.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.807 HG22 ' ND1' ' A' ' 36' ' ' HIS . 4.6 t -149.67 144.07 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.832 -1.167 . . . . 0.0 110.168 -179.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.586 ' CB ' HG12 ' A' ' 85' ' ' ILE . 1.3 p -142.09 118.76 11.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.2 -0.938 . . . . 0.0 109.897 179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . 1.039 HD13 HG23 ' A' ' 34' ' ' ILE . 4.5 mm -91.38 131.85 37.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.3 -0.875 . . . . 0.0 109.493 179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.583 ' O ' ' CD1' ' A' ' 32' ' ' TYR . 5.4 mt -116.91 150.75 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.258 -0.901 . . . . 0.0 109.201 179.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.067 ' HB2' ' CZ ' ' A' ' 32' ' ' TYR . . . -123.21 147.09 47.26 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.361 -0.837 . . . . 0.0 109.642 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.21 132.71 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 109.384 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASN . . . . . 0.506 ' HB3' ' HB2' ' A' ' 79' ' ' GLU . 0.1 OUTLIER -121.08 53.37 1.14 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.244 -0.91 . . . . 0.0 109.422 179.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 80.95 -69.85 3.17 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 17.8 tpp85 -126.08 -0.58 7.15 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.218 -1.166 . . . . 0.0 109.647 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.525 ' O ' ' CG ' ' A' ' 80' ' ' GLU . 6.7 mm-40 -106.71 178.11 4.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.232 -0.917 . . . . 0.0 109.399 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.525 ' CG ' ' O ' ' A' ' 79' ' ' GLU . 56.1 mt-10 -160.81 105.52 1.39 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.218 -0.926 . . . . 0.0 109.659 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.562 ' CB ' ' HD2' ' A' ' 82' ' ' PRO . 0.9 OUTLIER -60.15 179.57 0.21 Allowed Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.28 -0.887 . . . . 0.0 109.103 179.71 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.562 ' HD2' ' CB ' ' A' ' 81' ' ' SER . 34.3 Cg_endo -77.43 149.25 27.3 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.35 2.033 . . . . 0.0 110.238 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.509 ' HA ' ' O ' ' A' ' 72' ' ' ILE . 35.8 Cg_endo -77.96 106.24 2.14 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.65 2.233 . . . . 0.0 111.175 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.714 HD22 ' O ' ' A' ' 5' ' ' PRO . 12.3 tp -78.91 119.91 22.76 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . 0.586 HG12 ' CB ' ' A' ' 71' ' ' SER . 0.5 OUTLIER -106.88 163.95 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.008 -1.058 . . . . 0.0 110.292 -179.365 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.554 ' N ' ' CG2' ' A' ' 85' ' ' ILE . . . -156.42 164.31 32.44 Favored Glycine 0 N--CA 1.483 1.817 0 N-CA-C 108.147 -1.981 . . . . 0.0 108.147 179.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -117.93 141.66 48.19 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.124 -1.221 . . . . 0.0 110.034 -179.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.573 ' CG ' HD11 ' A' ' 13' ' ' ILE . 2.1 mm-40 -165.27 137.6 4.29 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.644 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.56 ' HA ' ' HA ' ' A' ' 67' ' ' GLU . . . -103.26 148.87 25.29 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.129 -0.982 . . . . 0.0 110.102 -179.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.471 ' O ' ' HA2' ' A' ' 65' ' ' GLY . 0.7 OUTLIER -74.75 139.83 43.66 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 179.55 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.956 HG21 ' HB3' ' A' ' 116' ' ' ALA . 2.3 t -64.77 176.6 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 CA-C-O 121.486 0.66 . . . . 0.0 110.571 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.645 ' H ' HG12 ' A' ' 91' ' ' VAL . 75.4 m -81.0 139.67 35.64 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . 0.545 ' HA ' ' CG1' ' A' ' 117' ' ' VAL . 49.3 t0 -74.78 -45.73 41.73 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.262 -0.899 . . . . 0.0 110.723 -179.258 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.831 HG23 ' HD2' ' A' ' 95' ' ' PRO . 1.4 mt -86.41 144.12 37.52 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 120.931 -1.106 . . . . 0.0 109.917 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . 0.831 ' HD2' HG23 ' A' ' 94' ' ' ILE . 35.9 Cg_endo -78.87 -159.32 0.1 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.735 2.29 . . . . 0.0 109.947 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.526 ' O ' ' CB ' ' A' ' 97' ' ' ASP . 0.0 OUTLIER -174.28 156.12 2.51 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.194 -0.941 . . . . 0.0 109.635 179.817 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 96' ' ' ARG . 1.4 t0 78.38 25.5 0.58 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.396 -0.815 . . . . 0.0 109.928 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.897 HD22 ' CD2' ' A' ' 162' ' ' LEU . 27.9 tp -67.46 101.39 0.97 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.062 -1.023 . . . . 0.0 109.114 179.635 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -138.26 -171.92 3.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.196 -0.94 . . . . 0.0 109.642 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.5 p -107.14 144.24 16.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.227 -0.921 . . . . 0.0 109.837 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.923 HD11 HD22 ' A' ' 109' ' ' LEU . 22.8 pt -126.75 -4.32 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.364 -0.835 . . . . 0.0 109.373 179.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.978 ' HB3' ' HB2' ' A' ' 109' ' ' LEU . . . -152.38 91.38 1.58 Allowed 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.505 ' HB2' ' OH ' ' A' ' 182' ' ' TYR . 4.9 p -85.31 85.97 7.41 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.526 -0.733 . . . . 0.0 110.298 -178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' THR . . . . . 0.547 ' OG1' ' N ' ' A' ' 107' ' ' SER . 0.6 OUTLIER -74.42 163.29 69.33 Favored Pre-proline 0 C--N 1.306 -1.307 0 O-C-N 121.045 -1.034 . . . . 0.0 108.462 179.215 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 104' ' ' THR . 29.7 Cg_endo -68.47 -3.1 10.36 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.437 2.091 . . . . 0.0 110.775 -179.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.922 ' C ' HG22 ' A' ' 152' ' ' ILE . 21.7 p -153.68 20.1 0.53 Allowed 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . 0.547 ' N ' ' OG1' ' A' ' 104' ' ' THR . 6.3 p -170.84 165.58 7.83 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.999 -1.08 . . . . 0.0 110.281 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 1.021 HD13 HD11 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -139.42 153.36 47.58 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -179.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.978 ' HB2' ' HB3' ' A' ' 102' ' ' ALA . 0.3 OUTLIER -105.53 98.43 8.13 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.319 -0.863 . . . . 0.0 108.904 179.296 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.763 HD11 ' HB3' ' A' ' 147' ' ' ALA . 1.3 pt -74.62 134.56 29.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.168 -0.958 . . . . 0.0 109.612 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.406 ' HA ' HG22 ' A' ' 146' ' ' THR . 12.8 t -134.05 111.15 10.13 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.554 -0.716 . . . . 0.0 109.237 179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' TRP . . . . . 0.576 ' CD2' ' O ' ' A' ' 145' ' ' SER . 37.4 p90 -130.03 137.96 50.52 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.331 -0.855 . . . . 0.0 109.158 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.475 ' O ' ' HD3' ' A' ' 115' ' ' PRO . 2.4 mt-10 -44.65 131.73 4.97 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.187 -0.946 . . . . 0.0 108.944 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' PRO . . . . . 0.5 ' HB3' ' CB ' ' A' ' 145' ' ' SER . 35.4 Cg_endo -77.85 111.37 3.1 Favored 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.362 2.041 . . . . 0.0 110.364 -179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 113' ' ' GLU . 36.6 Cg_endo -78.65 152.16 25.67 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 C-N-CA 122.308 2.005 . . . . 0.0 109.707 179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ALA . . . . . 0.956 ' HB3' HG21 ' A' ' 91' ' ' VAL . . . -90.43 92.88 9.07 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.143 -0.973 . . . . 0.0 109.222 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.83 ' CA ' HG22 ' A' ' 14' ' ' THR . 0.0 OUTLIER -140.42 -179.91 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 109.831 179.687 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' SER . . . . . . . . . . . . . 55.3 m -104.4 44.02 1.06 Allowed 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.831 ' HA ' HG22 ' A' ' 166' ' ' THR . 2.2 t -74.41 124.58 32.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.522 -0.736 . . . . 0.0 109.548 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.423 ' NE ' ' O ' ' A' ' 166' ' ' THR . 0.0 OUTLIER -74.86 -31.63 61.68 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 179.269 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.51 ' HB2' ' O ' ' A' ' 140' ' ' VAL . 3.6 p90 -165.77 162.17 18.41 Favored 'General case' 0 C--N 1.304 -1.381 0 C-N-CA 119.942 -0.703 . . . . 0.0 109.352 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' TYR . . . . . 0.553 ' CD1' ' N ' ' A' ' 122' ' ' TYR . 3.6 m-85 -111.46 126.83 55.37 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 178.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.485 ' O ' ' HA ' ' A' ' 162' ' ' LEU . 15.1 ttp180 -84.9 91.6 8.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.139 -0.976 . . . . 0.0 109.398 -179.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ILE . . . . . 0.788 HD12 ' CZ ' ' A' ' 138' ' ' PHE . 19.2 mt -84.45 138.77 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.889 . . . . 0.0 109.59 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.509 ' HA ' ' HA ' ' A' ' 137' ' ' GLU . 25.9 p -112.7 129.63 56.34 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.411 -0.805 . . . . 0.0 109.889 -179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' TYR . . . . . 0.647 ' CZ ' ' CG2' ' A' ' 149' ' ' ILE . 2.2 m-85 -75.36 131.75 40.46 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.449 -0.782 . . . . 0.0 109.091 179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLY . . . . . 0.601 ' O ' ' CG ' ' A' ' 158' ' ' TYR . . . -101.47 107.03 3.15 Favored Glycine 0 N--CA 1.487 2.055 0 N-CA-C 109.949 -1.261 . . . . 0.0 109.949 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.491 ' O ' ' C ' ' A' ' 129' ' ' THR . 3.9 mt-10 -107.21 141.14 38.98 Favored 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.115 -1.227 . . . . 0.0 108.932 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' THR . . . . . 1.079 ' CG2' ' HB1' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -32.55 -53.76 0.33 Allowed 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.344 0.592 . . . . 0.0 110.09 -179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.464 ' N ' ' OG1' ' A' ' 129' ' ' THR . . . 111.87 102.24 2.62 Favored Glycine 0 N--CA 1.488 2.112 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLY . . . . . . . . . . . . . . . 172.67 -28.22 0.1 OUTLIER Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.452 ' O ' ' HB3' ' A' ' 133' ' ' SER . 2.6 p30 -121.99 -2.61 9.18 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.112 -1.228 . . . . 0.0 109.804 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.452 ' HB3' ' O ' ' A' ' 132' ' ' ASN . 1.1 p 175.84 160.65 0.43 Allowed Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.166 -0.959 . . . . 0.0 109.611 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.42 -175.74 2.89 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.614 2.209 . . . . 0.0 110.318 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.442 ' H ' HG22 ' A' ' 135' ' ' VAL . 3.5 m -68.56 169.19 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 O-C-N 121.238 -0.914 . . . . 0.0 109.563 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' GLN . . . . . 0.566 ' CB ' ' HB2' ' A' ' 126' ' ' TYR . 0.1 OUTLIER -122.42 105.44 10.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.28 -0.888 . . . . 0.0 109.084 179.645 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 125' ' ' THR . 1.9 tm-20 -88.57 123.22 32.85 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.236 -0.915 . . . . 0.0 110.39 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.788 ' CZ ' HD12 ' A' ' 124' ' ' ILE . 38.7 p90 -125.42 140.62 52.63 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 179.003 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.479 HG22 ' CE1' ' A' ' 121' ' ' TYR . 8.5 p -74.44 162.8 28.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.106 -0.996 . . . . 0.0 110.342 -178.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.748 HG21 ' CD1' ' A' ' 124' ' ' ILE . 2.4 t -131.44 142.37 45.13 Favored Pre-proline 0 C--N 1.304 -1.403 0 O-C-N 121.602 -0.686 . . . . 0.0 109.625 -178.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PRO . . . . . 0.493 ' HD2' HG13 ' A' ' 140' ' ' VAL . 34.9 Cg_endo -77.48 140.54 19.23 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.408 2.072 . . . . 0.0 109.935 179.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -87.3 24.88 8.68 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.906 -1.277 . . . . 0.0 109.906 -179.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.51 ' O ' ' CG ' ' A' ' 144' ' ' LYS . 2.1 p -105.42 32.22 4.42 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.147 -1.207 . . . . 0.0 109.664 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.51 ' CG ' ' O ' ' A' ' 143' ' ' SER . 1.7 mttt -177.83 156.63 1.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.095 -1.003 . . . . 0.0 109.773 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.576 ' O ' ' CD2' ' A' ' 112' ' ' TRP . 1.1 p -95.17 -14.52 24.06 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.884 . . . . 0.0 109.357 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 110' ' ' ILE . 6.5 p -118.92 137.88 53.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.271 -0.893 . . . . 0.0 109.118 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.763 ' HB3' HD11 ' A' ' 110' ' ' ILE . . . -118.99 164.22 15.79 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.143 -0.973 . . . . 0.0 109.696 -179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 14.8 t -95.15 156.48 16.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.246 -0.909 . . . . 0.0 109.144 179.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.647 ' CG2' ' CZ ' ' A' ' 126' ' ' TYR . 9.7 mm -134.96 68.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.202 -0.936 . . . . 0.0 109.577 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.534 ' O ' ' CB ' ' A' ' 151' ' ' ASN . 1.4 m-80 -83.44 166.39 18.39 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.46 -0.775 . . . . 0.0 109.496 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ASN . . . . . 0.534 ' CB ' ' O ' ' A' ' 150' ' ' ASN . 2.0 t30 79.02 31.6 0.3 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.352 -0.843 . . . . 0.0 109.794 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.922 HG22 ' C ' ' A' ' 106' ' ' THR . 2.7 tt -94.04 159.96 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.169 -0.957 . . . . 0.0 109.47 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 50.8 mmtt -103.94 120.77 50.14 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.169 -0.957 . . . . 0.0 109.301 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.14 147.45 23.53 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 C-N-CA 122.424 2.083 . . . . 0.0 110.507 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 156' ' ' ALA . . . 72.52 61.59 3.55 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 1.079 ' HB1' ' CG2' ' A' ' 129' ' ' THR . . . 177.56 129.17 0.05 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.29 -1.124 . . . . 0.0 109.582 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.564 ' N ' HG22 ' A' ' 129' ' ' THR . 4.4 t0 -46.05 160.69 0.06 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.129 -0.982 . . . . 0.0 108.455 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TYR . . . . . 0.601 ' CG ' ' O ' ' A' ' 127' ' ' GLY . 0.2 OUTLIER -148.39 178.46 8.57 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.736 -1.228 . . . . 0.0 110.242 -179.574 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' THR . . . . . 0.557 ' HB ' ' HA3' ' A' ' 127' ' ' GLY . 6.1 m -161.73 108.92 1.39 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.38 -0.825 . . . . 0.0 109.209 179.498 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 1.021 HD11 HD13 ' A' ' 108' ' ' LEU . 15.4 mt -98.85 133.21 42.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.608 -1.307 . . . . 0.0 109.824 -179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 1.007 HG23 ' CB ' ' A' ' 179' ' ' SER . 1.6 m -141.39 174.18 10.79 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.312 -0.867 . . . . 0.0 109.339 179.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.897 ' CD2' HD22 ' A' ' 98' ' ' LEU . 0.7 OUTLIER -163.99 148.63 10.27 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.063 -1.023 . . . . 0.0 110.997 179.956 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' TYR . . . . . 0.617 ' CD2' ' HB3' ' A' ' 177' ' ' PRO . 2.6 m-85 -125.32 81.73 2.0 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.593 ' HB1' HG11 ' A' ' 119' ' ' VAL . . . -45.18 99.06 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.952 -1.093 . . . . 0.0 109.15 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.605 HG23 ' O ' ' A' ' 163' ' ' TYR . 70.7 t -90.93 135.45 26.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.264 -0.898 . . . . 0.0 109.917 -179.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . 0.831 HG22 ' HA ' ' A' ' 119' ' ' VAL . 45.3 p -115.3 -62.91 1.53 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.418 -0.801 . . . . 0.0 109.405 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 172' ' ' PRO . . . -81.86 135.09 13.82 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.46 -1.456 . . . . 0.0 109.46 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.1 mtp180 -137.19 125.44 23.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.273 -1.134 . . . . 0.0 109.461 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 144.44 -122.75 1.84 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -82.38 8.59 10.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.229 -1.16 . . . . 0.0 109.54 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' SER . . . . . . . . . . . . . 3.8 m -159.51 69.71 3.24 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.238 -0.914 . . . . 0.0 109.436 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.487 ' HA ' ' O ' ' A' ' 167' ' ' GLY . 35.5 Cg_endo -78.08 94.23 1.07 Allowed 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.616 2.211 . . . . 0.0 110.405 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -107.67 143.4 36.21 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.227 -0.921 . . . . 0.0 109.542 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.11 133.66 26.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.237 -0.914 . . . . 0.0 109.371 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.492 ' HB2' ' CG1' ' A' ' 94' ' ' ILE . 96.9 p -53.82 161.33 1.17 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.213 -0.929 . . . . 0.0 109.351 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LYS . . . . . 0.548 ' N ' HD11 ' A' ' 94' ' ' ILE . 3.4 mttt -46.25 142.95 3.94 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.174 -0.954 . . . . 0.0 108.588 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.617 ' HB3' ' CD2' ' A' ' 163' ' ' TYR . 35.0 Cg_endo -77.88 141.52 19.2 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 122.345 2.03 . . . . 0.0 111.397 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.2 t -114.99 134.68 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' SER . . . . . 1.007 ' CB ' HG23 ' A' ' 161' ' ' THR . 1.1 p -133.29 162.25 32.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.109 -0.994 . . . . 0.0 111.02 -178.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.886 HG21 ' O ' ' A' ' 98' ' ' LEU . 13.5 pt -142.26 152.13 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -93.33 152.1 19.36 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.987 -1.071 . . . . 0.0 109.853 -179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.667 ' CZ ' HD22 ' A' ' 108' ' ' LEU . 53.6 t80 -146.53 130.03 16.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.399 -0.813 . . . . 0.0 109.468 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -106.34 119.34 39.01 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.241 -0.912 . . . . 0.0 109.444 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' THR . . . . . 0.488 ' OG1' ' N ' ' A' ' 156' ' ' ALA . 1.5 p . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.484 -179.958 . . . . . . . . 1 1 . 1 stop_ save_